PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Correia, IL; Franco, IS; de Sa-Nogueira, I				Correia, Isabel Lopes; Franco, Irina Saraiva; de Sa-Nogueira, Isabel			Towards Novel Amino Acid-Base Contacts in Gene Regulatory Proteins: AraR - A Case Study	PLOS ONE			English	Article							L-ARABINOSE METABOLISM; BACILLUS-SUBTILIS; TRANSCRIPTIONAL REGULATION; EFFECTOR-BINDING; DNA INTERACTIONS; INDIRECT READOUT; RECOGNITION; INOSINE; IDENTIFICATION; DIAMINOPURINE	AraR is a transcription factor involved in the regulation of carbon catabolism in Bacillus subtilis. This regulator belongs to the vast GntR family of helix-turn-helix (HTH) bacterial metabolite-responsive transcription factors. In this study, AraR-DNA specific interactions were analysed by an in vitro missing-contact probing and validated using an in vivo model. We show that amino acid E30 of AraR, a highly conserved residue in GntR regulators, is indirectly responsible for the specificity of amino acid-base contacts, and that by mutating this residue it will be possible to achieve new specificities towards DNA contacts. The results highlight the importance in DNA recognition and binding of highly conserved residues across certain families of transcription factors that are located in the DNA-binding domain but not predicted to specifically contact bases on the DNA. These new findings not only contribute to a more detailed comprehension of AraR-operator interactions, but may also be useful for the establishment of a framework of rules governing protein-DNA recognition.	[Correia, Isabel Lopes; de Sa-Nogueira, Isabel] Fac Ciencias & Tecnol FCT UNL, Ctr Recursos Microbiol CREM, Dept Ciencias Vida, Caparica, Portugal; [Correia, Isabel Lopes; Franco, Irina Saraiva] Inst Tecnol Quim & Biol ITQB UNL, Oeiras, Portugal		de Sa-Nogueira, I (corresponding author), Fac Ciencias & Tecnol FCT UNL, Ctr Recursos Microbiol CREM, Dept Ciencias Vida, Caparica, Portugal.	isn@fct.unl.pt	Franco, Irina S/I-7247-2013; de Sá-Nogueira, Isabel/B-9139-2011; de Sá-Nogueira, Isabel/AAC-4189-2020	Franco, Irina S/0000-0002-7243-3185; de Sá-Nogueira, Isabel/0000-0001-6665-7994; de Sá-Nogueira, Isabel/0000-0001-6665-7994	Fundacao para a Ciencia e a Tecnologia [PPCDT/BIA-MIC/61140/2004, PTDC/AGR-AAM/102345/2008]; Centro de Recursos Microbiologicos [PEst-OE/ BIA/ UI0457/2011];  [SFRH/BD/29469/2006]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Centro de Recursos Microbiologicos; 	This work was supported by the Fundacao para a Ciencia e a Tecnologia [grant numbers PPCDT/BIA-MIC/61140/2004 and PTDC/AGR-AAM/102345/2008 to I.S.N.; PEst-OE/ BIA/ UI0457/2011 to Centro de Recursos Microbiologicos; fellowship SFRH/BD/29469/2006 to I.L.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLY C, 1995, EMBO J, V14, P2121, DOI 10.1002/j.1460-2075.1995.tb07204.x; BAILLY C, 1995, J MOL BIOL, V253, P1, DOI 10.1006/jmbi.1995.0530; BRUNELLE A, 1989, J MOL BIOL, V209, P607, DOI 10.1016/0022-2836(89)90598-6; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; EBRIGHT RH, 1991, METHOD ENZYMOL, V208, P620; Franco IS, 2007, NUCLEIC ACIDS RES, V35, P4755, DOI 10.1093/nar/gkm509; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; Hilchey SP, 1997, J BIOL CHEM, V272, P1646, DOI 10.1074/jbc.272.3.1646; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Jain D, 2013, NUCLEIC ACIDS RES, V41, P639, DOI 10.1093/nar/gks962; Lindemose S, 2008, NUCLEIC ACIDS RES, V36, P4797, DOI 10.1093/nar/gkn452; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Martin AM, 1999, NAT STRUCT BIOL, V6, P269; Miller J.H., 1972, EXPT MOL GENETICS; Mollegaard NE, 1997, NUCLEIC ACIDS RES, V25, P3497, DOI 10.1093/nar/25.17.3497; Mota LJ, 2001, J BACTERIOL, V183, P4190, DOI 10.1128/JB.183.14.4190-4201.2001; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PASCAL M, 1971, BIOCHIMIE, V53, P1059, DOI 10.1016/S0300-9084(71)80193-1; Prochazkova K, 2012, ACTA CRYSTALLOGR D, V68, P176, DOI 10.1107/S090744491105414X; Raposo MP, 2004, J BACTERIOL, V186, P1287, DOI 10.1128/JB.186.5.1287-1296.2004; Sambrook J., 2002, MOL CLONING LAB MANU; SaNogueira I, 1997, J BACTERIOL, V179, P7705, DOI 10.1128/jb.179.24.7705-7711.1997; SaNogueira I, 1997, MICROBIOL-SGM, V143, P957, DOI 10.1099/00221287-143-3-957; SaNogueira I, 1997, J BACTERIOL, V179, P1598, DOI 10.1128/jb.179.5.1598-1608.1997; SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200	37	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111802	10.1371/journal.pone.0111802	http://dx.doi.org/10.1371/journal.pone.0111802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364981	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100124
J	Occelli, F; Deram, A; Genin, M; Noel, C; Cuny, D; Glowacki, F				Occelli, Florent; Deram, Annabelle; Genin, Michael; Noel, Christian; Cuny, Damien; Glowacki, Francois		Nephronor Network	Mapping End-Stage Renal Disease (ESRD): Spatial Variations on Small Area Level in Northern France, and Association with Deprivation	PLOS ONE			English	Article							REPLACEMENT THERAPY; SOCIOECONOMIC-STATUS; GEOGRAPHICAL VARIATION; RACIAL-DIFFERENCES; KIDNEY-DISEASE; UNITED-STATES; PATTERNS; INEQUALITIES; PREVALENCE; EXPOSURE	Background: Strong geographic variations in the incidence of end-stage renal disease (ESRD) are observed in developed countries. The reasons for these variations are unknown. They may reflect regional inequalities in the population's sociodemographic characteristics, related diseases, or medical practice patterns. In France, at the district level, the highest incidence rates have been found in the Nord-Pas-de-Calais region. This area, with a high population density and homogeneous healthcare provision, represents a geographic situation which is quite suitable for the study, over small areas, of spatial disparities in the incidence of ESRD, together with their correlation with a deprivation index and other risk factors. Methods: The Renal Epidemiology and Information Network is a national registry, which lists all ESRD patients in France. All cases included in the Nord-Pas-de-Calais registry between 2005 and 2011 were extracted. Adjusted and smoothed standardized incidence ratio (SIR) was calculated for each of the 170 cantons, thanks to a hierarchical Bayesian model. The correlation between ESRD incidence and deprivation was assessed using the quintiles of Townsend index. Relative risk (RR) and credible intervals (CI) were estimated for each quintile. Results: Significant spatial disparities in ESRD incidence were found within the Nord-Pas-de-Calais region. The sex- and age-adjusted, smoothed SIRs varied from 0.66 to 1.64. Although no correlation is found with diabetic or vascular nephropathy, the smoothed SIRs are correlated with the Townsend index (RR: 1.18, 95% CI [1.00-1.34] for Q2; 1.28, 95% CI [1.11-1.47] for Q3; 1.30, 95% CI [1.14-1.51] for Q4; 1.44, 95% CI [1.32-1.74] for Q5). Conclusion: For the first time at this aggregation level in France, this study reveals significant geographic differences in ESRD incidence. Unlike the time of renal replacement care, deprivation is certainly a determinant in this phenomenon. This association is probably independent of the patients' financial ability to gain access to healthcare.	[Occelli, Florent; Deram, Annabelle; Cuny, Damien; Glowacki, Francois] Univ Lille Nord France, EA 4483, Fac Pharm Lille, Lille, France; [Deram, Annabelle] Fac Ingn & Management Sante ILIS, Loos, France; [Genin, Michael] Univ Lille Nord France, EA 2694, Fac Med Pole Rech, Lille, France; [Noel, Christian; Glowacki, Francois] CHRU Lille, Hop Huriez, Serv Nephrol, F-59037 Lille, France; [Noel, Christian; Glowacki, Francois; Nephronor Network] CHRU Lille, Hop Huriez, Reseau Nephronor, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Occelli, F (corresponding author), Univ Lille Nord France, EA 4483, Fac Pharm Lille, Lille, France.	florent.occelli@univ-lille2.fr	Genin, Michael/O-3639-2019; Occelli, Florent Angelo/M-6642-2016; Genin, Michael/P-5423-2014	Genin, Michael/0000-0002-9098-7528; Occelli, Florent Angelo/0000-0001-7478-7000; Genin, Michael/0000-0002-9098-7528; Frimat, Marie/0000-0002-7461-8298; Glowacki, Francois/0000-0001-5443-9172; Hazzan, Marc/0000-0002-9863-8840; DERAM, Annabelle/0000-0002-8993-6475	Agence de Biomedecine, Renal Epidemiology and Information Network; Conseil Regional Nord, Pas de Calais, DRESTIC; Universite Lille 2 Droit et Sante [ED446]	Agence de Biomedecine, Renal Epidemiology and Information Network; Conseil Regional Nord, Pas de Calais, DRESTIC(Region Hauts-de-France); Universite Lille 2 Droit et Sante	This work was supported by Agence de Biomedecine, Renal Epidemiology and Information Network (www.soc-nephrologie.org/REIN/); Conseil Regional Nord, Pas de Calais, DRESTIC (www.nordpasdecalais.fr/jcms/c_5001/accueil); and Universite Lille 2 Droit et Sante, ED446 (http://edbsl.univ-lille2.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, DIS MAPPING WINBUGS; Bell EK, 2012, AM J HYPERTENS, V25, P789, DOI 10.1038/ajh.2012.48; BERNARDINELLI L, 1995, STAT MED, V14, P2411, DOI 10.1002/sim.4780142111; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Boyle PJ, 1996, QJM-MON J ASSOC PHYS, V89, P151; Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Couchoud C, 2012, NEPHROL DIAL TRANSPL, V27, P2312, DOI 10.1093/ndt/gfr639; Couchoud C, 2010, NEPHROL DIAL TRANSPL, V25, P1576, DOI 10.1093/ndt/gfp675; Counil E, 2008, AM J KIDNEY DIS, V51, P463, DOI 10.1053/j.ajkd.2007.10.032; Declercq C, 2004, INT SOC MORT REG NOR; Fan ZJ, 2007, HEALTH PLACE, V13, P179, DOI 10.1016/j.healthplace.2005.12.002; FOXMAN B, 1991, J AM SOC NEPHROL, V2, P1144; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Gilg J, 2013, 16 UK REN REG, P9; Grace BS, 2012, NEPHROL DIAL TRANSPL, V27, P4173, DOI 10.1093/ndt/gfs361; Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031; Hellstrom L, 2001, AM J KIDNEY DIS, V38, P1001, DOI 10.1053/ajkd.2001.28589; Hodgson S, 2007, AM J EPIDEMIOL, V165, P72, DOI 10.1093/aje/kwj345; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P2624, DOI 10.1093/ndt/gfq110; Huang YL, 2014, AM J KIDNEY DIS, V63, P76, DOI 10.1053/j.ajkd.2013.07.024; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lora CM, 2011, AM J KIDNEY DIS, V58, P282, DOI 10.1053/j.ajkd.2011.05.004; Maheswaran R, 2003, J EPIDEMIOL COMMUN H, V57, P523, DOI 10.1136/jech.57.7.523; MOULTON LH, 1992, AM J KIDNEY DIS, V20, P55, DOI 10.1016/S0272-6386(12)80317-9; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; Muntner P, 2007, ENVIRON RES, V104, P396, DOI 10.1016/j.envres.2007.04.001; National Kidney andUrologic Diseases Information National, 2012, NIH PUBLICATION; Renal Epidemiology and Information Network (REIN), 2013, GUID REMPL DIAD INF; Reseau Epidemiologie et Information en Nephrologie (REIN), 2012, 2012 REIN; Roderick P, 1999, J Health Serv Res Policy, V4, P139; ROSANSKY SJ, 1990, AM J NEPHROL, V10, P198, DOI 10.1159/000168081; Spiegelhalter DJ, 2003, WINBUGS V 1 4 US MAN; Tanner RM, 2013, AM J KIDNEY DIS, V61, P395, DOI 10.1053/j.ajkd.2012.10.018; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; U.S. Renal Data System (USRDS), 2013, ANN DAT REP ATL CHR, P215; US Renal Data System (USRDS), 2013, ANN DAT REP ATL CHR, P333; Usami T, 2000, JAMA-J AM MED ASSOC, V284, P2622, DOI 10.1001/jama.284.20.2622; van de Luijtgaarden MWM, 2012, AM J KIDNEY DIS, V60, P940, DOI 10.1053/j.ajkd.2012.07.015; Volkova N, 2008, J AM SOC NEPHROL, V19, P356, DOI 10.1681/ASN.2006080934; Wakai K, 2004, NEPHROL DIAL TRANSPL, V19, P2044, DOI 10.1093/ndt/gfh317; Wakefield J, 2008, ANNU REV PUBL HEALTH, V29, P75, DOI 10.1146/annurev.publhealth.29.020907.090821; Ward MM, 2008, AM J KIDNEY DIS, V51, P563, DOI 10.1053/j.ajkd.2007.11.023; Wimmer F, 2003, NEPHROL DIAL TRANSPL, V18, P1562, DOI 10.1093/ndt/gfg184; Yan GF, 2013, CLIN J AM SOC NEPHRO, V8, P610, DOI 10.2215/CJN.07780812; YOUNG EW, 1994, KIDNEY INT, V45, P907, DOI 10.1038/ki.1994.120; Zoccali C, 2010, CLIN KIDNEY J, V3, P213, DOI 10.1093/ndtplus/sfp127	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110132	10.1371/journal.pone.0110132	http://dx.doi.org/10.1371/journal.pone.0110132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365039	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100016
J	Gollhofer, J; Timofeev, R; Lan, P; Schmidt, W; Buckhout, TJ				Gollhofer, Julia; Timofeev, Roman; Lan, Ping; Schmidt, Wolfgang; Buckhout, Thomas J.			Vacuolar-Iron-Transporter1-Like Proteins Mediate Iron Homeostasis in Arabidopsis	PLOS ONE			English	Article							VACUOLAR IRON; DEFICIENCY RESPONSE; METAL HOMEOSTASIS; TRANSPORTER; PLANTS; ROOTS; THALIANA; MOBILIZATION; EXPRESSION; FERRITINS	Iron deficiency is a nutritional problem in plants and reduces crop productivity, quality and yield. With the goal of improving the iron (Fe) storage properties of plants, we have investigated the function of three Arabidopsis proteins with homology to Vacuolar Iron Transporter1 (AtVIT1). Heterologous expression of Vacuolar Iron Transporter-Like1 (AtVTL1; At1g21140), AtVTL2 (At1g76800) or AtVTL5 (At3g25190) in the yeast vacuolar Fe transport mutant, Delta ccc1, restored growth in the presence of 4 mM Fe. Isolated vacuoles from yeast expressing either of the VTL genes in the Delta ccc1 background had a three-to four-fold increase in Fe concentration compared to vacuoles isolated from the untransformed mutant. Transiently expressed GFP-tagged AtVTL1 was localized exclusively and AtVTL2 was localized primarily to the vacuolar membrane of onion epidermis cells. Seedling root growth of the Arabidopsis nramp3/nramp4 and vit1-1 mutants was decreased compared to the wild type when seedlings were grown under Fe deficiency. When expressed under the 35S promoter in the nramp3/nramp4 or vit1-1 backgrounds, AtVTL1, AtVTL2 or AtVTL5 restored root growth in both mutants. The seed Fe concentration in the nramp3/nramp4 mutant overexpressing AtVTL1, AtVTL2 or AtVTL5 was between 50 and 60% higher than in non-transformed double mutants or wild-type plants. We conclude that the VTL proteins catalyze Fe transport into vacuoles and thus contribute to the regulation of Fe homeostasis in planta.	[Gollhofer, Julia; Timofeev, Roman; Buckhout, Thomas J.] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Lan, Ping] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Schmidt, Wolfgang] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Schmidt, Wolfgang] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Schmidt, Wolfgang] Natl Taiwan Univ, Coll Life Sci, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan	Humboldt University of Berlin; Chinese Academy of Sciences; Institute of Soil Science, CAS; Academia Sinica - Taiwan; National Chung Hsing University; National Taiwan University	Buckhout, TJ (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	thomas.buckhout@rz.hu-berlin.de	Schmidt, Wolfgang/A-3234-2014; Lan, Ping/E-4791-2013; Schmidt, Wolfgang/AAA-2807-2022; lan, ping/T-1708-2017	Lan, Ping/0000-0002-8433-3149; Schmidt, Wolfgang/0000-0002-7850-6832; lan, ping/0000-0002-8433-3149	Deutsche Forschungsgemeinschaft [BU 713:4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft to TJB (BU 713:4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Blair D., 1961, TALANTA LONDON, V7, P163; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cohen CK, 1998, PLANT PHYSIOL, V116, P1063, DOI 10.1104/pp.116.3.1063; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Eckhardt U, 1998, J EXP BOT, V49, P1219, DOI 10.1093/jexbot/49.324.1219; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Fourcroy P, 2014, NEW PHYTOL, V201, P155, DOI 10.1111/nph.12471; Gollhofer J, 2011, PLANT PHYSIOL BIOCH, V49, P557, DOI 10.1016/j.plaphy.2011.02.011; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kobayashi T, 2014, PLANT SCI, V224, P36, DOI 10.1016/j.plantsci.2014.04.002; Kobayashi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3792; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Momonoi K, 2009, PLANT J, V59, P437, DOI 10.1111/j.1365-313X.2009.03879.x; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Rampey RA, 2006, GENETICS, V174, P1841, DOI 10.1534/genetics.106.061044; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rodriguez-Celma J, 2013, PLANT PHYSIOL, V162, P1473, DOI 10.1104/pp.113.220426; Rose MD., 1990, METHODS YEAST GENETI; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Schaaf G, 2006, J BIOL CHEM, V281, P25532, DOI 10.1074/jbc.M601062200; Schmid NB, 2014, PLANT PHYSIOL, V164, P160, DOI 10.1104/pp.113.228544; Schmidt W, 2011, PLANT PHYSIOL BIOCH, V49, P462, DOI 10.1016/j.plaphy.2010.12.001; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Zhang Y, 2012, PLANT J, V72, P400, DOI 10.1111/j.1365-313X.2012.05088.x	38	55	56	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110468	10.1371/journal.pone.0110468	http://dx.doi.org/10.1371/journal.pone.0110468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360591	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700036
J	Hong, MZ; Zhang, RM; Chen, GL; Huang, WQ; Min, F; Chen, T; Xu, JC; Pan, JS				Hong, Mei-Zhu; Zhang, Ru-Mian; Chen, Guo-Liang; Huang, Wen-Qi; Min, Feng; Chen, Tian; Xu, Jin-Chao; Pan, Jin-Shui			Liver Stiffness Measurement-Based Scoring System for Significant Inflammation Related to Chronic Hepatitis B	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; TRANSIENT ELASTOGRAPHY; SERUM MARKERS; FIBROSIS; DIAGNOSIS; CIRRHOSIS; MODEL	Objectives: Liver biopsy is indispensable because liver stiffness measurement alone cannot provide information on intrahepatic inflammation. However, the presence of fibrosis highly correlates with inflammation. We constructed a noninvasive model to determine significant inflammation in chronic hepatitis B patients by using liver stiffness measurement and serum markers. Methods: The training set included chronic hepatitis B patients (n = 327), and the validation set included 106 patients; liver biopsies were performed, liver histology was scored, and serum markers were investigated. All patients underwent liver stiffness measurement. Results: An inflammation activity scoring system for significant inflammation was constructed. In the training set, the area under the curve, sensitivity, and specificity of the fibrosis-based activity score were 0.964, 91.9%, and 90.8% in the HBeAg(+) patients and 0.978, 85.0%, and 94.0% in the HBeAg(-) patients, respectively. In the validation set, the area under the curve, sensitivity, and specificity of the fibrosis-based activity score were 0.971, 90.5%, and 92.5% in the HBeAg(+) patients and 0.977, 95.2%, and 95.8% in the HBeAg(-) patients. The liver stiffness measurement-based activity score was comparable to that of the fibrosis-based activity score in both HBeAg(+) and HBeAg(-) patients for recognizing significant inflammation (G >= 3). Conclusions: Significant inflammation can be accurately predicted by this novel method. The liver stiffness measurement-based scoring system can be used without the aid of computers and provides a noninvasive alternative for the prediction of chronic hepatitis B-related significant inflammation.	[Hong, Mei-Zhu; Huang, Wen-Qi; Min, Feng; Chen, Tian; Xu, Jin-Chao] Xiamen Univ, Hosp PLA 174, Chenggong Hosp, Dept Infect Dis, Xiamen, Fujian, Peoples R China; [Zhang, Ru-Mian; Chen, Guo-Liang] Xiamen Hosp Tradit Chinese Med, Hepatol Unit, Xiamen, Fujian, Peoples R China; [Zhang, Ru-Mian; Chen, Guo-Liang] Xiamen Hosp Tradit Chinese Med, Dept Infect Dis, Xiamen, Fujian, Peoples R China; [Pan, Jin-Shui] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Pan, JS (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China.	j.s.pan76@gmail.com	huang, wen/GXW-0661-2022; Pan, Jin-Shui/AAL-3125-2020	Pan, Jin-Shui/0000-0002-9586-7760	National Science Foundation for Young Scholars, China [81100285]; Natural Science Foundation of Fujian Province, China [2010J05086]; Science Fund for Distinguished Young Scholars of Xiamen, China [3502Z20105011]; Key Foundation of Health System for Young Talents of Fujian [2013-ZQN-ZD-33]	National Science Foundation for Young Scholars, China; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Science Fund for Distinguished Young Scholars of Xiamen, China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Foundation of Health System for Young Talents of Fujian	The study was funded by National Science Foundation for Young Scholars, China (No. 81100285) http://www.nsfc.gov.cn/Portal0/default152.htm; Natural Science Foundation of Fujian Province, China (No. 2010J05086) http://www.fjkjt.gov.cn/; Science Fund for Distinguished Young Scholars of Xiamen, China (No. 3502Z20105011) http://www.xminfo.net.cn/; Key Foundation of Health System for Young Talents of Fujian (No. 2013-ZQN-ZD-33) http://www.fjjsw.gov.cn/templates/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruni R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-394; Cardoso AC, 2011, GUT, V60, P759, DOI 10.1136/gut.2010.220863; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Chen YP, 2008, J GASTROEN HEPATOL, V23, P1228, DOI 10.1111/j.1440-1746.2008.05421.x; Cheong JY, 2011, LIVER INT, V31, P1352, DOI 10.1111/j.1478-3231.2011.02570.x; Cho HJ, 2012, CLIN BIOCHEM, V45, P1564, DOI 10.1016/j.clinbiochem.2012.07.107; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mao QG, 2010, WORLD J GASTROENTERO, V16, P3465, DOI 10.3748/wjg.v16.i27.3465; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Montazeri G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-32; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Poynard Thierry, 2004, Comp Hepatol, V3, P8, DOI 10.1186/1476-5926-3-8; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020	24	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111641	10.1371/journal.pone.0111641	http://dx.doi.org/10.1371/journal.pone.0111641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360742	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700137
J	Tijs, C; van Dieen, JH; Baan, GC; Maas, H				Tijs, Chris; van Dieen, Jaap H.; Baan, Guus C.; Maas, Huub			Three-Dimensional Ankle Moments and Nonlinear Summation of Rat Triceps Surae Muscles	PLOS ONE			English	Article							MYOFASCIAL FORCE TRANSMISSION; MUSCULOSKELETAL MODEL; RELATIVE POSITION; ACHILLES-TENDON; SOLEUS MUSCLE; CAT; HINDLIMB; TORQUES; COMPARTMENTS; RECRUITMENT	The Achilles tendon and epimuscular connective tissues mechanically link the triceps surae muscles. These pathways may cause joint moments exerted by each muscle individually not to sum linearly, both in magnitude and direction. The aims were (i) to assess effects of sagittal plane ankle angle (varied between 150 degrees and 70 degrees) on isometric ankle moments, in both magnitude and direction, exerted by active rat triceps surae muscles, (ii) to assess ankle moment summation between those muscles for a range of ankle angles and (iii) to assess effects of sagittal plane ankle angle and muscle activation on Achilles tendon length. At each ankle angle, soleus (SO) and gastrocnemius (GA) muscles were first excited separately to assess ankle-angle moment characteristics and subsequently both muscles were excited simultaneously to investigate moment summation. The magnitude of ankle moment exerted by SO and GA, the SO direction in the transverse and sagittal planes, and the GA direction in the transverse plane were significantly affected by ankle angle. SO moment direction in the frontal and sagittal planes were significantly different from that of GA. Nonlinear magnitude summation varied between 0.6 +/- 2.9% and -3.6 +/- 62.9%, while the nonlinear direction summation varied between 0.3 +/- 0.4 degrees and 20.4 +/- 0.7 degrees in the transverse plane, between 0.5 +/- 0.4 degrees and 0.1 +/- 0.4 degrees in the frontal plane, and between 3.0 +/- 7.9 degrees and 0.3 +/- 2.3 degrees in the sagittal plane. Changes in tendon length caused by SO contraction were significantly lower than those during contraction of GA and GA+SO simultaneously. Thus, moments exerted by GA and SO sum nonlinearly both in the magnitude and direction. The limited degree of nonlinear summation may be explained by different mechanisms acting in opposite directions.	[Tijs, Chris; van Dieen, Jaap H.; Baan, Guus C.; Maas, Huub] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Maas, H (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	h.maas@vu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; Tijs, Chris/0000-0003-4323-3886; Maas, Huub/0000-0002-2304-2735	Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]	Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research	Work supported by the Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt A, 2012, KNEE SURG SPORT TR A, V20, P1868, DOI 10.1007/s00167-011-1801-9; Carrasco DI, 1999, MOTOR CONTROL, V3, P436, DOI 10.1123/mcj.3.4.436; DERUITER CJ, 1995, ACTA PHYSIOL SCAND, V153, P313; HOY MG, 1990, J BIOMECH, V23, P157, DOI 10.1016/0021-9290(90)90349-8; Huijing PA, 2009, J BIOMECH, V42, P9, DOI 10.1016/j.jbiomech.2008.09.027; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Jarc AM, 2013, IEEE T BIO-MED ENG, V60, P1422, DOI 10.1109/TBME.2013.2237768; Johnson WL, 2008, J BIOMECH, V41, P610, DOI 10.1016/j.jbiomech.2007.10.004; LAWRENCE JH, 1993, J NEUROPHYSIOL, V69, P282, DOI 10.1152/jn.1993.69.1.282; Lawrence JH, 1999, J APPL BIOMECH, V15, P106, DOI 10.1123/jab.15.2.106; Lee SSM, 2008, J BIOMECH, V41, P3366, DOI 10.1016/j.jbiomech.2008.09.029; Maas H, 2004, J BIOMECH, V37, P99, DOI 10.1016/S0021-9290(03)00235-5; Maas H, 2008, J APPL PHYSIOL, V104, P1557, DOI 10.1152/japplphysiol.01208.2007; Maas H, 2003, J MECH MED BIOL, V3, P145, DOI 10.1142/S0219519403000703; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x; Markin SN, 2012, J NEUROPHYSIOL, V107, P2057, DOI 10.1152/jn.00865.2011; Mortimer J.T., 2004, NEUROPROSTHETICS THE, P638, DOI DOI 10.1142/4987; Olesen AT, 2014, J APPL PHYSIOL, V117, P989, DOI 10.1152/japplphysiol.00587.2014; Perreault EJ, 2002, P ANN INT IEEE EMBS, P2554, DOI 10.1109/IEMBS.2002.1053423; Prodanov D, 2005, MUSCLE NERVE, V32, P292, DOI 10.1002/mus.20378; Rode C, 2009, J MECH MED BIOL, V9, P105, DOI 10.1142/S0219519409002870; ROY RR, 1991, J APPL PHYSIOL, V70, P2522, DOI 10.1152/jappl.1991.70.6.2522; Sandercock TG, 2000, J APPL PHYSIOL, V89, P2206, DOI 10.1152/jappl.2000.89.6.2206; Sandercock TG, 2005, EXERC SPORT SCI REV, V33, P76, DOI 10.1097/00003677-200504000-00004; Sandercock TG, 2009, MED SCI SPORT EXER, V41, P184, DOI 10.1249/MSS.0b013e318183c0c3; SMITH JL, 1980, J NEUROPHYSIOL, V43, P612, DOI 10.1152/jn.1980.43.3.612; Tamaki H, 2011, J PHYSIOL SCI, V61, P411, DOI 10.1007/s12576-011-0157-8; Tian MY, 2012, J APPL PHYSIOL, V113, P517, DOI 10.1152/japplphysiol.00111.2012; van Antwerp KW, 2007, J BIOMECH, V40, P3570, DOI 10.1016/j.jbiomech.2007.06.001; Vieira TMM, 2013, HUM MOVEMENT SCI, V32, P753, DOI 10.1016/j.humov.2013.03.003; Wakeling JM, 2009, BIOL LETTERS, V5, P30, DOI 10.1098/rsbl.2008.0459; Wehner T, 2010, J BIOMECH, V43, P2473, DOI 10.1016/j.jbiomech.2010.05.028; Yeo SH, 2011, J EXP BIOL, V214, P735, DOI 10.1242/jeb.049163; YOUNG RP, 1993, EXP BRAIN RES, V96, P141, DOI 10.1007/BF00230447; YOUNG RP, 1992, NEUROSCI LETT, V145, P137, DOI 10.1016/0304-3940(92)90005-R	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111595	10.1371/journal.pone.0111595	http://dx.doi.org/10.1371/journal.pone.0111595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360524	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700126
J	Ko, HK; Guo, LW; Su, B; Gao, LQ; Gelman, IH				Ko, Hyun-Kyung; Guo, Li-wu; Su, Bing; Gao, Lingqiu; Gelman, Irwin H.			Suppression of Chemotaxis by SSeCKS via Scaffolding of Phosphoinositol Phosphates and the Recruitment of the Cdc42 GEF, Frabin, to the Leading Edge	PLOS ONE			English	Article							C-KINASE SUBSTRATE; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CYTOSKELETAL ARCHITECTURE; ONCOGENIC TRANSFORMATION; MEMBRANE INTERACTIONS; ACTIN-CYTOSKELETON; PROSTATE-CANCER; PLASMA-MEMBRANE; CELL INVASION	Chemotaxis is controlled by interactions between receptors, Rho-family GTPases, phosphatidylinositol 3-kinases, and cytoskeleton remodeling proteins. We investigated how the metastasis suppressor, SSeCKS, attenuates chemotaxis. Chemotaxis activity inversely correlated with SSeCKS levels in mouse embryo fibroblasts (MEF), DU145 and MDA-MB-231 cancer cells. SSeCKS loss induced chemotactic velocity and linear directionality, correlating with replacement of leading edge lamellipodia with fascin-enriched filopodia-like extensions, the formation of thickened longitudinal F-actin stress fibers reaching to filopodial tips, relative enrichments at the leading edge of phosphatidylinositol (3,4,5)P3 (PIP3), Akt, PKC-zeta, Cdc42-GTP and active Src (Src(poY416)), and a loss of Rac1. Leading edge lamellipodia and chemotaxis inhibition in SSeCKS-null MEF could be restored by full-length SSeCKS or SSeCKS deleted of its Src-binding domain (Delta Src), but not by SSeCKS deleted of its three MARCKS (myristylated alanine-rich C kinase substrate) polybasic domains (Delta PBD), which bind PIP2 and PIP3. The enrichment of activated Cdc42 in SSeCKS-null leading edge filopodia correlated with recruitment of the Cdc42-specific guanine nucleotide exchange factor, Frabin, likely recruited via multiple PIP2/3-binding domains. Frabin knockdown in SSeCKS-null MEF restores leading edge lamellipodia and chemotaxis inhibition. However, SSeCKS failed to co-immunoprecipitate with Rac1, Cdc42 or Frabin. Consistent with the notion that chemotaxis is controlled by SSeCKS-PIP (vs. -Src) scaffolding activity, constitutively-active phosphatidylinositol 3-kinase could override the ability of the Src inhibitor, SKI-606, to suppress chemotaxis and filopodial enrichment of Frabin in SSeCKS-null MEF. Our data suggest a role for SSeCKS in controlling Rac1 vs. Cdc42-induced cellular dynamics at the leading chemotactic edge through the scaffolding of phospholipids and signal mediators, and through the reorganization of the actin cytoskeleton controlling directional movement.	[Ko, Hyun-Kyung; Su, Bing; Gao, Lingqiu; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Guo, Li-wu] Natl Ctr Toxicol Res, Div Genet & Reprod Toxicol, Jefferson, AR 72079 USA	Roswell Park Cancer Institute; US Food & Drug Administration (FDA)	Gelman, IH (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	Irwin.gelman@roswellpark.org	Ko, Hyun-Kyung/H-7596-2017	Ko, Hyun-Kyung/0000-0002-7896-362X	National Cancer Institute [CA94108, CA116430]; Department of Defense grants [PC074228, PC101210]; National Cancer Institute Comprehensive Cancer Center [P30-CA016056]; NATIONAL CANCER INSTITUTE [R55CA094108, R01CA094108, P30CA016056, R01CA116430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grants(United States Department of Defense); National Cancer Institute Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by National Cancer Institute grants CA94108, CA116430, and Department of Defense grants PC074228, PC101210 to IHG, and in part, through National Cancer Institute Comprehensive Cancer Center funds (P30-CA016056). The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of of the manuscript.	Akakura S, 2010, CELL CYCLE, V9, P4656, DOI 10.4161/cc.9.23.13974; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chamberlain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025663; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Garbett D, 2014, MOL BIOL CELL, V25, P2315, DOI 10.1091/mbc.E14-04-0878; Gelman IH, 2006, MOL CANCER RES, V4, P151, DOI 10.1158/1541-7786.MCR-05-0252; Gelman IH, 2008, ADAPTOR PROTEINS CAN, P83; Gelman IH, 2012, CANCER METAST REV, V31, P493, DOI 10.1007/s10555-012-9360-1; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Guo LW, 2011, J BIOL CHEM, V286, P38356, DOI 10.1074/jbc.M111.258830; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hughes-Alford SK, 2012, CURR OPIN CELL BIOL, V24, P284, DOI 10.1016/j.ceb.2012.01.001; Ikeda W, 2001, ONCOGENE, V20, P3457, DOI 10.1038/sj.onc.1204463; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Maghazachi AA, 2000, INT J BIOCHEM CELL B, V32, P931, DOI 10.1016/S1357-2725(00)00035-2; Mardilovich K, 2012, FUTURE ONCOL, V8, P165, DOI [10.2217/fon.11.143, 10.2217/FON.11.143]; Maruta H, 1999, MICROSC RES TECHNIQ, V47, P61; McLaughlin S, 2005, BIOCHEM SOC SYMP, V72, P189, DOI 10.1042/bss0720189; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Nakanishi H, 2008, J CELL MOL MED, V12, P1169, DOI 10.1111/j.1582-4934.2008.00345.x; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Nelson PJ, 1999, J CELL SCI, V112, P361; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ono Y, 2000, ONCOGENE, V19, P3050, DOI 10.1038/sj.onc.1203631; Quintela-Fandino M, 2010, CLIN TRANSL ONCOL, V12, P662, DOI 10.1007/s12094-010-0575-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Singh Rajesh, 2011, Front Biosci (Schol Ed), V3, P1569; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Su B, 2013, ONCOGENE, V32, P2016, DOI 10.1038/onc.2012.218; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Weiger Michael C, 2012, Subcell Biochem, V59, P217, DOI 10.1007/978-94-007-3015-1_7; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Xia W, 2001, CANCER RES, V61, P5644; Xia W, 2002, EXP CELL RES, V277, P139, DOI 10.1006/excr.2002.5560; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350	65	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111534	10.1371/journal.pone.0111534	http://dx.doi.org/10.1371/journal.pone.0111534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356636	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000067
J	Polese, D; Martinelli, E; Marco, S; Di Natale, C; Gutierrez-Galvez, A				Polese, Davide; Martinelli, Eugenio; Marco, Santiago; Di Natale, Corrado; Gutierrez-Galvez, Agustin			Understanding Odor Information Segregation in the Olfactory Bulb by Means of Mitral and Tufted Cells	PLOS ONE			English	Article							PERIGLOMERULAR CELLS; IN-VITRO; INHIBITION; SYSTEM; DISCRIMINATION; RECEPTORS; GLOMERULI; NETWORK	Odor identification is one of the main tasks of the olfactory system. It is performed almost independently from the concentration of the odor providing a robust recognition. This capacity to ignore concentration information does not preclude the olfactory system from estimating concentration itself. Significant experimental evidence has indicated that the olfactory system is able to infer simultaneously odor identity and intensity. However, it is still unclear at what level or levels of the olfactory pathway this segregation of information occurs. In this work, we study whether this odor information segregation is performed at the input stage of the olfactory bulb: the glomerular layer. To this end, we built a detailed neural model of the glomerular layer based on its known anatomical connections and conducted two simulated odor experiments. In the first experiment, the model was exposed to an odor stimulus dataset composed of six different odorants, each one dosed at six different concentrations. In the second experiment, we conducted an odor morphing experiment where a sequence of binary mixtures going from one odor to another through intermediate mixtures was presented to the model. The results of the experiments were visualized using principal components analysis and analyzed with hierarchical clustering to unveil the structure of the high-dimensional output space. Additionally, Fisher's discriminant ratio and Pearson's correlation coefficient were used to quantify odor identity and odor concentration information respectively. Our results showed that the architecture of the glomerular layer was able to mediate the segregation of odor information obtaining output spiking sequences of the principal neurons, namely the mitral and external tufted cells, strongly correlated with odor identity and concentration, respectively. An important conclusion is also that the morphological difference between the principal neurons is not key to achieve odor information segregation.	[Polese, Davide] CNR, Ist Microelettron Microsistemi, Rome, Italy; [Martinelli, Eugenio; Di Natale, Corrado] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy; [Marco, Santiago; Gutierrez-Galvez, Agustin] Inst Bioengn Catalonia, Barcelona, Spain; [Marco, Santiago; Gutierrez-Galvez, Agustin] Univ Barcelona, Dept Elect, Barcelona, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Microelettronica e Microsistemi (IMM-CNR); University of Rome Tor Vergata; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona	Gutierrez-Galvez, A (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	agustin.guti@gmail.com	marco, santiago/H-3203-2019; Polese, Davide/Q-4111-2018; Martinelli, Eugenio/AAA-9105-2019; Di Natale, Corrado/M-8701-2014	marco, santiago/0000-0003-2663-2965; Polese, Davide/0000-0002-6332-5051; Martinelli, Eugenio/0000-0002-6673-2066; Di Natale, Corrado/0000-0002-0543-4348	European Community [216916]	European Community(European Commission)	This work was funded from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 216916: Biologically inspired computation for chemical sensing (NEUROCHEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bardoni R, 1995, BRAIN RES, V703, P19, DOI 10.1016/0006-8993(95)01039-4; Bardoni R, 1996, NEUROSCI LETT, V210, P95, DOI 10.1016/0304-3940(96)12677-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Cleland TA, 2014, PROG BRAIN RES, V208, P177, DOI 10.1016/B978-0-444-63350-7.00007-3; Cleland Thomas A, 2011, Front Neuroeng, V4, P21, DOI 10.3389/fneng.2011.00021; Duda RO, 1999, PATTERN CLASSIFICATI; Eyre MD, 2008, J NEUROSCI, V28, P8217, DOI 10.1523/JNEUROSCI.2490-08.2008; Friedrich RW, 2006, TRENDS NEUROSCI, V29, P40, DOI 10.1016/j.tins.2005.10.004; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Griff ER, 2008, CHEM SENSES, V33, P779, DOI 10.1093/chemse/bjn041; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Keller H. B., 1994, ANAL NUMERICAL METHO; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Linster C, 2009, NEURAL NETWORKS, V22, P1169, DOI 10.1016/j.neunet.2009.07.013; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SCHILD D, 1988, BIOPHYS J, V54, P1001, DOI 10.1016/S0006-3495(88)83038-8; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; Shen K, 2013, NEURON, V80, P1246, DOI 10.1016/j.neuron.2013.08.026; Shepherd WR, 2004, SYPNATIC ORG BRAIN; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2008, FRONT SYST NEUROSCI, V1, DOI 10.3389/neuro.06.003.2007; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wang L., 2002, NEURAL INFORM PROCES, V785, P1; WHITE EL, 1973, BRAIN RES, V60, P299, DOI 10.1016/0006-8993(73)90792-0; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	36	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109716	10.1371/journal.pone.0109716	http://dx.doi.org/10.1371/journal.pone.0109716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356586	Green Submitted, gold, Green Published			2022-12-27	WOS:000346765000006
J	Todiere, G; Pisciella, L; Barison, A; Del Franco, A; Zachara, E; Piaggi, P; Re, F; Pingitore, A; Emdin, M; Lombardi, M; Aquaro, GD				Todiere, Giancarlo; Pisciella, Lorena; Barison, Andrea; Del Franco, Annamaria; Zachara, Elisabetta; Piaggi, Paolo; Re, Federica; Pingitore, Alessandro; Emdin, Michele; Lombardi, Massimo; Aquaro, Giovanni Donato			Abnormal T2-STIR Magnetic Resonance in Hypertrophic Cardiomyopathy: A Marker of Advanced Disease and Electrical Myocardial Instability	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; HEART-RATE-VARIABILITY; SUDDEN CARDIAC DEATH; MICROVASCULAR DYSFUNCTION; PROGNOSTIC-SIGNIFICANCE; CLINICAL-SIGNIFICANCE; DELAYED ENHANCEMENT; RISK; ARRHYTHMIAS; FIBROSIS	Background: Myocardial hyperintensity on T2-weighted short-tau inversion recovery (STIR) (HyT2) cardiac magnetic resonance (CMR) images has been demonstrated in patients with hypertrophic cardiomyopathy (HCM) and is considered a sign of acute damage. The aim of the current study was to evaluate the relationship between HyT2 and both a) markers of ventricular electrical instability and b) clinical and CMR parameters. Methods: Sixty-five patients underwent a thorough clinical examination, consisting of 24-h ECG recording and CMR examination including functional evaluation, T2-STIR images and late gadolinium enhancement (LGE). Results: HyT2 was detected in 27 patients (42%), and subjects with HyT2 showed a greater left ventricle (LV) mass index (p<0.001), lower LV ejection fraction (p = 0.05) and greater extent of LGE (p<0.001) compared to those without HyT2. Twenty-two subjects (34%) presented non-sustained ventricular tachycardia (NSVT) on the 24-h ECG recording, 21 (95%) of whom exhibited HyT2. Based on the logistic regression analysis, HyT2 (odds ratio [OR]: 165, 95% CI 11-2455, p<0.001) and LGE extent (1.1, 1.0-1.3, p<0.001) served as independent predictors of NSVT, while the presence of LGE was not associated with NSVT occurrence (p = 0.49). The presence of HyT2 was associated with lower heart rate variability (p = 0.006) and a higher number of arrhythmic risk factors (p<0.001). Conclusions: In HCM patients, HyT2 upon CMR examination is associated with more advanced disease and increased arrhythmic burden.	[Todiere, Giancarlo; Barison, Andrea; Del Franco, Annamaria; Emdin, Michele; Aquaro, Giovanni Donato] CNR, Fdn G Monasterio Regione Toscana, I-56100 Pisa, Italy; [Pisciella, Lorena; Zachara, Elisabetta; Re, Federica] Azienda Osped San Camillo Forlanini, Rome, Italy; [Piaggi, Paolo] Univ Hosp, Endocrinol Unit, Pisa, Italy; [Pingitore, Alessandro] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Lombardi, Massimo] Multimodal Imaging Sect, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Azienda Ospedaliera San Camillo-Forlanini; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Todiere, G (corresponding author), CNR, Fdn G Monasterio Regione Toscana, I-56100 Pisa, Italy.	todiere@alice.it	Piaggi, Paolo/E-2539-2011; aquaro, giovanni donato/AAB-8978-2019; Barison, Andrea/J-3609-2016; Pingitore, Alessandro/K-1843-2018	Piaggi, Paolo/0000-0003-2774-9161; Barison, Andrea/0000-0001-9042-340X; Pingitore, Alessandro/0000-0002-4049-184X; aquaro, giovanni donato/0000-0003-0915-915X; Del Franco, Annamaria/0000-0003-1405-9436				Abdel-Aty H, 2005, J AM COLL CARDIOL, V45, P1815, DOI 10.1016/j.jacc.2004.11.069; Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6; Abdel-Aty H, 2008, J MAGN RESON IMAGING, V28, P242, DOI 10.1002/jmri.21381; Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Aquaro GD, 2011, HEART, V97, P2056, DOI 10.1136/hrt.2011.226977; Aquaro GD, 2011, J CARD FAIL, V17, P384, DOI 10.1016/j.cardfail.2011.01.006; Aquaro GD, 2010, AM J CARDIOL, V105, P392, DOI 10.1016/j.amjcard.2009.09.045; Aquaro GD, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-21; Biagini E, 2005, J AM COLL CARDIOL, V46, P1543, DOI 10.1016/j.jacc.2005.04.062; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Camm AJ, 1996, EUR HEART J, V17, P354; Cecchi F, 2003, NEW ENGL J MED, V349, P1027, DOI 10.1056/NEJMoa025050; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; COUMEL P, 1993, J CARDIOVASC ELECTR, V4, P338, DOI 10.1111/j.1540-8167.1993.tb01235.x; Doval HC, 1996, CIRCULATION, V94, P3198, DOI 10.1161/01.CIR.94.12.3198; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; Frenneaux MP, 2004, HEART, V90, P570, DOI 10.1136/hrt.2003.020529; Friedrich MG, 2008, J AM COLL CARDIOL, V51, P1581, DOI 10.1016/j.jacc.2008.01.019; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Frustaci A, 2007, EUR HEART J, V28, P733, DOI 10.1093/eurheartj/ehl525; Goldberger JJ, 2008, J AM COLL CARDIOL, V52, P1179, DOI 10.1016/j.jacc.2008.05.003; Harrigan CJ, 2011, RADIOLOGY, V258, P128, DOI 10.1148/radiol.10090526; Hen Y, 2013, HEART VESSELS, V28, P742, DOI 10.1007/s00380-012-0300-3; IKEGAWA T, 1987, CLIN CARDIOL, V10, P78, DOI 10.1002/clc.4960100202; Kohorst JJ, 2014, CONGENIT HEART DIS, V9, pE51, DOI 10.1111/chd.12073; La Rovere MT, 2001, CIRCULATION, V103, P2072; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Melacini P, 2008, INT J CARDIOL, V128, P364, DOI 10.1016/j.ijcard.2007.06.023; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026; Olivotto I, 2010, AM J CARDIOL, V106, P261, DOI 10.1016/j.amjcard.2010.03.020; PELLICCIA F, 1990, INT J CARDIOL, V29, P47, DOI 10.1016/0167-5273(90)90272-7; Petersen SE, 2007, CIRCULATION, V115, P2418, DOI 10.1161/CIRCULATIONAHA.106.657023; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026; SECHTEM U, 1987, CARDIOVASC INTER RAD, V10, P365, DOI 10.1007/BF02577347; Todiere G, 2012, J AM COLL CARDIOL, V60, P922, DOI 10.1016/j.jacc.2012.03.076; Uemura S, 1997, JPN CIRC J, V61, P819, DOI 10.1253/jcj.61.819; WILLERSON JT, 1977, AM J PATHOL, V87, P159	43	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111366	10.1371/journal.pone.0111366	http://dx.doi.org/10.1371/journal.pone.0111366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356653	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000055
J	Sogin, EM; Anderson, P; Williams, P; Chen, CS; Gates, RD				Sogin, Emilia M.; Anderson, Paul; Williams, Philip; Chen, Chii-Shiarng; Gates, Ruth D.			Application of H-1-NMR Metabolomic Profiling for Reef-Building Corals	PLOS ONE			English	Article							ENVIRONMENTAL METABOLOMICS; IDENTIFICATION; SPECTRA; NMR; METABOLITES; ACCLIMATIZATION; BIOSYNTHESIS; TEMPERATURE; ORGANISMS; DIVERSITY	In light of global reef decline new methods to accurately, cheaply, and quickly evaluate coral metabolic states are needed to assess reef health. Metabolomic profiling can describe the response of individuals to disturbance (i.e., shifts in environmental conditions) across biological models and is a powerful approach for characterizing and comparing coral metabolism. For the first time, we assess the utility of a proton-nuclear magnetic resonance spectroscopy (H-1-NMR)-based metabolomics approach in characterizing coral metabolite profiles by 1) investigating technical, intra-, and inter-sample variation, 2) evaluating the ability to recover targeted metabolite spikes, and 3) assessing the potential for this method to differentiate among coral species. Our results indicate H-1-NMR profiling of Porites compressa corals is highly reproducible and exhibits low levels of variability within and among colonies. The spiking experiments validate the sensitivity of our methods and showcase the capacity of orthogonal partial least squares discriminate analysis (OPLS-DA) to distinguish between profiles spiked with varying metabolite concentrations (0 mM, 0.1 mM, and 10 mM). Finally, H-1-NMR metabolomics coupled with OPLS-DA, revealed species-specific patterns in metabolite profiles among four reef-building corals (Pocillopora damicornis, Porites lobata, Montipora aequituberculata, and Seriatopora hystrix). Collectively, these data indicate that H-1-NMR metabolomic techniques can profile reef-building coral metabolomes and have the potential to provide an integrated picture of the coral phenotype in response to environmental change.	[Sogin, Emilia M.; Gates, Ruth D.] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Sogin, Emilia M.; Williams, Philip] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Anderson, Paul] Coll Charleston, Charleston, SC 29401 USA; [Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Checheng, Taiwan	University of Hawaii System; University of Hawaii Manoa; College of Charleston; National Museum of Marine Biology & Aquarium	Sogin, EM (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	esogin@hawaii.edu		Williams, Philip/0000-0001-8987-0683; Sogin, Emilia/0000-0001-7533-3705	National Science Foundation East Asian and Pacific Summer Institute [OISE-1107948]; National Science Foundation Experimental Program to Stimulate Competitive Research Hawaii [EPS-0903833]; Directorate For Geosciences [1236905] Funding Source: National Science Foundation; Office Of The Director [0903833] Funding Source: National Science Foundation	National Science Foundation East Asian and Pacific Summer Institute; National Science Foundation Experimental Program to Stimulate Competitive Research Hawaii; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by funding from the National Science Foundation East Asian and Pacific Summer Institute to EMS, Award # OISE-1107948, URL: www.nsf.gov/eapsi. It was also supported by the National Science Foundation Experimental Program to Stimulate Competitive Research Hawaii, Award # EPS-0903833, www.nsf.gov/epscor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PE, 2011, METABOLOMICS, V7, P179, DOI 10.1007/s11306-010-0242-7; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bharti SK, 2012, QUANTITATIVE ANAL CH, V35, P5; Boroujerdi AFB, 2009, ENVIRON SCI TECHNOL, V43, P7658, DOI 10.1021/es901675w; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CROSSLAND CJ, 1991, CORAL REEFS, V10, P55, DOI 10.1007/BF00571824; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046801; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Ellis RP, 2014, ENVIRON SCI TECHNOL, V48, P7044, DOI 10.1021/es501601w; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Field KJ, 2011, PHYSIOL PLANTARUM, V142, P352, DOI 10.1111/j.1399-3054.2011.01480.x; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Gates RD, 1999, AM ZOOL, V39, P30; Gaude E, 2013, CURR METABOL, V1, P180, DOI 10.2174/2213235X11301020005; Gordon BR, 2013, METHODS MOL BIOL, V1055, P129, DOI 10.1007/978-1-62703-577-4_10; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Grivet JP, 2009, PROG NUCL MAG RES SP, V54, P1, DOI 10.1016/j.pnmrs.2008.02.001; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hammer KM, 2012, COMP BIOCHEM PHYS D, V7, P292, DOI 10.1016/j.cbd.2012.06.001; Hines A, 2007, ENVIRON SCI TECHNOL, V41, P3375, DOI 10.1021/es062745w; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jacob D, 2013, ANAL BIOANAL CHEM, V405, P5049, DOI 10.1007/s00216-013-6852-y; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Lin CY, 2009, AQUAT TOXICOL, V95, P230, DOI 10.1016/j.aquatox.2009.09.006; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Martin-Pastor M, 2014, J AGR FOOD CHEM, V62, P1190, DOI 10.1021/jf4044869; Meyer E, 2012, BIOL BULL-US, V223, P44, DOI 10.1086/BBLv223n1p44; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Motti C, 2012, J MARINE SCI RES DEV, V2, P3; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Rosenblum ES, 2006, ENVIRON SCI TECHNOL, V40, P7077, DOI 10.1021/es061354e; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; SEBENS KP, 1994, AM ZOOL, V34, P115; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; Tapiolas DM, 2013, J EXP MAR BIOL ECOL, V443, P85, DOI 10.1016/j.jembe.2013.02.037; Tarrant AM, 2003, COMP BIOCHEM PHYS B, V136, P473, DOI 10.1016/S1096-4959(03)00253-7; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tuffnail W, 2009, METABOLOMICS, V5, P33, DOI 10.1007/s11306-008-0143-1; Tulpan D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-400; Viant MR, 2006, AQUAT TOXICOL, V77, P359, DOI 10.1016/j.aquatox.2006.01.009; Ward JL, 2010, METABOLOMICS, V6, P263, DOI 10.1007/s11306-010-0200-4; Wu HF, 2010, AQUAT TOXICOL, V100, P339, DOI 10.1016/j.aquatox.2010.08.005; Xi YX, 2008, ANAL CHIM ACTA, V614, P127, DOI 10.1016/j.aca.2008.03.024; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yost DM, 2013, ZOOLOGY, V116, P262, DOI 10.1016/j.zool.2013.06.001; Zheng C, 2011, BIOINFORMATICS, V27, P1637, DOI 10.1093/bioinformatics/btr118	65	27	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111274	10.1371/journal.pone.0111274	http://dx.doi.org/10.1371/journal.pone.0111274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354140	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200066
J	Meshkat, N; Kuo, CEZ; DiStefano, J				Meshkat, Nicolette; Kuo, Christine Er-zhen; DiStefano, Joseph, III			On Finding and Using Identifiable Parameter Combinations in Nonlinear Dynamic Systems Biology Models and COMBOS: A Novel Web Implementation	PLOS ONE			English	Article							STRUCTURAL IDENTIFIABILITY; ODE MODELS; GLOBAL IDENTIFIABILITY; BILIRUBIN KINETICS; IDENTIFICATION; AMBIGUITIES; EQUATIONS	Parameter identifiability problems can plague biomodelers when they reach the quantification stage of development, even for relatively simple models. Structural identifiability (SI) is the primary question, usually understood as knowing which of P unknown biomodel parameters p(1), ... , p(i), ... , p(P) are-and which are not-quantifiable in principle from particular input-output (I-O) biodata. It is not widely appreciated that the same database also can provide quantitative information about the structurally unidentifiable (not quantifiable) subset, in the form of explicit algebraic relationships among unidentifiable pi. Importantly, this is a first step toward finding what else is needed to quantify particular unidentifiable parameters of interest from new I-O experiments. We further develop, implement and exemplify novel algorithms that address and solve the SI problem for a practical class of ordinary differential equation (ODE) systems biology models, as a user-friendly and universally-accessible web application (app)-COMBOS. Users provide the structural ODE and output measurement models in one of two standard forms to a remote server via their web browser. COMBOS provides a list of uniquely and non-uniquely SI model parameters, and-importantly-the combinations of parameters not individually SI. If non-uniquely SI, it also provides the maximum number of different solutions, with important practical implications. The behind-the-scenes symbolic differential algebra algorithms are based on computing Grobner bases of model attributes established after some algebraic transformations, using the computer-algebra system Maxima. COMBOS was developed for facile instructional and research use as well as modeling. We use it in the classroom to illustrate SI analysis; and have simplified complex models of tumor suppressor p53 and hormone regulation, based on explicit computation of parameter combinations. It's illustrated and validated here for models of moderate complexity, with and without initial conditions. Built-in examples include unidentifiable 2 to 4-compartment and HIV dynamics models.	[DiStefano, Joseph, III] Univ Calif Los Angeles, Dept Comp Sci, Biocybernet Lab, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Computat & Syst Biol Interdept Program, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	DiStefano, J (corresponding author), Univ Calif Los Angeles, Dept Comp Sci, Biocybernet Lab, Los Angeles, CA 90024 USA.	joed@ucla.edu	DiStefano, Joseph/AAL-9463-2020		UCLA Academic Senate Committee on Research	UCLA Academic Senate Committee on Research	The authors acknowledge Nik Brown for invaluable assistance with web application implementation issues since the outset; Sami Yerunkar who fixed bugs, clarified error messages and inserted abort functionality; Keith Godfrey for critiquing, beta testing and challenging the software with examples previously solved analytically with great effort, as well as suggesting new applications; and the UCLA Academic Senate Committee on Research for initial funding of undergraduate student assistance.	Bellu G, 2007, COMPUT METH PROG BIO, V88, P52, DOI 10.1016/j.cmpb.2007.07.002; BERK PD, 1969, J CLIN INVEST, V48, P2176, DOI 10.1172/JCI106184; CHAPPELL MJ, 1990, MATH BIOSCI, V102, P41, DOI 10.1016/0025-5564(90)90055-4; Chis O, 2011, BIOINFORMATICS, V27, P2610, DOI 10.1093/bioinformatics/btr431; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; COBELLI C, 1975, COMPUT BIOMED RES, V8, P522, DOI 10.1016/0010-4809(75)90024-5; COBELLI C, 1980, AM J PHYSIOL, V239, pR7, DOI 10.1152/ajpregu.1980.239.1.R7; DiStefano J, 2014, DYNAMIC SYSTEMS BIOLOGY MODELING AND SIMULATION, P1; DISTEFANO JJ, 1975, AUTOMATICA, V11, P149, DOI 10.1016/0005-1098(75)90056-4; DISTEFANO JJ, 1983, MATH BIOSCI, V65, P51, DOI 10.1016/0025-5564(83)90070-6; DISTEFANO JJ, 1980, IEEE T AUTOMAT CONTR, V25, P830, DOI 10.1109/TAC.1980.1102439; Eisenberg M, 2006, THYROID, V16, P1279, DOI 10.1089/thy.2006.16.1279; Hengl S, 2007, BIOINFORMATICS, V23, P2612, DOI 10.1093/bioinformatics/btm382; Meshkat N, 2012, MATH BIOSCI, V239, P117, DOI 10.1016/j.mbs.2012.04.008; Meshkat N, 2011, MATH BIOSCI, V233, P19, DOI 10.1016/j.mbs.2011.06.001; Meshkat N, 2009, MATH BIOSCI, V222, P61, DOI 10.1016/j.mbs.2009.08.010; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; NESTEL PJ, 1969, J CLIN INVEST, V48, P982, DOI 10.1172/JCI106079; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Saccomani MP, 2011, B MATH BIOL, V73, P1734, DOI 10.1007/s11538-010-9588-2; Saccomani MP, 2010, COMPUT BIOL MED, V40, P402, DOI 10.1016/j.compbiomed.2010.02.004; Saccomani MP, 2003, AUTOMATICA, V39, P619, DOI 10.1016/S0005-1098(02)00302-3; SPECKER JL, 1984, ENDOCRINOLOGY, V115, P399, DOI 10.1210/endo-115-1-399; VAJDA S, 1981, MATH BIOSCI, V55, P39, DOI 10.1016/0025-5564(81)90012-2; WAGNER JG, 1981, RES COMMUN CHEM PATH, V32, P387; WAGNER JG, 1976, J PHARMACOKINET BIOP, V4, P443, DOI 10.1007/BF01062831; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104	27	50	51	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110261	10.1371/journal.pone.0110261	http://dx.doi.org/10.1371/journal.pone.0110261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350289	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100023
J	Okuma, H; Gonoi, W; Ishida, M; Shirota, G; Shintani, Y; Abe, H; Fukayama, M; Ohtomo, K				Okuma, Hidemi; Gonoi, Wataru; Ishida, Masanori; Shirota, Go; Shintani, Yukako; Abe, Hiroyuki; Fukayama, Masashi; Ohtomo, Kuni			Comparison of Atternkition of Striated Muscle between Postmort:m and Antemortem Computed Tc-aography: Results of' a Longitudinal Study	PLOS ONE			English	Article							TOMOGRAPHY RELATIONSHIP; MUSCULAR SYSTEM; CT-NUMBERS; DEATH; AUTOPSY; GAS; PHANTOM; MRI	Objective: We evaluated the postmortem changes of striated muscle by comparing computed tomography (CT) images obtained postmortem and antemortem in the same patients. Materials and Methods: We studied 33 consecutive patients who underwent antemortem CT, postmortem CT, and pathological autopsy in our tertiary care hospital between April 2009 and December 2010. Postmortem CT was performed within 20 h after death and was followed by pathological autopsy. Pathological autopsy confirmed the absence of muscular diseases such as amyotrophic lateral sclerosis, muscular dystrophy, myositis, and myasthenia, in all of the patients. The CT attenuation values of four cardiac muscle sites (anterior wall of the left ventricle, left ventricular free wall, posterior wall of the left ventricle, and the ventricular septum) and two skeletal muscle sites (the pectoralis major muscle and the erector spinae muscle) were compared between antemortem and postmortem CT using paired t test. Results: Striated muscle had significantly greater attenuation on postmortem CT than on antemortem CT (P<0.001) in all six tissue sites. No significant association was found between postmortem change in the CT attenuation of striated muscle and gender, age, or elapsed time since death. Conclusion: This is the first longitudinal study to show hyperattenuation of striated muscle on postmortem CT images compared with antemortem CT images in the same patients.	[Okuma, Hidemi; Gonoi, Wataru; Shirota, Go; Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 113, Japan; [Ishida, Masanori] Sanraku Hosp, Dept Radiol, Mututal Aid Assoc Tokyo Metropolitan Teachers & O, Chiyoda Ku, Tokyo, Japan; [Shintani, Yukako; Abe, Hiroyuki; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Okuma, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 113, Japan.	hokuma-tky@unim.ac.jp	Gonoi, Wataru/AAB-2160-2019; Okuma, Hidemi/M-2660-2018	Gonoi, Wataru/0000-0002-5018-4683; Okuma, Hidemi/0000-0001-5325-2699; Shintani-Domoto, Yukako/0000-0002-8061-6176	Japanese Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [25860264] Funding Source: KAKEN	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japanese Ministry of Health, Labor and Welfare, for research into "Usefulness of Postmortem Images as an Ancillary Method for Autopsy in Evaluation of Death Associated with Medical Practice (2008-2009)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; BULCKE JA, 1979, NEURORADIOLOGY, V17, P127; Cha JG, 2010, KOREAN J RADIOL, V11, P395, DOI 10.3348/kjr.2010.11.4.395; Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005; Flach Patricia M, 2014, AJR Am J Roentgenol, V202, pW325, DOI 10.2214/AJR.12.10283; Groell R, 2000, COMPUT MED IMAG GRAP, V24, P53, DOI 10.1016/S0895-6111(99)00043-9; HADAR H, 1983, AM J ROENTGENOL, V141, P895, DOI 10.2214/ajr.141.5.895; HAWLEY RJ, 1984, ARCH NEUROL-CHICAGO, V41, P383, DOI 10.1001/archneur.1984.04050160045014; Hyodoh H, 2012, JPN J RADIOL, V30, P840, DOI 10.1007/s11604-012-0134-z; Ishida M, 2014, AM J FOREN MED PATH, V35, P113, DOI 10.1097/PAF.0000000000000083; Ishida M, 2011, LEGAL MED-TOKYO, V13, P280, DOI 10.1016/j.legalmed.2011.09.004; Ishida M, 2011, LEGAL MED-TOKYO, V13, P318, DOI 10.1016/j.legalmed.2011.08.003; Ishida M, 2011, LEGAL MED-TOKYO, V13, P174, DOI 10.1016/j.legalmed.2011.03.002; Jackowski C, 2007, J TRAUMA, V62, P979, DOI 10.1097/01.ta.0000198733.22654.de; LEVI C, 1982, AM J ROENTGENOL, V139, P443, DOI 10.2214/ajr.139.3.443; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; Nishihara S, 2002, MED IMAG INFORM SCI, V20, P40; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Okuma H, 2013, INT J LEGA IN PRESS, DOI [10.1007/s00414-013-095S-z, DOI 10.1007/S00414-013-095S-Z]; Okuma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076026; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Shiotani S, 2004, FORENSIC SCI INT, V139, P39, DOI 10.1016/j.forsciint.2003.09.016; Shiotani Seiji, 2002, Radiat Med, V20, P201; Shiotani Seiji, 2003, Radiat Med, V21, P29; Singh MKC, 2009, FORENSIC SCI MED PAT, V5, P236, DOI 10.1007/s12024-009-9103-y; SMITH RD, 1950, ANAT RECORD, V108, P207, DOI 10.1002/ar.1091080203; Takahashi N, 2013, FORENSIC SCI INT, V225, P27, DOI 10.1016/j.forsciint.2012.04.037; TERMOTE JL, 1980, RADIOLOGY, V137, P439, DOI 10.1148/radiology.137.2.7433677; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Tsokos M., 2005, ENCY FORENSIC LEGAL, P456, DOI [10.1016/B0-12-369399-3/00091-4, DOI 10.1016/B0-12-369399-3/00091-4]	31	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111457	10.1371/journal.pone.0111457	http://dx.doi.org/10.1371/journal.pone.0111457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365255	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558100066
J	Streifel, KM; Gonzales, AL; De Miranda, B; Mouneimne, R; Earley, S; Tjalkens, R				Streifel, Karin M.; Gonzales, Albert L.; De Miranda, Briana; Mouneimne, Rola; Earley, Scott; Tjalkens, Ronald			Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in Astrocytes	PLOS ONE			English	Article							TRANSIENT RECEPTOR; TRPC3 CHANNELS; SYNAPTIC-TRANSMISSION; ACTIVATION; WAVES; EXPRESSION; PATHWAY; COMPLEX; FAMILY; CELLS	Dopaminergic nuclei in the basal ganglia are highly sensitive to damage from oxidative stress, inflammation, and environmental neurotoxins. Disruption of adenosine triphosphate (ATP)-dependent calcium (Ca2+) transients in astrocytes may represent an important target of such stressors that contributes to neuronal injury by disrupting critical Ca2+-dependent trophic functions. We therefore postulated that plasma membrane cation channels might be a common site of inhibition by structurally distinct cationic neurotoxicants that could modulate ATP-induced Ca2+ signals in astrocytes. To test this, we examined the capacity of two dopaminergic neurotoxicants to alter ATP-dependent Ca2+ waves and transients in primary murine striatal astrocytes: MPP+, the active metabolite of 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and 6-hydroxydopamine (6-OHDA). Both compounds acutely decreased ATP-induced Ca2+ transients and waves in astrocytes and blocked OAG-induced Ca2+ influx at micromolar concentrations, suggesting the transient receptor potential channel, TRPC3, as an acute target. MPP+ inhibited 1-oleoyl-2-acetyl-sn-glycerol (OAG)-induced Ca2+ transients similarly to the TRPC3 antagonist, pyrazole-3, whereas 6-OHDA only partly suppressed OAG-induced transients. RNAi directed against TRPC3 inhibited the ATP-induced transient as well as entry of extracellular Ca2+, which was augmented by MPP+. Whole-cell patch clamp experiments in primary astrocytes and TRPC3-overexpressing cells demonstrated that acute application of MPP+ completely blocked OAG-induced TRPC3 currents, whereas 6-OHDA only partially inhibited OAG currents. These findings indicate that MPP+ and 6-OHDA inhibit ATP-induced Ca2+ signals in astrocytes in part by interfering with purinergic receptor mediated activation of TRPC3, suggesting a novel pathway in glia that could contribute to neurotoxic injury.	[Streifel, Karin M.; De Miranda, Briana; Tjalkens, Ronald] Colorado State Univ, Ctr Environm Med, Ft Collins, CO 80523 USA; [Gonzales, Albert L.; Earley, Scott] Colorado State Univ, Dept Biomed Sci, Vasc Physiol Res Grp, Ft Collins, CO 80523 USA; [Mouneimne, Rola] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Colorado State University; Colorado State University; Texas A&M University System; Texas A&M University College Station	Tjalkens, R (corresponding author), Colorado State Univ, Ctr Environm Med, Ft Collins, CO 80523 USA.	Ron.Tjalkens@colostate.edu	Earley, Scott/A-4059-2008	Earley, Scott/0000-0001-9560-2941	National Institutes of Health [ES021656, HL091905, HL094145]; Michael J. Fox Foundation; Monfort Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL094145, R01HL091905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Monfort Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by National Institutes of Health www.nih.gov (ES021656 to RBT, HL091905 to SE, HL094145 to ALG), Rapid Response Innovation research grant from the Michael J. Fox Foundation for Parkinson's Research www.michaeljfox.org (to RBT) and Monfort Excellence Award from the Monfort Family Foundation (to SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00139; ASCHNER M, 1991, NEUROTOXICOLOGY, V12, P505; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Fischer W, 2009, NEUROSCIENCE, V160, P767, DOI 10.1016/j.neuroscience.2009.02.026; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Grimaldi M, 2006, J NEUROSCI RES, V84, P1738, DOI 10.1002/jnr.21064; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Kaddour H, 2013, J NEUROCHEM, V125, P620, DOI 10.1111/jnc.12140; Kim KH, 2011, ENVIRON HEALTH PERSP, V119, P519, DOI 10.1289/ehp.1002728; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Moreno JA, 2008, J NEUROSCI RES, V86, P2028, DOI 10.1002/jnr.21640; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Pessah IN, 2006, CHEM RES TOXICOL, V19, P92, DOI 10.1021/tx050196m; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Reading SA, 2005, AM J PHYSIOL-HEART C, V288, pH2055, DOI 10.1152/ajpheart.00861.2004; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Streifel KM, 2013, NEUROTOXICOLOGY, V34, P160, DOI 10.1016/j.neuro.2012.10.014; Tialkens RB, 2006, BRAIN RES, V1113, P210, DOI 10.1016/j.brainres.2006.07.053; Wouters J, 1996, ACTA CRYSTALLOGR C, V52, P1033, DOI 10.1107/S010827019501362X; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110996	10.1371/journal.pone.0110996	http://dx.doi.org/10.1371/journal.pone.0110996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365260	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100042
J	Chabane, YN; Marti, S; Rihouey, C; Alexandre, S; Hardouin, J; Lesouhaitier, O; Vila, J; Kaplan, JB; Jouenne, T; De, E				Chabane, Yassine Nait; Marti, Sara; Rihouey, Christophe; Alexandre, Stephane; Hardouin, Julie; Lesouhaitier, Olivier; Vila, Jordi; Kaplan, Jeffrey B.; Jouenne, Thierry; De, Emmanuelle			Characterisation of Pellicles Formed by Acinetobacter baumannii at the Air-Liquid Interface	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS SBW25; AERUGINOSA BIOFILM DEVELOPMENT; ESCHERICHIA-COLI; ABIOTIC SURFACES; GENETIC-ANALYSIS; MATRIX; FEATURES; ATTACHMENT; CELLULOSE; PATHOGEN	The clinical importance of Acinetobacter baumannii is partly due to its natural ability to survive in the hospital environment. This persistence may be explained by its capacity to form biofilms and, interestingly, A. baumannii can form pellicles at the air-liquid interface more readily than other less pathogenic Acinetobacter species. Pellicles from twenty-six strains were morphologically classified into three groups: I) egg-shaped (27%); II) ball-shaped (50%); and III) irregular pellicles (23%). One strain representative of each group was further analysed by Brewster's Angle Microscopy to follow pellicle development, demonstrating that their formation did not require anchoring to a solid surface. Total carbohydrate analysis of the matrix showed three main components: Glucose, GlcNAc and Kdo. Dispersin B, an enzyme that hydrolyzes poly-N-acetylglucosamine (PNAG) polysaccharide, inhibited A. baumannii pellicle formation, suggesting that this exopolysaccharide contributes to pellicle formation. Also associated with the pellicle matrix were three subunits of pili assembled by chaperon-usher systems: the major CsuA/B, A1S_1510 (presented 45% of identity with the main pilin F17-A from enterotoxigenic Escherichia coli pili) and A1S_2091. The presence of both PNAG polysaccharide and pili systems in matrix of pellicles might contribute to the virulence of this emerging pathogen.	[Chabane, Yassine Nait; Marti, Sara; Rihouey, Christophe; Alexandre, Stephane; Hardouin, Julie; Jouenne, Thierry; De, Emmanuelle] Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Unite Mixte Rech 6270, Mont St Aignan, France; [Lesouhaitier, Olivier] Univ Rouen, Lab Microbiol Signaux & Microenvironm, Equipe Accueil 4312, Evreux, France; [Vila, Jordi] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain; [Kaplan, Jeffrey B.] Amer Univ, Dept Biol, Washington, DC 20016 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Rouen Normandie; Universite de Rouen Normandie; University of Barcelona; Hospital Clinic de Barcelona; American University	Marti, S (corresponding author), Univ Rouen, Lab Polymeres Biopolymeres Surfaces, CNRS, Unite Mixte Rech 6270, Mont St Aignan, France.	saramarti2@yahoo.es; emmanuelle.de@univ-rouen.fr	Nait chabane, Yassine/GNN-0300-2022; Vila, Jordi/P-3613-2016; Marti, Sara/D-4823-2014	Vila, Jordi/0000-0002-8025-3926; Marti, Sara/0000-0002-0405-2305; NAIT CHABANE, Yassine/0000-0002-9528-2105; jouenne, thierry/0000-0003-0994-9944; Hardouin, Julie/0000-0003-4588-9811; ALEXANDRE, Stephane/0000-0003-0717-8592; De, Emmanuelle/0000-0002-9564-1649	Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Haute-Normandie region	Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC); Haute-Normandie region(Region Normandie)	SM has a post-doctoral fellowship from the Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica (SEIMC) and YNC has a doctoral fellowship from the Haute-Normandie region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Collet A, 2008, J PROTEOME RES, V7, P4659, DOI 10.1021/pr8001723; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eijkelkamp BA, 2013, INFECT IMMUN, V81, P2574, DOI 10.1128/IAI.00065-13; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; GIRARDEAU JP, 1980, ANN INST PASTEUR MIC, VB131, P31; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Henk MC, 2004, APPL ENVIRON MICROB, V70, P2486, DOI 10.1128/AEM.70.4.2486-2493.2004; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Konopka JB, 2012, SCIENTIFICA CAIRO, V2012; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030; Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pamp S.J., 2007, BIOFILM MODE LIFE ME, P37; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x; Rodriguez-Bano J, 2004, INFECT CONT HOSP EP, V25, P819, DOI 10.1086/502302; Romling U, 1999, FEMS MICROBIOL LETT, V180, P91; ROSENBERG M, 1981, INFECT IMMUN, V33, P29, DOI 10.1128/IAI.33.1.29-33.1981; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Visca P, 2011, IUBMB LIFE, V63, P1048, DOI 10.1002/iub.534; Yang L, 2011, ENVIRON MICROBIOL, V13, P1705, DOI 10.1111/j.1462-2920.2011.02503.x	52	46	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111660	10.1371/journal.pone.0111660	http://dx.doi.org/10.1371/journal.pone.0111660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360550	Green Published, gold			2022-12-27	WOS:000343943700140
J	Corradetti, B; Correani, A; Romaldini, A; Marini, MG; Bizzaro, D; Perrini, C; Cremonesi, F; Lange-Consiglio, A				Corradetti, Bruna; Correani, Alessio; Romaldini, Alessio; Marini, Maria Giovanna; Bizzaro, Davide; Perrini, Claudia; Cremonesi, Fausto; Lange-Consiglio, Anna			Amniotic Membrane-Derived Mesenchymal Cells and Their Conditioned Media: Potential Candidates for Uterine Regenerative Therapy in the Horse	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; STEM-CELLS; BONE-MARROW; WNT GENES; EPITHELIAL-CELLS; INTERFERON-TAU; ESTROUS-CYCLE; STROMAL CELLS; IN-VITRO; PROGESTERONE	Amniotic membrane-derived mesenchymal cells (AMCs) are considered suitable candidates for a variety of cell-based applications. In view of cell therapy application in uterine pathologies, we studied AMCs in comparison to cells isolated from the endometrium of mares at diestrus (EDCs) being the endometrium during diestrus and early pregnancy similar from a hormonal standpoint. In particular, we demonstrated that amnion tissue fragments (AM) shares the same transcriptional profile with endometrial tissue fragments (ED), expressing genes involved in early pregnancy (AbdB-like Hoxa genes), pre-implantantion conceptus development (Er alpha, PR, PGRMC1 and mPR) and their regulators (Wnt7a, Wnt4a). Soon after the isolation, only AMCs express Wnt4a and Wnt7a. Interestingly, the expression levels of prostaglandin-endoperoxide synthase 2 (PTGS2) were found greater in AM and AMCs than their endometrial counterparts thus confirming the role of AMCs as mediators of inflammation. The expression of nuclear progesterone receptor (PR), membrane-bound intracellular progesterone receptor component 1 (PGRMC1) and membrane-bound intracellular progesterone receptor (mPR), known to lead to improved endometrial receptivity, was maintained in AMCs over 5 passages in vitro when the media was supplemented with progesterone. To further explore the potential of AMCs in endometrial regeneration, their capacity to support resident cell proliferation was assessed by co-culturing them with EDCs in a transwell system or culturing in the presence of AMC-conditioned medium (AMC-CM). A significant increase in EDC proliferation rate exhibited the crucial role of soluble factors as mediators of stem cells action. The present investigation revealed that AMCs, as well as their derived conditioned media, have the potential to improve endometrial cell replenishment when low proliferation is associated to pregnancy failure. These findings make AMCs suitable candidates for the treatment of endometrosis in mares.	[Corradetti, Bruna; Correani, Alessio; Romaldini, Alessio; Marini, Maria Giovanna; Bizzaro, Davide] Univ Politecn Marche, Dept Life & Environm Sci, Ancona, Italy; [Perrini, Claudia; Cremonesi, Fausto; Lange-Consiglio, Anna] Univ Milan, Large Anim Hosp, Reprod Unit, Lodi, Italy; [Cremonesi, Fausto] Univ Milan, Dept Vet Sci Anim Hlth Prod & Food Safety, Milan, Italy	Marche Polytechnic University; University of Milan; University of Milan	Cremonesi, F (corresponding author), Univ Milan, Large Anim Hosp, Reprod Unit, Lodi, Italy.	fausto.cremonesi@unimi.it	Lange-Consiglio, Anna/AAI-4146-2021; Cremonesi, Fausto/J-2506-2014	Lange-Consiglio, Anna/0000-0002-7748-3413; Cremonesi, Fausto/0000-0001-8399-4626; corradetti, bruna/0000-0002-0345-4847; CORREANI, ALESSIO/0000-0001-5666-7806; Bizzaro, Davide/0000-0002-8336-1156; Romaldini, Alessio/0000-0003-0524-9000	Universita degli Studi di Milano; Universita Politecnica delle Marche	Universita degli Studi di Milano; Universita Politecnica delle Marche	General funding from Universita degli Studi di Milano and Universita Politecnica delle Marche is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atli MO, 2011, ANIM REPROD SCI, V125, P94, DOI 10.1016/j.anireprosci.2011.04.001; Bartholomew S, 2009, EQUINE VET J, V41, P724, DOI 10.2746/042516409X429446; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Benson GV, 1996, DEVELOPMENT, V122, P2687; BIGSBY RM, 1986, ENDOCRINOLOGY, V119, P390, DOI 10.1210/endo-119-1-390; Chen Q, 2009, MOL HUM REPROD, V15, P215, DOI 10.1093/molehr/gap009; Chong AKS, 2009, FRONT BIOSCI-LANDMRK, V14, P4598, DOI 10.2741/3552; Corradetti B, 2011, CELL PROLIFERAT, V44, P330, DOI 10.1111/j.1365-2184.2011.00759.x; Cremonesi F, 2008, VET RES COMMUN, V32, pS139, DOI 10.1007/s11259-008-9116-0; Daels PF, 2005, EQUINE REPROD, P121; de Ziegler D, 1998, J REPROD IMMUNOL, V39, P149, DOI 10.1016/S0165-0378(98)00019-9; Diedrich K, 2007, HUM REPROD UPDATE, V13, P365, DOI 10.1093/humupd/dmm011; Donofrio G, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-65; Dorniak P, 2013, ANIM REPROD, V10, P239; Falkenstein E, 2000, J CLIN ENDOCR METAB, V85, P2072, DOI 10.1210/jc.85.5.2072; Feroze-Zaidi F, 2007, ENDOCRINOLOGY, V148, P5020, DOI 10.1210/en.2007-0659; Fischer C, 2010, REPROD FERT DEVELOP, V22, P818, DOI 10.1071/RD09120; GINTHER OJ, 1985, THERIOGENOLOGY, V24, P73, DOI 10.1016/0093-691X(85)90213-4; Guest DJ, 2008, STEM CELLS CLONING, V1, P1, DOI 10.2147/SCCAA.S3824; Han K, 2008, CELL PROLIFERAT, V41, P709, DOI 10.1111/j.1365-2184.2008.00553.x; Hayashi K, 2007, ENDOCRINOLOGY, V148, P3496, DOI 10.1210/en.2007-0283; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hess AP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P337; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Hwang NS, 2009, WIRES SYST BIOL MED, V1, P97, DOI 10.1002/wsbm.26; Iacono E, 2012, VET RES COMMUN, V36, P107, DOI 10.1007/s11259-012-9520-3; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kiewisz J, 2008, REPROD DOMEST ANIM, V43, P92; Kim S, 2003, ENDOCRINOLOGY, V144, P5203, DOI 10.1210/en.2003-0665; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Lange-Consiglio A, 2013, EQUINE VET J, V45, P737, DOI 10.1111/evj.12052; Lange-Consiglio A, 2012, J TISSUE ENG REGEN M, V6, P622, DOI 10.1002/term.465; Lange-Consiglio A, 2013, STEM CELLS DEV, V22, P3015, DOI 10.1089/scd.2013.0214; Lange-Consiglio A, 2013, CYTOTHERAPY, V15, P1011, DOI 10.1016/j.jcyt.2013.03.002; LeBlanc MM, 2010, REPROD DOMEST ANIM, V45, P21, DOI 10.1111/j.1439-0531.2010.01634.x; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Ma L, 1998, DEV BIOL, V197, P141, DOI 10.1006/dbio.1998.8907; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; MERKT H, 1979, EQUINE VET J, V11, P256, DOI 10.1111/j.2042-3306.1979.tb01359.x; Miller C, 1998, MECH DEVELOP, V76, P91, DOI 10.1016/S0925-4773(98)00112-9; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Paria BC, 2000, SEMIN CELL DEV BIOL, V11, P67, DOI 10.1006/scdb.2000.0153; Passeri S, 2009, CELL BIOL INT, V33, P100, DOI 10.1016/j.cellbi.2008.10.012; Ponsuksili S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042402; Rambags BPB, 2008, THERIOGENOLOGY, V69, P366, DOI 10.1016/j.theriogenology.2007.10.011; Reed SA, 2008, J CELL PHYSIOL, V215, P329, DOI 10.1002/jcp.21312; Suzuki T, 2008, INVEST OPHTH VIS SCI, V49, P1797, DOI 10.1167/iovs.07-1458; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Tuohimaa P, 1996, MATURITAS, V23, pS3, DOI 10.1016/0378-5122(96)01004-3; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762	53	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111324	10.1371/journal.pone.0111324	http://dx.doi.org/10.1371/journal.pone.0111324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360561	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700084
J	Ha, HJ; Hwang, D; Choi, WR; Baek, J; Lee, SJ				Ha, Hojin; Hwang, Dongha; Choi, Woo-Rak; Baek, Jehyun; Lee, Sang Joon			Fluid-Dynamic Optimal Design of Helical Vascular Graft for Stenotic Disturbed Flow	PLOS ONE			English	Article							SPIRAL LAMINAR-FLOW; WALL SHEAR-STRESS; OF-PLANE GEOMETRY; PULSATILE FLOW; SECONDARY FLOW; STEADY FLOW; ANASTOMOSIS; ARTERY; MECHANICS; ATHEROSCLEROSIS	Although a helical configuration of a prosthetic vascular graft appears to be clinically beneficial in suppressing thrombosis and intimal hyperplasia, an optimization of a helical design has yet to be achieved because of the lack of a detailed understanding on hemodynamic features in helical grafts and their fluid dynamic influences. In the present study, the swirling flow in a helical graft was hypothesized to have beneficial influences on a disturbed flow structure such as stenotic flow. The characteristics of swirling flows generated by helical tubes with various helical pitches and curvatures were investigated to prove the hypothesis. The fluid dynamic influences of these helical tubes on stenotic flow were quantitatively analysed by using a particle image velocimetry technique. Results showed that the swirling intensity and helicity of the swirling flow have a linear relation with a modified Germano number (Gn*) of the helical pipe. In addition, the swirling flow generated a beneficial flow structure at the stenosis by reducing the size of the recirculation flow under steady and pulsatile flow conditions. Therefore, the beneficial effects of a helical graft on the flow field can be estimated by using the magnitude of Gn*. Finally, an optimized helical design with a maximum Gn* was suggested for the future design of a vascular graft.	[Ha, Hojin; Hwang, Dongha; Choi, Woo-Rak; Baek, Jehyun; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea; [Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Ctr Biofluid & Biomim Res, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeongbuk, South Korea.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019		National Research Foundation of Korea (NRF) - Korean government (MSIP) [2008-0061991]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) under a grant funded by the Korean government (MSIP) (No. 2008-0061991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1984, J BIOMECH, V17, P695, DOI 10.1016/0021-9290(84)90123-4; AHMED SA, 1983, J BIOMECH, V16, P505, DOI 10.1016/0021-9290(83)90065-9; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Bluestein D, 1997, ANN BIOMED ENG, V25, P344, DOI 10.1007/BF02648048; CANVER CC, 1995, CHEST, V108, P1150, DOI 10.1378/chest.108.4.1150; Caro CG, 2005, J ROY SOC INTERFACE, V2, P261, DOI 10.1098/rsif.2005.0044; Caro CG, 1996, P ROY SOC A-MATH PHY, V452, P185, DOI 10.1098/rspa.1996.0011; Caro CG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0578; Cookson AN, 2010, J COMPUT APPL MATH, V234, P2069, DOI 10.1016/j.cam.2009.08.065; Cookson AN, 2009, ANN BIOMED ENG, V37, P710, DOI 10.1007/s10439-009-9636-y; Coppola G, 2009, J R SOC INTERFACE, V6, P519, DOI 10.1098/rsif.2008.0417; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; DEPAOLA N, 1992, ARTERIOSCLER THROMB, V12, P1254, DOI 10.1161/01.ATV.12.11.1254; Deutsch S, 2006, ANNU REV FLUID MECH, V38, P65, DOI 10.1146/annurev.fluid.38.050304.092022; Einav S, 2004, ANN NY ACAD SCI, V1015, P351, DOI 10.1196/annals.1302.031; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; GERMANO M, 1989, J FLUID MECH, V203, P289, DOI 10.1017/S0022112089001473; Ghista DN, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-129; Ha HJ, 2014, MED ENG PHYS, V36, P1106, DOI 10.1016/j.medengphy.2014.06.004; Ha H, 2014, MED ENG PHYS, V36, P119, DOI 10.1016/j.medengphy.2013.10.008; Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x; HE GW, 1995, ANN THORAC SURG, V59, P676, DOI 10.1016/0003-4975(94)01011-0; Houston JG, 2004, NEPHROL DIAL TRANSPL, V19, P1786, DOI 10.1093/ndt/gfh238; IRIBARNE A, 1972, AICHE J, V18, P689, DOI 10.1002/aic.690180405; ISHIBASHI H, 1995, SURGERY, V117, P409, DOI 10.1016/S0039-6060(05)80061-3; Jamison RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075722; Kang YJ, 2012, LAB CHIP, V12, P1881, DOI 10.1039/c2lc21163g; Karri S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000934; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Lee J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026301; Li XM, 2001, J BIOMECH ENG-T ASME, V123, P270, DOI 10.1115/1.1372323; LIU SJ, 1993, J FLUID MECH, V251, P315, DOI 10.1017/S002211209300343X; Mari JM, 2012, ULTRASONICS, V52, P294, DOI 10.1016/j.ultras.2011.08.015; Morbiducci U, 2011, BIOMECH MODEL MECHAN, V10, P339, DOI 10.1007/s10237-010-0238-2; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; OJHA M, 1993, J BIOMECH, V26, P1377, DOI 10.1016/0021-9290(93)90089-W; OJHA M, 1990, J VASC SURG, V12, P747, DOI 10.1067/mva.1990.24365; Papaharilaou Y, 2002, J BIOMECH, V35, P1225, DOI 10.1016/S0021-9290(02)00072-6; Paul MC, 2009, MED ENG PHYS, V31, P1195, DOI 10.1016/j.medengphy.2009.07.008; Peterson SD, 2008, J FLUID MECH, V616, P263, DOI 10.1017/S0022112008003625; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Ravensbergen J, 1998, ARTERIOSCL THROM VAS, V18, P708, DOI 10.1161/01.ATV.18.5.708; Rocklage-Marliani G, 2003, FLOW TURBUL COMBUST, V70, P43, DOI 10.1023/B:APPL.0000004913.82057.81; Sherwin SJ, 2000, J BIOMECH ENG-T ASME, V122, P86, DOI 10.1115/1.429630; Stonebridge PA, 2004, INT ANGIOL, V23, P276; STONEBRIDGE PA, 1991, LANCET, V338, P1360, DOI 10.1016/0140-6736(91)92238-W; Stonebridge PA, 1996, CLIN SCI, V91, P17, DOI 10.1042/cs0910017; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Van Canneyt K, 2013, J BIOMECH, V46, P345, DOI 10.1016/j.jbiomech.2012.10.027; Varghese SS, 2007, J FLUID MECH, V582, P253, DOI 10.1017/S0022112007005848; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Vetel J, 2008, J FLUID MECH, V607, P351, DOI 10.1017/S0022112008002188; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299; Wootton DM, 2001, ANN BIOMED ENG, V29, P321, DOI 10.1114/1.1359449; Yildiz O, 2013, PHARM ARTERIAL GRAFT; Zhan F, 2010, ASAIO J, V56, P172, DOI 10.1097/MAT.0b013e3181d0ea15; Zhan F, 2010, THROMB RES, V125, P413, DOI 10.1016/j.thromres.2009.02.011; Zheng TH, 2009, ASAIO J, V55, P192, DOI 10.1097/MAT.0b013e31819b34f2	59	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111047	10.1371/journal.pone.0111047	http://dx.doi.org/10.1371/journal.pone.0111047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360705	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700059
J	Hwang, TL; Shen, HI; Liu, FC; Tsai, HI; Wu, YC; Chang, FR; Yu, HP				Hwang, Tsong-Long; Shen, Hsin-I; Liu, Fu-Chao; Tsai, Hsin-I; Wu, Yang-Chang; Chang, Fang-Rong; Yu, Huang-Ping			Ursolic Acid Inhibits Superoxide Production in Activated Neutrophils and Attenuates Trauma-Hemorrhage Shock-Induced Organ Injury in Rats	PLOS ONE			English	Article								Neutrophil activation is associated with the development of organ injury after trauma-hemorrhagic shock. In the present study, ursolic acid inhibited the superoxide anion generation and elastase release in human neutrophils. Administration of ursolic acid attenuated trauma-hemorrhagic shock-induced hepatic and lung injuries in rats. In addition, administration of ursolic acid attenuated the hepatic malondialdehyde levels and reduced the plasma aspartate aminotransferase and alanine aminotransferase levels after trauma-hemorrhagic shock. In conclusion, ursolic acid, a bioactive natural compound, inhibits superoxide anion generation and elastase release in human neutrophils and ameliorates trauma-hemorrhagic shock-induced organ injury in rats.	[Hwang, Tsong-Long; Shen, Hsin-I] Chang Gung Univ, Coll Med, Sch Tradit Med, Grad Inst Nat Prod, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Healthy Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Liu, Fu-Chao; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Liu, Fu-Chao; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Yang-Chang] China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan; [Wu, Yang-Chang] China Med Univ Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan; [Wu, Yang-Chang; Chang, Fang-Rong] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan.	yuhp2001@adm.cgmh.org.tw	Wu, Yang-Chang/C-5682-2009; Hwang, Tsong-Long/AAE-6944-2020; Liu, Fu-Chao/AAB-3780-2021	Wu, Yang-Chang/0000-0001-7815-2686; Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053; Chang, Fang-Rong/0000-0003-2549-4193	National Science Council [102-2314-B-182A-051-MY3, 100-2628-B-182-001-MY3]; Chang Gung Memorial Hospital [CMRPG3B1052]; Chang Gung University [CMRPD1B0481similar to3, EMRPD1D901]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University	This work was partially supported by grants from the National Science Council (102-2314-B-182A-051-MY3) and Chang Gung Memorial Hospital (CMRPG3B1052) to Huang-Ping Yu. Support was also provided by the National Science Council (100-2628-B-182-001-MY3) and Chang Gung Memorial Hospital and Chang Gung University (CMRPD1B0481 similar to 3, EMRPD1D901) to Tsong-Long Hwang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosz G, 2009, BIOCHEM PHARMACOL, V77, P1303, DOI 10.1016/j.bcp.2008.11.009; Doucet DR, 2010, J TRAUMA, V68, P35, DOI 10.1097/TA.0b013e3181bbbddb; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Hwang TL, 2009, FREE RADICAL BIO MED, V46, P520, DOI 10.1016/j.freeradbiomed.2008.11.014; Jian BX, 2014, MOL MED, V20, P10, DOI 10.2119/molmed.2013.00077; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Liu FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078861; Liu FC, 2013, J TRAUMA ACUTE CARE, V74, P1027, DOI 10.1097/TA.0b013e3182858389; Liu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053203; Miller M, 2014, J TRAUMA ACUTE CARE, V76, P1409, DOI 10.1097/TA.0000000000000237; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Sandhaus RA, 2013, COPD, V10, P60, DOI 10.3109/15412555.2013.764403; Shih HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059502; Tsai YF, 2014, TRANSPL P, V46, P1082, DOI 10.1016/j.transproceed.2014.01.009; van Berlo D, 2010, FREE RADICAL BIO MED, V49, P1685, DOI 10.1016/j.freeradbiomed.2010.08.031; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215; Yu HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065916; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026; Yu HP, 2009, BIOCHEM PHARMACOL, V78, P983, DOI 10.1016/j.bcp.2009.06.008	20	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111365	10.1371/journal.pone.0111365	http://dx.doi.org/10.1371/journal.pone.0111365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360589	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700092
J	Sun, J; Zhang, Q; Zhou, J; Wei, QP				Sun, Jian; Zhang, Qiang; Zhou, Jia; Wei, Qinping			Illumina Amplicon Sequencing of 16S rRNA Tag Reveals Bacterial Community Development in the Rhizosphere of Apple Nurseries at a Replant Disease Site and a New Planting Site	PLOS ONE			English	Article							SP-NOV.; MICROBIAL COMMUNITIES; CAUSAL ROLE; GROWTH; SOIL; MANAGEMENT; DIVERSITY; IMPACT; ENZYME; MANURE	We used a next-generation, Illumina-based sequencing approach to characterize the bacterial community development of apple rhizosphere soil in a replant site (RePlant) and a new planting site (NewPlant) in Beijing. Dwarfing apple nurseries of 'Fuji'/SH6/Pingyitiancha trees were planted in the spring of 2013. Before planting, soil from the apple rhizosphere of the replant site (ReSoil) and from the new planting site (NewSoil) was sampled for analysis on the Illumina MiSeq platform. In late September, the rhizosphere soil from both sites was resampled (RePlant and NewPlant). More than 16,000 valid reads were obtained for each replicate, and the community was composed of five dominant groups (Proteobacteria, Acidobacteria, Bacteroidetes, Gemmatimonadetes and Actinobacteria). The bacterial diversity decreased after apple planting. Principal component analyses revealed that the rhizosphere samples were significantly different among treatments. Apple nursery planting showed a large impact on the soil bacterial community, and the community development was significantly different between the replanted and newly planted soils. Verrucomicrobia were less abundant in RePlant soil, while Pseudomonas and Lysobacter were increased in RePlant compared with ReSoil and NewPlant. Both RePlant and ReSoil showed relatively higher invertase and cellulase activities than NewPlant and NewSoil, but only NewPlant soil showed higher urease activity, and this soil also had the higher plant growth. Our experimental results suggest that planting apple nurseries has a significant impact on soil bacterial community development at both replant and new planting sites, and planting on new site resulted in significantly higher soil urease activity and a different bacterial community composition.	[Sun, Jian; Zhang, Qiang; Zhou, Jia; Wei, Qinping] Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, QP (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China.	qinpingwei@gmail.com			China Agriculture Research System [CARS-28]; Minister of Agriculture (PRC); Beijing Technology Foundation for Selected Overseas Chinese Scholar, Human Resource and Social Security Bureau of Beijing	China Agriculture Research System; Minister of Agriculture (PRC); Beijing Technology Foundation for Selected Overseas Chinese Scholar, Human Resource and Social Security Bureau of Beijing	This work was supported by China Agriculture Research System, CARS-28, Minister of Agriculture (PRC), (http://english.agri.gov.cn/) (QPW), and Beijing Technology Foundation for Selected Overseas Chinese Scholar, Human Resource and Social Security Bureau of Beijing (http://www.bjld.gov.cn/) (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgarani E, 2000, J RADIAT RES, V41, P19, DOI 10.1269/jrr.41.19; Atucha A, 2014, PLANT SOIL, V376, P337, DOI 10.1007/s11104-013-1977-5; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Covey Jr RP, 1979, PHYTOPATHOLOGY, V69; Drenovsky RE, 2004, SOIL BIOL BIOCHEM, V36, P1793, DOI 10.1016/j.soilbio.2004.05.002; DULLAHIDE SR, 1994, AUST J EXP AGR, V34, P1177, DOI 10.1071/EA9941177; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fan H, 2008, ACTA HORTICULTURAE S, V12, P3; Garcia-Salamanca A, 2013, MICROB BIOTECHNOL, V6, P36, DOI 10.1111/j.1751-7915.2012.00358.x; GAUTHIER MJ, 1992, INT J SYST BACTERIOL, V42, P568, DOI 10.1099/00207713-42-4-568; Golebiewski M, 2014, MICROB ECOL, V67, P635, DOI 10.1007/s00248-013-0344-7; Himani S, 2011, PLANT DIS RES, V26; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Hofmann A, 2009, J APPL BOT FOOD QUAL, V82, P193; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Kaewkla O, 2013, INT J SYST EVOL MICR, V63, P1249, DOI 10.1099/ijs.0.041343-0; Kampfer P, 2003, INT J SYST EVOL MICR, V53, P93, DOI 10.1099/ijs.0.02073-0; Kanso S, 2004, INT J SYST EVOL MICR, V54, P2141, DOI 10.1099/ijs.0.63138-0; Kausar J, 1997, INT J SYST BACTERIOL, V47, P684, DOI 10.1099/00207713-47-3-684; Lee KCY, 2011, INT J SYST EVOL MICR, V61, P2482, DOI 10.1099/ijs.0.027235-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manici LM, 2013, APPL SOIL ECOL, V72, P207, DOI 10.1016/j.apsoil.2013.07.011; Mao Y, 2014, ENV MICROBIOLOGY REP; Mazzola M, 2005, PLANT DIS, V89, P1207, DOI 10.1094/PD-89-1207; Mazzola M, 2000, PHYTOPATHOLOGY, V90, P114, DOI 10.1094/PHYTO.2000.90.2.114; Mazzola M., 2013, Aspects of Applied Biology, P69; Mazzola M, 1998, PHYTOPATHOLOGY, V88, P930, DOI 10.1094/PHYTO.1998.88.9.930; Mazzola M, 2002, PHYTOPATHOLOGY, V92, P1363, DOI 10.1094/PHYTO.2002.92.12.1363; Mazzola M, 2012, ANNU REV PHYTOPATHOL, V50, P45, DOI 10.1146/annurev-phyto-081211-173005; Qian X, 2014, APPL SOIL ECOL, V77, P18, DOI 10.1016/j.apsoil.2014.01.003; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rumberger A, 2004, PLANT SOIL, V264, P247, DOI 10.1023/B:PLSO.0000047760.13004.94; Rumberger A, 2007, SOIL BIOL BIOCHEM, V39, P1645, DOI 10.1016/j.soilbio.2007.01.023; Santoyo G, 2012, BIOCONTROL SCI TECHN, V22, P855, DOI 10.1080/09583157.2012.694413; Sato T, 2013, ISME J; SEWELL GWF, 1981, ANN APPL BIOL, V97, P31, DOI 10.1111/j.1744-7348.1981.tb02992.x; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; St Laurent A, 2010, PLANT SOIL, V337, P259, DOI 10.1007/s11104-010-0522-z; Sun J, 2014, APPL SOIL ECOL, V78, P28, DOI 10.1016/j.apsoil.2014.02.004; Sun Jian, 2013, Journal of Fruit Science, V30, P230; Tian Jia, 2012, Journal of Agricultural Science and Technology (Beijing), V14, P115; Trujillo ME, 2006, INT J SYST EVOL MICR, V56, P407, DOI 10.1099/ijs.0.63745-0; Utkhede RS, 1993, 3 INT S REPL PROBL, V363, P25; Wang D, 2003, J YUNNAN U NATURAL S, V26, P265; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilson S, 2004, SCI HORTIC-AMSTERDAM, V102, P221, DOI 10.1016/j.scienta.2004.01.001; Xie YX, 2012, NAT PROD REP, V29, P1277, DOI 10.1039/c2np20064c; Xu Z, 2012, INT J SYST EVOL MICR, V62, P1081, DOI 10.1099/ijs.0.033290-0; Yang JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046420; Yim B, 2013, PLANT SOIL, P1; Yoon MH, 2007, INT J SYST EVOL MICR, V57, P1834, DOI 10.1099/ijs.0.65011-0; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076937, 10.1371/journal.pone.0082677]	56	46	57	0	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111744	10.1371/journal.pone.0111744	http://dx.doi.org/10.1371/journal.pone.0111744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360786	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700145
J	Waheed, AA; Kuruppu, ND; Felton, KL; D'Souza, D; Freed, EO				Waheed, Abdul A.; Kuruppu, Nishani D.; Felton, Kathryn L.; D'Souza, Darren; Freed, Eric O.			In COS Cells Vpu Can Both Stabilize Tetherin Expression and Counteract Its Antiviral Activity	PLOS ONE			English	Article							PARTICLE RELEASE; INHIBITS HIV-1; RETROVIRUS RELEASE; DOWN-MODULATION; VIRUS; RESTRICTION; PROTEIN; SURFACE; ANTAGONISM; MECHANISM	The interferon-inducible cellular protein tetherin (CD317/BST-2) inhibits the release of a broad range of enveloped viruses. The HIV-1 accessory protein Vpu enhances virus particle release by counteracting this host restriction factor. While the antagonism of human tetherin by Vpu has been associated with both proteasomal and lysosomal degradation, the link between Vpu-mediated tetherin degradation and the ability of Vpu to counteract the antiviral activity of tetherin remains poorly understood. Here, we show that human tetherin is expressed at low levels in African green monkey kidney (COS) cells. However, Vpu markedly increases tetherin expression in this cell line, apparently by sequestering it in an internal compartment that bears lysosomal markers. This stabilization of tetherin by Vpu requires the transmembrane sequence of human tetherin. Although Vpu stabilizes human tetherin in COS cells, it still counteracts the ability of tetherin to suppress virus release. The enhancement of virus release by Vpu in COS cells is associated with a modest reduction in cell-surface tetherin expression, even though the overall expression of tetherin is higher in the presence of Vpu. This study demonstrates that COS cells provide a model system in which Vpu-mediated enhancement of HIV-1 release is uncoupled from Vpu-mediated tetherin degradation.	[Waheed, Abdul A.; Kuruppu, Nishani D.; Felton, Kathryn L.; D'Souza, Darren; Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waheed, AA (corresponding author), NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21701 USA.	waheedab@mail.nih.gov			Intramural Research Program of the NIH, National Cancer Institute; Intramural AIDS targeted Antiviral Program; NATIONAL CANCER INSTITUTE [ZIABC010776] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in the Freed lab is supported by the Intramural Research Program of the NIH, National Cancer Institute, and by the Intramural AIDS targeted Antiviral Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2011, J VIROL, V85, P2611, DOI 10.1128/JVI.02080-10; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Blondeau C, 2013, J VIROL, V87, P13124, DOI 10.1128/JVI.02250-13; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; FREED EO, 1994, J VIROL, V68, P2503, DOI 10.1128/JVI.68.4.2503-2512.1994; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Giese S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004189; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOTO T, 1994, BLOOD, V84, P1922; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hancock J F, 1992, Methods Mol Biol, V8, P153, DOI 10.1385/0-89603-191-8:153; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Krementsov DN, 2010, TRAFFIC, V11, P1401, DOI 10.1111/j.1600-0854.2010.01111.x; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Lemaitre C, 2014, J VIROL; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Morrison JH, 2014, J VIROL, V88, P3255, DOI 10.1128/JVI.03814-13; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Rai T, 2010, J VIROL, V84, P9783, DOI 10.1128/JVI.01584-09; Reed JC, 2012, J CELL BIOL, V198, P439, DOI 10.1083/jcb.201111012; Rollason R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075680; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00163; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Serra-Moreno R, 2011, CELL HOST MICROBE, V9, P46, DOI 10.1016/j.chom.2010.12.005; Shingai M, 2011, J VIROL, V85, P9708, DOI 10.1128/JVI.00626-11; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Tokarev Andrey, 2011, Cell Logist, V1, P90; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Wen X, 2014, J VIROL; YANG WK, 1980, P NATL ACAD SCI-BIOL, V77, P2994, DOI 10.1073/pnas.77.5.2994; Yin X, 2014, J VIROL, V88, P1259, DOI 10.1128/JVI.03148-13; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008; Zhang JY, 2010, J VIROL, V84, P12336, DOI 10.1128/JVI.01228-10	71	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111628	10.1371/journal.pone.0111628	http://dx.doi.org/10.1371/journal.pone.0111628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360760	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700131
J	Xu, LJ; Ye, HH; Huang, F; Yang, ZX; Zhu, BA; Xu, Y; Qiu, YQ; Li, LJ				Xu, Lijun; Ye, Hanhui; Huang, Fan; Yang, Zongxing; Zhu, Biao; Xu, Yan; Qiu, Yunqing; Li, Lanjuan			Moderate/Severe Hyponatremia Increases the Risk of Death among Hospitalized Chinese Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TUBERCULOUS MENINGITIS; INDEPENDENT PREDICTOR; HIV-INFECTION; PRIMARY-CARE; MORTALITY; AIDS; HORMONE; DISEASE; COMPLICATIONS	Objectives: To evaluate whether the serum sodium concentration is associated with the progression and long-term prognosis of Chinese HIV/AIDS patients. Methods: Three hundred and eighty seven hospitalized patients were recruited into this retrospective cohort study. The strata of serum sodium concentration were moderate/severe hyponatremia, mild hyponatremia and normonatremia. Disease progression was estimated using CD4 counts and the WHO clinical stage. Correlation analysis was used to evaluate the serum sodium concentration with disease progression. The Kaplan-Meier method and the Cox proportional hazards model were used to analyze the effect of different serum sodium levels on survival. Results: In this study 206 patients (53.2%) had hyponatremia, including 10.6% patients with moderate/severe hyponatremia and 42.6% with mild hyponatremia. The serum sodium concentration was significantly correlated with the HIV/AIDS progression (P<0.001). During the follow-uP, 100 patients (25.6%) died. The cumulative survival rates of HIV/AIDS patients were 47.8%+/- 8.5% in patients with moderate/severe hyponatremia, 59.8%+/- 5.0% with mild hyponatremia and 79.9%+/- 3.4% with normonatremia (log-rank P<0.001). After adjusting for sex, age, WHO stage, CD4 count, hemoglobin and albumin, the relative hazard was 3.5 (95% CI: 1.9-6.5) for patients with moderate/severe hyponatremia (P<0.001), and 1.5 (95% CI: 0.9-2.4) for those with mild hyponatremia (P = 0.161), compared with normonatremic patients. Conclusions: The serum sodium level is closely correlated with the severity of patients. Only moderate/severe hyponatremia affects the prognosis of Chinese HIV/AIDS patients. Earlier intensive medical managements(including HAART) are necessary to increase the survival rates of Chinese HIV/AIDS patients with moderate/severe hyponatremia.	[Xu, Lijun; Yang, Zongxing; Zhu, Biao; Xu, Yan; Qiu, Yunqing; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Lijun; Zhu, Biao; Qiu, Yunqing; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Ye, Hanhui] Fujian Med Univ, Fuzhou Infect Dis Hosp, Clin Ctr HIV AIDS, Fuzhou, Peoples R China; [Huang, Fan] Jianxin Hosp Fujian Prov, Dept Infect Dis, Fuzhou, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Fujian Medical University	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Xu, Lijun/AAY-2968-2020	Xu, Lijun/0000-0001-7352-2086	Ministry of Science and Technology of China [2011ZX09302-003-03]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the 12th Five-Year Significant New Drugs Creation Plan of the Ministry of Science and Technology of China (Grant Number 2011ZX09302-003-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; AGARWAL A, 1989, NEPHRON, V53, P317, DOI 10.1159/000185774; Al-Salman J, 2002, WESTERN J MED, V176, P173, DOI 10.1136/ewjm.176.3.173; [Anonymous], 2006, PAT MON GUID HIV CAR; Berggren Ruth, 2005, Curr HIV/AIDS Rep, V2, P109, DOI 10.1007/s11904-005-0002-x; Cardenas A, 2008, NEW ENGL J MED, V359, P1060, DOI 10.1056/NEJMe0805570; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Costa A, 2000, EXP NEUROL, V166, P376, DOI 10.1006/exnr.2000.7502; CUSANO AJ, 1990, J ACQ IMMUN DEF SYND, V3, P949; Dao CN, 2011, AIDS RES HUM RETROV, V27, P1149, DOI [10.1089/aid.2010.0345, 10.1089/AID.2010.0345]; DECAUX G, 1980, JAMA-J AM MED ASSOC, V244, P589, DOI 10.1001/jama.244.6.589; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Li M, 2014, BIOSCI TRENDS, V8, P52, DOI 10.5582/bst.8.52; Milionis HJ, 2002, CAN MED ASSOC J, V166, P1056; Momi J, 2010, J HOSP MED, V5, P193, DOI 10.1002/jhm.516; Moore DM, 2006, HIV MED, V7, P383, DOI 10.1111/j.1468-1293.2006.00397.x; Morse CG, 2006, JAMA-J AM MED ASSOC, V296, P844, DOI 10.1001/jama.296.7.844; NAROTAM PK, 1994, NEUROSURGERY, V34, P982, DOI 10.1227/00006123-199406000-00005; Nettles R, 2002, INFECT DIS CLIN PRAC, V11, P361; Nzerue CM, 2003, J NATL MED ASSOC, V95, P335; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Olawumi HO, 2006, HIV MED, V7, P351, DOI 10.1111/j.1468-1293.2006.00391.x; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Piacenti FJ, 2006, PHARMACOTHERAPY, V26, P1111, DOI 10.1592/phco.26.8.1111; PURBA JS, 1993, BRAIN, V116, P795, DOI 10.1093/brain/116.4.795; Quinn TC, 2008, AIDS, V22, pS7, DOI 10.1097/01.aids.0000327510.68503.e8; Schambelan M, 2002, JAIDS-J ACQ IMM DEF, V31, P257, DOI 10.1097/00126334-200211010-00001; Smellie WSA, 2007, BMJ-BRIT MED J, V334, P473, DOI 10.1136/bmj.39098.744560.47; TANG WW, 1993, AM J MED, V94, P169, DOI 10.1016/0002-9343(93)90179-S; Uno K, 2007, INTERNAL MED, V46, P617, DOI 10.2169/internalmedicine.46.1886; VITTING KE, 1990, JAMA-J AM MED ASSOC, V263, P973, DOI 10.1001/jama.263.7.973; Wanke CA, 2002, CLIN INFECT DIS, V34, P248, DOI 10.1086/324744; WHO, 2010, ANT THER HIV INF AD; Wong KH, 2011, LANCET INFECT DIS, V11, P491, DOI 10.1016/S1473-3099(11)70118-9; World Health Organization, 2006, ANT THER HIV INF AD; Xu J, 2007, AIDS PATIENT CARE ST, V21, P787, DOI 10.1089/apc.2007.0005; Zhang F, 2012, CHINA FREE ART MANUA; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2007, CHINA FREE ART MANUA; Zhao DC, 2012, CHINESE MED J-PEKING, V125, P3514, DOI 10.3760/cma.j.issn.0366-6999.2012.19.028; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111077	10.1371/journal.pone.0111077	http://dx.doi.org/10.1371/journal.pone.0111077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360785	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700062
J	Brennan, CM; Mazzucca, NQ; Mezoian, T; Hunt, TM; Keane, ML; Leonard, JN; Scola, SE; Beer, EN; Perdue, S; Pellock, BJ				Brennan, Christopher M.; Mazzucca, Nicholas Q.; Mezoian, Taylor; Hunt, Taylor M.; Keane, Meaghan L.; Leonard, Jessica N.; Scola, Shelby E.; Beer, Emma N.; Perdue, Sarah; Pellock, Brett J.			Reduced Heme Levels Underlie the Exponential Growth Defect of the Shewanella oneidensis hfq Mutant	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; RNA; BIOSYNTHESIS; CYTOCHROMES; PROTEIN; GENOME; IDENTIFICATION; EXPRESSION; MANGANESE	The RNA chaperone Hfq fulfills important roles in small regulatory RNA (sRNA) function in many bacteria. Loss of Hfq in the dissimilatory metal reducing bacterium Shewanella oneidensis strain MR-1 results in slow exponential phase growth and a reduced terminal cell density at stationary phase. We have found that the exponential phase growth defect of the hfq mutant in LB is the result of reduced heme levels. Both heme levels and exponential phase growth of the hfq mutant can be completely restored by supplementing LB medium with 5-aminolevulinic acid (5-ALA), the first committed intermediate synthesized during heme synthesis. Increasing expression of gtrA, which encodes the enzyme that catalyzes the first step in heme biosynthesis, also restores heme levels and exponential phase growth of the hfq mutant. Taken together, our data indicate that reduced heme levels are responsible for the exponential growth defect of the S. oneidensis hfq mutant in LB medium and suggest that the S. oneidensis hfq mutant is deficient in heme production at the 5-ALA synthesis step.	[Brennan, Christopher M.; Mazzucca, Nicholas Q.; Mezoian, Taylor; Hunt, Taylor M.; Keane, Meaghan L.; Leonard, Jessica N.; Beer, Emma N.; Perdue, Sarah; Pellock, Brett J.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Scola, Shelby E.] Providence Coll, Dept Chem & Biochem, Providence, RI 02918 USA	Providence College; Providence College	Pellock, BJ (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.	bpellock@providence.edu		Pelletier, Jessica/0000-0003-1494-6764; Beer, Emma/0000-0001-7891-6228; /0000-0002-9399-7174	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [2 P20 GM103430]; Rhode Island IDeA Network for Excellence in Biomedical Research (RI-INBRE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Rhode Island IDeA Network for Excellence in Biomedical Research (RI-INBRE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number 2 P20 GM103430. IDeA website address: http://www.nigms.nih.gov/Training/IDeA/Pages/default.aspx. BJP's funding was awarded as a sub-project of the above grant through Rhode Island IDeA Network for Excellence in Biomedical Research (RI-INBRE, http://web.uri.edu/inbre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bouhenni R, 2005, APPL ENVIRON MICROB, V71, P4935, DOI 10.1128/AEM.71.8.4935-4937.2005; Brennan CM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-33; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Kane AL, 2013, ACS SYNTH BIOL, V2, P93, DOI 10.1021/sb300042w; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Muffler A, 1997, J BACTERIOL, V179, P445; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Panja S, 2012, J MOL BIOL, V417, P406, DOI 10.1016/j.jmb.2012.02.009; Schobert M, 2002, J MOL MICROB BIOTECH, V4, P287; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Simon R., 1983, NAT BIOTECHNOL, V1, P784, DOI [10.1038/nbt1183-784, DOI 10.1038/NBT1183-784]; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	31	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109879	10.1371/journal.pone.0109879	http://dx.doi.org/10.1371/journal.pone.0109879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356668	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000008
J	Chen, LJ; Phillips, MI; Miao, HL; Zeng, R; Qin, GJ; Kim, IM; Weintraub, NL; Tang, YL				Chen, Lijuan; Phillips, M. Ian; Miao, Hui-Lai; Zeng, Rong; Qin, Gangjian; Kim, Il-Man; Weintraub, Neal L.; Tang, Yaoliang			Infrared Fluorescent Protein 1.4 Genetic Labeling Tracks Engrafted Cardiac Progenitor Cells in Mouse Ischemic Hearts	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIATION; THERAPY; TRANSPLANTATION; CARDIOMYOCYTES; INHIBITION; EXPRESSION; BIOLOGY; DEEPER	Stem cell therapy has a potential for regenerating damaged myocardium. However, a key obstacle to cell therapy's success is the loss of engrafted cells due to apoptosis or necrosis in the ischemic myocardium. While many strategies have been developed to improve engrafted cell survival, tools to evaluate cell efficacy within the body are limited. Traditional genetic labeling tools, such as GFP-like fluorescent proteins (eGFP, DsRed, mCherry), have limited penetration depths in vivo due to tissue scattering and absorption. To circumvent these limitations, a near-infrared fluorescent mutant of the DrBphP bacteriophytochrome from Deinococcus radiodurans, IFP1.4, was developed for in vivo imaging, but it has yet to be used for in vivo stem/progenitor cell tracking. In this study, we incorporated IFP1.4 into mouse cardiac progenitor cells (CPCs) by a lentiviral vector. Live IFP1.4-labeled CPCs were imaged by their near-infrared fluorescence (NIRF) using an Odyssey scanner following overnight incubation with biliverdin. A significant linear correlation was observed between the amount of cells and NIRF signal intensity in in vitro studies. Lentiviral mediated IFP1.4 gene labeling is stable, and does not impact the apoptosis and cardiac differentiation of CPC. To assess efficacy of our model for engrafted cells in vivo, IFP1.4-labeled CPCs were intramyocardially injected into infarcted hearts. NIRF signals were collected at 1-day, 7-days, and 14-days post-injection using the Kodak in vivo multispectral imaging system. Strong NIRF signals from engrafted cells were imaged 1 day after injection. At 1 week after injection, 70% of the NIRF signal was lost when compared to the intensity of the day 1 signal. The data collected 2 weeks following transplantation showed an 88% decrease when compared to day 1. Our studies have shown that IFP1.4 gene labeling can be used to track the viability of transplanted cells in vivo.	[Chen, Lijuan] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Phillips, M. Ian] Keck Grad Inst, Claremont, CA USA; [Miao, Hui-Lai; Zeng, Rong] Guangdong Med Coll, Affiliated Hosp, Zhanjiang, Peoples R China; [Qin, Gangjian] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Chen, Lijuan; Weintraub, Neal L.; Tang, Yaoliang] Univ Cincinnati, Dept Med, Cincinnati, OH 45220 USA; [Kim, Il-Man; Weintraub, Neal L.; Tang, Yaoliang] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Dept Med, Augusta, GA USA	Southeast University - China; Claremont Colleges; Keck Graduate Institute; Guangdong Medical University; Northwestern University; Feinberg School of Medicine; University System of Ohio; University of Cincinnati; University System of Georgia; Augusta University	Tang, YL (corresponding author), Univ Cincinnati, Dept Med, Cincinnati, OH 45220 USA.	yaotang@gru.edu		Kim, Il-man/0000-0002-9268-8337; Weintraub, Neal/0000-0002-5138-3705; Tang, Yaoliang/0000-0002-8372-1545	American Heart Association Beginning [0765094Y]; National Institutes of Health [HL086555]; NIH [HL076684, HL62984]; National Natural Science Foundation of China [81270203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112640, R01HL086555, R01HL076684, P01HL062984, R01HL124251] Funding Source: NIH RePORTER	American Heart Association Beginning(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association Beginning Grant-in-Aid 0765094Y (to Y.T.); National Institutes of Health grant HL086555 (to Y.T.), and NIH grants HL076684 and HL62984 (to N.L.W.). National Natural Science Foundation of China (No. 81270203, to L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2011, MOL IMAGING BIOL, V13, P633, DOI 10.1007/s11307-010-0392-z; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; Chen LJ, 2012, STEM CELLS DEV, V21, P2122, DOI 10.1089/scd.2011.0463; Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Lecoq J, 2011, NAT BIOTECHNOL, V29, P715, DOI 10.1038/nbt.1941; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Nyolczas N, 2009, REGEN MED, V4, P407, DOI 10.2217/RME.09.14; Rajasingh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022550; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tang YLL, 2013, EXP BIOL MED, V238, P294, DOI 10.1177/1535370213477982; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Yang G, 2012, CELL TRANSPLANT, V21, P985, DOI 10.3727/096368911X593145; Yu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4626; Zhang L, 2014, CELL CYCLE, V13, P762, DOI 10.4161/cc.27677	20	6	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e107841	10.1371/journal.pone.0107841	http://dx.doi.org/10.1371/journal.pone.0107841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357000	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000002
J	Day, K; Song, J; Absher, D				Day, Kenneth; Song, Jun; Absher, Devin			Targeted Sequencing of Large Genomic Regions with CATCH-Seq	PLOS ONE			English	Article							ENRICHMENT; DISEASES; AMPLIFICATION; SELECTION; VARIANTS	Current target enrichment systems for large-scale next-generation sequencing typically require synthetic oligonucleotides used as capture reagents to isolate sequences of interest. The majority of target enrichment reagents are focused on gene coding regions or promoters en masse. Here we introduce development of a customizable targeted capture system using biotinylated RNA probe baits transcribed from sheared bacterial artificial chromosome clone templates that enables capture of large, contiguous blocks of the genome for sequencing applications. This clone adapted template capture hybridization sequencing (CATCH-Seq) procedure can be used to capture both coding and non-coding regions of a gene, and resolve the boundaries of copy number variations within a genomic target site. Furthermore, libraries constructed with methylated adapters prior to solution hybridization also enable targeted bisulfite sequencing. We applied CATCH-Seq to diverse targets ranging in size from 125 kb to 3.5 Mb. Our approach provides a simple and cost effective alternative to other capture platforms because of template-based, enzymatic probe synthesis and the lack of oligonucleotide design costs. Given its similarity in procedure, CATCH-Seq can also be performed in parallel with commercial systems.	[Day, Kenneth; Song, Jun; Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA	HudsonAlpha Institute for Biotechnology	Absher, D (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.	dabsher@hudsonalpha.org		Day, Kenneth/0000-0001-8235-8302				Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Borate U, 2012, EXPERT REV ANTICANC, V12, P1289, DOI [10.1586/era.12.116, 10.1586/ERA.12.116]; Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goh Gerald, 2012, Genomics & Informatics, V10, P214, DOI 10.5808/GI.2012.10.4.214; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johansson H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1005; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050386; Varley KE, 2008, GENOME RES, V18, P1844, DOI 10.1101/gr.078204.108; Whitcomb DC, 2012, NAT REV GASTRO HEPAT, V9, P418, DOI 10.1038/nrgastro.2012.100; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Yigit E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt081	23	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111756	10.1371/journal.pone.0111756	http://dx.doi.org/10.1371/journal.pone.0111756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357200	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000076
J	Plat, J; Hendrikx, T; Bieghs, V; Jeurissen, MLJ; Walenbergh, SMA; van Gorp, PJ; De Smet, E; Konings, M; Vreugdenhil, ACE; Guichot, YD; Rensen, SS; Buurman, WA; Greve, JWM; Lutjohann, D; Mensink, RP; Shiri-Sverdlov, R				Plat, Jogchum; Hendrikx, Tim; Bieghs, Veerle; Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; De Smet, Els; Konings, Maurice; Vreugdenhil, Anita C. E.; Guichot, Yasmin Dias; Rensen, Sander S.; Buurman, Wim A.; Greve, Jan Willem M.; Lutjohann, Dieter; Mensink, Ronald P.; Shiri-Sverdlov, Ronit			Protective Role of Plant Sterol and Stanol Esters in Liver Inflammation: Insights from Mice and Humans	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; CHOLESTEROL-METABOLISM; ACTIVATION; DISEASE; DESMOSTEROL; INHIBITION; MICROBIOTA; SYSTEM	The inflammatory component of non-alcoholic steatohepatitis (NASH) can lead to irreversible liver damage. Therefore there is an urgent need to identify novel interventions to combat hepatic inflammation. In mice, omitting cholesterol from the diet reduced hepatic inflammation. Considering the effects of plant sterol/stanol esters on cholesterol metabolism, we hypothesized that plant sterol/stanol esters reduces hepatic inflammation. Indeed, adding plant sterol/stanol esters to a high-fat-diet reduced hepatic inflammation as indicated by immunohistochemical stainings and gene expression for inflammatory markers. Finally, adding sterol/stanol esters lowered hepatic concentrations of cholesterol precursors lathosterol and desmosterol in mice, which were highly elevated in the HFD group similarly as observed in severely obese patients with NASH. In vitro, in isolated LPS stimulated bone marrow derived macrophages desmosterol activated cholesterol efflux whereas sitostanol reduced inflammation. This highly interesting observation that plant sterol/stanol ester consumption leads to complete inhibition of HFD-induced liver inflammation opens new venues in the treatment and prevention of hepatic inflammation.	[Plat, Jogchum; De Smet, Els; Konings, Maurice; Mensink, Ronald P.] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Hendrikx, Tim; Bieghs, Veerle; Jeurissen, Mike L. J.; Walenbergh, Sofie M. A.; van Gorp, Patrick J.; Guichot, Yasmin Dias; Shiri-Sverdlov, Ronit] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Mol Genet, Maastricht, Netherlands; [Vreugdenhil, Anita C. E.] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Pediat, Maastricht, Netherlands; [Rensen, Sander S.; Buurman, Wim A.; Greve, Jan Willem M.] Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Gen Surg, Maastricht, Netherlands; [Lutjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Greve, Jan Willem M.] Atrium Med Ctr Parkstad, Heerlen, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Bonn; Atrium Medical Center	Plat, J (corresponding author), Maastricht Univ, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands.	J.Plat@maastrichtuniversity.nl; R.Sverdlov@maastrichtuniversity.nl	van Gorp, Patrick/S-3892-2019; van Gorp, Patrick/L-9580-2018; Shiri-Sverdlov, Ronit/E-5571-2017; Hendrikx, Tim/AAI-8252-2021; Rensen, Sander/J-3224-2019; Hendrikx, Tim/AAE-2329-2020; Shiri-Sverdlov, Ronit/X-2642-2019	van Gorp, Patrick/0000-0002-0355-5349; van Gorp, Patrick/0000-0002-0355-5349; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Hendrikx, Tim/0000-0002-3381-2107; Rensen, Sander/0000-0001-5054-8400; Shiri-Sverdlov, Ronit/0000-0002-6736-7814				Baumgartner S, 2011, CURR PHARM DESIGN, V17, P922, DOI 10.2174/138161211795428795; Bayard M, 2006, AM FAM PHYSICIAN, V73, P1961; Bieghs V, 2013, GASTROENTEROLOGY, V144, P167, DOI 10.1053/j.gastro.2012.09.062; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034378; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Brull F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046895; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Martinez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Ostlund RE, 2002, ANNU REV NUTR, V22, P533, DOI 10.1146/annurev.nutr.22.020702.075220; Plat J, 2005, J LIPID RES, V46, P2468, DOI 10.1194/jlr.M500272-JLR200; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Simonen M, 2013, HEPATOLOGY, V58, P976, DOI 10.1002/hep.26342; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Thelen KM, 2006, J CLIN PHARMACOL, V46, P812, DOI 10.1177/0091270006289851; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x	22	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110758	10.1371/journal.pone.0110758	http://dx.doi.org/10.1371/journal.pone.0110758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356831	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000024
J	Zheng, YT; Li, HB; Lu, MX; Du, YZ				Zheng, Yu-Tao; Li, Hong-Bo; Lu, Ming-Xing; Du, Yu-Zhou			Evaluation and Validation of Reference Genes for qRT-PCR Normalization in Frankliniella occidentalis (Thysanoptera: Thripidae)	PLOS ONE			English	Article							REAL-TIME PCR; WESTERN FLOWER THRIPS; RT-PCR; HOUSEKEEPING GENES; EXPRESSION ANALYSIS; QUANTIFICATION; IDENTIFICATION; TRANSMISSION; RESISTANCE; CLONING	Quantitative real time PCR (qRT-PCR) has emerged as a reliable and reproducible technique for studying gene expression analysis. For accurate results, the normalization of data with reference genes is particularly essential. Once the transcriptome sequencing of Frankliniella occidentalis was completed, numerous unigenes were identified and annotated. Unfortunately, there are no studies on the stability of reference genes used in F. occidentalis. In this work, seven candidate reference genes, including actin, 18S rRNA, H3, tubulin, GAPDH, EF-1 and RPL32, were evaluated for their suitability as normalization genes under different experimental conditions using the statistical software programs BestKeeper, geNorm, Normfinder and the comparative Delta Ct method. Because the rankings of the reference genes provided by each of the four programs were different, we chose a user-friendly web-based comprehensive tool RefFinder to get the final ranking. The result demonstrated that EF-1 and RPL32 displayed the most stable expression in different developmental stages; RPL32 and GAPDH showed the most stable expression at high temperatures, while 18S and EF-1 exhibited the most stable expression at low temperatures. In this study, we validated the suitable reference genes in F. occidentalis for gene expression profiling under different experimental conditions. The choice of internal standard is very important in the normalization of the target gene expression levels, thus validating and selecting the best genes will help improve the quality of gene expression data of F. occidentalis. What is more, these validated reference genes could serve as the basis for the selection of candidate reference genes in other insects.	[Zheng, Yu-Tao; Li, Hong-Bo; Lu, Ming-Xing; Du, Yu-Zhou] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Peoples R China; [Zheng, Yu-Tao; Li, Hong-Bo; Lu, Ming-Xing; Du, Yu-Zhou] Yangzhou Univ, Inst Appl Entomol, Yangzhou, Peoples R China; [Li, Hong-Bo] Guizhou Inst Plant Protect, Guiyang, Peoples R China	Yangzhou University; Yangzhou University; Guizhou Academy of Agricultural Sciences	Du, YZ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Peoples R China.	yzdu@yzu.edu.cn			Special Fund for Agro-scientific Research in the Public Interest of China [201103026, 200803025]	Special Fund for Agro-scientific Research in the Public Interest of China	This research was funded by Special Fund for Agro-scientific Research in the Public Interest of China (201103026, 200803025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2004, AZ QUANT PCR; Bielza P, 2007, PEST MANAG SCI, V63, P682, DOI 10.1002/ps.1388; Boava Leonardo P, 2010, BMC Res Notes, V3, P43, DOI 10.1186/1756-0500-3-43; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chen XL, 2011, PESTIC BIOCHEM PHYS, V101, P34, DOI 10.1016/j.pestbp.2011.07.001; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Li HB, 2011, J THERM BIOL, V36, P437, DOI 10.1016/j.jtherbio.2011.07.010; Li HB, 2013, GENE, V520, P148, DOI 10.1016/j.gene.2013.02.026; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Lu MX, 2014, CELL STRESS CHAPERON, V19, P91, DOI 10.1007/s12192-013-0437-8; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Provenzano M, 2007, EUREKAH BIOSCIENCE, V2, P510; Reitz SR, 2009, FLA ENTOMOL, V92, P7, DOI 10.1653/024.092.0102; Rotenberg D, 2010, INSECT MOL BIOL, V19, P537, DOI 10.1111/j.1365-2583.2010.01012.x; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shen Y, 2011, J INSECT PHYSIOL, V57, P908, DOI 10.1016/j.jinsphys.2011.03.026; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tommasini MG., 1995, WAGENINGEN AGR U PAP, V95, P1; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Yang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098164; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhang ZJ, 2013, GENOMICS, V101, P296, DOI 10.1016/j.ygeno.2013.02.005; 张友军, 2003, [植物保护, Plant Protection], V29, P58	43	31	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111369	10.1371/journal.pone.0111369	http://dx.doi.org/10.1371/journal.pone.0111369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356721	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000056
J	MacDonald, EC; Frost, EH; MacNeil, SM; Hamilton, DJ; Barbeau, MA				MacDonald, Elizabeth C.; Frost, Elisabeth H.; MacNeil, Stephanie M.; Hamilton, Diana J.; Barbeau, Myriam A.			Behavioral Response of Corophium volutator to Shorebird Predation in the Upper Bay of Fundy, Canada	PLOS ONE			English	Article							MIGRATING SEMIPALMATED SANDPIPERS; REDSHANK TRINGA-TOTANUS; RISK TRADE-OFF; PREY AVAILABILITY; CALIDRIS-PUSILLA; VERTICAL-DISTRIBUTION; REPRODUCTIVE-BIOLOGY; ARENARIUM CRUSTACEA; ILYANASSA-OBSOLETA; AVOIDANCE-BEHAVIOR	Predator avoidance is an important component of predator-prey relationships and can affect prey availability for foraging animals. Each summer, the burrow-dwelling amphipod Corophium volutator is heavily preyed upon by Semipalmated Sandpipers (Calidris pusilla) on mudflats in the upper Bay of Fundy, Canada. We conducted three complementary studies to determine if adult C. volutator exhibit predator avoidance behavior in the presence of sandpipers. In a field experiment, we monitored vertical distribution of C. volutator adults in bird exclosures and adjacent control plots before sandpipers arrived and during their stopover. We also made polymer resin casts of C. volutator burrows in the field throughout the summer. Finally, we simulated shorebird pecking in a lab experiment and observed C. volutator behavior in their burrows. C. volutator adults were generally distributed deeper in the sediment later in the summer (after sandpipers arrived). In August, this response was detectably stronger in areas exposed to bird predation than in bird exclosures. During peak predator abundance, many C. volutator adults were beyond the reach of feeding sandpipers (>1.5 cm deep). However, burrow depth did not change significantly throughout the summer. Detailed behavioral observations indicated that C. volutator spent more time at the bottom of their burrow when exposed to a simulated predator compared to controls. This observed redistribution suggests that C. volutator adults move deeper into their burrows as an anti-predator response to the presence of sandpipers. This work has implications for predators that feed on burrow-dwelling invertebrates in soft-sediment ecosystems, as density may not accurately estimate prey availability.	[MacDonald, Elizabeth C.; Frost, Elisabeth H.; Hamilton, Diana J.] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [MacNeil, Stephanie M.; Barbeau, Myriam A.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	Mount Allison University; University of New Brunswick	MacDonald, EC (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	ecmacdonald@mta.ca			Natural Sciences and Engineering Research Council of Canada; Canada Summer Jobs Program; Mprime (a Network of Centres of Excellence for the mathematical sciences); New Brunswick Wildlife Trust Fund; Science Horizons Youth Internship Program (Environment Canada); Mount Allison Biology Department Ruggles-Gates Undergraduate Research Fellowship; Mount Allison University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Summer Jobs Program; Mprime (a Network of Centres of Excellence for the mathematical sciences); New Brunswick Wildlife Trust Fund; Science Horizons Youth Internship Program (Environment Canada); Mount Allison Biology Department Ruggles-Gates Undergraduate Research Fellowship; Mount Allison University	Funding was provided by Natural Sciences and Engineering Research Council of Canada (Discovery Grants to DJH and MAB and Undergraduate Summer Research Award to EHF), the Canada Summer Jobs Program, Mprime (a Network of Centres of Excellence for the mathematical sciences), New Brunswick Wildlife Trust Fund, the Science Horizons Youth Internship Program (Environment Canada), Mount Allison Biology Department Ruggles-Gates Undergraduate Research Fellowship (to field assistant C. E. Gilroy) and Mount Allison University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backwell PRY, 1998, ANIM BEHAV, V55, P1659, DOI 10.1006/anbe.1997.0713; Barbeau MA, 2009, J CRUSTACEAN BIOL, V29, P491, DOI 10.1651/08-3067.1; Barrett K., 2008, SPSS INTERMEDIATE ST, V3rd ed.; Beauchamp G, 2006, WATERBIRDS, V29, P221, DOI 10.1675/1524-4695(2006)29[221:STAWFI]2.0.CO;2; Beauchamp G, 2005, ETHOLOGY, V111, P785, DOI 10.1111/j.1439-0310.2005.01095.x; Beauchamp G, 2007, OECOLOGIA, V154, P403, DOI 10.1007/s00442-007-0818-8; Beauchamp G, 2009, OECOLOGIA, V161, P651, DOI 10.1007/s00442-009-1398-6; BOATES JS, 1995, ECOSCIENCE, V2, P123, DOI 10.1080/11956860.1995.11682276; BOATES JS, 1989, CAN J ZOOL, V67, P457, DOI 10.1139/z89-066; Boates JS, 1980, THESIS ACADIA U WOLF; Boudreau MR, 2012, MAR ECOL PROG SER, V465, P137, DOI 10.3354/meps09897; Bringloe TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069091; Brodin T, 2004, ECOLOGY, V85, P2927, DOI 10.1890/03-3120; Burnham J.P., 2002, MODEL SELECTION MULT; CAMPBELL JI, 1974, EXPERIENTIA, V30, P1396, DOI 10.1007/BF01919655; CHARNOV EL, 1976, AM NAT, V110, P247, DOI 10.1086/283062; Cheverie AV, 2014, J SEA RES IN PRESS; Coffin MRS, 2012, J EXP MAR BIOL ECOL, V418, P12, DOI 10.1016/j.jembe.2012.03.002; Coulthard ME, 2011, J EXP MAR BIOL ECOL, V397, P161, DOI 10.1016/j.jembe.2010.12.001; Crewe TL, 2001, ESTUAR COAST SHELF S, V53, P151, DOI 10.1006/ecss.2001.0795; De Backer A, 2010, HELGOLAND MAR RES, V64, P63, DOI 10.1007/s10152-009-0167-6; Dill LM, 1997, BEHAV ECOL, V8, P186, DOI 10.1093/beheco/8.2.186; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Drolet D, 2012, J SEA RES, V70, P1, DOI 10.1016/j.seares.2012.02.001; Drolet D, 2009, J CRUSTACEAN BIOL, V29, P51, DOI 10.1651/08-3010.1; Durell SEALD, 2000, BIOL REV, V75, P503; FISH JD, 1979, J MAR BIOL ASSOC UK, V59, P355, DOI 10.1017/S002531540004265X; Flynn AM, 2010, J EXP MAR BIOL ECOL, V383, P32, DOI 10.1016/j.jembe.2009.10.017; Forbes MR, 1996, CAN J ZOOL, V74, P1479, DOI 10.1139/z96-162; Gilroy CE, 2012, THESIS MOUNT ALLISON; Gingras MK, 2002, PALAIOS, V17, P206, DOI 10.1669/0883-1351(2002)017<0206:RCOMBP>2.0.CO;2; GOSSCUSTARD JD, 1977, J ANIM ECOL, V46, P21, DOI 10.2307/3944; GOSSCUSTARD JD, 1980, ARDEA, V68, P31; GOSSCUSTARD JD, 1970, J ANIM ECOL, V39, P91, DOI 10.2307/2891; GRATTO GW, 1984, CAN J ZOOL, V62, P1889, DOI 10.1139/z84-276; Gratto-Trevor C, 2012, WATERBIRDS, V35, P83, DOI 10.1675/063.035.0109; Griffiths CL, 2006, J EXP MAR BIOL ECOL, V331, P91, DOI 10.1016/j.jembe.2005.10.002; Hamilton DJ, 2006, HYDROBIOLOGIA, V567, P285, DOI 10.1007/s10750-006-0062-y; Hamilton DJ, 2003, CAN J ZOOL, V81, P1358, DOI 10.1139/Z03-130; Hicklin PW, 2012, WATERBIRDS, V35, P74, DOI 10.1675/063.035.0108; HICKLIN PW, 1984, CAN J ZOOL, V62, P2201, DOI 10.1139/z84-321; HICKLIN PW, 1987, WILSON BULL, V99, P540; HILL C, 1987, OIKOS, V49, P221, DOI 10.2307/3566029; Holohan BA, 1998, ESTUARIES, V21, P466, DOI 10.2307/1352844; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; Keppel G, 1991, DESIGN ANAL RES HDB; Kicklighter CE, 2007, OECOLOGIA, V151, P161, DOI 10.1007/s00442-006-0567-0; Kruse I, 2000, HYDROBIOLOGIA, V426, P43, DOI 10.1023/A:1003955523468; Lawrie SM, 1998, J EXP MAR BIOL ECOL, V224, P237, DOI 10.1016/S0022-0981(97)00199-8; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Limia J, 1997, J MAR BIOL ASSOC UK, V77, P409, DOI 10.1017/S0025315400071769; Lindquist N, 1996, ECOL MONOGR, V66, P431, DOI 10.2307/2963489; MacDonald EC, 2012, CONDOR, V114, P135, DOI 10.1525/cond.2012.100246; Manzur T, 2014, J ANIM ECOL, V83, P923, DOI 10.1111/1365-2656.12199; Mathews SL, 1992, ECOGRAPHY, V15, P393; McCurdy DG, 2005, J CRUSTACEAN BIOL, V25, P558, DOI 10.1651/C-2539.1; McCurdy DG, 2000, OIKOS, V88, P301, DOI 10.1034/j.1600-0706.2000.880208.x; McPeek MA, 2004, AM NAT, V163, pE88, DOI 10.1086/382755; MEADOWS PS, 1966, J ZOOL, V150, P387; Meerhoff M, 2007, FRESHWATER BIOL, V52, P1009, DOI 10.1111/j.1365-2427.2007.01748.x; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1981, ECOL MONOGR, V51, P429, DOI 10.2307/2937323; MILLS A, 1980, MAR BIOL, V58, P153, DOI 10.1007/BF00396127; Minderman J, 2006, J ANIM ECOL, V75, P713, DOI 10.1111/j.1365-2656.2006.01092.x; MYERS JP, 1980, CAN J ZOOL, V58, P1564, DOI 10.1139/z80-216; Neima SG, 2014, THESIS MOUNT ALLISON; Norusis M., 2008, SPSS 16 0 ADV STAT P; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Paterson RA, 2013, ANIM BEHAV, V86, P1301, DOI 10.1016/j.anbehav.2013.09.036; PEER DL, 1986, NETH J SEA RES, V20, P359, DOI 10.1016/0077-7579(86)90003-7; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Quinn JT, 2012, CAN J ZOOL, V90, P1181, DOI 10.1139/Z2012-086; R Core Team, 2020, R LANG ENV STAT COMP; RAFFAELLI D, 1987, ESTUAR COAST SHELF S, V24, P1, DOI 10.1016/0272-7714(87)90002-3; Riisgard HU, 2007, MAR BIOL RES, V3, P421, DOI 10.1080/17451000701696302; Robar NDP, 2006, THESIS MOUNT ALLISON; Robar NDP, 2007, WATERBIRDS, V30, P116, DOI 10.1675/1524-4695(2007)030[0116:AMFEHU]2.0.CO;2; SELMAN J, 1988, ANIM BEHAV, V36, P1542, DOI 10.1016/S0003-3472(88)80226-4; SPSS Inc, 2006, SPSS VERS 16 0; Stillman RA, 2000, BEHAV ECOL, V11, P597, DOI 10.1093/beheco/11.6.597; STODDARD PK, 1983, ANIM BEHAV, V31, P173, DOI 10.1016/S0003-3472(83)80186-9; Strobbe F, 2011, BEHAV ECOL SOCIOBIOL, V65, P241, DOI 10.1007/s00265-010-1032-y; Tallqvist M, 2001, MAR ECOL PROG SER, V212, P183, DOI 10.3354/meps212183; Vader W, 1964, NETH J SEA RES, V2, P189; Vieira EA, 2012, J EXP MAR BIOL ECOL, V412, P126, DOI 10.1016/j.jembe.2011.11.011; Wallace EH, 2008, THESIS MOUNT ALLISON; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WILSON WH, 1989, J EXP MAR BIOL ECOL, V132, P221, DOI 10.1016/0022-0981(89)90129-9; WILSON WH, 1990, ANNU REV ECOL SYST, V21, P221, DOI 10.1146/annurev.ecolsys.21.1.221; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yates MG, 2000, J ANIM ECOL, V69, P314, DOI 10.1046/j.1365-2656.2000.00394.x; Zar JH, 1999, BIOSTATISTICAL ANAL; ZWARTS L, 1989, MAR ECOL PROG SER, V56, P255, DOI 10.3354/meps056255	96	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110633	10.1371/journal.pone.0110633	http://dx.doi.org/10.1371/journal.pone.0110633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354218	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200031
J	Sundaram, S; Freemerman, AJ; Galanko, JA; McNaughton, KK; Bendt, KM; Darr, DB; Troester, MA; Makowski, L				Sundaram, Sneha; Freemerman, Alex J.; Galanko, Joseph A.; McNaughton, Kirk K.; Bendt, Katharine M.; Darr, David B.; Troester, Melissa A.; Makowski, Liza			Obesity-Mediated Regulation of HGF/c-Met Is Associated with Reduced Basal-Like Breast Cancer Latency in Parous Mice	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; MAMMARY-GLAND; WEIGHT-GAIN; RISK; PREGNANCY; TUMORIGENESIS; EPIDEMIOLOGY; INFLAMMATION; SUBTYPES	It is widely thought that pregnancy reduces breast cancer risk, but this lacks consideration of breast cancer subtypes. While a full term pregnancy reduces risk for estrogen receptor positive (ER+) and luminal breast cancers, parity is associated with increased risk of basal-like breast cancer (BBC) subtype. Basal-like subtypes represent less than 10% of breast cancers and are highly aggressive, affecting primarily young, African American women. Our previous work demonstrated that high fat diet-induced obesity in nulliparous mice significantly blunted latency in C3(1)-T-Ag mice, a model of BBC, potentially through the hepatocyte growth factor (HGF)/c-Met oncogenic pathway. Experimental studies have examined parity and obesity individually, but to date, the joint effects of parity and obesity have not been studied. We investigated the role of obesity in parous mice on BBC. Parity alone dramatically blunted tumor latency compared to nulliparous controls with no effects on tumor number or growth, while obesity had only a minor role in further reducing latency. Obesity-associated metabolic mediators and hormones such as insulin, estrogen, and progesterone were not significantly regulated by obesity. Plasma IL-6 was also significantly elevated by obesity in parous mice. We have previously reported a potential role for stromal-derived hepatocyte growth factor (HGF) via its cognate receptor c-Met in the etiology of obesity-induced BBC tumor onset and in both human and murine primary coculture models of BBC-aggressiveness. Obesity-associated c-Met concentrations were 2.5-fold greater in normal mammary glands of parous mice. Taken together, our studies demonstrate that, parity in C3(1)-T-Ag mice dramatically reduced BBC latency compared to nulliparous mice. In parous mice, c-Met is regulated by obesity in unaffected mammary gland and is associated with tumor onset. C3(1)-T-Ag mice recapitulate epidemiologic findings such that parity drives increased BBC risk and potential microenvironmental alterations in c-Met signaling may play a role in etiology.	[Galanko, Joseph A.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, UNC Nutr Obes Res Ctr, Chapel Hill, NC 27599 USA; [Sundaram, Sneha; Freemerman, Alex J.; Galanko, Joseph A.; McNaughton, Kirk K.; Bendt, Katharine M.; Darr, David B.; Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Bendt, Katharine M.; Darr, David B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Mouse Phase Unit 1, Chapel Hill, NC USA; [Darr, David B.; Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [McNaughton, Kirk K.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Troester, Melissa A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Troester, Melissa A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Galanko, Joseph A.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Med, Chapel Hill, NC USA; [Sundaram, Sneha; Freemerman, Alex J.; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Makowski, L (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, UNC Nutr Obes Res Ctr, Chapel Hill, NC 27599 USA.	liza.makowski@unc.edu	, Histology Research Core Facility/ABF-6317-2021	Makowski, Liza/0000-0002-5337-8037	University of North Carolina University Cancer Research Fund (UCRF); National Institutes of Health [AA017376, ES019472, R21CA180134, DK034987, DK056350, RO1-CA138255]; NATIONAL CANCER INSTITUTE [R01CA138255, P50CA058223, R21CA180134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017376, K99AA017376] Funding Source: NIH RePORTER	University of North Carolina University Cancer Research Fund (UCRF); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	LM was supported by University of North Carolina University Cancer Research Fund (UCRF (http://unclineberger.org/ucrf), National Institutes of Health AA017376, ES019472, and R21CA180134. LM and JAG were supported by National Institutes of Health grants DK034987 and DK056350. MAT was supported by National Institutes of Health ES019472 and RO1-CA138255 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBREKTSEN G, 1995, BRIT J CANCER, V72, P480, DOI 10.1038/bjc.1995.359; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Bhardwaj P, 2013, CANCER PREV RES, V6, P282, DOI 10.1158/1940-6207.CAPR-12-0467; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brauer HA, 2013, CLIN CANCER RES, V19, P571, DOI 10.1158/1078-0432.CCR-12-2123; Brisken C, 2010, COLD SPRING HARBOR P, P2; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carmichael AR, 2006, BJOG-INT J OBSTET GY, V113, P1160, DOI 10.1111/j.1471-0528.2006.01021.x; Casanova M, 1999, TOXICOL SCI, V51, P236, DOI 10.1093/toxsci/51.2.236; Casbas-Hernandez P, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3476; Eliassen AH, 2007, CANCER EPIDEM BIOMAR, V16, P161, DOI 10.1158/1055-9965.EPI-06-0693; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Engineer DR, 2012, INT J PEPTIDES; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gatenby RA, 2011, NAT REV CANCER, V11, P237, DOI 10.1038/nrc3036; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; INANO H, 1991, CARCINOGENESIS, V12, P1085, DOI 10.1093/carcin/12.6.1085; KEPPEL KG, 1993, AM J PUBLIC HEALTH, V83, P1100, DOI 10.2105/AJPH.83.8.1100; Key TJ, 2001, P NUTR SOC, V60, P81, DOI 10.1079/PNS200068; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Medina D, 1999, J NATL CANCER I, V91, P967, DOI 10.1093/jnci/91.11.967; Michels KB, 2012, INT J CANCER, V130, P902, DOI 10.1002/ijc.26069; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Phipps AI, 2008, CANCER EPIDEM BIOMAR, V17, P2078, DOI 10.1158/1055-9965.EPI-08-0206; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; SINHA DK, 1988, BRIT J CANCER, V57, P390, DOI 10.1038/bjc.1988.88; Sivaraman L, 1998, CARCINOGENESIS, V19, P1573, DOI 10.1093/carcin/19.9.1573; Stewart DA, 2012, MOL CANCER RES, V10, P727, DOI 10.1158/1541-7786.MCR-11-0604; Sun XZ, 2012, BREAST CANCER RES TR, V131, P1003, DOI 10.1007/s10549-011-1789-3; Sundaram S, 2013, CANC PREV R IN PRESS; Sundaram S, 2013, BREAST CANC RES TREA; Sundaram S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00175; Sundaram S, 2013, BREAST CANCER RES TR, V142, P489, DOI 10.1007/s10549-013-2741-5; Tiede B, 2011, CELL RES, V21, P245, DOI 10.1038/cr.2011.11; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Trivers KF, 2009, CANCER CAUSE CONTROL, V20, P1071, DOI 10.1007/s10552-009-9331-1; Troester MA, 2009, CLIN CANCER RES, V15, P7020, DOI 10.1158/1078-0432.CCR-09-1126; URSIN G, 1995, EPIDEMIOLOGY, V6, P137, DOI 10.1097/00001648-199503000-00009; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806	52	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111394	10.1371/journal.pone.0111394	http://dx.doi.org/10.1371/journal.pone.0111394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354395	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200078
J	Xiao, QG; Tan, YH; Guo, Y; Yang, HK; Mao, F; Xie, RF; Wang, BF; Lei, T; Guo, DS				Xiao, Qungen; Tan, Yihu; Guo, Yang; Yang, Hongkuan; Mao, Feng; Xie, Ruifan; Wang, Baofeng; Lei, Ting; Guo, Dongsheng			Soluble LRIG2 Ectodomain Is Released from Glioblastoma Cells and Promotes the Proliferation and Inhibits the Apoptosis of Glioblastoma Cells In Vitro and In Vivo in a Similar Manner to the Full-Length LRIG2	PLOS ONE			English	Article							NEGATIVE REGULATOR; GLIOMA-CELLS; MALIGNANT GLIOMAS; TUMOR-SUPPRESSOR; DOWN-REGULATION; BREAST-CANCER; GROWTH; EXPRESSION; RECEPTOR; SURVIVAL	The human leucine-rich repeats and immunoglobulin-like domains (LRIG) gene family contains LRIG1, 2 and 3, encoding integral membrane proteins with an ectodomain, a transmembrane domain and a cytoplasmic tail. LRIG1 negatively regulates multiple receptor tyrosine kinases signaling including the epidermal growth factor receptor (EGFR) and is a proposed tumor suppressor. The soluble LRIG1 ectodomain is demonstrated to be shed naturally and inhibit the progression of glioma. However, little is known regarding the functions of LRIG2. In oligodendroglioma, LRIG2 expression is associated with poor survival, suggesting that LRIG2 might have different functions compared with LRIG1. Since soluble LRIG1 ectodomain has a similar function to the full-length LRIG1, we hypothesize that the different roles exerted by LRIG2 and LRIG1 result from the difference of their ectodomains. Here, we addressed the functions of LRIG2 and LRIG2 ectodomain in the proliferation and apoptosis of glioma and the possible underlying mechanisms. Firstly, we found that LRIG2 expression levels positively correlated with the grade of glioma. Further, we demonstrated for the first time that soluble LRIG2 ectodomain was capable of being released from glioblastoma cells and exerted a pro-proliferative effect. Overexpression of LRIG2 ectodomain promoted the proliferation and inhibited the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2. Both full-length LRIG2 and LRIG2 ectodomain were found to physically interact with EGFR, enhance the activation of EGFR and its downstream PI3 K/Akt pathway. To our knowledge, this is the first report demonstrating that soluble LRIG2 ectodomain is capable of being released from glioblastoma cells and exerts a similar role to the full-length LRIG2 in the regulation of EGFR signaling in the progression of glioblastoma. LRIG2 ectodomain, with potent pro-tumor effects, holds promise for providing a new therapeutic target for the treatment of glioblastoma.	[Wang, Baofeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Sino German Neurooncol Mol Lab, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, BF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Peoples R China.	wbf620@163.com	Mao, Feng/B-8280-2019		National Natural Science Foundation of China [81001116, 81372711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (grant number 81001116, 81372711; URL: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirlak B, 2003, J NEURO-ONCOL, V63, P129, DOI 10.1023/A:1023906316524; Cai MJ, 2009, CANCER LETT, V278, P104, DOI 10.1016/j.canlet.2009.01.001; Effenberger T, 2014, FASEB J; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Guo DS, 2004, GENOMICS, V84, P157, DOI 10.1016/j.ygeno.2004.01.013; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Hedman H, 2010, ACTA ONCOL, V49, P812, DOI 10.3109/0284186X.2010.492789; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Holmlund C, 2009, NEUROPATHOLOGY, V29, P242, DOI 10.1111/j.1440-1789.2008.00970.x; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Johansson M, 2013, NEURO-ONCOLOGY, V15, P1200, DOI 10.1093/neuonc/not054; Ju HQ, 2011, EUR J PHARMACOL, V666, P26, DOI 10.1016/j.ejphar.2011.05.020; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mao F, 2013, INT J ONCOL, V42, P1081, DOI 10.3892/ijo.2013.1776; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Rondahl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073635; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Wang BF, 2009, CANCER BIOL THER, V8, P1018, DOI 10.4161/cbt.8.11.8375; Wang Y, 2013, BRIT J CANCER, V108, P1765, DOI 10.1038/bjc.2013.138; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xie RF, 2013, ONCOL REP, V29, P177, DOI 10.3892/or.2012.2102; Yang HK, 2011, J HUAZHONG U SCI-MED, V31, P667, DOI 10.1007/s11596-011-0579-9; Ye F, 2009, J NEURO-ONCOL, V94, P183, DOI 10.1007/s11060-009-9836-1; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005	33	20	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111419	10.1371/journal.pone.0111419	http://dx.doi.org/10.1371/journal.pone.0111419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353163	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200079
J	Fazzini, A; D'Antongiovanni, V; Giusti, L; Da Valle, Y; Ciregia, F; Piano, I; Caputo, A; D'Ursi, AM; Gargini, C; Lucacchini, A; Mazzoni, MR				Fazzini, Alessandra; D'Antongiovanni, Vanessa; Giusti, Laura; Da Valle, Ylenia; Ciregia, Federica; Piano, Ilaria; Caputo, Antonella; D'Ursi, Anna Maria; Gargini, Claudia; Lucacchini, Antonio; Mazzoni, Maria Rosa			Altered Protease-Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the beta-Catenin Gene	PLOS ONE			English	Article							THROMBIN RECEPTOR; COUPLED RECEPTORS; MOLECULAR-CLONING; LUNG-CANCER; THROMBOMODULIN; CARCINOMA; INVASION; CAVEOLAE; PAR1; INTERNALIZATION	Protease activated receptors (PARs) are G-protein coupled receptors that are activated by an unique proteolytic mechanism. These receptors play crucial roles in hemostasis and thrombosis but also in inflammation and vascular development. PARs have also been implicated in tumor progression, invasion and metastasis. In this study, we investigated expression and signaling of PAR(1) in nonmalignant pleural mesothelial (Met-5A) and malignant pleural mesothelioma (NCI-H28) cells. We found that the expression level of PAR(1) was markedly higher in NCI-H28 cells compared to Met-5A and human primary mesothelial cells. Other three malignant pleural mesothelioma cell lines, i.e. REN, Ist-Mes2, and Mero-14, did not show any significant PAR(1) over-expression compared to Met-5A cell line. Thrombin and PAR(1) activating peptides enhanced Met-5A and NCI-H28 cell proliferation but in NCI-H28 cells higher thrombin concentrations were required to obtain the same proliferation increase. Similarly, thrombin caused extracellular signal-regulated kinase 1/2 activation in both cell lines but NCI-H28 cells responded at higher agonist concentrations. We also determined that PAR(1) signaling through G(q) and G(12/13) proteins is severely altered in NCI-H28 cells compared to Met-5A cells. On the contrary, PAR(1) signaling through G(i) proteins was persistently maintained in NCI-H28 cells. Furthermore, we demonstrated a reduction of cell surface PAR(1) expression in NCI-H28 and malignant pleural mesothelioma REN cells. Thus, our results provide evidences for dysfunctional PAR(1) signaling in NCI-H28 cells together with reduced plasma membrane localization. The role of PAR(1) in mesothelioma progression is just emerging and our observations can promote further investigations focused on this G-protein coupled receptor.	[Fazzini, Alessandra; D'Antongiovanni, Vanessa; Giusti, Laura; Da Valle, Ylenia; Ciregia, Federica; Piano, Ilaria; Caputo, Antonella; Gargini, Claudia; Lucacchini, Antonio; Mazzoni, Maria Rosa] Univ Pisa, Dept Pharm, Pisa, Italy; [D'Ursi, Anna Maria] Univ Salerno, Dept Pharm, I-84100 Salerno, Italy	University of Pisa; University of Salerno	Mazzoni, MR (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	maria.mazzoni@farm.unipi.it	Mazzoni, Maria Rosa/AAA-2366-2022; Ciregia, Federica/K-6612-2016; D'Ursi, Anna M/E-8557-2016	Ciregia, Federica/0000-0002-5851-9249; D'Ursi, Anna M/0000-0001-6814-8472; D'ANTONGIOVANNI, Vanessa/0000-0002-3303-0674; GARGINI, MARIA CLAUDIA/0000-0002-4992-9086; Mazzoni, Maria Rosa/0000-0003-2612-432X; LUCACCHINI, ANTONIO/0000-0002-0917-4491; piano, ilaria/0000-0002-5073-7583; Giusti, Laura/0000-0001-7366-1932	Italian Board of Health [RF-2009-1529895]; University of Pisa grants	Italian Board of Health; University of Pisa grants	This work was supported by Italian Board of Health grant RF-2009-1529895 (A. Lucacchini), and University of Pisa grants (A. Lucacchini and M. R. Mazzoni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Asteriti S, 2012, BRIT J PHARMACOL, V167, P80, DOI 10.1111/j.1476-5381.2012.01974.x; Bar-Shavit R, 2011, IUBMB LIFE, V63, P397, DOI 10.1002/iub.452; Belling F, 2013, INT J ARTIF ORGANS, V36, P97, DOI 10.5301/ijao.5000174; Blackhart BD, 2000, MOL PHARMACOL, V58, P1178, DOI 10.1124/mol.58.6.1178; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Calizo RC, 2012, BIOCHEMISTRY-US, V51, P9513, DOI 10.1021/bi301107p; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; D'Ursi AM, 2006, MOL PHARMACOL, V69, P727, DOI 10.1124/mol.105.017715; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Keshava S, 2013, CANCER RES, V73, P3963, DOI 10.1158/0008-5472.CAN-12-1690; Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee YCG, 2005, AM J PHYSIOL-LUNG C, V288, pL734, DOI 10.1152/ajplung.00173.2004; Li T, 2011, J PATHOL, V223, P519, DOI 10.1002/path.2829; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Matsushita Y, 1998, CANCER LETT, V127, P195, DOI 10.1016/S0304-3835(98)00038-X; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Nguyen D, 2008, ANN THORAC SURG, V85, P1032, DOI 10.1016/j.athoracsur.2007.11.064; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nocchi L, 2011, J BIOL CHEM, V286, P19478, DOI 10.1074/jbc.M110.217331; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Ogawa H, 2000, CANCER LETT, V149, P95, DOI 10.1016/S0304-3835(99)00348-1; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pinton G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014110; Porchia F, 2008, J RECEPT SIG TRANSD, V28, P265, DOI [10.1080/10799890802084515, 10.1080/10799890802084515 ]; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sato M, 2012, J BIOL CHEM, V287, P20674, DOI 10.1074/jbc.M111.280651; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Shigemitsu K, 2001, ONCOGENE, V20, P4249, DOI 10.1038/sj.onc.1204557; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Tellez C, 2003, ONCOGENE, V22, P3130, DOI 10.1038/sj.onc.1206453; Trejo J, 1996, J BIOL CHEM, V271, P21536, DOI 10.1074/jbc.271.35.21536; VERSNEL MA, 1989, CANCER GENET CYTOGEN, V42, P115, DOI 10.1016/0165-4608(89)90014-9; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111550	10.1371/journal.pone.0111550	http://dx.doi.org/10.1371/journal.pone.0111550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364818	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100074
J	Li, B; Feng, YL; Ge, SY; Li, DS				Li, Bo; Feng, Yanli; Ge, Shiyu; Li, Dashe			A Bridge Role Metric Model for Nodes in Software Networks	PLOS ONE			English	Article							SCALE-FREE; COMPLEXITY METRICS	A bridge role metric model is put forward in this paper. Compared with previous metric models, our solution of a large-scale object-oriented software system as a complex network is inherently more realistic. To acquire nodes and links in an undirected network, a new model that presents the crucial connectivity of a module or the hub instead of only centrality as in previous metric models is presented. Two previous metric models are described for comparison. In addition, it is obvious that the fitting curve between the Bre results and degrees can well be fitted by a power law. The model represents many realistic characteristics of actual software structures, and a hydropower simulation system is taken as an example. This paper makes additional contributions to an accurate understanding of module design of software systems and is expected to be beneficial to software engineering practices.	[Li, Bo; Feng, Yanli; Li, Dashe] Shan Dong Inst Business & Technol, Key Lab Intelligent Informat Proc, Yantai, Shandong, Peoples R China; [Li, Bo; Feng, Yanli; Ge, Shiyu] Shan Dong Inst Business & Technol, Dept Comp Fdn Studies, Yantai, Shandong, Peoples R China	Shandong Technology & Business University; Shandong Technology & Business University	Li, B (corresponding author), Shan Dong Inst Business & Technol, Key Lab Intelligent Informat Proc, Yantai, Shandong, Peoples R China.	89646597@qq.com			National Natural Science Foundation [61070175]; Shandong Province Natural Science Foundation [ZR2013FL017, ZR2013FL018]; Shandong Province University Science and Technology of China [J12LJ03]; project development plan of science and technology of yanntai [2013ZH347, 2013ZH091]; Dr. Scientific Research Foundation in shandong institute of business and technology [BS201407]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Province University Science and Technology of China; project development plan of science and technology of yanntai; Dr. Scientific Research Foundation in shandong institute of business and technology	This work was funded by the National Natural Science Foundation (No. 61070175, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#); Shandong Province Natural Science Foundation(ZR2013FL017, ZR2013FL018, http://www.sdnsf.gov.cn/portal/); Shandong Province University Science and Technology of China (J12LJ03, http://jihlx.sdstc.gov.cn/stdpms/); project development plan of science and technology of yanntai(2013ZH347, 2013ZH091, http://www.ytstc.gov.cn/ArticleDetail.aspx?aid=11762), Dr. Scientific Research Foundation in shandong institute of business and technology (BS201407, http://www.ccec.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 1998, P 1998 INT C SOFTW E, P503; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauer M., 1999, P ECOOP 99 WORKSH LI, P170; Briand LC, 1996, IEEE T SOFTWARE ENG, V22, P68, DOI 10.1109/32.481535; CAI W, 2007, DYNAM CONT DIS SE S6, V14, P12; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Concas G, 2006, EUROPHYS LETT, V76, P1221, DOI 10.1209/epl/i2006-10384-1; Concas G, 2007, IEEE T SOFTWARE ENG, V33, P687, DOI [10.1109/TSE.2007.1019, 10.1109/TSE.2007.1016]; Dabrowski R, 2011, LECT NOTES COMPUT SC, V6903, P360, DOI 10.1007/978-3-642-23798-0_38; de Moura APS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.017102; Fenton N, 2002, IEEE SOFTWARE, V19, P116, DOI 10.1109/MS.2002.1020298; Fenton NE, 1999, J SYST SOFTWARE, V47, P149, DOI 10.1016/S0164-1212(99)00035-7; Furey S, 1997, IEEE SOFTWARE, V14, P28, DOI 10.1109/52.582971; Huang P, 2008, J ZHEJIANG UNIV-SC A, V9, P1390, DOI 10.1631/jzus.A0720073; Jenkins S, 2007, INFORM SCIENCES, V177, P2587, DOI 10.1016/j.ins.2007.01.021; Kpodjedo S, 2009, 1ST INTERNATIONAL SYMPOSIUM ON SEARCH BASED SOFTWARE ENGINEERING, PROCEEDINGS, P23, DOI 10.1109/SSBSE.2009.24; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Li B, 2011, IEEE INT SYMP CIRC S, P2119; Liu J, 2006, DYNAM CONT DIS SER B, V13, P955; Liu J, 2006, P INT COMP SOFTW APP, P229; Ma YT, 2005, P 6 INT C COMP INF T, P189; Ma YT, 2010, J COMPUT SCI TECH-CH, V25, P1184, DOI 10.1007/s11390-010-9398-x; Mens T., 2001, P 4 INT WORKSH PRINC, P83, DOI DOI 10.1145/602461.602476; Myers CR, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046116; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Pan WF, 2010, J COMPUT SCI TECH-CH, V25, P1202, DOI 10.1007/s11390-010-9399-9; Peng L, 2011, RES STRUCTURE CHARAC; Potanin A, 2005, COMMUN ACM, V48, P99, DOI 10.1145/1060710.1060716; Roach C, 2011, COMM COM INF SC, V116, P119; Subelj L, 2011, PHYSICA A, V390, P2968, DOI 10.1016/j.physa.2011.03.036; Valverde S, 2002, EUROPHYS LETT, V60, P512, DOI 10.1209/epl/i2002-00248-2; Valverdes S, 2003, SFI030744; Wei Wang, 2010, Journal of Software Engineering and Applications, V3, P185, DOI 10.4236/jsea.2010.32023; Wei Wang, 2010, Journal of Software Engineering and Applications, V3, P58, DOI 10.4236/jsea.2010.31007; Wen L, 2009, IEEE T SYST MAN CY B, V39, P845, DOI 10.1109/TSMCB.2009.2020206; Zhang HH, 2008, 2008 FOURTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, PROCEEDINGS, P954, DOI 10.1109/IIH-MSP.2008.294	36	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111613	10.1371/journal.pone.0111613	http://dx.doi.org/10.1371/journal.pone.0111613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364938	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100087
J	Liu, DL; Li, Y; Zhao, J; Deng, F; Duan, XM; Kou, C; Wu, T; Li, YJ; Wang, YX; Ma, J; Yang, JH; Hu, ZH; Zhang, FC; Zhang, YJ; Sun, SR				Liu, Dongliang; Li, Yang; Zhao, Jing; Deng, Fei; Duan, Xiaomei; Kou, Chun; Wu, Ting; Li, Yijie; Wang, Yongxing; Ma, Ji; Yang, Jianhua; Hu, Zhihong; Zhang, Fuchun; Zhang, Yujiang; Sun, Surong			Fine Epitope Mapping of the Central Immunodominant Region of Nucleoprotein from Crimean-Congo Hemorrhagic Fever Virus (CCHFV)	PLOS ONE			English	Article							B-CELL EPITOPES; RECOMBINANT NUCLEOPROTEIN; NUCLEOCAPSID PROTEIN; ANTIBODY DETECTION; EPIDEMIOLOGY; INTRABODIES; REPLICATION; EXPRESSION; PREDICTION; INDUCTION	Crimean-Congo hemorrhagic fever (CCHF), a severe viral disease known to have occurred in over 30 countries and distinct regions, is caused by the tick-borne CCHF virus (CCHFV). Nucleocapsid protein (NP), which is encoded by the S gene, is the primary antigen detectable in infected cells. The goal of the present study was to map the minimal motifs of B-cell epitopes (BCEs) on NP. Five precise BCEs (E1, (247)FDEAKK(252); E2a, (254)VEAL(257); E2b, (258)NGYLNKH(264); E3, (267)EVDKA(271); and E4, (DSMITN279)-D-274) identified through the use of rabbit antiserum, and one BCE (E5, (258)NGYL(261)) recognized using a mouse monoclonal antibody, were confirmed to be within the central region of NP and were partially represented among the predicted epitopes. Notably, the five BCEs identified using the rabbit sera were able to react with positive serum mixtures from five sheep which had been infected naturally with CCHFV. The multiple sequence alignment (MSA) revealed high conservation of the identified BCEs among ten CCHFV strains from different areas. Interestingly, the identified BCEs with only one residue variation can apparently be recognized by the positive sera of sheep naturally infected with CCHFV. Computer-generated three-dimensional structural models indicated that all the antigenic motifs are located on the surface of the NP stalk domain. This report represents the first identification and mapping of the minimal BCEs of CCHFV-NP along with an analysis of their primary and structural properties. Our identification of the minimal linear BCEs of CCHFV-NP may provide fundamental data for developing rapid diagnostic reagents and illuminating the pathogenic mechanism of CCHFV.	[Liu, Dongliang; Li, Yang; Zhao, Jing; Duan, Xiaomei; Kou, Chun; Wu, Ting; Li, Yijie; Wang, Yongxing; Ma, Ji; Yang, Jianhua; Zhang, Fuchun; Sun, Surong] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Xinjiang, Peoples R China; [Deng, Fei; Hu, Zhihong] Chinese Acad Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Zhang, Yujiang] Ctr Dis Control & Prevent Xinjiang Uyghur Autonom, Urumqi, Xinjiang, Peoples R China; [Yang, Jianhua] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA	Xinjiang University; Chinese Academy of Sciences; Baylor College of Medicine; Texas Children's Cancer Center	Zhang, YJ (corresponding author), Ctr Dis Control & Prevent Xinjiang Uyghur Autonom, Urumqi, Xinjiang, Peoples R China.	xjsyzhang@163.com; sr_sun2005@163.com	Hu, Zhihong/AAS-2215-2020; Liu, Dongliang/AAP-6335-2021; Liu, Dongliang/AAM-9595-2021	Hu, Zhihong/0000-0002-1560-0928; Liu, Dongliang/0000-0001-5843-5451; Liu, Dongliang/0000-0001-5843-5451	Science and Technology Basic Work Program from Ministry of Science and Technology of China [2013FY113500]; National Science Foundation of China [81460303, 30860225]; Open Research Fund Program of Xinjiang Key Laboratory of Biological Resources and Genetic Engineering [XJDX020l-2014-04]	Science and Technology Basic Work Program from Ministry of Science and Technology of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund Program of Xinjiang Key Laboratory of Biological Resources and Genetic Engineering	This work was supported partly by Science and Technology Basic Work Program 2013FY113500 from Ministry of Science and Technology of China, the National Science Foundation of China (grant no. 81460303, 30860225), and the Open Research Fund Program of Xinjiang Key Laboratory of Biological Resources and Genetic Engineering (grant no. XJDX020l-2014-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Burt FJ, 2013, J VIROL METHODS, V193, P706, DOI 10.1016/j.jviromet.2013.07.055; Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chinikar S, 2009, IRAN J MICROBIOL, V1, P7; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Dai Xiang, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1048; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deyde VM, 2006, J VIROL, V80, P8834, DOI 10.1128/JVI.00752-06; Dowall SD, 2012, J VIROL METHODS, V179, P335, DOI 10.1016/j.jviromet.2011.11.020; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Garcia S, 2006, J CLIN VIROL, V35, P154, DOI 10.1016/j.jcv.2005.02.016; Garnier J., 1989, PREDICTION PROTEIN S, P417; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Gurbuz Yunus, 2009, Int J Infect Dis, V13, pe105, DOI 10.1016/j.ijid.2008.08.002; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Karlberg H, 2011, J BIOL CHEM, V286, P3227, DOI 10.1074/jbc.M110.149369; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KINTS JP, 1989, J IMMUNOL METHODS, V119, P241, DOI 10.1016/0022-1759(89)90402-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladner Robert C, 2007, Biotechnol Genet Eng Rev, V24, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Dongliang, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P838; Lo A. S. -Y., 2008, V181, P343; Lundkvist A, 2002, VIRAL IMMUNOL, V15, P177, DOI 10.1089/088282402317340323; Magurano F, 1999, CLIN DIAGN LAB IMMUN, V6, P55, DOI 10.1128/CDLI.6.1.55-60.1999; Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008; Merrifield RB, 1968, ADV ENZYMOL RELAT AR, V32, P221; MORROW JF, 1974, P NATL ACAD SCI USA, V71, P1743, DOI 10.1073/pnas.71.5.1743; Moutel Sandrine, 2012, Methods Mol Biol, V907, P667, DOI 10.1007/978-1-61779-974-7_37; Papa A, 2002, EMERG INFECT DIS, V8, P50, DOI 10.3201/eid0801.010087; ROBERTS BL, 1992, P NATL ACAD SCI USA, V89, P2429, DOI 10.1073/pnas.89.6.2429; Saijo M, 2005, J MED VIROL, V75, P295, DOI 10.1002/jmv.20270; Saijo M, 2002, J CLIN MICROBIOL, V40, P1587, DOI 10.1128/JCM.40.5.1587-1591.2002; Samudzi RR, 2012, J VIROL METHODS, V179, P70, DOI 10.1016/j.jviromet.2011.09.023; Schwarz TF, 1996, J MED VIROL, V49, P83, DOI 10.1002/(SICI)1096-9071(199606)49:2&lt;83::AID-JMV2&gt;3.0.CO;2-F; Srinivasan Pappu, 2011, Frontiers in Genetics, V2, P72, DOI 10.3389/fgene.2011.00072; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Sun SR, 2009, J CLIN MICROBIOL, V47, P2536, DOI 10.1128/JCM.00265-09; Tang Q, 2003, CLIN DIAGN LAB IMMUN, V10, P489, DOI 10.1128/CDLI.10.3.489-491.2003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tse E, 2000, P NATL ACAD SCI USA, V97, P12266, DOI 10.1073/pnas.97.22.12266; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Wei Peng-fei, 2010, Virologica Sinica, V25, P45, DOI 10.1007/s12250-010-3067-7; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; *WHO, 2001, CRIM CONG HAEM FEV; Xu WX, 2012, AM J REPROD IMMUNOL, V68, P465, DOI 10.1111/j.1600-0897.2012.01177.x; Xu WX, 2009, J REPROD IMMUNOL, V81, P9, DOI 10.1016/j.jri.2009.04.004; Xu WX, 2012, MAPPING MINIMAL MOTI; Zhang ZW, 2010, VET MICROBIOL, V140, P25, DOI 10.1016/j.vetmic.2009.07.011; Zhou ZR, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00571-13	58	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e108419	10.1371/journal.pone.0108419	http://dx.doi.org/10.1371/journal.pone.0108419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365026	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100004
J	Chaudhary, VK; Shrivastava, N; Verma, V; Das, S; Kaur, C; Grover, P; Gupta, A				Chaudhary, Vijay K.; Shrivastava, Nimisha; Verma, Vaishali; Das, Shilpi; Kaur, Charanpreet; Grover, Payal; Gupta, Amita			Rapid Restriction Enzyme-Free Cloning of PCR Products: A High-Throughput Method Applicable for Library Construction	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; DNA-POLYMERASE; EXPRESSION; RECOMBINATION; SYSTEM	Herein, we describe a novel cloning strategy for PCR-amplified DNA which employs the type IIs restriction endonuclease Bsal to create a linearized vector with four base-long 5'-overhangs, and T4 DNA polymerase treatment of the insert in presence of a single dNTP to create vector-compatible four base-long overhangs. Notably, the insert preparation does not require any restriction enzyme treatment. The BsaI sites in the vector are oriented in such a manner that upon digestion with BsaI, a stuffer sequence along with both BsaI recognition sequences is removed. The sequence of the four base-long overhangs produced by BsaI cleavage were designed to be non-palindromic, non-compatible to each other. Therefore, only ligation of an insert carrying compatible ends allows directional cloning of the insert to the vector to generate a recombinant without recreating the BsaI sites. We also developed rapid protocols for insert preparation and cloning, by which the entire process from PCR to transformation can be completed in 6-8 h and DNA fragments ranging in size from 200 to 2200 bp can be cloned with equal efficiencies. One protocol uses a single tube for insert preparation if amplification is performed using polymerases with low 3'-exonuclease activity. The other protocol is compatible with any thermostable polymerase, including those with high 3'-exonuclease activity, and does not significantly increase the time required for cloning. The suitability of this method for high-throughput cloning was demonstrated by cloning batches of 24 PCR products with nearly 100% efficiency. The cloning strategy is also suitable for high efficiency cloning and was used to construct large libraries comprising more than 10(8) clones/mu g vector. Additionally, based on this strategy, a variety of vectors were constructed for the expression of proteins in E. coli, enabling large number of different clones to be rapidly generated.	[Chaudhary, Vijay K.; Shrivastava, Nimisha; Verma, Vaishali; Das, Shilpi; Kaur, Charanpreet; Grover, Payal] Univ Delhi, Dept Biochem, New Delhi 110021, India; [Gupta, Amita] Univ Delhi, Dept Microbiol, New Delhi 110021, India	University of Delhi; University of Delhi	Chaudhary, VK (corresponding author), Univ Delhi, Dept Biochem, South Campus,Benito Juarez Rd, New Delhi 110021, India.	vkchaudhary@south.du.ac.in; amitagupta@south.du.ac.in	Verma, Vaishali/ABH-2408-2021	Verma, Vaishali/0000-0001-5076-7435	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Government of India to VKC and AG. VV is the recipient of a research fellowship from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Berrow Nick S., 2009, V498, P75, DOI 10.1007/978-1-59745-196-3_5; CHOWDHURY PS, 1994, PROTEIN EXPRES PURIF, V5, P89, DOI 10.1006/prep.1994.1013; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Geng LA, 2006, MOL BIOTECHNOL, V33, P23; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075212; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kotera I, 2008, J BIOTECHNOL, V137, P1, DOI 10.1016/j.jbiotec.2008.07.1816; Kumar K, 2012, ARCH VIROL, V157, P1949, DOI 10.1007/s00705-012-1389-5; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zhou M Y, 2000, Curr Issues Mol Biol, V2, P1	22	9	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111538	10.1371/journal.pone.0111538	http://dx.doi.org/10.1371/journal.pone.0111538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360695	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700115
J	Gottardo, MF; Jaita, G; Magri, ML; Zarate, S; Ayala, MM; Ferraris, J; Eijo, G; Pisera, D; Candolfi, M; Seilicovich, A				Florencia Gottardo, Maria; Jaita, Gabriela; Laura Magri, Maria; Zarate, Sandra; Moreno Ayala, Mariela; Ferraris, Jimena; Eijo, Guadalupe; Pisera, Daniel; Candolfi, Marianela; Seilicovich, Adriana			Antiapoptotic Factor Humanin Is Expressed in Normal and Tumoral Pituitary Cells and Protects Them from TNF-alpha-Induced Apoptosis	PLOS ONE			English	Article							CYTOPROTECTIVE PEPTIDE HUMANIN; NEUROPROTECTIVE FACTOR; DEATH; GLAND; ESTROGENS; STRESS; BAX; ACTIVATION; RECEPTORS; SURVIVAL	Humanin (HN) is a 24-amino acid peptide with cytoprotective action in several cell types such as neurons and testicular germ cells. Rattin (HNr), a homologous peptide of HN expressed in several adult rat tissues, also has antiapoptotic action. In the present work, we demonstrated by immunocytochemical analysis and flow cytometry the expression of HNr in the anterior pituitary of female and male adult rats as well as in pituitary tumor GH3 cells. HNr was localized in lactotropes and somatotropes. The expression of HNr was lower in females than in males, and was inhibited by estrogens in pituitary cells from both ovariectomized female and orquidectomized male rats. However, the expression of HNr in pituitary tumor cells was not regulated by estrogens. We also evaluated HN action on the proapoptotic effect of TNF-alpha in anterior pituitary cells assessed by the TUNEL method. HN (5 mu M) per se did not modify basal apoptosis of anterior pituitary cells but completely blocked the proapoptotic effect of TNF-alpha in total anterior pituitary cells, lactotropes and somatotropes from both female and male rats. Also, HN inhibited the apoptotic effect of TNF-alpha on pituitary tumor cells. In summary, our results demonstrate that HNr is present in the anterior pituitary gland, its expression showing sexual dimorphism, which suggests that gonadal steroids may be involved in the regulation of HNr expression in this gland. Antiapoptotic action of HN in anterior pituitary cells suggests that this peptide could be involved in the homeostasis of this gland. HNr is present and functional in GH3 cells, but it lacks regulation by estrogens, suggesting that HN could participate in the pathogenesis of pituitary tumors.	[Florencia Gottardo, Maria; Jaita, Gabriela; Laura Magri, Maria; Zarate, Sandra; Moreno Ayala, Mariela; Ferraris, Jimena; Eijo, Guadalupe; Pisera, Daniel; Candolfi, Marianela; Seilicovich, Adriana] Univ Buenos Aires, Inst Invest Biomed, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Seilicovich, A (corresponding author), Univ Buenos Aires, Inst Invest Biomed, CONICET, Buenos Aires, DF, Argentina.	adyseili@fmed.uba.ar		Ferraris, Jimena/0000-0001-7472-0439	Consejo de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 159]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 053]; University of Buenos Aires, Argentina [M054]	Consejo de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); University of Buenos Aires, Argentina(University of Buenos Aires)	This work was funded by the Consejo de Investigaciones Cientificas y Tecnicas (CONICET, grant PIP 159), Agencia Nacional de Promocion Cientifica y Tecnica (grant PICT 053) and University of Buenos Aires (grant M054), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191; Radl DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018097; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; Candolfi M, 2004, NEUROENDOCRINOLOGY, V80, P83, DOI 10.1159/000081313; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Caricasole A, 2002, FASEB J, V16, P1331, DOI 10.1096/fj.02-0018fje; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; Ferraris J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097383; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hanisch A, 2000, J CLIN ENDOCR METAB, V85, P4411, DOI 10.1210/jc.85.11.4411; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2004, EUR J NEUROSCI, V19, P2357, DOI 10.1111/j.1460-9568.2004.03298.x; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Jia Y, 2013, ANDROLOGY-US, V1, P651, DOI 10.1111/j.2047-2927.2013.00091.x; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Klein LE, 2013, BIOCHEM BIOPH RES CO, V440, P197, DOI 10.1016/j.bbrc.2013.08.055; Liu W, 2014, CNS NEUROSCI THER, V20, P95, DOI 10.1111/cns.12211; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Maftei M, 2012, J PEPT SCI, V18, P373, DOI 10.1002/psc.2404; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Moretti E, 2010, FERTIL STERIL, V94, P2888, DOI 10.1016/j.fertnstert.2010.04.075; Mottaghi-Dastjerdi N, 2014, DARU, V22, DOI 10.1186/2008-2231-22-14; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; OISHI Y, 1993, ANAT RECORD, V235, P111, DOI 10.1002/ar.1092350111; Perez-Castro C, 2012, PHYSIOL REV, V92, P1, DOI 10.1152/physrev.00003.2011; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Takeshita Y, 2013, J BIOL CHEM, V288, P24691, DOI 10.1074/jbc.M113.469692; Widmer RJ, 2013, AM J PHYSIOL-HEART C, V304, pH393, DOI 10.1152/ajpheart.00765.2012; Yadav VK, 2004, MOL HUM REPROD, V10, P629, DOI 10.1093/molehr/gah089; Yang ZK, 2008, NEUROCHEM INT, V52, P1176, DOI 10.1016/j.neuint.2007.12.008; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zacharias DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031065; Zapala B, 2010, PHARMACOL REP, V62, P767, DOI 10.1016/S1734-1140(10)70337-6; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008; Zarate S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041299; Zarate S, 2010, NEUROENDOCRINOLOGY, V92, P215, DOI 10.1159/000321683; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200	48	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111548	10.1371/journal.pone.0111548	http://dx.doi.org/10.1371/journal.pone.0111548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360890	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700118
J	Marchione, P; Morreale, M; Giacomini, P; Izzo, C; Pontecorvo, S; Altieri, M; Bernardi, S; Frontoni, M; Francia, A				Marchione, Pasquale; Morreale, Manuela; Giacomini, Patrizia; Izzo, Chiara; Pontecorvo, Simona; Altieri, Marta; Bernardi, Silvia; Frontoni, Marco; Francia, Ada			Ultrasonographic Evaluation of Cerebral Arterial and Venous Haemodynamics in Multiple Sclerosis: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR AUTONOMIC DYSFUNCTION; BLOOD-FLOW; WHITE-MATTER; BRAIN; INSUFFICIENCY; PERFUSION; CCSVI; PREVALENCE; VENOGRAPHY; DISABILITY	Objective: Although recent studies excluded an association between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis (MS), controversial results account for some cerebrovascular haemodynamic impairment suggesting a dysfunction of cerebral autoregulation mechanisms. The aim of this cross-sectional, case-control study is to evaluate cerebral arterial inflow and venous outflow by means of a non-invasive ultrasound procedure in Relapsing Remitting (RR), Primary Progressive (PP) Multiple Sclerosis and age and sex-matched controls subjects. Material and Methods: All subjects underwent a complete extra-intracranial arterial and venous ultrasound assessment with a color-coded duplex sonography scanner and a transcranial doppler equipment, in both supine and sitting position by means of a tilting chair. Basal arterial and venous morphology and flow velocities, postural changes in mean flow velocities (MFV) of middle cerebral arteries (MCA), differences between cerebral venous outflow (CVF) in clinostatism and in the seated position (DCVF) and non-invasive cerebral perfusion pressure (CPP) were evaluated. Results: 85 RR-MS, 83 PP-MS and 82 healthy controls were included. DCVF was negative in 45/85 (52.9%) RR-MS, 63/83 (75.9%) PP-MS (p = 0.01) and 11/82 (13.4%) controls (p<0.001), while MFVs on both MCAs in sitting position were significantly reduced in RR-MS and PP-MS patients than in control, particularly in EDSS >= 5 subgroup (respectively, 42/50, 84% vs. 66/131, 50.3%, p<0.01 and 48.3 +/- 2 cm/s vs. 54.6 +/- 3 cm/s, p = 0.01). No significant differences in CPP were observed within and between groups. Conclusions: The quantitative evaluation of cerebral blood flow (CBF) and CVF and their postural dependency may be related to a dysfunction of autonomic nervous system that seems to characterize more disabled MS patients. It's not clear whether the altered postural control of arterial inflow and venous outflow is a specific MS condition or simply an "epiphenomenon'' of neurodegenerative events.	[Marchione, Pasquale; Morreale, Manuela; Giacomini, Patrizia; Izzo, Chiara] Univ Roma La Sapienza, Dept Med & Surg Sci & Biotechnol, Neurol Sect, Neurovasc Diag Unit, I-00185 Rome, Italy; [Marchione, Pasquale; Izzo, Chiara] Inst Neurosci, Neurol Ctr Latium, Dept Clin Neurosci, Rome, Italy; [Morreale, Manuela; Pontecorvo, Simona; Altieri, Marta; Bernardi, Silvia; Frontoni, Marco; Francia, Ada] Univ Roma La Sapienza, Multiple Sclerosis Ctr, Dept Neurol & Psychiat, I-00185 Rome, Italy; [Pontecorvo, Simona] Ist Ric & Cura Carattere Sci Neuromed, Pozzilli, Isernia, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Neuromed	Morreale, M (corresponding author), Univ Roma La Sapienza, Dept Med & Surg Sci & Biotechnol, Neurol Sect, Neurovasc Diag Unit, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	manuelamorreale@yahoo.it	altieri, marta/AAV-6678-2021	Pontecorvo, Simona/0000-0002-4256-2568; Francia, Ada/0000-0002-9550-9082; bernardi, silvia/0000-0002-1050-3096	Merck Serono; Teva; Novartis; Bayer Schering; Sanofi-Aventis; Biogen Idec	Merck Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Novartis(Novartis); Bayer Schering(Bayer AG); Sanofi-Aventis(Sanofi-Aventis); Biogen Idec(Biogen)	PM, CI and PG have no potential conflicts of interest to disclose. MM, SP, MA, SB, MF and AF have no financial activities related to the present article to disclose and received payment for travel, accommodations, or meeting expenses from Merck Serono, Teva, Novartis, Bayer Schering, Sanofi-Aventis, and Biogen Idec. SP, MF and AF received payment for lectures including service on speakers bureaus from Merck Serono, Teva, Novartis, Sanofi-Aventis, and Biogen Idec. Declared financial activities do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALLEN IV, 1981, NEUROPATH APPL NEURO, V7, P169, DOI 10.1111/j.1365-2990.1981.tb00087.x; Baracchini C, 2012, J NEUROL, V259, P2585, DOI 10.1007/s00415-012-6541-3; Charcot JM, 1868, GAZETTE HO PITAUX, V41; Comi G, 2013, NEUROL SCI, V34, P1297, DOI 10.1007/s10072-012-1269-5; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; D'haeseleer M, 2011, LANCET NEUROL, V10, P657, DOI 10.1016/S1474-4422(11)70105-3; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; Dorfler P, 2000, J CEREBR BLOOD F MET, V20, P269; Ertl-Wagner B, 2012, MULT SCLER J, V18, P1000, DOI 10.1177/1352458511432742; Flachenecker P, 1999, J NEUROL, V246, P578, DOI 10.1007/s004150050407; Flachenecker P, 2001, MULT SCLER, V7, P327, DOI 10.1177/135245850100700509; Frontoni M, 1996, ACTA NEUROL SCAND, V93, P241; Garaci FG, 2012, RADIOLOGY, V265, P233, DOI 10.1148/radiol.12112245; Gonul M, 2008, EUR J NEUROL, V15, P725, DOI 10.1111/j.1468-1331.2008.02179.x; Heckmann JG, 1999, NEUROL RES, V21, P457, DOI 10.1080/01616412.1999.11740959; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Labuz-Roszak B, 2007, CLIN AUTON RES, V17, P375, DOI 10.1007/s10286-007-0443-y; LACHENECKER P, 2001, MULT SCLER, V7, P327; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Mancini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092730; Monti L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025012; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Putnam TJ, 1933, NEW ENGL J MED, V209, P786, DOI 10.1056/NEJM193310192091604; Reekers J, 2014, CARDIOVASC INTER RAD, V37, P287, DOI 10.1007/s00270-013-0833-6; Saari A, 2004, CLIN NEUROPHYSIOL, V115, P1473, DOI 10.1016/j.clinph.2004.01.012; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; SCHELLING F, 1986, MED HYPOTHESES, V21, P141, DOI 10.1016/0306-9877(86)90003-4; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Stolz E, 2001, J NEUROIMAGING, V11, P385, DOI 10.1111/j.1552-6569.2001.tb00067.x; Sun X, 1998, Ann Nucl Med, V12, P89; Talbert DG, 2008, MED HYPOTHESES, V70, P1112, DOI 10.1016/j.mehy.2007.10.009; Tan IL, 2000, AM J NEURORADIOL, V21, P1039; Traboulsee AL, 2014, LANCET, V383, P138, DOI 10.1016/S0140-6736(13)61747-X; Valdueza JM, 2000, LANCET, V355, P200; Valdueza JM, 2013, J CEREBR BLOOD F MET, V33, P657, DOI 10.1038/jcbfm.2013.31; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; VITA G, 1993, J NEUROL SCI, V120, P82, DOI 10.1016/0022-510X(93)90029-X; Wilson TD, 2005, J CEREBR BLOOD F MET, V25, P136, DOI 10.1038/sj.jcbfm.9600015; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589	41	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111486	10.1371/journal.pone.0111486	http://dx.doi.org/10.1371/journal.pone.0111486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360597	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700106
J	Mychajliw, AM; Harrison, RG				Mychajliw, Alexis M.; Harrison, Richard G.			Genetics Reveal the Origin and Timing of a Cryptic Insular Introduction of Muskrats in North America	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; SOFTWARE; MUTATION; BOTTLENECK; NUMBER; REDUCTIONS; ALLELES; MAMMALS; GROWTH	The muskrat, Ondatra zibethicus, is a semiaquatic rodent native to North America that has become a highly successful invader across Europe, Asia, and South America. It can inflict ecological and economic damage on wetland systems outside of its native range. Anecdotal evidence suggests that, in the early 1900s, a population of muskrats was introduced to the Isles of Shoals archipelago, located within the Gulf of Maine, for the purposes of fur harvest. However, because muskrats are native to the northeastern coast of North America, their presence on the Isles of Shoals could be interpreted as part of the native range of the species, potentially obscuring management planning and biogeographic inferences. To investigate their introduced status and identify a historic source population, muskrats from Appledore Island of the Isles of Shoals, and from the adjacent mainland of Maine and New Hampshire, were compared for mitochondrial cytochrome b sequences and allele frequencies at eight microsatellite loci. Appledore Island muskrats consistently exhibited reduced genetic diversity compared with mainland populations, and displayed signatures of a historic bottleneck. The distribution of mitochondrial haplotypes is suggestive of a New Hampshire source population. The data presented here are consistent with a human-mediated introduction that took place in the early 1900s. This scenario is further supported by the zooarchaeological record and island biogeographic patterns. This is the first genetic study of an introduced muskrat population within US borders and of any island muskrat population, and provides an important contrast with other studies of introduced muskrat populations worldwide.	[Mychajliw, Alexis M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Harrison, Richard G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Stanford University; Cornell University	Mychajliw, AM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	amychajl@stanford.edu			Biology Research Fellowship Program of Cornell University; Hunter R. Rawlings III Cornell Presidential Research Scholarship; Dextra Undergraduate Research Endowment Fund at Cornell University	Biology Research Fellowship Program of Cornell University; Hunter R. Rawlings III Cornell Presidential Research Scholarship; Dextra Undergraduate Research Endowment Fund at Cornell University	The Biology Research Fellowship Program of Cornell University (http://biology.cornell.edu/biology-research-fellows-program), Hunter R. Rawlings III Cornell Presidential Research Scholarship (http://www.commitment.cornell.edu/cprs/default.php), and Dextra Undergraduate Research Endowment Fund at Cornell University (http://cals.cornell.edu/academics/student-research/undergraduate-grants-proposal/) provided funding to AMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery JD, 2013, MOL ECOL, V22, P2313, DOI 10.1111/mec.12236; Barun A, 2013, BIOL INVASIONS, V15, P2243, DOI 10.1007/s10530-013-0447-6; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; BLOOM AL, 1963, AM J SCI, V261, P862, DOI 10.2475/ajs.261.9.862; Borror AC, 2009, BORRORS SPECIES CHEC; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conroy Chris J., 1999, Journal of Mammalian Evolution, V6, P221, DOI 10.1023/A:1020561623890; Cook JA, 2010, J MAMMAL, V91, P1401, DOI 10.1644/09-MAMM-A-386.1; Cornuet JM, 1996, GENETICS, V144, P2001; CROWELL KL, 1986, BIOL J LINN SOC, V28, P37, DOI 10.1111/j.1095-8312.1986.tb01748.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fu YX, 1997, GENETICS, V147, P915; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Harrington F, 1988, CONTEXT, V6, P13; Harrington F, 1990, PRELIMINARY REPORT 1; Hartl D., 1989, PRINCIPLES POPULATIO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Helgen KM, 2008, J MAMMAL, V89, P282, DOI 10.1644/07-MAMM-A-155R.1; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; KIMURA M, 1964, GENETICS, V49, P725; Laurence S, 2009, MOL ECOL RESOUR, V9, P654, DOI 10.1111/j.1755-0998.2008.02501.x; Laurence S, 2011, J HERED, V102, P688, DOI 10.1093/jhered/esr071; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Long JL, 2003, INTRO MAMMALS WORLD; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Lyman E, 1984, THESIS U NEW HAMPSHI; Manville Richard H., 1942, JOUR MAMMAL, V23, P391, DOI 10.2307/1375049; Marshall JCJ, 2009, CONSERV GENET, V10, P465, DOI 10.1007/s10592-008-9624-z; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nichols WF, 2008, RHODORA, V110, P245, DOI 10.3119/07-14.1; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schneider S, 1999, GENETICS, V152, P1079; Simberloff D, 2009, BIOL INVASIONS, V11, P1735, DOI 10.1007/s10530-008-9400-5; SLATKIN M, 1995, GENETICS, V139, P457; Spear SF, 2006, CONSERV GENET, V7, P605, DOI 10.1007/s10592-005-9095-4; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Thaxter C, 1873, ISLES SHOALS; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY	56	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111856	10.1371/journal.pone.0111856	http://dx.doi.org/10.1371/journal.pone.0111856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360617	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700155
J	Ali, SE; Thoen, E; Evensen, O; Wiik-Nielsen, J; Gamil, AAA; Skaar, I				Ali, Shimaa E.; Thoen, Even; Evensen, Oystein; Wiik-Nielsen, Jannicke; Gamil, Amr A. A.; Skaar, Ida			Mitochondrial Dysfunction Is Involved in the Toxic Activity of Boric Acid against Saprolegnia	PLOS ONE			English	Article							TETRAZOLIUM FORMAZAN ASSAY; COLLETOTRICHUM-GLOEOSPORIOIDES; VIABILITY; BORATE	There has been a significant increase in the incidence of Saprolegnia infections over the past decades, especially after the banning of malachite green. Very often these infections are associated with high economic losses in salmonid farms and hatcheries. The use of boric acid to control the disease has been investigated recently both under in vitro and in vivo conditions, however its possible mode of action against fish pathogenic Saprolegnia is not known. In this study, we have explored the transformation in Saprolegnia spores/hyphae after exposure to boric acid (1 g/L) over a period 4-24 h post treatment. Using transmission electron microscopy (TEM), early changes in Saprolegnia spores were detected. Mitochondrial degeneration was the most obvious sign observed following 4 h treatment in about 20% of randomly selected spores. We also investigated the effect of the treatment on nuclear division, mitochondrial activity and function using confocal laser scanning microscopy (CLSM). Fluorescence microscopy was also used to test the effect of treatment on mitochondrial membrane potential and formation of reactive oxygen species. Additionally, the viability and proliferation of treated spores that correlated to mitochondrial enzymatic activity were tested using an MTS assay. All obtained data pointed towards changes in the mitochondrial structure, membrane potential and enzymatic activity following treatment. We have found that boric acid has no effect on the integrity of membranes of Saprolegnia spores at concentrations tested. It is therefore likely that mitochondrial dysfunction is involved in the toxic activity of boric acid against Saprolegnia spp.	[Ali, Shimaa E.; Thoen, Even; Wiik-Nielsen, Jannicke; Skaar, Ida] Norwegian Vet Inst, Oslo, Norway; [Thoen, Even; Evensen, Oystein; Gamil, Amr A. A.] Norwegian Univ Life Sci, Oslo, Norway	Norwegian Veterinary Institute; Norwegian University of Life Sciences	Skaar, I (corresponding author), Norwegian Vet Inst, Oslo, Norway.	ida.skaar@vetinst.no	Evensen, Øystein/O-3011-2015; Ali, Shimaa E/HHD-0713-2022	Evensen, Øystein/0000-0002-4856-3043; Gamil, Amr/0000-0001-9920-6487; Ali, Shimaa E/0000-0002-0227-8124	European Commission through the EU [238550]	European Commission through the EU	The work has been funded by the European Commission through the EU Marie Curie ITN project SAPRO (238550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091878; Ali SE, 2013, VET MICROBIOL, V163, P133, DOI 10.1016/j.vetmic.2012.12.012; AlRubeai M, 1997, CYTOTECHNOLOGY, V24, P161, DOI 10.1023/A:1007910920355; Amberg DC, 2006, CSH PROTOC, V2006; BEAKES GW, 1980, CAN J BOT, V58, P195, DOI 10.1139/b80-021; Bruno DW, 1999, FISH DISEASES AND DISORDERS, VOL 3, P599; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P895, DOI 10.1101/pdb.prot5641; Coder DM, 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0902s15, DOI 10.1002/0471142956.CY0902S15]; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Coughlin JR, 1996, J TRACE ELEM EXP MED, V9, P137; De Seta F, 2009, J ANTIMICROB CHEMOTH, V63, P325, DOI 10.1093/jac/dkn486; Eckhert CD, 1998, J NUTR, V128, P2488, DOI 10.1093/jn/128.12.2488; Hardham AR, 2001, MOL CELL BIOL FILAME, P127; HEATH IB, 1980, J CELL BIOL, V84, P531, DOI 10.1083/jcb.84.3.531; Hulvey JP, 2007, MYCOLOGIA, V99, P421, DOI 10.3852/mycologia.99.3.421; Joshi D.C., 2011, JOVE-J VIS EXP, V23, P7588; JOVANOVIC R, 1991, J REPROD MED, V36, P593; KU WW, 1993, REPROD TOXICOL, V7, P321, DOI 10.1016/0890-6238(93)90021-X; Levina NN, 2006, FUNGAL GENET BIOL, V43, P65, DOI 10.1016/j.fgb.2005.06.008; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Martins VD, 2011, J BIOENERG BIOMEMBR, V43, P81, DOI 10.1007/s10863-011-9331-1; Mucha J, 2009, MYCOL RES, V113, P981, DOI 10.1016/j.mycres.2009.06.002; Ruy F, 2006, J BIOENERG BIOMEMBR, V38, P129, DOI 10.1007/s10863-006-9012-7; Shi XQ, 2011, PLANT DIS, V95, P63, DOI 10.1094/PDIS-06-10-0437; Shi XQ, 2012, POSTHARVEST BIOL TEC, V67, P138, DOI 10.1016/j.postharvbio.2012.01.003; Silverman-Gavrila LB, 2003, MICROBIOL-SGM, V149, P2475, DOI 10.1099/mic.0.26302-0; Smith SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026908; Stueland S, 2005, J FISH DIS, V28, P445, DOI 10.1111/j.1365-2761.2005.00635.x; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Zuo XM, 2011, MOL PHARMACOL, V80, P476, DOI 10.1124/mol.111.072322	36	11	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110343	10.1371/journal.pone.0110343	http://dx.doi.org/10.1371/journal.pone.0110343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354209	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000345204200022
J	Chen, LM; Du, WJ; Dai, J; Zhang, Q; Si, GX; Yang, H; Ye, EL; Chen, QS; Yu, LC; Zhang, C; Lu, XM				Chen, Liang-Miao; Du, Wen-Jun; Dai, Jie; Zhang, Qian; Si, Guang-Xin; Yang, Hong; Ye, En-Ling; Chen, Qing-Shou; Yu, Le-Chu; Zhang, Chi; Lu, Xue-Mian			Effects of Subclinical Hypothyroidism on Maternal and Perinatal Outcomes during Pregnancy: A Single-Center Cohort Study of a Chinese Population	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; LOW-BIRTH-WEIGHT; THYROID-FUNCTION; PREMATURE RUPTURE; SUBSEQUENT FETAL; HEART-FAILURE; MANAGEMENT; DYSFUNCTION; CHILDREN; HORMONE	Objective: Adverse maternal outcomes and perinatal complications are closely associated with overt maternal hypothyroidism, but whether these complications occur in women with subclinical hypothyroidism (SCH) during pregnancy remains controversial. The aim of this study was to evaluate the effects of SCH on maternal and perinatal outcomes during pregnancy. Methods: A prospective study of data from 8012 pregnant women (371 women with SCH, 7641 euthyroid women) was performed. Maternal serum samples were collected in different trimesters to examine thyroid hormone concentrations. SCH was defined as a thyroid stimulating hormone concentration exceeding the trimester-specific reference value with a normal free thyroxine concentration. The occurrence of maternal outcomes, including gestational hypertension (GH), gestational diabetes mellitus, placenta previa, placental abruption, prelabor rupture of membranes (PROM), and premature delivery; and perinatal outcomes, including intrauterine growth restriction (IUGR), fetal distress, low birth weight (LBW; live birth weight <= 2500 g), stillbirth, and malformation, was recorded. Logistic regression with adjustment for confounding demographic and medical factors was used to determine the risks of adverse outcomes in patients with SCH. Results: Compared with euthyroid status, SCH was associated with higher rates of GH (1.819% vs. 3.504%, P = 0.020; chi(2) = 7.345; odds ratio (OR), 2.243; 95% confidence interval (CI), 1.251-4.024), PROM (4.973% vs. 8.625%, P = 0.002; chi(2) = 72.102; adjusted OR, 6.014; 95% CI, 3.975-9.099), IUGR (1.008% vs. 2.965%, <0.001; chi(2) = 13.272; adjusted OR, 3.336; 95% CI, 1.745-6.377), and LBW (1.885% vs. 4.582%, P<0.001; chi(2) = 13.558; adjusted OR, 2.919; 95% CI, 1.650-5.163). Conclusions: The results of this study indicate that pregnant women with SCH had increased risks of GH and PROM, and their fetuses and infants had increased risks of IUGR and LBW. Thus, routine maternal thyroid function testing is necessary to improve maternal and perinatal outcomes.	[Chen, Liang-Miao; Du, Wen-Jun; Dai, Jie; Zhang, Qian; Si, Guang-Xin; Yang, Hong; Ye, En-Ling; Chen, Qing-Shou; Yu, Le-Chu; Lu, Xue-Mian] Wenzhou Med Univ, Affiliated Hosp 3, Dept Endocrinol, Ruian, Zhejiang, Peoples R China; [Zhang, Chi; Lu, Xue-Mian] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Peoples R China; [Zhang, Chi; Lu, Xue-Mian] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Affiliated Hosp 3, Ruian Ctr, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhang, C (corresponding author), Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Peoples R China.	zhangchi515@126.com; lu89118@medmail.com.cn	Cai, Lu/AAG-9920-2019	Liangmiao, Chen/0000-0002-6687-5825	Medical Science Research Foundation of Zhejiang Province [2009A198]; Third Batch of Science and Technology Project of Ruian city [20093092]; National Science Foundation of China [81000294, 81370917]; Wenzhou Medical University [QTJ13005]	Medical Science Research Foundation of Zhejiang Province; Third Batch of Science and Technology Project of Ruian city; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University	This study was supported in part by Medical Science Research Foundation of Zhejiang Province (2009A198, to XL), the Third Batch of Science and Technology Project of Ruian city (20093092, to XL), Young Scientist Award from National Science Foundation of China (81000294, to CZ), National Science Foundation of China (81370917, to CZ), Research Development Fund of Wenzhou Medical University (QTJ13005, to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetrics and Gynecology, 2002, Int J Gynaecol Obstet, V79, P171; Ashoor G, 2010, THYROID, V20, P989, DOI 10.1089/thy.2010.0058; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Casey BM, 2006, OBSTET GYNECOL, V107, P337, DOI 10.1097/01.AOG.0000197991.64246.9a; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Danzi S, 2003, CURR HYPERTENS REP, V5, P513, DOI 10.1007/s11906-003-0060-7; Danzi S, 2012, MED CLIN N AM, V96, P257, DOI 10.1016/j.mcna.2012.01.006; DAVIS LE, 1988, OBSTET GYNECOL, V72, P108; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Di Renzo GC, 2006, J PERINAT MED, V34, P359, DOI 10.1515/JPM.2006.073; Fattal-Valevski A, 1999, J CHILD NEUROL, V14, P724, DOI 10.1177/088307389901401107; Fletcher AK, 1998, J HUM HYPERTENS, V12, P79, DOI 10.1038/sj.jhh.1000574; Gartner R, 2009, CURR OPIN OBSTET GYN, V21, P501, DOI 10.1097/GCO.0b013e328332a836; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Goh ECL, 2006, J INTERGENER RELATSH, V4, P7, DOI 10.1300/J194v04n03_02; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Horacek J, 2010, EUR J ENDOCRINOL, V163, P645, DOI 10.1530/EJE-10-0516; Idris I, 2005, CLIN ENDOCRINOL, V63, P560, DOI 10.1111/j.1365-2265.2005.02382.x; Julvez J, 2013, EPIDEMIOLOGY, V24, P150, DOI 10.1097/EDE.0b013e318276ccd3; KJOS SL, 1995, AM J OBSTET GYNECOL, V173, P1532, DOI 10.1016/0002-9378(95)90645-2; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Laurberg P, 2013, CLIN ENDOCRINOL, V79, P297, DOI 10.1111/cen.12232; Lazarus JH, 2011, BRIT MED BULL, V97, P137, DOI 10.1093/bmb/ldq039; Le J, 2003, GYNECOLOGY OBSTET, P92; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; LEUNG AS, 1993, OBSTET GYNECOL, V81, P349; LIPPER E, 1981, PEDIATRICS, V67, P502; Lu XM, 2012, J MED RES, V41, P70; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nelson DB, 2014, AM J PERINAT, V31, P77, DOI 10.1055/s-0033-1334457; North RA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5183; Ohashi M, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/619718; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Oppenheimer L, 2007, J OBSTET GYNAECOL CA, V29, P261, DOI 10.1016/S1701-2163(16)32401-X; Polzin WJ, 1998, CLIN OBSTET GYNECOL, V41, P810, DOI 10.1097/00003081-199812000-00004; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Qin C, 2012, MATERN CHILD HLTH J, V16, P1484, DOI 10.1007/s10995-011-0913-7; Rashid M, 2007, OBSTET GYNECOL SURV, V62, P680, DOI 10.1097/01.ogx.0000281558.59184.b5; Reid SM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007752.pub2; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Sahay Rakesh Kumar, 2012, Indian J Endocrinol Metab, V16, P364, DOI 10.4103/2230-8210.95667; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sheffield JS, 2004, AM J OBSTET GYNECOL, V190, P211, DOI 10.1016/S0002-9378(03)00944-X; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83; Stagnaro-Green A, 2012, NAT REV ENDOCRINOL, V8, P650, DOI 10.1038/nrendo.2012.171; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Taddei S, 2003, J CLIN ENDOCR METAB, V88, P3731, DOI 10.1210/jc.2003-030039; Tirosh D, 2013, PEERJ, V1, DOI 10.7717/peerj.52; Tudela CM, 2012, OBSTET GYNECOL, V119, P983, DOI 10.1097/AOG.0b013e318250aeeb; Vaidya B, 2007, J CLIN ENDOCR METAB, V92, P203, DOI 10.1210/jc.2006-1748; Velkeniers B, 2013, HUM REPROD UPDATE, V19, P251, DOI 10.1093/humupd/dms052; Wilson Carol, 2012, Nat Rev Endocrinol, V8, P624, DOI 10.1038/nrendo.2012.156; Wilson KL, 2012, OBSTET GYNECOL, V119, P315, DOI 10.1097/AOG.0b013e318240de6a; Woeber KA, 1997, ARCH INTERN MED, V157, P1065, DOI 10.1001/archinte.157.10.1065; Wollmann HA, 1998, HORM RES, V49, P1, DOI 10.1159/000053079	63	77	87	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109364	10.1371/journal.pone.0109364	http://dx.doi.org/10.1371/journal.pone.0109364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353960	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200010
J	Mao, CT; Tsai, ML; Wang, CY; Wen, MS; Hsieh, IC; Hung, MJ; Wang, CH; Chen, CC; Chen, TH				Mao, Chun-Tai; Tsai, Ming-Lung; Wang, Chao-Yung; Wen, Ming-Shien; Hsieh, I-Chang; Hung, Ming-Jui; Wang, Chao-Hung; Chen, Chun-Chi; Chen, Tien-Hsing			Outcomes and Characteristics of Patients Undergoing Percutaneous Angioplasty Followed by Below-Knee or Above-Knee Amputation for Peripheral Artery Disease	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATION; CRITICAL LIMB ISCHEMIA; CORONARY ATHEROSCLEROSIS; MORTALITY; RISK; REVASCULARIZATION; ASSOCIATION; PROGRESSION; MANAGEMENT; SURGERY	Objective: Little is known about long-term outcomes among patients who receive percutaneous angioplasty (PTA) for peripheral artery disease (PAD) then undergo below-knee or above-knee amputations. We sought to determine clinical outcomes associated with below-knee or above-knee amputation, along with possible explanatory factors and treatment strategies. Methods: Using data from Taiwan's National Health Insurance Research Database from 1997 to 2010, 7,568 adult patients were divided into three groups: lower extremity preserved (LE), below-knee amputation (BK) and above-knee amputation (AK). We assessed outcomes including major adverse cardiovascular events (MACE) and associated risk factors. Results: Overall MACE was significantly higher in the AK group compared to the LE and BK groups, over a mean follow-up of 2.45 years (hazard ratio [HR]: 1.81; 95% confidence interval [CI]: 1.50-2.18 for AK vs. LE; HR: 1.67; 95% CI: 1.36-2.06 for AK vs. BK). However MACE were similar for the BK and LE groups (HR: 1.08; 95% CI: 0.98-1.20). Overall mortality was highest in the AK group (HR: 1.65, 95% CI: 1.34-2.04 for AK vs. BK). As for patient characteristics, atrial fibrillation was more prevalent in the AK group than in the BK group (17% vs. 7%). Independent risk factors associated with death after above-or below-knee amputation included advanced age, heart failure, dialysis, male gender and high patient volume. Conclusion: The MACE rate was highest in the AK group, whereas the LE and BK groups were similar in this regard. Furthermore, overall mortality increased with larger area of amputation.	[Mao, Chun-Tai; Hung, Ming-Jui; Wang, Chao-Hung] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Heart Failure Ctr, Keelung, Taiwan; [Tsai, Ming-Lung; Wang, Chao-Yung; Wen, Ming-Shien; Hsieh, I-Chang; Chen, Chun-Chi; Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taipei 10591, Taiwan; [Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Cardiol, Xiamen, Peoples R China; [Mao, Chun-Tai; Tsai, Ming-Lung; Wang, Chao-Yung; Wen, Ming-Shien; Hsieh, I-Chang; Hung, Ming-Jui; Wang, Chao-Hung; Chen, Chun-Chi; Chen, Tien-Hsing] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chen, TH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	mr7599@outlook.com	Wang, Chao-Yung/ABA-6757-2021; Wang, Chao/GXF-8353-2022	Wang, Chao-Yung/0000-0003-1546-7298; 				Abou-Zamzam AM, 2003, ANN VASC SURG, V17, P86, DOI 10.1007/s10016-001-0340-0; Ballantyne CM, 2008, CIRCULATION, V117, P2458, DOI 10.1161/CIRCULATIONAHA.108.773747; Chen JJ, 2012, INT J ANGIOL, V21, P35, DOI 10.1055/s-0032-1302437; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cruz CP, 2003, AM J SURG, V186, P449, DOI 10.1016/j.amjsurg.2003.07.027; D'Ascenzo F, 2013, ATHEROSCLEROSIS, V226, P178, DOI 10.1016/j.atherosclerosis.2012.10.065; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Goodney PP, 2009, J VASC SURG, V50, P54, DOI 10.1016/j.jvs.2009.01.035; HARRIS JP, 1988, J CARDIOVASC SURG, V29, P741; Hirohata A, 2010, J AM COLL CARDIOL, V55, P976, DOI 10.1016/j.jacc.2009.09.062; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; Jain A, 2013, J AM COLL CARDIOL, V61, P1820, DOI 10.1016/j.jacc.2013.01.060; Jones WS, 2013, AM HEART J, V165, P809, DOI 10.1016/j.ahj.2012.12.002; Kinlay S, 2013, CIRCULATION, V127, P1241, DOI 10.1161/CIRCULATIONAHA.112.001232; Kontos MC, 2013, CIRC-CARDIOVASC QUAL, V6, P659, DOI 10.1161/CIRCOUTCOMES.113.000233; Margolis Jay, 2005, J Manag Care Pharm, V11, P727; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Menke J, 2010, AM J CARDIOL, V105, P502, DOI 10.1016/j.amjcard.2009.10.018; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Ouriel K, 1998, SURGERY, V124, P336, DOI 10.1016/S0039-6060(98)70139-4; Ouriel K, 1998, NEW ENGL J MED, V338, P1105, DOI 10.1056/NEJM199804163381603; Peacock JM, 2011, PREV CHRONIC DIS, V8; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Titsworth WL, 2012, J NEUROSURG, V116, P1379, DOI 10.3171/2012.2.JNS111881; Tseng Chin-Hsiao, 1994, Journal of the Formosan Medical Association, V93, P388; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Yang YW, 2011, STROKE, V42, P319, DOI 10.1161/STROKEAHA.110.596361	32	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111130	10.1371/journal.pone.0111130	http://dx.doi.org/10.1371/journal.pone.0111130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354252	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200058
J	Martinez-Martinez, N; Martinez-Alonso, E; Ballesta, J; Martinez-Menarguez, JA				Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Ballesta, Jose; Martinez-Menarguez, Jose A.			Phospholipase D2 Is Involved in the Formation of Golgi Tubules and ArfGAP1 Recruitment	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHATIDIC-ACID; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; MEMBRANE CURVATURE; RECYCLING PATHWAY; COPI VESICLES; TRANSPORT; COMPLEX; DIACYLGLYCEROL	Lipids and lipid-modifying enzymes play a key role in the biogenesis, maintenance and fission of transport carriers in the secretory and endocytic pathways. In the present study we demonstrate that phosphatidic acid generated by phospholipase D2 (PLD2) is involved in the formation of Golgi tubules. The main evidence to support this is: 1) inhibitors of phosphatidic acid formation and PLD2 depletion inhibit the formation of tubules containing resident enzymes and regulators of intra-Golgi transport in a low temperature (15 degrees C) model of Golgi tubulation but do not affect brefeldin A-induced tubules, 2) inhibition of PLD2 enzymatic activity and PLD2 depletion in cells cultured under physiological conditions (37 degrees C) induce the formation of tubules specifically containing Golgi matrix proteins, and, 3) over-expression of PLD2 induces the formation of a tubular network. In addition, it was found that the generation of this lipid by the isoenzyme is necessary for ArfGAP1 recruitment to Golgi membranes. These results suggest that both proteins are involved in the molecular mechanisms which drive the formation of different types of Golgi tubules.	[Martinez-Martinez, Narcisa; Martinez-Alonso, Emma; Ballesta, Jose; Martinez-Menarguez, Jose A.] Univ Murcia, Dept Cell Biol & Histol, Sch Med, IMIB Arrixaca, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia	Martinez-Menarguez, JA (corresponding author), Univ Murcia, Dept Cell Biol & Histol, Sch Med, IMIB Arrixaca, Murcia, Spain.	jamartin@um.es	ALONSO, EMMA MARTINEZ/L-7468-2014; Martinez-Martinez, Narcisa/I-1778-2015	ALONSO, EMMA MARTINEZ/0000-0002-8121-0442; Martinez-Martinez, Narcisa/0000-0002-8672-184X; ballesta, Jose/0000-0001-7965-5277	Ministerio de Ciencia e Innovacion (Spain) [Consolider COAT CSD2009-00016]; Fundacion Seneca de la Comunidad Autonoma de la Region de Murcia [04542/GERM/06]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca de la Comunidad Autonoma de la Region de Murcia(Fundacion Seneca)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (Spain) (Consolider COAT CSD2009-00016) and Fundacion Seneca de la Comunidad Autonoma de la Region de Murcia (04542/GERM/06) to JAM-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Beznoussenko GV, 2014, ELIFE, V3, DOI 10.7554/eLife.02009; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brown WJ, 2008, TRAFFIC, V9, P786, DOI 10.1111/j.1600-0854.2008.00711.x; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; CHALIFOUR R, 1982, J NEUROCHEM, V39, P299, DOI 10.1111/j.1471-4159.1982.tb03946.x; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; de Figueiredo P, 2000, TRAFFIC, V1, P504, DOI 10.1034/j.1600-0854.2000.010608.x; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762; Drecktrah D, 2003, MOL BIOL CELL, V14, P3459, DOI 10.1091/mbc.E02-11-0711; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gonzalez-Rubio P, 2011, BBA-BIOMEMBRANES, V1808, P2119, DOI 10.1016/j.bbamem.2011.05.006; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Gutierrez-Martinez E, 2013, J CELL SCI, V126, P2641, DOI 10.1242/jcs.117705; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Kim H, 2007, CELL BIOL INT, V31, P148, DOI 10.1016/j.cellbi.2006.09.020; Klumperman J, 1998, J CELL SCI, V111, P3411; Klumperman J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005181; Kolesnikov YS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1, DOI 10.1134/S0006297912010014; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; KOUL O, 1987, ARCH BIOCHEM BIOPHYS, V253, P453, DOI 10.1016/0003-9861(87)90199-8; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Kurooka T, 2011, J BIOL CHEM, V286, P6832, DOI 10.1074/jbc.M110.183772; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Lopez-Andreo MJ, 2003, MOL BIOL CELL, V14, P4885, DOI 10.1091/mbc.E03-05-0295; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Martinez-Alonso E, 2007, TRAFFIC, V8, P359, DOI 10.1111/j.1600-0854.2006.00533.x; Martinez-Alonso E, 2013, HISTOCHEM CELL BIOL, V140, P327, DOI 10.1007/s00418-013-1114-9; Martinez-Menarguez JA, 2013, ISRN CELL BIOL, V2013, P1; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Polishchuk RS, 2009, FEBS LETT, V583, P3847, DOI 10.1016/j.febslet.2009.10.031; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shiba Y, 2012, HISTOL HISTOPATHOL, V27, P1143, DOI 10.14670/HH-27.1143; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	55	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111685	10.1371/journal.pone.0111685	http://dx.doi.org/10.1371/journal.pone.0111685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354038	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200092
J	Warnke, P; Frickmann, H; Ottl, P; Podbielski, A				Warnke, Philipp; Frickmann, Hagen; Ottl, Peter; Podbielski, Andreas			Nasal Screening for MRSA: Different Swabs - Different Results!	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PORT-A-CUL; METHICILLIN-RESISTANT; TRANSPORT-SYSTEMS; ANAEROBIC-BACTERIA; NEISSERIA-GONORRHOEAE; ECONOMIC-IMPACT; FLOCKED SWABS; NOSOCOMIAL INFECTIONS; HOSPITAL ADMISSION	Objectives: Swab-based nasal screening is commonly used to identify asymptomatic carriage of Staphylococcus aureus in patients. Bacterial detection depends on the uptake and release capacities of the swabs and on the swabbing technique itself. This study investigates the performance of different swab-types in nasal MRSA-screening by utilizing a unique artificial nose model to provide realistic and standardized screening conditions. Methods: An anatomically correct artificial nose model was inoculated with a numerically defined mixture of MRSA and Staphylococcus epidermidis bacteria at quantities of 4x10(2) and 8x10(2) colony forming units (CFU), respectively. Five swab-types were tested following a strict protocol. Bacterial recovery was measured for direct plating and after elution into Amies medium by standard viable count techniques. Results: Mean recovered bacteria quantities varied between 209 and 0 CFU for MRSA, and 365 and 0 CFU for S. epidermidis, resulting swab-type-dependent MRSA-screening-sensitivities ranged between 0 and 100%. Swabs with nylon flocked tips or cellular foam tips performed significantly better compared to conventional rayon swabs referring to the recovered bacterial yield (p<0.001). Best results were obtained by using a flocked swab in combination with Amies preservation medium. Within the range of the utilized bacterial concentrations, recovery ratios for the particular swab-types were independent of the bacterial species. Conclusions: This study combines a realistic model of a human nose with standardized laboratory conditions to analyze swab-performance in MRSA-screening situations. Therefore, influences by inter-individual anatomical differences as well as diverse colonization densities in patients could be excluded. Recovery rates vary significantly between different swab-types. The choice of the swab has a great impact on the laboratory result. In fact, the swab-type contributes significantly to true positive or false negative detection of nasal MRSA carriage. These findings should be considered when screening a patient.	[Warnke, Philipp; Frickmann, Hagen; Podbielski, Andreas] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Frickmann, Hagen] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Ottl, Peter] Rostock Univ Hosp, Dept Prosthodont & Mat Sci, Rostock, Germany	University of Rostock; Bernhard Nocht Institut fur Tropenmedizin; University of Rostock	Warnke, P (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de						Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Abu-Diab A, 2008, J CLIN MICROBIOL, V46, P2414, DOI 10.1128/JCM.00369-08; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Barber S, 1998, PATHOLOGY, V30, P179, DOI 10.1080/00313029800169196; Bartolitius L, 2014, EUR J MICROBIOL IMMU, V4, P159, DOI 10.1556/EUJMI-D-14-00020; Bocher S, 2008, J CLIN MICROBIOL, V46, P3136, DOI 10.1128/JCM.00478-08; BROOK I, 1987, J CLIN MICROBIOL, V25, P2020, DOI 10.1128/JCM.25.10.2020-2022.1987; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Citron DM, 2000, J CLIN MICROBIOL, V38, P892, DOI 10.1128/JCM.38.2.892-894.2000; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Drake C, 2005, J CLIN MICROBIOL, V43, P1301, DOI 10.1128/JCM.43.3.1301-1303.2005; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Farhat SE, 2001, J CLIN MICROBIOL, V39, P2958, DOI 10.1128/JCM.39.8.2958-2960.2001; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Herr CEW, 2003, INFECT CONT HOSP EP, V24, P673, DOI 10.1086/502274; Hindiyeh M, 2001, J CLIN MICROBIOL, V39, P377, DOI 10.1128/JCM.39.1.377-380.2001; Hsu LY, 2005, J CLIN MICROBIOL, V43, P2923, DOI 10.1128/JCM.43.6.2923-2925.2005; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Kalmeijer MD, 2000, INFECT CONT HOSP EP, V21, P319, DOI 10.1086/501763; Kim T, 2001, INFECT CONT HOSP EP, V22, P99, DOI 10.1086/501871; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Kopp BJ, 2004, ANN PHARMACOTHER, V38, P1377, DOI 10.1345/aph.1E028; Lee S, 2008, ANN CLIN LAB SCI, V38, P254; Lodise TP, 2005, DIAGN MICR INFEC DIS, V52, P113, DOI 10.1016/j.diagmicrobio.2005.02.007; Melter O., 2006, EURO SURVEILL, V11; Mermel LA, 2010, INFECT CONT HOSP EP, V31, P592, DOI 10.1086/652778; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Morosini MI, 2006, DIAGN MICR INFEC DIS, V56, P19, DOI 10.1016/j.diagmicrobio.2006.02.011; NCCLS (The National Committee for Clinical Laboratory Standards), 2003, M40A NCCLS; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Nys S, 2010, EUR J CLIN MICROBIOL, V29, P453, DOI 10.1007/s10096-010-0883-5; Olsen CC, 1999, J CLIN MICROBIOL, V37, P3583, DOI 10.1128/JCM.37.11.3583-3585.1999; Osterblad M, 2003, J CLIN MICROBIOL, V41, P1894, DOI 10.1128/JCM.41.5.1894-1900.2003; Paule SM, 2009, AM J CLIN PATHOL, V131, P532, DOI 10.1309/AJCP18ONZUTDUGAQ; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Perry JL, 1997, J CLIN MICROBIOL, V35, P1269, DOI 10.1128/JCM.35.5.1269-1271.1997; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; Roelofsen E, 1999, J CLIN MICROBIOL, V37, P3041, DOI 10.1128/JCM.37.9.3041-3043.1999; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; ROTH RR, 1989, J AM ACAD DERMATOL, V20, P367, DOI 10.1016/S0190-9622(89)70048-7; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Smismans A, 2009, DIAGN MICR INFEC DIS, V65, P108, DOI 10.1016/j.diagmicrobio.2009.06.015; Smith JMB, 2005, EPIDEMIOL INFECT, V133, P899, DOI 10.1017/S0950268805004024; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Van Horn KG, 2008, DIAGN MICR INFEC DIS, V62, P471, DOI 10.1016/j.diagmicrobio.2008.08.004; Verhoeven P, 2010, J CLIN MICROBIOL, V48, P4242, DOI 10.1128/JCM.01425-10; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102215; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; White A, 1963, ANTIMICROB AGENTS CH, V161, P667	70	36	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111627	10.1371/journal.pone.0111627	http://dx.doi.org/10.1371/journal.pone.0111627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353631	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200090
J	Weaver, J; Watts, T; Li, PW; Rye, HS				Weaver, Jeremy; Watts, Tylan; Li, Pingwei; Rye, Hays S.			Structural Basis of Substrate Selectivity of E. coli Prolidase	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; AMINOPEPTIDASE-P; PROLINE DIPEPTIDASE; ENZYMATIC FUNCTION; PYROCOCCUS; PURIFICATION; GENE; IDENTIFICATION; DEFICIENCY; METABOLISM	Prolidases, metalloproteases that catalyze the cleavage of Xaa-Pro dipeptides, are conserved enzymes found in prokaryotes and eukaryotes. In humans, prolidase is crucial for the recycling of collagen. To further characterize the essential elements of this enzyme, we utilized the Escherichia coli prolidase, PepQ, which shares striking similarity with eukaryotic prolidases. Through structural and bioinformatic insights, we have extended previous characterizations of the prolidase active site, uncovering a key component for substrate specificity. Here we report the structure of E. coli PepQ, solved at 2.0 angstrom resolution. The structure shows an antiparallel, dimeric protein, with each subunit containing N-terminal and C-terminal domains. The C-terminal domain is formed by the pita-bread fold typical for this family of metalloproteases, with two Mg(II) ions coordinated by five amino-acid ligands. Comparison of the E. coli PepQ structure and sequence with homologous structures and sequences from a diversity of organisms reveals distinctions between prolidases from Gram-positive eubacteria and archaea, and those from Gram-negative eubacteria, including the presence of loop regions in the E. coli protein that are conserved in eukaryotes. One such loop contains a completely conserved arginine near the catalytic site. This conserved arginine is predicted by docking simulations to interact with the C-terminus of the substrate dipeptide. Kinetic analysis using both a charge-neutralized substrate and a charge-reversed variant of PepQ support this conclusion, and allow for the designation of a new role for this key region of the enzyme active site.	[Weaver, Jeremy; Watts, Tylan; Li, Pingwei; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137	National Institutes of Health [GM065421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (GM065421) to H. S. R. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberto ME, 2011, INORG CHEM, V50, P3394, DOI 10.1021/ic1022517; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; BAZAN JF, 1994, P NATL ACAD SCI USA, V91, P2473, DOI 10.1073/pnas.91.7.2473; Besio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058792; BROWNE P, 1983, J BIOL CHEM, V258, P6147; Cheng TC, 1998, ANN NY ACAD SCI, V864, P253, DOI 10.1111/j.1749-6632.1998.tb10316.x; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDO F, 1989, J INHERIT METAB DIS, V12, P351, DOI 10.1007/BF01799240; FernandezEspla MD, 1997, APPL ENVIRON MICROB, V63, P314; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Forlino A, 2002, HUM GENET, V111, P314, DOI 10.1007/s00439-002-0792-5; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Ghosh M, 1998, J BACTERIOL, V180, P4781, DOI 10.1128/JB.180.18.4781-4789.1998; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hu KK, 2009, BBA-PROTEINS PROTEOM, V1794, P1715, DOI 10.1016/j.bbapap.2009.08.005; ITO Y, 1984, J BIOCHEM-TOKYO, V96, P1; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Jalving R, 2002, MOL GENET GENOMICS, V267, P218, DOI 10.1007/s00438-002-0655-8; Jun X, 2011, J BACTERIOL, V193, P4297, DOI 10.1128/JB.05345-11; Jung JH, 2012, J BACTERIOL, V194, P4434, DOI 10.1128/JB.00824-12; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Kitchener RL, 2012, J APPL MICROBIOL, V113, P233, DOI 10.1111/j.1365-2672.2012.05310.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecompte O, 2001, GENOME RES, V11, P981, DOI 10.1101/gr.GR1653R; Ledoux P, 1996, AM J HUM GENET, V59, P1035; LEDOUX P, 1994, AM J HUM GENET, V54, P1014; Lee HS, 2011, J BACTERIOL, V193, P3666, DOI 10.1128/JB.05150-11; Lowther WT, 2000, BBA-PROTEIN STRUCT M, V1477, P157, DOI 10.1016/S0167-4838(99)00271-X; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Lupi A, 2008, AMINO ACIDS, V35, P739, DOI 10.1007/s00726-008-0055-4; Lupi A, 2006, FEBS J, V273, P5466, DOI 10.1111/j.1742-4658.2006.05538.x; Maeder DL, 1999, GENETICS, V152, P1299; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; MILLER CG, 1978, J BACTERIOL, V135, P603, DOI 10.1128/JB.135.2.603-611.1978; MYARA I, 1984, LIFE SCI, V34, P1985, DOI 10.1016/0024-3205(84)90363-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Park MS, 2004, ARCH BIOCHEM BIOPHYS, V429, P224, DOI 10.1016/j.abb.2004.06.022; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shao ZX, 1996, CURR OPIN STRUC BIOL, V6, P513, DOI 10.1016/S0959-440X(96)80117-5; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; SJOSTROM H, 1973, BIOCHIM BIOPHYS ACTA, V327, P457, DOI 10.1016/0005-2744(73)90429-4; Stepankova A, 2013, ACTA CRYSTALLOGR F, V69, P346, DOI 10.1107/S1744309113002674; Surazynski A, 2008, AMINO ACIDS, V35, P731, DOI 10.1007/s00726-008-0051-8; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vyas NK, 2010, BIOCHEMISTRY-US, V49, P547, DOI 10.1021/bi9011989; Wang SH, 2005, ARCH TOXICOL, V79, P253, DOI 10.1007/s00204-004-0634-4; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wilcox DE, 1996, CHEM REV, V96, P2435, DOI 10.1021/cr950043b; Willingham K, 2001, ACTA CRYSTALLOGR D, V57, P428, DOI 10.1107/S0907444900020187; Zhang LB, 1998, J BIOL INORG CHEM, V3, P470, DOI 10.1007/s007750050257	63	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111531	10.1371/journal.pone.0111531	http://dx.doi.org/10.1371/journal.pone.0111531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354344	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200087
J	Misic, B; Fatima, Z; Askren, MK; Buschkuehl, M; Churchill, N; Cimprich, B; Deldin, PJ; Jaeggi, S; Jung, M; Korostil, M; Kross, E; Krpan, KM; Peltier, S; Reuter-Lorenz, PA; Strother, SC; Jonides, J; McIntosh, AR; Berman, MG				Misic, Bratislav; Fatima, Zainab; Askren, Mary K.; Buschkuehl, Martin; Churchill, Nathan; Cimprich, Bernadine; Deldin, Patricia J.; Jaeggi, Susanne; Jung, Misook; Korostil, Michele; Kross, Ethan; Krpan, Katherine M.; Peltier, Scott; Reuter-Lorenz, Patricia A.; Strother, Stephen C.; Jonides, John; McIntosh, Anthony R.; Berman, Marc G.			The Functional Connectivity Landscape of the Human Brain	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; DEFAULT-MODE NETWORK; COMPONENT ANALYSIS; NEUROANATOMY; VALIDATION; COMPLEXITY; INTERVIEW; SUBJECT; MOTION; ROBUST	Functional brain networks emerge and dissipate over a primarily static anatomical foundation. The dynamic basis of these networks is inter-regional communication involving local and distal regions. It is assumed that inter-regional distances play a pivotal role in modulating network dynamics. Using three different neuroimaging modalities, 6 datasets were evaluated to determine whether experimental manipulations asymmetrically affect functional relationships based on the distance between brain regions in human participants. Contrary to previous assumptions, here we show that short-and long-range connections are equally likely to strengthen or weaken in response to task demands. Additionally, connections between homotopic areas are the most stable and less likely to change compared to any other type of connection. Our results point to a functional connectivity landscape characterized by fluid transitions between local specialization and global integration. This ability to mediate functional properties irrespective of spatial distance may engender a diverse repertoire of cognitive processes when faced with a dynamic environment.	[Misic, Bratislav; Fatima, Zainab; Churchill, Nathan; Korostil, Michele; Strother, Stephen C.; McIntosh, Anthony R.] Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada; [Askren, Mary K.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Buschkuehl, Martin] MIND Res Inst, Irvine, CA USA; [Cimprich, Bernadine] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Deldin, Patricia J.; Jaeggi, Susanne; Kross, Ethan; Peltier, Scott; Reuter-Lorenz, Patricia A.; Jonides, John] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Jung, Misook] Chungnam Natl Univ, Dept Psychol, Taejon, South Korea; [Krpan, Katherine M.; Berman, Marc G.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Berman, Marc G.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chungnam National University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Chicago	Misic, B (corresponding author), Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada.	bmisic@research.baycrest.org; bermanm@uchicago.edu	Strother, Stephen C/D-6752-2011; Strother, Stephen/ABF-3371-2021	Strother, Stephen C/0000-0002-3198-217X; Strother, Stephen/0000-0002-3198-217X; , Ethan/0000-0002-8664-2711; McIntosh, Anthony/0000-0002-1784-5662; deldin, patricia/0000-0002-3584-3513; Jung, Mi Sook/0000-0002-5895-8954; Korostil, Michele/0000-0002-5309-4528	Tom and Kitty Stoner Foundation (TKF); National Institutes of Mental Health (NIMH) [MH 60655]; National Institutes of Health (NIH) [NIH-NINR-R01-NRO10939]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060655] Funding Source: NIH RePORTER	Tom and Kitty Stoner Foundation (TKF); National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by 1) Tom and Kitty Stoner Foundation (TKF) Grant to MGB, 2) National Institutes of Mental Health (NIMH) Grant MH 60655 to JJ, and 3) National Institutes of Health (NIH) grant NIH-NINR-R01-NRO10939 to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen E. A., 2012, CEREBRAL CORTEX; Askren MK, 2014, BREAST CANC RES TREA; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Berman MG, 2013, HLTH PSYCHOL; Berman MG, 2014, NEUROIMAGE; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Chen KW, 2004, NEUROIMAGE, V22, P134, DOI 10.1016/j.neuroimage.2004.01.002; Churchill NW, 2012, NEUROIMAGE, V59, P1299, DOI 10.1016/j.neuroimage.2011.08.021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fatima Z, 2013, NEUROIMAGE, V78, P284, DOI 10.1016/j.neuroimage.2013.04.033; Fatima Z, 2011, EXP BRAIN RES, V214, P9, DOI 10.1007/s00221-011-2745-5; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Kovacevic N, 2007, NEUROIMAGE, V35, P1103, DOI 10.1016/j.neuroimage.2007.01.016; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Larsen J, 2002, COMPUT STAT DATA AN, V38, P517, DOI 10.1016/S0167-9473(01)00076-7; Lazar NA, 2001, INT STAT REV, V69, P105, DOI 10.1111/j.1751-5823.2001.tb00482.x; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; McIntosh AR, 2013, ANNU REV PSYCHOL, V64, P499, DOI 10.1146/annurev-psych-113011-143804; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Riggs L, 2009, NEUROIMAGE, V45, P627, DOI 10.1016/j.neuroimage.2008.11.018; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	54	22	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111007	10.1371/journal.pone.0111007	http://dx.doi.org/10.1371/journal.pone.0111007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350370	Green Published, gold			2022-12-27	WOS:000343943100051
J	Fessel, G; Li, YF; Diederich, V; Guizar-Sicairos, M; Schneider, P; Sell, DR; Monnier, VM; Snedeker, JG				Fessel, Gion; Li, Yufei; Diederich, Vincent; Guizar-Sicairos, Manuel; Schneider, Philipp; Sell, David R.; Monnier, Vincent M.; Snedeker, Jess G.			Advanced Glycation End-Products Reduce Collagen Molecular Sliding to Affect Collagen Fibril Damage Mechanisms but Not Stiffness	PLOS ONE			English	Article							X-RAY-DIFFRACTION; HUMAN SERUM-ALBUMIN; CROSS-LINKING; TENDON COLLAGEN; BIOMECHANICAL PROPERTIES; VISCOELASTIC PROPERTIES; NONENZYMATIC GLYCATION; SYNCHROTRON-RADIATION; I COLLAGEN; METHYLGLYOXAL	Advanced glycation end-products (AGE) contribute to age-related connective tissue damage and functional deficit. The documented association between AGE formation on collagens and the correlated progressive stiffening of tissues has widely been presumed causative, despite the lack of mechanistic understanding. The present study investigates precisely how AGEs affect mechanical function of the collagen fibril - the supramolecular functional load-bearing unit within most tissues. We employed synchrotron small-angle X-ray scattering (SAXS) and carefully controlled mechanical testing after introducing AGEs in explants of rat-tail tendon using the metabolite methylglyoxal (MGO). Mass spectrometry and collagen fluorescence verified substantial formation of AGEs by the treatment. Associated mechanical changes of the tissue (increased stiffness and failure strength, decreased stress relaxation) were consistent with reports from the literature. SAXS analysis revealed clear changes in molecular deformation within MGO treated fibrils. Underlying the associated increase in tissue strength, we infer from the data that MGO modified collagen fibrils supported higher loads to failure by maintaining an intact quarter-staggered conformation to nearly twice the level of fibril strain in controls. This apparent increase in fibril failure resistance was characterized by reduced side-by-side sliding of collagen molecules within fibrils, reflecting lateral molecular interconnectivity by AGEs. Surprisingly, no change in maximum fibril modulus (2.5 GPa) accompanied the changes in fibril failure behavior, strongly contradicting the widespread assumption that tissue stiffening in ageing and diabetes is directly related to AGE increased fibril stiffness. We conclude that AGEs can alter physiologically relevant failure behavior of collagen fibrils, but that tissue level changes in stiffness likely occur at higher levels of tissue architecture.	[Fessel, Gion; Li, Yufei; Snedeker, Jess G.] Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Zurich, Switzerland; [Fessel, Gion; Li, Yufei; Schneider, Philipp; Snedeker, Jess G.] ETH, Inst Biomech, Zurich, Switzerland; [Diederich, Vincent] ETH, Inst Chem & Bioengn, Zurich, Switzerland; [Guizar-Sicairos, Manuel] Paul Scherrer Inst, Villigen, Switzerland; [Schneider, Philipp] Univ Southampton, Fac Engn & Environm, Southampton, Hants, England; [Sell, David R.; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Southampton; Case Western Reserve University; Case Western Reserve University	Snedeker, JG (corresponding author), Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Zurich, Switzerland.	jsnedeker@research.balgrist.ch	Guizar-Sicairos, Manuel/I-4899-2013; Snedeker, Jess/C-2105-2009; Guizar-Sicairos, Manuel/AAB-3793-2019; Snedeker, Jess G./X-2098-2019; Schneider, Philipp/AAP-6133-2021	Guizar-Sicairos, Manuel/0000-0002-8293-3634; Snedeker, Jess/0000-0002-8115-0275; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Snedeker, Jess G./0000-0002-8115-0275; Schneider, Philipp/0000-0001-7499-3576	Swiss National Science Foundation [205321-118036]; National Institutes of Health [EY07099, DK - 79432]; NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK079432] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Swiss National Science Foundation grant number 205321-118036 and in part by National Institutes of Health grants EY07099 to VMM and DK - 79432 to DRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Bruel A, 1996, ATHEROSCLEROSIS, V127, P155, DOI 10.1016/S0021-9150(96)05947-3; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Dai ZY, 2008, J PROTEOME RES, V7, P2756, DOI 10.1021/pr700874a; DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371; de Oliveira R., 2011, ANN BIOMED ENG, P1; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Eppell SJ, 2006, J R SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100; Fan XJ, 2010, FREE RADICAL BIO MED, V49, P847, DOI 10.1016/j.freeradbiomed.2010.06.003; Fessel G, 2014, ACTA BIOMATER, V10, P1897, DOI 10.1016/j.actbio.2013.12.048; Fessel G, 2011, ANN ANAT, V193, P237, DOI 10.1016/j.aanat.2011.03.007; Fessel G, 2011, J THEOR BIOL, V268, P77, DOI 10.1016/j.jtbi.2010.10.007; Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002; Folkhard E, 1987, INT J BIOL MACROMOL, V9, P169; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Gautieri A, 2013, MATRIX BIOL; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Goh KL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898732; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; Gupta HS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158101; Hadley JC, 1998, GLYCOCONJUGATE J, V15, P835, DOI 10.1023/A:1006928403140; HAUT RC, 1992, J BIOMECH, V25, P163, DOI 10.1016/0021-9290(92)90273-4; Hull D, 2003, CAMBRIDGE SOLID STAT; JAMES VJ, 1991, DIABETES, V40, P391, DOI 10.2337/diabetes.40.3.391; Klopfer A, 2011, J AGR FOOD CHEM, V59, P394, DOI 10.1021/jf103116c; Kraft P, 2009, IEEE T NUCL SCI, V56, P758, DOI 10.1109/TNS.2008.2009448; Krauss S, 2009, BONE, V44, P1105, DOI 10.1016/j.bone.2009.02.009; Lai-Fook SJ, 2000, J APPL PHYSIOL, V89, P163, DOI 10.1152/jappl.2000.89.1.163; Layton BE, 2006, ACTA BIOMATER, V2, P595, DOI 10.1016/j.actbio.2006.05.013; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P2499, DOI 10.1016/S0968-0896(99)00212-6; Li Y, 2012, INVESTIGATING AGE RE; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; MCLELLAN AC, 1992, ANAL CHIM ACTA, V263, P137, DOI 10.1016/0003-2670(92)85435-9; Meier M, 2008, J BIOMECHANICS, V41; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; MOSLER E, 1985, J MOL BIOL, V182, P589, DOI 10.1016/0022-2836(85)90244-X; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Sasaki N, 1999, J BIOMECH, V32, P285, DOI 10.1016/S0021-9290(98)00174-2; Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7; Seehra GP, 2006, SKIN RES TECHNOL, V12, P190, DOI 10.1111/j.0909-752X.2006.00150.x; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; Sherwood D, 2011, CRYSTALS XRAYS PROTE; Siegmund T, 2008, J BIOMECH, V41, P1427, DOI 10.1016/j.jbiomech.2008.02.017; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Slatter DA, 2008, INT J BIOCHEM CELL B, V40, P2253, DOI 10.1016/j.biocel.2008.03.006; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Tang Y, 2010, J R SOC INTERFACE, V7, P839, DOI 10.1098/rsif.2009.0390; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang L, 2012, J MECH BEHAV BIOMED, V6, P148, DOI 10.1016/j.jmbbm.2011.11.008; Zhou GH, 2004, AM J PATHOL, V165, P2033, DOI 10.1016/S0002-9440(10)63254-3; Zimmermann EA, 2011, P NATL ACAD SCI	63	75	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110948	10.1371/journal.pone.0110948	http://dx.doi.org/10.1371/journal.pone.0110948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364829	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000345558100038
J	Neumayer, G; Nguyen, MD				Neumayer, Gernot; Minh Dang Nguyen			TPX2 Impacts Acetylation of Histone H4 at Lysine 16: Implications for DNA Damage Response	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DEPHOSPHORYLATES GAMMA-H2AX; SPINDLE; PROTEIN; ATM; PHOSPHATASE; CHROMATIN; H2AX; PHOSPHORYLATION; FRAGMENTATION	During interphase, the spindle assembly factor TPX2 is compartmentalized in the nucleus where its roles remain largely uncharacterized. Recently, we found that TPX2 regulates the levels of serine 139-phosphoryated H2AX (gamma-H2AX) at chromosomal breaks induced by ionizing radiation. Here, we report that TPX2 readily associates with the chromatin in the absence of ionizing radiation. Overexpression of TPX2 alters the DAPI staining pattern of interphase cells and depletion of TPX2 constitutively decreases the levels of histone H4 acetylated at lysine16 ( H4K16ac) during G1-phase. Upon ionizing irradiation, this constitutive TPX2 depletion-dependent decrease in H4K16ac levels correlates with increased levels of gamma-H2AX. The inversely correlated levels of H4K16ac and gamma-H2AX can also be modified by altering the levels of SIRT1, herein identified as a novel protein complex partner of TPX2. Furthermore, we find that TPX2 depletion also interferes with formation of 53BP1 ionizing radiation-induced foci, known to depend on gamma-H2AX and the acetylation status of H4K16. In brief, our study is the first indication of a constitutive control of TPX2 on H4K16ac levels, with potential implications for DNA damage response.	[Neumayer, Gernot] Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Dept Cell Biol & Anat, Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Neumayer, G (corresponding author), Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada.	ggneumay@ucalgary.ca; mdnguyen@ucalgary.ca			Canadian Institutes of Health Research (CIHR); Alberta Innovates-Health Solutions (AIHS); Austrian Academy of Sciences at the University of Calgary, an Achievers in Medical Sciences recruitment award at the University of Calgary; Alberta Cancer Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AIHS); Austrian Academy of Sciences at the University of Calgary, an Achievers in Medical Sciences recruitment award at the University of Calgary; Alberta Cancer Foundation	MDN receives support from the Canadian Institutes of Health Research (CIHR) and Alberta Innovates-Health Solutions (AIHS). GN received a DOC-scholarship from the Austrian Academy of Sciences at the University of Calgary, an Achievers in Medical Sciences recruitment award at the University of Calgary and a scholarship from the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss R, 2004, CELL CYCLE, V3, P404; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Cha H, 2010, CANCER RES, V70, P4112, DOI 10.1158/0008-5472.CAN-09-4244; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; David Allis C., 2007, EPIGENETICS-US; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Giunta S, 2011, CELL CYCLE, V10, P1215, DOI 10.4161/cc.10.8.15334; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goshima G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028120; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kahana JA, 2001, SCIENCE, V291, P1718, DOI 10.1126/science.1059765; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Neumayer G, 2012, J BIOL CHEM, V287, P42206, DOI 10.1074/jbc.M112.385674; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Petrovska B, 2013, J EXP BOT, V64, P4575, DOI 10.1093/jxb/ert271; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wu JX, 2011, NAT STRUCT MOL BIOL, V18, P761, DOI 10.1038/nsmb.2078; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	66	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110994	10.1371/journal.pone.0110994	http://dx.doi.org/10.1371/journal.pone.0110994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365214	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100041
J	Sollars, PJ; Weiser, MJ; Kudwa, AE; Bramley, JR; Ogilvie, MD; Spencer, RL; Handa, RJ; Pickard, GE				Sollars, Patricia J.; Weiser, Michael J.; Kudwa, Andrea E.; Bramley, Jayne R.; Ogilvie, Malcolm D.; Spencer, Robert L.; Handa, Robert J.; Pickard, Gary E.			Altered Entrainment to the Day/Night Cycle Attenuates the Daily Rise in Circulating Corticosterone in the Mouse	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; CORTICOTROPIN-RELEASING HORMONE; MEDIATED PRESYNAPTIC INHIBITION; RECEPTOR KNOCKOUT MICE; SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHM; GLUCOCORTICOID-RECEPTOR; GANGLION-CELLS; CLOCK PROTEIN; OVAL NUCLEUS	The suprachiasmatic nucleus (SCN) is a circadian oscillator entrained to the day/night cycle via input from the retina. Serotonin (5-HT) afferents to the SCN modulate retinal signals via activation of 5-HT1B receptors, decreasing responsiveness to light. Consequently, 5-HT1B receptor knockout (KO) mice entrain to the day/night cycle with delayed activity onsets. Since circulating corticosterone levels exhibit a robust daily rhythm peaking around activity onset, we asked whether delayed entrainment of activity onsets affects rhythmic corticosterone secretion. Wheel-running activity and plasma corticosterone were monitored in mice housed under several different lighting regimens. Both duration of the light: dark cycle (T cycle) and the duration of light within that cycle was altered. 5-HT1B KO mice that entrained to a 9.5L:13.5D (short day in a T = 23 h) cycle with activity onsets delayed more than 4 h after light offset exhibited a corticosterone rhythm in phase with activity rhythms but reduced 50% in amplitude compared to animals that initiated daily activity <4 h after light offset. Wild type mice in 8L:14D (short day in a T = 22 h) conditions with highly delayed activity onsets also exhibited a 50% reduction in peak plasma corticosterone levels. Exogenous adrenocorticotropin (ACTH) stimulation in animals exhibiting highly delayed entrainment suggested that the endogenous rhythm of adrenal responsiveness to ACTH remained aligned with SCN-driven behavioral activity. Circadian clock gene expression in the adrenal cortex of these same animals suggested that the adrenal circadian clock was also aligned with SCN-driven behavior. Under T cycles <24 h, altered circadian entrainment to short day (winter-like) conditions, manifest as long delays in activity onset after light offset, severely reduces the amplitude of the diurnal rhythm of plasma corticosterone. Such a pronounced reduction in the glucocorticoid rhythm may alter rhythmic gene expression in the central nervous system and in peripheral organs contributing to an array of potential pathophysiologies.	[Sollars, Patricia J.; Weiser, Michael J.; Kudwa, Andrea E.; Bramley, Jayne R.; Ogilvie, Malcolm D.; Handa, Robert J.; Pickard, Gary E.] Colorado State Univ, Div Neurosci, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Sollars, Patricia J.; Bramley, Jayne R.; Ogilvie, Malcolm D.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Weiser, Michael J.; Spencer, Robert L.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Handa, Robert J.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85004 USA	Colorado State University; University of Nebraska System; University of Nebraska Lincoln; University of Colorado System; University of Colorado Boulder; University of Arizona	Sollars, PJ (corresponding author), Colorado State Univ, Div Neurosci, Dept Biomed Sci, Ft Collins, CO 80523 USA.	psollars2@unl.edu			National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS039951, R01NS077003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077003, R01NS039951] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by RH - R01NS039951, National Institutes of Health, National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov); PS & GP - R01NS077003, National Institutes of Health, National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; ANDREWS RV, 1964, COMP BIOCHEM PHYSIOL, V11, P393, DOI 10.1016/0010-406X(64)90006-4; Avery DH, 1997, BIOL PSYCHIAT, V41, P1109, DOI 10.1016/S0006-3223(96)00210-7; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2001, J COMP NEUROL, V432, P371, DOI 10.1002/cne.1109; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Bouwknecht JA, 2001, PSYCHOPHARMACOLOGY, V153, P484, DOI 10.1007/s002130000598; Bramley JR, 2005, J NEUROPHYSIOL, V93, P3157, DOI 10.1152/jn.00770.2004; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Buijs RM, 2007, ENDOCRINOLOGY, V148, P5162, DOI 10.1210/en.2007-0926; BURGESS LH, 1992, ENDOCRINOLOGY, V131, P1261, DOI 10.1210/en.131.3.1261; Canteras NS, 2011, BRAIN RES REV, V65, P150, DOI 10.1016/j.brainresrev.2010.09.006; Chung S, 2011, ANN NY ACAD SCI, V1220, P71, DOI 10.1111/j.1749-6632.2010.05923.x; Clark JA, 2008, MOL PSYCHIATR, V13, P498, DOI 10.1038/sj.mp.4002041; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dallman MF, 2000, INT J OBESITY, V24, pS40, DOI 10.1038/sj.ijo.0801276; DALLMAN MF, 1978, AM J PHYSIOL, V235, pR210, DOI 10.1152/ajpregu.1978.235.5.R210; Deuschle M, 1997, J CLIN ENDOCR METAB, V82, P234, DOI 10.1210/jc.82.1.234; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Endo T, 1999, JPN J PHYSIOL, V49, P425, DOI 10.2170/jjphysiol.49.425; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Engeland William C, 2013, Handb Clin Neurol, V117, P37, DOI 10.1016/B978-0-444-53491-0.00004-3; Girotti M, 2007, ENDOCRINOLOGY, V148, P2542, DOI 10.1210/en.2006-1304; Girotti M, 2009, AM J PHYSIOL-ENDOC M, V296, pE888, DOI 10.1152/ajpendo.90946.2008; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hoff J, 2000, LAB ANIMAL, V29, P47; Husse J, 2014, FASEB J; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; JOSEPHVANDERPOOL JR, 1991, J CLIN ENDOCR METAB, V72, P1382, DOI 10.1210/jcem-72-6-1382; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; KANEKO M, 1981, ENDOCRINOLOGY, V109, P70, DOI 10.1210/endo-109-1-70; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kiessling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092959; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Lam RW, 2000, J PSYCHIATR NEUROSCI, V25, P469; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lavoie MP, 2009, BIOL PSYCHIAT, V66, P253, DOI 10.1016/j.biopsych.2008.11.020; Leproult R, 2001, J CLIN ENDOCR METAB, V86, P151, DOI 10.1210/jc.86.1.151; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; LEWY AJ, 1990, CHRONOBIOL INT, V7, P15, DOI 10.3109/07420529009056949; Lewy AJ, 1989, SEASONAL AFFECTIVE D, P201; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Lilley TR, 2012, ENDOCRINOLOGY, V153, P732, DOI 10.1210/en.2011-1624; LINKOWSKI P, 1985, J CLIN ENDOCR METAB, V61, P429, DOI 10.1210/jcem-61-3-429; Lucas RJ, 1999, ENDOCRINOLOGY, V140, P758, DOI 10.1210/en.140.2.758; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; Maywood ES, 2007, ENDOCRINOLOGY, V148, P5624, DOI 10.1210/en.2007-0660; Meier AH, 1976, ENDOCRINOLOGY, V79, P884; Minton GO, 2009, NEUROPSYCHOPHARMACOL, V34, P2265, DOI 10.1038/npp.2009.53; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Muglia LJ, 1997, J CLIN INVEST, V99, P2923, DOI 10.1172/JCI119487; Nexon L, 2011, EUR J NEUROSCI, V33, P1308, DOI 10.1111/j.1460-9568.2010.07586.x; Oren DA, 1996, BIOL PSYCHIAT, V39, P157, DOI 10.1016/0006-3223(95)00079-8; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; OTTENWELLER JE, 1982, ENDOCRINOLOGY, V111, P1334, DOI 10.1210/endo-111-4-1334; Pickard GE, 1999, J NEUROSCI, V19, P4034; Pickard GE, 1996, J NEUROSCI, V16, P8208; PICKARD GE, 1981, J COMP NEUROL, V196, P155, DOI 10.1002/cne.901960111; Pickard GE, 2008, THE SENSES VISION, P537; Posener JA, 2000, ARCH GEN PSYCHIAT, V57, P755, DOI 10.1001/archpsyc.57.8.755; Rea MA, 2000, BRAIN RES, V858, P424, DOI 10.1016/S0006-8993(99)02462-2; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roecklein KA, 2009, J AFFECT DISORDERS, V114, P279, DOI 10.1016/j.jad.2008.08.005; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Scheer FAJL, 1999, J CLIN ENDOCR METAB, V84, P3395, DOI 10.1210/jc.84.9.3395; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2010, J MOL NEUROSCI, V42, P176, DOI 10.1007/s12031-010-9375-4; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Smith BN, 2001, J BIOL RHYTHM, V16, P25, DOI 10.1177/074873040101600104; Sollars PJ, 2006, NEUROSCI LETT, V401, P209, DOI 10.1016/j.neulet.2006.03.012; Sollars PJ, 2006, J BIOL RHYTHM, V21, P21, DOI 10.1177/0748730405283765; Sollars PJ, 2002, J BIOL RHYTHM, V17, P428, DOI 10.1177/074873002237137; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; SPACKMAN DH, 1978, SCIENCE, V200, P87, DOI 10.1126/science.635580; Spiga F, 2009, BRAIN RES, V1293, P101, DOI 10.1016/j.brainres.2009.02.001; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Terman M., 2005, PRINCIPLES PRACTICE, V4, P1424, DOI [10.1016/B0-72-160797-7/50128-2, DOI 10.1016/B0-72-160797-7/50128-2, 10.1016/B0-72-160797-7/50128-2.]; Thalen BE, 1997, ACTA PSYCHIAT SCAND, V96, P385, DOI 10.1111/j.1600-0447.1997.tb09934.x; Thorn L, 2004, PSYCHONEUROENDOCRINO, V29, P925, DOI 10.1016/j.psyneuen.2003.08.005; Torres-Farfan C, 2008, AM J PRIMATOL, V70, P93, DOI 10.1002/ajp.20461; Tsang AH, 2014, J MOL ENDOCRINOL, V52, pR1, DOI 10.1530/JME-13-0118; Ulrich-Lai YM, 2006, AM J PHYSIOL-REG I, V290, pR1128, DOI 10.1152/ajpregu.00042.2003; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; UNGAR F, 1962, SCIENCE, V137, P1058, DOI 10.1126/science.137.3535.1058; Wei Q, 2007, J NEUROSCI, V27, P8836, DOI 10.1523/JNEUROSCI.0910-07.2007; WEITZMAN ED, 1983, J CLIN ENDOCR METAB, V56, P352, DOI 10.1210/jcem-56-2-352; Wever AM, 1979, CIRCADIAN SYSTEM MAN; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Yoshida M, 2005, J PHARMACOL EXP THER, V315, P1119, DOI 10.1124/jpet.105.091488	104	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111944	10.1371/journal.pone.0111944	http://dx.doi.org/10.1371/journal.pone.0111944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365210	gold, Green Published			2022-12-27	WOS:000345558100137
J	Bouskila, J; Javadi, P; Palmour, RM; Bouchard, JF; Ptito, M				Bouskila, Joseph; Javadi, Pasha; Palmour, Roberta M.; Bouchard, Jean-Francois; Ptito, Maurice			Standardized Full-Field Electroretinography in the Green Monkey (Chlorocebus sabaeus)	PLOS ONE			English	Article							VERVET MONKEY; CLINICAL ELECTRORETINOGRAPHY; ADAPTED ELECTRORETINOGRAM; CEREBRAL HEMISPHERECTOMY; OPTOKINETIC NYSTAGMUS; ALCOHOL EXPOSURE; PHOTOPIC HILL; B-WAVE; RETINA; PRIMATES	Full-field electroretinography is an objective measure of retinal function, serving as an important diagnostic clinical tool in ophthalmology for evaluating the integrity of the retina. Given the similarity between the anatomy and physiology of the human and Green Monkey eyes, this species has increasingly become a favorable non-human primate model for assessing ocular defects in humans. To test this model, we obtained full-field electroretinographic recordings (ERG) and normal values for standard responses required by the International Society for Clinical Electrophysiology of Vision (ISCEV). Photopic and scotopic ERG recordings were obtained by full-field stimulation over a range of 6 log units of intensity in dark-adapted or light-adapted eyes of adult Green Monkeys (Chlorocebus sabaeus). Intensity, duration, and interval of light stimuli were varied separately. Reproducible values of amplitude and latency were obtained for the a-and b-waves, under well-controlled adaptation and stimulus conditions; the i-wave was also easily identifiable and separated from the a-b-wave complex in the photopic ERG. The recordings obtained in the healthy Green Monkey matched very well with those in humans and other non-human primate species (Macaca mulatta and Macaca fascicularis). These results validate the Green Monkey as an excellent non-human primate model, with potential to serve for testing retinal function following various manipulations such as visual deprivation or drug evaluation.	[Bouskila, Joseph; Javadi, Pasha; Bouchard, Jean-Francois; Ptito, Maurice] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Bouskila, Joseph] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Palmour, Roberta M.] Behav Sci Fdn, Caribbean, St Kitts & Nevi; [Palmour, Roberta M.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Palmour, Roberta M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, BRAINlab, Copenhagen, Denmark; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, Neuropsychiat Lab, Copenhagen, Denmark	Universite de Montreal; Universite de Montreal; McGill University; McGill University; University of Copenhagen; University of Copenhagen	Ptito, M (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	maurice.ptito@umontreal.ca	Ptito, Maurice/G-3422-2013; Bouchard, Jean-Francois/AAI-1229-2021	Ptito, Maurice/0000-0002-5173-5862; Bouchard, Jean-Francois/0000-0001-9622-6239	Natural Science and Engineering Research Council of Canada [6362-2012, 311892-2010]; Canadian Institutes of Health Research [MOP-130337]; Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR; "Chercheur-Boursier Senior'' from the Fonds de recherche du Quebec Sante (FRQ-S)	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR(Canadian Institutes of Health Research (CIHR)); "Chercheur-Boursier Senior'' from the Fonds de recherche du Quebec Sante (FRQ-S)	The Natural Science and Engineering Research Council of Canada (6362-2012, MP; 311892-2010, JFB) and the Canadian Institutes of Health Research (MOP-130337, JFB) supported this work. JB received support from a Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award from CIHR. JFB is supported by a "Chercheur-Boursier Senior'' from the Fonds de recherche du Quebec Sante (FRQ-S). MP is Harland Sanders Chair professor in Visual Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CS, 2002, OPHTHALMOLOGY, V109, P575, DOI 10.1016/S0161-6420(01)00981-2; Bee W H, 2001, Curr Opin Drug Discov Devel, V4, P81; BEE WH, 1995, OCULAR TOXICOLOGY, P53; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P207; BIRCH DG, 1992, INVEST OPHTH VIS SCI, V33, P2365; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Boire D, 2001, PROG BRAIN RES, V134, P379; Boire D, 2002, EXP BRAIN RES, V142, P208, DOI 10.1007/s00221-001-0921-8; Bouskila J, 2012, NEUROSCIENCE, V202, P117, DOI 10.1016/j.neuroscience.2011.11.041; Bouskila J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081080; Bouskila J, 2013, J COMP NEUROL, V521, P2399, DOI 10.1002/cne.23333; BUIST DP, 1982, LAB ANIM SCI, V32, P91; Burke M, 2009, J VIS EXP; Burke MW, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/852423; Burke MW, 2009, NEUROREPORT, V20, P13, DOI 10.1097/WNR.0b013e32831b449c; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; Finlay BL, 2008, VISUAL NEUROSCI, V25, P289, DOI 10.1017/S0952523808080371; Freund PR, 2011, DOC OPHTHALMOL, V122, P177, DOI 10.1007/s10633-011-9273-2; Frishman L. J., 2006, PRINCIPLES PRACTICE, P139; Herbin M, 1997, J COMP NEUROL, V383, P459, DOI 10.1002/(SICI)1096-9861(19970714)383:4<459::AID-CNE5>3.0.CO;2-1; Holopigian K, 2001, INVEST OPHTH VIS SCI, V42, P779; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; JACOBI PC, 1993, DOC OPHTHALMOL, V85, P95, DOI 10.1007/BF01371126; Jasinska AJ, 2007, MAMM GENOME, V18, P347, DOI 10.1007/s00335-007-9026-4; KNAPP AG, 1988, J NEUROPHYSIOL, V60, P1010, DOI 10.1152/jn.1988.60.3.1010; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Mikula S., 2008, BRAINS MINDS MEDIA, V3; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Osterberg G., 1935, ACTA OPHTHALMOL, V6, P11; Palmour RM, 1997, AM J HUM GENET, V61, P481, DOI 10.1086/515526; Papia MF, 2010, EXP BRAIN RES, V205, P263, DOI 10.1007/s00221-010-2364-6; Ptito M, 1996, PROG BRAIN RES, V112, P385; Rangaswamy NV, 2004, INVEST OPHTH VIS SCI, V45, P3827, DOI 10.1167/iovs.04-0458; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Rosolen SG, 2004, VET OPHTHALMOL, V7, P189, DOI 10.1111/j.1463-5224.2004.04022.x; Rotenstreich Y, 2003, BRIT J OPHTHALMOL, V87, P1268, DOI 10.1136/bjo.87.10.1268; Rufiange M, 2003, VISION RES, V43, P1405, DOI 10.1016/S0042-6989(03)00118-4; Rufiange Marianne, 2002, Documenta Ophthalmologica, V104, P231, DOI 10.1023/A:1015265812018; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Steinberg R. H., 1985, PROGR RETINAL RES, P33, DOI 10.1016/0278-4327(85)90004-5; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Theoret H, 2000, BRAIN RES BULL, V53, P239, DOI 10.1016/S0361-9230(00)00345-2; Theoret H, 2001, BRAIN RES, V894, P274, DOI 10.1016/S0006-8993(01)02030-3; TIAN N, 1995, VISION RES, V35, P1359, DOI 10.1016/0042-6989(95)98715-L; Ueno S, 2004, INVEST OPHTH VIS SCI, V45, P1033, DOI 10.1167/iovs.03-0657; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; WALI N, 1992, DOC OPHTHALMOL, V80, P335, DOI 10.1007/BF00154382; WELEBER RG, 1981, INVEST OPHTH VIS SCI, V20, P392; Westall Carol A., 2001, Documenta Ophthalmologica, V102, P115, DOI 10.1023/A:1017535207481; Wolf JE, 1996, VISION RES, V36, P2369, DOI 10.1016/0042-6989(95)00316-9; Woods RP, 2011, NEUROIMAGE, V54, P1872, DOI 10.1016/j.neuroimage.2010.09.070	52	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111569	10.1371/journal.pone.0111569	http://dx.doi.org/10.1371/journal.pone.0111569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360686	gold, Green Published			2022-12-27	WOS:000343943700122
J	Kasper, JR; Andrews, EC; Park, C				Kasper, Joseph R.; Andrews, Elizabeth C.; Park, Chiwook			Product Inhibition in Native-State Proteolysis	PLOS ONE			English	Article							ESCHERICHIA-COLI; AMINOPEPTIDASE-P; THERMOLYSIN; HYDROLYSIS; PROTEINS; DEGRADATION; MECHANISM; SUBSTRATE; PEPTIDES; KINETICS	The proteolysis kinetics of intact proteins by nonspecific proteases provides valuable information on transient partial unfolding of proteins under native conditions. Native-state proteolysis is an approach to utilize the proteolysis kinetics to assess the energetics of partial unfolding in a quantitative manner. In native-state proteolysis, folded proteins are incubated with nonspecific proteases, and the rate of proteolysis is determined from the disappearance of the intact protein. We report here that proteolysis of intact proteins by nonspecific proteases, thermolysin and subtilisin deviates from first-order kinetics. First-order kinetics has been assumed for the analysis of native-state proteolysis. By analyzing the kinetics of proteolysis with varying concentrations of substrate proteins and also with cleavage products, we found that the deviation from first-order kinetics results from product inhibition. A kinetic model including competitive product inhibition agrees well with the proteolysis time course and allows us to determine the uninhibited rate constant for proteolysis as well as the apparent inhibition constant. Our finding suggests that the likelihood of product inhibition must be considered for quantitative assessment of proteolysis kinetics.	[Kasper, Joseph R.; Andrews, Elizabeth C.; Park, Chiwook] Purdue Univ, Bindley Biosci Ctr, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Park, C (corresponding author), Purdue Univ, Bindley Biosci Ctr, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	chiwook@purdue.edu	Park, Chiwook/HIK-2724-2022	Park, Chiwook/0000-0002-2161-6459	National Science Foundation Grant [1021652]	National Science Foundation Grant(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant 1021652 to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold U, 2001, EUR J BIOCHEM, V268, P93, DOI 10.1046/j.1432-1327.2001.01849.x; Chang Y, 2009, J MOL BIOL, V393, P543, DOI 10.1016/j.jmb.2009.08.006; Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; FEDER J, 1974, BIOCHEMISTRY-US, V13, P1186, DOI 10.1021/bi00703a600; Hamada Y, 2012, ACS MED CHEM LETT, V3, P193, DOI 10.1021/ml2002373; HOLDEN HM, 1988, J BIOL CHEM, V263, P3256; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; IMOTO T, 1986, J MOL BIOL, V190, P647, DOI 10.1016/0022-2836(86)90250-0; IWAKURA M, 1995, J BIOCHEM, V117, P480, DOI 10.1093/oxfordjournals.jbchem.a124733; Kasper JR, 2014, PROTEIN SCI IN PRESS; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; KESTER WR, 1977, BIOCHEMISTRY-US, V16, P2506, DOI 10.1021/bi00630a030; LINDERSTROMLANG K, 1949, COLD SPRING HARB SYM, V14, P117, DOI 10.1101/SQB.1950.014.01.016; MATSUBARA H, 1966, ARCH BIOCHEM BIOPHYS, V115, P324, DOI 10.1016/0003-9861(66)90282-7; Mock WL, 1996, BIOCHEMISTRY-US, V35, P7369, DOI 10.1021/bi952827p; MORIHARA K, 1968, ARCH BIOCHEM BIOPHYS, V123, P572, DOI 10.1016/0003-9861(68)90179-3; MORIHARA K, 1970, EUR J BIOCHEM, V15, P374, DOI 10.1111/j.1432-1033.1970.tb01018.x; MORIHARA K, 1971, BIOCHEM BIOPH RES CO, V42, P1000, DOI 10.1016/0006-291X(71)90002-7; NISHINO N, 1980, J BIOL CHEM, V255, P3482; PACE CN, 1984, BIOCHEM J, V219, P411, DOI 10.1042/bj2190411; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; RUPLEY JA, 1960, BIOCHIM BIOPHYS ACTA, V44, P191, DOI 10.1016/0006-3002(60)91547-X; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Spudich G, 2002, PROTEIN SCI, V11, P522, DOI 10.1110/ps.37202; STAUFFER CE, 1971, BIOCHIM BIOPHYS ACTA, V251, P407, DOI 10.1016/0005-2795(71)90129-2; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Stockel-Maschek A, 2003, ANAL BIOCHEM, V322, P60, DOI 10.1016/S0003-2697(03)00464-0; Wildes D, 2006, PROTEIN SCI, V15, P1769, DOI 10.1110/ps.062136006; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Youn K, 2009, PROTEIN PEPTIDE LETT, V16, P1093, DOI 10.2174/092986609789055287	32	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111416	10.1371/journal.pone.0111416	http://dx.doi.org/10.1371/journal.pone.0111416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360755	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700102
J	Kim, DK; Park, MH; Chang, DY; Eun, KM; Shin, HW; Mo, JH; Shin, EC; Jin, HR; Shin, S; Roh, EY; Han, DH; Kim, DW				Kim, Dong-Kyu; Park, Min-Hyun; Chang, Dong-Yeop; Eun, Kyung Mi; Shin, Hyun-Woo; Mo, Ji-Hun; Shin, Eui-Cheol; Jin, Hong Ryul; Shin, Sue; Roh, Eun Youn; Han, Doo Hee; Kim, Dae Woo			MBP-Positive and CD11c-Positive Cells Are Associated with Different Phenotypes of Korean Patients with Non-Asthmatic Chronic Rhinosinusitis	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; NASAL POLYPS; DENDRITIC CELLS; SINUS MUCOSA; T-CELLS; INFLAMMATION; FEATURES; SUBCLASSIFICATION; ENTEROTOXINS; IMMUNITY	Background: Asthmatic nasal polyps primarily exhibit eosinophilic infiltration. However, the identities of the immune cells that infiltrate non-asthmatic nasal polyps remain unclear. Thus, we thought to investigate the distribution of innate immune cells and its clinical relevance in non-asthmatic chronic rhinosinusitis (CRS) in Korea. Methods: Tissues from uncinate process (UP) were obtained from controls (n = 18) and CRS without nasal polyps (CRSsNP, n = 45). Nasal polyps (NP) and UP were obtained from CRS with nasal polyps (CRSwNP, n = 56). The innate immune cells was evaluated by immunohistochemistry such as, eosinophil major basic protein (MBP), tryptase, CD68, CD163, CD11c, 2D7, human neutrophil elastase (HNE) and its distribution was analyzed according to clinical parameters. Results: In comparisons between UP from each group, CRSwNP had a higher number of MPB+, CD68(+), and CD11c(+) cells relative to CRSsNP. Comparisons between UP and NP from CRSwNP indicated that NP have a higher infiltrate of MBP+, CD163(+), CD11c(+), 2D7(+) and HNE+ cells, whereas fewer CD68(+) cells were found in NP. In addition, MBP+ and CD11c(+) cells were increased from UP of CRSsNP, to UP of CRSwNP, and to NP of CRSwNP. Moreover, in UP from CRSwNP, the number of MBP+ and CD11c(+) cells positively correlated with CT scores. In the analysis of CRSwNP phenotype, allergic eosinophilic polyps had a higher number of MBP+, tryptase(+), CD11c(+), 2D7(+) cells than others, whereas allergic non-eosinophilic polyps showed mainly infiltration of HNE+ and 2D7(+) cells. Conclusions: The infiltration of MBP+ and CD11c(+) innate immune cells show a significant association with phenotype and disease extent of CRS and allergic status also may influences cellular phenotype in non-asthmatic CRSwNP in Korea.	[Kim, Dong-Kyu] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chunchon, South Korea; [Park, Min-Hyun; Eun, Kyung Mi; Jin, Hong Ryul; Kim, Dae Woo] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Med Ctr, Seoul, South Korea; [Chang, Dong-Yeop; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea; [Shin, Hyun-Woo] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Mo, Ji-Hun] Dankook Univ, Coll Med, Dept Otorhinolaryngol, Cheonan, South Korea; [Shin, Sue; Roh, Eun Youn] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Lab Med, Seoul, South Korea; [Han, Doo Hee] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Dankook University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, DW (corresponding author), Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Med Ctr, Seoul, South Korea.	kicubi@daum.net	Mo, Ji-Hun/E-5586-2011; Shin, Eui-Cheol/C-1690-2011	Mo, Ji-Hun/0000-0003-1331-364X; Shin, Eui-Cheol/0000-0002-6308-9503; Park, Min-Hyun/0000-0003-4156-7639; Kim, Dong-Kyu/0000-0003-4917-0177	SK Telecom Research Fund [06-2012-109]	SK Telecom Research Fund	This work was supported by a clinical research grant-in-aid by grant no. 06-2012-109 from SK Telecom Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarvak T, 2001, SCAND J IMMUNOL, V54, P100, DOI 10.1046/j.1365-3083.2001.00957.x; Ayers CM, 2011, INT FORUM ALLERGY RH, V1, P296, DOI 10.1002/alr.20046; Bachert C, 1998, ALLERGY, V53, P2, DOI 10.1111/j.1398-9995.1998.tb03767.x; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Han JK, 2013, LARYNGOSCOPE, V123, pS15, DOI 10.1002/lary.23979; Ikeda K, 2013, LARYNGOSCOPE, V123, pE1, DOI 10.1002/lary.24154; Kato H, 1999, GENES IMMUN, V1, P97, DOI 10.1038/sj.gene.6363638; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Lin XS, 2013, EXP THER MED, V5, P1476, DOI 10.3892/etm.2013.986; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; LUND VJ, 1995, ANN OTO RHINOL LARYN, V104, P17, DOI 10.1177/000348949510410s02; Mahdavinia M, 2014, J ALLERGY CLIN IMMUN, V133, P1759, DOI 10.1016/j.jaci.2013.12.1092; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mulligan JK, 2012, OTOLARYNG HEAD NECK, V147, P773, DOI 10.1177/0194599812448852; NONAKA M, 1995, J IMMUNOL, V155, P3234; Payne SC, 2011, LARYNGOSCOPE, V121, P2262, DOI 10.1002/lary.21969; Polzehl D, 2006, ALLERGY, V61, P1275, DOI 10.1111/j.1398-9995.2006.01132.x; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Robinson S, 2006, AM J RHINOL, V20, P625, DOI 10.2500/ajr.2006.20.2907; Shi J, 2009, J INVEST ALLERG CLIN, V19, P276; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Suzuki H, 1996, J ALLERGY CLIN IMMUN, V98, P659, DOI 10.1016/S0091-6749(96)70100-8; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; van Drunen CM, 2012, CURR ALLERGY ASTHM R, V12, P120, DOI 10.1007/s11882-012-0249-4; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Voegels RL, 2001, AM J RHINOL, V15, P9, DOI 10.2500/105065801781329365; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang N, 2006, AM J RHINOL, V20, P445, DOI 10.2500/ajr.2006.20.2887	37	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111352	10.1371/journal.pone.0111352	http://dx.doi.org/10.1371/journal.pone.0111352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25361058	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700090
J	Montgomery, SL; Vorojeikina, D; Huang, W; Mackay, TFC; Anholt, RRH; Rand, MD				Montgomery, Sara L.; Vorojeikina, Daria; Huang, Wen; Mackay, Trudy F. C.; Anholt, Robert R. H.; Rand, Matthew D.			Genome-Wide Association Analysis of Tolerance to Methylmercury Toxicity in Drosophila Implicates Myogenic and Neuromuscular Developmental Pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MTF-1; GENETIC REFERENCE PANEL; MYOBLAST FUSION; MINAMATA DISEASE; ROLLING PEBBLES; ENHANCER FACTOR; METHYL MERCURY; MELANOGASTER; EXPOSURE; FISH	Methylmercury (MeHg) is a persistent environmental toxin present in seafood that can compromise the developing nervous system in humans. The effects of MeHg toxicity varies among individuals, despite similar levels of exposure, indicating that genetic differences contribute to MeHg susceptibility. To examine how genetic variation impacts MeHg tolerance, we assessed developmental tolerance to MeHg using the sequenced, inbred lines of the Drosophila melanogaster Genetic Reference Panel (DGRP). We found significant genetic variation in the effects of MeHg on development, measured by eclosion rate, giving a broad sense heritability of 0.86. To investigate the influence of dietary factors, we measured MeHg toxicity with caffeine supplementation in the DGRP lines. We found that caffeine counteracts the deleterious effects of MeHg in the majority of lines, and there is significant genetic variance in the magnitude of this effect, with a broad sense heritability of 0.80. We performed genome-wide association (GWA) analysis for both traits, and identified candidate genes that fall into several gene ontology categories, with enrichment for genes involved in muscle and neuromuscular development. Overexpression of glutamate-cysteine ligase, a MeHg protective enzyme, in a muscle-specific manner leads to a robust rescue of eclosion of flies reared on MeHg food. Conversely, mutations in kirre, a pivotal myogenic gene identified in our GWA analyses, modulate tolerance to MeHg during development in accordance with kirre expression levels. Finally, we observe disruptions of indirect flight muscle morphogenesis in MeHg-exposed pupae. Since the pathways for muscle development are evolutionarily conserved, it is likely that the effects of MeHg observed in Drosophila can be generalized across phyla, implicating muscle as an additional hitherto unrecognized target for MeHg toxicity. Furthermore, our observations that caffeine can ameliorate the toxic effects of MeHg show that nutritional factors and dietary manipulations may offer protection against the deleterious effects of MeHg exposure.	[Montgomery, Sara L.; Vorojeikina, Daria; Rand, Matthew D.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Huang, Wen; Mackay, Trudy F. C.; Anholt, Robert R. H.] N Carolina State Univ, Dept Biol Sci, Genet Program, Raleigh, NC 27695 USA; [Huang, Wen; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of Rochester; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rand, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA.	matthew_rand@urmc.rochester.edu	Anholt, Robert/S-5977-2019	Huang, Wen/0000-0001-6788-8364	National Institute of Environmental Sciences [P30 ES001247, T32 ES07026]; National Institute of General Medical Sciences [GM045146, R21 ES021719]; NCSU Initiative for Biological Complexity, North Carolina State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021719, T32ES007026, P30ES001247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	National Institute of Environmental Sciences; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCSU Initiative for Biological Complexity, North Carolina State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding by P30 ES001247, T32 ES07026 (http://www.niehs.nih.gov/) National Institute of Environmental Sciences (MDR, SLM), GM045146, R21 ES021719, (http://www.nigms.nih.gov/) National Institute of General Medical Sciences (RRHA, TFCM), and NCSU Initiative for Biological Complexity, North Carolina State University (WH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; ALSALEEM T, 1976, B WORLD HEALTH ORGAN, V53, P99; AMINZAKI L, 1974, PEDIATRICS, V54, P587; Bahadorani S, 2010, NEUROBIOL AGING, V31, P1215, DOI 10.1016/j.neurobiolaging.2008.08.001; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Baines RA, 2005, MOL NEUROBIOL, V32, P113, DOI 10.1385/MN:32:2:113; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Bulchand S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009374; CHOI BH, 1978, J NEUROPATH EXP NEUR, V37, P719, DOI 10.1097/00005072-197811000-00001; Debes F, 2006, NEUROTOXICOL TERATOL, V28, P363, DOI [10.1016/j.ntt.2006.02.005, 10.1016/j.ntt.2006.02.004]; Devenport D, 2007, DEV BIOL, V308, P294, DOI 10.1016/j.ydbio.2007.02.046; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; DUTCZAK WJ, 1994, J BIOL CHEM, V269, P9746; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Engel GL, 2012, TOXICOL IN VITRO, V26, P485, DOI 10.1016/j.tiv.2011.12.014; Engel GL, 2014, NEUROTOXICOL TERATOL, V43, P11, DOI 10.1016/j.ntt.2014.03.001; Fernandes JJ, 2005, DEV BIOL, V277, P493, DOI 10.1016/j.ydbio.2004.09.038; Fernandes JJ, 1996, DEVELOPMENT, V122, P3755; Gildor B, 2012, DEVELOPMENT, V139, P4040, DOI 10.1242/dev.077495; Goodrich JM, 2013, INT J HYG ENVIR HEAL, V216, P195, DOI 10.1016/j.ijheh.2012.03.001; HARADA M, 1978, TERATOLOGY, V18, P285, DOI 10.1002/tera.1420180216; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; HUGHES WL, 1957, ANN NY ACAD SCI, V65, P454, DOI 10.1111/j.1749-6632.1956.tb36650.x; Jordan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038722; Julvez J, 2013, EPIDEMIOLOGY, V24, P643, DOI 10.1097/EDE.0b013e31829d5c93; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Lee BE, 2010, ENVIRON HEALTH PERSP, V118, P437, DOI 10.1289/ehp.0900731; LEVESQUE PC, 1988, TOXICOL APPL PHARM, V94, P55, DOI 10.1016/0041-008X(88)90336-5; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llop S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097172; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mahapatra CT, 2010, TOXICOL SCI, V116, P225, DOI 10.1093/toxsci/kfq097; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Morozova TV, 2011, GENETICS, V187, P1193, DOI 10.1534/genetics.110.125229; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Myers GJ, 2007, J NUTR, V137, P2805, DOI 10.1093/jn/137.12.2805; Myers GJ, 1997, NEUROTOXICOLOGY, V18, P819; Nyland JF, 2011, ENVIRON HEALTH PERSP, V119, P1733, DOI 10.1289/ehp.1103741; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Passos Carlos J. S., 2008, Cad. Saúde Pública, V24, ps503; Prediger RDS, 2010, J ALZHEIMERS DIS, V20, pS205, DOI 10.3233/JAD-2010-091459; Putz M, 2005, MECH DEVELOP, V122, P1206, DOI 10.1016/j.mod.2005.07.001; RABENSTEIN DL, 1978, BIOINORG CHEM, V8, P107, DOI 10.1016/S0006-3061(00)80237-9; Ramon R, 2009, AM J CLIN NUTR, V90, P1047, DOI 10.3945/ajcn.2009.27944; Rand MD, 2012, TOXICOLOGY, V300, P75, DOI 10.1016/j.tox.2012.06.001; SABBAGH K, 1977, BRIT MED J, V2, P1215, DOI 10.1136/bmj.2.6096.1215-a; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Toyama T, 2011, ENVIRON HEALTH PERSP, V119, P1117, DOI 10.1289/ehp.1003123; Valera B, 2013, ENVIRON RES, V120, P102, DOI 10.1016/j.envres.2012.08.002; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Weitkunat M, 2014, METHODS; Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1; Yazdani U, 2008, GENETICS, V178, P919, DOI 10.1534/genetics.107.078030; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	62	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110375	10.1371/journal.pone.0110375	http://dx.doi.org/10.1371/journal.pone.0110375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360876	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700033
J	Tao, WS; Moore, R; Smith, ER; Xu, XX				Tao, Wensi; Moore, Robert; Smith, Elizabeth R.; Xu, Xiang-Xi			Hormonal Induction and Roles of Disabled-2 in Lactation and Involution	PLOS ONE			English	Article							MAMMARY-GLAND INVOLUTION; MAP KINASE PHOSPHORYLATION; BREAST-CANCER; CELL-DEATH; SIGNALING PATHWAY; BINDING PARTNER; 1ST STAGE; MYOSIN-VI; DAB2; GENE	Disabled-2 (Dab2) is a widely expressed endocytic adaptor that was first isolated as a 96 KDa phospho-protein, p96, involved in MAPK signal transduction. Dab2 expression is lost in several cancer types including breast cancer, and Dab2 is thought to have a tumor suppressor function. In mammary epithelia, Dab2 was induced upon pregnancy and further elevated during lactation. We constructed mutant mice with a mosaic Dab2 gene deletion to bypass early embryonic lethality and to investigate the roles of Dab2 in mammary physiology. Loss of Dab2 had subtle effects on lactation, but Dab2-deficient mammary glands showed a strikingly delayed cell clearance during involution. In primary cultures of mouse mammary epithelial cells, Dab2 proteins were also induced by estrogen, progesterone, and/or prolactin. Dab2 null mammary epithelial cells were refractory to growth suppression induced by TGF-beta. However, Dab2 deletion did not affect Smad2 phosphorylation; rather TGF-beta-stimulated MAPK activation was enhanced in Dab2-deficient cells. We conclude that Dab2 expression is induced by hormones and Dab2 plays a role in modulating TGF-beta signaling to enhance apoptotic clearance of mammary epithelial cells during involution.	[Xu, Xiang-Xi] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Grad Program Mol Cell & Dev Biol, Dept Cell Biol, Miami, FL 33136 USA	University of Miami; University of Miami	Xu, XX (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	xxu2@med.miami.edu			National Cancer Institute of the National Institutes of Health (USA) [R01 CA095071, CA79716, CA75389]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA095071, R01CA075389, R01CA079716] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by R01 CA095071, CA79716, and CA75389 to X.X.Xu from National Cancer Institute of the National Institutes of Health (USA). R. Moore was partially supported by funding from the American Cancer Society (2009 Institutional Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antalffy G, 2011, BIOCHEM BIOPH RES CO, V410, P322, DOI 10.1016/j.bbrc.2011.05.147; Bagadi SAR, 2007, BREAST CANCER RES TR, V104, P277, DOI 10.1007/s10549-006-9422-6; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bierie B, 2009, J CELL PHYSIOL, V219, P57, DOI 10.1002/jcp.21646; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; BUDAY L, 1995, ONCOGENE, V11, P1327; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; Chetrit D, 2009, BIOCHEM J, V418, P701, DOI 10.1042/BJ20081288; Chlon TM, 2008, J NUTR, V138, P1323, DOI 10.1093/jn/138.7.1323; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Dickson R B, 1988, Cancer Treat Res, V40, P119; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Flanders KC, 2009, J MAMMARY GLAND BIOL, V14, P131, DOI 10.1007/s10911-009-9122-z; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Furth PA, 1999, J MAMMARY GLAND BIOL, V4, P123, DOI 10.1023/A:1018764922082; Furth PA, 1997, APOPTOSIS, V2, P19, DOI 10.1023/A:1026454207398; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; Heermeier K, 1996, MECH DEVELOP, V56, P197, DOI 10.1016/0925-4773(96)88032-4; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Jiang Y, 2008, ONCOGENE, V27, P1865, DOI 10.1038/sj.onc.1210829; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P146, DOI 10.3322/canjclin.41.3.146; LaMarca HL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1740; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Li ML, 1997, P NATL ACAD SCI USA, V94, P3425, DOI 10.1073/pnas.94.7.3425; Li ML, 1996, CELL GROWTH DIFFER, V7, P13; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Medina D, 2004, CLIN CANCER RES, V10, p380S, DOI 10.1158/1078-0432.CCR-031211; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Mok SC, 1998, ONCOGENE, V16, P2381, DOI 10.1038/sj.onc.1201769; Monks J, 2009, J MAMMARY GLAND BIOL, V14, P159, DOI 10.1007/s10911-009-9121-0; Moore R, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-39; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Newcomb PA, 1997, J MAMMARY GLAND BIOL, V2, P311, DOI 10.1023/A:1026344707161; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Ohi A, 2011, AM J PHYSIOL-RENAL, V301, pF1105, DOI 10.1152/ajprenal.00663.2010; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Radisky DC, 2009, J MAMMARY GLAND BIOL, V14, P181, DOI 10.1007/s10911-009-9123-y; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; ROZAKISADCOCK M, 1995, ONCOGENE, V11, P1417; Russo Irma H., 2007, V174, P111; Russo IH, 2008, WOMENS HEALTH, V4, P1, DOI 10.2217/17455057.4.1.1; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Schorr K, 1999, CANCER RES, V59, P2541; Schorr K, 1999, J MAMMARY GLAND BIOL, V4, P153, DOI 10.1023/A:1018773123899; Schwahn DJ, 1998, ONCOGENE, V17, P1173, DOI 10.1038/sj.onc.1202038; Sheng ZJ, 2001, GENE, V268, P31, DOI 10.1016/S0378-1119(01)00401-2; Sheng ZJ, 2000, GENOMICS, V70, P381, DOI 10.1006/geno.2000.6383; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Sivaraman L, 2002, J MAMMARY GLAND BIOL, V7, P77, DOI 10.1023/A:1015774524076; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; van der Heide LP, 2011, J BIOL CHEM, V286, P5003, DOI 10.1074/jbc.M110.167379; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Xu XX, 1998, ONCOGENE, V16, P1561, DOI 10.1038/sj.onc.1201678; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	89	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110737	10.1371/journal.pone.0110737	http://dx.doi.org/10.1371/journal.pone.0110737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360623	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700044
J	Velasquez, JT; Watts, ME; Todorovic, M; Nazareth, L; Pastrana, E; Diaz-Nido, J; Lim, F; Ekberg, JAK; Quinn, RJ; St John, JA				Velasquez, Johana Tello; Watts, Michelle E.; Todorovic, Michael; Nazareth, Lynnmaria; Pastrana, Erika; Diaz-Nido, Javier; Lim, Filip; Ekberg, Jenny A. K.; Quinn, Ronald J.; St John, James A.			Low-Dose Curcumin Stimulates Proliferation, Migration and Phagocytic Activity of Olfactory Ensheathing Cells	PLOS ONE			English	Article							SPINAL-CORD-INJURY; IN-VITRO; OEC TRANSPLANTATION; AXONAL REGENERATION; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; NEURONAL DEBRIS; UP-REGULATION; EXPRESSION; MICROGLIA	One of the promising strategies for neural repair therapies is the transplantation of olfactory ensheathing cells (OECs) which are the glial cells of the olfactory system. We evaluated the effects of curcumin on the behaviour of mouse OECs to determine if it could be of use to further enhance the therapeutic potential of OECs. Curcumin, a natural polyphenol compound found in the spice turmeric, is known for its anti-cancer properties at doses over 10 mu M, and often at 50 mu M, and it exerts its effects on cancer cells in part by activation of MAP kinases. In contrast, we found that low-dose curcumin (0.5 mu M) applied to OECs strikingly modulated the dynamic morphology, increased the rate of migration by up to 4-fold, and promoted significant proliferation of the OECs. Most dramatically, low-dose curcumin stimulated a 10-fold increase in the phagocytic activity of OECs. All of these potently stimulated behavioural characteristics of OECs are favourable for neural repair therapies. Importantly, low-dose curcumin gave a transient activation of p38 kinases, which is in contrast to the high dose curcumin effects on cancer cells in which these MAP kinases tend to undergo prolonged activation. Low-dose curcumin mediated effects on OECs demonstrate cell-type specific stimulation of p38 and ERK kinases. These results constitute the first evidence that low-dose curcumin can modulate the behaviour of olfactory glia into a phenotype potentially more favourable for neural repair and thereby improve the therapeutic use of OECs for neural repair therapies.	[Velasquez, Johana Tello; Watts, Michelle E.; Todorovic, Michael; Nazareth, Lynnmaria; Ekberg, Jenny A. K.; Quinn, Ronald J.; St John, James A.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia; [Nazareth, Lynnmaria; Ekberg, Jenny A. K.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Pastrana, Erika] Nat Commun, New York, NY USA; [Diaz-Nido, Javier] Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Lim, Filip] Univ Autonoma Madrid, Madrid, Spain	Griffith University; Queensland University of Technology (QUT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	St John, JA (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia.	j.stjohn@griffith.edu.au	Ekberg, Jenny/AAV-2006-2020; St John, James A/B-4478-2008; Quinn, Ronald J/A-7931-2008; Lim, Filip/C-7412-2011; Velasquez, Johana Tello/ABE-6109-2020; Watts, Michelle/V-8749-2019; St John, James/AAZ-9789-2020; Diaz-Nido, Javier/L-2371-2013	St John, James A/0000-0001-7536-3381; Quinn, Ronald J/0000-0002-4022-2623; Lim, Filip/0000-0001-6570-1017; Velasquez, Johana Tello/0000-0002-0065-4448; Watts, Michelle/0000-0002-3178-3429; St John, James/0000-0001-7536-3381; Pastrana, Erika/0000-0003-1745-8635; Ekberg, Jenny/0000-0001-5151-4966; Diaz-Nido, Javier/0000-0002-0927-7925; Nazareth, Lynn/0000-0002-0354-595X; Todorovic, Michael/0000-0003-0806-5610	Australian Research Council [DP0986294]	Australian Research Council(Australian Research Council)	The author(s) received funding for this work from Australian Research Council, Grant DP0986294 to JE (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Bisht K, 2009, BIOCHEM BIOPH RES CO, V379, P632, DOI 10.1016/j.bbrc.2008.12.135; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cao L, 2004, BRAIN, V127, P535, DOI 10.1093/brain/awh072; Chehrehasa F, 2010, MOL CELL NEUROSCI, V45, P277, DOI 10.1016/j.mcn.2010.07.002; Cholfin JA, 2008, J COMP NEUROL, V509, P144, DOI 10.1002/cne.21709; Chuah MI, 2011, EXP NEUROL, V229, P46, DOI 10.1016/j.expneurol.2010.08.012; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DOUCETTE R, 1995, HISTOL HISTOPATHOL, V10, P503; Edelmann K, 2013, J COMP NEUROL, V521, P3099, DOI 10.1002/cne.23347; Ekberg JAK, 2011, J NEUROSCI METH, V196, P88, DOI 10.1016/j.jneumeth.2011.01.008; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Franceschini IA, 1996, DEV BIOL, V173, P327, DOI 10.1006/dbio.1996.0027; Garcia-Escudero V, 2012, NEUROSCI LETT, V509, P27, DOI 10.1016/j.neulet.2011.12.037; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; He BR, 2014, MOL NEUROBIOL, V49, P1501, DOI 10.1007/s12035-013-8588-2; Huang TY, 2010, J AGR FOOD CHEM, V58, P10639, DOI 10.1021/jf1016303; Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kavakli HS, 2011, ULUS TRAVMA ACIL CER, V17, P14, DOI 10.5505/tjtes.2011.31391; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Ladeby R, 2005, GLIA, V50, P121, DOI 10.1002/glia.20159; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lankford KL, 2008, GLIA, V56, P1664, DOI 10.1002/glia.20718; Leung JYK, 2008, CELL MOL LIFE SCI, V65, P2732, DOI 10.1007/s00018-008-8184-1; Li L, 2014, EUROPEAN SPINE J; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2003, J NEUROSCI, V23, P7783; Liao KK, 2012, J AGR FOOD CHEM, V60, P433, DOI 10.1021/jf203290r; Lima C, 2006, J SPINAL CORD MED, V29, P191, DOI 10.1080/10790268.2006.11753874; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Lipson AC, 2003, EXP NEUROL, V180, P167, DOI 10.1016/S0014-4886(02)00058-4; Liu Y, 2010, MOL VIS, V16, P2903; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; Marczylo TH, 2007, CANCER CHEMOTH PHARM, V60, P171, DOI 10.1007/s00280-006-0355-x; Mimche PN, 2012, J ANTIMICROB CHEMOTH, V67, P1895, DOI 10.1093/jac/dks132; Moreno-Flores MT, 2003, J NEUROCHEM, V85, P861, DOI 10.1046/j.1471-4159.2003.01729.x; Ormond DR, 2012, J NEUROSURG-SPINE, V16, P497, DOI 10.3171/2012.1.SPINE11769; Panni P, 2013, NEUROSCI LETT, V539, P65, DOI 10.1016/j.neulet.2013.01.052; Patzko A, 2012, BRAIN, V135, P3551, DOI 10.1093/brain/aws299; Ramon-Cueto A, 2000, PROG BRAIN RES, V128, P265; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Rogers NM, 2010, CLIN EXP IMMUNOL, V162, P460, DOI 10.1111/j.1365-2249.2010.04232.x; Sandvig I, 2012, CONTRAST MEDIA MOL I, V7, P403, DOI 10.1002/cmmi.1465; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Simon D, 2011, GLIA, V59, P1458, DOI 10.1002/glia.21189; St John JA, 2003, CHEM SENSES, V28, P773, DOI 10.1093/chemse/bjg068; Stamegna JC, 2011, EXP NEUROL, V229, P120, DOI 10.1016/j.expneurol.2010.07.002; Su ZD, 2013, GLIA, V61, P490, DOI 10.1002/glia.22450; Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008; Su ZD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008141; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Vincent AJ, 2005, J NEUROCYTOL, V34, P65, DOI 10.1007/s11068-005-5048-6; Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Windus LCE, 2007, GLIA, V55, P1708, DOI 10.1002/glia.20586; Windus LCE, 2011, CELL MOL LIFE SCI, V68, P3233, DOI 10.1007/s00018-011-0630-9; Windus LCE, 2010, CELL MOL LIFE SCI, V67, P1735, DOI 10.1007/s00018-010-0280-3; Woodhall E, 2003, CELL MOL LIFE SCI, V60, P2241, DOI 10.1007/s00018-003-3265-7; Yamada J, 2013, J COMP NEUROL, V521, P1184, DOI 10.1002/cne.23228; Yan HL, 2003, GLIA, V44, P26, DOI 10.1002/glia.10265; Yang H, 2014, MOL NEUROBIOL; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	73	48	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111787	10.1371/journal.pone.0111787	http://dx.doi.org/10.1371/journal.pone.0111787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360677	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700150
J	Bouffier, AM; Arnold, J; Schuttler, HB				Bouffier, Amanda M.; Arnold, Jonathan; Schuettler, H. Bernd			A MINE Alternative to D-Optimal Designs for the Linear Model	PLOS ONE			English	Article							NEUROSPORA-CRASSA; SYSTEMS BIOLOGY; CELLULAR PROCESSES; CLOCK; GENE	Doing large-scale genomics experiments can be expensive, and so experimenters want to get the most information out of each experiment. To this end the Maximally Informative Next Experiment (MINE) criterion for experimental design was developed. Here we explore this idea in a simplified context, the linear model. Four variations of the MINE method for the linear model were created: MINE-like, MINE, MINE with random orthonormal basis, and MINE with random rotation. Each method varies in how it maximizes the MINE criterion. Theorem 1 establishes sufficient conditions for the maximization of the MINE criterion under the linear model. Theorem 2 establishes when the MINE criterion is equivalent to the classic design criterion of D-optimality. By simulation under the linear model, we establish that the MINE with random orthonormal basis and MINE with random rotation are faster to discover the true linear relation with p regression coefficients and n observations when p > > n. We also establish in simulations with n < 100, p = 1000, sigma = 0: 01 and 1000 replicates that these two variations of MINE also display a lower false positive rate than the MINE-like method and additionally, for a majority of the experiments, for the MINE method.	[Bouffier, Amanda M.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Arnold, Jonathan] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Schuettler, H. Bernd] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Arnold, J (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	arnold@uga.edu	Schuttler, Heinz-Bernd/AFT-0395-2022	arnold, jonathan/0000-0001-5845-1048	National Science Foundation [DBI-1426834]; Div Of Biological Infrastructure [1426834] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded was provided by the National Science Foundation DBI-1426834. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, STAT DESIGN ANAL EXP; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BJORCK A, 1992, SIAM J MATRIX ANAL A, V13, P176; Bouffier A, 2013, THESIS U GEORGIA; Box E. P., 1992, BAYESIAN INFERENCE S; Box EP, 2005, STAT EXPT; Box EP, 1998, EVOLUTIONARY OPERATI; Chakrabarty A, 2013, WIRES SYST BIOL MED, V5, P181, DOI 10.1002/wsbm.1204; Dette H, 1997, J ROY STAT SOC B MET, V59, P97, DOI 10.1111/1467-9868.00056; Dette H, 2003, J AM STAT ASSOC, V98, P679, DOI 10.1198/016214503000000585; Dette H, 2003, J ROY STAT SOC B, V65, P725, DOI 10.1111/1467-9868.00412; Donahue MM, 2010, IET SYST BIOL, V4, P249, DOI 10.1049/iet-syb.2009.0031; Dong WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003105; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; DUMOUCHEL W, 1994, TECHNOMETRICS, V36, P37, DOI 10.2307/1269197; Federov V.V., 1972, THEORY OPTIMAL EXPT; Fisher RA, 1935, DESIGN EXPT; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; Kiefer J, 1960, CAN J MATH, V12, P234; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Liepe J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002888; Lopez-Fidalgo J, 2004, J AM STAT ASSOC, V99, P1190, DOI 10.1198/016214504000001736; Marvel SW, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-21; Mathworks T, 1998, JAMA JAV MATR PACK; Poon LW, 2008, ANNU REV GERONTOL GE, V27, P231; Press W. H., 1992, ART SCI COMPUTING; Sagi D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002780; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Townsend JP, 2010, SYST BIOL, V59, P446, DOI 10.1093/sysbio/syq025; TSAY JY, 1976, J AM STAT ASSOC, V71, P671, DOI 10.2307/2285598; Vandenberghe L, 1998, SIAM J MATRIX ANAL A, V19, P499, DOI 10.1137/S0895479896303430; Dinh V, 2014, B MATH BIOL, V76, P597, DOI 10.1007/s11538-014-9935-9; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110234	10.1371/journal.pone.0110234	http://dx.doi.org/10.1371/journal.pone.0110234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356931	Green Submitted, gold, Green Published			2022-12-27	WOS:000346765000013
J	Jutten, K; Pieperhoff, P; Sudmeyer, M; Schleicher, A; Ferrea, S; Caspers, S; Zilles, K; Schnitzler, A; Amunts, K; Lux, S				Juetten, Kerstin; Pieperhoff, Peter; Suedmeyer, Martin; Schleicher, Axel; Ferrea, Stefano; Caspers, Svenja; Zilles, Karl; Schnitzler, Alfons; Amunts, Katrin; Lux, Silke			Neuropsychological and Brain Volume Differences in Patients with Left- and Right-Beginning Corticobasal Syndrome	PLOS ONE			English	Article							PARIETAL CORTEX; HEMISPHERIC-ASYMMETRY; MR-IMAGES; DEGENERATION; VARIABILITY; LATERALIZATION; MORPHOMETRY; REDUCTION; CRITERIA; ATROPHY	Background: Corticobasal Syndrome (CBS) is a rare neurodegenerative syndrome characterized by unilaterally beginning frontoparietal and basal ganglia atrophy. The study aimed to prove the hypothesis that there are differences in hemispheric susceptibility to disease-related changes. Methods: Two groups of CBS patients with symptoms starting either on the left or right body side were investigated. Groups consisted of four patients each and were matched for sex, age and disease duration. Patient groups and a group of eight healthy age-matched controls were analyzed using deformation field morphometry and neuropsychological testing. To further characterize individual disease progression regarding brain atrophy and neuropsychological performance, two female, disease duration-matched patients differing in initially impaired body side were followed over six months. Results: A distinct pattern of neural atrophy and neuropsychological performance was revealed for both CBS: Patients with initial right- sided impairment (r-CBS) revealed atrophy predominantly in frontoparietal areas and showed, except from apraxia, no other cognitive deficits. In contrast, patients with impairment of the left body side (I-CBS) revealed more widespread atrophy, extending from frontoparietal to orbitofrontal and temporal regions; and apraxia, perceptional and memory deficits could be found. A similar pattern of morphological and neuropsychological differences was found for the individual disease progression in I-CBS and r-CBS single cases. Conclusions: For similar durations of disease, volumetric grey matter loss related to CBS pathology appeared earlier and progressed faster in I-CBS than in r-CBS. Cognitive impairment in r-CBS was characterized by apraxia, and additional memory and perceptional deficits for I-CBS.	[Juetten, Kerstin; Pieperhoff, Peter; Schleicher, Axel; Caspers, Svenja; Zilles, Karl; Amunts, Katrin; Lux, Silke] Res Ctr Julich, INM 1, Julich, Germany; [Suedmeyer, Martin; Ferrea, Stefano; Schnitzler, Alfons] Univ Dusseldorf, Fac Med, Ctr Movement Disorders & Neuromodulat, Dept Neurol, Dusseldorf, Germany; [Suedmeyer, Martin; Ferrea, Stefano; Schnitzler, Alfons] Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Zilles, Karl] JARA Brain, Julich Aachen Res Alliance, Julich, Germany; [Zilles, Karl] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Amunts, Katrin] Univ Dusseldorf, C&O Vogt Inst Brain Res, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; RWTH Aachen University; Heinrich Heine University Dusseldorf	Jutten, K (corresponding author), Res Ctr Julich, INM 1, Julich, Germany.	k.juetten@fz-juelich.de	Schnitzler, Alfons/K-4625-2014; Zilles, Karl/Y-3784-2019; Schnitzler, Alfons/AAT-1054-2021; Caspers, Svenja/H-9346-2013; Ferrea, Stefano/AAP-5169-2020; Schnitzler, Alfons/Q-5520-2019; Amunts, Katrin/I-3470-2013; Zilles, Karl/J-9704-2013	Schnitzler, Alfons/0000-0002-6414-7939; Zilles, Karl/0000-0002-4705-4175; Caspers, Svenja/0000-0001-5083-4669; Schnitzler, Alfons/0000-0002-6414-7939; Amunts, Katrin/0000-0001-5828-0867; Zilles, Karl/0000-0001-9296-9959	"Helmholtz Alliance for Mental Health in an Ageing Society'' (HelMA) [HA-215]; Helmholtz Association	"Helmholtz Alliance for Mental Health in an Ageing Society'' (HelMA); Helmholtz Association(Helmholtz Association)	The project was supported by the "Helmholtz Alliance for Mental Health in an Ageing Society'' (HelMA, HA-215) and the portfolio theme "Supercomputing and Modeling the Human brain'' by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Assal F, 2012, BEHAV NEUROLOGY; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Belfor N, 2006, MECH AGEING DEV, V127, P203, DOI 10.1016/j.mad.2005.09.013; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Draca S, 2012, NEUROREHABILITATION, V30, P247, DOI 10.3233/NRE-2012-0752; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Geyer S, 2001, ANAT EMBRYOL, V204, P351, DOI 10.1007/s004290100200; GIBB WRG, 1989, BRAIN, V112, P1171, DOI 10.1093/brain/112.5.1171; GOLDSTEIN G, 1981, Journal of Clinical Neuropsychology, V3, P65, DOI 10.1080/01688638108403114; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Kitagaki H, 2000, RADIOLOGY, V216, P31, DOI 10.1148/radiology.216.1.r00ma0531; Koyama M, 2007, NEURORADIOLOGY, V49, P905, DOI 10.1007/s00234-007-0265-6; Lux S, 2008, J ANAT, V212, P235, DOI 10.1111/j.1469-7580.2008.00855.x; Mathew R, 2012, J NEUROL NEUROSUR PS, V83, P405, DOI 10.1136/jnnp-2011-300875; Mimura M, 1997, J NEUROPSYCH CLIN N, V9, P94; Pieperhoff P, 2008, NEUROIMAGE, V43, P269, DOI 10.1016/j.neuroimage.2008.07.031; Robichon F, 2000, EUR J NEUROL, V7, P35, DOI 10.1046/j.1468-1331.2000.00020.x; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Seritan AL, 2004, J NEUROPSYCH CLIN N, V16, P393, DOI 10.1176/appi.neuropsych.16.4.393; Shalev L, 2000, COGNITIVE NEUROPSYCH, V17, P339, DOI 10.1080/026432900380436; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Sudmeyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041873; Taniwaki T, 1998, J NEUROL SCI, V161, P70, DOI 10.1016/S0022-510X(98)00269-X; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Valverdea AH, 2011, CASE REP NEUROL, V3, P185, DOI [10.1159/000329820, 10.1159/e00329820]; Wenning GK, 1998, J NEUROL NEUROSUR PS, V64, P184, DOI 10.1136/jnnp.64.2.184; Whitwell JL, 2010, NEUROLOGY, V75, P1879, DOI 10.1212/WNL.0b013e3181feb2e8; Winkelmann J, 1999, MOVEMENT DISORD, V14, P669, DOI 10.1002/1531-8257(199907)14:4<669::AID-MDS1018>3.0.CO;2-Y; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	37	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110326	10.1371/journal.pone.0110326	http://dx.doi.org/10.1371/journal.pone.0110326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357176	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000015
J	Purrier, N; Engeland, WC; Kofuji, P				Purrier, Nicole; Engeland, William C.; Kofuji, Paulo			Mice Deficient of Glutamatergic Signaling from Intrinsically Photosensitive Retinal Ganglion Cells Exhibit Abnormal Circadian Photoentrainment	PLOS ONE			English	Article							CYCLASE-ACTIVATING PEPTIDE; SUPRACHIASMATIC NUCLEUS; PHOTIC ENTRAINMENT; VISUAL FUNCTIONS; PHASE-SHIFTS; LIGHT; MELANOPSIN; PACAP; RHYTHMS; CLOCK	Several aspects of behavior and physiology, such as sleep and wakefulness, blood pressure, body temperature, and hormone secretion exhibit daily oscillations known as circadian rhythms. These circadian rhythms are orchestrated by an intrinsic biological clock in the suprachiasmatic nuclei (SCN) of the hypothalamus which is adjusted to the daily environmental cycles of day and night by the process of photoentrainment. In mammals, the neuronal signal for photoentrainment arises from a small subset of intrinsically photosensitive retinal ganglion cells (ipRGCs) that send a direct projection to the SCN. ipRGCs also mediate other non-image-forming (NIF) visual responses such as negative masking of locomotor activity by light, and the pupillary light reflex (PLR) via co-release of neurotransmitters glutamate and pituitary adenylate cyclase-activating peptide (PACAP) from their synaptic terminals. The relative contribution of each neurotransmitter system for the circadian photoentrainment and other NIF visual responses is still unresolved. We investigated the role of glutamatergic neurotransmission for circadian photoentrainment and NIF behaviors by selective ablation of ipRGC glutamatergic synaptic transmission in mice. Mutant mice displayed delayed re-entrainment to a 6 h phase shift (advance or delay) in the light cycle and incomplete photoentrainment in a symmetrical skeleton photoperiod regimen (1 h light pulses between 11 h dark periods). Circadian rhythmicity in constant darkness also was reduced in some mutant mice. Other NIF responses such as the PLR and negative masking responses to light were also partially attenuated. Overall, these results suggest that glutamate from ipRGCs drives circadian photoentrainment and negative masking responses to light.	[Purrier, Nicole; Engeland, William C.; Kofuji, Paulo] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kofuji, P (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	kofuj001@.umn.edu	Kofuji, Paulo/AAR-7835-2021	Kofuji, Paulo/0000-0002-4840-9986	National Science Foundation grant [IOS1025119]; University of Minnesota Foundation Bridge Grant [B-0314-02]; NATIONAL EYE INSTITUTE [P30EY011374] Funding Source: NIH RePORTER	National Science Foundation grant(National Science Foundation (NSF)); University of Minnesota Foundation Bridge Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Science Foundation grant IOS1025119 (http://www.nsf.gov/div/index.jsp?div=IOS), and the University of Minnesota Foundation Bridge Grant B-0314-02 (http://www.mmf.umn.edu/academic/grants/faculty/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; Delwig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083974; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Engelund A, 2012, BRAIN RES, V1453, P17, DOI 10.1016/j.brainres.2012.03.005; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harrington ME, 1999, J NEUROSCI, V19, P6637; Hatanaka M, 2008, NEUROSCI LETT, V444, P153, DOI 10.1016/j.neulet.2008.08.030; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Johnson J, 2007, J NEUROSCI, V27, P7245, DOI 10.1523/JNEUROSCI.0815-07.2007; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Kriegsfeld LJ, 2008, EUR J NEUROSCI, V27, P2907, DOI 10.1111/j.1460-9568.2008.06239.x; Laemle LK, 1998, PHYSIOL BEHAV, V64, P165, DOI 10.1016/S0031-9384(98)00045-6; Land PW, 2004, BRAIN RES, V996, P251, DOI 10.1016/j.brainres.2003.10.032; Mintz EM, 1999, J NEUROSCI, V19, P5124; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Sand A, 2012, PROG RETIN EYE RES; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Sheely C, 2011, THESIS, P114; SHIRAKAWA T, 1994, NEUROSCI LETT, V178, P47, DOI 10.1016/0304-3940(94)90286-0; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Van Gelder RN, 2005, METHOD ENZYMOL, V393, P746, DOI 10.1016/S0076-6879(05)93039-5; Wassle H, 2006, J COMP NEUROL, V496, P544, DOI 10.1002/cne.20942; Wee R, 2002, J NEUROSCI, V22, P10427; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405	42	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111449	10.1371/journal.pone.0111449	http://dx.doi.org/10.1371/journal.pone.0111449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357191	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000063
J	Xin, JJ; Shang, QL; Desneux, N; Gao, XW				Xin, Juan-Juan; Shang, Qing-Li; Desneux, Nicolas; Gao, Xi-Wu			Genetic Diversity of Sitobion avenae (Homoptera: Aphididae) Populations from Different Geographic Regions in China	PLOS ONE			English	Article							CHERRY-OAT APHID; GRAIN APHID; LIFE-CYCLE; METAPOPULATION STRUCTURE; HEMIPTERA APHIDIDAE; SOYBEAN APHID; MICROSATELLITE; EVOLUTION; SOFTWARE; ARCHITECTURE	Sitobion avenae is a major agricultural pest of wheat in China. Using microsatellite markers, we studied the potential gene flow, genetic diversity, genetic differentiation, and genetic structure of seven S. avenae populations from different regions of China (Beijing, Hebei, Henan, Hubei, Jiangsu, Shandong, and Shanxi provinces). The populations from Henan, Shandong, and Jiangsu showed high levels of genic and genotypic diversity. By contrast, the genic diversity in the Beijing and Hebei populations was much lower. Despite this low genic diversity, the genotypic diversity of the Beijing population was higher than that of all of the other populations, except those from Jiangsu and Shandong. Overall, the genetic divergence among the seven S. avenae populations tested was high, though there was almost no differentiation between the Shandong and Henan populations. We observed significant negative correlation between the strength of gene flow and the geographic distances among populations. Based on genetic analysis, the seven S. avenae populations studied can be divided into four distinct clusters; (i) Hubei, (ii) Shanxi, (iii) Beijing and Hebei, and (iv) Shandong, Henan, and Jiangsu. The present results provide a basis for potentially optimizing integrated pest management (IPM) programs in China, through adapting control methods that target biological traits shared by various populations of the same genotype.	[Xin, Juan-Juan; Gao, Xi-Wu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Shang, Qing-Li] Jilin Univ, Coll Plant Sci & Technol, Changchun 130023, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	China Agricultural University; Jilin University; INRAE	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	gaoxiwu@263.net.cn	Desneux, Nicolas/J-6262-2013		National Basic Research and Development Program of China [2012CB114103]	National Basic Research and Development Program of China(National Basic Research Program of China)	This research was supported by National Basic Research and Development Program of China (Contract No. 2012CB114103) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkhir K., 2004, GENETIX 4 05 LOGICIE; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; BLACKMAN RL, 1971, B ENTOMOL RES, V60, P533, DOI 10.1017/S0007485300042292; BLACKMAN RL, 1972, B ENTOMOL RES, V62, P281, DOI 10.1017/S0007485300047726; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Cai Qing-Nian, 2004, Entomological Knowledge, V41, P285; Carter MJ, 2012, ECOL EVOL, V2, P1414, DOI 10.1002/ece3.247; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Dedryver CA, 1998, ECOL ENTOMOL, V23, P123, DOI 10.1046/j.1365-2311.1998.00113.x; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Demotte F, 2001, P ROY SOC B, V263, P321; Dixon AFG, 1988, APHID ECOLOGY; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gao SX, 2014, INSECT SCI, V21, P352, DOI 10.1111/1744-7917.12085; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillemaud T, 2003, HEREDITY, V91, P143, DOI 10.1038/sj.hdy.6800292; Guo W, 2005, PROG NAT SCI-MATER, V15, P1000; Hand S. C., 1980, Bulletin SROP, V3, P59; HARDIE J, 1993, J AGR ENTOMOL, V10, P239; Huang XL, 2013, ENVIRON ENTOMOL, V42, P1174, DOI 10.1603/EN13132; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JAMES BD, 1982, ECOL ENTOMOL, V7, P277, DOI 10.1111/j.1365-2311.1982.tb00667.x; Klueken AM, 2012, J APPL ENTOMOL, V135, P347, DOI 10.1111/j.1439-0418.2011.01654.x; Lavandero B, 2009, B ENTOMOL RES, V99, P97, DOI 10.1017/S0007485308006196; LEATHER SR, 1980, ENTOMOL EXP APPL, V27, P96, DOI 10.1007/BF00377245; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lopes-Da-Silva M, 2010, BRAZ ARCH BIOL TECHN, V53, P911, DOI 10.1590/S1516-89132010000400021; LOXDALE HD, 1985, B ENTOMOL RES, V75, P121, DOI 10.1017/S0007485300014218; LOXDALE HD, 1993, BIOL REV, V68, P291, DOI 10.1111/j.1469-185X.1993.tb00998.x; Loxdale HD, 2003, INFECT GENET EVOL, V3, P259, DOI 10.1016/S1567-1348(03)00091-1; Loxdale HD, 2011, BIOL J LINN SOC, V104, P838, DOI 10.1111/j.1095-8312.2011.01761.x; Lu Y, 2009, B ENTOMOL RES, V99, P611, DOI 10.1017/S0007485309006725; Lu YH, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.0901; Lushai G, 2002, GENET RES, V79, P1, DOI 10.1017/S0016672301009582; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Margaritopoulos John T., 2009, BMC Ecology, V9, P13, DOI 10.1186/1472-6785-9-13; Massonnet B, 2002, MOL ECOL, V11, P2511, DOI 10.1046/j.1365-294X.2002.01633.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Ota T, 1993, DISPAN GENETIC DISTA; Peccoud J, 2010, CR BIOL, V333, P474, DOI 10.1016/j.crvi.2010.03.004; Power Alison G., 1995, P259; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rispe C, 1998, J EVOLUTION BIOL, V11, P685, DOI 10.1007/s000360050113; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SIMON JC, 1991, B ENTOMOL RES, V81, P315, DOI 10.1017/S0007485300033599; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; SIMON JC, 1995, HEREDITY, V74, P346, DOI 10.1038/hdy.1995.52; SLATKIN M, 1981, GENETICS, V99, P323; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Venette RC, 2004, ANN ENTOMOL SOC AM, V97, P219, DOI 10.1603/0013-8746(2004)097[0219:ATIBSA]2.0.CO;2; Vorburger C, 2006, J EVOLUTION BIOL, V19, P97, DOI 10.1111/j.1420-9101.2005.00985.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]; Wilson ACC, 1997, GENET RES, V69, P233, DOI 10.1017/S0016672397002747; Wright S, 1978, EVOLUTION GENETICS P, V4, P79; Wright S., 1969, EVOLUTION GENETICS P; Xu ZH, 2011, AGR SCI CHINA, V10, P1041, DOI 10.1016/S1671-2927(11)60092-8; Xu ZH, 2011, J ECON ENTOMOL, V104, P1080, DOI 10.1603/EC10204; Zhang B, 2012, MOL ECOL, V21, P2130, DOI 10.1111/j.1365-294X.2012.05517.x; Zhang Y, 2008, ENVIRON ENTOMOL, V37, P301, DOI 10.1603/0046-225X(2008)37[301:FPOTSA]2.0.CO;2; Zhang YJ, 2009, CHINA PLANT PROT, V29, P33	70	20	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109349	10.1371/journal.pone.0109349	http://dx.doi.org/10.1371/journal.pone.0109349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356548	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000005
J	Feinberg, JA; Newman, CE; Watkins-Colwell, GJ; Schlesinger, MD; Zarate, B; Curry, BR; Shaffer, HB; Burger, J				Feinberg, Jeremy A.; Newman, Catherine E.; Watkins-Colwell, Gregory J.; Schlesinger, Matthew D.; Zarate, Brian; Curry, Brian R.; Shaffer, H. Bradley; Burger, Joanna			Cryptic Diversity in Metropolis: Confirmation of a New Leopard Frog Species (Anura: Ranidae) from New York City and Surrounding Atlantic Coast Regions	PLOS ONE			English	Article							RANA-PIPIENS; CONSERVATION; INFERENCE; HYLIDAE; MRBAYES	We describe a new cryptic species of leopard frog from the New York City metropolitan area and surrounding coastal regions. This species is morphologically similar to two largely parapatric eastern congeners, Rana sphenocephala and R. pipiens. We primarily use bioacoustic and molecular data to characterize the new species, but also examine other lines of evidence. This discovery is unexpected in one of the largest and most densely populated urban parts of the world. It also demonstrates that new vertebrate species can still be found periodically even in well-studied locales rarely associated with undocumented biodiversity. The new species typically occurs in expansive open-canopied wetlands interspersed with upland patches, but centuries of loss and impact to these habitats give some cause for conservation concern. Other concerns include regional extirpations, fragmented extant populations, and a restricted overall geographic distribution. We assign a type locality within New York City and report a narrow and largely coastal lowland distribution from central Connecticut to northern New Jersey (based on genetic data) and south to North Carolina (based on call data).	[Feinberg, Jeremy A.; Curry, Brian R.; Burger, Joanna] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Newman, Catherine E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Newman, Catherine E.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Watkins-Colwell, Gregory J.] Yale Peabody Museum Nat Hist, Div Vertebrate Zool, New Haven, CT USA; [Schlesinger, Matthew D.] SUNY Albany, Coll Environm Sci & Forestry, New York Nat Heritage Program, Albany, NY 12222 USA; [Zarate, Brian] New Jersey Div Fish & Wildlife, Endangered & Nongame Species Program, Clinton, NJ USA; [Shaffer, H. Bradley] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Shaffer, H. Bradley] Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA USA; [Burger, Joanna] Rutgers State Univ, Cell Biol & Neurosci & Environm & Occupat Hlth Sc, Piscataway, NJ USA	Rutgers State University New Brunswick; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) College of Environmental Science & Forestry; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rutgers State University New Brunswick	Feinberg, JA (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	jeremy.feinberg@rutgers.edu		Newman, Catherine/0000-0002-1862-7245; Watkins-Colwell, Greg/0000-0002-7789-9806	Rutgers Graduate School of New Brunswick Bevier Dissertation Fellowship; New Jersey Department of Environmental Protection Conserve Wildlife Matching Grant; NIH NIEHS Center [P30ES005022]; Hudson River Foundation; Rutgers Graduate Program in Ecology and Evolution, Brookhaven National Laboratory; Foundation for Ecological Research in the Northeast; Tiko Fund; NSF [DEB-1146033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; Direct For Biological Sciences [1257648] Funding Source: National Science Foundation	Rutgers Graduate School of New Brunswick Bevier Dissertation Fellowship; New Jersey Department of Environmental Protection Conserve Wildlife Matching Grant; NIH NIEHS Center; Hudson River Foundation; Rutgers Graduate Program in Ecology and Evolution, Brookhaven National Laboratory; Foundation for Ecological Research in the Northeast; Tiko Fund; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for field work and analysis was primarily provided by a Rutgers Graduate School of New Brunswick Bevier Dissertation Fellowship and a New Jersey Department of Environmental Protection Conserve Wildlife Matching Grant to JAF, an NIH NIEHS Center grant P30ES005022 to JB, and a Hudson River Foundation grant to JB and JAF. Partial support was also provided by the Rutgers Graduate Program in Ecology and Evolution, Brookhaven National Laboratory, the Foundation for Ecological Research in the Northeast, and the Tiko Fund. Funding for genetics laboratory work for the holotype, performed at the Louisiana State University Museum of Natural Science, was provided by NSF DEB-1146033 (to Christopher C. Austin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; Barbour T., 1923, CHECK LIST N AM AMPH; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boulenger GA, 1920, P AM ACAD ARTS SCI, V55, P411; Bragg Arthur N., 1941, GREAT BASIN NAT, V2, P109; Bridges AS, 2000, COPEIA, P587, DOI 10.1643/0045-8511(2000)000[0587:TVIACB]2.0.CO;2; Brown L.E, 1977, Bulletin of Zoological Nomenclature, V33, P195; BROWN LE, 1973, AM ZOOL, V13, P73; Burger J, 2014, ECOHEALTH, V11, P154, DOI 10.1007/s10393-014-0913-3; BURT CHARLES E., 1938, TRANS KANSAS ACAD SCI, V41, P331; Charif RA, 2010, RAVEN PRO V 1 4 US M; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Conant R., 1991, FIELD GUIDE REPTILES; Conant R., 1979, PINE BARRENS ECOSYST, P467; Cope E.D., 1889, B US NATL MUSEUM, V34, P1, DOI DOI 10.5962/BHL.TITLE; Daudin FM, 1802, HIST NATURELLE RAINE; Dickerson MC, 1906, FROG BOOK N AM TOADS, DOI [10.5962/bhl.title.1542, DOI 10.5962/BHL.TITLE.1542]; ESRI,, 2010, ARCGIS DESKT REL 10; Florida R, 2008, CAMB J REG ECON SOC, V1, P459, DOI 10.1093/cjres/rsn018; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, 2013, AMPHIBIAN SPECIES WO; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gerhardt H. Carl, 1995, Amphibian Biology, V2, P603; Grant R., 1941, Copeia, V1941, P151, DOI 10.2307/1437739; Harlan R, 1826, AM J SCI ARTS, V10, P53; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; HILLIS DM, 1988, ANNU REV ECOL SYST, V19, P39; Hinckley M. H., 1882, Proceedings of the Boston Society, Vxxi, P307; Holbrook J.E., 1836, N AM HERPETOLOGY; Holmes SJ, 1916, BIOL FROG, DOI [10.5962/bhl.title.30369, DOI 10.5962/BHL.TITLE.30369]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulse A.C., 2001, AMPHIBIANS REPTILES; JOHNSON C, 1966, TEX J SCI, V18, P361; Kauffeld C. F., 1937, Herpetologica Chicago, V1, P84; Kauffeld CF, 1936, HERPETOLOGICA, V1, P11; Kellogg R., 1932, US Nat Mus Washington Bull, V160, P1; Kiviat E., 2011, FROG CALL SURVEYS UR; KLEMENS M W, 1987, Northeastern Environmental Science, V6, P99; Klemens M. W., 1993, BULLETIN, V112, P1; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lannoo MJ., 2005, AMPHIBIAN DECLINES C, DOI [10.1525/california/9780520235922.001.0001., DOI 10.1525/CALIFORNIA/9780520235922.001.0001, 10.1525/california/9780520235922.001.0001]; LATHAM R, 1971, Engelhardtia, V4, P58; Lavilla EO, 2010, ZOOTAXA, P1; Lemmon EM, 2008, ZOOTAXA, P1; Mathewson R, 1955, P STATEN ISLAND I AR, V17, P28; McCoy CJ, 1982, CARNEGIE MUS NAT HIS, V6, P1; MOORE JA, 1949, EVOLUTION, V3, P1, DOI 10.2307/2405448; MOORE JA, 1975, AM ZOOL, V15, P837; Moore JA, 1944, B AM MUS NAT HIST, V82, P346; Napoli MF, 2005, HERPETOLOGICA, V61, P63, DOI 10.1655/03-41; Netting MG, 1933, P PENN ACAD SCI, V7, P100; Newman CE, 2012, MOL PHYLOGENET EVOL, V63, P445, DOI 10.1016/j.ympev.2012.01.021; Overton F, 1914, BROOKLYN MUS Q, V1, P30; Overton F, 1914, MUS BROOKLYN I ARTS, V2, P21; PACE A. E., 1974, MISC PUBL MUS ZOOL, P1; Penna M, 2011, ETHOLOGY, V117, P63, DOI 10.1111/j.1439-0310.2010.01847.x; PLATZ JE, 1972, COPEIA, P232; PORTER K. R., 1941, BIOL BULL, V80, P238, DOI 10.2307/1537601; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RORABAUGH JC, 2005, AMPHIBIAN DECLINES C, P00570; RUIBAL RODOLFO, 1957, COPEIA, V1957, P212, DOI 10.2307/1439360; Savage J.M., 2002, AMPHIBIANS REPTILES; SCHLAUCH F C, 1971, Engelhardtia, V4, P47; Schlauch F.C, 1978, PITCH PINE NAT, V4, P5; Schmidt K.P., 1953, CHECK LIST N AM AMPH, V6th; Schreber H., 1782, NATURFORSCHER HALLE, V18, P182; SHAFFER LL, 1991, PENNSYLVANIA AMPHIBI; Sherwood WJ, 1898, P LINN SOC NY, V10, P9; Shiels AL, 1999, PENNSYLVANIA ANGLER, V1999, P58; Smith Hobart M., 1995, Herpetological Review, V26, P14; SMITH PHILIP W., 1961, ILLINOIS NAT HIST SURV BULL, V28, P1; Stanaka W, 1933, P PENN ACAD SCI, V7, P96; Stejneger LH, 1939, CHECK LIST N AM AMPH, DOI [10.4159/harvard.9780674592728, DOI 10.4159/HARVARD.9780674592728]; STEJNEGER LH, 1933, CHECK LIST N AM AMPH; Surface HA, 1913, ZOOL B PENN DEP AGRI, V3, P66; Trapido H., 1938, Copeia Ann Arbor, P117; Villani R, 1997, LONG ISLAND NATUTAL; Wells K.D., 2010, ECOLOGY BEHAV AMPHIB, DOI DOI 10.7208/CHICAGO/9780226893334.001.0001.; Wollerman L, 1999, ANIM BEHAV, V57, P529, DOI 10.1006/anbe.1998.1013; Wright A, 1949, HDB FROGS TOADS US C; Wright AH, 1933, HDB FROGS TOADS US C, DOI [10.5962/bhl.title.6753, DOI 10.5962/BHL.TITLE.6753]	83	31	32	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e108213	10.1371/journal.pone.0108213	http://dx.doi.org/10.1371/journal.pone.0108213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354068	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204200004
J	Plaszewski, M; Bettany-Saltikov, J				Plaszewski, Maciej; Bettany-Saltikov, Josette			Non-Surgical Interventions for Adolescents with Idiopathic Scoliosis: An Overview of Systematic Reviews	PLOS ONE			English	Article							EXERCISES REDUCE; SPINAL DEFORMITY; MEASUREMENT TOOL; EFFICACY; QUALITY	Background: Non-surgical interventions for adolescents with idiopathic scoliosis remain highly controversial. Despite the publication of numerous reviews no explicit methodological evaluation of papers labeled as, or having a layout of, a systematic review, addressing this subject matter, is available. Objectives: Analysis and comparison of the content, methodology, and evidence-base from systematic reviews regarding non-surgical interventions for adolescents with idiopathic scoliosis. Design: Systematic overview of systematic reviews. Methods: Articles meeting the minimal criteria for a systematic review, regarding any non-surgical intervention for adolescent idiopathic scoliosis, with any outcomes measured, were included. Multiple general and systematic review specific databases, guideline registries, reference lists and websites of institutions were searched. The AMSTAR tool was used to critically appraise the methodology, and the Oxford Centre for Evidence Based Medicine and the Joanna Briggs Institute's hierarchies were applied to analyze the levels of evidence from included reviews. Results: From 469 citations, twenty one papers were included for analysis. Five reviews assessed the effectiveness of scoliosis-specific exercise treatments, four assessed manual therapies, five evaluated bracing, four assessed different combinations of interventions, and one evaluated usual physical activity. Two reviews addressed the adverse effects of bracing. Two papers were high quality Cochrane reviews, Three were of moderate, and the remaining sixteen were of low or very low methodological quality. The level of evidence of these reviews ranged from 1 or 1+ to 4, and in some reviews, due to their low methodological quality and/or poor reporting, this could not be established. Conclusions: Higher quality reviews indicate that generally there is insufficient evidence to make a judgment on whether non-surgical interventions in adolescent idiopathic scoliosis are effective. Papers labeled as systematic reviews need to be considered in terms of their methodological rigor; otherwise they may be mistakenly regarded as high quality sources of evidence.	[Plaszewski, Maciej] Univ Sch Phys Educ, Fac Phys Educ & Sport Biala Podlaska, Warsaw, Biala Podlaska, Poland; [Bettany-Saltikov, Josette] Univ Teesside, Sch Hlth & Social Care, Middlesbrough, Cleveland, England	Jozef Pilsudski University Physical Education in Warsaw; University of Teesside	Plaszewski, M (corresponding author), Univ Sch Phys Educ, Fac Phys Educ & Sport Biala Podlaska, Ul Akad 2, Warsaw, Biala Podlaska, Poland.	plaszewski@wp.pl	Bettany-Saltikov (nee Damato), Josette Arielle/C-5388-2011	Bettany-Saltikov (nee Damato), Josette Arielle/0000-0001-7784-500X	Faculty of Physical Education and Sport in Biala Podlaska, Warsaw University School of Physical Education, Poland	Faculty of Physical Education and Sport in Biala Podlaska, Warsaw University School of Physical Education, Poland	Publication of this manuscript was supported by the Faculty of Physical Education and Sport in Biala Podlaska, Warsaw University School of Physical Education, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other financial support for conducting this study.	Altaf F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2508; [Anonymous], 2008, DISABIL REHABIL, V30, P731; [Anonymous], 2010, HS, V122, p[1, 4]; Bettany-Saltikov J, 2014, EUR J PHYS REHAB MED, V50, P111; CASSELLA MC, 1991, PHYS THER, V71, P897, DOI 10.1093/ptj/71.12.897; Centre for Reviews and Dissemination, 2008, SYSTEMATIC REV CRDS; Davies Evan, 2011, Evid Based Spine Care J, V2, P25, DOI 10.1055/s-0030-1267102; Dickson RA, 1999, SPINE, V24, P2601, DOI 10.1097/00007632-199912150-00007; Dolan LA, 2007, SPINE, V32, pS91, DOI 10.1097/BRS.0b013e318134ead9; Falk B, 2014, SPINE J EPUB AHEAD P, DOI [10.1016/j.spinee.2014.05.00, DOI 10.1016/J.SPINEE.2014.05.00]; FOCARILE FA, 1991, SPINE, V16, P395, DOI 10.1097/00007632-199104000-00001; Fred M, 2011, CURR REV MUSCULOSKE, V4, P175, DOI 10.1007/s12178-011-9100-0; Fusco C., 2011, Physiotherapy Theory and Practice, V27, P80, DOI 10.3109/09593985.2010.533342; Gagnier Joel J, 2013, J Bone Joint Surg Am, V95, pe771, DOI 10.2106/JBJS.L.00597; Gianola S, 2013, PHYS THER, V93, P1456, DOI 10.2522/ptj.20120382; Gleberzon Brian J, 2012, J Can Chiropr Assoc, V56, P128; Green BN, 2009, J CHIROPR MED, V8, P25, DOI 10.1016/j.jcm.2008.11.001; Hartling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049667; Hasson S, 2011, PHYSIOTHER THEOR PRA, V271; Hawes Martha C, 2003, Pediatr Rehabil, V6, P171; Horne JP, 2014, AM FAM PHYSICIAN, V89, P193; Howick J, 2011, EXPLANATION 20111 OX; Hresko MT, 2013, NEW ENGL J MED, V368, P834, DOI 10.1056/NEJMcp1209063; Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party, 2014, SUPP DOC JOANN BRIGG; Karolinska Institutet, 2012, TRIAL 3 TREAT SCOL C; Kepler CK, 2012, SPINE J, V12, P676, DOI 10.1016/j.spinee.2012.05.011; Lenssinck MLB, 2005, PHYS THER, V85, P1329, DOI 10.1093/ptj/85.12.1329; Li XF, 2008, EUR SPINE J, V17, P1431, DOI 10.1007/s00586-008-0757-z; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LONSTEIN JE, 1994, LANCET, V344, P1407; Maruyama Toru, 2011, Physiotherapy Theory and Practice, V27, P26, DOI 10.3109/09593985.2010.503989; McKenney K, 2013, J ATHL TRAINING, V48, P522, DOI 10.4085/1062-6050-48.3.17; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monticone M, 2014, EUR SPINE J, V23, P1204, DOI 10.1007/s00586-014-3241-y; Mordecai SC, 2012, EUR SPINE J, V21, P382, DOI 10.1007/s00586-011-2063-4; National Institute for Health Research Health Technology Assessment Programme, 2012, ACT TREAT ID AD SCO; Negrini S, 2008, DISABIL REHABIL, V30, P772, DOI 10.1080/09638280801889568; Negrini S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006850.pub2; Negrini Stefano, 2003, Pediatr Rehabil, V6, P227; Negrini S, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-3; OCEBM Levels of Evidence Working Group, 2011, OXFORD 2011 LEVELS E; Plaszewski M, 2014, EUR SPINE J, V23, P2572, DOI 10.1007/s00586-014-3307-x; Popovich I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050403; Posadzki P, 2013, PEDIATRICS, V132, P140, DOI 10.1542/peds.2012-3959; Posadzki P, 2011, NEW ZEAL MED J, V124, P55; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; Rihn JA, 2009, AM J MED QUAL, V24, p4S, DOI 10.1177/1062860609349214; Romano M, 2008, SCOLIOSIS, V3, P2; Romano M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007837.pub2; Rowe DE, 1997, J BONE JOINT SURG AM, V79A, P664, DOI 10.2106/00004623-199705000-00005; Saccucci M, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-15; Sanders JO, 2014, J BONE JOINT SURG AM, V96A, P649, DOI 10.2106/JBJS.M.00290; Sanders James O, 2012, J Pediatr Orthop, V32 Suppl 2, pS153, DOI 10.1097/BPO.0b013e31825199e5; Schiller JR, 2010, CLIN ORTHOP RELAT R, V468, P670, DOI 10.1007/s11999-009-0884-9; Scoliosis Research Society, 2014, AD ID SCO TREAT; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Skaggs DL, 1996, AM FAM PHYSICIAN, V53, P2327; Sponseller PD, 2011, J PEDIATR ORTHOPED, V31, pS53, DOI 10.1097/BPO.0b013e3181f73e87; Stokes OM, 2013, BONE JOINT J, V95B, P1308, DOI 10.1302/0301-620X.95B10.31474; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party, 2014, NEW JBI LEV EV; University of Alberta, 2012, SCHROTH EX TRIAL SCO; US Preventive Services Task Force, 2004, AHRQ PUB, V05-0568-B; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337; Weiss HR, 2008, EUR J PHYS REHAB MED, V44, P177; Weiss HR, 2006, SCOLIOSIS SPINAL DIS, V1, DOI [10.1186/1748-7161-1-5, 10.1186/1748-7161-1-1]; Weiss Hans-Rudolf, 2003, Pediatr Rehabil, V6, P183; Weiss HR, 2012, POL ANN MED, V19, P72; Zaina F, 2014, EUR J PHYS REHAB MED, V50, P93; Zarzycka Maja, 2009, Ortop Traumatol Rehabil, V11, P396	72	8	9	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110254	10.1371/journal.pone.0110254	http://dx.doi.org/10.1371/journal.pone.0110254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353954	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200019
J	Hamon, R; Homan, CC; Tran, HB; Mukaro, VR; Lester, SE; Roscioli, E; Bosco, MD; Murgia, CM; Ackland, ML; Jersmann, HP; Lang, C; Zalewski, PD; Hodge, SJ				Hamon, Rhys; Homan, Claire C.; Tran, Hai B.; Mukaro, Violet R.; Lester, Susan E.; Roscioli, Eugene; Bosco, Mariea D.; Murgia, Chiara M.; Ackland, Margaret Leigh; Jersmann, Hubertus P.; Lang, Carol; Zalewski, Peter D.; Hodge, Sandra J.			Zinc and Zinc Transporters in Macrophages and Their Roles in Efferocytosis in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR MACROPHAGES; EXPRESSION; LUNG; HOMEOSTASIS; DEFICIENCY; RECEPTOR; ACTIVATION; CELLS; PHAGOCYTOSIS	Our previous studies have shown that nutritional zinc restriction exacerbates airway inflammation accompanied by an increase in caspase-3 activation and an accumulation of apoptotic epithelial cells in the bronchioles of the mice. Normally, apoptotic cells are rapidly cleared by macrophage efferocytosis, limiting any secondary necrosis and inflammation. We therefore hypothesized that zinc deficiency is not only pro-apoptotic but also impairs macrophage efferocytosis. Impaired efferocytic clearance of apoptotic epithelial cells by alveolar macrophages occurs in chronic obstructive pulmonary disease (COPD), cigarette-smoking and other lung inflammatory diseases. We now show that zinc is a factor in impaired macrophage efferocytosis in COPD. Concentrations of zinc were significantly reduced in the supernatant of bronchoalveolar lavage fluid of patients with COPD who were current smokers, compared to healthy controls, smokers or COPD patients not actively smoking. Lavage zinc was positively correlated with AM efferocytosis and there was decreased efferocytosis in macrophages depleted of Zn in vitro by treatment with the membrane-permeable zinc chelator TPEN. Organ and cell Zn homeostasis are mediated by two families of membrane ZIP and ZnT proteins. Macrophages of mice null for ZIP1 had significantly lower intracellular zinc and efferocytosis capability, suggesting ZIP1 may play an important role. We investigated further using the human THP-1 derived macrophage cell line, with and without zinc chelation by TPEN to mimic zinc deficiency. There was no change in ZIP1 mRNA levels by TPEN but a significant 3-fold increase in expression of another influx transporter ZIP2, consistent with a role for ZIP2 in maintaining macrophage Zn levels. Both ZIP1 and ZIP2 proteins were localized to the plasma membrane and cytoplasm in normal human lung alveolar macrophages. We propose that zinc homeostasis in macrophages involves the coordinated action of ZIP1 and ZIP2 transporters responding differently to zinc deficiency signals and that these play important roles in macrophage efferocytosis.	[Hamon, Rhys; Homan, Claire C.; Tran, Hai B.; Bosco, Mariea D.; Lang, Carol; Zalewski, Peter D.; Hodge, Sandra J.] Univ Adelaide, Queen Elizabeth Hosp, Discipline Med, Woodville, SA 5011, Australia; [Tran, Hai B.; Mukaro, Violet R.; Jersmann, Hubertus P.; Hodge, Sandra J.] Royal Adelaide Hosp, Dept Thorac Med, Lung Res Lab, Hanson Inst, Adelaide, SA 5000, Australia; [Lester, Susan E.] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA 5011, Australia; [Roscioli, Eugene] Univ Adelaide, Queen Elizabeth Hosp, Discipline Surg, Woodville, SA 5011, Australia; [Murgia, Chiara M.] CRA NUT, Rome, Italy; [Ackland, Margaret Leigh] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Melbourne, Vic, Australia	University of Adelaide; Hanson Institute; Royal Adelaide Hospital; University of Adelaide; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Deakin University	Zalewski, PD (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Discipline Med, Woodville, SA 5011, Australia.	peter.zalewski@adelaide.edu.au	Zalewski, Peter/ABF-1742-2020; Homan, Claire C/P-9469-2018; Ackland, M Leigh/L-5086-2018; Jersmann, Hubertus/ABC-5287-2020; Murgia, Chiara/Y-6102-2018	Ackland, M Leigh/0000-0002-7474-6556; Jersmann, Hubertus/0000-0003-1763-2736; Homan, Claire/0000-0003-2847-8586; Mukaro, Violet/0000-0002-3968-6551; Hamon, Rhys/0000-0002-5474-8490; Roscioli, Eugene/0000-0002-3201-3899	National Health and Medical Research Council (NHMRC) [627223]; National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Grant # 627223 to PDZ, and National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bao SY, 2006, AM J PHYSIOL-LUNG C, V290, pL433, DOI 10.1152/ajplung.00341.2005; Cordts F, 2011, LIFE SCI, V89, P806, DOI 10.1016/j.lfs.2011.08.018; de los Monteros MTLE, 2000, REV CLIN ESP, V200, P649; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dufner-Beattie J, 2006, GENESIS, V44, P239, DOI 10.1002/dvg.20211; Grasseschi RM, 2003, CHEST, V124, P1924, DOI 10.1378/chest.124.5.1924; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2010, AM J RESP CELL MOL, V42, P235, DOI 10.1165/rcmb.2008-0486OC; Jayaram L, 2011, RESPIROLOGY, V16, P459, DOI 10.1111/j.1440-1843.2011.01932.x; Joshi PC, 2008, AM J RESP CELL MOL, V39, P218, DOI 10.1165/rcmb.2007-0344OC; Joshi PC, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-36; Joshi PC, 2009, AM J RESP CELL MOL, V41, P207, DOI 10.1165/rcmb.2008-0209OC; Kirkil G, 2008, RESP MED, V102, P840, DOI 10.1016/j.rmed.2008.01.010; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Lang CJ, 2011, BIOMETALS, V24, P23, DOI 10.1007/s10534-010-9370-9; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lin YS, 2013, J TOXICOL ENV HEAL A, V76, P1, DOI 10.1080/15287394.2012.722185; Lin YS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-53; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Lundahl J, 1996, EUR RESPIR J, V9, P1188, DOI 10.1183/09031936.96.09061188; Mehta AJ, 2013, AM J RESP CRIT CARE, V188, P716, DOI 10.1164/rccm.201301-0061OC; Mehta AJ, 2011, ALCOHOL CLIN EXP RES, V35, P1519, DOI 10.1111/j.1530-0277.2011.01488.x; Michalczyk AA, 2013, GENES NUTR, V8, P475, DOI 10.1007/s12263-013-0332-z; MIURA Y, 1957, CR SOC BIOL, V151, P1460; Murgia C, 2006, CURR DRUG TARGETS, V7, P607, DOI 10.2174/138945006776818683; Murgia C, 2011, NUTRIENTS, V3, P910, DOI 10.3390/nu3110910; Napolitano JR, 2012, AM J PHYSIOL-LUNG C, V302, pL909, DOI 10.1152/ajplung.00351.2011; Prasad AS, 2007, J NUTR, V137, P1345, DOI 10.1093/jn/137.5.1345; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; SCRUTTON MC, 1971, P NATL ACAD SCI USA, V68, P2497, DOI 10.1073/pnas.68.10.2497; Soriano C, 2012, LUNG CANCER, V77, P38, DOI 10.1016/j.lungcan.2012.01.017; Tanrikulu AC, 2011, BIOL TRACE ELEM RES, V143, P659, DOI 10.1007/s12011-010-8897-5; Thambiayya K, 2012, AM J PHYSIOL-LUNG C, V302, pL1287, DOI 10.1152/ajplung.00385.2011; Tone K, 1991, Kitasato Arch Exp Med, V64, P263; Tran Hai B, 2012, J Allergy (Cairo), V2012, P819176, DOI 10.1155/2012/819176; Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026; Truong-Tran AQ, 2002, AM J RESP CELL MOL, V27, P286, DOI 10.1165/rcmb.2001-0014OC; Vachon E, 2007, BLOOD, V110, P4492, DOI 10.1182/blood-2007-02-076539; WIRTH JJ, 1989, IMMUNOLOGY, V68, P114; Zalewski P, 2006, BIOTECHNIQUES, V40, P509, DOI 10.2144/06404RR02	46	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110056	10.1371/journal.pone.0110056	http://dx.doi.org/10.1371/journal.pone.0110056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350745	Green Published, gold			2022-12-27	WOS:000343943100019
J	Nguyen, PTM; Falsetta, ML; Hwang, G; Gonzalez-Begne, M; Koo, H				Phuong Thi Mai Nguyen; Falsetta, Megan L.; Hwang, Geelsu; Gonzalez-Begne, Mireya; Koo, Hyun			alpha-Mangostin Disrupts the Development of Streptococcus mutans Biofilms and Facilitates Its Mechanical Removal	PLOS ONE			English	Article							PROTEIN DOCKING; DENTAL-CARIES; ORAL STREPTOCOCCI; IN-VIVO; POLYSACCHARIDE PRODUCTION; EXOPOLYSACCHARIDE MATRIX; GRAPHICS PROCESSORS; ALKALI PRODUCTION; TT-FARNESOL; GLUCOSYLTRANSFERASES	alpha-Mangostin (alpha MG) has been reported to be an effective antimicrobial agent against planktonic cells of Streptococcus mutans, a biofilm-forming and acid-producing cariogenic organism. However, its anti-biofilm activity remains to be determined. We examined whether alpha MG, a xanthone purified from Garcinia mangostana L grown in Vietnam, disrupts the development, acidogenicity, and/or the mechanical stability of S. mutans biofilms. Treatment regimens simulating those experienced clinically (twice-daily, 60 s exposure each) were used to assess the bioactivity of alpha MG using a saliva-coated hydroxyapatite (sHA) biofilm model. Topical applications of early-formed biofilms with alpha MG (150 mu M) effectively reduced further biomass accumulation and disrupted the 3D architecture of S. mutans biofilms. Biofilms treated with alpha MG had lower amounts of extracellular insoluble and intracellular iodophilic polysaccharides (30-45%) than those treated with vehicle control (P<0.05), while the number of viable bacterial counts was unaffected. Furthermore, alpha MG treatments significantly compromised the mechanical stability of the biofilm, facilitating its removal from the sHA surface when subjected to a constant shear stress of 0.809 N/m(2) (. 3-fold biofilm detachment from sHA vs. vehicle-treated biofilms; P<0.05). Moreover, acid production by S. mutans biofilms was disrupted following alpha MG treatments (vs. vehicle-control, P<0.05). The activity of enzymes associated with glucan synthesis, acid production, and acid tolerance (glucosyltransferases B and C, phosphotransferase-PTS system, and F1F0-ATPase) were significantly inhibited by alpha MG. The expression of manL, encoding a key component of the mannose PTS, and gtfB were slightly repressed by alpha MG treatment (P<0.05), while the expression of atpD (encoding F-ATPase) and gtfC genes was unaffected. Hence, this study reveals that brief exposures to alpha MG can disrupt the development and structural integrity of S. mutans biofilms, at least in part via inhibition of key enzymatic systems associated with exopolysaccharide synthesis and acidogenicity. alpha MG could be an effective anti-virulence additive for the control and/or removal of cariogenic biofilms.	[Phuong Thi Mai Nguyen] Vietnam Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam; [Falsetta, Megan L.; Gonzalez-Begne, Mireya; Koo, Hyun] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Hwang, Geelsu; Koo, Hyun] Univ Penn, Sch Dent Med, Dept Orthodont, Levy Ctr Oral Hlth,Biofilm Res Labs, Philadelphia, PA 19104 USA	Vietnam Academy of Science & Technology (VAST); University of Rochester; University of Pennsylvania	Nguyen, PTM (corresponding author), Vietnam Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam.	phuong_nguyen_99@yahoo.com; koohy@dental.upenn.edu	Falsetta, Megan L./AAE-1586-2020; Hwang, Geelsu/F-9484-2011	Hwang, Geelsu/0000-0001-7277-5639	National Foundation for Science and Technology Development (Nafosted) [106.05-2011.44]; Vietnam Education Foundation (VEF); National Institutes of Health (NIH) [DE018023]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018023] Funding Source: NIH RePORTER	National Foundation for Science and Technology Development (Nafosted)(National Foundation for Science & Technology Development (NAFOSTED)); Vietnam Education Foundation (VEF); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Foundation for Science and Technology Development (Nafosted) grant (106.05-2011.44) to PTMN (http://www.nafosted.gov.vn); Vietnam Education Foundation (VEF) research scholar grant (VEF 2012) to PTMN (https://home.vef.gov); and National Institutes of Health (NIH) grant (DE018023) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Burne R A, 2009, Adv Dent Res, V21, P17, DOI 10.1177/0895937409335593; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cense AW, 2006, J MICROBIOL METH, V67, P463, DOI 10.1016/j.mimet.2006.04.023; Colby SM, 1997, J APPL MICROBIOL, V83, pS80, DOI 10.1046/j.1365-2672.83.s1.9.x; Cross SE, 2007, MICROBIOL-SGM, V153, P3124, DOI 10.1099/mic.0.2007/007625-0; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; Dye Bruce A, 2007, Vital Health Stat 11, P1; Ee GCL, 2006, NAT PROD RES, V20, P1067, DOI 10.1080/14786410500463114; Ee GCL, 2008, J ASIAN NAT PROD RES, V10, P481, DOI 10.1080/10286020801948490; Falsetta ML, 2012, ANTIMICROB AGENTS CH, V56, P6201, DOI 10.1128/AAC.01381-12; Flemmig TF, 2011, PERIODONTOL 2000, V55, P9, DOI 10.1111/j.1600-0757.2010.00383.x; Gundampati R. K., 2013, American Journal of Biochemistry and Biotechnology, V9, P318; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057182; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hamilton I R, 1990, J Dent Res, V69 Spec No, P660; Hamilton IR, 1976, SPECIAL SUPPLEMENT M, V3, P683; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hope CK, 2004, ANTIMICROB AGENTS CH, V48, P1461, DOI 10.1128/AAC.48.5.1461-1468.2004; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Jones WL, 2011, BIOFOULING, V27, P207, DOI 10.1080/08927014.2011.554977; Jung HA, 2006, J AGR FOOD CHEM, V54, P2077, DOI 10.1021/jf052649z; Kaomongkolgit Ruchadaporn, 2009, J Oral Sci, V51, P401; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478; Koo H, 2006, CARIES RES, V40, P20, DOI 10.1159/000088901; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Koo H, 2000, CARIES RES, V34, P418, DOI 10.1159/000016617; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Kosem N, 2013, J NAT MED-TOKYO, V67, P255, DOI 10.1007/s11418-012-0673-8; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2013, MICROBIOL-SGM, V159, P436, DOI 10.1099/mic.0.066134-0; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1967, ARCH ORAL BIOL, V12, P189, DOI 10.1016/0003-9969(67)90037-4; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Marsh PD, 2012, BRIT DENT J, V212, P601, DOI 10.1038/sj.bdj.2012.524; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MOOSER G, 1991, J BIOL CHEM, V266, P8916; Nguyen PTM, 2011, CAN J MICROBIOL, V57, P217, DOI 10.1139/W10-122; Nyvad B, 2013, CARIES RES, V47, P89, DOI 10.1159/000345367; Obolskiy D, 2009, PHYTOTHER RES, V23, P1047, DOI 10.1002/ptr.2730; Phan TN, 2004, ORAL MICROBIOL IMMUN, V19, P31, DOI 10.1046/j.0902-0055.2003.00109.x; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; Simoes M, 2004, INT C BIOF 2014 STRU, P171; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Tanzer JM, 1976, SPEDIAL S MICROBIOLO, V3, P596; Venkatraman V, 2012, PROTEINS, V80, P2262, DOI 10.1002/prot.24115; Venkitaraman AR, 1995, J DENT RES, V74, P1695, DOI 10.1177/00220345950740101101; Vinogradov A., 2004, BIOFILMS, V1, P49, DOI DOI 10.1017/S1479050503001078; Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502; Waters MS, 2014, ACS APPL MATER INTER, V6, P327, DOI 10.1021/am404344h; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x	69	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111312	10.1371/journal.pone.0111312	http://dx.doi.org/10.1371/journal.pone.0111312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350668	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100063
J	Garruna-Hernandez, R; Orellana, R; Larque-Saavedra, A; Canto, A				Garruna-Hernandez, Rene; Orellana, Roger; Larque-Saavedra, Alfonso; Canto, Azucena			Understanding the Physiological Responses of a Tropical Crop (Capsicum chinense Jacq.) at High Temperature	PLOS ONE			English	Article							HEAT-STRESS; FRUIT ABORTION; PHOTOSYNTHESIS; ACCLIMATION; RUBISCO; CLIMATE; GROWTH; PEPPER; L.	Temperature is one of the main environmental factors involved in global warming and has been found to have a direct effect on plants. However, few studies have investigated the effect of higher temperature on tropical crops. We therefore performed an experiment with a tropical crop of Habanero pepper (Capsicum Chinense Jacq.). Three growth chambers were used, each with 30 Habanero pepper plants. Chambers were maintained at a diurnal maximum air temperature (DMT) of 30 (chamber 1), 35 (chamber 2) and 40 degrees C (chamber 3). Each contained plants from seedling to fruiting stage. Physiological response to variation in DMT was evaluated for each stage over the course of five months. The results showed that both leaf area and dry mass of Habanero pepper plants did not exhibit significant differences in juvenile and flowering phenophases. However, in the fruiting stage, the leaf area and dry mass of plants grown at 40 degrees C DMT were 51 and 58% lower than plants at 30 degrees C DMT respectively. Meanwhile, an increase in diurnal air temperature raised both stomatal conductance and transpiration rate, causing an increase in temperature deficit (air temperature - leaf temperature). Thus, leaf temperature decreased by 5 degrees C, allowing a higher CO2 assimilation rate in plants at diurnal maximum air temperature (40 degrees C). However, in CO2 measurements when leaf temperature was set at 40 degrees C, physiological parameters decreased due to an increase in stomatal limitation. We conclude that the thermal optimum range in a tropical crop such as Habanero pepper is between 30 and 35 degrees C (leaf temperature, not air temperature). In this range, gas exchange through stomata is probably optimal. Also, the air temperature-leaf temperature relationship helps to explain how temperature keeps the major physiological processes of Habanero pepper healthy under experimental conditions.	[Garruna-Hernandez, Rene; Orellana, Roger; Larque-Saavedra, Alfonso; Canto, Azucena] Ctr Invest Cient Yucatan, Unidad Recursos Nat, Merida, Mexico; [Garruna-Hernandez, Rene] Inst Tecnol Conkal, Div Estudios Posgrad & Invest, Conkal, Yucatan, Mexico	Centro de Investigacion Cientifica de Yucatan	Garruna-Hernandez, R (corresponding author), Ctr Invest Cient Yucatan, Unidad Recursos Nat, Merida, Mexico.	renegh10@hotmail.com	Canto, Azucena/ABD-3097-2020	Canto, Azucena/0000-0002-0712-2241; LARQUE SAAVEDRA, ALFONSO/0000-0001-9462-5682	Mexican Council of Science and Technology (CONACYT)	Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Mexican Council of Science and Technology (CONACYT) supports the doctoral studies of Rene Garruna-Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Lopez JL, 2006, BIOTECHNOL LETT, V28, P1101, DOI 10.1007/s10529-006-9060-4; Atkin OK, 2006, GLOBAL CHANGE BIOL, V12, P500, DOI 10.1111/j.1365-2486.2006.01114.x; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Cazares-Sanchez E, 2005, AGROCIENCIA-MEXICO, V39, P627; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Farrar JF, 1996, J EXP BOT, V47, P1273, DOI 10.1093/jxb/47.Special_Issue.1273; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Garruna-Hernandez R, 2013, J SCI FOOD AGR, V93, P1385, DOI 10.1002/jsfa.5904; Garruna-Hernandez R, 2012, J FOOD AGRIC ENVIRON, V10, P802; Haldimann P, 2005, PLANT CELL ENVIRON, V28, P302, DOI 10.1111/j.1365-3040.2005.01289.x; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Jaimez R. E., 2011, Journal of Agricultural Science (Toronto), V3, P134, DOI 10.5539/jas.v3n3p134; Larcher W., 2003, PHYSL PLANT ECOLOGY, DOI DOI 10.1007/978-3-662-05214-3; Lawlor D. W., 1993, P85; Lobell DB, 2003, SCIENCE, V299, P1032, DOI 10.1126/science.1077838; Marcelis LFM, 2004, J EXP BOT, V55, P2261, DOI 10.1093/jxb/erh245; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; Nobel P., 1999, PHYSICOCHEMICAL ENV, V2nd; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Sato S, 2006, ANN BOT-LONDON, V97, P731, DOI 10.1093/aob/mcl037; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Sharkey TD, 2006, PHYSIOLOGY AND MOLECULAR BIOLOGY OF STRESS TOLERANCE IN PLANTS, P101, DOI 10.1007/1-4020-4225-6_4; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038	28	26	28	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111402	10.1371/journal.pone.0111402	http://dx.doi.org/10.1371/journal.pone.0111402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365043	Green Published, gold			2022-12-27	WOS:000345558100064
J	Huang, JN; Tsai, MC; Fang, SL; Chang, MDT; Wu, YR; Tsai, JJ; Fu, LS; Lin, HK; Chen, YJ; Li, TW				Huang, Jing-Ning; Tsai, Ming-Chin; Fang, Shun-Lung; Chang, Margaret Dah-Tsyr; Wu, Yu-Rou; Tsai, Jaw-Ji; Fu, Lin-Shien; Lin, Heng-Kuei; Chen, Yi-Jun; Li, Tsai-Wei			Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions	PLOS ONE			English	Article							ALLERGIC AIRWAY RESPONSES; EXERCISE-INDUCED ASTHMA; NF-KAPPA-B; INHALED HEPARIN; MOUSE MODEL; TRANSCRIPTION FACTORS; P-SELECTIN; INFLAMMATION; BINDING; CELLS	Background: We evaluated the effects of T helper cell differentiation in a mite-allergic animal model treated with inhaled heparins of different molecular weight. Method: BALB/c mice were divided into four groups: 1. Control, 2. Mite intratracheal (mIT), 3. Inhaled heparin (hIN), 4. Inhaled low-molecular-weight heparin (lmwhIN). Groups 2, 3, and 4 were sensitized twice with Der p allergen subcutaneously on day 1 and day 8. Der p allergen was administered intratracheally on day 15. Groups 3 and 4 were treated with heparin or low-molecular-weight (lmw) heparin intranasally from day 1 to 22. Splenocytes from sacrificed mice stimulated with 16 mu g/ml of Der p were cultured for 72 hours. Supernatants of splenocyte were collected to analyze the effect of Interleukin (IL) 17-A/F, Interferon(IFN)-gamma, IL-4, IL-13, and IL-10. Serum was also collected for Der P-specific IgE level on day 23. Total RNA was extracted from spleen tissue for mRNA expression. Gene expression of Foxp3, IL-10 IFN-gamma, GATA3, IL5, and ROR gamma t were analyzed. Results: Both hIN and lmwhIN groups had lower serum IgE level than that of the mIT group (both p, 0.0001). Both hIN and lmwhIN groups showed significantly decreased transcripts of GATA-3, IFN-gamma, IL-5, and ROR gamma t mRNA in their spleen. Regarding the supernatant of splenocyte culture stimulated with Der p, compared with the mIT group, there were significant decreases in IL-17A/F, IFN-c, IL-4, IL-13, and IL-10 secretion in inhaled hIN and lmwhIN groups. Conclusions: From this balb/c mice study, the analyses of mRNA and cytokines revealed that both intranasal heparin and lmw heparin treatment decreased the expression of Th1, Th2, and Th17 in spleen. The underlying mechanism(s) warrant further studies.	[Huang, Jing-Ning; Tsai, Ming-Chin; Fu, Lin-Shien; Lin, Heng-Kuei; Chen, Yi-Jun; Li, Tsai-Wei] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Tsai, Jaw-Ji] Taichung Vet Gen Hosp, Taichung, Taiwan; [Fu, Lin-Shien] Natl Yang Ming Med Univ, Dept Pediat, Taipei, Taiwan; [Fang, Shun-Lung; Chang, Margaret Dah-Tsyr; Wu, Yu-Rou] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Fang, Shun-Lung; Chang, Margaret Dah-Tsyr; Wu, Yu-Rou] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Tsing Hua University; National Tsing Hua University	Fu, LS (corresponding author), Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan.	linshienfu@yahoo.com.tw			Veterans General Hospitals, University System of Taiwan, Joint Research Program [101DFA0400013, 101DFA0400014, VGHUST100-G6-2-2, VGHUST101-G6-2-2]; National Science Council [100-2622-B-007-001-CC1, 99-3112-B-007002]	Veterans General Hospitals, University System of Taiwan, Joint Research Program; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Veterans General Hospitals, University System of Taiwan, Joint Research Program (grant numbers 101DFA0400013, 101DFA0400014, VGHUST100-G6-2-2, and VGHUST101-G6-2-2), as well as National Science Council (grant numbers 100-2622-B-007-001-CC1 and 99-3112-B-007002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, AM J RESP CRIT CARE, V160, P576, DOI 10.1164/ajrccm.160.2.9812076; AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Akimoto H, 1996, CIRCULATION, V93, P810, DOI 10.1161/01.CIR.93.4.810; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; ASA D, 1992, GLYCOBIOLOGY, V2, P395, DOI 10.1093/glycob/2.5.395; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; CEYHAN B, 1995, CHEST, V107, P1009, DOI 10.1378/chest.107.4.1009; CIFONELLI JA, 1974, CARBOHYD RES, V37, P145, DOI 10.1016/S0008-6215(00)87070-6; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Dudas J, 2000, BIOCHEM J, V350, P245, DOI 10.1042/0264-6021:3500245; Fang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057318; Fu LS, 2013, INT J IMMUNOPATH PH, V26, P349, DOI 10.1177/039463201302600208; Garrigo J, 1996, AM J RESP CRIT CARE, V153, P1702, DOI 10.1164/ajrccm.153.5.8630624; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Harris N, 2014, BBA-GEN SUBJECTS, V1840, P245, DOI 10.1016/j.bbagen.2013.09.023; Hasan M, 1999, J IMMUNOL, V162, P1064; Hecht I, 2004, J LEUKOCYTE BIOL, V75, P1139, DOI 10.1189/jlb.1203659; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Jones Sarah A, 2012, Nat Immunol, V13, P1022, DOI 10.1038/ni.2450; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim SJ, 2009, J ASTHMA, V46, P884, DOI 10.3109/02770900903089998; Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375; Krstic A, 2012, J BIOL REG HOMEOS AG, V26, P641; LAURENT TC, 1978, BIOCHEM J, V175, P691, DOI 10.1042/bj1750691; LETOURNEUR D, 1995, J CELL PHYSIOL, V165, P687, DOI 10.1002/jcp.1041650328; Lin LH, 2012, IMMUNOL RES, V52, P276, DOI 10.1007/s12026-012-8339-x; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Martinez-Salas J, 1998, J APPL PHYSIOL, V84, P222, DOI 10.1152/jappl.1998.84.1.222; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; NELSON RM, 1993, BLOOD, V82, P3253; Peysselon F, 2013, MATRIX BIOL; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Shi Y, 2012, INFLAMM RES, V61, P1369, DOI 10.1007/s00011-012-0538-3; Vancheri C, 2001, J ALLERGY CLIN IMMUN, V108, P703, DOI 10.1067/mai.2001.118785; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; WEILER JM, 1992, J IMMUNOL, V148, P3210; Wills-Karp M, 2003, CURR OPIN PULM MED, V9, P21, DOI 10.1097/00063198-200301000-00004; Yagmurdur MC, 2003, TRANSPL P, V35, P2566, DOI 10.1016/j.transproceed.2003.08.076; Yang M, 2010, CLIN EXP ALLERGY, V40, P668, DOI 10.1111/j.1365-2222.2009.03442.x; Young E, 1999, THROMB RES, V96, P373, DOI 10.1016/S0049-3848(99)00125-5; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026; Zhang B, 2012, INT J MOL MED, V30, P248, DOI 10.3892/ijmm.2012.1010	45	72	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e109996	10.1371/journal.pone.0109996	http://dx.doi.org/10.1371/journal.pone.0109996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364825	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100014
J	Prevost-Boure, NC; Dequiedt, S; Thioulouse, J; Lelievre, M; Saby, NPA; Jolivet, C; Arrouays, D; Plassart, P; Lemanceau, P; Ranjard, L				Prevost-Boure, Nicolas Chemidlin; Dequiedt, Samuel; Thioulouse, Jean; Lelievre, Melanie; Saby, Nicolas P. A.; Jolivet, Claudy; Arrouays, Dominique; Plassart, Pierre; Lemanceau, Philippe; Ranjard, Lionel			Similar Processes but Different Environmental Filters for Soil Bacterial and Fungal Community Composition Turnover on a Broad Spatial Scale	PLOS ONE			English	Article							TAXA-AREA; BETA-DIVERSITY; DISTANCE-DECAY; LAND-USE; PATTERNS; BIOGEOGRAPHY; MICROBES; EVOLUTIONARY; FRAMEWORK; GRADIENT	Spatial scaling of microorganisms has been demonstrated over the last decade. However, the processes and environmental filters shaping soil microbial community structure on a broad spatial scale still need to be refined and ranked. Here, we compared bacterial and fungal community composition turnovers through a biogeographical approach on the same soil sampling design at a broad spatial scale (area range: 13300 to 31000 km(2)): i) to examine their spatial structuring; ii) to investigate the relative importance of environmental selection and spatial autocorrelation in determining their community composition turnover; and iii) to identify and rank the relevant environmental filters and scales involved in their spatial variations. Molecular fingerprinting of soil bacterial and fungal communities was performed on 413 soils from four French regions of contrasting environmental heterogeneity (Landes<Burgundy <= Brittany<<South-East) using the systematic grid of French Soil Quality Monitoring Network to evaluate the communities' composition turnovers. The relative importance of processes and filters was assessed by distance-based redundancy analysis. This study demonstrates significant community composition turnover rates for soil bacteria and fungi, which were dependent on the region. Bacterial and fungal community composition turnovers were mainly driven by environmental selection explaining from 10% to 20% of community composition variations, but spatial variables also explained 3% to 9% of total variance. These variables highlighted significant spatial autocorrelation of both communities unexplained by the environmental variables measured and could partly be explained by dispersal limitations. Although the identified filters and their hierarchy were dependent on the region and organism, selection was systematically based on a common group of environmental variables: pH, trophic resources, texture and land use. Spatial autocorrelation was also important at coarse (80 to 120 km radius) and/or medium (40 to 65 km radius) spatial scales, suggesting dispersal limitations at these scales.	[Prevost-Boure, Nicolas Chemidlin; Lemanceau, Philippe; Ranjard, Lionel] Univ Bourgogne, INRA, AgroSup Dijon, Unite Mixte Rech Agroecol 1347, Dijon, France; [Dequiedt, Samuel; Lelievre, Melanie; Plassart, Pierre; Ranjard, Lionel] Univ Bourgogne, INRA, AgroSup Dijon, Unite Mixte Rech Agroecol Plateforme GenoSol 2347, Dijon, France; [Thioulouse, Jean] Univ Lyon 1, CNRS, Unite Mixte Rech Lab Biometrie & Biol Evolut 555, F-69622 Villeurbanne, France; [Saby, Nicolas P. A.; Jolivet, Claudy; Arrouays, Dominique] INRA, Unite Serv InfoSol 1106, Orleans, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Prevost-Boure, NC (corresponding author), Univ Bourgogne, INRA, AgroSup Dijon, Unite Mixte Rech Agroecol 1347, Dijon, France.	n.chemidlin@agrosupdijon.fr	Prévost-Bouré, Nicolas Chemidlin/U-7714-2017	Prévost-Bouré, Nicolas Chemidlin/0000-0002-8575-4295; Jolivet, Claudy/0000-0001-5871-6413; Saby, Nicolas/0000-0001-8964-1194; Thioulouse, Jean/0000-0001-7664-0598	ADEME (Energy and Environment Management Agency); French National Research Agency (ANR); French state via the National Agency for Research under the program "Investments for the Future" [ANR-11-INBS-0001]; Regional Council of Burgundy	ADEME (Energy and Environment Management Agency); French National Research Agency (ANR)(French National Research Agency (ANR)); French state via the National Agency for Research under the program "Investments for the Future"(French National Research Agency (ANR)); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This study was granted by ADEME (Energy and Environment Management Agency) and by the French National Research Agency (ANR). RMQS soil sampling and physico-chemical analyses were supported by a French Scientific Group of Interest on soils: the "GIS Sol", involving the French Ministry for Ecology and Sustainable Development (MEDAD), the French Ministry of Agriculture (MAP), the French Institute for Environment (IFEN), the French Agency for Energy and Environment (ADEME), the French Institute for Research and Development (IRD) and the National Institute for Agronomic Research (INRA). This work, through the involvement of technical facilities of the GenoSol platform of the infrastructure ANAEE378 Services, received a grant from the French state via the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001), as well as a grant from the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrouays Dominique, 2002, Comptes Rendus de l'Academie d'Agriculture de France, V88, P93; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Brodie E, 2003, FEMS MICROBIOL ECOL, V45, P105, DOI 10.1016/S0168-6496(03)00126-0; Brodie E, 2002, MICROB ECOL, V44, P260, DOI 10.1007/s00248-002-2012-1; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Dequiedt S, 2011, GLOBAL ECOL BIOGEOGR, V20, P641, DOI 10.1111/j.1466-8238.2010.00628.x; Dequiedt S, 2009, ENV MICROBIOL REP, V1, P251, DOI 10.1111/j.1758-2229.2009.00040.x; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Drenovsky RE, 2010, GLOBAL ECOL BIOGEOGR, V19, P27, DOI 10.1111/j.1466-8238.2009.00486.x; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Fenchel T, 2003, SCIENCE, V301, P925, DOI 10.1126/science.1089242; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Gilbert J, 2010, EARTH MICROBIOME PRO; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hossain Z, 2011, EUR J SOIL BIOL, V47, P88, DOI 10.1016/j.ejsobi.2010.11.007; Hovatter SR, 2011, ECOLOGY, V92, P57, DOI 10.1890/10-0332.1; Jobe RT, 2008, ECOLOGY, V89, P174, DOI 10.1890/06-1722.1; Kong AYY, 2011, SOIL BIOL BIOCHEM, V43, P20, DOI 10.1016/j.soilbio.2010.09.005; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lienhard P, 2013, AGRON SUSTAIN DEV, V33, P375, DOI 10.1007/s13593-012-0099-4; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MAC ARTHUR ROBERT H., 1967; Maron PA, 2011, CR BIOL, V334, P403, DOI 10.1016/j.crvi.2010.12.003; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Monroy F, 2012, SOIL BIOL BIOCHEM, V45, P1, DOI 10.1016/j.soilbio.2011.10.006; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; Noguez AM, 2005, GLOBAL ECOL BIOGEOGR, V14, P241, DOI 10.1111/j.1466-822x.2005.00156.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Pasternak Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070576, 10.1371/journal.pone.0069705]; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; R Core Team, 2016, R FDN STAT COMP; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Ranjard L, 2000, RES MICROBIOL, V151, P167, DOI 10.1016/S0923-2508(00)00136-4; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Ranjard L, 2001, RES MICROBIOL, V152, P707, DOI 10.1016/S0923-2508(01)01251-7; Ranjard L, 2009, ENV MICROBIOL REP, V1, P97, DOI 10.1111/j.1758-2229.2009.00023.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Taylor DL, 2010, CAN J FOREST RES, V40, P1288, DOI 10.1139/X10-081; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Woodcock S, 2006, ECOL LETT, V9, P805, DOI 10.1111/j.1461-0248.2006.00929.x; Yergeau E, 2010, ENVIRON MICROBIOL, V12, P2096, DOI 10.1111/j.1462-2920.2009.02053.x; Zinger L, 2014, MOL ECOL, V23, P954, DOI 10.1111/mec.12640; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019950	70	34	34	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111667	10.1371/journal.pone.0111667	http://dx.doi.org/10.1371/journal.pone.0111667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365044	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100100
J	Chen, HL; Hu, CP; Yi, KX; Huang, GX; Gao, JM; Zhang, SQ; Zheng, JL; Liu, QL; Xi, JG				Chen, Helong; Hu, Caiping; Yi, Kexian; Huang, Guixiu; Gao, Jianming; Zhang, Shiqing; Zheng, Jinlong; Liu, Qiaolian; Xi, Jingen			Cloning of Insertion Site Flanking Sequence and Construction of Transfer DNA Insert Mutant Library in Stylosanthes Colletotrichum	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENETIC-TRANSFORMATION; PATHOGENIC DIVERSITY; GLOEOSPORIOIDES; TUMEFACIENS; MUTAGENESIS; ANTHRACNOSE; GUIANENSIS; VIRULENCE; SPP.	Stylosanthes sp. is the most important forage legume in tropical areas worldwide. Stylosanthes anthracnose, which is mainly caused by Colletotrichum gloeosporioides, is a globally severe disease in stylo production. Little progress has been made in anthracnose molecular pathogenesis research. In this study, Agrobacterium tumefaciens-mediated transformation was used to transform Stylosanthes colletotrichum strain CH008. The major factors of the genetic transformation system of S. colletotrichum were optimized as follows: A. tumefaciens' AGL-1 concentration (OD600), 0.8; concentration of Colletotrichum conidium, 1x10(6) conidia/mL; acetosyringone concentration, 100 mmol/L; induction time, 6 h; co-culture temperature, 25 degrees C; and co-culture time, 3 d. Thus, the transformation efficiency was increased to 300-400 transformants per 106 conidia. Based on the optimized system, a mutant library containing 4616 mutants was constructed, from which some mutants were randomly selected for analysis. Results show that the mutants were single copies that could be stably inherited. The growth rate, spore amount, spore germination rate, and appressorium formation rate in some mutants were significantly different from those in the wild-type strain. We then selected the most appropriate method for the preliminary screening and rescreening of each mutant's pathogenic defects. We selected 1230 transformants, and obtained 23 strains with pathogenic defects, namely, 18 strains with reduced pathogenicity and five strains with lost pathogenicity. Thermal asymmetric interlaced PCR was used to identify the transfer DNA (T-DNA) integration site in the mutant that was coded 2430, and a sequence of 476 bp was obtained. The flanking sequence of T-DNA was compared with the Colletotrichum genome by BLAST, and a sequence of 401 bp was found in Contig464 of the Colletotrichum genome. By predicting the function of the flanking sequence, we discovered that T-DNA insertion in the promoter region of the putative gene had 79% homology with the aspartate aminotransferase gene in Magnaporthe oryzae (XP_003719674.1).	[Chen, Helong; Hu, Caiping; Yi, Kexian; Gao, Jianming; Zhang, Shiqing; Liu, Qiaolian] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Peoples R China; [Yi, Kexian; Huang, Guixiu; Zheng, Jinlong; Xi, Jingen] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Key Lab Integrated Pest Management Trop Crops, Minist Agr, Haikou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Yi, KX (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Peoples R China.	yikexian@126.com			National Natural Science Foundation of China (NSFC) [31072076]; Special Fund for Agro-scientific Research in the Public Interest [201303057]; Major Technology Project of Hainan [ZDZX2013023-1]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Major Technology Project of Hainan	We thank the National Natural Science Foundation of China (NSFC, No. 31072076), Special Fund for Agro-scientific Research in the Public Interest (201303057) and The Major Technology Project of Hainan (ZDZX2013023-1) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyong ASM, 2012, J BASIC MICROB, V52, P372, DOI 10.1002/jobm.201100250; Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; BRAITHWAITE K S, 1990, Australian Systematic Botany, V3, P733, DOI 10.1071/SB9900733; BRAITHWAITE KS, 1990, MYCOL RES, V94, P1129, DOI 10.1016/S0953-7562(09)81345-2; Cai ZY, 2013, MICROBIOL RES, V168, P340, DOI 10.1016/j.micres.2013.01.005; Campoy S, 2003, CURR GENET, V43, P447, DOI 10.1007/s00294-003-0417-0; Chakraborty S, 2002, PHYTOPATHOLOGY, V92, P553, DOI 10.1094/PHYTO.2002.92.5.553; Chakraborty S, 1999, PLANT DIS, V83, P333, DOI 10.1094/PDIS.1999.83.4.333; DALE JL, 1988, T BRIT MYCOL SOC, V91, P671, DOI 10.1016/S0007-1536(88)80043-3; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Deng Y., 2010, J ANHUI AGR SCI, V38, P2229; Flowers JL, 2005, CURR GENET, V48, P380, DOI 10.1007/s00294-005-0034-1; He ChunPing, 2007, Journal of Agricultural Biotechnology, V15, P877; HOLFORD P, 1992, PLANT CELL REP, V11, P196, DOI 10.1007/BF00232532; [胡新文 Hu Xinwen], 2005, [热带作物学报, Chinese Journal of Tropical Crops], V26, P38; [黄贵修 Huang Guixiu], 2008, [热带作物学报, Chinese Journal of Tropical Crops], V29, P27; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; IRWIN JAG, 1978, AUST J AGR RES, V29, P305, DOI 10.1071/AR9780305; Jia PS, 2012, MIAN HUA XUE BAO, V24, P62; Jiang CS, 2004, ACTA BOT SIN, V46, P480; Kelemu S, 1996, PLANT DIS, V80, P1355, DOI 10.1094/PD-80-1355; Kelemu S, 1997, TROP GRASSLANDS, V31, P387; LENNE JM, 1990, PHYTOPATHOLOGY, V80, P728, DOI 10.1094/Phyto-80-728; Lenne JM, 1984, BIOL AGRONOMY STYLOS, P279; Li Ai-Hong, 2006, Acta Genetica Sinica, V33, P319, DOI 10.1016/S0379-4172(06)60057-7; Li MX, 2005, FEMS MICROBIOL LETT, V243, P323, DOI 10.1016/j.femsle.2004.12.033; [林春花 Lin Chunhua], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P1495; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Liu CP, 2010, ANHUI NONG YE KE XUE, V38, P1141; [刘刚 LIU Gang], 2011, [生物技术, Biotechnology], V21, P44; Liu GD, 1997, TROP GRASSLANDS, V31, P460; Manners J. M., 1993, P233; Manners J. M., 1992, Colletotrichum: biology, pathology and control., P250; Manners JM, 2000, COLLETOTRICHUM, P180; Maruthachalam K, 2011, MOL BIOTECHNOL, V49, P209, DOI 10.1007/s12033-011-9392-8; Maruthachatam K, 2008, J MICROBIOL BIOTECHN, V18, P234; Meyer V, 2003, CURR GENET, V43, P371, DOI 10.1007/s00294-003-0406-3; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; MIRANDA A, 1992, J BACTERIOL, V174, P2288, DOI 10.1128/JB.174.7.2288-2297.1992; MISHRA NC, 1973, P NATL ACAD SCI USA, V70, P3875, DOI 10.1073/pnas.70.12.3875; Mullins ED, 2001, CELL MOL LIFE SCI, V58, P2043, DOI 10.1007/PL00000835; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Munaut F, 1998, PLANT PATHOL, V47, P641, DOI 10.1046/j.1365-3059.1998.00287.x; Munaut F, 2002, MYCOL RES, V106, P579, DOI 10.1017/S0953756202005932; Nyilasi I, 2005, FOLIA MICROBIOL, V50, P415, DOI 10.1007/BF02931423; Rao Zhiming, 2007, Chinese Journal of Applied and Environmental Biology, V13, P868; Rogers LM, 2000, P NATL ACAD SCI USA, V97, P9813, DOI 10.1073/pnas.160271497; Segenet K, 2005, AFR J BIOTECHNOL, V4, P1025; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; [Sun Bingyao 孙丙耀], 2004, [生物工程学报, Chinese Journal of Biotechnology], V20, P821; Takahara Hiroyuki, 2004, Journal of General Plant Pathology, V70, P93, DOI 10.1007/s10327-003-0099-y; Tanaka Soichi, 2007, Journal of General Plant Pathology, V73, P242, DOI 10.1007/s10327-007-0021-0; Troy EB, 2013, INFECT IMMUN, V81, P2347, DOI 10.1128/IAI.00266-13; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; [王海艳 Wang Haiyan], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1799; Weeds PL, 2003, PHYTOPATHOLOGY, V93, P176, DOI 10.1094/PHYTO.2003.93.2.176; Williams R. J., 1984, The biology and agronomy of Stylosanthes., P73; Wu XY, 2010, RICE SCI, V17, P129, DOI 10.1016/S1672-6308(08)60115-8; Yi Kexian, 2003, Weishengwu Xuebao, V43, P379; Zeilinger S, 2004, CURR GENET, V45, P54, DOI 10.1007/s00294-003-0454-8	61	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111172	10.1371/journal.pone.0111172	http://dx.doi.org/10.1371/journal.pone.0111172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25361073	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700069
J	David, AL; Holloway, A; Thomasson, L; Syngelaki, A; Nicolaides, K; Patel, RR; Sommerlad, B; Wilson, A; Martin, W; Chitty, LS				David, Anna L.; Holloway, Andrew; Thomasson, Louise; Syngelaki, Argyro; Nicolaides, Kypros; Patel, Roshni R.; Sommerlad, Brian; Wilson, Amie; Martin, William; Chitty, Lyn S.			A Case-Control Study of Maternal Periconceptual and Pregnancy Recreational Drug Use and Fetal Malformation Using Hair Analysis	PLOS ONE			English	Article							PRENATAL COCAINE EXPOSURE; BIRTH-DEFECTS; GASTROSCHISIS; ABUSE; ABNORMALITIES; INFANTS; GROWTH; RISKS; MODEL	Objective: Maternal recreational drug use may be associated with the development of fetal malformations such as gastroschisis, brain and limb defects, the aetiology due to vascular disruption during organogenesis. Using forensic hair analysis we reported evidence of recreational drug use in 18% of women with a fetal gastroschisis. Here we investigate this association in a variety of fetal malformations using the same method. Methods: In a multi-centre study, women with normal pregnancies (controls) and those with fetal abnormalities (cases) gave informed consent for hair analysis for recreational drug metabolites using mass spectrometry. Hair samples cut at the root were tested in sections corresponding to 3 month time periods (pre and periconceptual period). Results: Women whose fetus had gastroschisis, compared to women with a normal control fetus, were younger (mean age 23.78 +/- SD4.79 years, 18-37 vs 29.79 +/- SD6 years, 18-42, p = 0.00001), were more likely to have evidence of recreational drug use (15, 25.4% vs 21, 13%, OR2.27, 95th CI 1.08-4.78, p = 0.028), and were less likely to report periconceptual folic acid use (31, 53.4% vs 124, 77.5%, OR0.33, 95th CI 0.18-0.63, p = 0.001). Age-matched normal control women were no less likely to test positive for recreational drugs than women whose fetus had gastroschisis. After accounting for all significant factors, only young maternal age remained significantly associated with gastroschisis. Women with a fetus affected by a non-neural tube central nervous system (CNS) anomaly were more likely to test positive for recreational drugs when compared to women whose fetus was normal (7, 35% vs 21, 13%, OR3.59, 95th CI1.20-10.02, p = 0.01). Conclusions: We demonstrate a significant association between non neural tube CNS anomalies and recreational drug use in the periconceptual period, first or second trimesters, but we cannot confirm this association with gastroschisis. We confirm the association of gastroschisis with young maternal age.	[David, Anna L.; Holloway, Andrew; Thomasson, Louise; Nicolaides, Kypros] UCL, Inst Womens Hlth, London, England; [David, Anna L.; Holloway, Andrew; Thomasson, Louise; Chitty, Lyn S.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Syngelaki, Argyro; Nicolaides, Kypros] Kings Coll Hosp London, Harris Birthright Ctr, London, England; [Patel, Roshni R.] St Michaels Hosp, Fetal Med Unit, Bristol, Avon, England; [Sommerlad, Brian] Great Ormond St Hosp Sick Children, North Thames Cleft Lip & Palate Unit, London, England; [Wilson, Amie] Brigham & Womens Hosp, Birmingham, W Midlands, England; [Chitty, Lyn S.] UCL Inst Child Hlth, Clin & Mol Genet Unit, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Birmingham Women's Hospital; University of London; University College London	David, AL (corresponding author), UCL, Inst Womens Hlth, London, England.	a.david@ucl.ac.uk	Wilson, Amie/HHS-0117-2022; Sommerlad, Brian/AAG-3946-2020	Wilson, Amie/0000-0002-1015-3786; Patel, Roshni/0000-0002-1399-3131; Syngelaki, Argyro/0000-0001-5856-6072; Nicolaides, Kypros/0000-0003-1266-0711; David, Anna/0000-0002-0199-6140; chitty, lyn/0000-0002-4857-7138	BDF Newlife; UK Central and East London Comprehensive Local Research Network;  [06/29]; National Institute for Health Research [NF-SI-0513-10141] Funding Source: researchfish	BDF Newlife; UK Central and East London Comprehensive Local Research Network; ; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a grant "Recreational drugs as aetiological factors in fetal malformations" from BDF Newlife (http://www.newlifecharity.co.uk/). Funding was used to support the cost of hair analysis for recreational drugs, and a salary for a research assistant to co-ordinate the study. Grant reference: 06/29. Recruitment was supported by funding from the UK Central and East London Comprehensive Local Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bays J, 1994, PEDIATRICS, V87, P416; Beaty TH, 2001, ANN EPIDEMIOL, V11, P434, DOI 10.1016/S1047-2797(01)00222-8; Bower C, 2006, AUST NZ J PUBL HEAL, V30, P258, DOI 10.1111/j.1467-842X.2006.tb00867.x; Chief Medical Officer's Annual Report, 2004, CHIEF MED OFF ANN RE; Colado MI, 1997, BRIT J PHARMACOL, V121, P827, DOI 10.1038/sj.bjp.0701201; DOMINGUEZ R, 1991, AM J DIS CHILD, V145, P688, DOI 10.1001/archpedi.1991.02160060106030; Draper ES, 2008, AM J EPIDEMIOL, V167, P485, DOI 10.1093/aje/kwm335; Godwin KA, 2008, CANADIAN J PUB HLTH, V99, P71; GRANT T, 1994, OBSTET GYNECOL, V83, P524, DOI 10.1097/00006250-199404000-00007; He N, 2004, NEUROTOXICOLOGY, V25, P419, DOI 10.1016/j.neuro.2003.10.002; Huestis MA, 2002, FORENSIC SCI INT, V128, P20, DOI 10.1016/S0379-0738(02)00160-3; Hume RF, 1997, FETAL DIAGN THER, V12, P292; HUME RF, 1994, FETAL DIAGN THER, V9, P239; Kashiwagi M, 2003, BIRTH DEFECTS RES A, V67, P951, DOI 10.1002/bdra.10101; Klein J, 2000, FORENSIC SCI INT, V107, P281, DOI 10.1016/S0379-0738(99)00171-1; Kline J, 1997, AM J PUBLIC HEALTH, V87, P352, DOI 10.2105/AJPH.87.3.352; LIPSHULTZ SE, 1991, J PEDIATR-US, V118, P44, DOI 10.1016/S0022-3476(05)81842-6; Markov D, 2003, Clin Exp Obstet Gynecol, V30, P109; MIYAZAWA N, 1992, THER DRUG MONIT, V14, P525, DOI 10.1097/00007691-199212000-00015; Morrison JJ, 2005, BJOG-INT J OBSTET GY, V112, P1022, DOI 10.1111/j.1471-0528.2005.00655.x; NAKAHARA Y, 1992, J ANAL TOXICOL, V16, P253, DOI 10.1093/jat/16.4.253; NORA JJ, 1970, LANCET, V1, P1290; Orrico A, 2002, EUR J NEUROL, V9, P679, DOI 10.1046/j.1468-1331.2002.00473.x; Paranjothy S, 2012, INT J EPIDEMIOL, V41, P1141, DOI 10.1093/ije/dys092; Plessinger MA, 1998, OBSTET GYN CLIN N AM, V25, P119, DOI 10.1016/S0889-8545(05)70361-2; Spiehler V, 2000, FORENSIC SCI INT, V107, P249, DOI 10.1016/S0379-0738(99)00168-1; Tan KH, 1996, BRIT MED J, V313, P903; TORFS CP, 1994, TERATOLOGY, V50, P44, DOI 10.1002/tera.1420500107; Villain M, 2004, CLIN CHEM LAB MED, V42, P1265, DOI 10.1515/CCLM.2004.247; WEBSTER WS, 1990, TERATOLOGY, V41, P689, DOI 10.1002/tera.1420410605; Werler MM, 2003, EPIDEMIOLOGY, V14, P349, DOI 10.1097/00001648-200305000-00016; Yamamoto Y, 1992, Nihon Hoigaku Zasshi, V46, P126	32	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111038	10.1371/journal.pone.0111038	http://dx.doi.org/10.1371/journal.pone.0111038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360669	Green Published, gold			2022-12-27	WOS:000343943700058
J	Gurgel, RQ; Alvarez, AD; Rodrigues, A; Ribeiro, RR; Dolabella, SS; Da Mota, NL; Santos, VS; Iturriza-Gomara, M; Cunliffe, NA; Cuevas, LE				Gurgel, Ricardo Q.; Alvarez, Alberto De Juan; Rodrigues, Alda; Ribeiro, Robergson R.; Dolabella, Silvio S.; Da Mota, Natanael L.; Santos, Victor S.; Iturriza-Gomara, Miren; Cunliffe, Nigel A.; Cuevas, Luis E.			Incidence of Rotavirus and Circulating Genotypes in Northeast Brazil during 7 Years of National Rotavirus Vaccination	PLOS ONE			English	Article							TEMPORAL TRENDS; GASTROENTERITIS; CHILDREN; HOSPITALIZATIONS; PENTAVALENT; EFFICACY; VACCINES; STRAINS; SAFETY; AGE	Background and Aims: Rotavirus causes severe diarrhoea and Brazil introduced the Rotarix G1P[8] vaccine in 2006. We aimed to describe changes in rotavirus incidence and diarrhoea epidemiology before and after vaccine introduction. Methods: Design: (i) hospital-based survey of children with diarrhoea (2006-2012); (ii) diarrhea-mortality and hospitalization surveillance (1999-2012). Setting: (i) Aracaju and (ii) state and national level. Results: 1841 children were enrolled and 231 (12.5%) had rotavirus. Rotavirus was less frequent from January-June than from July-December (9.4% versus 20.9%, p<0.01), but the seasonal variation was less defined after 2009. Very few rotavirus cases (8-3.9%) were detected in 2011, with an increase in 2012 (13-18.5%). In 2006, unvaccinated children were more likely to have rotavirus, but thereafter unvaccinated and vaccinated children had equally low incidence. Older children and those with rotavirus were more likely to have severe diarrhea episodes. The most frequent genotype from 2006 to 2010 was G2P[4]; except in 2009, when most cases were G1P[8]. Very few G2P[4] were detected from 2011 and 50% cases in 2012 were G8P[4]. Diarrhoea-hospitalizations decreased nationally from 89,934 (2003) to 53,705 (2012; 40.3% reduction) and in the state from 1729 to 748 (56.7% reduction). Diarrhoea-deaths decreased nationally from 4368 in 1999 to 697 in 2012 (84% reduction, p<0.001) and in the state from 132 to 18 (86% reduction). These changes were much larger after vaccine introduction. Conclusions: The vaccine was associated with substantial reductions in rotavirus incidence and diarrhoea-hospitalizations and deaths. The G2P[4] genotype predominance disappeared over time and may be replaced by other heterotypic genotypes.	[Gurgel, Ricardo Q.; Rodrigues, Alda; Ribeiro, Robergson R.; Dolabella, Silvio S.; Da Mota, Natanael L.; Santos, Victor S.] Univ Fed Sergipe, Aracaju, Brazil; [Alvarez, Alberto De Juan; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Iturriza-Gomara, Miren; Cunliffe, Nigel A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Universidade Federal de Sergipe; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Cuevas, LE (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	lcuevas@liv.ac.uk	Cuevas, Luis E/I-3697-2015; Dolabella, Silvio/X-4351-2019; Santos, Victor Santana/B-8738-2014; Gurgel, RQ/N-5105-2018; Gomara, Miren Iturriza/B-4351-2013	Cuevas, Luis E/0000-0002-6581-0587; Santos, Victor Santana/0000-0003-0194-7397; Gurgel, RQ/0000-0001-9651-3713; Gomara, Miren Iturriza/0000-0001-5816-6423; Cunliffe, Nigel/0000-0002-5449-4988; Santana Dolabella, Silvio/0000-0001-5576-3214	CNPq/UFS-COPES/PIBIC; calls Edital MCT/CNPq Universal [478082/2006-9]; Edital MCT/CNPq Universal [475914/2011-2]	CNPq/UFS-COPES/PIBIC; calls Edital MCT/CNPq Universal; Edital MCT/CNPq Universal	Financial support for this study was received from CNPq/UFS-COPES/PIBIC - 2008-2012, calls Edital MCT/CNPq Universal 14/2009 (#478082/2006-9), Edital MCT/CNPq Universal 14/2011 (#475914/2011-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 2014, PEDIATR INFECT DIS J, V33, pS28, DOI 10.1097/INF.0000000000000048; [Anonymous], 2013, VACCINE, V31, P6170, DOI 10.1016/j.vaccine.2013.05.037; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P2; BROWNING GF, 1992, J CLIN MICROBIOL, V30, P59, DOI 10.1128/JCM.30.1.59-62.1992; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; De Oliveira LH, 2013, VACCINE, V31, pC99, DOI 10.1016/j.vaccine.2013.05.065; Dey A, 2012, MED J AUSTRALIA, V197, P453, DOI 10.5694/mja12.10062; Gurgel RG, 2009, GASTROENTEROLOGY, V137, P1970, DOI 10.1053/j.gastro.2009.07.046; Gurgel RQ, 2008, LANCET, V371, P301, DOI 10.1016/S0140-6736(08)60164-6; Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412; IBGE IBdGeEP, 2010, CENS DEM 2010; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Linhares AC, 2011, REV MED VIROL; Matthijnssens J., 2014, CLIN MICROBIOL INFEC; Matthijnssens J, 2012, EXPERT REV VACCINES, V11, P1347, DOI [10.1586/ERV.12.105, 10.1586/erv.12.105]; Meloni A, 2011, J MATERN-FETAL NEO M, V24, P49, DOI 10.3109/14767058.2011.601920; Mendes PSD, 2013, J PEDIAT-BRAZIL, V89, P315, DOI 10.1016/j.jped.2012.10.002; Nakagomi T, 2005, J INFECT DIS, V192, pS106, DOI 10.1086/431503; Paulke-Korinek M, 2011, VACCINE, V29, P2791, DOI 10.1016/j.vaccine.2011.01.104; Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164; Pukuta ES, 2014, PEDIATR INFECT DIS J, V33, P355, DOI 10.1097/INF.0000000000000212; Rha B, 2014, EXPERT REV VACCINES, V13, P365, DOI 10.1586/14760584.2014.877846; Rivera L, 2011, VACCINE, V29, P9508, DOI 10.1016/j.vaccine.2011.10.015; de Oliveira TCR, 2010, REV SAUDE PUBL, V44, P102, DOI 10.1590/S0034-89102010000100011; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Todd S, 2010, J INFECT DIS, V202, pS34, DOI 10.1086/653555; Tsolenyanu E, 2014, PEDIATR INFECT DIS J, V33, pS14, DOI 10.1097/INF.0000000000000046; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Yi JM, 2013, EXPERT REV VACCINES, V12, P585, DOI [10.1586/ERV.13.43, 10.1586/erv.13.43]; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	30	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110217	10.1371/journal.pone.0110217	http://dx.doi.org/10.1371/journal.pone.0110217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360784	gold, Green Accepted, Green Published			2022-12-27	WOS:000343943700026
J	Haugum, K; Johansen, J; Gabrielsen, C; Brandal, LT; Bergh, K; Ussery, DW; Drablos, F; Afset, JE				Haugum, Kjersti; Johansen, Jostein; Gabrielsen, Christina; Brandal, Lin T.; Bergh, Kare; Ussery, David W.; Drablos, Finn; Afset, Jan Egil			Comparative Genomics to Delineate Pathogenic Potential in Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) from Patients with and without Haemolytic Uremic Syndrome (HUS) in Norway	PLOS ONE			English	Article							EPIDEMIOLOGIC FEATURES; HEMORRHAGIC COLITIS; PARALLEL EVOLUTION; SEQUENCE; STRAINS; VIRULENCE; O157; INFECTIONS; PHAGES; IDENTIFICATION	Shiga toxin-producing Escherichia coli (STEC) cause infections in humans ranging from asymptomatic carriage to bloody diarrhoea and haemolytic uremic syndrome (HUS). Here we present whole genome comparison of Norwegian non-O157 STEC strains with the aim to distinguish between strains with the potential to cause HUS and less virulent strains. Whole genome sequencing and comparisons were performed across 95 non-O157 STEC strains. Twenty-three of these were classified as HUS-associated, including strains from patients with HUS (n = 19) and persons with an epidemiological link to a HUS-case (n = 4). Genomic comparison revealed considerable heterogeneity in gene content across the 95 STEC strains. A clear difference in gene profile was observed between strains with and without the Locus of Enterocyte Effacement (LEE) pathogenicity island. Phylogenetic analysis of the core genome showed high degree of diversity among the STEC strains, but all HUS-associated STEC strains were distributed in two distinct clusters within phylogroup B1. However, non-HUS strains were also found in these clusters. A number of accessory genes were found to be significantly overrepresented among HUS-associated STEC, but none of them were unique to this group of strains, suggesting that different sets of genes may contribute to the pathogenic potential in different phylogenetic STEC lineages. In this study we were not able to clearly distinguish between HUS-associated and non-HUS non-O157 STEC by extensive genome comparisons. Our results indicate that STECs from different phylogenetic backgrounds have independently acquired virulence genes that determine pathogenic potential, and that the content of such genes is overlapping between HUS-associated and non-HUS strains.	[Haugum, Kjersti; Gabrielsen, Christina; Bergh, Kare; Afset, Jan Egil] Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med, N-7034 Trondheim, Norway; [Johansen, Jostein; Drablos, Finn] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, Trondheim, Norway; Norwegian Inst Publ Hlth, Dept Foodborne Infect, Oslo, Norway; [Ussery, David W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Bergh, Kare; Afset, Jan Egil] St Olavs Univ Hosp, Dept Med Microbiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH); United States Department of Energy (DOE); Oak Ridge National Laboratory; Norwegian University of Science & Technology (NTNU)	Haugum, K (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med, N-7034 Trondheim, Norway.	kjersti.haugum@stolav.no	Ussery, David/J-2026-2019; Drablos, Finn/L-4970-2019; Afset, Jan Egil/G-9579-2013	Ussery, David/0000-0003-3632-5512; Drablos, Finn/0000-0001-5794-828X; Afset, Jan Egil/0000-0003-2489-4179; Aas, Christina Gabrielsen/0000-0002-9605-3283; Brandal, Lin Thorstensen/0000-0003-2514-7933	Norwegian University of Science and Technology (NTNU) [81723800]; Kontaktutvalget ved St. Olavs Hospital og DMF, NTNU [46023900]	Norwegian University of Science and Technology (NTNU); Kontaktutvalget ved St. Olavs Hospital og DMF, NTNU	The funding for this project was part of the Ph.D. grant No. 81723800 to KH from the Norwegian University of Science and Technology (NTNU), www.ntnu.no. Whole genome sequencing was partially funded from Grant No. 46023900 from "Kontaktutvalget ved St. Olavs Hospital og DMF, NTNU'', http://www.ntnu.no/dmf/rad/samorg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baldi DL, 2012, INFECT IMMUN, V80, P2042, DOI 10.1128/IAI.06160-11; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bonnet R, 1998, J CLIN MICROBIOL, V36, P1777, DOI 10.1128/JCM.36.6.1777-1780.1998; Brandal LT, 2012, APPL ENVIRON MICROB, V78, P4083, DOI 10.1128/AEM.00186-12; Brandal LT, 2007, J MICROBIOL METH, V68, P331, DOI 10.1016/j.mimet.2006.09.013; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Buvens G, 2013, J CLIN MICROBIOL, V51, P1633, DOI 10.1128/JCM.03025-12; Buvens G, 2012, FOODBORNE PATHOG DIS, V9, P530, DOI 10.1089/fpd.2011.1073; Centers for Disease Control and Prevention (CDC), 2012, NAT SHIG TOX PROD ES; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Delannoy S, 2013, J CLIN MICROBIOL, V51, P3257, DOI 10.1128/JCM.01471-13; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Elliott EJ, 2001, ARCH DIS CHILD, V85, P125, DOI 10.1136/adc.85.2.125; European Centre for Disease Prevention and Control, 2013, QAC14001ENC ECDC; European Centre for Disease Prevention and Control and European Food Safety Authority, 2011, SHIG TOX VER PROD ES; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Haugum K, 2014, J CLIN MICROBIOL; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hazen TH, 2013, P NATL ACAD SCI USA, V110, P12810, DOI 10.1073/pnas.1306836110; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jackson Robert W, 2011, Mob Genet Elements, V1, P55; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Jenssen GR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-265; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Kappeli U, 2011, EMERG INFECT DIS, V17, P180, DOI 10.3201/eid1702.100909; Karch H, 1999, INFECT IMMUN, V67, P5994, DOI 10.1128/IAI.67.11.5994-6001.1999; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Laing CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037362; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Nivaskumar M, 2014, BIOCH BIOPHYS ACTA; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Ribeiro FJ, 2012, GENOME RES, V22, P2270, DOI 10.1101/gr.141515.112; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ronen R, 2012, BIOINFORMATICS, V28, pI188, DOI 10.1093/bioinformatics/bts219; Saha R, 2013, J BASIC MICROB, V53, P303, DOI 10.1002/jobm.201100552; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Schuller S, 2011, TOXINS, V3, P626, DOI 10.3390/toxins3060626; Smith DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-311; Steyert SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00133; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	74	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111788	10.1371/journal.pone.0111788	http://dx.doi.org/10.1371/journal.pone.0111788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360710	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700151
J	Johnston, JB; Nickerson, JG; Daroszewski, J; Mogg, TJ; Burton, GW				Johnston, James B.; Nickerson, James G.; Daroszewski, Janusz; Mogg, Trevor J.; Burton, Graham W.			Biologically Active Polymers from Spontaneous Carotenoid Oxidation: A New Frontier in Carotenoid Activity	PLOS ONE			English	Article							BETA-CAROTENE; IMMUNE-RESPONSE; RETINOIC ACID; VITAMIN; CANCER	In animals carotenoids show biological activity unrelated to vitamin A that has been considered to arise directly from the behavior of the parent compound, particularly as an antioxidant. However, the very property that confers antioxidant activity on some carotenoids in plants also confers susceptibility to oxidative transformation. As an alternative, it has been suggested that carotenoid oxidative breakdown or metabolic products could be the actual agents of activity in animals. However, an important and neglected aspect of the behavior of the highly unsaturated carotenoids is their potential to undergo addition of oxygen to form copolymers. Recently we reported that spontaneous oxidation of beta-carotene transforms it into a product dominated by beta-carotene-oxygen copolymers. We now report that the polymeric product is biologically active. Results suggest an overall ability to prime innate immune function to more rapidly respond to subsequent microbial challenges. An underlying structural resemblance to sporopollenin, found in the outer shell of spores and pollen, may allow the polymer to modulate innate immune responses through interactions with the pattern recognition receptor system. Oxygen copolymer formation appears common to all carotenoids, is anticipated to be widespread, and the products may contribute to the health benefits of carotenoid-rich fruits and vegetables.	[Johnston, James B.] Natl Res Council Canada, Charlottetown, PE, Canada; [Nickerson, James G.] Avivagen Inc, Charlottetown, PE, Canada; [Daroszewski, Janusz; Mogg, Trevor J.; Burton, Graham W.] Avivagen Inc, Ottawa, ON, Canada	National Research Council Canada	Burton, GW (corresponding author), Avivagen Inc, Ottawa, ON, Canada.	g.burton@avivagen.com			Atlantic Canada Opportunities Agency Atlantic Canada Innovation Fund [189074]; Innovation PEI Discovery and Development Fund	Atlantic Canada Opportunities Agency Atlantic Canada Innovation Fund; Innovation PEI Discovery and Development Fund	Funding support provided by the Atlantic Canada Opportunities Agency Atlantic Canada Innovation Fund, Contract No. 189074. http://www.acoa-apeca.gc.ca/eng/ImLookingFor/ProgramInformation/AtlanticInnovationFund/Pages/AtlanticInnovationFund.aspx to GWB JGN JD TJM and Innovation PEI Discovery and Development Fund (http://www.innovationpei.com/dcfund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blackwell LJ, 2007, THESIS U HULL; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Britton George, 2008, V4, P309, DOI 10.1007/978-3-7643-7499-0_15; BROOKS J, 1968, NATURE, V219, P532, DOI 10.1038/219532a0; BROOKS J, 1978, Grana, V17, P91; Brooks J., 1971, POLLEN, P99; Brooks J, 1971, SPOROPOLLENIN P INT, P351; Burton GW, 2014, CAN J CHEM, V92, P305, DOI 10.1139/cjc-2013-0494; BURTON GW, 1984, SCIENCE, V224, P569, DOI 10.1126/science.6710156; Chew BP, 2011, VET IMMUNOL IMMUNOP, V140, P199, DOI 10.1016/j.vetimm.2010.12.004; Chew BP, 2009, CAROTENOIDS SER, V5, P363, DOI 10.1007/978-3-7643-7501-0_17; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Chew BP, 2000, J NUTR, V130, P1910, DOI 10.1093/jn/130.8.1910; Duquette SC, 2014, AM J VET RE IN PRESS, P75; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Huang Q, 2013, ANIM SCI J, V84, P247, DOI 10.1111/j.1740-0929.2012.01064.x; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Palozza P, 2009, CAROTENOIDS SER, V5, P211, DOI 10.1007/978-3-7643-7501-0_11; Park JS, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-18; Perez-Fons L, 2011, BBA-MOL CELL BIOL L, V1811, P177, DOI 10.1016/j.bbalip.2010.12.009; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Shaw G., 1971, SPOROPOLLENIN, P305; Wang XD, 2009, CAROTENOIDS SER, V5, P383, DOI 10.1007/978-3-7643-7501-0_18; Yeum KJ, 2009, CAROTENOIDS SER, V5, P235, DOI 10.1007/978-3-7643-7501-0_12	28	14	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111346	10.1371/journal.pone.0111346	http://dx.doi.org/10.1371/journal.pone.0111346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360750	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700087
J	Lloyd, S; Yiend, J; Schmidt, U; Tchanturia, K				Lloyd, Samantha; Yiend, Jenny; Schmidt, Ulrike; Tchanturia, Kate			Perfectionism in Anorexia Nervosa: Novel Performance Based Evidence	PLOS ONE			English	Article							EATING-DISORDER EXAMINATION; QUESTIONNAIRE EDE-Q; SELF-REPORT; PERSONALITY-TRAITS; HOSPITAL ANXIETY; INTERVIEW; VALIDITY; PSYCHOPATHOLOGY; INDIVIDUALS; WOMEN	Existing research into perfectionism in Anorexia Nervosa (AN) is limited by a reliance upon self-report measures. This study used novel performance based measures to investigate whether there is behavioural evidence for elevated perfectionism in AN. 153 participants took part in the study - 81 with a diagnosis of AN and 72 healthy controls (HCs). Participants completed two performance based tasks assessing perfectionism - a text replication task and a bead sorting task - along with self-report measures of perfectionism. Significant group differences were observed on both tasks. In the text replication task the AN group took significantly longer compared with healthy controls (p = 0.03, d = 0.36) and produced significantly higher quality copies (p=<0.01, d = 0.45). In the bead sorting task, there was a trend towards more participants in the AN group choosing to check their work compared with the HC group (p = 0.07, d = 0.30) and the AN group took significantly longer checking than those in the HC group (p=<0.01, d = 0.45). Only copy quality uniquely predicted scores on self report measures of perfectionism. This study provides empirically tested evidence of elevated performance based perfectionism in AN compared with a healthy control group.	[Lloyd, Samantha; Schmidt, Ulrike; Tchanturia, Kate] Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England; [Yiend, Jenny] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England; [Schmidt, Ulrike; Tchanturia, Kate] South London & Maudsley NHS Fdn Trust, London, England; [Tchanturia, Kate] Illia State Univ, Tbilisi, Georgia	University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust	Tchanturia, K (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England.	kate.tchanturia@kcl.ac.uk	Yiend, Jenny/AAQ-8439-2020; Tchanturia, Kate/H-1474-2011	Yiend, Jenny/0000-0002-1967-6292; Tchanturia, Kate/0000-0001-8988-3265	Medical Research Council/Institute of Psychiatry Excellence Studentship; Medical Research Council [1241653] Funding Source: researchfish	Medical Research Council/Institute of Psychiatry Excellence Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SL is supported by a Medical Research Council/Institute of Psychiatry Excellence Studentship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2006, J ANXIETY DISORD, V20, P1016, DOI 10.1016/j.janxdis.2006.03.001; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; Back MD, 2009, J PERS SOC PSYCHOL, V97, P533, DOI 10.1037/a0016229; Bardone-Cone AM, 2007, CLIN PSYCHOL REV, V27, P384, DOI 10.1016/j.cpr.2006.12.005; Bizeul C, 2001, EUR PSYCHIAT, V16, P232, DOI 10.1016/S0924-9338(01)00570-3; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Boone L, 2012, APPETITE, V59, P531, DOI 10.1016/j.appet.2012.06.015; Bouchard C, 1999, BEHAV RES THER, V37, P239, DOI 10.1016/S0005-7967(98)00141-7; COOPER Z, 1987, INT J EAT DISORDER, V6, P1, DOI 10.1002/1098-108X(198701)6:1<1::AID-EAT2260060102>3.0.CO;2-9; Dickie L, 2012, PERS INDIV DIFFER, V52, P865, DOI 10.1016/j.paid.2012.02.003; Egan SJ, 2011, CLIN PSYCHOL REV, V31, P203, DOI 10.1016/j.cpr.2010.04.009; Enns MW, 2002, NATURE ASSESSMENT PE; Fairburn CG, 1999, BEHAV RES THER, V37, P1, DOI 10.1016/S0005-7967(98)00102-8; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2007, SCIDIP; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Freund PA, 2012, PSYCHOL BULL, V138, P296, DOI 10.1037/a0026556; FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967; Hewitt P.L., 1991, PSYCHOL ASSESS, V3, P464, DOI [10.1037/1040-3590.3.3.464, DOI 10.1037/1040-3590.3.3.464]; IBMCorp, 2012, IBM SPSS STAT WIND V; Jacobs MJ, 2009, PSYCHOL MED, V39, P451, DOI 10.1017/S0033291708003826; Keski-Rahkonen A, 2014, INT J EAT DISORDER, V47, P117, DOI 10.1002/eat.22168; Konstantakopoulos G, 2011, PSYCHOL MED, V41, P1951, DOI 10.1017/S0033291710002539; Lang K, 2014, WORLD J BIOL PSYCHIA, V15, P586, DOI 10.3109/15622975.2014.909606; Lilenfeld LRR, 2006, CLIN PSYCHOL REV, V26, P299, DOI 10.1016/j.cpr.2005.10.003; Lilenfeld LRR, 2008, EUR EAT DISORD REV, V16, P124, DOI 10.1002/erv.842; Lloyd S, 2015, BEHAV COGN PSYCHOTH, V43, P705, DOI 10.1017/S1352465814000162; Lounes N, 2011, J INT NEUROPSYCH SOC, V17, P925, DOI 10.1017/S1355617711000671; LP S, 2011, STAT STAT SOFTW REL; MacLeod C, 2012, CURR OPIN PSYCHIATR, V25, P114, DOI 10.1097/YCO.0b013e32834fda4a; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Perugini M, 2011, EUR J PERSONALITY, V25, P465, DOI 10.1002/per.826; Pliner P, 1996, INT J EAT DISORDER, V19, P381, DOI 10.1002/(SICI)1098-108X(199605)19:4<381::AID-EAT5>3.0.CO;2-H; Riley C, 2007, BEHAV RES THER, V45, P2221, DOI 10.1016/j.brat.2006.12.003; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Shafran R, 2006, BEHAV RES THER, V44, P897, DOI 10.1016/j.brat.2005.08.009; Shafran R, 2001, CLIN PSYCHOL REV, V21, P879, DOI 10.1016/S0272-7358(00)00072-6; Shafran R, 2003, J ADOLESCENCE, V26, P137, DOI 10.1016/S0140-1971(02)00083-0; Shafran R, 2002, BEHAV RES THER, V40, P773, DOI 10.1016/S0005-7967(01)00059-6; Sutandar-Pinnock K, 2003, INT J EAT DISORDER, V33, P225, DOI 10.1002/eat.10127; Uher R, 2008, J ANXIETY DISORD, V22, P979, DOI 10.1016/j.janxdis.2007.10.001; Wade TD, 2008, PSYCHOSOM MED, V70, P239, DOI 10.1097/PSY.0b013e31815c40f1; Woodside DB, 2002, INT J EAT DISORDER, V31, P290, DOI 10.1002/eat.10032; Yiend J, 2014, CLIN PSYCHOL SCI; Yiend J, 2014, COGNITIVE THER RES, V38, P146, DOI 10.1007/s10608-013-9571-y; Yiend J, 2011, BEHAV RES THER, V49, P892, DOI 10.1016/j.brat.2011.10.004; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	26	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111697	10.1371/journal.pone.0111697	http://dx.doi.org/10.1371/journal.pone.0111697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360690	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700143
J	Sheehan, VA; Crosby, JR; Sabo, A; Mortier, NA; Howard, TA; Muzny, DM; Dugan-Perez, S; Aygun, B; Nottage, KA; Boerwinkle, E; Gibbs, RA; Ware, RE; Flanagan, JM				Sheehan, Vivien A.; Crosby, Jacy R.; Sabo, Aniko; Mortier, Nicole A.; Howard, Thad A.; Muzny, Donna M.; Dugan-Perez, Shannon; Aygun, Banu; Nottage, Kerri A.; Boerwinkle, Eric; Gibbs, Richard A.; Ware, Russell E.; Flanagan, Jonathan M.			Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia	PLOS ONE			English	Article							COMMON DISEASES; MORBIDITY; MORTALITY; STRATEGY; BENEFITS; THERAPY; RISKS	Hydroxyurea has proven efficacy in children and adults with sickle cell anemia (SCA), but with considerable inter-individual variability in the amount of fetal hemoglobin (HbF) produced. Sibling and twin studies indicate that some of that drug response variation is heritable. To test the hypothesis that genetic modifiers influence pharmacological induction of HbF, we investigated phenotype-genotype associations using whole exome sequencing of children with SCA treated prospectively with hydroxyurea to maximum tolerated dose (MTD). We analyzed 171 unrelated patients enrolled in two prospective clinical trials, all treated with dose escalation to MTD. We examined two MTD drug response phenotypes: HbF (final %HbF minus baseline %HbF), and final %HbF. Analyzing individual genetic variants, we identified multiple low frequency and common variants associated with HbF induction by hydroxyurea. A validation cohort of 130 pediatric sickle cell patients treated to MTD with hydroxyurea was genotyped for 13 non-synonymous variants with the strongest association with HbF response to hydroxyurea in the discovery cohort. A coding variant in Spalt-like transcription factor, or SALL2, was associated with higher final HbF in this second independent replication sample and SALL2 represents an outstanding novel candidate gene for further investigation. These findings may help focus future functional studies and provide new insights into the pharmacological HbF upregulation by hydroxyurea in patients with SCA.	[Sheehan, Vivien A.; Flanagan, Jonathan M.] Baylor Coll Med, Dept Pediat, Hematol Ctr, Houston, TX 77030 USA; [Crosby, Jacy R.] Univ Texas Houston, Grad Sch Biomed Sci, Sch Dept Biostat Bioinformat & Syst Biol, Houston, TX USA; [Crosby, Jacy R.; Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX USA; [Sabo, Aniko; Muzny, Donna M.; Dugan-Perez, Shannon; Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mortier, Nicole A.; Howard, Thad A.; Ware, Russell E.] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA; [Aygun, Banu] Steven & Alexandra Cohen Childrens Med Ctr New Yo, New Hyde Pk, NY USA; [Nottage, Kerri A.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; St Jude Children's Research Hospital	Sheehan, VA (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Ctr, Houston, TX 77030 USA.	vsheehan@bcm.edu	Flanagan, Jonathan/J-6284-2019		National Human Genome Research Institute [U54-HGOO3273]; National Heart, Lung and Blood Institute [U01-HL078787, R01-HL090941]; Doris Duke Charitable Foundation [2010036]; Russell and Diana Hawkins Family Foundation Discovery Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090941, U01HL078787] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Russell and Diana Hawkins Family Foundation Discovery Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Human Genome Research Institute (U54-HGOO3273)(EB, RAG), National Heart, Lung and Blood Institute (U01-HL078787, R01-HL090941)(REW), Doris Duke Charitable Foundation (2010036)(REW), and the Russell and Diana Hawkins Family Foundation Discovery Fellowship (JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Chai L, 2011, TRANSFUSION, V51, p87S, DOI 10.1111/j.1537-2995.2011.03371.x; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; CHEETHAM RC, 1979, J MOL BIOL, V129, P45, DOI 10.1016/0022-2836(79)90058-5; Lobo CLD, 2013, BRIT J HAEMATOL, V161, P852, DOI 10.1111/bjh.12323; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Green NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055709; Kinney TR, 1999, BLOOD, V94, P1550; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lebensburger J, 2011, AM J HEMATOL, V86, P430, DOI 10.1002/ajh.21994; Lebensburger JD, 2010, HAEMATOL-HEMATOL J, V95, P1599, DOI 10.3324/haematol.2010.023325; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maier-Redelsperger M, 1998, BLOOD, V91, P4472, DOI 10.1182/blood.V91.12.4472.412k16_4472_4479; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Smith WR, 2011, PAIN MED, V12, P697, DOI 10.1111/j.1526-4637.2011.01096.x; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Steinberg MH, 2003, AM J HEMATOL, V72, P121, DOI 10.1002/ajh.10264; Steinberg MH, 2001, HEMOGLOBIN, V25, P195, DOI 10.1081/HEM-100104028; Voskaridou E, 2010, BLOOD, V115, P2354, DOI 10.1182/blood-2009-05-221333; Ware RE, 2002, BLOOD, V99, P10, DOI 10.1182/blood.V99.1.10; Ware Russell E, 2009, Hematology Am Soc Hematol Educ Program, P62, DOI 10.1182/asheducation-2009.1.62; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Ware RE, 2011, BLOOD, V118, P4985, DOI 10.1182/blood-2011-07-364190; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475	31	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110740	10.1371/journal.pone.0110740	http://dx.doi.org/10.1371/journal.pone.0110740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360671	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700045
J	Zhong, W; Yang, BC; He, F; Wang, L; Swami, S; Zeng, GH				Zhong, Wen; Yang, Bicheng; He, Fang; Wang, Liang; Swami, Sunil; Zeng, Guohua			Surgical Management of Urolithiasis in Patients after Urinary Diversion	PLOS ONE			English	Article							SHOCK-WAVE LITHOTRIPSY; TRACT CALCULI; STONES; CYSTECTOMY; COMPLICATION; CONDUIT; LASER; RISK; KOCK	Objective: To present our experience in surgical management of urolithiasis in patients after urinary diversion. Patients and Methods: Twenty patients with urolithiasis after urinary diversion received intervention. Percutaneous nephrolithotomy, percutaneous based antegrade ureteroscopy with semi-rigid or flexible ureteroscope, transurethral reservoir lithotripsy, percutaneous pouch lithotripsy and open operation were performed in 8, 3, 2, 6, and 1 patients, respectively. The operative finding and complications were retrospectively collected and analyzed. Results: The mean stone size was 4.563.1 (range 1.5-11.2) cm. The mean operation time was 82.0 +/- 11.5 (range 55-120) min. Eighteen patients were rendered stone free with a clearance of 90%. Complications occurred in 3 patients (15%). Two patients (10%) had postoperative fever greater than 38.5 degrees C, and one patient (5%) suffered urine extravasations from percutaneous tract. Conclusions: The percutaneous based procedures, including percutaneous nephrolithotomy, antegrade ureteroscopy with semi-rigid ureteroscope or flexible ureteroscope from percutaneous tract, and percutaneous pouch lithotripsy, provides a direct and safe access to the target stones in patients after urinary diversion, and with high stone free rate and minor complications. The surgical management of urolithiasis in patients after urinary diversion requires comprehensive evaluation and individualized consideration depending upon the urinary diversion type, stone location, stone burden, available resource and surgeon experience.	[Zhong, Wen; Yang, Bicheng; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [He, Fang] Guangzhou Med Univ, Affiliated Hosp 3, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China; [Wang, Liang] E Tennessee State Univ, Coll Publ Hlth, Dept Biostat & Epidemiol, Johnson City, TN USA; [Swami, Sunil] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA	Guangzhou Medical University; Guangzhou Medical University; East Tennessee State University; State University System of Florida; University of Florida	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Urol, Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com	Swami, Sunil/X-7870-2019; Zhong, Wen/L-2138-2017	Swami, Sunil/0000-0003-1592-5279; Zhong, Wen/0000-0003-0540-7195				ARAI Y, 1993, J UROLOGY, V150, P51, DOI 10.1016/S0022-5347(17)35394-6; CASS AS, 1992, J UROLOGY, V148, P1123, DOI 10.1016/S0022-5347(17)36837-4; COHEN TD, 1994, UROLOGY, V43, P865, DOI 10.1016/0090-4295(94)90154-6; Cohen TD, 1996, J UROLOGY, V155, P62, DOI 10.1016/S0022-5347(01)66540-6; Coleman RL, 2002, GYNECOL ONCOL, V84, P473, DOI 10.1006/gyno.2001.6543; Daneshmand S, 2011, EXPERT REV ANTICANC, V11, P941, DOI [10.1586/ERA.11.19, 10.1586/era.11.19]; Delvecchio FC, 2000, J ENDOUROL, V14, P251, DOI 10.1089/end.2000.14.251; Desai M, 2009, J ENDOUROL, V23, P1641, DOI 10.1089/end.2009.1530; El-Assmy A, 2005, UROLOGY, V66, P510, DOI 10.1016/j.urology.2005.04.008; Fais PO, 2011, PROG UROL, V21, P811, DOI 10.1016/j.purol.2011.10.001; Fernandez A, 2011, J ENDOUROL, V25, P1615, DOI 10.1089/end.2011.0045; Franzoni DF, 1999, J UROLOGY, V162, P777, DOI 10.1097/00005392-199909010-00042; GINSBERG D, 1991, J UROLOGY, V145, P956, DOI 10.1016/S0022-5347(17)38499-9; Hautmann RE, 2011, NAT REV UROL, V8, P667, DOI 10.1038/nrurol.2011.147; L'Esperance JO, 2004, CURR OPIN UROL, V14, P129, DOI 10.1097/00042307-200403000-00014; Li X, 2009, J ENDOUROL, V23, P1693, DOI 10.1089/end.2009.1537; Madbouly K, 2010, UROL ANNALS, V2, P96, DOI 10.4103/0974-7796.68856; Manohar T, 2008, J ENDOUROL, V22, P443, DOI 10.1089/end.2007.0288; Okhunov Z, 2011, BJU INT, V108, P330, DOI 10.1111/j.1464-410X.2011.10194.x; ROTH S, 1994, BRIT J UROL, V73, P316, DOI 10.1111/j.1464-410X.1994.tb07527.x; TERAI A, 1995, J UROLOGY, V153, P37, DOI 10.1097/00005392-199501000-00016; Terai A, 1996, J UROLOGY, V155, P66, DOI 10.1016/S0022-5347(01)66541-8; Turk TMT, 1999, WORLD J UROL, V17, P305, DOI 10.1007/s003450050151	23	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111371	10.1371/journal.pone.0111371	http://dx.doi.org/10.1371/journal.pone.0111371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360621	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700093
J	Khan, MMH; Gruebner, O; Kraemer, A				Khan, Md. Mobarak Hossain; Gruebner, Oliver; Kraemer, Alexander			The Geography of Diabetes among the General Adults Aged 35 Years and Older in Bangladesh: Recent Evidence from a Cross-Sectional Survey	PLOS ONE			English	Article							RISK-FACTORS; LIFE-STYLE; URBAN-POPULATION; PREVALENCE; OBESITY; URBANIZATION; MELLITUS; EPIDEMIC; DISEASES; BURDEN	Objective: To report geographical variations of sex-specific diabetes by place of residence (large cities/city corporations, small towns/other urban areas, rural areas) and region of residence (divided into seven divisions) among general adults (35+ years of age) in Bangladesh. Methods: The recent cross-sectional data, extracted from the nationally representative Bangladesh Demographic and Health Survey 2011, was used. A total of 3,720 men and 3,823 women aged 35+ years, who participated in the fasting blood sugar testing, were analysed. Any person with either fasting plasma glucose level (mmol/L) >= 7.0 or taking medication for diabetes was considered as a person with diabetes. Results: The prevalence of diabetes was 10.6% in men and 11.3% in women. Bivariable analyses indicated significant variations of diabetes by both geographical variables. The prevalence was highest in city corporations (men 18.0%, women 22.3%), followed by small towns (men 13.6%, women 15.2%) and rural areas (men 9.3%, women 9.5%). Regional disparities in diabetes prevalence were also remarkable, with the highest prevalence in Chittagong division and lowest prevalence in Khulna division. Multivariable logistic regression analyses provided mixed patterns of geographical disparities (depending on the adjusted variables). Some other independent risk factors for diabetes were advancing age, higher level of education and wealth, having TV (a proxy indicator of physical activity), overweight/obesity and hypertension. Conclusions: Over 10% of the general adults aged 35 years and older were having diabetes. Most of the persons with diabetes were unaware of this before testing fasting plasma glucose level. Although significant disparities in diabetes prevalence by geographical variables were observed, such disparities are very much influenced by the adjusted variables. Finally, we underscore the necessities of area-specific strategies including early diagnosis and health education programmes for changing lifestyles to reduce the risk of diabetes in Bangladesh.	[Khan, Md. Mobarak Hossain; Kraemer, Alexander] Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, D-33615 Bielefeld, Germany; [Gruebner, Oliver] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	University of Bielefeld; Columbia University	Khan, MMH (corresponding author), Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, D-33615 Bielefeld, Germany.	mobarak.khan@uni-bielefeld.de	Gruebner, Oliver/H-7947-2019; Gruebner, Oliver/X-2675-2019; Kraemer, Alexander/F-8832-2016; Gruebner, Oliver/G-5126-2010	Gruebner, Oliver/0000-0001-9783-4770; Gruebner, Oliver/0000-0001-9783-4770; Kraemer, Alexander/0000-0003-2774-7860; Gruebner, Oliver/0000-0001-9783-4770				AbuSayeed M, 1997, DIABETES CARE, V20, P551, DOI 10.2337/diacare.20.4.551; Ahsan Karar Zunaid, 2009, Glob Health Action, V2, DOI 10.3402/gha.v2i0.1904; Azimi-Nezhad M, 2008, SINGAP MED J, V49, P571; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; Hussain A, 2007, EUR J PUBLIC HEALTH, V17, P291, DOI 10.1093/eurpub/ckl235; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Khan MMH, 2009, SINGAP MED J, V50, P804; Khan MMH, 2014, INT J SOC WELF, V23, P373, DOI 10.1111/ijsw.12053; Khan MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075261; Khan MMH, 2011, B WORLD HEALTH ORGAN, V89, P583, DOI 10.2471/BLT.11.087429; Khanam MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020259; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu FH, 1998, DIABETIC MED, V15, P564, DOI 10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H; Mahmood S. A. I., 2013, Journal of Public Health and Epidemiology, V5, P424; Mayega RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072554; Mohan V, 2004, J Assoc Physicians India, V52, P468; Mohan V, 2003, J Assoc Physicians India, V51, P771; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Olatunbosun ST, 1998, J NATL MED ASSOC, V90, P293; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Parr JD, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-309; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rahman Md Mafuzar, 2007, Bangladesh Med Res Counc Bull, V33, P48; Ramachandran A, 1999, DIABETES RES CLIN PR, V44, P207, DOI 10.1016/S0168-8227(99)00024-8; Ramachandran A, 2002, CURR SCI INDIA, V83, P1471; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Sayeed MA, 2003, DIABETES CARE, V26, P1034, DOI 10.2337/diacare.26.4.1034; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110756	10.1371/journal.pone.0110756	http://dx.doi.org/10.1371/journal.pone.0110756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356781	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000023
J	Koller, T; Bent, AF				Koller, Teresa; Bent, Andrew F.			FLS2-BAK1 Extracellular Domain Interaction Sites Required for Defense Signaling Activation	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; RECEPTOR-LIKE KINASES; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; FLAGELLIN PERCEPTION; PLANT IMMUNITY; ARABIDOPSIS; BAK1; FLS2; RESISTANCE	Signaling initiation by receptor-like kinases (RLKs) at the plasma membrane of plant cells often requires regulatory leucinerich repeat (LRR) RLK proteins such as SERK or BIR proteins. The present work examined how the microbe-associated molecular pattern (MAMP) receptor FLS2 builds signaling complexes with BAK1 (SERK3). We first, using in vivo methods that validate separate findings by others, demonstrated that flg22 (flagellin epitope) ligand-initiated FLS2-BAK1 extracellular domain interactions can proceed independent of intracellular domain interactions. We then explored a candidate SERK protein interaction site in the extracellular domains (ectodomains; ECDs) of the significantly different receptors FLS2, EFR (MAMP receptors), PEPR1 (damage-associated molecular pattern (DAMP) receptor), and BRI1 (hormone receptor). Repeat conservation mapping revealed a cluster of conserved solvent-exposed residues near the C-terminus of models of the folded LRR domains. However, site-directed mutagenesis of this conserved site in FLS2 did not impair FLS2-BAK1 ECD interactions, and mutations in the analogous site of EFR caused receptor maturation defects. Hence this conserved LRR C-terminal region apparently has functions other than mediating interactions with BAK1. In vivo tests of the subsequently published FLS2-flg22-BAK1 ECD co-crystal structure were then performed to functionally evaluate some of the unexpected configurations predicted by that crystal structure. In support of the crystal structure data, FLS2-BAK1 ECD interactions were no longer detected in in vivo co-immunoprecipitation experiments after site-directed mutagenesis of the FLS2 BAK1-interaction residues S554, Q530, Q627 or N674. In contrast, in vivo FLS2-mediated signaling persisted and was only minimally reduced, suggesting residual FLS2-BAK1 interaction and the limited sensitivity of co-immunoprecipitation data relative to in vivo assays for signaling outputs. However, Arabidopsis plants expressing FLS2 with the Q530A + Q627A double mutation were impaired both in detectable interaction with BAK1 and in FLS2-mediated responses, lending overall support to current models of FLS2 structure and function.	[Koller, Teresa; Bent, Andrew F.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bent, AF (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	afbent@wisc.edu	Bent, Andrew/E-5391-2016	Bent, Andrew/0000-0001-6610-9525	U.S. Department of Energy Basic Energy Biosciences [DE-FG02-02ER15342]; University of Wisconsin Hatch Funding	U.S. Department of Energy Basic Energy Biosciences; University of Wisconsin Hatch Funding	This research was funded by U.S. Department of Energy Basic Energy Biosciences Grant DE-FG02-02ER15342 and University of Wisconsin Hatch Funding to AFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2013, PLANT PHYSIOL, V163, P1504, DOI 10.1104/pp.113.227736; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Belkhadir Y., 2014, TRENDS BIOCH SCI; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Cao YR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003313; Chen XW, 2014, MOL PLANT, V7, P874, DOI 10.1093/mp/ssu003; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Farid A, 2013, PLANT PHYSIOL, V162, P24, DOI 10.1104/pp.113.215509; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Halter T, 2013, CURR BIOL; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Helft L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021614; Kim BH, 2013, MOL CELLS, V35, P7, DOI 10.1007/s10059-013-2255-3; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Maki-Yonekura S, 2010, NAT STRUCT MOL BIOL, V17, P417, DOI 10.1038/nsmb.1774; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mueller K, 2012, PLANT CELL, V24, P2213, DOI 10.1105/tpc.112.096073; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Robatzek S, 2012, PROTOPLASMA, V21; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Su W, 2012, MOL PLANT, V5, P929, DOI 10.1093/mp/sss042; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; von Numers N, 2010, MOL PLANT, V3, P740, DOI 10.1093/mp/ssq017; Wu Y, 2013, J INTEGR PLANT BIOL, V55, P1271, DOI 10.1111/jipb.12123; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	52	17	18	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111185	10.1371/journal.pone.0111185	http://dx.doi.org/10.1371/journal.pone.0111185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356676	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000044
J	Nigorikawa, K; Hazeki, K; Guo, Y; Hazeki, O				Nigorikawa, Kiyomi; Hazeki, Kaoru; Guo, Ying; Hazeki, Osamu			Involvement of Class II Phosphoinositide 3-Kinase alpha-Isoform in Antigen-Induced Degranulation in RBL-2H3 Cells	PLOS ONE			English	Article							MAST-CELLS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; GRANULE EXOCYTOSIS; MAMMALIAN-CELLS; C2 DOMAIN; ACTIVATION; SECRETION; MEMBRANE; C2-ALPHA; C2-BETA	In this study, we present findings that suggest that PI3K-C2 alpha, a member of the class II phosphoinositide 3-kinase (PI3K) subfamily, regulates the process of FcRI-triggered degranulation. RBL-2H3 cells were transfected with shRNA targeting PI3K-C2 alpha. The knockdown impaired the FceRI-induced release of a lysosome enzyme, beta-hexosaminidase, without affecting the intracellular Ca2+ mobilization. The release of mRFP-tagged neuropeptide-Y, a reporter for the regulated exocytosis, was also decreased in the PI3K-C2 alpha-deficient cells. The release was increased significantly by the expression of the siRNA-resistant version of PI3K-C2a. In wild-type cells, Fc epsilon RI stimulation induced the formation of large vesicles, which were associated with CD63, a marker protein of secretory granules. On the vesicles, the existence of PI3K-C2 alpha and PtdIns3,4) P-2 was observed. These results indicated that PI3K-C2 alpha and its product PtdIns3,4) P-2 may play roles in the secretory process.	[Nigorikawa, Kiyomi; Hazeki, Kaoru; Guo, Ying; Hazeki, Osamu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Nigorikawa, K (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	knigo@hiroshima-u.ac.jp			(Kakenhi) from the Japan Society for the Promotion of Science [23590078, 22590065]	(Kakenhi) from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid (Kakenhi) from the Japan Society for the Promotion of Science (grant number 23590078 to OH and 22590065 to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Azouz NP, 2012, J IMMUNOL, V189, P2169, DOI 10.4049/jimmunol.1200542; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Guillemot JC, 1997, J CELL SCI, V110, P2215; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hazeki K, 2012, FEBS LETT, V586, P4010, DOI 10.1016/j.febslet.2012.09.043; Kraft S, 2013, J IMMUNOL, V191, P2871, DOI 10.4049/jimmunol.1202323; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Puri N, 2003, J IMMUNOL, V171, P5345, DOI 10.4049/jimmunol.171.10.5345; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Rozycka M, 1998, GENOMICS, V54, P569, DOI 10.1006/geno.1998.5621; SCHMAUDERCHOCK EA, 1987, HISTOCHEM J, V19, P413, DOI 10.1007/BF01675751; Srivastava S, 2012, MOL CELL BIOL, V32, P3132, DOI 10.1128/MCB.00019-12; Srivastava S, 2009, MOL BIOL CELL, V20, P3783, DOI 10.1091/mbc.E09-05-0390; Tuvim MJ, 1999, AM J RESP CELL MOL, V20, P79, DOI 10.1165/ajrcmb.20.1.3279; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Williams RM, 2000, J CELL SCI, V113, P3839	37	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111698	10.1371/journal.pone.0111698	http://dx.doi.org/10.1371/journal.pone.0111698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357130	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000075
J	Tai, DQ; Tian, J; Zhang, J; Song, TT; Yao, YC				Tai, Deqiang; Tian, Ji; Zhang, Jie; Song, Tingting; Yao, Yuncong			A Malus Crabapple Chalcone Synthase Gene, McCHS, Regulates Red Petal Color and Flavonoid Biosynthesis	PLOS ONE			English	Article							R2R3-MYB TRANSCRIPTION FACTOR; PROANTHOCYANIDIN BIOSYNTHESIS; ANTHOCYANIN SYNTHESIS; NUCLEOTIDE-SEQUENCE; MOLECULAR ANALYSIS; CAMELLIA-SINENSIS; VITIS-VINIFERA; APPLE FRUIT; EXPRESSION; MYB	Chalcone synthase is a key and often rate-limiting enzyme in the biosynthesis of anthocyanin pigments that accumulate in plant organs such as flowers and fruits, but the relationship between CHS expression and the petal coloration level in different cultivars is still unclear. In this study, three typical crabapple cultivars were chosen based on different petal colors and coloration patterns. The two extreme color cultivars, 'Royalty' and 'Flame', have dark red and white petals respectively, while the intermediate cultivar 'Radiant' has pink petals. We detected the flavoniods accumulation and the expression levels of McCHS during petals expansion process in different cultivars. The results showed McCHS have their special expression patterns in each tested cultivars, and is responsible for the red coloration and color variation in crabapple petals, especially for color fade process in 'Radiant'. Furthermore, tobacco plants constitutively expressing McCHS displayed a higher anthocyanins accumulation and a deeper red petal color compared with control untransformed lines. Moreover, the expression levels of several anthocyanin biosynthetic genes were higher in the transgenic McCHS overexpressing tobacco lines than in the control plants. A close relationship was observed between the expression of McCHS and the transcription factors McMYB4 and McMYB5 during petals development in different crabapple cultivars, suggesting that the expression of McCHS was regulated by these transcription factors. We conclude that the endogenous McCHS gene is a critical factor in the regulation of anthocyanin biosynthesis during petal coloration in Malus crabapple.	[Tai, Deqiang; Tian, Ji; Zhang, Jie; Song, Tingting; Yao, Yuncong] Beijing Agr Univ, Dept Plant Sci & Technol, Beijing 100094, Peoples R China; [Tian, Ji; Zhang, Jie; Song, Tingting; Yao, Yuncong] Beijing Agr Univ, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China; [Tai, Deqiang] Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Shanxi Agricultural University	Yao, YC (corresponding author), Beijing Agr Univ, Dept Plant Sci & Technol, Beijing 100094, Peoples R China.	yaoyc_20@126.com			Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [IDHT20140509]; National Natural Science Foundation of China [31301762]; National Modern Agricultural Science City Achievement for People Service Technology Demonstration Project [Z121100007412003]	Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Modern Agricultural Science City Achievement for People Service Technology Demonstration Project	Financial support was provided by the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (IDHT20140509), the National Natural Science Foundation of China (31301762) and the National Modern Agricultural Science City Achievement for People Service Technology Demonstration Project (Z121100007412003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKADA S, 1991, PLANT MOL BIOL, V16, P751, DOI 10.1007/BF00023443; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; Bai YH, 2011, PLANTA, V234, P363, DOI 10.1007/s00425-011-1407-y; BEERHUES L, 1988, PLANTA, V173, P544, DOI 10.1007/BF00958968; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; COURTNEYGUTTERSON N, 1994, BIO-TECHNOL, V12, P268, DOI 10.1038/nbt0394-268; Crifo T, 2012, J AGR FOOD CHEM, V60, P476, DOI 10.1021/jf203891e; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; Czemmel S, 2012, PROTOPLASMA, V249, P109, DOI 10.1007/s00709-012-0380-z; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; Dare AP, 2013, PLANT J, V74, P398, DOI 10.1111/tpj.12140; Davies KM, 2007, MUTAT RES-FUND MOL M, V622, P122, DOI 10.1016/j.mrfmmm.2007.02.003; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Debes MA, 2011, AM J BOT, V98, P2077, DOI 10.3732/ajb.1000373; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Deroles SC, 1998, MOL BREEDING, V4, P59, DOI 10.1023/A:1009621903402; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; FEINBAUM RL, 1988, MOL CELL BIOL, V8, P1985, DOI 10.1128/MCB.8.5.1985; Feng FJ, 2013, PLANT PHYSIOL BIOCH, V69, P54, DOI 10.1016/j.plaphy.2013.04.020; FRANKEN P, 1991, EMBO J, V10, P2605, DOI 10.1002/j.1460-2075.1991.tb07802.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goto-Yamamoto N, 2002, PLANT SCI, V162, P867, DOI 10.1016/S0168-9452(02)00042-0; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; GUTTERSON N, 1995, HORTSCIENCE, V30, P964, DOI 10.21273/HORTSCI.30.5.964; HARKER CL, 1990, PLANT CELL, V2, P185, DOI 10.1105/tpc.2.3.185; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Horsch R.B., 1989, PLANT MOL BIOL MANUA, P63, DOI [10.1007/978-94-009-0951-9_5, DOI 10.1007/978-94-009-0951-9_5]; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; JUNGHANS H, 1993, PLANT MOL BIOL, V22, P239, DOI 10.1007/BF00014932; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Kuckuck H, 1936, MOL GENET GENOMICS, V71, P429; Kutchan TM, 2005, CURR OPIN PLANT BIOL, V8, P292, DOI 10.1016/j.pbi.2005.03.009; Li BY, 2012, J CELL SCI, V125, P4913, DOI 10.1242/jcs.111922; Li SJ, 2005, PLANT CELL REP, V23, P716, DOI 10.1007/s00299-004-0871-2; Liu XJ, 2012, PLANTA, V236, P401, DOI 10.1007/s00425-012-1616-z; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Lunkenbein S, 2006, J AGR FOOD CHEM, V54, P2145, DOI 10.1021/jf052574z; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Nakatsuka T, 2008, PLANT BIOTECHNOL-NAR, V25, P61, DOI 10.5511/plantbiotechnology.25.61; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; PRICE SF, 1995, AM J ENOL VITICULT, V46, P187; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; REIMOLD U, 1983, EMBO J, V2, P1801, DOI 10.1002/j.1460-2075.1983.tb01661.x; ROHDE W, 1991, PLANT MOL BIOL, V16, P1103, DOI 10.1007/BF00016087; Schenke D, 2011, PLANT CELL ENVIRON, V34, P1849, DOI 10.1111/j.1365-3040.2011.02381.x; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Shen HX, 2012, ACTA PHYSIOL PLANT, V34, P1353, DOI 10.1007/s11738-012-0932-z; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian J, 2011, SCI HORTIC-AMSTERDAM, V129, P449, DOI 10.1016/j.scienta.2011.04.015; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang CK, 2006, BOT STUD, V47, P71; Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI DOI 10.1111/J.1365-3040.2011.02316.X; Wang WJ, 2014, J EXP BOT, V65, P2147, DOI 10.1093/jxb/eru084; Wang Y, 2012, PLANT CELL PHYSIOL, V53, P1470, DOI 10.1093/pcp/pcs088; Wang YP, 2009, J CELL SCI, V122, P2673, DOI 10.1242/jcs.049023; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V141, P7, DOI 10.1016/j.scienta.2012.04.013; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu XL, 2005, J AGR FOOD CHEM, V53, P3101, DOI 10.1021/jf0478861; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang HB, 2012, MOL PLANT, V5, P73, DOI 10.1093/mp/ssr056; Zhang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097904; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhu Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-806	83	44	56	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110570	10.1371/journal.pone.0110570	http://dx.doi.org/10.1371/journal.pone.0110570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357207	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000016
J	Verbovsek, U; Motaln, H; Rotter, A; Atai, NA; Gruden, K; Van Noorden, CJF; Lah, TT				Verbovsek, Urska; Motaln, Helena; Rotter, Ana; Atai, Nadia A.; Gruden, Kristina; Van Noorden, Cornelis J. F.; Lah, Tamara T.			Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma	PLOS ONE			English	Article							CANCER; CELLS; DEFICIENCY; MECHANISMS; PHENOTYPE; CYSTATINS; SURVIVAL; GLIOMAS; MATRIX; MODELS	Background: Cancer genome and transcriptome analyses advanced our understanding of cancer biology. We performed transcriptome analysis of all known genes of peptidases also called proteases and their endogenous inhibitors in glioblastoma multiforme (GBM), which is one of the most aggressive and deadly types of brain cancers, where unbalanced proteolysis is associated with tumor progression. Methods: Comparisons were performed between the transcriptomics of primary GBM tumors and unmatched nonmalignant brain tissue, and between GBM cell lines (U87-MG and U373) and a control human astrocyte cell line (NHA). Publicly-available data sets and our own datasets were integrated and normalized using bioinformatics tools to reveal protease and protease inhibitor genes with deregulated expression in both malignant versus non-malignant tissues and cells. Results: Of the 311 protease genes identified to be differentially expressed in both GBM tissues and cells, 5 genes were highly overexpressed, 2 genes coding for non-peptidase homologues transferrin receptor (TFRC) and G protein-coupled receptor 56 (GPR56), as well as 3 genes coding for the proteases endoplasmic reticulum aminopeptidase 2 (ERAP2), glutamine-fructose-6-phosphate transaminase 2 (GFPT2) and cathepsin K (CTSK), whereas one gene, that of the serine protease carboxypeptidase E (CPE) was strongly reduced in expression. Seventy five protease inhibitor genes were differentially expressed, of which 3 genes were highly overexpressed, the genes coding for stefin B (CSTB), peptidase inhibitor 3 (PI3 also named elafin) and CD74. Seven out of 8 genes (except CSTB) were validated using RT-qPCR in GBM cell lines. CTSK overexpression was validated using RT-qPCR in GBM tissues as well. Cathepsin K immunohistochemical staining and western blotting showed that only proteolytically inactive proforms of cathepsin K were overexpressed in GBM tissues and cells. Conclusions: The presence of high levels of inactive proforms of cathepsin K in GBM tissues and cells indicate that in GBM the proteolytic/collagenolytic role is not its primary function but it plays rather a different yet unknown role.	[Verbovsek, Urska; Motaln, Helena; Lah, Tamara T.] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia; [Atai, Nadia A.; Van Noorden, Cornelis J. F.] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Atai, Nadia A.; Van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Lah, Tamara T.] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia	National Institute of Biology - Slovenia; National Institute of Biology - Slovenia; University of Amsterdam; Academic Medical Center Amsterdam; University of Ljubljana	Van Noorden, CJF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.vannoorden@amc.uva.nl	Gruden, kristina/AAI-6439-2020; Motaln, Helena/AAD-1507-2022; Motaln, Helena/AAF-3489-2019	Motaln, Helena/0000-0002-0646-7934; Rotter, Ana/0000-0002-6879-0980; gruden, kristina/0000-0001-5906-8569	Slovenian Research Agency [P1-0245]; AMC scholarship	Slovenian Research Agency(Slovenian Research Agency - Slovenia); AMC scholarship	This work was financed by the Slovenian Research Agency (program P1-0245 granted to T. T. L. and the young researcher fellowship granted to U. V.) and by an AMC scholarship of N.A.A. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Affymetrix, 2003, DES PERF GENECHIP HU; Anway MD, 2004, BIOL REPROD, V70, P562, DOI 10.1095/biolreprod.103.018291; Arampatzidou M, 2012, BIOL CHEM, V393, P1391, DOI 10.1515/hsz-2012-0204; Atai NA, 2011, J HISTOCHEM CYTOCHEM, V59, P489, DOI 10.1369/0022155411400606; Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Beklen A, 2015, ORAL DIS, V21, P163, DOI 10.1111/odi.12230; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Bromme D, 2011, EXPERT OPIN INV DRUG, V18, P585, DOI DOI 10.1517/13543780902832661.CATHEPSIN; Cherney MM, 2011, J BIOL CHEM, V286, P8988, DOI 10.1074/jbc.M110.126706; Chieco P, 2013, PROG HISTOCHEM CYTO, V47, P211, DOI 10.1016/j.proghi.2012.09.001; Chirasani SR, 2009, CELLULAR MOL MECH GL, P120; Colin C, 2009, ACTA NEUROPATHOL, V118, P745, DOI 10.1007/s00401-009-0592-2; Dauth S, 2012, BIOL CHEM, V393, P959, DOI 10.1515/hsz-2012-0145; Dauth S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-74; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eronen L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-119; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Ferrone Soldano, 2008, V1, P35, DOI 10.1007/978-1-4020-6750-1_2; Flannery T, 2006, INT J CANCER, V119, P854, DOI 10.1002/ijc.21911; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Gole B, 2012, INT J CANCER, V131, P1779, DOI 10.1002/ijc.27453; Gole B, 2009, PATHOL ONCOL RES, V15, P711, DOI 10.1007/s12253-009-9175-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Illumina, 2011, ARR BAS GEN EXPR AN; Illumina, 2010, MRNA EXPR AN DAT SHE; Kitange GJ, 2010, J NEURO-ONCOL, V100, P177, DOI 10.1007/s11060-010-0186-9; Lah TT, 2006, EXPERT OPIN BIOL TH, V6, P257, DOI 10.1517/14712598.6.3.257; LAH TT, 1992, CANCER LETT, V61, P243, DOI 10.1016/0304-3835(92)90295-7; Lah TT, 2008, CANC DEGRADOME; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lemaire PA, 2014, J BIOL CHEM IN PRESS; Levicar N, 2003, ACTA NEUROCHIR, V145, P825, DOI 10.1007/s00701-003-0097-z; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Liang J, 2014, CLIN CANCER RES, V20, P187, DOI 10.1158/1078-0432.CCR-13-1279; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Mentlein R, 2012, BBA-REV CANCER, V1825, P178, DOI 10.1016/j.bbcan.2011.12.001; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Motaln H, 2012, CELL TRANSPLANT, V21, P1529, DOI 10.3727/096368912X640547; Nallaseth FS, 2013, BIOCHEMISTRY-US, V52, P7742, DOI 10.1021/bi401051j; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Pietschmann P, 2013, CRIT REV EUKAR GENE, V23, P11, DOI 10.1615/CritRevEukarGeneExpr.2013005929; R Core Team, 2018, R LANG ENV STAT COMP; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rauch U, 2007, BIOCHEM SOC T, V35, P656, DOI 10.1042/BST0350656; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RECHT L, 1990, J NEUROSURG, V72, P941, DOI 10.3171/jns.1990.72.6.0941; Saftig P, 2000, ADV EXP MED BIOL, V477, P293; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strojnik T, 2005, CANCER DETECT PREV, V29, P448, DOI 10.1016/j.cdp.2005.07.006; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00093; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Zhang DW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-72; Zhang HL, 2004, J CLIN ENDOCR METAB, V89, P748, DOI 10.1210/jc.2003-031286	65	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111819	10.1371/journal.pone.0111819	http://dx.doi.org/10.1371/journal.pone.0111819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356585	gold, Green Published			2022-12-27	WOS:000346765000078
J	Westhoff, JT; Paukert, CP				Westhoff, Jacob T.; Paukert, Craig P.			Climate Change Simulations Predict Altered Biotic Response in a Thermally Heterogeneous Stream System	PLOS ONE			English	Article							WATER TEMPERATURE MODEL; SMALLMOUTH BASS; AIR-TEMPERATURE; POTENTIAL IMPACTS; BULL TROUT; GROUNDWATER RECHARGE; PREY CONSUMPTION; PATCH DYNAMICS; BROOK TROUT; COHO SALMON	Climate change is predicted to increase water temperatures in many lotic systems, but little is known about how changes in air temperature affect lotic systems heavily influenced by groundwater. Our objectives were to document spatial variation in temperature for spring-fed Ozark streams in Southern Missouri USA, create a spatially explicit model of mean daily water temperature, and use downscaled climate models to predict the number of days meeting suitable stream temperature for three aquatic species of concern to conservation and management. Longitudinal temperature transects and stationary temperature loggers were used in the Current and Jacks Fork Rivers during 2012 to determine spatial and temporal variability of water temperature. Groundwater spring influence affected river water temperatures in both winter and summer, but springs that contributed less than 5% of the main stem discharge did not affect river temperatures beyond a few hundred meters downstream. A multiple regression model using variables related to season, mean daily air temperature, and a spatial influence factor (metric to account for groundwater influence) was a strong predictor of mean daily water temperature (r(2) = 0.98; RMSE = 0.82). Data from two downscaled climate simulations under the A2 emissions scenario were used to predict daily water temperatures for time steps of 1995, 2040, 2060, and 2080. By 2080, peak numbers of optimal growth temperature days for smallmouth bass are expected to shift to areas with more spring influence, largemouth bass are expected to experience more optimal growth days (21 - 317% increase) regardless of spring influence, and Ozark hellbenders may experience a reduction in the number of optimal growth days in areas with the highest spring influence. Our results provide a framework for assessing fine-scale (10 s m) thermal heterogeneity and predict shifts in thermal conditions at the watershed and reach scale.	[Westhoff, Jacob T.] Univ Missouri, Dept Fisheries & Wildlife Sci, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA; [Paukert, Craig P.] Univ Missouri, US Geol Survey, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia	Westhoff, JT (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA.	westhoffj@missouri.edu		Westhoff, Jacob/0000-0002-2347-5098; Paukert, Craig/0000-0002-9369-8545	United States Geological Survey Natural Resources Preservation Project through Missouri Cooperative Fish and Wildlife Research Unit [116]	United States Geological Survey Natural Resources Preservation Project through Missouri Cooperative Fish and Wildlife Research Unit	This project was funded through the United States Geological Survey Natural Resources Preservation Project through Research Work Order 116 of the Missouri Cooperative Fish and Wildlife Research Unit (http://www.nature.nps.gov/challenge/2011/nrpp.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Nedushan B, 2007, HYDROL PROCESS, V21, P21, DOI 10.1002/hyp.6353; Al-Chokhachy R, 2013, GLOBAL CHANGE BIOL, V19, DOI 10.1111/gcb.12262; Arismendi I, 2013, HYDROBIOLOGIA, V712, P61, DOI 10.1007/s10750-012-1327-2; Ayllon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081354; Bartholow J. M., 1989, 8917 US FISH WILDL S; Baxter CV, 2000, CAN J FISH AQUAT SCI, V57, P1470, DOI 10.1139/cjfas-57-7-1470; Benyahya L., 2007, CANADIAN WATER RESOU, V32, P179, DOI DOI 10.4296/CWRJ3203179; Bogan T, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002034; Brewer SK, 2013, RIVER RES APPL, V29, P269, DOI 10.1002/rra.1595; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carmona-Catot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054734; Cherkauer KA, 2005, J AM WATER RESOUR AS, V41, P1149, DOI 10.1111/j.1752-1688.2005.tb03790.x; Chu C, 2008, CAN J FISH AQUAT SCI, V65, P297, DOI 10.1139/F08-007; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DeWeber JT, 2014, J HYDROL, V517, P187, DOI 10.1016/j.jhydrol.2014.05.035; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Ebersole JL, 2001, ECOL FRESHW FISH, V10, P1, DOI 10.1034/j.1600-0633.2001.100101.x; Eby LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098812; Eckhardt K, 2003, J HYDROL, V284, P244, DOI 10.1016/j.jhydrol.2003.08.005; Erickson TR, 2000, J HYDROL ENG, V5, P317, DOI 10.1061/(ASCE)1084-0699(2000)5:3(317); Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Garrett James W., 1998, North American Journal of Fisheries Management, V18, P925, DOI 10.1577/1548-8675(1998)018<0925:EISFKS>2.0.CO;2; Hague MJ, 2014, N AM J FISH MANAGE, V34, P132, DOI 10.1080/02755947.2013.847879; Herb WR, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009586; HILL DK, 1990, T AM FISH SOC, V119, P265, DOI 10.1577/1548-8659(1990)119<0265:PEOGCW>2.3.CO;2; Hostetler S. W., 2011, 20111238 US GEOL SUR; Howell PJ, 2010, ECOL FRESHW FISH, V19, P96, DOI 10.1111/j.1600-0633.2009.00393.x; Hu Q, 2005, ENVIRON MODEL ASSESS, V10, P9, DOI 10.1007/s10666-004-4266-0; HUTCHISON V H, 1976, Herpetologica, V32, P327; Imholt C, 2013, RIVER RES APPL, V29, P403, DOI 10.1002/rra.1608; Intergovernmental Panel on Climate Change, 2000, SUMM POL MAK EM SCEN; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Isaak DJ, 2001, J AM WATER RESOUR AS, V37, P351, DOI 10.1111/j.1752-1688.2001.tb00974.x; Jeong DI, 2013, RIVER RES APPL, V29, P805, DOI 10.1002/rra.2574; JEPPESEN E, 1987, OIKOS, V49, P149, DOI 10.2307/3566020; Jones LA, 2014, RIVER RES APPL, V30, P204, DOI 10.1002/rra.2638; Jourdonnais Jon H., 1992, Rivers, V3, P153; Jyrkama MI, 2007, J HYDROL, V338, P237, DOI 10.1016/j.jhydrol.2007.02.036; Kanno Y, 2014, RIVER RES APPL, V30, P745, DOI 10.1002/rra.2677; King JR, 1999, T AM FISH SOC, V128, P656, DOI 10.1577/1548-8659(1999)128&lt;0656:ELBTHF&gt;2.0.CO;2; Kundzewicz ZW, 2008, HYDROLOG SCI J, V53, P3, DOI 10.1623/hysj.53.1.3; Labbe TR, 2000, ECOL APPL, V10, P1774, DOI 10.1890/1051-0761(2000)010[1774:DOISHR]2.0.CO;2; Lehtonen H., 1996, Fisheries Management and Ecology, V3, P59, DOI 10.1111/j.1365-2400.1996.tb00130.x; Lloyd C., 2010, SPATIAL DATA ANAL IN; Lucas LK, 2009, CONSERV GENET, V10, P1309, DOI 10.1007/s10592-008-9710-2; Madej MA, 2006, CAN J FISH AQUAT SCI, V63, P1384, DOI 10.1139/F06-043; Martin RW, 2009, J FRESHWATER ECOL, V24, P497, DOI 10.1080/02705060.2009.9664323; Matthews KR, 1997, J FISH BIOL, V50, P50, DOI 10.1111/j.1095-8649.1997.tb01339.x; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Meinzer OE, 1925, CONTRIBUTIONS HYDROG; Mohler HS, 1966, THESIS U MISSOURI CO; Mohseni O, 2003, CLIMATIC CHANGE, V59, P389, DOI 10.1023/A:1024847723344; Mohseni O, 1999, J HYDROL, V218, P128, DOI 10.1016/S0022-1694(99)00034-7; Mugel D. M., 2009, 20095138 US GEOL SUR; Neumann DW, 2003, J ENVIRON ENG-ASCE, V129, P667, DOI 10.1061/(ASCE)0733-9372(2003)129:7(667); Nichols AL, 2014, RIVER RES APPL, V30, P442, DOI 10.1002/rra.2655; Nohara D, 2006, J HYDROMETEOROL, V7, P1076, DOI 10.1175/JHM531.1; O'Driscoll MA, 2006, J HYDROL, V329, P140, DOI 10.1016/j.jhydrol.2006.02.010; Ormerod SJ, 2009, AQUAT CONSERV, V19, P609, DOI 10.1002/aqc.1062; Ouellet V, 2014, RIVER RES APPL, V30, P733, DOI 10.1002/rra.2664; Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1; Panfil M. S., 2001, USGSBRDBSR20010005; Pease AA, 2014, ECOL FRESHW FISH, V23, P336, DOI 10.1111/eff.12084; Peterson James T., 1996, North American Journal of Fisheries Management, V16, P738, DOI 10.1577/1548-8675(1996)016<0738:NTRFTW>2.3.CO;2; Peterson JT, 2001, T AM FISH SOC, V130, P898, DOI 10.1577/1548-8659(2001)130<0898:ETPCOC>2.0.CO;2; Petty JT, 2012, T AM FISH SOC, V141, P1060, DOI 10.1080/00028487.2012.681102; Pilgrim JM, 1998, J AM WATER RESOUR AS, V34, P1109, DOI 10.1111/j.1752-1688.1998.tb04158.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Poole GC, 2001, ENVIRON MANAGE, V27, P787, DOI 10.1007/s002670010188; Power G, 1999, HYDROL PROCESS, V13, P401, DOI 10.1002/(SICI)1099-1085(19990228)13:3<401::AID-HYP746>3.3.CO;2-1; Rahel FJ, 2008, CONSERV BIOL, V22, P551, DOI 10.1111/j.1523-1739.2008.00953.x; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Reese CD, 2002, T AM FISH SOC, V131, P599, DOI 10.1577/1548-8659(2002)131&lt;0599:TDIBJS&gt;2.0.CO;2; REYNOLDS WW, 1979, AM ZOOL, V19, P211; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Sada DW, 2005, DIVERS DISTRIB, V11, P91, DOI 10.1111/j.1366-9516.2005.00131.x; Schmidt C, 2006, HYDROL EARTH SYST SC, V10, P849, DOI 10.5194/hess-10-849-2006; SCHRAMM HL, 1991, FISHERIES, V16, P13, DOI 10.1577/1548-8446(1991)016<0013:SEABAO>2.0.CO;2; Selker J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027979; SHUTER BJ, 1980, T AM FISH SOC, V109, P1, DOI 10.1577/1548-8659(1980)109&lt;1:SSOTEO&gt;2.0.CO;2; SINOKROT BA, 1995, CLIMATIC CHANGE, V30, P181, DOI 10.1007/BF01091841; Smith H, 2002, HYDROBIOLOGIA, V487, P45, DOI 10.1023/A:1022932303652; SOWA SP, 1995, T AM FISH SOC, V124, P240, DOI 10.1577/1548-8659(1995)124<0240:REOTRO>2.3.CO;2; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Struber RJ, 1982, FWSOBS820116 US DEP; Taylor CA, 2009, J HYDROL, V375, P601, DOI 10.1016/j.jhydrol.2009.07.009; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Tonolla D, 2012, REMOTE SENS ENVIRON, V125, P134, DOI 10.1016/j.rse.2012.07.014; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Wehrly KE, 2003, T AM FISH SOC, V132, P18, DOI 10.1577/1548-8659(2003)132<0018:CRVITR>2.0.CO;2; Westhoff MC, 2007, HYDROL EARTH SYST SC, V11, P1469, DOI 10.5194/hess-11-1469-2007; Whitledge GW, 2006, ECOL APPL, V16, P1461, DOI 10.1890/1051-0761(2006)016[1461:RSAGEG]2.0.CO;2; Whitledge GW, 2002, J FRESHWATER ECOL, V17, P353, DOI 10.1080/02705060.2002.9663908; WILLIAMS J. D., 1982, OCCASIONAL PAPERS MU, V102, P1; Winemiller KO, 2010, J N AM BENTHOL SOC, V29, P84, DOI 10.1899/08-048.1; WINEMILLER KO, 1987, AM MIDL NAT, V117, P148, DOI 10.2307/2425716; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Zweifel Richard D., 1999, North American Journal of Fisheries Management, V19, P192, DOI 10.1577/1548-8675(1999)019<0192:BIIBBD>2.0.CO;2	104	28	28	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111438	10.1371/journal.pone.0111438	http://dx.doi.org/10.1371/journal.pone.0111438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356982	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000061
J	Alsamawi, A; Murray, J; Lenzen, M; Moran, D; Kanemoto, K				Alsamawi, Ali; Murray, Joy; Lenzen, Manfred; Moran, Daniel; Kanemoto, Keiichiro			The Inequality Footprints of Nations: A Novel Approach to Quantitative Accounting of Income Inequality	PLOS ONE			English	Article							WATER FOOTPRINTS; WAGE INEQUALITY; TRADE; GLOBALIZATION; CARBON	In this study we use economic input-output analysis to calculate the inequality footprint of nations. An inequality footprint shows the link that each country's domestic economic activity has to income distribution elsewhere in the world. To this end we use employment and household income accounts for 187 countries and an historical time series dating back to 1990. Our results show that in 2010, most developed countries had an inequality footprint that was higher than their within-country inequality, meaning that in order to support domestic lifestyles, these countries source imports from more unequal economies. Amongst exceptions are the United States and United Kingdom, which placed them on a par with many developing countries. Russia has a high within-country inequality nevertheless it has the lowest inequality footprint in the world, which is because of its trade connections with the Commonwealth of Independent States and Europe. Our findings show that the commodities that are inequality-intensive, such as electronic components, chemicals, fertilizers, minerals, and agricultural products often originate in developing countries characterized by high levels of inequality. Consumption of these commodities may implicate within-country inequality in both developing and developed countries.	[Alsamawi, Ali; Murray, Joy; Lenzen, Manfred] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Moran, Daniel] Norwegian Univ Sci & Technol, Programme Ind Ecol, Fac Engn, N-7034 Trondheim, Norway; [Kanemoto, Keiichiro] Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka 812, Japan	University of Sydney; Norwegian University of Science & Technology (NTNU); Kyushu University	Alsamawi, A (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	alia@physics.usyd.edu.au	Lenzen, Manfred/D-3161-2013; Moran, Daniel/AAE-6028-2019; Kanemoto, Keiichiro/O-9633-2016	Moran, Daniel/0000-0002-2310-2275; Kanemoto, Keiichiro/0000-0003-0230-9020; Lenzen, Manfred/0000-0002-0828-5288				ABS, 2011, HOUS EXP SURV DET EX; Alsamawi A, 2014, J IND ECOL, V18, P59, DOI 10.1111/jiec.12104; Atkinson AB, 2011, J ECON LIT, V49, P3, DOI 10.1257/jel.49.1.3; Basu K., 2009, J DEV EC, V88; Basu K., 2005, 200532 UNUWIDER; BORJAS GJ, 1995, Q J ECON, V110, P1075, DOI 10.2307/2946649; Brainerd Elizabeth, 1998, AM EC REV, V88; Burke J., 2000, CHILD LABOUR SCANDAL; Carnevale Anthony P., 2011, UNDEREDUCATED AM; Chapple S, 2009, INEQUALITY WELL BEIN; Collier P., 2007, BOTTOM BILLION WHY P; Denisova I, 2012, OECD SOCIAL EMPLOYME, V132; Dreher A, 2008, REV INT ECON, V16, P516, DOI 10.1111/j.1467-9396.2008.00743.x; Eora, 2012, EOR GLOB MULT INP OU; Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276; Foley S, 2009, WALMART EMBROILED CH; Galor O, 2000, Q J ECON, V115, P469, DOI 10.1162/003355300554827; Goldberg P, 2007, J ECON LIT, V45, P207; Goldberg PK, 2010, Q J ECON, V125, P1727, DOI 10.1162/qjec.2010.125.4.1727; GUINE-BISSAU, 2012, OBSERVATORY EC COMPL; Hertwich EG, 2009, ENVIRON SCI TECHNOL, V43, P6414, DOI 10.1021/es803496a; HM Government, 2005, SEC FUT UK SUST DEV; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; IBGE Instituto Brasileiro de Geografia e Estatstica. Pesquisa de Oramentos, 2010, FAM 20082009 POF; ILO (International Labor Organization), 2012, LABORSTA MAIN STAT A; International Monetary Fund, 2006, 06315 IMF; Irvin G, 2011, DEV CHANGE, V42, P154, DOI 10.1111/j.1467-7660.2010.01679.x; Jackson T., 2012, PROSPERITY GROWTH EC; Jenkins C, 2000, 203 UN U WIDER, V203; Kingstone Peter, 2011, POLITICAL EC LATIN A; KRUGMAN P, 1995, Q J ECON, V110, P857, DOI 10.2307/2946642; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Leontief W., 1963, STRUCTURAL INTERDEPE, P119; Leontief W, 1986, INPUT OUTPUT EC, P449; Los B, 2012, CHINA WORLD EC GLOBA; Milanovic B, 2005, WORLDS APART MEASURI; Miller R.E, 2010, INPUT OUTPUT ANAL FD; Murray J, 2013, PRACTITONERS GUIDE M; Nations United, 2009, RETH POV REP WORLD S; Norton MI, 2011, PERSPECT PSYCHOL SCI, V6, P9, DOI 10.1177/1745691610393524; OECD, 2011, DIV WE STAND WHY IN; Organisation of Economic Cooperation and Development (OECD), 2011, GROW INC IN OECD COU; Pavcnik Nina, 2011, GLOBALIZATION WITHIN, P233; Peters GP, 2010, CURR OPIN ENV SUST, V2, P245, DOI 10.1016/j.cosust.2010.05.004; Solt F, 2009, SOC SCI QUART, V90, P231, DOI 10.1111/j.1540-6237.2009.00614.x; Tang M. K, 2008, TWIN GLOBAL SHOCKS D; Tao S., 2012, GLOBAL THEMATIC CONS; The International Monetary Fund, 2007, WORLD EC OUTL GLOB I; UN Department of Economic and Social Affairs, 2010, IN PRED REP WORLD SO; UN DESA, 2005, IN PRED WORLD SOC SI; UNCTAD, 2012, TRAD DEV REP; United Nations, 2010, MILL DEV GOALS REP 2; United Nations Development Programme (UNDP), 2010, HUMAN DEV REPORT 201; UNSD, 2011, UN COMTR UN COMM TRA; Verhoogen EA, 2008, Q J ECON, V123, P489, DOI 10.1162/qjec.2008.123.2.489; WIEDMANN T, 2008, DEV EMBEDDED CARBON; World Bank, 2000, CAN AFR CLAIM 21 CEN	60	45	46	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110881	10.1371/journal.pone.0110881	http://dx.doi.org/10.1371/journal.pone.0110881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353333	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200044
J	Chen, Y; Zhang, RH; Shang, L				Chen, Yong; Zhang, Rong Hua; Shang, Lei			A Novel Method of Object Detection from a Moving Camera Based on Image Matching and Frame Coupling	PLOS ONE			English	Article								A new method based on image matching and frame coupling to handle the problems of object detection caused by a moving camera and object motion is presented in this paper. First, feature points are extracted from each frame. Then, motion parameters can be obtained. Sub-images are extracted from the corresponding frame via these motion parameters. Furthermore, a novel searching method for potential orientations improves efficiency and accuracy. Finally, a method based on frame coupling is adopted, which improves the accuracy of object detection. The results demonstrate the effectiveness and feasibility of our proposed method for a moving object with changing posture and with a moving camera.	[Chen, Yong; Zhang, Rong Hua; Shang, Lei] Univ Elect Sci & Technol China, Sch Energy Sci & Engn, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Chen, Y (corresponding author), Univ Elect Sci & Technol China, Sch Energy Sci & Engn, Chengdu 610054, Peoples R China.	ychencd@uestc.edu.cn		chen, yong/0000-0003-4580-8655	National Natural Science Foundation of China [61105030]; Fundamental Research Funds for the Central Universities [ZYGX2011J021]; Scientific and Technical Supporting Programs of Sichuan Province [2013GZ0054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific and Technical Supporting Programs of Sichuan Province	Funding was provided by National Natural Science Foundation of China under grant (61105030), The Fundamental Research Funds for the Central Universities (ZYGX2011J021), and the Scientific and Technical Supporting Programs of Sichuan Province (2013GZ0054). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiv G, 2009, IEEE T PATTERN ANAL, V7, P84; Araki S, 2000, IEICE T INF SYST, VE83D, P1583; Berrabah SA, 2006, IEEE IMAGE PROC, P1125, DOI 10.1109/ICIP.2006.312754; Chen Y., 2013, REV SCI INSTRUM, P1; Ghosh A, 2012, IEEE T CIRC SYST VID, V22, P1127, DOI 10.1109/TCSVT.2012.2190476; Peng XM, 2010, IMAGE VISION COMPUT, V28, P1280, DOI 10.1016/j.imavis.2010.01.007; Wang JB, 2008, IEEE T PATTERN ANAL, V30, P477, DOI 10.1109/TPAMI.2007.1178; Yu X, 2011, LASER OPTOELECTRON P, V7, P75	8	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109809	10.1371/journal.pone.0109809	http://dx.doi.org/10.1371/journal.pone.0109809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354301	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204200014
J	de Boer, CG; Hughes, TR				de Boer, Carl G.; Hughes, Timothy R.			Poly-dA:dT Tracts Form an In Vivo Nucleosomal Turnstile	PLOS ONE			English	Article							EUKARYOTIC GENOME; DNA-SEQUENCE; YEAST; ORGANIZATION; RESOLUTION; OCCUPANCY; REGIONS	Nucleosomes regulate many DNA-dependent processes by controlling the accessibility of DNA, and DNA sequences such as the poly-dA:dT element are known to affect nucleosome binding. We demonstrate that poly-dA: dT tracts form an asymmetric barrier to nucleosome movement in vivo, mediated by ATP-dependent chromatin remodelers. We theorize that nucleosome transit over poly-A elements is more energetically favourable in one direction, leading to an asymmetric arrangement of nucleosomes around these sequences. We demonstrate that different arrangements of poly-A and poly-T tracts result in very different outcomes for nucleosome occupancy in yeast, mouse, and human, and show that yeast takes advantage of this phenomenon in its promoter architecture.	[de Boer, Carl G.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto; University of Toronto	Hughes, TR (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	t.hughes@utoronto.ca		de Boer, Carl/0000-0001-8935-5921	Canadian Institutes of Health Research [MOP-111007]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) to TRH (MOP-111007) and by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) award to CGD (PGS D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogaard KR, 2012, METHOD ENZYMOL, V513, P315, DOI 10.1016/B978-0-12-391938-0.00014-8; Hampson S, 2002, BIOINFORMATICS, V18, P513, DOI 10.1093/bioinformatics/18.4.513; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; Wu R, 2010, GENOME RES, V20, P473, DOI 10.1101/gr.103226.109; Yigit E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt081; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	12	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110479	10.1371/journal.pone.0110479	http://dx.doi.org/10.1371/journal.pone.0110479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353956	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200028
J	Dudley, PN; Bonazza, R; Jones, TT; Wyneken, J; Porter, WP				Dudley, Peter N.; Bonazza, Riccardo; Jones, T. Todd; Wyneken, Jeanette; Porter, Warren P.			Leatherbacks Swimming In Silico: Modeling and Verifying Their Momentum and Heat Balance Using Computational Fluid Dynamics	PLOS ONE			English	Article							DERMOCHELYS-CORIACEA; THERMAL-CONDUCTIVITY; SEA-TURTLES; TISSUE; RANGE; NICHE; WHALE; FLAP; SIZE	As global temperatures increase throughout the coming decades, species ranges will shift. New combinations of abiotic conditions will make predicting these range shifts difficult. Biophysical mechanistic niche modeling places bounds on an animal's niche through analyzing the animal's physical interactions with the environment. Biophysical mechanistic niche modeling is flexible enough to accommodate these new combinations of abiotic conditions. However, this approach is difficult to implement for aquatic species because of complex interactions among thrust, metabolic rate and heat transfer. We use contemporary computational fluid dynamic techniques to overcome these difficulties. We model the complex 3D motion of a swimming neonate and juvenile leatherback sea turtle to find power and heat transfer rates during the stroke. We combine the results from these simulations and a numerical model to accurately predict the core temperature of a swimming leatherback. These results are the first steps in developing a highly accurate mechanistic niche model, which can assists paleontologist in understanding biogeographic shifts as well as aid contemporary species managers about potential range shifts over the coming decades.	[Dudley, Peter N.; Porter, Warren P.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Bonazza, Riccardo] Univ Wisconsin, Madison, WI 53706 USA; [Jones, T. Todd] NOAA Inouye Reg Ctr, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Wyneken, Jeanette] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; Florida Atlantic University	Dudley, PN (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	P.N.D.PhD@gmail.com		Dudley, Peter/0000-0002-3210-634X	NOAA Fisheries (Pacific Islands Fisheries Science Center); Joint Institute for Marine and Atmospheric Research; UW Foundation; Disney Worldwide Conservation Fund grant	NOAA Fisheries (Pacific Islands Fisheries Science Center); Joint Institute for Marine and Atmospheric Research; UW Foundation; Disney Worldwide Conservation Fund grant	Funding for the live neonate force trials was provided by NOAA Fisheries (Pacific Islands Fisheries Science Center), the Joint Institute for Marine and Atmospheric Research, the UW Foundation and a 2012 Disney Worldwide Conservation Fund grant to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JW also contributed substantial personal funds to the live neonate force trials.	Bagge LE, 2012, J EXP BIOL, V215, P4330, DOI 10.1242/jeb.071530; Blake RW, 2007, J EXP BIOL, V210, P2979, DOI 10.1242/jeb.006437; BOISCLAIR D, 1993, J FISH BIOL, V42, P169, DOI 10.1111/j.1095-8649.1993.tb00319.x; Bostrom BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013925; Cedeno FO, 2000, J CHEM ENG DATA, V45, P64, DOI 10.1021/je990164z; Chang Chun-Hsiang, 2003, Collection and Research, V16, P17; Cheng HLM, 2002, J MAGN RESON IMAGING, V16, P598, DOI 10.1002/jmri.10199; DAVENPORT J, 1990, J MAR BIOL ASSOC UK, V70, P33, DOI 10.1017/S0025315400034172; Davenport J, 2009, J EXP BIOL, V212, P2753, DOI 10.1242/jeb.026500; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Drucker EG, 1999, J EXP BIOL, V202, P2393; Dudley PN, 2013, J EXP ZOOL PART A, V319A, P319, DOI 10.1002/jez.1796; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOFF GP, 1988, COPEIA, P1071, DOI 10.2307/1445737; GREER AE, 1973, NATURE, V244, P181, DOI 10.1038/244181a0; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kvadsheim PH, 1996, J THERM BIOL, V21, P123, DOI 10.1016/0306-4565(95)00034-8; Liu H, 1997, J EXP BIOL, V200, P2807; Low KH, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P535, DOI 10.1109/ROBIO.2007.4522219; Marom S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P944, DOI 10.1086/505999; Miller DL, 2009, J WILDLIFE DIS, V45, P962, DOI 10.7589/0090-3558-45.4.962; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PARRY DA, 1949, Q J MICROSC SCI, V90, P13; Pavlov VV, 2012, MAR MAMMAL SCI, V28, pE16, DOI 10.1111/j.1748-7692.2011.00476.x; Phillips BL, 2008, WILDLIFE RES, V35, P222, DOI 10.1071/WR07101; Porter WP, 2009, P NATL ACAD SCI USA, V106, P19666, DOI 10.1073/pnas.0907321106; Schultz WW, 2002, INTEGR COMP BIOL, V42, P1018, DOI 10.1093/icb/42.5.1018; Skrovan RC, 1999, J EXP BIOL, V202, P2749; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Tobalske BW, 1999, J EXP BIOL, V202, P1725; Usherwood JR, 2003, J EXP BIOL, V206, P4051, DOI 10.1242/jeb.00624; Wallace BP, 2008, J EXP MAR BIOL ECOL, V356, P8, DOI 10.1016/j.jembe.2007.12.023; Ward S, 1999, J EXP BIOL, V202, P1589; Weber PW, 2009, J EXP BIOL, V212, P2149, DOI 10.1242/jeb.029868; WOLEDGE RC, 1968, J PHYSIOL-LONDON, V197, P685, DOI 10.1113/jphysiol.1968.sp008582; WRIGHT PG, 1984, S AFR J ZOOL, V19, P266	39	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110701	10.1371/journal.pone.0110701	http://dx.doi.org/10.1371/journal.pone.0110701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354303	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200032
J	Lovejoy, AF; Riordan, DP; Brown, PO				Lovejoy, Alexander F.; Riordan, Daniel P.; Brown, Patrick O.			Transcriptome-Wide Mapping of Pseudouridines: Pseudouridine Synthases Modify Specific mRNAs in S. cerevisiae	PLOS ONE			English	Article							RIBOSOMAL-RNA; NUCLEOTIDE RESOLUTION; SUBSTRATE-SPECIFICITY; NONCODING RNA; IN-VIVO; METHYLATION; YEAST; RESIDUES; REVEALS; GENE	We developed a novel technique, called pseudouridine site identification sequencing (PSI-seq), for the transcriptome-wide mapping of pseudouridylation sites with single-base resolution from cellular RNAs based on the induced termination of reverse transcription specifically at pseudouridines following CMCT treatment. PSI-seq analysis of RNA samples from S. cerevisiae correctly detected all of the 43 known pseudouridines in yeast 18S and 25S ribosomal RNA with high specificity. Moreover, application of PSI-seq to the yeast transcriptome revealed the presence of site-specific pseudouridylation within dozens of mRNAs, including RPL11a, TEF1, and other genes implicated in translation. To identify the mechanisms responsible for mRNA pseudouridylation, we genetically deleted candidate pseudouridine synthase (Pus) enzymes and reconstituted their activities in vitro. These experiments demonstrated that the Pus1 enzyme was necessary and sufficient for pseudouridylation of RPL11a mRNA, whereas Pus4 modified TEF1 mRNA, and Pus6 pseudouridylated KAR2 mRNA. Finally, we determined that modification of RPL11a at Psi -68 was observed in RNA from the related yeast S. mikitae, and psi -239 in TEF1 mRNA was maintained in S. mikitae as well as S. pombe, indicating that these pseudouridylations are ancient, evolutionarily conserved RNA modifications. This work establishes that site-specific pseudouridylation of eukaryotic mRNAs is a genetically programmed RNA modification that naturally occurs in multiple yeast transcripts via distinct mechanisms, suggesting that mRNA pseudouridylation may provide an important novel regulatory function. The approach and strategies that we report here should be generally applicable to the discovery of pseudouridylation, or other RNA modifications, in diverse biological contexts.	[Lovejoy, Alexander F.; Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Lovejoy, Alexander F.; Riordan, Daniel P.; Brown, Patrick O.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Riordan, Daniel P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Lovejoy, AF (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	lovejoy@stanford.edu; driordan@stanford.edu			Howard Hughes Medical Institute; National Institutes of Health [NIH RO1 CA77097]; Cellular, Biochemical, and Molecular Sciences Predoctoral Research Training Grant from the National Institutes of Health; Stanford Graduate Fellowship; Stanford Genome Training Program from the National Human Genome Research Institute [T32 HG00044]; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular, Biochemical, and Molecular Sciences Predoctoral Research Training Grant from the National Institutes of Health; Stanford Graduate Fellowship(Stanford University); Stanford Genome Training Program from the National Human Genome Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported mainly by the Howard Hughes Medical Institute and by a grant from the National Institutes of Health to POB (NIH RO1 CA77097). POB is an investigator for the Howard Hughes Medical Institute. AFL was partially supported by a Cellular, Biochemical, and Molecular Sciences Predoctoral Research Training Grant from the National Institutes of Health. DPR was partially supported by a Stanford Graduate Fellowship. DPR was also partially supported by the Stanford Genome Training Program (Grant Number T32 HG00044 from the National Human Genome Research Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MZ, 2009, EUKARYOT CELL, V8, P398, DOI 10.1128/EC.00329-08; BAKIN A, 1995, NUCLEIC ACIDS RES, V23, P3290, DOI 10.1093/nar/23.16.3290; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Baudin-Baillieu A, 2009, NUCLEIC ACIDS RES, V37, P7665, DOI 10.1093/nar/gkp816; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Charette M, 2000, IUBMB LIFE, V49, P341; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; DAVIS FF, 1957, J BIOL CHEM, V227, P907; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002; Grosjean H, 2005, TOP CURR GENET, V12, P1, DOI 10.1007/b106848; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; HO NWY, 1971, BIOCHEMISTRY-US, V10, P3651; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; Kladwang W, 2010, BIOCHEMISTRY-US, V49, P7414, DOI 10.1021/bi101123g; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Massenet S, 1999, MOL CELL BIOL, V19, P2142; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; ROTTMAN FM, 1994, BIOCHIMIE, V76, P1109, DOI 10.1016/0300-9084(94)90038-8; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Tuck MT, 1999, INT J BIOCHEM CELL B, V31, P837, DOI 10.1016/S1357-2725(99)00041-2; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yi CQ, 2011, ACCOUNTS CHEM RES, V44, P1380, DOI 10.1021/ar200057m; Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277; Yu AT, 2011, PROTEIN CELL, V2, P712, DOI 10.1007/s13238-011-1087-1; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	43	220	231	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110799	10.1371/journal.pone.0110799	http://dx.doi.org/10.1371/journal.pone.0110799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353621	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200036
J	Pappas, JJ; Petropoulos, S; Suderman, M; Iqbal, M; Moisiadis, V; Turecki, G; Matthews, SG; Szyf, M				Pappas, Jane J.; Petropoulos, Sophie; Suderman, Matthew; Iqbal, Majid; Moisiadis, Vasilis; Turecki, Gustavo; Matthews, Stephen G.; Szyf, Moshe			The Multidrug Resistance 1 Gene Abcb1 in Brain and Placenta: Comparative Analysis in Human and Guinea Pig	PLOS ONE			English	Article							P-GLYCOPROTEIN; MESSENGER-RNA; PHOSPHOGLYCOPROTEIN ABCB1; FETAL PROTECTION; PROGESTERONE; PRESCRIPTION; GESTATION; REGION; TISSUE; CELLS	The Multidrug Resistance 1 (MDR1; alternatively ABCB1) gene product P-glycoprotein (P-gp), an ATP binding cassette transporter, extrudes multiple endogenous and exogenous substrates from the cell, playing an important role in normal physiology and xenobiotic distribution and bioavailability. To date, the predominant animal models used to investigate the role of P-gp have been the mouse and rat, which have two distinct genes, Abcb1a and Abcb1b. In contrast, the human has a single gene, ABCB1, for which only a single isoform has been validated. We and others have previously shown important differences between Abcb1a and Abcb1b, limiting the extrapolation from rodent findings to the human. Since the guinea pig has a relatively long gestation, hemomonochorial placentation and neuroanatomically mature offspring, it is more similar to the human, and may provide a more comparable model for investigating the regulation of P-gp in the brain and placenta, however, to date, the Abcb1 gene in the guinea pig remains to be characterized. The placenta and fetal brain are barrier sites that express P-gp and that play a critical role of protection of the fetus and the fetal brain from maternally administered drugs and other xenobiotics. Using RNA sequencing (RNA-seq), reverse transcription-polymerase chain reaction (RT-PCR) and quantitative PCR (QPCR) to sequence the expressed isoforms of guinea pig Abcb1, we demonstrate that like the human, the guinea pig genome contains one gene for Abcb1 but that it is expressed as at least three different isoforms via alternative splicing and alternate exon usage. Further, we demonstrate that these isoforms are more closely related to human than to rat or mouse isoforms. This striking, overall similarity and evolutionary relatedness between guinea pig Abcb1 and human ABCB1 indicate that the guinea pig represents a relevant animal model for investigating the function and regulation of P-gp in the placenta and brain.	[Pappas, Jane J.; Petropoulos, Sophie; Suderman, Matthew; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Pappas, Jane J.; Iqbal, Majid; Moisiadis, Vasilis; Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Suderman, Matthew] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Suderman, Matthew] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Med, Toronto, ON, Canada	McGill University; University of Toronto; McGill University; McGill University; McGill University; McGill University; McGill University; University of Toronto; University of Toronto	Matthews, SG (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	Stephen.Matthews@utoronto.ca	Petropoulos, Sophie/D-6861-2016; Turecki, Gustavo/K-5100-2015; Petropoulos, Sophie/M-3090-2017; Matthews, Stephen/R-5147-2019; Matthews, Stephen G/N-7555-2018	Petropoulos, Sophie/0000-0003-2293-8238; Matthews, Stephen/0000-0002-9654-9940; Matthews, Stephen G/0000-0002-9654-9940; Turecki, Gustavo/0000-0003-4075-2736; Suderman, Matthew/0000-0002-2715-9930	Canadian Institutes of Health Research: [FRN-57746, FRN-84220]; GlaxoSmithKline	Canadian Institutes of Health Research:(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline(GlaxoSmithKline)	This work was supported by the Canadian Institutes of Health Research: (FRN-57746 and FRN-84220 to SGM and MS). This work was also supported by funding from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; Dean F, 1999, BRAIN RES, V846, P253, DOI 10.1016/S0006-8993(99)02064-8; DEAN M, 2002, HUMAN ATP BINDING CA; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Feinmesser RL, 1996, ONCOGENE, V12, P2725; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glover DD, 2003, AM J OBSTET GYNECOL, V188, P1039, DOI 10.1067/mob.2003.223; Gow JM, 2008, DRUG METAB DISPOS, V36, P10, DOI 10.1124/dmd.107.017087; Haimov-Kochman R, 2006, CLIN CHEM, V52, P159, DOI 10.1373/clinchem.2005.059758; Hembury A, 2008, CELL MOL NEUROBIOL, V28, P915, DOI 10.1007/s10571-008-9277-y; Ikemura K, 2013, MOL PHARMACOL, V83, P399, DOI 10.1124/mol.112.081844; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Kalabis GM, 2005, BIOL REPROD, V73, P591, DOI 10.1095/biolreprod.105.042242; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; Petropoulos S, 2010, BRAIN RES, V1357, P9, DOI 10.1016/j.brainres.2010.08.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIEKARZ RL, 1993, J BIOL CHEM, V268, P7613; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Prokipcak RD, 1999, BIOCHEM BIOPH RES CO, V261, P627, DOI 10.1006/bbrc.1999.1101; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Shang Y, 2013, ONCOGENE; Smit JW, 1999, J CLIN INVEST, V104, P1441, DOI 10.1172/JCI7963; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082062; Yang T, 2013, EXP BIOL MED, V238, P1024, DOI 10.1177/1535370213497321	29	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111135	10.1371/journal.pone.0111135	http://dx.doi.org/10.1371/journal.pone.0111135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353162	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200061
J	Jezzini, SH; Reyes-Colon, D; Sosa, MA				Jezzini, Sami H.; Reyes-Colon, Dalynes; Sosa, Maria A.			Characterization of a Prawn OA/TA Receptor in Xenopus Oocytes Suggests Functional Selectivity between Octopamine and Tyramine	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AGONISTIC BEHAVIOR; BIOGENIC-AMINES; ION CHANNELS; CL-CURRENTS; DROSOPHILA; CLONING; EXPRESSION; ACTIVATION; SEROTONIN	Here we report the characterization of an octopamine/tyramine (OA/TA or TyrR1) receptor (OA/TA(Mac)) cloned from the freshwater prawn, Macrobrachium rosenbergii, an animal used in the study of agonistic social behavior. The invertebrate OA/TA receptors are seven trans-membrane domain G-protein coupled receptors that are related to vertebrate adrenergic receptors. Behavioral studies in arthropods indicate that octopaminergic signaling systems modulate fight or flight behaviors with octopamine and/or tyramine functioning in a similar way to the adrenalins in vertebrate systems. Despite the importance of octopamine signaling in behavioral studies of decapod crustaceans there are no functional data available for any of their octopamine or tyramine receptors. We expressed OA/TA(Mac) in Xenopus oocytes where agonist-evoked transmembrane currents were used as readouts of receptor activity. The currents were most effectively evoked by tyramine but were also evoked by octopamine and dopamine. They were effectively blocked by yohimbine. The electrophysiological approach we used enabled the continuous observation of complex dynamics over time. Using voltage steps, we were able to simultaneously resolve two types of endogenous currents that are affected over different time scales. At higher concentrations we observe that octopamine and tyramine can produce different and opposing effects on both of these currents, presumably through the activity of the single expressed receptor type. The pharmacological profile and apparent functional-selectivity are consistent with properties first observed in the OA/TA receptor from the insect Drosophila melanogaster. As the first functional data reported for any crustacean OA/TA receptor, these results suggest that functional-selectivity between tyramine and octopamine is a feature of this receptor type that may be conserved among arthropods.	[Jezzini, Sami H.; Reyes-Colon, Dalynes; Sosa, Maria A.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Jezzini, Sami H.; Reyes-Colon, Dalynes; Sosa, Maria A.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Reyes-Colon, Dalynes] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Sosa, MA (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.	maria.sosa@upr.edu			National Institutes of Health [MBRS-SCORE S06GM008224, RCMI G12RR03051, MBRS-RISE R25-GM061838]; National Institute of Mental Health [MRISP MH48190]; National Science Foundation [DBI 0115825]; University of Puerto Rico Medical Sciences Campus School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008224, R25GM061838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH048190] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); University of Puerto Rico Medical Sciences Campus School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Supported by National Institutes of Health MBRS-SCORE S06GM008224 (MAS), National Institute of Mental Health MRISP MH48190 (MAS), National Institutes of Health RCMI G12RR03051 (Infrastructure Support to the Institute of Neurobiology), National Science Foundation DBI 0115825 (Infrastructure Support to the Institute of Neurobiology), National Institutes of Health MBRS-RISE R25-GM061838 (DRC), University of Puerto Rico Medical Sciences Campus School of Medicine (SHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, J EXP BIOL, V198, P1691; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; ARAKAWA S, 1990, NEURON, V4, P343, DOI 10.1016/0896-6273(90)90047-J; Bacon JP, 1995, J NEUROPHYSIOL, V74, P2739, DOI 10.1152/jn.1995.74.6.2739; Baier A, 2002, J EXP BIOL, V205, P1233; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Bayliss A, 2013, J NEUROCHEM, V125, P37, DOI 10.1111/jnc.12158; BEAR CE, 1991, J BIOL CHEM, V266, P19142; Beggs KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026809; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Blenau W, 2000, J NEUROCHEM, V74, P900, DOI 10.1046/j.1471-4159.2000.0740900.x; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BREEN CA, 1983, NATURE, V303, P716, DOI 10.1038/303716a0; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Callamaras N, 2000, AM J PHYSIOL-CELL PH, V278, pC667, DOI 10.1152/ajpcell.2000.278.4.C667; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V338, P1189, DOI 10.1016/j.bbrc.2005.10.058; Chang DJ, 2000, P NATL ACAD SCI USA, V97, P1829, DOI 10.1073/pnas.97.4.1829; Diedenhofen B., 2013, COCOR COMP CORRELATI; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Feng GP, 1996, J NEUROSCI, V16, P3925; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fort TJ, 2004, J NEUROPHYSIOL, V92, P3455, DOI 10.1152/jn.00550.2004; Goudeau H, 1998, DEV BIOL, V193, P225, DOI 10.1006/dbio.1997.8799; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Hansen KB, 2009, METHODS MOL BIOL, V552, P343, DOI 10.1007/978-1-60327-317-6_25; Hartzell HC, 1996, J GEN PHYSIOL, V108, P157, DOI 10.1085/jgp.108.3.157; Hoff M, 2011, FASEB J, V25, P2484, DOI 10.1096/fj.11-180703; Homberg U, 2013, J COMP NEUROL, V521, P2025, DOI 10.1002/cne.23269; Huang J, 2012, BRAIN BEHAV IMMUN, V26, P942, DOI 10.1016/j.bbi.2012.04.007; Huang J, 2009, INSECT BIOCHEM MOLEC, V39, P842, DOI 10.1016/j.ibmb.2009.10.001; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kuruma A, 2000, AM J PHYSIOL-CELL PH, V279, pC1401, DOI 10.1152/ajpcell.2000.279.5.C1401; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Lind U, 2010, MOL PHARMACOL, V78, P237, DOI 10.1124/mol.110.063594; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Martinez-Torres A, 2006, P NATL ACAD SCI USA, V103, P5120, DOI 10.1073/pnas.0600739103; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; Oginsky MF, 2010, J COMP NEUROL, V518, P255, DOI 10.1002/cne.22225; Ohta H, 2003, INSECT MOL BIOL, V12, P217, DOI 10.1046/j.1365-2583.2003.00404.x; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; Reale V, 1997, BRAIN RES, V769, P309, DOI 10.1016/S0006-8993(97)00723-3; Rex E, 2002, J NEUROCHEM, V82, P1352, DOI 10.1046/j.1471-4159.2002.01065.x; Reyes-Colon D, 2010, BRAIN RES, V1348, P42, DOI 10.1016/j.brainres.2010.06.021; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rudling JE, 2000, BRIT J PHARMACOL, V131, P933, DOI 10.1038/sj.bjp.0703644; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; Scimemi A, 2009, MOL NEUROBIOL, V40, P289, DOI 10.1007/s12035-009-8087-7; Selcho M, 2014, J COMP NEUROL, V522, P3485, DOI 10.1002/cne.23616; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Shih TM, 1998, METHOD ENZYMOL, V293, P529; Sneddon LU, 2000, J EXP BIOL, V203, P537; Sosa MA, 2002, CRUSTACEAN NERVOUS SYSTEM, P143; Stoffolano JG, 2007, J INSECT PHYSIOL, V53, P1293, DOI 10.1016/j.jinsphys.2007.07.002; Tierney AJ, 2003, MICROSC RES TECHNIQ, V60, P325, DOI 10.1002/jemt.10271; Tierney AJ, 2001, J COMP PHYSIOL A, V187, P757; Tinikul Y, 2009, TISSUE CELL, V41, P430, DOI 10.1016/j.tice.2009.05.001; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vazquez-Acevedo N, 2009, J COMP NEUROL, V513, P399, DOI 10.1002/cne.21979; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Verlinden H, 2010, J INSECT PHYSIOL, V56, P868, DOI 10.1016/j.jinsphys.2010.03.003; Vierk R, 2009, J COMP PHYSIOL A, V195, P265, DOI 10.1007/s00359-008-0404-5; WOODWARD RM, 1992, P NATL ACAD SCI USA, V89, P4708, DOI 10.1073/pnas.89.10.4708	75	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111314	10.1371/journal.pone.0111314	http://dx.doi.org/10.1371/journal.pone.0111314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350749	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100064
J	Alassaad, A; Bertilsson, M; Gillespie, U; Sundstrom, J; Hammarlund-Udenaes, M; Melhus, H				Alassaad, Anna; Bertilsson, Maria; Gillespie, Ulrika; Sundstrom, Johan; Hammarlund-Udenaes, Margareta; Melhus, Hakan			The Effects of Pharmacist Intervention on Emergency Department Visits in Patients 80 Years and Older: Subgroup Analyses by Number of Prescribed Drugs and Appropriate Prescribing	PLOS ONE			English	Article							STOPP SCREENING TOOL; POTENTIALLY INAPPROPRIATE; ELDERLY-PEOPLE; ALERT DOCTORS; PERSONS PRESCRIPTIONS; CONTROLLED-TRIAL; NURSING-HOMES; MEDICATION; QUALITY; CARE	Background: Clinical pharmacist interventions have been shown to have positive effect on occurrence of drug-related issues as well as on clinical outcomes. However, evidence about which patients benefiting most from the interventions is limited. We aimed to explore whether pharmacist intervention is equally effective in preventing emergency department (ED) visits in patients with few or many prescribed drugs and in those with different levels of inappropriate prescribing. Methods: Patient and outcome data from a randomized controlled trial exploring the clinical effects of a ward-based pharmacist intervention in patients, 80 years and older, were used. The patients were divided into subgroups according to the number of prescribed drugs (< 5 or >= 5 drugs) and the level of inappropriate prescribing [using the Screening Tool Of Older People's potentially inappropriate Prescriptions (STOPP) and the Screening Tool to Alert doctors to Right Treatment (START) with a score of >= 2 (STOPP) and >= 1 (START) as cutoff points]. The effect of the intervention on the number of times the different subgroups visited the ED was analyzed. Results: The pharmacist intervention was more effective with respect to the number of subsequent ED visits in patients taking < 5 drugs on admission than in those taking >= 5 drugs. The rate ratio (RR) for a subsequent ED visit was 0.22 [95% confidence interval (CI) 0.09-0.52] for,5 drugs and 0.70 (95% CI 0.47-1.04) for >= 5 drugs (p = 0.02 for the interaction). The effect of intervention did not differ between patients with high or low STOPP or START scores. Conclusion: In this exploratory study, the pharmacist intervention appeared to be more effective in preventing visits to the ED for patients who were taking fewer drugs before the intervention. Our analysis of STOPP and START scores indicated that the level of inappropriate prescribing on admission had no effect on the outcomes of intervention with respect to ED visits.	[Alassaad, Anna; Sundstrom, Johan; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Alassaad, Anna; Gillespie, Ulrika] Univ Uppsala Hosp, Uppsala, Sweden; [Bertilsson, Maria; Sundstrom, Johan] Uppsala Clin Res Ctr, Uppsala, Sweden; [Hammarlund-Udenaes, Margareta] Uppsala Univ, Dept Pharmaceut Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University	Alassaad, A (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	anna.alassaad@medsci.uu.se	Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454	Swedish Academy for Pharmaceutical Sciences	Swedish Academy for Pharmaceutical Sciences	The study was funded by the non-profit organization Swedish Academy for Pharmaceutical Sciences (one PhD student via scholarship). Uppsala University funded biostatistic consulting. The University Hospital of Uppsala and Uppsala University co-funded the study by letting involved physician and pharmacists participate in meetings during work hours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alassaad A, 2013, J EVAL CLIN PRACT, V19, P185, DOI 10.1111/j.1365-2753.2011.01798.x; Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Dormann H, 2013, DTSCH ARZTEBL INT, V110, P213, DOI 10.3238/arztebl.2013.0213; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2009, AGE AGEING, V38, P603, DOI 10.1093/ageing/afp058; Gallagher PF, 2008, AGE AGEING, V37, P96, DOI 10.1093/ageing/afm116; Gillespie U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062401; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Gordon AL, 2014, AGE AGEING, V43, P97, DOI 10.1093/ageing/aft077; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; Hughes CM, 2009, DRUG AGING, V26, P505, DOI 10.2165/00002512-200926060-00007; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; KOCH GG, 1982, BIOMETRICS, V38, P563, DOI 10.2307/2530041; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Olsson J, 2010, CLIN DRUG INVEST, V30, P289, DOI 10.2165/11534320-000000000-00000; PARKIN DM, 1976, BMJ-BRIT MED J, V2, P686, DOI 10.1136/bmj.2.6037.686; Patterson SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008165.pub2; Scott I, 2010, INTERN MED J, V40, P7, DOI 10.1111/j.1445-5994.2009.02040.x; Simonson W, 2005, DRUG AGING, V22, P559, DOI 10.2165/00002512-200522070-00002; Spinewine A, 2007, J AM GERIATR SOC, V55, P658, DOI 10.1111/j.1532-5415.2007.01132.x; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Stokes ME, 2000, CATEGORICAL DATA ANA	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111797	10.1371/journal.pone.0111797	http://dx.doi.org/10.1371/journal.pone.0111797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25364817	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100122
J	Franconi, F; Omboni, S; Ambrosioni, E; Reggiardo, G; Campesi, I; Borghi, C				Franconi, Flavia; Omboni, Stefano; Ambrosioni, Ettore; Reggiardo, Giorgio; Campesi, Ilaria; Borghi, Claudio			Effects of Treatment with Zofenopril in Men and Women with Acute Myocardial Infarction: Gender Analysis of the SMILE Program	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; CORONARY-HEART-DISEASE; VENTRICULAR SYSTOLIC DYSFUNCTION; DOUBLE-BLIND; ANGIOTENSIN; MANAGEMENT; PHARMACOKINETICS; HYPERTENSION; MORTALITY; FRANCE	Background: the SMILE studies proved the prognostic benefit of zofenopril vs. placebo or other ACE-inhibitors (ACEIs) in post-acute myocardial infarction (AMI). In this retrospective pooled analysis of these studies we assessed whether the zofenopril effect is influenced by gender. Methods: the four double-blind, randomized, parallel-group SMILE studies, compared the efficacy and safety of 6-48 week treatment with zofenopril 60 mg/day with that of placebo, lisinopril 10 mg/day or ramipril 10 mg/day in 3630 AMI patients. This pooled analysis compared treatment efficacy (1-year combined occurrence of death or hospitalization for CV causes) in 2733 men and 897 women. Results: women were older than men, had a higher prevalence of diabetes and of other major CV risk factors. The risk of a major CV event was significantly larger for women (23% vs. 17% men, p, 0.001). Between-gender risk difference was more marked for people living in Southern (+ 54%) than in Northern Europe (+ 12%). In both genders zofenopril similarly reduced the 1-year risk of CV morbidity and mortality vs. placebo (-39% men, p = 0.0001; -40% women, p = 0.005). The risk reduction was more marked with zofenopril than with the other ACEIs, particularly in men (-27%, p = 0.012; women: -14%, p = 0.479). The drug safety profile was similar between genders in zofenopril-treated patients, while it was worse in women treated with other ACEIs. Conclusions: post-AMI women are at higher risk of CV complications than men, particularly when living in Mediterranean countries. Their response to ACE-inhibition varies according to the type of drug and is usually better in men.	[Franconi, Flavia; Campesi, Ilaria] Univ Sassari, Lab Gender Med, Natl Inst Biostruct & Biosyst, I-07100 Sassari, Italy; [Franconi, Flavia; Campesi, Ilaria] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Omboni, Stefano] Italian Inst Telemed, Clin Res Unit, Varese, Italy; [Ambrosioni, Ettore; Borghi, Claudio] Univ Bologna, Unit Internal Med, Policlin S Orsola, Bologna, Italy; [Reggiardo, Giorgio] Mediservice, Milan, Italy	University of Sassari; University of Sassari; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Franconi, F (corresponding author), Univ Sassari, Lab Gender Med, Natl Inst Biostruct & Biosyst, I-07100 Sassari, Italy.	franconi@uniss.it	Omboni, Stefano/D-1327-2015; CAMPESI, ILARIA/AAJ-7672-2021; Campesi, Ilaria/AFE-4953-2022; Campesi, Ilaria/AAE-9580-2022	Omboni, Stefano/0000-0002-7124-2096; CAMPESI, ILARIA/0000-0002-1681-6448; 	Menarini International Operations Luxembourg S.A.; Laboratori Guidotti S.p.A.; Istituto Lusofarmaco d'Italia S.p.A. (Menarini Group) through an unconditional and unrestricted grant	Menarini International Operations Luxembourg S.A.; Laboratori Guidotti S.p.A.; Istituto Lusofarmaco d'Italia S.p.A. (Menarini Group) through an unconditional and unrestricted grant	This work was financially supported by Menarini International Operations Luxembourg S.A., Laboratori Guidotti S.p.A. and Istituto Lusofarmaco d'Italia S.p.A. (Menarini Group) through an unconditional and unrestricted grant. The funding source did not influence or commented on planned methods, protocol, data analysis and the draft report.	AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Ambrosioni E, 2007, AM J CARDIOVASC DRUG, V7, P17, DOI 10.2165/00129784-200707010-00002; Borghi C, 2003, AM HEART J, V145, P80, DOI 10.1067/mhj.2003.24; Borghi C, 2012, EXPERT REV CARDIOVAS, V10, P973, DOI [10.1586/ERC.12.81, 10.1586/erc.12.81]; Borghi C, 2012, CLIN CARDIOL, V35, P416, DOI 10.1002/clc.22017; Borghi C, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.12.005; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; Dodd KS, 2011, J AM GERIATR SOC, V59, P506, DOI 10.1111/j.1532-5415.2010.03305.x; Ducimetiere P, 2001, INT J EPIDEMIOL, V30, P1057, DOI 10.1093/ije/30.5.1057; Franconi F, 2014, BRIT J PHARMACOL, V171, P580, DOI 10.1111/bph.12362; Franconi F, 2011, THER DELIV, V2, P1437, DOI 10.4155/TDE.11.117; Franconi F, 2011, CURR PHARM DESIGN, V17, P1095, DOI 10.2174/138161211795656918; Germano G, 2012, EUR HEART J, V33, P137; Hausmann Ricardo, 2011, GLOBAL GENDER GAP RE; Hilliard LM, 2013, CURR HYPERTENS REP, V15, P71, DOI 10.1007/s11906-012-0319-y; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Maas AHEM, 2011, EUR HEART J, V32, P1362, DOI 10.1093/eurheartj/ehr048; Mackay FJ, 1999, BRIT J CLIN PHARMACO, V47, P111; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Montaye M, 2013, EUR J PREV CARDIOL, V20, P275, DOI 10.1177/2047487312438983; Morris RW, 2003, STROKE, V34, P2604, DOI 10.1161/01.STR.0000092489.98235.1D; Omboni S, 2011, THER CLIN RISK MANAG, V7, P459, DOI 10.2147/TCRM.S25976; Papakonstantinou NA, 2013, J CARDIOL, V62, P4, DOI 10.1016/j.jjcc.2013.03.001; Puymirat E, 2013, EUR HEART J-ACUTE CA, V2, P359, DOI 10.1177/2048872613497341; Raz Limor, 2012, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-30726-3_7; Schmotzer GL, 2012, ETHNIC DIS, V22, P226; Seeland Ute, 2012, Handb Exp Pharmacol, P211, DOI 10.1007/978-3-642-30726-3_11; Shah MR, 2000, AM J MED, V109, P489, DOI 10.1016/S0002-9343(00)00529-5; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; Shepherd J, 1996, LANCET, V348, P1339; SLATER EE, 1988, JAMA-J AM MED ASSOC, V260, P967, DOI 10.1001/jama.260.7.967; Solimene MC, 2010, CLINICS, V65, P99, DOI 10.1590/S1807-59322010000100015; von Lueder TG, 2013, CARDIOVASC DRUG THER, V27, P171, DOI 10.1007/s10557-012-6424-y; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Woodard-Grice AV, 2010, PHARMACOGENET GENOM, V20, P532, DOI 10.1097/FPC.0b013e32833d3acb	38	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111558	10.1371/journal.pone.0111558	http://dx.doi.org/10.1371/journal.pone.0111558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364906	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100075
J	Jonsson, U; Alexanderson, K; Kjeldgard, L; Mittendorfer-Rutz, E				Jonsson, Ulf; Alexanderson, Kristina; Kjeldgard, Linnea; Mittendorfer-Rutz, Ellenor			Psychiatric Diagnoses and Risk of Suicidal Behaviour in Young Disability Pensioners: Prospective Cohort Studies of All 19-23 Year Olds in Sweden in 1995, 2000, and 2005, Respectively	PLOS ONE			English	Article							TRENDS; MORTALITY; REGISTER; ADULTS; ADHD	Objective: Increasing rates of disability pension (DP) have been observed among young adults. We studied specific psychiatric DP diagnoses and subsequent risk of suicidal behaviour in a series of three cohorts of young adult in Sweden. Method: In a nationwide register study, we included all young adults who in 1995, 2000, and 2005, respectively, were 19-23 years old and lived in Sweden (n approximate to 500,000 per cohort). Rates of DP and specific psychiatric DP diagnoses were recorded in each cohort. Hazard ratios (HRs) and 95% confidence intervals (CIs) for suicidal behaviour during the following five years, with the corresponding age group as reference, were calculated by Cox proportional hazard regression, adjusted for demographic variables and previous own and parental suicidal behaviour. Results: The overall proportion with DP in this age group increased from 0.92% in 1995 to 2.29% in 2005, with particularly large increases in psychiatric diagnoses such as hyperkinetic disorders, pervasive developmental disorders, and depression/anxiety. The overall proportion of young disability pensioners attempting suicide during the five-year follow-up increased from 2.21% in the 1995 cohort to 3.81% in the 2005 cohort. Within most psychiatric DP diagnoses, the risk of attempted suicide did not change significantly over time, whereas suicide attempts increased in the reference group. Accordingly, the HRs for suicide attempt decreased in some psychiatric DP diagnoses. The highest adjusted HRs were observed for depression/anxiety (16.41; CI: 9.06 to 29.74) and schizophrenia (9.37; 6.13 to 14.31) in the 1995 cohort. The rate of suicide among young disability pensioners during follow-up ranged from 0.19% in 1995 to 0.37% in 2005, mainly occurring in individuals with psychiatric diagnoses. Conclusion: Suicidal behaviour has become more prevalent among young disability pensioners, which co-occurred with an increased tendency to grant DP in psychiatric diagnoses with a known high risk of suicidal behaviour. Preventive measures are warranted.	[Jonsson, Ulf; Alexanderson, Kristina; Kjeldgard, Linnea; Mittendorfer-Rutz, Ellenor] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Jonsson, U (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	ulf.jonsson@ki.se		Kjeldgard, Linnea/0000-0002-4575-7483	Swedish Council for Working Life and Social Research (through the Stockholm Stress Center) [2007-1762, 2009-1758]; Swedish Investigation of Social Insurances; Swedish Research Council [522-2010-2683]	Swedish Council for Working Life and Social Research (through the Stockholm Stress Center); Swedish Investigation of Social Insurances; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by the Swedish Council for Working Life and Social Research (http://www.forte.se/en/) grant numbers 2007-1762 and 20091758 (through the Stockholm Stress Center) and the Swedish Investigation of Social Insurances (http://www.psfu.se/sv/start). EMR is the recipient of the Assistant Professorship grant from the Swedish Research Council (grant number 522-2010-2683) (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bernitz BK, 2013, SCAND J PUBLIC HEALT, V41, P3, DOI 10.1177/1403494813496931; Bolte S, 2013, EUR CHILD ADOLESC PS; Bolte S, 2014, AUTISM RES, V7, P167, DOI 10.1002/aur.1335; Daniel SS, 2009, SUICIDE LIFE-THREAT, V39, P252, DOI 10.1521/suli.2009.39.3.252; Druss BG, 2009, MOL PSYCHIATR, V14, P728, DOI 10.1038/mp.2008.13; Erikson R, 2006, SOC SCI MED, V62, P2151, DOI 10.1016/j.socscimed.2005.09.009; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; JARVISALO J., 2005, MENTAL DISORDERS MAJ; Jonsson U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002286; Lager A, 2012, SCAND J PUBLIC HEALT, V40, P42, DOI 10.1177/1403494812459459; LJUNGDAHL LO, 1991, SCAND J SOC MED, V19, P148, DOI 10.1177/140349489101900302; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mandell DS, 2005, PSYCHIAT SERV, V56, P56, DOI 10.1176/appi.ps.56.1.56; Mittendorfer-Rutz E, 2014, PSYCHOL MED, V44, P2331, DOI 10.1017/S0033291713003097; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; OECD, 2013, HLTH GLANC 2013 OECD; OECD, 2003, TRANSF DIS AB POL PR; Ramberg IL, 2000, PSYCHOL MED, V30, P1189, DOI 10.1017/S003329179900238X; Robinson J, 2011, AUST NZ J PSYCHIAT, V45, P3, DOI 10.3109/00048674.2010.511147; Robison LM, 2005, PSYCHIAT SERV, V56, P1497, DOI 10.1176/appi.ps.56.12.1497; Rutz EM, 2004, EUR CHILD ADOLES PSY, V13, P321, DOI 10.1007/s00787-004-0406-y; Social Insurance Agency, 2012, SOC INS FIG 2012; Social Security Administration, 2012, FAST FACTS FIG SOC S; van der Feltz-Cornelis CM, 2011, CRISIS, V32, P319, DOI 10.1027/0227-5910/a000109; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; *WHO, 1993, INT STAT CLASS DIS	29	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111618	10.1371/journal.pone.0111618	http://dx.doi.org/10.1371/journal.pone.0111618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365217	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100089
J	Lan, WZ; Feldkaemper, M; Schaeffel, F				Lan, Weizhong; Feldkaemper, Marita; Schaeffel, Frank			Intermittent Episodes of Bright Light Suppress Myopia in the Chicken More than Continuous Bright Light	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; LENS-INDUCED MYOPIA; DOPAMINE RELEASE; RETINAL DOPAMINE; OUTDOOR ACTIVITY; REFRACTIVE DEVELOPMENT; ENDOGENOUS DOPAMINE; AMBIENT ILLUMINANCE; AMACRINE NEURONS; MUDPUPPY RETINA	Purpose: Bright light has been shown a powerful inhibitor of myopia development in animal models. We studied which temporal patterns of bright light are the most potent in suppressing deprivation myopia in chickens. Methods: Eight-day-old chickens wore diffusers over one eye to induce deprivation myopia. A reference group (n = 8) was kept under office-like illuminance (500 lux) at a 10:14 light:dark cycle. Episodes of bright light (15 000 lux) were superimposed on this background as follows. Paradigm I:exposure to constant bright light for either 1 hour (n = 5), 2 hours (n = 5), 5 hours (n = 4) or 10 hours (n = 4). Paradigm II:exposure to repeated cycles of bright light with 50% duty cycle and either 60 minutes (n = 7), 30 minutes (n = 8), 15 minutes (n = 6), 7 minutes (n = 7) or 1 minute (n = 7) periods, provided for 10 hours. Refraction and axial length were measured prior to and immediately after the 5-day experiment. Relative changes were analyzed by paired t-tests, and differences among groups were tested by one-way ANOVA. Results: Compared with the reference group, exposure to continuous bright light for 1 or 2 hours every day had no significant protective effect against deprivation myopia. Inhibition of myopia became significant after 5 hours of bright light exposure but extending the duration to 10 hours did not offer an additional benefit. In comparison, repeated cycles of 1:1 or 7:7 minutes of bright light enhanced the protective effect against myopia and could fully suppress its development. Conclusions: The protective effect of bright light depends on the exposure duration and, to the intermittent form, the frequency cycle. Compared to the saturation effect of continuous bright light, low frequency cycles of bright light (1:1 min) provided the strongest inhibition effect. However, our quantitative results probably might not be directly translated into humans, but rather need further amendments in clinical studies.	[Lan, Weizhong; Feldkaemper, Marita; Schaeffel, Frank] Univ Tubingen, Ctr Ophthalmol, Sect Neurobiol Eye, Tubingen, Germany; [Lan, Weizhong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Lan, Weizhong] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Sun Yat Sen University; Eberhard Karls University of Tubingen	Lan, WZ (corresponding author), Univ Tubingen, Ctr Ophthalmol, Sect Neurobiol Eye, Tubingen, Germany.	brucelarm@gmail.com		Feldkaemper, Marita Pauline/0000-0001-6938-3714; Lan, Weizhong/0000-0002-3829-7415	National Natural Science Foundation of China, Beijing, China [81170871, 81200714]; German Academic Exchange Service (DAAD)	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from National Natural Science Foundation of China, Beijing, China (grant no.: 81170871, 81200714), (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html) and a scholarship from German Academic Exchange Service (DAAD), (https://www.daad.de) awarded to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P5247, DOI 10.1167/iovs.09-4689; Backhouse S, 2013, OPHTHAL PHYSL OPT, V33, P563, DOI 10.1111/opo.12069; BESHARSE JC, 1992, NEUROCHEM INT, V20, P193, DOI 10.1016/0197-0186(92)90167-P; BOATRIGHT JH, 1989, BRAIN RES, V482, P164, DOI 10.1016/0006-8993(89)90555-6; BRAINARD GC, 1987, BRAIN RES, V424, P199, DOI 10.1016/0006-8993(87)91211-X; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Cohen Y, 2012, EXP EYE RES, V103, P33, DOI 10.1016/j.exer.2012.08.004; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; DONG CJ, 1992, J NEUROPHYSIOL, V67, P364, DOI 10.1152/jn.1992.67.2.364; DONG CJ, 1991, J PHYSIOL-LONDON, V440, P291, DOI 10.1113/jphysiol.1991.sp018709; French AN, 2013, EXP EYE RES, V114, P58, DOI 10.1016/j.exer.2013.04.018; Gandini S, 2011, PROG BIOPHYS MOL BIO, V107, P362, DOI 10.1016/j.pbiomolbio.2011.09.011; Gao QY, 2006, GRAEF ARCH CLIN EXP, V244, P1329, DOI 10.1007/s00417-006-0254-1; GOTTLIEB M D, 1987, Society for Neuroscience Abstracts, V13, P1297; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Hammond DS, 2012, VISION RES, V67, P44, DOI 10.1016/j.visres.2012.06.021; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; IUVONE PM, 1989, VISUAL NEUROSCI, V2, P465, DOI 10.1017/S0952523800012360; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; IUVONE PM, 1978, SCIENCE, V202, P901, DOI 10.1126/science.30997; Jobke S, 2008, CLIN OPHTHALMOL, V2, P601; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; KIRSCH M, 1989, VISION RES, V29, P147, DOI 10.1016/0042-6989(89)90120-X; KRAMER SG, 1971, INVEST OPHTH VISUAL, V10, P438; LI T, 1995, VISION RES, V35, P1203, DOI 10.1016/0042-6989(94)00231-A; Megaw PL, 2006, NEUROCHEM INT, V48, P17, DOI 10.1016/j.neuint.2005.08.004; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P355, DOI 10.1111/opo.12059; Morgan IG., 2012, INVEST OPHTH VIS SCI, V53, P2735; Mutti DO, 2011, OPTOMETRY VISION SCI, V88, P377, DOI 10.1097/OPX.0b013e31820b0385; Nickla DL, 2010, EXP EYE RES, V91, P715, DOI 10.1016/j.exer.2010.08.021; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Onal S, 2007, OPTOMETRY VISION SCI, V84, P175, DOI 10.1097/OPX.0b013e3180335c52; ROHRER B, 1993, VISUAL NEUROSCI, V10, P447, DOI 10.1017/S0952523800004673; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; SCHAEFFEL F, 1995, VISION RES, V35, P1247, DOI 10.1016/0042-6989(94)00221-7; SCHAEFFEL F, 1991, VISION RES, V31, P717, DOI 10.1016/0042-6989(91)90011-S; Schmid KL, 2004, OPTOMETRY VISION SCI, V81, P137, DOI 10.1097/00006324-200402000-00012; Seidemann A, 2002, VISION RES, V42, P2409, DOI 10.1016/S0042-6989(02)00262-6; Siegwart Jr JT, 2011, VITAMIN D3 SUPPLEMEN; Siegwart JT, 2012, ARVO M ABSTR INV OPH, V53, P3457; Smith EL, 2013, INVEST OPHTH VIS SCI, V54, P2959, DOI 10.1167/iovs.13-11713; Smith EL, 2012, INVEST OPHTH VIS SCI, V53, P421, DOI 10.1167/iovs.11-8652; SMITH EL, 1987, INVEST OPHTH VIS SCI, V28, P1236; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; UMINO O, 1991, VISUAL NEUROSCI, V7, P451, DOI 10.1017/S0952523800009743; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; WEISS S, 1993, J COMP PHYSIOL A, V172, P263, DOI 10.1007/BF00216608; Wolfram C, 2014, BRIT J OPHTHALMOL, V55, P2041; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Yi Jun-Hui, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P32; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhu XY, 2013, INVEST OPHTH VIS SCI, V54, P2634, DOI 10.1167/iovs.12-10514	57	37	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110906	10.1371/journal.pone.0110906	http://dx.doi.org/10.1371/journal.pone.0110906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360635	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700051
J	Lavallee, LT; Schramm, D; Witiuk, K; Mallick, R; Fergusson, D; Morash, C; Cagiannos, I; Breau, RH				Lavallee, Luke T.; Schramm, David; Witiuk, Kelsey; Mallick, Ranjeeta; Fergusson, Dean; Morash, Christopher; Cagiannos, Ilias; Breau, Rodney H.			Peri-Operative Morbidity Associated with Radical Cystectomy in a Multicenter Database of Community and Academic Hospitals	PLOS ONE			English	Article							BLADDER-CANCER; COMPLICATIONS; MORTALITY; RECOVERY; SURGERY; VOLUME; CARE	Objective: To characterize the frequency and timing of complications following radical cystectomy in a cohort of patients treated at community and academic hospitals. Patients and Methods: Radical cystectomy patients captured from NSQIP hospitals from January 1 2006 to December 31 2012 were included. Baseline information and complications were abstracted by study surgical clinical reviewers through a validated process of medical record review and direct patient contact. We determined the incidence and timing of each complication and calculated their associations with patient and operative characteristics. Results: 2303 radical cystectomy patients met inclusion criteria. 1115 (48%) patients were over 70 years old and 1819 (79%) were male. Median hospital stay was 8 days (IQR 7-13 days). 1273 (55.3%) patients experienced at least 1 post-operative complication of which 191 (15.6%) occurred after hospital discharge. The most common complication was blood transfusion (n = 875; 38.0%), followed by infectious complications with 218 (9.5%) urinary tract infections, 193 (8.4%) surgical site infections, and 223 (9.7%) sepsis events. 73 (3.2%) patients had fascial dehiscence, 82 (4.0%) developed a deep vein thrombosis, and 67 (2.9%) died. Factors independently associated with the occurrence of any post-operative complication included: age, female gender, ASA class, pre-operative sepsis, COPD, low serum albumin concentration, pre-operative radiotherapy, pre-operative transfusion >4 units, and operative time >6 hours (all p<0.05). Conclusion: Complications remain common following radical cystectomy and a considerable proportion occur after discharge from hospital. This study identifies risk factors for complications and quality improvement needs.	[Lavallee, Luke T.; Morash, Christopher; Cagiannos, Ilias; Breau, Rodney H.] Univ Ottawa, Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada; [Lavallee, Luke T.; Schramm, David; Witiuk, Kelsey; Mallick, Ranjeeta; Fergusson, Dean; Breau, Rodney H.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Schramm, David] Univ Ottawa, Ottawa Hosp, Dept Otolaryngol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Breau, RH (corresponding author), Univ Ottawa, Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada.	rbreau@toh.on.ca		Fergusson, Dean/0000-0002-3389-2485; Schramm, David/0000-0002-6875-3709; Breau, Rodney/0000-0003-2344-9022				Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Cerantola Y, 2013, CLIN NUTR, V32, P879, DOI 10.1016/j.clnu.2013.09.014; Chang SS, 2002, J UROLOGY, V167, P2012, DOI 10.1016/S0022-5347(05)65074-4; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Hollenbeck BK, 2005, J UROLOGY, V174, P1231, DOI 10.1097/01.ju.0000173923.35338.99; Hu M, 2014, CANCER; Karl A, 2014, J UROLOGY, V191, P335, DOI 10.1016/j.juro.2013.08.019; Kulkarni GS, 2013, CANCER-AM CANCER SOC, V119, P3546, DOI 10.1002/cncr.28235; Lawrentschuk N, 2010, EUR UROL, V57, P983, DOI 10.1016/j.eururo.2010.02.024; Lee KL, 2004, UROLOGY, V63, P1095, DOI 10.1016/j.urology.2004.01.029; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Shabsigh A, 2009, EUR UROL, V55, P164, DOI 10.1016/j.eururo.2008.07.031; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Thompson IM, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.06.006; Yu HY, 2012, EUR UROL, V61, P1239, DOI 10.1016/j.eururo.2012.03.032	17	82	82	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111281	10.1371/journal.pone.0111281	http://dx.doi.org/10.1371/journal.pone.0111281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360904	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700083
J	Wang, XB; Cui, NH; Yang, J; Qiu, XP; Gao, JJ; Yang, N; Zheng, F				Wang, Xue-bin; Cui, Ning-hua; Yang, Jie; Qiu, Xue-ping; Gao, Jia-jia; Yang, Na; Zheng, Fang			Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; RISK-FACTORS; ACE GENE; DNA POLYMORPHISMS; I/D POLYMORPHISM; APOLIPOPROTEIN-E; ASSOCIATION; SUSCEPTIBILITY; GENOTYPE; ALLELE	Angiotensin-converting enzyme gene (ACE) insertion/deletion (I/D) polymorphism have long been linked to sporadic Alzheimer disease (SAD), but the established data remained controversial. To clarify this inconsistency, a comprehensive meta-analysis was conducted. Through searching of Pubmed, Embase, Alzgene, China National Knowledge Infrastructure (CNKI) and manually searching relevant references, 53 independent studies from 48 articles were included, involving a total of 8153 cases and 14932 controls. The strength of association was assessed by using odds ratios (ORs) with 95% confidence intervals (CIs). Further stratified analyses and heterogeneity analyses were tested, as was publication bias. Overall, significant associations were revealed between I/D polymorphism and SAD risk using allelic comparison (OR = 1.09, 95% CI = 1.01-1.17, p = 0.030), homozygote comparison (OR = 1.17, 95% CI = 1.01-1.34, p = 0.030) and the dominant model (OR = 1.16, 95% CI = 1.04-1.29, p = 0.008), but they were not sufficiently robust to withstand the false-positive report probability (FPRP) analyses. Otherwise, in subgroup analyses restricted to the high quality studies, the large sample size studies and studies with population-based controls, no significant association was observed in any genetic models. In summary, the current meta-analysis suggested that the ACE I/D polymorphism is unlikely to be a major determining factor in the development of SAD.	[Wang, Xue-bin; Yang, Jie; Qiu, Xue-ping; Gao, Jia-jia; Yang, Na; Zheng, Fang] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China; [Cui, Ning-hua] Childrens Hosp Zhengzhou, Dept Clin Lab, Zhengzhou, Henan, Peoples R China	Wuhan University	Zheng, F (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China.	zhengfang@whu.edu.cn			National Basic Research Program of China (973 Program) [2012CB720600]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants from the National Basic Research Program of China (973 Program, 2012CB720600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 1999, J NEUROL NEUROSUR PS, V67, P733, DOI 10.1136/jnnp.67.6.733; Amouyel P, 2000, ANN NY ACAD SCI, V903, P437, DOI 10.1111/j.1749-6632.2000.tb06395.x; Arlt S, 2013, CURR ALZHEIMER RES, V10, P72; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Biller H, 2006, EUR RESPIR J, V28, P1085, DOI 10.1183/09031936.00050106; Buss S, 2002, AM J MED GENET, V114, P440, DOI 10.1002/ajmg.10306; Camelo D, 2004, J NEUROL SCI, V218, P47, DOI 10.1016/j.jns.2003.10.008; Carbonell J, 2003, PSYCHIAT GENET, V13, P47, DOI 10.1097/00041444-200303000-00008; Chalmers KA, 2004, NEUROREPORT, V15, P95, DOI 10.1097/00001756-200401190-00019; Chapman J, 1998, STROKE, V29, P1401, DOI 10.1161/01.STR.29.7.1401; Cheng CY, 2002, EUR NEUROL, V47, P26, DOI 10.1159/000047943; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; Crawford F, 2000, NEUROSCI LETT, V280, P215, DOI 10.1016/S0304-3940(00)00791-6; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elkins JS, 2004, NEUROLOGY, V62, P363, DOI 10.1212/01.WNL.0000106823.72493.FF; Farrer LA, 2000, ARCH NEUROL-CHICAGO, V57, P210, DOI 10.1001/archneur.57.2.210; Feng YQ, 2004, CHIN J GERIATR HEART, V6, P181; FOGARTY DG, 1994, LANCET, V343, P851, DOI 10.1016/S0140-6736(94)92050-8; Han B, 2008, J SHANXI MED U, V39, P692; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu J, 1999, NEUROSCI LETT, V277, P65, DOI 10.1016/S0304-3940(99)00827-7; Huy NT, 2010, CRIT CARE, V14, DOI 10.1186/cc9268; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Isbir T, 2000, CELL BIOCHEM FUNCT, V18, P141, DOI 10.1002/(SICI)1099-0844(200006)18:2<141::AID-CBF856>3.3.CO;2-#; Isbir T, 2001, Am J Alzheimers Dis Other Demen, V16, P205, DOI 10.1177/153331750101600407; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kehoe PG, 2003, HUM MOL GENET, V12, P859, DOI 10.1093/hmg/ddg094; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Keikhaee MR, 2006, NEUROCHEM RES, V31, P1079, DOI 10.1007/s11064-006-9119-6; Kolsch H, 2005, NEUROSCI LETT, V377, P37, DOI 10.1016/j.neulet.2004.11.062; Langan D, 2012, J CLIN EPIDEMIOL, V65, P511, DOI 10.1016/j.jclinepi.2011.10.009; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; Lendon CL, 2002, NEUROSCI LETT, V328, P314, DOI 10.1016/S0304-3940(02)00553-0; Liu M, 2007, CHINESE J PRACTICAL, V13, P1028; Lucatelli JF, 2011, NEUROCHEM RES, V36, P1533, DOI 10.1007/s11064-011-0481-7; Mattila KM, 2000, J MED GENET, V37, P766, DOI 10.1136/jmg.37.10.766; Meng Y, 2006, AM J HUM GENET, V78, P871, DOI 10.1086/503687; Miners S, 2009, AM J TRANSL RES, V1, P163; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monastero R, 2002, NEUROSCI LETT, V335, P147, DOI 10.1016/S0304-3940(02)01182-5; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Myllykangas L, 2000, NEUROSCI LETT, V292, P195, DOI 10.1016/S0304-3940(00)01467-1; Nacmias B, 2007, ARCH GERONTOL GERIAT, V45, P201, DOI 10.1016/j.archger.2006.10.011; Narain Y, 2000, J MED GENET, V37, P695, DOI 10.1136/jmg.37.9.695; Ning M, 2010, ALZ DIS ASSOC DIS, V24, P390, DOI 10.1097/WAD.0b013e3181e6a575; Nirmal S, 2011, INT J NEUROSCI, V121, P557, DOI 10.3109/00207454.2011.591513; Palumbo B, 1999, NEUROSCI LETT, V267, P97, DOI 10.1016/S0304-3940(99)00329-8; Panza F, 2003, J NEUROL NEUROSUR PS, V74, P1159, DOI 10.1136/jnnp.74.8.1159; Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304; Perry RT, 2001, AM J MED GENET, V105, P332, DOI 10.1002/ajmg.1371; Richard F, 2001, NEUROLOGY, V56, P1593, DOI 10.1212/WNL.56.11.1593; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Scacchi R, 1998, DEMENT GERIATR COGN, V9, P186, DOI 10.1159/000017045; Schjeide BM, 2009, NEUROGENETICS, V10, P19, DOI 10.1007/s10048-008-0151-3; Seripa D, 2003, NEUROBIOL AGING, V24, P933, DOI 10.1016/S0197-4580(03)00040-X; Shcherbatykh T V, 2001, Neurosci Behav Physiol, V31, P179, DOI 10.1023/A:1005264324466; Shinohara M, 2014, BRAIN, V137, P1533, DOI 10.1093/brain/awu046; Sleegers K, 2005, NEUROBIOL AGING, V26, P1153, DOI 10.1016/j.neurobiolaging.2004.09.011; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; van Esch JHM, 2008, J HYPERTENS, V26, P706, DOI 10.1097/HJH.0b013e3282f465d2; Vardy ERLC, 2009, J ALZHEIMERS DIS, V16, P609, DOI 10.3233/JAD-2009-1002; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakutani Y, 2002, ANN NY ACAD SCI, V977, P232, DOI 10.1111/j.1749-6632.2002.tb04820.x; Wang B, 2010, J HEPATOL, V53, P508, DOI 10.1016/j.jhep.2010.03.026; Wang BB, 2006, J MOL NEUROSCI, V30, P267, DOI 10.1385/JMN:30:3:267; Wang HK, 2006, J NEURAL TRANSM, V113, P1499, DOI 10.1007/s00702-005-0424-z; Wehr H, 2006, DEMENT GERIATR COGN, V22, P1, DOI 10.1159/000092845; Wu Chuanshen, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P401; Wu JJ, 2012, CLIN CANCER RES, V18, P3972, DOI 10.1158/1078-0432.CCR-11-1531; Wu SJ, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.01.003; Yang JD, 2000, NEUROSCI LETT, V295, P41, DOI 10.1016/S0304-3940(00)01591-3; Yang YH, 2008, TOHOKU J EXP MED, V215, P295, DOI 10.1620/tjem.215.295; Yang YH, 2011, AGE AGEING, V40, P238, DOI 10.1093/ageing/afq179; [张淑萍 Zhang Shuping], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P259; Zhang JW, 2005, DEMENT GERIATR COGN, V20, P52, DOI 10.1159/000085075; Zhang ZS, 2012, NEUROSCI LETT, V514, P131, DOI 10.1016/j.neulet.2012.02.074; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011; Zuliani G, 2001, ACTA NEUROL SCAND, V103, P304, DOI 10.1034/j.1600-0404.2001.103005304.x	85	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111406	10.1371/journal.pone.0111406	http://dx.doi.org/10.1371/journal.pone.0111406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360660	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700100
J	Kawamura, T; Miyagawa, S; Fukushima, S; Yoshida, A; Kashiyama, N; Kawamura, A; Ito, E; Saito, A; Maeda, A; Eguchi, H; Toda, K; Lee, JK; Miyagawa, S; Sawa, Y				Kawamura, Takuji; Miyagawa, Shigeru; Fukushima, Satsuki; Yoshida, Akira; Kashiyama, Noriyuki; Kawamura, Ai; Ito, Emiko; Saito, Atsuhiro; Maeda, Akira; Eguchi, Hiroshi; Toda, Koichi; Lee, Jong-Kook; Miyagawa, Shuji; Sawa, Yoshiki			N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							DIFFERENTIATION; MOUSE; GLYCOSYLATION; DISEASE; DISCOVERY; EMBRYOS; ACID	Cell surface glycans vary widely, depending on cell properties. We hypothesized that glycan expression on induced pluripotent stem cells (iPSCs) might change during cardiomyogenic differentiation toward the myocardial phenotype. N-glycans were isolated from iPSCs, iPSC-derived cardiomyocytes (iPSC-CM), and original C57BL/6 mouse myocardium (Heart). Their structures were analyzed by a mapping technique based on HPLC elution times and MALDI-TOF/MS spectra. Sixty-eight different N-glycans were isolated; the structures of 60 of these N-glycans were identified. The quantity of high-mannose type (immature) N-glycans on the iPSCs decreased with cardiomyogenic differentiation, but did not reach the low levels observed in the heart. We observed a similar reduction in neutral N-glycans and an increase in fucosylated or sialyl N-glycans. Some structural differences were detected between iPSC-CM and Heart. No N-glycolyl neuraminic acid (NeuGc) structures were detected in iPSC-CM, whereas the heart contained numerous NeuGc structures, corresponding to the expression of cytidine monophosphate-N-acetylneuraminic acid hydroxylase. Furthermore, several glycans containing Gal alpha 1-6 Gal, rarely identified in the other cells, were detected in the iPSC-CM. The expression of N-glycan on murine iPSCs changed toward the myocardial phenotype during cardiomyogenic differentiation, leaving the structural differences of NeuGc content or Gal alpha 1-6 Gal structures. Further studies will be warranted to reveal the meaning of the difference of N-glycans between the iPSC-CM and the myocardium.	[Kawamura, Takuji; Miyagawa, Shigeru; Fukushima, Satsuki; Kashiyama, Noriyuki; Kawamura, Ai; Ito, Emiko; Saito, Atsuhiro; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Yoshida, Akira; Lee, Jong-Kook] Osaka Univ, Grad Sch Med, Dept Cardiovasc Regenerat Med, Suita, Osaka, Japan; [Maeda, Akira; Eguchi, Hiroshi; Miyagawa, Shuji] Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Maeda, Akira/0000-0001-7334-5438; Miyagawa, Shigeru/0000-0003-0015-6569	Research Center Network for Realization of Regenerative Medicine; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [26293188, 25670593] Funding Source: KAKEN	Research Center Network for Realization of Regenerative Medicine; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YS received the funding to support this work from the Research Center Network for Realization of Regenerative Medicine managed by Centers for Clinical Application Research on Specific Disease/Organ and funded by Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Amano M, 2010, MOL CELL PROTEOMICS, V9, P523, DOI 10.1074/mcp.M900559-MCP200; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Gonzales C, 2009, EXP CELL RES, V315, P3077, DOI 10.1016/j.yexcr.2009.09.006; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hasehira K, 2012, MOL CELL PROTEOMICS, V11, P1913, DOI 10.1074/mcp.M112.020586; Hato M, 2006, MOL CELL PROTEOMICS, V5, P2146, DOI 10.1074/mcp.M600213-MCP200; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kraushaar DC, 2012, J BIOL CHEM, V287, P22691, DOI 10.1074/jbc.M112.368241; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Miki K, 2012, STEM CELL TRANSL MED, V1, P430, DOI 10.5966/sctm.2011-0038; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Sinnecker D, 2013, CIRC RES, V112, P961, DOI 10.1161/CIRCRESAHA.112.268623; SURANI MAH, 1979, CELL, V18, P217; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Yu T, 2013, CIRC J, V77, P1297, DOI 10.1253/circj.CJ-12-0977	32	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111064	10.1371/journal.pone.0111064	http://dx.doi.org/10.1371/journal.pone.0111064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357199	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000039
J	Kellner, KF; Swihart, RK				Kellner, Kenneth F.; Swihart, Robert K.			Accounting for Imperfect Detection in Ecology: A Quantitative Review	PLOS ONE			English	Review							ESTIMATING SPECIES RICHNESS; ESTIMATING POPULATION-SIZE; ESTIMATING SITE OCCUPANCY; CAPTURE-RECAPTURE DATA; LESS-THAN ONE; MARK-RECAPTURE; DETECTION PROBABILITY; PLANT-DISTRIBUTION; SURVIVAL RATES; BIRD SURVEYS	Detection in studies of species abundance and distribution is often imperfect. Assuming perfect detection introduces bias into estimation that can weaken inference upon which understanding and policy are based. Despite availability of numerous methods designed to address this assumption, many refereed papers in ecology fail to account for non-detection error. We conducted a quantitative literature review of 537 ecological articles to measure the degree to which studies of different taxa, at various scales, and over time have accounted for imperfect detection. Overall, just 23% of articles accounted for imperfect detection. The probability that an article incorporated imperfect detection increased with time and varied among taxa studied; studies of vertebrates were more likely to incorporate imperfect detection. Among articles that reported detection probability, 70% contained per-survey estimates of detection that were less than 0.5. For articles in which constancy of detection was tested, 86% reported significant variation. We hope that our findings prompt more ecologists to consider carefully the detection process when designing studies and analyzing results, especially for subdisciplines where incorporation of imperfect detection in study design and analysis so far has been lacking.	[Kellner, Kenneth F.; Swihart, Robert K.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kellner, KF (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	kkellner@purdue.edu	Swihart, Robert K/D-2787-2016		Purdue University Graduate School; Purdue Department of Forestry and Natural Resources	Purdue University Graduate School; Purdue Department of Forestry and Natural Resources	Funding was provided by the Purdue University Graduate School and the Purdue Department of Forestry and Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052762; Alexander HM, 2009, J ECOL, V97, P267, DOI 10.1111/j.1365-2745.2008.01468.x; [Anonymous], 1978, USERS MANUAL PROGRAM; Bart J, 2004, WILDLIFE SOC B, V32, P1242, DOI 10.2193/0091-7648(2004)032[1242:DEIWS]2.0.CO;2; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckland Stephen T., 2011, P25; BURNHAM KP, 1981, STUDIES AVIAN BIOL, V6, P324; CAUGHLEY G, 1972, J WILDLIFE MANAGE, V36, P135, DOI 10.2307/3799197; Chen GK, 2013, J ECOL, V101, P183, DOI 10.1111/1365-2745.12021; Chen GK, 2009, J ECOL, V97, P1383, DOI 10.1111/j.1365-2745.2009.01560.x; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Clark J. S, 2007, MODELS ECOLOGICAL DA; Cooper CB, 2008, ECOLOGY, V89, P3349, DOI 10.1890/08-0315.1; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Dettmers R, 1999, J WILDLIFE MANAGE, V63, P815, DOI 10.2307/3802794; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2012, BIOMETRICS, V68, P1303, DOI 10.1111/j.1541-0420.2012.01779.x; Efford MG, 2014, SECR SPATIALLY EXPLI; Ellingson AR, 2003, WILDLIFE SOC B, V31, P896; Ergon T, 2014, METHODS ECOL EVOL, V5, P1327, DOI 10.1111/2041-210X.12133; Fiske I, 2014, UNMARKED MODELS DATA; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Gilroy JJ, 2012, ECOLOGY, V93, P1509, DOI 10.1890/12-0124.1; Gimenez O, 2008, AM NAT, V172, P441, DOI 10.1086/589520; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Guillera-Arroita G, 2011, J AGR BIOL ENVIR ST, V16, P301, DOI 10.1007/s13253-010-0053-3; Hines J., 2006, PRESENCE2 SOFTWARE E; Hines JE, 1999, BIRD STUDY, V46, P209; Hutto RL, 2003, WILDLIFE SOC B, V31, P903; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kellner KF, 2013, J WILDLIFE MANAGE, V77, P1650, DOI 10.1002/jwmg.613; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M., 2010, INTRO WINBUGS ECOLOG; Laake J, 2014, MARKED R CODE MARK R; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Lele SR, 2012, J PLANT ECOL-UK, V5, P22, DOI 10.1093/jpe/rtr042; Lichti NI, 2014, ECOLOGY, V95, P1746, DOI 10.1890/13-1657.1; Lincoln F.C., 1930, 118 USDA; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; NICHOLS JD, 1983, J MAMMAL, V64, P253, DOI 10.2307/1380555; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; OTIS DL, 1978, WILDLIFE MONOGR, P1; Petersen C. G. J., 1896, REPORT DANISH BIOL S, V6, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Plummer M., 2003, P 3 INT WORKSH DISTR; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Pollock KH, 1990, WILDL MONOGR, V107; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rosenbaum PR., 2005, ENCY STAT BEHAV SCI, P1451; Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Royle J. Andrew, 2012, Journal of Ornithology, V152, pS521, DOI 10.1007/s10336-010-0619-4; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2014, SPATIAL CAPTURERECAP; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shefferson RP, 2001, ECOLOGY, V82, P145, DOI 10.2307/2680092; Su Y., 2014, R2JAGS PACKAGE RUNNI; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Tingley MW, 2013, ECOLOGY, V94, P598, DOI 10.1890/12-0928.1; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Urban NA, 2012, ECOL INDIC, V15, P188, DOI 10.1016/j.ecolind.2011.09.031; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	85	166	167	3	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111436	10.1371/journal.pone.0111436	http://dx.doi.org/10.1371/journal.pone.0111436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356904	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000060
J	Miyake, A; Chitose, T; Kamei, E; Murakami, A; Nakayama, Y; Konishi, M; Itoh, N				Miyake, Ayumi; Chitose, Tatsuya; Kamei, Eriko; Murakami, Atsuko; Nakayama, Yoshiaki; Konishi, Morichika; Itoh, Nobuyuki			Fgf16 Is Required for Specification of GABAergic Neurons and Oligodendrocytes in the Zebrafish Forebrain	PLOS ONE			English	Article							SONIC HEDGEHOG; PROMOTES NEUROGENESIS; ISTHMIC ORGANIZER; GROWTH-FACTOR; CELL FATE; EXPRESSION; DIFFERENTIATION; HINDBRAIN; GENES; PROLIFERATION	Fibroblast growth factor (Fgf) signaling plays crucial roles in various developmental processes including those in the brain. We examined the role of Fgf16 in the formation of the zebrafish brain. The knockdown of fgf16 decreased cell proliferation in the forebrain and midbrain. fgf16 was also essential for development of the ventral telencephalon and diencephalon, whereas fgf16 was not required for dorsoventral patterning in the midbrain. fgf16 was additionally required for the specification and differentiation of gamma-aminobutyric acid (GABA) ergic interneurons and oligodendrocytes, but not for those of glutamatergic neurons in the forebrain. Cross talk between Fgf and Hedgehog (Hh) signaling was critical for the specification of GABAergic interneurons and oligodendrocytes. The expression of fgf16 in the forebrain was down-regulated by the inhibition of Hh and Fgf19 signaling, but not by that of Fgf3/Fgf8 signaling. The fgf16 morphant phenotype was similar to that of the fgf19 morphant and embryos blocked Hh signaling. The results of the present study indicate that Fgf16 signaling, which is regulated by the downstream pathways of Hh-Fgf19 in the forebrain, is involved in forebrain development.	[Miyake, Ayumi; Chitose, Tatsuya; Kamei, Eriko; Murakami, Atsuko; Nakayama, Yoshiaki; Konishi, Morichika; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto, Japan	Kyoto University	Miyake, A (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto, Japan.	miyakea@pharm.kyoto-u.ac.jp		Nakayama, Yoshiaki/0000-0003-2187-3292	JSPS KAKENHI [23659035, 26460096]; Suzuken Memorial Fundation; Takeda Science Foundation, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Fundation; Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This work was in part supported by JSPS KAKENHI Grant Number 23659035 (to N.I.), 26460096 (to A.M.), the Suzuken Memorial Fundation and the Takeda Science Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Alexandre P, 2003, DEVELOPMENT, V130, P5331, DOI 10.1242/dev.00756; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhat RV, 1996, GLIA, V17, P169; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; Bosco A, 2013, DEVELOPMENT, V140, P372, DOI 10.1242/dev.089094; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Dickinson PJ, 1996, NEUROPATH APPL NEURO, V22, P188; Farah MH, 2000, DEVELOPMENT, V127, P693; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Guner B, 2007, GENE EXPR PATTERNS, V7, P596, DOI 10.1016/j.modgep.2007.01.002; Hall A, 1996, DEVELOPMENT, V122, P4085; Hashimoto-Torii K, 2003, MECH DEVELOP, V120, P1097, DOI 10.1016/j.mod.2003.09.001; Hatch EP, 2009, DEV DYNAM, V238, P358, DOI 10.1002/dvdy.21681; Hayes SG, 2003, J COMP NEUROL, V463, P45, DOI 10.1002/cne.10749; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hotta Y, 2008, DEV DYNAM, V237, P2947, DOI 10.1002/dvdy.21726; Incardona JP, 1998, DEVELOPMENT, V125, P3553; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jones E. G., 2002, THALAMUS RELAT SYST, V1, P283; Katahira T, 2000, MECH DEVELOP, V91, P43, DOI 10.1016/S0925-4773(99)00262-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Konishi M, 2000, J BIOL CHEM, V275, P12119, DOI 10.1074/jbc.275.16.12119; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Koshida S, 1998, DEVELOPMENT, V125, P1957; Koshida S, 2002, DEV BIOL, V244, P9, DOI 10.1006/dbio.2002.0581; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lu SY, 2008, AM J PHYSIOL-CELL PH, V294, pC1242, DOI 10.1152/ajpcell.00529.2007; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Maroon H, 2002, DEVELOPMENT, V129, P2099; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Martinez S, 2001, INT J DEV BIOL, V45, P367; Matsumoto E, 2013, GENES CELLS, V18, P544, DOI 10.1111/gtc.12055; Maves L, 2002, DEVELOPMENT, V129, P3825; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mione M, 2001, MECH DEVELOP, V100, P93, DOI 10.1016/S0925-4773(00)00501-3; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; Miyake A, 2013, BIOL OPEN, V2, P515, DOI 10.1242/bio.20134226; Miyake A, 2012, MECH DEVELOP, V128, P577, DOI 10.1016/j.mod.2012.01.001; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Mueller T, 2006, J COMP NEUROL, V494, P620, DOI 10.1002/cne.20824; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nomura R, 2006, BIOCHEM BIOPH RES CO, V347, P340, DOI 10.1016/j.bbrc.2006.06.108; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Peyron F, 1997, J NEUROSCI RES, V50, P190; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Sato T, 2001, DEVELOPMENT, V128, P2461; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shimizu S, 2014, GLIA, V62, P709, DOI 10.1002/glia.22636; Shinya M, 2001, DEVELOPMENT, V128, P4153; Sontag DP, 2003, MOL CELL BIOCHEM, V242, P65, DOI 10.1023/A:1021133611130; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; TIMSIT S, 1995, J NEUROSCI, V15, P1012; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Vasiliauskas D, 2001, CELL, V106, P133, DOI 10.1016/S0092-8674(01)00442-1; Viktorin G, 2009, DEV DYNAM, V238, P1984, DOI 10.1002/dvdy.22031; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Walshe J, 2002, CURR BIOL, V12, P1117, DOI 10.1016/S0960-9822(02)00899-0; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xu JS, 2000, DEVELOPMENT, V127, P1833; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699	85	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110836	10.1371/journal.pone.0110836	http://dx.doi.org/10.1371/journal.pone.0110836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357195	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000028
J	Yang, J; Lin, Q; Ng, TB; Ye, XY; Lin, J				Yang, Jie; Lin, Qi; Ng, Tzi Bun; Ye, Xiuyun; Lin, Juan			Purification and Characterization of a Novel Laccase from Cerrena sp HYB07 with Dye Decolorizing Ability	PLOS ONE			English	Article							WHITE-ROT; BIOCHEMICAL-CHARACTERIZATION; FUNGAL LACCASE; UNICOLOR; GENE; EXPRESSION; CLONING; INDUCTION; SEQUENCES; ISOFORMS	Laccases (EC 1.10.3.2) are a class of multi-copper oxidases with important industrial values. A basidiomycete strain Cerrena sp. HYB07 with high laccase yield was identified. After cultivation in the shaking flask for 4 days, a maximal activity of 210.8 U mL(-1) was attained. A 58.6-kDa laccase (LacA) with 7.2% carbohydrate and a specific activity of 1952.4 U mg(-1) was purified. 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) was the optimal substrate, with K-m and k(cat) being 93.4 mu M and 2468.0 s(-1), respectively. LacA was stable at 60 degrees C, pH 5.0 and above, and in organic solvents. Metal ions Na+, K+, Ca2+, Mg2+, Mn2+, Zn2+ enhanced LacA activity, while Fe2+ and Li+ inhibited LacA activity. LacA decolorized structurally different dyes and a real textile effluent. Its gene and cDNA sequences were obtained. Putative cis-acting transcriptional response elements were identified in the promoter region. The high production yield and activity, robustness and dye decolorizing capacity make LacA and Cerrena sp. HYB07 potentially useful for industrial and environmental applications such as textile finishing and wastewater treatment.	[Yang, Jie; Lin, Qi; Ye, Xiuyun; Lin, Juan] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China; [Yang, Jie; Ye, Xiuyun; Lin, Juan] Natl Engn Lab Enzyme Express, Fuzhou, Fujian, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Fuzhou University; Chinese University of Hong Kong	Lin, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China.	ljuan@fzu.edu.cn			Natural Science Foundation of China [41306120]; Oceanic Public Welfare Industry Special Research Project of China [201305015]; State Key Laboratory of Pollution Control and Resource Reuse Foundation [PCRRF12011]; Fujian Provincial Development and Reform Commission Bio-industry Special Project [[2011]1598]; Fuzhou Science and Technology Bureau [2012-G-125]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oceanic Public Welfare Industry Special Research Project of China; State Key Laboratory of Pollution Control and Resource Reuse Foundation; Fujian Provincial Development and Reform Commission Bio-industry Special Project; Fuzhou Science and Technology Bureau	This study was funded by Natural Science Foundation of China (41306120), Oceanic Public Welfare Industry Special Research Project of China (201305015), State Key Laboratory of Pollution Control and Resource Reuse Foundation (PCRRF12011), Fujian Provincial Development and Reform Commission Bio-industry Special Project ([2011]1598) and Fuzhou Science and Technology Bureau (2012-G-125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadulla E, 2000, APPL ENVIRON MICROB, V66, P3357, DOI 10.1128/AEM.66.8.3357-3362.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bischoff KM, 1998, ANAL BIOCHEM, V260, P1, DOI 10.1006/abio.1998.2680; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SC, 2012, PROTEIN ENG DES SEL, V25, P761, DOI 10.1093/protein/gzs082; CHUNG KT, 1993, ENVIRON TOXICOL CHEM, V12, P2121, DOI 10.1002/etc.5620121120; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; D'Souza DT, 2006, ENZYME MICROB TECH, V38, P504, DOI 10.1016/j.enzmictec.2005.07.005; D'Souza-Ticlo D, 2009, MAR BIOTECHNOL, V11, P725, DOI 10.1007/s10126-009-9187-0; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dsouza TM, 1996, APPL ENVIRON MICROB, V62, P3739, DOI 10.1128/AEM.62.10.3739-3744.1996; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Fan FF, 2011, BIORESOURCE TECHNOL, V102, P3126, DOI 10.1016/j.biortech.2010.10.079; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Janusz G, 2007, WORLD J MICROB BIOT, V23, P1459, DOI 10.1007/s11274-007-9390-y; Janusz G, 2013, ENZYME MICROB TECH, V52, P1, DOI 10.1016/j.enzmictec.2012.10.003; Kim Y, 2002, B KOREAN CHEM SOC, V23, P985; Lin Juan, 2013, Journal of Chinese Institute of Food Science and Technology, V13, P110; Lisova ZA, 2010, J BASIC MICROB, V50, P72, DOI 10.1002/jobm.200900382; Liu W, 2003, APPL MICROBIOL BIOT, V63, P174, DOI 10.1007/s00253-003-1398-0; Liu Ziyong, 2008, Weishengwu Xuebao, V48, P667; Matijosyte I, 2010, J MOL CATAL B-ENZYM, V62, P142, DOI 10.1016/j.molcatb.2009.09.019; Michniewicz A, 2006, APPL MICROBIOL BIOT, V69, P682, DOI 10.1007/s00253-005-0015-9; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Nozaki K, 2008, J BIOSCI BIOENG, V105, P69, DOI 10.1263/jbb.105.69; Palmieri G, 1997, J BIOL CHEM, V272, P31301, DOI 10.1074/jbc.272.50.31301; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sambrook J., 2001, MOL CLONING LAB MANU; Shin KS, 1998, BIOTECHNOL TECH, V12, P101; Si J, 2013, BIORESOURCE TECHNOL, V128, P49, DOI 10.1016/j.biortech.2012.10.085; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soden DM, 2003, J APPL MICROBIOL, V95, P553, DOI 10.1046/j.1365-2672.2003.02012.x; Songulashvili G, 2012, FUNGAL BIOL-UK, V116, P883, DOI 10.1016/j.funbio.2012.05.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wong YX, 1999, WATER RES, V33, P3512, DOI 10.1016/S0043-1354(99)00066-4; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063; Yang YC, 2013, PROCESS BIOCHEM, V48, P351, DOI 10.1016/j.procbio.2012.12.011; Zhuo R, 2011, J HAZARD MATER, V192, P855, DOI 10.1016/j.jhazmat.2011.05.106	47	51	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110834	10.1371/journal.pone.0110834	http://dx.doi.org/10.1371/journal.pone.0110834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356987	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000026
J	Kitamura, C; Guellai, B; Kim, J				Kitamura, Christine; Guellai, Bahia; Kim, Jeesun			Motherese by Eye and Ear: Infants Perceive Visual Prosody in Point-Line Displays of Talking Heads	PLOS ONE			English	Article							SPEECH-PERCEPTION; BIOLOGICAL MOTION; DIRECTED SPEECH; INTERMODAL REPRESENTATION; EXPRESSIVE BEHAVIORS; PHONETIC INFORMATION; PREFERENCE; SYNCHRONY; VOICE; ATTRIBUTES	Infant-directed (ID) speech provides exaggerated auditory and visual prosodic cues. Here we investigated if infants were sensitive to the match between the auditory and visual correlates of ID speech prosody. We presented 8-month-old infants with two silent line-joined point-light displays of faces speaking different ID sentences, and a single vocal-only sentence matched to one of the displays. Infants looked longer to the matched than mismatched visual signal when full-spectrum speech was presented; and when the vocal signals contained speech low-pass filtered at 400 Hz. When the visual display was separated into rigid (head only) and non-rigid (face only) motion, the infants looked longer to the visual match in the rigid condition; and to the visual mismatch in the non-rigid condition. Overall, the results suggest 8-month-olds can extract information about the prosodic structure of speech from voice and head kinematics, and are sensitive to their match; and that they are less sensitive to the match between lip and voice information in connected speech.	[Kitamura, Christine] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Kitamura, Christine; Kim, Jeesun] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia; [Guellai, Bahia] Univ Paris Ouest Nanterre La Def, Lab Ethol, Paris, France	Western Sydney University; Western Sydney University; Universite Paris Nanterre	Kitamura, C (corresponding author), Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia.	c.kitamura@uws.edu.au		Kim, Jeesun/0000-0003-2651-1020	Australian Research Council (ARC) [ARC DP120104298, ARC DP0666857]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Australian Research Council (ARC): ARC DP120104298 [CK JK] and ARC DP0666857 [JK]. http://www.arc.gov.au/ncgp/default.htm. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aldridge MA, 1999, DEVELOPMENTAL SCI, V2, P42, DOI 10.1111/1467-7687.00052; Arterberry ME, 2002, COGNITION, V86, P1, DOI 10.1016/S0010-0277(02)00108-7; Bardi L, 2011, DEVELOPMENTAL SCI, V14, P353, DOI 10.1111/j.1467-7687.2010.00985.x; BERTONCINI J, 1981, INFANT BEHAV DEV, V4, P247, DOI 10.1016/S0163-6383(81)80027-6; Bidet-Ildei C, 2014, DEV PSYCHOL, V50, P113, DOI 10.1037/a0032956; BIJELJACBABIC R, 1993, DEV PSYCHOL, V29, P711, DOI 10.1037/0012-1649.29.4.711; Blossom M., 2006, 30 ANN BOST U C LANG; Chong SCF, 2003, INFANT CHILD DEV, V12, P211, DOI 10.1002/icd.286; COOPER RP, 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; CUTLER A, 1993, J PHONETICS, V21, P103, DOI 10.1016/S0095-4470(19)31323-3; Cvejic E, 2010, SPEECH COMMUN, V52, P555, DOI 10.1016/j.specom.2010.02.006; Davis C, 2004, Q J EXP PSYCHOL-A, V57, P1103, DOI 10.1080/02724980343000701; Davis C, 2006, COGNITION, V100, pB21, DOI 10.1016/j.cognition.2005.09.002; Desjardins RN, 2004, DEV PSYCHOBIOL, V45, P187, DOI 10.1002/dev.20033; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; GOLINKOFF RM, 1987, J CHILD LANG, V14, P23, DOI 10.1017/S030500090001271X; Grant KW, 2004, SPEECH COMMUN, V44, P43, DOI 10.1016/j.specom.2004.06.004; Green JR, 2010, J SPEECH LANG HEAR R, V53, P1529, DOI 10.1044/1092-4388(2010/09-0005); Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Karzon R, 1985, J EXPT CHILD PSYCHOL, V39; Kemler Nelson DG, 1989, J CHILD LANGUAGE, V16; Kim J, 2012, P INT, P1119; Kitamura C, 2003, INFANCY, V4, P85, DOI 10.1207/S15327078IN0401_5; Kitamura C, 2002, INFANT BEHAV DEV, V24, P372; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; KUHL PK, 1991, J EXP PSYCHOL HUMAN, V17, P829, DOI 10.1037/0096-1523.17.3.829; KUHL PK, 1984, INFANT BEHAV DEV, V7, P361, DOI 10.1016/S0163-6383(84)80050-8; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Lewkowicz DJ, 2010, DEV PSYCHOL, V46, P66, DOI 10.1037/a0015579; Lewkowicz DJ, 2000, CHILD DEV, V71, P1241, DOI 10.1111/1467-8624.00226; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; Measurements IsoS, 1969, IEEE REC PRACT SPEEC, P227; MOON C, 1992, J CHILD LANG, V19, P1, DOI 10.1017/S030500090001360X; Munhall KG, 1998, BEHAV BRAIN SCI, V21, P524, DOI 10.1017/S0140525X98391268; Munhall KG, 2004, PSYCHOL SCI, V15, P133, DOI 10.1111/j.0963-7214.2004.01502010.x; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; SOKEN NH, 1992, CHILD DEV, V63, P787; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Swerts M, 2008, J PHONETICS, V36, P219, DOI 10.1016/j.wocn.2007.05.001; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Vignali G., 2005, P CROSS MODAL PROCES, P59; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437	47	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111467	10.1371/journal.pone.0111467	http://dx.doi.org/10.1371/journal.pone.0111467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353978	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200083
J	Lawson, DW; Mulder, MB; Ghiselli, ME; Ngadaya, E; Ngowi, B; Mfinanga, SGM; Hartwig, K; James, S				Lawson, David W.; Mulder, Monique Borgerhoff; Ghiselli, Margherita E.; Ngadaya, Esther; Ngowi, Bernard; Mfinanga, Sayoki G. M.; Hartwig, Kari; James, Susan			Ethnicity and Child Health in Northern Tanzania: Maasai Pastoralists Are Disadvantaged Compared to Neighbouring Ethnic Groups	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FOOD INSECURITY; NOMADIC TURKANA; DAIRY-PRODUCTS; YOUNG-CHILDREN; LINEAR GROWTH; MORTALITY; SURVIVAL; EQUITY; LIVELIHOODS	The Maasai of northern Tanzania, a semi-nomadic ethnic group predominantly reliant on pastoralism, face a number of challenges anticipated to have negative impacts on child health, including marginalisation, vulnerabilities to drought, substandard service provision and on-going land grabbing conflicts. Yet, stemming from a lack of appropriate national survey data, no large-scale comparative study of Maasai child health has been conducted. Savannas Forever Tanzania surveyed the health of over 3500 children from 56 villages in northern Tanzania between 2009 and 2011. The major ethnic groups sampled were the Maasai, Sukuma, Rangi, and the Meru. Using multilevel regression we compare each ethnic group on the basis of (i) measurements of child health, including anthropometric indicators of nutritional status and self-reported incidence of disease; and (ii) important proximate determinants of child health, including food insecurity, diet, breastfeeding behaviour and vaccination coverage. We then (iii) contrast households among the Maasai by the extent to which subsistence is reliant on livestock herding. Measures of both child nutritional status and disease confirm that the Maasai are substantially disadvantaged compared to neighbouring ethnic groups, Meru are relatively advantaged, and Rangi and Sukuma intermediate in most comparisons. However, Maasai children were less likely to report malaria and worm infections. Food insecurity was high throughout the study site, but particularly severe for the Maasai, and reflected in lower dietary intake of carbohydrate-rich staple foods, and fruits and vegetables. Breastfeeding was extended in the Maasai, despite higher reported consumption of cow's milk, a potential weaning food. Vaccination coverage was lowest in Maasai and Sukuma. Maasai who rely primarily on livestock herding showed signs of further disadvantage compared to Maasai relying primarily on agriculture. We discuss the potential ecological, socioeconomic, demographic and cultural factors responsible for these differences and the implications for population health research and policy.	[Lawson, David W.] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Mulder, Monique Borgerhoff] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Mulder, Monique Borgerhoff; James, Susan] Savannas Forever Tanzania, Arusha, Tanzania; [Ghiselli, Margherita E.] Univ Minnesota, Minneapolis, MN USA; [Ngadaya, Esther; Ngowi, Bernard; Mfinanga, Sayoki G. M.] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [Hartwig, Kari] St Catherine Univ, Minneapolis, MN USA	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities; National Institute of Medical Research	Lawson, DW (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England.	David.Lawson@lshtm.ac.uk		Ngadaya, Esther/0000-0003-4540-5637	UK Medical Research Council (MRC) [MR/K021672/1]; MRC; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; United States Agency for International Development; Partners for Development; University of Minnesota; Institute on the Environment; Canadian Foodgrains Bank; MRC [MR/K021672/1] Funding Source: UKRI; Medical Research Council [MR/K021672/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States Agency for International Development(United States Agency for International Development (USAID)); Partners for Development; University of Minnesota(University of Minnesota System); Institute on the Environment; Canadian Foodgrains Bank; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Data analysis and the production of this manuscript were funded by a UK Medical Research Council (MRC) Fellowship Award to DWL (grant number: MR/K021672/1). This fellowship is jointly funded by the MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. All data come from the Whole Village Project (WVP). The WVP was generously funded by the United States Agency for International Development (www.usaid.gov), Partners for Development (www.pfd.org), the University of Minnesota, including the Institute on the Environment (environment.umn.edu), and the Canadian Foodgrains Bank (www.foodgrainsbank.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099987; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Azarya V., 2004, CURR SOCIOL, V52, P949, DOI DOI 10.1177/0011392104046617; Batura N, 2013, THESIS U LONDON; Brainard J. M., 1991, HLTH DEV RURAL KENYA; Brockerhoff M, 2000, B WORLD HEALTH ORGAN, V78, P30; Buzinde CN, 2014, ANN TOURISM RES, V44, P20, DOI 10.1016/j.annals.2013.08.010; Campbell J., 1999, NATIONS NATL, V5, P105, DOI [10.1111/j.1354-5078.1999.00105.x, DOI 10.1111/J.1354-5078.1999.00105.X]; Catley A., 2013, PASTORALISM DEV AFRI, DOI [10.4324/9780203105979, DOI 10.4324/9780203105979]; Clarke P, 2008, J EPIDEMIOL COMMUN H, V62, P752, DOI 10.1136/jech.2007.060798; Coast E, 2001, THESIS U LONDON; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Corbett S, 2003, ECOL FOOD NUTR, V42, P193, DOI 10.1080/03670240390228978; Crawhall N., 2006, Indigenous Affairs - International Work Group for Indigenous Affairs, P6; de Beer H, 2012, ECON HUM BIOL, V10, P299, DOI 10.1016/j.ehb.2011.08.003; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; Deaton A, 2007, P NATL ACAD SCI USA, V104, P13232, DOI 10.1073/pnas.0611500104; Faris S, 2013, BLOOMBERG BUISNESSWE; Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867; Fratkin E, 2013, PATHWAY SUSTAIN, P197; Galaty JG, 2013, PASTORALISM DEV AFRI, P131; GALVIN KA, 1992, AM J HUM BIOL, V4, P209, DOI 10.1002/ajhb.1310040206; Garenne M, 2006, DHS COMP REPORTS; Goldman MJ, 2013, GLOBAL ENVIRON CHANG, V23, P588, DOI 10.1016/j.gloenvcha.2013.02.010; Hadley C, 2005, AM J PHYS ANTHROPOL, V128, P682, DOI 10.1002/ajpa.20056; Hadley C, 2007, PUBLIC HEALTH NUTR, V10, P544, DOI 10.1017/S1368980007246725; Hadley C, 2012, AM J PHYS ANTHROPOL, V149, P72, DOI 10.1002/ajpa.22161; Hadley C, 2010, CURR ANTHROPOL, V51, P551, DOI 10.1086/653998; Hampshire K, 2002, SOC SCI MED, V54, P1025, DOI 10.1016/S0277-9536(01)00078-8; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hill AG, 1985, POPULATION HLTH NUTR; Hodgson DL, 2002, AM ANTHROPOL, V104, P1086, DOI 10.1525/aa.2002.104.4.1086; Hodgson Dorothy, 2011, BEING MAASAI BECOMIN; Homewood K. M., 1992, Ecology of Food and Nutrition, V29, P61, DOI 10.1080/03670244.1992.9991291; Hoppe C, 2006, ANNU REV NUTR, V26, P131, DOI 10.1146/annurev.nutr.26.010506.103757; Iannotti LL, 2014, AM J CLIN NUTR, V99, P198, DOI 10.3945/ajcn.113.063883; Kalavar JM, 2014, J CROSS-CULT GERONTO, V29, P53, DOI 10.1007/s10823-013-9221-6; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Kruger C, 2013, RURAL REMOTE HEALTH, V13; Lawson D., 2014, APPL EVOLUTIONARY AN, P85, DOI DOI 10.1007/978-1-4939-0280-4_5; Lawson DW, 2011, PHILOS T R SOC B, V366, P333, DOI 10.1098/rstb.2010.0297; Levi JM, 2012, INDIGENOUS PEOPLES, POVERTY, AND DEVELOPMENT, P73; LITTLE MA, 1987, HUM BIOL, V59, P695; Little MA, 1988, COPING UNCERTAINTY F, P288; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; Migliano AB, 2007, PNAS, V104, P18; Moradi A, 2005, WORLD DEV, V33, P1233, DOI 10.1016/j.worlddev.2005.04.010; Mulder MB, 2011, PHILOS T R SOC B, V366, P344, DOI 10.1098/rstb.2010.0231; Mulholland EK, 2008, B WORLD HEALTH ORGAN, V86, P399, DOI 10.2471/BLT.07.044545; Nathan MA, 1996, SOC SCI MED, V43, P503, DOI 10.1016/0277-9536(95)00428-9; Nelson, 2010, COMMUNITY RIGHTS CON, P269; NESTEL PS, 1989, ECOL FOOD NUTR, V23, P17, DOI 10.1080/03670244.1989.9991085; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; Oiye S., 2009, Indigenous peoples' food systems: the many dimensions of culture, diversity and environment for nutrition and health, P231; Omariba DWR, 2007, J MARRIAGE FAM, V69, P528, DOI 10.1111/j.1741-3737.2007.00381.x; Ruhago GM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1119; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Sellen D.W., 1996, NOMAD PEOPLES, V39, P107; Sellen DW, 1999, AM J PHYS ANTHROPOL, V109, P187, DOI 10.1002/(SICI)1096-8644(199906)109:2<187::AID-AJPA5>3.0.CO;2-P; Sellen DW, 2001, HUM NATURE-INT BIOS, V12, P47, DOI 10.1007/s12110-001-1013-y; Sellen DW, 2000, ANN HUM BIOL, V27, P345, DOI 10.1080/03014460050044838; Sikar N. K., 2006, Indigenous Affairs - International Work Group for Indigenous Affairs, P30; Spear Thomas, 1993, BEING MAASAI ETHNICI; StataCorp, 2013, STAT STAT SOFTW REL; Strassmann BI, 1997, CURR ANTHROPOL, V38, P688, DOI 10.1086/204657; Trench P. C., 2010, STAYING MAASAI LIVEL; Walker B., 2013, STATE WORLDS MINORIT; Walker R, 2006, AM J HUM BIOL, V18, P295, DOI 10.1002/ajhb.20510; Wander K, 2013, EVOLUTIONARY ECOLOGY; Weber A., 2009, CAUSES POLITICIZATIO; Wiley AS, 2012, AM J HUM BIOL, V24, P130, DOI 10.1002/ajhb.22201; Wiley AS, 2009, ANN HUM BIOL, V36, P125, DOI 10.1080/03014460802680466; Wirth ME, 2006, B WORLD HEALTH ORGAN, V84, P519, DOI 10.2471/BLT.04.019984; Zinsstag J, 2006, TROP MED INT HEALTH, V11, P565, DOI 10.1111/j.1365-3156.2006.01615.x	75	46	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110447	10.1371/journal.pone.0110447	http://dx.doi.org/10.1371/journal.pone.0110447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353164	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000345204200025
J	Al Dera, H; Callaghan, BP; Brock, JA				Al Dera, Hussain; Callaghan, Brid P.; Brock, James A.			Modified Cytoplasmic Ca2+ Sequestration Contributes to Spinal Cord Injury-Induced Augmentation of Nerve-Evoked Contractions in the Rat Tail Artery	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NORADRENALINE RELEASE; NEUROVASCULAR TRANSMISSION; SYMPATHETIC ACTIVITY; CALCIUM-CHANNELS; RESPONSES; CALMODULIN; MODULATION; EXPRESSION; RYANODINE	In rat tail artery (RTA), spinal cord injury (SCI) increases nerve-evoked contractions and the contribution of L-type Ca2+ channels to these responses. In RTAs from unoperated rats, these channels play a minor role in contractions and Bay K8644 (L-type channel agonist) mimics the effects of SCI. Here we investigated the mechanisms underlying the facilitatory actions of SCI and Bay K8644 on nerve-evoked contractions of RTAs and the hypothesis that Ca2+ entering via L-type Ca2+ channels is rapidly sequestered by the sarcoplasmic reticulum (SR) limiting its role in contraction. In situ electrochemical detection of noradrenaline was used to assess if Bay K8644 increased noradrenaline release. Perforated patch recordings were used to assess if SCI changed the Ca2+ current recorded in RTA myocytes. Wire myography was used to assess if SCI modified the effects of Bay K8644 and of interrupting SR Ca2+ uptake on nerve-evoked contractions. Bay K8644 did not change noradrenaline-induced oxidation currents. Neither the size nor gating of Ca2+ currents differed between myocytes from sham-operated (control) and SCI rats. Bay K8644 increased nerve-evoked contractions in RTAs from both control and SCI rats, but the magnitude of this effect was reduced by SCI. By contrast, depleting SR Ca2+ stores with ryanodine or cyclopiazonic acid selectively increased nerve-evoked contractions in control RTAs. Cyclopiazonic acid also selectively increased the blockade of these responses by nifedipine (L-type channel blocker) in control RTAs, whereas ryanodine increased the blockade produced by nifedipine in both groups of RTAs. These findings suggest that Ca2+ entering via L-type channels is normally rapidly sequestered limiting its access to the contractile mechanism. Furthermore, the findings suggest SCI reduces the role of this mechanism.	[Al Dera, Hussain; Callaghan, Brid P.; Brock, James A.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Al Dera, Hussain] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia	University of Melbourne; King Saud Bin Abdulaziz University for Health Sciences	Brock, JA (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia.	j.brock@unimelb.edu.au	Callaghan, Brid/N-1764-2019; alDera, Hussain/GVU-0786-2022; Brock, James A/A-2929-2012	Callaghan, Brid/0000-0001-7251-8851; Brock, James/0000-0002-1381-1983	National Health and Medical Research Council of Australia [ID GNT1024485]; Transport Accident Commission (Victoria); King Saud Bin Abdulaziz University for Health Sciences, College of Medicine (Riyadh, Saudi Arabia)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission (Victoria); King Saud Bin Abdulaziz University for Health Sciences, College of Medicine (Riyadh, Saudi Arabia)	This work was supported by grants from the National Health and Medical Research Council of Australia (Grant ID GNT1024485) and the Transport Accident Commission (Victoria). H. Al Dera was supported by a postgraduate award from King Saud Bin Abdulaziz University for Health Sciences, College of Medicine (Riyadh, Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dera H, 2012, AM J PHYSIOL-HEART C, V302, pH752, DOI 10.1152/ajpheart.00745.2011; BAO JX, 1993, N-S ARCH PHARMACOL, V347, P601, DOI 10.1007/BF00166943; Brock JA, 2006, AM J PHYSIOL-HEART C, V290, pH398, DOI 10.1152/ajpheart.00712.2005; Brock JA, 2004, BRIT J PHARMACOL, V142, P267, DOI 10.1038/sj.bjp.0705779; Brock JA, 1999, BRIT J PHARMACOL, V126, P11, DOI 10.1038/sj.bjp.0702256; BULTMANN R, 1993, BRIT J PHARMACOL, V108, P1062; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Garcha RS, 1997, BRIT J PHARMACOL, V122, P142, DOI 10.1038/sj.bjp.0701337; Laporte R, 2004, PHARMACOL REV, V56, P439, DOI 10.1124/pr.56.4.1; Maiorov DN, 1997, AM J PHYSIOL-HEART C, V272, pH625, DOI 10.1152/ajpheart.1997.272.2.H625; Martinez-Pinna J, 2002, BRAIN RES, V951, P227, DOI 10.1016/S0006-8993(02)03165-7; Mathias C. J., 1999, AUTONOMIC FAILURE TX, P494; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nomura Y, 2000, JPN J PHARMACOL, V83, P335, DOI 10.1254/jjp.83.335; ORALLO F, 1992, GEN PHARMACOL, V23, P257, DOI 10.1016/0306-3623(92)90021-B; PAN M, 1988, J CARDIOVASC PHARM, V11, P127; Petkov GV, 2001, ACTA PHYSIOL SCAND, V173, P257, DOI 10.1046/j.1365-201X.2001.00907.x; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Quintas LEM, 2005, EUR J PHARMACOL, V525, P54, DOI 10.1016/j.ejphar.2005.10.006; Rathner JA, 1998, J AUTONOM NERV SYST, V69, P127, DOI 10.1016/S0165-1838(98)00014-9; Rummery NM, 2010, J NEUROTRAUM, V27, P2077, DOI 10.1089/neu.2010.1468; SCHULTE L, 1994, AM J PHYSIOL, V267, pC617, DOI 10.1152/ajpcell.1994.267.2.C617; Smith JE, 1998, J AUTONOM NERV SYST, V68, P109, DOI 10.1016/S0165-1838(97)00124-0; Somogyi GT, 1997, J PHYSIOL-LONDON, V499, P645, DOI 10.1113/jphysiol.1997.sp021957; Thakali KM, 2010, CIRC RES, V106, P739, DOI 10.1161/CIRCRESAHA.109.206763; Tripovic D, 2010, BRIT J PHARMACOL, V159, P142, DOI 10.1111/j.1476-5381.2009.00520.x; Tsai H, 1998, NEUROBIOL AGING, V19, P89, DOI 10.1016/S0197-4580(98)00008-6; VANBREEMEN C, 1995, TRENDS PHARMACOL SCI, V16, P98, DOI 10.1016/S0165-6147(00)88990-7; WALLIN BG, 1984, BRAIN, V107, P183, DOI 10.1093/brain/107.1.183; WANG R, 1989, AM J PHYSIOL, V256, pH1361, DOI 10.1152/ajpheart.1989.256.5.H1361; Weaver LC, 2006, PROG BRAIN RES, V152, P245, DOI 10.1016/S0079-6123(05)52016-8; Wilkinson MF, 1996, FASEB J, V10, P785, DOI 10.1096/fasebj.10.7.8635696; Yeoh M, 2004, J PHYSIOL-LONDON, V561, P583, DOI 10.1113/jphysiol.2004.074948; Yeoh M, 2004, J PHYSIOL-LONDON, V556, P545, DOI 10.1113/jphysiol.2003.056424	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111804	10.1371/journal.pone.0111804	http://dx.doi.org/10.1371/journal.pone.0111804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350563	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100080
J	Zhou, JH; Ding, YZ; He, Y; Chu, YF; Zhao, P; Ma, LY; Wang, XJ; Li, XR; Liu, YS				Zhou, Jian-hua; Ding, Yao-zhong; He, Ying; Chu, Yue-feng; Zhao, Ping; Ma, Li-ya; Wang, Xin-jun; Li, Xue-rui; Liu, Yong-sheng			The Effect of Multiple Evolutionary Selections on Synonymous Codon Usage of Genes in the Mycoplasma bovis Genome	PLOS ONE			English	Article							MICROCOCCUS-LUTEUS; TRANSFER-RNAS; G+C CONTENT; SEQUENCE; BIAS; BACTERIUM; ADAPTATION; PATTERNS; DISEASE; HOST	Mycoplasma bovis is a major pathogen causing arthritis, respiratory disease and mastitis in cattle. A better understanding of its genetic features and evolution might represent evidences of surviving host environments. In this study, multiple factors influencing synonymous codon usage patterns in M. bovis (three strains' genomes) were analyzed. The overall nucleotide content of genes in the M. bovis genome is AT-rich. Although the G and C contents at the third codon position of genes in the leading strand differ from those in the lagging strand (p<0.05), the 59 synonymous codon usage patterns of genes in the leading strand are highly similar to those in the lagging strand. The over-represented codons and the under-represented codons were identified. A comparison of the synonymous codon usage pattern of M. bovis and cattle (susceptible host) indicated the independent formation of synonymous codon usage of M. bovis. Principal component analysis revealed that (i) strand-specific mutational bias fails to affect the synonymous codon usage pattern in the leading and lagging strands, (ii) mutation pressure from nucleotide content plays a role in shaping the overall codon usage, and (iii) the major trend of synonymous codon usage has a significant correlation with the gene expression level that is estimated by the codon adaptation index. The plot of the effective number of codons against the G+C content at the third codon position also reveals that mutation pressure undoubtedly contributes to the synonymous codon usage pattern of M. bovis. Additionally, the formation of the overall codon usage is determined by certain evolutionary selections for gene function classification (30S protein, 50S protein, transposase, membrane protein, and lipoprotein) and translation elongation region of genes in M. bovis. The information could be helpful in further investigations of evolutionary mechanisms of the Mycoplasma family and heterologous expression of its functionally important proteins.	[Zhou, Jian-hua; Ding, Yao-zhong; He, Ying; Chu, Yue-feng; Zhao, Ping; Ma, Li-ya; Wang, Xin-jun; Li, Xue-rui; Liu, Yong-sheng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Li, XR (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	liuyongsheng@caas.cn; lixuerui@caas.cn	Chu, Yuefeng/K-9892-2019		National Natural Science Foundation of China [31302100, 31172335, 31072143]; Bacterial Disease in Grazing animal Team	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bacterial Disease in Grazing animal Team	This study was supported by National Natural Science Foundation of China (No. 31302100, No. 31172335 and No. 31072143), in addition, this study was also supported by Bacterial Disease in Grazing animal Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1995, BIOCHEM CELL BIOL, V73, P775, DOI 10.1139/o95-086; ANDERSSON SGE, 1991, MOL BIOL EVOL, V8, P530; ARBER W, 1993, GENE, V135, P49, DOI 10.1016/0378-1119(93)90048-8; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Feng C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-732; GONZALEZ YRC, 1995, VET MICROBIOL, V47, P183, DOI 10.1016/0378-1135(95)00058-I; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; KANO A, 1991, J MOL BIOL, V221, P387, DOI 10.1016/0022-2836(91)80061-X; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lafay B, 1999, NUCLEIC ACIDS RES, V27, P1642, DOI 10.1093/nar/27.7.1642; Li WC, 2007, ANTON LEEUW INT J G, V92, P417, DOI 10.1007/s10482-007-9170-6; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nayak KC, 2013, GENE, V513, P163, DOI 10.1016/j.gene.2012.10.024; Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8; OBA T, 1991, P NATL ACAD SCI USA, V88, P921, DOI 10.1073/pnas.88.3.921; OHAMA T, 1990, NUCLEIC ACIDS RES, V18, P1565, DOI 10.1093/nar/18.6.1565; Ohno H, 2001, GENE, V276, P107, DOI 10.1016/S0378-1119(01)00670-9; Qi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038239; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-43; Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239; Zhou JH, 2013, VIRUS RES, V176, P298, DOI 10.1016/j.virusres.2013.06.006; Zhou JH, 2013, VIRUS GENES, V46, P271, DOI 10.1007/s11262-012-0847-1; Zhou T, 2006, GENE, V368, P117, DOI 10.1016/j.gene.2005.10.035	43	17	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e108949	10.1371/journal.pone.0108949	http://dx.doi.org/10.1371/journal.pone.0108949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350396	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100007
J	Alsaleh, G; Francois, A; Philippe, L; Gong, YZ; Bahram, S; Cetin, S; Pfeffer, S; Gottenberg, JE; Wachsmann, D; Georgel, P; Sibilia, J				Alsaleh, Ghada; Francois, Antoine; Philippe, Lucas; Gong, Ya-Zhuo; Bahram, Seiamak; Cetin, Semih; Pfeffer, Sebastien; Gottenberg, Jacques-Eric; Wachsmann, Dominique; Georgel, Philippe; Sibilia, Jean			MiR-30a-3p Negatively Regulates BAFF Synthesis in Systemic Sclerosis and Rheumatoid Arthritis Fibroblasts	PLOS ONE			English	Article							CELL-ACTIVATING FACTOR; B-LYMPHOCYTE STIMULATOR; AUTOIMMUNE-DISEASES; EPITHELIAL-CELLS; TNF FAMILY; SYNOVIAL FIBROBLASTS; EXPRESSION; SYNOVIOCYTES; MICRORNAS; RELEASE	We evaluated micro (mi) RNA-mediated regulation of BAFF expression in fibroblasts using two concomitant models: (i) synovial fibroblasts (FLS) isolated from healthy controls (N) or Rheumatoid Arthritis (RA) patients; (ii) human dermal fibroblasts (HDF) isolated from healthy controls (N) or Systemic Sclerosis (SSc) patients. Using RT-qPCR and ELISA, we first showed that SScHDF synthesized and released BAFF in response to Poly(I:C) or IFN-gamma treatment, as previously observed in RAFLS, whereas NHDF released BAFF preferentially in response to IFN-gamma. Next, we demonstrated that miR-30a-3p expression was down regulated in RAFLS and SScHDF stimulated with Poly(I:C) or IFN-gamma. Moreover, we demonstrated that transfecting miR-30a-3p mimic in Poly(I:C)- and IFN-gamma-activated RAFLS and SScHDF showed a strong decrease on BAFF synthesis and release and thus B cells survival in our model. Interestingly, FLS and HDF isolated from healthy subjects express higher levels of miR-30a-3p and lower levels of BAFF than RAFLS and SScHDF. Transfection of miR-30a-3p antisense in Poly(I:C)- and IFN-gamma-activated NFLS and NHDF upregulated BAFF secretion, confirming that this microRNA is a basal repressors of BAFF expression in cells from healthy donors. Our data suggest a critical role of miR-30a-3p in the regulation of BAFF expression, which could have a major impact in the regulation of the autoimmune responses occurring in RA and SSc.	[Alsaleh, Ghada; Francois, Antoine; Philippe, Lucas; Gong, Ya-Zhuo; Bahram, Seiamak; Gottenberg, Jacques-Eric; Wachsmann, Dominique; Georgel, Philippe; Sibilia, Jean] Univ Strasbourg, FMTS, Fac Med, Ctr Rech Immunol & Hematol,INSERM UMR S 1109, Strasbourg, France; [Alsaleh, Ghada; Francois, Antoine; Philippe, Lucas; Gong, Ya-Zhuo; Bahram, Seiamak; Gottenberg, Jacques-Eric; Wachsmann, Dominique; Georgel, Philippe; Sibilia, Jean] Hop Univ Strasbourg, Ctr Natl Reference Malad Syst Autoimmunes Rares, Strasbourg, France; [Cetin, Semih; Pfeffer, Sebastien] Univ Strasbourg, UPR 9002, Strasbourg, France; [Cetin, Semih; Pfeffer, Sebastien] Inst Biol Mol & Cellulaire, CNRS ARN, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Alsaleh, G (corresponding author), Univ Strasbourg, FMTS, Fac Med, Ctr Rech Immunol & Hematol,INSERM UMR S 1109, Strasbourg, France.	galfarhan@unistra.fr	georgel, philippe/P-5676-2016; Pfeffer, Sébastien/H-3212-2019; Bahram, Seiamak/GZA-7150-2022	georgel, philippe/0000-0001-6853-7080; Pfeffer, Sébastien/0000-0002-8458-348X; Lucas, Philippe/0000-0003-2704-2676; alsaleh, ghada/0000-0002-4211-3420; Sibilia, Jean/0000-0002-1601-4795; Bahram, Seiamak/0000-0002-6928-9952	Bristol Myers Squibb; Roche; Pfizer; Courtin Foundation; CAMPLP; European Research Council [ERC-StG-260767]; Agence Nationale pour la Recherche (labex netRNA) [ANR-10-LABX-36]	Bristol Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Pfizer(Pfizer); Courtin Foundation; CAMPLP; European Research Council(European Research Council (ERC)European Commission); Agence Nationale pour la Recherche (labex netRNA)(French National Research Agency (ANR))	Prof. Jean Sibilia's work was supported by grants from Bristol Myers Squibb, Roche, Pfizer, Courtin Foundation and CAMPLP. Sebastien Pfeffer's work was supported by the European Research Council (ERC-StG-260767) and Agence Nationale pour la Recherche (labex netRNA, ANR-10-LABX-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh G, 2007, ARTHRITIS RHEUM, V56, P3202, DOI 10.1002/art.22915; Alsaleh G, 2011, EUR J IMMUNOL, V41, P2113, DOI 10.1002/eji.201041194; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Ceribelli A, 2011, FEBS LETT, V585, P3667, DOI 10.1016/j.febslet.2011.05.020; Chan AC, 2011, MOL IMMUNOL, V48, P1344, DOI 10.1016/j.molimm.2010.11.021; Chugh PK, 2013, INT J RHEUM DIS, V16, P4, DOI 10.1111/1756-185x.12002; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Ferraccioli G, 2007, AUTOIMMUN REV, V7, P109, DOI 10.1016/j.autrev.2007.02.013; Finnegan A, 2012, AUTOIMMUNITY, V45, P353, DOI 10.3109/08916934.2012.665526; Ittah M, 2008, EUR J IMMUNOL, V38, P1058, DOI 10.1002/eji.200738013; Ittah M, 2009, EUR J IMMUNOL, V39, P1271, DOI 10.1002/eji.200839086; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kalled SL, 2005, IMMUNOL REV, V204, P43, DOI 10.1111/j.0105-2896.2005.00219.x; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Li HT, 2012, RHEUMATOL INT, V32, P307, DOI 10.1007/s00296-010-1615-y; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Matsushita T, 2007, J RHEUMATOL, V34, P2056; Matsushita T, 2007, EXP DERMATOL, V16, P87, DOI 10.1111/j.1600-0625.2006.00485.x; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Moisini I, 2009, CLIN EXP IMMUNOL, V158, P155, DOI 10.1111/j.1365-2249.2009.04007.x; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ohata J, 2005, J IMMUNOL, V174, P864, DOI 10.4049/jimmunol.174.2.864; Pers JO, 2005, ANN NY ACAD SCI, V1050, P34, DOI 10.1196/annals.1313.004; Philippe L, 2013, ANN RHEUM DIS, V72, P1071, DOI 10.1136/annrheumdis-2012-201654; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Seyler TM, 2005, J CLIN INVEST, V115, P3083, DOI 10.1172/JCI25265; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stohl W, 2013, J RHEUMATOL, V40, P579, DOI 10.3899/jrheum.120886; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang M, 2005, INT IMMUNOL, V17, P1081, DOI 10.1093/intimm/dxh287; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	42	47	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111266	10.1371/journal.pone.0111266	http://dx.doi.org/10.1371/journal.pone.0111266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360821	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700082
J	Lacoeuilhe, A; Machon, N; Jullen, JF; Le Bocq, A; Kerbiriou, C				Lacoeuilhe, Aurelie; Machon, Nathalie; Jullen, Jean-Francois; Le Bocq, Agathe; Kerbiriou, Christian			The Influence of Low Intensities of Light Pollution on Bat Communities in a Semi-Natural Context	PLOS ONE			English	Article							FORAGING BEHAVIOR; TIME	Anthropogenic light pollution is an increasingly significant issue worldwide. Over the past century, the use of artificial lighting has increased in association with human activity. Artificial lights are suspected to have substantial effects on the ecology of many species, e.g., by producing discontinuities in the territories of nocturnal animals. We analyzed the potential influence of the intensity and type of artificial light on bat activity in a semi-natural landscape in France. We used a species approach, followed by a trait-based approach, to light sensitivity. We also investigated whether the effect of light could be related to foraging traits. We performed acoustic surveys at sites located along a gradient of light intensities to assess the activity of 15 species of bats. We identified 2 functional response groups of species: one group that was light-tolerant and one group that was light-intolerant. Among the species in the latter group that appear to be disadvantaged by lighting conditions, many are rare and threatened in Europe, whereas the species from the former group are better able to thrive in disturbed habitats such as lighted areas and may actually benefit from artificial lighting. Finally, several methods of controlling light pollution are suggested for the conservation of bat communities. Recommendations for light management and the creation of dim-light corridors are proposed; these strategies may play an important role in protecting against the impact of light pollution on nocturnal animals.	[Lacoeuilhe, Aurelie; Machon, Nathalie; Jullen, Jean-Francois; Kerbiriou, Christian] UPMC, CNRS, Ecol & Sci Conservat Ctr, Natl Museum Nat Hist,CESCO UMR7204, Paris, France; [Lacoeuilhe, Aurelie; Le Bocq, Agathe] Elect France SA EDF, R&D, EPI Dept, Moret Sur Loing, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Electricite de France (EDF)	Lacoeuilhe, A (corresponding author), UPMC, CNRS, Ecol & Sci Conservat Ctr, Natl Museum Nat Hist,CESCO UMR7204, Paris, France.	lacoeuilhe@mnhn.fr			EDF company (Electricite de France S.A.)	EDF company (Electricite de France S.A.)	Funding was provided by the EDF company (Electricite de France S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1999, CAN J ZOOL, V77, P27, DOI 10.1139/cjz-77-1-27; Arlettaz R, 2000, BIOL CONSERV, V93, P55, DOI 10.1016/S0006-3207(99)00112-3; Arthur L, 2009, BIOTOPE MEZE MUSEUM; BLAKE D, 1994, J ZOOL, V234, P453, DOI 10.1111/j.1469-7998.1994.tb04859.x; Burnham K. P., 2002, MODEL SELECTION AND; Burt J, 2006, SYRINX A SOFTWARE FO; Catto CMC, 1996, J ZOOL, V238, P623, DOI 10.1111/j.1469-7998.1996.tb05419.x; CORELA, 2007, HEDGEROWS DATABASE; CORELA, 2007, LAND USE DATABASE; Crawley MJ, 2009, SPATIAL ANALYSIS A G; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Dietz C, 2009, LENCYCLOPEDIE DES CH; Faraway J.J., 2006, EXTENDING THE LINEAR; Fenton MB, 2002, CAN J ZOOL, V80, P1004, DOI 10.1139/Z02-083; Fox J, 2011, AN R COMPANION TO AP; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; IUCN, 2012, THE IUCN RED LIST OF; Jackman S, 2012, PSCL CLASSES AND MET; JONES G, 1994, PHILOS T R SOC B, V346, P445, DOI 10.1098/rstb.1994.0161; McGuire LP, 2010, ACTA CHIROPTEROL, V12, P247, DOI 10.3161/150811010X504734; Meteo France, 2012, FRENCH NATIONAL METE; Mitchell-Jones A. J., 1999, THE ATLAS OF EUROPEA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rainho A, 2007, ACTA CHIROPTEROL, V9, P171, DOI 10.3161/1733-5329(2007)9[171:SFHOBI]2.0.CO;2; Rich C., 2006, ECOLOGICAL CONSEQUEN; Roche N. C., 2005, IRISH WILDLIFE MANUA; Russ J, 1999, ALANA BOOKS; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; RYDELL J, 1995, BIOL J LINN SOC, V54, P183, DOI 10.1006/bijl.1995.0011; Rydell Jens, 2006, P43; Rydell Jens, 1996, Entomologisk Tidskrift, V117, P129; Scanlon AT, 2008, WILDLIFE RES, V35, P821, DOI 10.1071/WR08035; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Stahlschmidt P, 2012, METHODS ECOL EVOL, V3, P503, DOI 10.1111/j.2041-210X.2012.00188.x; Stebbings R. E., 1988, THE CONSERVATION OF; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Zuur Alain F., 2009, P1	44	55	57	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e103042	10.1371/journal.pone.0103042	http://dx.doi.org/10.1371/journal.pone.0103042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360638	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700002
J	Prinja, S; Bahuguna, P; Lakshmi, PVM; Mokashi, T; Aggarwal, AK; Kaur, M; Reddy, KR; Kumar, R				Prinja, Shankar; Bahuguna, Pankaj; Lakshmi, P. V. M.; Mokashi, Tushar; Aggarwal, Arun Kumar; Kaur, Manmeet; Reddy, K. Rahul; Kumar, Rajesh			Evaluation of Publicly Financed and Privately Delivered Model of Emergency Referral Services for Maternal and Child Health Care in India	PLOS ONE			English	Article							INTERRUPTED TIME-SERIES; TRANSPORT; MORTALITY; HARYANA; IMPACT	Background: Emergency referral services (ERS) are being strengthened in India to improve access for institutional delivery. We evaluated a publicly financed and privately delivered model of ERS in Punjab state, India, to assess its extent and pattern of utilization, impact on institutional delivery, quality and unit cost. Methods: Data for almost 0.4 million calls received from April 2012 to March 2013 was analysed to assess the extent and pattern of utilization. Segmented linear regression was used to analyse month-wise data on number of institutional deliveries in public sector health facilities from 2008 to 2013. We inspected ambulances in 2 districts against the Basic Life Support (BLS) standards. Timeliness of ERS was assessed for determining quality. Finally, we computed economic cost of implementing ERS from a health system perspective. Results: On an average, an ambulance transported 3-4 patients per day. Poor and those farther away from the health facility had a higher likelihood of using the ambulance. Although the ERS had an abrupt positive effect on increasing the institutional deliveries in the unadjusted model, there was no effect on institutional delivery after adjustment for autocorrelation. Cost of operating the ambulance service was INR 1361 (USD 22.7) per patient transported or INR 21 (USD 0.35) per km travelled. Conclusion: Emergency referral services in Punjab did not result in a significant change in public sector institutional deliveries. This could be due to high baseline coverage of institutional delivery and low barriers to physical access. Choice of interventions for reduction in Maternal Mortality Ratio (MMR) should be context-specific to have high value for resources spent. The ERS in Punjab needs improvement in terms of quality and reduction of cost to health system.	[Prinja, Shankar; Bahuguna, Pankaj; Lakshmi, P. V. M.; Aggarwal, Arun Kumar; Kaur, Manmeet; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Mokashi, Tushar; Reddy, K. Rahul] Minist Hlth & Family Welf, Natl Hlth Syst Resource Ctr, New Delhi, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com		Bahuguna, Pankaj/0000-0001-9952-6077	Punjab Health Systems Corporation (PHSC) of the Government of Punjab	Punjab Health Systems Corporation (PHSC) of the Government of Punjab	The study was funded by the Punjab Health Systems Corporation (PHSC) of the Government of Punjab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, Soc Sci Med, V40, P657; Austin P C, 2012, MULTIVARIATE BEHAV R, V46, P119; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Bos E, 2007, OBSTET CARE POOR SET; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Gujarati DN, 2003, DETECTING AUTOCORREL, P462; Heinrich C., 2010, IMPACT EVALUATION GU, VIDB-TN-161; Hussein J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001264; Kalter HD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-41; Khan N, 2012, J HLTH POPULATION NU, V31, P262; Kwast BE, 1998, STUD FAMILY PLANN, V17, P288; Lagarde M, 2009, COCHRANE DATABASE SY, V7; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; MoHFW, 2010, DISTR LEV HOUS FAC S; MOHFW, 2005, NAT RUR HLTH MISS IM; MOHFW, 2008, DIR INN IMPL HLTH SE; NHSRC, 2011, PROGR EV JAN SUR YOJ; NRHM, 2012, STAT PIP BUDG 2012 1; Prinja S, 2014, INDIAN J MED RES, V139, P883; Prinja S, 2013, INDIAN J MED RES, V138, P1003; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; RGI, 2008, SRS B SAMPL REG SYST; RGI, 2011, SPEC B MAT MORT IND; RGI, 2012, SRS B SAMPL REG SYST; RGI, 2013, SPEC B MAT MORT IND; RGI, 2009, SRS B SAMPL REG SYST; RGI, 2011, SRS B SAMPL REG SYST; Sidney K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096287; Singh S., 2009, BARRIERS SAFE MOTHER; Sundararaman T, 2012, PUBLICLY FINANCED EM; Sundararaman T, 2012, BMC P, V8; TABACHNICK BARBARA G., 2007, TIME SERIES ANAL; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNFPA, 2009, CONC ASS JAN SUR YOJ; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO U, 2012, TRENDS MAT MORT 1999; Wilson A, 2013, INT J GYNECOL OBSTET, V122, P192, DOI 10.1016/j.ijgo.2013.03.030	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109911	10.1371/journal.pone.0109911	http://dx.doi.org/10.1371/journal.pone.0109911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360798	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700020
J	Wang, YQ; Zhu, C; Zhang, JW; Jian, YD				Wang, Yuanquan; Zhu, Ce; Zhang, Jiawan; Jian, Yuden			Convolutional Virtual Electric Field for Image Segmentation Using Active Contours	PLOS ONE			English	Article							GRADIENT VECTOR FLOW; EXTERNAL FORCE; SNAKE; DRIVEN; SYNCHRONIZATION; TRACKING; MUMFORD; MODELS; ENERGY; SHAPE	Gradient vector flow (GVF) is an effective external force for active contours; however, it suffers from heavy computation load. The virtual electric field (VEF) model, which can be implemented in real time using fast Fourier transform (FFT), has been proposed later as a remedy for the GVF model. In this work, we present an extension of the VEF model, which is referred to as CONvolutional Virtual Electric Field, CONVEF for short. This proposed CONVEF model takes the VEF model as a convolution operation and employs a modified distance in the convolution kernel. The CONVEF model is also closely related to the vector field convolution (VFC) model. Compared with the GVF, VEF and VFC models, the CONVEF model possesses not only some desirable properties of these models, such as enlarged capture range, u-shape concavity convergence, subject contour convergence and initialization insensitivity, but also some other interesting properties such as G-shape concavity convergence, neighboring objects separation, and noise suppression and simultaneously weak edge preserving. Meanwhile, the CONVEF model can also be implemented in real-time by using FFT. Experimental results illustrate these advantages of the CONVEF model on both synthetic and natural images.	[Wang, Yuanquan] Tianjin Univ Technol, Sch Comp Sci, Tianjin, Peoples R China; [Zhu, Ce] Univ Elect Sci & Technol China, Sch Elect Engn, Chengdu 610054, Peoples R China; [Zhang, Jiawan] Tianjin Univ, Sch Software Engn, Tianjin 300072, Peoples R China; [Jian, Yuden] Beijing Inst Technol, Sch Comp Sci, Beijing 100081, Peoples R China	Tianjin University of Technology; University of Electronic Science & Technology of China; Tianjin University; Beijing Institute of Technology	Zhang, JW (corresponding author), Tianjin Univ, Sch Software Engn, Tianjin 300072, Peoples R China.	jwzhang@tju.edu.cn	Zhu, Ce/AEN-1875-2022	Wang, Yuanquan/0000-0002-9232-5392				Adam A, 2009, IEEE T PATTERN ANAL, V31, P1708, DOI 10.1109/TPAMI.2009.21; Ben Ayed I, 2009, INT J COMPUT VISION, V85, P115, DOI 10.1007/s11263-009-0249-6; Boukerroui D, 2012, PATTERN RECOGN, V45, P626, DOI 10.1016/j.patcog.2011.07.007; Brox T, 2009, INT J COMPUT VISION, V84, P184, DOI 10.1007/s11263-008-0153-5; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Darolti C, 2008, IEEE T IMAGE PROCESS, V17, P2275, DOI 10.1109/TIP.2008.2006443; De Vylder J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054068; Estellers V, 2014, IEEE T IMAGE PROCESS, V23, P69, DOI 10.1109/TIP.2013.2286326; Fergani K, 2014, COMPUT VIS IMAGE UND, V125, P85, DOI 10.1016/j.cviu.2014.03.011; Fu S, 2010, ELECTRON LETT, V46, P907, DOI 10.1049/el.2010.0027; Fu SJ, 2012, OPT LETT, V37, P422, DOI 10.1364/OL.37.000422; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P3866, DOI 10.1109/TIP.2013.2263147; Ghita O, 2010, PATTERN RECOGN, V43, P2646, DOI 10.1016/j.patcog.2010.02.023; Hassouna MS, 2009, IEEE T PATTERN ANAL, V31, P2257, DOI 10.1109/TPAMI.2008.271; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kim W, 2013, IEEE T IMAGE PROCESS, V22, P1665, DOI 10.1109/TIP.2012.2231689; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Li B, 2008, IEEE T IMAGE PROCESS, V17, P1406, DOI 10.1109/TIP.2008.925375; Li B, 2007, IEEE T IMAGE PROCESS, V16, P2096, DOI 10.1109/TIP.2007.899601; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li L, 2014, P NATL ACAD SCI USA; Li P, 2013, INT C COMP VIS ICCV; Li PH, 2013, J MATH IMAGING VIS, V46, P44, DOI 10.1007/s10851-012-0369-4; Lu SP, 2010, LECT NOTES COMPUT SC, V5994, P147; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Muralidhar GS, 2010, IEEE T MED IMAGING, V29, P1768, DOI 10.1109/TMI.2010.2052064; Myronenko A, 2009, PROC CVPR IEEE, P2790; Nakhmani A, 2012, IEEE T IMAGE PROCESS, V21, P3150, DOI 10.1109/TIP.2012.2188808; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; Paragios N, 2000, IEEE T PATTERN ANAL, V22, P266, DOI 10.1109/34.841758; Paragios N, 2004, IEEE T PATTERN ANAL, V26, P402, DOI 10.1109/TPAMI.2004.1262337; Park HK, 2002, ELECTRON LETT, V38, P1500, DOI 10.1049/el:20021037; Prasad VSN, 2004, IEEE T IMAGE PROCESS, V13, P1559, DOI 10.1109/TIP.2004.837564; Qin LM, 2013, IEEE T CIRC SYST VID, V23, P883, DOI 10.1109/TCSVT.2013.2242554; Ray N, 2004, IEEE T MED IMAGING, V23, P1466, DOI 10.1109/TMI.2004.835603; Ray N, 2003, IEEE T MED IMAGING, V22, P189, DOI 10.1109/TMI.2002.808354; Ren DW, 2013, PATTERN RECOGN LETT, V34, P219, DOI 10.1016/j.patrec.2012.09.017; Rodtook A, 2010, PATTERN RECOGN, V43, P3522, DOI 10.1016/j.patcog.2010.04.003; Shih FY, 2007, COMPUT VIS IMAGE UND, V105, P93, DOI 10.1016/j.cviu.2006.08.007; Shivakumara P, 2013, IEEE T CIRC SYST VID, V23, P1729, DOI 10.1109/TCSVT.2013.2255396; Srikrishnan V, 2011, IMAGE VISION COMPUT, V29, P317, DOI 10.1016/j.imavis.2010.12.004; Srikrishnan V, 2009, IEEE T IMAGE PROCESS, V18, P1859, DOI 10.1109/TIP.2009.2021310; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wang WP, 2014, NONLINEAR DYNAM, V76, P591, DOI 10.1007/s11071-013-1153-8; Wang WP, 2014, NEURAL NETWORKS, V53, P8, DOI 10.1016/j.neunet.2014.01.010; Wang Y, 2008, ELECTRON LETT, V44, P105, DOI 10.1049/el:20081650; Wang Y, 2009, P AS C COMP VIS; Wang Y, 2007, LECT NOTES COMPUT SC, V4844, P754; Wang YQ, 2013, COMPUT MATH APPL, V66, P1729, DOI 10.1016/j.camwa.2013.08.034; Wang YQ, 2013, COMPUT ELECTR ENG, V39, P1506, DOI 10.1016/j.compeleceng.2013.03.017; Wang YQ, 2010, IEEE SIGNAL PROC LET, V17, P875, DOI 10.1109/LSP.2010.2060482; Wu H, 2013, IEEE T PATTERN ANAL, V35, P1298, DOI 10.1109/TPAMI.2012.207; Wu YW, 2013, COMPUT VIS IMAGE UND, V117, P1421, DOI 10.1016/j.cviu.2013.05.003; Wu YW, 2013, COMPUT VIS IMAGE UND, V117, P990, DOI 10.1016/j.cviu.2012.12.008; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu CY, 1998, SIGNAL PROCESS, V71, P131, DOI 10.1016/S0165-1684(98)00140-6; Yuan D, 2002, INT C PATT RECOG, P83, DOI 10.1109/ICPR.2002.1044618; YUE ZJ, 1995, IEEE T MED IMAGING, V14, P525, DOI 10.1109/42.414618; Zhang KH, 2010, PATTERN RECOGN, V43, P1199, DOI 10.1016/j.patcog.2009.10.010; Zhao DW, 2012, COMPUT MATH APPL, V64, P611, DOI 10.1016/j.camwa.2011.12.067; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	62	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110032	10.1371/journal.pone.0110032	http://dx.doi.org/10.1371/journal.pone.0110032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360586	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700022
J	Zhang, JX; Zheng, L; Zhu, DL; An, HR; Yang, YR; Liang, Y; Zhao, WG; Ding, WJ; Wu, XQ				Zhang, Junxian; Zheng, Li; Zhu, Donglin; An, Huiru; Yang, Yourong; Liang, Yan; Zhao, Weiguo; Ding, Wenjun; Wu, Xueqiong			Polymorphisms in the Interleukin 18 Receptor 1 Gene and Tuberculosis Susceptibility among Chinese	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; PULMONARY TUBERCULOSIS; PROTECTIVE IMMUNITY; GRANULOMA-FORMATION; T-CELLS; INFECTION; ASSOCIATION; MICE; HOST	Tuberculosis (TB), an infectious disease caused by infection of Mycobacterium tuberculosis, is a major public health challenge globally. Genetic epidemiological evidence suggests a genetic basis for TB, but the molecular mechanism for a genetic predisposition to TB remains largely unknown. Thirty-five tag single-nucleotide polymorphisms (SNPs) across 11 candidate cytokines and related genes, including IL-12/IFN-gamma axis genes (IL12B, IL12RB1, IL18R1, IL27, IFNGR1, IFNGR2 and STAT1), the TNF gene locus (TNF and LTA), IL10, and CCL2, were genotyped using Sequenom's iPLEX assays in 1,032 patients with TB and 1,008 controls of Chinese Han origin. We did not find that any of the 35 tag SNPs individually or as haplotypes was significantly associated with susceptibility to TB, on the basis of multivariable logistic regression analysis with adjustment for age and sex. However, stratification analyses showed that, in those with age 46 years or older, carrying the rs1974675 T allele in the IL18R1 gene had a significantly decreased susceptibility to TB occurrence compared with carrying the C/C genotype (OR = 0.57, P = 5.0 x 10(-4)). Further analysis indicated that a SNP in absolute linkage disequilibrium with rs1974675, rs3755276, is located within a CpG dinucleotide and showed hypomethylation in controls than in patients (19.6% vs. 31.4%; P = 1.0 x 10(-4)) and genotype-specific DNA methylation at the IL18R1 promoter and IL18R1 mRNA levels. In addition, DNA methylation levels were significantly inversely correlated with mRNA levels. Thus, decreased mRNA levels of IL18R1 due to rs3755276 may partially mediate the increased susceptibility to TB risk.	[Zhang, Junxian; Zhu, Donglin; An, Huiru; Yang, Yourong; Liang, Yan; Zhao, Weiguo; Wu, Xueqiong] 309th Hosp Chinese PLA, Inst TB Res, Army TB Prevent & Control Key Lab, Beijing, Peoples R China; [Zheng, Li; Ding, Wenjun] Univ Chinese Acad Sci, Coll Life Sci, Lab Environm & Hlth, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ding, WJ (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Lab Environm & Hlth, Beijing, Peoples R China.	dingwj@ucas.ac.cn; wu-xueqiong@263.net			Army "Twelfth Five" Scientific Research Foundation [BWS11J050]	Army "Twelfth Five" Scientific Research Foundation	This work was supported by a grant from the Army "Twelfth Five" Scientific Research Foundation (BWS11J050). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1989, J CLIN EPIDEMIOL, V42, P659, DOI 10.1016/0895-4356(89)90009-7; Ansari AW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00312; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Bean AGD, 1999, J IMMUNOL, V162, P3504; Ben-Selma W, 2012, INT J INFECT DIS, V16, pE543, DOI 10.1016/j.ijid.2011.11.016; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Grant AV, 2013, AM J HUM GENET, V92, P407, DOI 10.1016/j.ajhg.2013.01.013; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hijikata M, 2012, HUM GENET, V131, P675, DOI 10.1007/s00439-011-1112-8; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Jacobs M, 2000, LAB INVEST, V80, P901, DOI 10.1038/labinvest.3780094; Keeton R, 2014, J CLIN INVEST, V124, P1537, DOI 10.1172/JCI45005; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Kusuhara K, 2007, INT J IMMUNOGENET, V34, P35, DOI 10.1111/j.1744-313X.2007.00653.x; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Longhi RMP, 2013, BRAZ J INFECT DIS, V17, P363, DOI 10.1016/j.bjid.2012.11.001; Rajagopalan S, 2000, Z GERONTOL GERIATR, V33, P374, DOI 10.1007/s003910070034; Rajagopalan S, 2000, INFECT CONT HOSP EP, V21, P611, DOI 10.1086/501816; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Senaldi G, 1996, J IMMUNOL, V157, P5022; Torrado E, 2013, ADV EXP MED BIOL, V783, P121, DOI 10.1007/978-1-4614-6111-1_7; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yano S, 2003, J IMMUNOL, V171, P2510, DOI 10.4049/jimmunol.171.5.2510; Yu Q, 2008, J IMMUNOL, V181, P3346, DOI 10.4049/jimmunol.181.5.3346	40	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110734	10.1371/journal.pone.0110734	http://dx.doi.org/10.1371/journal.pone.0110734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360588	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700043
J	Ahman, B; Svensson, K; Ronnegard, L				Ahman, Birgitta; Svensson, Kristin; Ronnegard, Lars			High Female Mortality Resulting in Herd Collapse in Free-Ranging Domesticated Reindeer (Rangifer tarandus tarandus) in Sweden	PLOS ONE			English	Article							LYNX-LYNX; EURASIAN LYNX; DENSITY; CARIBOU; REPRODUCTION; SURVIVAL; SNOW; POPULATIONS; LIMITATION; PREDATION	Reindeer herding in Sweden is a form of pastoralism practised by the indigenous Sami population. The economy is mainly based on meat production. Herd size is generally regulated by harvest in order not to overuse grazing ranges and keep a productive herd. Nonetheless, herd growth and room for harvest is currently small in many areas. Negative herd growth and low harvest rate were observed in one of two herds in a reindeer herding community in Central Sweden. The herds (A and B) used the same ranges from April until the autumn gathering in October-December, but were separated on different ranges over winter. Analyses of capture-recapture for 723 adult female reindeer over five years (2007-2012) revealed high annual losses (7.1% and 18.4%, for herd A and B respectively). A continuing decline in the total reindeer number in herd B demonstrated an inability to maintain the herd size in spite of a very small harvest. An estimated breakpoint for when herd size cannot be kept stable confirmed that the observed female mortality rate in herd B represented a state of herd collapse. Lower calving success in herd B compared to A indicated differences in winter foraging conditions. However, we found only minor differences in animal body condition between the herds in autumn. We found no evidence that a lower autumn body mass generally increased the risk for a female of dying from one autumn to the next. We conclude that the prime driver of the on-going collapse of herd B is not high animal density or poor body condition. Accidents or disease seem unlikely as major causes of mortality. Predation, primarily by lynx and wolverine, appears to be the most plausible reason for the high female mortality and state of collapse in the studied reindeer herding community.	[Ahman, Birgitta] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Svensson, Kristin; Ronnegard, Lars] Dalarna Univ, Sch Technol & Business Studies, Falun, Sweden	Swedish University of Agricultural Sciences; Dalarna University	Ahman, B (corresponding author), Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden.	birgitta.ahman@slu.se		Ronnegard, Lars/0000-0002-1057-5401	Swedish Board of Agriculture [31-7132/07, 31-5841/08, 31-4347/09, 31-4665/10]	Swedish Board of Agriculture	Funding for the project was granted by the Swedish Board of Agriculture (contract 31-7132/07, 31-5841/08, 31-4347/09 and 31-4665/10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 2002, WILDLIFE BIOL, V8, P299, DOI 10.2981/wlb.2002.027; [Anonymous], 2014, AVSKJUNTINGSRAPPORT; [Anonymous], 1991, UTVECKLINGSPLANERING; [Anonymous], 2002, FORESKRIFTER ANDRING; Arnesson-Westerdahl A, 1995, FORSLAG UTFORMMING N; Bastille-Rousseau G, 2013, CAN J ZOOL, V91, P820, DOI 10.1139/cjz-2013-0154; Bjarvall A., 1990, RENAR ROVDJUR ROVDJU; Caswell H, 1989, MATRIX POPULATION MO; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Cuyler Christine, 2007, Rangifer, P219; Eloranta E., 1986, RANGIFER, V1, P115, DOI DOI 10.7557/2.6.2.635; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gunn Anne, 2003, Rangifer, P105; Haglund B, 1966, J VILTREVY, V4, P81; Hegel Troy M., 2013, Rangifer, V33, P59; HELLE T, 1993, ARCTIC, V46, P72; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Klein DR, 2009, AMBIO, V38, P11, DOI 10.1579/0044-7447-38.1.11; KLEIN DR, 1968, J WILDLIFE MANAGE, V32, P350, DOI 10.2307/3798981; Kumpula J, 1998, CAN J ZOOL, V76, P269, DOI 10.1139/cjz-76-2-269; Kumpula J, 2003, POLAR RES, V22, P225, DOI 10.1111/j.1751-8369.2003.tb00109.x; Landa AJ, 2001, JERV SKANDINAVIA AKT; Lauvergne Jean J., 2010, Rangifer, V30, P11; Lundqvist H, 2007, THESIS SWEDISH U AGR; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; Mattisson J, 2011, J MAMMAL, V92, P1321, DOI 10.1644/11-MAMM-A-099.1; Miller FL, 2009, ARCTIC, V62, P175; Muuttoranta K, 2012, ACTA AGR SCAND A-AN, V62, P142, DOI 10.1080/09064702.2012.747560; Nieminen M., 2013, Rangifer, V33, P79; Nieminen Mauri, 2011, Rangifer, V31, P71; Norberg H, 2006, WILDLIFE BIOL, V12, P393, DOI 10.2981/0909-6396(2006)12[393:PBGEAC]2.0.CO;2; Nybakk K, 2002, WILDLIFE BIOL, V8, P63, DOI 10.2981/wlb.2002.009; Odden J, 2006, EUR J WILDLIFE RES, V52, P237, DOI 10.1007/s10344-006-0052-4; Olofsson Anna, 2011, Rangifer, V31, P7; Pape R, 2012, AMBIO, V41, P421, DOI 10.1007/s13280-012-0257-6; Pedersen VA, 1999, WILDLIFE BIOL, V5, P203; Ronnegard L, 2002, CAN J ZOOL, V80, P2047, DOI 10.1139/z02-192; Scoones I., 1993, Economics and ecology: new frontiers and sustainable development., P96; SKOGLAND T, 1989, OIKOS, V55, P101, DOI 10.2307/3565879; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; SKOGLAND T, 1983, OECOLOGIA, V60, P156, DOI 10.1007/BF00379517; SKOGLAND T, 1990, OECOLOGIA, V84, P442, DOI 10.1007/BF00328158; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Tyler NJC, 2010, ECOL MONOGR, V80, P197, DOI 10.1890/09-1070.1; Ulvevadet B, 2011, J ENVIRON MANAGE, V92, P2794, DOI 10.1016/j.jenvman.2011.06.026	48	7	7	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111509	10.1371/journal.pone.0111509	http://dx.doi.org/10.1371/journal.pone.0111509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356591	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000066
J	Mostaghel, EA; Morgan, A; Zhang, XT; Marck, BT; Xia, J; Hunter-Merrill, R; Gulati, R; Plymate, S; Vessella, RL; Corey, E; Higano, CS; Matsumoto, AM; Montgomery, RB; Nelson, PS				Mostaghel, Elahe A.; Morgan, Andrew; Zhang, Xiaotun; Marck, Brett T.; Xia, Jing; Hunter-Merrill, Rachel; Gulati, Roman; Plymate, Stephen; Vessella, Robert L.; Corey, Eva; Higano, Celestia S.; Matsumoto, Alvin M.; Montgomery, R. Bruce; Nelson, Peter S.			Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis	PLOS ONE			English	Article							INCREASED SURVIVAL; HORMONAL-THERAPY; CARCINOMA; DIHYDROTESTOSTERONE; TESTOSTERONE; PROGRESSION; ABIRATERONE; RESISTANCE; ENZALUTAMIDE; INDEPENDENCE	Background: Factors influencing differential responses of prostate tumors to androgen receptor (AR) axis-directed therapeutics are poorly understood, and predictors of treatment efficacy are needed. We hypothesized that the efficacy of inhibiting DHT ligand synthesis would associate with intra-tumoral androgen ratios indicative of relative dependence on DHT-mediated growth. Methods: We characterized two androgen-sensitive prostate cancer xenograft models after androgen suppression by castration in combination with the SRD5A inhibitor, dutasteride, as well as a panel of castration resistant metastases obtained via rapid autopsy. Results: In LuCaP35 tumors (intra-tumoral T: DHT ratio 2: 1) dutasteride suppressed DHT to 0.02 ng/gm and prolonged survival vs. castration alone (337 vs. 152 days, HR 2.8, p = 0.0015). In LuCaP96 tumors (T: DHT 10: 1), survival was not improved despite similar DHT reduction (0.02 ng/gm). LuCaP35 demonstrated higher expression of steroid biosynthetic enzymes maintaining DHT levels (5-fold higher SRD5A1, 41 fold higher, 99-fold higher RL-HSD, p<0.0001 for both), reconstitution of intra-tumoral DHT (to similar to 30% of untreated tumors), and similar to 2 fold increased expression of full length AR. In contrast, LuCaP96 demonstrated higher levels of steroid catabolizing enzymes (6.9-fold higher AKR1C2, 3000-fold higher UGT2B15, p = 0.002 and p<0.0001 respectively), persistent suppression of intra-tumoral DHT, and 6-8 fold induction of full length AR and the ligand independent V7 AR splice variant. Human metastases demonstrated bio-active androgen levels and AR full length and AR splice-variant expression consistent with the range observed in xenografts. Conclusions: Intrinsic differences in basal steroidogenesis, as well as variable expression of full length and splice-variant AR, associate with response and resistance to pre-receptor AR ligand suppression. Expression of steroidogenic enzymes and AR isoforms may serve as potential biomarkers of sensitivity to potent AR-axis inhibition and should be validated in additional models.	[Mostaghel, Elahe A.; Morgan, Andrew; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Mostaghel, Elahe A.; Marck, Brett T.; Plymate, Stephen; Higano, Celestia S.; Matsumoto, Alvin M.; Montgomery, R. Bruce; Nelson, Peter S.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Zhang, Xiaotun; Vessella, Robert L.; Corey, Eva] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA; [Marck, Brett T.; Plymate, Stephen; Matsumoto, Alvin M.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Xia, Jing; Hunter-Merrill, Rachel; Gulati, Roman] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Fred Hutchinson Cancer Center	Mostaghel, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	emostagh@fhcrc.org	Gulati, Roman/AAE-4298-2019; Matsumoto, Alvin/AAH-6096-2020	Gulati, Roman/0000-0002-7592-6567; 	Prostate Cancer Foundation Career Development Award; Challenge Award; Damon Runyon Genentech-Clinical Investigator Award [C-40-08]; NIH grant [1K23 CA122820-01]; DOD New Investigator Award [W81XWH-10-1-0228]; GlaxoSmithKline; NIH/NCI Pacific Northwest Prostate Cancer SPORE [P50CA97186]; Department of Veterans Affairs;  [1RC1 CA146849];  [PC093509];  [PO1 CA 85859]; NATIONAL CANCER INSTITUTE [K23CA122820, RC1CA146849, P50CA097186, P01CA085859] Funding Source: NIH RePORTER	Prostate Cancer Foundation Career Development Award; Challenge Award; Damon Runyon Genentech-Clinical Investigator Award; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD New Investigator Award; GlaxoSmithKline(GlaxoSmithKline); NIH/NCI Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Prostate Cancer Foundation Career Development Award (E. A. M.) and Challenge Award (E. A. M., S. P., R. L. V., A. M. M., R. B. M., P.S.N.), Damon Runyon Genentech-Clinical Investigator Award C-40-08 (E. A. M.), NIH grant 1K23 CA122820-01 (E. A. M.), DOD New Investigator Award W81XWH-10-1-0228 (E. A. M.); GlaxoSmithKline (A. M. and P.S.N.); 1RC1 CA146849 (P.S.N.); PC093509 (P.S.N.); PO1 CA 85859 (J.X., R. G., R. V., P.S.N.); the NIH/NCI Pacific Northwest Prostate Cancer SPORE P50CA97186 (J.X., R. H., R. G., P.S.N., R. V.); and the Department of Veterans Affairs (B. T. M., S. P. and A. M. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arnold JT, 2007, PROSTATE, V67, P1152, DOI 10.1002/pros.20585; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; GELLER J, 1978, J CLIN ENDOCR METAB, V46, P440; Gregory CW, 2001, CANCER RES, V61, P4315; GRINO PB, 1990, ENDOCRINOLOGY, V126, P1165, DOI 10.1210/endo-126-2-1165; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hobisch A, 1996, PROSTATE, V28, P129; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mohler JL, 1996, CLIN CANCER RES, V2, P889; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2011, CLIN CANC RES; Page ST, 2007, J ANDROL JANDROL, V107; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; SADI MV, 1991, CANCER, V67, P3057, DOI 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2009, CLIN CANCER RES, V15, P7099, DOI 10.1158/1078-0432.CCR-09-1722; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Watson PA, 2010, P NATL ACAD SCI; Wright AS, 1996, J CLIN INVEST, V98, P2558, DOI 10.1172/JCI119074; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	39	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111545	10.1371/journal.pone.0111545	http://dx.doi.org/10.1371/journal.pone.0111545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356728	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000069
J	Koo, HK; Park, JH; Park, HK; Jung, H; Lee, SS				Koo, Hyeon-Kyoung; Park, Joo-Hyun; Park, Hye Kyeong; Jung, Hoon; Lee, Sung-Soon			Conflicting Role of Sarcopenia and Obesity in Male Patients with Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BODY-MASS INDEX; PROGNOSTIC VALUE; COPD; PREVALENCE; DYSPNEA	Objective: To determine the impact of sarcopenia and obesity on pulmonary function and quality of life (QOL) in chronic obstructive pulmonary disease (COPD) patients. Research Design and Methods: Data were obtained from the Korea National Health and Nutrition Examination Survey, including data from health interviews, health examinations, nutritional questionnaires, and laboratory findings. Laboratory data included pulmonary function assessment and dual energy X-ray absorptiometry results. Sarcopenia was measured by dual energy X-ray absorptiometry, and obesity was defined by body mass index. Male COPD patients were then classified into 4 groups according to the presence of sarcopenia and obesity. Results: In male patients with COPD, the prevalence of sarcopenia was found to be 29.3%, and that of sarcopenic obesity was 14.2%. Furthermore, 22.5% of the patients observed in this study had impaired QOL. Following multivariable statistical analysis, both sarcopenia and obesity were independent risk factors for worsening lung function. Adjusted values of forced vital capacity and forced expiratory volume in 1 second were the lowest in the sarcopenic obesity group. Sarcopenia was also associated with more subjective activity limitation and poorer QOL; however obesity was related to less subjective limitation and better QOL after multivariable analysis. Adjusted value of QOL was the lowest in sarcopenic subjects without obesity, and the highest in obese subject without sarcopenia. Conclusions: Both sarcopenia and obesity were found to be associated with worsening lung function in male COPD patients. However, obesity was positively correlated with improved QOL while sarcopenia was negatively correlated with QQL.	[Koo, Hyeon-Kyoung; Park, Joo-Hyun; Park, Hye Kyeong; Jung, Hoon; Lee, Sung-Soon] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea	Inje University	Lee, SS (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea.	LeeSS@paik.ac.kr						[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Chin SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060119; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim JH, 2010, ANN GERIATR MED RES, V14, P121, DOI 10.4235/jkgs.2010.14.3.121; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Miravitlles M, 2005, RESP MED, V99, P985, DOI 10.1016/j.rmed.2005.01.012; Prescott E, 2002, EUR RESPIR J, V20, P539, DOI 10.1183/09031936.02.00532002; Roisin RR, 2011, GLOBAL STRATEGY DIAG; SAHEBJAMI H, 1993, AM J MED, V94, P469, DOI 10.1016/0002-9343(93)90080-9; Wilke S, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-98; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289	23	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110448	10.1371/journal.pone.0110448	http://dx.doi.org/10.1371/journal.pone.0110448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353344	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200026
J	Nilsson, OB; Neimert-Andersson, T; Bronge, M; Grundstrom, J; Sarma, R; Uchtenhagen, H; Kikhney, A; Sandalova, T; Holmgren, E; Svergun, D; Achour, A; van Hage, M; Gronlund, H				Nilsson, Ola B.; Neimert-Andersson, Theresa; Bronge, Mattias; Grundstrom, Jeanette; Sarma, Ranjana; Uchtenhagen, Hannes; Kikhney, Alexey; Sandalova, Tatyana; Holmgren, Erik; Svergun, Dmitri; Achour, Adnane; van Hage, Marianne; Gronlund, Hans			Designing a Multimer Allergen for Diagnosis and Immunotherapy of Dog Allergic Patients	PLOS ONE			English	Article							CARBOHYDRATE-BASED PARTICLES; IMMUNOLOGICAL CHARACTERIZATION; LIPOCALIN ALLERGEN; CROSS-REACTIVITY; CAT; SCATTERING; ASTHMA; DANDER; INFLAMMATION; PROTEINS	Background: Dog dander extract used for diagnosis and allergen-specific immunotherapy is often of variable and of poor quality. Objective: To assemble four well-established dog allergen components into one recombinant folded protein for improved diagnosis and vaccination of allergy to dog. Methods: A linked molecule, comprising the four dog lipocalin allergens Can f 1, Can f 2, Can f 4 and Can f 6 was constructed. The tetrameric protein was structurally characterized by small angle X-ray scattering, and compared with each single recombinant lipocalin allergen or an equimolar mix of the four allergens by analytical size exclusion chromatography, circular dichroism, allergen-specific IgE in serum by ELISA and allergen-dependent capacity to activate basophils. The immunogenicity of the fusion protein was evaluated in immunized mice by assessing splenocyte proliferation and antibody production. Results: The linked tetrameric construct was produced as a soluble fusion protein, with the specific folds of the four individual allergens conserved. This multi-allergen molecule was significantly more efficient (p < 0.001) than each single recombinant allergen in binding to dog-specific IgE, and the epitope spectrum was unaffected compared to an equimolar mix of the four allergens. Basophil degranulation revealed that the biologic activity of the linked molecule was retained. Immunization of mice with the linked construct induced comparable allergen-specific IgG responses with blocking capacity towards all included allergens and generated comparably low T-cell responses. Conclusion: We provide the first evidence for a linked recombinant molecule covering the major dog allergens for potential use in diagnostics and allergy vaccination of dog allergic patients.	[Nilsson, Ola B.; Grundstrom, Jeanette; Holmgren, Erik; van Hage, Marianne] Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med, Stockholm, Sweden; [Nilsson, Ola B.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Neimert-Andersson, Theresa; Bronge, Mattias; Holmgren, Erik; Gronlund, Hans] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design Unit, Stockholm, Sweden; [Sarma, Ranjana; Uchtenhagen, Hannes; Sandalova, Tatyana; Achour, Adnane] Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden; [Kikhney, Alexey; Svergun, Dmitri] DESY, European Mol Biol Lab EMBL Hamburg Outstn, Hamburg, Germany	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Gronlund, H (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Therapeut Immune Design Unit, Stockholm, Sweden.	hans.gronlund@ki.se	van Hage, Marianne/A-9678-2017	van Hage, Marianne/0000-0003-3091-1596; Bronge, Mattias/0000-0002-1258-3982; Sandalova, Tatyana/0000-0002-7694-6420; Holmgren, Erik/0000-0002-2656-1864; Svergun, Dmitri/0000-0003-0830-5696; Gronlund, Hans/0000-0003-4882-7624; Achour, Adnane/0000-0003-0432-710X	Erling-Persson Family Foundation; Swedish Asthma and Allergy Association's Research Foundation; Cancer and Allergy Foundation; Konsul Th C Bergh Foundation; Hesselman Foundation; Swedish Research Council; Swedish Heart-Lung Foundation; Stockholm County Council; Centre for Allergy Research; European Commission (the 7th Framework Program) BioStruct-X project [283570]; Karolinska Institutet	Erling-Persson Family Foundation; Swedish Asthma and Allergy Association's Research Foundation; Cancer and Allergy Foundation; Konsul Th C Bergh Foundation; Hesselman Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Centre for Allergy Research; European Commission (the 7th Framework Program) BioStruct-X project; Karolinska Institutet(Karolinska Institutet)	This research was funded by grants from the Erling-Persson Family Foundation, the Swedish Asthma and Allergy Association's Research Foundation, the Cancer and Allergy Foundation, the Konsul Th C Bergh Foundation, the Hesselman Foundation, the Swedish Research Council, the Swedish Heart-Lung Foundation, the Stockholm County Council, the Centre for Allergy Research, the European Commission (the 7th Framework Program) BioStruct-X project (contract number 283570) and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse R, 2011, ALLERGY, V66, P28, DOI 10.1111/j.1398-9995.2011.02628.x; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Blanchet CE, 2012, J APPL CRYSTALLOGR, V45, P489, DOI 10.1107/S0021889812013490; Burks AW, 2013, J ALLERGY CLIN IMMUN, V131, P1288, DOI 10.1016/j.jaci.2013.01.049; Curin M, 2011, INT ARCH ALLERGY IMM, V154, P258, DOI 10.1159/000321113; Flower DR, 1996, BIOCHEM J, V318, P1; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Gronlund H, 2008, CLIN EXP ALLERGY, V38, P1275, DOI 10.1111/j.1365-2222.2008.03003.x; Gronlund H, 2002, IMMUNOLOGY, V107, P523, DOI 10.1046/j.1365-2567.2002.01535.x; HEDLIN G, 1991, J ALLERGY CLIN IMMUN, V87, P955, DOI 10.1016/0091-6749(91)90417-M; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Ling M, 2010, ALLERGY ASTHMA PROC, V31, P385, DOI 10.2500/aap.2010.31.3390; Linhart B, 2012, CURR OPIN IMMUNOL, V24, P354, DOI 10.1016/j.coi.2012.03.006; Madhurantakam C, 2010, J MOL BIOL, V401, P68, DOI 10.1016/j.jmb.2010.05.043; Mattsson L, 2010, CLIN EXP ALLERGY, V40, P1276, DOI 10.1111/j.1365-2222.2010.03533.x; Neimert-Andersson T, 2008, ALLERGY, V63, P518, DOI 10.1111/j.1398-9995.2008.01644.x; Nilsson OB, 2012, ALLERGY, V67, P751, DOI 10.1111/j.1398-9995.2012.02826.x; Nilsson OB, 2014, METHODS, V66, P86, DOI 10.1016/j.ymeth.2013.09.002; Nilsson OB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024558; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Saarne T, 2005, CLIN EXP ALLERGY, V35, P657, DOI 10.1111/j.1365-2222.2005.02234.x; Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P1290, DOI 10.1016/j.jaci.2012.02.026; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; SPITZAUER S, 1994, J ALLERGY CLIN IMMUN, V93, P614, DOI 10.1016/S0091-6749(94)70073-7; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896; Valenta R, 2011, ALLERGY; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; Winther L, 2006, CLIN EXP ALLERGY, V36, P254, DOI 10.1111/j.1365-2222.2006.02340.x	34	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111041	10.1371/journal.pone.0111041	http://dx.doi.org/10.1371/journal.pone.0111041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353166	gold, Green Published			2022-12-27	WOS:000345204200052
J	O'Connor, C; Joffe, H				O'Connor, Cliodhna; Joffe, Helene			Gender on the Brain: A Case Study of Science Communication in the New Media Environment	PLOS ONE			English	Article							SOCIAL REPRESENTATIONS; PSYCHOLOGICAL ESSENTIALISM; SYSTEM JUSTIFICATION; STEREOTYPE CONTENT; PRESS RELEASES; MASS-MEDIA; SEX BIAS; NEUROSCIENCE; BIOTECHNOLOGY; JOURNALISM	Neuroscience research on sex difference is currently a controversial field, frequently accused of purveying a 'neurosexism' that functions to naturalise gender inequalities. However, there has been little empirical investigation of how information about neurobiological sex difference is interpreted within wider society. This paper presents a case study that tracks the journey of one high-profile study of neurobiological sex differences from its scientific publication through various layers of the public domain. A content analysis was performed to ascertain how the study was represented in five domains of communication: the original scientific article, a press release, the traditional news media, online reader comments and blog entries. Analysis suggested that scientific research on sex difference offers an opportunity to rehearse abiding cultural understandings of gender. In both scientific and popular contexts, traditional gender stereotypes were projected onto the novel scientific information, which was harnessed to demonstrate the factual truth and normative legitimacy of these beliefs. Though strains of misogyny were evident within the readers' comments, most discussion of the study took pains to portray the sexes' unique abilities as equal and 'complementary'. However, this content often resembled a form of benevolent sexism, in which praise of women's social-emotional skills compensated for their relegation from more esteemed trait-domains, such as rationality and productivity. The paper suggests that embedding these stereotype patterns in neuroscience may intensify their rhetorical potency by lending them the epistemic authority of science. It argues that the neuroscience of sex difference does not merely reflect, but can actively shape the gender norms of contemporary society.	[O'Connor, Cliodhna; Joffe, Helene] UCL, Div Psychol & Language Sci, London, England	University of London; University College London	O'Connor, C (corresponding author), UCL, Div Psychol & Language Sci, London, England.	oconnor.c@ucl.ac.uk	O'Connor, Cliodhna/AAB-3343-2019	O'Connor, Cliodhna/0000-0001-8134-075X	'Uses and Abuses of Biology' grants programme [0025 / UAB 008]	'Uses and Abuses of Biology' grants programme	The research was supported by a grant (ref. TWCF 0025 / UAB 008) awarded under the 'Uses and Abuses of Biology' grants programme administered by the Faraday Institute at St. Edmund's College, Cambridge (http://www.uabgrants.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier J, 2013, BIOSCIENCE, V63, P284, DOI 10.1525/bio.2013.63.4.8; Bair Rita M., 2000, QUALITATIVE RES TEXT, P131, DOI [10.4135/9781849209731.n8, DOI 10.4135]; Bangerter A, 2004, BRIT J SOC PSYCHOL, V43, P605, DOI 10.1348/0144666042565353; Bangerter A, 2000, BRIT J SOC PSYCHOL, V39, P521, DOI 10.1348/014466600164615; Bauer MW, 2009, SCI TECHNOL SOC, V14, P221, DOI 10.1177/097172180901400202; Bauer MW, 2005, INT J PUBLIC OPIN R, V17, P5, DOI 10.1093/ijpor/edh054; Bauer MW, 1999, J THEOR SOC BEHAV, V29, P163, DOI 10.1111/1468-5914.00096; Bauer MW, 2002, PUBLIC UNDERST SCI, V11, P93, DOI 10.1088/0963-6625/11/2/301; Baxter P, 2008, QUAL REP, V13, P544; Becker JC, 2011, J PERS SOC PSYCHOL, V101, P62, DOI 10.1037/a0022615; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bluhm R, 2012, NEW DIR PHILOS COGN, P1, DOI 10.1057/9780230368385; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; Brescoll V, 2004, PSYCHOL SCI, V15, P515, DOI 10.1111/j.0956-7976.2004.00712.x; Brescoll VL, 2013, J PERS SOC PSYCHOL, V105, P891, DOI 10.1037/a0034701; Broer C, 2013, SOCIOL HEALTH ILL, V35, P49, DOI 10.1111/j.1467-9566.2012.01477.x; Brossard D, 2009, PUBLIC UNDERST SCI, V18, P258, DOI 10.1177/0963662507084398; Brumfiel G, 2009, NATURE, V458, P274, DOI 10.1038/458274a; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Choudhury S, 2012, CRITICAL NEUROSCIENCE: A HANDBOOK OF THE SOCIAL AND CULTURAL CONTEXTS OF NEUROSCIENCE, P1; Choudhury S, 2009, BIOSOCIETIES, V4, P61, DOI 10.1017/S1745855209006437; Coleman JM, 2008, SELF IDENTITY, V7, P34, DOI 10.1080/15298860600980185; Collins RL, 2011, SEX ROLES, V64, P290, DOI 10.1007/s11199-010-9929-5; Dar-Nimrod I, 2006, SCIENCE, V314, P435, DOI 10.1126/science.1131100; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Dumit Joseph, 2004, PICTURING PERSONHOOD; Eliot L, 2011, NEURON, V72, P895, DOI 10.1016/j.neuron.2011.12.001; Eliot L, 2013, SEX ROLES, V69, P363, DOI 10.1007/s11199-011-0037-y; Fausto-Sterling A, 2000, SEXING BODY GENDER P; Fine C, 2010, DELUSIONS GENDER; Fine C, 2013, TRENDS COGN SCI, V17, P550, DOI 10.1016/j.tics.2013.08.010; Fine C, 2013, NEUROETHICS-NETH, V6, P369, DOI 10.1007/s12152-012-9169-1; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123; Gerring J, 2007, CASE STUDY RESEARCH: PRINCIPLES AND PRACTICES, P86; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; HILGARTNER S, 1990, SOC STUD SCI, V20, P519, DOI 10.1177/030631290020003006; Holton G, 1996, DAEDALUS, V125, P183; Holtzman NA, 2005, COMMUNITY GENET, V8, P133, DOI 10.1159/000086756; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jacobs J.E., 1985, EDUC RES, V14, P20, DOI DOI 10.3102/0013189X014003020; Jaspal R, 2013, SCI COMMUN, V35, P383, DOI 10.1177/1075547012459274; Joffe H., 1999, RISK AND THE OTHER; Joffe H, 2013, EARTHQ SPECTRA, V29, P367, DOI 10.1193/1.4000138; Joffe H, 2011, PUBLIC UNDERST SCI, V20, P446, DOI 10.1177/0963662510391604; Jordan-Young R, 2012, NEUROETHICS-NETH, V5, P305, DOI 10.1007/s12152-011-9134-4; Jordan-Young Rebecca, 2010, BRAIN STORM FLAWS SC; Jost JT, 2005, J PERS SOC PSYCHOL, V88, P498, DOI 10.1037/0022-3514.88.3.498; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Jovchelovitch S, 2008, J THEOR SOC BEHAV, V38, P431, DOI 10.1111/j.1468-5914.2008.00378.x; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Koteyko N, 2013, GEOGR J, V179, P74, DOI 10.1111/j.1475-4959.2012.00479.x; Krippendorf Klaus, 2004, CONTENT ANAL INTRO I; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laslo E, 2011, JOURNALISM, V12, P847, DOI 10.1177/1464884911412709; Latour B., 1986, LAB LIFE CONSTRUCTIO; Lee EJ, 2010, COMMUN RES, V37, P825, DOI 10.1177/0093650210376189; Matusall S, 2013, SOC STUD SCI, V43, P780, DOI 10.1177/0306312713488843; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; Meurk C, 2014, NEUROETHICS-NETH, V7, P51, DOI 10.1007/s12152-013-9180-1; Morton TA, 2006, POLIT PSYCHOL, V27, P823, DOI 10.1111/j.1467-9221.2006.00539.x; Morton TA, 2009, J PERS SOC PSYCHOL, V96, P653, DOI 10.1037/a0012966; MOSCOVICI S, 1993, J THEOR SOC BEHAV, V23, P343, DOI 10.1111/j.1468-5914.1993.tb00540.x; MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303; National Science Board, 2012, SCI ENG IND 2012; Neuendorf KA, 2011, SEX ROLES, V64, P276, DOI 10.1007/s11199-010-9893-0; Noor K., 2008, AM J APPL SCI, V5, P1602, DOI DOI 10.3844/AJASSP.2008.1602.1604; O'Connell G, 2011, EMBO REP, V12, P630, DOI 10.1038/embor.2011.115; O'Connor C, 2014, SCI COMMUN, V36, P617, DOI 10.1177/1075547014549481; O'Connor C, 2013, SOC SCI MED, V97, P297, DOI 10.1016/j.socscimed.2012.09.048; O'Connor C, 2013, PUBLIC UNDERST SCI, V22, P254, DOI 10.1177/0963662513476812; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; Pearce W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094785; Pickersgill M, 2013, CURR SOCIOL, V61, P322, DOI 10.1177/0011392113476464; Pickersgill M, 2011, SUBJECTIVITY, V4, P346, DOI 10.1057/sub.2011.10; Prentice DA, 2007, CURR DIR PSYCHOL SCI, V16, P202, DOI 10.1111/j.1467-8721.2007.00504.x; Racine E, 2006, SCI COMMUN, V28, P122, DOI 10.1177/1075547006291990; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Rose N., 2013, NEURO NEW BRAIN SCI; Rowe G, 2008, HEALTH RISK SOC, V10, P361, DOI 10.1080/13698570802166456; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Seale C, 2010, SOC SCI MED, V71, P861, DOI 10.1016/j.socscimed.2010.05.048; Shema H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035869, 10.4161/psb.19467]; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Singh I, 2013, SOCIOL HEALTH ILL, V35, P813, DOI 10.1111/j.1467-9566.2012.01531.x; Smith NW, 2009, J RISK RES, V12, P647, DOI 10.1080/13669870802586512; Smith N, 2013, PUBLIC UNDERST SCI, V22, P16, DOI 10.1177/0963662512440913; Stafford T, 2012, TRENDS COGN SCI, V16, P489, DOI 10.1016/j.tics.2012.08.001; Ten Eyck TA, 2005, PUBLIC UNDERST SCI, V14, P305, DOI 10.1177/0963662505052888; Thoman DB, 2008, SEX ROLES, V58, P702, DOI 10.1007/s11199-008-9390-x; Van Eperen L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-199; Vidal C, 2012, NEUROETHICS-NETH, V5, P295, DOI 10.1007/s12152-011-9121-9; Wagner W, 2002, BRIT J SOC PSYCHOL, V41, P323, DOI 10.1348/014466602760344241; WAGNER W, 1995, EUR J SOC PSYCHOL, V25, P671, DOI 10.1002/ejsp.2420250606; Wagner W, 2007, PUBLIC UNDERST SCI, V16, P7, DOI 10.1177/0963662506071785; Washer P, 2006, SOC SCI MED, V62, P457, DOI 10.1016/j.socscimed.2005.06.001; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; Whiteley L, 2012, BIOSOCIETIES, V7, P245, DOI 10.1057/biosoc.2012.21; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308; Yin RK., 2013, CASE STUDY RES DESIG	106	37	37	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110830	10.1371/journal.pone.0110830	http://dx.doi.org/10.1371/journal.pone.0110830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25354280	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000345204200041
J	Shah, S; McArthur, E; Farag, A; Nartey, M; Fleet, JL; Knoll, GA; Kim, SJ; Garg, AX; Jain, AK				Shah, Sachin; McArthur, Eric; Farag, Alexandra; Nartey, Michael; Fleet, Jamie L.; Knoll, Greg A.; Kim, S. Joseph; Garg, Amit X.; Jain, Arsh K.			Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; RECEPTOR BLOCKERS; ACE-INHIBITOR; COUGH; METAANALYSIS; MORTALITY; REFLEX	Objective: To characterize the 90-day risk of hospitalization with pneumonia among patients treated with different antihypertensive drug classes. Design: Population based cohort study using five linked databases. Participants: Individuals over the age of 65 who filled a new outpatient prescription for one of four anti-hypertensive medications: ACE inhibitors (n = 86 775), ARBs (n = 33 953), calcium channel blockers (CCB, n = 34 240), beta blockers (BB, n = 35 331) and thiazide diuretics (n = 64 186). Primary Outcome: Hospitalization with pneumonia within 90 days of a qualifying prescription. We adjusted for ten a priori selected covariates, including age, sex, diabetes and number of visits to a family doctor. Results: Baseline characteristics of the groups were relatively well matched, except for age, sex, diabetes and frequency of family doctor visits. 128 of the 86 775 patients (0.15%) initiated on an ACE inhibitor and 43 of the 33953 patients (0.13%) of patients initiated on an ARB were hospitalized with pneumonia in the subsequent 90 days. 135 of 64 186 patients (0.21%) initiated on a thiazide, 112 of 35 331 patients (.32%) initiated on a BB, and 89 of 34 240 (0.26%) patients initiated on a CCB achieved the primary outcome. Compared to calcium channel blockers, ACE inhibitors (adjusted OR 0.61, 95% CI 0.46 to 0.81) and ARBs (adjusted OR 0.52, 95% CI 0.36 to 0.76) were associated with a lower risk of pneumonia. No benefit was seen with thiazides (adjusted OR 0.87, 95% CI 0.66 to 1.14) or beta blockers (adjusted OR 1.21, 95% CI 0.91 to 1.60). Conclusion: Initiating medications that block the renin angiotensin system, compared to other anti-hypertensive medications, is associated with a small absolute reduction in the 90 day risk of hospitalization with pneumonia.	[Shah, Sachin; Farag, Alexandra; Nartey, Michael; Fleet, Jamie L.; Garg, Amit X.; Jain, Arsh K.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Garg, Amit X.; Jain, Arsh K.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [McArthur, Eric; Garg, Amit X.; Jain, Arsh K.] Inst Clin Evaluat Sci, London, ON, Canada; [Knoll, Greg A.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Div Nephrol, Ottawa, ON, Canada; [Kim, S. Joseph] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Nephrol, Toronto, ON M5G 1L7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Jain, AK (corresponding author), Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada.	arsh.jain@lhsc.on.ca	Jain, Arsh/G-3308-2011; Fleet, Jamie L/GYJ-7373-2022; Garg, Amit X/G-3295-2011	Knoll, Greg/0000-0001-5442-9310; Fleet, Jamie/0000-0002-9468-0697	Ontario Ministry of Health and Long-term Care; Academic Medical Organization of Southwestern Ontario	Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES) Western Site. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-term Care. ICES@Western is funded by an operating grant from the Academic Medical Organization of Southwestern Ontario. Dr. Jain receives unrestricted grant support from the Academic Medical Organization of Southwestern Ontario. The opinions, results and conclusions reported in this paper are those of the authors and are independent of the funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; Arai T, 2001, CHEST, V119, P660, DOI 10.1378/chest.119.2.660; Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Caldeira D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4260; Etminan M, 2006, PHARMACOTHERAPY, V26, P479, DOI 10.1592/phco.26.4.479; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; Gonzalez NC, 2007, AM J PHYSIOL-HEART C, V292, pH2285, DOI 10.1152/ajpheart.00981.2006; Hagiwara S, 2009, CRIT CARE MED, V37, P626, DOI 10.1097/CCM.0b013e3181958d91; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; Joffe MM, 1998, STAT MED, V17, P2233, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2233::AID-SIM922>3.0.CO;2-0; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Marrie TJ, 2000, CLIN INFECT DIS, V31, P1066, DOI 10.1086/318124; MORICE AH, 1987, LANCET, V2, P1116; Mukamal KJ, 2010, J HYPERTENS, V28, P401, DOI 10.1097/HJH.0b013e3283330948; Nahmod KA, 2013, CLIN INFECT DIS, V56, P1193, DOI 10.1093/cid/cit007; Nakayama K, 1998, CHEST, V113, P1425, DOI 10.1378/chest.113.5.1425; Ohkubo T, 2004, AM J RESP CRIT CARE, V169, P1041, DOI 10.1164/rccm.200309-1219OC; Okaishi K, 1999, AM J HYPERTENS, V12, P778, DOI 10.1016/S0895-7061(99)00035-7; Sekizawa K, 1998, LANCET, V352, P1069, DOI 10.1016/S0140-6736(05)60114-6; Tomaki M, 1996, THORAX, V51, P199, DOI 10.1136/thx.51.2.199; Vinogradova Y, 2009, BRIT J GEN PRACT, V59, P742, DOI 10.3399/bjgp09X472629; Yusuf S, 2000, NEW ENGL J MED, V342, P145	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110165	10.1371/journal.pone.0110165	http://dx.doi.org/10.1371/journal.pone.0110165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353172	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200016
J	An, XW; Hohne, J; Ming, D; Blankertz, B				An, Xingwei; Hoehne, Johannes; Ming, Dong; Blankertz, Benjamin			Exploring Combinations of Auditory and Visual Stimuli for Gaze-Independent Brain-Computer Interfaces	PLOS ONE			English	Article							P300; INTEGRATION; ATTENTION; SPELLER	For Brain-Computer Interface (BCI) systems that are designed for users with severe impairments of the oculomotor system, an appropriate mode of presenting stimuli to the user is crucial. To investigate whether multi-sensory integration can be exploited in the gaze-independent event-related potentials (ERP) speller and to enhance BCI performance, we designed a visual-auditory speller. We investigate the possibility to enhance stimulus presentation by combining visual and auditory stimuli within gaze-independent spellers. In this study with N = 15 healthy users, two different ways of combining the two sensory modalities are proposed: simultaneous redundant streams (Combined-Speller) and interleaved independent streams (Parallel-Speller). Unimodal stimuli were applied as control conditions. The workload, ERP components, classification accuracy and resulting spelling speed were analyzed for each condition. The Combined-speller showed a lower workload than uni-modal paradigms, without the sacrifice of spelling performance. Besides, shorter latencies, lower amplitudes, as well as a shift of the temporal and spatial distribution of discriminative information were observed for Combined-speller. These results are important and are inspirations for future studies to search the reason for these differences. For the more innovative and demanding Parallel-Speller, where the auditory and visual domains are independent from each other, a proof of concept was obtained: fifteen users could spell online with a mean accuracy of 87.7% (chance level <3%) showing a competitive average speed of 1.65 symbols per minute. The fact that it requires only one selection period per symbol makes it a good candidate for a fast communication channel. It brings a new insight into the true multisensory stimuli paradigms. Novel approaches for combining two sensory modalities were designed here, which are valuable for the development of ERP-based BCI paradigms.	[An, Xingwei; Ming, Dong] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [An, Xingwei; Hoehne, Johannes; Blankertz, Benjamin] Berlin Inst Technol, Neurotechnol Grp, Berlin, Germany; [Hoehne, Johannes] Berlin Inst Technol, Machine Learning Grp, Berlin, Germany	Tianjin University; Technical University of Berlin; Technical University of Berlin	An, XW (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China.	xing-wei.an@hotmail.com; richardming@tju.edu.cn		Blankertz, Benjamin/0000-0002-2437-4846	China Scholarship Council; National Natural Science Foundation of China [81222021]; BMBF [16SV5839, 01GQ0850]; European ICT Programme Project [FP7-224631]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BMBF(Federal Ministry of Education & Research (BMBF)); European ICT Programme Project	This work was supported by the China Scholarship Council and National Natural Science Foundation of China (Grant No. 81222021). Furthermore, the authors acknowledge financial support by the BMBF Grant Nos. 16SV5839 and 01GQ0850, by the European ICT Programme Project FP7-224631. This paper only reflects the authors' views and funding agencies are not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2013, CLIN NEUROPHYSIOL, V124, P901, DOI 10.1016/j.clinph.2012.12.050; Aloise F, 2012, ERGONOMICS, V55, P538, DOI 10.1080/00140139.2012.661084; Belitski A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025022; Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Brouwer A.-M., 2010, SRX NEUROSCIENCE, V2010, DOI DOI 10.3814/2010/967027; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Campanella S, 2010, CLIN NEUROPHYSIOL, V121, P1855, DOI 10.1016/j.clinph.2010.04.004; Dornhege G., 2007, BRAIN COMPUTER INTER; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Halder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053513; Hohne J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098322; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Kathner I, 2013, CLIN NEUROPHYSIOL, V124, P327, DOI 10.1016/j.clinph.2012.08.006; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; Kubler A, 2009, ANN NY ACAD SCI, V1157, P90, DOI 10.1111/j.1749-6632.2008.04122.x; Liu Y, 2011, CLIN NEUROPHYSIOL, V122, P1127, DOI 10.1016/j.clinph.2010.10.049; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Pasqualotto E, 2011, INT J BIOELECTROMAGN, V13, P121; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Riccio A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025028; Schaeff S, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045006; Schreuder M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036025; Schreuder M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00112; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; Thurlings ME, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045005; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van der Waal M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045002; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Zhang D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026016	38	27	30	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111070	10.1371/journal.pone.0111070	http://dx.doi.org/10.1371/journal.pone.0111070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350547	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100053
J	Raifman, JRG; Lanthorn, HE; Rokicki, S; Fink, G				Raifman, Julia R. G.; Lanthorn, Heather E.; Rokicki, Slawa; Fink, Guenther			The Impact of Text Message Reminders on Adherence to Antimalarial Treatment in Northern Ghana: A Randomized Trial	PLOS ONE			English	Article							MALARIA	Background: Low rates of adherence to artemisinin-based combination therapy (ACT) regimens increase the risk of treatment failure and may lead to drug resistance, threatening the sustainability of current anti-malarial efforts. We assessed the impact of text message reminders on adherence to ACT regimens. Methods: Health workers at hospitals, clinics, pharmacies, and other stationary ACT distributors in Tamale, Ghana provided flyers advertising free mobile health information to individuals receiving malaria treatment. The messaging system automatically randomized self-enrolled individuals to the control group or the treatment group with equal probability; those in the treatment group were further randomly assigned to receive a simple text message reminder or the simple reminder plus an additional statement about adherence in 12-hour intervals. The main outcome was self-reported adherence based on follow-up interviews occurring three days after treatment initiation. We estimated the impact of the messages on treatment completion using logistic regression. Results: 1140 individuals enrolled in both the study and the text reminder system. Among individuals in the control group, 61.5% took the full course of treatment. The simple text message reminders increased the odds of adherence (adjusted OR 1.45, 95% CI [1.03 to 2.04], p-value 0.028). Receiving an additional message did not result in a significant change in adherence (adjusted OR 0.77, 95% CI [0.50 to 1.20], p-value 0.252). Conclusion: The results of this study suggest that a simple text message reminder can increase adherence to antimalarial treatment and that additional information included in messages does not have a significant impact on completion of ACT treatment. Further research is needed to develop the most effective text message content and frequency.	[Raifman, Julia R. G.; Fink, Guenther] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Lanthorn, Heather E.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Rokicki, Slawa] Harvard Univ, Grad Sch Arts & Sci, Dept Hlth Policy, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Raifman, JRG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	JuliaRGoldberg@gmail.com		Rokicki, Slawa/0000-0001-9176-373X	Clinton Health Access Initiative; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000055] Funding Source: NIH RePORTER	Clinton Health Access Initiative; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The Clinton Health Access Initiative funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMFm Task Force of the Roll Back Malaria Partnership, 2007, AMFM TECHN DES; Banek K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-7; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Ghana Statistical Services, 2012, 2010 POP HOUS CENS; Government of Ghana Ghana Statistical Service Ghana Health Service UNICEF UNFPA, 2011, GHAN MULT IND CLUST; International Telecommunications Union, 2012, ICT DATA STAT; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Laxminarayan R, 2012, SCIENCE, V338, P615, DOI 10.1126/science.1231010; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; National Health Insurance Authority, 2011, ANN REP 2011; Perera R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006285; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; StataCorp, 2021, STATA STAT SOFTWARE; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; Turner BJ, 2001, ANN INTERN MED, V134, P1004, DOI 10.7326/0003-4819-134-10-200105150-00015; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zurovac D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001176; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	24	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109032	10.1371/journal.pone.0109032	http://dx.doi.org/10.1371/journal.pone.0109032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350546	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100008
J	Chang, L; Wang, YL; Ji, HH; Dai, DJ; Xu, XT; Jiang, DJ; Hong, QX; Ye, HD; Zhang, XN; Zhou, XH; Liu, Y; Li, JF; Chen, ZM; Li, Y; Zhou, DS; Zhuo, RJ; Zhang, YZ; Yin, HL; Mao, CC; Duan, SW; Wang, QW				Chang, Lan; Wang, Yunliang; Ji, Huihui; Dai, Dongjun; Xu, Xuting; Jiang, Danjie; Hong, Qingxiao; Ye, Huadan; Zhang, Xiaonan; Zhou, Xiaohui; Liu, Yu; Li, Jinfeng; Chen, Zhongming; Li, Ying; Zhou, Dongsheng; Zhuo, Renjie; Zhang, Yuzheng; Yin, Honglei; Mao, Congcong; Duan, Shiwei; Wang, Qinwen			Elevation of Peripheral BDNF Promoter Methylation Links to the Risk of Alzheimer's Disease	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; C-REACTIVE PROTEIN; DNA METHYLATION; NEUROTROPHIC FACTOR; SERUM-ALBUMIN; BRAIN; PLASMA; ASSAY; ACID; HYDROXYMETHYLATION	Brain derived neurotrophic factor (BDNF) has been known to play an important role in various mental disorders or diseases such as Alzheimer's disease (AD). The aim of our study was to assess whether BDNF promoter methylation in peripheral blood was able to predict the risk of AD. A total of 44 AD patients and 62 age- and gender-matched controls were recruited in the current case-control study. Using the bisulphite pyrosequencing technology, we evaluated four CpG sites in the promoter of the BDNF. Our results showed that BDNF methylation was significantly higher in AD cases than in the controls (CpG1: p = 10.021; CpG2: p = 0.002; CpG3: p = 0.007; CpG4: p = 0.005; average methylation: p = 0.004). In addition, BDNF promoter methylation was shown to be significantly correlated with the levels of alkaline phosphatase (ALP), glucose, Lp(a), ApoE and ApoA in males (ALP: r = -0.308, p = 0.042; glucose: r = -0.383, p = 0.010; Lp(a): r = 0.333, p = 0.027; ApoE: r = -0.345, p = 0.032;), ApoA levels in females (r = 0.362, p = 0.033), and C Reactive Protein (CRP) levels in both genders (males: r = -0.373, p = 0.016; females: r = -0.399, p = 0.021). Our work suggested that peripheral BDNF promoter methylation might be a diagnostic marker of AD risk, although its underlying function remains to be elaborated in the future.	[Chang, Lan; Ji, Huihui; Dai, Dongjun; Xu, Xuting; Jiang, Danjie; Hong, Qingxiao; Ye, Huadan; Zhang, Xiaonan; Liu, Yu; Zhuo, Renjie; Mao, Congcong; Duan, Shiwei; Wang, Qinwen] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Yunliang; Li, Jinfeng; Zhang, Yuzheng; Yin, Honglei] 148 Cent Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China; [Zhou, Xiaohui] Xinjiang Med Univ, Dept Internal Med Cadres, Affiliated Hosp 1, Urumqi, Peoples R China; [Chen, Zhongming; Zhou, Dongsheng] Ningbo Kangning Hosp, Ningbo, Zhejiang, Peoples R China; [Li, Ying] Ningbo 1 Hosp, Ningbo, Zhejiang, Peoples R China	Ningbo University; Xinjiang Medical University	Wang, YL (corresponding author), 148 Cent Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China.	wangyunliang81@163.com; duanshiwei@nbu.edu.cn; wangqinwen@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022; li, jinfeng/GVS-5425-2022	Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [31100919, 81371469]; 973 Program from the Ministry of Science and Technology of China [2013CB835100]; Natural Science Foundation of Zhejiang Province [LR13H020003]; Disciplinary Project of Ningbo University [B01350104900]; C. Wong Magna Fund in Ningbo University; Ningbo Social Development Research Projects [2012C50032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program from the Ministry of Science and Technology of China(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Disciplinary Project of Ningbo University; C. Wong Magna Fund in Ningbo University; Ningbo Social Development Research Projects	The research was supported by grants from: National Natural Science Foundation of China (31100919 and 81371469), 973 Program from the Ministry of Science and Technology of China (2013CB835100), Natural Science Foundation of Zhejiang Province (LR13H020003), Disciplinary Project of Ningbo University (B01350104900), C. Wong Magna Fund in Ningbo University, and Ningbo Social Development Research Projects (2012C50032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASROW G, 1969, ANAL BIOCHEM, V28, P130, DOI 10.1016/0003-2697(69)90164-X; Boersma GJ, 2013, EPIGENETICS OFFICIAL, V9; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; CAZZOLATO G, 1983, CLIN CHIM ACTA, V135, P203, DOI 10.1016/0009-8981(83)90136-5; Chen C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-199; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089128; Cheng J, 2013, EXP THER MED, V5, P1687, DOI 10.3892/etm.2013.1069; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Coppede F, 2012, CURR ALZHEIMER RES, V9, P550, DOI 10.2174/156720512800618062; Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031; DACOL P, 1983, CLIN CHEM, V29, P1045; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEYO RA, 1980, J RHEUMATOL, V7, P279; DOUMAS BT, 1975, CLIN CHEM, V21, P1159; Egloff M, 1999, ANN BIOL CLIN-PARIS, V57, P561; Emanuele E, 2004, DEMENT GERIATR COGN, V18, P189, DOI 10.1159/000079200; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Fukumoto N, 2010, AM J MED GENET B, V153B, P235, DOI 10.1002/ajmg.b.30986; Furuya TK, 2012, NEUROCHEM INT, V61, P973, DOI 10.1016/j.neuint.2012.07.014; Girault A, 1981, Ric Clin Lab, V11 Suppl 2, P19; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hosseinzadeh S, 2013, IRAN J PSYCHIATRY BE, V7, P37; HUNZIKER P, 1975, Z KLIN CHEM KLIN BIO, V13, P89; Ikegame T, 2013, NEUROSCI RES, V77, P208, DOI 10.1016/j.neures.2013.08.004; JAYNES PK, 1982, CLIN CHEM, V28, P114; Jiang DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096822; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Kang HJ, 2013, J AFFECT DISORDERS, V151, P679, DOI 10.1016/j.jad.2013.08.001; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Keeney JTR, 2013, PROTEOM CLIN APPL, V7, P109, DOI 10.1002/prca.201200087; KNOB M, 1975, Z KLIN CHEM KLIN BIO, V13, P493; Kubota Takeo, 2013, Rinsho Shinkeigaku, V53, P1339; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; Maloney B, 2012, CURR ALZHEIMER RES, V9, P589, DOI 10.2174/156720512800617955; MCPHERSO.IG, 1972, CLIN CHIM ACTA, V37, P117, DOI 10.1016/0009-8981(72)90422-6; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; NATH R. L., 1962, BULL CALCUTTA SCH TROP MED, V10, P71; Nazef K, 2014, ARCH MED RES; Parrish RR, 2013, NEUROSCIENCE, V248, P602, DOI 10.1016/j.neuroscience.2013.06.029; Penaloza CG, 2014, FASEB J, V28, P966, DOI 10.1096/fj.13-233320; Piferrer F, 2013, DEV DYNAM, V242, P360, DOI 10.1002/dvdy.23924; Pradhan V, 2013, Indian J Nephrol, V23, P434, DOI 10.4103/0971-4065.120341; Rao AT, 2014, AM J NEURORADIOL, V35, P457, DOI 10.3174/ajnr.A3545; Rao JS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.55; RIFAI N, 1987, CLIN CHIM ACTA, V163, P207, DOI 10.1016/0009-8981(87)90024-6; Roberts RF, 2004, CLIN CHIM ACTA, V344, P95, DOI 10.1016/j.cccn.2004.02.013; Russo-Neustadt Amelia, 2003, Semin Clin Neuropsychiatry, V8, P109, DOI 10.1053/scnp.2003.50014; Solfrizzi V, 2002, J NEUROL NEUROSUR PS, V72, P732, DOI 10.1136/jnnp.72.6.732; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; TABACCO A, 1979, CLIN CHEM, V25, P336; Tang Lin-Lin, 2013, Yichuan, V35, P1143, DOI 10.3724/SP.J.1005.2013.01143; Sanchez-Mut JV, 2014, HIPPOCAMPUS, V24, P363, DOI 10.1002/hipo.22245; WHITLOW K, 1978, CLIN CHEM, V24, P2018; Xu L, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/151723; Xu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073129; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Yang XL, 2010, ANAL SCI, V26, P1193, DOI 10.2116/analsci.26.1193; Yarchoan M, 2013, J NEUROL SCI, V333, P9, DOI 10.1016/j.jns.2013.05.028; Zhang GH, 2005, BIOCHEM BIOPH RES CO, V326, P87, DOI 10.1016/j.bbrc.2004.11.005; Zhang LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063455; Zhang XM, 2008, NEUROTOXICOLOGY, V29, P406, DOI 10.1016/j.neuro.2008.01.006	64	51	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110773	10.1371/journal.pone.0110773	http://dx.doi.org/10.1371/journal.pone.0110773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364831	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100026
J	Kasai, H; Sugiura, T; Tanabe, N; Sakurai, Y; Yahaba, M; Matsuura, Y; Shigeta, A; Kawata, N; Sakao, S; Kasahara, Y; Tatsumi, K				Kasai, Hajime; Sugiura, Toshihiko; Tanabe, Nobuhiro; Sakurai, Yoriko; Yahaba, Misuzu; Matsuura, Yukiko; Shigeta, Ayako; Kawata, Naoko; Sakao, Seiichiro; Kasahara, Yasunori; Tatsumi, Koichiro			Electrocardiogram-Gated 320-Slice Multidetector Computed Tomography for the Measurement of Pulmonary Arterial Distensibility in Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							MAGNETIC-RESONANCE; STIFFNESS; MORTALITY; DISEASE; TRUNK; FLOW	Background: We aimed to study whether pulmonary arterial distensibility (PAD) correlates with hemodynamic parameters in chronic thromboembolic pulmonary hypertension (CTEPH) using electrocardiogram (ECG)-gated 320-slice multidetector computed tomography (MDCT). Methods and Findings: ECG-gated 320-slice MDCT and right heart catheterization (RHC) was performed in 53 subjects (60.6 +/- 11.4 years old; 37 females) with CTEPH. We retrospectively measured the minimum and maximum values of the cross sectional area (CSA) of the main pulmonary artery (mainPA), right pulmonary artery (rtPA), and left pulmonary artery (ltPA) during one heartbeat. PAD was calculated using the following formula: PAD = [(CSAmaximum-CSAminimum)/CSAmaximum] x100(%). The correlation between hemodynamic parameters and PAD was assessed. Mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR) were 40.8 +/- 8.7 mmHg and 8.3 +/- 3.0 wood units, respectively. PAD values were as follows: mainPA (14.0 +/- 5.0%), rtPA (12.8 +/- 5.6%), and ltPA (9.7 +/- 4.6%). Good correlations existed between mainPAD, with mPAP (r = -20.594, p<0.001) and PVR (r = -20.659, p<0.001). The correlation coefficients between rtPAD and ltPAD with pulmonary hemodynamics were all lower or equal than for mainPAD. Conclusions: PAD measured using ECG-gated 320-slice MDCT correlates with pulmonary hemodynamics in subjects with CTEPH. The mainPA is suitable for PAD measurement.	[Kasai, Hajime; Sugiura, Toshihiko; Tanabe, Nobuhiro; Sakurai, Yoriko; Yahaba, Misuzu; Matsuura, Yukiko; Shigeta, Ayako; Kawata, Naoko; Sakao, Seiichiro; Kasahara, Yasunori; Tatsumi, Koichiro] Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Japan; [Tanabe, Nobuhiro; Shigeta, Ayako] Chiba Univ, Dept Adv Med Pulm Hypertens, Grad Sch Med, Chiba, Japan	Chiba University; Chiba University	Kasai, H (corresponding author), Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Japan.	daikasai6075@yahoo.co.jp						BOGREN HG, 1989, AM HEART J, V118, P990, DOI 10.1016/0002-8703(89)90235-4; Botney MD, 1999, AM J RESP CRIT CARE, V159, P361, DOI 10.1164/ajrccm.159.2.9805075; BOUCHARD A, 1985, AM J CARDIOL, V56, P938, DOI 10.1016/0002-9149(85)90408-4; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Fedullo P, 2011, AM J RESP CRIT CARE, V183, P1605, DOI 10.1164/rccm.201011-1854CI; Gan CTJ, 2007, CHEST, V132, P1906, DOI 10.1378/chest.07-1246; Gorgulu Sevket, 2003, Anadolu Kardiyol Derg, V3, P92; HARRIS P, 1965, BRIT HEART J, V27, P660; Jardim C, 2007, EUR RESPIR J, V29, P476, DOI 10.1183/09031936.00016806; Jenkins D, 2012, EUR RESPIR REV, V21, P32, DOI 10.1183/09059180.00009211; Kang KW, 2011, CIRC J, V75, P2244, DOI 10.1253/circj.CJ-10-1310; Kim Nick H S, 2006, Proc Am Thorac Soc, V3, P584, DOI 10.1513/pats.200605-106LR; Lankhaar JW, 2008, EUR HEART J, V29, P1688, DOI 10.1093/eurheartj/ehn103; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; PASIERSKI TJ, 1993, CHEST, V103, P1080, DOI 10.1378/chest.103.4.1080; PAZ R, 1993, EUR HEART J, V14, P1524, DOI 10.1093/eurheartj/14.11.1524; REUBEN SR, 1971, CIRC RES, V29, P40, DOI 10.1161/01.RES.29.1.40; Revel MP, 2009, RADIOLOGY, V250, P558, DOI 10.1148/radiol.2502080315; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; SLIFE DM, 1990, AM J PHYSIOL, V258, pH1823, DOI 10.1152/ajpheart.1990.258.6.H1823; Sugiura T, 2013, CHEST, V143, P1070, DOI 10.1378/chest.12-0407; Toshner MR, 2010, J HEART LUNG TRANSPL, V29, P610, DOI 10.1016/j.healun.2009.12.014; Wu DK, 2008, CIRC J, V72, P1454, DOI 10.1253/circj.CJ-08-0223	25	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111563	10.1371/journal.pone.0111563	http://dx.doi.org/10.1371/journal.pone.0111563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365168	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100077
J	Donnelly, RF; McCrudden, MTC; Alkilani, AZ; Larraneta, E; McAlister, E; Courtenay, AJ; Kearney, MC; Singh, TRR; McCarthy, HO; Kett, VL; Caffarel-Salvador, E; Al-Zahrani, S; Woolfson, AD				Donnelly, Ryan F.; McCrudden, Maeliosa T. C.; Alkilani, Ahlam Zaid; Larraneta, Eneko; McAlister, Emma; Courtenay, Aaron J.; Kearney, Mary-Carmel; Singh, Thakur Raghu Raj; McCarthy, Helen O.; Kett, Victoria L.; Caffarel-Salvador, Ester; Al-Zahrani, Sharifa; Woolfson, A. David			Hydrogel-Forming Microneedles Prepared from "Super Swelling'' Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery	PLOS ONE			English	Article							DISSOLVING MICRONEEDLES; ARRAYS; SKIN; TECHNOLOGIES; INCREASE; SYSTEMS	We describe, for the first time, hydrogel-forming microneedle arrays prepared from "super swelling'' polymeric compositions. We produced a microneedle formulation with enhanced swelling capabilities from aqueous blends containing 20% w/w Gantrez S-97, 7.5% w/w PEG 10,000 and 3% w/w Na2CO3 and utilised a drug reservoir of a lyophilised wafer-like design. These microneedle-lyophilised wafer compositions were robust and effectively penetrated skin, swelling extensively, but being removed intact. In in vitro delivery experiments across excised neonatal porcine skin, approximately 44 mg of the model high dose small molecule drug ibuprofen sodium was delivered in 24 h, equating to 37% of the loading in the lyophilised reservoir. The super swelling microneedles delivered approximately 1.24 mg of the model protein ovalbumin over 24 h, equivalent to a delivery efficiency of approximately 49%. The integrated microneedle-lyophilised wafer delivery system produced a progressive increase in plasma concentrations of ibuprofen sodium in rats over 6 h, with a maximal concentration of approximately 179 mu g/ml achieved in this time. The plasma concentration had fallen to 71 +/- 6.7 mu g/ml by 24 h. Ovalbumin levels peaked in rat plasma after only 1 hour at 42.36 +/- 17.01 ng/ml. Ovalbumin plasma levels then remained almost constant up to 6 h, dropping somewhat at 24 h, when 23.61 +/- 4.84 ng/ml was detected. This work represents a significant advancement on conventional microneedle systems, which are presently only suitable for bolus delivery of very potent drugs and vaccines. Once fully developed, such technology may greatly expand the range of drugs that can be delivered transdermally, to the benefit of patients and industry. Accordingly, we are currently progressing towards clinical evaluations with a range of candidate molecules.	[Donnelly, Ryan F.; McCrudden, Maeliosa T. C.; Alkilani, Ahlam Zaid; Larraneta, Eneko; McAlister, Emma; Courtenay, Aaron J.; Kearney, Mary-Carmel; Singh, Thakur Raghu Raj; McCarthy, Helen O.; Kett, Victoria L.; Caffarel-Salvador, Ester; Al-Zahrani, Sharifa; Woolfson, A. David] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Alkilani, Ahlam Zaid] Zarqa Univ, Sch Pharm, Zarqa, Jordan	Queens University Belfast; Zarqa University	Donnelly, RF (corresponding author), Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland.	r.donnelly@qub.ac.uk	Larrañeta, Eneko/U-9650-2017; Kett, Vicky/V-5222-2019; Zaid Alkilani, Ahlam/J-6214-2019; Kett, Vicky/D-2276-2010; Singh, Raj/HDN-1244-2022	Larrañeta, Eneko/0000-0003-3710-0438; Kett, Vicky/0000-0002-6250-6053; Zaid Alkilani, Ahlam/0000-0002-9646-6328; Kett, Vicky/0000-0002-6250-6053; Courtenay, Aaron/0000-0002-2651-7839; Donnelly, Ryan/0000-0002-0766-4147; Kearney, Mary-Carmel/0000-0002-4752-9943; Caffarel-Salvador, Ester/0000-0002-2844-7598; McCarthy, Helen/0000-0002-1254-3745	Biotechnology and Biological Sciences Research Council grant [BB/FOF/287, BB/E020534/1]; Wellcome Trust [WT094085MA]; BBSRC [BB/E020534/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020534/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Biotechnology and Biological Sciences Research Council grant numbers BB/FOF/287 and BB/E020534/1 (http://www.bbsrc.ac.uk/) and Wellcome Trust grant number WT094085MA (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai SK, 2001, J APPL POLYM SCI, V80, P2782, DOI 10.1002/app.1394; Chandrasekhar S, 2013, EXPERT OPIN DRUG DEL, V10, P1155, DOI 10.1517/17425247.2013.797405; DOLLERY C, 1991, THERAPEUTIC DRUGS; Donnelly RF, 2014, PHOTOCHEM PHOTOBIOL, V90, P641, DOI 10.1111/php.12209; Donnelly RF, 2013, INT J PHARMACEUT, V451, P76, DOI 10.1016/j.ijpharm.2013.04.045; Donnelly RF, 2012, ADV FUNCT MATER, V22, P4879, DOI 10.1002/adfm.201200864; Donnelly RF, 2010, J CONTROL RELEASE, V147, P333, DOI 10.1016/j.jconrel.2010.08.008; Donnelly RF, 2011, PHARM RES-DORDR, V28, P41, DOI 10.1007/s11095-010-0169-8; FOURTANIER A, 1989, PHOTOCHEM PHOTOBIOL, V50, P771, DOI 10.1111/j.1751-1097.1989.tb02908.x; Gratieri T, 2013, EUR J PHARM SCI, V50, P609, DOI 10.1016/j.ejps.2013.03.019; Hirobe S, 2013, PHARM RES-DORDR, V30, P2664, DOI 10.1007/s11095-013-1092-6; Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401; Ito Y, 2012, INT J PHARMACEUT, V436, P387, DOI 10.1016/j.ijpharm.2012.06.047; Koutsonanos DG, 2013, ADV EXP MED BIOL, V785, P121, DOI 10.1007/978-1-4614-6217-0_13; McCarron PA, 2004, J APPL POLYM SCI, V91, P1576, DOI 10.1002/app.13228; McCrudden MTC, 2014, J CONTROL RELEASE, V180, P71, DOI 10.1016/j.jconrel.2014.02.007; McCrudden MTC, 2015, J PHARM PHARMACOL, V67, P409, DOI 10.1111/jphp.12248; Migalska K, 2011, PHARM RES-DORDR, V28, P1919, DOI 10.1007/s11095-011-0419-4; Mikolajewska P, 2010, PHARM RES-DORDR, V27, P2213, DOI 10.1007/s11095-010-0227-2; Peniche C, 1997, POLYMER, V38, P5977, DOI 10.1016/S0032-3861(96)01058-0; Peppas N.A., 1987, HYDROGELS MED PHARM, V3, P109; Pierre MBR, 2014, CURR DRUG TARGETS, V15, P281; RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6; SHEVCHENKO LL, 1963, RUSS CHEM REV, V32, P201, DOI 10.1070/RC1963v032n04ABEH001329; Singh TRR, 2009, EUR POLYM J, V45, P1239, DOI 10.1016/j.eurpolymj.2008.12.019; WOOLFSON AD, 1995, J APPL POLYM SCI, V58, P1291, DOI 10.1002/app.1995.070580810	26	179	185	9	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111547	10.1371/journal.pone.0111547	http://dx.doi.org/10.1371/journal.pone.0111547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360806	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700117
J	Hirsch, EB; Raux, BR; Lancaster, JW; Mann, RL; Leonard, SN				Hirsch, Elizabeth B.; Raux, Brian R.; Lancaster, Jason W.; Mann, Rachael L.; Leonard, Steven N.			Surface Microbiology of the iPad Tablet Computer and the Potential to Serve as a Fomite in Both Inpatient Practice Settings as Well as Outside of the Hospital Environment	PLOS ONE			English	Article							BACTERIAL-CONTAMINATION; MOBILE; INFECTION; DEVICES	Background: The use of tablet computers and other touch screen technology within the healthcare system has rapidly expanded. It has been reported that these devices can harbor pathogens in hospitals; however, much less is known about what pathogens they can harbor when used outside the hospital environment compared to hospital practice. Methods: Thirty iPads belonging to faculty with a variety of practice settings were sampled to determine the presence and quantity of clinically-relevant organisms. Flocked nylon swabs and neutralizer solution were used to sample the surface of each iPad. Samples were then plated on a variety of selective agars for presence and quantity of selected pathogens. In addition, faculty members were surveyed to classify the physical location of their practice settings and usage patterns. Continuous variables were compared via an unpaired Student's t test with two-tailed distribution; categorical variables were compared with the Fisher's exact test. Results: Of the iPads sampled, 16 belonged to faculty practicing within a hospital and 14 belonged to a faculty member practicing outside a hospital. More faculty within the hospital group used their iPads at their practice sites (78.6% vs. 31.3%; p = 0.014) and within patient care areas (71.4% vs. 18.8%; p = 0.009) than the non-hospital group. There were no differences in the presence, absence, or quantity of, any of the pathogens selectively isolated between groups. Problematic nosocomial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and P. aeruginosa were isolated from both hospital and non-hospital faculty iPads. Conclusions: Gram positive and Gram negative organisms were recovered from the surfaces of iPads regardless of practice setting; these included problematic multidrug-resistant pathogens like MRSA, VRE, and Pseudomonas aeruginosa. Healthcare personnel in all settings should be aware of the potential for tablet computers to serve as a nidus for microorganism transmission.	[Hirsch, Elizabeth B.; Raux, Brian R.; Lancaster, Jason W.; Mann, Rachael L.; Leonard, Steven N.] Northeastern Univ, Bouve Coll Hlth Sci, Sch Pharm, Boston, MA 02115 USA	Northeastern University	Leonard, SN (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Sch Pharm, Boston, MA 02115 USA.	s.leonard@neu.edu			Northeastern University's Provost Undergraduate Award	Northeastern University's Provost Undergraduate Award	A portion of this work was supported by the Northeastern University's Provost Undergraduate Award (EBH and BRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this work.	Apple Inc, CLEAN APPL PROD; Berger Eric, 2010, Ann Emerg Med, V56, pA21; Brady RR, 2007, J HOSP INFECT, V66, P397, DOI 10.1016/j.jhin.2007.04.015; Brady RRW, 2009, J HOSP INFECT, V71, P295, DOI 10.1016/j.jhin.2008.12.009; Brady RRW, 2006, J HOSP INFECT, V62, P123, DOI 10.1016/j.jhin.2005.05.005; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Goff DA, 2012, PHARMACOTHERAPY, V32, P657, DOI 10.1002/j.1875-9114.2012.01102.x; Halton K, 2011, CLIN MICROBIOL INFEC, V17, P868, DOI 10.1111/j.1469-0691.2011.03494.x; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Howell V, 2014, J HOSP INFECT, V87, P77, DOI 10.1016/j.jhin.2014.01.012; Kiedrowski L.M., 2013, AM J INFECT CONTROL; Manning ML, 2013, AM J INFECT CONTROL, V41, P1073, DOI 10.1016/j.ajic.2013.03.304; Moodley A, 2013, CLIN INFECT DIS, V57, P1145, DOI 10.1093/cid/cit455; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; Pandey A, 2010, INDIAN J PATHOL MICR, V53, P711, DOI 10.4103/0377-4929.72047; Singh D, 2002, INFECT CONT HOSP EP, V23, P274, DOI 10.1086/502048; Talon D, 1999, J HOSP INFECT, V43, P13, DOI 10.1053/jhin.1999.0613; Ulger F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-7	19	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111250	10.1371/journal.pone.0111250	http://dx.doi.org/10.1371/journal.pone.0111250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360719	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700080
J	Jin, H; Zhang, XR; Li, KP; Niu, YX; Guo, M; Hu, CJ; Wan, X; Gong, YM; Huang, FH				Jin, Hu; Zhang, Xinran; Li, Kunpeng; Niu, Yanxing; Guo, Mian; Hu, Chuanjiong; Wan, Xia; Gong, Yangmin; Huang, Fenghong			Direct Bio-Utilization of Untreated Rapeseed Meal for Effective Iturin A Production by Bacillus subtilis in Submerged Fermentation	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; BIOTECHNOLOGICAL APPLICATIONS; WASTE-WATER; ACID; OIL; BIOCONVERSION; LIPOPEPTIDES; BIOCONTROL; SURFACTIN; SEED	The feasibility of using untreated rapeseed meal as a nitrogen source for iturin A production by Bacillus subtilis 3-10 in submerged fermentation was first evaluated by comparison with two different commercial nitrogen sources of peptone and ammonium nitrate. A significant promoting effect of rapeseed meal on iturin A production was observed and the maximum iturin A concentration of 0.60 g/L was reached at 70 h, which was 20% and 8.0 fold higher than that produced from peptone and ammonium nitrate media, respectively. It was shown that rapeseed meal had a positive induction effect on protease secretion, contributing to the release of soluble protein from low water solubility solid rapeseed meal for an effective supply of available nitrogen during fermentation. Moreover, compared to raw rapeseed meal, the remaining residue following fermentation could be used as a more suitable supplementary protein source for animal feed because of the great decrease of major anti-nutritional components including sinapine, glucosinolate and its degradation products of isothiocyanate and oxazolidine thione. The results obtained from this study demonstrate the potential of direct utilization of low cost rapeseed meal as a nitrogen source for commercial production of iturin A and other secondary metabolites by Bacillus subtilis.	[Jin, Hu; Zhang, Xinran; Li, Kunpeng; Niu, Yanxing; Guo, Mian; Hu, Chuanjiong; Wan, Xia; Gong, Yangmin; Huang, Fenghong] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Jin, Hu; Li, Kunpeng; Niu, Yanxing; Guo, Mian; Huang, Fenghong] Hubei Key Lab Lipid Chem & Nutr, Wuhan, Peoples R China; [Zhang, Xinran] Hubei Univ, Coll Life Sci, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Hubei University	Huang, FH (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.	jiagongzx@oilcrops.cn	Niu, Yanxing/GLV-2117-2022		National Natural Science Foundation of China [31201461]; National High-tech R&D Program of China (863 Program) [2011AA100904]; National Key Technology Research and Development Program [2012BAD49G00]; Oil Crops Research Institute [1610172014006, 1610172013005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technology Research and Development Program(National Key Technology R&D Program); Oil Crops Research Institute	This work was supported by the National Natural Science Foundation of China (No. 31201461), National High-tech R&D Program of China (863 Program, No. 2011AA100904), National Key Technology Research and Development Program (No. 2012BAD49G00), and Director Fund of Oil Crops Research Institute (Nos. 1610172014006, 1610172013005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELQVIST LA, 1967, J SCI FOOD AGR, V18, P510, DOI 10.1002/jsfa.2740181105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai R, 2001, J AM OIL CHEM SOC, V78, P903, DOI 10.1007/s11746-001-0362-4; Chaplin MF, 1990, ENZYME TECHNOLOGY, P40; Chen KQ, 2011, ENZYME MICROB TECH, V48, P339, DOI 10.1016/j.enzmictec.2010.12.009; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Jung J, 2012, BIOTECHNOL BIOENG, V109, P2349, DOI 10.1002/bit.24524; Kachrimanidou V, 2013, WASTE BIOMASS VALORI, V4, P529, DOI 10.1007/s12649-012-9191-x; Kiran EU, 2012, ENZYME MICROB TECH, V50, P337, DOI 10.1016/j.enzmictec.2012.03.004; Koutinas AA, 2007, BIOFUEL BIOPROD BIOR, V1, P24, DOI 10.1002/bbb.6; Lee SC, 2008, BIORESOURCE TECHNOL, V99, P2288, DOI 10.1016/j.biortech.2007.05.020; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Makkar RS, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-5; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Mizumoto S, 2007, APPL MICROBIOL BIOT, V75, P1267, DOI 10.1007/s00253-007-0973-1; Mizumoto S, 2006, APPL MICROBIOL BIOT, V72, P869, DOI 10.1007/s00253-006-0389-3; Mizumoto S, 2007, APPL MICROBIOL BIOT, V76, P101, DOI 10.1007/s00253-007-0994-9; Nitschke M, 2006, BIORESOURCE TECHNOL, V97, P336, DOI 10.1016/j.biortech.2005.02.044; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Ramachandran S, 2007, BIORESOURCE TECHNOL, V98, P2000, DOI 10.1016/j.biortech.2006.08.002; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Thakore Y., 2006, Industrial biotechnology, V2, P194, DOI 10.1089/ind.2006.2.194; Tripathi MK, 2007, ANIM FEED SCI TECH, V132, P1, DOI 10.1016/j.anifeedsci.2006.03.003; Vig AP, 2001, BIORESOURCE TECHNOL, V78, P309, DOI 10.1016/S0960-8524(01)00030-X; Wang QJ, 2008, BIORESOURCE TECHNOL, V99, P3318, DOI 10.1016/j.biortech.2007.05.052; Wang RH, 2010, ENZYME MICROB TECH, V47, P77, DOI 10.1016/j.enzmictec.2010.05.005; WATHELET JP, 1988, FRESEN Z ANAL CHEM, V332, P689, DOI 10.1007/BF00472670; Whang LM, 2009, J HAZARD MATER, V164, P1045, DOI 10.1016/j.jhazmat.2008.09.006	30	15	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111171	10.1371/journal.pone.0111171	http://dx.doi.org/10.1371/journal.pone.0111171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360892	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700068
J	Xiao, Y; Xiang, TX; Luo, XR; Li, CH; Li, QQ; Peng, WY; Li, LL; Li, SM; Wang, ZY; Tang, LP; Ren, GS; Tao, Q				Xiao, Yun; Xiang, Tingxiu; Luo, Xinrong; Li, Chunhong; Li, Qianqian; Peng, Weiyan; Li, Lili; Li, Shuman; Wang, Zhenyu; Tang, Liping; Ren, Guosheng; Tao, Qian			Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer	PLOS ONE			English	Article							GROWTH; TRANSCRIPTION; IDENTIFICATION; DISEASE	Kruppel-associated box-containing zinc finger proteins (KRAP-ZFPs) are well recognized as key regulators of transcription, which play a crucial role in the regulation of cell proliferation, differentiation, apoptosis and tumorigenesis. We previously identified a KRAP-ZFP protein ZNF545 acting as a tumor suppressor involved in tumor pathogenesis. However, its expression and biological function in breast cancer remain elusive. In this study, we found that ZNF545 was frequently downregulated in estrogen receptor-positive (ER+), progesterone receptor-positive (PR+) and human epidermal growth factor receptor 2-negative (HER2-) breast tumor tissues compared with paired adjacent non-tumor tissues. We further examined its expression and methylation in breast cancer cell lines by semi-quantitative RT-PCR and methylation-specific PCR. We found that ZNF545 was silenced by promoter methylation in MCF7 cell line, and its expression could be restored by demethylation, concomitant with increased unmethylated alleles. ZNF545 methylation was detected in 29% of breast tumor tissues, but not in normal breast tissues, suggesting tumor-specific methylation of ZNF545 in breast cancer. Ectopic expression of ZNF545 in MCF7 cells inhibited cell proliferation through inducing cell cycle G0/G1 arrest and apoptosis, thus as a tumor suppressor. Moreover, ZNF545 upregulated mRNA and protein levels of c-Jun/AP1, BAX, p53 and Caspase 3. Taken together, these results demonstrate that ZNF545 inhibits breast tumor cell proliferation through inducing apoptosis and is disrupted by promoter methylation in breast cancer.	[Xiao, Yun; Xiang, Tingxiu; Luo, Xinrong; Li, Chunhong; Li, Qianqian; Peng, Weiyan; Li, Shuman; Wang, Zhenyu; Tang, Liping; Ren, Guosheng; Tao, Qian] Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China; [Xiao, Yun; Ren, Guosheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China; [Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Canc Epigenet Lab, Dept Clin Oncol, State Key Lab Oncol South China,Sir YK Pao Ctr Ca, Hong Kong, Hong Kong, Peoples R China; [Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Lili; Tao, Qian] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong	Ren, GS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China.	rgs726@163.com; qtao@cuhk.edu.hk	Tao, Qian/T-4743-2018; Li, Lili/Q-5750-2018	Tao, Qian/0000-0001-5383-4808; Li, Lili/0000-0002-0292-5889	National Natural Science Foundation [81372898, 81172582, 31171243, 81000907]; Chinese University of Hong Kong	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was supported by grants from National Natural Science Foundation (#81372898, #81172582, #31171243, #81000907) and The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Y, 2012, MOL CANC RES; Cheng YD, 2012, MOL CANCER RES, V10, P925, DOI 10.1158/1541-7786.MCR-11-0594; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Huang XQ, 2006, BIOCHEM BIOPH RES CO, V346, P621, DOI 10.1016/j.bbrc.2006.05.109; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Imoto I, 2003, CANCER RES, V63, P5691; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Nonet GH, 2001, CANCER RES, V61, P1250; Oda T, 2007, BLOOD, V109, P5016, DOI 10.1182/blood-2006-08-038638; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Rousseau-Merck MF, 2002, CYTOGENET GENOME RES, V98, P147, DOI 10.1159/000069802; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Urrutia R, 2003, GENOME BIOL; Wang SY, 2013, GUT, V62, P833, DOI 10.1136/gutjnl-2011-301776; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wang Y, 2009, CANCER RES, V69, P5194, DOI 10.1158/0008-5472.CAN-08-3694; Xiang T, 2013, J CELL MOL MED; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Yin XD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3399; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Zhang QA, 2010, J UROLOGY, V184, P731, DOI 10.1016/j.juro.2010.03.108	31	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110990	10.1371/journal.pone.0110990	http://dx.doi.org/10.1371/journal.pone.0110990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360542	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700056
J	August, TA; Nunn, MA; Fensome, AG; Linton, DM; Mathews, F				August, Tom A.; Nunn, Miles A.; Fensome, Amy G.; Linton, Danielle M.; Mathews, Fiona			Sympatric Woodland Myotis Bats Form Tight-Knit Social Groups with Exclusive Roost Home Ranges	PLOS ONE			English	Article							ASSOCIATION PATTERNS; PIPISTRELLE BATS; NETWORKS; FEMALE; DAUBENTONII; SELECTION; RESERVOIR; FISSION; FUSION; RATES	Background: The structuring of wild animal populations can influence population dynamics, disease spread, and information transfer. Social network analysis potentially offers insights into these processes but is rarely, if ever, used to investigate more than one species in a community. We therefore compared the social, temporal and spatial networks of sympatric Myotis bats (M. nattereri (Natterer's bats) and M. daubentonii (Daubenton's bats)), and asked: (1) are there long-lasting social associations within species? (2) do the ranges occupied by roosting social groups overlap within or between species? (3) are M. daubentonii bachelor colonies excluded from roosting in areas used by maternity groups? Results: Using data on 490 ringed M. nattereri and 978 M. daubentonii from 379 colonies, we found that both species formed stable social groups encompassing multiple colonies. M. nattereri formed 11 mixed-sex social groups with few (4.3%) inter-group associations. Approximately half of all M. nattereri were associated with the same individuals when recaptured, with many associations being long-term (. 100 days). In contrast, M. daubentonii were sexually segregated; only a quarter of pairs were associated at recapture after a few days, and inter-sex associations were not long-lasting. Social groups of M. nattereri and female M. daubentonii had small roost home ranges (mean 0.2 km(2) in each case). Intra-specific overlap was low, but inter-specific overlap was high, suggesting territoriality within but not between species. M. daubentonii bachelor colonies did not appear to be excluded from roosting areas used by females. Conclusions: Our data suggest marked species-and sex-specific patterns of disease and information transmission are likely between bats of the same genus despite sharing a common habitat. The clear partitioning of the woodland amongst social groups, and their apparent reliance on small patches of habitat for roosting, means that localised woodland management may be more important to bat conservation than previously recognised.	[August, Tom A.; Nunn, Miles A.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [August, Tom A.; Mathews, Fiona] Univ Exeter, Exeter, Devon, England; [Fensome, Amy G.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Linton, Danielle M.] Univ Oxford, Wildlife Conservat Res Unit, Oxford, England	UK Centre for Ecology & Hydrology (UKCEH); University of Exeter; University of Exeter; University of Oxford	Mathews, F (corresponding author), Univ Exeter, Exeter, Devon, England.	F.Mathews@exeter.ac.uk	August, Tom/F-9047-2019	August, Tom/0000-0003-1116-3385	Natural Environment Research Council [NE/G523571]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is funded by the Natural Environment Research Council Grant no NE/G523571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 1996, BATS BIOL BEHAV; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Borgatti S. P., 2002, UCINET 6 WINDOWS SOF; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; Borkin KM, 2011, BIODIVERS CONSERV, V20, P3537, DOI 10.1007/s10531-011-0144-7; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; Dietz M, 2006, ACTA CHIROPTEROL, V8, P403, DOI 10.3161/1733-5329(2006)8[403:SSDPOF]2.0.CO;2; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Encarnacao JA, 2005, MAMMAL REV, V35, P285, DOI 10.1111/j.1365-2907.2005.00066.x; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Garroway CJ, 2007, CAN J ZOOL, V85, P956, DOI 10.1139/Z07-079; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Johnson JS, 2012, J MAMMAL, V93, P1545, DOI 10.1644/12-MAMM-A-097.1; Johnson JB, 2012, FOREST ECOL MANAG, V266, P223, DOI 10.1016/j.foreco.2011.11.032; Kelly A, 2008, ANIM WELFARE, V17, P375; Kerth G, 1999, BEHAVIOUR, V136, P1187, DOI 10.1163/156853999501711; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Miller MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000624; Mitchell-Jones A.J., 2004, BAT WORKERS MANUAL, V3rd; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; O'Donnell CFJ, 2000, ANIM CONSERV, V3, P287, DOI 10.1017/S1367943000001013; Park KJ, 1998, J ZOOL, V244, P379, DOI 10.1017/S0952836998003094; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; R Core Development Team, 2011, R LANG ENV STAT COMP; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Russo D, 2002, MAMMALIA, V66, P543, DOI 10.1515/mamm.2002.66.4.543; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Shi ZL, 2013, SCI CHINA LIFE SCI, V56, P678, DOI 10.1007/s11427-013-4517-x; Swift SM, 1997, J ZOOL, V242, P375; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; Weber N, 2013, CURR BIOL, V23, pR915, DOI 10.1016/j.cub.2013.09.011; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	42	18	18	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e112225	10.1371/journal.pone.0112225	http://dx.doi.org/10.1371/journal.pone.0112225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356770	Green Accepted, gold, Green Published			2022-12-27	WOS:000346765000082
J	Cai, GQ; Yang, QY; Yi, B; Fan, CC; Edwards, D; Batley, J; Zhou, YM				Cai, Guangqin; Yang, Qingyong; Yi, Bin; Fan, Chuchuan; Edwards, David; Batley, Jacqueline; Zhou, Yongming			A Complex Recombination Pattern in the Genome of Allotetraploid Brassica napus as Revealed by a High-Density Genetic Map	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; RAPHANUS-SATIVUS; OLERACEA GENOME; CANDIDATE GENES; FLOWERING TIME; OILSEED RAPE; SNP MARKERS; LINKAGE MAP; EVOLUTION; IDENTIFICATION	Polyploidy plays a crucial role in plant evolution. Brassica napus (2n = 38, AACC), the most important oil crop in the Brassica genus, is an allotetraploid that originated through natural doubling of chromosomes after the hybridization of its progenitor species, B. rapa (2n = 20, AA) and B. oleracea (2n = 18, CC). A better understanding of the evolutionary relationship between B. napus and B. rapa, B. oleracea, as well as Arabidopsis, which has a common ancestor with these three species, will provide valuable information about the generation and evolution of allopolyploidy. Based on a high-density genetic map with single nucleotide polymorphism (SNP) and simple sequence repeat (SSR) markers, we performed a comparative genomic analysis of B. napus with Arabidopsis and its progenitor species B. rapa and B. oleracea. Based on the collinear relationship of B. rapa and B. oleracea in the B. napus genetic map, the B. napus genome was found to consist of 70.1% of the skeleton components of the chromosomes of B. rapa and B. oleracea, with 17.7% of sequences derived from reciprocal translocation between homoeologous chromosomes between the A-and C-genome and 3.6% of sequences derived from reciprocal translocation between non-homologous chromosomes at both intra-and inter-genomic levels. The current study thus provides insights into the formation and evolution of the allotetraploid B. napus genome, which will allow for more accurate transfer of genomic information from B. rapa, B. oleracea and Arabidopsis to B. napus.	[Cai, Guangqin; Yang, Qingyong; Yi, Bin; Fan, Chuchuan; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Cai, Guangqin; Zhou, Yongming] Huazhong Agr Univ, Key Lab Rapeseed Genet & Breeding Agr, Minist China, Wuhan, Peoples R China; [Edwards, David; Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia	Huazhong Agricultural University; Huazhong Agricultural University; University of Queensland	Zhou, YM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ymzhou@mail.hzau.edu.cn	Batley, Jacqueline/A-5723-2008; Edwards, David/H-3710-2015	Batley, Jacqueline/0000-0002-5391-5824; Edwards, David/0000-0001-7599-6760; Yang, Qing-Yong/0000-0002-3510-8906; Fan, Chuchuan/0000-0001-8443-7194	Ministry of Agriculture of China [nycytx-00503]; Ministry of Agriculture of China (948 project) [2011-G23]; National Natural Science Foundation of China [31371659, 31171188]; Huazhong Agricultural University [STSIF 2010YB05]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Ministry of Agriculture of China (948 project)(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University	The work is financially supported by funding from the Ministry of Agriculture of China (nycytx-00503 and 948 project (2011-G23)), National Natural Science Foundation of China (31371659, 31171188), and Huazhong Agricultural University (STSIF 2010YB05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Cai GQ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-105; Chen X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-346; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ge XH, 2009, ANN BOT-LONDON, V104, P19, DOI 10.1093/aob/mcp099; Gomez-Campo C, 1999, DEV PL GEN, V4, P3; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034253; Hua YW, 2006, ANN BOT-LONDON, V97, P993, DOI 10.1093/aob/mcl073; Jiang CC, 2011, THEOR APPL GENET, V123, P927, DOI 10.1007/s00122-011-1637-1; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kaczmarek M, 2009, GENOME, V52, P620, DOI 10.1139/G09-035; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KOWALSKI SP, 1994, GENETICS, V138, P499; Lagercrantz U, 1998, GENETICS, V150, P1217; Lan TH, 2000, GENOME RES, V10, P776, DOI 10.1101/gr.10.6.776; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Li F, 2011, DNA RES, V18, P401, DOI 10.1093/dnares/dsr027; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Lincoln S, 1993, CONSTRUCTING GENETIC; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Liu XP, 2005, PLANT BREEDING, V124, P9, DOI 10.1111/j.1439-0523.2004.01051.x; Liu Z, 2012, THEOR APPL GENET, V125, P773, DOI 10.1007/s00122-012-1870-2; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lu W, 2013, ANN BOT-LONDON, V111, P305, DOI 10.1093/aob/mcs260; Lukens L, 2003, GENETICS, V164, P359; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Meyers LA, 2006, EVOLUTION, V60, P1198, DOI 10.1111/j.0014-3820.2006.tb01198.x; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; PALMER JD, 1983, THEOR APPL GENET, V65, P181, DOI 10.1007/BF00308062; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Raman H, 2014, PLANT BIOTECHNOL J, V12, P851, DOI 10.1111/pbi.12186; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Ryder CD, 2001, GENOME, V44, P808, DOI 10.1139/gen-44-5-808; Sarilar V, 2013, NEW PHYTOL, V198, P593, DOI 10.1111/nph.12156; Schmidt R, 2011, PLANT GENET GENOMICS, V9, P1, DOI 10.1007/978-1-4419-7118-0; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shi TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054559; Shirasawa K, 2011, DNA RES, V18, P221, DOI 10.1093/dnares/dsr013; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; U. N., 1935, Japanese Journal of Botany, V7, P389; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067740; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Zhao JY, 2012, THEOR APPL GENET, V124, P407, DOI 10.1007/s00122-011-1716-3; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	66	32	33	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109910	10.1371/journal.pone.0109910	http://dx.doi.org/10.1371/journal.pone.0109910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356735	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000009
J	Titti, F; Maggiorella, MT; Ferrantelli, F; Sernicola, L; Bellino, S; Collacchi, B; Belasio, EF; Moretti, S; Cossut, MRP; Belli, R; Olivieri, E; Farcomeni, S; Compagnoni, D; Michelini, Z; Sabbatucci, M; Sparnacci, K; Tondelli, L; Laus, M; Cafaro, A; Caputo, A; Ensoli, B				Titti, Fausto; Maggiorella, Maria T.; Ferrantelli, Flavia; Sernicola, Leonardo; Bellino, Stefania; Collacchi, Barbara; Belasio, Emanuele Fanales; Moretti, Sonia; Cossut, Maria Rosaria Pavone; Belli, Roberto; Olivieri, Erika; Farcomeni, Stefania; Compagnoni, Daniela; Michelini, Zuleika; Sabbatucci, Michela; Sparnacci, Katia; Tondelli, Luisa; Laus, Michele; Cafaro, Aurelio; Caputo, Antonella; Ensoli, Barbara			Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-1 TAT; CYNOMOLGUS MONKEYS; RHESUS MACAQUES; PROTECTIVE EFFICACY; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; TYPE-1 TAT; RECOMBINANT GLYCOPROTEIN; DISEASE PROGRESSION	Here we describe a prime-boost regimen of vaccination in Macaca fascicularis that combines priming with novel anionic microspheres designed to deliver the biologically active HIV-1 Tat protein and boosting with Tat in Alum. This regimen of immunization modulated the IgG subclass profile and elicited a balanced Th1-Th2 type of humoral and cellular responses. Remarkably, following intravenous challenge with SHIV89.6P(cy243), vaccinees significantly blunted acute viremia, as compared to control monkeys, and this control was associated with significantly lower CD4(+) T cell depletion rate during the acute phase of infection and higher ability to resume the CD4(+) T cell counts in the post-acute and chronic phases of infection. The long lasting control of viremia was associated with the persistence of high titers anti-Tat antibodies whose profile clearly distinguished vaccinees in controllers and viremics. Controllers, as opposed to vaccinated and viremic cynos, exhibited significantly higher pre-challenge antibody responses to peptides spanning the glutamine-rich and the RGD-integrin-binding regions of Tat. Finally, among vaccinees, titers of anti-Tat IgG1, IgG3 and IgG4 subclasses had a significant association with control of viremia in the acute and post-acute phases of infection. Altogether these findings indicate that the Tat/H1D/Alum regimen of immunization holds promise for next generation vaccines with Tat protein or other proteins for which maintenance of the native conformation and activity are critical for optimal immunogenicity. Our results also provide novel information on the role of anti-Tat responses in the prevention of HIV pathogenesis and for the design of new vaccine candidates.	[Titti, Fausto; Maggiorella, Maria T.; Ferrantelli, Flavia; Sernicola, Leonardo; Bellino, Stefania; Collacchi, Barbara; Belasio, Emanuele Fanales; Moretti, Sonia; Cossut, Maria Rosaria Pavone; Belli, Roberto; Olivieri, Erika; Farcomeni, Stefania; Compagnoni, Daniela; Michelini, Zuleika; Sabbatucci, Michela; Cafaro, Aurelio; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Sparnacci, Katia; Laus, Michele] Univ East Piemonte, Dept Environm & Live Sci, Alessandria, Italy; [Tondelli, Luisa] CNR, ISOF, I-40126 Bologna, Italy; [Caputo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy	Istituto Superiore di Sanita (ISS); University of Eastern Piedmont Amedeo Avogadro; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); University of Padua	Ensoli, B (corresponding author), Ist Super Sanita, Natl AIDS Ctr, Viale Regina Elena 299, I-00161 Rome, Italy.	barbara.ensoli@iss.it	farcomeni, stefania/K-4640-2016; Caputo, Antonella/ABE-7851-2020; BELASIO, EMANUELE FANALES/C-7718-2016; Michelini, Zuleika/J-9003-2016; COLLACCHI, BARBARA/AAC-4491-2022; michelini, zuleika/Q-4383-2019; Moretti, Sonia/K-5687-2016; Ferrantelli, Flavia/J-7794-2016; Cafaro, Aurelio/K-5314-2016; maggiorella, maria teresa/K-4072-2016; Sparnacci, Katia/Z-1744-2019; tondelli, luisa/C-1414-2012; Ensoli, Barbara/J-9169-2016; Sparnacci, Katia/C-1138-2009; Sabbatucci, Michela/M-9642-2017	farcomeni, stefania/0000-0001-5058-476X; Caputo, Antonella/0000-0002-1241-0299; BELASIO, EMANUELE FANALES/0000-0003-2369-9996; Michelini, Zuleika/0000-0001-6841-7396; COLLACCHI, BARBARA/0000-0001-6330-6283; michelini, zuleika/0000-0001-6841-7396; Moretti, Sonia/0000-0003-4812-1496; Ferrantelli, Flavia/0000-0002-0768-1078; maggiorella, maria teresa/0000-0001-5058-476X; Sparnacci, Katia/0000-0003-2102-9649; tondelli, luisa/0000-0002-3971-3361; Ensoli, Barbara/0000-0002-0545-8737; Sparnacci, Katia/0000-0003-2102-9649; Sabbatucci, Michela/0000-0001-5889-1780; Cafaro, Aurelio/0000-0001-9675-6344; Bellino, Stefania/0000-0003-1149-3835; Laus, Michele/0000-0002-4296-3732	Italian National AIDS Programme [3H/23]; Italy/USA Scientific Cooperation Agreement from Concerted Action on HIV-AIDS Vaccine Development (ICAV) [11US/37]; European Vaccines and Microbicides Enterprise(EUROPRISE) [037611]	Italian National AIDS Programme; Italy/USA Scientific Cooperation Agreement from Concerted Action on HIV-AIDS Vaccine Development (ICAV); European Vaccines and Microbicides Enterprise(EUROPRISE)	This work was supported in part by grants from the from The Italian National AIDS Programme 3H/23, from Italy/USA Scientific Cooperation Agreement 11US/37, from Concerted Action on HIV-AIDS Vaccine Development (ICAV) and part from European Vaccines and Microbicides Enterprise(EUROPRISE) Contract no.: 037611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaoui-Attarki K, 1998, VACCINE, V16, P685, DOI 10.1016/S0264-410X(97)00261-2; Ataman-Onal Y, 2006, J CONTROL RELEASE, V112, P175, DOI 10.1016/j.jconrel.2006.02.006; Bachler BC, 2013, J VIROL, V87, P4403, DOI 10.1128/JVI.02888-12; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Banerjee K, 2010, AIDS RES HUM RETROV, V26, P445, DOI 10.1089/aid.2009.0223; Barillari G, 1999, BLOOD, V94, P663; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Belliard G, 2005, VACCINE, V23, P1399, DOI 10.1016/j.vaccine.2004.08.037; Bellino S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-49; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Borsetti A, 2008, ARCH VIROL, V153, P463, DOI 10.1007/s00705-007-0009-2; Borsetti A, 2012, TISSUE ANTIGENS, V80, P36, DOI 10.1111/j.1399-0039.2012.01875.x; Borsetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093235; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Butto S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cafaro A, 2001, VACCINE, V19, P2862, DOI 10.1016/S0264-410X(01)00002-0; Cafaro A, 2010, J VIROL, V84, P8953, DOI 10.1128/JVI.00377-10; Caputo A, 2004, VACCINE, V22, P2910, DOI 10.1016/j.vaccine.2003.12.025; Caputo A, 2009, VACCINE, V27, P3605, DOI 10.1016/j.vaccine.2009.03.047; Caputo Antonella, 2008, Current Drug Delivery, V5, P230, DOI 10.2174/156720108785914961; Cavacini LA, 2003, AIDS RES HUM RETROV, V19, P785, DOI 10.1089/088922203769232584; CAVACINI LA, 1995, J IMMUNOL, V155, P3638; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059194; Chesko J, 2005, J PHARM SCI-US, V94, P2510, DOI 10.1002/jps.20472; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; Demberg T, 2013, VIROLOGY, V440, P210, DOI 10.1016/j.virol.2013.02.024; Demirhan I, 2000, J HUMAN VIROL, V3, P137; Devadas K, 2007, PEPTIDES, V28, P496, DOI 10.1016/j.peptides.2006.11.007; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Goletti D, 2006, MED SCI MONITOR, V12, pBR330; Gorse GJ, 1999, AIDS RES HUM RETROV, V15, P115, DOI 10.1089/088922299311547; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Himeno A, 2010, VACCINE, V28, P5377, DOI 10.1016/j.vaccine.2010.04.110; Kashi VP, 2009, VACCINE, V27, P6739, DOI 10.1016/j.vaccine.2009.08.078; Lamalle-Bernard D, 2006, J CONTROL RELEASE, V115, P57, DOI 10.1016/j.jconrel.2006.07.006; Laus M, 2001, J BIOMAT SCI-POLYM E, V12, P209, DOI 10.1163/156856201750180933; Lefeber DJ, 2003, INFECT IMMUN, V71, P6915, DOI 10.1128/IAI.71.12.6915-6920.2003; Li JCB, 2010, AIDS, V24, P1609, DOI 10.1097/QAD.0b013e32833ac6a0; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; Maggiorella MT, 2004, VACCINE, V22, P3258, DOI 10.1016/j.vaccine.2004.03.009; Manocha M, 2005, VACCINE, V23, P5599, DOI 10.1016/j.vaccine.2005.06.031; Manoussaka MS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-59; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mediouni Sonia, 2011, Infectious Disorders - Drug Targets, V11, P57; Monini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048781; Moreau E, 2004, J GEN VIROL, V85, P2893, DOI 10.1099/vir.0.80365-0; Nayak B, 2009, J MICROENCAPSUL, V26, P154, DOI [10.1080/02652040802211709, 10.1080/02652040802211709 ]; Negri DRM, 2004, J GEN VIROL, V85, P1191, DOI 10.1099/vir.0.79794-0; Negri DRM, 2001, J MED PRIMATOL, V30, P197, DOI 10.1034/j.1600-0684.2001.d01-53.x; O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017; Otten GR, 2005, J VIROL, V79, P8189, DOI 10.1128/JVI.79.13.8189-8200.2005; Partidos CD, 2005, EUR J IMMUNOL, V35, P1521, DOI 10.1002/eji.200425676; Rappuoli R, 2007, NAT BIOTECHNOL, V25, P1361, DOI 10.1038/nbt1207-1361; Re MC, 2001, J CLIN VIROL, V21, P81, DOI 10.1016/S1386-6532(00)00189-X; REISS P, 1990, J MED VIROL, V30, P163, DOI 10.1002/jmv.1890300303; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richardson MW, 2003, BIOMED PHARMACOTHER, V57, P4, DOI 10.1016/S0753-3322(02)00327-X; Rodriguez SK, 2006, J INFECT DIS, V194, P760, DOI 10.1086/507042; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Sernicola L, 1999, VIROLOGY, V256, P291, DOI 10.1006/viro.1999.9652; Singh M, 2004, PHARM RES, V21, P2148, DOI 10.1007/s11095-004-7666-6; Singh Manmohan, 2006, Current Drug Delivery, V3, P115, DOI 10.2174/156720106775197565; Sparnacci K, 2005, J BIOMAT SCI-POLYM E, V16, P1557, DOI 10.1163/156856205774576673; Tamber H, 2005, ADV DRUG DELIVER REV, V57, P357, DOI 10.1016/j.addr.2004.09.002; Titti F, 2007, EXPERT OPIN EMERG DR, V12, P23, DOI 10.1517/14728214.12.1.23; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Turbant S, 2009, VACCINE, V27, P5349, DOI 10.1016/j.vaccine.2009.06.083; TURNER GS, 1978, J GEN VIROL, V40, P595, DOI 10.1099/0022-1317-40-3-595; van de Weert M, 2000, PHARM RES-DORDR, V17, P1159, DOI 10.1023/A:1026498209874; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Voltan R, 2007, PHARM RES-DORDR, V24, P1870, DOI 10.1007/s11095-007-9310-8; Voltan R, 2009, VACCINE, V27, P4498, DOI 10.1016/j.vaccine.2009.05.031; Walter E, 1999, J CONTROL RELEASE, V61, P361, DOI 10.1016/S0168-3659(99)00151-0; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V32, P65, DOI 10.1016/S0928-8244(01)00267-X; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Zagury J F, 1998, J Hum Virol, V1, P282	87	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111360	10.1371/journal.pone.0111360	http://dx.doi.org/10.1371/journal.pone.0111360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356594	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000054
J	Xu, L; Lin, ZY; Tao, Q; Liang, MX; Zhao, GM; Yin, XZ; Fu, RX				Xu, Li; Lin, Zhongyuan; Tao, Qing; Liang, Mingxiang; Zhao, Gengmao; Yin, Xiangzhen; Fu, Ruixin			Multiple NUCLEAR FACTOR Y Transcription Factors Respond to Abiotic Stress in Brassica napus L.	PLOS ONE			English	Article							NF-Y; EXPRESSION ANALYSIS; GENE-EXPRESSION; HIGH-SALINITY; ARABIDOPSIS; DROUGHT; IDENTIFICATION; SUBUNITS; COMPLEX; FAMILY	Members of the plant NUCLEAR FACTOR Y (NF-Y) family are composed of the NF-YA, NF-YB, and NF-YC subunits. In Brassica napus (canola), each of these subunits forms a multimember subfamily. Plant NF-Ys were reported to be involved in several abiotic stresses. In this study, we demonstrated that multiple members of thirty three BnNF-Ys responded rapidly to salinity, drought, or ABA treatments. Transcripts of five BnNF-YAs, seven BnNF-YBs, and two BnNF-YCs were up-regulated by salinity stress, whereas the expression of thirteen BnNF-YAs, ten BnNF-YBs, and four BnNF-YCs were induced by drought stress. Under NaCl treatments, the expression of one BnNF-YA10 and four NF-YBs (BnNF-YB3, BnNF-YB7, BnNF-YB10, and BnNF-YB14) were greatly increased. Under PEG treatments, the expression levels of four NF-YAs (BnNF-YA9, BnNF-YA10, BnNF-YA11, and BnNF-YA12) and five NF-YBs (BnNF-YB1, BnNF-YB8, BnNF-YB10, BnNF-YB13, and BnNF-YB14) were greatly induced. The expression profiles of 20 of the 27 salinity-or drought-induced BnNF-Ys were also affected by ABA treatment. The expression levels of six NF-YAs (BnNF-YA1, BnNF-YA7, BnNF-YA8, BnNF-YA9, BnNF-YA10, and BnNF-YA12) and seven BnNF-YB members (BnNF-YB2, BnNF-YB3, BnNF-YB7, BnNF-YB10, BnNF-YB11, BnNF-YB13, and BnNF-YB14) and two NF-YC members (BnNF-YC2 and BnNF-YC3) were greatly up-regulated by ABA treatments. Only a few BnNF-Ys were inhibited by the above three treatments. Several NF-Y subfamily members exhibited collinear expression patterns. The promoters of all stress-responsive BnNF-Ys harbored at least two types of stress-related cis-elements, such as ABRE, DRE, MYB, or MYC. The cis-element organization of BnNF-Ys was similar to that of Arabidopsis thaliana, and the promoter regions exhibited higher levels of nucleotide sequence identity with Brassica rapa than with Brassica oleracea. This work represents an entry point for investigating the roles of canola NF-Y proteins during abiotic stress responses and provides insight into the genetic evolution of Brassica NF-Ys.	[Xu, Li; Lin, Zhongyuan; Tao, Qing; Liang, Mingxiang; Zhao, Gengmao; Yin, Xiangzhen; Fu, Ruixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Lin, Zhongyuan; Tao, Qing; Liang, Mingxiang; Zhao, Gengmao; Yin, Xiangzhen; Fu, Ruixin] Jiangsu Key Lab Marine Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liang, MX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	liangmx@njau.edu.cn		Liang, Mingxiang/0000-0002-8530-9714	Natural Science Foundation of Jiangsu province [BK2011635]; Doctoral Program of Higher Education of China [20120097120015]; Fundamental Research Funds for the Central Universities [KYZ201206]; Scientific Research Foundation of the State Human Resource Ministry; Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program) [809001]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation of the State Human Resource Ministry; Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program)	This research was supported by grants from the Natural Science Foundation of Jiangsu province (BK2011635), the Doctoral Program of Higher Education of China (20120097120015), Fundamental Research Funds for the Central Universities (KYZ201206), the Scientific Research Foundation of the State Human Resource Ministry, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (RAPD program (809001)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; [Anonymous], 2013, P IEEE INT C WIR COM, DOI DOI 10.1109/WCSP.2013.6677288; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hackenberg D, 2012, INT J MOL SCI, V13, P3458, DOI 10.3390/ijms13033458; Han X, 2013, J EXP BOT; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jules J, 2009, PLANT BREEDING REV; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Li Li, 2013, 2013 IEEE Proceedings of 14th International Vacuum Electronics Conference (IVEC2013), P1; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054369, 10.1371/journal.pone.0055108, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994]; Liang M, 2012, PLANTA, P1; Liang MX, 2014, PLANTA, V239, P107, DOI 10.1007/s00425-013-1964-3; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; SONG K, 1992, GENOME, V35, P992, DOI 10.1139/g92-152; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; U. N., 1935, Japanese Journal of Botany, V7, P389; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yan DH, 2013, PLANT MOL BIOL REP, P1; Zhang XG, 2011, PLANT MOL BIOL REP, V29, P481, DOI 10.1007/s11105-010-0251-8; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	46	30	34	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111354	10.1371/journal.pone.0111354	http://dx.doi.org/10.1371/journal.pone.0111354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356551	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000053
J	De Vleeschouwer, F; Vanneste, H; Mauquoy, D; Piotrowska, N; Torrejon, F; Roland, T; Stein, A; Le Roux, G				De Vleeschouwer, Francois; Vanneste, Heleen; Mauquoy, Dmitri; Piotrowska, Natalia; Torrejon, Fernando; Roland, Thomas; Stein, Ariel; Le Roux, Gael			Emissions from Pre-Hispanic Metallurgy in the South American Atmosphere	PLOS ONE			English	Article							PEAT CORES; LAKE-SEDIMENTS; LEAD; DEPOSITION; COPPER; RECONSTRUCTION; PALEOCLIMATE; METALS; RECORD; BOG	Metallurgical activities have been undertaken in northern South America (NSA) for millennia. However, it is still unknown how far atmospheric emissions from these activities have been transported. Since the timing of metallurgical activities is currently estimated from scarce archaeological discoveries, the availability of reliable and continuous records to refine the timing of past metal deposition in South America is essential, as it provides an alternative to discontinuous archives, as well as evidence for global trace metal transport. We show in a peat record from Tierra del Fuego that anthropogenic metals likely have been emitted into the atmosphere and transported from NSA to southern South America (SSA) over the last 4200 yrs. These findings are supported by modern time back-trajectories from NSA to SSA. We further show that apparent anthropogenic Cu and Sb emissions predate any archaeological evidence for metallurgical activities. Lead and Sn were also emitted into the atmosphere as by-products of Inca and Spanish metallurgy, whereas local coal-gold rushes and the industrial revolution contributed to local contamination. We suggest that the onset of pre-Hispanic metallurgical activities is earlier than previously reported from archaeological records and that atmospheric emissions of metals were transported from NSA to SSA.	[De Vleeschouwer, Francois; Vanneste, Heleen; Le Roux, Gael] Univ Toulouse, INP, UPS, EcoLab,Lab Ecol Fonct & Environm,ENSAT, Castanet Tolosan, France; [De Vleeschouwer, Francois; Vanneste, Heleen; Le Roux, Gael] CNRS, EcoLab, Castanet Tolosan, France; [Mauquoy, Dmitri] Univ Aberdeen, Sch Geosci, Aberdeen, Scotland; [Piotrowska, Natalia] Silesian Tech Univ, Inst Phys, Dept Radioisotopes, Gliwice, Poland; [Torrejon, Fernando] Univ Concepcion, Environm Sci Ctr EULA Chile, Concepcion, Chile; [Roland, Thomas] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Roland, Thomas] Univ Southampton, Palaeoenvironm Lab PLUS, Southampton, Hants, England; [Stein, Ariel] NOAA, Air Resources Lab, R ARL NCWCP, College Pk, MD USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of Aberdeen; Silesian University of Technology; Universidad de Concepcion; University of Exeter; University of Southampton; National Oceanic Atmospheric Admin (NOAA) - USA	De Vleeschouwer, F (corresponding author), Univ Toulouse, INP, UPS, EcoLab,Lab Ecol Fonct & Environm,ENSAT, Castanet Tolosan, France.	francois.devleeschouwer@ensat.fr	Stein, Ariel/ABE-7423-2021; Mauquoy, Dmitri/AAF-1044-2019; Piotrowska, Natalia/S-4528-2018; Stein, Ariel F/L-9724-2014; Le Roux, Gael/K-1154-2012; Roland, Thomas/B-4703-2013	Stein, Ariel/0000-0002-9560-9198; Piotrowska, Natalia/0000-0002-8194-6767; Stein, Ariel F/0000-0002-9560-9198; Le Roux, Gael/0000-0002-1579-0178; Roland, Thomas/0000-0002-9237-1364; De Vleeschouwer, Francois/0000-0002-0979-6397; Mauquoy, Dmitri/0000-0002-8056-8258	Young Researcher Grant of the Agence Nationale de la Recherche (ANR) [ANR-2011-JS56-006-01]	Young Researcher Grant of the Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This research is supported by a Young Researcher Grant of the Agence Nationale de la Recherche (ANR) to F. De Vleeschouwer (Project ANR-2011-JS56-006-01 "PARAD"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2003, SCIENCE, V301, P1893, DOI 10.1126/science.1087806; Allan M, 2013, ENVIRON POLLUT, V178, P381, DOI 10.1016/j.envpol.2013.03.018; Auer V, 1965, GEOL GEOGR, V80, P1; Augustyniak Szymon, 2004, Chungará (Arica), V36, P19, DOI 10.4067/S0717-73562004000100003; Barber KE, 1994, QUATERNARY CUMBRIA F, P20; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Cooke CA, 2007, ENVIRON SCI TECHNOL, V41, P3469, DOI 10.1021/es062930+; De Vleeschouwer F., 2010, MIRES PEAT, V7, P1; Desaulty AM, 2011, P NATL ACAD SCI USA, V108, P9002, DOI 10.1073/pnas.1018210108; DONAHUE DJ, 1990, RADIOCARBON, V32, P135, DOI 10.1017/S0033822200040121; Draxler R. R., 1997, DESCRIPTION HYSPLIT; Eerkens JW, 2009, ANTIQUITY, V83, P738, DOI 10.1017/S0003598X00098951; Fagel N, 2008, J PALEOLIMNOL, V39, P253, DOI 10.1007/s10933-007-9116-z; Givelet N, 2004, J ENVIRON MONITOR, V6, P481, DOI 10.1039/b401601g; González Luis R, 2002, Estud. atacam., V0, P21, DOI 10.4067/S0718-10432002002400003; Graffam G, 1996, LAT AM ANTIQ, V7, P101; Gusinde M, 1951, FUEGINOS HOMBRES PRI; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Heusser CJ, 2000, J QUATERNARY SCI, V15, P101, DOI 10.1002/(SICI)1099-1417(200002)15:2<101::AID-JQS500>3.0.CO;2-Y; Hinkley T, 2007, GEOPHYS RES LETT, V34; Hong SM, 2004, J ENVIRON MONITOR, V6, P322, DOI 10.1039/b314251e; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kilian R, 2012, QUATERNARY SCI REV, V53, P1, DOI 10.1016/j.quascirev.2012.07.017; Krachler M, 2004, J ANAL ATOM SPECTROM, V19, P354, DOI 10.1039/b314956k; Le Roux G, 2006, DEV EARTH S, V9, P197, DOI 10.1016/S0928-2025(06)09009-2; Le Roux G., 2010, MIRES PEAT, V7, P1; Markgraf V, 2000, QUATERNARY SCI REV, V19, P125, DOI 10.1016/S0277-3791(99)00058-X; MARTINIC B. MATEO, 2004, Historia (Santiago), V37, P129; MARTINIC BEROS MATEO, 2003, Historia (Santiago), V36, P219; Martinic Mateo, 1982, TIERRA FUEGOS; Mauquoy D, 2004, QUATERNARY RES, V61, P148, DOI 10.1016/j.yqres.2003.10.001; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McCulloch RD, 2001, PALAEOGEOGR PALAEOCL, V173, P143, DOI 10.1016/S0031-0182(01)00316-9; Meharg AA, 2012, J ARCHAEOL SCI, V39, P717, DOI 10.1016/j.jas.2011.10.037; Nunez L, 2006, ARQUEOLOGIA ANTROPOL, V32, P93, DOI DOI 10.4067/S0718-10432006000200008; Onursal B, 1997, BANCO MUNDIAL; Palacios T, 2011, REV SAM, V8, P15; Perez R.L., 2010, MAGUARE, V24, P297; Piotrowska N, 2013, NUCL INSTRUM METH B, V294, P176, DOI 10.1016/j.nimb.2012.05.017; Piotrowska N, 2010, MIRES PEAT, V7; Rabassa J, 2006, DEV EARTH S, V9, P129, DOI 10.1016/S0928-2025(06)09006-7; Rausch N, 2005, ENVIRON SCI TECHNOL, V39, P5989, DOI 10.1021/es050260m; RENBERG I, 1994, NATURE, V368, P323, DOI 10.1038/368323a0; Rosman KJR, 1997, ENVIRON SCI TECHNOL, V31, P3413, DOI 10.1021/es970038k; Salazar D., 2011, REV ANTROPOL, V23, P123; Salazar Diego, 2010, Bol. Mus. Chil. Arte Precolomb., V15, P9; Salazar D, 2010, ESTUD ATACAMENOS, P23, DOI 10.4067/S0718-10432010000200003; Scattolin M. C., 1992, B LINSTITUT FRANCAIS, V21, P59; Scattolin M. Cristina, 2010, Bol. Mus. Chil. Arte Precolomb., V15, P25, DOI 10.4067/S0718-68942010000100003; Shotyk W, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002113; Shotyk W, 1998, SCIENCE, V281, P1635, DOI 10.1126/science.281.5383.1635; Shotyk W, 2005, MET IONS BIOL SYST, V43, P239; Stern CR, 2008, B VOLCANOL, V70, P435, DOI 10.1007/s00445-007-0148-z; Stern CR, 2000, ACTAS 9 C GEOL CHIL, V2, P77; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Vleeschouwer F. de, 2010, PAGES (Past Global Changes) News, V18, P20; Yafa C, 2004, J ENVIRON MONITOR, V6, P493, DOI 10.1039/b315647h; Zori C, 2013, J ARCHAEOL SCI, V40, P1165, DOI 10.1016/j.jas.2012.09.012	58	24	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111315	10.1371/journal.pone.0111315	http://dx.doi.org/10.1371/journal.pone.0111315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353346	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200071
J	Sanchez-Sanchez, J; Garcia-Unanue, J; Jimenez-Reyes, P; Gallardo, A; Burillo, P; Felipe, JL; Gallardo, L				Sanchez-Sanchez, Javier; Garcia-Unanue, Jorge; Jimenez-Reyes, Pedro; Gallardo, Ana; Burillo, Pablo; Luis Felipe, Jose; Gallardo, Leonor			Influence of the Mechanical Properties of Third-Generation Artificial Turf Systems on Soccer Players' Physiological and Physical Performance and Their Perceptions	PLOS ONE			English	Article							REPEATED SPRINT ABILITY; NATURAL GRASS; PLAYING SURFACE; INTERMITTENT EXERCISE; ROTATIONAL TRACTION; FOOTBALL PLAYERS; SYNTHETIC TURF; ELITE FOOTBALL; RESPONSES; SAND	The aim of this research was to evaluate the influence of the mechanical properties of artificial turf systems on soccer players' performance. A battery of perceptive physiological and physical tests were developed on four different structural systems of artificial turf (System 1: Compacted gravel sub-base without elastic layer; System 2: Compacted gravel sub-base with elastic layer; System 3: Asphalt sub-base without elastic layer; System 4: Asphalt sub-base with elastic layer). The sample was composed of 18 soccer players (22.44 +/- 1.72 years) who typically train and compete on artificial turf. The artificial turf system with less rotational traction (S3) showed higher total time in the Repeated Sprint Ability test in comparison to the systems with intermediate values (49.46 +/- 1.75 s vs 47.55 +/- 1.82 s (S1) and 47.85 +/- 1.59 s (S2); p < 0.001). The performance in jumping tests (countermovement jump and squat jump) and ball kicking to goal decreased after the RSA test in all surfaces assessed (p < 0.05), since the artificial turf system did not affect performance deterioration (p > 0.05). The physiological load was similar in all four artificial turf systems. However, players felt more comfortable on the harder and more rigid system (S4; visual analogue scale = 70.83 +/- 14.28) than on the softer artificial turf system (S2; visual analogue scale = 54.24 +/- 19.63). The lineal regression analysis revealed a significant influence of the mechanical properties of the surface of 16.5%, 15.8% and 7.1% on the mean time of the sprint, the best sprint time and the maximum mean speed in the RSA test respectively. Results suggest a mechanical heterogeneity between the systems of artificial turf which generate differences in the physical performance and in the soccer players' perceptions.	[Sanchez-Sanchez, Javier; Jimenez-Reyes, Pedro; Gallardo, Ana] Univ Catolica San Antonio, UCAM, Sch Sport Sci, Murcia, Spain; [Sanchez-Sanchez, Javier; Garcia-Unanue, Jorge; Burillo, Pablo; Luis Felipe, Jose; Gallardo, Leonor] Univ Castilla La Mancha, IGOID Res Grp, Toledo, Spain; [Burillo, Pablo] Camilo Jose Cela Univ, Sport Sci Inst, Madrid, Spain; [Luis Felipe, Jose] European Univ, Sch Sport Sci, Madrid, Spain	Universidad Catolica de Murcia; Universidad de Castilla-La Mancha; Camilo Jose Cela University	Sanchez-Sanchez, J (corresponding author), Univ Catolica San Antonio, UCAM, Sch Sport Sci, Murcia, Spain.	jssanchez@ucam.edu	Garcia-Unanue, Jorge/AAY-6231-2020; Felipe, Jose Luis/M-1442-2015; Felipe, José Luis/U-1062-2017; García-Unanue, Jorge/F-6674-2016; Jimenez-Reyes, Pedro/P-1075-2016; Guerrero, Ana Maria Gallardo/K-3103-2017	Garcia-Unanue, Jorge/0000-0002-1741-5566; Felipe, José Luis/0000-0002-2029-1277; García-Unanue, Jorge/0000-0002-1741-5566; Jimenez-Reyes, Pedro/0000-0002-8156-243X; Gallardo Guerrero, Ana Maria/0000-0001-8803-9820; Gallardo Guerrero, Leonor/0000-0002-6296-6121; Sanchez-Sanchez, Javier/0000-0003-0017-0184				Alcantara E, 2009, P I MECH ENG P-J SPO, V223, P1, DOI 10.1243/17543371JSET27; Allgeuer T., 2008, SPORT TECHNOL, V1, P29; Andersson H, 2008, J SPORT SCI, V26, P113, DOI 10.1080/02640410701422076; [Anonymous], 2010, SPORTS TECHNOLOGY; Bishop D, 2003, J SPORT MED PHYS FIT, V43, P418; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Bravo DF, 2008, INT J SPORTS MED, V29, P668, DOI 10.1055/s-2007-989371; Brito J, 2012, HUM MOVEMENT SCI, V31, P946, DOI 10.1016/j.humov.2011.08.011; Buchheit M, 2010, EUR J APPL PHYSIOL, V110, P1007, DOI 10.1007/s00421-010-1587-3; Burillo P., 2012, SCI RES ESSAYS, V7, P2457, DOI DOI 10.5897/SRE11.1454; Burillo P, 2014, EUR J SPORT SCI, V14, pS437, DOI 10.1080/17461391.2012.713005; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Castagna C, 2008, J STRENGTH COND RES, V22, P923, DOI 10.1519/JSC.0b013e31816a4281; Chamari K, 2008, J STRENGTH COND RES, V22, P944, DOI 10.1519/JSC.0b013e31816a57c6; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2663, DOI [10.1519/JSC.0b013e3181e347f4, 10.1519/JSC.0b013e3181d65071]; Comite Europeen de Normalisation, 2014, 1533012014 EN; De Clercq D, 2014, FOOTWEAR SCI, V6, P81, DOI 10.1080/19424280.2014.895056; Di Michele R, 2009, J STRENGTH COND RES, V23, P939, DOI 10.1519/JSC.0b013e3181a07b6e; Dixon SJ., 2003, SPORTS ENG, V6, P1, DOI [10.1007/BF02844155, DOI 10.1007/BF02844155]; Dragoo JL, 2010, SPORTS MED, V40, P981, DOI 10.2165/11535910-000000000-00000; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; FIFA, 2012, FIFA HDB REQ; FIFA, 2012, FIFA HDB TEST METH; Figueiredo AJ, 2009, J SPORT SCI, V27, P883, DOI 10.1080/02640410902946469; Fitzsimons M., 1993, AUST J SCI MED SPORT, V25, P82; Ford KR, 2006, J SCI MED SPORT, V9, P433, DOI 10.1016/j.jsams.2006.03.019; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Gains GL, 2010, J STRENGTH COND RES, V24, P2613, DOI 10.1519/JSC.0b013e3181eccdf8; Giatsis George, 2004, Sports Biomech, V3, P145, DOI 10.1080/14763140408522835; Goedecke JH, 2013, NUTRIENTS, V5, P5193, DOI 10.3390/nu5125193; Greig M, 2007, BRIT J SPORT MED, V41, P908, DOI 10.1136/bjsm.2006.030387; Hardin EC, 2004, MED SCI SPORT EXER, V36, P838, DOI 10.1249/01.MSS.0000126605.65966.40; Hennig EM, 2014, FOOTWEAR SCI, V6, P119, DOI 10.1080/19424280.2013.873486; Hughes MG, 2013, J SPORT SCI, V31, P878, DOI 10.1080/02640414.2012.757340; Ivarez JC, 2009, J SCI MED SPORT, V13, P232; Kalapotharakos VI, 2006, J SPORT MED PHYS FIT, V46, P515; Kanaras V, 2014, AM J SPORT SCI, V2, P1; Kerdok AE, 2002, J APPL PHYSIOL, V92, P469, DOI 10.1152/japplphysiol.01164.2000; Krustrup P, 2001, J SPORT SCI, V19, P881, DOI 10.1080/026404101753113831; Kuhlman S, 2010, P I MECH ENG P-J SPO, V224, P155, DOI 10.1243/17543371JSET56; Lara AJ, 2006, J SPORT MED PHYS FIT, V46, P419; Lejeune TM, 1998, J EXP BIOL, V201, P2071; Livesay GA, 2006, AM J SPORT MED, V34, P415, DOI 10.1177/0363546505284182; Luo G, 2011, FOOTWEAR SCI, V3, P127, DOI 10.1080/19424280.2011.639807; McGhie D, 2013, AM J SPORT MED, V41, P177, DOI 10.1177/0363546512464697; Mohr M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039202; Muller C, 2010, SPORT BIOMECH, V9, P193, DOI 10.1080/14763141.2010.511679; Naunheim R, 2004, J TRAUMA, V57, P1311, DOI 10.1097/01.TA.0000136154.36483.98; Nedelec M, 2013, J SPORT SCI, V31, P529, DOI 10.1080/02640414.2012.738923; Oliver JL, 2009, J SCI MED SPORT, V12, P20, DOI 10.1016/j.jsams.2007.10.010; Perez Soriano P, 2009, J HUM SPORT EXERC, V4, P78; Pinnington HC, 2005, EUR J APPL PHYSIOL, V94, P242, DOI 10.1007/s00421-005-1323-6; Pinnington HC, 2001, J SCI MED SPORT, V4, P416, DOI 10.1016/S1440-2440(01)80051-7; Potthast W, 2010, SPORT TECHNOL, V3, P5; Potthast W, 2010, FOOTWEAR SCI, V2, P29, DOI 10.1080/19424280903535447; Poulos CCN, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-11; Pyne DB, 2008, J STRENGTH COND RES, V22, P1633, DOI 10.1519/JSC.0b013e318181fe7a; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Rebelo A, 2013, INT J SPORTS MED, V34, P312, DOI 10.1055/s-0032-1323729; Sanchez-Sanchez J, 2014, P I MECH ENG P-J SPO; Schrier NM, 2014, FOOTWEAR SCI, V6, P69, DOI 10.1080/19424280.2014.886302; Spencer M, 2006, J SCI MED SPORT, V9, P181, DOI 10.1016/j.jsams.2005.05.001; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Villwock MR, 2009, P I MECH ENG P-J SPO, V223, P11, DOI 10.1243/17543371JSET26; Villwock MR, 2009, AM J SPORT MED, V37, P518, DOI 10.1177/0363546508328108; Zanetti EM, 2009, APPL ERGON, V40, P485, DOI 10.1016/j.apergo.2008.09.007	68	33	33	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111368	10.1371/journal.pone.0111368	http://dx.doi.org/10.1371/journal.pone.0111368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354188	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200075
J	Lau, K; Lai, KP; Bao, JYJ; Zhang, N; Tse, A; Tong, A; Li, JW; Lok, S; Kong, RYC; Lui, WY; Wong, A; Wu, RSS				Lau, Karen; Lai, Keng Po; Bao, Jessie Yun Juan; Zhang, Na; Tse, Anna; Tong, Amy; Li, Jing Woei; Lok, Si; Kong, Richard Yuen Chong; Lui, Wing Yee; Wong, Alice; Wu, Rudolf Shiu Sun			Identification and Expression Profiling of MicroRNAs in the Brain, Liver and Gonads of Marine Medaka (Oryzias melastigma) and in Response to Hypoxia	PLOS ONE			English	Article							MOLECULAR RESPONSES; GENE-EXPRESSION; LET-7 FAMILY; CANCER; CELLS; ZEBRAFISH; RNAS; DIFFERENTIATION; DISCOVERY; LATIPES	The marine medaka (Oryzias melastigma) has been increasingly used as a fish model for detecting environmental stresses and chemical contaminants in the marine environment. Recent mammalian studies have shown that environmental stresses can alter the expression profiles of microRNAs (miRNAs), leading to transgenerational effects. Here, we use high-throughput Illumina RNA sequencing (RNA-Seq) for miRNA transcriptome analysis of brain, liver, and gonads from sexually mature male and female marine medaka. A total of 128,883,806 filtered sequence reads were generated from six small RNA libraries, identifying a total of 2,125,663 non-redundant sequences. These sequences were aligned and annotated to known animal miRNAs (miRBase) using the BLAST method. A total of 223 distinct miRNA types were identified, with the greatest number expressed in brain tissue. Our data suggested that 55 miRNA types from 34 families are common to all tested tissues, while some of the miRNAs are tissue-enriched or sex-enriched. Quantitative real-time PCR analysis further demonstrated that let-7a, miR-122, and miR-9-3p were downregulated in hypoxic female medaka, while miR-2184 was specifically upregulated in the testis of hypoxic male fish. This is the first study to identify miRNAs in O. melastigma using small RNA deep sequencing technology. Because miRNA expression is highly conserved between marine medaka and other vertebrates, marine medaka may serve as a good model for studies on the functional roles of miRNAs in hypoxia stress response and signaling in marine fish.	[Lau, Karen; Lai, Keng Po; Tse, Anna; Lui, Wing Yee; Wong, Alice; Wu, Rudolf Shiu Sun] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Lau, Karen; Lai, Keng Po; Tse, Anna; Kong, Richard Yuen Chong; Wu, Rudolf Shiu Sun] State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China; [Bao, Jessie Yun Juan; Zhang, Na; Tong, Amy; Lok, Si] Univ Hong Kong, Hong Kong Jockey Club Bldg Interdisciplinary Res, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Li, Jing Woei] Chinese Univ Hong Kong, Hong Kong Bioinformat Ctr, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, K (corresponding author), Univ Hong Kong, Sch Biol Sci, Kadoorie Biol Sci Bldg, Hong Kong, Hong Kong, Peoples R China.	karenytlau@hotmail.com; rudolfwu@hku.hk	; Lui, Wing Yee/A-2743-2010	LAI, Keng Po/0000-0001-8135-6030; Li, Jing Woei/0000-0001-6167-7689; Lui, Wing Yee/0000-0002-3096-1158; KONG, Yuen Chong Richard/0000-0002-4636-5756				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bannister SC, 2011, BIOL REPROD, V85, P22, DOI 10.1095/biolreprod.110.088476; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brevik A., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/407431; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen Z, 2013, J CLIN INVEST, V123, P1057, DOI 10.1172/JCI65344; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Dunaeva TY, 2008, B EXP BIOL MED+, V146, P385, DOI 10.1007/s10517-009-0316-6; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Kissling GE, 2006, TOXICOL SCI, V92, P143, DOI 10.1093/toxsci/kfj181; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kure EH, 2013, AQUAT TOXICOL, V138, P98, DOI 10.1016/j.aquatox.2013.04.004; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S8; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lind GE, 2006, J PATHOL, V210, P441, DOI 10.1002/path.2064; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Shan FB, 2014, J CELL PHYSIOL, V229, P1511, DOI 10.1002/jcp.24593; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908	50	50	52	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110698	10.1371/journal.pone.0110698	http://dx.doi.org/10.1371/journal.pone.0110698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350659	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100036
J	Ramly, M; Ming, MF; Chinna, K; Suboh, S; Pendek, R				Ramly, Mazliza; Ming, Moy Foong; Chinna, Karuthan; Suboh, Suhaili; Pendek, Rokiah			Effect of Vitamin D Supplementation on Cardiometabolic Risks and Health-Related Quality of Life among Urban Premenopausal Women in a Tropical Country - A Randomized Controlled Trial	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; PLACEBO-CONTROLLED TRIAL; METABOLIC SYNDROME; D DEFICIENCY; INSULIN-RESISTANCE; PHYSICAL FUNCTION; HEART-FAILURE; DOUBLE-BLIND; WEIGHT-LOSS; ASSOCIATION	Background: Many observational studies linked vitamin D to cardiometabolic risks besides its pivotal role in musculoskeletal diseases, but evidence from trials is lacking and inconsistent. Aim: To determine whether Vitamin D supplementation in urban premenopausal women with vitamin D deficiency can improve cardiometabolic risks and health-related quality of life (HRQOL). Design: A double-blind randomized controlled trial was conducted in Kuala Lumpur, Malaysia. A total of 192 vitamin D deficient (<50 nmol/l) premenopausal women were randomized to receive either vitamin D 50,000 IU or placebo once a week for 2 months and then monthly for 10 months. Primary outcomes were serum 25(OH)D, serum lipid profiles, blood pressure and HOMA-IR measured at baseline, 6 months and 12 months. HRQOL was assessed with SF-36 at baseline and 12 months. Results: Ninety three and ninety-nine women were randomised into intervention and placebo groups respectively. After 12 months, there were significant differences in the serum 25(OH) D concentration (mean difference: 49.54; 95% CI: 43.94 to 55.14) nmol/l) and PTH levels (mean difference: -1.02; 95% CI: -1.67 to -0.38 pmol/l) in the intervention group compared to placebo group. There was significant difference between treatment group in both serum 25(OH)D and PTH. There was no effect of supplementation on HOMA-IR, serum lipid profiles and blood pressure (all p>0.05) between two groups. There was a small but significant improvement in HRQOL in the components of vitality (mean difference: 5.041; 95% CI: 0.709 to 9.374) and mental component score (mean difference: 2.951; 95% CI: 0.573 to 5.329) in the intervention group compared to placebo group. Conclusion: Large and less frequent dosage vitamin D supplementation was safe and effective in the achievement of vitamin D sufficiency. However, there was no improvement in measured cardiometabolic risk factors in premenopausal women. Conversely vitamin D supplementation improves some components of HRQOL.	[Ramly, Mazliza; Chinna, Karuthan; Suboh, Suhaili] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Ming, Moy Foong] Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Pendek, Rokiah] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ramly, M (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	drmazliza@siswa.um.edu.my	Moy, Foong Ming/B-7899-2010	Moy, Foong Ming/0000-0002-0306-4419	University Malaya [PV080/2012A]; Ministry of Education High Impact Research Grant (MOE HIR) [E 2000069-20001]	University Malaya(Universiti Malaya); Ministry of Education High Impact Research Grant (MOE HIR)	The study was funded by the University Malaya (Post Graduate Research Grant, PV080/2012A) and the Ministry of Education High Impact Research Grant (MOE HIR No. E 2000069-20001). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Daghri N, 2010, OSTEOPOROSIS INT, V21, pS726; Al-Daghri NM, 2012, METABOLISM, V61, P661, DOI 10.1016/j.metabol.2011.09.017; Alam U, 2012, DIABETIC MED, V29, P1343, DOI 10.1111/j.1464-5491.2012.03692.x; Anand S, 2011, NEPHROL DIAL TRANSPL, V26, P3683, DOI 10.1093/ndt/gfr098; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Azman A B, 2003, Med J Malaysia, V58, P694; Basaran S, 2007, QUAL LIFE RES, V16, P1491, DOI 10.1007/s11136-007-9257-6; Begg GA, 2010, CIRC-HEART FAIL, V3, pE24, DOI 10.1161/CIRCHEARTFAILURE.110.952549; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Breslavsky A, 2013, CLIN NUTR, V32, P970, DOI 10.1016/j.clnu.2013.01.020; Chacko SA, 2011, AM J CLIN NUTR, V94, P209, DOI 10.3945/ajcn.110.010272; Chailurkit LO, 2012, CLIN ENDOCRINOL, V77, P658, DOI 10.1111/j.1365-2265.2012.04422.x; Chao YS, 2014, QUAL LIFE RES; Ecemis GC, 2013, J ENDOCRINOL INVEST, V36, P622, DOI 10.3275/8898; El-Menyar A, 2012, OPEN CARDIOVASC MED, V6, P76, DOI 10.2174/1874192401206010076; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Harris SS, 2012, DIABETES OBES METAB, V14, P789, DOI 10.1111/j.1463-1326.2012.01605.x; Heaney RP, 2003, AM J CLIN NUTR, V78, P912, DOI 10.1093/ajcn/78.5.912; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653; Hosseinpanah F, 2011, ATHEROSCLEROSIS, V218, P238, DOI 10.1016/j.atherosclerosis.2011.05.016; Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d; Istiany A, 2012, INT J SCI ENG INVEST, V1, P91; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Ju SY, 2013, J NUTR HEALTH AGING, V17, P447, DOI 10.1007/s12603-012-0418-0; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Kayaniyil S, 2011, J CLIN ENDOCR METAB, V96, P168, DOI 10.1210/jc.2010-1439; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Lee HY, 2012, ANN ACAD MED SINGAP, V41, P17; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Major GC, 2007, AM J CLIN NUTR, V85, P54; Maki KC, 2009, J CLIN LIPIDOL, V3, P289, DOI 10.1016/j.jacl.2009.07.003; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; May HT, 2010, AM HEART J, V159, P1037, DOI 10.1016/j.ahj.2010.03.017; McCarty MF, 2009, MED HYPOTHESES, V72, P647, DOI 10.1016/j.mehy.2008.12.031; Michael YL, 2011, J WOMENS HEALTH, V20, P1603, DOI 10.1089/jwh.2010.2606; Minambres I, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-7; Ministry of Health M, 2011, 15 NIH SCI M INC NHM; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Motsinger S, 2012, MATURITAS, V71, P267, DOI 10.1016/j.maturitas.2011.12.005; Moy FM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-735; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Nurbazlin M, 2013, ASIA PAC J CLIN NUTR, V22, P391, DOI 10.6133/apjcn.2013.22.3.15; Ohta H, 2014, CLIN THER, V36, P225, DOI 10.1016/j.clinthera.2013.12.007; Penckofer Sue, 2010, Issues Ment Health Nurs, V31, P385, DOI 10.3109/01612840903437657; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Ramly M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-416; Rejnmark L, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/957174; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Ryu OH, 2013, ENDOCR J; Sakalli H, 2012, RHEUMATOL INT, V32, P2279, DOI 10.1007/s00296-011-1943-6; Shaffer JA, 2014, PSYCHOSOM MED; Siadat ZD, 2012, J RES MED SCI, V17, P1052; Tai K, 2008, NUTRITION, V24, P950, DOI 10.1016/j.nut.2008.04.009; Talaei A, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-8; Vacek JL, 2012, AM J CARDIOL, V109, P359, DOI 10.1016/j.amjcard.2011.09.020; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111; Whiting S, 2013, ANN NUTR METAB, V63, P347; Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899; Wood AD, 2012, J CLIN ENDOCR METAB, V97, P3557, DOI 10.1210/jc.2012-2126; Yang Zy, 2013, FOOD NUTR BULL, V34, pS81, DOI 10.1177/15648265130342S110; Zhou QG, 2008, DIABETES-METAB RES, V24, P459, DOI 10.1002/dmrr.873; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	66	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110476	10.1371/journal.pone.0110476	http://dx.doi.org/10.1371/journal.pone.0110476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BH	25350669	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100027
J	Kularatna, S; Whitty, JA; Johnson, NW; Jayasinghe, R; Scuffham, PA				Kularatna, Sanjeewa; Whitty, Jennifer A.; Johnson, Newell W.; Jayasinghe, Ruwan; Scuffham, Paul A.			EQ-5D-3L Derived Population Norms for Health Related Quality of Life in Sri Lanka	PLOS ONE			English	Article							STATES; INDEX; QUESTIONNAIRE; AUSTRALIA; COUNTRIES	Background: Health Related Quality of Life (HRQoL) is an important outcome measure in health economic evaluation that guides health resource allocations. Population norms for HRQoL are an essential ingredient in health economics and in the evaluation of population health. The aim of this study was to produce EQ-5D-3L-derived population norms for Sri Lanka. Method: A population sample (n = 780) was selected from four districts of Sri Lanka. A stratified cluster sampling approach with probability proportionate to size was employed. Twenty six clusters of 30 participants each were selected; each participant completed the EQ-5D-3L in a face-to-face interview. Utility weights for their EQ-5D-3L health states were assigned using the Sri Lankan EQ-5D-3L algorithm. The population norms are reported by age and socio-economic variables. Results: The EQ-5D-3L was completed by 736 people, representing a 94% response rate. Sixty per cent of the sample reported being in full health. The percentage of people responding to any problems in the five EQ-5D-3L dimensions increased with age. The mean EQ-5D-3L weight was 0.85 (SD 0.008; 95%CI 0.84-0.87). The mean EQ-5D-3L weight was significantly associated with age, housing type, disease experience and religiosity. People above 70 years of age were 7.5 times more likely to report mobility problems and 3.7 times more likely to report pain/discomfort than those aged 18-29 years. Those with a tertiary education were five times less likely to report any HRQoL problems than those without a tertiary education. A person living in a shanty was 4.3 more likely to have problems in usual activities than a person living in a single house. Conclusion: The population norms in Sri Lanka vary with socio-demographic characteristics. The socioeconomically disadvantaged have a lower HRQoL. The trends of population norms observed in this lower middle income country were generally similar to those previously reported in high income countries.	[Kularatna, Sanjeewa; Whitty, Jennifer A.; Scuffham, Paul A.] Griffith Univ, Sch Med, Ctr Appl Hlth Econ, Brisbane, Qld 4111, Australia; [Kularatna, Sanjeewa; Whitty, Jennifer A.; Johnson, Newell W.; Scuffham, Paul A.] Griffith Univ, Griffith Hlth Inst, Populat & Social Hlth Res Programme, Brisbane, Qld 4111, Australia; [Whitty, Jennifer A.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Jayasinghe, Ruwan] Univ Peradeniya, Fac Dent Sci, Peradeniya, Sri Lanka	Griffith University; Griffith University; Menzies Health Institute Queensland; University of Queensland; University of Peradeniya	Kularatna, S (corresponding author), Griffith Univ, Sch Med, Ctr Appl Hlth Econ, Brisbane, Qld 4111, Australia.	s.kularatna@griffith.edu.au	Scuffham, Paul/B-3066-2014; Scuffham, Paul/AAS-8084-2021; Johnson, Newell W/D-8152-2019; Whitty, Jennifer A/N-6434-2013; Jayasinghe, Ruwan/AAW-1160-2021	Scuffham, Paul/0000-0001-5931-642X; Scuffham, Paul/0000-0001-5931-642X; Johnson, Newell W/0000-0001-5866-262X; Whitty, Jennifer A/0000-0002-5886-1933; Jayasinghe, Ruwan/0000-0002-8054-4301; Kularatna, Sanjeewa/0000-0001-5650-154X	Griffith University Post Graduate Research Scholarship; Griffith University International Postgraduate Research Scholarship; Population and Social Health Research Programme, Griffith University	Griffith University Post Graduate Research Scholarship(Griffith University); Griffith University International Postgraduate Research Scholarship; Population and Social Health Research Programme, Griffith University	This work was funded by Griffith University Post Graduate Research Scholarship and Griffith University International Postgraduate Research Scholarship. The data collection was partly funded by a research grant from the Population and Social Health Research Programme, Griffith University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin E, 2013, QUAL LIFE RES, V22, P2983, DOI 10.1007/s11136-013-0405-x; Burstrom K, 2013, QUAL LIFE RES; Centers for Disease Control and Prevention, 2012, HLTH REL QUAL LIF; Chandrasena TGAN, 2007, T ROY SOC TROP MED H, V101, P245, DOI 10.1016/j.trstmh.2006.08.012; Clemens S, 2014, QUAL LIFE RES, V23, P2375, DOI 10.1007/s11136-014-0676-x; Department of Census and Statistics Sri Lanka, 2013, PREL REP; Department of Census and Statistics Sri Lanka, 2012, POP HOUS; Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N; Ekanayake L, 2003, Gerodontology, V20, P95, DOI 10.1111/j.1741-2358.2003.00095.x; EuroQol, 2004, MEAS SELF REP HLTH I; Gudex C, 1994, TIME TRADE USER MANU; Gundgaard J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-53; Jayasekara H, 2009, PSYCHO-ONCOLOGY, V18, P1116, DOI 10.1002/pon.1430; Kaseloo PA, 2014, J COMP PHYSL B; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kind Paul, 2005, Health Policy, V71, P303, DOI 10.1016/j.healthpol.2004.02.008; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078; Kularatna S, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-149; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; Ministry of Health, 2014, FAM HLTH BER; Ministry of Health SriLanka, 2014, EP UN; Nanayakkara SD, 2009, ASIA-PAC J PUBLIC HE, V21, P303, DOI 10.1177/1010539509336010; Norman R, 2013, AUST NZ J PUBL HEAL, V37, P17, DOI 10.1111/1753-6405.12005; Norman R, 2009, VALUE HEALTH, V12, P1194, DOI 10.1111/j.1524-4733.2009.00581.x; Ranawaka CK, 2013, CEYLON MED J, V58, P156, DOI 10.4038/cmj.v58i3.6103; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Shver I.A., 1986, HYDROMETIZDAT; Sorensen J, 2009, SCAND J PUBLIC HEALT, V37, P467, DOI 10.1177/1403494809105286; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; Tasiemski T, 2013, J SPINAL CORD MED, V36, P118, DOI 10.1179/2045772312Y.0000000074; Viney R, 2011, VALUE HEALTH, V14, P928, DOI 10.1016/j.jval.2011.04.009; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2014, SRI LANK	34	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e108434	10.1371/journal.pone.0108434	http://dx.doi.org/10.1371/journal.pone.0108434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365171	Green Published, gold, Green Accepted			2022-12-27	WOS:000345558100005
J	Liao, Y; Cai, B; Li, Y; Chen, J; Tao, CM; Huang, HJ; Wang, LL				Liao, Yun; Cai, Bei; Li, Yi; Chen, Jie; Tao, Chuanmin; Huang, Hengjian; Wang, Lanlan			Association of HLA-DP/DQ and STAT4 Polymorphisms with HBV Infection Outcomes and a Mini Meta-Analysis	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; GENOME-WIDE ASSOCIATION; HEPATOCELLULAR-CARCINOMA; VIRUS CLEARANCE; DP; LOCUS; VARIANTS; HLA-DPA1	Background: Though HLA-DP/DQ is regarded to associate with HBV susceptibility and HBV natural clearance, its role in hepatocellular carcinoma (HCC) development is obscure. And the role of STAT4 in HBV susceptibility and clearance as well as HCC development is still contentious. Therefore, we conducted this study, aiming to clarify these obscure relationships. Methods: We recruited 1312 Chinese Han subjects including healthy controls, HBV carriers and HCC patients in the experiment stage. The meta-analysis included 3467 HCC patients and 5821 HBV carriers to appraise the association with HCC development. Results: Consistent with previous studies, HLA-DP/DQ associated with HBV susceptibility and HBV natural clearance (p, 0.05). However, the experiment showed that HLA-DP rs3077, rs9277535 and rs7453920 did not associate with HCC development (dominant model, rs3077, OR = 0.86, 95%CI = 0.62-1.18; rs9277535, OR = 0.94, 95%CI = 0.68-1.30; rs7453920, OR = 0.75, 95%CI = 0.44-1.27). Meta-analysis again consolidated this conclusion (allele model, rs3077, OR = 0.94, 95%CI = 0.87-1.02; rs9277535, OR = 1.04, 95%CI = 0.97-1.11; rs7453920, OR = 0.89, 95%CI = 0.76-1.02). As for STAT4 rs7574865, we did not find any significant association with HBV susceptibility (OR = 0.91, 95%CI = 0.66-1.26) or HBV natural clearance (OR = 1.13, 95%CI = 0.86-1.49). Moreover, current data failed to acquire positive connection of rs7574865 with HCC development (experiment, OR = 0.86, 95%CI = 0.62-1.19; meta-analysis, OR = 0.87, 95%CI = 0.74-1.03), which may be due to the small sample size. Conclusions: HLA-DP/DQ polymorphisms (rs3077, rs9277535, rs7453920) did not associate with HCC development, but did correlate with HBV susceptibility and HBV natural clearance. STAT4 rs7574865 seemed not to correlate with HBV susceptibility or natural clearance. And it seemed rather ambiguous in its role on HCC development at present.	[Liao, Yun; Cai, Bei; Li, Yi; Chen, Jie; Tao, Chuanmin; Huang, Hengjian; Wang, Lanlan] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	wangll_wch@163.com			Natural Science Foundation of China [81072443, 81100536, 81273256]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded in full by grants from Natural Science Foundation of China (grant numbers 81072443, 81100536, and 81273256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080445; An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077315; Cheng HL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068675, 10.1371/journal.pone.0053008]; Clark A, 2013, INFECT GENET EVOL, V18, P257, DOI 10.1016/j.meegid.2013.05.025; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Seto WK, 2013, CLIN INFECT DIS, V56, P1695, DOI 10.1093/cid/cit121; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhang Q, 2013, J VIROL, V87, P12176, DOI 10.1128/JVI.02073-13	27	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111677	10.1371/journal.pone.0111677	http://dx.doi.org/10.1371/journal.pone.0111677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365208	Green Submitted, gold, Green Published			2022-12-27	WOS:000345558100101
J	Martin, AC; Johnston, E; Xing, CG; Hegeman, AD				Martin, Amanda C.; Johnston, Ed; Xing, Chengguo; Hegeman, Adrian D.			Measuring the Chemical and Cytotoxic Variability of Commercially Available Kava (Piper methysticum G. Forster)	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; LUNG TUMORIGENESIS; CANCER CELLS; EXTRACTS; CULTIVARS; HEPATOTOXICITY; IDENTIFICATION; CONSTITUENTS; FLAVOKAVINS; CHALCONE	Formerly used world-wide as a popular botanical medicine to reduce anxiety, reports of hepatotoxicity linked to consuming kava extracts in the late 1990s have resulted in global restrictions on kava use and have hindered kava-related research. Despite its presence on the United States Food and Drug Administration consumer advisory list for the past decade, export data from kava producing countries implies that US kava imports, which are not publicly reported, are both increasing and of a fairly high volume. We have measured the variability in extract chemical composition and cytotoxicity towards human lung adenocarcinoma A549 cancer cells of 25 commercially available kava products. Results reveal a high level of variation in chemical content and cytotoxicity of currently available kava products. As public interest and use of kava products continues to increase in the United States, efforts to characterize products and expedite research of this potentially useful botanical medicine are necessary.	[Martin, Amanda C.; Hegeman, Adrian D.] Univ Minnesota, Dept Hort Sci, Plant Biol Sci Grad Program, Dept Plant Biol, Minneapolis, MN USA; [Martin, Amanda C.; Hegeman, Adrian D.] Univ Minnesota, Microbial & Plant Genom Inst, Minneapolis, MN 55455 USA; [Johnston, Ed] Alia Point Awa Nursery, Pepeekeo, HI USA; [Xing, Chengguo] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Xing, CG (corresponding author), Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA.	xingx009@umn.edu; hegem007@umn.edu	; Hegeman, Adrian/D-5984-2013	Martin, Amanda C./0000-0002-6958-6332; Hegeman, Adrian/0000-0003-1008-6066	National Science Foundation Plant Genome Research Program [IOS-0923960, IOS-1238812]; National Science Foundation Graduate Research Fellowship [00006595]; National Cancer Institute, National Institutes of Health [R01 CA142649]; NATIONAL CANCER INSTITUTE [R01CA193278, R01CA142649] Funding Source: NIH RePORTER	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Science Foundation Plant Genome Research Program grants IOS-0923960 and IOS-1238812 (www.nsf.gov)(ACM,ADH), the National Science Foundation Graduate Research Fellowship Program 00006595 (www.nsf.gov) (ACM), and the National Cancer Institute, National Institutes of Health grant R01 CA142649 (www.cancer.gov) (CX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anke J, 2004, J ETHNOPHARMACOL, V93, P153, DOI 10.1016/j.jep.2004.04.009; Behl M, 2011, FOOD CHEM TOXICOL, V49, P2820, DOI 10.1016/j.fct.2011.07.067; Dasgupta A., 2011, Herbal supplements: efficacy, toxicity, interactions with Western drugs, and effects on clinical laboratory tests, P155; Dinh LD, 2001, PLANTA MED, V67, P306, DOI 10.1055/s-2001-14334; Discussion paper on the development of a standard for kava products, 2012, DISC PAP DEV STAND K; Dragull K, 2003, PHYTOCHEMISTRY, V63, P193, DOI 10.1016/S0031-9422(03)00111-0; Fiji Bureau of Statistics, 2013, 2011 EXP STAT; He XG, 1997, PLANTA MED, V63, P70, DOI 10.1055/s-2006-957608; Hegeman AD, 2010, BRIEF FUNCT GENOMICS, V9, P139, DOI 10.1093/bfgp/elp053; Jhoo JW, 2006, J AGR FOOD CHEM, V54, P3157, DOI 10.1021/jf051853j; Johansen HN, 1996, J AGR FOOD CHEM, V44, P1470, DOI 10.1021/jf950482b; Johnson BM, 2003, CHEM RES TOXICOL, V16, P733, DOI 10.1021/tx020113r; Johnson TE, 2011, AM J CHINESE MED, V39, P727, DOI 10.1142/S0192415X11009202; Johnson TE, 2008, CANCER PREV RES, V1, P430, DOI 10.1158/1940-6207.CAPR-08-0027; Jokhan A., 2004, S PAC J NAT SCI, V22, P43; Lapornik B, 2005, J FOOD ENG, V71, P214, DOI 10.1016/j.jfoodeng.2004.10.036; Lebot V, 1999, ECON BOT, V53, P407, DOI 10.1007/BF02866720; Lebot V, 2014, FOOD CHEM, V151, P554, DOI 10.1016/j.foodchem.2013.11.120; Lebot V, 2004, ETHNOBOT RES APPL, V2, P19; Lebot V, 2006, HERBALGRAM, V71, P34; Leitzman P, 2014, CANCER PREV RES, V7, P86, DOI 10.1158/1940-6207.CAPR-13-0301; Meissner O, 2005, J CHROMATOGR B, V826, P46, DOI 10.1016/j.jchromb.2005.08.003; Olsen LR, 2011, CHEM RES TOXICOL, V24, P992, DOI 10.1021/tx100412m; Rogers H., 2006, HAWAIIAN AWA VIEWS E, P1; Sarris J, 2011, PLANTA MED, V77, P107, DOI 10.1055/s-0030-1250290; Shaik AA, 2009, BIOORG MED CHEM LETT, V19, P5732, DOI 10.1016/j.bmcl.2009.08.003; Shao Y, 1998, J CHROMATOGR A, V825, P1, DOI 10.1016/S0021-9673(98)00699-2; Simeoni P, 2002, BIOCHEM SYST ECOL, V30, P413, DOI 10.1016/S0305-1978(01)00093-X; SMITH RM, 1984, J CHROMATOGR, V283, P303, DOI 10.1016/S0021-9673(00)96265-4; Steiner G G, 2000, Hawaii Med J, V59, P420; Teschke R, 2003, PHYTOMEDICINE, V10, P440, DOI 10.1078/0944-7113-00314; Teschke R, 2011, AM HERB PROD ASS REP, V26, P8; Teschke R, 2011, PHYTOTHER RES, V25, P1263, DOI 10.1002/ptr.3464; Teschke R, 2011, FOOD CHEM TOXICOL, V49, P2503, DOI 10.1016/j.fct.2011.06.075; Teschke R, 2011, DIGEST LIVER DIS, V43, P676, DOI 10.1016/j.dld.2011.01.018; Teschke R, 2011, BRIT J CLIN PHARMACO, V71, P445, DOI 10.1111/j.1365-2125.2010.03775.x; Teschke R, 2011, PHYTOMEDICINE, V18, P96, DOI 10.1016/j.phymed.2010.10.002; Teschke R, 2009, J ETHNOPHARMACOL, V123, P378, DOI 10.1016/j.jep.2009.03.038; Tonga Statistics Department, 2008, KING TONG ANN FOR TR; U.S. Food and Drug Administration, 2002, US FDA PUBL; Vanuatu National Statistics Office, 2013, STAT UPD OV TRAD; Warmka JK, 2012, BIOCHEM BIOPH RES CO, V424, P488, DOI 10.1016/j.bbrc.2012.06.140; Whitton PA, 2003, PHYTOCHEMISTRY, V64, P673, DOI 10.1016/S0031-9422(03)00381-9; Yang X, 2011, PHYTOMEDICINE, V18, P592, DOI 10.1016/j.phymed.2011.02.006; Zhang LY, 2011, PHYTOTHER RES, V25, P629, DOI 10.1002/ptr.3301; Zhou P, 2010, FASEB J, V24, P4722, DOI 10.1096/fj.10-163311; Zi XL, 2005, CANCER RES, V65, P3479, DOI 10.1158/0008-5472.CAN-04-3803; Zou L, 2004, PHYTOMEDICINE, V11, P285, DOI 10.1078/0944711041495263	48	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111572	10.1371/journal.pone.0111572	http://dx.doi.org/10.1371/journal.pone.0111572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365244	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100078
J	Wang, Y; Wang, SM; Xu, SG; Qu, JQ; Liu, B				Wang, Ying; Wang, Shumin; Xu, Shiguang; Qu, Jiaqi; Liu, Bo			Clinicopathologic Features of Patients with Non-Small Cell Lung Cancer Harboring the EML4-ALK Fusion Gene: A Meta-Analysis	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CIGARETTE-SMOKING; ALK; REARRANGEMENT; MUTATIONS; WOMEN; EGFR	Background: The frequencies of EML4-ALK fusion gene in non-small cell lung cancer (NSCLC) with different clinicopathologic features described by previous studies are inconsistent. The key demographic and pathologic features associated with EML4-ALK fusion gene have not been definitively established. This meta-analysis was conducted to compare the frequency of the EML4-ALK fusion gene in patients with different clinicopathologic features and to identify an enriched population of patients with NSCLC harboring EML4-ALK fusion gene. Methods: The Pubmed and Embase databases for all studies on EML4-ALK fusion gene in NSCLC patients were searched up to July 2014. A criteria list and exclusion criteria were established to screen the studies. The frequency of the EML4-ALK fusion gene and the clinicopathologic features, including smoking status, pathologic type, gender, and EGFR status were abstracted. Results: Seventeen articles consisting of 4511 NSCLC cases were included in this meta-analysis. A significant lower EML4-ALK fusion gene positive rate was associated with smokers (pooled OR = 0.40, 95% CI = 0.30-0.54, P<0.00001). A significantly higher EML4-ALK fusion gene positivity rate was associated with adenocarcinomas (pooled OR = 2.53, 95% CI = 1.66-3.86, P<0.0001) and female (pooled OR = 0.61, 95% CI = 0.41-0.90, P = 0.01). We found that a significantly lower EML4-ALK fusion gene positivity rate was associated with EGFR mutation (pooled OR = 0.07, 95% CI = 0.03-0.19, P<0.00001). No publication bias was observed in any meta-analysis (all P value of Egger's test >0.05); however, because of the small sample size, no results were in the meta-analysis regarding EGFR gene status. Conclusion: This meta-analysis revealed that the EML4-ALK fusion gene is highly correlated with a never/light smoking history, female and the pathologic type of adenocarcinoma, and is largely mutually exclusive of EGFR.	[Wang, Ying] Shenyang Med Coll, Dept Pathol, Shenyang, Liaoning, Peoples R China; [Wang, Shumin; Xu, Shiguang; Qu, Jiaqi; Liu, Bo] Gen Hosp, Shenyang Mil Area Command, Thorac Dept, Shenyang, Liaoning, Peoples R China	Shenyang Medical College	Liu, B (corresponding author), Gen Hosp, Shenyang Mil Area Command, Thorac Dept, Shenyang, Liaoning, Peoples R China.	dr_liubo@126.com			Liaoning Science and Technology Project [2007408001-8, 2012225019]; Natural Science Foundation of Liaoning Province [20061030]	Liaoning Science and Technology Project; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This study was funded by Liaoning Science and Technology Project (grant No. 2007408001-8, 2012225019) and Natural Science Foundation of Liaoning Province (No. 20061030). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Dietz PM, 2011, AM J EPIDEMIOL, V173, P355, DOI 10.1093/aje/kwq381; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Kobayashi M, 2014, RESPIR INVESTIG, V52, P49, DOI 10.1016/j.resinv.2013.06.003; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; LI Y, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0077864; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; R Core Team, 2021, R LANGUAGE ENV STAT; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shinmura K, 2008, LUNG CANCER, V61, P163, DOI 10.1016/j.lungcan.2007.12.013; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Takeda M, 2012, ANN ONCOL, V23, P2931, DOI 10.1093/annonc/mds124; Tsai YW, 2008, J WOMENS HEALTH, V17, P971, DOI 10.1089/jwh.2007.0621; Tufman ALH, 2014, J THORAC ONCOL, V9, P109, DOI 10.1097/JTO.0000000000000043; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101551; Wang ZJ, 2012, ONCOLOGY-BASEL, V83, P248, DOI 10.1159/000341381; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064821; Zhong Shan, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P252, DOI 10.3760/cma.j.issn.0529-5807.2013.04.009; Zhou JX, 2013, ANN ONCOL, V24, P1319, DOI 10.1093/annonc/mds626; Zhou SZ, 2012, GENE CHROMOSOME CANC, V51, P925, DOI 10.1002/gcc.21976; Zimmermann S, 2012, ANN ONCOL, V23, P197, DOI 10.1093/annonc/mds319	31	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110617	10.1371/journal.pone.0110617	http://dx.doi.org/10.1371/journal.pone.0110617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360721	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700039
J	Costabile, A; Santarelli, S; Claus, SP; Sanderson, J; Hudspith, BN; Brostoff, J; Ward, JL; Lovegrove, A; Shewry, PR; Jones, HE; Whitley, AM; Gibson, GR				Costabile, Adele; Santarelli, Sara; Claus, Sandrine P.; Sanderson, Jeremy; Hudspith, Barry N.; Brostoff, Jonathan; Ward, Jane L.; Lovegrove, Alison; Shewry, Peter R.; Jones, Hannah E.; Whitley, Andrew M.; Gibson, Glenn R.			Effect of Breadmaking Process on In Vitro Gut Microbiota Parameters in Irritable Bowel Syndrome	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GASTROINTESTINAL MICROBIOTA; OLIGONUCLEOTIDE PROBES; INTESTINAL MICROBIOTA; BACTERIAL-POPULATIONS; SITU HYBRIDIZATION; PROBIOTICS; SYMPTOMS; FIBER; FERMENTATION	A variety of foods have been implicated in symptoms of patients with Irritable Bowel Syndrome (IBS) but wheat products are most frequently cited by patients as a trigger. Our aim was to investigate the effects of breads, which were fermented for different lengths of time, on the colonic microbiota using in vitro batch culture experiments. A set of in vitro anaerobic culture systems were run over a period of 24 h using faeces from 3 different IBS donors (Rome Criteria-mainly constipated) and 3 healthy donors. Changes in gut microbiota during a time course were identified by fluorescence in situ hybridisation (FISH), whilst the small -molecular weight metabolomic profile was determined by NMR analysis. Gas production was separately investigated in non pH-controlled, 36 h batch culture experiments. Numbers of bifidobacteria were higher in healthy subjects compared to IBS donors. In addition, the healthy donors showed a significant increase in bifidobacteria (P<0.005) after 8 h of fermentation of a bread produced using a sourdough process (type C) compared to breads produced with commercial yeasted dough (type B) and no time fermentation (Chorleywood Breadmaking process) (type A). A significant decrease of delta-Proteobacteria and most Gemmatimonadetes species was observed after 24 h fermentation of type C bread in both IBS and healthy donors. In general, IBS donors showed higher rates of gas production compared to healthy donors. Rates of gas production for type A and conventional long fermentation (type B) breads were almost identical in IBS and healthy donors. Sourdough bread produced significantly lower cumulative gas after 15 h fermentation as compared to type A and B breads in IBS donors but not in the healthy controls. In conclusion, breads fermented by the traditional long fermentation and sourdough are less likely to lead to IBS symptoms compared to bread made using the Chorleywood Breadmaking Process.	[Costabile, Adele; Santarelli, Sara; Claus, Sandrine P.; Gibson, Glenn R.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Sanderson, Jeremy; Hudspith, Barry N.; Brostoff, Jonathan] Kings Coll London, Dept Nutr & Dietet, London, England; [Ward, Jane L.; Lovegrove, Alison; Shewry, Peter R.] Rothamsted Res, Harpenden, Herts, England; [Shewry, Peter R.] Sch Agr Policy & Dev, Reading, Berks, England; [Whitley, Andrew M.] Bread Matters Ltd, West Linton, Peeblesshire, Scotland	University of Reading; University of London; King's College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Reading	Costabile, A (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.	a.costabile@reading.ac.uk		Costabile, Adele/0000-0003-3185-030X; Claus, Sandrine/0000-0002-3789-9780	Biotechnology and Biological Sciences of the UK; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004976, BBS/E/C/00005206] Funding Source: researchfish; BBSRC [BBS/E/C/00005206, BBS/E/C/00004976] Funding Source: UKRI	Biotechnology and Biological Sciences of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Miss Meline Bes and Dr Delia-Irina Corol for excellent technical assistance. Rothamsted Research receives strategic funding from the Biotechnology and Biological Sciences of the UK.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baker JM, 2006, PLANT BIOTECHNOL J, V4, P381, DOI 10.1111/j.1467-7652.2006.00197.x; Bijkerk CJ, 2004, ALIMENT PHARM THER, V19, P245, DOI 10.1111/j.0269-2813.2004.01862.x; Brenner DM, 2009, AM J GASTROENTEROL, V104, P1033, DOI 10.1038/ajg.2009.25; Camilleri M, 2008, J CLIN GASTROENTEROL, V42, pS123, DOI 10.1097/MCG.0b013e3181574393; Clarke G, 2012, ALIMENT PHARM THER, V35, P403, DOI 10.1111/j.1365-2036.2011.04965.x; De Angelis M, 2007, BRIT J NUTR, V98, P1196, DOI 10.1017/S0007114507772689; DICAGNO R, 2008, J FOOD PROTECT, V71, P113; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Fan TWM, 2008, PROG NUCL MAG RES SP, V52, P69, DOI 10.1016/j.pnmrs.2007.03.002; Ford AC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2313; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Ghoshal UC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/151085; Ghoshal UC, 2010, J GASTROEN HEPATOL, V25, P244, DOI 10.1111/j.1440-1746.2009.06133.x; Gibson PR, 2010, J GASTROEN HEPATOL, V25, P252, DOI 10.1111/j.1440-1746.2009.06149.x; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Hong YS, 2011, J CLIN GASTROENTEROL, V45, P415, DOI 10.1097/MCG.0b013e318207f76c; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Hunter J. O., 1985, TOPICS GASTROENTEROL, V12, P305; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Katina K, 2005, TRENDS FOOD SCI TECH, V16, P104, DOI 10.1016/j.tifs.2004.03.008; Koide A, 2000, AM J GASTROENTEROL, V95, P1735; Kopecny J, 2002, ACTA VET BRNO, V71, P421, DOI 10.2754/avb200271040421; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001; Lee BJ, 2011, J NEUROGASTROENTEROL, V17, P252, DOI 10.5056/jnm.2011.17.3.252; Lee KJ, 2010, NEUROGASTROENT MOTIL, V22, P493, DOI 10.1111/j.1365-2982.2010.01482.x; Lucker S, 2007, J MICROBIOL METH, V69, P523, DOI 10.1016/j.mimet.2007.02.009; Lyra A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-110; Maccaferri S, 2012, MOL NUTR FOOD RES, V56, P1342, DOI 10.1002/mnfr.201200046; Malinen E, 2010, WORLD J GASTROENTERO, V16, P4532, DOI 10.3748/wjg.v16.i36.4532; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; MORTENSEN PB, 1987, SCAND J GASTROENTERO, V22, P185, DOI 10.3109/00365528708991878; Parkes GC, 2008, AM J GASTROENTEROL, V103, P1557, DOI 10.1111/j.1572-0241.2008.01869.x; Ponnusamy K, 2011, J MED MICROBIOL, V60, P817, DOI 10.1099/jmm.0.028126-0; Santelmann H, 2005, EUR J GASTROEN HEPAT, V17, P21, DOI 10.1097/00042737-200501000-00005; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Simren M, 2006, GUT, V55, P297, DOI 10.1136/gut.2005.075127; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Staudacher HM, 2011, J HUM NUTR DIET, V24, P487, DOI 10.1111/j.1365-277X.2011.01162.x; STEFANINI GF, 1995, SCAND J GASTROENTERO, V30, P535, DOI 10.3109/00365529509089786; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Thompson WG, 1999, GUT, V45, P43; Treem WR, 1996, J PEDIATR GASTR NUTR, V23, P280, DOI 10.1097/00005176-199610000-00013; Valeur J, 2010, NEUROGASTROENTEROLY, DOI [10.1111/j.1365-2982.2010.01558.x, DOI 10.1111/J.1365-2982.2010.01558.X]; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005	47	33	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111225	10.1371/journal.pone.0111225	http://dx.doi.org/10.1371/journal.pone.0111225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356771	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000346765000046
J	Gandolfi, B; Daniel, RJ; O'Brien, DP; Guo, LT; Youngs, MD; Leach, SB; Jones, BR; Shelton, GD; Lyons, LA				Gandolfi, Barbara; Daniel, Rob J.; O'Brien, Dennis P.; Guo, Ling T.; Youngs, Melanie D.; Leach, Stacey B.; Jones, Boyd R.; Shelton, G. Diane; Lyons, Leslie A.			A Novel Mutation in CLCN1 Associated with Feline Myotonia Congenita	PLOS ONE			English	Article							MUSCLE CHLORIDE CHANNEL; REPETITIVE NERVE-STIMULATION; MOLECULAR-BASIS; HEREDITARY MYOTONIA; MISSENSE MUTATION; SPLICE SITES; GENE; DOMINANT; INACTIVATION; DECREMENT	Myotonia congenita (MC) is a skeletal muscle channelopathy characterized by inability of the muscle to relax following voluntary contraction. Worldwide population prevalence in humans is 1:100,000. Studies in mice, dogs, humans and goats confirmed myotonia associated with functional defects in chloride channels and mutations in a skeletal muscle chloride channel (CLCN1). CLCN1 encodes for the most abundant chloride channel in the skeletal muscle cell membrane. Five random bred cats from Winnipeg, Canada with MC were examined. All cats had a protruding tongue, limited range of jaw motion and drooling with prominent neck and proximal limb musculature. All cats had blepharospasm upon palpebral reflex testing and a short-strided gait. Electromyograms demonstrated myotonic discharges at a mean frequency of 300 Hz resembling the sound of a 'swarm of bees'. Muscle histopathology showed hypertrophy of all fiber types. Direct sequencing of CLCN1 revealed a mutation disrupting a donor splice site downstream of exon 16 in only the affected cats. In vitro translation of the mutated protein predicted a premature truncation and partial lack of the highly conserved CBS1 (cystathionine beta-synthase) domain critical for ion transport activity and one dimerization domain pivotal in channel formation. Genetic screening of the Winnipeg random bred population of the cats' origin identified carriers of the mutation. A genetic test for population screening is now available and carrier cats from the feral population can be identified.	[Gandolfi, Barbara; Daniel, Rob J.; O'Brien, Dennis P.; Leach, Stacey B.; Lyons, Leslie A.] Univ Missouri, Sch Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Guo, Ling T.; Shelton, G. Diane] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Youngs, Melanie D.] Winnipeg Humane Soc, Winnipeg, MB, Canada; [Jones, Boyd R.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	University of Missouri System; University of Missouri Columbia; University of California System; University of California San Diego; Massey University	Gandolfi, B (corresponding author), Univ Missouri, Sch Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.	gandolfib@missouri.edu		Lyons, Leslie/0000-0002-1628-7726	National Center for Research Resources [R24 RR016094]; Office of Research Infrastructure Programs/OD [R24OD010928]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from the National Center for Research Resources R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs/OD R24OD010928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RH, 1974, J PHYSIOL-LONDON, V240, P505, DOI 10.1113/jphysiol.1974.sp010620; AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; AMINOFF MJ, 1977, NEUROLOGY, V27, P812, DOI 10.1212/WNL.27.9.812; Beck CL, 1996, P NATL ACAD SCI USA, V93, P11248, DOI 10.1073/pnas.93.20.11248; Bernard G, 2008, J CHILD NEUROL, V23, P163, DOI 10.1177/0883073807307974; Borges AS, 2013, NEUROMUSCULAR DISORD, V23, P206, DOI 10.1016/j.nmd.2012.11.008; BRAUND KG, 1995, AM J VET RES, V56, P349; Brown GL, 1939, BRAIN, V62, P341, DOI 10.1093/brain/62.4.341; Bryant S H, 1979, Ann N Y Acad Sci, V317, P314, DOI 10.1111/j.1749-6632.1979.tb56540.x; Colding-Jorgensen E, 2005, MUSCLE NERVE, V32, P19, DOI 10.1002/mus.20295; Colding-Jorgensen E, 2003, MUSCLE NERVE, V27, P449, DOI 10.1002/mus.10347; De Lahunta A., 2015, VET NEUROANATOMY CLI, P214; Deymeer F, 1998, MUSCLE NERVE, V21, P1334, DOI 10.1002/(SICI)1097-4598(199810)21:10<1334::AID-MUS16>3.0.CO;2-1; Donahue CP, 2006, J BIOL CHEM, V281, P23302, DOI 10.1074/jbc.C600143200; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Duno M, 2004, EUR J HUM GENET, V12, P738, DOI 10.1038/sj.ejhg.5201218; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ENGEL WK, 1966, ANN NY ACAD SCI, V138, P160; FARROW BRH, 1981, J SMALL ANIM PRACT, V22, P451, DOI 10.1111/j.1748-5827.1981.tb00629.x; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fournier E, 2004, ANN NEUROL, V56, P650, DOI 10.1002/ana.20241; Fournier E, 2006, ANN NEUROL, V60, P356, DOI 10.1002/ana.20905; Gandolfi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053173; Gaschen F, 2004, J FELINE MED SURG, V6, P355, DOI 10.1016/j.jfms.2004.02.003; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; Hickford FH, 1998, J SMALL ANIM PRACT, V39, P281, DOI 10.1111/j.1748-5827.1998.tb03651.x; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jin YF, 2011, RNA BIOL, V8, P450, DOI 10.4161/rna.8.3.15388; Kimura J, 2013, ELECTRODIAGNOSIS DIS, V4th; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KORTZ G, 1989, SEMIN VET MED SURG, V4, P141; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; Lossin C, 2008, ADV GENETICS; Malik R, 2008, J SMALL ANIM PRACTIC, V30, P20; McKay OM, 2006, CLIN NEUROPHYSIOL, V117, P2064, DOI 10.1016/j.clinph.2006.05.014; MEYERKLEINE C, 1995, AM J HUM GENET, V57, P1325; Michel P, 2007, MUSCLE NERVE, V36, P643, DOI 10.1002/mus.20856; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; MITCHELL MM, 1978, ANESTHESIOLOGY, V49, P44, DOI 10.1097/00000542-197807000-00014; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Rhodes TH, 1999, FEBS LETT, V456, P54, DOI 10.1016/S0014-5793(99)00926-6; Richardson RC, 2014, MUSCLE NERVE, V49, P593, DOI 10.1002/mus.23976; Roca X, 2012, GENE DEV, V26, P1098, DOI 10.1101/gad.190173.112; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; Sims M. H., 1990, Progress in Veterinary Neurology, V1, P311; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; STEINBERG S, 1962, SCIENCE, V137, P979, DOI 10.1126/science.137.3534.979; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Sun C, 2001, EUR J HUM GENET, V9, P903, DOI 10.1038/sj.ejhg.5200736; Tang CY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/685328; Toll J, 1998, J SMALL ANIM PRACT, V39, P499, DOI 10.1111/j.1748-5827.1998.tb03690.x; Toll J, 1998, J VET INTERN MED, V12, P116, DOI 10.1111/j.1939-1676.1998.tb02105.x; Treisman R, 1983, Prog Clin Biol Res, V134, P99; Vite CH, 1999, J HERED, V90, P578, DOI 10.1093/jhered/90.5.578; Wentink G H, 1974, Tijdschr Diergeneeskd, V99, P729; White GR, 1904, AM VET REV, V28, P556; WIERINGA B, 1983, NATURE, V301, P38, DOI 10.1038/301038a0; Wijnberg ID, 2012, NEUROMUSCULAR DISORD, V22, P361, DOI 10.1016/j.nmd.2011.10.001	62	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109926	10.1371/journal.pone.0109926	http://dx.doi.org/10.1371/journal.pone.0109926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356766	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000010
J	Kim, KN; Kim, JH; Kwon, HJ; Hong, SJ; Kim, BJ; Lee, SY; Hong, YC; Bae, S				Kim, Kyoung-Nam; Kim, Jin Hee; Kwon, Ho-Jang; Hong, Soo-Jong; Kim, Byoung-Ju; Lee, So-Yeon; Hong, Yun-Chul; Bae, Sanghyuk			Bisphenol A Exposure and Asthma Development in School-Age Children: A Longitudinal Study	PLOS ONE			English	Article							CHILDHOOD ASTHMA; OXIDATIVE STRESS; URINARY CONCENTRATIONS; AIRWAY RESPONSIVENESS; CYTOKINE PRODUCTION; GENDER-DIFFERENCES; FETAL EXPOSURE; RISK; METHACHOLINE; PREVALENCE	Background: Although the effect of bisphenol A on various health outcomes has been extensively examined, few studies have investigated its effect on asthma. Objective: We hypothesized that exposure to bisphenol A in school-age children was associated with wheezing and asthma. Methods: Participants included 127 children aged 7-8 years without a previous asthma diagnosis in an elementary school in Seoul, Korea. Three surveys were conducted, each 2 years apart. Bisphenol A concentration was measured at the baseline survey, and PC20, which is defined as the methacholine concentration that induces a decrease in FEV1 of 20% from baseline, was measured at every survey. Associations between bisphenol A concentration at 7-8 years of age and wheezing, asthma, and PC20 at ages up to 11-12 years were examined using generalized estimating equations, a marginal Cox regression model, and a linear mixed model. Results: The log-transformed creatinine-adjusted urinary bisphenol A concentration at 7-8 years was positively associated with wheezing (odds ratio, 2.48; 95% confidence interval, 1.15-5.31; P =.02) and asthma (hazard ratio, 2.13; 95% confidence interval, 1.51-3.00; P <.001) at ages up to 11-12 years. Bisphenol A was also negatively associated with PC20 (beta = 22.33; P =.02). When stratified by sex, the association between bisphenol A and asthma remained significant only in girls (hazard ratio, 2.45; 95% confidence interval, 2.18-2.76; P <.001). Conclusion: Increased urinary bisphenol A concentrations at 7-8 years old were positively associated with wheezing and asthma and negatively associated with PC20 at ages up to 11-12 years.	[Kim, Kyoung-Nam; Hong, Yun-Chul; Bae, Sanghyuk] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Jin Hee; Hong, Yun-Chul] Inst Environm Med, Med Res Ctr, Seoul, South Korea; [Kwon, Ho-Jang] Dankook Univ, Coll Med, Dept Prevent Med & Publ Hlth, Cheonan, South Korea; [Hong, Soo-Jong] Univ Ulsan, Coll Med, Asan Med Ctr,Dept Pediat, Childhood Asthma Atopy Ctr,Res Ctr Standardizat A, Seoul, South Korea; [Kim, Byoung-Ju] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Pediat, Pusan, South Korea; [Lee, So-Yeon] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Pediat, Anyang, South Korea	Seoul National University (SNU); Dankook University; University of Ulsan; Asan Medical Center; Inje University; Hallym University	Bae, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	sanghyukbae@snu.ac.kr	Hong, Yun-Chul/J-5725-2012; Hong, Soo-Jong/AAR-1788-2020; Bae, Sanghyuk/AAQ-6635-2020	Hong, Soo-Jong/0000-0003-1409-2113; Bae, Sanghyuk/0000-0002-4995-6543; KIM, JIN HEE/0000-0003-1204-7079; Kim, Byoung-Ju/0000-0003-0271-9417	Korean Ministry of Environment	Korean Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This research was funded by the Korean Ministry of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS JGJV, 1994, EUR RESPIR J, V7, P895; Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Alves MFA, 2006, INT J ENVIRON HEAL R, V16, P255, DOI 10.1080/09603120600734147; Anjum S, 2011, FOOD CHEM TOXICOL, V49, P2849, DOI 10.1016/j.fct.2011.07.062; Bae S, 2012, HYPERTENSION, V60, P786, DOI 10.1161/HYPERTENSIONAHA.112.197715; Barr RG, 2004, ARCH INTERN MED, V164, P379, DOI 10.1001/archinte.164.4.379; Bauer SM, 2012, TOXICOL SCI, V130, P82, DOI 10.1093/toxsci/kfs227; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Bonds RS, 2013, CURR OPIN ALLERGY CL, V13, P92, DOI 10.1097/ACI.0b013e32835a6dd6; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Bushnik T, 2010, HEALTH REP, V21; Cai YP, 2012, INT ARCH ALLERGY IMM, V158, P252, DOI 10.1159/000331437; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-62; Cao XL, 2010, J FOOD PROTECT, V73, P1085, DOI 10.4315/0362-028X-73.6.1085; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Christensen KLY, 2012, ENVIRON INT, V50, P7, DOI 10.1016/j.envint.2012.09.002; Clark NM, 2010, CLIN PEDIATR, V49, P931, DOI 10.1177/0009922809357339; COCKCROFT DW, 1983, THORAX, V38, P55, DOI 10.1136/thx.38.1.55; D'Cruz SC, 2012, REPROD SCI, V19, P163, DOI 10.1177/1933719111415547; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-31; Ezz HSA, 2015, CYTOTECHNOLOGY, V67, P145, DOI 10.1007/s10616-013-9672-1; Fu Liang, 2014, Ann Am Thorac Soc, V11, P939, DOI 10.1513/AnnalsATS.201402-084OC; Gardner RM, 2010, TOXICOL LETT, V198, P182, DOI 10.1016/j.toxlet.2010.06.015; Gerstenberger SL, 2010, ENVIRON TOXICOL CHEM, V29, P237, DOI 10.1002/etc.32; Hansen TE, 2013, ACTA PAEDIATR, V102, P47, DOI 10.1111/apa.12030; Hassan ZK, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/194829; Hong SB, 2013, J CHILD PSYCHOL PSYC, V54, P890, DOI 10.1111/jcpp.12050; Hong Soyoung, 2012, Environ Health Toxicol, V27, pe2012006, DOI 10.5620/eht.2012.27.e2012006; Jayet PY, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-131; Jing H, 2012, ANAT HISTOL EMBRYOL, V41, P170, DOI 10.1111/j.1439-0264.2011.01120.x; Koh YY, 2002, CLIN EXP ALLERGY, V32, P921, DOI 10.1046/j.1365-2222.2002.01399.x; Kwak Eun Soo, 2009, Open Allergy J, V2, P45; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lee MR, 2014, J EPIDEMIOL COMMUN H, V68, P312, DOI 10.1136/jech-2013-202548; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Lee SI, 2010, ALLERGY ASTHMA IMMUN, V2, P61, DOI 10.4168/aair.2010.2.2.61; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li DK, 2010, J ANDROL, V31, P500, DOI 10.2164/jandrol.110.010413; Macsali F, 2011, AM J RESP CRIT CARE, V183, P8, DOI 10.1164/rccm.200912-1886OC; Marcon A, 2014, J ALLERGY CLIN IMMUN, V133, P104, DOI 10.1016/j.jaci.2013.03.040; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Melzer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043378; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Nakajima Y, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-8; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Nyland JF, 2011, ENVIRON HEALTH PERSP, V119, P1733, DOI 10.1289/ehp.1103741; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Protudjer JLP, 2014, ANN ALLERG ASTHMA IM, V112, P78, DOI 10.1016/j.anai.2013.10.015; Sakai T, 2010, J NUTR SCI VITAMINOL, V56, P72, DOI 10.3177/jnsv.56.72; Sawai C, 2003, ENVIRON HEALTH PERSP, V111, P1883, DOI 10.1289/ehp.6359; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Song SZ, 2014, INT J ENV RES PUB HE, V11, P3728, DOI 10.3390/ijerph110403728; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Sugiura-Ogasawara M, 2005, HUM REPROD, V20, P2325, DOI 10.1093/humrep/deh888; Sumino K, 2012, J ALLERGY CLIN IMMUN, V130, P69, DOI 10.1016/j.jaci.2012.02.025; Sutherland ER, 2010, J ALLERGY CLIN IMMUN, V126, P747, DOI 10.1016/j.jaci.2010.07.024; Tantisira KG, 2008, AM J RESP CRIT CARE, V178, P325, DOI 10.1164/rccm.200708-1174OC; Tian XL, 2003, INT ARCH ALLERGY IMM, V132, P240, DOI 10.1159/000074305; Tiwari D, 2012, MUTAT RES-GEN TOX EN, V743, P83, DOI 10.1016/j.mrgentox.2011.12.023; van Schayck OCP, 2013, PRIM CARE RESP J, V22, P239, DOI 10.4104/pcrj.2013.00052; Van Winkle LS, 2013, ENVIRON HEALTH PERSP, V121, P912, DOI 10.1289/ehp.1206064; Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022; Vink NM, 2010, J ALLERGY CLIN IMMUN, V126, P498, DOI 10.1016/j.jaci.2010.06.018; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Vollmer WM, 1998, AM J RESP CRIT CARE, V157, P1079, DOI 10.1164/ajrccm.157.4.9704140; Vrijheid M, 2014, ENVIRON HEALTH PERSP, V122, P535, DOI 10.1289/ehp.1307204; Weiss ST, 2000, AM J RESP CRIT CARE, V162, P50, DOI 10.1164/ajrccm.162.1.9811005; Wilson NK, 2007, ENVIRON RES, V103, P9, DOI 10.1016/j.envres.2006.04.006; Wolff MS, 2008, ENVIRON RES, V107, P393, DOI 10.1016/j.envres.2008.03.006; Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690; Wong GWK, 2008, PEDIATR PULM, V43, P107, DOI 10.1002/ppul.20755; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030	86	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111383	10.1371/journal.pone.0111383	http://dx.doi.org/10.1371/journal.pone.0111383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356742	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000057
J	Devlin, HC; Zaki, J; Ong, DC; Gruber, J				Devlin, Hillary C.; Zaki, Jamil; Ong, Desmond C.; Gruber, June			Not As Good as You Think? Trait Positive Emotion Is Associated with Increased Self-Reported Empathy but Decreased Empathic Performance	PLOS ONE			English	Article							SOCIAL COGNITION; MOOD; HAPPINESS; STATES; NEUROSCIENCE; DIMENSIONS; EXPERIENCE; HAPPY	How is positive emotion associated with our ability to empathize with others? Extant research provides support for two competing predictions about this question. An empathy amplification hypothesis suggests positive emotion would be associated with greater empathy, as it often enhances other prosocial processes. A contrasting empathy attenuation hypothesis suggests positive emotion would be associated with lower empathy, because positive emotion promotes self-focused or antisocial behaviors. The present investigation tested these competing perspectives by examining associations between dispositional positive emotion and both subjective (i.e., self-report) and objective (i.e., task performance) measures of empathy. Findings revealed that although trait positive emotion was associated with increased subjective beliefs about empathic tendencies, it was associated with both increases and decreases in task-based empathic performance depending on the target's emotional state. More specifically, trait positive emotion was linked to lower overall empathic accuracy toward a high-intensity negative target, but also a higher sensitivity to emotion upshifts (i.e., shifts in emotion from negative to positive) toward positive targets. This suggests that trait positive affect may be associated with decreased objective empathy in the context of mood incongruent (i.e., negative) emotional stimuli, but may increase some aspects of empathic performance in the context of mood congruent (i.e., positive) stimuli. Taken together, these findings suggest that trait positive emotion engenders a compelling subjective-objective gap regarding its association with empathy, in being related to a heightened perception of empathic tendencies, despite being linked to mixed abilities in regards to empathic performance. (Word count: 242).	[Devlin, Hillary C.; Gruber, June] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Zaki, Jamil; Ong, Desmond C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Gruber, June] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Yale University; Stanford University; University of Colorado System; University of Colorado Boulder	Gruber, J (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	june.gruber@colorado.edu		Ong, Desmond/0000-0002-6781-8072				Algoe SB, 2010, PERS RELATIONSHIP, V17, P217, DOI 10.1111/j.1475-6811.2010.01273.x; Ames DR, 2004, J NONVERBAL BEHAV, V28, P187, DOI 10.1023/B:JONB.0000039649.20015.0e; Ayduk O, 2002, PSYCHOL SCI, V13, P443, DOI 10.1111/1467-9280.00478; Berry DS, 1996, J PERS SOC PSYCHOL, V71, P796, DOI 10.1037/0022-3514.71.4.796; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Converse BA, 2008, EMOTION, V8, P725, DOI 10.1037/a0013283; Cusi A, 2010, PSYCHIAT RES, V178, P354, DOI 10.1016/j.psychres.2009.07.009; DAVIS MH, 1987, J PERS SOC PSYCHOL, V53, P397, DOI 10.1037/0022-3514.53.2.397; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Duan CM, 2002, PSYCHOTHER RES, V12, P23, DOI 10.1080/713869615; Dunning D, 2003, CURR DIR PSYCHOL SCI, V12, P83, DOI 10.1111/1467-8721.01235; Dutra SJ, 2014, MOTIV EMOTION, V38, P157, DOI 10.1007/s11031-013-9363-4; EISENBERG N, 1994, J PERS SOC PSYCHOL, V66, P776, DOI 10.1037/0022-3514.66.4.776; Eisenberg N., 2009, PROSOCIAL MOTIVES EM, P129; Epley N, 2008, SOC PERSONAL PSYCHOL, V2, P1455, DOI 10.1111/j.1751-9004.2008.00115.x; Fisher RA, 1914, BIOMETRIKA, V10, P507; Forgas, 1991, EMOTION SOCIAL JUDGM, P31; Forgas JP, 2008, J EXP SOC PSYCHOL, V44, P1362, DOI 10.1016/j.jesp.2008.04.010; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Fredrickson BL, 1998, REV GEN PSYCHOL, V2, P300, DOI DOI 10.1037/1089-2680.2.3.300; Gonzaga GC, 2001, J PERS SOC PSYCHOL, V81, P247, DOI 10.1037//0022-3514.81.2.247; Gruber J, 2011, CURR DIR PSYCHOL SCI, V20, P217, DOI 10.1177/0963721411414632; Gruber J, 2011, PERSPECT PSYCHOL SCI, V6, P222, DOI 10.1177/1745691611406927; Gruber J, 2009, BEHAV RES THER, V47, P697, DOI 10.1016/j.brat.2009.05.005; Gruhn D, 2008, EMOTION, V8, P753, DOI 10.1037/a0014123; Halberstadt JB, 1997, J PERS SOC PSYCHOL, V72, P1017, DOI 10.1037/0022-3514.72.5.1017; Hawk ST, 2011, EMOTION, V11, P502, DOI 10.1037/a0022762; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; ICKES W, 1993, J PERS, V61, P587, DOI 10.1111/j.1467-6494.1993.tb00783.x; ISEN AM, 1976, J PERS SOC PSYCHOL, V34, P385, DOI 10.1037/0022-3514.34.3.385; Kang Y, 2013, EMOTION, V13, P290, DOI 10.1037/a0030780; Keltner D, 2006, EVOLUTION SOCIAL PSY, P115; Kross E, 2005, PSYCHOL SCI, V16, P709, DOI 10.1111/j.1467-9280.2005.01600.x; Lembke A, 2002, AM J PSYCHIAT, V159, P302, DOI 10.1176/appi.ajp.159.2.302; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V63, P234, DOI 10.1037/0022-3514.63.2.234; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MEHRABIAN A, 1980, J PERS SOC PSYCHOL, V38, P492, DOI 10.1037/0022-3514.38.3.492; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Park J, 2000, J PERS SOC PSYCHOL, V78, P1005, DOI 10.1037//0022-3514.78.6.1005; PAULHUS DL, 1991, J PERS SOC PSYCHOL, V60, P307, DOI 10.1037/0022-3514.60.2.307; Piff PK, 2012, COGNITION EMOTION, V26, P1116, DOI 10.1080/02699931.2011.633987; Rameson LT, 2009, SOC PERSONAL PSYCHOL, V3, P94, DOI 10.1111/j.1751-9004.2008.00154.x; Realo A, 2003, J RES PERS, V37, P420, DOI 10.1016/S0092-6566(03)00021-7; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shiota MN, 2004, REGULATION OF EMOTION, P127; Tan HB, 2010, J EXP SOC PSYCHOL, V46, P571, DOI 10.1016/j.jesp.2010.01.007; Vincent LC, 2013, PSYCHOL SCI, V24, P595, DOI 10.1177/0956797612458806; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; WEGENER DT, 1994, J PERS SOC PSYCHOL, V66, P1034, DOI 10.1037/0022-3514.66.6.1034; Zaki J, 2008, PSYCHOL SCI, V19, P399, DOI 10.1111/j.1467-9280.2008.02099.x; Zaki J, 2013, PERSPECT PSYCHOL SCI, V8, P296, DOI 10.1177/1745691613475454; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085; Zaki J, 2011, PSYCHOL INQ, V22, P159, DOI 10.1080/1047840X.2011.551743	55	35	35	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110470	10.1371/journal.pone.0110470	http://dx.doi.org/10.1371/journal.pone.0110470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353635	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200027
J	Gilbert, M; Miquelle, DG; Goodrich, JM; Reeve, R; Cleaveland, S; Matthews, L; Joly, DO				Gilbert, Martin; Miquelle, Dale G.; Goodrich, John M.; Reeve, Richard; Cleaveland, Sarah; Matthews, Louise; Joly, Damien O.			Estimating the Potential Impact of Canine Distemper Virus on the Amur Tiger Population (Panthera tigris altaica) in Russia	PLOS ONE			English	Article							FAR-EAST; VIABILITY ANALYSIS; SIBERIAN TIGER; LIONS; CARNIVORES; INFECTION; EPIDEMIC; PERSISTENCE; PREVALENCE; DISEASE	Lethal infections with canine distemper virus (CDV) have recently been diagnosed in Amur tigers (Panthera tigris altaica), but long-term implications for the population are unknown. This study evaluates the potential impact of CDV on a key tiger population in Sikhote-Alin Biosphere Zapovednik (SABZ), and assesses how CDV might influence the extinction potential of other tiger populations of varying sizes. An individual-based stochastic, SIRD (susceptible-infected-recovered/dead) model was used to simulate infection through predation of infected domestic dogs, and/or wild carnivores, and direct tiger-to-tiger transmission. CDV prevalence and effective contact based on published and observed data was used to define plausible low-and high-risk infection scenarios. CDV infection increased the 50-year extinction probability of tigers in SABZ by 6.3% to 55.8% compared to a control population, depending on risk scenario. The most significant factors influencing model outcome were virus prevalence in the reservoir population(s) and its effective contact rate with tigers. Adjustment of the mortality rate had a proportional impact, while inclusion of epizootic infection waves had negligible additional impact. Small populations were found to be disproportionately vulnerable to extinction through CDV infection. The 50-year extinction risk in populations consisting of 25 individuals was 1.65 times greater when CDV was present than that of control populations. The effects of density dependence do not protect an endangered population from the impacts of a multi-host pathogen, such as CDV, where they coexist with an abundant reservoir presenting a persistent threat. Awareness of CDV is a critical component of a successful tiger conservation management policy.	[Gilbert, Martin; Miquelle, Dale G.; Joly, Damien O.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Gilbert, Martin; Reeve, Richard; Cleaveland, Sarah; Matthews, Louise] Univ Glasgow, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Goodrich, John M.] Panthera, New York, NY USA; [Joly, Damien O.] Metabiota, San Francisco, CA USA	Wildlife Conservation Society; University of Glasgow	Gilbert, M (corresponding author), Wildlife Conservat Soc, Bronx, NY 10460 USA.	mgilbert@wcs.org	Matthews, Louise/E-2913-2013; Reeve, Richard/K-9918-2015	Matthews, Louise/0000-0003-4420-8367; Reeve, Richard/0000-0003-2589-8091; Gilbert, Martin/0000-0002-9930-4383; Cleaveland, Sarah/0000-0002-0456-0959	Morris Animal Foundation; Zoo Boise; Biotechnology and Biological Sciences Research Council [BBSRC DTG - BB/F016786/1]; Biological Sciences Research Council through their Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute	Morris Animal Foundation; Zoo Boise; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biological Sciences Research Council through their Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank all institutions who generously supported this work including the Morris Animal Foundation http://www.morrisanimalfoundation.org/ (MG, DGM, LM, SC), Zoo Boise http://www.zooboise.org/ (MG, DGM), and the Biotechnology and Biological Sciences Research Council http://www.bbsrc.com/home/home.aspx (MG, LM, SM) directly through a doctoral training grant (BBSRC DTG - BB/F016786/1), and through their Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2010, COMP IMMUNOL MICROB, V33, P249, DOI 10.1016/j.cimid.2008.10.005; Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; APPEL MJ, 1987, VIRUS INFECT CARNIVO, P00133; APPEL MJG, 1994, J VET DIAGN INVEST, V6, P277, DOI 10.1177/104063879400600301; BLYTHE LL, 1983, J AM VET MED ASSOC, V183, P1159; Carroll C, 2006, J APPL ECOL, V43, P1056, DOI 10.1111/j.1365-2664.2006.01237.x; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Chundawat RS, 2011, IUCN RED LIST THREAT; Craft ME, 2009, P ROY SOC B-BIOL SCI, V276, P1777, DOI 10.1098/rspb.2008.1636; Creel S, 2002, INFECT DIS AFRICAN W, P269; Daoust PY, 2009, J WILDLIFE DIS, V45, P611, DOI 10.7589/0090-3558-45.3.611; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; FANSHAWE J H, 1991, Oryx, V25, P137; Frolich K, 2000, VET MICROBIOL, V74, P283, DOI 10.1016/S0378-1135(00)00192-9; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Goodrich JM, 2012, J WILDLIFE DIS, V48, P186, DOI 10.7589/0090-3558-48.1.186; Goodrich JM, 2010, J MAMMAL, V91, P737, DOI 10.1644/09-MAMM-A-293.1; Greene C.E., 2006, INFECT DIS DOG CAT, P25; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Haydon DT, 2002, CONSERV BIOL, V16, P1372, DOI 10.1046/j.1523-1739.2002.00559.x; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; Konjevic D, 2011, ACTA VET BRNO, V80, P47, DOI 10.2754/avb201180010047; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Meli ML, 2010, VET MICROBIOL, V146, P132, DOI 10.1016/j.vetmic.2010.04.024; Miller C., 2012, AMUR TIGER PREDATION; Miquelle D, 2005, CONSERV BIOL SER, V9, P305; Miquelle Dale G., 1996, Journal of Wildlife Research, V1, P138; Miquelle Dale G., 2010, P325; Mochizuki M, 2008, J VET MED SCI, V70, P563, DOI 10.1292/jvms.70.563; Munson L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002545; Myers DL, 1997, CLIN DIAGN LAB IMMUN, V4, P180, DOI 10.1128/CDLI.4.2.180-184.1997; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Pavlacik L, 2007, VET MED-CZECH, V52, P69, DOI 10.17221/2057-VETMED; Posuwan N, 2010, ASIAN BIOMED, V4, P563, DOI 10.2478/abm-2010-0071; Quigley KS, 2010, J WILDLIFE DIS, V46, P1252, DOI 10.7589/0090-3558-46.4.1252; Ranganathan J, 2008, BIOL CONSERV, V141, P67, DOI 10.1016/j.biocon.2007.09.003; RAUTENBACH GH, 1991, J S AFR VET ASSOC, V62, P158; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Roscoe E, 1993, J WILDLIFE DIS, V29, P390; Sanderson E., 2006, SETTING PRIORITIES C; Seimon TA, 2013, MBIO, V4, DOI 10.1128/mBio.00410-13; Smirnov Evgeny N., 1999, P61; Sunquist M, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P19, DOI 10.1016/B978-0-8155-1570-8.00002-5; Timm SF, 2009, J WILDLIFE DIS, V45, P333, DOI 10.7589/0090-3558-45.2.333; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; WILLIAMS ES, 1988, J WILDLIFE DIS, V24, P385, DOI 10.7589/0090-3558-24.3.385	48	37	43	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110811	10.1371/journal.pone.0110811	http://dx.doi.org/10.1371/journal.pone.0110811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354196	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000345204200040
J	Lucas, AR; Verma, RK; Dai, EB; Liu, LY; Chen, H; Kesavalu, S; Rivera, M; Velsko, I; Ambadapadi, S; Chukkapalli, S; Kesavalu, L				Lucas, Alexandra R.; Verma, Raj K.; Dai, Erbin; Liu, Liying; Chen, Hao; Kesavalu, Sheela; Rivera, Mercedes; Velsko, Irina; Ambadapadi, Sriram; Chukkapalli, Sasanka; Kesavalu, Lakshmyya			Myxomavirus Anti-Inflammatory Chemokine Binding Protein Reduces the Increased Plaque Growth Induced by Chronic Porphyromonas gingivalis Oral Infection after Balloon Angioplasty Aortic Injury in Mice	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SERINE PROTEINASE; PERIODONTAL-DISEASE; VIRAL SERPIN; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; VIRUS; INFLAMMATION; MODEL; M-T7	Thrombotic occlusion of inflammatory plaque in coronary arteries causes myocardial infarction. Treatment with emergent balloon angioplasty (BA) and stent implant improves survival, but restenosis (regrowth) can occur. Periodontal bacteremia is closely associated with inflammation and native arterial atherosclerosis, with potential to increase restenosis. Two virus-derived anti-inflammatory proteins, M-T7 and Serp-1, reduce inflammation and plaque growth after BA and transplant in animal models through separate pathways. M-T7 is a broad spectrum C, CC and CXC chemokine-binding protein. Serp-1 is a serine protease inhibitor (serpin) inhibiting thrombotic and thrombolytic pathways. Serp-1 also reduces arterial inflammation and improves survival in a mouse herpes virus (MHV68) model of lethal vasculitis. In addition, Serp-1 demonstrated safety and efficacy in patients with unstable coronary disease and stent implant, reducing markers of myocardial damage. We investigate here the effects of Porphyromonas gingivalis, a periodontal pathogen, on restenosis after BA and the effects of blocking chemokine and protease pathways with M-T7 and Serp-1. ApoE(-/-) mice had aortic BA and oral P. gingivalis infection. Arterial plaque growth was examined at 24 weeks with and without anti-inflammatory protein treatment. Dental plaques from mice infected with P. gingivalis tested positive for infection. Neither Serp-1 nor M-T7 treatment reduced infection, but IgG antibody levels in mice treated with Serp-1 and M-T7 were reduced. P. gingivalis significantly increased monocyte invasion and arterial plaque growth after BA (P < 0.025). Monocyte invasion and plaque growth were blocked by M-T7 treatment (P < 0.023), whereas Serp-1 produced only a trend toward reductions. Both proteins modified expression of TLR4 and MyD88. In conclusion, aortic plaque growth in ApoE(-/-) mice increased after angioplasty in mice with chronic oral P. gingivalis infection. Blockade of chemokines, but not serine proteases significantly reduced arterial plaque growth, suggesting a central role for chemokine-mediated inflammation after BA in P. gingivalis infected mice.	[Lucas, Alexandra R.; Dai, Erbin; Liu, Liying; Chen, Hao; Ambadapadi, Sriram] Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, Gainesville, FL 32611 USA; [Lucas, Alexandra R.; Dai, Erbin; Liu, Liying; Chen, Hao; Ambadapadi, Sriram] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Div Cardiovasc Med, Gainesville, FL USA; [Verma, Raj K.; Kesavalu, Sheela; Rivera, Mercedes; Velsko, Irina; Chukkapalli, Sasanka; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lucas, AR (corresponding author), Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, Gainesville, FL 32611 USA.	alexandra.lucas@medicine.ufl.edu; kesavalu@dental.ufl.edu		Ambadapadi, Sriram/0000-0001-6542-4259	USPHS from National Institute of Dental, Craniofacial Research (NIH/NIDCR) [U24 DE016509]; NIH [R01DE015720-01, DE020820-01, 1RC1HL100202-01]; University of Florida Research Opportunity seed fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015720, U24DE016509] Funding Source: NIH RePORTER	USPHS from National Institute of Dental, Craniofacial Research (NIH/NIDCR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Research Opportunity seed fund(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by USPHS research grant U24 DE016509 from National Institute of Dental, Craniofacial Research (NIH/NIDCR), NIH grants R01DE015720-01, DE020820-01, and 1RC1HL100202-01, and the University of Florida Research Opportunity seed fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bartee MY, 2014, CYTOKINE, V65, P79, DOI 10.1016/j.cyto.2013.10.005; Bartee MY, 2009, METHOD ENZYMOL, V460, P209, DOI 10.1016/S0076-6879(09)05210-0; Bot I, 2003, CIRC RES, V93, P464, DOI 10.1161/01.RES.0000090993.01633.D4; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Chen H, 2013, ANTIMICROB AGENTS CH, V57, P4114, DOI 10.1128/AAC.02594-12; Chen H, 2011, METHOD ENZYMOL, V499, P301, DOI 10.1016/B978-0-12-386471-0.00015-8; Dai E, 2003, J BIOL CHEM, V278, P18563, DOI 10.1074/jbc.M209683200; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Hamalainen M, 2013, BASIC CLIN PHARMACOL, V112, P296, DOI 10.1111/bcpt.12056; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Jalandhara NB, 2009, AM J THER, V16, P257, DOI [10.1097/MJT.0b013e3181788cdf, 10.1097/MJT.0b013e31804c7238]; Jiang J, 2007, TRANSPLANTATION, V84, P1158, DOI 10.1097/01.tp.0000286099.50532.b0; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kobayashi N, 2012, J VASC RES, V49, P417, DOI 10.1159/000339583; Liu D, 2004, TRANSPLANTATION, V77, P1652, DOI 10.1097/01.TP.0000131173.52424.84; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Lucas A, 2009, ADV EXP MED BIOL, V666, P132; MACEN JL, 1993, VIROLOGY, V195, P348, DOI 10.1006/viro.1993.1385; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x; Petrov L, 2005, J VASC RES, V42, P292, DOI 10.1159/000085905; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Scott NA, 2006, ADV DRUG DELIVER REV, V58, P358, DOI 10.1016/j.addr.2006.01.015; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; TURNER PC, 1995, J VIROL, V69, P5978, DOI 10.1128/JVI.69.10.5978-5987.1995; UPTON C, 1990, VIROLOGY, V179, P618, DOI 10.1016/0042-6822(90)90129-F; Velsko IM, 2014, PLOS ONE, V9; Viswanathan K, 2009, J LEUKOCYTE BIOL, V85, P418, DOI 10.1189/jlb.0808506; Yuan HP, 2013, P NATL ACAD SCI USA, V110, pE5059, DOI 10.1073/pnas.1320862110; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111353	10.1371/journal.pone.0111353	http://dx.doi.org/10.1371/journal.pone.0111353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354050	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200074
J	Manvati, S; Mangalhara, KC; Kalaiarasan, P; Srivastava, N; Kumar, B; Bamezai, RNK				Manvati, Siddharth; Mangalhara, Kailash Chandra; Kalaiarasan, P.; Srivastava, Niloo; Kumar, Bhupender; Bamezai, R. N. K.			MiR-101 Induces Senescence and Prevents Apoptosis in the Background of DNA Damage in MCF7 Cells	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; CELLULAR SENESCENCE; IONIZING-RADIATION; BREAST-CANCER; FIBROBLASTS; EXPRESSION; REPRESSION; MICRORNAS; STABILITY; PATHWAY	Moderately increased DNA damage due to the exogenous miR-101 (4 fold) over-expression in MCF7 cells was substantiated by an increase in the number of gamma-H2AX foci, correlating with a simple-to-do Halo-assay. miR-101 induced mild/moderate DNA damage favoured senescence rather than apoptosis. An experimental support emanated from the induced mild/moderate DNA damage with 1 mu M/5 mu M etoposide in MCF7 cells, which resulted in an endogenous miR-101 over-expression (10/4 fold, respectively), followed by senescence. On the other hand, the severe DNA damage induced with 10 mu M etoposide, resulted in a low (<1 fold) endogenous expression of miR-101 and an elevated percentage of apoptotic cells. Using bioinformatics tools along with in-vitro and in-vivo validations, miR-101 was found to target and downregulate the mRNA expression of UBE2N and SMARCA4, involved in DNA damage repair (DDR) pathways. Recovery of the expression of the two novel targets in anti-miR-101 transfection validated the results. We conclude that a threshold range of over-expressed miR-101, capable of inducing mild/moderate DNA damage, is sensed by cells to become senescent. The observation derives further support from in-silico protein-protein network analysis where the two novel targets showed their involvement in senescence pathway.	[Manvati, Siddharth; Kalaiarasan, P.] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Kakrayal, Jammu & Kashmir, India; [Mangalhara, Kailash Chandra; Srivastava, Niloo; Kumar, Bhupender; Bamezai, R. N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India	Shri Mata Vaishno Devi University; Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	bamezai@hotmail.com	Kumar, Bhupender/GLR-8413-2022	Kumar, Bhupender/0000-0003-3887-5040	Jammu and Kashmir, Department of Science and Technology, Govt of India, through Shri Mata Vaishnov Devi University	Jammu and Kashmir, Department of Science and Technology, Govt of India, through Shri Mata Vaishnov Devi University	The study was funded by Jammu and Kashmir, Department of Science and Technology, Govt of India, through Shri Mata Vaishnov Devi University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio N, 2013, CELL MOL LIFE SCI, V70, P1637, DOI 10.1007/s00018-012-1224-x; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen SS, 2011, INT J RADIAT ONCOL, V81, P1524, DOI 10.1016/j.ijrobp.2011.05.031; Collard TJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.142; Das S, 2008, CELL CYCLE, V7, P154, DOI 10.4161/cc.7.2.5236; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Galaz-Leiva S, 2012, BIOTECH HISTOCHEM, V87, P208, DOI 10.3109/10520295.2011.604163; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Greussing R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-224; Hibio N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00996; Hogstrand K, 1999, MUTAT RES-FUND MOL M, V423, P155, DOI 10.1016/S0027-5107(98)00239-5; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kim KS, 2013, INT J RAD BIOL; Li Z, 2013, TOXICOL SCI; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mok MTS, 2012, RADIOTHER ONCOL, V103, P415, DOI 10.1016/j.radonc.2012.04.009; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Sandberg AA, 2010, CANCER GENET CYTOGEN, V203, P102, DOI 10.1016/j.cancergencyto.2010.10.004; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Strillacci A, 2009, EXP CELL RES, V315, P1439, DOI 10.1016/j.yexcr.2008.12.010; Sun Yang, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P460, DOI 10.3760/cma.j.issn.0529-5807.2013.07.007; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; Van Oorschot B, 2013, CELL MOL BIOL LETT; Xiaoping L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.197; Zhao LY, 2012, INT J BIOCHEM CELL B, V44, P2051, DOI 10.1016/j.biocel.2012.08.005	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111177	10.1371/journal.pone.0111177	http://dx.doi.org/10.1371/journal.pone.0111177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353636	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200063
J	Pinhasi, R; Meshveliani, T; Matskevich, Z; Bar-Oz, G; Weissbrod, L; Miller, CE; Wilkinson, K; Lordkipanidze, D; Jakeli, N; Kvavadze, E; Higham, TFG; Belfer-Cohen, A				Pinhasi, Ron; Meshveliani, Tengiz; Matskevich, Zinovi; Bar-Oz, Guy; Weissbrod, Lior; Miller, Christopher E.; Wilkinson, Keith; Lordkipanidze, David; Jakeli, Nino; Kvavadze, Eliso; Higham, Thomas F. G.; Belfer-Cohen, Anna			Satsurblia: New Insights of Human Response and Survival across the Last Glacial Maximum in the Southern Caucasus	PLOS ONE			English	Article							UPPER PALEOLITHIC CAVE; SEQUENCE; MIDDLE; ZOOARCHAEOLOGY; DZUDZUANA; TAPHONOMY; HOVK-1; DEMISE; SITE	The region of western Georgia (Imereti) has been a major geographic corridor for human migrations during the Middle and Upper Palaeolithic (MP/UP). Knowledge of the MP and UP in this region, however, stems mostly from a small number of recent excavations at the sites of Ortvale Klde, Dzudzuana, Bondi, and Kotias Klde. These provide an absolute chronology for the Late MP and MP-UP transition, but only a partial perspective on the nature and timing of UP occupations, and limited data on how human groups in this region responded to the harsh climatic oscillations between 37,000-11,500 years before present. Here we report new UP archaeological sequences from fieldwork in Satsurblia cavein the same region. A series of living surfaces with combustion features, faunal remains, stone and bone tools, and ornaments provide new information about human occupations in this region (a) prior to the Last Glacial Maximum (LGM) at 25.5-24.4 ka cal. BP and (b) after the LGM at 17.9-16.2 ka cal. BP. The latter provides new evidence in the southern Caucasus for human occupation immediately after the LGM. The results of the campaigns in Satsurblia and Dzudzuana suggest that at present the most plausible scenario is one of a hiatus in the occupation of this region during the LGM (between 24.4-17.9 ka cal. BP). Analysis of the living surfaces at Satsurblia offers information about human activities such as the production and utilisation of lithics and bone tools, butchering, cooking and consumption of meat and wild cereals, the utilisation of fibers, and the use of certain woods. Microfaunal and palynological analyses point to fluctuations in the climate with consequent shifts in vegetation and the faunal spectrum not only before and after the LGM, but also during the two millennia following the end of the LGM.	[Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 2, Ireland; [Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 2, Ireland; [Meshveliani, Tengiz; Lordkipanidze, David; Jakeli, Nino] Georgian State Museum, Dept Prehist, Tbilisi, Georgia; [Matskevich, Zinovi] Israel Antiqu Author, Jerusalem, Israel; [Bar-Oz, Guy; Weissbrod, Lior] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Miller, Christopher E.] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Miller, Christopher E.] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [Wilkinson, Keith] Univ Winchester, Dept Archaeol, Winchester, Hants, England; [Kvavadze, Eliso] Natl Museum Georgia, Inst Paleobiol, Tbilisi, Georgia; [Higham, Thomas F. G.] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Res Lab Archaeol & Hist Art, Oxford, England; [Belfer-Cohen, Anna] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	University College Dublin; University College Dublin; University of Haifa; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Winchester; University of Oxford; Hebrew University of Jerusalem	Pinhasi, R (corresponding author), Univ Coll Dublin, Earth Inst, Dublin 2, Ireland.	ron.pinhasi@ucd.ie; Anna.Belfer-Cohen@mail.huji.ac.il	Lordkipanidze, David/AAH-6472-2020; Higham, Tom/Y-2707-2019; Weissbrod, Lior/I-8735-2019; Pinhasi, Ron/AAT-1531-2020; BarOz, Guy/ABF-6518-2020	Higham, Tom/0000-0002-5949-598X; Weissbrod, Lior/0000-0003-3401-8180; Pinhasi, Ron/0000-0003-1629-8131; BarOz, Guy/0000-0002-1009-5619	National Geographic-Global Exploration Fund [GEFNE78-13]; European Research Council Starter [ERC-2010-StG 263441]	National Geographic-Global Exploration Fund(National Geographic Society); European Research Council Starter	National Geographic-Global Exploration Fund funded this research from April 2013 to February 2014 (grant- GEFNE78-13). Additional support was receieved from European Research Council Starter (grant- ERC-2010-StG 263441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DS, 2008, J HUM EVOL, V55, P817, DOI 10.1016/j.jhevol.2008.08.010; Adler DS, 2006, CURR ANTHROPOL, V47, P89, DOI 10.1086/432455; Amorosi T., 1989, BRIT ARCHAEOLOGICAL; Bader N. O., 1984, PALEOLIT SSSR, P272; Bar-Oz G, 2008, INT J OSTEOARCHAEOL, V18, P131, DOI 10.1002/oa.926; Bar-Oz G, 2009, ARCHAEOL ETHNOL ANTH, V37, P15, DOI 10.1016/j.aeae.2009.05.002; Bar-Oz Guy, 2005, Journal of Taphonomy, V3, P185; Bar-Oz G, 2012, J ARCHAEOL SCI, V39, P2452, DOI 10.1016/j.jas.2012.02.014; Bar-Yosef O, 2011, ANTIQUITY, V85, P331, DOI 10.1017/S0003598X0006779X; Baryshnikov Gennady F., 2002, Russian Journal of Theriology, V1, P61; Cuenca-Bescos G, 2009, J ARCHAEOL SCI, V36, P947, DOI 10.1016/j.jas.2008.09.025; Gabunia M, 2003, DZIEBANI, V12, P5; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Golovanova LV, 2014, QUATERN INT, V337, P189, DOI 10.1016/j.quaint.2012.04.034; Grigolia GK, 1977, CENTRALURI KOLHETIS; Gromov IM, 1980, KUDARO PALEOLITHIC C, P79; HEPTNER VG, 1989, MAMMALS SOVIET UNION, V1; Kalandadze A.N., 1978, CAVES GEORGIA, P116; Kalandadze KS, 2004, TSKALTUBO EXPEDITION; Kandel AW, 2011, ARAMAZD, V2, P7; Krystufek B, 2008, IUCN RED LIST THREAT; KURTEN BJORN, 1958, ACTA ZOOL FENNICA, V95, P1; Kvavadze E, 2011, P NAT PREH SECT GEOR, P85; Kvavadze E, 2011, C VIEW MOUSNT BERN S; Liubin VP, 1966, ISTOKOV DREVNIKH KUL, V126, P155; Lopez-Garcia JM, 2014, PALAEOGEOGR PALAEOCL, V409, P169, DOI 10.1016/j.palaeo.2014.05.017; Meshveliani T, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P129; Meshveliani T., 2007, PALEORIENT, V33, P47, DOI [10.3406/paleo.2007.5220, DOI 10.3406/PALEO.2007.5220]; Montoya C, 2013, J HUM EVOL, V65, P621, DOI 10.1016/j.jhevol.2013.07.011; Nioradze MG, 2000, ANTHROPOLOGIE, V104, P265; Payne S., 1988, ARCHAEOZOOLOGIA, V2, P27; Pinhasi R, 2012, J HUM EVOL, V63, P770, DOI 10.1016/j.jhevol.2012.08.004; Pinhasi R, 2011, QUATERNARY SCI REV, V30, P3846, DOI 10.1016/j.quascirev.2011.09.020; Smith A. T, 2008, IUCN RED LIST THREAT; Soffer O, 1990, HIGH LATITUDES, V1; Stiner MC, 1998, J HUM EVOL, V34, P303, DOI 10.1006/jhev.1997.0198; Tsytsulina K., 2008, IUCN RED LIST THREAT; Tushabramishvili D., 1960, PALEOLITHIC REMAINS; Tushabramishvili N, 2012, J HUM EVOL, V62, P179, DOI 10.1016/j.jhevol.2011.11.001; VERESHCHAGIN N. K., 1958, ZOOL ZHUR, V37, P1874; Vereshchagin NK, 1967, MAMMALS CAUCASUS HIS; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Yigit Nuri, 2006, Turkish Journal of Zoology, V30, P291; Zamiatnin SN, 1957, COLLECTION PAPERS AN, V17, P432	44	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111271	10.1371/journal.pone.0111271	http://dx.doi.org/10.1371/journal.pone.0111271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354048	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200065
J	Dommaraju, K; Kijak, G; Carlson, JM; Larsen, BB; Tovanabutra, S; Geraghty, DE; Deng, W; Maust, BS; Edlefsen, PT; Sanders-Buell, E; Ratto-Kim, S; deSouza, MS; Rerks-Ngarm, S; Nitayaphan, S; Pitisuttihum, P; Kaewkungwal, J; O'Connell, RJ; Robb, ML; Michael, NL; Mullins, JI; Kim, JH; Rolland, M				Dommaraju, Kalpana; Kijak, Gustavo; Carlson, Jonathan M.; Larsen, Brendan B.; Tovanabutra, Sodsai; Geraghty, Dan E.; Deng, Wenjie; Maust, Brandon S.; Edlefsen, Paul T.; Sanders-Buell, Eric; Ratto-Kim, Silvia; deSouza, Mark S.; Rerks-Ngarm, Supachai; Nitayaphan, Sorachai; Pitisuttihum, Punnee; Kaewkungwal, Jaranit; O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.; Mullins, James I.; Kim, Jerome H.; Rolland, Morgane			CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants	PLOS ONE			English	Article							VACCINE EFFICACY; PROTEIN; ANTIBODIES; INFECTION; ENVELOPE; REGIONS	The modest protection afforded by the RV144 vaccine offers an opportunity to evaluate its mechanisms of protection. Differences between HIV-1 breakthrough viruses from vaccine and placebo recipients can be attributed to the RV144 vaccine as this was a randomized and double-blinded trial. CD8 and CD4 T cell epitope repertoires were predicted in HIV-1 proteomes from 110 RV144 participants. Predicted Gag epitope repertoires were smaller in vaccine than in placebo recipients (p = 0.019). After comparing participant-derived epitopes to corresponding epitopes in the RV144 vaccine, the proportion of epitopes that could be matched differed depending on the protein conservation (only 36% of epitopes in Env vs 84-91% in Gag/Pol/Nef for CD8 predicted epitopes) or on vaccine insert subtype (55% against CRF01_AE vs 7% against subtype B). To compare predicted epitopes to the vaccine, we analyzed predicted binding affinity and evolutionary distance measurements. Comparisons between the vaccine and placebo arm did not reveal robust evidence for a T cell driven sieve effect, although some differences were noted in Env-V2 (0.022 <= p-value <= 0.231). The paucity of CD8 T cell responses identified following RV144 vaccination, with no evidence for V2 specificity, considered together both with the association of decreased infection risk in RV 144 participants with V-specific antibody responses and a V2 sieve effect, lead us to hypothesize that this sieve effect was not T cell specific. Overall, our results did not reveal a strong differential impact of vaccine-induced T cell responses among breakthrough infections in RV144 participants.	[Dommaraju, Kalpana; Kijak, Gustavo; Tovanabutra, Sodsai; Sanders-Buell, Eric; Ratto-Kim, Silvia; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Rolland, Morgane] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Dommaraju, Kalpana; Kijak, Gustavo; Tovanabutra, Sodsai; Sanders-Buell, Eric; Ratto-Kim, Silvia; Robb, Merlin L.; Rolland, Morgane] Henry Jackson Fdn, Bethesda, MD USA; [Carlson, Jonathan M.] Microsoft Res, Los Angeles, CA USA; [Larsen, Brendan B.; Deng, Wenjie; Maust, Brandon S.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Geraghty, Dan E.; Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [deSouza, Mark S.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Rerks-Ngarm, Supachai] Thai Minist Publ Hlth, Nonthaburi, Thailand; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Royal Thai Army Component, Bangkok 10400, Thailand; [Pitisuttihum, Punnee; Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Microsoft; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University	Rolland, M (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.	mrolland@hivresearch.org		Ratto-Kim, Silvia/0000-0003-2025-6399; Kaewkungwal, Jaranit/0000-0001-7916-8460	U.S. Army Medical Research and Material Command [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054165, N01AI002642] Funding Source: NIH RePORTER	U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by an Interagency Agreement Y1-AI-2642-12 between the U.S. Army Medical Research and Material Command and the National Institutes of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Edlefsen PT, 2013, CURR OPIN HIV AIDS, V8, P432, DOI 10.1097/COH.0b013e328362db2b; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; HURLEY CK, 2006, 13 INT HIST WORKSH P, P179; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rolland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017969; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316	17	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111334	10.1371/journal.pone.0111334	http://dx.doi.org/10.1371/journal.pone.0111334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350851	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100065
J	Gibbs, JP; Hunter, EA; Shoemaker, KT; Tapia, WH; Cayot, LJ				Gibbs, James P.; Hunter, Elizabeth A.; Shoemaker, Kevin T.; Tapia, Washington H.; Cayot, Linda J.			Demographic Outcomes and Ecosystem Implications of Giant Tortoise Reintroduction to Espanola Island, Galapagos	PLOS ONE			English	Article							SURVIVAL RATES; CONSERVATION; TRANSLOCATION; RESTORATION; YELLOWSTONE; TOOL; REPATRIATION; POPULATIONS; LANDSCAPE; ENGINEERS	Restoration of extirpated species via captive breeding has typically relied on population viability as the primary criterion for evaluating success. This criterion is inadequate when species reintroduction is undertaken to restore ecological functions and interactions. Herein we report on the demographic and ecological outcomes of a five-decade-long population restoration program for a critically endangered species of "ecosystem engineer'': the endemic Espanola giant Galapagos tortoise (Chelonoidis hoodensis). Our analysis of complementary datasets on tortoise demography and movement, tortoise-plant interactions and Espanola Island's vegetation history indicated that the repatriated tortoise population is secure from a strictly demographic perspective: about half of tortoises released on the island since 1975 were still alive in 2007, in situ reproduction is now significant, and future extinction risk is low with or without continued repatriation. Declining survival rates, somatic growth rates, and body condition of repatriates suggests, however, that resources for continued population growth are increasingly limited. Soil stable carbon isotope analyses indicated a pronounced shift toward woody plants in the recent history of the island's plant community, likely a legacy of changes in competitive relations between woody and herbaceous plants induced by now-eradicated feral goats and prolonged absence of tortoises. Woody plants are of concern because they block tortoise movement and hinder recruitment of cactus-a critical resource for tortoises. Tortoises restrict themselves to remnant cactus patches and areas of low woody plant density in the center of the island despite an apparent capacity to colonize a far greater range, likely because of a lack of cactus elsewhere on the island. We conclude that ecosystem-level criteria for success of species reintroduction efforts take much longer to achieve than population-level criteria; moreover, reinstatement of endangered species as fully functioning ecosystem engineers may often require large-scale habitat restoration efforts in concert with population restoration.	[Gibbs, James P.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Hunter, Elizabeth A.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Shoemaker, Kevin T.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Tapia, Washington H.] Galapagos Natl Pk Serv, Dept Appl Res, Puerto Ayora, Galapagos, Ecuador; [Cayot, Linda J.] Galapagos Conservancy, Fairfax, VA USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gibbs, JP (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	jpgibbs@esf.edu		Tapia, Washington/0000-0002-5222-1804; Hunter, Elizabeth/0000-0003-4710-167X	Galapagos Conservancy; Galapagos National Park Service; Prometeo Program of Ecuador's National Secretariat for Higher Education, Science, Technology and Innovation; U.S. National Science Foundation [DEB 1258062]; Direct For Biological Sciences [1258062, 1146198] Funding Source: National Science Foundation	Galapagos Conservancy; Galapagos National Park Service; Prometeo Program of Ecuador's National Secretariat for Higher Education, Science, Technology and Innovation; U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The 2010 field surveys of tortoise-plant interactions as well as this synthesis of the accumulated information was funded by the Galapagos Conservancy in collaboration with the Galapagos National Park Service, the Prometeo Program of Ecuador's National Secretariat for Higher Education, Science, Technology and Innovation, and U.S. National Science Foundation grant DEB 1258062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson David J., 2002, Marine Ornithology, V30, P63; Anderson DJ, 2008, ALBATROSS THEIR WORL; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Armstrong DP, 2005, J ANIM ECOL, V74, P160, DOI 10.1111/j.1365-2656.2004.00908.x; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Bai E, 2012, ORG GEOCHEM, V42, P1512, DOI 10.1016/j.orggeochem.2010.11.004; Beyer HL, 2007, ECOL APPL, V17, P1563, DOI 10.1890/06-1254.1; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Bolker B, 2008, ECOLOGICAL MODELS DA; Bourn D, 1999, P ROY SOC B-BIOL SCI, V266, P1091, DOI 10.1098/rspb.1999.0748; Browning DM, 2011, ECOL APPL, V21, P1629, DOI 10.1890/10-0542.1; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cayot L. J., 1987, ECOLOGY GIANT TORTOI; Cayot Linda J., 2008, Galapagos Research, V65, P39; Chiari Y, 2011, J MORPHOL, V272, P379, DOI 10.1002/jmor.10923; Chiari Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006272; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Crawley M.J., 2007, R BOOK; Cromsigt JPGM, 2014, J ECOL, V102, P1365; Cruz Márquez, 2003, Ecol. apl., V2, P21; Davidson AD, 2014, J WILDLIFE IN PRESS; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DODD CK, 1991, HERPETOLOGICA, V47, P336; Douglas HD, 1998, CONDOR, V100, P737, DOI 10.2307/1369757; Field KJ, 2007, BIOL CONSERV, V136, P232, DOI 10.1016/j.biocon.2006.11.022; Froyd CA, 2014, ECOL LETT, V17, P144, DOI 10.1111/ele.12203; Gibbs JP, 2008, RESTOR ECOL, V16, P88, DOI 10.1111/j.1526-100X.2007.00265.x; Gibbs James P., 2010, Galapagos Research, V67, P18; Gibbs JP, 2010, BIOTROPICA, V42, P208, DOI 10.1111/j.1744-7429.2009.00552.x; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; HAMANN O, 1993, BIODIVERS CONSERV, V2, P138, DOI 10.1007/BF00056130; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Hicks DJ, 1996, HASELTONIA, P89; Hicks DJ, 2000, BIOTROPICA, V32, P235, DOI 10.1111/j.1744-7429.2000.tb00466.x; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Hunter EA, 2014, RESTOR ECOL, V22, P248, DOI 10.1111/rec.12055; Johnson BE, 2007, CONSERV BIOL, V21, P515, DOI 10.1111/j.1523-1739.2006.00610.x; Liu MaoXiu, 2014, Advanced Science, Engineering and Medicine (ASEM), V6, P236; MARQUEZ C, 1991, Noticias de Galapagos, P17; Marquez C., 1999, CRIANZA TORTUGAS GIG; Márquez Cruz, 2004, Ecol. apl., V3, P98; Milinkovitch MC, 2004, P ROY SOC B-BIOL SCI, V271, P341, DOI 10.1098/rspb.2003.2607; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Nicoll MAC, 2003, J ANIM ECOL, V72, P917, DOI 10.1046/j.1365-2656.2003.00768.x; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; R Development Core Team, 2012, R LANG ENV STAT COMP; RACINE C H, 1974, Biotropica, V6, P175, DOI 10.2307/2989650; Reinert HK, 1999, J HERPETOL, V33, P45, DOI 10.2307/1565542; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Shoemaker KT, 2014, CONSERVATION BIOL; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; SWINGLAND IR, 1979, PHILOS T ROY SOC B, V286, P177, DOI 10.1098/rstb.1979.0025; Tortoise & Freshwater Turtle Specialist Group, 1996, IUCN 2013 IUCN RED L; Trueman M, 2013, LANDSCAPE ECOL, V28, P519, DOI 10.1007/s10980-013-9854-4; Truett Joe, 2009, Ecological Restoration, V27, P144, DOI 10.3368/er.27.2.144; Tuberville TD, 2008, BIOL CONSERV, V141, P2690, DOI 10.1016/j.biocon.2008.08.004; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Yott A, 2010, RESTORATION ECOLOGY, V19, P70	68	41	41	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110742	10.1371/journal.pone.0110742	http://dx.doi.org/10.1371/journal.pone.0110742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350744	Green Published, gold			2022-12-27	WOS:000343943100037
J	Hraiech, S; Hiblot, J; Lafleur, J; Lepidi, H; Papazian, L; Rolain, JM; Raoult, D; Elias, M; Silby, MW; Bzdrenga, J; Bregeon, F; Chabriere, E				Hraiech, Sami; Hiblot, Julien; Lafleur, John; Lepidi, Hubert; Papazian, Laurent; Rolain, Jean-Marc; Raoult, Didier; Elias, Mikael; Silby, Mark W.; Bzdrenga, Janek; Bregeon, Fabienne; Chabriere, Eric			Inhaled Lactonase Reduces Pseudomonas aeruginosa Quorum Sensing and Mortality in Rat Pneumonia	PLOS ONE			English	Article							ANTIBACTERIAL EFFICACY; BIOFILM FORMATION; VIRULENCE; MODEL; INHIBITORS; INFECTION; EXPRESSION; MOLECULE; AUTOINDUCTION; ENZYME	Rationale: The effectiveness of antibiotic molecules in treating Pseudomonas aeruginosa pneumonia is reduced as a result of the dissemination of bacterial resistance. The existence of bacterial communication systems, such as quorum sensing, has provided new opportunities of treatment. Lactonases efficiently quench acyl-homoserine lactone-based bacterial quorum sensing, implicating these enzymes as potential new anti-Pseudomonas drugs that might be evaluated in pneumonia. Objectives: The aim of the present study was to evaluate the ability of a lactonase called SsoPox-I to reduce the mortality of a rat P. aeruginosa pneumonia. Methods: To assess SsoPox-I-mediated quorum quenching, we first measured the activity of the virulence gene lasB, the synthesis of pyocianin, the proteolytic activity of a bacterial suspension and the formation of biofilm of a PAO1 strain grown in the presence of lactonase. In an acute lethal model of P. aeruginosa pneumonia in rats, we evaluated the effects of an early or deferred intra-tracheal treatment with SsoPox-I on the mortality, lung bacterial count and lung damage. Measurements and Primary Results: SsoPox-I decreased PAO1 lasB virulence gene activity, pyocianin synthesis, proteolytic activity and biofilm formation. The early use of SsoPox-I reduced the mortality of rats with acute pneumonia from 75% to 20%. Histological lung damage was significantly reduced but the lung bacterial count was not modified by the treatment. A delayed treatment was associated with a non-significant reduction of mortality. Conclusion: These results demonstrate the protective effects of lactonase SsoPox-I in P. aeruginosa pneumonia and open the way for a future therapeutic use.	[Hraiech, Sami; Hiblot, Julien; Lepidi, Hubert; Papazian, Laurent; Rolain, Jean-Marc; Raoult, Didier; Bzdrenga, Janek; Bregeon, Fabienne; Chabriere, Eric] Aix Marseille Univ, IFR48, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS IRD 6236, Marseille, France; [Hraiech, Sami; Papazian, Laurent] CHU Nord, APHM, Reanimat Detresses Respiratoires & Infect Severe, Marseille, France; [Lafleur, John; Silby, Mark W.] Univ Massachusetts, Dept Biol, Dartmouth, MA USA; [Lafleur, John] Alpert Sch Med, Dept Emergency Med, Providence, RI USA; [Elias, Mikael] Weizmann Inst Sci Biol Chem, Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Massachusetts System; University Massachusetts Dartmouth	Bregeon, F (corresponding author), Aix Marseille Univ, IFR48, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS IRD 6236, Marseille, France.	Fabienne.bregeon@ap-hm.fr; Eric.chabriere@univ-amu.fr	Elias, Mikael/AAH-9385-2021; Rolain, Jean-Marc/Y-3788-2019; RAOULT, Didier/A-8434-2008; Hiblot, Julien/AAA-4452-2020	Elias, Mikael/0000-0003-0406-7539; Rolain, Jean-Marc/0000-0002-2402-4467; RAOULT, Didier/0000-0002-0633-5974; Hiblot, Julien/0000-0002-7883-8079; Silby, Mark/0000-0002-3092-8008; Bzdrenga, Janek/0000-0003-3705-3459	Aix Marseille University (AMU)	Aix Marseille University (AMU)	This study was funded by Aix Marseille University (AMU) and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; Agodi A, 2007, INTENS CARE MED, V33, P1155, DOI 10.1007/s00134-007-0671-6; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Bakker-Woudenberg IAJM, 2002, ANTIMICROB AGENTS CH, V46, P2575, DOI 10.1128/AAC.46.8.2575-2581.2002; Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051; Bjarnsholt T, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001420; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Galloway WRJD, 2012, TRENDS MICROBIOL, V20, P449, DOI 10.1016/j.tim.2012.06.003; Garcia-Quintanilla M, 2013, TRENDS MICROBIOL, V21, P157, DOI 10.1016/j.tim.2012.12.002; Grabiner MA, 2014, J IMMUNOL, V193, P1459, DOI 10.4049/jimmunol.1303437; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hiblot J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075272; Hiblot J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00779; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hraiech S, 2013, ANTIMICROB AGENTS CH, V57, P5120, DOI 10.1128/AAC.00700-13; Hraiech S, 2012, J ANTIMICROB CHEMOTH, V67, P2452, DOI 10.1093/jac/dks230; Ilangovan A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003508; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Lesprit P, 2003, AM J RESP CRIT CARE, V167, P1478, DOI 10.1164/rccm.200207-736BC; Marquette CH, 1999, CHEST, V115, P200, DOI 10.1378/chest.115.1.200; Migiyama Y, 2013, ANTIMICROB AGENTS CH, V57, P3653, DOI 10.1128/AAC.00456-13; Ng FSW, 2011, APPL ENVIRON MICROB, V77, P1181, DOI 10.1128/AEM.01642-10; Nicodeme M, 2005, J APPL MICROBIOL, V99, P641, DOI 10.1111/j.1365-2672.2005.02634.x; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Papaioannou E, 2009, ANTIMICROB AGENTS CH, V53, P4891, DOI 10.1128/AAC.00380-09; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pearson JP, 2000, INFECT IMMUN, V68, P4331, DOI 10.1128/IAI.68.7.4331-4334.2000; Pei RT, 2014, APPL ENVIRON MICROB, V80, P5340, DOI 10.1128/AEM.01434-14; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0; Rezaiguia S, 1997, J CLIN INVEST, V99, P325, DOI 10.1172/JCI119161; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Stanton TB, 2013, TRENDS MICROBIOL, V21, P111, DOI 10.1016/j.tim.2012.11.002; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; van Delden C, 2012, INTENS CARE MED, V38, P1118, DOI 10.1007/s00134-012-2559-3; Wagner VE, 2006, TRENDS MICROBIOL, V14, P55, DOI 10.1016/j.tim.2005.12.002; Wagner VE, 2004, VACCINE, V22, pS15, DOI 10.1016/j.vaccine.2004.08.011; Wen J, 2014, INFLAMMATION, V37, P933, DOI 10.1007/s10753-014-9813-5; Wilkins MR, 1999, METH MOL B, V112, P531; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005	53	63	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e107125	10.1371/journal.pone.0107125	http://dx.doi.org/10.1371/journal.pone.0107125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350373	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100006
J	Chu, SM; Hsu, JF; Lee, CW; Lien, RY; Huang, HR; Chiang, MC; Fu, RH; Tsai, MH				Chu, Shih-Ming; Hsu, Jen-Fu; Lee, Chiang-Wen; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Tsai, Ming-Horng			Neurological Complications after Neonatal Bacteremia: The Clinical Characteristics, Risk Factors, and Outcomes	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; LATE-ONSET SEPSIS; BACTERIAL-MENINGITIS; SUBDURAL EMPYEMA; INFECTION; DISEASE; INTERVENTION; BURDEN	Background: Neonates with bacteremia are at risk of neurologic complications. Relevant information warrants further elucidation. Study Design: This was a retrospective cohort study of neonates with bacteremia-related neurologic complications (BNCs) in a tertiary-level neonatal intensive care unit (NICU). A systemic chart review was performed conducted to identify clinical characteristics and outcomes. A cohort of related conditions was constructed as the control group. Logistic regression analysis was used to identify independent risk factors for BNC. Results: Of 1037 bacteremia episodes, 36 (3.5%) had BNCs. Twenty-four cases of BNCs were related to meningitis, five were presumed meningitis, and seven occurred after septic shock. The most common causative pathogens were Group B streptococcus (41.7%) and E. coli (16.7%). The major BNCs consisted of seizures (28), hydrocephalus (20), encephalomalacia (11), cerebral infarction (7), subdural empyema (6), ventriculitis (8), and abscess (4). Eight (22.8%) neonates died and six (16.7%) were discharged in critical condition when the family withdrew life-sustaining treatment. Among the 22 survivors, eight had neurologic sequelae upon discharge. After multivariate logistic regression analysis, neonates with meningitis caused by Group B streptococcus (adjusted odds ratio [OR]: 8.90, 95% confidence interval [CI]: 2.20-36.08; p = 0.002) and combined meningitis and septic shock (OR, 5.94; 95% CI: 1.53-23.15; p = 0.010) were independently associated with BNCs. Conclusions: Neonates with bacteremia-related neurologic complications are associated with adverse outcomes or sequelae. Better strategies aimed at early detection and reducing the emergence of neurologic complications and aggressive treatment of Group B streptococcus sepsis are needed in neonates with meningitis and septic shock.	[Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Neonatol, Taoyuan, Taiwan; [Tsai, Ming-Horng] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan; [Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Tsai, Ming-Horng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Dept Nursing, Div Basic Med Sci, Chiayi, Taiwan; [Lee, Chiang-Wen; Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan; [Lee, Chiang-Wen] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Tsai, MH (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan.	mingmin.tw@yahoo.com.tw						Atif ML, 2008, INFECT CONT HOSP EP, V29, P1066, DOI 10.1086/591858; Berardi A, 2013, PEDIATRICS, V131, pE361, DOI 10.1542/peds.2012-1231; Carter JE, 2008, CLIN NEUROL NEUROSUR, V110, P614, DOI 10.1016/j.clineuro.2008.03.012; Chang YC, 1997, PEDIATR NEUROL, V17, P144, DOI 10.1016/S0887-8994(97)00078-7; de Goede CGEL, 2006, EUR J PAEDIATR NEURO, V10, P31, DOI 10.1016/j.ejpn.2005.10.001; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; GRAY JE, 1992, PEDIATRICS, V90, P561; Ho JJ, 2001, PEDIATR INFECT DIS J, V20, P557, DOI 10.1097/00006454-200106000-00002; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hughes DC, 2010, POSTGRAD MED J, V86, P478, DOI 10.1136/pgmj.2010.097022; Jim KK, 2012, NEUROLOGY, V79, P2133, DOI 10.1212/WNL.0b013e3182752d0e; Jordan HT, 2008, PEDIATR INFECT DIS J, V27, P1057, DOI 10.1097/INF.0b013e318180b3b9; Liu ZH, 2010, J NEUROSURG-PEDIATR, V6, P38, DOI 10.3171/2010.4.PEDS09433; Magalhaes V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063244; Makhoul IR, 2002, PEDIATRICS, V109, P34, DOI 10.1542/peds.109.1.34; May M, 2005, ARCH DIS CHILD-FETAL, V90, pF324, DOI 10.1136/adc.2004.066134; Mohan S, 2012, NEUROIMAG CLIN N AM, V22, P557, DOI 10.1016/j.nic.2012.04.003; Nakanishi H, 2010, J PERINATOL, V30, P751, DOI 10.1038/jp.2010.41; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Trijbels-Smeulders MAJM, 2006, PEDIATR INFECT DIS J, V25, P945, DOI 10.1097/01.inf.0000237821.65559.08; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Vasilopoulou VA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-214; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2; William Taeusch H, 2006, AVERYS DIS NEWBORN	30	30	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e105294	10.1371/journal.pone.0105294	http://dx.doi.org/10.1371/journal.pone.0105294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364821	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100002
J	Hermans, C; Anz, D; Engel, J; Kirchner, T; Endres, S; Mayr, D				Hermans, Cecilia; Anz, David; Engel, Jutta; Kirchner, Thomas; Endres, Stefan; Mayr, Doris			Analysis of FoxP3+T-Regulatory Cells and CD8+T-Cells in Ovarian Carcinoma: Location and Tumor Infiltration Patterns Are Key Prognostic Markers	PLOS ONE			English	Article							REGULATORY T-CELLS; FOXP3 EXPRESSION; SELF-TOLERANCE; TGF-BETA; CANCER; SUPPRESSION; LYMPHOCYTES; POPULATION; ACCUMULATE; MECHANISM	Purpose: Tumor infiltrating CD4+CD25+FoxP3+ regulatory immune cells (Treg) have been associated with impaired antitumor immune response and unfavorable prognosis for patients affected by ovarian carcinoma, whereas CD8+T-cells have been found to positively influence survival rates in a large panel of solid tumors. Recently, density, location and tumor infiltration patterns of the respective immune cell subtypes have been identified as key prognostic factors for different types of tumors. Patients and Methods: We stained 210 human ovarian carcinoma samples immunhistochemically for FoxP3 and CD8 to identify the impact different immune cell patterns have on generally accepted prognostic variables as well as on overall survival. Results: We found that FoxP3+ cells located within lymphoid aggregates surrounding the tumor were strongly associated with reduced survival time (P = 0.007). Central accumulation of CD8+ effector cells within the tumor bed shows a positive effect on survival (P = 0,001). Conclusion: The distribution pattern of immune cells within the tumor environment strongly influences prognosis and overall survival time of patients with ovarian carcinoma.	[Hermans, Cecilia; Kirchner, Thomas; Mayr, Doris] Univ Munich, Dept Pathol, Munich, Germany; [Engel, Jutta] Univ Munich, Inst Med Informat Biometry & Epidemiol, Tumorregister Munich, Munich, Germany; [Anz, David; Endres, Stefan] Univ Munich, Div Clin Pharmacol, Ctr Integrated Prot Sci Munich, Munich, Germany	University of Munich; University of Munich; University of Munich	Hermans, C (corresponding author), Univ Munich, Dept Pathol, Munich, Germany.	Cecilia.Hermans@med.uni-muenchen.de						Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; AWWAD M, 1988, J EXP MED, V168, P2193, DOI 10.1084/jem.168.6.2193; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Deutsche Krebsgesellschaft, 2006, INT S2K LEITL DIAGN, P76; Dunn GP, 2005, IMMUNOL RES, V32, P231, DOI 10.1385/IR:32:1-3:231; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Ebelt K, 2009, EUR J CANCER, V45, P1664, DOI 10.1016/j.ejca.2009.02.015; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Fachgesellschaften AdWM, 2007, DIAGN THER MAL OV; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Feyler S, 2009, BRIT J HAEMATOL, V144, P686, DOI 10.1111/j.1365-2141.2008.07530.x; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kmieciak M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-89; Koch-Institut R, 2010, VERBREITUNG KREBSERK; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Larmonier N, 2007, CANCER IMMUNOL IMMUN, V56, P48, DOI 10.1007/s00262-006-0160-8; Le DT, 2011, INT J CANCER, V129, P636, DOI 10.1002/ijc.25693; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Rahir G, 2012, CANCER IMMUNOL IMMUN, V61, P751, DOI 10.1007/s00262-012-1253-1; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, EUR J IMMUNOL, V38, P901, DOI 10.1002/eji.200890012; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schmalfeldt B, 2007, MANUAL MALIGNE OVARI; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shimizu Y, 1998, GYNECOL ONCOL, V70, P2, DOI 10.1006/gyno.1998.5051; Tavassoli FA, 2004, PATHOLOGY GENETICS T; Wang LC, 2010, WORLD J SURG, V34, P1059, DOI 10.1007/s00268-010-0448-x; WHO WHO, 2009, WORLD HLTH OBS; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Woodward ER, 2007, BJOG-INT J OBSTET GY, V114, P1500, DOI 10.1111/j.1471-0528.2007.01499.x; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	56	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111757	10.1371/journal.pone.0111757	http://dx.doi.org/10.1371/journal.pone.0111757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365237	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100114
J	Holmgren, NMA; Norrstrom, N; Aps, R; Kuikka, S				Holmgren, Noel Michael Andre; Norrstrom, Niclas; Aps, Robert; Kuikka, Sakari			A Concept of Bayesian Regulation in Fisheries Management	PLOS ONE			English	Article							GAINING ECOLOGICAL INFORMATION; CONSTANT-CATCH; FISH; UNCERTAINTY; POPULATIONS; FORAGERS; FLUCTUATIONS; STRATEGIES; BEHAVIOR; EXAMPLE	Stochastic variability of biological processes and uncertainty of stock properties compel fisheries managers to look for tools to improve control over the stock. Inspired by animals exploiting hidden prey, we have taken a biomimetic approach combining catch and effort in a concept of Bayesian regulation (BR). The BR provides a real-time Bayesian stock estimate, and can operate without separate stock assessment. We compared the performance of BR with catch-only regulation (CR), alternatively operating with N-target (the stock size giving maximum sustainable yield, MSY) and F-target (the fishing mortality giving MSY) on a stock model of Baltic Sea herring. N-targeted BR gave 3% higher yields than F-targeted BR and CR, and 7% higher yields than N-targeted CR. The BRs reduced coefficient of variance (CV) in fishing mortality compared to CR by 99.6% (from 25.2 to 0.1) when operated with F-target, and by about 80% (from 158.4 to 68.4/70.1 depending on how the prior is set) in stock size when operated with N-target. Even though F-targeted fishery reduced CV in pre-harvest stock size by 19-22%, it increased the dominant period length of population fluctuations from 20 to 60-80 years. In contrast, N-targeted BR made the periodic variation more similar to white noise. We discuss the conditions when BRs can be suitable tools to achieve sustainable yields while minimizing undesirable fluctuations in stock size or fishing effort.	[Holmgren, Noel Michael Andre; Norrstrom, Niclas] Univ Skovde, Sch Biosci, Syst Biol Res Ctr, Skovde, Sweden; [Aps, Robert] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia; [Kuikka, Sakari] Univ Helsinki, Dept Environm Sci, Fisheries & Environm Management Grp, Helsinki, Finland	University of Skovde; University of Tartu; Estonian Marine Institute; University of Helsinki	Holmgren, NMA (corresponding author), Univ Skovde, Sch Biosci, Syst Biol Res Ctr, Skovde, Sweden.	noel.holmgren@his.se		Holmgren, Noel/0000-0003-3000-8786; Kuikka, Sakari/0000-0001-8802-8013	European Community's Seventh Framework Programme [217246]; Baltic Sea research and development programme BONUS; FORMAS, Sweden; Academy of Finland; Estonian Science Foundation [7609]; Estonian [SF0180104s08]	European Community's Seventh Framework Programme(European Commission); Baltic Sea research and development programme BONUS; FORMAS, Sweden(Swedish Research Council Formas); Academy of Finland(Academy of Finland); Estonian Science Foundation; Estonian	The study is part of the IBAM project "Integrated Bayesian risk analysis of ecosystem management - Gulf of Finland as a case study", which received funding from the European Community's Seventh Framework Programme under grant agreement 217246 made with the joint Baltic Sea research and development programme BONUS (http://www.bonusportal.org/), from FORMAS, Sweden, the Academy of Finland, and an Estonian Science Foundation grant 7609, Estonian target financed theme SF0180104s08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Aps R, 2011, SEARCH I SER DEV ATT, P69, DOI 10.2495/ECO110061; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; GETZ WM, 1987, CAN J FISH AQUAT SCI, V44, P1370, DOI 10.1139/f87-164; GETZ WM, 1985, J OPTIMIZ THEORY APP, V46, P505, DOI 10.1007/BF00939155; GREEN RF, 1984, AM NAT, V123, P30, DOI 10.1086/284184; GREEN RF, 1980, THEOR POPUL BIOL, V18, P244, DOI 10.1016/0040-5809(80)90051-9; HIGHTOWER JE, 1985, CAN J FISH AQUAT SCI, V42, P982, DOI 10.1139/f85-123; Hilborn Ray, 1997, V28; Hjerne O, 2001, FISH RES, V53, P57, DOI 10.1016/S0165-7836(00)00266-6; Holmgren NMA, 2012, ICES J MAR SCI, V69, P257, DOI 10.1093/icesjms/fsr202; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; ICES, 2012, WORKSH 3 IMPL ICES F, P1; ICES, 2009, REP ICES ADV COMM 20; ICES, 2012, REP ICES ADV COMM 20; International Council for the Exploration of the Sea (ICES), 2011, WORKSH IMPL ICES FMS; IWASA Y, 1981, AM NAT, V117, P710, DOI 10.1086/283754; Jonzen N, 2002, AM NAT, V159, P427, DOI 10.1086/339456; Kell LT, 2005, ICES J MAR SCI, V62, P750, DOI 10.1016/j.icesjms.2005.01.001; KOONCE JF, 1987, CAN J FISH AQUAT SCI, V44, P61; Kraak SBM, 2010, FISH FISH, V11, P119, DOI 10.1111/j.1467-2979.2009.00352.x; Mantyniemi S, 2009, ICES J MAR SCI, V66, P2278, DOI 10.1093/icesjms/fsp206; Marchal P, 1998, ICES J MAR SCI, V55, P213, DOI 10.1006/jmsc.1997.9994; MAY RM, 1978, MATH BIOSCI, V42, P219, DOI 10.1016/0025-5564(78)90097-4; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; MURAWSKI SA, 1989, T AM FISH SOC, V118, P349, DOI 10.1577/1548-8659(1989)118<0349:YSUCPA>2.3.CO;2; Olsson O, 1998, BEHAV ECOL, V9, P345, DOI 10.1093/beheco/9.4.345; Olsson O, 1999, OIKOS, V87, P264, DOI 10.2307/3546741; Olsson O, 1999, OIKOS, V87, P251, DOI 10.2307/3546740; Patterson K, 2001, FISH FISH, V2, P125, DOI 10.1046/j.1467-2960.2001.00042.x; Patterson KR, 1999, CAN J FISH AQUAT SCI, V56, P208, DOI 10.1139/cjfas-56-2-208; PELLETIER D, 1992, ICES J MAR SCI, V49, P389, DOI 10.1093/icesjms/49.4.389; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Prager MH, 2003, N AM J FISH MANAGE, V23, P349, DOI 10.1577/1548-8675(2003)023<0349:TALFMO>2.0.CO;2; Ripa J, 1996, P ROY SOC B-BIOL SCI, V263, P1751, DOI 10.1098/rspb.1996.0256; Rochet MJ, 2009, ICES J MAR SCI, V66, P754, DOI 10.1093/icesjms/fsp023; Rohlf F.J., 1995, STAT TABLES; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Shertzer KW, 2008, FISH B-NOAA, V106, P225; Stephenson R., 2001, HERRING EXPECTATIONS, P741; VALONE TJ, 1989, ECOLOGY, V70, P1800, DOI 10.2307/1938113; VALONE TJ, 1991, ANIM BEHAV, V41, P569, DOI 10.1016/S0003-3472(05)80897-8; Virtala M, 1998, ICES J MAR SCI, V55, P892, DOI 10.1006/jmsc.1998.0368; WALTERS CJ, 1981, CAN J FISH AQUAT SCI, V38, P704, DOI 10.1139/f81-093; Wikstrom A, 2012, THEOR POPUL BIOL, V82, P348, DOI 10.1016/j.tpb.2011.12.008; Yodzis P, 1991, INTRO THEORETICAL EC	49	2	2	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111614	10.1371/journal.pone.0111614	http://dx.doi.org/10.1371/journal.pone.0111614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365071	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100088
J	Singh, V; Gupta, D; Arora, R; Tripathi, RP; Almasan, A; Macklis, RM				Singh, Vijay; Gupta, Damodar; Arora, Rajesh; Tripathi, Rajendra Prashad; Almasan, Alexandru; Macklis, Roger M.			Surface Levels of CD20 Determine Anti-CD20 Antibodies Mediated Cell Death In Vitro	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMA; HUMAN B-CELLS; MONOCLONAL-ANTIBODIES; TYROSINE PHOSPHORYLATION; INDUCED APOPTOSIS; DOWN-REGULATION; RITUXIMAB; EXPRESSION; COMPLEMENT	In Background: The sensitivity of human Burkitt's lymphoma cells to rituximab (Rtx) and tositumomab (Tst) was assessed on cells expressing different levels of CD20 on surface. Cells that harbor low CD20 levels may resists against therapeutics response to CD20-specific antibodies. We postulated that, radiation-induced modulation of CD20 surface levels may play a crucial and central role in determining the relative efficacy of rituximab and tositumomab in treating Burkitt's lymphoma disease. Here, we examined the gamma-radiation-induced CD20 expression in the Burkitt lymphoma cell line 'Daudi' and the relation of differential levels of CD20 with anti-CD20 mAbs mediated cell death. Methodology: In this study we examined kinetics of CD20 expression following sub lethal doses of gamma-radiation to Daudi cells and thereafter anti-CD20 mAbs (rituximab and tositumomab) were added in cell suspensions. The correlation of kinetics of CD20 expression and cells treated with anti-CD20 mAbs/or corresponding isotype Abs with special reference to changes in mitochondrial membrane potential and reactive oxygen species generation was also examined. Further, we also investigated the efficacy of anti-CD20 mAbs and possible induction of cell death in relation to levels of CD20 cell surface expression. Conclusion: This report provides evidence that CD20 expression can be induced by exposure of cells to c-radiation. In addition, these findings demonstrated that the efficacy of anti-CD20 mAbs is dependent on the surface levels of CD20. Based on these findings, we hypothesized (i) irradiation just prior to immunotherapy may provide new treatment options even in aggressive B cell tumors, which are resistant to current therapies in vivo (ii) The efficacy of induction of apoptosis varies with type of monoclonal antibodies in vitro.	[Singh, Vijay; Gupta, Damodar; Arora, Rajesh; Tripathi, Rajendra Prashad] Inst Nucl Med & Allied Sci, Div Radiat Biosci, Delhi, India; [Almasan, Alexandru; Macklis, Roger M.] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA; [Almasan, Alexandru] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Cleveland Clinic Foundation; Cleveland Clinic Foundation	Gupta, D (corresponding author), Inst Nucl Med & Allied Sci, Div Radiat Biosci, Brig SK Mazumdar Marg, Delhi, India.	damodar.gupta@gmail.com; macklir@ccf.org	Arora, Rajesh/AAE-4596-2021; Almasan, Alex/C-2715-2008	Arora, Rajesh/0000-0001-7307-9221; Almasan, Alex/0000-0002-8916-6650; SINGH, VIJAY/0000-0002-0789-5551	University Grants Commission; NATIONAL CANCER INSTITUTE [R01CA184137] Funding Source: NIH RePORTER	University Grants Commission(University Grants Commission, India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	DG is grateful to University Grants Commission for the award of research fellowship. The authors are also grateful to Director, INMAS for providing opportunity to carry out this research work, and to Defence Research and Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari M, 2013, INT J RADIAT BIOL, V89, P200, DOI 10.3109/09553002.2013.741285; Alas S, 2001, CLIN CANCER RES, V7, P709; Alinari L, 2011, BLOOD, V117, P4530, DOI 10.1182/blood-2010-08-303354; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bologna L, 2011, J IMMUNOL, V186, P3762, DOI 10.4049/jimmunol.1000303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chan HTC, 2003, CANCER RES, V63, P5480; Chandna S, 2004, CYTOM PART A, V61A, P127, DOI 10.1002/cyto.a.20071; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Crosby ME, 2007, ONCOGENE, V26, P1897, DOI 10.1038/sj.onc.1209998; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; Dalle S, 2011, MOL CANCER THER, V10, P178, DOI 10.1158/1535-7163.MCT-10-0385; DEANS JP, 1993, J IMMUNOL, V151, P4494; Ge XW, 2011, CLIN CANCER RES, V17, P6702, DOI 10.1158/1078-0432.CCR-11-0647; Ghetie MA, 2001, BLOOD, V97, P1392, DOI 10.1182/blood.V97.5.1392; Golay J, 2001, BLOOD, V98, P3383, DOI 10.1182/blood.V98.12.3383; Goldenberg DM, 2009, BLOOD, V113, P1062, DOI 10.1182/blood-2008-07-168146; Gomez-Tejedor G. Garcia, 2012, RAD DAMAGE BIOMOLECU; Gupta D, 2008, FREE RADICAL BIO MED, V44, P614, DOI 10.1016/j.freeradbiomed.2007.10.048; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Honeychurch J, 2012, BLOOD, V119, P3523, DOI 10.1182/blood-2011-12-395541; Ivanov A, 2008, CLIN CANCER RES, V14, P4925, DOI 10.1158/1078-0432.CCR-07-5072; Jazirehi AR, 2003, MOL CANCER THER, V2, P1183; Kunala S, 2001, INT J CANCER, V96, P178, DOI 10.1002/ijc.1018; Leach JK, 2001, CANCER RES, V61, P3894; Lim SH, 2010, HAEMATOL-HEMATOL J, V95, P135, DOI 10.3324/haematol.2008.001628; Mattes MJ, 2009, CANCER BIOTHER RADIO, V24, P185, DOI 10.1089/cbr.2008.0567; Mone AP, 2004, BLOOD, V103, P1846, DOI 10.1182/blood-2003-08-2836; OETTGEN HC, 1983, HYBRIDOMA, V2, P17, DOI 10.1089/hyb.1983.2.17; Pedersen IM, 2002, BLOOD, V99, P1314, DOI 10.1182/blood.V99.4.1314; Philippe J, 1997, CYTOMETRY, V29, P242, DOI 10.1002/(SICI)1097-0320(19971101)29:3<242::AID-CYTO7>3.3.CO;2-Z; Pohlman B, 2006, EXPERT REV ANTICANC, V6, P445, DOI 10.1586/14737140.6.3.445; Shan D, 1998, BLOOD, V91, P1644, DOI 10.1182/blood.V91.5.1644.1644_1644_1652; STASHENKO P, 1980, J IMMUNOL, V125, P1678; Takei K, 2006, LEUKEMIA RES, V30, P625, DOI 10.1016/j.leukres.2005.09.008; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	40	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111113	10.1371/journal.pone.0111113	http://dx.doi.org/10.1371/journal.pone.0111113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364827	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100050
J	Sun, FL; Wang, YS; Wu, ML; Jiang, ZY; Sun, CC; Cheng, H				Sun, Fu-Lin; Wang, You-Shao; Wu, Mei-Lin; Jiang, Zhao-Yu; Sun, Cui-Ci; Cheng, Hao			Genetic Diversity of Bacterial Communities and Gene Transfer Agents in Northern South China Sea	PLOS ONE			English	Article							ROSEOBACTER CLADE BACTERIA; BACTERIOPLANKTON; ATLANTIC; RHODOBACTERALES; PROCHLOROCOCCUS; EXPRESSION; LINEAGES; WATERS; OCEAN; DNA	Pyrosequencing of the 16S ribosomal RNA gene (rDNA) amplicons was performed to investigate the unique distribution of bacterial communities in northern South China Sea (nSCS) and evaluate community structure and spatial differences of bacterial diversity. Cyanobacteria, Proteobacteria, Actinobacteria, and Bacteroidetes constitute the majority of bacteria. The taxonomic description of bacterial communities revealed that more Chroococcales, SAR11 clade, Acidimicrobiales, Rhodobacterales, and Flavobacteriales are present in the nSCS waters than other bacterial groups. Rhodobacterales were less abundant in tropical water (nSCS) than in temperate and cold waters. Furthermore, the diversity of Rhodobacterales based on the gene transfer agent (GTA) major capsid gene (g5) was investigated. Four g5 gene clone libraries were constructed from samples representing different regions and yielded diverse sequences. Fourteen g5 clusters could be identified among 197 nSCS clones. These clusters were also related to known g5 sequences derived from genome-sequenced Rhodobacterales. The composition of g5 sequences in surface water varied with the g5 sequences in the sampling sites; this result indicated that the Rhodobacterales population could be highly diverse in nSCS. Phylogenetic tree analysis result indicated distinguishable diversity patterns among tropical (nSCS), temperate, and cold waters, thereby supporting the niche adaptation of specific Rhodobacterales members in unique environments.	[Sun, Fu-Lin; Wang, You-Shao; Wu, Mei-Lin; Jiang, Zhao-Yu; Sun, Cui-Ci; Cheng, Hao] Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Sun, Fu-Lin; Wang, You-Shao; Sun, Cui-Ci] Chinese Acad Sci, South China Sea Inst Oceanol, Daya Bay Marine Biol Res Stn, Shenzhen, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Wang, YS (corresponding author), Chinese Acad Sci, State Key Lab Trop Oceanog, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.	yswang@scsio.ac.cn	Wu, Mei-Lin/G-4776-2011		National Natural Science Foundation of China [41406130, 41176101, 41430966, 31270528, 41206082]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA10020225]; key projects in the National Science & Technology Pillar Program [2012BAC07B0402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); key projects in the National Science & Technology Pillar Program	This research was supported by the National Natural Science Foundation of China (41406130, 41176101, 41430966, 31270528 and 41206082), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA10020225), and the key projects in the National Science & Technology Pillar Program in the Eleventh Five-year Plan Period (2012BAC07B0402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2003, APPL ENVIRON MICROB, V69, P5051, DOI 10.1128/AEM.69.9.5051-5059.2003; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Fu YY, 2013, FEMS MICROBIOL ECOL, V84, P564, DOI 10.1111/1574-6941.12085; Fu YY, 2010, AQUAT MICROB ECOL, V59, P283, DOI 10.3354/ame01398; Giebel HA, 2009, ENVIRON MICROBIOL, V11, P2164, DOI 10.1111/j.1462-2920.2009.01942.x; Giovannoni S, 2007, NAT REV MICROBIOL, V5, P820, DOI 10.1038/nrmicro1752; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; Han W.Y., 1998, MARINE CHEM S CHINA; Henriques IS, 2004, FEMS MICROBIOL ECOL, V49, P269, DOI 10.1016/j.femsec.2004.04.003; Hill PG, 2010, FEMS MICROBIOL LETT, V306, P82, DOI 10.1111/j.1574-6968.2010.01940.x; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lang AS, 2000, P NATL ACAD SCI USA, V97, P859, DOI 10.1073/pnas.97.2.859; Lenk S, 2012, ISME J, V6, P2178, DOI 10.1038/ismej.2012.66; Leps J., 2003, MULTIVARIATE ANAL EC; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Lu ZM, 2010, J MARINE SYST, V82, P35, DOI 10.1016/j.jmarsys.2010.03.002; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Moran MA, 2003, GEOMICROBIOL J, V20, P375, DOI 10.1080/01490450303901; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Qu T, 2000, J GEOPHYS RES-OCEANS, V105, P6415, DOI 10.1029/1999JC900323; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SOLIOZ M, 1977, ARCH BIOCHEM BIOPHYS, V181, P300, DOI 10.1016/0003-9861(77)90508-2; Suzuki MT, 2004, MICROB ECOL, V48, P473, DOI 10.1007/s00248-004-0213-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zhao YL, 2009, ISME J, V3, P364, DOI 10.1038/ismej.2008.115	36	9	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111892	10.1371/journal.pone.0111892	http://dx.doi.org/10.1371/journal.pone.0111892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364820	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100134
J	Ma, FJ; Liu, ZB; Hu, X; Ling, H; Li, S; Wu, J; Shao, ZM				Ma, Fang-Jing; Liu, Zhe-Bin; Hu, Xin; Ling, Hong; Li, Shan; Wu, Jiong; Shao, Zhi-Ming			Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients	PLOS ONE			English	Article							INFILTRATING DUCTAL CARCINOMA; IMMUNE CELLS; TUMOR; EXPRESSION; PROLIFERATION; METASTASIS; ACTIVATION; PACLITAXEL; SURVIVAL; GROWTH	Purpose: Breast cancer remains a major cause of death in women worldwide, and tumor metastasis is the leading cause of death in breast cancer patients after conventional treatment. Chronic inflammation is often related to the occurrence and growth of various malignancies. This study evaluated the prognosis of breast cancer patients based on contributors to the innate immune response: myeloid differentiation primary response 88 (MyD88) and Toll-like receptor 4 (TLR4). Methods: We analyzed data from 205 breast invasive ductal carcinoma (IDC) patients who were treated at the Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, from 2002 to 2006. Overall survival (OS) and disease-free survival (DFS) were compared. Results: In total, 152 patients (74.15%) were disease-free without relapse or metastasis, whereas 53 (25.85%) patients developed recurrence or metastasis. A significant positive correlation was observed between MyD88 and TLR4 expression (p<0.001). Patients with high expression were more likely to experience death and recurrence/metastasis events (p<0.05). Patients with low MyD88 or TLR4 expression levels had better DFS and OS than patients with high expression levels (log-rank test: p<0.001). Patients with low MyD88 and TLR4 expression levels had better DFS and OS than patients with high expression levels of either (log-rank test: p<0.001). In a multivariate analysis, high MyD88 expression was an independent predictive factor for decreased DFS (adjusted HR, 3.324; 95% CI, 1.663-6.641; p = 0.001) and OS (adjusted HR, 4.500; 95% CI, 1.546-13.098; p = 0.006). Conclusions: TLR4-MyD88 signaling pathway activation or MyD88 activation alone may be a risk factor for poor prognosis in breast cancer. Therefore, TLR4-MyD88 signaling pathway activation in tumor biology provides a novel potential target for breast cancer therapy.	[Ma, Fang-Jing; Liu, Zhe-Bin; Hu, Xin; Ling, Hong; Li, Shan; Wu, Jiong; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China; [Ma, Fang-Jing; Liu, Zhe-Bin; Hu, Xin; Ling, Hong; Li, Shan; Wu, Jiong; Shao, Zhi-Ming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Ma, Fang-Jing] Xinjiang Med Univ, Affiliated Hosp 1, Dept Breast Surg, Urumqi, Xinjiang Uygur, Peoples R China	Fudan University; Fudan University; Xinjiang Medical University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [81202080, 81302009, 81201531]; Shanghai Committee of Science and Technology Funds [12ZR1442400, 12DZ2260100, 12ZR1406400, 12ZR1406200, 1241010707700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This research is supported by grants from the National Natural Science Foundation of China (Contract grant numbers: 81202080, 81302009, 81201531) and the Shanghai Committee of Science and Technology Funds (Contract grant numbers: 12ZR1442400, 12DZ2260100, 12ZR1406400, 12ZR1406200, 1241010707700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2013, ANN SURG ONCOL, V20, pS389, DOI 10.1245/s10434-012-2595-9; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bhattacharya D, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/716564; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Cao AY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-91; Cao AY, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-152; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Costantini S, 2009, IMMUNOL LETT, V126, P91, DOI 10.1016/j.imlet.2009.08.006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Liang BB, 2013, CLIN CANCER RES, V19, P2905, DOI 10.1158/1078-0432.CCR-12-1245; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Molteni M, 2006, CANCER LETT, V235, P75, DOI 10.1016/j.canlet.2005.04.006; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Reed W, 2000, CANCER, V88, P804, DOI 10.1002/(SICI)1097-0142(20000215)88:4<804::AID-CNCR11>3.0.CO;2-Y; Ren T, 2007, CANCER BIOL THER, V6, P1704, DOI 10.4161/cbt.6.11.4826; Ren T, 2009, PATHOL ONCOL RES, V15, P623, DOI 10.1007/s12253-009-9162-0; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Vaisanen MR, 2010, PROSTATE, V70, P817, DOI 10.1002/pros.21115; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	34	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111639	10.1371/journal.pone.0111639	http://dx.doi.org/10.1371/journal.pone.0111639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360699	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700136
J	Pitt, C; Robert, JA; Bonnett, TR; Keeling, CI; Bohlmann, J; Huber, DPW				Pitt, Caitlin; Robert, Jeanne A.; Bonnett, Tiffany R.; Keeling, Christopher I.; Bohlmann, Joerg; Huber, Dezene P. W.			Proteomics Indicators of the Rapidly Shifting Physiology from Whole Mountain Pine Beetle, Dendroctonus ponderosae (Coleoptera: Curculionidae), Adults during Early Host Colonization	PLOS ONE			English	Article							IPS-PARACONFUSUS COLEOPTERA; JUVENILE-HORMONE; BARK BEETLES; GENE-EXPRESSION; PHEROMONE BIOSYNTHESIS; ENGRAVER BEETLE; RANGE EXPANSION; SCOLYTIDAE; DEFENSE; TRANSCRIPTOME	We developed proteome profiles for host colonizing mountain pine beetle adults, Dendroctonus ponderosae Hopkins (Coleoptera: Curculionidae). Adult insects were fed in pairs on fresh host lodgepole pine, Pinus contorta Dougl. ex Loud, phloem tissue. The proteomes of fed individuals were monitored using iTRAQ and compared to those of starved beetles, revealing 757 and 739 expressed proteins in females and males, respectively, for which quantitative information was obtained. Overall functional category distributions were similar for males and females, with the majority of proteins falling under carbohydrate metabolism (glycolysis, gluconeogenesis, citric acid cycle), structure (cuticle, muscle, cytoskeleton), and protein and amino acid metabolism. Females had 23 proteins with levels that changed significantly with feeding (p<0.05, FDR<0.20), including chaperones and enzymes required for vitellogenesis. In males, levels of 29 proteins changed significantly with feeding (p<0.05, FDR<0.20), including chaperones as well as motor proteins. Only two proteins, both chaperones, exhibited a significant change in both females and males with feeding. Proteins with differential accumulation patterns in females exhibited higher fold changes with feeding than did those in males. This difference may be due to major and rapid physiological changes occurring in females upon finding a host tree during the physiological shift from dispersal to reproduction. The significant accumulation of chaperone proteins, a cytochrome P450, and a glutathione S-transferase, indicate secondary metabolite-induced stress physiology related to chemical detoxification during early host colonization. The females' activation of vitellogenin only after encountering a host indicates deliberate partitioning of resources and a balancing of the needs of dispersal and reproduction.	[Pitt, Caitlin; Robert, Jeanne A.; Bonnett, Tiffany R.; Huber, Dezene P. W.] Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada; [Keeling, Christopher I.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	University of Northern British Columbia; University of British Columbia	Pitt, C (corresponding author), Univ No British Columbia, Ecosyst Sci & Management Program, Prince George, BC V2L 5P2, Canada.	pitt@unbc.ca; huber@unbc.ca	Keeling, Christopher I./I-3371-2012; Huber, Dezene P.W./AAG-9638-2019	Keeling, Christopher I./0000-0001-7885-8558; Huber, Dezene P.W./0000-0002-6495-1759	Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship; Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant; Genome Canada; Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program; Canada Foundation for Innovation (CFI); British Columbia Knowledge Development Fund (BCKDF); Genome BC	Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship; Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Genome British Columbia; Genome Alberta; Canada Research Chairs (CRC) Program(Canada Research Chairs); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); British Columbia Knowledge Development Fund (BCKDF); Genome BC	This work was supported by the following: Natural Science and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship (http://www.nserc-crsng.gc.ca/index_eng.asp); Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng.asp); Genome Canada (http://www.genomecanada.ca); Genome British Columbia (http://www.genomebc.ca); Genome Alberta (http://genomealberta.ca); Canada Research Chairs (CRC) Program (http://www.chairs-chaires.gc.ca); Canada Foundation for Innovation (CFI) (http://www.innovation.ca; and British Columbia Knowledge Development Fund (BCKDF) (http://www.aved.gov.bc.ca/researchandinnovation/Funding/BCKDF/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported in part by Genome Canada, Genome BC, and Genome Alberta as part of the Tria Project (www.thetriaproject.ca). This does not alter our adherence to PLOS ONE policies on sharing data and materials and no competing interests exist. Information for all proteins in the dataset is provided in the Supplemental Materials file.	Amman GD., 1977, ROLE ARTHROPODS FORE, P3; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Asgari S, 2003, J INSECT PHYSIOL, V49, P545, DOI 10.1016/S0022-1910(03)00025-8; Aw T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-215; Barkawi LS, 2003, INSECT BIOCHEM MOLEC, V33, P773, DOI 10.1016/S0965-1748(03)00069-9; Bearfield JC, 2006, INSECT MOL BIOL, V15, P187, DOI 10.1111/j.1365-2583.2006.00627.x; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bonnett TR, 2012, INSECT BIOCHEM MOLEC, V42, P890, DOI 10.1016/j.ibmb.2012.08.003; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; Borden J.H., 1985, P257; BULLARD B, 1977, BIOCHEM J, V161, P399, DOI 10.1042/bj1610399; BYERS JA, 1990, NATURWISSENSCHAFTEN, V77, P385, DOI 10.1007/BF01135739; BYERS JA, 1989, EXPERIENTIA, V45, P271, DOI 10.1007/BF01951813; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; CHEN NM, 1988, J CHEM ECOL, V14, P1087, DOI 10.1007/BF01019337; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Eigenheer AL, 2003, GENE, V316, P127, DOI 10.1016/S0378-1119(03)00749-2; Elkin CM, 2005, FUNCT ECOL, V19, P102, DOI 10.1111/j.0269-8463.2005.00935.x; ElMezgueldi M, 1996, INT J BIOCHEM CELL B, V28, P1185, DOI 10.1016/S1357-2725(96)00085-4; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; GOLL DE, 1972, J MOL BIOL, V67, P469, DOI 10.1016/0022-2836(72)90464-0; Graf M, 2012, CAN ENTOMOL, V144, P467, DOI 10.4039/tce.2012.38; Hakimov HA, 2009, PROTEOMICS, V9, P4000, DOI 10.1002/pmic.200900049; Hall DE, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-80; Hall GM, 2002, INSECT BIOCHEM MOLEC, V32, P1525, DOI 10.1016/S0965-1748(02)00073-5; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hojo M, 2005, INSECT BIOCHEM MOLEC, V35, P347, DOI 10.1016/j.ibmb.2005.01.007; Huber DPW, 2009, AGR FOREST ENTOMOL, V11, P83, DOI 10.1111/j.1461-9563.2008.00411.x; Huber DPW, 2003, ENVIRON ENTOMOL, V32, P742, DOI 10.1603/0046-225X-32.4.742; Huber DPW, 2000, CHEMOECOLOGY, V10, P103, DOI 10.1007/PL00001811; Jordal BH, 2011, MOL PHYLOGENET EVOL, V59, P708, DOI 10.1016/j.ympev.2011.03.016; Keeling CI, 2013, P NATL ACAD SCI USA, V110, P18838, DOI 10.1073/pnas.1316498110; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Keeling CI, 2006, INSECT MOL BIOL, V15, P207, DOI 10.1111/j.1365-2583.2006.00629.x; Keeling CI, 2004, NATURWISSENSCHAFTEN, V91, P324, DOI 10.1007/s00114-004-0523-y; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lindgren BS, 1989, P S MAN LODG PIN MIN, P83; Lippert DN, 2009, PROTEOMICS, V9, P350, DOI 10.1002/pmic.200800252; LYON R. L., 1958, CANADIAN ENT, V90, P582; MARCEY D, 1991, EMBO J, V10, P4259, DOI 10.1002/j.1460-2075.1991.tb05004.x; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Oberprieler Rolf G., 2007, Zootaxa, V1668, P491; Ohlund LB, 2011, SAMPLE PREPARATION IN BIOLOGICAL MASS SPECTROMETRY, P575, DOI 10.1007/978-94-007-0828-0_28; Park K, 2008, ENV TOX, V24, P555; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Robert JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077777; RUDINSKY JA, 1962, ANNU REV ENTOMOL, V7, P327, DOI 10.1146/annurev.en.07.010162.001551; Safranyik L, 1992, J APPL ENTOMOL, V113, P1; SEYBOLD SJ, 1995, P NATL ACAD SCI USA, V92, P8393, DOI 10.1073/pnas.92.18.8393; Seybold Steven J., 2006, Phytochemistry Reviews, V5, P143, DOI 10.1007/s11101-006-9002-8; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tittiger C, 2005, RECENT ADV PHYTOCHEM, V39, P57; Tittiger C, 1999, CELL MOL LIFE SCI, V55, P121, DOI 10.1007/s000180050275; Tittiger C, 2003, MOL CELL ENDOCRINOL, V199, P11, DOI 10.1016/S0303-7207(02)00358-1; Walton A, 2013, PROVINCIAL LEVEL PRO; Wood SL, 1992, GREAT BASIN NAT, V13, P159	67	24	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110673	10.1371/journal.pone.0110673	http://dx.doi.org/10.1371/journal.pone.0110673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360753	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700040
J	Syed, W; Colaco, M; Misquith, S				Syed, Wajeed; Colaco, Melwin; Misquith, Sandra			Mutational Analysis Gives Insight into Substrate Preferences of a Nucleotidyl Cyclase from Mycobacterium avium	PLOS ONE			English	Article							ADENYLYL-CYCLASE; GUANYLYL CYCLASES; CRYSTAL-STRUCTURE; CYCLIC-GMP; CATALYTIC DOMAIN; TUBERCULOSIS; RV1625C; SPECIFICITY; EVOLUTION	Mutational, crystallographic and phylogenetic analysis of nucleotidyl cyclases have been used to understand how these enzymes discriminate between substrates. Ma1120, a class III adenylyl cyclase (AC) from Mycobacterium avium, was used as a model to study the amino acid residues that determine substrate preference, by systematically replacing ATP specifying residues with those known to specify GTP. This enzyme was found to possess residual guanylyl cyclase (GC) activity at alkaline pH. Replacement of key residues lysine (101) and aspartate (157) with residues conserved across GCs by site directed mutagenesis, led to a marked improvement in GC activity and a decrease in AC activity. This could be correlated to the presence and strength of the hydrogen bond between the second substrate binding residue (157) and the base of the nucleotide triphosphate. This is substantiated by the fact that the pH optimum is highly dependent on the amino acid residues present at positions 101 and 157.	[Syed, Wajeed; Colaco, Melwin; Misquith, Sandra] St Josephs Coll, Dept Chem, Bangalore, Karnataka, India	St. Josephs College	Misquith, S (corresponding author), St Josephs Coll, Dept Chem, Bangalore, Karnataka, India.	s.misquith@sjc.ac.in	Colaço, Melwin/ABD-9691-2021; Wajeed, Syed/ABF-5775-2021	Wajeed, Syed/0000-0002-1382-9972; Colaco, Melwin/0000-0002-6565-0595	CSIR, New Delhi [37(1271)/06/EMR-II]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by CSIR, New Delhi: 37(1271)/06/EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; An SQ, 2013, EMBO J, V32, P2430, DOI 10.1038/emboj.2013.165; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; BEUVE A, 1992, J MOL BIOL, V225, P933, DOI 10.1016/0022-2836(92)90093-Y; Beuve A, 1999, METHODS, V19, P545, DOI 10.1006/meth.1999.0896; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kasahara M, 2001, J BIOL CHEM, V276, P10564, DOI 10.1074/jbc.M008006200; Ketkar AD, 2004, ACTA CRYSTALLOGR D, V60, P371, DOI 10.1107/S0907444903028002; LARSON JW, 1984, INORG CHEM, V23, P2029, DOI 10.1021/ic00182a010; Linder JU, 2005, IUBMB LIFE, V57, P797, DOI 10.1080/15216540500415636; Linder JU, 2002, J BIOL CHEM, V277, P15271, DOI 10.1074/jbc.M200235200; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Linder JU, 2008, CURR OPIN STRUC BIOL, V18, P667, DOI 10.1016/j.sbi.2008.11.008; Marden JN, 2011, MOL MICROBIOL, V79, P600, DOI 10.1111/j.1365-2958.2010.07513.x; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Reddy SK, 2001, J BIOL CHEM, V276, P35141, DOI 10.1074/jbc.M104108200; Roelofs J, 2001, BIOCHEM J, V354, P697, DOI 10.1042/0264-6021:3540697; Sambrook J., 2001, MOL CLONING LAB MANU; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Shan SO, 1996, P NATL ACAD SCI USA, V93, P14474, DOI 10.1073/pnas.93.25.14474; Shenoy AR, 2005, BIOCHEM J, V387, P541, DOI 10.1042/BJ20041040; Shenoy AR, 2003, FEBS LETT, V545, P253, DOI 10.1016/S0014-5793(03)00580-5; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Shenoy AR, 2005, BIOCHIMIE, V87, P557, DOI 10.1016/j.biochi.2005.01.017; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Yan SZ, 1997, J BIOL CHEM, V272, P12342, DOI 10.1074/jbc.272.19.12342; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109358	10.1371/journal.pone.0109358	http://dx.doi.org/10.1371/journal.pone.0109358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360748	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700012
J	Wurtz, M; Nissen, PH; Grove, EL; Kristensen, SD; Hvas, AM				Wurtz, Morten; Nissen, Peter H.; Grove, Erik Lerkevang; Kristensen, Steen Dalby; Hvas, Anne-Mette			Genetic Determinants of On-Aspirin Platelet Reactivity: Focus on the Influence of PEAR1	PLOS ONE			English	Article							AGGREGATION; RESISTANCE; RECEPTOR; PHARMACOGENETICS; ACTIVATION; VARIANT	Background: Platelet aggregation during aspirin treatment displays considerable inter-individual variability. A genetic etiology likely exists, but it remains unclear to what extent genetic polymorphisms determine platelet aggregation in aspirin-treated individuals. Aim: To identify platelet-related single nucleotide polymorphisms (SNPs) influencing platelet aggregation during aspirin treatment. Furthermore, we explored to what extent changes in cyclooxygenase-1 activity and platelet activation may explain such influence. Methods: We included 985 Danish patients with stable coronary artery disease treated with aspirin 75 mg/day mono antiplatelet therapy. Patients were genotyped for 16 common SNPs in platelet-related genes using standard PCR-based methods (TaqMan). Platelet aggregation was evaluated by whole blood platelet aggregometry employing Multiplate Analyzer (agonists: arachidonic acid and collagen) and VerifyNow Aspirin. Serum thromboxane B-2 was measured to confirm aspirin adherence and was used as a marker of cyclooxygenase-1 activity. Soluble P-selectin was used as marker of platelet activation. Platelet aggregation, cyclooxygenase-1 activity, and platelet activation were compared across genotypes in adjusted analyses. Results: The A-allele of the rs12041331 SNP in the platelet endothelial aggregation receptor-1 (PEAR1) gene was associated with reduced platelet aggregation and increased platelet activation, but not with cyclooxygenase-1 activity. Platelet aggregation was unaffected by the other SNPs analyzed. Conclusion: A common genetic variant in PEAR1 (rs12041331) reproducibly influenced platelet aggregation in aspirin-treated patients with coronary artery disease. The exact biological mechanism remains elusive, but the effect of this polymorphism may be related to changes in platelet activation. Furthermore, 14 SNPs previously suggested to influence aspirin efficacy were not associated with on-aspirin platelet aggregation.	[Wurtz, Morten; Grove, Erik Lerkevang; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Wurtz, Morten] Reg Hosp West Jutland, Dept Internal Med, Herning, Denmark; [Nissen, Peter H.; Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Hvas, AM (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	am.hvas@dadlnet.dk		Grove, Erik/0000-0002-1466-0865	Gangsted Fonden; A.P.MAller Foundation for The Advancement of Medical Sciences	Gangsted Fonden; A.P.MAller Foundation for The Advancement of Medical Sciences	Support for this study was provided by Gangsted Fonden, No grant number available, URL: (http://www.gangstedfonden.dk); The A.P.MAller Foundation for The Advancement of Medical Sciences, No grant number available, URL: (http://www.apmollerfonde.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; Armstrong PCJ, 2010, J THROMB HAEMOST, V8, P613, DOI 10.1111/j.1538-7836.2009.03714.x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Conneely KN, 2010, GENET EPIDEMIOL, V34, P739, DOI 10.1002/gepi.20538; Faraday N, 2007, CIRCULATION, V115, P2490, DOI 10.1161/CIRCULATIONAHA.106.667584; Faraday N, 2011, BLOOD, V118, P3367, DOI 10.1182/blood-2010-11-320788; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Frelinger AL, 2011, THROMB HAEMOSTASIS, V106, P219, DOI 10.1160/TH11-03-0185; Goodman T, 2008, BRIT J CLIN PHARMACO, V66, P222, DOI 10.1111/j.1365-2125.2008.03183.x; Grove EL, 2012, CURR PHARM DESIGN, V18, P5379; Gurbel PA, 2007, CIRCULATION, V115, P3156, DOI 10.1161/CIRCULATIONAHA.106.675587; Gurbel PA, 2010, J AM COLL CARDIOL, V56, P112, DOI 10.1016/j.jacc.2010.04.008; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Herrera-Galeano JE, 2008, ARTERIOSCL THROM VAS, V28, P1484, DOI 10.1161/ATVBAHA.108.168971; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Kauskot A, 2013, BLOOD, V121, P5208, DOI 10.1182/blood-2012-10-462887; Kauskot A, 2012, BLOOD, V119, P4056, DOI 10.1182/blood-2011-11-392787; Kim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064179; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Lewis JP, 2013, CIRC-CARDIOVASC GENE, V6, P184, DOI 10.1161/CIRCGENETICS.111.964627; Lordkipanidze M, 2011, THROMB RES, V128, P47, DOI 10.1016/j.thromres.2011.02.019; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; Nanda N, 2005, J BIOL CHEM, V280, P24680, DOI 10.1074/jbc.M413411200; O'Donnell CJ, 2001, CIRCULATION, V103, P3051, DOI 10.1161/01.CIR.103.25.3051; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Roberts R, 2012, J AM COLL CARDIOL, V60, P1715, DOI 10.1016/j.jacc.2011.12.062; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Schwartz KA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-46; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wurtz M, 2013, J THROMB HAEMOST, V11, P1627, DOI 10.1111/jth.12318; Wurtz M, 2014, PLATELETS, V25, P628, DOI 10.3109/09537104.2013.849804; Wurtz M, 2012, CURR PHARM DESIGN, V18, P5344, DOI 10.2174/138161212803251925; Wurtz M, 2012, CURR PHARM DESIGN, V18, P5294, DOI 10.2174/138161212803251907; Wurtz M, 2010, HEART, V96, P368, DOI 10.1136/hrt.2009.181107	35	38	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111816	10.1371/journal.pone.0111816	http://dx.doi.org/10.1371/journal.pone.0111816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360888	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700153
J	Xie, ML; Shan, ZL; Zhang, Y; Chen, SJ; Yang, W; Bao, W; Rong, Y; Yu, XF; Hu, FB; Liu, LG				Xie, Manling; Shan, Zhilei; Zhang, Yan; Chen, Sijing; Yang, Wei; Bao, Wei; Rong, Ying; Yu, Xuefeng; Hu, Frank B.; Liu, Liegang			Aspirin for Primary Prevention of Cardiovascular Events: Meta-Analysis of Randomized Controlled Trials and Subgroup Analysis by Sex and Diabetes Status	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; AMERICAN-HEART-ASSOCIATION; PLACEBO-CONTROLLED TRIAL; MYOCARDIAL-INFARCTION; SCIENTIFIC STATEMENT; GENERAL-POPULATION; VASCULAR-DISEASE; WHOLE-BLOOD; MELLITUS; RISK	Objective: To evaluate the benefits and harms of aspirin for the primary prevention of CVD and determine whether the effects vary by sex and diabetes status. Methods: We searched Medline, Embase, and Cochrane databases for randomized controlled trials comparing the effects of aspirin with placebo or control in people with no pre-existing CVD. Two investigators independently extracted data and assessed the study quality. Analyses were performed using Stata version 12. Results: Fourteen trials (107,686 participants) were eligible. Aspirin was associated with reductions in major cardiovascular events (risk ratio, 0.90; 95% confidence interval, 0.85-0.95), myocardial infarction (0.86; 0.75-0.93), ischemic stroke (0.86; 0.75-0.98) and all-cause mortality (0.94; 0.89-0.99). There were also increases in hemorrhagic stroke (1.34; 1.01-1.79) and major bleeding (1.55; 1.35-1.78) with aspirin. The number needed to treat to prevent 1 major cardiovascular event over a mean follow-up of 6.8 years was 284. By comparison, the numbers needed to harm to cause 1 major bleeding is 299. In subgroup analyses, pooled results demonstrated a reduction in myocardial infarction among men (0.71; 0.59-0.85) and ischemic stroke among women (0.77; 0.63-0.93). Aspirin use was associated with a reduction (0.65; 0.51-0.82) in myocardial infarction among diabetic men. In meta-regression analyses, the results suggested that aspirin therapy might be associated with a decrease in stroke among diabetic women and a decrease in MI among diabetic men and risk reductions achieved with low doses (75 mg/day) were as large as those obtained with higher doses (650 mg/day). Conclusions: The use of low-dose aspirin was beneficial for primary prevention of CVD and the decision regarding an aspirin regimen should be made on an individual patient basis. The effects of aspirin therapy varied by sex and diabetes status. A clear benefit of aspirin in the primary prevention of CVD in people with diabetes needs more trials.	[Xie, Manling; Shan, Zhilei; Zhang, Yan; Chen, Sijing; Yang, Wei; Bao, Wei; Rong, Ying; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg,Hubei Key Lab Food Nutr & Sa, Wuhan 430074, Peoples R China; [Xie, Manling; Shan, Zhilei; Zhang, Yan; Chen, Sijing; Yang, Wei; Bao, Wei; Rong, Ying; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430074, Peoples R China; [Yu, Xuefeng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med,Div Endocrinol, Wuhan 430074, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu; lgliu@mails.tjmu.edu.cn	Bao, Wei/AAG-2431-2019; Shan, Zhilei/S-5189-2019	Bao, Wei/0000-0002-7301-5786; 	National Natural Science Foundation of China [NSFC 81072291]; National Science and Technology Support Program of China [2012BAI02B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China	This review was funded by grants from the National Natural Science Foundation of China (NSFC 81072291) and the National Science and Technology Support Program of China (2012BAI02B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algra A, 2009, LANCET, V373, P1821, DOI 10.1016/S0140-6736(09)61003-5; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Alzahrani SH, 2010, DIABETES VASC DIS RE, V7, P260, DOI 10.1177/1479164110383723; [Anonymous], 2008, TYP 2 DIAB NAT CLIN; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2011, AM HEART J, V162, P115, DOI 10.1016/j.ahj.2011.04.006; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Butalia S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-25; Calonge N, 2009, ANN INTERN MED, V150, P396; Calvin AD, 2009, DIABETES CARE, V32, P2300, DOI 10.2337/dc09-1297; Capodanno D, 2011, CIRC-CARDIOVASC INTE, V4, P180, DOI 10.1161/CIRCINTERVENTIONS.110.960187; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; COTE R, 1995, ANN INTERN MED, V123, P649, DOI 10.7326/0003-4819-123-9-199511010-00002; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; De Berardis Giorgia, 2009, BMJ, V339, pb4531, DOI 10.1136/bmj.b4531; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Erkan D, 2007, ARTHRITIS RHEUM-US, V56, P2382, DOI 10.1002/art.22663; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kappagoda T, 2012, J CARDIOPULM REHABIL, V32, P1, DOI 10.1097/HCR.0b013e31822f1aa7; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Meade TW, 1998, LANCET, V351, P233; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Milicic Davor, 2011, Lijec Vjesn, V133, P337; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mortensen SB, 2010, THROMB RES, V126, pE318, DOI 10.1016/j.thromres.2010.03.013; Mylotte D, 2012, PLATELETS, V23, P439, DOI 10.3109/09537104.2011.634932; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Patrono C, 2004, CHEST, V126, p234S, DOI 10.1378/chest.126.3_suppl.234S; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Perneby C, 2006, THROMB HAEMOSTASIS, V95, P652, DOI 10.1160/TH05-10-0653; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Raichand S, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-16; Reid CM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-3; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schnell O, 2012, DIABETES VASC DIS RE, V9, P245, DOI 10.1177/1479164112441486; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Simpson SH, 2011, J GEN INTERN MED, V26, P1336, DOI 10.1007/s11606-011-1757-y; Spectre G, 2011, THROMB HAEMOSTASIS, V106, P491, DOI 10.1160/TH11-04-0216; Stavrakis S, 2011, AM J MED SCI, V341, P1, DOI 10.1097/MAJ.0b013e3181f1fba8; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TSCHOEPE D, 1995, SEMIN THROMB HEMOST, V21, P152, DOI 10.1055/s-2007-1000390; Undas A, 2007, BLOOD, V109, P2285, DOI 10.1182/blood-2006-01-010645; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vivas D, 2011, J THROMB THROMBOLYS, V32, P356, DOI 10.1007/s11239-011-0596-3; Watala C, 2004, THROMB RES, V113, P101, DOI 10.1016/j.thromres.2003.12.016; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009; Younis N, 2010, EXPERT OPIN PHARMACO, V11, P1459, DOI 10.1517/14656561003792538; Zhang CY, 2010, DIABETES RES CLIN PR, V87, P211, DOI 10.1016/j.diabres.2009.09.029	79	38	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e90286	10.1371/journal.pone.0090286	http://dx.doi.org/10.1371/journal.pone.0090286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360605	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700001
J	Zhang, J; Wang, LL; Du, W; Yu, YC; Ju, WZ; Man, YL; Li, XR; Chen, Y; Wang, ZD; Gu, WJ; Zhang, FX; Wang, H; Wu, CT; Cao, KJ				Zhang, Jian; Wang, Lin-Lin; Du, Wei; Yu, Yi-Chao; Ju, Wei-Zhu; Man, Yi-Long; Li, Xiao-Rong; Chen, Yan; Wang, Zi-Dun; Gu, Wei-Juan; Zhang, Feng-Xiang; Wang, Hua; Wu, Chu-Tse; Cao, Ke-Jiang			Hepatocyte Growth Factor Modification Enhances the Anti-Arrhythmic Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; CELLULAR CARDIOMYOPLASTY; VENTRICULAR-ARRHYTHMIAS; HEART FUNCTION; ISCHEMIA; MODEL; TRANSPLANTATION; EXPRESSION; DIFFERENTIATION	Background/Aims: Chronic myocardial infarction (MI) results in the formation of arrhythmogenic substrates, causing lethal ventricular arrhythmia (VA). We aimed to determine whether mesenchymal stem cells (MSCs) carrying a hepatocyte growth factor (HGF) gene modification (HGF-MSCs) decrease the levels of arrhythmogenic substrates and reduce the susceptibility to developing VA compared with unmodified MSCs and PBS in a swine infarction model. Methods: The left descending anterior artery was balloon-occluded to establish an MI model. Four weeks later, the randomly grouped pigs were administered MSCs, PBS or HGF-MSCs via thoracotomy. After an additional four weeks, dynamic electrocardiography was performed to assess heart rate variability, and programmed electrical stimulation was conducted to evaluate the risk for VA. Then, the pigs were euthanized for morphometric, immunofluorescence and western blot analyses. Results: The HGF-MSC group displayed the highest vessel density and Cx43 expression levels, and the lowest levels of apoptosis, and tyrosine hydroxylase (TH) and growth associated protein 43 (GAP43) expression. Moreover, the HGF-MSC group exhibited a decrease in the number of sympathetic nerve fibers, substantial decreases in the low frequency and the low-/high-frequency ratio and increases in the root mean square of successive differences (rMSSD) and the percentage of successive normal sinus R-R intervals longer than 50 ms (pNN50), compared with the other two groups. Finally, the HGF-MSC group displayed the lowest susceptibility to developing VA. Conclusion: HGF-MSCs displayed potent antiarrhythmic effects, reducing the risk for VA.	[Zhang, Jian; Wang, Lin-Lin; Du, Wei; Ju, Wei-Zhu; Man, Yi-Long; Li, Xiao-Rong; Chen, Yan; Wang, Zi-Dun; Gu, Wei-Juan; Zhang, Feng-Xiang; Cao, Ke-Jiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Yu, Yi-Chao] Nanjing Med Univ, Affiliated Hosp 2, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Wang, Hua; Wu, Chu-Tse] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Academy of Military Medical Sciences - China	Cao, KJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	kjcao_nj@126.com	Zhang, Fengxiang/Z-2807-2019	Wu, Chu-tse/0000-0003-0417-8925	National Natural Science Foundation of China [81170157, 81170160, 81470456]; Six Peak Talents Foundation of Jiangsu Province [2011-WS-071]; Graduate Innovation Foundation of Jiangsu Province [CXZZ 12_0568, JX22013218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Six Peak Talents Foundation of Jiangsu Province; Graduate Innovation Foundation of Jiangsu Province	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81170157, 81170160, 81470456), Six Peak Talents Foundation of Jiangsu Province (Grant No. 2011-WS-071), the Graduate Innovation Foundation of Jiangsu Province (Grant No. CXZZ 12_0568, JX22013218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajijola OA, 2013, AM J PHYSIOL-HEART C, V305, pH1031, DOI 10.1152/ajpheart.00434.2013; Bian L, 2009, IN VIVO, V23, P21; [边莉 BIAN Li], 2006, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V30, P323; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen PS, 2001, CARDIOVASC RES, V50, P409, DOI 10.1016/S0008-6363(00)00308-4; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; Falcone C, 2005, CIRCULATION, V112, P1959, DOI 10.1161/CIRCULATIONAHA.105.545111; Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003; FRANZ MR, 1984, CIRCULATION, V69, P593, DOI 10.1161/01.CIR.69.3.593; Frisch SM, 1996, J CELL BIOL, V135, P1377, DOI 10.1083/jcb.135.5.1377; Funatsu T, 2002, J THORAC CARDIOV SUR, V124, P1099, DOI 10.1067/mtc.2002.123809; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Ha X, 2010, ZHONGGUO XIU FU CHON, V24, P613; HELD P, 1989, CARDIOLOGY, V76, P132, DOI 10.1159/000174484; Kocovic DZ, 1999, J AM COLL CARDIOL, V34, P381, DOI 10.1016/S0735-1097(99)00205-3; Kuhlmann MT, 2006, J EXP MED, V203, P87, DOI 10.1084/jem.20051151; Lee K, 2001, MOL THER, V3, P857, DOI 10.1006/mthe.2001.0327; Liu Hong-Jun, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P1044; Lohr J. W., 2000, Journal of Medicine (Westbury), V31, P131; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Maurel A, 2005, TRANSPLANTATION, V80, P660, DOI 10.1097/01.tp.0000172178.35488.31; Mills WR, 2007, J MOL CELL CARDIOL, V42, P304, DOI 10.1016/j.yjmcc.2006.09.011; Myerburg RJ, 2006, HEART RHYTHM, V3, P235, DOI 10.1016/j.hrthm.2005.09.023; NORI SL, 1995, CELL MOL BIOL, V41, P799; Oh YS, 2006, HEART RHYTHM, V3, P728, DOI 10.1016/j.hrthm.2006.02.005; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Pinto JMB, 1999, CARDIOVASC RES, V42, P284, DOI 10.1016/S0008-6363(99)00013-9; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Tung R, 2012, CIRC-ARRHYTHMIA ELEC, V5, P264, DOI 10.1161/CIRCEP.111.967976; Wang DG, 2011, INT J CARDIOL, V152, P314, DOI 10.1016/j.ijcard.2010.07.025; Wang H, 2013, HUM GENE THER, V24, P343, DOI 10.1089/hum.2012.177; Zhang FX, 2014, J CELL BIOCHEM, V115, P531, DOI 10.1002/jcb.24687	43	14	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111246	10.1371/journal.pone.0111246	http://dx.doi.org/10.1371/journal.pone.0111246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360679	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700079
J	da Silva, PG; Hernandez, MIM				da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel			Local and Regional Effects on Community Structure of Dung Beetles in a Mainland-Island Scenario	PLOS ONE			English	Article							BETA DIVERSITY; COLEOPTERA SCARABAEIDAE; ATLANTIC FOREST; METACOMMUNITY STRUCTURE; ASSEMBLAGES COLEOPTERA; PARTITIONING DIVERSITY; HABITAT ASSOCIATIONS; LANDSCAPE STRUCTURE; SPECIES RICHNESS; FRAGMENTATION	Understanding the ecological mechanisms driving beta diversity is a major goal of community ecology. Metacommunity theory brings new ways of thinking about the structure of local communities, including processes occurring at different spatial scales. In addition to new theories, new methods have been developed which allow the partitioning of individual and shared contributions of environmental and spatial effects, as well as identification of species and sites that have importance in the generation of beta diversity along ecological gradients. We analyzed the spatial distribution of dung beetle communities in areas of Atlantic Forest in a mainland-island scenario in southern Brazil, with the objective of identifying the mechanisms driving composition, abundance and biomass at three spatial scales (mainland-island, areas and sites). We sampled 20 sites across four large areas, two on the mainland and two on the island. The distribution of our sampling sites was hierarchical and areas are isolated. We used standardized protocols to assess environmental heterogeneity and sample dung beetles. We used spatial eigenfunctions analysis to generate the spatial patterns of sampling points. Environmental heterogeneity showed strong variation among sites and a mild increase with increasing spatial scale. The analysis of diversity partitioning showed an increase in beta diversity with increasing spatial scale. Variation partitioning based on environmental and spatial variables suggests that environmental heterogeneity is the most important driver of beta diversity at the local scale. The spatial effects were significant only at larger spatial scales. Our study presents a case where environmental heterogeneity seems to be the main factor structuring communities at smaller scales, while spatial effects are more important at larger scales. The increase in beta diversity that occurs at larger scales seems to be the result of limitation in species dispersal ability due to habitat fragmentation and the presence of geographical barriers.	[da Silva, Pedro Giovani; Medina Hernandez, Malva Isabel] Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Hernandez, MIM (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	pedrogiovanidasilva@yahoo.com.br	da Silva, Pedro Giovâni/F-7605-2014; Hernandez, Malva I. M./E-3485-2013	da Silva, Pedro Giovâni/0000-0002-0702-9186; Hernandez, Malva I. M./0000-0002-6820-5980	Coordenacao de Pessoal de Nivel Superior [Proc. 001/2010 MEC/CAPES/PNPD]; Coordenacao de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [Proc. 303800/2010-0]	Coordenacao de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is part of the Project "Biodiversidade de artropodes terrestres e aquaticos em diferentes gradientes ambientais da Mata Atlantica do estado de Santa Catarina,'' and was supported by Coordenacao de Pessoal de Nivel Superior (Proc. 001/2010 MEC/CAPES/PNPD). PGS received a post-graduate fellowship from Coordenacao de Pessoal de Nivel Superior. MIMH received a research grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Research Productivity/PQ/2010, Proc. 303800/2010-0, Project "Comportamento de besouros Scarabaeinae e sua funcao no ciclo de decomposicao da materia organica''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida S, 2011, BIOTROPICA, V43, P704, DOI 10.1111/j.1744-7429.2011.00751.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Arellano L, 2008, LANDSCAPE ECOL, V23, P69, DOI 10.1007/s10980-007-9165-8; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brower J. E., 1984, FIELD LAB METHODS GE; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Campos RC, 2013, REV BRAS ENTOMOL, V57, P47, DOI 10.1590/S0085-56262013000100008; Caruso MML, 1983, DESMATAMENTO IIHA SA; Cornell HV, 2007, ECOLOGY, V88, P1707, DOI 10.1890/06-0742.1; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; da Silva PG, 2013, AN ACAD BRAS CIENC, V85, P679, DOI 10.1590/S0001-37652013005000033; Davies KF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P170; Davies KF, 2001, ECOLOGY, V82, P1830, DOI 10.1890/0012-9658(2001)082[1830:EOWABP]2.0.CO;2; Davis Adrian L. V., 2001, Diversity and Distributions, V7, P161, DOI 10.1111/j.1472-4642.2001.00102.x; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Davis ALV, 1996, PEDOBIOLOGIA, V40, P260; Davis Andrew J., 1998, Diversity and Distributions, V4, P167, DOI 10.1046/j.1472-4642.1998.00017.x; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Escobar F, 2005, GLOBAL ECOL BIOGEOGR, V14, P327, DOI 10.1111/j.1466-822x.2005.00161.x; Feer F, 2013, REV BIOL TROP, V61, P753; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gianuca AT, 2013, AUSTRAL ECOL, V38, P864, DOI 10.1111/aec.12023; Giladi I, 2011, J VEG SCI, V22, P983, DOI 10.1111/j.1654-1103.2011.01309.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Halffter G, 2002, BIOTROPICA, V34, P144, DOI 10.1111/j.1744-7429.2002.tb00250.x; Halffter Gonzalo, 1993, Biology International, V27, P15; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Heino J, 2014, CURR OPIN INSECT SCI, V2, P7, DOI 10.1016/j.cois.2014.06.002; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Howeth JG, 2010, ECOLOGY, V91, P2727, DOI 10.1890/09-1004.1; Hubbell Stephen P., 2001, V32, pi; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Kelt DA, 1999, OIKOS, V85, P320, DOI 10.2307/3546498; Klein A. H. F., 2006, EROSAO PROGRADACAO L, P401; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LOBO JM, 1988, REV ECOL BIOL SOL, V25, P77; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MacNeil MA, 2009, ECOLOGY, V90, P252, DOI 10.1890/07-0487.1; May F, 2013, ECOGRAPHY, V36, P842, DOI 10.1111/j.1600-0587.2012.07793.x; Hernandez MIM, 2009, REV BRAS ENTOMOL, V53, P607, DOI 10.1590/S0085-56262009000400010; Meynard CN, 2013, J BIOGEOGR, V40, P1560, DOI 10.1111/jbi.12116; Mouquet N, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P237; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nouhuys S, 2005, METACOMMUNITIES SPAT, P99; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; de Macedo-Soares LCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091241; R Core Team, 2021, R LANGUAGE ENV STAT; R-Forge Administration and Development Team, 2013, SPAT EC DAT AN R R D; Ramos F.A., 2000, J RES LEPIDOPTERA, V35, P29; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Ricklefs Robert E., 1993, P350; Roslin Tomas, 2011, P220; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Simmons LW, 2011, ECOLOGY EVOLUTION DU, P1, DOI DOI 10.1002/9781444342000; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Spector S, 2003, BIOTROPICA, V35, P394; Spector Sacha, 1998, Conservation Biology Series (Cambridge), V1, P181; Tabarelli M, 2005, MEGADIVERSIDADE, V1, P132; Tack AJM, 2009, OIKOS, V118, P809, DOI 10.1111/j.1600-0706.2008.17397.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Veech JA, 2009, PARTITION SOFTWARE H; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Veloso H. M. P., 1991, CLASSIFICACAO VEGETA; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007	98	63	66	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111883	10.1371/journal.pone.0111883	http://dx.doi.org/10.1371/journal.pone.0111883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356729	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000081
J	Ma, J; Song, ZQ; Yan, FH				Ma, Jing; Song, Zhi-Qiang; Yan, Fu-Hua			Separation of Hepatic Iron and Fat by Dual-Source Dual-Energy Computed Tomography Based on Material Decomposition: An Animal Study	PLOS ONE			English	Article							DIFFUSE LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEMOCHROMATOSIS; OVERLOAD; CT; QUANTIFICATION; ACCUMULATION; TOOL	Objective: To explore the feasibility of dual-source dual-energy computed tomography (DSDECT) for hepatic iron and fat separation in vivo. Materials and Methods: All of the procedures in this study were approved by the Research Animal Resource Center of Shanghai Ruijin Hospital. Sixty rats that underwent DECT scanning were divided into the normal group, fatty liver group, liver iron group, and coexisting liver iron and fat group, according to Prussian blue and HE staining. The data for each group were reconstructed and post-processed by an iron-specific, three-material decomposition algorithm. The iron enhancement value and the virtual non-iron contrast value, which indicated overloaded liver iron and residual liver tissue, respectively, were measured. Spearman's correlation and one-way analysis of variance (ANOVA) were performed, respectively, to analyze statistically the correlations with the histopathological results and differences among groups. Results: The iron enhancement values were positively correlated with the iron pathology grading (r = 0.729, p<0.001). Virtual non-iron contrast (VNC) values were negatively correlated with the fat pathology grading (r = 20.642, p<0.0001). Different groups showed significantly different iron enhancement values and VNC values (F = 25.308, p<0.001; F = 10.911, p<0.001, respectively). Among the groups, significant differences in iron enhancement values were only observed between the iron-present and iron-absent groups, and differences in VNC values were only observed between the fat-present and fat-absent groups. Conclusion: Separation of hepatic iron and fat by dual energy material decomposition in vivo was feasible, even when they coexisted.	[Yan, Fu-Hua] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Ma, Jing] Fudan Univ, Shanghai Zhongshan Hosp, Shanghai Med Coll, Dept Radiol, Shanghai 200433, Peoples R China; [Ma, Jing; Song, Zhi-Qiang] Shi Hezi Univ, Corps Hosp, Affiliated Hosp 2, Sch Med,Dept Radiol, Urumqi, Xinjiang Prov, Peoples R China	Shanghai Jiao Tong University; Fudan University	Yan, FH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	missingshz@163.com			Shanghai Science and Technology Council Foundation [124119a3000]	Shanghai Science and Technology Council Foundation	This work was supported by Shanghai Science and Technology Council Foundation (NO. 124119a3000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Boll DT, 2009, RADIOGRAPHICS, V29, P1591, DOI 10.1148/rg.296095513; Castiella A, 2011, EUR RADIOL, V21, P137, DOI 10.1007/s00330-010-1899-z; Chook JB, 2011, J MED VIROL, V83, P594, DOI 10.1002/jmv.22016; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; Di Marco V, 2010, BLOOD, V116, P2875, DOI 10.1182/blood-2009-11-248724; Duman DG, 2006, DIGEST DIS SCI, V51, P346, DOI 10.1007/s10620-006-3136-9; Feher Janos, 2010, Orvosi Hetilap, V151, P933, DOI 10.1556/OH.2010.28900; Fischer MA, 2011, EUR RADIOL, V21, P1727, DOI 10.1007/s00330-011-2119-1; Fischer MA, 2011, INVEST RADIOL, V46, P351, DOI 10.1097/RLI.0b013e31820e1486; GANDON Y, 1994, RADIOLOGY, V193, P533, DOI 10.1148/radiology.193.2.7972774; GUYADER D, 1990, ANN GASTROENT HEPATO, V26, P21; Joe E, 2012, RADIOLOGY, V262, P126, DOI 10.1148/radiol.11110060; Kanayama Y, 2013, ULTRASOUND MED BIOL, V39, P692, DOI 10.1016/j.ultrasmedbio.2012.10.021; Mastoi AA, 2010, WORLD J GASTROENTERO, V16, P603, DOI 10.3748/wjg.v16.i5.603; Midiri M, 2002, Radiol Med, V103, P171; Mortele KJ, 2001, SEMIN LIVER DIS, V21, P195, DOI 10.1055/s-2001-15496; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P4673, DOI 10.3748/wjg.v13.i35.4673; Silva M, 2008, NUTR RES, V28, P391, DOI 10.1016/j.nutres.2008.02.009; Sumida Y, 2009, HEPATOL RES, V39, P213, DOI 10.1111/j.1872-034X.2008.00442.x; Tacikowski Tadeusz, 2004, Pol Arch Med Wewn, V111, P571; Toyokuni S, 2011, FREE RADICAL RES, V45, P906, DOI 10.3109/10715762.2011.564170; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	23	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110964	10.1371/journal.pone.0110964	http://dx.doi.org/10.1371/journal.pone.0110964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356845	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000035
J	Rego, HHA; Braunstein, LA; D'Agostino, G; Stanley, HE; Miyazima, S				Aragao Rego, Henio Henrique; Braunstein, Lidia A.; D'Agostino, Gregorio; Stanley, H. Eugene; Miyazima, Sasuke			When a Text Is Translated Does the Complexity of Its Vocabulary Change? Translations and Target Readerships	PLOS ONE			English	Article							POWER-LAW DISTRIBUTION; EARTHQUAKES; FLUCTUATIONS; CENTURIES; PHYSICS; MODEL	In linguistic studies, the academic level of the vocabulary in a text can be described in terms of statistical physics by using a "temperature'' concept related to the text's word-frequency distribution. We propose a "comparative thermo-linguistic'' technique to analyze the vocabulary of a text to determine its academic level and its target readership in any given language. We apply this technique to a large number of books by several authors and examine how the vocabulary of a text changes when it is translated from one language to another. Unlike the uniform results produced using the Zipf law, using our "word energy'' distribution technique we find variations in the power-law behavior. We also examine some common features that span across languages and identify some intriguing questions concerning how to determine when a text is suitable for its intended readership.	[Aragao Rego, Henio Henrique] Inst Fed Educ Ciencia & Tecnol Maranhao, Dept Fis, Sao Luis, Brazil; [Aragao Rego, Henio Henrique; Braunstein, Lidia A.; Stanley, H. Eugene; Miyazima, Sasuke] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Braunstein, Lidia A.] Univ Nacl Mar del Plata, CONICET, Inst Invest Fis Mar del Plata IFIMAR, Dept Fis,Fac Ciencias Exactas & Nat, Mar Del Plata, Buenos Aires, Argentina; [D'Agostino, Gregorio] ENEA CR Casaccia, Rome, Italy; [Miyazima, Sasuke] Chubu Univ, Dept Nat Sci, Kasugai, Aichi 487, Japan	Instituto Federal do Maranhao; Boston University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; Italian National Agency New Technical Energy & Sustainable Economics Development; Chubu University	Rego, HHA (corresponding author), Inst Fed Educ Ciencia & Tecnol Maranhao, Dept Fis, Sao Luis, Brazil.	henio@bu.edu		Stanley, H./0000-0003-2800-4495	ONR [N00014-14-1-0738]; DTRA [HDTRA1-14-1-0017]; NSF [CMMI 1125290]; CAPES Foundation; Ministry of Education of Brazil, Braslia/DF [BEX18007/12-0]; UNMdP [PICT-2013-0429]	ONR(Office of Naval Research); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NSF(National Science Foundation (NSF)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil, Braslia/DF; UNMdP	The authors thank the Boston University Center for Polymer Studies and Department of Physics where this research was developed and carried out. The Boston University work was supported by ONR Grant N00014-14-1-0738, DTRA Grant HDTRA1-14-1-0017, and NSF Grant CMMI 1125290). This work was partially supported by the CAPES Foundation and the Ministry of Education of Brazil, Braslia/DF (Proc. No. BEX18007/12-0). LAB also acknowledges UNMdP and grant PICT-2013-0429 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; Bak P, 2002, PHYS REV LETT, V88, P2714; Barabasi AL, 1996, PHYS REV LETT, V76, P2192, DOI 10.1103/PhysRevLett.76.2192; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beaugrande R De, 1998, J SOCIOLING, V3, P128; BERBER SARDINHA Tony, 2004, LINGUISTICA CORPUS; Camargo DC, 2011, TRADTERM, V16, P217; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Champernowne DG, 1953, ECON J, V63, P318, DOI 10.2307/2227127; Cordoba JC, 2008, J URBAN ECON, V63, P177, DOI 10.1016/j.jue.2007.01.005; Francis W.N., 1964, STANDARD CORPUS PRES; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gao JB, 2012, J R SOC INTERFACE, V9, P1956, DOI 10.1098/rsif.2011.0846; Grosjean F., 2010, BILINGUAL; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Miyazima S, 2000, PHYSICA A, V278, P282, DOI 10.1016/S0378-4371(99)00546-4; Miyazima S, 2008, FRACTALS, V16, P25, DOI 10.1142/S0218348X08003776; Papa ARR, 1997, THEOR BIOSCI, V116, P321; Perc M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0378; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Sornette D, 1996, J GEOPHYS RES-SOL EA, V101, P13883, DOI 10.1029/96JB00177; Vallianatos F, 2013, TECTONOPHYSICS, V590, P52, DOI 10.1016/j.tecto.2013.01.009; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Zipf G. K., 1932, SELECTED STUDIES PRI; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110213	10.1371/journal.pone.0110213	http://dx.doi.org/10.1371/journal.pone.0110213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353343	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200017
J	Hofstra, LM; Mudrikova, T; Stam, AJ; Otto, S; Tesselaar, K; Nijhuis, M; Wensing, AMJ				Hofstra, Laura Marije; Mudrikova, Tania; Stam, Arjen J.; Otto, Sigrid; Tesselaar, Kiki; Nijhuis, Monique; Wensing, Annemarie M. J.			Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients	PLOS ONE			English	Article							INTERMITTENT VIREMIA; VIROLOGICAL FAILURE; DRUG-RESISTANCE; INFECTED PATIENTS; 50 COPIES/ML; LOAD; RNA; SUPPRESSION; 1ST-LINE; THERAPY	Background: It has been suggested that low-level viremia or blips in HIV-infected patients on antiretroviral treatment are related to assay variation and/or increased sensitivity of new commercial assays. The 50-copy cut-off for virologic failure is, therefore, under debate. Methods: Treated patients with low-level viremia (persistent viral loads (VL) of 50-1000 copies/mL, group A, N = 16) or a blip (single detectable VL, group B, N = 77) were compared to a control group (consistently suppressed viremia since start therapy (<50 copies/mL), N = 79). Residual viremia (detectable viral RNA <50 copies/ml) in the year preceding the first VL above 50 copies/mL (T0) was determined using Roche Cobas-Amplicor v1.5 or CAP-CTM v2.0. Subsequent virologic failure (2 consecutive VLs>500 or 1 VL>1000 copies/mL that was not followed by a VL<50 copies/mL; median follow up 34 months) was assessed. Results: Significantly more patients in groups A and B had residual viremia in the year preceding T0 compared to controls (50% and 19% vs 3% respectively; p<0.001). Residual viremia was associated with development of low-level viremia or blips (OR 10.9 (95% CI 2.9-40.6)). Subsequent virologic failure was seen more often in group A (3/16) and B (2/77) than in the control group (0/79). Conclusion: Residual viremia is associated with development of blips and low-level viremia. Virologic failure occurred more often in patients with low-level viremia. These results suggest that low-level viremia results from viral production/replication rather than only assay variation.	[Hofstra, Laura Marije; Stam, Arjen J.; Nijhuis, Monique; Wensing, Annemarie M. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Mudrikova, Tania] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Otto, Sigrid; Tesselaar, Kiki] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Wensing, AMJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	a.m.j.wensing@umcutrecht.nl		Tesselaar, Kiki/0000-0002-9847-0814; Hofstra, Laura Marije/0000-0001-6671-4629	Netherlands Organisation for Scientific Research (NWO) VIDI [91796349]	Netherlands Organisation for Scientific Research (NWO) VIDI(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by The Netherlands Organisation for Scientific Research (NWO) VIDI (91796349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding did not cover all expenses; additional costs were covered internal.	Estevez MA, 2013, J CLIN MICROBIOL, V51, P1555, DOI 10.1128/JCM.00100-13; Charpentier C, 2012, J ANTIMICROB CHEMOTH, V67, P2231, DOI 10.1093/jac/dks191; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; European AIDS Clinical Society, 2013, EACS GUID; Geretti AM, 2008, ANTIVIR THER, V13, P927; Gianotti N, 2012, J ANTIMICROB CHEMOTH, V67, P213, DOI 10.1093/jac/dkr422; Gonzalez-Serna A, 2014, CLIN INFECT DIS, V58, P1165, DOI 10.1093/cid/ciu019; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Ibrahim KY, 2012, AIDS PATIENT CARE ST, V26, P512, DOI 10.1089/apc.2012.0199; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Laprise C, 2013, CLIN INFECT DIS; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Maggiolo F, 2012, JAIDS-J ACQ IMM DEF, V60, P473, DOI 10.1097/QAI.0b013e3182567a57; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Martinez V, 2005, AIDS, V19, P1065, DOI 10.1097/01.aids.0000174453.55627.de; Masquelier B, 2005, J CLIN VIROL, V33, P75, DOI 10.1016/j.jcv.2004.11.012; McConnell MJ, 2011, JAIDS-J ACQ IMM DEF, V58, P446, DOI 10.1097/QAI.0b013e3182364513; Mira JA, 2002, ANTIVIR THER, V7, P251; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; Podsadecki TJ, 2007, J INFECT DIS, V196, P1773, DOI 10.1086/523704; Pugliese P, 2013, HIV MED, V14, P509, DOI 10.1111/hiv.12041; Raboud JM, 2002, AIDS, V16, P1627, DOI 10.1097/00002030-200208160-00008; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Smit E, 2009, JAIDS-J ACQ IMM DEF, V51, P364, DOI 10.1097/QAI.0b013e3181aa13b3; Sungkanuparph S, 2006, HIV MED, V7, P437, DOI 10.1111/j.1468-1293.2006.00403.x; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Swenson LC, 2014, AIDS; Swenson LC, 2014, J CLIN MICROBIOL, V52, P517, DOI 10.1128/JCM.02461-13; Taiwo B, 2013, JAIDS-J ACQ IMM DEF, V63, P101, DOI 10.1097/QAI.0b013e3182895af4; Taiwo B, 2011, J INFECT DIS, V204, P515, DOI 10.1093/infdis/jir353; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Zoufaly A, 2014, HIV MED	39	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110749	10.1371/journal.pone.0110749	http://dx.doi.org/10.1371/journal.pone.0110749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354368	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200033
J	Stanfield, BA; Stahl, J; Chouljenko, VN; Subramanian, R; Charles, AS; Saied, AA; Walker, JD; Kousoulas, KG				Stanfield, Brent A.; Stahl, Jacque; Chouljenko, Vladimir N.; Subramanian, Ramesh; Charles, Anu-Susan; Saied, Ahmad A.; Walker, Jason D.; Kousoulas, Konstantin G.			A Single Intramuscular Vaccination of Mice with the HSV-1 VC2 Virus with Mutations in the Glycoprotein K and the Membrane Protein UL20 Confers Full Protection against Lethal Intravaginal Challenge with Virulent HSV-1 and HSV-2 Strains	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; OCULARLY-INFECTED MICE; T-CELL EPITOPE; GENITAL HERPES; TYPE-2 INFECTION; IMMUNODEFICIENCY-VIRUS; AMINO-TERMINUS; GUINEA-PIGS; HERPES-SIMPLEX-VIRUS-2 INFECTION; REPLICATION-COMPETENT	Herpes Simplex Virus type-1 (HSV-1) and type-2 (HSV-2) establish life-long infections and cause significant orofacial and genital infections in humans. HSV-1 is the leading cause of infectious blindness in the western world. Currently, there are no available vaccines to protect against herpes simplex infections. Recently, we showed that a single intramuscular immunization with an HSV-1(F) mutant virus lacking expression of the viral glycoprotein K (gK), which prevents the virus from entering into distal axons of ganglionic neurons, conferred significant protection against either virulent HSV-1(McKrae) or HSV-2(G) intravaginal challenge in mice. Specifically, 90% of the mice were protected against HSV-1(McKrae) challenge, while 70% of the mice were protected against HSV-2(G) challenge. We constructed the recombinant virus VC2 that contains specific mutations in gK and the membrane protein UL20 preventing virus entry into axonal compartments of neurons, while allowing efficient replication in cell culture, unlike the gK-null virus, which has a major defect in virus replication and spread. Intramuscular injection of mice with 10(7) VC2 plaque forming units did not cause any significant clinical disease in mice. A single intramuscular immunization with the VC2 virus protected 100% of mice against lethal intravaginal challenge with either HSV-1(McKrae) or HSV-2(G) viruses. Importantly, vaccination with VC2 produced robust cross protective humoral and cellular immunity that fully protected vaccinated mice against lethal disease. Quantitative PCR did not detect any viral DNA in ganglionic tissues of vaccinated mice, while unvaccinated mice contained high levels of viral DNA. The VC2 virus may serve as an efficient vaccine against both HSV-1 and HSV-2 infections, as well as a safe vector for the production of vaccines against other viral and bacterial pathogens.	[Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA; Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Kousoulas, KG (corresponding author), Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA.	vtgusk@lsu.edu	Stanfield, Brent/A-3266-2019	Stanfield, Brent/0000-0002-0966-9662; KOUSOULAS, KONSTANTIN/0000-0001-7077-9003	Louisiana Board of Regents Biotechnology Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110760] Funding Source: NIH RePORTER	Louisiana Board of Regents Biotechnology Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Louisiana Board of Regents Biotechnology Initiative grant to KGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhrameyeva NV, 2011, J VIROL, V85, P5036, DOI 10.1128/JVI.02548-10; Allen SJ, 2014, INVEST OPHTH VIS SCI, V55, P2442, DOI 10.1167/iovs.14-14013; Allen SJ, 2010, VIROLOGY, V399, P11, DOI 10.1016/j.virol.2009.12.011; Anuradha K, 2008, INDIAN J DERMATOL VE, V74, P230; Augustinova H, 2004, J VIROL, V78, P5756, DOI 10.1128/JVI.78.11.5756-5765.2004; Awasthi S, 2014, J INFECT DIS, V209, P813, DOI 10.1093/infdis/jit658; Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BLANK H, 1973, J INVEST DERMATOL, V61, P223, DOI 10.1111/1523-1747.ep12676442; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brans R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-163; Brans R, 2009, J INVEST DERMATOL, V129, P2470, DOI 10.1038/jid.2009.86; Brittle EE, 2008, J VIROL, V82, P8431, DOI 10.1128/JVI.00551-08; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Chentoufi AA, 2008, J VIROL, V82, P11792, DOI 10.1128/JVI.00692-08; Chouljenko VN, 2010, J VIROL, V84, P8596, DOI 10.1128/JVI.00298-10; Chouljenko VN, 2009, J VIROL, V83, P12301, DOI 10.1128/JVI.01329-09; Chowdhury S, 2013, J VIROL, V87, P3305, DOI 10.1128/JVI.02982-12; Coleman JL, 2013, HUM VACC IMMUNOTHER, V9, P729, DOI 10.4161/hv.23289; COOK SD, 1991, INVEST OPHTH VIS SCI, V32, P1558; Da Costa XJ, 2001, VIROLOGY, V288, P256, DOI 10.1006/viro.2001.1094; David AT, 2008, CURR EYE RES, V33, P455, DOI 10.1080/02713680802130362; David AT, 2012, MBIO, V3, DOI 10.1128/mBio.00144-12; Dervillez X, 2012, FUTURE VIROL, V7, P371, DOI 10.2217/FVL.12.22; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Dudek T, 2008, VIROLOGY, V372, P165, DOI 10.1016/j.virol.2007.10.014; Dudley KL, 2000, VIROLOGY, V270, P454, DOI 10.1006/viro.2000.0298; Foster TP, 2008, J VIROL, V82, P6310, DOI 10.1128/JVI.00147-08; Foster TP, 2004, J VIROL, V78, P13262, DOI 10.1128/JVI.78.23.13262-13277.2004; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2009, VACCINE, V27, P940, DOI 10.1016/j.vaccine.2008.11.074; Ghiasi H, 2000, VIRUS RES, V68, P137, DOI 10.1016/S0168-1702(00)00165-9; Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Harrington KJ, 2010, CLIN CANCER RES, V16, P4005, DOI 10.1158/1078-0432.CCR-10-0196; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hofstetter AM, 2014, CURR OPIN INFECT DIS, V27, P75, DOI 10.1097/QCO.0000000000000029; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Iyer AV, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-317; Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066; Kim IJ, 2014, CURR EYE RE IN PRESS; Kim IJ, 2013, J VIROL, V87, P8029, DOI 10.1128/JVI.01181-13; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; KOUSOULAS KG, 1988, VIROLOGY, V166, P423, DOI 10.1016/0042-6822(88)90513-2; Lee HC, 2009, J VIROL, V83, P6115, DOI 10.1128/JVI.00128-09; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Mertz GJ, 2008, J INFECT DIS, V198, P1098, DOI 10.1086/591914; Milligan GN, 1998, J IMMUNOL, V160, P6093; Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2009, INVEST OPHTH VIS SCI, V50, P2903, DOI 10.1167/iovs.08-2957; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Murphy CG, 2000, J VIROL, V74, P7745, DOI 10.1128/JVI.74.17.7745-7754.2000; PEREIRA L, 1980, INFECT IMMUN, V29, P724; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Roth K, 2013, MICROB PATHOGENESIS, V58, P45, DOI 10.1016/j.micpath.2012.11.001; Rupp R, 2008, EXPERT OPIN EMERG DR, V13, P41, DOI 10.1517/14728214.13.1.41 ; Saied AA, 2014, CURR EYE RES, V39, P596, DOI 10.3109/02713683.2013.855238; Sartori E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-166; Schiffer JT, 2013, NAT MED, V19, P280, DOI 10.1038/nm.3103; Seppanen M, 2006, J INFECT DIS, V194, P571, DOI 10.1086/506477; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; St Leger AJ, 2011, J NEUROVIROL, V17, P528, DOI 10.1007/s13365-011-0062-1; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; van Lint AL, 2007, VIROLOGY, V368, P227, DOI 10.1016/j.virol.2007.08.030; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watanabe D, 2007, VIROLOGY, V357, P186, DOI 10.1016/j.virol.2006.08.015; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu XP, 2014, VIRUSES-BASEL, V6, P371, DOI 10.3390/v6020371	77	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109890	10.1371/journal.pone.0109890	http://dx.doi.org/10.1371/journal.pone.0109890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350288	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100014
J	Beyeler, J; Schnyder, I; Katsaros, C; Chiquet, M				Beyeler, Joel; Schnyder, Isabelle; Katsaros, Christos; Chiquet, Matthias			Accelerated Wound Closure In Vitro by Fibroblasts from a Subgroup of Cleft Lip/Palate Patients: Role of Transforming Growth Factor-alpha	PLOS ONE			English	Article							FACTOR RECEPTOR; TGF-ALPHA; CRANIOFACIAL DEVELOPMENT; EGF-RECEPTOR; ORAL CLEFTS; WAVY HAIR; PALATE; LIP; EXPRESSION; MYOFIBROBLASTS	In a fraction of patients surgically treated for cleft lip/palate, excessive scarring disturbs maxillary growth and dento-alveolar development. Since certain genes are involved in craniofacial morphogenesis as well as tissue repair, a primary defect causing cleft lip/palate could lead to altered wound healing. We performed in vitro wound healing assays with primary lip fibroblasts from 16 cleft lip/palate patients. Nine foreskin fibroblast strains were included for comparison. Cells were grown to confluency and scratch wounds were applied; wound closure was monitored morphometrically over time. Wound closure rate showed highly significant differences between fibroblast strains. Statistically, fibroblast strains from the 25 individuals could be divided into three migratory groups, namely "fast", "intermediate", and "slow". Most cleft lip/palate fibroblasts were distributed between the "fast" (5 strains) and the "intermediate" group (10 strains). These phenotypes were stable over different cell passages from the same individual. Expression of genes involved in cleft lip/palate and wound repair was determined by quantitative PCR. Transforming growth factor-alpha mRNA was significantly up-regulated in the "fast" group. 5 ng/ml transforming growth factor-alpha added to the culture medium increased the wound closure rate of cleft lip/palate strains from the "intermediate" migratory group to the level of the "fast", but had no effect on the latter group. Conversely, antibody to transforming growth factor-alpha or a specific inhibitor of its receptor most effectively reduced the wound closure rate of "fast" cleft lip/palate strains. Thus, fibroblasts from a distinct subgroup of cleft lip/palate patients exhibit an increased migration rate into wounds in vitro, which is linked to higher transforming growth factor-alpha expression and attenuated by interfering with its signaling.	[Beyeler, Joel; Katsaros, Christos; Chiquet, Matthias] Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Schnyder, Isabelle] Univ Hosp Bern, Univ Clin Childrens Surg, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Chiquet, M (corresponding author), Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland.	matthias.chiquet@zmk.unibe.ch		Chiquet, Matthias/0000-0001-7812-4853; Katsaros, Christos/0000-0001-5545-6740	Swiss National Science Foundation [31003A_146825]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by grant 31003A_146825 from the Swiss National Science Foundation (www.snf.ch) to MC and CK. The funder had no role in study design, data collection and analysis, decision to publish, or peparation of the manuscript. No additional external funding was received for this study.	Allan CH, 2006, WOUND REPAIR REGEN, V14, P398, DOI 10.1111/j.1743-6109.2006.00139.x; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Baroni T, 2003, J PERIODONTOL, V74, P1447, DOI 10.1902/jop.2003.74.10.1447; Benjamini Y, 2001, ANN STAT, V29, P1165; BERKOWITZ S, 1977, CLEFT PALATE J, V14, P288; Biggs LC, 2014, J CELL SCI, V28, P28; BLUTH RF, 1995, HUM PATHOL, V26, P1333, DOI 10.1016/0046-8177(95)90298-8; Bodnar RJ, 2013, ADV WOUND CARE, V2, P24, DOI 10.1089/wound.2011.0326; Brown GD, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-93; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chanprapaph K, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/734249; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; Cvikl B, 2014, CLIN ORAL INVESTIG; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; DIXON MJ, 1991, ANAT EMBRYOL, V184, P83, DOI 10.1007/BF01744264; DIXON MJ, 1992, ARCH ORAL BIOL, V37, P395, DOI 10.1016/0003-9969(92)90024-3; Donovan J, 2013, FRONT BIOSCI-LANDMRK, V18, P106, DOI 10.2741/4090; Fiske WH, 2009, EXP CELL RES, V315, P583, DOI 10.1016/j.yexcr.2008.10.043; Fudalej P, 2012, J DENT RES, V91, P47, DOI 10.1177/0022034511425674; Fudalej P, 2010, J CRANIOFAC SURG, V21, P1468, DOI 10.1097/SCS.0b013e3181ecc6c7; Gagliano N, 2010, CLEFT PALATE-CRAN J, V47, P393, DOI 10.1597/07-196.1; Gibson DJ, 2013, ADV WOUND CARE, V2, P18, DOI 10.1089/wound.2011.0359; Gkantidis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047762; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4511, DOI 10.3748/wjg.v11.i29.4511; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI 10.2217/FON.09.10; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Jones JLP, 2010, J CRANIOFAC SURG, V21, P1350, DOI 10.1097/SCS.0b013e3181ec6aad; Josh F, 2013, J NIPPON MED SCH, V80, P140, DOI 10.1272/jnms.80.140; Jugessur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011493; Khanna R, 2012, INDIAN J PLAST SURG, V45, P68, DOI 10.4103/0970-0358.96590; Kim I, 2001, WOUND REPAIR REGEN, V9, P386, DOI 10.1046/j.1524-475x.2001.00386.x; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Letra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045441; Lu XC, 2014, AM J EPIDEMIOL, V179, P267, DOI 10.1093/aje/kwt262; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinelli M, 2009, INT J PEDIATR OTORHI, V73, P929, DOI 10.1016/j.ijporl.2009.02.013; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Mitchell LE, 1997, GENET EPIDEMIOL, V14, P231; Moreira I, 2014, AM J ORTHOD DENTOFAC, V145, P341, DOI 10.1016/j.ajodo.2013.11.018; MOSKAL TL, 1995, CANCER EPIDEM BIOMAR, V4, P127; Mossey PA, 2012, FRONT ORAL BIOL, V16, P1, DOI 10.1159/000337464; Nollet PJPM, 2008, INT J ORAL MAX SURG, V37, P123, DOI 10.1016/j.ijom.2007.09.168; Nollet PJPM, 2005, PLAST RECONSTR SURG, V116, P1255, DOI 10.1097/01.prs.0000181652.84855.a3; Park CH, 2011, J DERMATOL SCI, V64, P134, DOI 10.1016/j.jdermsci.2011.07.002; POULIN ML, 1995, DEV DYNAM, V202, P378, DOI 10.1002/aja.1002020407; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Shetye PR, 2004, CLIN PLAST SURG, V31, P361, DOI 10.1016/S0094-1298(03)00137-8; Shetye PR, 2006, ANGLE ORTHOD, V76, pIV; Singh B, 2014, SEMIN CELL DEV BIOL, V28, P12, DOI 10.1016/j.semcdb.2014.03.003; Smith PC, 2009, J PERIODONTAL RES, V44, P73, DOI 10.1111/j.1600-0765.2007.01081.x; Stephens P, 1996, J DENT RES, V75, P1358, DOI 10.1177/00220345960750060601; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; van Beurden HE, 2005, J DENT RES, V84, P871, DOI 10.1177/154405910508401002; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; Vieira AR, 2006, AM J EPIDEMIOL, V163, P790, DOI 10.1093/aje/kwj103; Wilson ADH, 2008, CLEFT PALATE-CRAN J, V45, P614, DOI 10.1597/07-072.1; Yamamoto T, 2003, DEV BIOL, V260, P512, DOI 10.1016/S0012-1606(03)00275-6; Young DL, 2000, CRIT REV ORAL BIOL M, V11, P304, DOI 10.1177/10454411000110030201	68	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111752	10.1371/journal.pone.0111752	http://dx.doi.org/10.1371/journal.pone.0111752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360592	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700148
J	Gambhira, R; Keele, BF; Schell, JB; Hunter, MJ; Dufour, JP; Montefiori, DC; Tang, H; Rose, JK; Rose, N; Marx, PA				Gambhira, Ratish; Keele, Brandon F.; Schell, John B.; Hunter, Meredith J.; Dufour, Jason P.; Montefiori, David C.; Tang, Haili; Rose, John K.; Rose, Nina; Marx, Preston A.			Transmitted/Founder Simian Immunodeficiency Virus Envelope Sequences in Vesicular Stomatitis and Semliki Forest Virus Vector Immunized Rhesus Macaques	PLOS ONE			English	Article							BIOLOGICAL PHENOTYPE; GLYCOSYLATION SITES; GENETIC IDENTITY; PATHOGENIC SIV; HIV; PROTECTION; CHALLENGE; INFECTION; MUCOSAL; COINFECTIONS	Identification of transmitted/founder simian immunodeficiency virus (SIV) envelope sequences responsible for infection may prove critical for understanding HIV/SIV mucosal transmission. We used single genome amplification and phylogenetic analyses to characterize transmitted/founder SIVs both in the inoculum and in immunized-infected rhesus monkeys. Single genome amplification of the SIVsmE660 inoculum revealed a maximum diversity of 1.4%. We also noted that the consensus sequence of the challenge stock differed from the vaccine construct in 10 amino acids including 3 changes in the V4 loop. Viral env was prepared from rhesus plasma in 3 groups of 6 immunized with vesicular stomatitis virus (VSV) vectors and boosted with Semliki forest virus (SFV) replicons expressing (a) SIVsmE660 gag-env (b) SIVsmE660 gag-env plus rhesus GM-CSF and (c) control influenza hemagglutinin protein. Macaques were immunized twice with VSV-vectors and once with SFV vector and challenged intrarectally with 4000 TCID50. Single genome amplification characterized the infections of 2 unprotected animals in the gag-env immunized group, both of which had reduced acute plasma viral loads that ended as transient infections indicating partial immune control. Four of 6 rhesus were infected in the gag-env + GM-CSF group which demonstrated that GM-CSF abrogated protection. All 6 animals from the control group were infected having high plasma viral loads. We obtained 246 full-length envelope sequences from SIVsmE660 infected macaques at the peak of infection and determined the number of transmitted/founder variants per animal. Our analysis found that 2 of 2 gag-env vaccinated but infected macaques exhibited single but distinct virus envelope lineages whereas rhesus vaccinated with gag-env-GM-CSF or HA control exhibited both single and multiple env lineages. Because there were only 2 infected animals in the gagenv vaccinated rhesus compared to 10 infected rhesus in the other 2 groups, the significance of finding single env variants in the gag-env vaccinated group could not be established.	[Gambhira, Ratish; Hunter, Meredith J.; Dufour, Jason P.; Marx, Preston A.] Tulane Univ, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA 70433 USA; [Keele, Brandon F.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Schell, John B.; Rose, John K.; Rose, Nina] Yale Univ, Dept Pathol, New Haven, CT USA; [Montefiori, David C.; Tang, Haili] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Yale University; Duke University	Marx, PA (corresponding author), Tulane Univ, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA 70433 USA.	pmarx@tulane.edu		Schell, John/0000-0001-6707-7051	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NIH grant [AI45510]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P51 RR00164]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164, T32RR021309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045510, R56AI045510] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, T32OD011124, T32OD011064] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part with federal funds from the National Cancer Institute, National Institutes of Health under contract HHSN261200800001E, NIH grant AI45510 and by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number P51 RR00164 to the Tulane National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baan E, 2012, AIDS RES HUM RETROV, V28, P715, DOI [10.1089/aid.2011.0023, 10.1089/AID.2011.0023]; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; CHOI WS, 1994, J VIROL, V68, P5395, DOI 10.1128/JVI.68.9.5395-5402.1994; Cruz I, 2006, INDIAN J MED RES, V123, P357; Dittmer U, 1996, J BIOTECHNOL, V44, P105, DOI 10.1016/0168-1656(95)00160-3; Evering T, 2006, PARASITE IMMUNOL, V28, P549, DOI 10.1111/j.1365-3024.2006.00886.x; Funnye AS, 2003, J NATL MED ASSOC, V95, P363; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Gnanadurai CW, 2010, J VIROL, V84, P12245, DOI 10.1128/JVI.01603-10; Haigwood NL, 1999, IMMUNOL LETT, V66, P183, DOI 10.1016/S0165-2478(98)00156-4; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Ho YS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-14; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; LETVIN NL, 1985, SCIENCE, V230, P71, DOI 10.1126/science.2412295; Letvin NL, 2011, SCI TRANSL MED, V3, P1; Li H, 2010, AIDS RES HUM RETROV, V26, pA168; Lim SY, 2010, PLOS PATHOG, V6, P1; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; OVERBAUGH J, 1992, J VIROL, V66, P5937, DOI 10.1128/JVI.66.10.5937-5948.1992; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Ross AC, 2011, CURR OPIN INFECT DIS, V24, P212, DOI 10.1097/QCO.0b013e3283460d34; Rossenkhan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035491; Ruhnke M, 2004, DRUGS, V64, P1163, DOI 10.2165/00003495-200464110-00002; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schell JB, 2012, VACCINE, V30, P4233, DOI 10.1016/j.vaccine.2012.04.046; Schell JB, 2011, J VIROL, V85, P5764, DOI 10.1128/JVI.00342-11; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Waters L, 2005, EXPERT OPIN PHARMACO, V6, P2633, DOI 10.1517/14656566.6.15.2633; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wu F, 2012, J VIROL, V86, P8835, DOI 10.1128/JVI.00923-12	39	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109678	10.1371/journal.pone.0109678	http://dx.doi.org/10.1371/journal.pone.0109678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360552	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700014
J	Gao, M; Zhang, XX; Chen, X; Mi, CY; Tang, YJ; Zhou, JZ; Li, XH				Gao, Meng; Zhang, Xingxing; Chen, Xin; Mi, Cunyun; Tang, Yujie; Zhou, Jianzhi; Li, Xiaohui			Prenatal Exposure to Lipopolysaccharide Results in Local RAS Activation in the Adipose Tissue of Rat Offspring	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; DEVELOPMENTAL ORIGINS; HYPERTENSION; HEALTH	Background: Adult metabolic syndrome may originate in part during fetal or early life. This study was designed to investigate the effects of prenatal exposure to lipopolysaccharide (LPS) on adipose development and local renin-angiotensin system (RAS) activation in rat offspring. Methods: Pregnant rats were randomly divided into three groups (n = 8 in each), including an NS group (pregnant rats were only treated with 0.5 ml normal saline from the 8th to the 14th day of gestation); an LPS group (pregnant rats were injected intraperitoneally with 0.79 mg/kg LPS on the 8th, 10th and 12th days of pregnancy); and an LPS+pyrrolidine dithiocarbamate (PDTC) group (identical to the LPS group except that 100 mg/kg PDTC was administered from the 8 th to the 14 th day of gestation). Results: Prenatal exposure to LPS resulted in increased blood pressure, adipose coefficient and body weight in rat offspring. Specifically, during the infancy of the offspring rats, the LPS stimulus promoted the differentiation of adipose cells, diminishing their diameters and proportions while simultaneously increasing cell number. In contrast, once the rats were grown, adipose cell differentiation was inhibited, and the diameters and proportions of the cells were increased. Moreover, each component of the RAS was changed and was shown to be activated. PDTC, an inhibitor of NF-kappa B, could reverse the influence of the stimulus during pregnancy. Conclusion: Prenatal exposure to LPS in rats results in increased blood pressure, adipose coefficient, body weight and activation of adipose RAS in offspring.	[Gao, Meng; Chen, Xin; Mi, Cunyun; Tang, Yujie; Zhou, Jianzhi; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China; [Zhang, Xingxing] 159 Hosp PLA, Dept Medicament & Instrument, Zhumadian, Herts, Peoples R China	Army Medical University	Zhou, JZ (corresponding author), Third Mil Med Univ, Coll Pharm, Inst Mat Med, Chongqing, Peoples R China.	jazi891@aliyun.com; lpsh008@aliyun.com			National Natural Science Foundation of China [81072630, 81373420]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81072630, No. 81373420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biermann D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047916; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Carey RM, 2013, CLIN EXP PHARMACOL P, V40, P527, DOI 10.1111/1440-1681.12059; Girard S, 2009, NEUROSCIENCE, V158, P673, DOI 10.1016/j.neuroscience.2008.10.032; Guron G, 2006, NEPHROL DIAL TRANSPL, V21, P522, DOI 10.1093/ndt/gfi288; Hao XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088127; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; Iwai M, 2011, BIOCHEM BIOPH RES CO, V406, P123, DOI 10.1016/j.bbrc.2011.02.007; Johnson RJ, 2008, J HYPERTENS, V26, P381, DOI 10.1097/HJH.0b013e3282f29876; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lebenthal E, 2007, J NUTR, V137, P1073, DOI 10.1093/jn/137.4.1073; Mao C, 2014, NEUROBIOLOGY BODY FL; Martinovic J, 2001, LANCET, V358, P241, DOI 10.1016/S0140-6736(01)05426-5; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Moon Ju-Young, 2013, Electrolyte Blood Press, V11, P41, DOI 10.5049/EBP.2013.11.2.41; Nakatani S, 2014, DIABETES RES CLIN PR, V105, P40, DOI 10.1016/j.diabres.2014.04.019; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Samuelsson AM, 2004, ENDOCRINOLOGY, V145, P4897, DOI 10.1210/en.2004-0742; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Stiefel P, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/685238; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076992; Wang R, 2009, PUBLIC HEALTH, V123, P534, DOI 10.1016/j.puhe.2009.06.009; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Xu JA, 2010, AM J PHYSIOL-HEART C, V299, pH1328, DOI 10.1152/ajpheart.00538.2010	24	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111376	10.1371/journal.pone.0111376	http://dx.doi.org/10.1371/journal.pone.0111376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360670	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700094
J	Lee, SL; Hashimoto, H; Kohro, T; Horiguchi, H; Koide, D; Komuro, I; Fushimi, K; Yamazaki, T; Yasunaga, H				Lee, Seitetsu L.; Hashimoto, Hideki; Kohro, Takahide; Horiguchi, Hiromasa; Koide, Daisuke; Komuro, Issei; Fushimi, Kiyohide; Yamazaki, Tsutomu; Yasunaga, Hideo			Influence of Municipality-Level Mean Income on Access to Aortic Valve Surgery: A Cross-Sectional Observational Study under Japan's Universal Health-Care Coverage	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SOCIOECONOMIC-STATUS; CARDIAC PROCEDURES; MORTALITY; DEPRIVATION; DISEASE; INEQUITIES; INCREASES; ETHNICITY; SURVIVAL	Background: Universal health-care coverage has attracted the interest of policy makers as a way of achieving health equity. However, previous reports have shown that despite universal coverage, socioeconomic disparity persists in access to high-tech invasive care, such as cardiac treatment. In this study, we aimed to investigate the association between socioeconomic status and care of aortic stenosis in the context of Japan's health-care system, which is mainly publicly funded. Methods: We chose aortic stenosis in older people as a target because such patients are likely to be affected by socioeconomic disparity. Using a large Japanese claim-based inpatient database, we identified 12,893 isolated aortic stenosis patients aged over 65 years who were hospitalized between July 2010 and March 2012. Municipality socioeconomic status was represented by the mean household income of the patients' residential municipality, categorized into quartiles. The likelihood of undergoing aortic valve surgery and in-hospital mortality was regressed against socioeconomic status level with adjustments for hospital volume, regional number of cardiac surgeons per 1 million population, and patients' clinical status. Results: We found no significant differences between the highest and lowest quartile groups in surgical indication (odds ratio, 0.84; 95% confidence interval, 0.69-1.03) or in-hospital mortality (1.00; 0.68-1.48). Hospital volume was significantly associated with lower postoperative mortality (odds ratio of the highest volume tertile to the lowest, 0.49; 0.34-0.71). Conclusions: Under Japan's current universal health-care coverage, municipality socioeconomic status did not appear to have a systematic relationship with either treatment decision for surgical intervention or postoperative survival following aortic valve surgery among older patients. Our results imply that universal health-care coverage with high publicly funded coverage offers equal access to high-tech cardiovascular care.	[Lee, Seitetsu L.; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Hashimoto, Hideki] Univ Tokyo, Dept Hlth & Social Behav, Tokyo, Japan; [Yamazaki, Tsutomu] Univ Tokyo, Clin Res Support Ctr, Tokyo, Japan; [Koide, Daisuke] Univ Tokyo, Dept Clin Epidemiol & Syst, Tokyo, Japan; [Yasunaga, Hideo] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Kohro, Takahide] Jichi Med Univ, Dept Clin Informat, Mibu, Tochigi, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Jichi Medical University; Tokyo Medical & Dental University (TMDU)	Hashimoto, H (corresponding author), Univ Tokyo, Dept Hlth & Social Behav, Tokyo, Japan.	hidehashimoto-circ@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H22-Policy-031, H22-Policy-033]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22390131]; Council for Science and Technology Policy, Japan [0301002001001]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council for Science and Technology Policy, Japan	This study is supported by a Grant-in-Aid for Research on Policy Planning and Evaluation (H22-Policy-031 and, in part, H22-Policy-033) from the Ministry of Health, Labour and Welfare, Japan; by a Grant-in-Aid for Scientific Research B (No. 22390131) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Technology Policy, Japan (No. 0301002001001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Amano J, 2013, GEN THORAC CARDIOVAS, V61, P578, DOI [10.1007/s11748-013-0289-2, 10.1007/s11748-012-0177-1]; Ambrosio A, 2014, OTOLARYNG HEAD NECK, V151, P137, DOI 10.1177/0194599814525570; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Bennett KM, 2010, ANN SURG, V252, P552, DOI 10.1097/SLA.0b013e3181f2ac64; Casale SN, 2007, AM HEART J, V154, P989, DOI 10.1016/j.ahj.2007.07.006; Chaix B, 2007, EPIDEMIOLOGY, V18, P104, DOI 10.1097/01.ede.0000249573.22856.9a; Daumit GL, 1999, ANN INTERN MED, V130, P173, DOI 10.7326/0003-4819-130-3-199902020-00002; Dunning J, 2011, J THORAC CARDIOV SUR, V142, P776, DOI 10.1016/j.jtcvs.2011.04.048; Fukuda Y, 2007, PUBLIC HEALTH, V121, P163, DOI 10.1016/j.puhe.2006.10.015; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Kazui T, 2007, GEN THORAC CARDIOVAS, V55, P483, DOI 10.1007/s11748-007-0172-0; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Korda RJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-460; Matsuda S, 2009, EUROHEALTH, V14, P25; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; Murata C, 2010, INT J ENV RES PUB HE, V7, P1330, DOI 10.3390/ijerph7041330; Nakamura M, 2013, CARDIOVASC INTERV TH, V28, P30, DOI 10.1007/s12928-012-0128-x; Nishi A, 2012, B WORLD HEALTH ORGAN, V90, P426, DOI 10.2471/BLT.11.095380; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; Pilote L, 2007, MED CARE, V45, P638, DOI 10.1097/MLR.0b013e3180536779; Sakata R, 2012, GEN THORAC CARDIOVAS, V60, P625, DOI 10.1007/s11748-012-0128-x; The Statistics Bureau Ministry of Internal Affairs ans Communications Japan, 2012, SOC OBS SHI KU MACH; van Walraven C, 2013, J HOSP MED, V8, P261, DOI 10.1002/jhm.2025; Walker A, 2014, J SURG RES, V190, P87, DOI 10.1016/j.jss.2014.02.028; Wang JY, 2014, INT J CARDIOL, V172, P82, DOI 10.1016/j.ijcard.2013.12.082; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Winkleby M, 2007, AM J PREV MED, V32, P97, DOI 10.1016/j.amepre.2006.10.002; Yeates K, 2009, J AM SOC NEPHROL, V20, P172, DOI 10.1681/ASN.2007070820	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111071	10.1371/journal.pone.0111071	http://dx.doi.org/10.1371/journal.pone.0111071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360759	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700061
J	Zheng, XL; Xie, ZH; Zhu, ZY; Liu, Z; Wang, Y; Wei, LF; Yang, H; Yang, HN; Liu, YQ; Bi, JZ				Zheng, XiaoLei; Xie, ZhaoHong; Zhu, ZhengYu; Liu, Zhen; Wang, Yun; Wei, LiFei; Yang, Hui; Yang, HongNa; Liu, YiQing; Bi, JianZhong			Methyllycaconitine Alleviates Amyloid-beta Peptides-Induced Cytotoxicity in SH-SY5Y Cells	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; ALZHEIMERS-DISEASE; CLINICAL-FEATURES; AUTOPHAGY; PROTEIN; NEUROTOXICITY; MECHANISMS; BRAIN; NEURODEGENERATION; INVOLVEMENT	Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder. As the most common form of dementia, it affects more than 35 million people worldwide and is increasing. Excessive extracellular deposition of amyloid-beta peptide (A beta) is a pathologic feature of AD. Accumulating evidence indicates that macroautophagy is involved in the pathogenesis of AD, but its exact role is still unclear. Although major findings on the molecular mechanisms have been reported, there are still no effective treatments to prevent, halt, or reverse Alzheimer's disease. In this study, we investigated whether A beta(25-35) could trigger an autophagy process and inhibit the growth of SH-SY5Y cells. Furthermore, we examined the effect of methyllycaconitine (MLA) on the cytotoxity of A beta(25-35). MLA had a protective effect against cytotoxity of A beta, which may be related to its inhibition of A beta-induced autophagy and the involvement of the mammalian target of rapamycin pathway. Moreover, MLA had a good safety profile. MLA treatment may be a promising therapeutic tool for AD.	[Zheng, XiaoLei; Xie, ZhaoHong; Zhu, ZhengYu; Liu, Zhen; Wang, Yun; Wei, LiFei; Yang, Hui; Yang, HongNa; Liu, YiQing; Bi, JianZhong] Shandong Univ, Hosp 2, Dept Neural Med, Jinan 250100, Peoples R China; [Bi, JianZhong] Shandong Univ, Inst Neurol, Jinan 250100, Peoples R China; [Bi, JianZhong] Shandong Univ, Key Lab Translat Med Neurol Degenerat Dis, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Bi, JZ (corresponding author), Shandong Univ, Hosp 2, Dept Neural Med, Jinan 250100, Peoples R China.	bjz@sdu.edu.cn		wei, li fei/0000-0002-8547-8921	National Natural Science Foundation of China [81171214, 81371420]; Shandong Province Natural Science Foundation [ZR2011HM064]; Jinan Science and Technology Development Foundation [201202048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Jinan Science and Technology Development Foundation	This research was supported by the National Natural Science Foundation of China (No. 81171214, 81371420), Shandong Province Natural Science Foundation (ZR2011HM064) and Jinan Science and Technology Development Foundation (201202048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKONDON M, 1992, MOL PHARMACOL, V41, P802; Barnett A, 2011, J ALZHEIMERS DIS, V25, P385, DOI 10.3233/JAD-2011-101989; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Cho HJ, 2009, FASEB J, V23, P2639, DOI 10.1096/fj.08-126383; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Cumming T, 2010, INT J STROKE, V5, P453, DOI 10.1111/j.1747-4949.2010.00527.x; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Frozza RL, 2009, NEUROCHEM RES, V34, P295, DOI 10.1007/s11064-008-9776-8; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jiang H, 2010, J INT MED RES, V38, P1305, DOI 10.1177/147323001003800412; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Liu RT, 2009, ACTA PHARMACOL SIN, V30, P899, DOI 10.1038/aps.2009.74; Lockman PR, 2005, J NEUROCHEM, V94, P37, DOI 10.1111/j.1471-4159.2005.03162.x; Luo SJ, 2012, NEUROCHEM RES, V37, P2787, DOI 10.1007/s11064-012-0872-4; Mancuso M, 2010, ADV EXP MED BIOL, V685, P34; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Maycotte P, 2010, J NEUROSCI RES, V88, P73, DOI 10.1002/jnr.22168; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Navarro HA, 2000, J MED CHEM, V43, P142, DOI 10.1021/jm990544f; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Puttfarcken PS, 1996, EXP NEUROL, V138, P73, DOI 10.1006/exnr.1996.0048; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Son SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.039; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HM, 2010, J ALZHEIMERS DIS, V21, P597, DOI 10.3233/JAD-2010-091207; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Yang SN, 2012, J ALZHEIMERS DIS, V28, P345, DOI 10.3233/JAD-2011-110863; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	47	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111536	10.1371/journal.pone.0111536	http://dx.doi.org/10.1371/journal.pone.0111536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360664	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700114
J	Leonard, A; Paton, AW; El-Quadi, M; Paton, JC; Fazal, F				Leonard, Antony; Paton, Adrienne W.; El-Quadi, Monaliza; Paton, James C.; Fazal, Fabeha			Preconditioning with Endoplasmic Reticulum Stress Ameliorates Endothelial Cell Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; RELA/P65 NUCLEAR TRANSLOCATION; UNFOLDED PROTEIN RESPONSE; TISSUE-FACTOR; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; ICAM-1 EXPRESSION; INDUCED INCREASE	Endoplasmic Reticulum (ER) stress, caused by disturbance in ER homeostasis, has been implicated in several pathological conditions such as ischemic injury, neurodegenerative disorders, metabolic diseases and more recently in inflammatory conditions. Our present study aims at understanding the role of ER stress in endothelial cell (EC) inflammation, a critical event in the pathogenesis of acute lung injury (ALI). We found that preconditioning human pulmonary artery endothelial cells (HPAEC) to ER stress either by depleting ER chaperone and signaling regulator BiP using siRNA, or specifically cleaving (inactivating) BiP using subtilase cytotoxin (SubAB), alleviates EC inflammation. The two approaches adopted to abrogate BiP function induced ATF4 protein expression and the phosphorylation of eIF2 alpha, both markers of ER stress, which in turn resulted in blunting the activation of NF-kappa B, and restoring endothelial barrier integrity. Pretreatment of HPAEC with BiP siRNA inhibited thrombin-induced IkB alpha degradation and its resulting downstream signaling pathway involving NF-kappa B nuclear translocation, DNA binding, phosphorylation at serine536, transcriptional activation and subsequent expression of adhesion molecules. However, TNF alpha-mediated NF-kappa B signaling was unaffected upon BiP knockdown. In an alternative approach, SubAB-mediated inactivation of NF-kappa B was independent of IkB alpha degradation. Mechanistic analysis revealed that pretreatment of EC with SubAB interfered with the binding of the liberated NF-kappa B to the DNA, thereby resulting in reduced expression of adhesion molecules, cytokines and chemokines. In addition, both knockdown and inactivation of BiP stimulated actin cytoskeletal reorganization resulting in restoration of endothelial permeability. Together our studies indicate that BiP plays a central role in EC inflammation and injury via its action on NF-kappa B activation and regulation of vascular permeability.	[Leonard, Antony; El-Quadi, Monaliza; Fazal, Fabeha] Univ Rochester, Sch Med & Dent, Dept Pediat, Lung Biol & Dis Program, Rochester, NY 14627 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Rochester; University of Adelaide	Fazal, F (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Lung Biol & Dis Program, Rochester, NY 14627 USA.	Fabeha_Fazal@URMC.Rochester.edu			National Heart, Lung and Blood Institute [HL096907]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096907] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute Grant HL096907. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2012, ARCH BIOCHEM BIOPHYS, V520, P30, DOI 10.1016/j.abb.2012.01.014; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Anthoni C, 2007, J EXP MED, V204, P1595, DOI 10.1084/jem.20062354; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bijli KM, 2012, AM J RESP CELL MOL, V47, P660, DOI 10.1165/rcmb.2012-0047OC; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; Harama D, 2009, J IMMUNOL, V183, P1368, DOI 10.4049/jimmunol.0804066; Hayakawa K, 2010, J AM SOC NEPHROL, V21, P73, DOI 10.1681/ASN.2009040432; Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu CCA, 2009, J EXP MED, V206, P2429, DOI 10.1084/jem.20090782; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; Inagi R, 2008, J AM SOC NEPHROL, V19, P915, DOI 10.1681/ASN.2007070745; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Levitt JE, 2006, SEMIN RESP CRIT CARE, V27, P426, DOI 10.1055/s-2006-948296; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Prell T, 2014, J NEUROIMMUNOL, V270, P29, DOI 10.1016/j.jneuroim.2014.03.005; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rath E, 2011, EUR J NUTR, V50, P219, DOI 10.1007/s00394-011-0197-0; Sabit R, 2010, CHEST, V138, P47, DOI 10.1378/chest.09-2764; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Undas A, 2010, THROMB HAEMOSTASIS, V104, P224, DOI 10.1160/TH10-02-0091; Usuki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02346; Vaidyula VR, 2009, THROMB RES, V124, P259, DOI 10.1016/j.thromres.2008.12.030; van der Poll T, 2008, CRIT CARE, V12, DOI 10.1186/cc7026; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoo SA, 2012, J EXP MED, V209, P871, DOI 10.1084/jem.20111783	57	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110949	10.1371/journal.pone.0110949	http://dx.doi.org/10.1371/journal.pone.0110949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356743	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000033
J	Sparks, EL; Cebrian, J; Smith, SM				Sparks, Eric L.; Cebrian, Just; Smith, Sara M.			Removal of Fast Flowing Nitrogen from Marshes Restored in Sandy Soils	PLOS ONE			English	Article							FRINGING MARSH; RESTORATION; ECOSYSTEM; NUTRIENT; TRACKING	Groundwater flow rates and nitrate removal capacity from an introduced solution were examined for five marsh restoration designs and unvegetated plots shortly after planting and 1 year post-planting. The restoration site was a sandy beach with a wave-dampening fence 10 m offshore. Simulated groundwater flow into the marsh was introduced at a rate to mimic intense rainfall events. Restoration designs varied in initial planting density and corresponded to 25%, 50%, 75% and 100% of the plot area planted. In general, groundwater flow was slower with increasing planting density and decreased from year 0 to year 1 across all treatments. Nevertheless, removal of nitrate from the introduced solution was similar and low for all restoration designs (3-7%) and similar to the unvegetated plots. We suggest that the low NO3- removal was due to sandy sediments allowing rapid flow of groundwater through the marsh rhizosphere, thereby decreasing the contact time of the NO3- with the marsh biota. Our findings demonstrate that knowledge of the groundwater flow regime for restoration projects is essential when nutrient filtration is a target goal of the project.	[Sparks, Eric L.; Cebrian, Just; Smith, Sara M.] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Sparks, Eric L.; Cebrian, Just] Univ S Alabama, Mobile, AL 36688 USA	Dauphin Island Sea Lab; University of South Alabama	Sparks, EL (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA.	esparks4040@gmail.com			Alabama Department of Conservation and Natural Resources, State Lands Division, Coastal Section; National Oceanic and Atmospheric Administration, Office of Ocean and Coastal Resource Management [10NOS4190206]	Alabama Department of Conservation and Natural Resources, State Lands Division, Coastal Section; National Oceanic and Atmospheric Administration, Office of Ocean and Coastal Resource Management(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this project provided by the Alabama Department of Conservation and Natural Resources, State Lands Division, Coastal Section, in part, by a grant from the National Oceanic and Atmospheric Administration, Office of Ocean and Coastal Resource Management, Award #10NOS4190206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Chapman MG, 2000, WETLANDS, V19, P28; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Corbett DR, 2000, ESTUAR COAST SHELF S, V51, P227; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dingman S.L., 2008, PHYS HYDROLOGY, V2; Drake DC, 2009, ECOLOGY, V90, P2535, DOI 10.1890/08-1051.1; Ehrenfeld JG, 2000, RESTOR ECOL, V8, P2, DOI 10.1046/j.1526-100x.2000.80002.x; ELEUTERIUS L N, 1976, Chesapeake Science, V17, P289, DOI 10.2307/1350516; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Hamersley MR, 2005, MAR ECOL PROG SER, V299, P123, DOI 10.3354/meps299123; HARRELL J, 1978, J SEDIMENT PETROL, V48, P25; Hilderbrand RH, 2005, ECOL SOC, V10; LaSalle M.W, 1996, WRPRE15 US ARM CORPS; Lewis RR, 1982, CREATION RESTORATION, P153; Maynard DG, 1993, SOIL SAMPLING METHOD, P25; Moeller I, 1996, J COASTAL RES, V12, P1009; Quinn GP, 2003, EXPT DESIGN DATA ANA; Soro, 1992, DETERMINATION HYDRAU; Sparks EL, 2013, ECOL ENG, V53, P250, DOI 10.1016/j.ecoleng.2012.12.053; Stout JP, 1998, MESC CONTRIBUTION; STUMPF RP, 1983, ESTUAR COAST SHELF S, V17, P495, DOI 10.1016/0272-7714(83)90002-1; Tobias CR, 2001, LIMNOL OCEANOGR, V46, P1977, DOI 10.4319/lo.2001.46.8.1977; Tobias CR, 2001, LIMNOL OCEANOGR, V46, P604, DOI 10.4319/lo.2001.46.3.0604; Tobias CR, 2001, MAR ECOL PROG SER, V210, P25, DOI 10.3354/meps210025; Tobias C, 2019, COASTAL WETLANDS: AN INTEGRATED ECOSYSTEM APPROACH, 2ND EDITION, P539, DOI 10.1016/B978-0-444-63893-9.00016-2; Turner R.E., 2002, APPROACHES COASTAL W; TURNER RE, 1990, AM ZOOL, V30, P89; VALIELA I, 1978, LIMNOL OCEANOGR, V23, P798, DOI 10.4319/lo.1978.23.4.0798; VALIELA I, 1990, BIOGEOCHEMISTRY, V10, P177; Valiela I, 2002, ECOSYSTEMS, V5, P92, DOI 10.1007/s10021-001-0058-4; Wilkins S, 2003, RESTOR ECOL, V11, P489, DOI 10.1046/j.1526-100X.2003.rec0244.x; Zedler JB, 1999, RESTOR ECOL, V7, P69, DOI 10.1046/j.1526-100X.1999.07108.x	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111456	10.1371/journal.pone.0111456	http://dx.doi.org/10.1371/journal.pone.0111456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353607	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200081
J	Hill, AE; Plyler, ZE; Tiwari, H; Patki, A; Tully, JP; McAtee, CW; Moseley, LA; Sorscher, EJ				Hill, Aubrey E.; Plyler, Zackery E.; Tiwari, Hemant; Patki, Amit; Tully, Joel P.; McAtee, Christopher W.; Moseley, Leah A.; Sorscher, Eric J.			Longevity and Plasticity of CFTR Provide an Argument for Noncanonical SNP Organization in Hominid DNA	PLOS ONE			English	Article							HUMAN-Y-CHROMOSOMES; GENOME SEQUENCE VARIATION; MUTATION-RATE EVOLUTION; RECENT COMMON ANCESTRY; CYSTIC-FIBROSIS; NUCLEOTIDE SUBSTITUTION; DROSOPHILA-MELANOGASTER; NONCODING DNA; HUMAN-DISEASE; MOUSE MODEL	Like many other ancient genes, the cystic fibrosis transmembrane conductance regulator (CFTR) has survived for hundreds of millions of years. In this report, we consider whether such prodigious longevity of an individual gene - as opposed to an entire genome or species - should be considered surprising in the face of eons of relentless DNA replication errors, mutagenesis, and other causes of sequence polymorphism. The conventions that modern human SNP patterns result either from purifying selection or random (neutral) drift were not well supported, since extant models account rather poorly for the known plasticity and function (or the established SNP distributions) found in a multitude of genes such as CFTR. Instead, our analysis can be taken as a polemic indicating that SNPs in CFTR and many other mammalian genes may have been generated-and continue to accrue-in a fundamentally more organized manner than would otherwise have been expected. The resulting viewpoint contradicts earlier claims of 'directional' or 'intelligent design-type' SNP formation, and has important implications regarding the pace of DNA adaptation, the genesis of conserved non-coding DNA, and the extent to which eukaryotic SNP formation should be viewed as adaptive.	[Hill, Aubrey E.; Tully, Joel P.] Univ Alabama Birmingham, Dept Comp & Informat Sci, Birmingham, AL 35294 USA; [Plyler, Zackery E.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tiwari, Hemant; Patki, Amit] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Tully, Joel P.; McAtee, Christopher W.; Moseley, Leah A.; Sorscher, Eric J.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA; [Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sorscher, EJ (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35233 USA.	sorscher@uab.edu		Sorscher, Eric J./0000-0001-9341-3354	National Institutes of Health [P30DK72482]; Cystic Fibrosis Foundation [R464]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [P30DK72482 to E. S.]; and the Cystic Fibrosis Foundation [R464 to E. S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2013, J INFECT DIS, V208, P780, DOI 10.1093/infdis/jit251; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Blanchette Mathieu, 2008, V422, P171, DOI 10.1007/978-1-59745-581-7_11; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CAIRNS J, 1995, SCIENCE, V269, P288, DOI 10.1126/science.269.5222.288; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GABRIEL W, 1993, EVOLUTION, V47, P1744, DOI 10.1111/j.1558-5646.1993.tb01266.x; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Gulyas-Kovacs A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036546; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Havasi V, 2010, FERTIL STERIL, V94, P2122, DOI 10.1016/j.fertnstert.2009.11.044; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hodgkinson A, 2010, GENOME BIOL EVOL, V2, P547, DOI 10.1093/gbe/evq039; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1979, P NATL ACAD SCI USA, V76, P3440, DOI 10.1073/pnas.76.7.3440; Kondrashov AS, 2008, P NATL ACAD SCI USA, V105, P9133, DOI 10.1073/pnas.0804749105; Koonin EV, 2012, LOGIC CHANCE NATURES; Kreitman M, 1996, BIOESSAYS, V18, P678, DOI 10.1002/bies.950180812; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Kumar S, 2005, NAT REV GENET, V6, P654, DOI 10.1038/nrg1659; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Laszlo C, 2011, METHODS MOL BIOL, V741, P443, DOI 10.1007/978-1-61779-117-8_28; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI 10.1111/j.1558-5646.1990.tb05244.x; Lynch M, 2012, MOL BIOL EVOL, V29, P1353, DOI 10.1093/molbev/msr300; Lynch M, 2010, P NATL ACAD SCI USA, V107, P16577, DOI 10.1073/pnas.1010836107; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClellan DA, 2004, J THEOR BIOL, V226, P393, DOI 10.1016/j.jtbi.2003.09.019; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meyer Steven, 2013, DARWINS DOUBT EXPLOS; Mitchell RJ, 1996, CURR OPIN GENET DEV, V6, P737, DOI 10.1016/S0959-437X(96)80029-3; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nachman MW, 2000, GENETICS, V156, P297; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Ostedgaard LS, 2011, P NATL ACAD SCI USA, V108, P2921, DOI 10.1073/pnas.1019752108; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Plyler ZE, SNP DISTRIB IN PRESS; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Rishishwar L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042336; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SAWYER SA, 1992, GENETICS, V132, P1161; Sayres MAW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004064; Schon I, 2003, P ROY SOC B-BIOL SCI, V270, P827, DOI 10.1098/rspb.2002.2314; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Sung W, 2013, P NATL ACAD SCI USA, V110, pE860, DOI 10.1073/pnas.1220650110; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Tucker AE, 2013, P NATL ACAD SCI USA, V110, P15740, DOI 10.1073/pnas.1313388110; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Yang ZH, 2000, GENETICS, V155, P431; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	90	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109186	10.1371/journal.pone.0109186	http://dx.doi.org/10.1371/journal.pone.0109186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350658	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100009
J	Wang, SH; Sun, ZY; Dong, SZ; Liu, Y; Liu, Y				Wang, Shihui; Sun, Zeya; Dong, Shengzhao; Liu, Yang; Liu, Yun			Molecular Interactions between (-)-Epigallocatechin Gallate Analogs and Pancreatic Lipase	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; AMYLOID-BETA-PROTEIN; THERMODYNAMIC ANALYSIS; DIFFERENT POLYPHENOLS; GREEN TEA; IN-VITRO; INSULIN; OBESITY; KINETICS; CONFORMATION	The molecular interactions between pancreatic lipase (PL) and four tea polyphenols (EGCG analogs), like (-)epigallocatechin gallate (EGCG), (-)-gallocatechin gallate (GCG), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin (EC), were studied from PL activity, conformation, kinetics and thermodynamics. It was observed that EGCG analogs inhibited PL activity, and their inhibitory rates decreased by the order of EGCG. GCG. ECG. EC. PL activity at first decreased rapidly and then slowly with the increase of EGCG analogs concentrations. alpha-Helix content of PL secondary structure decreased dependent on EGCG analogs concentration by the order of EGCG. GCG. ECG. EC. EGCG, ECG, and EC could quench PL fluorescence both dynamically and statically, while GCG only quenched statically. EGCG analogs would induce PL self-assembly into complexes and the hydrodynamic radii of the complexes possessed a close relationship with the inhibitory rates. Kinetics analysis showed that EGCG analogs non-competitively inhibited PL activity and did not bind to PL catalytic site. DSC measurement revealed that EGCG analogs decreased the transition midpoint temperature of PL enzyme, suggesting that these compounds reduced PL enzyme thermostability. In vitro renaturation through urea solution indicated that interactions between PL and EGCG analogs were weak and non-covalent.	[Wang, Shihui; Sun, Zeya; Dong, Shengzhao; Liu, Yang; Liu, Yun] Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Biorefinery Res & Engn Ctr, Minist Educ China,Coll Life Sci & Technol, Beijing 100029, Peoples R China	Beijing University of Chemical Technology; Ministry of Education, China	Liu, Y (corresponding author), Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Biorefinery Res & Engn Ctr, Minist Educ China,Coll Life Sci & Technol, Beijing 100029, Peoples R China.	liuyun@mail.buct.edu.cn			Beijing Municipal Natural Science Foundation [5142013]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was funded by Beijing Municipal Natural Science Foundation (5142013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; Ballinger A, 2002, EUR J PHARMACOL, V440, P109, DOI 10.1016/S0014-2999(02)01422-X; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Cai SB, 2012, J AGR FOOD CHEM, V60, P7245, DOI 10.1021/jf3009958; Chen L, 2014, PLOS ONE, V9, DOI DOI 10.1371/journal.pone.0085771; de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013; Goncalves R, 2010, J AGR FOOD CHEM, V58, P11901, DOI 10.1021/jf103026x; Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139; Hasni I, 2011, FOOD CHEM, V126, P630, DOI 10.1016/j.foodchem.2010.11.087; Ishii T, 2010, BIOSCI BIOTECH BIOCH, V75, P100; de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924; Lean M, 2006, BMJ-BRIT MED J, V333, P959, DOI 10.1136/bmj.333.7575.959; Liu Y, 2012, ENZYME MICROB TECH, V51, P354, DOI 10.1016/j.enzmictec.2012.08.003; Liu Y, 2010, PROCESS BIOCHEM, V45, P1176, DOI 10.1016/j.procbio.2010.03.023; LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2; Mahapatra P, 2009, BIOCATAL BIOTRANSFOR, V27, P124, DOI 10.1080/10242420802583366; MCGRAW SE, 1990, PHARMACEUT RES, V7, P606, DOI 10.1023/A:1015866127447; Mendes AA, 2012, J MOL CATAL B-ENZYM, V78, P119, DOI 10.1016/j.molcatb.2012.03.004; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Papadopoulou A, 2005, J AGR FOOD CHEM, V53, P158, DOI 10.1021/jf048693g; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Ramos P, 2003, BIOCHEMISTRY-US, V42, P12488, DOI 10.1021/bi034900e; SCHRAG JD, 1991, NATURE, V351, P761, DOI 10.1038/351761a0; Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074; Skrt M, 2012, FOOD CHEM, V135, P2418, DOI 10.1016/j.foodchem.2012.06.114; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Tang SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031067; Wang SH, 2012, J PHYS CHEM B, V116, P5803, DOI 10.1021/jp209406t; Wang SH, 2012, INT J BIOL MACROMOL, V50, P1229, DOI 10.1016/j.ijbiomac.2012.04.010; Wang SH, 2012, BIOCHEM ENG J, V63, P38, DOI 10.1016/j.bej.2012.02.002; Wang SH, 2012, BIOCHEM ENG J, V62, P70, DOI 10.1016/j.bej.2012.01.005; Wang SH, 2010, J PHYS CHEM B, V114, P11576, DOI 10.1021/jp1001435; Wang SH, 2014, PROCESS BIOCHEM, V49, P237, DOI 10.1016/j.procbio.2013.10.018; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072146; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087161	39	35	34	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111143	10.1371/journal.pone.0111143	http://dx.doi.org/10.1371/journal.pone.0111143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365042	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100052
J	Al-Ahmad, A; Zou, P; Solarte, DLG; Hellwig, E; Steinberg, T; Lienkamp, K				Al-Ahmad, Ali; Zou, Peng; Solarte, Diana Lorena Guevara; Hellwig, Elmar; Steinberg, Thorsten; Lienkamp, Karen			Development of a Standardized and Safe Airborne Antibacterial Assay, and Its Evaluation on Antibacterial Biomimetic Model Surfaces	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; SYNTHETIC MIMICS; QUANTIFICATION; ADHESION	Bacterial infection of biomaterials is a major concern in medicine, and different kinds of antimicrobial biomaterial have been developed to deal with this problem. To test the antimicrobial performance of these biomaterials, the airborne bacterial assay is used, which involves the formation of biohazardous bacterial aerosols. We here describe a new experimental set-up which allows safe handling of such pathogenic aerosols, and standardizes critical parameters of this otherwise intractable and strongly user-dependent assay. With this new method, reproducible, thorough antimicrobial data (number of colony forming units and live-dead-stain) was obtained. Poly(oxonorbornene)-based Synthetic Mimics of Antimicrobial Peptides (SMAMPs) were used as antimicrobial test samples. The assay was able to differentiate even between subtle sample differences, such as different sample thicknesses. With this new set-up, the airborne bacterial assay was thus established as a useful, reliable, and realistic experimental method to simulate the contamination of biomaterials with bacteria, for example in an intraoperative setting.	[Al-Ahmad, Ali; Solarte, Diana Lorena Guevara; Hellwig, Elmar] Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, D-79106 Freiburg, Germany; [Zou, Peng; Lienkamp, Karen] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Zou, Peng; Solarte, Diana Lorena Guevara; Lienkamp, Karen] Univ Freiburg, Dept Microsyst Engn IMTEK, D-79106 Freiburg, Germany; [Steinberg, Thorsten] Univ Freiburg, Univ Med Ctr, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Al-Ahmad, A (corresponding author), Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ali.al-ahmad@uniklinik-freiburg.de		Steinberg, Thorsten/0000-0003-1924-2694	Freiburg Institute for Advanced Studies (FRIAS); German Research Foundation (DFG) [LI 1714/5-1]	Freiburg Institute for Advanced Studies (FRIAS)(Fonds de la Recherche Scientifique - FNRS); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the Freiburg Institute for Advanced Studies (FRIAS) and the German Research Foundation (DFG, LI 1714/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2006, J MED MICROBIOL, V55, P109, DOI 10.1099/jmm.0.46280-0; Al-Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073812; Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0; Dorner F, 2014, RSC POLYM CHEM SER, V10, P97; FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772; Gabriel GJ, 2008, LANGMUIR, V24, P12489, DOI 10.1021/la802232p; Haenle M, 2010, HIP INT, V20, P248, DOI 10.1177/112070001002000217; Haldar J, 2007, NAT PROTOC, V2, P2412, DOI 10.1038/nprot.2007.353; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Jones D, 1991, MAINTENANCE MICROORG, P45; Karygianni L, 2013, MATERIALS, V6, P5659, DOI 10.3390/ma6125659; Kimmerle H, 2012, ARCH ORAL BIOL, V57, P689, DOI 10.1016/j.archoralbio.2011.11.012; Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea; Lienkamp K, 2008, J AM CHEM SOC, V130, P9836, DOI 10.1021/ja801662y; Lienkamp K, 2009, CHEM-EUR J, V15, P11784, DOI 10.1002/chem.200900049; Lienkamp K, 2009, CHEM-EUR J, V15, P11715, DOI 10.1002/chem.200900606; Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044; Madkour AE, 2009, LANGMUIR, V25, P1060, DOI 10.1021/la802953v; McCarthy NL, 2010, AM J INFECT CONTROL, V38, P600, DOI 10.1016/j.ajic.2010.01.006; Steinberg T., 2013, TEST APPARATUS TESTI; Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3; Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299; Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zou P, 2012, J MATER CHEM, V22, P19579, DOI 10.1039/c2jm31695a	28	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111357	10.1371/journal.pone.0111357	http://dx.doi.org/10.1371/journal.pone.0111357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360525	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700091
J	Funk, K; Scheerer, N; Verhaegh, R; Putter, C; Fandrey, J; de Groot, H				Funk, Kristina; Scheerer, Nina; Verhaegh, Rabea; Puetter, Carolin; Fandrey, Joachim; de Groot, Herbert			Severe Blunt Muscle Trauma in Rats: Only Marginal Hypoxia in the Injured Area	PLOS ONE			English	Article							SOFT-TISSUE INJURY; OXYGEN-PRESSURE FIELDS; SKELETAL-MUSCLE; CIRCULATORY PATHOPHYSIOLOGY; SECONDARY INJURY; INDUCIBLE FACTOR; IN-VIVO; MICROCIRCULATION; INFLAMMATION; CRYOTHERAPY	Background: After severe muscle trauma, hypoxia due to microvascular perfusion failure is generally believed to further increase local injury and to impair healing. However, detailed analysis of hypoxia at the cellular level is missing. Therefore, in the present work, spectroscopic measurements of microvascular blood flow and O-2 supply were combined with immunological detection of hypoxic cells to estimate O-2 conditions within the injured muscle area. Materials and Methods: Severe blunt muscle trauma was induced in the right Musculus gastrocnemius of male Wistar rats by a standardized "weight-drop'' device. Microvascular blood flow, relative hemoglobin amount, and hemoglobin O-2 saturation were determined by laser Doppler and white-light spectroscopy. Hypoxic cells were detected by histologic evaluation of covalent binding of pimonidazole and expression of HIF-1 alpha. Results: Directly after trauma and until the end of experiment (480 minutes), microvascular blood flow and relative hemoglobin amount were clearly increased. In contrast to blood flow and relative hemoglobin amount, there was no immediate but a delayed increase of microvascular hemoglobin O-2 saturation. Pimonidazole immunostaining revealed a hypoxic fraction (percentage area of pimonidazole-labelled muscle cells within the injured area) between 8 to 3%. There was almost no HIF-1 alpha expression detectable in the muscle cells under each condition studied. Conclusions: In the early phase (up to 8 hours) after severe blunt muscle trauma, the overall microvascular perfusion of the injured area and thus its O-2 supply is clearly increased. This increased O-2 supply is obviously sufficient to ensure normoxic (or even hyperoxic) conditions in the vast majority of the cells.	[Funk, Kristina; Verhaegh, Rabea; de Groot, Herbert] Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany; [Scheerer, Nina; Fandrey, Joachim] Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol, Essen, Germany; [Puetter, Carolin] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	de Groot, H (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Physiol Chem, Essen, Germany.	herbert.de-groot@uni-duisburg-essen.de	Fandrey, Joachim/AAA-3524-2021	Fandrey, Joachim/0000-0001-9585-0531	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Deutsche Forschungsgemeinschaft for taking over the publication fee. The Deutsche Forschungsgemeinschaft had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon M, 2006, J TRAUMA, V61, P924, DOI 10.1097/01.ta.0000195979.25659.fe; Blalock A, 1930, ARCH SURG-CHICAGO, V20, P26, DOI 10.1001/archsurg.1930.01150070029004; Bliss M R, 1998, J Tissue Viability, V8, P4; Brookes ZLS, 2000, BRIT J ANAESTH, V85, P901, DOI 10.1093/bja/85.6.901; CHAPMAN JD, 1981, BRIT J CANCER, V43, P546, DOI 10.1038/bjc.1981.79; EGER EI, 1981, ANESTHESIOLOGY, V55, P559, DOI 10.1097/00000542-198111000-00014; FRANK KH, 1989, PHYS MED BIOL, V34, P1883, DOI 10.1088/0031-9155/34/12/011; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Gaehtgens P, 1977, UNTERSUCHUNGEN BEZIE; Gierer P, 2008, J SURG RES, V147, P68, DOI 10.1016/j.jss.2007.07.025; Gillani S, 2012, INJURY, V43, P670, DOI 10.1016/j.injury.2011.03.008; Gradl G, 2005, SHOCK, V24, P219, DOI 10.1097/01.shk.0000174022.33182.4b; HOLMSTROM A, 1985, MICROCIRC ENDOTH LYM, V2, P293; Kang S, 2013, WOUND REPAIR REGEN, V21, P730, DOI 10.1111/wrr.12081; Kapral S, 2006, INTENSIVMED, P1362; KELLETT J, 1986, MED SCI SPORT EXER, V18, P489; Kerkweg U, 2010, SHOCK, V33, P513, DOI 10.1097/SHK.0b013e3181c4f56e; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Knappe T, 2005, CRIT CARE MED, V33, P1805, DOI 10.1097/01.CCM.0000172613.74775.C5; Knight KL, 1995, CRYOTHERAPY SPORTS I, P3; KNIGHT KL, 1976, ATHL TRAIN, V11, P7; LEWIS DH, 1970, ACTA ORTHOP SCAND, V41, P17, DOI 10.3109/17453677008991975; LEWIS DH, 1970, ACTA ORTHOP SCAND, V41, P37, DOI 10.3109/17453677008991976; LIU CT, 1968, J TRAUM, V8, P75, DOI 10.1097/00005373-196801000-00008; LUND N, 1980, ACTA ANAESTH SCAND, V24, P155, DOI 10.1111/j.1399-6576.1980.tb01525.x; Merrick MA, 1999, MED SCI SPORT EXER, V31, P1516, DOI 10.1097/00005768-199911000-00004; Merrick MA, 2010, J SPORT REHABIL, V19, P380, DOI 10.1123/jsr.19.4.380; Reikeras O, 2010, INFLAMM RES, V59, P409, DOI 10.1007/s00011-010-0167-7; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Rotter R, 2012, J TRAUMA ACUTE CARE, V73, P73, DOI 10.1097/TA.0b013e31824afddd; Rubinstein I, 1998, J CLIN INVEST, V101, P1325, DOI 10.1172/JCI810; SANDEGARD J, 1975, ACTA RADIOL DIAGN, V16, P279, DOI 10.1177/028418517501600308; Schaser KD, 1999, J ORTHOP RES, V17, P678, DOI 10.1002/jor.1100170509; Schaser KD, 2007, AM J SPORT MED, V35, P93, DOI 10.1177/0363546506294569; Scheerer N, 2013, J IMMUNOL, V191, P407, DOI 10.4049/jimmunol.1103779; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shuler MS, 2009, J BONE JOINT SURG AM, V91A, P1360, DOI 10.2106/JBJS.H.00347; SMITH TL, 1993, MICROSURG, V14, P487, DOI 10.1002/micr.1920140805; Szczesny G, 2001, J TRAUMA, V51, P508, DOI 10.1097/00005373-200109000-00014; Toumi H, 2003, BRIT J SPORT MED, V37, P284, DOI 10.1136/bjsm.37.4.284; Williams DT, 2003, CRIT CARE MED, V31, pS547, DOI 10.1097/01.CCM.0000081430.34066.1D; Xing DM, 2011, WOUND REPAIR REGEN, V19, P205, DOI 10.1111/j.1524-475X.2010.00656.x	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111151	10.1371/journal.pone.0111151	http://dx.doi.org/10.1371/journal.pone.0111151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360779	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700066
J	Manson, GA; Sayenko, DG; Masani, K; Goodman, R; Wong, L; Popovic, MR; Tremblay, L; Welsh, TN				Manson, Gerome A.; Sayenko, Dimitry G.; Masani, Kei; Goodman, Rachel; Wong, Lokman; Popovic, Milos R.; Tremblay, Luc; Welsh, Timothy N.			Action Possibility Judgments of People with Varying Motor Abilities Due to Spinal Cord Injury	PLOS ONE			English	Article							ACTION PERCEPTION; FITTSS LAW; HEIGHT	Predictions about one's own action capabilities as well as the action capabilities of others are thought to be based on a simulation process involving linked perceptual and motor networks. Given the central role of motor experience in the formation of these networks, one's present motor capabilities are thought to be the basis of their perceptual judgments about actions. However, it remains unknown whether the ability to form these action possibility judgments is affected by performance related changes in the motor system. To determine if judgments of action capabilities are affected by long-term changes in one's own motor capabilities, participants with different degrees of upper-limb function due to their level (cervical vs. below cervical) of spinal cord injury (SCI) were tested on a perceptual-motor judgment task. Participants observed apparent motion videos of reciprocal aiming movements with varying levels of difficulty. For each movement, participants determined the shortest movement time (MT) at which they themselves and a young adult could perform the task while maintaining accuracy. Participants also performed the task. Analyses of MTs revealed that perceptual judgments for participant's own movement capabilities were consistent with their actual performance-people with cervical SCI had longer judged and actual MTs than people with below cervical SCI. However, there were no between-group differences in judged MTs for the young adult. Although it is unclear how the judgments were adjusted (altered simulation vs. threshold modification), the data reveal that people with different motor capabilities due to SCI are not completely biased by their present capabilities and can effectively adjust their judgments to estimate the actions of others.	[Manson, Gerome A.; Goodman, Rachel; Wong, Lokman; Tremblay, Luc; Welsh, Timothy N.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Manson, Gerome A.; Masani, Kei; Goodman, Rachel; Tremblay, Luc; Welsh, Timothy N.] Univ Toronto, Ctr Motor Control, Toronto, ON, Canada; [Sayenko, Dimitry G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Masani, Kei; Popovic, Milos R.; Welsh, Timothy N.] Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Masani, Kei; Popovic, Milos R.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto	Manson, GA (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	gerome.manson@utoronto.ca	Sayenko, Dimitry/AAP-4936-2020; Masani, Kei/B-4991-2010	Sayenko, Dimitry/0000-0002-4154-6873; Masani, Kei/0000-0002-0207-3241; , Luc/0000-0002-1148-1722; Popovic, Milos R/0000-0002-2837-2346	Early Research Award from the Ontario Ministry of Research and Innovation; Discovery Grants from the Natural Sciences and Engineering Research Council of Canada	Early Research Award from the Ontario Ministry of Research and Innovation; Discovery Grants from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an Early Research Award from the Ontario Ministry of Research and Innovation and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosbach S, 2005, NAT NEUROSCI, V8, P1295, DOI 10.1038/nn1535; Chandrasekharan S, 2012, Q J EXP PSYCHOL, V65, P976, DOI 10.1080/17470218.2011.638720; Cordovil R, 2011, HUM MOVEMENT SCI, V30, P976, DOI 10.1016/j.humov.2010.08.011; Cordovil R, 2012, J EXP CHILD PSYCHOL, V111, P319, DOI 10.1016/j.jecp.2011.09.005; Eskenazi T, 2012, SOC NEUROSCI-UK, V7, P30, DOI 10.1080/17470919.2011.576871; Eskenazi T, 2009, PSYCHOL RES-PSYCH FO, V73, P477, DOI 10.1007/s00426-009-0231-5; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Ramenzoni VC, 2008, COGNITION, V106, P1059, DOI 10.1016/j.cognition.2007.04.008; Ramenzoni V, 2008, J EXP PSYCHOL HUMAN, V34, P919, DOI 10.1037/0096-1523.34.4.919; Ramenzoni VC, 2008, Q J EXP PSYCHOL, V61, P1487, DOI 10.1080/17470210802100073; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Welsh TN, 2013, ACTA PSYCHOL, V143, P235, DOI 10.1016/j.actpsy.2013.04.003; Wong L, 2013, BEHAV BRAIN RES, V257, P242, DOI 10.1016/j.bbr.2013.09.045; Zar JH., 1999, BIOSTAT ANAL	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110250	10.1371/journal.pone.0110250	http://dx.doi.org/10.1371/journal.pone.0110250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360601	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700029
J	Nathan, AM; Rani, F; Lee, RJY; Zaki, R; Westerhout, C; Sam, IC; Lum, LCS; de Bruyne, J				Nathan, Anna Marie; Rani, Fairuz; Lee, Rachel Jiun Yi; Zaki, Rafdzah; Westerhout, Caroline; Sam, I-Ching; Lum, Lucy Chai See; de Bruyne, Jessie			Clinical Risk Factors for Life-Threatening Lower Respiratory Tract Infections in Children: A Retrospective Study in an Urban City in Malaysia	PLOS ONE			English	Article							PNEUMONIA; MORTALITY; ETIOLOGY; EPIDEMIOLOGY; ADMISSION; OUTCOMES; VIRUS	Aim: Lower respiratory tract infections (LRTIs) are an important cause of morbidity and mortality, especially in low income countries. The aim of this study was to determine risk factors of life-threatening LRTIs in hospitalised children in Malaysia. Methods: This retrospective study included children aged less than 18 years admitted for LRTIs over 13 months in a tertiary referral centre in Kuala Lumpur, Malaysia. Neonates, children with asthma and those with either no or a normal chest radiograph were excluded. Life-threatening infection was defined as that needing non-invasive ventilation or admission to the paediatric intensive care unit. Routine blood investigations and nasopharyngeal secretion results (bacterial and viral) were obtained. Chest radiographs were reviewed by a designated radiologist. Environmental data (rainfall, particulate matter <= 10 mu m [PM10] and air pollution index [API]) was obtained from the respective government departments. Results: Three hundred and ninety-one episodes of LRTIs were included. Viruses were implicated in 48.5% of LRTIs, with respiratory syncytial virus (RSV) being detected in 44% of viral LRTIs. Forty-six (11.8%) children had life-threatening disease and the overall mortality rate was 1.3% (5 children). RSV was detected in 26% of children with life-threatening LRTIs. In multivariate logistic regression, chronic lung disease, presenting history of apnoea and signs of hypoxia, was associated with life threatening LRTIs. Increased LRTI admissions were associated with low rainfall but not PM10 nor API. Of those on follow-up, 39% had persistent respiratory symptoms. Conclusion: One in nine children admitted with LRTI had a life-threatening LRTI. The aetiology was viral in almost half of admitted children. RSV was detected in a quarter of children with life-threatening LRTIs. Children who present with LRTIs and either have chronic lung disease, presenting history of apnoea or signs of hypoxia, should be observed carefully as the risk of deterioration to life-threatening illness is high.	[Nathan, Anna Marie; Lum, Lucy Chai See; de Bruyne, Jessie] Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia; [Nathan, Anna Marie; Lum, Lucy Chai See; de Bruyne, Jessie] Univ Malaya, Paediat & Child Hlth Res Grp, Kuala Lumpur, Malaysia; [Rani, Fairuz] Hosp Sultan Haji Ahmad Shah, Dept Obstet & Gynaecol, Temerloh, Pahang, Malaysia; [Lee, Rachel Jiun Yi] Raigmore Hosp, Dept Med, Inverness, Scotland; [Zaki, Rafdzah] Univ Malaya, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Westerhout, Caroline] Univ Malaya, Med Ctr, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Sam, I-Ching] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Nathan, AM (corresponding author), Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia.	psr9900@hotmail.com	Nathan, Anna/ABH-2362-2021; ZAKI, RAFDZAH AHMAD/B-9520-2010; Sam, Jamal I-Ching/B-8688-2010; de Bruyne, Jessie/B-8710-2010; Nathan, Anna M/G-4148-2015; Lum, Lucy/Q-9871-2017	Nathan, Anna/0000-0003-3618-5820; ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; Sam, Jamal I-Ching/0000-0002-1296-7898; de Bruyne, Jessie/0000-0002-3388-6173; Lum, Lucy/0000-0002-7452-4208	University Malaya [UM.C/625/1/HIR/MOHE/MED/42]; UMR by University Malaya [UM.TNC2/RC/HTM/RP026-14HTM]	University Malaya(Universiti Malaya); UMR by University Malaya	This study was partly funded by a High Impact Research Grant (no. UM.C/625/1/HIR/MOHE/MED/42) awarded to AMN, ICS and JdB by University Malaya and by the UMR Grant (no. UM.TNC2/RC/HTM/RP026-14HTM) awarded to AMN, RZ, CW, and JdB by University Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan PWK, 1999, J PAEDIATR CHILD H, V35, P287, DOI 10.1046/j.1440-1754.1999.00359.x; Chang AB, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00029; Chen Z, 2013, ARCH VIROL; Goyet S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089637; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hon KL, 2008, PEDIATR PULM, V43, P275, DOI 10.1002/ppul.20768; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Khamapirad T, 1987, Semin Respir Infect, V2, P130; Lai HK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-360; Li Feng, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P664; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Moreno L, 2006, PEDIATR PULM, V41, P331, DOI 10.1002/ppul.20364; Paynter S, 2013, EPIDEMIOL INFECT, V141, P1328, DOI 10.1017/S0950268812001379; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; Trenholme AA, 2013, PEDIATR PULM, V48, P772, DOI 10.1002/ppul.22661; Wilkins Tyler R, 2005, Radiol Technol, V77, P106; Zamberi S, 2003, Med J Malaysia, V58, P681; Zhang Qingli, 2013, BMC Res Notes, V6, P447, DOI 10.1186/1756-0500-6-447; Zhang QL, 2013, PEDIATR PULM, V48, P390, DOI 10.1002/ppul.22608	24	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111162	10.1371/journal.pone.0111162	http://dx.doi.org/10.1371/journal.pone.0111162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360811	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700067
J	Schmidt, A; Lenzig, P; Oslender-Bujotzek, A; Kusch, J; Lucas, SD; Grunder, S; Wiemuth, D				Schmidt, Axel; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Kusch, Jana; Lucas, Susana Dias; Gruender, Stefan; Wiemuth, Dominik			The Bile Acid-Sensitive Ion Channel (BASIC) Is Activated by Alterations of Its Membrane Environment	PLOS ONE			English	Article							NA+ CHANNEL; K+ CHANNELS; FUNCTIONAL EXPRESSION; BIOLOGICAL-MEMBRANES; NUCLEAR RECEPTOR; BILAYER COUPLES; LIGAND-BINDING; INTESTINE; CHOLESTEROL; INHIBITION	The bile acid-sensitive ion channel (BASIC) is a member of the DEG/ENaC family of ion channels. Channels of this family are characterized by a common structure, their physiological functions and modes of activation, however, are diverse. Rat BASIC is expressed in brain, liver and intestinal tract and activated by bile acids. The physiological function of BASIC and its mechanism of bile acid activation remain a puzzle. Here we addressed the question whether amphiphilic bile acids activate BASIC by directly binding to the channel or indirectly by altering the properties of the surrounding membrane. We show that membrane-active substances other than bile acids also affect the activity of BASIC and that activation by bile acids and other membrane-active substances is non-additive, suggesting that BASIC is sensitive for changes in its membrane environment. Furthermore based on results from chimeras between BASIC and ASIC1a, we show that the extracellular and the transmembrane domains are important for membrane sensitivity.	[Schmidt, Axel; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Gruender, Stefan; Wiemuth, Dominik] Rhein Westfal TH Aachen, Inst Physiol, Aachen, Germany; [Kusch, Jana] Univ Jena, Univ Hosp Jena, Inst Physiol 2, Jena, Germany; [Lucas, Susana Dias] Univ Lisbon, Fac Farm, Inst Invest Medicamento iMed ULisboa, P-1699 Lisbon, Portugal	RWTH Aachen University; Friedrich Schiller University of Jena; Universidade de Lisboa	Wiemuth, D (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Aachen, Germany.	dwiemuth@ukaachen.de	Gründer, Stefan/I-2495-2019; Schmidt, Axel/GLR-2893-2022; Lucas, Susana D/D-6201-2011; Kusch, Jana/ABC-9738-2020	Gründer, Stefan/0000-0002-7635-9883; Schmidt, Axel/0000-0002-9780-7243; Lucas, Susana D/0000-0002-5555-5594; Kusch, Jana/0000-0001-7206-8133	Deutsche Forschungsgemeinschaft [WI 4176/1-1]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/64265/2009]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by a grant of the Deutsche Forschungsgemeinschaft to DW (WI 4176/1-1). SDL is supported by Fundacao para a Ciencia e Tecnologia (SFRH/BPD/64265/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akare S, 2005, BBA-MOL CELL BIOL L, V1735, P59, DOI 10.1016/j.bbalip.2005.04.006; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; Boiko N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091326; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; DEUTICKE B, 1968, BIOCHIM BIOPHYS ACTA, V163, P494, DOI 10.1016/0005-2736(68)90078-3; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; HOFMANN AF, 1994, SCAND J GASTROENTE S, V204, P1; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Lefevre CM, 2013, PFLUGERS ARCH, V466, P256; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Macchiarulo A, 2013, ACS MED CHEM LETT, V4, P1158, DOI 10.1021/ml400247k; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Mello-Vieira J, 2013, BBA-BIOMEMBRANES, V1828, P2152, DOI 10.1016/j.bbamem.2013.05.021; Nache V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003110; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; SHEETZ MP, 1976, J CELL BIOL, V70, P193, DOI 10.1083/jcb.70.1.193; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Wiemuth D., 2013, CHANNELS AUSTIN, V8, P29; Wiemuth D, 2012, CHANNELS AUSTIN, V7, P38; Wiemuth D, 2014, PFLUG ARCH EUR J PHY, V466, P1725, DOI 10.1007/s00424-013-1403-0; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Zheng Jie, 2003, Sci STKE, V2003, pPL7, DOI 10.1126/stke.2003.176.pl7; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116	45	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111549	10.1371/journal.pone.0111549	http://dx.doi.org/10.1371/journal.pone.0111549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360526	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700119
J	Sgobio, C; Kupferschmidt, DA; Cui, GH; Sun, LX; Li, Z; Cai, HB; Lovinger, DM				Sgobio, Carmelo; Kupferschmidt, David A.; Cui, Guohong; Sun, Lixin; Li, Zheng; Cai, Huaibin; Lovinger, David M.			Optogenetic Measurement of Presynaptic Calcium Transients Using Conditional Genetically Encoded Calcium Indicator Expression in Dopaminergic Neurons	PLOS ONE			English	Article							MUTANT ALPHA-SYNUCLEIN; KNOCK-OUT MICE; CHOLINERGIC INTERNEURONS; PARKINSONS-DISEASE; NEUROTRANSMITTER RELEASE; STRIATAL SYNAPTOSOMES; 5-HT1B RECEPTORS; DORSAL STRIATUM; NEURAL ACTIVITY; TRANSMISSION	Calcium triggers dopamine release from presynaptic terminals of midbrain dopaminergic (mDA) neurons in the striatum. However, calcium transients within mDA axons and axon terminals are difficult to study and little is known about how they are regulated. Here we use a newly-developed method to measure presynaptic calcium transients (PreCaTs) in axons and terminals of mDA neurons with a genetically encoded calcium indicator (GECI) GCaMP3 expressed in transgenic mice. Using a photomultiplier tube-based system, we measured electrical stimulation-induced PreCaTs of mDA neurons in dorsolateral striatum slices from these mice. Single-pulse stimulation produced a transient increase in fluorescence that was completely blocked by a combination of N- and P/Q-type calcium channel blockers. DA and cholinergic, but not serotoninergic, signaling pathways modulated the PreCaTs in mDA fibers. These findings reveal heretofore unexplored dynamic modulation of presynaptic calcium in nigrostriatal terminals.	[Sgobio, Carmelo; Sun, Lixin; Cai, Huaibin] NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Kupferschmidt, David A.; Cui, Guohong; Lovinger, David M.] Natl Inst Alcohol Abuse & Alcoholism, Lab Integrat Neurosci, NIH, Rockville, MD USA; [Li, Zheng] NIMH, Unit Synapse Dev & Plast, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Cai, HB (corresponding author), NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	caih@mail.nih.gov; lovindav@mail.nih.gov	Sgobio, Carmelo/AAD-7207-2021; Cui, Guohong/E-4089-2019; Sgobio, Carmelo/AAH-3257-2020; Li, Zheng/I-8016-2014; Cai, Huaibin/H-3359-2013; Sgobio, Carmelo/AAU-4652-2021	Sgobio, Carmelo/0000-0002-6282-369X; Cui, Guohong/0000-0002-4555-028X; Li, Zheng/0000-0002-2978-2531; Cai, Huaibin/0000-0002-8596-6108; 	National Institute on Aging [Z01-000928, 000929]; Division of Intramural Clinical and Biological Research of NIAAA [ZIA AA000407]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division of Intramural Clinical and Biological Research of NIAAA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by the intramural program of National Institute on Aging (Z01-000928, 000929) and the Division of Intramural Clinical and Biological Research of NIAAA (ZIA AA000407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; BIGORNIA L, 1990, J PHARMACOL EXP THER, V252, P586; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Cai HB, 2005, J NEUROSCI, V25, P7567, DOI 10.1523/JNEUROSCI.1645-05.2005; CALABRESI P, 1993, BRAIN, V116, P433; Carlsson A, 2002, J NEURAL TRANSM, V109, P777, DOI 10.1007/s007020200064; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Chen BT, 2006, J NEUROCHEM, V96, P645, DOI 10.1111/j.1471-4159.2005.03519.x; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; De Groote L, 2003, EUR J PHARMACOL, V476, P71, DOI 10.1016/S0014-2999(03)02154-X; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Ford CP, 2010, J NEUROSCI, V30, P6975, DOI 10.1523/JNEUROSCI.1020-10.2010; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gibb A.J., 1994, MICROELECTRODE TECHN, P225; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Nikolaou N, 2012, NEURON, V76, P317, DOI 10.1016/j.neuron.2012.08.040; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Phillips PEM, 2000, BRAIN RES, V884, P139, DOI 10.1016/S0006-8993(00)02958-9; RAPIER C, 1988, J NEUROCHEM, V50, P1123, DOI 10.1111/j.1471-4159.1988.tb10582.x; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Sarhan H, 2000, N-S ARCH PHARMACOL, V361, P12, DOI 10.1007/s002109900163; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Smits SM, 2006, J NEURAL TRANSM-SUPP, P57; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Walker AS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00034; WU LG, 1994, J NEUROSCI, V14, P645; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	44	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111749	10.1371/journal.pone.0111749	http://dx.doi.org/10.1371/journal.pone.0111749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360513	gold, Green Published			2022-12-27	WOS:000343943700147
J	Wang, Q; Peng, JM; Sun, Y; Chen, JZ; An, TQ; Leng, CL; Li, L; Zhao, HY; Guo, X; Ge, XN; Yang, HC; Tian, ZJ				Wang, Qian; Peng, Jinmei; Sun, Yan; Chen, Jiazeng; An, Tongqing; Leng, Chaoliang; Li, Lin; Zhao, Hongyuan; Guo, Xin; Ge, Xinna; Yang, Hanchun; Tian, Zhijun			Unique Epitopes Recognized by Monoclonal Antibodies against HP-PRRSV: Deep Understanding of Antigenic Structure and Virus-Antibody Interaction	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; PROTEINS; REGION; STRAIN	Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) is a member of the genus Arterivirus within the family Arteriviridae. N and GP3 proteins are the immunodominance regions of the PRRSV viral proteins. To identify the B-cell linear antigenic epitopes within HP-PRRSV N and GP3 proteins, two monoclonal antibodies (mAbs) against N and GP3 proteins were generated and characterized, designated as 3D7 and 1F10 respectively. The mAb 3D7 recognized only HuN4-F112 not the corresponding virulent strain (HuN4-F5). It also recognized two other commercial vaccines (JXA1-R and TJM-F92), but not two other HP-PRRSV strains (HNZJJ-F1 and HLJMZ-F2). The B-cell epitope recognized by the mAb 3D7 was localized to N protein amino acids 7-33. Western blot showed that the only difference amino acid between HuN4-F112-N and HuN4-F5-N did not change the mAb 3D7 recognization to N protein. The epitope targeted by the mAb 1F10 was mapped by truncated proteins. We found a new epitope (68-76aa) can be recognized by the mAb. However, the epitope could not be recognized by the positive sera, suggesting the epitope could not induce antibody in pigs. These results should extend our understanding of the antigenic structure of the N protein and antigen-antibody reactions of the GP3 protein in different species.	[Wang, Qian; Peng, Jinmei; Sun, Yan; Chen, Jiazeng; An, Tongqing; Leng, Chaoliang; Li, Lin; Zhao, Hongyuan; Tian, Zhijun] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Swine Infect Dis, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China; [Wang, Qian; Guo, Xin; Ge, Xinna; Yang, Hanchun] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China; [Wang, Qian; Guo, Xin; Ge, Xinna; Yang, Hanchun] China Agr Univ, State Key Lab Agribiotechnol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Yang, HC (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China.	yanghanchun1@cau.edu.cn; tzj@hvri.ac.cn			National Natural Science Foundation of China [31001050]; Heilongjiang National Funds for Distinguished Young Scientists [JC201314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang National Funds for Distinguished Young Scientists	This study was supported by the National Natural Science Foundation of China (grant No. 31001050) and the Heilongjiang National Funds for Distinguished Young Scientists (No. JC201314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista EM, 1996, ARCH VIROL, V141, P1357, DOI 10.1007/BF01718837; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Cancel-Tirado SM, 2004, VET IMMUNOL IMMUNOP, V102, P249, DOI 10.1016/j.vetimm.2004.09.017; Cavanagh D, 1997, ARCH VIROL, V142, P629; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; DREW TW, 1995, J GEN VIROL, V76, P1361, DOI 10.1099/0022-1317-76-6-1361; Duran JP, 1997, VIRUS GENES, V14, P19, DOI 10.1023/A:1007931322271; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Gonin P, 1998, ARCH VIROL, V143, P1927, DOI 10.1007/s007050050430; Hedges JF, 1999, VIROLOGY, V264, P92, DOI 10.1006/viro.1999.9982; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; KATZ JB, 1995, VET MICROBIOL, V44, P65, DOI 10.1016/0378-1135(94)00113-B; Larochelle R, 1997, VET MICROBIOL, V58, P1, DOI 10.1016/S0378-1135(97)00150-8; Leng CL, 2012, VET MICROBIOL, V159, P273, DOI 10.1016/j.vetmic.2012.06.018; Li Y, 2013, VET IMMUNOL IMMUNOP, V151, P331, DOI 10.1016/j.vetimm.2012.11.011; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Loemba HD, 1996, ARCH VIROL, V141, P751, DOI 10.1007/BF01718333; Meulenberg J J, 1995, Adv Exp Med Biol, V380, P271; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; NELSON EA, 1993, J CLIN MICROBIOL, V31, P3184, DOI 10.1128/JCM.31.12.3184-3189.1993; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Oleksiewicz MB, 2002, J GEN VIROL, V83, P1407, DOI 10.1099/0022-1317-83-6-1407; Rodriguez MJ, 1997, J GEN VIROL, V78, P2269, DOI 10.1099/0022-1317-78-9-2269; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian ZJ, 2009, VET MICROBIOL, V138, P34, DOI 10.1016/j.vetmic.2009.03.003; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; van Aken D, 2006, J GEN VIROL, V87, P3473, DOI 10.1099/vir.0.82269-0; vanNieuwstadt AP, 1996, J VIROL, V70, P4767, DOI 10.1128/JVI.70.7.4767-4772.1996; Yang HC, 2007, SWINE IND SCI, V1, P77; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x; Zhou YJ, 2006, VIRUS RES, V118, P98, DOI 10.1016/j.virusres.2005.11.019; Zhou YJ, 2011, CHINESE J ANIMAL INF, V19, P1	33	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111633	10.1371/journal.pone.0111633	http://dx.doi.org/10.1371/journal.pone.0111633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360600	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700134
J	Zhang, HM; Peng, C; Duan, XD; Shen, D; Lan, GH; Xiao, WT; Tan, H; Wang, L; Hou, JL; Zhu, JC; He, RW; Zhang, HB; Zheng, LL; Yang, JY; Zhang, Z; Zhou, ZW; Li, WH; Hu, ML; Zhong, JH; Chen, YH				Zhang, Haiming; Peng, Cong; Duan, Xiaodong; Shen, Dan; Lan, Guanghua; Xiao, Wutao; Tan, Hai; Wang, Ling; Hou, Jialei; Zhu, Jiancui; He, Riwen; Zhang, Haibing; Zheng, Lilan; Yang, Jianyu; Zhang, Zhen; Zhou, Zhiwei; Li, Wenhua; Hu, Mailing; Zhong, Jinhui; Chen, Yuhua			A Cross-Sectional Study of Avian Influenza in One District of Guangzhou, 2013	PLOS ONE			English	Article							LIVE-BIRD MARKETS; A H7N9 VIRUS; HUMAN INFECTION; HONG-KONG; POULTRY; CHINA; H9N2; H5N1; PATHOGENICITY; ORIGIN	Since Feb, 2013, more than 100 human beings had been infected with novel H7N9 avian influenza virus. As of May 2013, several H7N9 viruses had been found in retail live bird markets (LBMs) in Guangdong province of southern China where several human cases were confirmed later. However, the real avian influenza virus infection status especially H7N9 in Guangzhou remains unclear. Therefore, a cross-sectional study of avian influenza in commercial poultry farms, the wholesale LBM and retail LBMs in one district of Guangzhou was conducted from October to November, 2013. A total of 1505 cloacal and environmental samples from 52 commercial poultry farms, 1 wholesale LBM and 18 retail LBMs were collected and detected using real-time RT-PCR for type A, H7, H7N9 and H9 subtype avian influenza virus, respectively. Of all the flocks randomly sampled, 6 farms, 12 vendors of the wholesale LBM and 18 retail LBMs were type A avian influenza virus positive with 0, 3 and 11 positive for H9, respectively. The pooled prevalence and individual prevalence of type A avian influenza virus were 33.9% and 7.9% which for H9 subtype was 7.6% and 1.6%, respectively. None was H7 and H7N9 subtype virus positive. Different prevalence and prevalence ratio were found in different poultry species with partridges having the highest prevalence for both type A and H9 subtype avian influenza virus. Our results suggest that LBM may have a higher risk for sustaining and transmission of avian influenza virus than commercial poultry farms. The present study also indicates that different species may play different roles in the evolution and transmission of avian influenza virus. Therefore, risk-based surveillance and management measures should be conducted in future in this area.	[Zhang, Haiming; Peng, Cong; Duan, Xiaodong; Shen, Dan; Tan, Hai; Wang, Ling; Hou, Jialei; Zhu, Jiancui; He, Riwen; Zhang, Haibing; Zheng, Lilan; Yang, Jianyu; Zhang, Zhen; Zhou, Zhiwei; Li, Wenhua; Hu, Mailing; Zhong, Jinhui; Chen, Yuhua] Guangzhou Anim Dis Prevent & Control Ctr, Guangzhou, Guangdong, Peoples R China; [Lan, Guanghua; Xiao, Wutao] Huadu Anim Hlth Inspect Inst, Huadu, Peoples R China		Peng, C (corresponding author), Guangzhou Anim Dis Prevent & Control Ctr, Guangzhou, Guangdong, Peoples R China.	pc13902493400@163.com			preventive and control program of major animal diseases of Guangzhou Bureau of Agriculture	preventive and control program of major animal diseases of Guangzhou Bureau of Agriculture	This work was financially supported by the preventive and control program of major animal diseases of Guangzhou Bureau of Agriculture. The funders had no role in study design, data collection and analysis, publishing decision or manuscript preparation.	Cardona C, 2009, POULTRY SCI, V88, P856, DOI 10.3382/ps.2008-00338; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chen Z, 2014, EMERG INFECT DIS; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garber L, 2007, AVIAN DIS, V51, P417, DOI 10.1637/7571-033106R.1; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Kung NY, 2007, EMERG INFECT DIS, V13, P412, DOI 10.3201/eid1303.060365; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077132; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; Trock SC, 2008, AVIAN DIS, V52, P160, DOI 10.1637/7980-040607-Reg; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; World Organization for Animal Health, 2011, TERR AN HLTH COD 201; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Yu X, 2014, J VIROL	29	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111218	10.1371/journal.pone.0111218	http://dx.doi.org/10.1371/journal.pone.0111218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356738	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000045
J	Caetano, AL; Marques, CR; Gavina, A; Carvalho, F; Goncalves, F; da Silva, EF; Pereira, R				Caetano, Ana Luisa; Marques, Catarina R.; Gavina, Ana; Carvalho, Fernando; Goncalves, Fernando; da Silva, Eduardo Ferreira; Pereira, Ruth			Contribution for the Derivation of a Soil Screening Value (SSV) for Uranium, Using a Natural Reference Soil	PLOS ONE			English	Article							ECOLOGICAL RISK-ASSESSMENT; ENZYME-ACTIVITIES; FOLSOMIA-CANDIDA; ECOSYSTEM SERVICES; EISENIA-ANDREI; HEAVY-METALS; HERBICIDE PHENMEDIPHAM; CONTAMINATED SOILS; DEPLETED URANIUM; CENTRAL PORTUGAL	In order to regulate the management of contaminated land, many countries have been deriving soil screening values (SSV). However, the ecotoxicological data available for uranium is still insufficient and incapable to generate SSVs for European soils. In this sense, and so as to make up for this shortcoming, a battery of ecotoxicological assays focusing on soil functions and organisms, and a wide range of endpoints was carried out, using a natural soil artificially spiked with uranium. In terrestrial ecotoxicology, it is widely recognized that soils have different properties that can influence the bioavailability and the toxicity of chemicals. In this context, SSVs derived for artificial soils or for other types of natural soils, may lead to unfeasible environmental risk assessment. Hence, the use of natural regional representative soils is of great importance in the derivation of SSVs. A Portuguese natural reference soil PTRS1, from a granitic region, was thereby applied as test substrate. This study allowed the determination of NOEC, LOEC, EC20 and EC50 values for uranium. Dehydrogenase and urease enzymes displayed the lowest values (34.9 and,134.5 mg U Kg, respectively). Eisenia andrei and Enchytraeus crypticus revealed to be more sensitive to uranium than Folsomia candida. EC50 values of 631.00, 518.65 and 851.64 mg U Kg were recorded for the three species, respectively. Concerning plants, only Lactuca sativa was affected by U at concentrations up to 1000 mg U kg(1). The outcomes of the study may in part be constrained by physical and chemical characteristics of soils, hence contributing to the discrepancy between the toxicity data generated in this study and that available in the literature. Following the assessment factor method, a predicted no effect concentration (PNEC) value of 15.5 mg kg(dw)(-1) was obtained for U. This PNEC value is proposed as a SSV for soils similar to the PTRS1.	[Caetano, Ana Luisa; Marques, Catarina R.; Goncalves, Fernando] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Caetano, Ana Luisa; Marques, Catarina R.; Gavina, Ana; Goncalves, Fernando] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Carvalho, Fernando] ITN, Dept Radiol Protect & Nucl Safety, Sacavem, Portugal; [da Silva, Eduardo Ferreira] Univ Aveiro, Dept Geosci, GeoBioTec Res Ctr, P-3800 Aveiro, Portugal; [Pereira, Ruth] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal; [Gavina, Ana; Pereira, Ruth] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4100 Oporto, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Lisboa; Universidade de Aveiro; Universidade do Porto; Universidade do Porto	Caetano, AL (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3800 Aveiro, Portugal.	ana.caetano@ua.pt	Caetano, Ana Luisa/AAI-1543-2020; Pereira, Ruth/AAY-3535-2021; Gonçalves, Fernando J. M./B-8000-2008; da Silva, Eduardo A Ferreira/B-3317-2012; da Silva, Eduardo Ferreira/AAT-5115-2020; Gavina, Ana Catarina Soares/T-8943-2017	Pereira, Ruth/0000-0001-6857-5968; Gonçalves, Fernando J. M./0000-0002-9326-187X; da Silva, Eduardo A Ferreira/0000-0002-3019-8471; da Silva, Eduardo Ferreira/0000-0002-3019-8471; Gavina, Ana Catarina Soares/0000-0001-5085-2197; Carvalho, Fernando da Piedade/0000-0002-6639-6138; Marques, Catarina/0000-0001-6908-8272; Caetano, Ana/0000-0001-7333-6312	Fundacao para a Ciencia e Tecnologia (FCT)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	ALC was supported by a PhD grant from Fundacao para a Ciencia e Tecnologia (FCT) (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga P, 2008, CHEMOSPHERE, V72, P1774, DOI 10.1016/j.chemosphere.2008.04.042; Alvarenga P, 2012, ENVIRON POLLUT, V161, P50, DOI 10.1016/j.envpol.2011.09.044; Amorim MJB, 2005, CHEMOSPHERE, V61, P1102, DOI 10.1016/j.chemosphere.2005.03.048; Amorim MJB, 2005, ARCH ENVIRON CON TOX, V49, P343, DOI 10.1007/s00244-004-0220-z; Antunes S, 2011, SCI TOTAL ENVIRON, P410; Arogunjo AM, 2009, J ENVIRON RADIOACTIV, V100, P232, DOI 10.1016/j.jenvrad.2008.12.004; ASTDR, 2011, AG TOX SUBST DIS REG; Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004; Bednar AJ, 2007, CHEMOSPHERE, V70, P237, DOI 10.1016/j.chemosphere.2007.06.032; BERG P, 1985, BIOL FERT SOILS, V1, P131, DOI 10.1007/BF00301780; Bone J, 2010, ENVIRON INT, V36, P609, DOI 10.1016/j.envint.2010.04.010; Caetano AL, 2012, J ENVIRON MONITOR, V14, P925, DOI 10.1039/c2em10827e; Carlon C., 2007, DERIVATION METHODS S, P306; Carvalho F, 2011, J AM SCI ENV PUBL SC, V7, P547; Carvalho FP, 2007, J ENVIRON RADIOACTIV, V96, P39, DOI 10.1016/j.jenvrad.2007.01.016; Carvalho FP, 2009, B ENVIRON CONTAM TOX, V83, P668, DOI 10.1007/s00128-009-9808-3; Chelinho S, 2011, ENVIRON TOXICOL CHEM, V30, P1050, DOI 10.1002/etc.480; CLAPP J, 2012, OXFAM RES REPORTS, P1; Coppolecchia D, 2011, SOIL BIOL BIOCHEM, V43, P1798, DOI 10.1016/j.soilbio.2010.06.018; Dai J, 2004, APPL SOIL ECOL, V25, P99, DOI 10.1016/j.apsoil.2003.09.003; Domene X, 2011, ENVIRON TOXICOL CHEM, V30, P1497, DOI 10.1002/etc.533; Dominati E, 2010, ECOL ECON, V69, P1858, DOI 10.1016/j.ecolecon.2010.05.002; *FAOUN, 1984, SOILS B, V10, P1; Figueiredo MO, 2011, J GEOCHEM EXPLOR, V109, P134, DOI 10.1016/j.gexplo.2010.09.004; Fishwick S., 2004, SOIL SCREENING VALUE; Gavrilescu M, 2009, J HAZARD MATER, V163, P475, DOI 10.1016/j.jhazmat.2008.07.103; Geng F, 2012, J RADIOANAL NUCL CH, V292, P453, DOI 10.1007/s10967-011-1451-x; Geras'kin SA, 2007, J ENVIRON RADIOACTIV, V94, P151, DOI 10.1016/j.jenvrad.2007.01.003; Giovanetti A, 2010, J ENVIRON RADIOACTIV, V101, P509, DOI 10.1016/j.jenvrad.2010.03.003; Gongalsky KB, 2003, ENVIRON MONIT ASSESS, V89, P197, DOI 10.1023/A:1026031224658; Gopal R, 2008, CHEMOSPHERE, V70, P1539, DOI 10.1016/j.chemosphere.2007.08.043; Gulser F, 2008, ENVIRON MONIT ASSESS, V145, P127, DOI 10.1007/s10661-007-0022-7; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Hofman J., 2009, P223, DOI 10.1007/978-0-387-88959-7_24; Hu B, 2013, ENVIRON TOXICOL CHEM, V32, P1109, DOI 10.1002/etc.2152; Hubalek T, 2007, ARCH ENVIRON CON TOX, V52, P1, DOI 10.1007/s00244-006-0030-6; International Organization for Standardization I., 1998, 112682 ISO; Islam E, 2011, INT BIODETER BIODEGR, V65, P1043, DOI 10.1016/j.ibiod.2011.08.005; *ISO, 2005, 112692 ISO; ISO, 1999, 11267 ISO; ISO (International Organization for Standardization), 2008, 175121 ISO; ISO-International Organization for Standardization, 2003, 16387 ISO; Jansch S, 2011, ENVIRON REV, V13, P51; Jensen J, 2006, ECOLOGICAL RISK ASSE; Joner EJ, 2007, ENVIRON TOXICOL CHEM, V26, P1644, DOI 10.1897/06-551R.1; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kandeler E., 1996, METHODS SOIL BIOL, P146; Kenarova A, 2010, 2 BALK C BIOL, P5; Khan S, 2007, J ENVIRON SCI, V19, P834, DOI 10.1016/S1001-0742(07)60139-9; Kizilkaya R, 2005, APPL SOIL ECOL, V30, P192, DOI 10.1016/j.apsoil.2005.02.009; Kuperman RG, 2006, EUR J SOIL BIOL, V42, pS234, DOI 10.1016/j.ejsobi.2006.07.028; Kuperman RG, 2004, ECOTOX ENVIRON SAFE, V57, P48, DOI 10.1016/j.ecoenv.2003.08.010; Laurette J, 2012, ENVIRON EXP BOT, V77, P87, DOI 10.1016/j.envexpbot.2011.11.005; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Layinka T, 2011, P ENV MANAGEMENT C, P489; Lee SH, 2011, J HAZARD MATER, V188, P44, DOI 10.1016/j.jhazmat.2011.01.046; Lee SH, 2009, J HAZARD MATER, V170, P382, DOI 10.1016/j.jhazmat.2009.04.088; Li LXY, 2009, J HAZARD MATER, V167, P634, DOI 10.1016/j.jhazmat.2009.01.013; Liu XL, 2007, ECOTOX ENVIRON SAFE, V68, P305, DOI 10.1016/j.ecoenv.2006.11.001; Lock K, 2001, ECOTOXICOLOGY, V10, P315, DOI 10.1023/A:1016767519556; Lourenco J, 2011, CHEMOSPHERE, V85, P1630, DOI 10.1016/j.chemosphere.2011.08.027; Lourenco J, 2012, ECOTOX ENVIRON SAFE, V75, P46, DOI 10.1016/j.ecoenv.2011.08.024; Lourenco JI, 2011, J HAZARD MATER, V186, P788, DOI 10.1016/j.jhazmat.2010.11.073; Malyshkina N, 2010, ENVIRON SCI TECHNOL, V44, P9134, DOI 10.1021/es100730q; MAOTDR, 2006, MIN AMB ORD TERR DES; Meyer MC, 1998, J ENVIRON QUAL, V27, P1306, DOI 10.2134/jeq1998.00472425002700060006x; Mitchell N, 2013, J RADIOL PROT, V33, pR17, DOI 10.1088/0952-4746/33/2/R17; Momcilovic M, 2010, RADIAT MEAS, V45, P225; Natal-da-Luz T, 2011, ECOTOX ENVIRON SAFE, V74, P1715, DOI 10.1016/j.ecoenv.2011.05.017; Niemeyer JC, 2010, J SOIL SEDIMENT, V10, P1557, DOI 10.1007/s11368-010-0255-x; O'Halloran K, 2006, HUM ECOL RISK ASSESS, V12, P74, DOI 10.1080/10807030500428603; ohlinger R., 1996, METHODS SOIL BIOL; Papa S, 2010, ENVIRON MONIT ASSESS, V165, P193, DOI 10.1007/s10661-009-0938-1; Patra AC, 2011, J ENVIRON MANAGE, V92, P919, DOI 10.1016/j.jenvman.2010.10.046; Peijnenburg WJGM, 1999, ECOTOX ENVIRON SAFE, V44, P294, DOI 10.1006/eesa.1999.1838; Peijnenburg WJGM, 2003, ECOTOX ENVIRON SAFE, V56, P63, DOI 10.1016/S0147-6513(03)00051-4; Pereira AJSC, 2012, J ENVIRON RADIOACTIV, V112, P96, DOI 10.1016/j.jenvrad.2012.05.022; Pereira R, 2008, SCI TOTAL ENVIRON, V390, P377, DOI 10.1016/j.scitotenv.2007.08.051; Pereira R, 2006, SOIL SEDIMENT CONTAM, V15, P147, DOI 10.1080/15320380500506813; Pereira R, 2014, ENVIRON GEOCHEM HLTH, V36, P285, DOI 10.1007/s10653-013-9563-6; Pereira R, 2009, APPL SOIL ECOL, V42, P209, DOI 10.1016/j.apsoil.2009.04.002; Provoost J, 2008, J SOIL SEDIMENT, V8, P298, DOI 10.1007/s11368-008-0026-0; Rombke J, 2006, ENVIRON TOXICOL CHEM, V25, P776, DOI 10.1897/04-584R.1; Rooney CP, 2007, ENVIRON POLLUT, V145, P596, DOI 10.1016/j.envpol.2006.04.008; Scheele F, 2011, SSRN ELECT J; SCHINNER F, 1990, SOIL BIOL BIOCHEM, V22, P511, DOI 10.1016/0038-0717(90)90187-5; Schinner F., 1996, METHODS SOIL BIOL; Scott-Fordsmand JJ, 1995, 48 DAN ENV PROT AG; Sheppard SC, 2012, B ENVIRON CONTAM TOX, V88, P43, DOI 10.1007/s00128-011-0442-5; SHEPPARD SC, 1992, ARCH ENVIRON CON TOX, V23, P117; Sheppard SC, 2005, J ENVIRON RADIOACTIV, V79, P55, DOI 10.1016/j.jenvrad.2004.05.015; SHEPPARD SC, 1992, ENVIRON TOXIC WATER, V7, P275, DOI 10.1002/tox.2530070307; Sivakumar S, 2012, J HAZARD MATER, V227, P179, DOI 10.1016/j.jhazmat.2012.05.030; Song J, 2006, ENVIRON TOXICOL CHEM, V25, P1663, DOI 10.1897/05-480R2.1; Soudek P, 2011, AGROCHIMICA, V55, P15; Soudek P, 2011, J ENVIRON RADIOACTIV, V102, P598, DOI 10.1016/j.jenvrad.2011.03.008; *SPAC, 2000, HDB REF METH; Stojanovic M, 2009, WATER AIR SOIL POLL, V200, P101, DOI 10.1007/s11270-008-9896-4; TABATABAI MA, 1970, SOIL SCI SOC AM PRO, V34, P225, DOI 10.2136/sssaj1970.03615995003400020016x; Thavamani P, 2012, J ENVIRON MANAGE, V99, P10, DOI 10.1016/j.jenvman.2011.12.030; Tunney H, 2009, J PLANT NUTR SOIL SC, V172, P346, DOI 10.1002/jpln.200800069; Turner BL, 2002, BETA GLUCOSIDASE ACT; USEPA, 2003, US ENV PROT AG GUID; van Gestel CAM, 2012, ZOOKEYS, P275, DOI 10.3897/zookeys.176.2275; van Gestel CAM, 2011, ECOTOX ENVIRON SAFE, V74, P1, DOI 10.1016/j.ecoenv.2010.10.001; VanAssche F, 2002, TEST METHODS DETERMI, P37; Vandenhove H, 2007, ENVIRON POLLUT, V145, P587, DOI 10.1016/j.envpol.2006.04.011; Vandenhove H, 2006, J ENVIRON RADIOACTIV, V88, P118, DOI 10.1016/j.jenvrad.2006.01.008; Viehweger K, 2010, ENVIRON EXP BOT, V69, P39, DOI 10.1016/j.envexpbot.2010.03.001; Wang JH, 2007, ENVIRON GEOCHEM HLTH, V29, P395, DOI 10.1007/s10653-007-9084-2; Wang ME, 2011, ENVIRON SCI POLLUT R, V18, P958, DOI 10.1007/s11356-011-0445-0; Winding A, 2005, ECOTOX ENVIRON SAFE, V62, P230, DOI 10.1016/j.ecoenv.2005.03.026	112	10	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e108041	10.1371/journal.pone.0108041	http://dx.doi.org/10.1371/journal.pone.0108041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353962	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200003
J	Esposito, G; Nakazawa, J; Ogawa, S; Stival, R; Kawashima, A; Putnick, DL; Bornstein, MH				Esposito, Gianluca; Nakazawa, Jun; Ogawa, Shota; Stival, Rita; Kawashima, Akiko; Putnick, Diane L.; Bornstein, Marc H.			Baby, You Light-Up My Face: Culture-General Physiological Responses to Infants and Culture-Specific Cognitive Judgements of Adults	PLOS ONE			English	Article							UNITED-STATES; MOTHER; SKIN; EXPOSURE; CUTENESS; SCHEMA; JAPAN	Infants universally elicit in adults a set of solicitous behaviors that are evolutionarily important for the survival of the species. However, exposure, experience, and prejudice appear to govern adults' social choice and ingroup attitudes towards other adults. In the current study, physiological arousal and behavioral judgments were assessed while adults processed unfamiliar infant and adult faces of ingroup vs. outgroup members in two contrasting cultures, Japan and Italy. Physiological arousal was investigated using the novel technique of infrared thermography and behavioral judgments using ratings. We uncovered a dissociation between physiological and behavioral responses. At the physiological level, both Japanese and Italian adults showed significant activation (increase of facial temperature) for both ingroup and outgroup infant faces. At the behavioral level, both Japanese and Italian adults showed significant preferences for ingroup adults. Arousal responses to infants appear to be mediated by the autonomic nervous system and are not dependent on direct caregiving exposure, but behavioral responses appear to be mediated by higher-order cognitive processing based on social acceptance and cultural exposure.	[Esposito, Gianluca; Stival, Rita] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy; [Esposito, Gianluca] Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 639798, Singapore; [Nakazawa, Jun] Chiba Univ, Fac Educ, Dept Dev Sci, Chiba, Japan; [Ogawa, Shota] Tokyo Gakugei Univ, United Grad Sch Educ, Chiba, Japan; [Kawashima, Akiko] Tokyo Univ Social Welf, Sch Social Welf, Tokyo, Japan; [Putnick, Diane L.; Bornstein, Marc H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	University of Trento; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chiba University; Tokyo Gakugei University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Esposito, G (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Rovereto, TN, Italy.	gianluca.esposito@unitn.it; Marc_H_Bornstein@nih.gov	Esposito, Gianluca/B-1374-2012; Putnick, Diane L/B-1707-2009	Esposito, Gianluca/0000-0002-9442-0254; Putnick, Diane L/0000-0002-6323-749X	Japan Society for the Promotion of Science [JSPS PE09064, 22530694, 24730563, 26285149]; FPR Program (RIKEN Brain Science Institute); National Institutes of Health (NIH), NICHD (USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001119] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FPR Program (RIKEN Brain Science Institute); National Institutes of Health (NIH), NICHD (USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the ST fellowship from Japan Society for the Promotion of Science (JSPS PE09064), Grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (Projects #22530694, #24730563, and #26285149), the FPR Program (RIKEN Brain Science Institute), and the Intramural Research Program of the National Institutes of Health (NIH), NICHD (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe B, 2007, DEV PSYCHOL, V43, P1360, DOI 10.1037/0012-1649.43.6.1360; BORNSTEIN MH, 1989, DEV REV, V9, P171, DOI 10.1016/0273-2297(89)90028-2; BORNSTEIN MH, 1990, INT J BEHAV DEV, V13, P289, DOI 10.1177/016502549001300303; BORNSTEIN MH, 1990, INT J BEHAV DEV, V13, P267, DOI 10.1177/016502549001300302; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Caria A, 2012, NEUROIMAGE, V60, P884, DOI 10.1016/j.neuroimage.2011.12.068; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Chen X., 2012, HDB TEMPERAMENT, P462; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dunham Y, 2013, PSYCHOL SCI, V24, P860, DOI 10.1177/0956797612463081; Esposito G, 2015, EARLY CHILD DEV CARE, V185, P438, DOI 10.1080/03004430.2014.932153; FELDSTEIN S, 1993, INFANT BEHAV DEV, V16, P455, DOI 10.1016/0163-6383(93)80004-R; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Hrdy S., 2009, MOTHERS OTHERS; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Lorenz K, 1971, STUDIES ANIMAL HUMAN, VII; MCCALL RB, 1980, J EXP CHILD PSYCHOL, V29, P189, DOI 10.1016/0022-0965(80)90015-6; MIZUKAMI K, 1990, INFANT BEHAV DEV, V13, P257, DOI 10.1016/0163-6383(90)90034-6; Nakanishi R, 2008, INFANT BEHAV DEV, V31, P137, DOI 10.1016/j.infbeh.2007.09.001; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Ochs E., 1984, CULTURE THEORY ESSAY, P276; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Parsons CE, 2013, SOC NEUROSCI-UK, V8, P268, DOI 10.1080/17470919.2013.795189; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Peer P, 2003, CVL FACE DATABASE; RimmKaufman SE, 1996, MOTIV EMOTION, V20, P63, DOI 10.1007/BF02251007; Sanefuji W, 2007, J ETHOL, V25, P249, DOI 10.1007/s10164-006-0018-8; Senese VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080379; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Solina F, 2003, P MIR INRIA ROCQ FRA; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; Stern D.N., 1985, INTERPERSONAL WORLD; Trevarthen C, 2003, PARENT INFANT PSYCHO, P25; Triandis HC, 1995, INDIVIDUALISM COLLEC; Van Duuren M, 2003, INT J BEHAV DEV, V27, P212, DOI 10.1080/01650250244000218; Williams LM, 2000, NEUROREPORT, V11, P3011, DOI 10.1097/00001756-200009110-00037; Winecoff A, 2013, J NEUROSCI, V33, P11032, DOI 10.1523/JNEUROSCI.4317-12.2013; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042; ZAJONC RB, 1989, PSYCHOL REV, V96, P395, DOI 10.1037/0033-295X.96.3.395; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154	46	36	36	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e106705	10.1371/journal.pone.0106705	http://dx.doi.org/10.1371/journal.pone.0106705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353362	Green Published, gold			2022-12-27	WOS:000345204200001
J	Flueckiger, L; Lieb, R; Meyer, AH; Mata, J				Flueckiger, Lavinia; Lieb, Roselind; Meyer, Andrea H.; Mata, Jutta			How Health Behaviors Relate to Academic Performance via Affect: An Intensive Longitudinal Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TASK-PERFORMANCE; AEROBIC EXERCISE; SLEEP QUALITY; INTELLIGENCE; ACHIEVEMENT; BRAIN; MOOD; ADOLESCENTS; PREVALENCE	Objective: This intensive longitudinal study examined how sleep and physical activity relate to university students' affect and academic performance during a stressful examination period. Methods: On 32 consecutive days, 72 first-year students answered online questionnaires on their sleep quality, physical activity, positive and negative affect, learning goal achievement, and examination grades. First-year university students are particularly well-suited to test our hypotheses: They represent a relatively homogeneous population in a natural, but controlled setting, and simultaneously deal with similar stressors, such as examinations. Data were analyzed using multilevel structural equation models. Results: Over the examination period, better average sleep quality but not physical activity predicted better learning goal achievement. Better learning goal achievement was associated with increased probability of passing all examinations. Relations of average sleep quality and average physical activity with learning goal achievement were mediated by experienced positive affect. In terms of day-to-day dynamics, on days with better sleep quality, participants reported better learning goal achievement. Day-to-day physical activity was not related to daily learning goal achievement. Daily positive and negative affect both mediated the effect of day-to-day sleep quality and physical activity on daily learning goal achievement. Conclusion: Health behaviors such as sleep quality and physical activity seem important for both academic performance and affect experience, an indicator of mental health, during a stressful examination period. These results are a first step toward a better understanding of between-and within-person variations in health behaviors, affect, and academic performance, and could inform prevention and intervention programs for university students.	[Flueckiger, Lavinia; Lieb, Roselind; Meyer, Andrea H.; Mata, Jutta] Univ Basel, Dept Psychol, Div Clin Psychol & Epidemiol, Basel, Switzerland; [Mata, Jutta] Max Planck Inst Human Dev, ARC, Berlin, Germany	University of Basel; Max Planck Society	Mata, J (corresponding author), Univ Basel, Dept Psychol, Div Clin Psychol & Epidemiol, Basel, Switzerland.	jutta.mata@unibas.ch	Mata, Jutta/M-5817-2016	Mata, Jutta/0000-0003-2498-5054	Swiss National Science Foundation [140991]; grant for promotion of "Dual Career Couples" (DCC) at Swiss Universities [01/10]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); grant for promotion of "Dual Career Couples" (DCC) at Swiss Universities	This study was supported by a grant of the Swiss National Science Foundation (No. 140991) to Jutta Mata and Roselind Lieb, and a grant for promotion of "Dual Career Couples" (DCC) at Swiss Universities 2008-2011 within the scope of the national program of equality of opportunities awarded to Roselind Lieb (01/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrberg K, 2012, J PSYCHIATR RES, V46, P1618, DOI 10.1016/j.jpsychires.2012.09.008; ALWIN DF, 1975, AM SOCIOL REV, V40, P37, DOI 10.2307/2094445; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bower B, 2010, J SLEEP RES, V19, P323, DOI 10.1111/j.1365-2869.2009.00816.x; Brown GW, 1989, LIFE EVENTS ILLNESS; Bundesamt fur Statistik [Federal agency for statistics], 2012, STUD RETR NACH HOCHS; Bussmann JBJ, 2009, EUR PSYCHOL, V14, P142, DOI 10.1027/1016-9040.14.2.142; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Daniels LM, 2009, J EDUC PSYCHOL, V101, P948, DOI 10.1037/a0016096; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dyson R, 2006, J CLIN PSYCHOL, V62, P1231, DOI 10.1002/jclp.20295; Fedewa AL, 2011, RES Q EXERCISE SPORT, V82, P521; Field T, 2001, ADOLESCENCE, V36, P105; Franzen PL, 2008, J SLEEP RES, V17, P34, DOI 10.1111/j.1365-2869.2008.00635.x; Furnham A, 2002, LEARN INDIVID DIFFER, V14, P47, DOI 10.1016/j.lindif.2003.08.002; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hogan CL, 2013, PSYCHOL AGING, V28, P587, DOI 10.1037/a0032634; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Kantomaa MT, 2010, HEALTH EDUC RES, V25, P368, DOI 10.1093/her/cyp048; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kramer AF, 1999, NATURE, V402, P750; Kristjansson AL, 2010, HEALTH EDUC BEHAV, V37, P51, DOI 10.1177/1090198107313481; KUHL J, 1994, INTERNATIONAL PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, VOL 2: THE STATE OF THE ART, P311; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacIntosh BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085163; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Mata J, 2012, J ABNORM PSYCHOL, V121, P297, DOI 10.1037/a0023533; Mega C, 2014, J EDUC PSYCHOL, V106, P121, DOI 10.1037/a0033546; Miner AG, 2010, ORGAN BEHAV HUM DEC, V112, P43, DOI 10.1016/j.obhdp.2009.11.009; Morisano D, 2010, J APPL PSYCHOL, V95, P255, DOI 10.1037/a0018478; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; OECD, 2012, ED GLANC 2012 HIGHL; Organisation for Economic Cooperation and Development (OECD), 2010, HIGHL ED GLANC 2010; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Perkins HW, 2002, J STUD ALCOHOL, P91, DOI 10.15288/jsas.2002.s14.91; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Reed J, 2009, PSYCHOL SPORT EXERC, V10, P581, DOI 10.1016/j.psychsport.2009.05.009; Richard EM, 2011, ORGAN BEHAV HUM DEC, V115, P99, DOI 10.1016/j.obhdp.2010.11.008; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Riemann D, 1996, BEHANDLUNG SCHLAFSTO; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Robbins SB, 2009, J APPL PSYCHOL, V94, P1163, DOI 10.1037/a0015738; Roecke C, 2006, THESIS FREIE U BERLI; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; Seo MG, 2004, ACAD MANAGE REV, V29, P423, DOI 10.2307/20159052; Sonnentag S, 2008, J APPL PSYCHOL, V93, P674, DOI 10.1037/0021-9010.93.3.674; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; TOTTERDELL P, 1994, SLEEP, V17, P466, DOI 10.1093/sleep/17.5.466; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zheng JL, 2002, J COLL STUDENT DEV, V43, P267	65	22	22	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111080	10.1371/journal.pone.0111080	http://dx.doi.org/10.1371/journal.pone.0111080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353638	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000345204200054
J	Hosking, JG; Lam, FCW; Winstanley, CA				Hosking, Jay G.; Lam, Fred C. W.; Winstanley, Catharine A.			Nicotine Increases Impulsivity and Decreases Willingness to Exert Cognitive Effort despite Improving Attention in "Slacker" Rats: Insights into Cholinergic Regulation of Cost/Benefit Decision Making	PLOS ONE			English	Article							REACTION-TIME-TASK; MUSCARINIC ACETYLCHOLINE-RECEPTORS; DOPAMINERGIC MODULATION; SELECTIVE ATTENTION; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; BASAL FOREBRAIN; PARIETAL CORTEX; PERFORMANCE; ENHANCEMENT	Successful decision making in our daily lives requires weighing an option's costs against its associated benefits. The neuromodulator acetylcholine underlies both the etiology and treatment of a number of illnesses in which decision making is perturbed, including Alzheimer's disease, attention-deficit/hyperactivity disorder, and schizophrenia. Nicotine acts on the cholinergic system and has been touted as a cognitive enhancer by both smokers and some researchers for its attention-boosting effects; however, it is unclear whether treatments that have a beneficial effect on attention would also have a beneficial effect on decision making. Here we utilize the rodent Cognitive Effort Task (rCET), wherein animals can choose to allocate greater visuospatial attention for a greater reward, to examine cholinergic contributions to both attentional performance and choice based on attentional demand. Following the establishment of baseline behavior, four drug challenges were administered: nicotine, mecamylamine, scopolamine, and oxotremorine (saline plus three doses for each). As per previous rCET studies, animals were divided by their baseline preferences, with "worker" rats choosing high-effort/high-reward options more than their "slacker" counterparts. Nicotine caused slackers to choose even fewer high-effort trials than at baseline, but had no effect on workers' choice. Despite slackers' decreased willingness to expend effort, nicotine improved their attentional performance on the task. Nicotine also increased measures of motor impulsivity in all animals. In contrast, scopolamine decreased animals' choice of high-effort trials, especially for workers, while oxotremorine decreased motor impulsivity for all animals. In sum, the cholinergic system appears to contribute to decision making, and in part these contributions can be understood as a function of individual differences. While nicotine has been considered as a cognitive enhancer, these data suggest that its modest benefits to attention may be coupled with impulsiveness and decreased willingness to work hard, especially in individuals who are particularly sensitive to effort costs (i.e. slackers).	[Hosking, Jay G.; Lam, Fred C. W.; Winstanley, Catharine A.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Hosking, JG (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jayhosking@psych.ubc.ca	Winstanley, Catharine/K-5003-2015	Winstanley, Catharine/0000-0001-7032-4471	Canadian Natural Sciences and Engineering Council; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research (CIHR) New Investigator Award program; CIHR Doctoral Research Award	Canadian Natural Sciences and Engineering Council; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR) New Investigator Award program(Canadian Institutes of Health Research (CIHR)); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR))	This work was supported by a discovery grant awarded to CAW from the Canadian Natural Sciences and Engineering Council (http://www.nserc-crsng.gc.ca/index_eng.asp). CAW also receives salary support through the Michael Smith Foundation for Health Research (http://www.msfhr.org/) and the Canadian Institutes of Health Research (CIHR) New Investigator Award program (http://www.cihr-irsc.gc.ca/e/193.html). JGH was supported by a CIHR Doctoral Research Award (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch DM, 2014, J ABNORM PSYCHOL, V123, P387, DOI 10.1037/a0036299; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Bracco L, 2014, J ALZHEIMERS DIS, V40, P737, DOI 10.3233/JAD-131154; Bruno JP, 2006, EUR J NEUROSCI, V24, P2749, DOI 10.1111/j.1460-9568.2006.05176.x; Bucci DJ, 1998, J NEUROSCI, V18, P8038; Cardinal R., 2006, ANOVA BEHAV SCI RES, DOI [10.4324/9780203763933, DOI 10.4324/9780203763933]; Cocker PJ, 2012, NEUROPSYCHOPHARMACOL; COUSINS MS, 1994, PSYCHOPHARMACOLOGY, V116, P529, DOI 10.1007/BF02247489; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Fadel JR, 2011, BEHAV BRAIN RES, V221, P527, DOI 10.1016/j.bbr.2010.02.022; Floresco SB, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00062; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Fobbs WC, 2014, PROG MOL BIOL TRANSL, V122, P233, DOI 10.1016/B978-0-12-420170-5.00009-X; Gleichgerrcht E, 2010, NAT REV NEUROL, V6, P611, DOI 10.1038/nrneurol.2010.148; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Hahn B, 2002, PSYCHOPHARMACOLOGY, V162, P129, DOI 10.1007/s00213-002-1005-6; Hahn B, 2009, CEREB CORTEX, V19, P1990, DOI 10.1093/cercor/bhn226; Harrell PT, 2012, EXP CLIN PSYCHOPHARM, V20, P278, DOI 10.1037/a0028652; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Hosking JG, 2014, NEUROPSYCHOPHARMACOL, V39, P1558, DOI 10.1038/npp.2014.27; JONES DNC, 1995, PSYCHOPHARMACOLOGY, V120, P142, DOI 10.1007/BF02246186; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Kuhl DE, 1996, ANN NEUROL, V40, P399, DOI 10.1002/ana.410400309; Mackowick KM, 2014, PROG NEURO-PSYCHOPH, V52, P79, DOI 10.1016/j.pnpbp.2013.07.010; Mendez IA, 2013, NEUROSCIENCE, V230, P121, DOI 10.1016/j.neuroscience.2012.10.067; Mendez IA, 2012, PSYCHOPHARMACOLOGY, V224, P489, DOI 10.1007/s00213-012-2777-y; Mirza NR, 2000, PSYCHOPHARMACOLOGY, V148, P243, DOI 10.1007/s002130050048; Mirza NR, 1998, PSYCHOPHARMACOLOGY, V138, P266, DOI 10.1007/s002130050671; Mirza NR, 2001, PSYCHOPHARMACOLOGY, V154, P8, DOI 10.1007/s002130000605; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Nunes EJ, 2013, NEUROSCI BIOBEHAV R, V37, P2015, DOI 10.1016/j.neubiorev.2013.04.002; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Randall PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047934; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Ruotsalainen S, 2000, PSYCHOPHARMACOLOGY, V148, P111, DOI 10.1007/s002130050032; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Shannon HE, 2006, BEHAV PHARMACOL, V17, P71, DOI 10.1097/01.fbp.0000189813.54178.e3; Stolerman IP, 2009, BEHAV PHARMACOL, V20, P742, DOI 10.1097/FBP.0b013e328333b290; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Wilens TE, 2007, BIOCHEM PHARMACOL, V74, P1212, DOI 10.1016/j.bcp.2007.07.002; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Winstanley CA, 2010, BEHAV BRAIN RES, V210, P263, DOI 10.1016/j.bbr.2010.02.044; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243	49	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111580	10.1371/journal.pone.0111580	http://dx.doi.org/10.1371/journal.pone.0111580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353339	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200089
J	Srivastava, G; Mehrotra, RC				Srivastava, Gaurav; Mehrotra, R. C.			Phytogeographical Implication of Bridelia Will. (Phyllanthaceae) Fossil Leaf from the Late Oligocene of India	PLOS ONE			English	Article							MAKUM COALFIELD; CLIMATE; ASSAM; SEDIMENTS; EVOLUTION; GONDWANA; EUPHORBIACEAE; DISPERSAL; PETROLOGY; AFRICA	Background: The family Phyllanthaceae has a predominantly pantropical distribution. Of its several genera, Bridelia Willd. is of a special interest because it has disjunct equally distributed species in Africa and tropical Asia i.e. 18-20 species in Africa-Madagascar (all endemic) and 18 species in tropical Asia (some shared with Australia). On the basis of molecular phylogenetic study on Bridelia, it has been suggested that the genus evolved in Southeast Asia around 33 +/- 5 Ma, while speciation and migration to other parts of the world occurred at 10 +/- 2 Ma. Fossil records of Bridelia are equally important to support the molecular phylogenetic studies and plate tectonic models. Results: We describe a new fossil leaf of Bridelia from the late Oligocene (Chattian, 28.4-23 Ma) sediments of Assam, India. The detailed venation pattern of the fossil suggests its affinities with the extant B. ovata, B. retusa and B. stipularis. Based on the present fossil evidence and the known fossil records of Bridelia from the Tertiary sediments of Nepal and India, we infer that the genus evolved in India during the late Oligocene (Chattian, 28.4-23 Ma) and speciation occurred during the Miocene. The stem lineage of the genus migrated to Africa via "Iranian route'' and again speciosed in Africa-Madagascar during the late Neogene resulting in the emergence of African endemic clades. Similarly, the genus also migrated to Southeast Asia via Myanmar after the complete suturing of Indian and Eurasian plates. The emergence and speciation of the genus in Asia and Africa is the result of climate change during the Cenozoic. Conclusions: On the basis of present and known fossil records of Bridelia, we have concluded that the genus evolved during the late Oligocene in northeast India. During the Neogene, the genus diversified and migrated to Southeast Asia via Myanmar and Africa via "Iranian Route''.	[Srivastava, Gaurav; Mehrotra, R. C.] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Srivastava, G (corresponding author), Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India.	gaurav_jan10@yahoo.co.in	Srivastava, Gaurav/A-1384-2019	Srivastava, Gaurav/0000-0001-7498-4338				Ahmed M, 1996, INT J COAL GEOL, V30, P319, DOI 10.1016/0166-5162(95)00051-8; Ascherson PFA, 1864, FLORA PROVINZ BRANDE, V1, P59; Awasthi N., 1992, GEOPHYTOLOGY, V22, P193; Awasthi N, 1995, PALEOBOTANIST, V44, P157; AWASTHI N, 1989, PALEOBOTANIST, V37, P147; Bailey IW, 1924, ANN BOT-LONDON, V38, P439, DOI 10.1093/oxfordjournals.aob.a089910; BANDE MB, 1986, REV PALAEOBOT PALYNO, V49, P203, DOI 10.1016/0034-6667(86)90028-X; Bande MB., 1974, GEOPHYTOLOGY, V4, P189; Bibi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016688; Bobe R, 2006, J ARID ENVIRON, V66, P564, DOI 10.1016/j.jaridenv.2006.01.010; Bonnefille R, 2010, GLOBAL PLANET CHANGE, V72, P390, DOI 10.1016/j.gloplacha.2010.01.015; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Chatterjee S, 1999, P INDIAN NATL SCI A, V65, P397; Chatterjee S, 2013, GONDWANA RES, V23, P238, DOI 10.1016/j.gr.2012.07.001; DILCHER DL, 1974, BOT REV, V40, P1, DOI 10.1007/BF02860067; Dressler S, 1996, BLUMEA, V41, P263; Forster Paul I., 1999, Austrobaileya, V5, P405; Ganju JI, 1986, B OIL NAT GAS COMM, V23, P129; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Gregory M., 2009, IAWA J SUPPL, V6, P220; Griffin DL, 2002, PALAEOGEOGR PALAEOCL, V182, P65, DOI 10.1016/S0031-0182(01)00453-9; GRUASCAVAGNETTO C, 1992, GRANA, V31, P291, DOI 10.1080/00173139209429452; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; Hooker J.D., 1885, FLORA BRIT INDIA, V4, P644; Jussieu ALD, 1820, PRIROZENOSTI ROSTIN, V225; Kumar M, 2012, PALAEOGEOGR PALAEOCL, V342, P143, DOI 10.1016/j.palaeo.2012.05.001; LAKHANPAL R N, 1970, Taxon, V19, P675, DOI 10.2307/1219280; Li PT, 2008, FLORA CHINA, P172; Li YQ, 2009, SYST BOT, V34, P521, DOI 10.1600/036364409789271263; Madel E, 1962, SENCKENBERG LETH, V43, P283; Martinov II, 1820, TEKHNOBOTANICHESKII, DOI Sanktpeterburgie; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Mehrotra R. C., 1998, Phytomorphology, V48, P91; Mehrotra RC, 2003, GEOBIOS-LYON, V36, P83, DOI 10.1016/S0016-6995(02)00107-9; Mehrotra RC, 2009, PALEOBOTANIST, V58, P1, DOI DOI 10.1016/S0016-6995(02)00107-9; Mishra HK, 1996, INT J COAL GEOL, V30, P65, DOI 10.1016/0166-5162(95)00038-0; Misra BK, 1992, PALEOBOTANIST, V39, P309; Molnar P, 2009, TECTONICS, V28; Muller Argoviensis J, 1864, BOT ZEITUNG, V22, P324; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Pascoe E. H, 1964, MANUAL GEOLOGY INDIA, V1; Pathak NR, 1969, J SEN MEMORIAL VOLUM, P379; Prasad M, 2008, PALAEONTOGR ABT B, V278, P13, DOI 10.1127/palb/278/2008/13; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; Ramanujam CGK., 1960, PALAEONTOGR ABT B, V106, P99; Shukla A, 2013, ALCHERINGA, V37, P1, DOI 10.1080/03115518.2012.688688; Srivastava G.A., 2010, MEMOIR GEOLOGICAL SO, V75, P123; Srivastava G, 2013, J EARTH SYST SCI, V122, P1341, DOI 10.1007/s12040-013-0354-3; Srivastava G, 2013, J EARTH SYST SCI, V122, P283, DOI 10.1007/s12040-013-0277-z; Srivastava G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053177; Srivastava G, 2012, J EARTH SYST SCI, V121, P747, DOI 10.1007/s12040-012-0179-5; Srivastava G, 2012, PALAEOGEOGR PALAEOCL, V342, P130, DOI 10.1016/j.palaeo.2012.05.002; Srivastava G, 2012, CURR SCI INDIA, V102, P398; Srivastava G, 2010, J GEOL SOC INDIA, V75, P820, DOI 10.1007/s12594-010-0069-x; STEENIS C. G. G. J. VAN., 1962, Blumea, V11, P235; Tomlinson P. B., 1990, The structural biology of palms.; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; WHEELER EA, 1987, BOT J LINN SOC, V94, P111; WILLDENOW CL, 1806, SPECIES PLANTARUM, P4; Wolfe J.A., 1993, US GEOLOGICAL SURVEY, V2040, P1, DOI DOI 10.3133/B2040; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	63	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111140	10.1371/journal.pone.0111140	http://dx.doi.org/10.1371/journal.pone.0111140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353345	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200062
J	Wullschleger, M; Aghlmandi, S; Egger, M; Zwahlen, M				Wullschleger, Marcel; Aghlmandi, Soheila; Egger, Marcel; Zwahlen, Marcel			High Incorrect Use of the Standard Error of the Mean (SEM) in Original Articles in Three Cardiovascular Journals Evaluated for 2012	PLOS ONE			English	Article							STATISTICAL-METHODS; MEDICINE; MISUSE	Rationale: In biomedical journals authors sometimes use the standard error of the mean (SEM) for data description, which has been called inappropriate or incorrect. Objective: To assess the frequency of incorrect use of SEM in articles in three selected cardiovascular journals. Methods and Results: All original journal articles published in 2012 in Cardiovascular Research, Circulation: Heart Failure and Circulation Research were assessed by two assessors for inappropriate use of SEM when providing descriptive information of empirical data. We also assessed whether the authors state in the methods section that the SEM will be used for data description. Of 441 articles included in this survey, 64% (282 articles) contained at least one instance of incorrect use of the SEM, with two journals having a prevalence above 70% and "Circulation: Heart Failure'' having the lowest value (27%). In 81% of articles with incorrect use of SEM, the authors had explicitly stated that they use the SEM for data description and in 89% SEM bars were also used instead of 95% confidence intervals. Basic science studies had a 7.4-fold higher level of inappropriate SEM use (74%) than clinical studies (10%). Limitations: The selection of the three cardiovascular journals was based on a subjective initial impression of observing inappropriate SEM use. The observed results are not representative for all cardiovascular journals. Conclusion: In three selected cardiovascular journals we found a high level of inappropriate SEM use and explicit methods statements to use it for data description, especially in basic science studies. To improve on this situation, these and other journals should provide clear instructions to authors on how to report descriptive information of empirical data.	[Wullschleger, Marcel; Egger, Marcel] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; [Aghlmandi, Soheila; Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Bern; University of Bern	Zwahlen, M (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	zwahlen@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346	Swiss National Science Foundation; European Community [290025]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission)	MW performed this work in his time off. Furthermore, he is working on a project in cardiac physiology supported by the Swiss National Science Foundation. SA is supported by the European Community's Seventh Framework Program FP7/2011: Marie Curie Initial Training Network MEDIASRES ("Novel Statistical Methodology for Diagnostic / Prognostic and Therapeutic Studies and Systematic Reviews"; www.mediasres-itn.eu) with the Grant Agreement Number 290025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2005, BRIT MED J, V331, P903, DOI 10.1136/bmj.331.7521.903; ALTMAN DG, 1983, BRIT MED J, V286, P1489, DOI 10.1136/bmj.286.6376.1489; [Anonymous], 2005, ENCY BIOSTATISTICS, P811; AVRAM MJ, 1985, ANESTH ANALG, V64, P607; CRUESS DF, 1989, AM J TROP MED HYG, V41, P619, DOI 10.4269/ajtmh.1989.41.619; EMERSON JD, 1983, NEW ENGL J MED, V309, P709, DOI 10.1056/NEJM198309223091206; Encyclopedia of Biostatistics, 2005, ENCY BIOSTATISTICS, P2270; FEINSTEIN AR, 1976, CLIN PHARMACOL THER, V20, P617; FELSON DT, 1984, ARTHRITIS RHEUM, V27, P1018, DOI 10.1002/art.1780270908; Fisher DM, 2000, ANESTHESIA, VI, P753; Lang T, 2004, CROAT MED J, V45, P361; LANG TA, 1997, REPORT STAT MED ANNO; MACARTHUR RD, 1984, J INFECT DIS, V149, P349, DOI 10.1093/infdis/149.3.349; Nagele P, 2003, BRIT J ANAESTH, V90, P514, DOI 10.1093/bja/aeg087; Olsen CH, 2003, INFECT IMMUN, V71, P6689, DOI 10.1128/IAI.71.12.6689-6692.2003; Streiner DL, 1996, CAN J PSYCHIAT, V41, P498, DOI 10.1177/070674379604100805; WHITE SJ, 1979, BRIT J PSYCHIAT, V135, P336, DOI 10.1192/bjp.135.4.336	18	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110364	10.1371/journal.pone.0110364	http://dx.doi.org/10.1371/journal.pone.0110364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354300	Green Published, gold			2022-12-27	WOS:000345204200023
J	Calik, MW; Carley, DW				Calik, Michael W.; Carley, David W.			Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin-Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CISPLATIN-INDUCED EMESIS; 5-HT3 RECEPTORS; CB1 RECEPTORS; GUINEA-PIG; HYPOGLOSSAL; DELTA(9)-TETRAHYDROCANNABINOL; DELTA-9-TETRAHYDROCANNABINOL; IDENTIFICATION; ONDANSETRON	The prevalence of obstructive sleep apnea (OSA) in Americans is 9% and increasing. Increased afferent vagal activation may predispose to OSA by reducing upper airway muscle activation/patency and disrupting respiratory rhythmogenesis. Vagal afferent neurons are inhibited by cannabinoid type 1 (CB1) or cannabinoid type 2 (CB2) receptors in animal models of vagally-mediated behaviors. Injections of dronabinol, a non-selective CB1/CB2 receptor agonist, into the nodose ganglia reduced serotonin (5-HT)-induced reflex apneas. It is unknown what role CB1 and/or CB2 receptors play in reflex apnea. Here, to determine the independent and combined effects of activating CB1 and/or CB2 receptors on dronabinol's attenuating effect, rats were pre-treated with CB1 (AM251) and/or CB2 (AM630) receptor antagonists. Adult male Sprague-Dawley rats were anesthetized, instrumented with bilateral electrodes to monitor genioglossus electromyogram (EMGgg) and a piezoelectric strain gauge to monitor respiratory pattern. Following intraperitoneal treatment with AM251 and/or AM630, or with vehicle, serotonin was intravenously infused into a femoral vein to induce reflex apnea. After baseline recordings, the nodose ganglia were exposed and 5-HT-induced reflex apneas were again recorded to confirm that the nerves remained functionally intact. Dronabinol was injected into each nodose ganglion and 5-HT infusion was repeated. Prior to dronabinol injection, there were no significant differences in 5-HT-induced reflex apneas or phasic and tonic EMGgg before or after surgery in the CB1, CB 2, combined CB1/CB2 antagonist, and vehicle groups. In the vehicle group, dronabinol injections reduced 5-HT-induced reflex apnea duration. In contrast, dronabinol injections into nodose ganglia of the CB1, CB2, and combined CB1/CB2 groups did not attenuate 5-HT-induced reflex apnea duration. However, the CB1 and CB2 antagonists had no effect on dronabinol's ability to increase phasic EMGgg. These findings underscore the therapeutic potential of dronabinol in the treatment of OSA and implicate participation of both cannabinoid receptors in dronabinol's apnea suppression effect.	[Calik, Michael W.; Carley, David W.] Univ Illinois, Ctr Narcolepsy Sleep & Hlth Res, Chicago, IL 60607 USA; [Calik, Michael W.; Carley, David W.] Univ Illinois, Dept Biobehav Hlth Sci, Chicago, IL USA; [Carley, David W.] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Calik, MW (corresponding author), Univ Illinois, Ctr Narcolepsy Sleep & Hlth Res, Chicago, IL 60607 USA.	mcalik@uic.edu		Calik, Michael/0000-0001-6295-7420	National Institutes of Health [1UM1HL112856]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL112856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Grant 1UM1HL112856 awarded to DWC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barann M, 2002, BRIT J PHARMACOL, V137, P589, DOI 10.1038/sj.bjp.0704829; Belvisi MG, 2008, BRIT J PHARMACOL, V155, P547, DOI 10.1038/bjp.2008.298; Burdyga G, 2010, AM J PHYSIOL-GASTR L, V299, pG63, DOI 10.1152/ajpgi.00059.2010; Calik MW, 2014, RESP PHYSIOL NEUROBI, V190, P20, DOI 10.1016/j.resp.2013.10.001; Carley DW, 2002, SLEEP, V25, P391; Carley DW, 1999, CHEST, V115, P1397, DOI 10.1378/chest.115.5.1397; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Darmani NA, 2004, EUR J PHARMACOL, V488, P201, DOI 10.1016/j.ejphar.2004.02.018; Darmani NA, 2001, PHARMACOL BIOCHEM BE, V69, P239, DOI 10.1016/S0091-3057(01)00531-7; Doan TN, 1999, J PHYSIOL-LONDON, V514, P125, DOI 10.1111/j.1469-7793.1999.125af.x; Doan TN, 2004, J NEUROSCI, V24, P3335, DOI 10.1523/JNEUROSCI.5156-03.2004; FAN P, 1995, J NEUROPHYSIOL, V73, P907, DOI 10.1152/jn.1995.73.2.907; Fenik P, 2001, SLEEP, V24, P871, DOI 10.1093/sleep/24.8.871; GINZEL KH, 1954, J PHYSIOL-LONDON, V123, P277, DOI 10.1113/jphysiol.1954.sp005050; Glazebrook PA, 2002, J PHYSIOL-LONDON, V541, P467, DOI 10.1113/jphysiol.2001.018333; Haji A, 2000, PHARMACOL THERAPEUT, V86, P277, DOI 10.1016/S0163-7258(00)00059-0; Hermes SM, 2014, J COMP NEUROL, V522, P642, DOI 10.1002/cne.23438; Kaczynska K, 2013, PHYSIOL RES, V62, P227, DOI 10.33549/physiolres.932412; Khlaifia A, 2013, J NEUROSCI, V33, P12627, DOI 10.1523/JNEUROSCI.1028-13.2013; Marchenko V, 2000, BRAIN RES, V857, P99, DOI 10.1016/S0006-8993(99)02377-X; Mason M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003002.pub3; Mukhtarov M, 2005, J PHYSIOL-LONDON, V569, P817, DOI 10.1113/jphysiol.2005.094862; NISHI K, 1975, BRIT J PHARMACOL, V55, P27, DOI 10.1111/j.1476-5381.1975.tb07606.x; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Parhizgar F, 2011, J CLIN SLEEP MED, V7, P401, DOI 10.5664/JCSM.1204; Patel HJ, 2003, BRIT J PHARMACOL, V140, P261, DOI 10.1038/sj.bjp.0705435; Peever JH, 2001, PFLUG ARCH EUR J PHY, V442, P78, DOI 10.1007/s004240000502; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Prasad Bharati, 2013, Front Psychiatry, V4, P1, DOI 10.3389/fpsyt.2013.00001; Prasad B, 2010, SLEEP, V33, P982, DOI 10.1093/sleep/33.7.982; Radulovacki M, 1998, SLEEP, V21, P131, DOI 10.1093/sleep/21.2.131; Ray AP, 2009, BEHAV BRAIN RES, V196, P30, DOI 10.1016/j.bbr.2008.07.028; Rohof WO, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01868.x; Saito Y, 2002, J PHYSIOL-LONDON, V544, P183, DOI 10.1113/jphysiol.2002.022566; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100536; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Tadjalli A, 2010, J NEUROSCI, V30, P16886, DOI 10.1523/JNEUROSCI.3394-10.2010; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Veasey SC, 2001, SLEEP, V24, P155, DOI 10.1093/sleep/24.2.155; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Yang KHS, 2010, NEUROSCIENCE, V171, P40, DOI 10.1016/j.neuroscience.2010.08.044; YOSHIOKA M, 1992, J PHARMACOL EXP THER, V260, P917; Zhuo H, 1997, PROG NEUROBIOL, V52, P79, DOI 10.1016/S0301-0082(97)00003-8	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111412	10.1371/journal.pone.0111412	http://dx.doi.org/10.1371/journal.pone.0111412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350456	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100070
J	Choi, J; Lee, HE; Kim, MA; Jang, BG; Lee, HS; Kim, WH				Choi, Jiwoon; Lee, Hee Eun; Kim, Min A.; Jang, Bo Gun; Lee, Hye Seung; Kim, Woo Ho			Analysis of MET mRNA Expression in Gastric Cancers Using RNA In Situ Hybridization Assay: Its Clinical Implication and Comparison with Immunohistochemistry and Silver In Situ Hybridization	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; THERAPEUTIC TARGET; FACTOR RECEPTOR; AMPLIFICATION; CARCINOMAS; GENE; OVEREXPRESSION; ONCOGENE; PROTEIN	We investigated MET mRNA expression status using RNA in situ hybridization (ISH) technique in primary and metastatic lesions of 535 surgically resected gastric carcinoma (GC) cases. We compared the results with those of immunohistochemistry and silver in situ hybridization, and examined the association with clinicopathologic characteristics and prognosis. Among 535 primary GCs, 391 (73.1%) were scored 0, 87 (16.3%) were scored 1, 38 (7.1%) were scored 2, 12 (2.2%) were scored 3 and 7 (1.3%) were scored 4 by RNA ISH. High MET mRNA expression (score >= 3) was associated with lymph node metastasis (P = .014), distant metastasis (P = .001), and higher TNM stage (P<.001). MET mRNA expression was correlated with protein expression (r = 0.398; P<.001) and gene copy number (r = 0.345; P<.001). The patients showing high-MET mRNA in primary or metastatic lesions had shorter overall survival than those showing low-MET mRNA (primary tumors, P = .002; metastatic lymph nodes, P<.001). The patients showing positive conversion of MET mRNA status in metastatic lymph node had shorter overall survival than those with no conversion (P = .011). Multivariate analysis demonstrated that high MET mRNA expression in metastatic lymph node was an independent prognostic factor for overall survival (P = .007). Therefore, this study suggests that MET mRNA expression assessed by RNA ISH could be useful as a potential marker to identify MET oncogene-addicted GC.	[Choi, Jiwoon; Lee, Hee Eun; Kim, Min A.; Jang, Bo Gun; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, WH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.	woohokim@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986	National Research Foundation of Korea (NRF) A3 Foresight program	National Research Foundation of Korea (NRF) A3 Foresight program	This work was supported by the National Research Foundation of Korea (NRF) A3 Foresight program (http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya H, 2002, ONCOLOGY-BASEL, V63, P286, DOI 10.1159/000065477; Asaoka Y, 2010, BIOCHEM BIOPH RES CO, V394, P1042, DOI 10.1016/j.bbrc.2010.03.120; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Drebber U, 2008, ONCOL REP, V19, P1477; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Hara T, 1998, LAB INVEST, V78, P1143; Huang TJ, 2001, ACTA ONCOL, V40, P638; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Kaji M, 1996, CANCER GENE THER, V3, P393; Kim MA, 2013, HUM PATHOL, V44, P487, DOI 10.1016/j.humpath.2012.06.022; KUNIYASU H, 1993, INT J CANCER, V55, P72, DOI 10.1002/ijc.2910550114; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Nakajima M, 1999, CANCER, V85, P1894; Park WS, 2000, APMIS, V108, P195, DOI 10.1034/j.1600-0463.2000.d01-44.x; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	28	15	17	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111658	10.1371/journal.pone.0111658	http://dx.doi.org/10.1371/journal.pone.0111658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364819	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100098
J	Zhou, FC; Hou, WM; Wang, CY; Ungvari, GS; Chiu, HFK; Correll, CU; Shum, DHK; Man, D; Liu, DT; Xiang, YT				Zhou, Fu-Chun; Hou, Wei-Min; Wang, Chuan-Yue; Ungvari, Gabor S.; Chiu, Helen F. K.; Correll, Christoph U.; Shum, David H. K.; Man, David; Liu, Deng-Tang; Xiang, Yu-Tao			Prospective Memory Performance in Non-Psychotic First-Degree Relatives of Patients with Schizophrenia: A Controlled Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HIGH-RISK PROJECT; WORKING-MEMORY; RETROSPECTIVE-MEMORY; SIBLINGS DISCORDANT; SPECTRUM DISORDERS; COGNITIVE DEFICITS; PREFRONTAL CORTEX; METAANALYSIS; FMRI	Objective: We aimed at investigating prospective memory and its socio-demographic and neurocognitive correlates in nonpsychotic, first-degree relatives (FDRs) of patients with schizophrenia compared to patients with first episode schizophrenia (FES), and healthy controls (HCs). Methods: Forty-seven FES patients, 50 non-psychotic FDRs (23 offspring and 27 siblings) of patients with chronic schizophrenia (unrelated to the FES group) and 51 HCs were studied. The Chinese version of the Cambridge Prospective Memory Test (C-CAMPROMPT) was used to measure time-based prospective memory (TBPM) and event-based prospective memory (EBPM) performance. Other cognitive functions (involving respective memory and executive functions) were evaluated with standardized tests. Results: After controlling for basic demographic characteristics including age, gender and educational level, there was a significant difference between FDRs, FES and HCs with respect to both TBPM (F-(2,F-142) = 10.4, p<0.001) and EBPM (F-(2,F-142) = 10.8, p<0.001). Multiple linear regression analyses revealed that lower scores of the Hopkins Verbal Learning TestRevised (HVLT-R) and the STROOP Word-Color Test (SWCT) contributed to TBPM impairment, while lower educational level and higher scores of the Color Trails Test-2 (CTT-2) contributed to EBPM deficit in FDRs. Conclusions: FDRs share similar but attenuated prospective memory impairments with schizophrenia patients, suggesting that prospective memory deficits may represent an endophenotype of schizophrenia.	[Zhou, Fu-Chun; Wang, Chuan-Yue] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China; [Hou, Wei-Min] Beijing Daxing Mental Hlth Ctr, Beijing, Peoples R China; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Correll, Christoph U.] North Shore Long Isl Jewish Hlth Syst, Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA; [Shum, David H. K.] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Man, David] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Liu, Deng-Tang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai 200030, Peoples R China; [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Macao Sar, Peoples R China	Capital Medical University; University of Western Australia; Chinese University of Hong Kong; Northwell Health; Griffith University; Griffith University; Menzies Health Institute Queensland; Hong Kong Polytechnic University; Shanghai Jiao Tong University; University of Macau	Wang, CY (corresponding author), Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China.	wang.cy@163.net; xyutly@gmail.com	Shum, David/A-3914-2008; Wang, Chuan-Yue/C-9369-2015; Correll, Christoph U/AAY-3179-2021; Correll, Christoph/D-3530-2011	Shum, David/0000-0002-4810-9262; Wang, Chuan-Yue/0000-0001-6549-3713; Correll, Christoph/0000-0002-7254-5646	National Natural Science Foundation of China [81171270, 30800367, 30770776]; Beijing Sciences and Technology Nova Program [2008B59]; National Scientific and Technical Supporting Programs of China [2007BAI17B04]; National High Technology Research and Development Program of China (863 Program) [2009AA022702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Sciences and Technology Nova Program; National Scientific and Technical Supporting Programs of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	The study was supported by the National Natural Science Foundation of China (Grant No. 81171270, 30800367, 30770776), the Beijing Sciences and Technology Nova Program (Grant No. 2008B59), the National Scientific and Technical Supporting Programs of China (Grant No. 2007BAI17B04), and the National High Technology Research and Development Program of China (863 Program. Grant No. 2009AA022702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; APA, 1994, DIAGN STAT MAN MENT; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Barrantes-Vidal N, 2007, SCHIZOPHR RES, V95, P70, DOI 10.1016/j.schres.2007.06.020; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Burgess P.W., 2007, ROLE ROSTRAL PREFRON; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Chan RCK, 2008, SCHIZOPHR RES, V103, P229, DOI 10.1016/j.schres.2008.02.019; Churchwell JC, 2011, BEHAV BRAIN RES, V225, P389, DOI 10.1016/j.bbr.2011.07.045; Davalos DB, 2004, SCHIZOPHR RES, V67, P123, DOI 10.1016/S0920-9964(03)00187-7; de la Serna E, 2011, SCHIZOPHR RES, V131, P35, DOI 10.1016/j.schres.2011.06.015; Egan MF, 2001, BIOL PSYCHIAT, V50, P98, DOI 10.1016/S0006-3223(01)01133-7; Einstein G. O., 1996, PROSPECTIVE MEMORY T, P115; Einstein G. O., 1990, MEM COGNITION, V16, P717, DOI [10.1037/0278-7393.16.4.717, DOI 10.1037/0278-7393.16.4.717]; Elvevag B, 2003, BMC PSYCHIATRY, V3, DOI 10.1186/1471-244X-3-9; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; First M.B., 2014, STRUCTURED CLIN INTE; Fis NP, 2008, EUR CHILD ADOLES PSY, V17, P424, DOI 10.1007/s00787-008-0684-x; Frith CD, 1997, FUNCTIONAL BRAIN IMA; Goldstein JM, 2000, SCHIZOPHRENIA BULL, V26, P323, DOI 10.1093/oxfordjournals.schbul.a033456; Goto Y, 2008, CEREB CORTEX, V18, P1407, DOI 10.1093/cercor/bhm172; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Groom MJ, 2008, SCHIZOPHR RES, V99, P85, DOI 10.1016/j.schres.2007.11.008; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Hughes C, 2005, ACTA PSYCHIAT SCAND, V111, P185, DOI 10.1111/j.1600-0447.2004.00392.x; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kremen WS, 1998, AM J PSYCHIAT, V155, P672, DOI 10.1176/ajp.155.5.672; Kumar D, 2005, J CLIN EXP NEUROPSYC, V27, P867, DOI 10.1080/13803390490919100; Kumar D, 2008, CLIN NEUROPSYCHOL, V22, P497, DOI 10.1080/13854040701396687; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Lou ZL, 2009, THESIS SUN YAT SEN U; Lui SSY, 2011, NEUROPSYCHOLOGIA, V49, P2217, DOI 10.1016/j.neuropsychologia.2011.04.002; Mann K, 1997, BIOL PSYCHIAT, V42, P655, DOI 10.1016/S0006-3223(96)00497-0; Maziade M, 2008, ACTA PSYCHIAT SCAND, V117, P118, DOI 10.1111/j.1600-0447.2007.01125.x; Maziade M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019153; McIntosh AM, 2011, BIOL PSYCHIAT, V69, P953, DOI 10.1016/j.biopsych.2010.11.003; Meda SA, 2008, SCHIZOPHR RES, V101, P95, DOI 10.1016/j.schres.2008.02.007; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Ott SL, 1998, SCHIZOPHR RES, V31, P1, DOI 10.1016/S0920-9964(98)00010-3; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Rabelo Ivan Sant' Ana, 2010, Psychol. Neurosci., V3, P93, DOI 10.3922/j.psns.2010.1.012; Reichenberg A, 2006, J CLIN EXP NEUROPSYC, V28, P193, DOI 10.1080/13803390500360372; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; [石川 Shi Chuan], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P343; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; Skelley SL, 2008, SCHIZOPHR RES, V105, P78, DOI 10.1016/j.schres.2008.05.027; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; Spreen O, 1998, COMPENDIUM NEUROPSYC; Ungvari GS, 2008, ARCH CLIN NEUROPSYCH, V23, P613, DOI 10.1016/j.acn.2008.06.005; Wang Y, 2008, SCHIZOPHR RES, V105, P114, DOI 10.1016/j.schres.2008.07.002; Wang Y, 2010, PSYCHIAT RES, V179, P285, DOI 10.1016/j.psychres.2009.07.011; Wang Y, 2009, SCHIZOPHR RES, V114, P64, DOI 10.1016/j.schres.2009.07.009; Wang Y, 2008, SCHIZOPHR RES, V106, P70, DOI 10.1016/j.schres.2007.07.020; Winterer G, 2003, BIOL PSYCHIAT, V54, P1181, DOI 10.1016/S0006-3223(03)00532-8; Wolf LE, 2002, SCHIZOPHR RES, V57, P173, DOI 10.1016/S0920-9964(01)00301-2; Xiang YT, 2010, ARCH CLIN NEUROPSYCH, V25, P680, DOI 10.1093/arclin/acq062; Zhou FC, 2012, SCHIZOPHR RES, V135, P34, DOI 10.1016/j.schres.2011.12.001; Zhuo K, 2012, SCHIZOPHRENIA RES	70	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111562	10.1371/journal.pone.0111562	http://dx.doi.org/10.1371/journal.pone.0111562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365028	Green Published, gold			2022-12-27	WOS:000345558100076
J	Cheng, DS; Fei, Y; Liu, YM; Li, JH; Chen, YQ; Wang, XX; Wang, NS				Cheng, Dongsheng; Fei, Yang; Liu, Yumei; Li, Junhui; Chen, Yuqiang; Wang, Xiaoxia; Wang, Niansong			Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients with Moderate to Severe Renal Impairment: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							IMPROVES GLYCEMIC CONTROL; RECEPTOR AGONISTS; GLYCATED ALBUMIN; DPP-4 INHIBITORS; SITAGLIPTIN; VILDAGLIPTIN; DIALYSIS; KIDNEY; SAXAGLIPTIN; THERAPY	Objective: To perform a systematic review and meta-analysis regarding the efficacy and safety of dipeptidyl peptidase-4 (DDP-4) inhibitors ("gliptins'') for the treatment of type 2 diabetes mellitus (T2DM) patients with moderate to severe renal impairment. Methods: All available randomized-controlled trials (RCTs) that assessed the efficacy and safety of DDP-4 inhibitors compared with placebo, no treatment, or active drugs were identified using PubMed, EMBASE, Cochrane CENTRAL, conference abstracts, clinical trials.gov, pharmaceutical company websites, the FDA, and the EMA (up to June 2014). Two independent reviewers extracted the data, and a random-effects model was applied to estimate summary effects. Results: Thirteen reports of ten studies with a total of 1,915 participants were included in the final analysis. Compared with placebo or no treatment, DPP-4 inhibitors reduced HbA1c significantly (-0.52%, 95% CI -0.64 to -0.39) and had no increased risk of hypoglycemia (RR 1.10, 95% CI 0.92 to 1.32) or weight gain. In contrast to glipizide monotherapy, DPP-4 inhibitors showed no difference in HbA1c lowering effect (-0.08%, 95% CI -0.40 to 0.25) but had a lower incidence of hypoglycemia (RR 0.40, 95% CI 0.23 to 0.69). Furthermore, DPP-4 inhibitors were well-tolerated, without any additional mortality and adverse events. However, the quality of evidence was mostly as low, as assessed using the GRADE system for each outcome. Conclusions: DPP-4 inhibitors are effective at lowering HbA1c in T2DM patients with moderate to severe renal impairment. DPP-4 inhibitors also have a potential advantage in lowering the risk of adverse events. Regarding the low quality of the evidence according to GRADE, additional well-designed randomized trials that focus on the safety and efficacy of DPP-4 inhibitors in various CKD stages are needed urgently.	[Cheng, Dongsheng; Fei, Yang; Liu, Yumei; Li, Junhui; Chen, Yuqiang; Wang, Xiaoxia; Wang, Niansong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, NS (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China.	wangniansong2012@163.com	Chen, Yuqiang/GQZ-0688-2022	chen, yuqiang/0000-0002-0646-7571	National Nature Science Foundation of China [81270824]; Shanghai Science and Technology Project [11DZ1921904, 11410708500]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Project	This research is supported by grant from the Project of National Nature Science Foundation of China (81270824), Shanghai Science and Technology Project (11DZ1921904 and 11410708500). The funders played no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Chan JCN, 2008, DIABETES OBES METAB, V10, P545, DOI 10.1111/j.1463-1326.2008.00914.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferreira JCA, 2013, AM J KIDNEY DIS, V61, P579, DOI 10.1053/j.ajkd.2012.11.043; Ferreira JCA, 2013, DIABETES CARE, V36, P1067, DOI 10.2337/dc12-1365; Freedman BI, 2011, CLIN J AM SOC NEPHRO, V6, P1635, DOI 10.2215/CJN.11491210; Giorda CB, 2014, ENDOCRINE, V46, P406, DOI 10.1007/s12020-014-0179-0; Glorie LLF, 2012, AM J PHYSIOL-RENAL, V303, pF681, DOI 10.1152/ajprenal.00075.2012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Iglesias P, 2008, DIABETES OBES METAB, V10, P811, DOI 10.1111/j.1463-1326.2007.00802.x; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Ito M, 2011, ENDOCR J, V58, P979, DOI 10.1507/endocrj.EJ11-0025; Joo KW, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-98; Kao DP, 2008, DIABETIC MED, V25, P1229, DOI 10.1111/j.1464-5491.2008.02536.x; Karagiannis T, 2012, BMJ-BRIT MED J, V344, pe1369, DOI DOI 10.1136/BMJ.E1369; Kothny W, 2012, DIABETES OBES METAB, V14, P1032, DOI 10.1111/j.1463-1326.2012.01634.x; Laakso M, 2013, AM DIAB ASS ADA 73 S; Leiter L, 2013, EUR ASS STUD DIAB EA; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lukashevich V, 2011, DIABETES OBES METAB, V13, P947, DOI 10.1111/j.1463-1326.2011.01467.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McGill JB, 2013, DIABETES CARE, V36, P237, DOI 10.2337/dc12-0706; Mehrotra R, 2013, CURR OPIN NEPHROL HY, V22, P663, DOI 10.1097/MNH.0b013e328365b3d1; Monami M, 2010, NUTR METAB CARDIOVAS, V20, P224, DOI 10.1016/j.numecd.2009.03.015; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Nowicki M, 2011, INT J CLIN PRACT, V65, P1230, DOI 10.1111/j.1742-1241.2011.02812.x; Nowicki M, 2011, DIABETES OBES METAB, V13, P523, DOI 10.1111/j.1463-1326.2011.01382.x; Park H, 2012, ANN PHARMACOTHER, V46, P1453, DOI 10.1345/aph.1R041; Pendergrass M, 2012, DIABETES OBES METAB, V14, P596, DOI 10.1111/j.1463-1326.2012.01567.x; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Ramirez G, 2013, ENDOCR PRACT, V19, P1025, DOI 10.4158/EP12306.RA; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Wang TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103798; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	40	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111543	10.1371/journal.pone.0111543	http://dx.doi.org/10.1371/journal.pone.0111543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360775	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700116
J	Dhoubhadel, BG; Yasunami, M; Nguyen, HAT; Suzuki, M; Vu, TH; Nguyen, ATT; Dang, DA; Yoshida, LM; Ariyoshi, K				Dhoubhadel, Bhim Gopal; Yasunami, Michio; Hien Anh Thi Nguyen; Suzuki, Motoi; Thu Huong Vu; Ai Thi Thuy Nguyen; Duc Anh Dang; Yoshida, Lay-Myint; Ariyoshi, Koya			Bacterial Load of Pneumococcal Serotypes Correlates with Their Prevalence and Multiple Serotypes Is Associated with Acute Respiratory Infections among Children Less Than 5 Years of Age	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; KILIFI DISTRICT; IN-VITRO; COLONIZATION; COMPETITION; ACQUISITION; DISEASE; TRANSMISSION; CLEARANCE	Background: Among pneumococcal serotypes, some serotypes are more prevalent in the nasopharynx than others; determining factors for higher prevalence remain to be fully explored. As non-vaccine serotypes have emerged after the introduction of 7-valent conjugate vaccines, study of serotype specific epidemiology is in need. When two or more serotypes co-colonize, they evolve rapidly to defend host's immune responses; however, a clear association of co-colonization with a clinical outcome is lacking. Methods: Children less than 5 years old who were admitted to hospital due to acute respiratory infections (ARI) (n = 595) and healthy children (n = 350) were recruited. Carriage of pneumococcus was determined by culture and lytA PCR in the nasopharyngeal samples. Serotype/serogroup detection and its quantification were done by the nanofluidic real time PCR system. Spearman's correlation and logistic regression were used to examine a correlation of serotype/serogroup specific bacterial load with its prevalence and an association of co-colonization with ARI respectively. Results: Serotype/serogroup specific bacterial load was correlated with its prevalence, both in ARI cases (Spearman's rho = 0.44, n = 186; P<0.0001) and healthy children (Spearman's rho = 0.41, n = 115; P<0.0001). The prevalence of multiple serotypes was more common in ARI cases than in healthy children (18.5% vs 7.1%; aOR 2.92, 95% CI: 1.27-6.71; P = 0.01). The dominant serotype in the co-colonization had a 2 log10 higher bacterial load than the subdominant serotype, both in ARI cases (P<0.001) and healthy children (P<0.05). Conclusions: High bacterial load in the nasopharynx may help transmit pneumococci among hosts, and increase the chance of successful acquisition and colonization. Co-colonization of multiple serotypes of pneumococci is linked with ARI, which infers the interactions of multiple serotypes may increase their pathogenicity; however, they may compete for growth in number.	[Dhoubhadel, Bhim Gopal; Yasunami, Michio; Suzuki, Motoi; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Hien Anh Thi Nguyen; Thu Huong Vu; Duc Anh Dang] Natl Inst Hyg & Epidemiol, Dept Bacteriol, Hanoi, Vietnam; [Ai Thi Thuy Nguyen] Khanh Hoa Gen Hosp, Dept Microbiol, NhaTrang, Vietnam; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan; [Ariyoshi, Koya] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University; National Institute of Hygiene & Epidemiology (NIHE); Nagasaki University; Nagasaki University	Yoshida, LM (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan.	lmyoshi@nagasaki-u.ac.jp		Dhoubhadel, Bhim Gopal/0000-0001-5279-2044; Suzuki, Motoi/0000-0002-8340-0880; YOSHIDA, LAYMYINT/0000-0002-7567-3248	Government of Japan, Ministry of Education, Culture, Sports, Science, and Technology for Monbukagakusho (MEXT) scholarship; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Japan Science and Technology, Japan; Grants-in-Aid for Scientific Research [25257509] Funding Source: KAKEN	Government of Japan, Ministry of Education, Culture, Sports, Science, and Technology for Monbukagakusho (MEXT) scholarship; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology, Japan(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	BGD received scholarship from the Government of Japan, Ministry of Education, Culture, Sports, Science, and Technology for Monbukagakusho (MEXT) scholarship. The study was funded by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and Japan Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Azzari C, 2008, CLIN INFECT DIS, V47, P997, DOI 10.1086/591967; Battig P, 2006, MICROBES INFECT, V8, P2612, DOI 10.1016/j.micinf.2006.07.013; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; Dhoubhadel BG, 2014, J MED MICROBIOL, V63, P528, DOI 10.1099/jmm.0.071464-0; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; HANSMAN D, 1985, J HYG-CAMBRIDGE, V95, P677, DOI 10.1017/S0022172400060782; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hathaway LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002574; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Leung MHY, 2011, INFECT GENET EVOL, V11, P1989, DOI 10.1016/j.meegid.2011.09.002; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P510, DOI 10.1097/EDE.0b013e31824f2f32; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Tigoi CC, 2012, CLIN INFECT DIS, V55, P180, DOI 10.1093/cid/cis371; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Zhang Y, 2004, EPIDEMIOL INFECT, V132, P1073, DOI 10.1017/S0950268804002894	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110777	10.1371/journal.pone.0110777	http://dx.doi.org/10.1371/journal.pone.0110777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360707	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700046
J	Kohler, PK; Okanda, J; Kinuthia, J; Mills, LA; Olilo, G; Odhiambo, F; Laserson, KF; Zierler, B; Voss, J; John-Stewart, G				Kohler, Pamela K.; Okanda, John; Kinuthia, John; Mills, Lisa A.; Olilo, George; Odhiambo, Frank; Laserson, Kayla F.; Zierler, Brenda; Voss, Joachim; John-Stewart, Grace			Community-Based Evaluation of PMTCT Uptake in Nyanza Province, Kenya	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; ANTENATAL CARE; PREVENTION; TANZANIA; SERVICES; MOTHERS; HEALTH	Introduction: Facility-based assessments of prevention of mother-to-child HIV transmission (PMTCT) programs may overestimate population coverage. There are few community-based studies that evaluate PMTCT coverage and uptake. Methods: During 2011, a cross-sectional community survey among women who gave birth in the prior year was performed using the KEMRI-CDC Health and Demographic Surveillance System in Western Kenya. A random sample (n = 405) and a sample of women known to be HIV-positive through previous home-based testing (n = 247) were enrolled. Rates and correlates of uptake of antenatal care (ANC), HIV-testing, and antiretrovirals (ARVs) were determined. Results: Among 405 women in the random sample, 379 (94%) reported accessing ANC, most of whom (87%) were HIV tested. Uptake of HIV testing was associated with employment, higher socioeconomic status, and partner HIV testing. Among 247 known HIV-positive women, 173 (70%) self-disclosed their HIV status. Among 216 self-reported HIV-positive women (including 43 from the random sample), 82% took PMTCT ARVs, with 54% completing the full antenatal, peripartum, and postpartum course. Maternal ARV use was associated with more ANC visits and having an HIV tested partner. ARV use during delivery was lowest (62%) and associated with facility delivery. Eighty percent of HIV infected women reported having their infant HIV tested, 11% of whom reported their child was HIV infected, 76% uninfected, 6% declined to say, 7% did not recall; 79% of infected children were reportedly receiving HIV care and treatment. Conclusions: Community-based assessments provide data that complements clinic-based PMTCT evaluations. In this survey, antenatal HIV test uptake was high; most HIV infected women received ARVs, though many women did not self-disclose HIV status to field team. Community-driven strategies that encourage early ANC, partner involvement, and skilled delivery, and provide PMTCT education, may facilitate further reductions in vertical transmission.	[Kohler, Pamela K.] Univ Washington, Seattle, WA 98195 USA; [Okanda, John; Olilo, George; Odhiambo, Frank] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Kinuthia, John] Univ Nairobi, Kenyatta Natl Hosp, Nairobi, Kenya; [Mills, Lisa A.; Laserson, Kayla F.] KEMRI, CDC Res & Publ Hlth Collaborat, Ctr Dis Control & Prevent, Kisumu, Kenya; [Mills, Lisa A.; Laserson, Kayla F.] CDC, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Zierler, Brenda; Voss, Joachim] Univ Washington, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Kenyatta National Hospital; University of Nairobi; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kohler, PK (corresponding author), Univ Washington, Seattle, WA 98195 USA.	pkohler2@uw.edu	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019; Voss, Joachim/AAA-1277-2020; Kohler, Pamela/GYE-0155-2022	Kohler, Pamela/0000-0001-6176-6374; John-Stewart, Grace/0000-0002-4301-1573; Kinuthia, John/0000-0001-6571-8927; Voss, Joachim/0000-0002-8072-6244	National Institutes of Health: A Kenya Free of AIDS [R24 HD056799]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R24HD056799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health: A Kenya Free of AIDS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institutes of Health (www.nih.gov): A Kenya Free of AIDS (R24 HD056799); and received assistance from the University of Washington Center for AIDS Research (P30 AI027757 and K24 HD054314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 2013 PROGR REP GLOB; Barker PM, 2011, JAIDS-J ACQ IMM DEF, V56, pE45, DOI 10.1097/QAI.0b013e3181fdbf20; Chamla Dick D, 2007, Confl Health, V1, P12, DOI 10.1186/1752-1505-1-12; Chiasson MA, 2010, JAIDS-J ACQ IMM DEF, V55, pS94, DOI 10.1097/QAI.0b013e3181fcb878; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Jasseron C, 2011, AIDS BEHAV; Jehu-Appiah C, 2010, HEALTH POLICY, V95, P166, DOI 10.1016/j.healthpol.2009.11.017; Karanja S, 2011, PAN AFR MED J, V10; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Kiarie J, 2012, 19 C RETR OPP INF SE; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kinuthia J, 2010, 17 C RETR OPP INF SA; Kinuthia J, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-61; Larsson EC, 2009, AIDS, V23, P1924, DOI 10.1097/QAD.0b013e32832eff81; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Marazzi MC, 2009, PEDIATR INFECT DIS J, V28, P483, DOI 10.1097/INF.0b013e3181950c56; Mbonye AK, 2010, J BIOSOC SCI, V42, P271, DOI 10.1017/S002193200999040X; Mbuagbaw LCE, 2011, MATERN CHILD HLTH J, V15, P1427, DOI 10.1007/s10995-010-0707-3; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; NACC NASCOP, 2012, KEN AIDS EP UPD 2011; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; National AIDS Control Council, 2010, UN GEN ASS SPEC SESS; Nguyen Thu Anh, 2008, AIDS Res Ther, V5, P7, DOI 10.1186/1742-6405-5-7; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Otieno PA, 2010, AIDS CARE, P1; Otim R, 2012, DAILY MONITOR; Peltzer Karl, 2007, Afr J Reprod Health, V11, P57, DOI 10.2307/30032488; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sirengo M, 2014, JAIDS-J ACQ IMM DEF, V66, pS66, DOI 10.1097/QAI.0000000000000115; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Stringer Jeffrey S A, 2013, PLoS Med, V10, pe1001424, DOI 10.1371/journal.pmed.1001424; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNICEF, 2008, 2 UNICEF; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	38	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110110	10.1371/journal.pone.0110110	http://dx.doi.org/10.1371/journal.pone.0110110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360758	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700025
J	Matheson, NJ; Peden, AA; Lehner, PJ				Matheson, Nicholas J.; Peden, Andrew A.; Lehner, Paul J.			Antibody-Free Magnetic Cell Sorting of Genetically Modified Primary Human CD4+T Cells by One-Step Streptavidin Affinity Purification	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; I HEAVY-CHAINS; RECOMBINANT PROTEINS; BINDING PEPTIDE; GENE-TRANSFER; CAS9; INTERNALIZATION; DISLOCATION; LYMPHOCYTES; THERAPY	Existing methods for phenotypic selection of genetically modified mammalian cells suffer disadvantages of time, cost and scalability and, where antibodies are used to bind exogenous cell surface markers for magnetic selection, typically yield cells coated with antibody-antigen complexes and beads. To overcome these limitations we have developed a method termed Antibody-Free Magnetic Cell Sorting in which the 38 amino acid Streptavidin Binding Peptide (SBP) is displayed at the cell surface by the truncated Low Affinity Nerve Growth Receptor (LNGFRF) and used as an affinity tag for one-step selection with streptavidin-conjugated magnetic beads. Cells are released through competition with the naturally occurring vitamin biotin, free of either beads or antibody-antigen complexes and ready for culture or use in downstream applications. Antibody-Free Magnetic Cell Sorting is a rapid, cost-effective, scalable method of magnetic selection applicable to either viral transduction or transient transfection of cell lines or primary cells. We have optimised the system for enrichment of primary human CD4+ T cells expressing shRNAs and exogenous genes of interest to purities of >99%, and used it to isolate cells following Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 genome editing.	[Matheson, Nicholas J.; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Peden, Andrew A.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Cambridge; University of Sheffield	Matheson, NJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge, England.	njm25@cam.ac.uk; pjl30@cam.ac.uk		Peden, Andrew/0000-0003-0144-7712; Lehner, Paul Joseph/0000-0001-9383-1054; Matheson, Nicholas/0000-0002-3318-1851	Wellcome Trust; National Institute for Health Research Cambridge Biomedical Research Centre; Medical Research Council [G120/952] Funding Source: researchfish; MRC [G120/952] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Research Centre. NM is a Wellcome Trust Research Training Fellow (093964/Z/10/Z) and Raymond and Beverly Sackler student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard F, 2002, J IMMUNOL METHODS, V271, P99, DOI 10.1016/S0022-1759(02)00412-X; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brent R., 2001, CURR PROTOC PROTEIN; Burr ML, 2013, P NATL ACAD SCI USA, V110, P14290, DOI 10.1073/pnas.1303380110; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dainiak MB, 2007, ADV BIOCHEM ENG BIOT, V106, P1, DOI 10.1007/10_2007_069; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Gotoh H, 2007, GENE, V389, P146, DOI 10.1016/j.gene.2006.10.019; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Han HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026380; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Helman D, 2014, CYTOM PART A, V85, P162, DOI 10.1002/cyto.a.22308; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Lee Mathia Y, 2012, J Biomol Tech, V23, P69, DOI 10.7171/jbt.12-2302-003; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mahmoudi M, 2012, CHEM REV, V112, P2323, DOI 10.1021/cr2002596; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Neurauter AA, 2007, ADV BIOCHEM ENG BIOT, V106, P41, DOI 10.1007/10_2007_072; Peterson CW, 2013, GENE THER, V20, P695, DOI 10.1038/gt.2012.98; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Rogers ML, 2008, J BIOL REG HOMEOS AG, V22, P1; Ruggieri L, 1997, HUM GENE THER, V8, P1611, DOI 10.1089/hum.1997.8.13-1611; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Winnard PT, 2007, CANCER BIOL THER, V6, P1889, DOI 10.4161/cbt.6.12.4963; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	39	13	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111437	10.1371/journal.pone.0111437	http://dx.doi.org/10.1371/journal.pone.0111437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360777	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000343943700103
J	Minai, K; Ogawa, T; Kawai, M; Komukai, K; Tanaka, T; Ogawa, K; Nagoshi, T; Arase, S; Morimoto, S; Inoue, Y; Sekiyama, H; Urabe, A; Matsuo, S; Hongo, K; Yoshimura, M				Minai, Kosuke; Ogawa, Takayuki; Kawai, Makoto; Komukai, Kimiaki; Tanaka, Toshikazu; Ogawa, Kazuo; Nagoshi, Tomohisa; Arase, Satoshi; Morimoto, Satoshi; Inoue, Yasunori; Sekiyama, Hiroshi; Urabe, Akihiro; Matsuo, Seiichiro; Hongo, Kenichi; Yoshimura, Michihiro			The Plasma B-Type Natriuretic Peptide Levels Are Low in Males with Stable Ischemic Heart Disease (IHD) Compared to Those Observed in Patients with Non-IHD: A Retrospective Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR DYSFUNCTION; FOLLOW-UP; BNP SYSTEM; BRAIN; FAILURE; GENE; POLYMORPHISM; RISK; SEX	Objective: Although the plasma B-type natriuretic peptide (BNP) level is a marker of heart failure, it is unclear whether BNP per se plays a pivotal role for pathogenic mechanisms underlying the development of ischemic heart disease (IHD). In this study, we retrospectively examined the plasma BNP levels in stable patients with IHD and compared to stable patients with cardiovascular diseases other than IHD. Methods: The study population was 2088 patients (1698 males and 390 females) who were admitted to our hospital due to IHD (n = 1,661) and non-IHD (n = 427) and underwent cardiac catheterization. Measurements of the hemodynamic parameters and blood sampling were performed. Results: The plasma BNP levels were significantly lower in the IHD group than in the non-IHD group (p<0.001). The multiple regression analysis examining the logBNP values showed that age, a male gender, low left ventricular ejection fraction, low body mass index, serum creatinine, atrial fibrillation and IHD per se were significant explanatory variables. When the total study population was divided according to gender, the plasma BNP levels were found to be significantly lower in the IHD group than in the non-IHD group among males (p<0.001), but not females (p = NS). Furthermore, a multiple logistic regression analysis of IHD showed the logBNP value to be a significant explanatory variable in males (regression coefficient: -0.669, p<0.001), but not females (p = NS). Conclusions: The plasma BNP levels were relatively low in stable patients with IHD compared with those observed in stable patients with non-IHD; this tendency was evident in males. Perhaps, the low reactivity of BNP is causally associated with IHD in males. We hope that this study will serve as a test of future prospective studies.	[Minai, Kosuke; Ogawa, Takayuki; Kawai, Makoto; Komukai, Kimiaki; Tanaka, Toshikazu; Ogawa, Kazuo; Nagoshi, Tomohisa; Arase, Satoshi; Morimoto, Satoshi; Inoue, Yasunori; Sekiyama, Hiroshi; Urabe, Akihiro; Matsuo, Seiichiro; Hongo, Kenichi; Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan	Jikei University	Minai, K (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan.	heart@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880; Komukai, Kimiaki/0000-0003-3569-974X				Belluardo P, 2006, AM J PHYSIOL-HEART C, V291, pH1529, DOI 10.1152/ajpheart.00107.2006; Cataliotti A, 2001, MAYO CLIN PROC, V76, P1111, DOI 10.4065/76.11.1111; Choquet H, 2009, HUM MOL GENET, V18, P2495, DOI 10.1093/hmg/ddp169; Costello-Boerrigter LC, 2011, MAYO CLIN PROC, V86, P210, DOI 10.4065/mcp.2010.0708; Ellis KL, 2011, J MOL CELL CARDIOL, V50, P695, DOI 10.1016/j.yjmcc.2011.01.010; FERRARI P, 1990, J CLIN ENDOCR METAB, V71, P944, DOI 10.1210/jcem-71-4-944; Gorbe A, 2010, BASIC RES CARDIOL, V105, P643, DOI 10.1007/s00395-010-0097-0; Hawkridge AM, 2005, P NATL ACAD SCI USA, V102, P17442, DOI 10.1073/pnas.0508782102; Inoue T, 2010, INTERNAL MED, V49, P2659, DOI 10.2169/internalmedicine.49.4211; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kawai M, 2013, INTERNAL MED, V52, P171, DOI 10.2169/internalmedicine.52.8704; Knudsen CW, 2004, EUR J HEART FAIL, V6, P55, DOI 10.1016/j.ejheart.2003.10.006; Komukai K, 2008, CIRC J, V72, P1152, DOI 10.1253/circj.72.1152; Macheret F, 2011, J AM COLL CARDIOL, V57, P1386, DOI 10.1016/j.jacc.2011.01.005; Malkin CJ, 2003, QJM-INT J MED, V96, P521, DOI 10.1093/qjmed/hcg086; MORITA E, 1993, CIRCULATION, V88, P82, DOI 10.1161/01.CIR.88.1.82; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Nakane T, 2012, INTERNAL MED, V51, P239, DOI 10.2169/internalmedicine.51.6206; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Nishikimi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053233; Njolstad I, 1996, CIRCULATION, V93, P450; OGAWA Y, 1994, J CLIN INVEST, V93, P1911, DOI 10.1172/JCI117182; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Poreba R, 2009, POL ARCH MED WEWN, V119, P219, DOI 10.20452/pamw.658; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Richards AM, 2003, CIRCULATION, V107, P2786, DOI 10.1161/01.CIR.0000070953.76250.B9; Rod NH, 2010, INT J EPIDEMIOL, V39, P530, DOI 10.1093/ije/dyp354; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Suzuki S, 2004, CIRCULATION, V110, P1387, DOI 10.1161/01.CIR.0000141295.60857.30; Szabo G, 2011, CLIN CHIM ACTA, V412, P1371, DOI 10.1016/j.cca.2011.04.012; Tsutamoto T, 1997, CIRCULATION, V96, P509; Vassalle C, 2007, CLIN CHEM, V53, P1886, DOI 10.1373/clinchem.2007.088302; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Weber M, 2008, EUR J HEART FAIL, V10, P482, DOI 10.1016/j.ejheart.2008.03.009; YARNELL JWG, 1993, ARTERIOSCLER THROMB, V13, P517, DOI 10.1161/01.ATV.13.4.517; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195	38	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e108983	10.1371/journal.pone.0108983	http://dx.doi.org/10.1371/journal.pone.0108983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360594	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700008
J	Pouliopoulos, J; Chik, W; Byth, K; Wallace, E; Kovoor, P; Thiagalingam, A				Pouliopoulos, Jim; Chik, William; Byth, Karen; Wallace, Elizabeth; Kovoor, Pramesh; Thiagalingam, Aravinda			Spatial Characterization of Electrogram Morphology from Transmural Recordings in the Intact Normal Heart	PLOS ONE			English	Article							VENTRICULAR ACTIVATION; CARDIAC-MUSCLE; MYOCARDIUM; POTENTIALS; UNIPOLAR; MODEL; EXCITATION; TISSUE; STIMULATION; PROPAGATION	Purpose: Unipolar (UE) and bipolar electrograms (BE) are utilized to identify arrhythmogenic substrate. We quantified the effect of increasing distance from the source of propagation on local electrogram amplitude; and determined if transmural electrophysiological gradients exist with respect to propagation and stimulation depth. Methods: Mapping was performed on 5 sheep. Deployment of>50 quadripolar transmural needles in the LV were located in Cartesian space using Ensite. Contact electrograms from all needles were recorded during multisite bipolar pacing from epicardial then endocardial electrodes. Analysis was performed to determine stimulus distance to local activation time, peak negative amplitude (V-P), and peak-peak amplitude (VP-P) for (1) unfiltered UE, and (2) unfiltered and 30 Hz high-pass filtered BEs. Each sheep was analysed using repeated ANOVA. Results: Increasing distance from the pacing sites led to significant (p<0.01) attenuation of UEs (V-P = 7.0 +/- 0.5%; VP-P = 5.4 +/- 0.3% per cm). Attenuation of BE with distance was insignificant (Vp-p unfiltered = 2.2 +/- 0.5%; filtered = 1.7 +/- 1.4% per cm). Independent of pacing depth, significant (p<0.01) transmural electrophysiological gradients were observed, with highest amplitude occurring at epicardial layers for UE and endocardial layers for BE. Furthermore, during pacing, propagation was earlier at the epicardium than endocardial layer by 1.6 +/- 2.0 ms (UE) and 1.4 +/- 2.8 ms (BE) (all p>0.01) during endocardial stimulation, and 2.3 +/- 2.4 ms (UE) and 1.8 +/- 3.7 ms (BE) during epicardal stimulation (all p<0.01). Conclusions: Electrogram amplitude is inversely proportional to propagation distance for unipolar modalities only, which affected V-P>VP-P. Conduction propagates preferentially via the epicardium during stimulation and is believed to contribute to a transmural amplitude gradient.	[Pouliopoulos, Jim; Chik, William; Byth, Karen; Wallace, Elizabeth; Kovoor, Pramesh; Thiagalingam, Aravinda] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia; [Pouliopoulos, Jim; Chik, William; Kovoor, Pramesh; Thiagalingam, Aravinda] Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Pouliopoulos, J (corresponding author), Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia.	jim.pouliopoulos@sydney.edu.au		Thiagalingam, Aravinda/0000-0002-7763-7806; Pouliopoulos, Jim/0000-0002-9160-8630; Byth Wilson, Karen/0000-0002-1253-6393	Westmead Hospital Charitable Trust; National Health and Medical Research Council of Australia	Westmead Hospital Charitable Trust; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Westmead Hospital Charitable Trust and the National Health and Medical Research Council of Australia awarded to Associate Professor Pramesh Kovoor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JS, 2007, J CARDIOVASC ELECTR, V18, P1306, DOI 10.1111/j.1540-8167.2007.00963.x; Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3; Caldwell BJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P433, DOI 10.1161/CIRCEP.108.830133; COLLI-FRANZONE P, 1982, CIRC RES, V51, P330, DOI 10.1161/01.RES.51.3.330; COLLI-FRANZONE P, 1993, J CARDIOVASC ELECTR, V4, P144, DOI 10.1111/j.1540-8167.1993.tb01219.x; CORBIN LV, 1977, CIRC RES, V41, P58, DOI 10.1161/01.RES.41.1.58; FRAZIER DW, 1988, CIRC RES, V63, P135, DOI 10.1161/01.RES.63.1.135; GESELOWITZ DB, 1982, CIRC RES, V51, P602, DOI 10.1161/01.RES.51.5.602; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Hooks DA, 2002, CIRC RES, V91, P331, DOI 10.1161/01.RES.0000031957.70034.89; Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075; Horner SM, 1996, CIRCULATION, V94, P1131, DOI 10.1161/01.CIR.94.5.1131; Hutchinson MD, 2011, CIRC-ARRHYTHMIA ELEC, V4, P49, DOI 10.1161/CIRCEP.110.959957; Jacobson JT, 2006, HEART RHYTHM, V3, P189, DOI 10.1016/j.hrthm.2005.11.007; Jalife J, 2009, IMPULSE INITIATION P, P92; Jalife J M D, 2000, INTRO CARDIAC ELECTR, P83; Jouk PS, 2000, ANAT EMBRYOL, V202, P103, DOI 10.1007/s004290000103; Kavanagh KM, 2008, CARDIOVASC RES, V77, P81, DOI 10.1093/cvr/cvm036; Kimber S, 1996, PACE, V19, P1196, DOI 10.1111/j.1540-8159.1996.tb04189.x; Kovoor P, 2003, PACE, V26, P1979, DOI 10.1046/j.1460-9592.2003.00305.x; Kucera JP, 1998, CIRC RES, V83, P795, DOI 10.1161/01.RES.83.8.795; MASHIMA S, 1978, CIRC RES, V42, P757, DOI 10.1161/01.RES.42.6.757; PLONSEY R, 1987, BIOPHYS J, V51, P547, DOI 10.1016/S0006-3495(87)83380-5; Potse M, 2004, J ELECTROCARDIOL, V37, P1, DOI 10.1016/j.jelectrocard.2003.10.008; Sivagangabalan G, 2008, CIRCULATION ARHYTHMI; SPACH MS, 1975, CIRC RES, V37, P243, DOI 10.1161/01.RES.37.2.243; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Taccardi B, 1998, J CARDIOVASC ELECTR, V9, P1062, DOI 10.1111/j.1540-8167.1998.tb00884.x; TACCARDI B, 1994, CIRCULATION, V90, P3076, DOI 10.1161/01.CIR.90.6.3076; Taccardi B, 2008, AM J PHYSIOL-HEART C, V294, pH1753, DOI 10.1152/ajpheart.01400.2007; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Thiagalingam A, 2004, CIRCULATION, V110, P3175, DOI 10.1161/01.CIR.0000147234.82755.90; Thiagalingam A, 2004, PACE, V27, P570, DOI 10.1111/j.1540-8159.2004.00489.x; Trew ML, 2006, EXP PHYSIOL, V91, P355, DOI 10.1113/expphysiol.2005.031054	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110399	10.1371/journal.pone.0110399	http://dx.doi.org/10.1371/journal.pone.0110399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25361049	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700034
J	Siddiqui, S; Anderson, P; Al-Jawad, M				Siddiqui, Samera; Anderson, Paul; Al-Jawad, Maisoon			Recovery of Crystallographic Texture in Remineralized Dental Enamel	PLOS ONE			English	Article							CARIES-LIKE LESIONS; CRYSTAL-STRUCTURE; APATITE CRYSTALS; DEMINERALIZATION; GROWTH; MICRORADIOGRAPHY; NANOSTRUCTURE; ARRANGEMENT; FUSION	Dental caries is the most prevalent disease encountered by people of all ages around the world. Chemical changes occurring in the oral environment during the caries process alter the crystallography and microstructure of dental enamel resulting in loss of mechanical function. Little is known about the crystallographic effects of demineralization and remineralization. The motivation for this study was to develop understanding of the caries process at the crystallographic level in order to contribute towards a long term solution. In this study synchrotron X-ray diffraction combined with scanning electron microscopy and scanning microradiography have been used to correlate enamel crystallography, microstructure and mineral concentration respectively in enamel affected by natural caries and following artificial demineralization and remineralization regimes. In particular, the extent of destruction and re-formation of this complex structure has been measured. 2D diffraction patterns collected at the European Synchrotron Radiation Facility were used to quantify changes in the preferred orientation (crystallographic texture) and position of the (002) Bragg reflection within selected regions of interest in each tooth slice, and then correlated with the microstructure and local mineral mass. The results revealed that caries and artificial demineralization cause a large reduction in crystallographic texture which is coupled with the loss of mineral mass. Remineralization restores the texture to the original level seen in healthy enamel and restores mineral density. The results also showed that remineralization promotes ordered formation of new crystallites and growth of pre-existing crystallites which match the preferred orientation of healthy enamel. Combining microstructural and crystallographic characterization aids the understanding of caries and erosion processes and assists in the progress towards developing therapeutic treatments to allow affected enamel to regain structural integrity.	[Siddiqui, Samera; Anderson, Paul; Al-Jawad, Maisoon] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England	University of London; Queen Mary University London	Al-Jawad, M (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	m.al-jawad@qmul.ac.uk		Al-Jawad, Maisoon/0000-0002-5832-7925	EPSRC	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was performed on the EPSRC-funded XMaS beamline at the ESRF, directed by M.J. Cooper, C.A. Lucas and T.P.A. Hase. We are grateful to the beam line team of S. D. Brown, O. Bikondoa, D. Wermeille, L. Bouchenoire and P. Thompson for their invaluable assistance, and to K. Lampard and J. Kervin for additional support. The authors thank Dr Rory Wilson for his help and support during beamtime.	Al-Jawad M, 2007, BIOMATERIALS, V28, P2908, DOI 10.1016/j.biomaterials.2007.02.019; Al-Jawad M, 2012, J DENT, V40, P1074, DOI 10.1016/j.jdent.2012.08.020; Anderson P, 2004, ARCH ORAL BIOL, V49, P199, DOI 10.1016/j.archoralbio.2003.10.001; Anderson P, 1998, ARCH ORAL BIOL, V43, P649, DOI 10.1016/S0003-9969(98)00052-1; Applebaum E., 1932, J DENT RES, V12, P619, DOI [10.1177/00220345320120040901, DOI 10.1177/00220345320120040901]; ARENDS J, 1986, J DENT RES, V65, P2, DOI 10.1177/00220345860650010201; Banerjee A., 2011, PICKARDS MANUAL OPER; Cochrane NJ, 2012, J DENT RES, V91, P185, DOI 10.1177/0022034511429570; Czajka-Jakubowska A, 2009, MED SCI MONITOR, V15, pMT84; DARLING A I, 1961, Ann R Coll Surg Engl, V29, P354; DARLING AI, 1961, ARCH ORAL BIOL, V4, P80, DOI 10.1016/0003-9969(61)90083-8; Deyhle H, 2014, ACTA BIOMATER, V10, P355, DOI 10.1016/j.actbio.2013.08.024; Deyhle H, 2011, NANOMED-NANOTECHNOL, V7, P694, DOI 10.1016/j.nano.2011.09.005; Dowker SEP, 2006, EUR J ORAL SCI, V114, P353, DOI 10.1111/j.1600-0722.2006.00315.x; Elliott J C, 1994, J Xray Sci Technol, V4, P102, DOI 10.3233/XST-1994-4204; Elliott JC, 2005, MINERAL MAG, V69, P643, DOI 10.1180/0026461056950276; Featherstone J D B, 2008, Aust Dent J, V53, P286, DOI 10.1111/j.1834-7819.2008.00064.x; Gaiser S, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0004-8; GAO XJ, 1993, J CHEM SOC FARADAY T, V89, P2907, DOI 10.1039/ft9938902907; Hammersley A. P., 1997, ESRF97HA02T; HICKS MJ, 1984, CARIES RES, V18, P315, DOI 10.1159/000260782; HIROTA F, 1982, ARCH ORAL BIOL, V27, P931, DOI 10.1016/0003-9969(82)90099-1; KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0; Kidd E A M, 2004, J Dent Res, V83 Spec No C, pC35; Leventouri T, 2009, INT J BIOMATER, V2009, DOI 10.1155/2009/698547; Low IM, 2004, J AM CERAM SOC, V87, P2125, DOI 10.1111/j.1151-2916.2004.tb06369.x; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; POOLE DFG, 1961, ARCH ORAL BIOL, V5, P14, DOI 10.1016/0003-9969(61)90110-8; Robinson C, 2000, CRIT REV ORAL BIOL M, V11, P481, DOI 10.1177/10454411000110040601; Robinson C., 1995, DENT ENAMEL FORMATIO, P223; Shah S, 2011, EUR J ORAL SCI, V119, P13, DOI 10.1111/j.1600-0722.2011.00899.x; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P975, DOI 10.1016/0003-9969(84)90144-4; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Simmons LM, 2013, ARCH ORAL BIOL, V58, P1726, DOI 10.1016/j.archoralbio.2013.08.012; Simmons LM, 2011, EUR J ORAL SCI, V119, P19, DOI 10.1111/j.1600-0722.2011.00909.x; Tanaka T, 2010, CARIES RES, V44, P253, DOI 10.1159/000314672; Thewlis J, 1940, Proc R Soc Med, V33, P387; TOHDA H, 1990, J ELECTRON MICROSC, V39, P238; TOHDA H, 1987, J DENT RES, V66, P1647, DOI 10.1177/00220345870660110901; TOHDA H, 1989, J ELECTRON MICROSC, V38, P309; VOEGEL JC, 1977, CALC TISS RES, V24, P19, DOI 10.1007/BF02223292; Wcislak L, 2002, J APPL CRYSTALLOGR, V35, P82, DOI 10.1107/S0021889801019902; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; Yagi N, 2009, J SYNCHROTRON RADIAT, V16, P398, DOI 10.1107/S090904950900449X; Yanagisawa T, 2003, J ELECTRON MICROSC, V52, P605, DOI 10.1093/jmicro/52.6.605	45	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e108879	10.1371/journal.pone.0108879	http://dx.doi.org/10.1371/journal.pone.0108879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360532	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700007
J	Yan, WQ; Li, JF; Chai, RJ; Guo, WT; Xu, L; Han, YC; Bai, XH; Wang, HB				Yan, Wenqing; Li, Jianfeng; Chai, Renjie; Guo, Wentao; Xu, Lei; Han, Yuechen; Bai, Xiaohui; Wang, Haibo			Combining Use of Captopril and Losartan Attenuates the Progress of Streptococcus pneumoniae-Induced Tympanosclerosis through the Suppression of TGF-beta 1 Expression	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); ANGIOTENSIN-II; TGF-BETA; OTITIS-MEDIA; DIFFERENTIATION; INHIBITION; FIBROSIS; MATRIX	Objectives: In this study, using an Streptococcus pneumoniae-induced tympanosclerosis (TS) model, we explored the effects of captopril and losartan in the treatment of TS and the possible mechanisms. Study Design: A prospective experimental animal study. Methods: We set up the TS models in both guinea pig and wistar rat by inoculation of type-3 Streptococcus pneumoniae microorganisms and then treated the animals with the combining use of captopril and losartan. Otomicroscopy was employed to observe the development of TS. Auditory brainstem response was used to test the hearing function of animals. Hematoxylin-eosin and von Kossa staining were performed to determine the morphological changes and calcium depositions. The protein expressions of transforming growth factor beta 1 (TGF-beta 1) were assessed by western blot and immunohistochemistry staining, and the mRNA level of TGF-beta 1 was measured by quantitative reverse transcription-polymerase chain reaction. Results: The combining use of captopril and losartan attenuated TS responses in terms of a decrease in the TS incidence and the ABR threshold, a reduction of hyalinization and calcification in the middle ear mucosa and the thickness of the mucosa. In addition, the TGF-beta 1 expression was decreased at both protein and mRNA levels. Conclusion: Our data indicate, for the first time, that the combining use of captopril and losartan obviously attenuates TS progress through inhibiting the overexpressing of TGF-beta 1.	[Yan, Wenqing; Li, Jianfeng; Guo, Wentao; Xu, Lei; Han, Yuechen; Bai, Xiaohui; Wang, Haibo] Shandong Univ, Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China; [Yan, Wenqing; Li, Jianfeng; Bai, Xiaohui; Wang, Haibo] Shandong Inst Otolaryngol, Jinan, Peoples R China; [Li, Jianfeng; Bai, Xiaohui; Wang, Haibo] Shandong Prov Key Lab Otol, Jinan, Peoples R China; [Chai, Renjie] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Minist Educ, Nanjing, Jiangsu, Peoples R China	Shandong University; Southeast University - China	Bai, XH (corresponding author), Shandong Univ, Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China.	sphbaixiaohui@hotmail.com; wang.hb7585@hotmail.com			National Natural Science Foundation of China [81000407, 81100711]; Outstanding Young Scientist Research Award Foundation of Province [BS2010YY051]; Science and Technology Development Program of Shandong province [2012G0021838]; Fundamental Research Funds for the Central Universities [2242014R30022, NO2013WSN085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scientist Research Award Foundation of Province; Science and Technology Development Program of Shandong province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (81000407, 81100711), Outstanding Young Scientist Research Award Foundation of Province (BS2010YY051), The Science and Technology Development Program of Shandong province (2012G0021838), and Fundamental Research Funds for the Central Universities (2242014R30022, NO2013WSN085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2011, J LARYNGOL OTOL, V125, P142, DOI 10.1017/S002221511000201X; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Cooter MS, 1998, LARYNGOSCOPE, V108, P1066, DOI 10.1097/00005537-199807000-00021; Cordeiro MF, 2002, PROG RETIN EYE RES, V21, P75, DOI 10.1016/S1350-9462(01)00021-0; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; FERLITO A, 1979, J LARYNGOL OTOL, V93, P25, DOI 10.1017/S0022215100086680; Fukuda D, 2009, BIOMED PHARMACOTHER, V63, P754, DOI 10.1016/j.biopha.2009.02.006; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Guo WT, 2012, LARYNGOSCOPE, V122, P2037, DOI 10.1002/lary.23415; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Iriz A, 2011, J LARYNGOL OTOL, V125, P1121, DOI 10.1017/S0022215111002301; KIM SK, 1995, J PHARMACOL EXP THER, V273, P509; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lora CM, 2013, ETHNIC DIS, V23, P189; Melhus A, 2000, INFECT IMMUN, V68, P4024, DOI 10.1128/IAI.68.7.4024-4031.2000; Opelz G, 2011, AM J TRANSPLANT, V11, P2483, DOI 10.1111/j.1600-6143.2011.03681.x; Ozcan I, 2008, LARYNGOSCOPE, V118, P1051, DOI 10.1097/MLG.0b013e31816770ba; Paclik D, 2011, INFLAMM BOWEL DIS, V17, P1449, DOI 10.1002/ibd.21743; Ruiz-Ortega M, 2003, CURR HYPERTENS REP, V5, P73, DOI 10.1007/s11906-003-0014-0; SHEEHY JL, 1962, ARCHIV OTOLARYNGOL, V76, P151; Siegert A, 1999, J MOL MED-JMM, V77, P437, DOI 10.1007/s001090050374; SORENSEN H, 1972, ACTA OTO-LARYNGOL, V73, P18, DOI 10.3109/00016487209138189; Uneri C, 2006, LARYNGOSCOPE, V116, P140, DOI 10.1097/01.mlg.0000191460.32862.bf; WIELINGA EWJ, 1993, CLIN OTOLARYNGOL, V18, P341, DOI 10.1111/j.1365-2273.1993.tb00590.x; Xaubet A, 2003, AM J RESP CRIT CARE, V168, P431, DOI 10.1164/rccm.200210-1165OC	26	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111620	10.1371/journal.pone.0111620	http://dx.doi.org/10.1371/journal.pone.0111620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360706	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700129
J	Dang, VTA; Tanabe, K; Tanaka, Y; Tokumoto, N; Misumi, T; Saeki, Y; Fujikuni, N; Ohdan, H				Dang, Vu T. A.; Tanabe, Kazuaki; Tanaka, Yuka; Tokumoto, Noriaki; Misumi, Toshihiro; Saeki, Yoshihiro; Fujikuni, Nobuaki; Ohdan, Hideki			Fasting Enhances TRAIL-Mediated Liver Natural Killer Cell Activity via HSP70 Upregulation	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; APOPTOSIS-INDUCING LIGAND; NK CELLS; HEPATOCELLULAR-CARCINOMA; ANTITUMOR RESPONSES; TUMOR-METASTASIS; STRESS-PROTEINS; CANCER-THERAPY; IMMUNE-SYSTEM; MICE	Acute starvation, which is frequently observed in clinical practice, sometimes augments the cytolytic activity of natural killer cells against neoplastic cells. In this study, we investigated the molecular mechanisms underlying the enhancement of natural killer cell function by fasting in mice. The total number of liver resident natural killer cells in a unit weight of liver tissue obtained from C57BL/6J mice did not change after a 3-day fast, while the proportions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)(+) and CD69(+) natural killer cells were significantly elevated (n = 7, p <0.01), as determined by flow cytometric analysis. Furthermore, we found that TRAIL(-) natural killer cells that were adoptively transferred into Rag-2(-/-) gamma chain(-/-) mice could convert into TRAIL(+) natural killer cells in fasted mice at a higher proportion than in fed mice. Liver natural killer cells also showed high TRAIL-mediated antitumor function in response to 3-day fasting. Since these fasted mice highly expressed heat shock protein 70 (n = 7, p <0.05) in liver tissues, as determined by western blot, the role of this protein in natural killer cell activation was investigated. Treatment of liver lymphocytes with 50 mu g/mL of recombinant heat shock protein 70 led to the upregulation of both TRAIL and CD69 in liver natural killer cells (n = 6, p <0.05). In addition, HSP70 neutralization by intraperitoneally injecting an anti- heat shock protein 70 monoclonal antibody into mice prior to fasting led to the downregulation of TRAIL expression (n = 6, p <0.05). These findings indicate that acute fasting enhances TRAIL-mediated liver natural killer cell activity against neoplastic cells through upregulation of heat shock protein 70.	[Dang, Vu T. A.; Tanabe, Kazuaki; Tanaka, Yuka; Misumi, Toshihiro; Saeki, Yoshihiro; Fujikuni, Nobuaki; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Hiroshima, Japan; [Tokumoto, Noriaki] Hiroshima City Hosp, Dept Surg, Hiroshima, Japan	Hiroshima University; Hiroshima City Hospital	Tanabe, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg Appl Life Sc, Hiroshima, Japan.	ktanabe2@hiroshima-u.ac.jp	Ohdan, Hideki/G-4719-2019; tanabe, kazuaki/S-6282-2019; Tanaka, Yuka/G-9580-2019	Ohdan, Hideki/0000-0002-9066-1288; 	Japan Society for the Promotion of Science and Research on Hepatitis [25461949, 25462023]; Japanese Ministry of Health, Labor, and Welfare	Japan Society for the Promotion of Science and Research on Hepatitis; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research C (25461949 and 25462023) from the Japan Society for the Promotion of Science and Research on Hepatitis, and BSE grant from the Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; BOUWENS L, 1987, EUR J IMMUNOL, V17, P37, DOI 10.1002/eji.1830170107; Clinthorne JF, 2013, J IMMUNOL, V190, P712, DOI 10.4049/jimmunol.1201837; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Giuliano Jr JS, 2011, OPEN INFLAMMATION J, V4, P12; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Jolesch A, 2012, EUR J CELL BIOL, V91, P48, DOI 10.1016/j.ejcb.2011.02.001; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Juhasz K, 2013, CURR PHARM DESIGN, V19, P430, DOI 10.2174/138161213804143644; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Langers I, 2012, BIOL-TARGETS THER, V6, P73, DOI 10.2147/BTT.S23976; Lv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588; Maksimovic-Ivanic D, 2012, IMMUNOL RES, V52, P157, DOI 10.1007/s12026-012-8284-8; Marzio R, 1999, IMMUNOPHARM IMMUNOT, V21, P565, DOI 10.3109/08923979909007126; Multhoff G, 1997, J IMMUNOL, V158, P4341; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Nishihara M, 1998, TRANSPLANT P, V30, P3697, DOI 10.1016/S0041-1345(98)01200-7; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Schmid TE, 2012, CURR MED CHEM, V19, P1765; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shen JW, 2009, CELL IMMUNOL, V259, P66, DOI 10.1016/j.cellimm.2009.05.015; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Stangl S, 2006, J IMMUNOL, V176, P6270, DOI 10.4049/jimmunol.176.10.6270; Takahashi Y, 1998, TRANSPL P, V30, P3700, DOI 10.1016/S0041-1345(98)01201-9; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	35	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110748	10.1371/journal.pone.0110748	http://dx.doi.org/10.1371/journal.pone.0110748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356750	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000022
J	Wang, L; Xing, JN; Chen, FF; Yan, RX; Ge, L; Qin, QQ; Wang, LY; Ding, ZW; Guo, W; Wang, N				Wang, Lu; Xing, Jiannan; Chen, Fangfang; Yan, Ruixue; Ge, Lin; Qin, Qianqian; Wang, Liyan; Ding, Zhengwei; Guo, Wei; Wang, Ning			Spatial Analysis on Hepatitis C Virus Infection in Mainland China: From 2005 to 2011	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; B-VIRUS; EPIDEMIOLOGY; PREVALENCE; PROVINCE; YUNNAN; HIV-1; RISK	Background: The burden of Hepatitis C virus (HCV) has become more and more considerable in China. A macroscopic spatial analysis of HCV infection that can provide scientific information for further intervention and disease control is lacking. Methods: All geo-referenced HCV cases that had been recorded by the China Information System for Disease Control and Prevention (CISDCP) during 2005-2011 were included in the study. In order to learn about the changes of demographic characteristics and geographic distribution, trend test and spatial analysis were conducted to reflect the changing pattern of HCV infection. Results: Over 770,000 identified HCV infection cases had specific geographic information during the study period (2005-2011). Ratios of gender (Male/Female, Z-value = 218.53, P<0.001), age group (<= 30 years old/>= 31 years old, Z-value = -51.03, P<0.001) and diagnosis type (Clinical diagnosis/Laboratory diagnosis, Z-value = -130.47, P<0.001) declined. HCV infection was not distributed randomly. Provinces Henan, Guangdong, Guangxi, Xinjiang, and Jilin reported more than 40,000 HCV infections during 2005 to 2011, accounting for 43.91% of all cases. The strength of cluster of disease was increasing in China during the study period. Overall, 11 provinces had once been detected as hotspots during 7 years, most of which were located in the central or border parts of China. Tibet, Qinghai, Jiangxi were the regions that had coldspots. Conclusions: The number of clustering of HCV infection among older adults increased in recent years. Specific interventions and prevention programs targeting at main HCV epidemic areas are urgently in need in mainland China.	[Wang, Lu; Xing, Jiannan; Chen, Fangfang; Yan, Ruixue; Ge, Lin; Qin, Qianqian; Wang, Liyan; Ding, Zhengwei; Guo, Wei; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Xing, Jiannan] Beijing Human Resources & Social Secur Bur, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022	chen, fang fang/0000-0002-0854-1667	mega-projects of national scientific research under the 12th Five-Year Plan of China [2012ZX10001001]	mega-projects of national scientific research under the 12th Five-Year Plan of China	This study was supported by the mega-projects of national scientific research under the 12th Five-Year Plan of China (2012ZX10001001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Chen X, 2013, ARCH VIROL, V158, P1889, DOI 10.1007/s00705-013-1681-z; Choi SYP, 2007, AIDS CARE, V19, P1, DOI 10.1080/09540120600900496; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Gao XF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-88; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Huang B, 2013, PRACTICAL PREVENTIVE, V20, P556; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Kuang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082304; Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054815; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; National Bureau of Statistics of China, 2011, CHIN STAT YB 2011; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Peng ZH, 2011, GEOSPATIAL HEALTH, V5, P177, DOI 10.4081/gh.2011.169; [秦倩倩 Qin Qianqian], 2013, [中华流行病学杂志, Chinese Journal of Epidemiology], V34, P548; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050343; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; WHO, 2013, HEP C FACT SHEET; Williams CT, 2011, AIDS BEHAV, V15, P1011, DOI 10.1007/s10461-010-9764-2; Wu SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040872; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	23	11	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110861	10.1371/journal.pone.0110861	http://dx.doi.org/10.1371/journal.pone.0110861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356554	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000029
J	Wilkinson, E; Engelbrecht, S; de Oliveira, T				Wilkinson, Eduan; Engelbrecht, Susan; de Oliveira, Tulio			Detection of Transmission Clusters of HIV-1 Subtype C over a 21-Year Period in Cape Town, South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; RECONSTRUCTION; SEQUENCES; EPIDEMIOLOGY; EMERGENCE; INFECTION; INFERENCE; DYNAMICS; ACCURATE	Introduction: Despite recent breakthroughs in the fight against the HIV/AIDS epidemic within South Africa, the transmission of the virus continues at alarmingly high rates. It is possible, with the use of phylogenetic methods, to uncover transmission events of HIV amongst local communities in order to identify factors that may contribute to the sustained transmission of the virus. The aim of this study was to uncover transmission events of HIV amongst the infected population of Cape Town. Methods and Results: We analysed gag p24 and RT-pol sequences which were generated from samples spanning over 21-years with advanced phylogenetic techniques. We identified two transmission clusters over a 21-year period amongst randomly sampled patients from Cape Town and the surrounding areas. We also estimated the origin of each of the identified transmission clusters with the oldest cluster dating back, on average, 30 years and the youngest dating back roughly 20 years. Discussion and Conclusion: These transmission clusters represent the first identified transmission events among the heterosexual population in Cape Town. By increasing the number of randomly sampled specimens within a dataset over time, it is possible to start to uncover transmission events of HIV amongst local communities in generalized epidemics. This information can be used to produce targeted interventions to decrease transmission of HIV in Africa.	[Wilkinson, Eduan; Engelbrecht, Susan] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, Western Cape Pr, South Africa; [Wilkinson, Eduan; de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, KwaZulu Natal, South Africa; [Engelbrecht, Susan] Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, Western Cape Pr, South Africa; [de Oliveira, Tulio] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, KwaZulu Natal, South Africa; [de Oliveira, Tulio] UCL, Res Dept Infect, London, England	Stellenbosch University; University of Cape Town; University of Kwazulu Natal; Tygerberg Hospital; University of Kwazulu Natal; University of London; University College London	de Oliveira, T (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, KwaZulu Natal, South Africa.	tuliodna@gmail.com	Engelbrecht, Susan/G-7286-2011	Engelbrecht, Susan/0000-0002-1318-5994	South African National Research Foundation (NRF); Poliomyelitis Research Foundation (PRF) in South Africa; Harry-Crossly Foundation; Faculty of Medicine and Health Science of Stellenbosch University; National Health Laboratory Services (NHLS) Research Trust; Wellcome Trust [082384/Z/07/Z]; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa; German/South African DFG/NRF International Research Training Group	South African National Research Foundation (NRF)(National Research Foundation - South Africa); Poliomyelitis Research Foundation (PRF) in South Africa; Harry-Crossly Foundation; Faculty of Medicine and Health Science of Stellenbosch University; National Health Laboratory Services (NHLS) Research Trust; Wellcome Trust(Wellcome TrustEuropean Commission); School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa; German/South African DFG/NRF International Research Training Group	Funding for this project was provided by the South African National Research Foundation (NRF), the Poliomyelitis Research Foundation (PRF) in South Africa, the Harry-Crossly Foundation, the Faculty of Medicine and Health Science of Stellenbosch University and the National Health Laboratory Services (NHLS) Research Trust. Further acknowledgment to the Africa Centre for Health and Population Studies (Mtubatuba, Kwa-Zulu Natal, South Africa) for training and technical assistance and to the first German/South African DFG/NRF International Research Training Group for other financial and academic assistance. Tulio de Oliveira is funded by the Wellcome Trust (082384/Z/07/Z) and School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, S AFRICAN NATL HIV P; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Caldwell JC, 2000, POPUL DEV REV, V26, P117, DOI 10.1111/j.1728-4457.2000.00117.x; Chevenet F, 2013, BIOINFORMATICS, V29, P561, DOI 10.1093/bioinformatics/btt010; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Goedhals D, 2012, LANCET, V380, P702, DOI 10.1016/S0140-6736(12)60957-X; Gordon M, 2003, J VIROL, V77, P2587, DOI 10.1128/JVI.77.4.2587-2599.2003; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Jacobs GB, 2009, J MED VIROL, V81, P1852, DOI 10.1002/jmv.21609; JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K; Joska JA, 2011, AIDS BEHAV, V15, P1197, DOI 10.1007/s10461-010-9744-6; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Middelkoop K, 2014, JAIDS-J ACQ IMM DEF, V65, P473, DOI 10.1097/QAI.0000000000000067; Mitsunaga TM, 2005, JAIDS-J ACQ IMM DEF, V39, P478, DOI 10.1097/01.qai.0000152396.60014.69; National Strategic Plan for HIV and AIDS, 2011, NAT STRAT PLAN HIV A; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; OTTEN MW, 1994, AIDS, V8, P549, DOI 10.1097/00002030-199404000-00020; Paraskevis D, 2004, J MOL EVOL, V59, P709, DOI 10.1007/s00239-004-2651-6; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SHER R, 1989, S AFR MED J, V76, P314; Sherman GG, 2014, SAMJ S AFR MED J, V104, P235, DOI [10.7196/SAMJ.7598, 10.7196/samj.7598]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; UNAIDS, 2010, GLOB REP 2010; UNIADS, 2010, S AFR COUNTR PROGR R; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Yeager R, 1995, AIDS Anal Afr, V5, P10	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109296	10.1371/journal.pone.0109296	http://dx.doi.org/10.1371/journal.pone.0109296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357201	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000004
J	Dong, XH; Wu, DT; Jia, CF; Ruan, Y; Feng, XC; Wang, GX; Liu, J; Shen, Y; Li, H; Li, LX				Dong, Xuehong; Wu, Dingting; Jia, Chengfang; Ruan, Yu; Feng, Xiaocheng; Wang, Guoxing; Liu, Jun; Shen, Yi; Li, Hong; Li, Lianxi			Low Ankle-Brachial Index Is Associated with Early-Stage Chronic Kidney Disease in Type 2 Diabetic Patients Independent of Albuminuria	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PERIPHERAL ARTERIAL-DISEASE; RISK-FACTORS; CARDIOVASCULAR MORTALITY; RENAL-INSUFFICIENCY; CHINESE; POPULATION; PREVALENCE; ATHEROSCLEROSIS; NEPHROPATHY	Aims: The role of low ankle-brachial index (ABI) in early-stage chronic kidney disease (CKD) is not fully known. This study was designed to investigate the prevalence of low ABI in early-stage CKD defined as an estimated glomerular filtration rate (eGFR) between 60-89 ml/min/1.73 m(2) of type 2 diabetic patients without albuminuria and to determine the association between the low ABI and mildly decreased eGFR. Methods: The cross-sectional study enrolled 448 type 2 diabetic patients with normoalbuminuria. The patients were stratified into two groups according to the CKD-EPI eGFR level: the normal group with eGFR level >= 90 mL/min/1.73 m(2) and the lower group with eGFR of 60-89. ABI was categorized as normal (1.0-1.39), low-normal (0.9-0.99), and low (<0.9). Both stepwise forward multiple linear regression and binary logistic regression analyses were performed to examine the association between ABI categories and eGFR levels and to assess the relation of low ABI and early-stage CKD. Results: The prevalence of low ABI in early-stage CKD of type 2 diabetic patients without albuminuria was 39.5%. Low ABI was associated with an approximate 3-fold greater risk of early-stage CKD in bivariate logistic regression analysis, and remained significantly associated with a 2.2 fold risk (95% confidence interval: 1.188-4.077; P = 0.012) after adjusting traditional chronic kidney disease risk factors. Conclusions: There was a high prevalence of low ABI in early-stage CKD patients of type 2 diabetes with normoalbuminuria and a close relation between low ABI and early-stage CKD, suggesting that we should pay much more attention to the patients who have only mildly decreased eGFR and normoalbuminuria but have already had a low ABI in clinic work and consider the preventive therapy in early stage.	[Dong, Xuehong; Wu, Dingting; Jia, Chengfang; Ruan, Yu; Feng, Xiaocheng; Wang, Guoxing; Liu, Jun; Li, Hong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Xuehong; Wu, Dingting; Jia, Chengfang; Ruan, Yu; Feng, Xiaocheng; Wang, Guoxing; Liu, Jun; Li, Hong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Yi] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Lianxi] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Shanghai Jiao Tong University	Li, H (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China.	lihongheyi@126.com; lilx@sjtu.edu.cn			National Natural Science Foundation of China [30900703, 81170759]; Ministry of Education of China [200803351042]; Zhejiang Project of Science and Technology [2009A11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Zhejiang Project of Science and Technology	This research was supported by the National Natural Science Foundation of China for young scientists (30900703), the Doctoral Fund of Ministry of Education of China (200803351042), the Zhejiang Project of Science and Technology (2009A11), and the National Natural Science Foundation of China (81170759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse AD, 2014, DIABETES CARE; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; ANDERSON S, 1986, AM J MED, V80, P435, DOI 10.1016/0002-9343(86)90718-7; [Anonymous], 1992, MUSCLE NERVE, V15, P229; Banerjee S, 2014, AM J CARDIOL; Bi YF, 2014, JAMA-J AM MED ASSOC, V311, P200, DOI 10.1001/jama.2013.283143; Clase CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013291.78621.26; de Vinuesa SG, 2005, KIDNEY INT, V67, pS44, DOI 10.1111/j.1523-1755.2005.09310.x; Dong X, 2007, DIABETIC MED, V24, P1482, DOI 10.1111/j.1464-5491.2007.02275.x; Dwyer JP, 2012, CARDIORENAL MED, V2, P1, DOI 10.1159/000333249; Ekinci EI, 2013, DIABETES CARE, V36, P3620, DOI 10.2337/dc12-2572; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foster MC, 2013, AM J KIDNEY DIS, V61, P204, DOI 10.1053/j.ajkd.2012.07.009; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jia WP, 2009, NEPHROL DIAL TRANSPL, V24, P3724, DOI 10.1093/ndt/gfp349; Karalliedde J, 2010, J AM SOC NEPHROL, V21, P2020, DOI 10.1681/ASN.2010030250; Kesteloot H, 1996, J HUM HYPERTENS, V10, P245; Kshirsagar AV, 2004, RENAL FAILURE, V26, P433, DOI 10.1081/JDI-120039828; Lee AJ, 2004, CIRCULATION, V110, P3075, DOI 10.1161/01.CIR.0000143102.38256.DE; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lou QL, 2012, DIABETES METAB J, V36, P433, DOI 10.4093/dmj.2012.36.6.433; MacIsaac R, 2004, DIABETES CARE, V27, P195, DOI 10.2337/diacare.27.1.195; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Murgatroyd H, 2004, BRIT J OPHTHALMOL, V88, P920, DOI 10.1136/bjo.2003.026385; O'Hare AM, 2005, ARCH INTERN MED, V165, P1481, DOI 10.1001/archinte.165.13.1481; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Scanlon PH, 2005, DIABETES CARE, V28, P2448, DOI 10.2337/diacare.28.10.2448; Thomas MC, 2009, DIABETES CARE, V32, P1497, DOI 10.2337/dc08-2186; Turner ST, 2011, J HYPERTENS, V29, P1796, DOI 10.1097/HJH.0b013e328349052b; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Xu BH, 2014, ATHEROSCLEROSIS, V232, P285, DOI 10.1016/j.atherosclerosis.2013.11.046; Yamashita T, 2013, J ATHEROSCLER THROMB, V20, P790	38	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109641	10.1371/journal.pone.0109641	http://dx.doi.org/10.1371/journal.pone.0109641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354133	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200012
J	O'Callaghan, CA				O'Callaghan, Christopher A.			OxMaR: Open Source Free Software for Online Minimization and Randomization for Clinical Trials	PLOS ONE			English	Article							RANDOM ALLOCATION; SYSTEM	Minimization is a valuable method for allocating participants between the control and experimental arms of clinical studies. The use of minimization reduces differences that might arise by chance between the study arms in the distribution of patient characteristics such as gender, ethnicity and age. However, unlike randomization, minimization requires real time assessment of each new participant with respect to the preceding distribution of relevant participant characteristics within the different arms of the study. For multi-site studies, this necessitates centralized computational analysis that is shared between all study locations. Unfortunately, there is no suitable freely available open source or free software that can be used for this purpose. OxMaR was developed to enable researchers in any location to use minimization for patient allocation and to access the minimization algorithm using any device that can connect to the internet such as a desktop computer, tablet or mobile phone. The software is complete in itself and requires no special packages or libraries to be installed. It is simple to set up and run over the internet using online facilities which are very low cost or even free to the user. Importantly, it provides real time information on allocation to the study lead or administrator and generates real time distributed backups with each allocation. OxMaR can readily be modified and customised and can also be used for standard randomization. It has been extensively tested and has been used successfully in a low budget multi-centre study. Hitherto, the logistical difficulties involved in minimization have precluded its use in many small studies and this software should allow more widespread use of minimization which should lead to studies with better matched control and experimental arms. OxMaR should be particularly valuable in low resource settings.	Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Oxford	O'Callaghan, CA (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	chris.ocallaghan@ndm.ox.ac.uk			National Institute for Health Research Oxford Comprehensive Biomedical Research Centre (BRC) Program; British Renal Society [11-007]; Medical Research Council [MRC Scf G116/165]; MRC [G116/165] Funding Source: UKRI; Medical Research Council [G116/165] Funding Source: researchfish	National Institute for Health Research Oxford Comprehensive Biomedical Research Centre (BRC) Program; British Renal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the National Institute for Health Research Oxford Comprehensive Biomedical Research Centre (BRC) Program (www.nihr.ac.uk), the British Renal Society (www.britishrenal.org) (11-007) and the Medical Research Council (www.mrc.ac.uk) (MRC Scf G116/165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; BEGG CB, 1980, BIOMETRICS, V36, P81, DOI 10.2307/2530497; Cai HW, 2010, CONTEMP CLIN TRIALS, V31, P510, DOI 10.1016/j.cct.2010.07.009; Cai HW, 2006, J BIOMED INFORM, V39, P706, DOI 10.1016/j.jbi.2006.02.015; Evans S, 2004, MINIM ALLOCATION MIN; Fegan W, 2008, PLOS MED, V5, P347, DOI 10.1371/journal.pmed.0050006; JENSEN CV, 1991, COMPUT BIOMED RES, V24, P429, DOI 10.1016/0010-4809(91)90018-R; Kenjo Y, 2000, COMPUT METH PROG BIO, V62, P45, DOI 10.1016/S0169-2607(99)00047-4; KLOTZ JH, 1978, BIOMETRICS, V34, P283, DOI 10.2307/2530018; Leroux H, 2011, STUD HEALTH TECHNOL, V168, P89, DOI 10.3233/978-1-60750-791-8-89; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Saghaei M., 2011, J BIOMED SCI ENG, V4, P734, DOI [10.4236/jbise.2011.411090, DOI 10.4236/JBISE.2011.411090]; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Taves DR, 2010, CONTEMP CLIN TRIALS, V31, P180, DOI 10.1016/j.cct.2009.12.005; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; U.S. Department of Health and Human Services, 1998, INT C HARM GUID IND; van Rossum G., 1995, CENTRUM WISKUNDE INF; Wall L, 1991, PROGRAMMING PERL	19	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110761	10.1371/journal.pone.0110761	http://dx.doi.org/10.1371/journal.pone.0110761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353169	Green Published, gold			2022-12-27	WOS:000345204200034
J	Ehlers, I; Betson, TR; Vetter, W; Schleucher, J				Ehlers, Ina; Betson, Tatiana R.; Vetter, Walter; Schleucher, Jurgen			Elucidating Turnover Pathways of Bioactive Small Molecules by Isotopomer Analysis: The Persistent Organic Pollutant DDT	PLOS ONE			English	Article							HYDROGEN; RATIOS; DISTRIBUTIONS; DEGRADATION; RESIDUES	The persistent organic pollutant DDT (1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane) is still indispensable in the fight against malaria, although DDT and related compounds pose toxicological hazards. Technical DDT contains the dichloro congener DDD (1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethyl] benzene) as by-product, but DDD is also formed by reductive degradation of DDT in the environment. To differentiate between DDD formation pathways, we applied deuterium NMR spectroscopy to measure intramolecular deuterium distributions (H-2 isotopomer abundances) of DDT and DDD. DDD formed in the technical DDT synthesis was strongly deuterium-enriched at one intramolecular position, which we traced back to H-2/H-1 fractionation of a chlorination step in the technical synthesis. In contrast, DDD formed by reductive degradation was strongly depleted at the same position, which was due to the incorporation of 2 H-depleted hydride equivalents during reductive degradation. Thus, intramolecular isotope distributions give mechanistic information on reaction pathways, and explain a puzzling difference in the whole-molecule H-2/H-1 ratio between DDT and DDD. In general, our results highlight that intramolecular isotope distributions are essential to interpret whole-molecule isotope ratios. Intramolecular isotope information allows distinguishing pathways of DDD formation, which is important to identify polluters or to assess DDT turnover in the environment. Because intramolecular isotope data directly reflect isotope fractionation of individual chemical reactions, they are broadly applicable to elucidate transformation pathways of small bioactive molecules in chemistry, physiology and environmental science.	[Ehlers, Ina; Betson, Tatiana R.; Schleucher, Jurgen] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Vetter, Walter] Univ Hohenheim, Dept Food Chem, Stuttgart, Germany	Umea University; University Hohenheim	Schleucher, J (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	jurgen.schleucher@chem.umu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [216-2008-764]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; JS; grant 216-2008-764 (http://www.formas.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie JM, 1997, NEW ZEAL J AGR RES, V40, P269, DOI 10.1080/00288233.1997.9513247; Armbruster W, 2006, ANAL BIOANAL CHEM, V384, P237, DOI 10.1007/s00216-005-0160-0; Betson TR, 2006, ANAL CHEM, V78, P8406, DOI 10.1021/ac061050a; Elsner M, 2010, J ENVIRON MONITOR, V12, P2005, DOI 10.1039/c0em00277a; Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; FISHBEIN L, 1974, J CHROMATOGR, V98, P177, DOI 10.1016/S0021-9673(00)84785-8; Guillette LJ, 1996, GEN COMP ENDOCR, V101, P32, DOI 10.1006/gcen.1996.0005; Kovacs H, 2005, PROG NUCL MAG RES SP, V46, P131, DOI 10.1016/j.pnmrs.2005.03.001; Kuder T, 2013, ENVIRON SCI TECHNOL, V47, P1461, DOI 10.1021/es303476v; Lesot P, 2009, PROG NUCL MAG RES SP, V55, P128, DOI 10.1016/j.pnmrs.2009.01.001; Lind PM, 2014, ENVIRON RES, V129, P27, DOI 10.1016/j.envres.2013.12.003; LUO YH, 1991, PLANT CELL PHYSIOL, V32, P897; Markai S, 2002, CHEMBIOCHEM, V3, P212, DOI 10.1002/1439-7633(20020301)3:2/3<212::AID-CBIC212>3.0.CO;2-R; MARTIN GJ, 1982, ANAL CHEM, V54, P2380, DOI 10.1021/ac00250a057; Melander L., 1980, REACTION RATES ISOTO; Remaud GS, 1997, J AGR FOOD CHEM, V45, P859, DOI 10.1021/jf960518f; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Sayles GD, 1997, ENVIRON SCI TECHNOL, V31, P3448, DOI 10.1021/es9701669; Schleucher J, 1999, PLANT CELL ENVIRON, V22, P525, DOI 10.1046/j.1365-3040.1999.00440.x; Schmidt Hanns-Ludwig, 2003, Phytochemistry Reviews, V2, P61, DOI 10.1023/B:PHYT.0000004185.92648.ae; Schmidt HL, 2003, NATURWISSENSCHAFTEN, V90, P537, DOI 10.1007/s00114-003-0485-5; Sheng JJ, 2013, ENVIRON SCI TECHNOL, V47, P3199, DOI 10.1021/es305201s; Shouakar-Stash O, 2013, RAPID COMMUN MASS SP, V27, P1335, DOI 10.1002/rcm.6578; SLADEN WJL, 1966, NATURE, V210, P670, DOI 10.1038/210670a0; Turusov V, 2002, ENVIRON HEALTH PERSP, V110, P125, DOI 10.1289/ehp.02110125; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; Walter S, 2012, BIOGEOSCIENCES, V9, P4115, DOI 10.5194/bg-9-4115-2012; WIBERG KB, 1955, CHEM REV, V55, P713, DOI 10.1021/cr50004a004; Wolfsberg M., 2010, ISOTOPE EFFECTS CHEM; World Health Organization, 2013, US DDT MAL VECT CONT	31	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110648	10.1371/journal.pone.0110648	http://dx.doi.org/10.1371/journal.pone.0110648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350380	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100033
J	Liu, ZJ; Hu, XM; Huang, CC; Zheng, K; Takebayashi, H; Cao, C; Qiu, MS				Liu, Zijing; Hu, Xuemei; Huang, Chengcheng; Zheng, Kang; Takebayashi, Hirohide; Cao, Cheng; Qiu, Mengsheng			Olig3 Is Not Involved in the Ventral Patterning of Spinal Cord	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; OLIGODENDROCYTE DIFFERENTIATION; NEURONAL IDENTITY; NEURAL-TUBE; SPECIFICATION; NKX2.2; INTERNEURONS; IDENTIFICATION; EXPRESSION; FAMILY	At embryonic stages, Olig3 is initially expressed in the dorsal-most region of the spinal cord, but later in the ventral marginal zone as well. Previous studies indicated that Olig3 controlled the patterning of dorsal spinal cord and loss of Olig3 function led to the re-specification of dI2 and dI3 neurons into dI4 interneurons. However, the role of Olig3 in regulating the development of ventral spinal cord has remained unknown. BrdU labeling demonstrated that ventral Olig3 was expressed in the post-mitotic neurons and Olig3+ cells seen at late embryonic stages were born at the earlier stage but remained in the marginal zone throughout embryogenesis. Loss-of-function and gain-of-function experiment indicated that Nkx2.2 regulated the expression of Olig3 in V3 interneurons. However, Olig3 mutation didn't apparently affect the generation and migration of ventral neurons. These findings suggest that Olig3 plays different roles in regulating the development of dorsal and ventral spinal cord.	[Liu, Zijing; Hu, Xuemei; Qiu, Mengsheng] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Liu, Zijing; Huang, Chengcheng; Cao, Cheng] Beijing Inst Biotechnol, Beijing, Peoples R China; [Zheng, Kang; Qiu, Mengsheng] Hangzhou Normal Univ, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou, Zhejiang, Peoples R China; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan	University of Louisville; Hangzhou Normal University; Niigata University	Liu, ZJ (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	zijingsy@yahoo.com; m0qiu001@yahoo.com	huang, chengcheng/GRX-5340-2022; Cao, Cheng/GNP-6156-2022; Takebayashi, Hirohide/AAO-1693-2020	Liu, Zijing/0000-0001-7790-0590	Natural Science Foundation of China [31371102]; National Key Basic Research Program of China [2012CB910402, 2013CB531300]; National Institutes of Health [R01 NS37717]; Kentucky Spinal Cord and Head Injury Trust (KSHIRT)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Trust (KSHIRT)	ZL was supported by Natural Science Foundation of China (31371102); MQ was supported by National Key Basic Research Program of China (2012CB910402; 2013CB531300), National Institutes of Health (R01 NS37717) and Kentucky Spinal Cord and Head Injury Trust (KSHIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Borowska J, 2013, J NEUROSCI, V33, P18553, DOI 10.1523/JNEUROSCI.2005-13.2013; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Ding L, 2005, DEV DYNAM, V234, P622, DOI 10.1002/dvdy.20545; Francius C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070325; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Holz A, 2010, DEVELOPMENT, V137, P4249, DOI 10.1242/dev.053819; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Liu Z, 2008, J NEUROSCI, V28, P10124, DOI 10.1523/JNEUROSCI.3769-08.2008; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Matise MP, 2013, WIRES DEV BIOL, V2, P419, DOI 10.1002/wdev.83; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Qi YC, 2001, DEVELOPMENT, V128, P2723; Storm R, 2009, DEVELOPMENT, V136, P295, DOI 10.1242/dev.027193; Sussel L, 1998, DEVELOPMENT, V125, P2213; Takebayashi H, 2002, MECH DEVELOP, V113, P169, DOI 10.1016/S0925-4773(02)00021-7; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111076	10.1371/journal.pone.0111076	http://dx.doi.org/10.1371/journal.pone.0111076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350849	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100056
J	Emerson, RO; Mathew, JM; Konieczna, IM; Robins, HS; Leventhal, JR				Emerson, Ryan O.; Mathew, James M.; Konieczna, Iwona M.; Robins, Harlan S.; Leventhal, Joseph R.			Defining the Alloreactive T Cell Repertoire Using High-Throughput Sequencing of Mixed Lymphocyte Reaction Culture	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CROSS-REACTIVITY; TOLERANCE; RECEPTOR; NAIVE; TRANSPLANTATION; ANTIGEN; HUMANS; GENERATION; INFECTION	The cellular immune response is the most important mediator of allograft rejection and is a major barrier to transplant tolerance. Delineation of the depth and breadth of the alloreactive T cell repertoire and subsequent application of the technology to the clinic may improve patient outcomes. As a first step toward this, we have used MLR and high-throughput sequencing to characterize the alloreactive T cell repertoire in healthy adults at baseline and 3 months later. Our results demonstrate that thousands of T cell clones proliferate in MLR, and that the alloreactive repertoire is dominated by relatively high-abundance T cell clones. This clonal make up is consistently reproducible across replicates and across a span of three months. These results indicate that our technology is sensitive and that the alloreactive TCR repertoire is broad and stable over time. We anticipate that application of this approach to track donor-reactive clones may positively impact clinical management of transplant patients.	[Emerson, Ryan O.] Adapt Biotechnol Corp, Seattle, WA USA; [Mathew, James M.; Konieczna, Iwona M.; Leventhal, Joseph R.] Northwestern Univ, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Mathew, James M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Robins, Harlan S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Northwestern University; Northwestern University; Fred Hutchinson Cancer Center	Leventhal, JR (corresponding author), Northwestern Univ, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA.	jleventh@nmh.org						Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; BAIN B, 1964, SCIENCE, V145, P1315, DOI 10.1126/science.145.3638.1315; BAIN B, 1964, BLOOD, V23, P108, DOI 10.1182/blood.V23.1.108.108; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Brook MO, 2006, TRANSPLANTATION, V82, P1, DOI 10.1097/01.tp.0000226082.17507.da; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; D'Orsogna LJ, 2012, IMMUNOGENETICS, V64, P77, DOI 10.1007/s00251-011-0590-0; D'Orsogna LJA, 2011, TRANSPLANTATION, V91, P645, DOI 10.1097/TP.0b013e318208c071; D'Orsogna LJA, 2011, TRANSPL IMMUNOL, V24, P141, DOI 10.1016/j.trim.2010.12.001; Danziger-Isakov L, 2010, TRANSPLANTATION, V89, P838, DOI 10.1097/TP.0b013e3181ca56f8; Ely LK, 2008, CURR OPIN IMMUNOL, V20, P575, DOI 10.1016/j.coi.2008.07.006; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Griesemer AD, 2010, TRANSPLANTATION, V90, P465, DOI 10.1097/TP.0b013e3181e7e54f; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Levitsky J, 2013, TRANSPLANTATION, V96, P689, DOI 10.1097/TP.0b013e31829f1607; Levitsky J, 2012, HUM IMMUNOL, V73, P141, DOI 10.1016/j.humimm.2011.11.008; Macedo C, 2009, AM J TRANSPLANT, V9, P2057, DOI 10.1111/j.1600-6143.2009.02742.x; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; Mathew JM, 2003, TRANSPL IMMUNOL, V11, P307, DOI 10.1016/S0966-3274(03)00056-X; Mifsud NA, 2010, TRANSPLANTATION, V90, P1439, DOI 10.1097/TP.0b013e3181ff4ff3; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SCHILD H, 1990, SCIENCE, V247, P1587, DOI 10.1126/science.2321019; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Wang TM, 2008, J IMMUNOL, V180, P5991, DOI 10.4049/jimmunol.180.9.5991; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820	34	27	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111943	10.1371/journal.pone.0111943	http://dx.doi.org/10.1371/journal.pone.0111943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365040	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100136
J	Schanz, M; Liechti, T; Zagordi, O; Miho, E; Reddy, ST; Gunthard, HF; Trkola, A; Huber, M				Schanz, Merle; Liechti, Thomas; Zagordi, Osvaldo; Miho, Enkelejda; Reddy, Sai T.; Guenthard, Huldrych F.; Trkola, Alexandra; Huber, Michael			High-Throughput Sequencing of Human Immunoglobulin Variable Regions with Subtype Identification	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; HIV-1-NEUTRALIZING ANTIBODIES; HIV-1 INFECTION; B-CELLS; GENERATION; VIRUS; TYPE-1; POTENT; REPERTOIRE; SUBCLASSES	The humoral immune response plays a critical role in controlling infection, and the rapid adaptation to a broad range of pathogens depends on a highly diverse antibody repertoire. The advent of high-throughput sequencing technologies in the past decade has enabled insights into this immense diversity. However, not only the variable, but also the constant region of antibodies determines their in vivo activity. Antibody isotypes differ in effector functions and are thought to play a defining role in elicitation of immune responses, both in natural infection and in vaccination. We have developed an Illumina MiSeq high-throughput sequencing protocol that allows determination of the human IgG subtype alongside sequencing full-length antibody variable heavy chain regions. We thereby took advantage of the Illumina procedure containing two additional short reads as identifiers. By performing paired-end sequencing of the variable regions and customizing one of the identifier sequences to distinguish IgG subtypes, IgG transcripts with linked information of variable regions and IgG subtype can be retrieved. We applied our new method to the analysis of the IgG variable region repertoire from PBMC of an HIV-1 infected individual confirmed to have serum antibody reactivity to the Membrane Proximal External Region (MPER) of gp41. We found that IgG3 subtype frequencies in the memory B cell compartment increased after halted treatment and coincided with increased plasma antibody reactivity against the MPER domain. The sequencing strategy we developed is not restricted to analysis of IgG. It can be adopted for any Ig subtyping and beyond that for any research question where phasing of distant regions on the same amplicon is needed.	[Schanz, Merle; Liechti, Thomas; Zagordi, Osvaldo; Trkola, Alexandra; Huber, Michael] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Miho, Enkelejda; Reddy, Sai T.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Huber, M (corresponding author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.	huber.michael@virology.uzh.ch	Trkola, Alexandra/K-2115-2012; Huber, Michael/B-8509-2015; Zagordi, Osvaldo/H-2879-2019; gunthard, huldrych f/F-1724-2011; Reddy, Sai/B-4190-2012	Trkola, Alexandra/0000-0003-1013-876X; Huber, Michael/0000-0002-0384-0000; Zagordi, Osvaldo/0000-0002-9082-8607; gunthard, huldrych f/0000-0002-1142-6723; Miho, Enkelejda/0000-0001-6461-0519; Liechti, Thomas/0000-0001-8738-6679; Reddy, Sai/0000-0002-9177-0857	Swiss National Science Foundation [310000-120739, 310030-152663]; SystemsX.ch RTD grant (AntibodyX); University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch RTD grant (AntibodyX); University of Zurich	Funding was provided by the Swiss National Science Foundation (www.snf.ch) grant 310000-120739 and 310030-152663 to AT, a SystemsX.ch RTD grant (AntibodyX), and the Clinical Research Priority Program Viral Infectious Diseases of the University of Zurich (http://www.viralinfectiousdiseases.uzh.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Beenhouwer DO, 2007, INFECT IMMUN, V75, P1424, DOI 10.1128/IAI.01161-06; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Di Giallonardo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074249; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mathonet P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00265; Menzel U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096727; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Roux KH, 1997, J IMMUNOL, V159, P3372; Sblattero D, 1998, IMMUNOTECHNOLOGY, V3, P271, DOI 10.1016/S1380-2933(97)10004-5; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Versiani FG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-294; Wenniger LJMD, 2013, HEPATOLOGY, V57, P2390, DOI 10.1002/hep.26232; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315	33	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111726	10.1371/journal.pone.0111726	http://dx.doi.org/10.1371/journal.pone.0111726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364977	Green Published, gold, Green Accepted			2022-12-27	WOS:000345558100112
J	Veldwijk, J; Lambooij, MS; de Bekker-Grob, EW; Smit, HA; de Wit, GA				Veldwijk, Jorien; Lambooij, Mattijs S.; de Bekker-Grob, Esther W.; Smit, Henriette A.; de Wit, G. Ardine			The Effect of Including an Opt-Out Option in Discrete Choice Experiments	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; STATUS-QUO; PHYSICAL-ACTIVITY; CONJOINT-ANALYSIS; THINK ALOUD; PREFERENCES; BARRIERS; HEALTH; EXERCISE; CARE	Objective: to determine to what extent the inclusion of an opt-out option in a DCE may have an effect on choice behaviour and therefore might influence the attribute level estimates, the relative importance of the attributes and calculated trade-offs. Methods: 781 Dutch Type 2 Diabetes Mellitus patients completed a questionnaire containing nine choice tasks with an opt-out option and nice forced choice tasks. Mixed-logit models were used to estimate the relative importance of the five lifestyle program related attributes that were included. Willingness to pay (WTP) values were calculated and it was tested whether results differed between respondents who answered the choice tasks with an opt-out option in the first or second part of the questionnaire. Results: 21.4% of the respondents always opted out. Respondents who were given the opt-out option in the first part of the questionnaire as well as lower educated respondents significantly more often opted out. For both the forced and unforced choice model, different attributes showed significant estimates, the relative importance of the attributes was equal. However, due to differences in relative importance weights, the WTP values for the PA schedule differed significantly between both datasets. Conclusions: Results show differences in opting out based on the location of the opt-out option and respondents' educational level; this resulted in small differences between the forced and unforced choice model. Since respondents seem to learn from answering forced choice tasks, a dual response design might result in higher data quality compared to offering a direct opt-out option. Future research should empirically explore how choice sets should be presented to make them as easy and less complex as possible in order to reduce the proportion of respondents that opts-out due to choice task complexity. Moreover, future research should debrief respondents to examine the reasons for choosing the opt-out alternative.	[Veldwijk, Jorien; Lambooij, Mattijs S.; de Wit, G. Ardine] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands; [Veldwijk, Jorien; Smit, Henriette A.; de Wit, G. Ardine] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Bekker-Grob, Esther W.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Veldwijk, J (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands.	jorien.veldwijk@rivm.nl		Veldwijk, Jorien/0000-0003-4822-5068; de Wit, G. Ardine/0000-0002-1375-7657	Strategic Research RIVM; National Institute for Public Health and the Environment	Strategic Research RIVM; National Institute for Public Health and the Environment	This study was funded by the Strategic Research RIVM (SOR) of the National Institute for Public Health and the Environment (to MSL and GAW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Bliemer MCJ, 2009, TRANSP RES BROAD ANN; Boxall P, 2009, AUST J AGR RESOUR EC, V53, P503, DOI 10.1111/j.1467-8489.2009.00469.x; Brazell JD, 2006, MARKET LETT, V17, P255, DOI 10.1007/s11002-006-7943-8; Cascetta E, 2009, SPRINGER SER OPTIM A, V29, P89, DOI 10.1007/978-0-387-75857-2_3; Cheraghi-Sohi S, 2007, FAM PRACT, V24, P276, DOI 10.1093/fampra/cmm007; Ciliska D, 2012, INTRO EVIDENCE INFOR; Coast Joanna, 2007, J Health Serv Res Policy, V12, P25, DOI 10.1258/135581907779497602; Cook J, 2007, ECON INQ, V45, P100, DOI 10.1111/j.1465-7295.2006.00038.x; de Bekker-Grob EW, 2013, PHARMACOECONOMICS, V31, P623, DOI 10.1007/s40273-013-0059-0; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Dhar R, 1997, J CONSUM RES, V24, P215, DOI 10.1086/209506; Dhar R, 2003, J MARKETING RES, V40, P146, DOI 10.1509/jmkr.40.2.146.19229; Dube MC, 2006, DIABETES RES CLIN PR, V72, P20, DOI 10.1016/j.diabres.2005.08.008; Elwyn G, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-75; Forbes CC, 2010, DIABETES EDUCATOR, V36, P801, DOI 10.1177/0145721710378538; Huber J, 1996, J MARKETING RES, V33, P307, DOI 10.2307/3152127; Iyengar SS, 2007, WORKING PAPER; KARNI E, 1977, J ECON THEORY, V16, P38, DOI 10.1016/0022-0531(77)90122-3; Krosnick JA, 2002, PUBLIC OPIN QUART, V66, P371; Lakerveld J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-17; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2006, HEALTH ECON, V15, P797, DOI 10.1002/hec.1104; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Louviere JJ, 2008, J CONSUM RES, V35, P360, DOI 10.1086/586913; Luce MF, 1999, J MARKETING RES, V36, P143, DOI 10.2307/3152089; Luce MF, 1998, J CONSUM RES, V24, P409, DOI 10.1086/209518; Marshall D, 2010, PATIENT, V3, P249, DOI 10.2165/11539650-000000000-00000; Marshall DA, 2007, VALUE HEALTH, V10, P415, DOI 10.1111/j.1524-4733.2007.00196.x; Marshall DA, 2009, HEALTH ECON, V18, P1420, DOI 10.1002/hec.1437; Meyerhoff J, 2009, LAND ECON, V85, P515; Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x; Nowlis SM, 2002, J CONSUM RES, V29, P319, DOI 10.1086/344431; Owen K, 2010, PUBLIC HEALTH NUTR, V13, P245, DOI 10.1017/S1368980009990784; Revelt D, 1998, REV ECON STAT, V80, P647, DOI 10.1162/003465398557735; RITOV I, 1992, J RISK UNCERTAINTY, V5, P49; Roux L, 2004, OBES RES, V12, P1342, DOI 10.1038/oby.2004.169; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Ryan M, 2009, HEALTH ECON, V18, P321, DOI 10.1002/hec.1369; San Miguel F, 2005, HEALTH ECON, V14, P307, DOI 10.1002/hec.912; SEN A, 1993, ECONOMETRICA, V61, P495, DOI 10.2307/2951715; SHAFIR E, 1993, COGNITION, V49, P11, DOI 10.1016/0010-0277(93)90034-S; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; TVERSKY A, 1992, PSYCHOL SCI, V3, P358, DOI 10.1111/j.1467-9280.1992.tb00047.x; van Gils PF, 2011, PATIENT PREFER ADHER, V5, P537, DOI 10.2147/PPA.S16854; Vijan S, 2005, DIABETIC MED, V22, P32, DOI 10.1111/j.1464-5491.2004.01342.x; von Haefen RH, 2005, AM J AGR ECON, V87, P1061, DOI 10.1111/j.1467-8276.2005.00794.x; Wood FG, 2002, WESTERN J NURS RES, V24, P502, DOI 10.1177/019394502400446388; Yousefi-Nooraie R, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-118	55	94	95	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111805	10.1371/journal.pone.0111805	http://dx.doi.org/10.1371/journal.pone.0111805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365169	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100125
J	Parida, L; Neogi, S; Padmanabhan, V				Parida, Lipika; Neogi, Sudarsan; Padmanabhan, Venkat			Effect of Temperature Pre-Exposure on the Locomotion and Chemotaxis of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CHEMOSENSORY NEURONS; PLASTICITY; AVOIDANCE; THERMOTAXIS; DOPAMINE; BEHAVIOR; CIRCUIT; SYSTEM	The effect of temperature pre-exposure on locomotion and chemotaxis of the soil-dwelling nematode Caenorhabditis elegans has been extensively studied. The behavior of C. elegans was quantified using a simple harmonic curvature-based model. Animals showed increased levels of activity, compared to control worms, immediately after pre-exposure to 30 degrees C. This high level of activity in C. elegans translated into frequent turns by making 'complex' shapes, higher velocity of locomotion, and higher chemotaxis index (CI) in presence of a gradient of chemoattractant. The effect of pre-exposure was observed to be persistent for about 20 minutes after which the behavior (including velocity and CI) appeared to be comparable to that of control animals (maintained at 20 degrees C). Surprisingly, after 30 minutes of recovery, the behavior of C. elegans continued to deteriorate further below that of control worms with a drastic reduction in the curvature of the worms' body. A majority of these worms also showed negative chemotaxis index indicating a loss in their chemotaxis ability.	[Parida, Lipika; Neogi, Sudarsan; Padmanabhan, Venkat] Indian Inst Technol, Dept Chem Engn, Kharagpur 721302, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Padmanabhan, V (corresponding author), Indian Inst Technol, Dept Chem Engn, Kharagpur 721302, W Bengal, India.	venkatp@che.iitkgp.ernet.in		Parida, Lipika/0000-0002-8251-0148	Department of Science and Technology, New Delhi, India	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	Funding provided by Department of Science and Technology, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW PA, 1976, NEMATOLOGICA, V22, P451, DOI 10.1163/187529276X00454; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; CHALFIE M, 1985, J NEUROSCI, V5, P956; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Frankel G. S., 1961, ORIENTATION ANIMALS; GRAY J, 1964, J EXP BIOL, V41, P135; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HANCOCK GJ, 1953, PROC R SOC LON SER-A, V217, P96, DOI 10.1098/rspa.1953.0048; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9; MacMillan K, 2012, EXPEDITION, V1; Matsuura T, 2010, ZOOL SCI, V27, P629, DOI 10.2108/zsj.27.629; Matsuura T, 2009, J EXP ZOOL PART A, V311A, P483, DOI 10.1002/jez.545; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Padmanabhan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040121; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramnanan CJ, 2006, J EXP BIOL, V209, P677, DOI 10.1242/jeb.02052; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Rose JK, 2001, LEARN MEMORY, V8, P63, DOI 10.1101/lm.37801; Saeki S, 2001, J EXP BIOL, V204, P1757; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sambongi Y, 2000, NEUROREPORT, V11, P2229, DOI 10.1097/00001756-200007140-00033; Sidorov AV, 2003, ZH VYSSH NERV DEYAT+, V53, P513; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Yamada Y, 2003, J EXP BIOL, V206, P2581, DOI 10.1242/jeb.00477; Zhao B, 2003, J NEUROSCI, V23	37	9	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111342	10.1371/journal.pone.0111342	http://dx.doi.org/10.1371/journal.pone.0111342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360667	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700086
J	Penman, TD; Collins, L; Syphard, AD; Keeley, JE; Bradstock, RA				Penman, Trent D.; Collins, Luke; Syphard, Alexandra D.; Keeley, Jon E.; Bradstock, Ross A.			Influence of Fuels, Weather and the Built Environment on the Exposure of Property to Wildfire	PLOS ONE			English	Article							BAYESIAN BELIEF NETWORKS; WILDLAND-URBAN INTERFACE; SOUTHERN CALIFORNIA; SYDNEY REGION; RELATIVE IMPORTANCE; SPATIAL-PATTERNS; EXPERT-JUDGMENT; SIERRA-NEVADA; FIRE BEHAVIOR; MANAGEMENT	Wildfires can pose a significant risk to people and property. Billions of dollars are spent investing in fire management actions in an attempt to reduce the risk of loss. One of the key areas where money is spent is through fuel treatment - either fuel reduction (prescribed fire) or fuel removal (fuel breaks). Individual treatments can influence fire size and the maximum distance travelled from the ignition and presumably risk, but few studies have examined the landscape level effectiveness of these treatments. Here we use a Bayesian Network model to examine the relative influence of the built and natural environment, weather, fuel and fuel treatments in determining the risk posed from wildfire to the wildland-urban interface. Fire size and distance travelled was influenced most strongly by weather, with exposure to fires most sensitive to changes in the built environment and fire parameters. Natural environment variables and fuel load all had minor influences on fire size, distance travelled and exposure of assets. These results suggest that management of fuels provided minimal reductions in risk to assets and adequate planning of the changes in the built environment to cope with the expansion of human populations is going to be vital for managing risk from fire under future climates.	[Penman, Trent D.; Bradstock, Ross A.] Univ Wollongong, Ctr Environm Risk Management Bushfires, Inst Conservat Biol & Environm Management, Wollongong, NSW 2522, Australia; [Collins, Luke] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Syphard, Alexandra D.] Conservat Biol Inst, La Mesa, CA USA; [Keeley, Jon E.] US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of Wollongong; Western Sydney University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles	Penman, TD (corresponding author), Univ Melbourne, Dept Forest & Ecosyst Sci, Melbourne, Vic 3010, Australia.	trent.penman@unimelb.edu.au	Penman, Trent D/A-7242-2012	Penman, Trent D/0000-0002-5203-9818; Collins, Luke/0000-0001-8059-0925; Syphard, Alexandra/0000-0003-3070-0596	U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	Funding from the U.S. Geological Survey was provided to University of Wollongong to cover salary of LC for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2000, FOREST ECOL MANAG, V127, P55, DOI 10.1016/S0378-1127(99)00116-4; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Arienti MC, 2006, CAN J FOREST RES, V36, P3155, DOI 10.1139/X06-188; Bar Massada A, 2011, ENVIRON MODELL SOFTW, V26, P583, DOI 10.1016/j.envsoft.2010.11.016; Bar Massada A, 2009, FOREST ECOL MANAG, V258, P1990, DOI 10.1016/j.foreco.2009.07.051; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Blanchi R, 2010, INT J WILDLAND FIRE, V19, P914, DOI 10.1071/WF08175; Boustras G, 2012, WILDFIRE COMMUNITY F, P151; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Bradstock RA, 2009, INT J WILDLAND FIRE, V18, P932, DOI 10.1071/WF08133; Bradstock RA, 1998, J ENVIRON MANAGE, V52, P259, DOI 10.1006/jema.1997.0177; Cary GJ, 2009, INT J WILDLAND FIRE, V18, P147, DOI 10.1071/WF07085; CBC, 2007, CAL BUILD COD MAT CO, V1 of 2; Chen SH, 2012, ENVIRON MODELL SOFTW, V37, P134, DOI 10.1016/j.envsoft.2012.03.012; Cohen JD, 2004, CAN J FOREST RES, V34, P1616, DOI 10.1139/X04-049; Cohen JD, 2000, J FOREST, V98, P15; Collins BM, 2007, LANDSCAPE ECOL, V22, P545, DOI 10.1007/s10980-006-9047-5; Collins L, 2013, INT J IN PRESS  0403; Dennison PE, 2008, INT J WILDLAND FIRE, V17, P18, DOI 10.1071/WF07017; Dennison PE, 2009, INT J WILDLAND FIRE, V18, P1021, DOI 10.1071/WF08055; Fernandes PM, 2003, INT J WILDLAND FIRE, V12, P117, DOI 10.1071/WF02042; Finney M.A., 1998, FARSITE FIRE AREA SI; Finney MA, 2001, FOREST SCI, V47, P219; Fule PZ, 2012, FOREST ECOL MANAG, V269, P68, DOI 10.1016/j.foreco.2011.12.025; Ganewatta G., 2008, Community bushfire safety, P151; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; Gill AM, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034014; Hammer RB, 2007, INT J WILDLAND FIRE, V16, P255, DOI 10.1071/WF05077; Hering AS, 2009, ENVIRON ECOL STAT, V16, P225, DOI 10.1007/s10651-007-0080-6; Hirsch KG, 2004, CAN J FOREST RES, V34, P705, DOI [10.1139/x03-237, 10.1139/X03-237]; Hirsch KG, 1998, FOREST SCI, V44, P539; Johnson S, 2010, ECOL MODEL, V221, P641, DOI 10.1016/j.ecolmodel.2009.11.012; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2003, ECOL STU AN, V160, P218; Keeley JE, 2004, J FOREST, V102, P26; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Keeley JE, 2013, NATURAL DISASTERS AND ADAPTATION TO CLIMATE CHANGE, P42; Keeley JE, 2009, J FOREST, V107, P287; Keeley JE, 2009, ECOL APPL, V19, P69, DOI 10.1890/08-0281.1; Korb KB, 2011, COMPUTER SCI DATA AN; Lampin-Maillet C, 2010, J ENVIRON MANAGE, V91, P732, DOI 10.1016/j.jenvman.2009.10.001; Langley AK, 2005, FIRE TECHNOL, V41, P125, DOI 10.1007/s10694-005-6387-7; Leonard J., 2009, REPORT 2009 VICTORIA; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; McCaffrey SM, 2009, J FOREST, V107, P9; McFarlane AC, 1997, SOC PSYCH PSYCH EPID, V32, P261, DOI 10.1007/BF00789038; McLennan J, 2013, FIRE SAFETY J, V61, P175, DOI 10.1016/j.firesaf.2013.09.003; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; Moritz MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041735; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Papadatou D, 2012, J TRAUMA STRESS, V25, P57, DOI 10.1002/jts.21656; PEARL J, 1986, ARTIF INTELL, V29, P241, DOI 10.1016/0004-3702(86)90072-X; Penman TD, 2014, ENVIRON MODELL SOFTW, V52, P166, DOI 10.1016/j.envsoft.2013.09.030; Penman TD, 2013, J ENVIRON MANAGE, V131, P325, DOI 10.1016/j.jenvman.2013.10.007; Penman TD, 2013, INT J WILDLAND FIRE, V22, P469, DOI 10.1071/WF12027; Penman TD, 2011, INT J WILDLAND FIRE, V20, P909, DOI 10.1071/WF10076; Penman TD, 2011, INT J WILDLAND FIRE, V20, P721, DOI 10.1071/WF09131; Plucinski MP, 2012, INT J WILDLAND FIRE, V21, P219, DOI 10.1071/WF11063; Plucinski MP, 2012, FOREST SCI, V58, P390, DOI 10.5849/forsci.10-096; Price OF, 2013, NATURAL HAZARDS ENV, V1, P4539; Price OE, 2012, J ENVIRON MANAGE, V113, P301, DOI 10.1016/j.jenvman.2012.08.042; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Price OF, 2010, INT J WILDLAND FIRE, V19, P35, DOI 10.1071/WF08167; Schoennagel T, 2009, P NATL ACAD SCI USA, V106, P10706, DOI 10.1073/pnas.0900991106; Standards Australia, 2009, AS39592009 SAI GLOB, P129; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Syphard AD, 2012, PLOS ONE, V7; Syphard AD, 2008, INT J WILDLAND FIRE, V17, P602, DOI 10.1071/WF07087; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Syphard AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071708; Syphard AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033954; Syphard AD, 2011, INT J WILDLAND FIRE, V20, P764, DOI 10.1071/WF10065; Syphard AD, 2011, FOREST ECOL MANAG, V261, P2038, DOI 10.1016/j.foreco.2011.02.030; Syphard AD, 2011, INT J WILDLAND FIRE, V20, P364, DOI 10.1071/WF09125; Thompson JR, 2009, FOREST ECOL MANAG, V258, P1684, DOI 10.1016/j.foreco.2009.07.031	78	27	27	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111414	10.1371/journal.pone.0111414	http://dx.doi.org/10.1371/journal.pone.0111414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360741	Green Published, gold			2022-12-27	WOS:000343943700101
J	Schrameyer, V; Wangpraseurt, D; Hill, R; Kuhl, M; Larkum, AWD; Ralph, PJ				Schrameyer, Verena; Wangpraseurt, Daniel; Hill, Ross; Kuehl, Michael; Larkum, Anthony W. D.; Ralph, Peter J.			Light Respiratory Processes and Gross Photosynthesis in Two Scleractinian Corals	PLOS ONE			English	Article							INORGANIC CARBON CONCENTRATION; REEF-BUILDING CORALS; STYLOPHORA-PISTILLATA; SYMBIODINIUM SP; SEA-WATER; CALCIFICATION; PHOTOINHIBITION; ZOOXANTHELLAE; MECHANISMS; SYMBIONTS	The light dependency of respiratory activity of two scleractinian corals was examined using O-2 microsensors and CO2 exchange measurements. Light respiration increased strongly but asymptotically with elevated irradiance in both species. Light respiration in Pocillopora damicornis was higher than in Pavona decussata under low irradiance, indicating species-specific differences in light-dependent metabolic processes. Overall, the coral P. decussata exhibited higher CO2 uptake rates than P. damicornis over the experimental irradiance range. P. decussata also harboured twice as many algal symbionts and higher total protein biomass compared to P. damicornis, possibly resulting in self-shading of the symbionts and/or changes in host tissue specific light distribution. Differences in light respiration and CO2 availability could be due to host-specific characteristics that modulate the symbiont microenvironment, its photosynthesis, and hence the overall performance of the coral holobiont.	[Schrameyer, Verena; Wangpraseurt, Daniel; Hill, Ross; Kuehl, Michael; Larkum, Anthony W. D.; Ralph, Peter J.] Univ Technol Sydney, Sch Environm, Ultimo, NSW, Australia; [Hill, Ross] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Hill, Ross] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney Inst Marine Sci, Sydney, NSW, Australia; [Kuehl, Michael] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Kuehl, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Sch Biol Sci, Singapore 639798, Singapore	University of Technology Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of New South Wales Sydney; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kuhl, M (corresponding author), Univ Technol Sydney, Sch Environm, Ultimo, NSW, Australia.	a.larkum@sydney.edu.au	Hill, Ross/E-6075-2013; Ralph, Peter J/C-5029-2009; Kühl, Michael/A-1977-2009; Ralph, Peter/L-1527-2019	Hill, Ross/0000-0002-4623-1563; Ralph, Peter J/0000-0002-3103-7346; Kühl, Michael/0000-0002-1792-4790; Ralph, Peter/0000-0002-3103-7346; Wangpraseurt, Daniel/0000-0003-4834-8981	Australian Research Council [DP110105200]; Danish Council for Independent Research\ Natural Science; University of Technology, Sydney	Australian Research Council(Australian Research Council); Danish Council for Independent Research\ Natural Science(Det Frie Forskningsrad (DFF)); University of Technology, Sydney	This work was funded by grant #DP110105200 awarded by the Australian Research Council, http://www.arc.gov.au to PR and the Danish Council for Independent Research vertical bar Natural Science, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council- 1/the-danish-council-for-independent-research-natural-sciences to MK, as well as Postgraduate scholarships from the University of Technology, Sydney to VS and DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini S, 2013, AQUAT BIOL, V18, P125, DOI 10.3354/ab00496; Al-Horani FA, 2003, J EXP MAR BIOL ECOL, V288, P1, DOI 10.1016/S0022-0981(02)00578-6; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; AlMoghrabi S, 1996, J EXP MAR BIOL ECOL, V199, P227, DOI 10.1016/0022-0981(95)00202-2; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown BE, 1999, CORAL REEFS, V18, P99; Buxton L, 2009, J PHYCOL, V45, P357, DOI 10.1111/j.1529-8817.2009.00659.x; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; Edmunds PJ, 2002, CORAL REEFS, V21, P193, DOI 10.1007/s00338-002-0214-0; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fisher PL, 2012, CORAL REEFS, V31, P473, DOI 10.1007/s00338-011-0853-0; Furla P, 2000, J EXP BIOL, V203, P3445; Gattuso JP, 1999, AM ZOOL, V39, P160; GLUD RN, 1992, J PHYCOL, V28, P51, DOI 10.1111/j.0022-3646.1992.00051.x; Godish T., 2004, AIR QUALITY, V4th; Goiran C, 1996, J EXP MAR BIOL ECOL, V199, P207, DOI 10.1016/0022-0981(95)00201-4; Graham D, 1976, AUSTR J PLANT PHYSL, V3, P153; Hennige SJ, 2011, MAR BIOL, V158, P2515, DOI 10.1007/s00227-011-1752-1; Herfort L, 2008, J PHYCOL, V44, P91, DOI 10.1111/j.1529-8817.2007.00445.x; Hill R, 2012, CORAL REEFS, V31, P963, DOI 10.1007/s00338-012-0914-z; Hill R, 2011, LIMNOL OCEANOGR, V56, P139, DOI 10.4319/lo.2011.56.1.0139; Hill R, 2009, B MAR SCI, V85, P223; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; JENSEN J, 1989, FEMS MICROBIOL ECOL, V62, P29, DOI 10.1111/j.1574-6968.1989.tb03655.x; JOKIEL PL, 1986, MAR BIOL, V91, P15, DOI 10.1007/BF00397566; Kramer WE, 2012, PHOTOCHEM PHOTOBIOL, V88, P398, DOI 10.1111/j.1751-1097.2011.01048.x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Leggat W, 2002, FUNCT PLANT BIOL, V29, P309, DOI 10.1071/PP01202; Leggat W, 1999, PLANT PHYSIOL, V121, P1247, DOI 10.1104/pp.121.4.1247; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Levy O, 2006, J EXP BIOL, V209, P273, DOI 10.1242/jeb.01983; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Lilley RM, 2010, PLANT CELL ENVIRON, V33, P995, DOI 10.1111/j.1365-3040.2010.02121.x; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Muller-Parker Gisele, 1997, P96; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Muscatine L., 1990, P75; Parys E, 2006, J PLANT PHYSIOL, V163, P638, DOI 10.1016/j.jplph.2005.05.009; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Pernice M, 2012, ISME J, V6, P1314, DOI 10.1038/ismej.2011.196; Ragni M, 2010, MAR ECOL PROG SER, V406, P57, DOI 10.3354/meps08571; RANDS ML, 1993, P ROY SOC B-BIOL SCI, V253, P161, DOI 10.1098/rspb.1993.0097; Raven JA, 2003, PHOTOSYNTH RES, V77, P155, DOI 10.1023/A:1025877902752; Raven JA, 2003, ADV PHOTO RESPIRAT, V14, P225; Raven JA, 1992, BIOL PLANTS; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P749, DOI 10.4319/lo.1983.28.4.0749; Reynaud S, 2002, MAR ECOL PROG SER, V238, P81, DOI 10.3354/meps238081; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Schrameyer V, 2013, DEFINING BIOENERGETI; Schreiber U, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P813; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tremblay P, 2014, CORAL REEFS, V33, P1, DOI 10.1007/s00338-013-1100-7; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Wang DL, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00427, 10.3389/fmicb.2012.00316]; Wangpraseurt D, 2014, J EXP BIOL, V217, P489, DOI 10.1242/jeb.091116; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; WEIS VM, 1989, MAR BIOL, V100, P195, DOI 10.1007/BF00391958; WEIS VM, 1993, J EXP MAR BIOL ECOL, V174, P209, DOI 10.1016/0022-0981(93)90018-J; WHITNEY SM, 1995, J PHYCOL, V31, P138, DOI 10.1111/j.0022-3646.1995.00138.x; Yellowlees D, 2003, PHOTOSYNTHESIS ALGAE; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	77	18	18	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110814	10.1371/journal.pone.0110814	http://dx.doi.org/10.1371/journal.pone.0110814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360746	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700047
J	Turnes, T; Salvador, AF; Lisboa, FD; de Aguiar, RA; Cruz, RSD; Caputo, F				Turnes, Tiago; Salvador, Amadeo Felix; Lisboa, Felipe Domingos; de Aguiar, Rafael Alves; de Oliveira Cruz, Rogerio Santos; Caputo, Fabrizio			A Fast-Start Pacing Strategy Speeds Pulmonary Oxygen Uptake Kinetics and Improves Supramaximal Running Performance	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; MAXIMAL EXERCISE; UPTAKE RESPONSE; ACHIEVE VO2MAX; O-2 UPTAKE; TIME; EXHAUSTION; ENERGETICS; INTENSITY; RELIABILITY	The focus of the present study was to investigate the effects of a fast-start pacing strategy on running performance and pulmonary oxygen uptake ((V) over dotO(2)) kinetics at the upper boundary of the severe-intensity domain. Eleven active male participants (28 +/- 10 years, 70 +/- 5 kg, 176 +/- 6 cm, 57 +/- 4 mL/kg/min) visited the laboratory for a series of tests that were performed until exhaustion: 1) an incremental test; 2) three laboratory test sessions performed at 95, 100 and 110% of the maximal aerobic speed; 3) two to four constant speed tests for the determination of the highest constant speed (HS) that still allowed achieving maximal oxygen uptake; and 4) an exercise based on the HS using a higher initial speed followed by a subsequent decrease. To predict equalized performance values for the constant pace, the relationship between time and distance/speed through log-log modelling was used. When a fast-start was utilized, subjects were able to cover a greater distance in a performance of similar duration in comparison with a constant-pace performance (constant pace: 670 m +/- 22%; fast-start: 683 m +/- 22%; P = 0.029); subjects also demonstrated a higher exercise tolerance at a similar average speed when compared with constant-pace performance (constant pace: 114 s +/- 30%; fast-start: 125 s +/- 26%; P = 0.037). Moreover, the mean (V) over dotO(2) response time was reduced after a fast start (constant pace: 22.2 s +/- 28%; fast-start: 19.3 s +/- 29%; P = 0.025). In conclusion, middle-distance running performances with a duration of 2-3 min are improved and (V) over dotO(2) response time is faster when a fast-start is adopted.	[Turnes, Tiago; Salvador, Amadeo Felix; Lisboa, Felipe Domingos; de Aguiar, Rafael Alves; de Oliveira Cruz, Rogerio Santos; Caputo, Fabrizio] Santa Catarina State Univ, Ctr Hlth & Sport Sci, Human Performance Res Grp, Florianopolis, SC, Brazil	Universidade do Estado de Santa Catarina	Caputo, F (corresponding author), Santa Catarina State Univ, Ctr Hlth & Sport Sci, Human Performance Res Grp, Florianopolis, SC, Brazil.	fabrizio.caputo@udesc.br	Caputo, Fabrizio/S-1648-2019; Turnes, Tiago/AAG-2491-2021; Cruz, Rogério S O/M-4055-2017; Lisbôa, Felipe D/P-4737-2018; Denadai, Benedito S/A-7263-2012; CAPUTO, FABRIZIO/H-3958-2012; de Aguiar, Rafael Alves/A-6484-2019	Turnes, Tiago/0000-0001-8797-0437; Cruz, Rogério S O/0000-0002-2921-899X; Lisbôa, Felipe D/0000-0002-8560-5943; Denadai, Benedito S/0000-0003-0775-1889; CAPUTO, FABRIZIO/0000-0003-4112-9858; de Aguiar, Rafael Alves/0000-0002-0056-9542	National Council of Scientific and Technological Development (CNPq)	National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was supported by National Council of Scientific and Technological Development (CNPq). Website: (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SJ, 2011, MED SCI SPORT EXER, V43, P457, DOI 10.1249/MSS.0b013e3181ef3dce; Billat LV, 1996, SPORTS MED, V22, P90, DOI 10.2165/00007256-199622020-00004; Billat VL, 2004, JPN J PHYSIOL, V54, P125, DOI 10.2170/jjphysiol.54.125; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BRANDON LJ, 1995, SPORTS MED, V19, P268, DOI 10.2165/00007256-199519040-00004; Caputo F., 2003, Archives of Physiology and Biochemistry, V111, P461, DOI 10.3109/13813450312331342337; Caputo F, 2006, INT J SPORTS MED, V27, P798, DOI 10.1055/s-2005-872962; Caputo F, 2004, EUR J APPL PHYSIOL, V93, P87, DOI 10.1007/s00421-004-1169-3; Caputo F, 2008, EUR J APPL PHYSIOL, V103, P47, DOI 10.1007/s00421-008-0670-5; Carr AJ, 2011, SPORTS MED, V41, P801, DOI 10.2165/11591440-000000000-00000; Carter H, 2000, J APPL PHYSIOL, V89, P899, DOI 10.1152/jappl.2000.89.3.899; CHANCE B, 1955, J BIOL CHEM, V217, P439; di Prampero PE, 2009, J APPL PHYSIOL, V107, P1068, DOI 10.1152/japplphysiol.00063.2009; DIPRAMPERO PE, 1993, J APPL PHYSIOL, V74, P2318, DOI 10.1152/jappl.1993.74.5.2318; DIPRAMPERO PE, 1986, EUR J APPL PHYSIOL O, V55, P259, DOI 10.1007/BF02343797; Draper SB, 2006, INTJ SPORT PHYSIOL, V1, P361, DOI 10.1123/ijspp.1.4.361; Hanon C, 2011, J SPORT SCI, V29, P905, DOI 10.1080/02640414.2011.562232; Hill DW, 2002, MED SCI SPORT EXER, V34, P709, DOI 10.1097/00005768-200204000-00023; Hinckson EA, 2005, MED SCI SPORT EXER, V37, P696, DOI 10.1249/01.MSS.0000159023.06934.53; Hopkins W.G., 2007, SPORTSCIENCE, V11, P16; Hopkins WG, 1999, MED SCI SPORT EXER, V31, P472, DOI 10.1097/00005768-199903000-00018; Hopkins WG, 2003, SPORTSCIENCE; Jones AM, 2008, SCAND J MED SCI SPOR, V18, P615, DOI 10.1111/j.1600-0838.2007.00725.x; Jones AM, 1999, EUR J APPL PHYSIOL, V80, P213, DOI 10.1007/s004210050584; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Laursen PB, 2007, MED SCI SPORT EXER, V39, P1374, DOI 10.1249/mss.0b013e31806010f5; MEDBO JI, 1988, J APPL PHYSIOL, V64, P50, DOI 10.1152/jappl.1988.64.1.50; Poole DC, 2012, COMPR PHYSIOL, V2, P933, DOI 10.1002/cphy.c100072; Sandals LE, 2006, INT J SPORTS MED, V27, P37, DOI 10.1055/s-2005-837468; Thomas C, 2005, INT J SPORTS MED, V26, P268, DOI 10.1055/s-2004-820998; Van Montfoort MCE, 2004, MED SCI SPORT EXER, V36, P1239, DOI 10.1249/01.MSS.0000132378.73975.25; Wilkerson DP, 2004, RESP PHYSIOL NEUROBI, V142, P211, DOI 10.1016/j.resp.2004.06.001	33	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111621	10.1371/journal.pone.0111621	http://dx.doi.org/10.1371/journal.pone.0111621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360744	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700130
J	Yoon, SJ; Kim, DH; Nam, GE; Yoon, YJ; Han, KD; Jung, DW; Park, SW; Kim, YE; Lee, SH; Lee, SS; Kim, YH				Yoon, Su-Jung; Kim, Do-Hoon; Nam, Ga-Eun; Yoon, Yeo-Joon; Han, Kyung-Do; Jung, Dong-Wook; Park, Sang-Woon; Kim, Young-Eun; Lee, Sung-Ho; Lee, Sang-Su; Kim, Yang-Hyun			Prevalence and Control of Hypertension and Albuminuria in South Korea: Focus on Obesity and Abdominal Obesity in the Korean National Health and Nutrition Examination Survey, 2011-2012	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ISOLATED SYSTOLIC HYPERTENSION; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; BODY-MASS INDEX; BLOOD-PRESSURE; METABOLIC SYNDROME; RENAL-FUNCTION; INCIDENT MICROALBUMINURIA	Background: Albuminuria is associated with cardiovascular disease, and the relationship between albuminuria and hypertension is well established in many studies. So the control of hypertension is critical for decreasing cardiovascular events and albuminuria. Obesity and abdominal obesity are also associated with hypertension and albuminuria. Therefore, we analyzed the relationship between albuminuria and the prevalence and control of hypertension in the general Korean population according to obesity status. Methods: We analyzed data from the 2011-2012 Korea National Health and Nutrition Examination Survey, and 9,519 subjects were included. Subjects were divided into four groups: non-obese/normal waist circumference, non-obese/high waist circumference, obese/normal waist circumference, and obese/high waist circumference. Results: Systolic blood pressure and diastolic blood pressure were positively associated with albumin-creatinine ratio in all groups (all p values <0.005). Non-obese/normal waist circumference group were more likely to have hypertension (odds ratios [95% confidential intervals (CIs)] were 3.20 [2.21-4.63] in microalbuminuria level and 3.09 [1.05-9.14] in macroalbuminuria level), and less likely to have controlled hypertension (odds ratios <1 for both albuminuria levels) after adjusting for all covariates. Obese/normal waist circumference group were also more likely to have hypertension (odds ratio [95% CI] were 3.10 [1.56-6.15] in microalbuminuria level and 21.75 [3.66-129.04] in macroalbuminuria level), and less likely to have controlled hypertension in macroalbuminuria level (odds ratio [95% CI], 0.04 [0.01-0.15]). Conclusions: Non-obese and normal waist circumference subjects have an increased prevalence and decreased control of hypertension in microalbuminuria and macroalbuminuria levels. Screening for albuminuria may provide helpful information about hypertension and blood pressure control, particularly in the non-obese and normal waist circumference subjects.	[Yoon, Su-Jung; Kim, Do-Hoon; Nam, Ga-Eun; Yoon, Yeo-Joon; Jung, Dong-Wook; Park, Sang-Woon; Kim, Young-Eun; Lee, Sung-Ho; Lee, Sang-Su; Kim, Yang-Hyun] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Han, Kyung-Do] Catholic Univ, Coll Med, Dept Med Stat, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea	Kim, YH (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea.	mrchir@naver.com	Nam, Ga Eun/AAA-1577-2021; Nam, Ga Eun/AAU-6055-2020	Nam, Ga Eun/0000-0002-6739-9904; Kim, Yang-Hyun/0000-0003-3548-8758; Kim, Do Hoon/0000-0001-7421-4501; Kim, Young-Eun/0000-0003-0694-6844				Amann K, 2013, SEMIN NEPHROL, V33, P23, DOI 10.1016/j.semnephrol.2012.12.003; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; ASSMANN G, 1989, AM J CARDIOL, V63, pH33; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bianchi S, 1999, AM J KIDNEY DIS, V34, P973, DOI 10.1016/S0272-6386(99)70002-8; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Cerasola G, 2010, J HYPERTENS, V28, P2357, DOI 10.1097/HJH.0b013e32833ec377; Chang A, 2013, AM J KIDNEY DIS, V62, P267, DOI 10.1053/j.ajkd.2013.02.363; Chico A, 2005, ENDOCRINE, V27, P213, DOI 10.1385/ENDO:27:3:213; Chobanian AV, 2007, NEW ENGL J MED, V357, P789, DOI 10.1056/NEJMcp071137; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi HJ, 2012, KOREAN J FAM MED, V33, P330, DOI 10.4082/kjfm.2012.33.6.330; Cirillo M, 2000, KIDNEY INT, V58, P1211, DOI 10.1046/j.1523-1755.2000.00276.x; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; Deaton C, 2011, J CARDIOVASC NURS, V26, pS5, DOI 10.1097/JCN.0b013e318213efcf; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Deen WM, 2004, J CLIN INVEST, V114, P1412, DOI 10.1172/JCI200423577; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Flack JM, 2007, VASC HEALTH RISK MAN, V3, P1029; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gupta NK, 2012, J AM COLL CARDIOL, V60, P1148, DOI 10.1016/j.jacc.2012.04.050; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hoffmann IS, 2001, J HUM HYPERTENS, V15, P407, DOI 10.1038/sj.jhh.1001193; Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Kim BJ, 2007, CIRC J, V71, P1283, DOI 10.1253/circj.71.1283; Kim BJ, 2011, J HYPERTENS, V29, P2091, DOI 10.1097/HJH.0b013e32834b5627; Kim YS, 2013, HYPERTENS RES, V36, P807, DOI 10.1038/hr.2013.44; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Knight EL, 2003, AM J KIDNEY DIS, V41, P588, DOI 10.1053/ajkd.2003.50120; Kramer H, 2009, DIABETES CARE, V32, P851, DOI 10.2337/dc08-2059; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lin WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047960; Liu XF, 2013, HYPERTENS RES, V36, P1100, DOI 10.1038/hr.2013.87; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; Mohamed-Ali V, 1999, AM J PHYSIOL-ENDOC M, V277, pE971, DOI 10.1152/ajpendo.1999.277.6.E971; Nam GE, 2013, J WOMENS HLTH LARCHM; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Ong KL, 2008, HYPERTENSION, V51, P1142, DOI 10.1161/HYPERTENSIONAHA.107.105205; Ovbiagele B, 2011, JAMA-J AM MED ASSOC, V306, P2137, DOI 10.1001/jama.2011.1650; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park J, 2014, PROG CARDIOVASC DIS, V56, P415, DOI 10.1016/j.pcad.2013.10.005; Pini R, 2002, J AM COLL CARDIOL, V40, P1283, DOI 10.1016/S0735-1097(02)02159-9; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Roest M, 2001, CIRCULATION, V103, P3057, DOI 10.1161/hc2501.091353; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; Rutkowski B, 2013, NEPHROL DIAL TRANSPL, V28, P204, DOI 10.1093/ndt/gft328; Schalkwijk CG, 2006, J CLIN ENDOCR METAB, V91, P129, DOI 10.1210/jc.2005-1117; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Shin DI, 2013, J KOREAN MED SCI, V28, P252, DOI 10.3346/jkms.2013.28.2.252; Smulyan H, 1997, J AM COLL CARDIOL, V29, P1407, DOI 10.1016/S0735-1097(97)00081-8; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tanaka Satoru, 2013, BMC Res Notes, V6, P256, DOI 10.1186/1756-0500-6-256; Thoenes M, 2009, VASC HEALTH RISK MAN, V5, P577; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Weir Matthew R, 2004, J Clin Hypertens (Greenwich), V6, P134; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; WILLIAMS SA, 1990, CLIN SCI, V79, P5, DOI 10.1042/cs0790005; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273; Yuyun MF, 2005, CURR OPIN NEPHROL HY, V14, P271, DOI 10.1097/01.mnh.0000165895.90748.3b; Yuyun MF, 2004, INT J EPIDEMIOL, V33, P189, DOI 10.1093/ije/dyh008	71	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111179	10.1371/journal.pone.0111179	http://dx.doi.org/10.1371/journal.pone.0111179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360593	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700071
J	Singh, I; Bard, I; Jackson, J				Singh, Ilina; Bard, Imre; Jackson, Jonathan			Robust Resilience and Substantial Interest: A Survey of Pharmacological Cognitive Enhancement among University Students in the UK and Ireland	PLOS ONE			English	Article							HEALTHY-INDIVIDUALS; STIMULANT USE; ADHD; NEUROENHANCEMENT; CHALLENGES; MOTIVES; MISUSE; USERS; DRUGS	Use of 'smart drugs' among UK students is described in frequent media reports as a rapidly increasing phenomenon. This article reports findings from the first large-scale survey of pharmacological cognitive enhancement (PCE) among students in the UK and Ireland. Conducted from February to September 2012, a survey of a convenience sample of 877 students measured PCE prevalence, attitudes, sources, purposes and ethics. Descriptive and logistic regression statistical methods were used to analyse the data. Lifetime prevalence of PCE using modafinil, methylphenidate or Adderall was under 10%, while past regular and current PCE users of these substances made up between 0.3%-4% of the survey population. A substantial majority of students was unaware of and/or uninterested in PCE; however about one third of students were interested in PCE. PCE users were more likely to be male, British and older students; predictors of PCE use included awareness of other students using PCEs, ADHD symptomatology, ethical concerns, and alcohol and cannabis use. The survey addresses the need for better evidence about PCE prevalence and practices among university students in the UK. We recommend PCE-related strategies for universities based on the survey findings.	[Singh, Ilina] Kings Coll London, Dept Social Sci Hlth & Med, London, England; [Bard, Imre; Jackson, Jonathan] London Sch Econ & Polit Sci, Dept Methodol, London, England	University of London; King's College London; University of London; London School Economics & Political Science	Singh, I (corresponding author), Kings Coll London, Dept Social Sci Hlth & Med, London, England.	ilina.singh@kcl.ac.uk	Bard, Imre/I-2073-2019; Jackson, Jonathan/C-5156-2008	Bard, Imre/0000-0001-6395-0335; Jackson, Jonathan/0000-0003-2426-2219; Singh, Ilina/0000-0003-4497-3587	LSE Sticerd Foundation; LSE Personal Research Fund	LSE Sticerd Foundation; LSE Personal Research Fund	The survey was funded by the LSE Sticerd Foundation and LSE Personal Research Fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2013, SKY NEWS        0928; [Anonymous], 2013, AUSTRALIAN; Bergstrom LS, 2008, SCAND J PUBLIC HEALT, V36, P532, DOI 10.1177/1403494807087558; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Castaldi S, 2012, J ADDICT MED, V6, P112, DOI 10.1097/ADM.0b013e3182479584; DeSantis A, 2010, J DRUG EDUC, V40, P157, DOI 10.2190/DE.40.2.d; DeSantis AD, 2008, J AM COLL HEALTH, V56, P315, DOI 10.3200/JACH.57.3.315-324; DeSantis AD, 2010, SUBST USE MISUSE, V45, P31, DOI 10.3109/10826080902858334; Eickenhorst P, 2012, J PSYCHOACTIVE DRUGS, V44, P418, DOI 10.1080/02791072.2012.736845; EMCDDA, 2002, HDB SURV DRUG US GEN; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Hildt E., 2013, COGNITIVE ENHANCEMEN; Holloway K, 2012, DRUG-EDUC PREV POLIC, V19, P137, DOI 10.3109/09687637.2011.594114; Ilumle T., 2010, STUDY DRUGS VINDER F; Italian Committee for Bioethics,, 2013, NEUR PHARM COGN ENH; Lennard N., 2009, VARSITY STUDENT 0306; Ly C, 2013, PSYCHIAT RES, V210, P1310, DOI 10.1016/j.psychres.2013.08.003; Maier LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077967; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Parliamentary Office of Science and Technology (POST), 2007, BETT BRAINS NO 285; Partridge B.J., 2013, COGNITIVE ENHANCEMEN, V1, P39, DOI DOI 10.1007/978-94-007-6253-4_; Paton G., 2013, TELEGRAPH; Peterkin AL, 2010, J ATTEN DISORD, DOI [10.1177/1089054710365980, DOI 10.1177/1089054710365980]; Pustovrh T, 2014, NEUROETHICS-NETH, V7, P137, DOI 10.1007/s12152-013-9192-x; Ragan CI, 2013, NEUROPHARMACOLOGY, V64, P588, DOI 10.1016/j.neuropharm.2012.06.016; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Scheske C, 2012, BASIC APPL SOC PSYCH, V34, P508, DOI 10.1080/01973533.2012.711692; Singh I, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0385-0; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; The President's Council on Bioethics, 2003, THER BIOT PURS HAPP; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Workman TA, 2010, ASSESSING RISKS ISSU	33	101	104	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e105969	10.1371/journal.pone.0105969	http://dx.doi.org/10.1371/journal.pone.0105969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2HU	25356917	gold, Green Published			2022-12-27	WOS:000346765000001
J	Tao, SY; Duanmu, YQ; Dong, HB; Ni, YD; Chen, J; Shen, XZ; Zhao, RQ				Tao, Shiyu; Duanmu, Yongqian; Dong, Haibo; Ni, Yingdong; Chen, Jie; Shen, Xiangzhen; Zhao, Ruqian			High Concentrate Diet Induced Mucosal Injuries by Enhancing Epithelial Apoptosis and Inflammatory Response in the Hindgut of Goats	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; NF-KAPPA B; DAIRY-COWS; RUMEN; LIPOPOLYSACCHARIDE; ENDOTOXIN; EXPRESSION; HEALTH; CATTLE; COLON	Purpose: It is widely accepted that lipopolysaccharide and volatile fatty acids (VFA) accumulate in the digestive tract of ruminants fed diets containing high portions of grain. Compared to the ruminal epithelium, the hindgut epithelium is composed of a monolayer structure that is more "leaky'' for lipopolysaccharide and susceptible to organic acid-induced damage. The aim of this study was to investigate changes in epithelial structure, apoptosis and inflammatory response in the hindgut of goats fed a high-concentrate diet for 6 weeks. Experimental Design: Eight local Chinese goats with rumen cannulas were randomly assigned to two groups: one group was fed a high-concentrate diet (65% concentrate of dry matter, HC) and the other group was fed a low-concentrate diet (35% concentrate of dry matter, LC) for 6 wks. Ruminal fluid, plasma, and hindgut mucosa tissues were collected. Histological techniques, real-time PCR and western blotting were used to evaluate the tissues structure, cell apoptosis and local inflammation in the hindguts. Results: Feeding HC diet for 6 wks resulted in a significant decrease of ruminal pH (p<0.01), and ruminal lipopolysaccharide concentrations were significantly increased in HC goats (p<0.05). Obvious damage was observed to mucosal epithelium of the hindgut and the intercellular tight junctions in HC, but not in LC, goats. The expression of MyD88 and caspase-8 mRNA was increased in colonic epithelium of HC goats compared to LC (p<0.05), and the expression of TLR-4 and caspase-3 showed a tendency to increase. In the cecum, interleukin-1 beta mRNA expression was decreased (p<0.05), and caspase-3 showed a potential increase (p = 0.07) in HC goats. The level of NF-kB protein was increased in colonic epithelium of HC goats. Caspase-3 activity was elevated in both colon and cecum, whereas caspase-8 activity was statistically increased only in colon. Conclusions: Feeding a high-concentrate diet to goats for 6 wks led to hindgut mucosal injuries via activating epithelial cells apoptosis and local inflammatory response.	[Tao, Shiyu; Duanmu, Yongqian; Dong, Haibo; Ni, Yingdong; Chen, Jie; Zhao, Ruqian] Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Shen, Xiangzhen] Nanjing Agr Univ, Coll Vet Med, Inst Small Anim Dis, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University	Ni, YD (corresponding author), Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Minist Agr, Nanjing, Jiangsu, Peoples R China.	niyingdong@njau.edu.cn		Tao, Shiyu/0000-0003-2600-3309; Dong, Haibo/0000-0001-6520-3739	National Basic Research Program of China [2011CB100802]; National Nature Science Foundation of China [31272470]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (Project No. 2011CB100802) and National Nature Science Foundation of China (Project No. 31272470) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2009, P JPN ACAD A-MATH, V85, P216, DOI 10.2183/pjab.85.216; ANDERSEN PH, 1994, ACTA VET SCAND, V35, P223; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beeman N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.14; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Chin AC, 2006, CAN J PHYSIOL PHARM, V84, P1043, DOI 10.1139/Y06-056; ELAM CJ, 1976, J ANIM SCI, V43, P898, DOI 10.2527/jas1976.434898x; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Emmanuel DGV, 2007, J DAIRY SCI, V90, P5552, DOI 10.3168/jds.2007-0257; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; GAEBEL G, 1989, Q J EXP PHYSIOL CMS, V74, P35, DOI 10.1113/expphysiol.1989.sp003237; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gozho GN, 2005, J DAIRY SCI, V88, P1399, DOI 10.3168/jds.S0022-0302(05)72807-1; Graham C, 2005, AM J PHYSIOL-REG I, V288, pR173, DOI 10.1152/ajpregu.00425.2004; Hollmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081602; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Khafipour E, 2009, J DAIRY SCI, V92, P1712, DOI 10.3168/jds.2008-1656; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kleen JL, 2003, J VET MED A, V50, P406, DOI 10.1046/j.1439-0442.2003.00569.x; Klevenhusen F, 2013, J DAIRY SCI, V96, P2293, DOI 10.3168/jds.2012-6187; Krause KM, 2005, J DAIRY SCI, V88, P3633, DOI 10.3168/jds.S0022-0302(05)73048-4; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Li S, 2012, J DAIRY SCI, V95, P294, DOI 10.3168/jds.2011-4447; Liu JH, 2013, AM J PHYSIOL-REG I, V305, pR232, DOI 10.1152/ajpregu.00068.2013; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024740; MacCallum A, 2005, MICROBIOL-SGM, V151, P2451, DOI 10.1099/mic.0.27950-0; Metzler-Zebeli BU, 2013, J ANIM SCI, V91, P4256, DOI 10.2527/jas.2012-5570; Metzler-Zebeli BU, 2013, ANAEROBE, V20, P65, DOI 10.1016/j.anaerobe.2013.02.005; MOTOI Y, 1993, J VET MED SCI, V55, P19, DOI 10.1292/jvms.55.19; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Penner GB, 2011, J ANIM SCI, V89, P1108, DOI 10.2527/jas.2010-3378; Plaizier JC, 2008, VET J, V176, P21, DOI 10.1016/j.tvjl.2007.12.016; Plaizier JC, 2012, ANIM FEED SCI TECH, V172, P9, DOI 10.1016/j.anifeedsci.2011.12.004; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Satoh M, 2008, INNATE IMMUN-LONDON, V14, P51, DOI 10.1177/1753425907087267; Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007; Yue C, 2012, INFLAMMATION, V35, P1880, DOI 10.1007/s10753-012-9510-1; Zebeli Q, 2012, RES VET SCI, V93, P1099, DOI 10.1016/j.rvsc.2012.02.004; Zebeli Q, 2009, J DAIRY SCI, V92, P3800, DOI 10.3168/jds.2009-2178; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	48	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111596	10.1371/journal.pone.0111596	http://dx.doi.org/10.1371/journal.pone.0111596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356790	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000071
J	Fan, M; Stuart-Fox, D; Cadena, V				Fan, Marie; Stuart-Fox, Devi; Cadena, Viviana			Cyclic Colour Change in the Bearded Dragon Pogona vitticeps under Different Photoperiods	PLOS ONE			English	Article							ELICITING PIGMENT DISPERSION; FIDDLER-CRAB; CIRCADIAN-RHYTHM; UCA-PUGILATOR; RELATIVE EFFECTIVENESS; ANOLIS-CAROLINENSIS; VISIBLE LIGHT; TIDAL RHYTHMS; TEMPERATURE; MELANOPHORES	The ability to change colour rapidly is widespread among ectotherms and has various functions including camouflage, communication and thermoregulation. The process of colour change can occur as an aperiodic event or be rhythmic, induced by cyclic environmental factors or regulated by internal oscillators. Despite the importance of colour change in reptile ecology, few studies have investigated the occurrence of a circadian rhythm in lizard pigmentation. Additionally, although colour change also entails changes in near-infrared reflectance, which may affect thermoregulation, little research has examined this part of the spectrum. We tested whether the bearded dragon lizard, Pogona vitticeps, displays an endogenous circadian rhythm in pigmentation changes that could be entrained by light/dark (LD) cycles and how light affected the relative change in reflectance in both ultraviolet-visible and near-infrared spectra. We subjected 11 lizards to four photoperiodic regimens:LD 12:12; LD 6:18; LD 18:6 and DD; and measured their dorsal skin reflectance at 3-hour intervals for 72 hours after a habituation period. A proportion of lizards displayed a significant rhythm under constant darkness, with maximum reflectance occurring in the subjective night. This endogenous rhythm synchronised to the different artificial LD cycles, with maximum reflectance occurring during dark phases, but did not vary in amplitude. In addition, the total ultraviolet-visible reflectance in relation to the total near-infrared reflectance was significantly higher during dark phases than during light phases. We conclude that P. vitticeps exhibits a circadian pigmentation rhythm of constant amplitude, regulated by internal oscillators and that can be entrained by light/dark cycles.	[Fan, Marie] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England; [Fan, Marie; Stuart-Fox, Devi; Cadena, Viviana] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia	University of Exeter; University of Melbourne	Fan, M (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England.	mf330@exeter.ac.uk		Stuart-Fox, Devi/0000-0003-3362-1412	Australian Research Council [DP120100105]	Australian Research Council(Australian Research Council)	DSF received funding from the Australian Research Council (http://www.arc.gov.au/) (Grant Number: DP120100105). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bagnara JT., 2006, PIGMENTARY SYSTEM PH, P11, DOI [10.1002/9780470987100.ch2, DOI 10.1002/9780470987100.CH2]; Bagnara JT, 1973, CHROMATOPHORES COLOR; BARNWELL FH, 1963, BIOL BULL, V125, P399, DOI 10.2307/1539355; Bertolucci C, 2004, CHRONOBIOL INT, V21, P501, DOI 10.1081/CBI-120039813; Binkley S, 1987, PINEAL RES REV, P133; BROWN FA, 1948, PHYSIOL ZOOL, V21, P371, DOI 10.1086/physzool.21.4.30152016; Cadena V, 2009, PHYSIOL BIOCHEM ZOOL, V82, P203, DOI 10.1086/597483; Campbell SS, 2001, CHRONOBIOL INT, V18, P137, DOI 10.1081/CBI-100103183; CASWELL HH, 1950, COPEIA, P87, DOI 10.2307/1438950; Chatfield C, 1980, ANAL TIME SERIES INT; Christian KA, 1996, AUST J ZOOL, V44, P59, DOI 10.1071/ZO9960059; Clusella-Trullas S, 2008, FUNCT ECOL, V22, P232, DOI 10.1111/j.1365-2435.2007.01377.x; COOHILL TP, 1970, PHYSIOL ZOOL, V43, P232, DOI 10.1086/physzool.43.3.30155532; COOHILL TP, 1975, PHYSIOL ZOOL, V48, P57, DOI 10.1086/physzool.48.1.30155638; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; Darnell MZ, 2012, J EXP MAR BIOL ECOL, V426, P39, DOI 10.1016/j.jembe.2012.05.014; de Velasco JB, 2008, J COMP PHYSIOL B, V178, P867, DOI 10.1007/s00360-008-0274-8; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; Dowse Harold B, 2007, Methods Mol Biol, V362, P29; Filadelfi AMC, 2005, COMP BIOCHEM PHYS A, V142, P370, DOI 10.1016/j.cbpa.2005.09.001; FINGERMAN M, 1955, BIOL BULL, V109, P255, DOI 10.2307/1538725; Foa A, 2006, CHRONOBIOL INT, V23, P317, DOI 10.1080/07420520500521954; Garcia TS, 2004, ECOL APPL, V14, P1055, DOI 10.1890/02-5288; Granato FC, 2004, COMP BIOCHEM PHYS A, V138, P313, DOI 10.1016/j.cbpb.2004.04.009; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; HINTON HE, 1972, NATURE, V238, P160, DOI 10.1038/238160a0; HOROWITZ SB, 1958, J CELL COMPAR PHYSL, V51, P341, DOI 10.1002/jcp.1030510304; KAVALIERS M, 1980, CAN J ZOOL, V58, P456, DOI 10.1139/z80-060; KING RB, 1994, COPEIA, P422; Kodric-Brown A, 1998, AM ZOOL, V38, P70; LERNER AB, 1956, RECENT PROG HORM RES, V12, P303; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Melville J, 2001, AUSTRAL ECOL, V26, P660, DOI 10.1046/j.1442-9993.2001.01152.x; MENAKER M, 1983, P NATL ACAD SCI-BIOL, V80, P6119, DOI 10.1073/pnas.80.19.6119; MINUTINI L, 1995, J COMP PHYSIOL A, V176, P281; Morgan E, 2004, BIOL RHYTHM RES, V35, P3, DOI 10.1080/09291010412331313205; Oshima N, 2001, PIGM CELL RES, V14, P312, DOI 10.1034/j.1600-0749.2001.140502.x; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PORTER WP, 1969, SCIENCE, V163, P482, DOI 10.1126/science.163.3866.482; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; THURMAN CL, 1988, COMP BIOCHEM PHYS C, V91, P171, DOI 10.1016/0742-8413(88)90184-3; UNDERWOOD H, 1985, J COMP PHYSIOL A, V157, P57, DOI 10.1007/BF00611095; UNDERWOOD H, 1987, Journal of Biological Rhythms, V2, P179, DOI 10.1177/074873048700200302; WILKENS JL, 1965, BIOL BULL, V128, P133, DOI 10.2307/1539396	45	26	26	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111504	10.1371/journal.pone.0111504	http://dx.doi.org/10.1371/journal.pone.0111504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354192	Green Published, gold			2022-12-27	WOS:000345204200085
J	Guaraldi, G; Besutti, G; Scaglioni, R; Santoro, A; Zona, S; Guido, L; Marchioni, A; Orlando, G; Carli, F; Beghe, B; Fabbri, L; Leipsic, J; Sin, DD; Man, SFP				Guaraldi, Giovanni; Besutti, Giulia; Scaglioni, Riccardo; Santoro, Antonella; Zona, Stefano; Guido, Ligabue; Marchioni, Alessandro; Orlando, Gabriella; Carli, Federica; Beghe, Bianca; Fabbri, Leonardo; Leipsic, Jonathon; Sin, Don D.; Man, S. F. Paul			The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy	PLOS ONE			English	Article							TELOMERE LENGTH; STANDARDIZATION; MORTALITY; DEATH; ABNORMALITIES; OBSTRUCTION; CAPACITY; RISK; ERA	Background: With the widespread use of anti-retroviral therapy (ART), individuals infected with human immune deficiency virus (HIV) are increasingly experiencing morbidity and mortality from respiratory disorders. However, the prevalence or the risk factors associated with emphysema and bronchiolitis are largely unknown. Methods: Thoracic computed tomography (CT) scans were performed in 1,446 patients infected with HIV who were on ART and who attended a tertiary care metabolic clinic (average age 48 years and 29% females). Detailed history and physical examination including anthropometric measurements were performed. Complete pulmonary function tests were performed in a subset of these patients (n = 364). No subjects were acutely ill with a respiratory condition at the time of CT scanning. Findings: Nearly 50% of the subjects had CT evidence for emphysema, bronchiolitis or both with 13% (n = 195) showing bronchiolitis, 19% (n = 274) showing emphysema and 16% (n = 238) revealing both. These phenotypes were synergistically associated with reduced regular physical activity (p for interaction <.0001). The most significant risk factors for both phenotypes were cigarette smoking, intravenous drug use and peripheral leucocytosis. Together, the area-under-the curve statistics was 0.713 (p = 0.0037) for discriminating those with and without these phenotypes. There were no significant changes in lung volumes or flow rates related to these phenotypes, though the carbon monoxide diffusion capacity was reduced for the emphysema phenotype. Interpretation: Emphysema and bronchiolitis are extremely common in HIV-infected patients who are treated with ART and can be identified by use of thoracic CT scanning.	[Guaraldi, Giovanni; Besutti, Giulia; Scaglioni, Riccardo; Santoro, Antonella; Zona, Stefano; Guido, Ligabue; Marchioni, Alessandro; Orlando, Gabriella; Carli, Federica; Beghe, Bianca; Fabbri, Leonardo] Modena & Reggio Emila Univ, Modena, Italy; [Sin, Don D.; Man, S. F. Paul] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [Leipsic, Jonathon] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Sin, Don D.; Man, S. F. Paul] UBC James Hogg Res Ctr, St Pauls Hosp, Vancouver, BC, Canada	Universita di Modena e Reggio Emilia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Man, SFP (corresponding author), Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada.	pman@providencehealth.bc.ca	Sin, Don/AAC-2219-2021; Leipsic, Jonathon/ABE-6194-2020; Guaraldi, Giovanni/J-9467-2018; Orlando, Gabriella/K-3954-2018; Fabbri, Leonardo M/I-4055-2012; Besutti, Giulia/K-5453-2018	Orlando, Gabriella/0000-0002-4590-9045; Fabbri, Leonardo M/0000-0001-8894-1689; Besutti, Giulia/0000-0001-5319-5495; Guaraldi, Giovanni/0000-0002-5724-3914; Santoro, Antonella/0000-0002-2345-9135; Zona, Stefano/0000-0003-3451-2744; Marchioni, Alessandro/0000-0003-3720-3517				Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Bestilny LJ, 2000, AIDS, V14, P771, DOI 10.1097/00002030-200005050-00002; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kuk JL, 2006, DIABETES CARE, V29, P679, DOI 10.2337/diacare.29.03.06.dc05-1500; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Madeddu G, 2012, INFECTION; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543	27	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109027	10.1371/journal.pone.0109027	http://dx.doi.org/10.1371/journal.pone.0109027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354261	Green Published, gold			2022-12-27	WOS:000345204200006
J	Ryan, CP; Anderson, WG; Berkvens, CN; Hare, JF				Ryan, Calen P.; Anderson, W. Gary; Berkvens, Charlene N.; Hare, James F.			Maternal Gestational Cortisol and Testosterone Are Associated with Trade-Offs in Offspring Sex and Number in a Free-Living Rodent (Urocitellus richardsonii)	PLOS ONE			English	Article							GROUND-SQUIRRELS; POTENTIAL MECHANISMS; RATIO; STRESS; ALLOCATION; SUPPORT; GLUCOCORTICOIDS; VERTEBRATES; BONFERRONI; ADJUSTMENT	The adaptive manipulation of offspring sex and number has been of considerable interest to ecologists and evolutionary biologists. The physiological mechanisms that translate maternal condition and environmental cues into adaptive responses in offspring sex and number, however, remain obscure. In mammals, research into the mechanisms responsible for adaptive sex allocation has focused on two major endocrine axes: the hypothalamic pituitary adrenal (HPA) axis and glucocorticoids, and the hypothalamic pituitary gonadal (HPG) axis and sex steroids, particularly testosterone. While stress-induced activation of the HPA axis provides an intuitive model for sex ratio and litter size adjustment, plasma glucocorticoids exist in both bound and free fractions, and may be acting indirectly, for example by affecting plasma glucose levels. Furthermore, in female mammals, activation of the HPA axis stimulates the secretion of adrenal testosterone in addition to glucocorticoids (GCs). To begin to untangle these physiological mechanisms influencing offspring sex and number, we simultaneously examined fecal glucocorticoid metabolites, free and bound plasma cortisol, free testosterone, and plasma glucose concentration during both gestation and lactation in a free-living rodent (Urocitellus richardsonii). We also collected data on offspring sex and litter size from focal females and from a larger study population. Consistent with previous work in this population, we found evidence for a trade-off between offspring sex and number, as well as positive and negative correlations between glucocorticoids and sex ratio and litter size, respectively, during gestation (but not lactation). We also observed a negative relationship between testosterone and litter size during gestation (but not lactation), but no effect of glucose on either sex ratio or litter size. Our findings highlight the importance of binding proteins, cross-talk between endocrine systems, and temporal windows in the regulation of trade-offs in offspring sex and number.	[Ryan, Calen P.; Anderson, W. Gary; Hare, James F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Berkvens, Charlene N.] Assiniboine Pk Zoo, Winnipeg, MB, Canada	University of Manitoba	Ryan, CP (corresponding author), Northwestern Univ, Dept Anthropol, Lab Human Biol Res, Evanston, IL 60208 USA.	calen.p.ryan@gmail.com			Natural Sciences and Engineering Research Council of Canada [154271, 311909]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (JFH-#154271; WGA-#311909). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banszegi O, 2012, PHYSIOL BEHAV, V105, P1226, DOI 10.1016/j.physbeh.2012.01.002; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; Boonstra R, 2001, CAN J ZOOL, V79, P49, DOI 10.1139/cjz-79-1-49; Breuner CW, 2013, FUNCT ECOL, V27, P24, DOI 10.1111/1365-2435.12016; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; CHARNOV E L, 1982; Christiansen K., 1998, TESTOSTERONE, P107, DOI DOI 10.1017/CBO9780511545221.005; Cizza G, 2012, J CLIN ENDOCR METAB, V97, P77, DOI 10.1210/jc.2011-3090; CLARK MM, 1993, DEV PSYCHOBIOL, V26, P25, DOI 10.1002/dev.420260103; Clary D, 2014, ETHOLOGY, V120, P1101, DOI 10.1111/eth.12283; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; Dickenson H, 2012, GLUCOCORTICOIDS NEW; Diez C, 2009, J EXP ZOOL PART A, V311A, P448, DOI 10.1002/jez.540; Drea CM, 2011, HORM BEHAV, V59, P417, DOI 10.1016/j.yhbeh.2010.09.011; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; French JA, 2010, GEN COMP ENDOCR, V165, P309, DOI 10.1016/j.ygcen.2009.07.015; Garcia-Herreros M, 2010, REPROD FERT DEVELOP, V22, P533, DOI 10.1071/RD09157; Gedir JV, 2014, OECOLOGIA, V174, P1225, DOI 10.1007/s00442-013-2861-y; Gotz AA, 2008, PHYSIOL BEHAV, V93, P1055, DOI 10.1016/j.physbeh.2008.01.009; Good TC, 2005, PHYSIOL BEHAV, V86, P96, DOI 10.1016/j.physbeh.2005.06.030; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Grant VJ, 2007, J THEOR BIOL, V246, P708, DOI 10.1016/j.jtbi.2007.02.005; Grant VJ, 2011, ANIM BEHAV, V82, P893, DOI 10.1016/j.anbehav.2011.07.029; Grant VJ, 2005, J EXP ZOOL PART A, V303A, P1120, DOI 10.1002/jez.a.233; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; Hardy ICW, 1997, APPL ANIM BEHAV SCI, V51, P217, DOI 10.1016/S0168-1591(96)01106-9; Hare JF, 2014, CURR ZOOL, V60, P591, DOI 10.1093/czoolo/60.5.591; Helle S, 2008, ANIM BEHAV, V75, P1031, DOI 10.1016/j.anbehav.2007.08.015; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; HOUTSMULLER EJ, 1995, PHYSIOL BEHAV, V57, P495, DOI 10.1016/0031-9384(94)00291-C; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; Krackow S, 2002, ETHOLOGY, V108, P1041, DOI 10.1046/j.1439-0310.2002.00843.x; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Michael AE, 2008, HUM REPROD UPDATE, V14, P497, DOI 10.1093/humupd/dmn021; MICHENER G R, 1985, Mammalian Species, P1, DOI 10.2307/3503990; MICHENER GR, 1980, J MAMMAL, V61, P531, DOI 10.2307/1379847; MICHENER GR, 1979, CAN J ZOOL, V57, P125, DOI 10.1139/z79-010; MICHENER GR, 1985, J MAMMAL, V66, P280, DOI 10.2307/1381240; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Navara KJ, 2010, J COMP PHYSIOL B, V180, P785, DOI 10.1007/s00360-010-0483-9; Szenczi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074066; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Powell LH, 2002, PSYCHOSOM MED, V64, P502, DOI 10.1097/00006842-200205000-00015; PRATT NC, 1989, J REPROD FERTIL, V87, P763, DOI 10.1530/jrf.0.0870763; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Ryan CP, 2012, BEHAV ECOL, V23, P160, DOI 10.1093/beheco/arr169; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; Schoech SJ, 2013, FUNCT ECOL, V27, P1100, DOI 10.1111/1365-2435.12142; Schwanz LE, 2014, BEHAV ECOL SOCIOBIOL, V68, P1085, DOI 10.1007/s00265-014-1720-0; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Sun M, 2012, AM J PHYSIOL-ENDOC M, V303, pE1373, DOI 10.1152/ajpendo.00421.2012; Thogerson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067867; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x	61	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111052	10.1371/journal.pone.0111052	http://dx.doi.org/10.1371/journal.pone.0111052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353347	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200053
J	Thompson-Booth, C; Viding, E; Mayes, LC; Rutherford, HJV; Hodsoll, S; McCrory, E				Thompson-Booth, Chloe; Viding, Essi; Mayes, Linda C.; Rutherford, Helena J. V.; Hodsoll, Sara; McCrory, Eamon			I Can't Take My Eyes Off of You: Attentional Allocation to Infant, Child, Adolescent and Adult Faces in Mothers and Non-Mothers	PLOS ONE			English	Article							FACIAL EXPRESSIONS; BABY SCHEMA; EMOTIONAL FACES; BRAIN; PERCEPTION; EXPERIENCE; ADVANTAGE; FEAR; DETERMINANTS; HYPOTHESIS	It has been reported previously that infant faces elicit enhanced attentional allocation compared to adult faces in adult women, particularly when these faces are emotional and when the participants are mothers, as compared to non-mothers [1]. However, it remains unclear whether this increased salience of infant faces as compared to adult faces extends to children older than infant age, or whether infant faces have a unique capacity to elicit preferential attentional allocation compared to juvenile or adult faces. Therefore, this study investigated attentional allocation to a variety of different aged faces (infants, pre-adolescent children, adolescents, and adults) in 84 adult women, 39 of whom were mothers. Consistent with previous findings, infant faces were found to elicit greater attentional engagement compared to pre-adolescent, adolescent, or adult faces, particularly when the infants displayed distress; again, this effect was more pronounced in mothers compared to non-mothers. Pre-adolescent child faces were also found to elicit greater attentional engagement compared to adolescent and adult faces, but only when they displayed distress. No preferential attentional allocation was observed for adolescent compared to adult faces. These findings indicate that cues potentially signalling vulnerability, specifically age and sad affect, interact to engage attention. They point to a potentially important mechanism, which helps facilitate caregiving behaviour.	[Thompson-Booth, Chloe; Viding, Essi; Hodsoll, Sara; McCrory, Eamon] UCL, Div Psychol & Language Sci, London, England; [Mayes, Linda C.; Rutherford, Helena J. V.] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA	University of London; University College London; Yale University	McCrory, E (corresponding author), UCL, Div Psychol & Language Sci, London, England.	e.mccrory@ucl.ac.uk		Viding, Essi/0000-0001-8468-8874	Economic and Social Research Council (ESRC)	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by an Economic and Social Research Council (ESRC) PhD studentship awarded to C. T. B. (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836; Blos P., 1979, ADOLESCENT PASSAGE; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Cassia VM, 2011, BRIT J PSYCHOL, V102, P816, DOI 10.1111/j.2044-8295.2011.02046.x; Cassia VM, 2009, PSYCHOL SCI, V20, P853, DOI 10.1111/j.1467-9280.2009.02376.x; Cassia VM, 2009, Q J EXP PSYCHOL, V62, P1099, DOI 10.1080/17470210802617654; Csermely D, 1983, BEHAV HUMAN INFANTS, P1; Darwin C., 1904, EXPRESS EMOT MAN, V2nd; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Ebner NC, 2010, COGNITION EMOTION, V24, P1095, DOI 10.1080/02699930903128395; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Hareli S, 2009, EMOTION, V9, P378, DOI 10.1037/a0015958; Helsen M, 2000, J YOUTH ADOLESCENCE, V29, P319, DOI 10.1023/A:1005147708827; HILDEBRANDT KA, 1979, INFANT BEHAV DEV, V2, P329, DOI 10.1016/S0163-6383(79)80043-0; Hodsoll S, 2011, EMOTION, V11, P346, DOI 10.1037/a0022771; Horstmann G, 2008, PERCEPT PSYCHOPHYS, V70, P1416, DOI 10.3758/PP.70.8.1416; Hrdy S.B., 2005, ATTACHMENT BONDING N, P9, DOI DOI 10.1016/J.GLOENVCHA.2013.12.001; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Luo LZ, 2011, J EXP CHILD PSYCHOL, V110, P115, DOI 10.1016/j.jecp.2011.04.002; Mogg K, 2007, BIOL PSYCHOL, V76, P163, DOI 10.1016/j.biopsycho.2007.07.005; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A, 1993, HDB EMOTIONS, P511; PAIKOFF RL, 1991, PSYCHOL BULL, V110, P47, DOI 10.1037/0033-2909.110.1.47; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pearson RM, 2010, PSYCHOL MED, V40, P621, DOI 10.1017/S0033291709990961; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Proverbio AM, 2011, J COGNITIVE NEUROSCI, V23, P3197, DOI 10.1162/jocn_a_00041; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Sanefuji W, 2007, J ETHOL, V25, P249, DOI 10.1007/s10164-006-0018-8; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Stanton-Salazar RD, 2005, YOUTH SOC, V36, P379, DOI 10.1177/0044118X04267814; Steinberg L., 2002, HDB PARENTING CHILDR, P103, DOI DOI 10.4324/9781410612137; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; STRUHSAKER T T, 1971, Animal Behaviour, V19, P233, DOI 10.1016/S0003-3472(71)80004-0; Swain JE, 2011, PROG NEURO-PSYCHOPH, V35, P1242, DOI 10.1016/j.pnpbp.2010.10.017; Thompson-Booth C, 2014, DEVELOPMENTAL SCI, V17, P35, DOI 10.1111/desc.12090; Tinbergen, 1951, STUDY INSTINCT; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Weisfeld, 1997, UNITING PSYCHOL BIOL, P315, DOI [DOI 10.1037/10242-008, 10.1037/10242-008]; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193; Zebrowitz LA, 2006, SOC COGNITION, V24, P657, DOI 10.1521/soco.2006.24.5.657	56	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109362	10.1371/journal.pone.0109362	http://dx.doi.org/10.1371/journal.pone.0109362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353640	Green Published, gold			2022-12-27	WOS:000345204200009
J	Zhang, RX; Brennan, TJ; Lo, AW				Zhang, Ruixun; Brennan, Thomas J.; Lo, Andrew W.			Group Selection as Behavioral Adaptation to Systematic Risk	PLOS ONE			English	Article							KIN SELECTION; INCLUSIVE FITNESS; NATURAL-SELECTION; DECISION-MAKING; TIME PREFERENCE; INSTITUTIONAL CHANGE; PREFRONTAL CORTEX; BIOLOGICAL BASIS; SOCIAL-BEHAVIOR; EVOLUTION	Despite many compelling applications in economics, sociobiology, and evolutionary psychology, group selection is still one of the most hotly contested ideas in evolutionary biology. Here we propose a simple evolutionary model of behavior and show that what appears to be group selection may, in fact, simply be the consequence of natural selection occurring in stochastic environments with reproductive risks that are correlated across individuals. Those individuals with highly correlated risks will appear to form "groups'', even if their actions are, in fact, totally autonomous, mindless, and, prior to selection, uniformly randomly distributed in the population. This framework implies that a separate theory of group selection is not strictly necessary to explain observed phenomena such as altruism and cooperation. At the same time, it shows that the notion of group selection does captures a unique aspect of evolution-selection with correlated reproductive risk-that may be sufficiently widespread to warrant a separate term for the phenomenon.	[Zhang, Ruixun] MIT Dept Math, Cambridge, MA USA; [Brennan, Thomas J.] Northwestern Univ, Sch Law, Chicago, IL 60611 USA; [Lo, Andrew W.] MIT Sloan Sch Management, CSAIL, Cambridge, MA 02142 USA; [Lo, Andrew W.] MIT Sloan Sch Management, EECS, Cambridge, MA USA; [Lo, Andrew W.] AlphaSimplex Grp LLC, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Northwestern University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lo, AW (corresponding author), MIT Sloan Sch Management, CSAIL, Cambridge, MA 02142 USA.	alo@mit.edu			MIT Laboratory for Financial Engineering	MIT Laboratory for Financial Engineering	Research support from the MIT Laboratory for Financial Engineering is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; [Anonymous], 1996, ADAPTATION NATURAL S; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Ben-Jacob E, 2008, EUROPEAN PHYSICS JOU, VB, P1; BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0; Bergstrom TC, 2002, J ECON PERSPECT, V16, P67, DOI 10.1257/0895330027265; Bergstrom TC, 2014, P NATL ACAD SCI USA, V111, P10860, DOI 10.1073/pnas.1400817111; BLUME L, 1992, J ECON THEORY, V58, P9, DOI 10.1016/0022-0531(92)90099-4; Boomsma JJ, 2011, NATURE, V471, pE4, DOI 10.1038/nature09832; Brennan TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050310; Brennan TJ, 2011, Q J FINANC, V1, P55, DOI 10.1142/S201013921100002X; Burger R, 2002, GENET RES, V80, P31, DOI 10.1017/S0016672302005682; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Burnham TC, 2013, J ECON BEHAV ORGAN, V90, pS113, DOI 10.1016/j.jebo.2012.12.015; CARACO T, 1980, ECOLOGY, V61, P119, DOI 10.2307/1937162; Childs DZ, 2010, P ROYAL SOC B; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COOPER WS, 1982, J THEOR BIOL, V94, P135, DOI 10.1016/0022-5193(82)90336-8; Curry PA, 2001, J ECON THEORY, V98, P357, DOI 10.1006/jeth.2000.2719; De Blasio FV, 1999, PHYS REV E, V60, P5912, DOI 10.1103/PhysRevE.60.5912; DENEUBOURG JL, 1987, EUR J OPER RES, V30, P168, DOI 10.1016/0377-2217(87)90093-2; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Ferriere R, 2011, NATURE, V471, pE6, DOI 10.1038/nature09834; Frank SA, 2013, J EVOLUTION BIOL, V26, P1151, DOI 10.1111/jeb.12131; Frank SA, 2012, J EVOLUTION BIOL, V25, P227, DOI 10.1111/j.1420-9101.2011.02431.x; Frank SA, 2011, J EVOLUTION BIOL, V24, P2310, DOI 10.1111/j.1420-9101.2011.02373.x; Frank SA, 2011, J EVOLUTION BIOL, V24, P2299, DOI 10.1111/j.1420-9101.2011.02378.x; FRANK SA, 1990, AM NAT, V136, P244, DOI 10.1086/285094; FRETWELL S D, 1972, P217; GILLESPIE JH, 1978, AM NAT, V112, P897, DOI 10.1086/283330; Grafen A, 1999, P ROY SOC B-BIOL SCI, V266, P799, DOI 10.1098/rspb.1999.0708; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HANSSON I, 1990, AM ECON REV, V80, P529; HARDER LD, 1987, ECOLOGY, V68, P1104, DOI 10.2307/1938384; Herre EA, 2011, NATURE, V471, pE8, DOI 10.1038/nature09835; HERRMANNPILLATH C, 1991, J SOC BIOL STRUCT, V14, P127, DOI 10.1016/0140-1750(91)90077-4; HIRSHLEIFER J, 1977, J LAW ECON, V20, P1, DOI 10.1086/466891; Hirshleifer J., 1978, J SOC BIOL STRUCT, V1, P319; Holldobler B., 1990, pi; Ingham CJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-36; Keasar T, 2002, BEHAV ECOL, V13, P757, DOI 10.1093/beheco/13.6.757; KELLY JL, 1956, BELL SYST TECH J, V35, P917, DOI 10.1002/j.1538-7305.1956.tb03809.x; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Kogan L, 2006, J FINANC, V61, P195, DOI 10.1111/j.1540-6261.2006.00834.x; Lehmann L, 2007, P NATL ACAD SCI USA, V104, P6736, DOI 10.1073/pnas.0700662104; LEVIN SA, 1984, THEOR POPUL BIOL, V26, P165, DOI 10.1016/0040-5809(84)90028-5; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; LEVINS RICHARD, 1968; Lion S, 2011, TRENDS ECOL EVOL, V26, P193, DOI 10.1016/j.tree.2011.01.006; Lo AW, 2004, J PORTFOLIO MANAGE, P15, DOI 10.3905/jpm.2004.442611; LUO GY, 1995, J ECON THEORY, V67, P223, DOI 10.1006/jeth.1995.1072; Luo GY, 1998, REV FINANC STUD, V11, P647, DOI 10.1093/rfs/11.3.647; Lynch M., 1993, BIOTIC INTERACTIONS, P235; Mangel M., 1988, DYNAMIC MODELING BEH; Marshall JAR, 2011, TRENDS ECOL EVOL, V26, P325, DOI 10.1016/j.tree.2011.04.008; Maynard S.J., 1982, EVOLUTION THEORY GAM; Mayr E., 2001, WHAT EVOLUTION IS; MCNAMARA JM, 1995, EVOL ECOL, V9, P185, DOI 10.1007/BF01237756; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Oster G. F., 1979, CASTE ECOLOGY SOCIAL, DOI DOI 10.1007/BF00046355; Pasteels JM, 1987, EXPERIENTIA S; Pekalski A, 2002, PHYSICA A, V314, P114, DOI 10.1016/S0378-4371(02)01061-0; Pekalski A, 1998, PHYSICA A, V252, P325, DOI 10.1016/S0378-4371(97)00639-0; Pekalski A, 1999, PHYSICA A, V265, P255, DOI 10.1016/S0378-4371(98)00646-3; Pfennig DW, 1999, BEHAV ECOL, V10, P436, DOI 10.1093/beheco/10.4.436; Pinker S, 2012, TECHNICAL REPORT; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; REAL L, 1986, ANNU REV ECOL SYST, V17, P371, DOI 10.1146/annurev.es.17.110186.002103; REAL LA, 1980, AM NAT, V115, P623, DOI 10.1086/283588; Robson A, 2001, J POLIT ECON, V109, P900, DOI 10.1086/322083; Robson AJ, 2001, J ECON LIT, V39, P11, DOI 10.1257/jel.39.1.11; Robson AJ, 1996, J ECON THEORY, V68, P397, DOI 10.1006/jeth.1996.0023; Robson AJ, 1996, GAME ECON BEHAV, V14, P190, DOI 10.1006/game.1996.0048; Robson AJ, 2008, AM ECON REV, V98, P1178, DOI 10.1257/aer.98.3.1178; Robson AJ, 2007, AM ECON REV, V97, P496, DOI 10.1257/aer.97.2.496; Robson AJ, 2009, AM ECON REV, V99, P1925, DOI 10.1257/aer.99.5.1925; ROGERS AR, 1994, AM ECON REV, V84, P460; Rubenstein D.I., 1982, P91; Safarzynska K, 2010, ECOL ECON, V69, P743, DOI 10.1016/j.ecolecon.2009.04.003; SAMUELSO.PA, 1971, P NATL ACAD SCI USA, V68, P2493, DOI 10.1073/pnas.68.10.2493; Samuelson L, 2001, J ECON THEORY, V97, P225, DOI 10.1006/jeth.2000.2753; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; Smallwood PD, 1996, AM ZOOL, V36, P392; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Stephens D.W., 1986, pi; Strassmann JE, 2011, NATURE, V471, pE5, DOI 10.1038/nature09833; Thorp E.O., 2006, HDB ASSET LIABILITY, V1, P385; Thorp EO, 1971, P AM STAT ASS, P215; THUIJSMAN F, 1995, J THEOR BIOL, V175, P305, DOI 10.1006/jtbi.1995.0144; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van den Bergh JCJM, 2009, J ECON BEHAV ORGAN, V72, P1, DOI 10.1016/j.jebo.2009.04.017; Wade MJ, 2010, NATURE, V463, pE8, DOI 10.1038/nature08809; WALDMAN M, 1994, AM ECON REV, V84, P482; Wild G, 2009, NATURE, V459, P983, DOI 10.1038/nature08071; Wilson DS, 2008, AM SCI, V96, P380, DOI 10.1511/2008.74.1; WILSON DS, 1994, BEHAV BRAIN SCI, V17, P585, DOI 10.1017/S0140525X00036104; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Wilson E.O., 1975, P1; Wilson EO, 2013, SOCIAL CONQUEST EART; Wilson EO, 2005, SOC RES, V72; WRIGHT S, 1980, EVOLUTION, V34, P825, DOI 10.1111/j.1558-5646.1980.tb04022.x; WYNNEEDWARDS VC, 1963, NATURE, V200, P623, DOI 10.1038/200623a0; YOSHIMURA J, 1991, EVOL ECOL, V5, P173, DOI 10.1007/BF02270833; Yoshimura J, 1996, RES POPUL ECOL, V38, P165, DOI 10.1007/BF02515724	115	4	4	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110848	10.1371/journal.pone.0110848	http://dx.doi.org/10.1371/journal.pone.0110848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353167	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200043
J	Miar, Y; Plastow, G; Bruce, H; Moore, S; Manafiazar, G; Kemp, R; Charagu, P; Huisman, A; van Haandel, B; Zhang, CY; McKay, R; Wang, ZQ				Miar, Younes; Plastow, Graham; Bruce, Heather; Moore, Stephen; Manafiazar, Ghader; Kemp, Robert; Charagu, Patrick; Huisman, Abe; van Haandel, Benny; Zhang, Chunyan; McKay, Robert; Wang, Zhiquan			Genetic and Phenotypic Correlations between Performance Traits with Meat Quality and Carcass Characteristics in Commercial Crossbred Pigs	PLOS ONE			English	Article							INDIVIDUAL BIRTH-WEIGHT; RESIDUAL FEED-INTAKE; LARGE WHITE-PIGS; PIGLET SURVIVAL; OUTDOOR CONDITIONS; INTRAMUSCULAR FAT; PORK QUALITY; DUROC PIGS; PARAMETERS; SELECTION	Genetic correlations between performance traits with meat quality and carcass traits were estimated on 6,408 commercial crossbred pigs with performance traits recorded in production systems with 2,100 of them having meat quality and carcass measurements. Significant fixed effects (company, sex and batch), covariates (birth weight, cold carcass weight, and age), random effects (additive, litter and maternal) were fitted in the statistical models. A series of pairwise bivariate analyses were implemented in ASREML to estimate heritability, phenotypic, and genetic correlations between performance traits (n = 9) with meat quality (n = 25) and carcass (n = 19) traits. The animals had a pedigree compromised of 9,439 animals over 15 generations. Performance traits had low-to-moderate heritabilities (+/- SE), ranged from 0.07 +/- 0.13 to 0.45 +/- 0.07 for weaning weight, and ultrasound backfat depth, respectively. Genetic correlations between performance and carcass traits were moderate to high. The results indicate that: (a) selection for birth weight may increase drip loss, lightness of longissimus dorsi, and gluteus medius muscles but may reduce fat depth; (b) selection for nursery weight can be valuable for increasing both quantity and quality traits; (c) selection for increased daily gain may increase the carcass weight and most of the primal cuts. These findings suggest that deterioration of pork quality may have occurred over many generations through the selection for less backfat thickness, and feed efficiency, but selection for growth had no adverse effects on pork quality. Low-to-moderate heritabilities for performance traits indicate that they could be improved using traditional selection or genomic selection. The estimated genetic parameters for performance, carcass and meat quality traits may be incorporated into the breeding programs that emphasize product quality in these Canadian swine populations.	[Miar, Younes; Plastow, Graham; Bruce, Heather; Moore, Stephen; Manafiazar, Ghader; Zhang, Chunyan; Wang, Zhiquan] Univ Alberta, Livestock Gentec Ctr, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Kemp, Robert] Genesus Genet, Oakville, MB, Canada; [Charagu, Patrick; van Haandel, Benny] Hypor Inc, Regina, SK, Canada; [Huisman, Abe] Hendrix Genet, Res & Technol Ctr, Boxmeer, Netherlands; [Moore, Stephen] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [McKay, Robert] McKay GENSTAT Consultants Inc, Brandon, MB, Canada	University of Alberta; University of Queensland	Wang, ZQ (corresponding author), Univ Alberta, Livestock Gentec Ctr, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	Zhiquan@ualberta.ca		Miar, Younes/0000-0001-9933-5414; Bruce, Heather/0000-0002-8522-813X; Plastow, Graham/0000-0002-3774-3110	Natural Sciences and Engineering Research Council of Canada (NSERC); Hypor Inc.; Genesus Genetics	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hypor Inc.; Genesus Genetics	The authors acknowledge the financial support from Natural Sciences and Engineering Research Council of Canada (NSERC): www.nserc-crsng.gc.ca; Hypor Inc.: http://www.hypor.com/; and Genesus Genetics: http://www.genesus.com/. The authors would like to extend thanks to the companies for providing the possibility and the facilities to collect the data. Except for the role of the industry staff in preparation of the manuscript as co-authors the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango J, 2006, LIVEST SCI, V101, P208, DOI 10.1016/j.livprodsci.2005.11.011; Cai W, 2008, J ANIM SCI, V86, P287, DOI 10.2527/jas.2007-0396; CAMERON ND, 1988, ANIM PROD, V46, P87, DOI 10.1017/S0003356100003147; CAMERON ND, 1990, LIVEST PROD SCI, V26, P119, DOI 10.1016/0301-6226(90)90061-A; Cassady JP, 2002, J ANIM SCI, V80, P2286; Ciobanu DC, 2011, GENETICS OF THE PIG, 2ND EDITION, P355, DOI 10.1079/9781845937560.0355; Clutter AC, 1998, GENETICS OF THE PIG, P427; Clutter AC, 2011, GENETICS OF THE PIG, 2ND EDITION, P325, DOI 10.1079/9781845937560.0325; DEVRIES AG, 1994, LIVEST PROD SCI, V40, P277, DOI 10.1016/0301-6226(94)90095-7; Dransfield E, 2005, MEAT SCI, V69, P61, DOI 10.1016/j.meatsci.2004.06.006; Ducos A, 1994, MISE POINT BIBLIO TE, V17, P35; Fix JS, 2010, LIVEST SCI, V127, P51, DOI 10.1016/j.livsci.2009.08.007; Gibson JP, 1998, P 6 WORLD C GENETICS, V23, P499; Gilbert H, 2007, J ANIM SCI, V85, P3182, DOI 10.2527/jas.2006-590; Gilmour AR, 2009, ASREML USER GUIDE RE; Hermesch S, 2000, LIVEST PROD SCI, V65, P249, DOI 10.1016/S0301-6226(00)00151-2; Hoque MA, 2007, J ANIM SCI, V85, P1873, DOI 10.2527/jas.2006-730; Jiang YZ, 2012, GENET MOL RES, V11, P4447, DOI 10.4238/2012.September.19.6; Kaufmann D, 2000, J ANIM BREED GENET, V117, P121, DOI 10.1111/j.1439-0388.2000x.00238.x; Knol EF, 2002, LIVEST PROD SCI, V78, P47, DOI 10.1016/S0301-6226(02)00184-7; Koots K.R., 1994, P 5 WORLD C GEN APPL, V18, P353; Latorre MA, 2008, LIVEST SCI, V115, P258, DOI 10.1016/j.livsci.2007.08.013; Lo LL, 1992, J ANIMAL SCI, V70, P2357; Maignel L., 2010, P 9 WORLD C GEN APPL; Miar Y, 2014, J ANIM SCI, V92, P2869, DOI 10.2527/jas.2014-7685; Miar Y, 2014, CAN J ANIM SCI, V94, P273, DOI [10.4141/CJAS2013-115, 10.4141/cjas2013-115]; National Swine Improvement Federation, 1997, GUID UN SWIN IMPR PR; Newcom DW, 2002, J ANIM SCI, V80, P3099; Olfert E.D, 1993, GUIDE CARE USE EXPT, V1; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Roehe R, 2010, J ANIM SCI, V88, P1276, DOI 10.2527/jas.2009-2287; Roehe R, 2009, LIVEST SCI, V121, P173, DOI 10.1016/j.livsci.2008.06.010; Roehe R, 1999, J ANIM SCI, V77, P330; Schwab CR, 2009, J ANIM SCI, V87, P2774, DOI 10.2527/jas.2008-1335; Sonesson AK, 1998, LIVEST PROD SCI, V57, P23, DOI 10.1016/S0301-6226(98)00163-8; Stewart T., 1991, GENETICS SWINE, P77; Suzuki K, 2005, J ANIM SCI, V83, P2058; van Wijk HJ, 2005, J ANIM SCI, V83, P324	38	38	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110105	10.1371/journal.pone.0110105	http://dx.doi.org/10.1371/journal.pone.0110105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350845	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100020
J	Gopal, A; Iyer, SC; Gopal, U; Devaraj, N; Halagowder, D				Gopal, Ashidha; Iyer, Soumya Chidambaram; Gopal, Udhayakumar; Devaraj, Niranjali; Halagowder, Devaraj			Shigella dysenteriae Modulates BMP Pathway to Induce Mucin Gene Expression In Vivo and In Vitro	PLOS ONE			English	Article							HOMEODOMAIN PROTEIN CDX2; EPITHELIAL-CELLS; REGULATE CDX2; BILE-ACIDS; ACTIVATION; INFECTION; MUC5AC; MODEL; PATHOGENESIS; METAPLASIA	Mucosal epithelial cells in the intestine act as the first line of host defense against pathogens by increasing mucin production for clearance. Despite this fact, the underlying molecular mechanisms by which Shigella dysenteriae transduce mucin gene expression remain poorly defined. The goal of this study was to determine the role of Bone morphogenetic protein (BMP) pathway in mucin gene expression during S. dysenteriae infection. In this study we demonstrate that S. dysenteriae activates BMP signaling to induce MUC2 and MUC5AC gene expression in rat ileal loop model and in vitro. We also observed that BMP pathway regulates CDX2 expression which plays a critical role in induction of MUC2 gene during S. dysenteriae infection. In SMAD4 silenced cells S. dysenteriae infection did not abrogate MUC2 and MUC5AC gene expression whereas in CDX2 silenced cells it induces differential expression of MUC5AC gene. These results suggest that SMAD4-CDX2 induces MUC2 gene expression whereas SMAD4 directly influences differential expression of MUC5AC gene. Altogether, our results show that during S. dysenteriae infection the BMP pathway modulates inflammatory transcription factors CDX2 and SMAD4 to induce MUC2 and MUC5AC gene expression which plays a key role in the regulation of host mucosal defense thereby paving a cue for therapeutic application.	[Gopal, Ashidha; Iyer, Soumya Chidambaram; Halagowder, Devaraj] Univ Madras, Dept Zool, Sch Life Sci, Biochem Unit, Madras 600025, Tamil Nadu, India; [Gopal, Udhayakumar] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Devaraj, Niranjali] Univ Madras, Dept Biochem, Madras 600025, Tamil Nadu, India	University of Madras; Duke University; University of Madras	Halagowder, D (corresponding author), Univ Madras, Dept Zool, Sch Life Sci, Biochem Unit, Guindy Campus, Madras 600025, Tamil Nadu, India.	hdrajum@yahoo.com	Gopal, Udhayakumar/K-9092-2019		Department of Biotechnology [BT/PR1440/AAQ/03/532/2010]	Department of Biotechnology	The authors acknowledge Department of Biotechnology Project No. BT/PR1440/AAQ/03/532/2010 for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARM HG, 1965, J BACTERIOL, V89, P803, DOI 10.1128/JB.89.3.803-809.1965; Barros R, 2008, J PATHOL, V215, P411, DOI 10.1002/path.2369; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Camilo V, 2012, CARCINOGENESIS, V33, P1985, DOI 10.1093/carcin/bgs233; Castillo D, 2012, J GASTROINTEST SURG, V16, P227, DOI 10.1007/s11605-011-1758-5; Coskun M, 2011, BBA-MOL BASIS DIS, V1812, P283, DOI 10.1016/j.bbadis.2010.11.008; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dyer LA, 2014, TRENDS ENDOCRIN MET, V25, P472, DOI 10.1016/j.tem.2014.05.003; Fernandez MI, 2003, CELL MICROBIOL, V5, P481, DOI 10.1046/j.1462-5822.2003.00295.x; Forgue-Lafitte ME, 2007, INT J CANCER, V121, P1543, DOI 10.1002/ijc.22865; Hasnain SZ, 2011, PARASITE IMMUNOL, V33, P45, DOI 10.1111/j.1365-3024.2010.01258.x; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hong SM, 2005, AM J CLIN PATHOL, V124, P361, DOI 10.1309/GTU1Y77MVR4DX5A2; Ikeda H, 2007, LAB INVEST, V87, P559, DOI 10.1038/labinvest.3700556; Kazumori H, 2006, GUT, V55, P16, DOI 10.1136/gut.2005.066209; Kringel H, 2006, INT J PARASITOL, V36, P915, DOI 10.1016/j.ijpara.2006.04.008; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mesquita P, 2003, J BIOL CHEM, V278, P51549, DOI 10.1074/jbc.M309019200; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Radhakrishnan P, 2007, BBA-GEN SUBJECTS, V1770, P884, DOI 10.1016/j.bbagen.2007.01.019; Raja SB, 2012, J CELL SCI, V125, P703, DOI 10.1242/jcs.092148; Shimada T, 2007, REGUL PEPTIDES, V140, P81, DOI 10.1016/j.regpep.2006.11.014; Takeda K, 2010, PARASITE IMMUNOL, V32, P420, DOI 10.1111/j.1365-3024.2010.01200.x; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2	37	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111408	10.1371/journal.pone.0111408	http://dx.doi.org/10.1371/journal.pone.0111408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365201	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100065
J	Mandal, A; Mandal, S; Park, MH				Mandal, Ajeet; Mandal, Swati; Park, Myung Hee			Genome-Wide Analyses and Functional Classification of Proline Repeat-Rich Proteins: Potential Role of eIF5A in Eukaryotic Evolution	PLOS ONE			English	Article							ELONGATION-FACTOR-P; FACTOR EF-P; SYNTHESIS INITIATION-FACTORS; AMINO-ACID; POSTTRANSLATIONAL SYNTHESIS; DEOXYHYPUSINE HYDROXYLASE; PROMOTES TRANSLATION; FACTOR 5A; HYPUSINE; RESOURCE	The eukaryotic translation factor, eIF5A has been recently reported as a sequence-specific elongation factor that facilitates peptide bond formation at consecutive prolines in Saccharomyces cerevisiae, as its ortholog elongation factor P (EF-P) does in bacteria. We have searched the genome databases of 35 representative organisms from six kingdoms of life for PPP (Pro-Pro- Pro) and/or PPG (Pro-Pro-Gly)-encoding genes whose expression is expected to depend on eIF5A. We have made detailed analyses of proteome data of 5 selected species, Escherichia coli, Saccharomyces cerevisiae, Drosophila melanogaster, Mus musculus and Homo sapiens. The PPP and PPG motifs are low in the prokaryotic proteomes. However, their frequencies markedly increase with the biological complexity of eukaryotic organisms, and are higher in newly derived proteins than in those orthologous proteins commonly shared in all species. Ontology classifications of S. cerevisiae and human genes encoding the highest level of polyprolines reveal their strong association with several specific biological processes, including actin/cytoskeletal associated functions, RNA splicing/turnover, DNA binding/transcription and cell signaling. Previously reported phenotypic defects in actin polarity and mRNA decay of eIF5A mutant strains are consistent with the proposed role for eIF5A in the translation of the polyproline-containing proteins. Of all the amino acid tandem repeats (>= 3 amino acids), only the proline repeat frequency correlates with functional complexity of the five organisms examined. Taken together, these findings suggest the importance of proline repeat-rich proteins and a potential role for eIF5A and its hypusine modification pathway in the course of eukaryotic evolution.	[Mandal, Ajeet; Mandal, Swati; Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Park, MH (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	mhpark@nih.gov			intramural program of the National Institute of Dental and Craniofacial Research; National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	intramural program of the National Institute of Dental and Craniofacial Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by the intramural program of the National Institute of Dental and Craniofacial Research, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Alba MM, 2004, GENOME RES, V14, P549, DOI 10.1101/gr.1925704; Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; BENNE R, 1978, J BIOL CHEM, V253, P3078; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; de Almeida OP, 2014, CURR PHARM DESIGN, V20, P284; DEVER TE, 2014, CRIT REV BIOCHEM MOL, P1; Doerfel LK, 2013, BIOPOLYMERS, V99, P837, DOI 10.1002/bip.22341; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Elam WA, 2013, PROTEIN SCI, V22, P405, DOI 10.1002/pro.2217; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; KANG HA, 1994, J BIOL CHEM, V269, P3934; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; LI T, 2014, GENETICS; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Patel PH, 2009, J CELL BIOL, V185, P1181, DOI 10.1083/jcb.200904161; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SIEVERT H, 2014, DIS MODEL MECH; Sugimoto A, 2004, DIFFERENTIATION, V72, P81, DOI 10.1111/j.1432-0436.2004.07202004.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Wang DY, 2005, MOL BIOL EVOL, V22, P142, DOI 10.1093/molbev/msh263; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zanelli CF, 2005, GENETICS, V171, P1571, DOI 10.1534/genetics.105.048082; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	57	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111800	10.1371/journal.pone.0111800	http://dx.doi.org/10.1371/journal.pone.0111800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364902	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100123
J	Sitges, M; Gomez, CD; Aldana, BI				Sitges, Maria; Gomez, Carlos D.; Aldana, Blanca I.			Sertraline Reduces IL-1 beta and TNF-alpha mRNA Expression and Overcomes Their Rise Induced by Seizures in the Rat Hippocampus	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INFLAMMATORY CYTOKINES; DEPRESSION; EPILEPSY; PATHOPHYSIOLOGY; INHIBITION; MECHANISM; MODELS; DRUGS; EEG	We recently discovered that the antidepressant sertraline is an effective inhibitor of hippocampus presynaptic Na+ channel permeability in vitro and of tonic-clonic seizures in animals in vivo. Several studies indicate that the pro-inflammatory cytokines in the central nervous system are increased in epilepsy and depression. On the other hand inhibition of Na+ channels has been shown to decrease pro-inflammatory cytokines in microglia. Therefore, the possibility that sertraline could overcome the rise in pro-inflammatory cytokine expression induced by seizures has been investigated. For this purpose, IL-1 beta and TNF-alpha mRNA expression was determined by RT-PCR in the hippocampus of rats administered once, or for seven consecutive days with sertraline at a low dose (0.75 mg/kg). The effect of sertraline at doses within the range of 0.75 to 25 mg/kg on the increase in IL-1 beta and TNF-alpha mRNA expression accompanying generalized tonic-clonic seizures, and increase in the pro-inflammatory cytokines expression induced by lipopolysaccharide was also investigated. We found that under basal conditions, a single 0.75 mg/kg sertraline dose decreased IL-1 beta mRNA expression, and also TNF-alpha expression after repeated doses. The increase in IL-1 beta and TNF-alpha expression induced by the convulsive agents and by the inoculation of lipopolysaccharide in the hippocampus was markedly reduced by sertraline also. Present results indicate that a reduction of brain inflammatory processes may contribute to the anti-seizure sertraline action, and that sertraline can be safely and successfully used at low doses to treat depression in epileptic patients.	[Sitges, Maria; Gomez, Carlos D.; Aldana, Blanca I.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Sitges, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico.	sitges@biomedicas.unam.mx		Aldana, Blanca/0000-0002-5027-1218; Gomez, Carlos/0000-0002-7065-8612	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico [IN200614]; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was financially supported by project IN200614 from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico. Carlos D. Gomez and Blanca I. Aldana are PhD students in the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, and were awarded with a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana BI, 2012, J NEUROCHEM, V121, P197, DOI 10.1111/j.1471-4159.2012.07674.x; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; FIESCHI C, 1980, LIFE SCI, V27, P239, DOI 10.1016/0024-3205(80)90143-5; Galvan E, 2004, NEUROCHEM RES, V29, P347, DOI 10.1023/B:NERE.0000013737.17288.ce; Hamid H, 2013, EPILEPSY BEHAV, V26, P261, DOI 10.1016/j.yebeh.2012.10.009; Hannestad J, 2011, NEUROPSYCHOPHARMACOL, V36, P2452, DOI 10.1038/npp.2011.132; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Janssen DGA, 2010, HUM PSYCHOPHARM CLIN, V25, P201, DOI 10.1002/hup.1103; Kanner AM, 2008, CURR OPIN NEUROL, V21, P190, DOI 10.1097/WCO.0b013e3282f4e978; Kanner AM, 2010, EPILEPSY BEHAV, V19, P156, DOI 10.1016/j.yebeh.2010.06.024; Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; MACDONALD RL, 1977, NATURE, V267, P720, DOI 10.1038/267720a0; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; Maes M, 1993, Rev Neurosci, V4, P407; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Mula M, 2012, NAT REV NEUROL, V8, P252, DOI 10.1038/nrneurol.2012.69; Noe KH, 2011, CURR TREAT OPTION NE, V13, P371, DOI 10.1007/s11940-011-0127-8; Plata-Salaman CR, 2000, MOL BRAIN RES, V75, P248, DOI 10.1016/S0169-328X(99)00306-X; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Sheehan DV, 2009, INT CLIN PSYCHOPHARM, V24, P43, DOI 10.1097/YIC.0b013e3282f4b616; Sinha S, 2008, EPILEPSY RES, V82, P171, DOI 10.1016/j.eplepsyres.2008.07.018; Sitges M, 2011, EPILEPSY RES, V96, P257, DOI 10.1016/j.eplepsyres.2011.06.006; Sitges M, 2012, EPILEPSY BEHAV, V25, P511, DOI 10.1016/j.yebeh.2012.09.005; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Stevanovic D, 2011, EPILEPSIA, V52, pE75, DOI 10.1111/j.1528-1167.2011.03133.x; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; TREMAINE LM, 1989, DRUG METAB DISPOS, V17, P542; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Walker FR, 2013, NEUROPHARMACOLOGY, V67, P304, DOI 10.1016/j.neuropharm.2012.10.002	38	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111665	10.1371/journal.pone.0111665	http://dx.doi.org/10.1371/journal.pone.0111665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364907	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100099
J	Monti, S; Palma, G; Ragucci, M; Mannelli, L; Mancini, M; Prinster, A				Monti, Serena; Palma, Giuseppe; Ragucci, Monica; Mannelli, Lorenzo; Mancini, Marcello; Prinster, Anna			Optimization of Tagged MRI for Quantification of Liver Stiffness Using Computer Simulated Data	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; HEPATIC-FIBROSIS; NONINVASIVE ASSESSMENT; MOTION; CIRRHOSIS; TRACKING; IMAGES; HEART	The heartbeat has been proposed as an intrinsic source of motion that can be used in combination with tagged Magnetic Resonance Imaging (MRI) to measure displacements induced in the liver as an index of liver stiffness. Optimizing a tagged MRI acquisition protocol in terms of sensitivity to these displacements, which are in the order of pixel size, is necessary to develop the method as a quantification tool for staging fibrosis. We reproduced a study of cardiac-induced strain in the liver at 3T and simulated tagged MR images with different grid tag patterns to evaluate the performance of the Harmonic Phase (HARP) image analysis method and its dependence on the parameters of tag spacing and grid angle. The Partial Volume Effect (PVE), T1 relaxation, and different levels of noise were taken into account. Four displacement fields of increasing intensity were created and applied to the tagged MR images of the liver. These fields simulated the deformation at different liver stiffnesses. An Error Index (EI) was calculated to evaluate the estimation accuracy for various parameter values. In the absence of noise, the estimation accuracy of the displacement fields increased as tag spacings decreased. EIs for each of the four displacement fields were lower at 0 degrees and the local minima of the EI were found to correspond to multiples of pixel size. The accuracy of the estimation decreased for increasing levels of added noise; as the level increased, the improved estimation caused by decreasing the tag spacing tended to zero. The optimal tag spacing turned out to be a compromise between the smallest tag period that is a multiple of the pixel size and is achievable in a real acquisition and the tag spacing that guarantees an accurate liver displacement measure in the presence of realistic levels of noise.	[Monti, Serena; Ragucci, Monica; Prinster, Anna] IRCCS SDN Fdn, Naples, Italy; [Palma, Giuseppe; Mancini, Marcello; Prinster, Anna] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Mannelli, Lorenzo] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Memorial Sloan Kettering Cancer Center	Monti, S (corresponding author), IRCCS SDN Fdn, Naples, Italy.	smonti@sdn-napoli.it	Monti, Serena/C-1062-2015; Prinster, Anna/AAW-3129-2020; Palma, Giuseppe/AAX-1413-2020; Prinster, Anna/B-8414-2015; Mannelli, Lorenzo/A-7165-2012; Palma, Giuseppe/GXV-0228-2022	Monti, Serena/0000-0002-8777-7837; Prinster, Anna/0000-0003-2706-3071; Mannelli, Lorenzo/0000-0002-9102-4176; Palma, Giuseppe/0000-0002-0210-268X				ATALAR E, 1994, IEEE T MED IMAGING, V13, P152, DOI 10.1109/42.276154; AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; Chung S, 2014, J MAGN RESON IMAGING, V39, P1301, DOI 10.1002/jmri.24260; Chung SH, 2011, MAGN RESON MED, V65, P949, DOI 10.1002/mrm.22785; Crum WR, 1997, JMRI-J MAGN RESON IM, V7, P416, DOI 10.1002/jmri.1880070228; Crum WR, 1998, J MAGN RESON IMAGING, V8, P1040, DOI 10.1002/jmri.1880080507; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Kim BH, 2011, J MAGN RESON IMAGING, V34, P1110, DOI 10.1002/jmri.22723; KUMAR S, 1994, IEEE T MED IMAGING, V13, P122, DOI 10.1109/42.276150; Mannelli L, 2012, J MAGN RESON IMAGING, V36, P1490, DOI 10.1002/jmri.23743; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Montillo A, 2004, PRO BIOMED OPT IMAG, V5, P1, DOI 10.1117/12.536860; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Osman NF, 1999, MAGN RESON MED, V42, P1048, DOI 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0.CO;2-M; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Papoulis A., 1991, PROBABILITY RANDOM V, V3; REEDER SB, 1994, MAGNET RESON MED, V31, P521, DOI 10.1002/mrm.1910310508; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Rustogi R, 2012, J MAGN RESON IMAGING, V35, P1356, DOI 10.1002/jmri.23585; Ryf S, 2002, P INT SOC MAG RESON, V10; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283	24	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111852	10.1371/journal.pone.0111852	http://dx.doi.org/10.1371/journal.pone.0111852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360557	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700154
J	Weng, PH; Huang, YL; Page, JH; Chen, JH; Xu, J; Koutros, S; Berndt, S; Chanock, S; Yeager, M; Witte, JS; Eeles, RA; Easton, DF; Neal, DE; Donovan, J; Hamdy, FC; Muir, KR; Giles, G; Severi, G; Smith, JR; Balistreri, CR; Shui, IM; Chen, YC				Weng, Pei-Hsuan; Huang, Yi-Ling; Page, John H.; Chen, Jen-Hau; Xu, Jianfeng; Koutros, Stella; Berndt, Sonja; Chanock, Stephen; Yeager, Meredith; Witte, John S.; Eeles, Rosalind A.; Easton, Douglas F.; Neal, David E.; Donovan, Jenny; Hamdy, Freddie C.; Muir, Kenneth R.; Giles, Graham; Severi, Gianluca; Smith, Jeffrey R.; Balistreri, Carmela R.; Shui, Irene M.; Chen, Yen-Ching			Polymorphisms of an Innate Immune Gene, Toll-Like Receptor 4, and Aggressive Prostate Cancer Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GENOME-WIDE ASSOCIATION; SEQUENCE VARIANTS; TLR4 POLYMORPHISMS; OXIDIZED LDL; SUSCEPTIBILITY; INFLAMMATION; ETIOLOGY; TOLL-LIKE-RECEPTOR-4; PATHOPHYSIOLOGY; ADENOCARCINOMA	Background: Toll-like receptor 4 (TLR4) is one of the best known TLR members expressed on the surface of several leukocytes and tissue cells and has a key function in detecting pathogen and danger-associated molecular patterns. The role of TLR4 in the pathophysiology of several age-related diseases is also well recognized, such as prostate cancer (PCa). TLR4 polymorphisms have been related to PCa risk, but the relationship between TLR4 genotypes and aggressive PCa risk has not been evaluated by any systematic reviews. Methods: We performed a systematic review and meta-analysis of candidate-gene and genome-wide association studies analyzing this relationship and included only white population. Considering appropriate criteria, only nine studies were analyzed in the meta-analysis, including 3,937 aggressive PCa and 7,382 controls. Results: Using random effects model, no significant association was found in the ten TLR4 SNPs reported by at least four included studies under any inheritance model (rs2737191, rs1927914, rs10759932, rs1927911, rs11536879, rs2149356, rs4986790, rs11536889, rs7873784, and rs1554973). Pooled estimates from another ten TLR4 SNPs reported by three studies also showed no significant association (rs10759930, rs10116253, rs11536869, rs5030717, rs4986791, rs11536897, rs1927906, rs913930, rs1927905, and rs7045953). Meta-regression revealed that study type was not a significant source of between-study heterogeneity. Conclusions: TLR4 polymorphisms were not significantly associated with the risk of aggressive PCa.	[Weng, Pei-Hsuan] Taiwan Adventist Hosp, Dept Family Med, Taipei, Taiwan; [Weng, Pei-Hsuan; Chen, Jen-Hau; Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Huang, Yi-Ling] Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Page, John H.] Brigham & Womens Hosp, Dept Epidemiol, Channing Lab, Boston, MA 02115 USA; [Chen, Jen-Hau] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Xu, Jianfeng] Wake Forest Univ, Sch Med, Ctr Human Gen, Winston Salem, NC 27109 USA; [Koutros, Stella; Berndt, Sonja; Chanock, Stephen] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Yeager, Meredith] NCI Frederick, SAIC Frederick Inc, Core Genotyping Fac, Frederick, MD USA; [Yeager, Meredith] NCI, Div Canc Epidemiol & Genet, DHHS, NIH, Bethesda, MD 20892 USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Ctr Human Genet, San Francisco, CA 94143 USA; [Eeles, Rosalind A.] Inst Canc Res, Sutton, Surrey, England; [Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Epidemiol, Strangeways Lab, Cambridge, England; [Easton, Douglas F.] Univ Cambridge, Dept Oncol, Strangeways Lab, Cambridge, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Surg Oncol Uro Oncol S4, Cambridge CB2 2QQ, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England; [Donovan, Jenny] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Hamdy, Freddie C.] Univ Sheffield, Acad Urol Unit, Sheffield, S Yorkshire, England; [Muir, Kenneth R.] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Giles, Graham; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Smith, Jeffrey R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Balistreri, Carmela R.] Univ Palermo, Dept Pathobiol, Palermo, Italy; [Shui, Irene M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; Tufts University; Harvard University; Brigham & Women's Hospital; National Taiwan University; National Taiwan University Hospital; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; Institute of Cancer Research - UK; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; University of Sheffield; University of Nottingham; Cancer Council Victoria; Vanderbilt University; University of Palermo; Harvard University; Harvard T.H. Chan School of Public Health; National Taiwan University; National Taiwan University	Chen, YC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw	Balistreri, Carmela/AAH-9522-2020; Yeager, Meredith/AAA-5322-2020; Berndt, Sonja I/J-8423-2016; Huang, YiLing/ABH-8788-2020; Koutros, Stella/W-5788-2019; Severi, Gianluca/Q-1824-2019; Balistreri, Carmela Rita CRB/K-9495-2016; Severi, Gianluca/H-3774-2018; Chen, Jen-Hau/AFP-2878-2022; Chen, Yen-Ching/D-1098-2010	Balistreri, Carmela/0000-0002-5393-1007; Koutros, Stella/0000-0001-5294-5485; Severi, Gianluca/0000-0001-7157-419X; Balistreri, Carmela Rita CRB/0000-0002-5393-1007; Severi, Gianluca/0000-0001-7157-419X; Chen, Yen-Ching/0000-0002-8159-7202; Eeles, Rosalind/0000-0002-3698-6241; Giles, Graham/0000-0003-4946-9099; Smith, Jeffrey/0000-0001-8424-910X	Cancer Research UK [16563, 17528, 15007] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP010221] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002502] Funding Source: NIH RePORTER; VA [5I01BX002502-03] Funding Source: Federal RePORTER; BLRD VA [I01 BX002502] Funding Source: Medline	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); BLRD VA		Balistreri CR, 2014, CANCER GENE THER, V21, P2, DOI 10.1038/cgt.2013.77; Balistreri CR, 2010, CURR PHARM DESIGN, V16, P718, DOI 10.2174/138161210790883877; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Breyer JP, 2009, CANCER EPIDEM BIOMAR, V18, P2137, DOI 10.1158/1055-9965.EPI-08-1223; Carantoni M, 1998, ARTERIOSCL THROM VAS, V18, P762, DOI 10.1161/01.ATV.18.5.762; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cheng I, 2007, BRIT J CANCER, V97, P557, DOI 10.1038/sj.bjc.6603874; Cheng I, 2007, CANCER EPIDEM BIOMAR, V16, P352, DOI 10.1158/1055-9965.EPI-06-0429; Das D, 2008, J VIROL, V82, P2705, DOI 10.1128/JVI.02461-07; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DeFranco A., 2007, IMMUNITY IMMUNE RESP; Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; FitzGerald LM, 2011, CANCER EPIDEM BIOMAR, V20, P1196, DOI 10.1158/1055-9965.EPI-10-1299; Haqq C, 2005, PROSTATE, V65, P101, DOI 10.1002/pros.20272; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Hong HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044483; Hua D, 2009, MOL IMMUNOL, V46, P2876, DOI 10.1016/j.molimm.2009.06.016; Jing JJ, 2012, GENE, V499, P237, DOI 10.1016/j.gene.2012.03.045; Klein EA, 2008, CURR OPIN UROL, V18, P315, DOI 10.1097/MOU.0b013e3282f9b3b7; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee LM, 2001, ANTICANCER RES, V21, P1291; Liberati A, 2009, PLOS MED, V6, DOI DOI 10.1186/s13643-016-0384-4; Lindstrom S, 2010, CANCER EPIDEM BIOMAR, V19, P873, DOI 10.1158/1055-9965.EPI-09-0618; Madoff LC, 2008, HARRISONS PRINCIPLES; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Nam RK, 2011, CANCER BIOL THER, V12, P997, DOI 10.4161/cbt.12.11.18366; Platz EA, 2004, J STEROID BIOCHEM, V92, P237, DOI 10.1016/j.jsbmb.2004.10.002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SAKR WA, 1994, IN VIVO, V8, P439; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Shashkin PN, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-13; Shui IM, 2012, PROSTATE, V72, P209, DOI 10.1002/pros.21423; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song J, 2009, CANCER GENET CYTOGEN, V190, P88, DOI 10.1016/j.cancergencyto.2008.12.011; Sutcliffe S, 2007, UROL ONCOL-SEMIN ORI, V25, P242, DOI 10.1016/j.urolonc.2006.09.014; Taylor ML, 2005, FAM MED, V37, P506; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang K, 2013, EUR J CANCER, V49, P946, DOI 10.1016/j.ejca.2012.09.022; Zheng SL, 2004, CANCER RES, V64, P2918, DOI 10.1158/0008-5472.CAN-03-3280; Zhu LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082858	55	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110569	10.1371/journal.pone.0110569	http://dx.doi.org/10.1371/journal.pone.0110569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360682	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700038
J	Caierao, J; Hawkins, P; Sant'anna, FH; da Cunha, GR; d'Azevedo, PA; McGee, L; Dias, C				Caierao, Juliana; Hawkins, Paulina; Sant'anna, Fernando Hayashi; da Cunha, Gabriela Rosa; d'Azevedo, Pedro Alves; McGee, Lesley; Dias, Cicero			Serotypes and Genotypes of Invasive Streptococcus pneumoniae Before and After PCV10 Implementation in Southern Brazil	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; MOLECULAR EPIDEMIOLOGY; UNITED-STATES; CLONE ST320; DISEASE; CHILDREN; CARRIAGE; 19A; POPULATION; MENINGITIS	To reduce the burden of pneumococcal diseases, different formulations of pneumococcal conjugate vaccines (PCV) have been introduced in many countries. In Brazil, PCV10 has been available since 2010. We aimed to analyze the serotype and genetic composition of invasive pneumococci from Brazil in pre- and post-vaccination periods (2007-2012). Antibiotic susceptibility was determined and genotypes of macrolide and fluoroquinolone resistance were characterized. The genotypes of isolates of the most frequent serotypes were determined by multilocus sequence typing. The study included 325 isolates, which were primarily recovered from blood. The most common serotypes recovered were 14, 3, 4, 23F, 7F, 9V, 12F, 20, 19F, 8, 19A, and 5. Thirty-eight pneumococci (11.7%) were from children <= 5 years old. Considering the overall population, PCV10 and PCV13 serotype coverage was 50.1% and 64.9%, respectively. During the pre-vaccine period, isolates with serotypes belonging to the PVC10 represented 51.5% (100/194), whereas in the post vaccine they represented 48.0% (63/131). PCV13 serotypes represented 67.5% (131/194) and 59.2% (77/131) of total for pre- and post-vaccination periods, respectively. Seventy different sequence types [STs] were found, accounting for 9 clonal complexes [CCs] and 45 singletons. Eight STs (156, 180, 218, 8889, 53, 191, 770, and 4967) represented the majority (51.5%) of isolates. Fifty STs were associated with the pre-vaccination period (27 exclusive) and 43 (20 exclusive) with the post-vaccination period; 23 STs were identified in both periods. Some serotypes were particularly clonal (7F, 8, 12F, 20). Non-susceptibility to penicillin was associated with serotype 19A, CC320. Erythromycin resistance was heterogeneous when considering serotype and ST. A single serotype 23F (ST4967) isolate was resistant to levofloxacin. Continued surveillance is required to determine vaccine impact and to monitor changes in pneumococcal population biology post-PCV10 introduction in Brazil.	[Caierao, Juliana; Sant'anna, Fernando Hayashi; da Cunha, Gabriela Rosa; d'Azevedo, Pedro Alves; Dias, Cicero] Fed Univ Hlth Sci, Porto Alegre, RS, Brazil; [Hawkins, Paulina] Emory Univ, Atlanta, GA 30322 USA; [McGee, Lesley] Ctr Dis Control & Prevent, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Dias, C (corresponding author), Fed Univ Hlth Sci, Porto Alegre, RS, Brazil.	cicero@ufcspa.edu.br	Dias, Cicero A G/A-1451-2017; CAIERÃO, JULIANA/K-8038-2018; Sant'Anna, Fernando H Hayashi/I-9129-2016	Dias, Cicero A G/0000-0002-8358-1183; Sant'Anna, Fernando H Hayashi/0000-0001-7767-8168	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [CNPq: Edital MCT/CNPq14/2008, 473607/2008-5]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) CNPq: Edital MCT/CNPq14/2008, 473607/2008-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Alvares JR, 2011, BRAZ J INFECT DIS, V15, P22, DOI 10.1590/S1413-86702011000100005; Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Barroso DE, 2012, PEDIATR INFECT DIS J, V31, P30, DOI 10.1097/INF.0b013e31822f8a92; Bettinger JA, 2010, VACCINE, V28, P2130, DOI 10.1016/j.vaccine.2009.12.026; Birtles A, 2005, J CLIN MICROBIOL, V43, P2004, DOI 10.1128/JCM.43.4.2004-2008.2005; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2002, ANTIMICROB AGENTS CH, V46, P680, DOI 10.1128/AAC.46.3.680-688.2002; Casado-Flores J, 2008, PEDIATR INFECT DIS J, V27, P1020, DOI 10.1097/INF.0b013e31817bd2dc; CLSI, 2013, PERFORMANCE STANDARD; de Quadros CA, 2009, VACCINE, V27, pC29, DOI 10.1016/j.vaccine.2009.06.006; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gene A, 2013, PEDIATR INFECT DIS J, V32, pE128, DOI 10.1097/INF.0b013e31827c54dc; Neves FPG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-318; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hsieh YC, 2013, J INFECT DIS, V208, P203, DOI 10.1093/infdis/jit145; Inverarity D, 2011, T ROY SOC TROP MED H, V105, P445, DOI 10.1016/j.trstmh.2011.04.013; Inverarity D, 2011, J MED MICROBIOL, V60, P793, DOI 10.1099/jmm.0.028803-0; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Laval CB, 2006, CLIN MICROBIOL INFEC, V12, P50, DOI 10.1111/j.1469-0691.2005.01304.x; Lin Chao-Jen, 2006, Journal of Microbiology Immunology and Infection, V39, P489; Lucarevschi Bianca R., 2003, J. Pediatr. (Rio J.), V79, P215, DOI 10.1590/S0021-75572003000300006; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mendes C., 2003, Braz J Infect Dis, V7, P44, DOI 10.1590/S1413-86702003000100006; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; PAHO, 2013, INF REG SIREVA 2 201; Pichon B, 2013, J CLIN MICROBIOL, V51, P820, DOI 10.1128/JCM.01917-12; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pimenta FC, 2011, J MED MICROBIOL, V60, P1455, DOI 10.1099/jmm.0.031450-0; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Rossi F, 2012, J BRAS PNEUMOL, V38, P66, DOI 10.1590/S1806-37132012000100010; Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Spellerberg B, 2011, MANUAL CLIN MICROBIO, P331; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; van der Linden M, 2012, VACCINE, V30, P5880, DOI 10.1016/j.vaccine.2012.06.068; Vestrheim DF, 2010, VACCINE, V28, P2214, DOI 10.1016/j.vaccine.2009.12.054; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Widdowson CA, 1998, EMERG INFECT DIS, V4, P277, DOI 10.3201/eid0402.980216; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Zemlickova H, 2005, MICROB DRUG RESIST, V11, P195, DOI 10.1089/mdr.2005.11.195; Zulz T, 2013, J CLIN MICROBIOL, V51, P1402, DOI 10.1128/JCM.02880-12	55	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111129	10.1371/journal.pone.0111129	http://dx.doi.org/10.1371/journal.pone.0111129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356595	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000042
J	Dainty, JR; Berry, R; Lynch, SR; Harvey, LJ; Fairweather-Tait, SJ				Dainty, Jack R.; Berry, Rachel; Lynch, Sean R.; Harvey, Linda J.; Fairweather-Tait, Susan J.			Estimation of Dietary Iron Bioavailability from Food Iron Intake and Iron Status	PLOS ONE			English	Article							PLASMA FERRITIN CONCENTRATIONS; SERUM FERRITIN; NONHEME-IRON; ABSORPTION; DEFICIENCY; STORES; PREDICTION; ALGORITHM; EXCRETION; WOMEN	Currently there are no satisfactory methods for estimating dietary iron absorption (bioavailability) at a population level, but this is essential for deriving dietary reference values using the factorial approach. The aim of this work was to develop a novel approach for estimating dietary iron absorption using a population sample from a sub-section of the UK National Diet and Nutrition Survey (NDNS). Data were analyzed in 873 subjects from the 2000-2001 adult cohort of the NDNS, for whom both dietary intake data and hematological measures (hemoglobin and serum ferritin (SF) concentrations) were available. There were 495 men aged 19-64 y (mean age 42.7 +/- 12.1 y) and 378 pre-menopausal women (mean age 35.7 +/- 8.2 y). Individual dietary iron requirements were estimated using the Institute of Medicine calculations. A full probability approach was then applied to estimate the prevalence of dietary intakes that were insufficient to meet the needs of the men and women separately, based on their estimated daily iron intake and a series of absorption values ranging from 1-40%. The prevalence of SF concentrations below selected cut-off values (indicating that absorption was not high enough to maintain iron stores) was derived from individual SF concentrations. An estimate of dietary iron absorption required to maintain specified SF values was then calculated by matching the observed prevalence of insufficiency with the prevalence predicted for the series of absorption estimates. Mean daily dietary iron intakes were 13.5 mg for men and 9.8 mg for women. Mean calculated dietary absorption was 8% in men (50th percentile for SF 85 mu g/L) and 17% in women (50th percentile for SF 38 mu g/L). At a ferritin level of 45 mu g/L estimated absorption was similar in men (14%) and women (13%). This new method can be used to calculate dietary iron absorption at a population level using data describing total iron intake and SF concentration.	[Dainty, Jack R.; Berry, Rachel; Harvey, Linda J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Lynch, Sean R.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Fairweather-Tait, Susan J.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Eastern Virginia Medical School; University of East Anglia	Fairweather-Tait, SJ (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	s.fairweather-tait@uea.ac.uk		Dainty, Jack/0000-0002-0056-1233; Fairweather-Tait, Susan/0000-0002-1413-5569	UK Biotechnology and Biological Sciences Research Council; EURRECA Network of Excellence Sixth Framework Programme [036196]	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EURRECA Network of Excellence Sixth Framework Programme	This work was supported by UK Biotechnology and Biological Sciences Research Council (JRD), and EURRECA Network of Excellence (www.eurreca.org) Sixth Framework Programme, contract 036196 (RB, LJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; Armah SM, 2013, J NUTR, V143, P1136, DOI 10.3945/jn.112.169904; Beard JL, 2007, J NUTR, V137, P1741, DOI 10.1093/jn/137.7.1741; BEZWODA WR, 1979, SCAND J HAEMATOL, V22, P113; Bothwell T.H., 1979, IRON METABOLISM MAN; Collings R, 2013, AM J CLIN NUTR, V98, P65, DOI 10.3945/ajcn.112.050609; COOK JD, 1991, AM J CLIN NUTR, V54, P717, DOI 10.1093/ajcn/54.4.717; COOK JD, 1974, AM J CLIN NUTR, V27, P681, DOI 10.1093/ajcn/27.7.681; GREEN R, 1968, AM J MED, V45, P336, DOI 10.1016/0002-9343(68)90069-7; HALLBERG L, 1993, BRIT J HAEMATOL, V85, P787, DOI 10.1111/j.1365-2141.1993.tb03225.x; Hallberg L, 2000, AM J CLIN NUTR, V71, P1147; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; Hallberg L, 1998, EUR J CLIN NUTR, V52, P623, DOI 10.1038/sj.ejcn.1600623; Harvey LJ, 2013, CRIT REV FOOD SCI, V53, P1064, DOI 10.1080/10408398.2012.742860; Harvey LJ, 2005, BRIT J NUTR, V94, P557, DOI 10.1079/BJN20051493; Hefnawi F, 1980, Int J Gynaecol Obstet, V17, P343; Henderson L., 2003, NATL DIET NUTR SURVE, V3, P14; Hoare J, 2004, NATL DIET NUTR SURVE, V5; Hunt JR, 2009, AM J CLIN NUTR, V89, P1792, DOI 10.3945/ajcn.2009.27439; Institute of Medicine, 2001, DIETARY REFERENCE IN; Lader D, 2009, 41 OFF NAT STAT OFF; LAYRISSE M, 1969, BLOOD-J HEMATOL, V33, P430, DOI 10.1182/blood.V33.3.430.430; LYNCH SR, 1989, BLOOD, V74, P2187; MAGNUSSON B, 1981, SCAND J HAEMATOL, V27, P201; MILMAN N, 1993, ACTA OBSTET GYN SCAN, V72, P601, DOI 10.3109/00016349309021150; R Core Team, 2021, R LANGUAGE ENV STAT; Reddy MB, 2000, AM J CLIN NUTR, V71, P937; Roughead ZK, 2000, AM J CLIN NUTR, V72, P982; Ruston D, 2004, NUTR DIET NUTR SURVE; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Serra-Majem L, 2009, BRIT J NUTR, V102, pS38, DOI 10.1017/S0007114509993138; Skouby SO, 2010, EUR J CONTRACEP REPR, V15, pS42, DOI 10.3109/13625187.2010.533002; TAYLOR P, 1988, J NUTR, V118, P1110, DOI 10.1093/jn/118.9.1110; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; WALTERS GO, 1975, GUT, V16, P188, DOI 10.1136/gut.16.3.188; World Health Organization, 2001, IR DEF AN ASS PREV C; Zafon C, 2010, OBES REV, V11, P322, DOI 10.1111/j.1467-789X.2009.00638.x; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	39	27	27	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111824	10.1371/journal.pone.0111824	http://dx.doi.org/10.1371/journal.pone.0111824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356629	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000346765000079
J	Bosiger, YJ; McCormick, MI				Bosiger, Yoland J.; McCormick, Mark I.			Temporal Links in Daily Activity Patterns between Coral Reef Predators and Their Prey	PLOS ONE			English	Article							ANTIPREDATOR RESPONSE; FEEDING-BEHAVIOR; ACTIVITY RHYTHMS; GAME-THEORY; FISH; RISK; DIEL; ABUNDANCE; COMPETITION; SERRANIDAE	Few studies have documented the activity patterns of both predators and their common prey over 24 h diel cycles. This study documents the temporal periodicity of two common resident predators of juvenile reef fishes, Cephalopholis cyanostigma (rockcod) and Pseudochromis fuscus (dottyback) and compares these to the activity and foraging pattern of a common prey species, juvenile Pomacentrus moluccensis (lemon damselfish). Detailed observations of activity in the field and using 24 h infrared video in the laboratory revealed that the two predators had very different activity patterns. C. cyanostigma was active over the whole 24 h period, with a peak in feeding strikes at dusk and increased activity at both dawn and dusk, while P. fuscus was not active at night and had its highest strike rates at midday. The activity and foraging pattern of P. moluccensis directly opposes that of C. cyanostigma with individuals reducing strike rate and intraspecific aggression at both dawn and dusk, and reducing distance from shelter and boldness at dusk only. Juveniles examined were just outside the size-selection window of P. fuscus. We suggest that the relatively predictable diel behaviour of coral reef predators results from physiological factors such as visual sensory abilities, circadian rhythmicity, variation in hunting profitability, and predation risk at different times of the day. Our study suggests that the diel periodicity of P. moluccensis behaviour may represent a response to increased predation risk at times when both the ability to efficiently capture food and visually detect predators is reduced.	[McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	McCormick, MI (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	mark.mccormick@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	Australian Research Council [DP0985015]	Australian Research Council(Australian Research Council)	This research was funded through an Australian Research Council Discovery grant to MIM (DP0985015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi J, 2013, MAR ECOL PROG SER, V486, P223, DOI 10.3354/meps10399; Ali MA, 1992, RHYTHMS FISHES; ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Beukers-Stewart BD, 2011, CORAL REEFS, V30, P855, DOI 10.1007/s00338-011-0792-9; Beukers-Stewart BD, 2004, J EXP MAR BIOL ECOL, V299, P155, DOI 10.1016/j.jembe.2003.08.015; Booth DJ, 2004, OECOLOGIA, V140, P289, DOI 10.1007/s00442-004-1608-1; Bosiger YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034535; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Colmenero AI, 2010, MAR ECOL PROG SER, V416, P255, DOI 10.3354/meps08766; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Danilowicz BS, 1999, MAR BIOL, V133, P337, DOI 10.1007/s002270050472; DOMM SB, 1973, PAC SCI, V27, P128; FEENER DH, 1988, BEHAV ECOL SOCIOBIOL, V22, P421, DOI 10.1007/BF00294980; Feeney WE, 2012, CORAL REEFS, V31, P909, DOI 10.1007/s00338-012-0894-z; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; Fox RJ, 2011, FUNCT ECOL, V25, P1096, DOI 10.1111/j.1365-2435.2011.01874.x; Gibran FZ, 2007, NEOTROP ICHTHYOL, V5, P387, DOI 10.1590/S1679-62252007000300018; GLADSTONE W, 1988, ENVIRON BIOL FISH, V21, P207, DOI 10.1007/BF00004864; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; Guthrie D.M., 1993, Fish and Fisheries Series, V7, P89; HARMELINVIVIEN ML, 1976, MAR BIOL, V37, P329, DOI 10.1007/BF00387488; Helfman G.S., 1993, BEHAV TELEOST FISHES, P479, DOI DOI 10.1007/978-94-011-1578-0; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; HELFMAN GS, 1981, CAN J FISH AQUAT SCI, V38, P1405, DOI 10.1139/f81-187; Hobson E.S., 1991, P69; Hobson E. S., 1965, Copeia, V1965, P291, DOI 10.2307/1440790; HOBSON ES, 1975, AM SCI, V63, P382; HOBSON ES, 1972, FISH BULL NATL OC AT, V70, P715; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holmes TH, 2012, CORAL REEFS, V31, P1113, DOI 10.1007/s00338-012-0934-8; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; HUGIE DM, 1994, J FISH BIOL, V45, P151, DOI 10.1111/j.1095-8649.1994.tb01090.x; Kavanau JL, 1998, BRAIN RES BULL, V46, P269, DOI 10.1016/S0361-9230(98)00018-5; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2011, CORAL REEFS, V30, P805, DOI 10.1007/s00338-011-0768-9; Lonnstedt OM, 2013, ECOL EVOL, V3, P38, DOI 10.1002/ece3.388; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Martin JM, 1994, THESIS J COOK U; McCormick MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep03280; McCormick MI, 2013, ECOL EVOL, V3, P4221, DOI 10.1002/ece3.793; McCormick MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042590; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; McFarland W.N., 1991, P16; Melinski M, 1990, BEHAV TELEOST FISHES, P285; Metcalfe NB, 1999, J ANIM ECOL, V68, P371, DOI 10.1046/j.1365-2656.1999.00289.x; Metcalfe NB, 1998, P ROY SOC B-BIOL SCI, V265, P1503, DOI 10.1098/rspb.1998.0464; Meyer CG, 2007, MAR BIOL, V151, P2133, DOI 10.1007/s00227-007-0647-7; Mitchell MD, 2013, BEHAV ECOL SOCIOBIOL, V67, P1123, DOI 10.1007/s00265-013-1537-2; Mitchell MD, 2011, ANIM COGN, V14, P707, DOI 10.1007/s10071-011-0405-6; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; PITCHER TJ, 1986, J FISH BIOL, V29, P59, DOI 10.1111/j.1095-8649.1986.tb04999.x; POTTS GW, 1990, LIGHT AND LIFE IN THE SEA, P221; Quinn GP, 2003, EXPT DESIGN DATA ANA; Randall JE, 1997, FISHES GREAT BARRER; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; Rickel S, 2005, ANIM BEHAV, V70, P133, DOI 10.1016/j.anbehav.2004.10.014; RIECHERT SE, 1983, ANNU REV ECOL SYST, V14, P377, DOI 10.1146/annurev.es.14.110183.002113; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; SHPIGEL M, 1989, ENVIRON BIOL FISH, V24, P67, DOI 10.1007/BF00001611; Sih A, 2000, TRENDS ECOL EVOL, V15, P3, DOI 10.1016/S0169-5347(99)01766-8; Smith R. Jan F., 1997, P163; Stephens D.W., 1986, pi; Stephens David W., 1993, P195; Stewart BD, 2000, MAR ECOL PROG SER, V197, P259, DOI 10.3354/meps197259; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Stier AC, 2014, CORAL REEFS, V33, P181, DOI 10.1007/s00338-013-1077-2; Sullivan AM, 2005, CHEM SIGNAL, V10, P349, DOI 10.1007/0-387-25160-X_40; SWEATMAN HPA, 1984, COPEIA, P187; Tessmar-Raible K, 2011, BIOESSAYS, V33, P165, DOI 10.1002/bies.201000096; Vail AL, 2011, BIOL LETTERS, V7, P921, DOI 10.1098/rsbl.2011.0380; WOLFE JL, 1989, ANIM BEHAV, V37, P410, DOI 10.1016/0003-3472(89)90088-2; WURTSBAUGH W, 1985, LIMNOL OCEANOGR, V30, P565, DOI 10.4319/lo.1985.30.3.0565; Yahel R, 2005, LIMNOL OCEANOGR, V50, P930, DOI 10.4319/lo.2005.50.3.0930; Zeller DC, 1997, MAR ECOL PROG SER, V154, P65, DOI 10.3354/meps154065	86	17	17	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111723	10.1371/journal.pone.0111723	http://dx.doi.org/10.1371/journal.pone.0111723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354096	Green Published, gold, Green Accepted			2022-12-27	WOS:000345204200093
J	Ibanez, F; Hancock, J; Tamborindeguy, C				Ibanez, Freddy; Hancock, Joseph; Tamborindeguy, Cecilia			Identification and Expression Analysis of Aquaporins in the Potato Psyllid, Bactericera cockerelli	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEINS; FUNCTIONAL-CHARACTERIZATION; WATER CHANNEL; PEA APHID; MOLECULAR CHARACTERIZATION; GUT SUCRASE; INSECT	Aquaporin (AQPs) proteins transport water and uncharged low molecular-weight solutes across biological membranes. Six to 8 AQP genes have been identified in many insect species, but presently only three aquaporins have been characterized in phloem feeding insects. The objective of this study was to identify candidate AQPs in the potato psyllid, Bactericera cockerelli. Herein, we identified four candidate aquaporin cDNAs in B. cockerelli transcriptome. Phylogenetic analysis showed that candidate BcAQP2-like had high similarity to PRIP aquaporins; while candidates BcAQP4-like, BcAQP5-like and BcAQP9-like clustered within clade B. In particular, candidates BcAQP4-like and BcAQP5-like clustered with functionally validated insect aquaglyceroporin proteins. Expression analyses using RT-qPCR showed that all candidates were expressed in all life stages and tissues. Candidates BcAQP4-like and BcAQP5-like were highly expressed in bacteriocytes, while BcAQP9-like appeared to be expressed at high levels in whole body but not in the assayed tissues. This study is the first global attempt to identify putative aquaporins in a phloem feeding insect.	[Ibanez, Freddy; Hancock, Joseph; Tamborindeguy, Cecilia] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Tamborindeguy, C (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ctamborindeguy@ag.tamu.edu			NIFA-AFRI [2012-67013-19431]; Texas AM University; Texas A&M Agrilife Research start-up funds; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	NIFA-AFRI; Texas AM University; Texas A&M Agrilife Research start-up funds; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	Funding for this work was provided by NIFA-AFRI grant 2012-67013-19431, Texas A&M University and Texas A&M Agrilife Research start-up funds. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	AGRE P, 1987, J BIOL CHEM, V262, P17497; Agre P, 2009, J VIS EXP; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashford DA, 2000, J INSECT PHYSIOL, V46, P335, DOI 10.1016/S0022-1910(99)00186-9; Azuma M, 2012, J INSECT PHYSIOL, V58, P523, DOI 10.1016/j.jinsphys.2012.01.007; Bienert GP, 2008, TRENDS BIOCHEM SCI, V33, P20, DOI 10.1016/j.tibs.2007.10.004; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Cicero JM, 2009, ANN ENTOMOL SOC AM, V102, P650, DOI 10.1603/008.102.0410; CROSSLIN JM, 2010, PLANT HLTH PROGR, DOI DOI 10.1094/PHP-2010-0317-1001-RV; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Fabrick JA, 2014, INSECT BIOCHEM MOLEC, V45, P125, DOI 10.1016/j.ibmb.2013.12.002; Goto SG, 2011, J INSECT PHYSIOL, V57, P1106, DOI 10.1016/j.jinsphys.2011.03.023; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Herraiz A, 2011, J EXP BIOL, V214, P3630, DOI 10.1242/jeb.057406; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Karley AJ, 2005, J INSECT PHYSIOL, V51, P1313, DOI 10.1016/j.jinsphys.2005.08.001; Kataoka N, 2009, INSECT MOL BIOL, V18, P303, DOI 10.1111/j.1365-2583.2009.00871.x; Kaufmann N, 2005, AM J PHYSIOL-CELL PH, V289, pC397, DOI 10.1152/ajpcell.00612.2004; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Mathew LG, 2011, INSECT BIOCHEM MOLEC, V41, P178, DOI 10.1016/j.ibmb.2010.12.002; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P307, DOI 10.1016/j.ibmb.2006.12.005; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Salvucci ME, 1997, J INSECT PHYSIOL, V43, P457, DOI 10.1016/S0022-1910(96)00124-2; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Staniscuaski F, 2013, J INSECT PHYSIOL, V59, P1140, DOI 10.1016/j.jinsphys.2013.08.013; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wallace IS, 2012, BBA-BIOMEMBRANES, V1818, P627, DOI 10.1016/j.bbamem.2011.11.032; Yakata K, 2007, BBA-BIOMEMBRANES, V1768, P688, DOI 10.1016/j.bbamem.2006.11.005	41	20	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111745	10.1371/journal.pone.0111745	http://dx.doi.org/10.1371/journal.pone.0111745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354208	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200094
J	Zhao, LQ; Qu, L; Zhou, J; Sun, ZD; Zou, H; Chen, YY; Marks, JD; Zhou, Y				Zhao, Lequn; Qu, Liang; Zhou, Jing; Sun, Zhengda; Zou, Hao; Chen, Yunn-Yi; Marks, James D.; Zhou, Yu			High Throughput Identification of Monoclonal Antibodies to Membrane Bound and Secreted Proteins Using Yeast and Phage Display	PLOS ONE			English	Article							NEUROTOXIN TYPE-A; BREAST-CANCER; SURFACE DISPLAY; SACCHAROMYCES-CEREVISIAE; RECEPTOR ANTIBODIES; EXPRESSION SYSTEMS; CD44 ISOFORMS; AFFINITY; CELLS; LIBRARIES	Antibodies are ubiquitous and essential reagents for biomedical research. Uses of antibodies include quantifying proteins, identifying the temporal and spatial pattern of expression in cells and tissue, and determining how proteins function under normal or pathological conditions. Specific antibodies are only available for a small portion of the proteome, limiting study of those proteins for which antibodies do not exist. The technologies to generate target-specific antibodies need to be improved to obtain high quality antibodies to the proteome at reasonable cost. Here we show that renewable, validated, and standardized monoclonal antibodies can be generated at high throughput, without the need for antigen production or animal immunizations. In this study, 60 protein domains from 24 selected secreted proteins were expressed on the surface of yeast and used for selection of phage antibodies, over 400 monoclonal antibodies were identified within 3 weeks. A subset of these antibodies was validated for binding to cancer cells that overexpress the target protein by flow cytometry or immunohistochemistry. This approach will be applicable to many of the membrane-bound and the secreted proteins, 20-40% of the proteome, accelerating the timeline for Ab generation while reducing the cost.	[Zhao, Lequn; Qu, Liang; Zhou, Jing; Sun, Zhengda; Zou, Hao; Marks, James D.; Zhou, Yu] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marks, JD (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	marksj@anesthesia.ucsf.edu; zhoue@anesthesia.ucsf.edu			NCI of the National Institutes of Health [P50 CA58207]; NATIONAL CANCER INSTITUTE [P50CA058207] Funding Source: NIH RePORTER	NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by NCI of the National Institutes of Health under award number P50 CA58207. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen DH, 2010, PROTEIN ENG DES SEL; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], 2008, CURRENT PROTOCOLS MO; Baggetta R, 2010, EUR J IMMUNOL, V40, P2182, DOI 10.1002/eji.200939995; Benedict CA, 1997, J IMMUNOL METHODS, V201, P223, DOI 10.1016/S0022-1759(96)00227-X; Berner HS, 2001, BREAST CANCER RES TR, V65, P23, DOI 10.1023/A:1006417412046; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gerngross TU, 2004, NAT BIOTECHNOL, V22, P1409, DOI 10.1038/nbt1028; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goding JW, 1983, MONOCLONAL ANTIBODIE; Grimsey NL, 2008, J NEUROSCI METH, V171, P78, DOI 10.1016/j.jneumeth.2008.02.014; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Huie MA, 2001, P NATL ACAD SCI USA, V98, P2682, DOI 10.1073/pnas.051631798; Isserlin R, 2007, PROTEOM CLIN APPL, V1, P1156, DOI 10.1002/prca.200700146; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Klee EW, 2008, ZEBRAFISH, V5, P131, DOI 10.1089/zeb.2008.0529; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Merritt WM, 2007, DIS MARKERS, V23, P419, DOI 10.1155/2007/257602; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen UB, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-24; O'Connell D, 2002, J MOL BIOL, V321, P49, DOI 10.1016/S0022-2836(02)00561-2; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Piatesi A, 2006, PROTEIN EXPRES PURIF, V48, P232, DOI 10.1016/j.pep.2006.01.026; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Pozner-Moulis S, 2007, LAB INVEST, V87, P251, DOI 10.1038/labinvest.3700515; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Reichert JM, 2009, MABS, V1, P387, DOI 10.4161/mabs.1.4.9031; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; ROBINSON AS, 1994, BIO-TECHNOL, V12, P381, DOI 10.1038/nbt0494-381; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Shiozaki M, 2011, ONCOL LETT, V2, P429, DOI 10.3892/ol.2011.264; Spellman PT, 2006, TRANSCRIPTION PROFIL; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Watanabe O, 2005, J EXP CLIN CANC RES, V24, P75; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071048; Zavrides HN, 2005, FOLIA HISTOCHEM CYTO, V43, P31; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038; Zhou Y, 2010, J MOL BIOL, V404, P88, DOI 10.1016/j.jmb.2010.09.006	57	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111339	10.1371/journal.pone.0111339	http://dx.doi.org/10.1371/journal.pone.0111339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353955	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200073
J	Ankarfeldt, MZ; Larsen, SC; Angquist, L; Husemoen, LLN; Roswall, N; Overvad, K; Jakobsen, MU; Halkjaer, J; Tjonneland, A; Linneberg, A; Toft, U; Hansen, T; Pedersen, O; Heitmann, BL; Astrup, A; Sorensen, TIA				Ankarfeldt, Mikkel Z.; Larsen, Sofus C.; Angquist, Lars; Husemoen, Lise Lotte N.; Roswall, Nina; Overvad, Kim; Jakobsen, Marianne Uhre; Halkjaer, Jytte; Tjonneland, Anne; Linneberg, Allan; Toft, Ulla; Hansen, Torben; Pedersen, Oluf; Heitmann, Berit L.; Astrup, Arne; Sorensen, Thorkild I. A.			Interaction between Genetic Predisposition to Adiposity and Dietary Protein in Relation to Subsequent Change in Body Weight and Waist Circumference	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; GLYCEMIC INDEX; CONFER RISK; MASS INDEX; VARIANTS; LOCI; MEN; METAANALYSIS	Background: Genetic predisposition to adiposity may interact with dietary protein in relation to changes of anthropometry. Objective: To investigate the interaction between genetic predisposition to higher body mass index (BMI), waist circumference (WC) or waist-hip ratio adjusted for BMI (WHRBMI) and dietary protein in relation to subsequent change in body weight (DBW) or change in WC (DWC). Design: Three different Danish cohorts were used. In total 7,054 individuals constituted the study population with information on diet, 50 single-nucleotide polymorphisms (SNPs) associated with BMI, WC or WHRBMI, as well as potential confounders. Mean follow-up time was similar to 5 years. Four genetic predisposition-scores were based on the SNPs; a complete-score including all selected adiposity-associated SNPs, and three scores including BMI, WC or WHRBMI associated polymorphisms, respectively. The association between protein intake and Delta BW or Delta WC were examined and interactions between SNP-score and protein were investigated. Analyses were based on linear regressions using macronutrient substitution models and meta-analyses. Results: When protein replaced carbohydrate, meta-analyses showed no associations with Delta BW (41.0 gram/y/5 energy% protein, [95% CI: 232.3; 114.3]) or Delta WC (<-0.1 mm/y/5 energy % protein, [-1.1; 1.1]). Similarly, there were no interactions for any SNP-scores and protein for either Delta BW (complete SNP-score: 1.8 gram/y/5 energy% protein/risk allele, [-7.0; 10.6]) or Delta WC (complete SNP-score: <0.1 mm/y/5 energy% protein/risk allele, [-0.1; 0.1]). Similar results were seen when protein replaced fat. Conclusion: This study indicates that the genetic predisposition to general and abdominal adiposity, assessed by gene-scores, does not seem to modulate the influence of dietary protein on Delta BW or Delta WC.	[Ankarfeldt, Mikkel Z.; Larsen, Sofus C.; Angquist, Lars; Heitmann, Berit L.; Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Ankarfeldt, Mikkel Z.; Larsen, Sofus C.] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark; [Husemoen, Lise Lotte N.; Linneberg, Allan; Toft, Ulla] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Roswall, Nina; Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Overvad, Kim; Jakobsen, Marianne Uhre] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res,Sect Metab Genet, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Astrup, Arne] Univ Copenhagen, NEXS, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Danish Cancer Society; Aarhus University; Aalborg University; Aalborg University Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark; University of Sydney; University of Copenhagen	Ankarfeldt, MZ (corresponding author), Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark.	mikkelza@gmail.com	Toft, Ulla/AAH-2589-2020; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Jakobsen, Marianne Uhre/I-8550-2018; Larsen, Sofus Christian/AAO-5894-2020; Roswall, Nina/AAJ-6700-2020; Astrup, Arne/B-1407-2015	Toft, Ulla/0000-0001-7770-8419; Pedersen, Oluf/0000-0002-3321-3972; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Larsen, Sofus Christian/0000-0002-0838-9378; Roswall, Nina/0000-0003-3071-1658; Overvad, Kim/0000-0001-6429-7921; Hansen, Torben/0000-0001-8748-3831; Tjonneland, Anne/0000-0003-4385-2097; Linneberg, Allan/0000-0002-0994-0184; Astrup, Arne/0000-0001-8968-8996; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Angquist, Lars/0000-0002-9516-4424	Danish Council for Strategic Research [09-067111]; Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; Ib Henriksen foundation; Becket foundation	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk(Novo Nordisk); Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus foundation; Ib Henriksen foundation; Becket foundation	This work is carried out as a part of the research program of Gene-Diet Interactions in Obesity (GENDINOB). GENDINOB is supported by the Danish Council for Strategic Research (Grant 09-067111). Data collection in the INTER99 study was supported economically by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish Pharmaceutical Association, Augustinus foundation, Ib Henriksen foundation and Becket foundation. The support by Novo Nordisk and The Danish Pharmaceutical Association were unconditional grants. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Adegboye ARA, 2010, J NUTR, V140, P1864, DOI 10.3945/jn.109.117770; Aller EE, 2014, INT J OBES LOND; Ankarfeldt MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101134; Ankarfeldt MZ, 2014, INT J OBES IN PRESS; Bender AM, 2012, EUROPEAN J PREVENTIV; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bigaard J, 2005, J NUTR, V135, P2263; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017436; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Fisher E, 2012, AM J CLIN NUTR, V95, P1468, DOI 10.3945/ajcn.111.014670; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Halkjaer J, 2011, INT J OBESITY, V35, P1104, DOI 10.1038/ijo.2010.254; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heitmann BL, 2009, OBESITY, V17, P136, DOI 10.1038/oby.2008.479; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Larsen LH, 2012, AM J CLIN NUTR, V95, P1254, DOI 10.3945/ajcn.111.016543; Larsen SC, 2014, AM J CLIN NUTR; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; MOLLER A, 1996, LEVNEDSMIDDELTABELLE; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sterne JACe, 2009, MET STAT UPD COLL ST; Stocks T, 2013, HUM HERED, V75, P213, DOI 10.1159/000353591; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Toft U, 2008, EUR J CLIN NUTR, V62, P1038, DOI 10.1038/sj.ejcn.1602815; Vergnaud AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057300; Vimaleswaran KS, 2012, OBESITY, V20, P1669, DOI 10.1038/oby.2012.49; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110890	10.1371/journal.pone.0110890	http://dx.doi.org/10.1371/journal.pone.0110890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350854	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943100047
J	Loomis, WP; Johnson, ML; Brasfield, A; Blanc, MP; Yi, J; Miller, SI; Cookson, BT; Hajjar, AM				Loomis, Wendy P.; Johnson, Matthew L.; Brasfield, Alicia; Blanc, Marie-Pierre; Yi, Jaehun; Miller, Samuel I.; Cookson, Brad T.; Hajjar, Adeline M.			Temporal and Anatomical Host Resistance to Chronic Salmonella Infection Is Quantitatively Dictated by Nramp1 and Influenced by Host Genetic Background	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MESENTERIC LYMPH-NODES; NATURAL-RESISTANCE; INTRACELLULAR PARASITES; SEQUENCE-ANALYSIS; MOUSE STRAINS; MICE; MACROPHAGES; DISEASE; DISSEMINATION	The lysosomal membrane transporter, Nramp1, plays a key role in innate immunity and resistance to infection with intracellular pathogens such as non-typhoidal Salmonella (NTS). NTS-susceptible C57BL/6 (B6) mice, which express the mutant Nramp1(D169) allele, are unable to control acute infection with Salmonella enterica serovar Typhimurium following intraperitoneal or oral inoculation. Introducing functional Nramp1(G169) into the B6 host background, either by constructing a congenic strain carrying Nramp1(G169) from resistant A/J mice (Nramp-Cg) or overexpressing Nramp1(G169) from a transgene (Nramp-Tg), conferred equivalent protection against acute Salmonella infection. In contrast, the contributions of Nramp1 for controlling chronic infection are more complex, involving temporal and anatomical differences in Nramp1-dependent host responses. Nramp-Cg, Nramp-Tg and NTS-resistant 129x1/SvJ mice survived oral Salmonella infection equally well for the first 2-3 weeks, providing evidence that Nramp1 contributes to the initial control of NTS bacteremia preceding establishment of chronic Salmonella infection. By day 30, increased host Nramp1 expression (Tg>Cg) provided greater protection as indicated by decreased splenic bacterial colonization (Tg<Cg). However, despite controlling bacterial growth within MLN as effectively as 129x1/SvJ mice, Nramp-Cg and Nramp-Tg mice eventually succumbed to infection. These data indicate: 1) discrete, anatomically localized host resistance is conferred by Nramp1 expression in NTS-susceptible mice, 2) restriction of systemic bacterial growth in the spleens of NTS-susceptible mice is enhanced by Nramp1 expression and dose-dependent, and 3) host genes other than Nramp1 also contribute to the ability of NTS-resistant 129x1/SvJ mice to control bacterial replication during chronic infection.	[Loomis, Wendy P.; Johnson, Matthew L.; Cookson, Brad T.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Brasfield, Alicia; Yi, Jaehun; Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Blanc, Marie-Pierre; Miller, Samuel I.; Cookson, Brad T.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hajjar, AM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	hajjar@uw.edu		Hajjar, Adeline/0000-0002-4838-8070	National Institute of Allergy and Infectious Diseases (NIAID) [U54 AI057141, U19 AI 090882]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090882, U54AI057141] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) under U54 AI057141 (SIM as PI, with core to AMH) and U19 AI 090882 (SIM as PI, with project to BTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrego A, 2006, MICROBES INFECT, V8, P2766, DOI 10.1016/j.micinf.2006.08.005; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Brown D. E., 2013, VET PATHOL; Caron J, 2005, GENES IMMUN, V6, P500, DOI 10.1038/sj.gene.6364234; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Mastroeni P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001840; McCoy MW, 2012, INFECT IMMUN, V80, P3642, DOI 10.1128/IAI.00656-12; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Melles DC, 2004, NETH J MED, V62, P45; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nakanaga K, 1999, J VET MED SCI, V61, P717, DOI 10.1292/jvms.61.717; NAUCIEL C, 1988, INFECT IMMUN, V56, P2407, DOI 10.1128/IAI.56.9.2407-2411.1988; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; PLANT J, 1974, NATURE, V248, P345, DOI 10.1038/248345a0; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Sancho-Shimizu V, 2007, GENETICS, V177, P1125, DOI 10.1534/genetics.107.075523; Trezena AG, 2002, MICROBES INFECT, V4, P1409, DOI 10.1016/S1286-4579(02)00023-0; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vidal SM, 1996, J IMMUNOL, V157, P3559; Voedisch S, 2009, INFECT IMMUN, V77, P3170, DOI 10.1128/IAI.00272-09; Watson KG, 2010, CELL MICROBIOL, V12, P1389, DOI 10.1111/j.1462-5822.2010.01511.x; Workman MR, 1996, BRIT MED J, V312, P1359, DOI 10.1136/bmj.312.7042.1359c; Yang IV, 2009, GENETICS, V183, P1535, DOI 10.1534/genetics.109.107540; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004	34	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111763	10.1371/journal.pone.0111763	http://dx.doi.org/10.1371/journal.pone.0111763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350459	Green Published, gold			2022-12-27	WOS:000343943100079
J	Schnitzler, F; Friedrich, M; Wolf, C; Angelberger, M; Diegelmann, J; Olszak, T; Beigel, F; Tillack, C; Stallhofer, J; Goke, B; Glas, J; Lohse, P; Brand, S				Schnitzler, Fabian; Friedrich, Matthias; Wolf, Christiane; Angelberger, Marianne; Diegelmann, Julia; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Stallhofer, Johannes; Goeke, Burkhard; Glas, Juergen; Lohse, Peter; Brand, Stephan			The NOD2 p.Leu1007fsX1008 Mutation (rs2066847) Is a Stronger Predictor of the Clinical Course of Crohn's Disease than the FOXO3A Intron Variant rs12212067	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; TRANSCRIPTION FACTORS; ULCERATIVE-COLITIS; FRAMESHIFT MUTATION; SUSCEPTIBILITY; HOMOZYGOSITY; METAANALYSIS; EXPRESSION; RISK	Background: Very recently, a sub-analysis of genome-wide association scans revealed that the non-coding single nucleotide polymorphism (SNP) rs12212067 in the FOXO3A gene is associated with a milder course of Crohn's disease (CD) (Cell 2013; 155: 57-69). The aim of our study was to evaluate the clinical value of the SNP rs12212067 in predicting the severity of CD by correlating CD patient genotype status with the most relevant complications of CD such as stenoses, fistulas, and CD-related surgery. Methodology/Principal Findings: We genotyped 550 CD patients for rs12212067 (FOXO3A) and the three common CD-associated NOD2 mutations rs2066844, rs2066847, and rs2066847 and performed genotype-phenotype analyses. Results: No significant phenotypic differences were found between the wild-type genotype TT of the FOXO3A SNP rs12212067 and the minor genotypes TG and GG independently from NOD2 variants. The allele frequency of the minor G allele was 12.7%. Age at diagnosis, disease duration, body mass index, surgery rate, stenoses, fistula, need for immunosuppressive therapy, and disease course were not significantly different. In contrast, the NOD2 mutant p. Leu1007fsX1008 (rs2066847) was highly associated with penetrating CD (p = 0.01), the development of fistulas (p = 0.01) and stenoses (p = 0.01), and ileal disease localization (p = 0.03). Importantly, the NOD2 SNP rs2066847 was a strong separator between an aggressive and a mild course of CD (p = 2.99 x 10(-5)), while the FOXO3A SNP rs12212067 did not separate between mild and aggressive CD behavior in our cohort (p = 0.35). 96.2% of the homozygous NOD2 p. Leu1007fsX1008 carriers had an aggressive disease behavior compared to 69.3% of the patients with the NOD2 wildtype genotype (p = 0.007). Conclusion/Significance: In clinical practice, the NOD2 variant p. Leu1007fsX1008 (rs2066847), in particular in homozygous form, is a much stronger marker for a severe clinical phenotype than the FOXO3A rs12212067 SNP for a mild disease course on an individual patient level despite its important impact on the inflammatory response of monocytes.	[Schnitzler, Fabian; Friedrich, Matthias; Angelberger, Marianne; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Stallhofer, Johannes; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Friedrich, Matthias; Diegelmann, Julia] LMU, Dept Prevent Dent & Periodontol, Munich, Germany; [Wolf, Christiane] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Lohse, Peter] LMU, Dept Clin Chem Grosshadern, Munich, Germany	University of Munich; University of Munich; Max Planck Society; RWTH Aachen University; University of Munich	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de		Stallhofer, Johannes/0000-0001-8698-6103	Deutsche Forschungsgemeinschaft (DFG) [BR 1912/6-1]; Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium) [2010_EKES.32]; DFG [BE 4490/2-1]; Ludwig-Maximilians University Munich (FoFoLe program); German Research Council (Deutsche Forschungsgemeinschaft/DFG) [OL/324-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); DFG(German Research Foundation (DFG)); Ludwig-Maximilians University Munich (FoFoLe program); German Research Council (Deutsche Forschungsgemeinschaft/DFG)(German Research Foundation (DFG))	S. Brand was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BR 1912/6-1) and the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32). F. Beigel was supported by DFG (BE 4490/2-1). C. Tillack was supported by a grant of the Ludwig-Maximilians University Munich (FoFoLe program). T. Olszak was supported by a grant of the German Research Council (Deutsche Forschungsgemeinschaft/DFG, OL/324-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Billiet T, 2014, EXPERT OPIN BIOL TH, V14, P75, DOI 10.1517/14712598.2014.858695; Brand S, 2013, GUT, V62, P1531, DOI 10.1136/gutjnl-2012-304151; Brand S, 2012, INFLAMM BOWEL DIS, V18, P393, DOI 10.1002/ibd.21914; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, J GASTROENTEROL, V45, P721, DOI 10.1007/s00535-010-0231-7; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Schnitzler F, 2012, INFLAMM BOWEL DIS, V18, P395, DOI 10.1002/ibd.21882; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076	31	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e108503	10.1371/journal.pone.0108503	http://dx.doi.org/10.1371/journal.pone.0108503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365249	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100006
J	Zhang, J; Huang, WJ; Zhou, QF				Zhang, Jing; Huang, Wenjiang; Zhou, Qifa			Reflectance Variation within the In-Chlorophyll Centre Waveband for Robust Retrieval of Leaf Chlorophyll Content	PLOS ONE			English	Article							RED EDGE POSITION; REMOTE ESTIMATION; SPECTRAL REFLECTANCE; INDEXES; NITROGEN; FLUORESCENCE; RATIO; CAROTENOIDS	The in-chlorophyll centre waveband (ICCW) (640-680 nm) is the specific chlorophyll (Chl) absorption band, but the reflectance in this band has not been used as an optimal index for non-destructive determination of plant Chl content in recent decades. This study develops a new spectral index based solely on the ICCW for robust retrieval of leaf Chl content for the first time. A glasshouse experiment for solution-culture of one chlorophyll-deficient rice mutant and six wild types of rice genotypes was conducted, and the leaf reflectance (400-900 nm) was measured with a high spectral resolution (1 nm) spectrophotometer and the contents of chlorophyll a (Chla), chlorophyll b (Chlb) and chlorophyll a+b (Chlt) of the rice leaves were determined. It was found that the reflectance curves from 640 nm to 674 nm and from 675 nm to 680 nm of the low-chlorophyll mutant leaf were drastically steeper than that of the wild types in the ICCW. The new index based on the reflectance variation within ICCW, the difference of the first derivative sum within the ICCW (DFDS_ICCW), was highly sensitive (r = -0.77, n = 93, P < 0.01) to Chlt while the mean reflectance (R_ICCW) in the ICCW became insensitive (r = -0.12, n = 93, P > 0.05) to Chlt when the leaf Chlt was higher than 200 mg/m(2). The best equations of R-ICCW and DFDS_ICCW yielded an RMSE of 78.7, 32.9 and 107.3 mg/m(2), and an RMSE of 37.4, 16.0 and 45.3 mg/m(-2), respectively, for predicting Chla, Chlb and Chlt. The new index could rank in the top 10 for prediction of Chla and Chlt as compared with the 55 existing indices. Additionally, most of the 55 existing Chl-related VIs performed robustly or strongly in simultaneous prediction of leaf Chla, Chlb and Chlt.	[Zhang, Jing; Zhou, Qifa] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Wenjiang] Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China	Zhejiang University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Zhou, QF (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zqifa2002@yahoo.com	huang, wenjiang/AAM-6844-2021		National Natural Science Foundation of China [41271363, 41271412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (grant numbers 41271363 and 41271412). QFZ received 41271363 and WJH received 41271412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Blackburn GA, 1998, REMOTE SENS ENVIRON, V66, P273, DOI 10.1016/S0034-4257(98)00059-5; Blackburn GA, 1999, REMOTE SENS ENVIRON, V70, P224, DOI 10.1016/S0034-4257(99)00048-6; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; Carter GA, 1996, J PLANT PHYSIOL, V148, P515, DOI 10.1016/S0176-1617(96)80070-8; CHAPPELLE EW, 1992, REMOTE SENS ENVIRON, V39, P239, DOI 10.1016/0034-4257(92)90089-3; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Datt B, 1998, REMOTE SENS ENVIRON, V66, P111, DOI 10.1016/S0034-4257(98)00046-7; Feret JB, 2011, REMOTE SENS ENVIRON, V115, P2742, DOI 10.1016/j.rse.2011.06.016; FILELLA I, 1994, INT J REMOTE SENS, V15, P1459, DOI 10.1080/01431169408954177; GITELSON A, 1994, J PHOTOCH PHOTOBIO B, V22, P247, DOI 10.1016/1011-1344(93)06963-4; Gitelson AA, 2003, J PLANT PHYSIOL, V160, P271, DOI 10.1078/0176-1617-00887; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; Gitelson AA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022688; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Guyot G., 1988, J CHEM INF MODEL, P279; Hatfield JL, 2008, AGRON J, V100, pS117, DOI 10.2134/agronj2006.0370c; He QX, 2005, J SCI FOOD AGR, V85, P1197, DOI 10.1002/jsfa.2109; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Jin XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072736; Kim M.S., 1994, USE HIGH SPECTRAL RE, P299; le Maire G, 2004, REMOTE SENS ENVIRON, V89, P1, DOI 10.1016/j.rse.2003.09.004; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lichtenthaler HK, 1996, J PLANT PHYSIOL, V148, P599, DOI 10.1016/S0176-1617(96)80081-2; Maccioni A, 2001, J PHOTOCH PHOTOBIO B, V61, P52, DOI 10.1016/S1011-1344(01)00145-2; Main R, 2011, ISPRS J PHOTOGRAMM, V66, P751, DOI 10.1016/j.isprsjprs.2011.08.001; MCMURTREY JE, 1994, REMOTE SENS ENVIRON, V47, P36, DOI 10.1016/0034-4257(94)90125-2; Merzlyak MN, 1999, PHYSIOL PLANTARUM, V106, P135, DOI 10.1034/j.1399-3054.1999.106119.x; PENUELAS J, 1994, REMOTE SENS ENVIRON, V48, P135, DOI 10.1016/0034-4257(94)90136-8; PENUELAS J, 1995, INT J REMOTE SENS, V16, P2727, DOI 10.1080/01431169508954588; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Read JJ, 2002, J ENVIRON QUAL, V31, P1442, DOI 10.2134/jeq2002.1442; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Schlemmer M, 2013, INT J APPL EARTH OBS, V25, P47, DOI 10.1016/j.jag.2013.04.003; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Steddom K, 2003, PHYTOPATHOLOGY, V93, P720, DOI 10.1094/PHYTO.2003.93.6.720; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; THOMAS JR, 1971, AGRON J, V63, P845, DOI 10.2134/agronj1971.00021962006300060007x; VOGELMANN JE, 1993, INT J REMOTE SENS, V14, P1563, DOI 10.1080/01431169308953986; YODER BJ, 1995, REMOTE SENS ENVIRON, V53, P199, DOI 10.1016/0034-4257(95)00135-N; Zarco-Tejada PJ, 1999, J GEOPHYS RES-ATMOS, V104, P27921, DOI 10.1029/1999JD900161	42	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110812	10.1371/journal.pone.0110812	http://dx.doi.org/10.1371/journal.pone.0110812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365207	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100029
J	Zhang, P; Liu, XD; Tong, HH; Lu, YG; Li, JQ				Zhang, Peng; Liu, Xiangdong; Tong, Hanhua; Lu, Yonggen; Li, Jinquan			Association Mapping for Important Agronomic Traits in Core Collection of Rice (Oryza sativa L.) with SSR Markers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADVANCED BACKCROSS POPULATION; LINKAGE DISEQUILIBRIUM; PLANT HEIGHT; DEVELOPMENTAL BEHAVIOR; YIELD COMPONENTS; COMPLEX TRAITS; GENE ACTIONS; WILD-RICE; P-VALUES	Mining elite genes within rice landraces is of importance for the improvement of cultivated rice. An association mapping for 12 agronomic traits was carried out using a core collection of rice consisting of 150 landraces (Panel 1) with 274 simple sequence repeat (SSR) markers, and the mapping results were further verified using a Chinese national rice micro-core collection (Panel 2) and a collection from a global molecular breeding program (Panel 3). Our results showed that (1) 76 significant (P<0.05) trait-marker associations were detected using mixed linear model (MLM) within Panel 1 in two years, among which 32% were identical with previously mapped QTLs, and 11 significant associations had >10% explained ratio of genetic variation; (2) A total of seven aforementioned trait-marker associations were verified within Panel 2 and 3 when using a general linear model (GLM) and 55 SSR markers of the 76 significant trait-marker associations. However, no significant trait-marker association was found to be identical within three panels when using the MLM model; (3) several desirable alleles of the loci which showed significant trait-marker associations were identified. The research provided important information for further mining these elite genes within rice landraces and using them for rice breeding.	[Zhang, Peng; Liu, Xiangdong; Lu, Yonggen; Li, Jinquan] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Zhang, Peng; Tong, Hanhua] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Li, Jinquan] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany	South China Agricultural University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Max Planck Society	Lu, YG (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	yglu@scau.edu.cn; lijinquan@scau.edu.cn			National Natural Science Foundation of China [30700494]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Fund of the National Natural Science Foundation of China grant 30700494. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Agrama HA, 2009, PLANT BREEDING, V128, P551, DOI 10.1111/j.1439-0523.2009.01631.x; Brown A. H. D., 1995, P3; Cao G, 2001, THEOR APPL GENET, V103, P153, DOI 10.1007/s001220100536; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Frankel OH, 1984, GENETICS NEW FRONTIE, V4, P1; Gao Yong-ming, 2004, J Zhejiang Univ Sci, V5, P371, DOI 10.1631/jzus.2004.0371; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; HUANG CF, 2003, THESIS S CHINA AGR U; Huang N, 1996, HEREDITY, V77, P130, DOI 10.1038/hdy.1996.117; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jiang Gong-Hao, 2004, Acta Genetica Sinica, V31, P63; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Katki HA, 2008, AM J EPIDEMIOL, V168, P384, DOI 10.1093/aje/kwn148; Kobayashi S, 2003, THEOR APPL GENET, V107, P1350, DOI 10.1007/s00122-003-1388-8; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Kunihiro Yasufumi, 2002, Acta Genetica Sinica, V29, P50; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li JQ, 2012, ASSESSMENT UTILIZATI; Li XL, 2011, RICE SCI, V18, P46, DOI 10.1016/S1672-6308(11)60007-3; Li XB, 2011, PLANTA, V234, P347, DOI 10.1007/s00425-011-1405-0; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Mei HW, 2005, THEOR APPL GENET, V110, P649, DOI 10.1007/s00122-004-1890-7; Mei HW, 2003, THEOR APPL GENET, V107, P89, DOI 10.1007/s00122-003-1192-5; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Xiao JH, 1998, GENETICS, V150, P899; Xing YZ, 2001, ACTA BOT SIN, V43, P840; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yang GH, 2006, HEREDITAS, V143, P236, DOI 10.1111/j.2006.0018-0661.01959.x; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yoshida S, 2002, BREEDING SCI, V52, P309, DOI 10.1270/jsbbs.52.309; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang N, 2005, THEOR APPL GENET, V110, P721, DOI 10.1007/s00122-004-1898-z; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; ZHENG K, 1994, THEOR APPL GENET, V88, P65, DOI 10.1007/BF00222395; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	65	56	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111508	10.1371/journal.pone.0111508	http://dx.doi.org/10.1371/journal.pone.0111508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360796	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700111
J	Park, MS; Bitto, E; Kim, KR; Bingman, CA; Miller, MD; Kim, HJ; Han, BW; Phillips, GN				Park, Mi Seul; Bitto, Eduard; Kim, Kyung Rok; Bingman, Craig A.; Miller, Mitchell D.; Kim, Hyun-Jung; Han, Byung Woo; Phillips, George N., Jr.			Crystal Structure of Human Protein N-Terminal Glutamine Amidohydrolase, an Initial Component of the N-End Rule Pathway	PLOS ONE			English	Article							UBIQUITIN LIGASE; MICE LACKING; DEGRADATION; AMIDASE; AUTOINDUCTION; PROTEOLYSIS; APOPTOSIS; ENZYME	The N-end rule states that half-life of protein is determined by their N-terminal amino acid residue. N-terminal glutamine amidohydrolase (Ntaq) converts N-terminal glutamine to glutamate by eliminating the amine group and plays an essential role in the N-end rule pathway for protein degradation. Here, we report the crystal structure of human Ntaq1 bound with the N-terminus of a symmetry-related Ntaq1 molecule at 1.5 angstrom resolution. The structure reveals a monomeric globular protein with alpha-beta-alpha three-layer sandwich architecture. The catalytic triad located in the active site, Cys-His-Asp, is highly conserved among Ntaq family and transglutaminases from diverse organisms. The N-terminus of a symmetry-related Ntaq1 molecule bound in the substrate binding cleft and the active site suggest possible substrate binding mode of hNtaq1. Based on our crystal structure of hNtaq1 and docking study with all the tripeptides with N-terminal glutamine, we propose how the peptide backbone recognition patch of hNtaq1 forms nonspecific interactions with N-terminal peptides of substrate proteins. Upon binding of a substrate with N-terminal glutamine, active site catalytic triad mediates the deamination of the N-terminal residue to glutamate by a mechanism analogous to that of cysteine proteases.	[Park, Mi Seul; Kim, Kyung Rok; Han, Byung Woo] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Bitto, Eduard] Georgian Court Univ, Dept Chem & Biochem, Lakewood, NJ USA; [Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Ctr Eukaryot Struct Gen, Dept Biochem, Madison, WI USA; [Miller, Mitchell D.; Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison; Rice University; Chung Ang University	Han, BW (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea.	bwhan@snu.ac.kr; georgep@rice.edu		Miller, Mitchell/0000-0003-1626-4943; Park, Mi Seul/0000-0003-2519-7121	National Institutes of Health Protein Structure Initiative [GM064598, GNPGM094816, GNP GM074901]; BioXFEL Science and Technology Center under National Science Foundation [GNP1231306]; Ministry of Science, ICT and Future Planning of Korea [MDM2013-043695, BWH 2014-001848]; Ministry of Health and Welfare of Korea [BWH A092006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098248, U54GM074901, P50GM064598, R01GM094816] Funding Source: NIH RePORTER	National Institutes of Health Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioXFEL Science and Technology Center under National Science Foundation; Ministry of Science, ICT and Future Planning of Korea; Ministry of Health and Welfare of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by GM064598, National Institutes of Health Protein Structure Initiative, (http://www.nigms.nih.gov/research/specificareas/PSI/pages/default.aspx), GNP GM074901, National Institutes of Health Protein Structure Initiative, (http://www.nigms.nih.gov/research/specificareas/PSI/pages/default.aspx, GNPGM094816), National Institutes of Health Protein Structure Initiative, (http://www.nigms.nih.gov/research/specificareas/PSI/pages/default.aspx), GNP1231306, The BioXFEL Science and Technology Center under National Science Foundation, (https://www.bioxfel.org/), MDM2013-043695, Ministry of Science, ICT and Future Planning of Korea, (www.msip.go.kr), BWH 2014-001848, Ministry of Science, ICT and Future Planning of Korea, (www.msip.go.kr), BWH A092006, Ministry of Health and Welfare of Korea, (www.mw.go.kr), BWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPHICS S; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; Bhaskaran SS, 2012, ACTA CRYSTALLOGR D, V68, P1613, DOI 10.1107/S0907444912039042; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chatterjee D, 2012, J BACTERIOL, V194, P4415, DOI 10.1128/JB.00640-12; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hashizume R, 2011, J BIOL CHEM, V286, P38691, DOI 10.1074/jbc.M111.255133; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Jeon Won Bae, 2005, Journal of Structural and Functional Genomics, V6, P143, DOI 10.1007/s10969-005-1908-7; Knop M, 1993, CURR OPIN CELL BIOL, V5, P990, DOI 10.1016/0955-0674(93)90082-2; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032	30	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111142	10.1371/journal.pone.0111142	http://dx.doi.org/10.1371/journal.pone.0111142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356641	gold, Green Published			2022-12-27	WOS:000346765000043
J	Wu, J; Qiu, L; Guo, XZ; Xu, T; Cheng, XQ; Zhang, L; Li, PC; Di, Q; Wang, Q; Ni, L; Zhu, GJ				Wu, Jie; Qiu, Ling; Guo, Xiu-zhi; Xu, Tao; Cheng, Xin-qi; Zhang, Lin; Li, Peng-chang; Di, Qian; Wang, Qing; Ni, Lan; Zhu, Guang-jin			Apolipoprotein E Gene Polymorphisms Are Associated with Primary Hyperuricemia in a Chinese Population	PLOS ONE			English	Article							SERUM URIC-ACID; C-REACTIVE PROTEIN; RISK-FACTORS; E GENOTYPES; CARDIOVASCULAR RISK; METABOLIC SYNDROME; LIPID PARAMETERS; GOUT; HYPERTENSION; DISEASE	Objective: Primary hyperuricemia, an excess of uric acid in the blood, is a major public health problem. In addition to the morbidity that is attributable to gout, hyperuricemia is also associated with metabolic syndrome, hypertension, and cardiovascular disease. This study aims to assess the genetic associations between Apolipoprotein E (APOE) polymorphisms and hyperuricemia in a Chinese population. Methods: A total of 770 subjects (356 hyperuricemic cases and 414 normouricemic controls) were recruited from the Ningxia Hui Autonomous Region, China. A physical examination was performed and fasting blood was collected for biochemical tests, including determination of the levels of serum lipid, creatinine, and uric acid. Multi-ARMS PCR was applied to determine the APOE genotypes, followed by an investigation of the distribution of APOE genotypes and alleles frequencies in the controls and cases. Results: The frequencies of the APOE-epsilon 2 epsilon 3 genotype (17.70% vs. 10.39%, P=0.003) and the APOE-epsilon 2 allele (10.53% vs. 5.80%, P=0.001) were significantly higher in the hyperuricemic group than in the normouricemic group. Furthermore, male cases were more likely to have the APOE-epsilon 2 epsilon 3 genotype and APOE-epsilon 2 allele, compared with male controls. In both Han and Hui subjects, cases were more likely to have the APOE-epsilon 2 epsilon 3 genotype and the APOE-epsilon 2 allele compared with controls. Furthermore, multivariate logistic regression showed that carriers of the APOE-epsilon 2 epsilon 3 genotype (P=0.001, OR=2.194) and the epsilon 2 allele (P = 0.001, OR = 2.099) were significantly more likely to experience hyperuricemia than carriers of the epsilon 3/epsilon 3 genotype and the epsilon 3 allele after adjustment for sex, body mass index (BMI), diastolic blood pressure (DBP), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), creatinine (Cr) and fasting blood glucose(FBG). Conclusions: The APOE-epsilon 2 epsilon 3 genotype and the APOE-epsilon 2 allele are associated with serum uric acid levels in Chinese subjects, indicating that individuals carrying the APOE-epsilon 2 allele have a higher risk of hyperuricemia than non-carriers.	[Wu, Jie; Qiu, Ling; Guo, Xiu-zhi; Cheng, Xin-qi; Zhang, Lin; Li, Peng-chang; Di, Qian] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100021, Peoples R China; [Wu, Jie; Qiu, Ling; Guo, Xiu-zhi; Cheng, Xin-qi; Zhang, Lin; Li, Peng-chang; Di, Qian] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Xu, Tao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing 100730, Peoples R China; [Xu, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Qing; Ni, Lan] Ningxia Med Univ, Gen Hosp, Ctr Med Expt, Yinchuan, Peoples R China; [Zhu, Guang-jin] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing 100730, Peoples R China; [Zhu, Guang-jin] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Ningxia Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qiu, L (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100021, Peoples R China.	lingqiubj@aliyun.com	ZHANG, LIN/GYD-9123-2022; Zhang, Lin/L-5132-2019; jiang, yu/HGU-0029-2022	Zhang, Lin/0000-0002-2064-8440; 	Ministry of Science and Technology of China [2006FY110300]; National Natural Science funding of China [81301508]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science funding of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special funding for Key Basic Research Project of the Ministry of Science and Technology of China (2006FY110300), the National Natural Science funding of China (grants 81301508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvim RO, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-128; Ang LS, 2008, EXP GERONTOL, V43, P615, DOI 10.1016/j.exger.2008.03.010; Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; Bazrgar M, 2012, GENET TEST MOL BIOMA, V16, P920, DOI 10.1089/gtmb.2011.0379; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Borges RL, 2010, CURR HYPERTENS REP, V12, P113, DOI 10.1007/s11906-010-0098-2; Cardona F, 2003, RHEUMATOLOGY, V42, P468, DOI 10.1093/rheumatology/keg166; Crunkhorn Sarah, 2013, Nat Rev Drug Discov, V12, P664, DOI 10.1038/nrd4106; Denzer C, 2003, J PEDIATR ENDOCR MET, V16, P1225; Donohoe GG, 1999, CLIN CHEM, V45, P143; Edwards NL, 2009, CURR OPIN RHEUMATOL, V21, P132, DOI 10.1097/BOR.0b013e3283257b96; Fernandes MAS, 1999, INT J MOL MED, V4, P179; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; Hn Z, 2011, BMC PUBLIC HLTH, V11, P832; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Leite MLC, 2013, HYPERTENS RES, V36, P270, DOI 10.1038/hr.2012.175; Liang S, 2009, MOL BIOL REP, V36, P1251, DOI 10.1007/s11033-008-9305-5; Liberopoulos EN, 2005, J INVEST MED, V53, P116, DOI 10.2310/6650.2005.00306; Liberopoulos EN, 2004, AM J KIDNEY DIS, V44, P300, DOI 10.1053/j.ajkd.2004.04.035; Lin KC, 2000, J RHEUMATOL, V27, P1501; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Qiu L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-664; RALL SC, 1982, J BIOL CHEM, V257, P4171; Sekine T, 2006, AM J PHYSIOL-RENAL, V290, pF251, DOI 10.1152/ajprenal.00439.2004; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Yin YW, 2013, METABOLISM; Yoo TW, 2005, CIRC J, V69, P928, DOI 10.1253/circj.69.928; Yoshida T, 2006, J CLIN ENDOCR METAB, V91, P2133, DOI 10.1210/jc.2005-2856; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	34	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110864	10.1371/journal.pone.0110864	http://dx.doi.org/10.1371/journal.pone.0110864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356596	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000030
J	Allievi, MC; Palomino, MM; Acosta, MP; Lanati, L; Ruzal, SM; Sanchez-Rivas, C				Claudia Allievi, Mariana; Mercedes Palomino, Maria; Prado Acosta, Mariano; Lanati, Leonardo; Monica Ruzal, Sandra; Sanchez-Rivas, Carmen			Contribution of S-Layer Proteins to the Mosquitocidal Activity of Lysinibacillus sphaericus	PLOS ONE			English	Article							THURINGIENSIS SUBSP MEDELLIN; SYNERGIZE BACILLUS-SPHAERICUS; AEDES-AEGYPTI; GENE; EXPRESSION; STRAINS; CHITINASES; VIRULENCE; TOXICITY; TOXIN	Lysinibacillus sphaericus strains belonging the antigenic group H5a5b produce spores with larvicidal activity against larvae of Culex mosquitoes. C7, a new isolated strain, which presents similar biochemical characteristics and Bin toxins in their spores as the reference strain 2362, was, however, more active against larvae of Culex mosquitoes. The contribution of the surface layer protein (S-layer) to this behaviour was envisaged since this envelope protein has been implicated in the pathogenicity of several bacilli, and we had previously reported its association to spores. Microscopic observation by immunofluorescence detection with anti S-layer antibody in the spores confirms their attachment. S-layers and BinA and BinB toxins formed high molecular weight multimers in spores as shown by SDS-PAGE and western blot detection. Purified S-layer from both L. sphaericus C7 and 2362 strain cultures was by itself toxic against Culex sp larvae, however, that from C7 strain was also toxic against Aedes aegypti. Synergistic effect between purified S-layer and spore-crystal preparations was observed against Culex sp. and Aedes aegypti larvae. This effect was more evident with the C7 strain. In silico analyses of the S-layer sequence suggest the presence of chitin-binding and hemolytic domains. Both biochemical characteristics were detected for both Slayers strains that must justify their contribution to pathogenicity.	[Claudia Allievi, Mariana; Mercedes Palomino, Maria; Prado Acosta, Mariano; Lanati, Leonardo; Monica Ruzal, Sandra; Sanchez-Rivas, Carmen] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, IQUIBICEN CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires	Ruzal, SM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, IQUIBICEN CONICET, Buenos Aires, DF, Argentina.	sandra@qb.fcen.uba.ar		Palomino, Mercedes/0000-0003-1988-7388; Ruzal, Sandra/0000-0001-6388-7567; Allievi, Mariana Claudia/0000-0002-8782-2810	Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET PIP0229]; Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT-2012-0789]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	Support was provided by Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET PIP0229 and Agencia Nacional de Promocion Cientifica y Tecnologica ANPCyT PICT-2012-0789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Alice AF, 2003, MICROBIOL-SGM, V149, P1687, DOI 10.1099/mic.0.26231-0; Alice AF, 2002, APPL ENVIRON MICROB, V68, P6410, DOI 10.1128/aem.68.12.6410-6415.2002; Allievi MC, 2011, J MICROBIOL BIOTECHN, V21, P147, DOI 10.4014/jmb.1009.09046; Allievi MC, 2012, THESIS U BUENOS AIRE; Balomenou S, 2013, MOL MICROBIOL, V87, P867, DOI 10.1111/mmi.12137; Balzarini M., 2008, INFOSTAT MANUAL USUA; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Cai YJ, 2007, APPL ENVIRON MICROB, V73, P7744, DOI 10.1128/AEM.01510-07; Charles JF, 1996, ANNU REV ENTOMOL, V41, P451, DOI 10.1146/annurev.en.41.010196.002315; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Fischer S, 2004, J VECTOR ECOL, V29, P365; Forsberg LS, 2012, GLYCOBIOLOGY, V22, P1103, DOI 10.1093/glycob/cws080; Forsberg LS, 2011, GLYCOBIOLOGY, V21, P934, DOI 10.1093/glycob/cwr026; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Gomez-Ramirez M, 2001, CHITIN ENZYMOLOGY, P273; Guo G, 2008, FEMS MICROBIOL LETT, V282, P1, DOI 10.1111/j.1574-6968.2008.01087.x; Hu XM, 2008, BIOSCI BIOTECH BIOCH, V72, P1257, DOI 10.1271/bbb.70747; Hu XM, 2008, J BACTERIOL, V190, P2892, DOI 10.1128/JB.01652-07; Itoh T, 2013, APPL ENVIRON MICROB, V79, P7482, DOI 10.1128/AEM.02483-13; Janesch B, 2013, J BACTERIOL, V195, P565, DOI 10.1128/JB.01487-12; Kailas L, 2011, P NATL ACAD SCI USA, V108, P16014, DOI 10.1073/pnas.1109419108; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; KRYCH VK, 1980, INT J SYST BACTERIOL, V30, P476, DOI 10.1099/00207713-30-2-476; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; LEWIS LO, 1987, J BACTERIOL, V169, P72, DOI 10.1128/jb.169.1.72-79.1987; Lopez-Diaz JA, 2013, ENVIRON MICROBIOL, V15, P3030, DOI 10.1111/1462-2920.12263; Lozano LC, 2011, BIOTECHNOL LETT, V33, P2037, DOI 10.1007/s10529-011-0666-9; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; MYERS PS, 1980, APPL ENVIRON MICROB, V39, P1205, DOI 10.1128/AEM.39.6.1205-1211.1980; Pena G, 2006, APPL ENVIRON MICROB, V72, P353, DOI 10.1128/AEM.72.1.353-360.2006; Pollmann K, 2006, BIOTECHNOL ADV, V24, P58, DOI 10.1016/j.biotechadv.2005.06.002; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Rippere KE, 1997, INT J SYST BACTERIOL, V47, P214, DOI 10.1099/00207713-47-1-214; Rodenburg CM, 2014, J STRUCT BIOL, V186, P181, DOI 10.1016/j.jsb.2014.02.018; Rodriguez-Almazan C, 2011, BIOCHEMISTRY-US, V50, P388, DOI 10.1021/bi101239r; RUSSELL BL, 1989, APPL ENVIRON MICROB, V55, P294, DOI 10.1128/AEM.55.2.294-297.1989; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Smith AW, 2005, J INVERTEBR PATHOL, V88, P27, DOI 10.1016/j.jip.2004.10.005; THANABALU T, 1991, J BACTERIOL, V173, P2776, DOI 10.1128/JB.173.9.2776-2785.1991; Thiery I, 1998, APPL ENVIRON MICROB, V64, P3910; Thiery I, 1997, APPL ENVIRON MICROB, V63, P468, DOI 10.1128/AEM.63.2.468-473.1997; TRAVERS RS, 1987, APPL ENVIRON MICROB, V53, P1263, DOI 10.1128/AEM.53.6.1263-1266.1987; van Frankenhuyzen K, 2013, J INVERTEBR PATHOL, V114, P76, DOI 10.1016/j.jip.2013.05.010; Wang YT, 2013, J BACTERIOL, V195, P596, DOI 10.1128/JB.02005-12; Wirth MC, 2007, APPL ENVIRON MICROB, V73, P6066, DOI 10.1128/AEM.00654-07; Wirth MC, 2001, APPL ENVIRON MICROB, V67, P3280, DOI 10.1128/AEM.67.7.3280-3284.2001; Yang YK, 2007, APPL ENVIRON MICROB, V73, P218, DOI 10.1128/AEM.01100-06; Yousten A A, 1984, Adv Biotechnol Processes, V3, P315; YOUSTEN AA, 1982, APPL ENVIRON MICROB, V44, P1449, DOI 10.1128/AEM.44.6.1449-1455.1982; Zhou Z, 2011, BMB REP, V44, P323, DOI 10.5483/BMBRep.2011.44.5.323	51	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111114	10.1371/journal.pone.0111114	http://dx.doi.org/10.1371/journal.pone.0111114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354162	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200057
J	Nomaler, O; Frenken, K; Heimeriks, G				Nomaler, Onder; Frenken, Koen; Heimeriks, Gaston			On Scaling of Scientific Knowledge Production in US Metropolitan Areas	PLOS ONE			English	Article								Using data on all scientific publications from the Scopus database, we find a superlinear scaling effect for U. S. metropolitan areas as indicated by the increase of per capita publication output with city size. We also find that the variance of residuals is much higher for mid-sized cities (100,000 to 500,000 inhabitants) compared to larger cities. The latter result is indicative of the critical mass required to establish a scientific center in a particular discipline. Finally, we observe that the largest cities publish much less than the scaling law would predict, indicating that the largest cities are relatively unattractive locations for scientific research.	[Nomaler, Onder] Eindhoven Univ Technol, Sch Innovat Sci, NL-5600 MB Eindhoven, Netherlands; [Frenken, Koen; Heimeriks, Gaston] Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands	Eindhoven University of Technology; Utrecht University	Heimeriks, G (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands.	GHeimeriks@gmail.com	Heimeriks, Gaston/G-1057-2012; Frenken, Koen/C-4486-2017	Heimeriks, Gaston/0000-0002-0577-6938; Frenken, Koen/0000-0003-4731-0201	Netherlands Organisation for Scientific Research (nwo.nl) under the VIDI programme [452-06-005]	Netherlands Organisation for Scientific Research (nwo.nl) under the VIDI programme	Part of the study has been financially supported by an unrestricted grant provided by The Netherlands Organisation for Scientific Research (nwo.nl) under the VIDI programme, number 452-06-005. The authors received no other specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bonaccorsi A, 2005, SCIENTOMETRICS, V63, P87, DOI 10.1007/s11192-005-0205-3; Bonaccorsi A., 2007, SCI PUBL POLICY, V34, P303, DOI DOI 10.3152/030234207X229411; Bonaccorsi A, 2008, MINERVA, V46, P285, DOI 10.1007/s11024-008-9101-3; Deville P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04770; Fragkias M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064727; Frenken K, 2009, J INFORMETR, V3, P222, DOI 10.1016/j.joi.2009.03.005; Gao X, 2009, J INFORMETR, V3, P321, DOI 10.1016/j.joi.2009.04.004; Grossetti M, 2014, URBAN STUD, V51, P2219, DOI 10.1177/0042098013506047; Heimeriks G, 2014, J ECON GEOGR, V14, P339, DOI 10.1093/jeg/lbs052; Heimeriks G, 2012, TECHNOL ANAL STRATEG, V24, P51, DOI 10.1080/09537325.2012.643562; Hoekman J, 2009, ANN REGIONAL SCI, V43, P721, DOI 10.1007/s00168-008-0252-9; Katz JS, 1999, RES POLICY, V28, P501, DOI 10.1016/S0048-7333(99)00010-4; Katz JS., 2000, SCI PUBL POLICY, V27, P23, DOI [DOI 10.3152/147154300781782156, 10.3152/147154300781782156]; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Pumain D., 2006, CYBERGEO EUROPEAN J; Storper M, 2011, J ECON GEOGR, V11, P333, DOI 10.1093/jeg/lbq033; UNESCO, 2010, UNESCO SCI REP 2010; van Raan AFJ, 2008, J AM SOC INF SCI TEC, V59, P461, DOI 10.1002/asi.20761; van Raan AFJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059384	22	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110805	10.1371/journal.pone.0110805	http://dx.doi.org/10.1371/journal.pone.0110805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT8TG	25353686	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200037
J	Clarke, RH; Moosa, S; Anzivino, M; Wang, Y; Floyd, DH; Purow, BW; Lee, KS				Clarke, Ryon H.; Moosa, Shayan; Anzivino, Matthew; Wang, Yi; Floyd, Desiree Hunt; Purow, Benjamin W.; Lee, Kevin S.			Sustained Radiosensitization of Hypoxic Glioma Cells after Oxygen Pretreatment in an Animal Model of Glioblastoma and In Vitro Models of Tumor Hypoxia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; INDUCIBLE FACTORS; INTRACRANIAL GLIOBLASTOMA; HYPERBARIC OXYGENATION; IMPLANTABLE RESONATORS; IONIZING-RADIATION; MALIGNANT GLIOMAS; EPR OXIMETRY	Glioblastoma multiforme (GBM) is the most common and lethal form of brain cancer and these tumors are highly resistant to chemo-and radiotherapy. Radioresistance is thought to result from a paucity of molecular oxygen in hypoxic tumor regions, resulting in reduced DNA damage and enhanced cellular defense mechanisms. Efforts to counteract tumor hypoxia during radiotherapy are limited by an attendant increase in the sensitivity of healthy brain tissue to radiation. However, the presence of heightened levels of molecular oxygen during radiotherapy, while conventionally deemed critical for adjuvant oxygen therapy to sensitize hypoxic tumor tissue, might not actually be necessary. We evaluated the concept that pre-treating tumor tissue by transiently elevating tissue oxygenation prior to radiation exposure could increase the efficacy of radiotherapy, even when radiotherapy is administered after the return of tumor tissue oxygen to hypoxic baseline levels. Using nude mice bearing intracranial U87-luciferase xenografts, and in vitro models of tumor hypoxia, the efficacy of oxygen pretreatment for producing radiosensitization was tested. Oxygen-induced radiosensitization of tumor tissue was observed in GBM xenografts, as seen by suppression of tumor growth and increased survival. Additionally, rodent and human glioma cells, and human glioma stem cells, exhibited prolonged enhanced vulnerability to radiation after oxygen pretreatment in vitro, even when radiation was delivered under hypoxic conditions. Over-expression of HIF-1 alpha reduced this radiosensitization, indicating that this effect is mediated, in part, via a change in HIF-1-dependent mechanisms. Importantly, an identical duration of transient hyperoxic exposure does not sensitize normal human astrocytes to radiation in vitro. Taken together, these results indicate that briefly pre-treating tumors with elevated levels of oxygen prior to radiotherapy may represent a means for selectively targeting radiation-resistant hypoxic cancer cells, and could serve as a safe and effective adjuvant to radiation therapy for patients with GBM.	[Clarke, Ryon H.; Anzivino, Matthew; Wang, Yi; Lee, Kevin S.] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; [Clarke, Ryon H.; Moosa, Shayan; Anzivino, Matthew; Wang, Yi; Floyd, Desiree Hunt; Purow, Benjamin W.; Lee, Kevin S.] Univ Virginia Hlth Syst, Sch Med, Charlottesville, VA USA; [Floyd, Desiree Hunt; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Neurol, Div Neurooncol, Charlottesville, VA USA; [Floyd, Desiree Hunt; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Floyd, Desiree Hunt; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Lee, Kevin S.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Lee, KS (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA.	ksl3h@virginia.edu			Pre-doctoral Research Neuroscience Training Grant [T32 6M008328]; Chester Research Fund [138857101DR0280240455]	Pre-doctoral Research Neuroscience Training Grant; Chester Research Fund	This study was supported by the Pre-doctoral Research Neuroscience Training Grant (T32 6M008328) and the Chester Research Fund (138857101DR0280240455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Beppu T, 2002, J NEURO-ONCOL, V58, P47, DOI 10.1023/A:1015832726054; Bernhardt WM, 2007, METHOD ENZYMOL, V435, P221, DOI 10.1016/S0076-6879(07)35012-X; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; CHAPMAN JD, 1979, NEW ENGL J MED, V301, P1429, DOI 10.1056/NEJM197912273012606; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; Chou CW, 2012, NEURO-ONCOLOGY, V14, P1227, DOI 10.1093/neuonc/nos195; COLEMAN CN, 1990, CRIT REV ONCOL HEMAT, V10, P225, DOI 10.1016/1040-8428(90)90033-O; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Dong Z, 2001, J BIOL CHEM, V276, P18702, DOI 10.1074/jbc.M011774200; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; FULTON DS, 1984, INT J RADIAT ONCOL, V10, P1709, DOI 10.1016/0360-3016(84)90533-9; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Grosu AL, 2005, INT J RADIAT ONCOL, V63, P511, DOI 10.1016/j.ijrobp.2005.01.056; Grosu AL, 2005, STRAHLENTHER ONKOL, V181, P483, DOI 10.1007/s00066-005-1422-7; Hadjipanayis CG, 2008, MOL THER, V16, P1783, DOI 10.1038/mt.2008.185; Hamza MA, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0379-z; Hou HG, 2012, J MAGN RESON, V214, P22, DOI 10.1016/j.jmr.2011.09.043; Hou HG, 2011, ADV EXP MED BIOL, V701, P61, DOI 10.1007/978-1-4419-7756-4_9; Hsieh CH, 2010, ONCOL REP, V24, P1629, DOI 10.3892/or_00001027; Huang LE, 2013, SCIENCE, V339, P1285, DOI 10.1126/science.1236966; Jackson CM, 2014, CLIN CANC RES; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Kanu OO, 2009, EXPERT OPIN THER TAR, V13, P701, DOI [10.1517/14728220902942348 , 10.1517/14728220902942348]; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Kohshi K, 1999, BRIT J CANCER, V80, P236, DOI 10.1038/sj.bjc.6690345; Kohshi K, 2007, J NEURO-ONCOL, V82, P297, DOI 10.1007/s11060-006-9283-1; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lanvin O, 2013, EUR J CANCER, V49, P2884, DOI 10.1016/j.ejca.2013.05.003; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu WW, 2012, NEUROL RES, V34, P415, DOI 10.1179/1743132812Y.0000000034; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lund EL, 2000, CLIN CANCER RES, V6, P971; Luo Z, 2014, NEUROPHARMACOLOGY; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; McGee MC, 2010, INT J RADIAT ONCOL, V76, P1537, DOI 10.1016/j.ijrobp.2009.12.010; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Radaelli E, 2009, HISTOL HISTOPATHOL, V24, P879, DOI 10.14670/HH-24.879; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Seshadri M, 2009, J CEREBR BLOOD F MET, V29, P1373, DOI 10.1038/jcbfm.2009.68; Shrieve DC, 2006, NEUROSURG CLIN N AM, V17, P67, DOI 10.1016/j.nec.2006.02.003; STEWART FA, 1989, INT J RADIAT ONCOL, V16, P1195, DOI 10.1016/0360-3016(89)90282-4; Strofer M, 2011, CELL PHYSIOL BIOCHEM, V28, P805, DOI 10.1159/000335794; Whitfield GA, 2014, CLIN ONCOL R COLL RA; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	58	24	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111199	10.1371/journal.pone.0111199	http://dx.doi.org/10.1371/journal.pone.0111199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350400	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100061
J	Kankova, S; Prochazkova, L; Flegr, J; Calda, P; Springer, D; Potlukova, E				Kankova, Sarka; Prochazkova, Lucie; Flegr, Jaroslav; Calda, Pavel; Springer, Drahomira; Potlukova, Eliska			Effects of Latent Toxoplasmosis on Autoimmune Thyroid Diseases in Pregnancy	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; HASHIMOTOS-THYROIDITIS; MURINE TOXOPLASMOSIS; GONDII INFECTION; HUMANS; INDUCTION; MODEL; MICROCHIMERISM; TESTOSTERONE; AUTOANTIGENS	Background: Toxoplasmosis, one of the most common zoonotic diseases worldwide, can induce various hormonal and behavioural alterations in infected hosts, and its most common form, latent toxoplasmosis, influences the course of pregnancy. Autoimmune thyroid diseases (AITD) belong to the well-defined risk factors for adverse pregnancy outcomes. The aim of this study was to investigate whether there is a link between latent toxoplasmosis and maternal AITD in pregnancy. Methods: Cross-sectional study in 1248 consecutive pregnant women in the 9-12 th gestational weeks. Serum thyroid-stimulating hormone (TSH), thyroperoxidase antibodies (TPOAb), and free thyroxine (FT4) were assessed by chemiluminescence; the Toxoplasma status was detected by the complement fixation test (CFT) and anti-Toxoplasma IgG enzyme-linked immunosorbent assay (ELISA). Results: Overall, 22.5% of the women were positive for latent toxoplasmosis and 14.7% were screened positive for AITD. Women with latent toxoplasmosis had more often highly elevated TPOAb than the Toxoplasma-negative ones (p = 0.004), and latent toxoplasmosis was associated with decrease in serum TSH levels (p = 0.049). Moreover, we found a positive correlation between FT4 and the index of positivity for anti-Toxoplasma IgG antibodies (p = 0.033), which was even stronger in the TPOAb-positive Toxoplasma-positive women, (p = 0.014), as well as a positive correlation between FT4 and log(2) CFT (p = 0.009). Conclusions: Latent toxoplasmosis was associated with a mild increase in thyroid hormone production in pregnancy. The observed Toxoplasma-associated changes in the parameters of AITD are mild and do not seem to be clinically relevant; however, they could provide new clues to the complex pathogenesis of autoimmune thyroid diseases.	[Kankova, Sarka; Prochazkova, Lucie; Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic; [Calda, Pavel] Charles Univ Prague, Gen Univ Hosp, Dept Obstet & Gynaecol, Prague, Czech Republic; [Calda, Pavel; Springer, Drahomira; Potlukova, Eliska] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Springer, Drahomira] Charles Univ Prague, Gen Univ Hosp, Inst Clin Biochem & Lab Diagnost, Prague, Czech Republic; [Potlukova, Eliska] Charles Univ Prague, Gen Univ Hosp, Dept Med 3, Prague, Czech Republic	Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague	Kankova, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic.	kankova.sarka@gmail.com	Springer, Drahomira/J-2474-2017; Šárka, Kaňková/F-8514-2019; Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021; Calda, Pavel/C-9171-2017	Springer, Drahomira/0000-0003-4756-0585; Šárka, Kaňková/0000-0002-3087-7538; Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Calda, Pavel/0000-0002-2903-5026; Potlukova, Eliska/0000-0003-4790-8860	Charles University [UNCE 204004, PRVOUK 25]; Ministry of Health of the Czech Republic [RVO-VFN64165]	Charles University; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The research was supported by project UNCE 204004 of the Charles University, the grant PRVOUK 25 of the Charles University, and research grant No. RVO-VFN64165 from the Ministry of Health of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Benvenga S, 2006, THYROID, V16, P225, DOI 10.1089/thy.2006.16.225; Benvenga S, 2004, THYROID, V14, P964, DOI 10.1089/thy.2004.14.964; CDC, 2013, TOX EP RISK FACT; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 2014, NEUROENDOCRINOL LETT, V35, P20; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Flegr J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-274; Fugazzola L, 2012, J CLIN ENDOCR METAB, V97, P1452, DOI 10.1210/jc.2011-3160; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; GAZZINELLI RT, 1993, INFECT AGENT DIS, V2, P139; GLINOER D, 1990, J CLIN ENDOCR METAB, V71, P276, DOI 10.1210/jcem-71-2-276; Groer MW, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.004; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kankova S, 2010, PARASITOL RES, V107, P1421, DOI 10.1007/s00436-010-2013-9; Kolbekova P, 2007, CLIN MICROBIOL INFEC, V13, P1012, DOI 10.1111/j.1469-0691.2007.01771.x; Limanova Zdenka, 2011, Cas Lek Cesk, V150, P389; Lindova J, 2006, INT J PARASITOL, V36, P1485, DOI 10.1016/j.ijpara.2006.07.008; Morohoshi K, 2011, DISCOV MED, V12, P505; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; Potlukova E, 2012, J CLIN ENDOCR METAB, V97, P1945, DOI 10.1210/jc.2011-3275; Prandota J, 2012, NEUROINFLAMMATION PA, P447; Ronet C, 2005, J IMMUNOL, V175, P899, DOI 10.4049/jimmunol.175.2.899; Shapira Y, 2012, J AUTOIMMUN, V39, P112, DOI 10.1016/j.jaut.2012.01.001; Shapira Y, 2012, CLIN REV ALLERG IMMU, V42, P154, DOI 10.1007/s12016-010-8241-z; Solerte SB, 2005, EUR J ENDOCRINOL, V152, P703, DOI 10.1530/eje.1.01906; Springer D, 2009, EUR J ENDOCRINOL, V160, P791, DOI 10.1530/EJE-08-0890; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Stahl W, 1998, PARASITOLOGY, V117, P217, DOI 10.1017/S003118209800300X; Stahl W, 1998, PARASITOLOGY, V117, P223, DOI 10.1017/S0031182098003035; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tozzoli R, 2008, AUTOIMMUN REV, V8, P112, DOI 10.1016/j.autrev.2008.07.013; Wasserman EE, 2009, AUTOIMMUNITY, V42, P439, DOI 10.1080/08916930902787716; Wolf A, 1939, AM J PATHOL, V15, P657	39	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110878	10.1371/journal.pone.0110878	http://dx.doi.org/10.1371/journal.pone.0110878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350671	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100045
J	Lizama, LEC; Pijnappels, M; Faber, GH; Reeves, PN; Verschueren, SM; van Dieen, JH				Lizama, L. Eduardo Cofre; Pijnappels, Mirjam; Faber, Gert H.; Reeves, Peter N.; Verschueren, Sabine M.; van Dieen, Jaap H.			Age Effects on Mediolateral Balance Control	PLOS ONE			English	Article							SENSORIMOTOR INTEGRATION; POSTURAL ORIENTATION; MUSCLE MASS; FALL-RISK; STABILITY; HIP; VARIABILITY; DEMANDS; DECLINE; PEOPLE	Background: Age-related balance impairments, particularly in mediolateral direction (ML) may cause falls. Sufficiently sensitive and reliable ML balance tests are, however, lacking. This study is aimed to determine (1) the effect of age on and (2) the reliability of ML balance performance using Center of Mass (CoM) tracking. Methods: Balance performance of 19 young (26 +/- 3 years) and 19 older (72 +/- 5 years) adults on ML-CoM tracking tasks was compared. Subjects tracked predictable and unpredictable target displacements at increasing frequencies with their CoM by shifting their weight sideward. Phase-shift (response delay) and gain (amplitude difference) between the CoM and target in the frequency domain were used to quantify performance. Thirteen older and all young adults were reassessed to determine reliability of balance performance measures. In addition, all older adults performed a series of clinical balance tests and conventional posturography was done in a sub-sample. Results: Phase-shift and gain dropped below pre-determined thresholds (-90 degrees and 0.5) at lower frequencies in the older adults and were even lower below these frequencies than in young adults. Performance measures showed good to excellent reliability in both groups. All clinical scores were close to the maximum and no age effect was found using posturography. ML balance performance measures exhibited small but systematic between-session differences indicative of learning. Conclusions: The ability to accurately perform ML-CoM tracking deteriorates with age. ML-CoM tracking tasks form a reliable tool to assess ML balance in young and older adults and are more sensitive to age-related impairment than posturography and clinical tests.	[Lizama, L. Eduardo Cofre; Pijnappels, Mirjam; Faber, Gert H.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Reeves, Peter N.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Verschueren, Sabine M.] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Rehabil Sci, Leuven, Belgium	Vrije Universiteit Amsterdam; Michigan State University; Michigan State University College of Osteopathic Medicine; KU Leuven	van Dieen, JH (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	j.van.dieen@vu.nl	Lizama, L. Eduardo Cofré/AAW-8548-2020; Verschueren, Sabine/K-4213-2015; van Dieen, Jaap/B-3937-2013	Verschueren, Sabine/0000-0003-2592-494X; van Dieen, Jaap/0000-0002-7719-5585; Pijnappels, Mirjam/0000-0001-8416-2602; Faber, Gert/0000-0003-3596-0389; Cofre Lizama, L. Eduardo/0000-0002-3490-4521	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program [2011-0015]; TOP-NIG from the Dutch Organization for Scientific Research (NWO) [91209021]	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program; TOP-NIG from the Dutch Organization for Scientific Research (NWO)	This research was funded by the European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program (2011-0015). Experimental set-up was supported by MOTEK Medical BV, Amsterdam, The Netherlands. Mirjam Pijnappels was financially supported by a TOP-NIG grant (#91209021) from the Dutch Organization for Scientific Research (NWO). The European Union as well as The Dutch Organization for Scientific Research (NWO) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bingham JT, 2011, J NEUROPHYSIOL, V106, P437, DOI 10.1152/jn.00010.2011; Brauer SG, 2000, J GERONTOL A-BIOL, V55, pM469, DOI 10.1093/gerona/55.8.M469; Cenciarini M, 2010, IEEE T BIO-MED ENG, V57, P267, DOI 10.1109/TBME.2009.2031874; Chang SHJ, 2005, ARCH PHYS MED REHAB, V86, P1843, DOI 10.1016/j.apmr.2005.03.006; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Close JCT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5153; Cofre Lizama LE, CAN VISUAL FEE UNPUB; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dionyssiotis Y, 2012, INT J GEN MED, V5, P805, DOI 10.2147/IJGM.S32651; Egerton T, 2010, HUM MOVEMENT SCI, V29, P1011, DOI 10.1016/j.humov.2010.06.001; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; Freiherr J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00863; Goodworth AD, 2009, J NEUROPHYSIOL, V102, P496, DOI 10.1152/jn.00118.2009; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HARADA N, 1995, PHYS THER, V75, P462, DOI 10.1093/ptj/75.6.462; Hay L, 1996, EXP BRAIN RES, V108, P129; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Lizama LEC, 2013, J BIOMECH, V46, P2831, DOI 10.1016/j.jbiomech.2013.08.018; Mak MKY, 2013, J REHABIL MED, V45, P565, DOI 10.2340/16501977-1144; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 2011, J SAFETY RES, V42, P473, DOI 10.1016/j.jsr.2011.02.002; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Orr R, 2010, EUR J PHYS REHAB MED, V46, P183; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Sparto PJ, 2014, GAIT POSTURE, V39, P799, DOI 10.1016/j.gaitpost.2013.10.021; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Thorbahn LDB, 1996, PHYS THER, V76, P576, DOI 10.1093/ptj/76.6.576; Tiedemann A, 2010, J GERONTOL A-BIOL, V65, P893, DOI 10.1093/gerona/glq067; TOPPER AK, 1993, J AM GERIATR SOC, V41, P479, DOI 10.1111/j.1532-5415.1993.tb01881.x; Tucker MG, 2009, CLIN BIOMECH, V24, P597, DOI 10.1016/j.clinbiomech.2009.06.002; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Wingert JR, 2014, ARCH PHYS MED REHAB, V95, P253, DOI 10.1016/j.apmr.2013.08.012; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; World Health Organization, 2007, GLOB REP FALLS PREV; Young WR, 2012, GAIT POSTURE, V36, P477, DOI 10.1016/j.gaitpost.2012.04.009	50	31	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110757	10.1371/journal.pone.0110757	http://dx.doi.org/10.1371/journal.pone.0110757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350846	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100038
J	Mendes, CS; Rajendren, SV; Bartos, I; Marka, S; Mann, RS				Mendes, Cesar S.; Rajendren, Soumya V.; Bartos, Imre; Marka, Szabolcs; Mann, Richard S.			Kinematic Responses to Changes in Walking Orientation and Gravitational Load in Drosophila melanogaster	PLOS ONE			English	Article							TIBIAL CAMPANIFORM SENSILLA; FREELY STANDING COCKROACHES; SPIKING LOCAL INTERNEURONS; FEMORAL CHORDOTONAL ORGAN; INTER-LEG COORDINATION; BODY LOAD; STICK INSECT; GENETIC MANIPULATION; HEXAPEDAL RUNNERS; SENSORY SIGNALS	Walking behavior is context-dependent, resulting from the integration of internal and external influences by specialized motor and pre-motor centers. Neuronal programs must be sufficiently flexible to the locomotive challenges inherent in different environments. Although insect studies have contributed substantially to the identification of the components and rules that determine locomotion, we still lack an understanding of how multi-jointed walking insects respond to changes in walking orientation and direction and strength of the gravitational force. In order to answer these questions we measured with high temporal and spatial resolution the kinematic properties of untethered Drosophila during inverted and vertical walking. In addition, we also examined the kinematic responses to increases in gravitational load. We find that animals are capable of shifting their step, spatial and inter-leg parameters in order to cope with more challenging walking conditions. For example, flies walking in an inverted orientation decreased the duration of their swing phase leading to increased contact with the substrate and, as a result, greater stability. We also find that when flies carry additional weight, thereby increasing their gravitational load, some changes in step parameters vary over time, providing evidence for adaptation. However, above a threshold that is between 1 and 2 times their body weight flies display locomotion parameters that suggest they are no longer capable of walking in a coordinated manner. Finally, we find that functional chordotonal organs are required for flies to cope with additional weight, as animals deficient in these proprioceptors display increased sensitivity to load bearing as well as other locomotive defects.	[Mendes, Cesar S.; Rajendren, Soumya V.; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Rajendren, Soumya V.] Columbia Univ, Neurosci & Behav Barnard Coll, New York, NY USA; [Bartos, Imre; Marka, Szabolcs] Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Mendes, CS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	cesar2001@gmail.com; rsm10@columbia.edu	Bartos, Imre/AAD-6024-2019; Bartos, Imre/A-2592-2017; Marka, Szabolcs/ABE-7493-2021	S. Mendes, Cesar/0000-0001-6974-9042	National Institutes of Health; Ellison Foundation [-NIH/5 R01 NS070644-03 (GG005430/5-38621), PG005402]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for CSM and RSM: National Institutes of Health (http://www.nih.gov/), -NIH/5 R01 NS070644-03 (GG005430/5-38621) Ellison Foundation (http://www.ellisonfoundation.org/), PG005402. Funding for SVR: Barnard College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay T, 2001, J NEUROPHYSIOL, V85, P594, DOI 10.1152/jn.2001.85.2.594; Akay T, 2007, J NEUROSCI, V27, P3285, DOI 10.1523/JNEUROSCI.5202-06.2007; Akay T, 2006, J NEUROPHYSIOL, V96, P3532, DOI 10.1152/jn.00625.2006; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; BASSLER U, 1977, J COMP PHYSIOL, V121, P99; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Bender JA, 2009, CURR BIOL, V19, pR186, DOI 10.1016/j.cub.2008.12.024; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BURROWS M, 1987, J NEUROSCI, V7, P1064; BURROWS M, 1985, J NEUROPHYSIOL, V54, P463, DOI 10.1152/jn.1985.54.3.463; Burrows M., 1996, NEUROBIOLOGY INSECT; Burrows M, 1988, J COMP PHYSL A; BUSCHGES A, 1994, J EXP BIOL, V189, P285; Buschges A, 2008, SENSES COMPREHENSIVE, P355; Chang YH, 2000, J EXP BIOL, V203, P229; CRUSE H, 1984, J COMP PHYSIOL, V154, P695, DOI 10.1007/BF01350223; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; Cruse H, 1976, FUNCTION LEGS FREE W, P235; Cruse H, 2007, PHILOS T R SOC A, V365, P221, DOI 10.1098/rsta.2006.1913; Davis KG, 2000, CLIN BIOMECH, V15, P703, DOI 10.1016/S0268-0033(00)00035-8; Dietz V, 1998, MOVEMENT DISORD, V13, P255, DOI 10.1002/mds.870130210; DUCH C, 1995, J EXP BIOL, V198, P1963; Durr V, 2004, ARTHROPOD STRUCT DEV, V33, P237, DOI 10.1016/j.asd.2004.05.004; FULL RJ, 1991, J EXP BIOL, V156, P215; FULL RJ, 1990, J EXP BIOL, V149, P307; FULL RJ, 1991, J EXP BIOL, V158, P369; Full RJ, 1999, J EXP BIOL, V202, P3325; Gorb SN, 2001, NATURWISSENSCHAFTEN, V88, P530, DOI 10.1007/s00114-001-0274-y; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1985, ADV INSECT PHYSIOL, V18, P31; GUTHRIE DM, 1967, J INSECT PHYSIOL, V13, P1637, DOI 10.1016/0022-1910(67)90159-X; Hess D, 1997, J NEUROBIOL, V33, P891; HOFMANN T, 1985, J EXP BIOL, V114, P207; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Jamon M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00011; Jindrich DL, 1999, J EXP BIOL, V202, P1603; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KAPLAN WD, 1974, GENETICS, V77, P721; Keller BR, 2007, J COMP PHYSIOL A, V193, P881, DOI 10.1007/s00359-007-0241-y; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; KOTO M, 1981, BRAIN RES, V221, P213, DOI 10.1016/0006-8993(81)90772-1; Kram R, 1996, J EXP BIOL, V199, P609; LARSEN GS, 1995, J COMP PHYSIOL A, V176, P229, DOI 10.1007/BF00239925; Lipp A, 2005, J EXP BIOL, V208, P707, DOI 10.1242/jeb.01434; MATHESON T, 1995, J EXP BIOL, V198, P1673; Matsuo E, 2013, J COMP PHYSIOL A, V199, P253, DOI 10.1007/s00359-013-0806-x; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; Moll K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052816; Muir G, 1999, J NEUROTRAUM, V16, P705, DOI 10.1089/neu.1999.16.705; Niederegger S, 2003, J INSECT PHYSIOL, V49, P611, DOI 10.1016/S0022-1910(03)00048-9; Noah JA, 2004, J COMP PHYSIOL A, V190, P201, DOI 10.1007/s00359-003-0487-y; Noah JA, 2001, J COMP PHYSIOL A, V187, P769, DOI 10.1007/s00359-001-0247-9; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; Pringle JWS, 1938, J EXP BIOL, V15, P114; Quimby LA, 2006, J COMP PHYSIOL A, V192, P247, DOI 10.1007/s00359-005-0062-9; Ridgel AL, 2001, J COMP PHYSIOL A, V187, P405, DOI 10.1007/s003590100213; Rossignol S, 2004, CAN J PHYSIOL PHARM, V82, P617, DOI 10.1139/Y04-068; Seidl T, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-8; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; SONG SM, 1989, MATH BIOSCI, V97, P199, DOI 10.1016/0025-5564(89)90005-9; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TING LH, 1994, J EXP BIOL, V197, P251; Triphan T, 2010, CURR BIOL, V20, P663, DOI 10.1016/j.cub.2010.02.055; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139; Zill S, 2004, ARTHROPOD STRUCT DEV, V33, P273, DOI 10.1016/j.asd.2004.05.005; ZILL SN, 1981, J EXP BIOL, V94, P43	73	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109204	10.1371/journal.pone.0109204	http://dx.doi.org/10.1371/journal.pone.0109204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350743	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100010
J	Wilton, CM; Puckett, EE; Beringer, J; Gardner, B; Eggert, LS; Belant, JL				Wilton, Clay M.; Puckett, Emily E.; Beringer, Jeff; Gardner, Beth; Eggert, Lori S.; Belant, Jerrold L.			Trap Array Configuration Influences Estimates and Precision of Black Bear Density and Abundance	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; MARK-RECAPTURE; GENETIC-STRUCTURE; URSUS-AMERICANUS; NATIONAL-PARK; CAMERA-TRAPS; DNA DATA; CAPTURE; MODELS; HABITAT	Spatial capture-recapture (SCR) models have advanced our ability to estimate population density for wide ranging animals by explicitly incorporating individual movement. Though these models are more robust to various spatial sampling designs, few studies have empirically tested different large-scale trap configurations using SCR models. We investigated how extent of trap coverage and trap spacing affects precision and accuracy of SCR parameters, implementing models using the R package secr. We tested two trapping scenarios, one spatially extensive and one intensive, using black bear (Ursus americanus) DNA data from hair snare arrays in south-central Missouri, USA. We also examined the influence that adding a second, lower barbed-wire strand to snares had on quantity and spatial distribution of detections. We simulated trapping data to test bias in density estimates of each configuration under a range of density and detection parameter values. Field data showed that using multiple arrays with intensive snare coverage produced more detections of more individuals than extensive coverage. Consequently, density and detection parameters were more precise for the intensive design. Density was estimated as 1.7 bears per 100 km(2) and was 5.5 times greater than that under extensive sampling. Abundance was 279 (95% CI = 193-406) bears in the 16,812 km(2) study area. Excluding detections from the lower strand resulted in the loss of 35 detections, 14 unique bears, and the largest recorded movement between snares. All simulations showed low bias for density under both configurations. Results demonstrated that in low density populations with non-uniform distribution of population density, optimizing the tradeoff among snare spacing, coverage, and sample size is of critical importance to estimating parameters with high precision and accuracy. With limited resources, allocating available traps to multiple arrays with intensive trap spacing increased the amount of information needed to inform parameters with high precision.	[Wilton, Clay M.; Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Puckett, Emily E.; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Beringer, Jeff] Missouri Dept Conservat, Columbia, MO USA; [Gardner, Beth] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	Mississippi State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University	Wilton, CM (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	cwilton@cfr.msstate.edu	Belant, Jerrold/HDM-7749-2022	Puckett, Emily/0000-0002-9325-4629	Missouri Department of Conservation; U.S. Fish and Wildlife Service Federal Aid in Wildlife Restoration; Department of Wildlife, Fisheries, and Aquaculture at Mississippi State University; Forest and Wildlife Research Center at Mississippi State University; Safari Club International Foundation	Missouri Department of Conservation; U.S. Fish and Wildlife Service Federal Aid in Wildlife Restoration; Department of Wildlife, Fisheries, and Aquaculture at Mississippi State University; Forest and Wildlife Research Center at Mississippi State University; Safari Club International Foundation	Funding was provided by the Missouri Department of Conservation; U.S. Fish and Wildlife Service Federal Aid in Wildlife Restoration; Department of Wildlife, Fisheries, and Aquaculture and Forest and Wildlife Research Center at Mississippi State University; and Safari Club International Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Baldwin RA, 2012, EUR J WILDLIFE RES, V58, P557, DOI 10.1007/s10344-011-0605-z; Bales SL, 2005, WILDLIFE SOC B, V33, P1342, DOI 10.2193/0091-7648(2005)33[1342:DOARPO]2.0.CO;2; Belant JL, 2005, URSUS, V16, P85, DOI 10.2192/1537-6176(2005)016[0085:ABBPSA]2.0.CO;2; BONDRUPNIELSEN S, 1983, CAN J ZOOL, V61, P2361, DOI 10.1139/z83-313; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Boulanger J, 2004, J WILDLIFE MANAGE, V68, P457, DOI 10.2193/0022-541X(2004)068[0457:SDABID]2.0.CO;2; Boulanger J, 2001, CAN J ZOOL, V79, P642, DOI 10.1139/cjz-79-4-642; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carmichael LE, 2005, J MAMMAL, V86, P160, DOI 10.1644/1545-1542(2005)086<0160:GOPPBI>2.0.CO;2; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; Drewry JM, 2013, J WILDLIFE MANAGE, V77, P153, DOI 10.1002/jwmg.443; Ebert C, 2010, WILDLIFE BIOL, V16, P225, DOI 10.2981/09-108; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Efford M. G., 2012, DENSITY 5 0 SOFTWARE; Efford M. G., 2013, SECR SPATIALLY EXPLI; Efford MG, 2005, WILDLIFE SOC B, V33, P731, DOI 10.2193/0091-7648(2005)33[731:AFTOTM]2.0.CO;2; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Frary VJ, 2011, WILDLIFE BIOL, V17, P404, DOI 10.2981/09-103; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; Garshelis DL, 2006, URSUS, V17, P109, DOI 10.2192/1537-6176(2006)17[109:OTAONG]2.0.CO;2; Garshelis DL, 2006, URSUS, V17, P1, DOI 10.2192/1537-6176(2006)17[1:SAPEOA]2.0.CO;2; Gross M, 2008, WILDLIFE CONSERVATIO; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P97, DOI 10.1007/978-4-431-99495-4_7; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kery M, 2011, CONSERV BIOL, V25, P356, DOI 10.1111/j.1523-1739.2010.01616.x; Lofroth EC, 2007, J WILDLIFE MANAGE, V71, P2159, DOI 10.2193/2007-094; MASTER LL, 1991, CONSERV BIOL, V5, P559, DOI 10.1111/j.1523-1739.1991.tb00370.x; Missouri Spatial Data Information Service, 2005, MSDIS DAT THEM LIST; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Neel MC, 2012, BIOSCIENCE, V62, P646, DOI 10.1525/bio.2012.62.7.7; Ngoprasert D, 2012, URSUS, V23, P117, DOI 10.2192/URSUS-D-11-00009.1; Nigh T.A., 2002, ATLAS MISSOURI ECORE; Noyce KV, 2011, BEHAV ECOL SOCIOBIOL, V65, P823, DOI 10.1007/s00265-010-1086-x; Noyce KV, 2001, URSUS-SERIES, V12, P211; O'Brien TG, 2011, ECOL APPL, V21, P2908, DOI 10.1890/10-2284.1; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Peacock E, 2011, J WILDLIFE MANAGE, V75, P1513, DOI 10.1002/jwmg.171; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Puckett EE, 2014, MOL ECOL, V23, P2414, DOI 10.1111/mec.12748; R Core Team, 2021, R LANGUAGE ENV STAT; RAEKER G., 2010, MISSOURIS FOREST RES; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P163, DOI 10.1007/978-4-431-99495-4_10; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Sanderlin JS, 2009, MOL ECOL RESOUR, V9, P288, DOI 10.1111/j.1755-0998.2008.02234.x; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Settlage KE, 2008, J WILDLIFE MANAGE, V72, P1035, DOI 10.2193/2006-472; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Sunarto, 2013, ORYX, V47, P211, DOI 10.1017/S0030605311001530; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; TURNER MG, 1995, ECOL APPL, V5, P12, DOI 10.2307/1942046; United States Geological Survey, 2009, SCI YOUR BACK MISS; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Wegge P, 2004, ANIM CONSERV, V7, P251, DOI 10.1017/S1367943004001441; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilton CM, 2014, URSUS, V25, P53, DOI 10.2192/URSUS-D-13-00017.1; Woods JG, 1999, WILDLIFE SOC B, V27, P616	76	46	46	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111257	10.1371/journal.pone.0111257	http://dx.doi.org/10.1371/journal.pone.0111257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350557	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100062
J	Marwaha, S; Schumacher, MA; Zavros, Y; Eghbalnia, HR				Marwaha, Shruti; Schumacher, Michael A.; Zavros, Yana; Eghbalnia, Hamid R.			Crosstalks between Cytokines and Sonic Hedgehog in Helicobacter pylori Infection: A Mathematical Model	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; SIGNALING PATHWAY; SYSTEMS BIOLOGY; INTERLEUKIN-8 PRODUCTION; GAMMA-INTERFERON; IMMUNE-RESPONSE; PANCREATIC-CANCER; HUMAN MONOCYTES; T-LYMPHOCYTES	Helicobacter pylori infection of gastric tissue results in an immune response dominated by Th1 cytokines and has also been linked with dysregulation of Sonic Hedgehog (SHH) signaling pathway in gastric tissue. However, since interactions between the cytokines and SHH during H. pylori infection are not well understood, any mechanistic understanding achieved through interpretation of the statistical analysis of experimental results in the context of currently known circuit must be carefully scrutinized. Here, we use mathematical modeling aided by restraints of experimental data to evaluate the consistency between experimental results and temporal behavior of H. pylori activated cytokine circuit model. Statistical analysis of qPCR data from uninfected and H. pylori infected wild-type and parietal cell-specific SHH knockout (PC-SHHKO) mice for day 7 and 180 indicate significant changes that suggest role of SHH in cytokine regulation. The experimentally observed changes are further investigated using a mathematical model that examines dynamic crosstalks among proinflammatory (IL1 beta, IL-12, IFN gamma, MIP-2) cytokines, anti-inflammatory (IL-10) cytokines and SHH during H. pylori infection. Response analysis of the resulting model demonstrates that circuitry, as currently known, is inadequate for explaining of the experimental observations; suggesting the need for additional specific regulatory interactions. A key advantage of a computational model is the ability to propose putative circuit models for in-silico experimentation. We use this approach to propose a parsimonious model that incorporates crosstalks between NF kappa B, SHH, IL-1 beta and IL-10, resulting in a feedback loop capable of exhibiting cyclic behavior. Separately, we show that analysis of an independent time-series GEO microarray data for IL-1 beta, IFN gamma and IL-10 in mock and H. pylori infected mice further supports the proposed hypothesis that these cytokines may follow a cyclic trend. Predictions from the in-silico model provide useful insights for generating new hypothesis and design of subsequent experimental studies.	[Marwaha, Shruti; Schumacher, Michael A.; Zavros, Yana; Eghbalnia, Hamid R.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Marwaha, S (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45220 USA.	marwahsi@mail.uc.edu	Schumacher, Michael/GYV-4197-2022; Marwaha, Shruti/ABF-5360-2020	Marwaha, Shruti/0000-0002-1877-2629; Schumacher, Michael/0000-0003-3353-0414	Department of Molecular and Cellular Physiology, University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Department of Molecular and Cellular Physiology, University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by start-up funds from the Department of Molecular and Cellular Physiology, University of Cincinnati (Hamid R. Eghbalnia). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Anderson J, 2011, AUTOMATICA, V47, P1165, DOI 10.1016/j.automatica.2011.03.010; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Badger K, 1997, GUT, V40, P739, DOI 10.1136/gut.40.6.739; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bimczok D, 2013, J IMMUNOL, V190, P6626, DOI 10.4049/jimmunol.1203330; Bisset K, 2012, INT PARALL DISTRIB P, P48, DOI 10.1109/IPDPS.2012.15; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; BLASER MJ, 1995, CANCER RES, V55, P562; BLASER MJ, 1990, J INFECT DIS, V161, P626, DOI 10.1093/infdis/161.4.626; Bliss CM, 1998, INFECT IMMUN, V66, P5357, DOI 10.1128/IAI.66.11.5357-5363.1998; Brazhnik P, 2006, CELL CYCLE, V5, P522, DOI 10.4161/cc.5.5.2493; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, BIOPHYS CHEM, V104, P573, DOI 10.1016/S0301-4622(03)00060-7; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; de Jonge R, 2001, FEMS MICROBIOL LETT, V196, P235, DOI 10.1016/S0378-1097(01)00074-X; Dunaeva M, 2010, BASIC RES CARDIOL, V105, P61, DOI 10.1007/s00395-009-0047-x; El-Zaatari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058935; Ernst P, 1999, ALIMENT PHARM THER, V13, P13, DOI 10.1046/j.1365-2036.1999.00003.x; Fehlings M, 2012, INFECT IMMUN, V80, P2724, DOI 10.1128/IAI.00381-12; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Franke R, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-4; Franks NR, 2001, SELF ORG BIOL SYSTEM; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Haeberle HA, 1997, INFECT IMMUN, V65, P4229, DOI 10.1128/IAI.65.10.4229-4235.1997; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Jhala NC, 2003, AM J CLIN PATHOL, V119, P101, DOI 10.1309/YDTXKE06XHTHFNP2; Katoh M, 2007, CANCER BIOL THER, V6, P832, DOI 10.4161/cbt.6.6.4196; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kim JH, 2010, ONCOL REP, V23, P1523, DOI 10.3892/or_00000791; KIRSCHNER DE, 1995, J THEOR BIOL, V176, P281, DOI 10.1006/jtbi.1995.0198; Koschorreck M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-336; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Kundu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016306; Lacy BE, 2001, J NUTR, V131, p2789S, DOI 10.1093/jn/131.10.2789S; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lee KM, 2010, CANCER LETT, V287, P44, DOI 10.1016/j.canlet.2009.05.032; Lee SY, 2007, ONCOL REP, V17, P1051; Lehmann J, 2001, J IMMUNOL, V167, P5304, DOI 10.4049/jimmunol.167.9.5304; Lindgren A, 2011, INNATE IMMUN-LONDON, V17, P191, DOI 10.1177/1753425909357970; Lohoff M, 2000, J BIOTECHNOL, V83, P33, DOI 10.1016/S0168-1656(00)00295-9; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Luzza F, DIG LIVER DIS, V33, P14; MAI UEH, 1991, J CLIN INVEST, V87, P894, DOI 10.1172/JCI115095; Martin J, 2010, DIGEST DIS SCI, V55, P1516, DOI 10.1007/s10620-010-1252-z; Maurya MR, 2005, IEE P SYST BIOL, V152, P229, DOI 10.1049/ip-syb:20050014; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Mueller A, 2004, GASTROENTEROLOGY, V127, P1446, DOI 10.1053/j.gastro.2004.08.054; Naito Y, 2002, FREE RADICAL BIO MED, V33, P323, DOI 10.1016/S0891-5849(02)00868-7; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Nakayama M, 2004, J BIOL CHEM, V279, P7024, DOI 10.1074/jbc.M308898200; Noto JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054344; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Nozawa Y, 2002, BIOCHEM PHARMACOL, V64, P21, DOI 10.1016/S0006-2952(02)01030-4; Pellicano A, 2007, INFECT IMMUN, V75, P1738, DOI 10.1128/IAI.01446-06; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Reinard JC, 2006, COMMUNICATION RES ST, P218; Remick DG, 2001, AM J PATHOL, V159, P1149, DOI 10.1016/S0002-9440(10)61791-9; Robinson K, 2008, GUT, V57, P1375, DOI 10.1136/gut.2007.137539; Romano MF, 1996, J IMMUNOL, V156, P2119; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Seo JH, 2004, LAB INVEST, V84, P49, DOI 10.1038/labinvest.3700010; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Thompson LJ, 2004, INFECT IMMUN, V72, P4668, DOI 10.1128/IAI.72.8.4668-4679.2004; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wan JH, 2014, BIORESEARCH OPEN ACC, V3, P53, DOI 10.1089/biores.2014.0001; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Xiao C, 2010, GASTROENTEROLOGY, V138, P550, DOI 10.1053/j.gastro.2009.11.002; Yamada H, 2001, BIOCHEM PHARMACOL, V61, P1595, DOI 10.1016/S0006-2952(01)00628-1; Yun CH, 2005, INFECT IMMUN, V73, P1482, DOI 10.1128/IAI.73.3.1482-1490.2005; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhang TL, 2009, BIOPHYS J, V97, P415, DOI 10.1016/j.bpj.2009.04.053	90	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111338	10.1371/journal.pone.0111338	http://dx.doi.org/10.1371/journal.pone.0111338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364910	gold, Green Published			2022-12-27	WOS:000345558100063
J	Nimmanee, P; Woo, PCY; Vanittanakom, P; Youngchim, S; Vanittanakom, N				Nimmanee, Panjaphorn; Woo, Patrick C. Y.; Vanittanakom, Pramote; Youngchim, Sirida; Vanittanakom, Nongnuch			Functional Analysis of atfA Gene to Stress Response in Pathogenic Thermal Dimorphic Fungus Penicillium marneffei	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; ASPERGILLUS-ORYZAE; IDENTIFICATION; TRANSFORMATION; BIOSYNTHESIS; EXPRESSION; PROTEINS; PATHWAY	Penicillium marneffei, the pathogenic thermal dimorphic fungus is a causative agent of a fatal systemic disease, penicilliosis marneffei, in immunocompromised patients especially HIV patients. For growth and survival, this fungus has to adapt to environmental stresses outside and inside host cells and this adaptation requires stress signaling pathways and regulation of gene expression under various kinds of stresses. In this report, P. marneffei activating transcription factor (atfA) gene encoding bZip-type transcription factor was characterized. To determine functions of this gene, atfA isogenic mutant strain was constructed using the modified split marker recombination method. The phenotypes and susceptibility to varieties of stresses including osmotic, oxidative, heat, UV, cell wall and cell membrane stresses of the mutant strain were compared with the wild type and the atfA complemented strains. Results demonstrated that the mRNA expression level of P. marneffei atfA gene increased under heat stress at 42 degrees C. The atfA mutant was more sensitive to sodium dodecyl sulphate, amphotericin B and tert-butyl hydroperoxide than the wild type and complemented strains but not hydrogen peroxide, menadione, NaCl, sorbitol, calcofluor white, itraconazole, UV stresses and heat stress at 39 degrees C. In addition, recovery of atfA mutant conidia after mouse and human macrophage infections was significantly decreased compared to those of wild type and complemented strains. These results indicated that the atfA gene was required by P. marneffei under specific stress conditions and might be necessary for fighting against host immune cells during the initiation of infection.	[Nimmanee, Panjaphorn; Youngchim, Sirida; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Woo, Patrick C. Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Woo, Patrick C. Y.] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China; [Vanittanakom, Pramote] Univ Phayao, Fac Med, Phayao, Thailand	Chiang Mai University; University of Hong Kong; University of Hong Kong; University of Phayao	Vanittanakom, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	drnongnuch@gmail.com	Woo, Patrick Chiu Yat/AAJ-6112-2020	Woo, Patrick Chiu Yat/0000-0001-9401-1832	Royal Golden Jubilee PhD Research Assistant Fellowship; Faculty of Medicine, Chiang Mai University; Faculty of Medicine, the University of Hong Kong	Royal Golden Jubilee PhD Research Assistant Fellowship; Faculty of Medicine, Chiang Mai University; Faculty of Medicine, the University of Hong Kong(University of Hong Kong)	This work was supported by: 1) a Royal Golden Jubilee PhD Research Assistant Fellowship, 2) Faculty of Medicine, Chiang Mai University, and 3) Faculty of Medicine, the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana David M., 2008, P151; Boyce KJ, 2011, MOL MICROBIOL, V82, P1164, DOI 10.1111/j.1365-2958.2011.07878.x; Boyce KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000678; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Canovas David, 2007, P213, DOI 10.1007/978-1-4020-6397-8_9; Cao CW, 2009, MYCOPATHOLOGIA, V168, P23, DOI 10.1007/s11046-009-9192-x; Carbo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001009; Cardoza RE, 2006, J MICROBIOL, V44, P383; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Cooper CR, 2008, FUTURE MICROBIOL, V3, P43, DOI 10.2217/17460913.3.1.43; Furukawa K, 2005, MOL MICROBIOL, V56, P1246, DOI 10.1111/j.1365-2958.2005.04605.x; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Hagiwara D, 2008, BIOSCI BIOTECH BIOCH, V72, P2756, DOI 10.1271/bbb.80001; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Iwai K, 2010, J BIOL CHEM, V285, P10597, DOI 10.1074/jbc.M109.090142; Jin FH, 2004, BIOSCI BIOTECH BIOCH, V68, P656, DOI 10.1271/bbb.68.656; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kummasook A, 2007, DNA SEQUENCE, V18, P385, DOI 10.1080/10425170701309012; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Lau SKP, 2013, FEBS J, V280, P6613, DOI 10.1111/febs.12566; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Liu D, 2009, MYCOSES, V54, P113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DM, 2013, MYCOPATHOLOGIA, V175, P13, DOI 10.1007/s11046-012-9600-5; Rodriguez-Pena JM, 2010, YEAST, V27, P495, DOI 10.1002/yea.1792; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Sakamoto K, 2008, FUNGAL GENET BIOL, V45, P922, DOI 10.1016/j.fgb.2008.03.009; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom N, 2002, J CLIN MICROBIOL, V40, P1739, DOI 10.1128/JCM.40.5.1739-1742.2002; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Woo PCY, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001871; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x	43	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111200	10.1371/journal.pone.0111200	http://dx.doi.org/10.1371/journal.pone.0111200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365258	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100054
J	Vinay-Lara, E; Hamilton, JJ; Stahl, B; Broadbent, JR; Reed, JL; Steele, JL				Vinay-Lara, Elena; Hamilton, Joshua J.; Stahl, Buffy; Broadbent, Jeff R.; Reed, Jennifer L.; Steele, James L.			Genome -Scale Reconstruction of Metabolic Networks of Lactobacillus casei ATCC 334 and 12A	PLOS ONE			English	Article							MODEL; PLANTARUM; GROWTH; OPTIMIZATION; PATHWAYS	Lactobacillus casei strains are widely used in industry and the utility of this organism in these industrial applications is strain dependent. Hence, tools capable of predicting strain specific phenotypes would have utility in the selection of strains for specific industrial processes. Genome-scale metabolic models can be utilized to better understand genotype-phenotype relationships and to compare different organisms. To assist in the selection and development of strains with enhanced industrial utility, genome-scale models for L. casei ATCC 334, a well characterized strain, and strain 12A, a corn silage isolate, were constructed. Draft models were generated from RAST genome annotations using the Model SEED database and refined by evaluating ATP generating cycles, mass-and-charge-balances of reactions, and growth phenotypes. After the validation process was finished, we compared the metabolic networks of these two strains to identify metabolic, genetic and ortholog differences that may lead to different phenotypic behaviors. We conclude that the metabolic capabilities of the two networks are highly similar. The L. casei ATCC 334 model accounts for 1,040 reactions, 959 metabolites and 548 genes, while the L. casei 12A model accounts for 1,076 reactions, 979 metabolites and 640 genes. The developed L. casei ATCC 334 and 12A metabolic models will enable better understanding of the physiology of these organisms and be valuable tools in the development and selection of strains with enhanced utility in a variety of industrial applications.	[Vinay-Lara, Elena; Steele, James L.] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Hamilton, Joshua J.; Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA; [Stahl, Buffy] DuPont Nutr & Hlth, Madison, WI USA; [Broadbent, Jeff R.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; DuPont; Utah System of Higher Education; Utah State University	Steele, JL (corresponding author), Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA.	jlsteele@wisc.edu	Broadbent, Jeff R/A-9626-2010; Reed, Jennifer L/E-5137-2011	Broadbent, Jeff R/0000-0002-0751-0877; Reed, Jennifer L/0000-0001-7854-6220; Hamilton, Joshua/0000-0001-9790-3609	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-67009-30043]; CONACyT; National Science Foundation Graduate Research Fellowship [DGE-0718123]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) and by the National Research Initiative Competitive Grant no. 2011-67009-30043 from the USDA National Institute of Food and Agriculture. Elena Vinay-Lara gratefully acknowledges the scholarship from CONACyT to pursue her postgraduate studies. Josh J. Hamilton received support through a National Science Foundation Graduate Research Fellowship (DGE-0718123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Bringel F, 2003, APPL ENVIRON MICROB, V69, P2674, DOI 10.1128/AEM.69.5.2674-2683.2003; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Christensen JE, 2003, J BACTERIOL, V185, P3297, DOI 10.1128/JB.185.11.3297-3306.2003; DeJongh M, 2012, BIOINFORMATICS, V28, P891, DOI 10.1093/bioinformatics/btr719; Flahaut NAL, 2013, APPL MICROBIOL BIOT, V97, P8729, DOI 10.1007/s00253-013-5140-2; Goldin B. R., 1992, Probiotics: the scientific basis., P355; Hamilton JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034670; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mayra-Makinen A, 1998, LACTIC ACID BACTERIA, P73; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pastink MI, 2009, APPL ENVIRON MICROB, V75, P3627, DOI 10.1128/AEM.00138-09; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002662; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Stiles ME, 1997, INT J FOOD MICROBIOL, V36, P1, DOI 10.1016/S0168-1605(96)01233-0; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; Vermeulen N, 2007, J APPL MICROBIOL, V103, P1197, DOI 10.1111/j.1365-2672.2007.03333.x; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Yebra MJ, 2007, APPL ENVIRON MICROB, V73, P3850, DOI 10.1128/AEM.00243-07; Zomorrodi AR, 2012, METAB ENG, V14, P672, DOI 10.1016/j.ymben.2012.09.005	28	25	26	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110785	10.1371/journal.pone.0110785	http://dx.doi.org/10.1371/journal.pone.0110785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365062	Green Published, gold			2022-12-27	WOS:000345558100028
J	Zaimi, K; Ishak, A; Pop, I				Zaimi, Khairy; Ishak, Anuar; Pop, Ioan			Flow Past a Permeable Stretching/Shrinking Sheet in a Nanofluid Using Two-Phase Model	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER; MULTIPLE SOLUTIONS; STAGNATION POINT; MICROPOLAR FLUID; MASS-TRANSFER; VISCOUS-FLOW; MHD FLOW; CONVECTION; SURFACE	The steady two-dimensional flow and heat transfer over a stretching/shrinking sheet in a nanofluid is investigated using Buongiorno's nanofluid model. Different from the previously published papers, in the present study we consider the case when the nanofluid particle fraction on the boundary is passively rather than actively controlled, which make the model more physically realistic. The governing partial differential equations are transformed into nonlinear ordinary differential equations by a similarity transformation, before being solved numerically by a shooting method. The effects of some governing parameters on the fluid flow and heat transfer characteristics are graphically presented and discussed. Dual solutions are found to exist in a certain range of the suction and stretching/shrinking parameters. Results also indicate that both the skin friction coefficient and the local Nusselt number increase with increasing values of the suction parameter.	[Zaimi, Khairy] Univ Malaysia Perlis, Inst Engn Math, Arau, Perlis, Malaysia; [Ishak, Anuar] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Math Sci, Ctr Modelling & Data Anal, Ukm Bangi, Selangor, Malaysia; [Pop, Ioan] Univ Babes Bolyai, Dept Math, R-3400 Cluj Napoca, Romania	Universiti Malaysia Perlis; Universiti Kebangsaan Malaysia; Babes Bolyai University from Cluj	Ishak, A (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Math Sci, Ctr Modelling & Data Anal, Ukm Bangi, Selangor, Malaysia.	anuar_mi@ukm.edu.my	Zaimi, Khairy/AAS-2819-2020; Ishak, Anuar/AAN-1341-2021; Ishak, Anuar/F-1093-2010; Zaimi, Khairy/AAS-2795-2020; Pop, Ioan/ABE-6678-2020	Ishak, Anuar/0000-0002-2353-5919; Ishak, Anuar/0000-0002-2353-5919; Zaimi, Khairy/0000-0001-8018-6471; Pop, Ioan/0000-0002-0660-6543	Universiti Kebangsaan Malaysia [DIP-2012-31]	Universiti Kebangsaan Malaysia	Funding provided by Universiti Kebangsaan Malaysia Grant number: DIP-2012-31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell M., 2005, MAPLE EXAMPLE, V3rd; Bachok N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060766; Bachok N, 2012, INT J HEAT MASS TRAN, V55, P2102, DOI 10.1016/j.ijheatmasstransfer.2011.12.013; Bachok N, 2010, INT J THERM SCI, V49, P1663, DOI 10.1016/j.ijthermalsci.2010.01.026; Bhattacharyya K, 2012, INT J HEAT MASS TRAN, V55, P2945, DOI 10.1016/j.ijheatmasstransfer.2012.01.051; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Chen CH, 1998, HEAT MASS TRANSFER, V33, P471, DOI 10.1007/s002310050217; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Fan J, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4002633; Fang TG, 2010, COMMUN NONLINEAR SCI, V15, P1831, DOI 10.1016/j.cnsns.2009.07.017; GOLDSTEIN S, 1965, J FLUID MECH, V21, P33, DOI 10.1017/S0022112065000034; GRUBKA LJ, 1985, J HEAT TRANS-T ASME, V107, P248, DOI 10.1115/1.3247387; Harris SD, 2009, TRANSPORT POROUS MED, V77, P267, DOI 10.1007/s11242-008-9309-6; Heck A., 2003, INTRO MAPLE; Hussain M, 2013, J FRANKLIN I, V350, P194, DOI 10.1016/j.jfranklin.2012.07.005; Ibrahim W, 2013, COMPUT FLUIDS, V75, P1, DOI 10.1016/j.compfluid.2013.01.014; Ishak A, 2006, ARAB J SCI ENG, V31, P165; Ishak A, 2008, ENERG CONVERS MANAGE, V49, P3265, DOI 10.1016/j.enconman.2007.11.013; Ishak A, 2008, J ENG MATH, V62, P23, DOI 10.1007/s10665-007-9169-z; Jaluria Y, 2003, COMPUTATIONAL HEAT T; Jaluria Y, 2012, ADV MECH ENG, DOI 10.1155/2012/972973; Kakac S, 2009, INT J HEAT MASS TRAN, V52, P3187, DOI 10.1016/j.ijheatmasstransfer.2009.02.006; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Kumaran V, 2011, INT COMMUN HEAT MASS, V38, P335, DOI 10.1016/j.icheatmasstransfer.2010.11.011; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Kuznetsov AV, 2013, INT J HEAT MASS TRAN, V65, P682, DOI 10.1016/j.ijheatmasstransfer.2013.06.054; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Li YJ, 2009, POWDER TECHNOL, V196, P89, DOI 10.1016/j.powtec.2009.07.025; Mahian O, 2013, INT J HEAT MASS TRAN, V57, P582, DOI 10.1016/j.ijheatmasstransfer.2012.10.037; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mansur S, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/350647; MERKIN JH, 1986, J ENG MATH, V20, P171, DOI 10.1007/BF00042775; Miklavcic M, 2006, Q APPL MATH, V64, P283, DOI 10.1090/S0033-569X-06-01002-5; Nandy SK, 2013, INT J HEAT MASS TRAN, V64, P1091, DOI 10.1016/j.ijheatmasstransfer.2013.05.040; Nield DA, 2014, INT J HEAT MASS TRAN, V77, P915, DOI 10.1016/j.ijheatmasstransfer.2014.06.020; Nield DA, 2014, INT J HEAT MASS TRAN, V68, P211, DOI 10.1016/j.ijheatmasstransfer.2013.09.026; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Paullet J, 2007, INT J NONLIN MECH, V42, P1084, DOI 10.1016/j.ijnonlinmec.2007.06.003; Postelnicu A, 2011, APPL MATH COMPUT, V217, P4359, DOI 10.1016/j.amc.2010.09.037; Rashid M.H., 2014, ALTERNATIVE ENERGY P, V1st, P1, DOI [10.1016/C2012-0-07333-4, DOI 10.1016/C2012-0-07333-4]; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rashidi MM, 2011, INT J NUMER METHOD H, V21, P864, DOI 10.1108/09615531111162837; Richards D., 2002, ADV MATH METHODS MAP; Ridha A, 1996, Z ANGEW MATH PHYS, V47, P341, DOI 10.1007/BF00916642; Rohni AM, 2012, INT J HEAT MASS TRAN, V55, P5846, DOI 10.1016/j.ijheatmasstransfer.2012.05.080; Rosca AV, 2013, INT J HEAT MASS TRAN, V60, P355, DOI 10.1016/j.ijheatmasstransfer.2012.12.028; Saidur R, 2011, RENEW SUST ENERG REV, V15, P1646, DOI 10.1016/j.rser.2010.11.035; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Turkyilmazoglu M, 2011, J THERMOPHYS HEAT TR, V25, P595, DOI 10.2514/1.T3749; Turkyilmazoglu M, 2011, INT J MECH SCI, V53, P886, DOI 10.1016/j.ijmecsci.2011.07.012; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; WANG CY, 1984, PHYS FLUIDS, V27, P1915, DOI 10.1063/1.864868; Weidman PD, 2006, INT J ENG SCI, V44, P730, DOI 10.1016/j.ijengsci.2006.04.005; Wong KV, 2010, ADV MECH ENG, DOI 10.1155/2010/519659; Yacob NA, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-314; Yao SS, 2011, COMMUN NONLINEAR SCI, V16, P752, DOI 10.1016/j.cnsns.2010.05.028; Zaimi K, 2012, ADV MECH ENG, DOI 10.1155/2012/340354	58	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111743	10.1371/journal.pone.0111743	http://dx.doi.org/10.1371/journal.pone.0111743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365118	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100113
J	Chang, YH; Sun, YH				Chang, Yung-Heng; Sun, Yi Henry			Carrier of Wingless (Cow), a Secreted Heparan Sulfate Proteoglycan, Promotes Extracellular Transport of Wingless	PLOS ONE			English	Article							MORPHOGEN GRADIENT FORMATION; FRIZZLED-RELATED PROTEINS; LONG-RANGE ACTION; DROSOPHILA EMBRYOS; DALLY-LIKE; ORGAN DEVELOPMENT; IMAGINAL DISKS; WNT PROTEINS; EXPRESSION; GENE	Morphogens are signaling molecules that regulate growth and patterning during development by forming a gradient and activating different target genes at different concentrations. The extracellular distribution of morphogens is tightly regulated, with the Drosophila morphogen Wingless (Wg) relying on Dally-like (Dlp) and transcytosis for its distribution. However, in the absence of Dlp or endocytic activity, Wg can still move across cells along the apical (Ap) surface. We identified a novel secreted heparan sulfate proteoglycan (HSPG) that binds to Wg and promotes its extracellular distribution by increasing Wg mobility, which was thus named Carrier of Wg (Cow). Cow promotes the Ap transport of Wg, independent of Dlp and endocytosis, and this function addresses a previous gap in the understanding of Wg movement. This is the first example of a diffusible HSPG acting as a carrier to promote the extracellular movement of a morphogen.	[Chang, Yung-Heng; Sun, Yi Henry] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chang, Yung-Heng; Sun, Yi Henry] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Sun, YH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	mbyhsun@gate.sinica.edu.tw	Sun, Y. Henry/ABC-4614-2021; Sun, Y. Henry/AAZ-7966-2021	Sun, Y. Henry/0000-0001-8279-5270; CHANG, YUNG-HENG/0000-0001-9459-0790	Academia Sinica, Taiwan, Republic of China [AS-91-IMB-4PP, AS-95-TP-B04]; National Science Council, Taiwan, Republic of China [NSC 96-2321-B-001-002, NSC 97-2321-B-001-002, NSC 98-2321-B-001-034, NSC 99-2321-B-001-016, NSC 100-2321-B-001-012]	Academia Sinica, Taiwan, Republic of China(Academia Sinica - Taiwan); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	YHS is supported by grants from Academia Sinica, Taiwan, Republic of China (AS-91-IMB-4PP, AS-95-TP-B04; http://www.sinica.edu.tw/index.shtml), and National Science Council, Taiwan, Republic of China (NSC 96-2321-B-001-002, NSC 97-2321-B-001-002, NSC 98-2321-B-001-034, NSC 99-2321-B-001-016, NSC 100-2321-B-001-012; http://www.most.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Baeg GH, 2001, DEVELOPMENT, V128, P87; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; BAKER NE, 1988, DEVELOPMENT, V102, P489; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; BaSalamah MAM, 2001, BIOCHEM BIOPH RES CO, V283, P1083, DOI 10.1006/bbrc.2001.4900; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; Berger EA, 2011, INVEST OPHTH VIS SCI, V52, P5339, DOI 10.1167/iovs.10-6920; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buechling T, 2011, CURR TOP DEV BIOL, V97, P21, DOI 10.1016/B978-0-12-385975-4.00008-5; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chou TB, 1996, GENETICS, V144, P1673; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COUSO JP, 1993, SCIENCE, V259, P484, DOI 10.1126/science.8424170; COUSO JP, 1994, DEVELOPMENT, V120, P621; Crozatier M, 2004, TRENDS GENET, V20, P498, DOI 10.1016/j.tig.2004.07.013; Edgell CJS, 2004, INT REV CYTOL, V236, P101, DOI 10.1016/S0074-7696(04)36003-1; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Hartmann U, 2001, MATRIX BIOL, V20, P23, DOI 10.1016/S0945-053X(00)00137-2; Hausser HJ, 2004, OSTEOARTHR CARTILAGE, V12, P870, DOI 10.1016/j.joca.2004.07.008; Hufnagel L, 2006, DEV BIOL, V300, P512, DOI 10.1016/j.ydbio.2006.08.076; Jafar-Nejad H, 2006, DEVELOPMENT, V133, P1683, DOI 10.1242/dev.02338; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Morata G, 2014, NATURE, V505, P162, DOI 10.1038/nature12848; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Nakada M, 2003, CANCER RES, V63, P3364; Nakada M, 2001, CANCER RES, V61, P8896; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Schnepp A, 2005, J BIOL CHEM, V280, P11274, DOI 10.1074/jbc.M414276200; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Solis GP, 2013, INT J MOL SCI, V14, P5130, DOI 10.3390/ijms14035130; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yao JG, 2005, EMBO J, V24, P2602, DOI 10.1038/sj.emboj.7600725; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang J, 1998, DEVELOPMENT, V125, P3075	68	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111573	10.1371/journal.pone.0111573	http://dx.doi.org/10.1371/journal.pone.0111573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360738	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700123
J	Chirumbolo, A; Brizi, A; Mastandrea, S; Mannetti, L				Chirumbolo, Antonio; Brizi, Ambra; Mastandrea, Stefano; Mannetti, Lucia			'Beauty Is No Quality in Things Themselves': Epistemic Motivation Affects Implicit Preferences for Art	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; AESTHETIC JUDGMENTS; ASSOCIATION TEST; IMPRESSIONAL PRIMACY; COGNITIVE CLOSURE; PERSONALITY; APPRECIATION; PAINTINGS; NEED; INFORMATION	Art preferences are affected by a number of subjective factors. This paper reports two studies which investigated whether need for closure shapes implicit art preferences. It was predicted that higher need for closure would negatively affect implicit preferences for abstract art. In study one, 60 participants were tested for dispositional need for closure and then completed an Implicit Association Test (IAT) task to measure their implicit preference for abstract (vs. figurative) paintings. In study two, 54 participants completed the same IAT task. In this experiment need for closure was both manipulated by cognitive load and tapped as a dispositional trait. Results of the studies converged in showing that after controlling for other important individual factors such as participants'expertise and cognitive ability, need for closure, both as a dispositional trait and as a situationally induced motivational state, was negatively associated with implicit preference for abstract art.	[Chirumbolo, Antonio; Brizi, Ambra; Mannetti, Lucia] Univ Roma La Sapienza, Dept Social & Dev Psychol, I-00185 Rome, Italy; [Mastandrea, Stefano] Univ Roma Tre, Dept Cultural & Educ Studies, Rome, Italy	Sapienza University Rome; Roma Tre University	Chirumbolo, A (corresponding author), Univ Roma La Sapienza, Dept Social & Dev Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	antonio.chirumbolo@uniroma1.it		Brizi, Ambra/0000-0001-6462-5059; Chirumbolo, Antonio/0000-0002-4274-2489				Aiken L. S., 1991, MULTIPLE REGRESSION; BARGH J A, 1989, P3; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Belke B., 2006, PSYCHOL SCI, V48, P115; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Bertamini M, 2013, I-PERCEPTION, V4, P317, DOI 10.1068/i0601JW; Boselie F., 1994, EMPIR STUD ARTS, V12, P85, DOI [10.2190/57V8-R1AQ-9WGQ-MMG1, DOI 10.2190/57V8-R1AQ-9WGQ-MMG1]; Cattell R. B, 1993, 16PF 5 EDITION QUEST; Chirumbolo A, 2008, 15 GEN M EUR ASS EXP; Chirumbolo A, 2010, 6 EUR SPRING C SOC P; Costa PT, 2007, REVISED NEO PERSONAL; De Dreu CKW, 2008, PERS SOC PSYCHOL REV, V12, P22, DOI 10.1177/1088868307304092; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Eysenck HJ, 1941, B J PSYCHOL-GEN SECT, V31, P262, DOI 10.1111/j.2044-8295.1941.tb00992.x; Eysenck HJ, 1940, B J PSYCHOL-GEN SECT, V31, P94, DOI 10.1111/j.2044-8295.1940.tb00977.x; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Feist G. J., 2004, EMPIR STUD ARTS, V22, P77, DOI [10.2190/Y7CA-TBY6-V7LR-76GK, DOI 10.2190/Y7CA-TBY6-V7LR-76GK]; FORD TE, 1995, PERS SOC PSYCHOL B, V21, P950, DOI 10.1177/0146167295219009; Furnham A, 2001, EUR J PERSONALITY, V15, P57, DOI 10.1002/per.340; Furnham A, 1997, PERS INDIV DIFFER, V23, P923, DOI 10.1016/S0191-8869(97)00131-1; FURNHAM A, 1988, EUR J PERSONALITY, V2, P67, DOI 10.1002/per.2410020106; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; HEINRICHS RW, 1985, J PERS, V53, P502, DOI 10.1111/j.1467-6494.1985.tb00379.x; Hume D., 1742, ESSAYS MORAL POLITIC; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2010, J ANAT, V216, P184, DOI 10.1111/j.1469-7580.2009.01164.x; Kettlewell N., 1990, EMPIR STUD ARTS, V8, P85, DOI [DOI 10.2190/Y8JA-3GUR-M08C-BPEC, 10.2190/Y8JA-3GUR-M08C-BPEC]; Kossowska M, 2010, SPRINGER SER HUM EXC, P369, DOI 10.1007/978-1-4419-1210-7_22; Kruglanski A., 1996, SOCIAL PSYCHOL HDB B, P493; Kruglanski A. W., 1990, HDB MOTIVATION COGNI, V2, P333; Kruglanski AW, 2009, EUR REV SOC PSYCHOL, V20, P146, DOI 10.1080/10463280902860037; Kruglanski Arie W., 2004, PSYCHOL CLOSED MINDE; KRUGLANSKI AW, 1983, J EXP SOC PSYCHOL, V19, P448, DOI 10.1016/0022-1031(83)90022-7; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; Landau MJ, 2006, J PERS SOC PSYCHOL, V90, P879, DOI 10.1037/0022-3514.90.6.879; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Lindell AK, 2011, J COGN PSYCHOL, V23, P453, DOI 10.1080/20445911.2011.539556; Litchfield RC, 2013, IND MARKET MANAG, V42, P106, DOI 10.1016/j.indmarman.2012.11.010; Locher P, 2008, SPATIAL VISION, V21, P55, DOI 10.1163/156856808782713762; Makin ADJ, 2012, EMOTION, V12, P1021, DOI 10.1037/a0026924; Mastandrea S, 2014, ART PERCEPT, V2, P141, DOI 10.1163/22134913-00002015; Mastandrea S, 2011, PSYCHOL AESTHET CREA, V5, P126, DOI 10.1037/a0021126; Mastandrea S, 2009, PSYCHOL AESTHET CREA, V3, P164, DOI 10.1037/a0013142; Masuda T, 2008, PERS SOC PSYCHOL B, V34, P1260, DOI 10.1177/0146167208320555; Millisecond Software, 2012, INQ 3 COMP SOFTW; Mueller JS, 2012, PSYCHOL SCI, V23, P13, DOI 10.1177/0956797611421018; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Palmer SE, 2013, PSYCHON B REV, V20, P453, DOI 10.3758/s13423-012-0355-2; Palmer SE, 2013, ANNU REV PSYCHOL, V64, P77, DOI 10.1146/annurev-psych-120710-100504; Pavlovic M, 2012, PSIHOLOGIJA, V45, P377, DOI 10.2298/PSI1204377P; Rawlings D, 2000, EUR J PERSONALITY, V14, P553; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Schimmel K., 2008, PSYCHOL AESTHET CREA, V2, P53, DOI DOI 10.1037/1931-3896; Silvia P.J., 2005, EMPIR STUD ARTS, V23, P119, DOI [10.2190/12AV-AH2P-MCEH-289E, DOI 10.2190/12AV-AH2P-MCEH-289E, https://doi.org/10.2190/12AV-AH2P-MCEH-289E]; Valentine C.W., 1962, INTRO EXPT PSYCHOL B, V1st ed., DOI [10.4324/9781315707617, DOI 10.4324/9781315707617]; Van Hiel A, 2002, SOC COGNITION, V20, P380; Vartanian O., 2004, B PSYCHOL ARTS, V5, P37, DOI [10.1037/e674852010-005, DOI 10.1037/E674852010-005]; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; Webster DM, 1996, J EXP SOC PSYCHOL, V32, P181, DOI 10.1006/jesp.1996.0009; Webster DM, 1998, J PERS SOC PSYCHOL, V8, P133, DOI DOI 10.1080/14792779643000100; Wiersema DV, 2012, PSYCHOL AESTHET CREA, V6, P168, DOI 10.1037/a0025878; Zuckerman M., 2014, SENSATION SEEKING OP	63	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110323	10.1371/journal.pone.0110323	http://dx.doi.org/10.1371/journal.pone.0110323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360697	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700031
J	Stock, W; Heylen, K; Sabbe, K; Willems, A; De Troch, M				Stock, Willem; Heylen, Kim; Sabbe, Koen; Willems, Anne; De Troch, Marleen			Interactions between Benthic Copepods, Bacteria and Diatoms Promote Nitrogen Retention in Intertidal Marine Sediments	PLOS ONE			English	Article							COUPLED NITRIFICATION-DENITRIFICATION; HARPACTICOID COPEPODS; NITRATE; ESTUARINE; NUTRIENT; COMMUNITIES; REDUCTION; MEIOFAUNA; CARBON; EUTROPHICATION	The present study aims at evaluating the impact of diatoms and copepods on microbial processes mediating nitrate removal in fine-grained intertidal sediments. More specifically, we studied the interactions between copepods, diatoms and bacteria in relation to their effects on nitrate reduction and denitrification. Microcosms containing defaunated marine sediments were subjected to different treatments: an excess of nitrate, copepods, diatoms (Navicula sp.), a combination of copepods and diatoms, and spent medium from copepods. The microcosms were incubated for seven and a half days, after which nutrient concentrations and denitrification potential were measured. Ammonium concentrations were highest in the treatments with copepods or their spent medium, whilst denitrification potential was lowest in these treatments, suggesting that copepods enhance dissimilatory nitrate reduction to ammonium over denitrification. We hypothesize that this is an indirect effect, by providing extra carbon for the bacterial community through the copepods' excretion products, thus changing the C/N ratio in favour of dissimilatory nitrate reduction. Diatoms alone had no effect on the nitrogen fluxes, but they did enhance the effect of copepods, possibly by influencing the quantity and quality of the copepods' excretion products. Our results show that small-scale biological interactions between bacteria, copepods and diatoms can have an important impact on denitrification and hence sediment nitrogen fluxes.	[Stock, Willem; Sabbe, Koen; De Troch, Marleen] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Heylen, Kim; Willems, Anne] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium	Ghent University; Ghent University	Stock, W (corresponding author), Univ Ghent, Dept Biol, B-9000 Ghent, Belgium.	Willem.Stock@Ugent.be	De Troch, Marleen/AAB-9809-2019; Willems, Anne/B-2872-2010	De Troch, Marleen/0000-0002-6800-0299; Willems, Anne/0000-0002-8421-2881; Stock, Willem/0000-0001-7648-6404	Ghent University (BOF-UGent) [GOA 01GA1911W]; Flemish Fund for Scientific Research [FWO11/PDO/084]	Ghent University (BOF-UGent)(Ghent University); Flemish Fund for Scientific Research(FWO)	This research was conducted within the frame of research project GOA 01GA1911W of the Special Research Fund at Ghent University (BOF-UGent) on "Understanding biodiversity effects on the functioning of marine benthic ecosystems". M. De Troch is a postdoctoral researcher financed by the same project. Kim Heylen is supported by the Flemish Fund for Scientific Research (FWO11/PDO/084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2001, LIMNOL OCEANOGR, V46, P62, DOI 10.4319/lo.2001.46.1.0062; An S, 2002, MARINE ECOLOGY PROGR, V237; Bartoli M, 2012, J EXP MAR BIOL ECOL, V438, P41, DOI 10.1016/j.jembe.2012.09.011; BERNER RA, 1985, AM J SCI, V285, P193, DOI 10.2475/ajs.285.3.193; Beyst B, 2001, J SEA RES, V46, P281, DOI 10.1016/S1385-1101(01)00087-9; BINNERUP SJ, 1992, APPL ENVIRON MICROB, V58, P303, DOI 10.1128/AEM.58.1.303-313.1992; Braeckman U, 2009, MARINE ECOLOGY PROGR, V399, P173; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; CHRISTENSEN PB, 1990, LIMNOL OCEANOGR, V35, P640, DOI 10.4319/lo.1990.35.3.0640; Cnudde C, UNPUB; Cnudde C, 2013, ENV MICROBIOL REP, V5, P301, DOI 10.1111/1758-2229.12018; Cornwell Jeffrey C., 1999, Aquatic Ecology, V33, P41, DOI 10.1023/A:1009921414151; Coull BC, 1999, AUST J ECOL, V24, P327, DOI 10.1046/j.1442-9993.1999.00979.x; De Troch M, 2006, MAR ENVIRON RES, V61, P265, DOI 10.1016/j.marenvres.2005.10.004; De Troch M, 2005, AQUAT MICROB ECOL, V39, P135, DOI 10.3354/ame039135; De Troch M, 2012, AQUAT MICROB ECOL, V67, P47, DOI 10.3354/ame01587; De Troch M, 2010, MICROB ECOL, V60, P581, DOI 10.1007/s00248-010-9669-7; Ferguson A, 2013, BIOGEOCHEMISTRY, V112, P423, DOI 10.1007/s10533-012-9736-x; Frangoulis C, 2005, ADV MAR BIOL, V47, P253; Giblin AE, 2013, IMPORTANCE DISSIMILA; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI [DOI 10.2147/DDDT.S165440, 10.1002/cber.187901201117., DOI 10.1002/CBER.187901201117]; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Herbert RA, 1999, FEMS MICROBIOL REV, V23, P563, DOI 10.1016/S0168-6445(99)00022-4; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Jetten MSM, 2001, CURR OPIN BIOTECH, V12, P283, DOI 10.1016/S0958-1669(00)00211-1; KOCH MS, 1992, ESTUAR COAST SHELF S, V34, P471, DOI 10.1016/S0272-7714(05)80118-0; Koop-Jakobsen K, 2010, LIMNOL OCEANOGR, V55, P789, DOI 10.4319/lo.2009.55.2.0789; Lau M, 2009, DTK DUNNETT TUKEY KR; Leach AM, 2012, ENVIRON DEV, V1, P40, DOI 10.1016/j.envdev.2011.12.005; Magalhaes CM, 2011, FEMS MICROBIOL ECOL, V77, P274, DOI 10.1111/j.1574-6941.2011.01107.x; Martin P, 2005, GLOBAL PLANET CHANGE, V46, P87, DOI 10.1016/j.gloplacha.2004.11.012; MONTAGNA PA, 1984, MAR ECOL PROG SER, V18, P119, DOI 10.3354/meps018119; Nascimento FJA, 2012, LIMNOL OCEANOGR, V57, P338, DOI 10.4319/lo.2012.57.1.0338; Navarro-Gonzalvez JA, 1998, CLIN CHEM, V44, P679; Nilsson P, 1991, MARINE ECOLOGY PROGR, V71; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Patsch J, 2010, CONT SHELF RES, V30, P203, DOI 10.1016/j.csr.2009.11.003; Parent S, 1999, CAN J FISH AQUAT SCI, V56, P1639, DOI 10.1139/cjfas-56-9-1639; Risgaard-Petersen N, 2004, APPL ENVIRON MICROB, V70, P5528, DOI 10.1128/AEM.70.9.5528-5537.2004; Risgaard-Petersen N, 2003, LIMNOL OCEANOGR, V48, P93; Schreiber F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00372; SORENSEN J, 1978, APPL ENVIRON MICROB, V35, P301; Stenstrom J, 1991, SWEDISH J AGR RES SW; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Sundback K, 1996, ESTUAR COAST SHELF S, V43, P689, DOI 10.1006/ecss.1996.0097; Sundback K, 2006, ESTUAR COAST, V29, P1196, DOI 10.1007/BF02781820; Teixeira C, 2012, AQUAT MICROB ECOL, V66, P23, DOI 10.3354/ame01548; Vadstein O, 2012, MAR ECOL PROG SER, V447, P55, DOI 10.3354/meps09473; Wheeler B., 2010, IMPERM PERMUTATION T	50	12	12	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111001	10.1371/journal.pone.0111001	http://dx.doi.org/10.1371/journal.pone.0111001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360602	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700057
J	Yap, HJ; Taha, Z; Dawal, SZM; Chang, SW				Yap, Hwa Jen; Taha, Zahari; Dawal, Siti Zawiah Md; Chang, Siow-Wee			Virtual Reality Based Support System for Layout Planning and Programming of an Industrial Robotic Work Cell	PLOS ONE			English	Article							TOOLS	Traditional robotic work cell design and programming are considered inefficient and outdated in current industrial and market demands. In this research, virtual reality (VR) technology is used to improve human-robot interface, whereby complicated commands or programming knowledge is not required. The proposed solution, known as VR-based Programming of a Robotic Work Cell (VR-Rocell), consists of two sub-programmes, which are VR-Robotic Work Cell Layout (VR-RoWL) and VR-based Robot Teaching System (VR-RoT). VR-RoWL is developed to assign the layout design for an industrial robotic work cell, whereby VR-RoT is developed to overcome safety issues and lack of trained personnel in robot programming. Simple and user-friendly interfaces are designed for inexperienced users to generate robot commands without damaging the robot or interrupting the production line. The user is able to attempt numerous times to attain an optimum solution. A case study is conducted in the Robotics Laboratory to assemble an electronics casing and it is found that the output models are compatible with commercial software without loss of information. Furthermore, the generated KUKA commands are workable when loaded into a commercial simulator. The operation of the actual robotic work cell shows that the errors may be due to the dynamics of the KUKA robot rather than the accuracy of the generated programme. Therefore, it is concluded that the virtual reality based solution approach can be implemented in an industrial robotic work cell.	[Yap, Hwa Jen; Dawal, Siti Zawiah Md] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia; [Taha, Zahari] Univ Malaysia Pahang, Fac Mech Engn, Pekan, Pahang, Malaysia; [Chang, Siow-Wee] Univ Malaya, Fac Engn, Bioinformat Program, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaysia Pahang; Universiti Malaya	Yap, HJ (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia.	hjyap737@um.edu.my	taha, zahari/F-6356-2015; YAP, HWA JEN/C-1065-2010; Chang, Siow-Wee/B-5287-2010; DAWAL, SITI ZAWIAH MD/B-9816-2010	YAP, HWA JEN/0000-0001-7637-9297; Chang, Siow-Wee/0000-0001-7038-6170; DAWAL, SITI ZAWIAH MD/0000-0003-0496-5128	Ministry of Higher Education Malaysia [UM.C/HIR/MOHE/ENG/35(D000035-16001)]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This work was supported by Ministry of Higher Education Malaysia with the grant number UM.C/HIR/MOHE/ENG/35(D000035-16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdea GC, 1999, IEEE T ROBOTIC AUTOM, V15, P400, DOI 10.1109/70.768174; Choo HK, 2014, VIRTUAL REALITY BASE; Crison F, 2005, P IEEE VIRT REAL ANN, P139; Du T., 2005, ADV ELECT BUSINESS, V1; Fauadi HF, 2008, MODELING SIMULATION; Gokdere LU, 2002, MECHATRONICS, V12, P575, DOI 10.1016/S0957-4158(01)00009-5; Guerra D, 2006, DIGITAL MANUFACTURIN; IFR, 2011, WORLD ROB STAT MARK; IFR, 2001, WORLD ROB STAT MARK; Iqbal M, 1999, APPL VIRTUAL REALITY, P1959; Jahangirian M, 2010, EUR J OPER RES, V203, P1, DOI 10.1016/j.ejor.2009.06.004; Jen YH, 2008, INT J IND ENG-THEORY, V15, P314; Kadir AA, 2011, ROBOT CIM-INT MANUF, V27, P494, DOI 10.1016/j.rcim.2010.10.003; Kim SC, 2000, INT J PERCISION ENG, V1, P84; Klingstam P, 1999, COMPUT IND, V38, P173, DOI 10.1016/S0166-3615(98)00117-1; Kumar R, 2011, ROBOT CIM-INT MANUF, V27, P994, DOI 10.1016/j.rcim.2011.05.003; Lawrence Associates, 1994, TECHNICAL REPORT; Lee WB, 2002, INT J ENG EDUC, V18, P584; Lee WB, 2001, J MATER PROCESS TECH, V113, P416, DOI 10.1016/S0924-0136(01)00668-9; Malaysian Anthropometry, 2008, ANTHR DAT MAL UNPUB; Mitsi S, 2005, INT J ADV MANUF TECH, V26, P262, DOI 10.1007/s00170-003-1728-5; Mujber TS, 2004, J MATER PROCESS TECH, V155, P1834, DOI 10.1016/j.jmatprotec.2004.04.401; Neto Pedro, 2010, 2010 IEEE Conference on Robotics, Automation and Mechatronics (RAM 2010), P333, DOI 10.1109/RAMECH.2010.5513169; Or CKL, 2009, INT J IND ERGONOM, V39, P807, DOI 10.1016/j.ergon.2009.01.003; OSHA Japan, 1995, 5 OSHA JAP JAP MIN L; Radhakrishnan R., 2008, BUSINESS PROCESS REE; Raneda A, 2003, FUSION ENG DES, V69, P183, DOI 10.1016/S0920-3796(03)00333-8; Santis AD, 2008, SAFETY ISSUES HUMAN, P1; Staranowicz A, 2011, SURVEY COMP COMMERCI; Taha Z, 2014, INT J IND ERGONOM, V44, P368, DOI 10.1016/j.ergon.2013.11.007; Wang Q. H., 2004, Virtual Reality, V7, P187, DOI 10.1007/s10055-004-0127-z; Whyte J, 2000, AUTOMAT CONSTR, V10, P43, DOI 10.1016/S0926-5805(99)00012-6; Xu ZJ, 1997, VIRTUAL REALITY BASE; Yap HJ, 2012, J ZHEJIANG U-SCI C, V13, P20, DOI 10.1631/jzus.C11a0077; Zhu LD, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON AUTOMATION AND LOGISTICS, VOLS 1-6, P2302, DOI 10.1109/ICAL.2008.4636550	35	21	21	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109692	10.1371/journal.pone.0109692	http://dx.doi.org/10.1371/journal.pone.0109692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360663	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700016
J	Antonioni, A; Cacault, MP; Lalive, R; Tomassini, M				Antonioni, Alberto; Cacault, Maria Paula; Lalive, Rafael; Tomassini, Marco			Know Thy Neighbor: Costly Information Can Hurt Cooperation in Dynamic Networks	PLOS ONE			English	Article							PROMOTE COOPERATION; EVOLUTIONARY GAMES; PRISONERS-DILEMMA; COEVOLUTION; POPULATIONS; HUMANS	People need to rely on cooperation with other individuals in many aspects of everyday life, such as teamwork and economic exchange in anonymous markets. We study whether and how the ability to make or break links in social networks fosters cooperate, paying particular attention to whether information on an individual's actions is freely available to potential partners. Studying the role of information is relevant as information on other people's actions is often not available for free: a recruiting firm may need to call a job candidate's references, a bank may need to find out about the credit history of a new client, etc. We find that people cooperate almost fully when information on their actions is freely available to their potential partners. Cooperation is less likely, however, if people have to pay about half of what they gain from cooperating with a cooperator. Cooperation declines even further if people have to pay a cost that is almost equivalent to the gain from cooperating with a cooperator. Thus, costly information on potential neighbors' actions can undermine the incentive to cooperate in fluid networks.	[Antonioni, Alberto; Cacault, Maria Paula; Lalive, Rafael; Tomassini, Marco] Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne	Tomassini, M (corresponding author), Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland.	marco.tomassini@unil.ch	Antonioni, Alberto/U-6497-2018	Antonioni, Alberto/0000-0002-5788-3348; Lalive, Rafael/0000-0003-1938-692X; Cacault, Maria Paula/0000-0001-9241-2368	Swiss National Science Foundation [200020-143224]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	AA received financial support from the Swiss National Science Foundation, http://www.snf.ch/en/Pages/default.aspx under grant number 200020-143224. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SUPER COOPERATORS AL; [Anonymous], 1995, EVOLUTIONARY GAME TH; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Flood MM, 1952, RM7891 RAND COOP; Gracia-Lazaro C, 2012, HUMAN BEHAV PRISONER, V2; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Greiner B., 2004, FORSCHUNG WISSENSCHA, P79, DOI DOI 10.1016/J.IJFORECAST.2005.03.004; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Jackson MO, 2012, AM ECON REV, V102, P1857, DOI 10.1257/aer.102.5.1857; Miyaji K, 2013, CHAOS SOLITON FRACT, V56, P13, DOI 10.1016/j.chaos.2013.05.007; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pestelacci Enea, 2008, Biological Theory, V3, P139, DOI 10.1162/biot.2008.3.2.139; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rapoport A, 1965, PRISONERS DILEMMA; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tanimoto J, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/05/P05003; Tanimoto J, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012106; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021126; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Wang Z, 2013, INTERDEPENDENT NETWO, V3; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Weber R, 2013, 130 U ZUR DEP EC; Yonenoh H, 2014, J THEOR BIOL, V351, P25, DOI 10.1016/j.jtbi.2014.02.006; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	34	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110788	10.1371/journal.pone.0110788	http://dx.doi.org/10.1371/journal.pone.0110788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356905	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000025
J	Berkner, H; von Loetzen, CS; Hartl, M; Randow, S; Gubesch, M; Vogel, L; Husslik, F; Reuter, A; Lidholm, J; Ballmer-Weber, B; Vieths, S; Rosch, P; Schiller, D				Berkner, Hanna; von Loetzen, Christian Seutter; Hartl, Maximilian; Randow, Stefanie; Gubesch, Michaela; Vogel, Lothar; Husslik, Felix; Reuter, Andreas; Lidholm, Jonas; Ballmer-Weber, Barbara; Vieths, Stefan; Roesch, Paul; Schiller, Dirk			Enlarging the Toolbox for Allergen Epitope Definition with an Allergen-Type Model Protein	PLOS ONE			English	Article							BET V 1; BIRCH-POLLEN ALLERGEN; SITE-DIRECTED MUTAGENESIS; X-RAY CRYSTALLOGRAPHY; MAJOR CHERRY ALLERGEN; IGE-BINDING EPITOPES; CROSS-REACTIVITY; FOOD ALLERGENS; IMMUNOLOGICAL CHARACTERIZATION; NORCOCLAURINE SYNTHASE	Background: Birch pollen-allergic subjects produce polyclonal cross-reactive IgE antibodies that mediate pollen-associated food allergies. The major allergen Bet v 1 and its homologs in plant foods bind IgE in their native protein conformation. Information on location, number and clinical relevance of IgE epitopes is limited. We addressed the use of an allergen-related protein model to identify amino acids critical for IgE binding of PR-10 allergens. Method: Norcoclaurine synthase (NCS) from meadow rue is structurally homologous to Bet v 1 but does not bind Bet v 1-reactive (IgE). NCS was used as the template for epitope grafting. NCS variants were tested with sera from 70 birch pollen allergic subjects and with monoclonal antibody BV16 reported to compete with IgE binding to Bet v 1. Results: We generated an NCS variant (Delta 29NCS(N57/I58E/D60N/V63P/D68K)) harboring an IgE epitope of Bet v 1. Bet v 1-type protein folding of the NCS variant was evaluated by H-1-(15) N-HSQC NMR spectroscopy. BV16 bound the NCS variant and 71% (50/70 sera) of our study population showed significant IgE binding. We observed IgE and BV16 cross-reactivity to the epitope presented by the NCS variant in a subgroup of Bet v 1-related allergens. Moreover BV16 blocked IgE binding to the NCS variant. Antibody cross-reactivity depended on a defined orientation of amino acids within the Bet v 1-type conformation. Conclusion: Our system allows the evaluation of patient-specific epitope profiles and will facilitate both the identification of clinically relevant epitopes as biomarkers and the monitoring of therapeutic outcomes to improve diagnosis, prognosis, and therapy of allergies caused by PR-10 proteins.	[Berkner, Hanna; von Loetzen, Christian Seutter; Hartl, Maximilian] Univ Bayreuth, Dept Biopolymers, Bayreuth, Bavaria, Germany; [Randow, Stefanie; Gubesch, Michaela; Vogel, Lothar; Husslik, Felix; Reuter, Andreas] Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany; [Lidholm, Jonas] Thermo Fisher Sci Inc, Div Immunodiagnost, Uppsala, Uppsala Ian, Sweden; [Ballmer-Weber, Barbara] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8091 Zurich, Switzerland	University of Bayreuth; Paul Ehrlich Institute; Thermo Fisher Scientific; University of Zurich; University Zurich Hospital	Schiller, D (corresponding author), Paul Ehrlich Inst, Div Allergol, Langen, Hesse, Germany.	Dirk.Schiller@pei.de		Lidholm, Jonas/0000-0002-7779-3411; Reuter, Andreas/0000-0002-6082-9000				Albrecht M, 2008, MOL NUTR FOOD RES, V52, pS186, DOI 10.1002/mnfr.200700424; AXEN RE, 1988, NEW ENG REG ALLERGY, V9, P503; Ballmer-Weber BK, 2005, CLIN EXP ALLERGY, V35, P970, DOI 10.1111/j.1365-2222.2005.02294.x; Berkner H, 2008, BIOCHEM J, V413, P281, DOI 10.1042/BJ20080306; Berkner H, 2007, PROTEIN EXPRES PURIF, V56, P197, DOI 10.1016/j.pep.2007.07.010; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; Dall'Antonia F, 2011, J ALLERGY CLIN IMMUN, V128, P872, DOI 10.1016/j.jaci.2011.07.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeWitt AM, 2002, CLIN EXP ALLERGY, V32, P1329, DOI 10.1046/j.1365-2222.2002.01467.x; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Holm J, 2011, J BIOL CHEM, V286, P17569, DOI 10.1074/jbc.M110.194878; Ilari A, 2009, J BIOL CHEM, V284, P897, DOI 10.1074/jbc.M803738200; Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026; Jimenez-Lopez JC, 2012, MOL BIOL REP, V39, P123, DOI 10.1007/s11033-011-0717-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kahlert H, 2008, INT ARCH ALLERGY IMM, V145, P193, DOI 10.1159/000109288; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN JN, 1993, INT ARCH ALLERGY IMM, V102, P249, DOI 10.1159/000236533; Lauer I, 2008, MOL NUTR FOOD RES, V52, pS262, DOI 10.1002/mnfr.200700426; Lebecque S, 1997, J ALLERGY CLIN IMMUN, V99, P374, DOI 10.1016/S0091-6749(97)70056-3; Levin M, 2014, CLIN EXP ALLERGY, V44, P288, DOI 10.1111/cea.12230; Ma Y, 2006, INT ARCH ALLERGY IMM, V139, P53, DOI 10.1159/000089756; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Scheurer S, 1997, MOL IMMUNOL, V34, P619, DOI 10.1016/S0161-5890(97)00072-2; Scheurer S, 1999, MOL IMMUNOL, V36, P155, DOI 10.1016/S0161-5890(99)00033-4; Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Spangfort MD, 1999, ACTA CRYSTALLOGR D, V55, P2035, DOI 10.1107/S0907444999011804; Subbarayal B, 2013, ALLERGY, V68, P1377, DOI 10.1111/all.12236; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wangorsch A, 2007, MOL IMMUNOL, V44, P2518, DOI 10.1016/j.molimm.2006.12.023; Wiche R, 2005, BIOCHEM J, V385, P319, DOI 10.1042/BJ20040842	50	12	12	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111691	10.1371/journal.pone.0111691	http://dx.doi.org/10.1371/journal.pone.0111691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356997	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000346765000074
J	Pedersen, C; Slepenkin, A; Andersson, SBE; Fagerberg, JH; Bergstrom, CAS; Peterson, EM				Pedersen, Christian; Slepenkin, Anatoly; Andersson, Sara B. E.; Fagerberg, Jonas H.; Bergstroem, Christel A. S.; Peterson, Ellena M.			Formulation of the Microbicide INP0341 for In Vivo Protection against a Vaginal Challenge by Chlamydia trachomatis	PLOS ONE			English	Article							SALICYLIDENE ACYLHYDRAZIDE; DRUG-DELIVERY; III SECRETION; GEL; PREVENTION; SOLUBILITY; INHIBITORS; INFECTION; BUFFERGEL; MODELS	The salicylidene acylhydrazide (SA) compounds have exhibited promising microbicidal properties. Previous reports have shown the SA compounds, using cell cultures, to exhibit activity against Chlamydia trachomatis, herpes simplex virus and HIV-1. In addition, using an animal model of a vaginal infection the SA compound INP0341, when dissolved in a liquid, was able to significantly protect mice from a vaginal infection with C. trachomatis. To expand upon this finding, in this report INP0341 was formulated as a vaginal gel, suitable for use in humans. Gelling agents (polymers) with inherent antimicrobial properties were chosen to maximize the total antimicrobial effect of the gel. In vitro formulation work generated a gel with suitable rheology and sustained drug release. A formulation containing 1 mM INP0341, 1.6 wt% Cremophor ELP (solubility enhancer) and 1.5 wt% poly(acrylic acid) (gelling and antimicrobial agent), was chosen for studies of efficacy and toxicity using a mouse model of a vaginal infection. The gel formulation was able to attenuate a vaginal challenge with C. trachomatis, serovar D. Formulations with and without INP0341 afforded protection, but the inclusion of INP0341 increased the protection. Mouse vaginal tissue treated with the formulation showed no indication of gel toxicity. The lack of toxicity was confirmed by in vitro assays using EpiVaginal tissues, which showed that a 24 h exposure to the gel formulation did not decrease the cell viability or the barrier function of the tissue. Therefore, the gel formulation described here appears to be a promising vaginal microbicide to prevent a C. trachomatis infection with the potential to be expanded to other sexually transmitted diseases.	[Pedersen, Christian; Andersson, Sara B. E.; Fagerberg, Jonas H.; Bergstroem, Christel A. S.] Uppsala Univ, Biomed Ctr, Dept Pharm, Uppsala, Sweden; [Slepenkin, Anatoly; Peterson, Ellena M.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA	Uppsala University; University of California System; University of California Irvine	Peterson, EM (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA.	epeterso@uci.edu		Fagerberg, Jonas/0000-0002-3260-8067	National Institute of Allergy and Infectious Diseases [R33AI079775]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI079775] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by grant number R33AI079775 (EMP) from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GP, 2009, EUR J PHARM BIOPHARM, V71, P505, DOI 10.1016/j.ejpb.2008.09.028; Balakrishnan A, 2004, J PHARM SCI-US, V93, P2064, DOI 10.1002/jps.20118; Bergstrom CAS, 2002, PHARMACEUT RES, V19, P182, DOI 10.1023/A:1014224900524; Chu H, 2010, CHARACTERIZATION INH, P141; Chu H, 2010, INT J ANTIMICROB AG, V36, P145, DOI 10.1016/j.ijantimicag.2010.03.018; Dahlgren MK, 2010, BIOORGAN MED CHEM, V18, P2686, DOI 10.1016/j.bmc.2010.02.022; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; Evans EB, 2012, SOC TOX 52 ANN M SAN; Forthal DN, 2012, INT J ANTIMICROB AG, V40, P354, DOI 10.1016/j.ijantimicag.2012.05.023; Garg S, 2001, PHARM TECHNOL, V25, P14; Holmberg K., 2003, SURFACTANTS POLYM AQ; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; KHAMESIPOUR A, 1994, J REPROD FERTIL, V101, P287, DOI 10.1530/jrf.0.1010287; Kieweg SL, 2006, J BIOMECH ENG-T ASME, V128, P540, DOI 10.1115/1.2206198; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Owen DH, 2000, CONTRACEPTION, V62, P321, DOI 10.1016/S0010-7824(00)00184-0; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Peterson EM, 1999, VACCINE, V17, P2901, DOI 10.1016/S0264-410X(99)00131-0; PETERSON EM, 1988, INFECT IMMUN, V56, P885, DOI 10.1128/IAI.56.4.885-891.1988; Shukla NB, 2009, POLYM DEGRAD STABIL, V94, P1238, DOI 10.1016/j.polymdegradstab.2009.04.020; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Slepenkin A, 2011, J INFECT DIS, V204, P1313, DOI 10.1093/infdis/jir552; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Zeitlin L, 2001, SEX TRANSM DIS, V28, P417, DOI 10.1097/00007435-200107000-00010	25	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110918	10.1371/journal.pone.0110918	http://dx.doi.org/10.1371/journal.pone.0110918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356686	Green Published, gold			2022-12-27	WOS:000346765000032
J	Xu, MY; Li, YH; Zhang, QX; Xu, T; Qiu, LJ; Fan, YL; Wang, L				Xu, Miaoyun; Li, Yinghui; Zhang, Qiuxue; Xu, Tao; Qiu, Lijuan; Fan, Yunliu; Wang, Lei			Novel MiRNA and PhasiRNA Biogenesis Networks in Soybean Roots from Two Sister Lines That Are Resistant and Susceptible to SCN Race 4	PLOS ONE			English	Article							SMALL RNAS; REGULATORY ROLES; SIRNA BIOGENESIS; MICRORNAS; IDENTIFICATION; TARGETS; GENES; EVOLUTION	The soybean cyst nematode (SCN), Heterodera glycines, is the most devastating pathogen of soybean worldwide. SiRNAs (small interfere RNAs) have been proven to induce the silencing of cyst nematode genes. However, whether small RNAs from soybean root have evolved a similar mechanism against SCN is unknown. Two genetically related soybean sister lines (ZP03-5373 and ZP03-5413), which are resistant and susceptible, respectively, to SCN race 4 infection were selected for small RNA deep sequencing to identify small RNAs targeted to SCN. We identified 71 less-conserved miRNAs-miRNAs* counterparts belonging to 32 families derived from 91 loci, and 88 novel soybean-specific miRNAs with distinct expression patterns. The identified miRNAs targeted 42 genes representing a wide range of enzymatic and regulatory activities. Roots of soybean conserved one TAS (Trans-acting siRNA) gene family with a similar but unique trans- acting small interfering RNA (tasiRNA) biogenesis profile. In addition, we found that six miRNAs (gma-miR393, 1507, 1510, 1515, 171, 2118) guide targets to produce secondary phasiRNAs (phased, secondary, small interfering RNAs) in soybean root. Multiple targets of these phasiRNAs were predicted and detected. Importantly, we also found that the expression of 34 miRNAs differed significantly between the two lines. Seven ZP03-5373-specific miRNAs were differentially expressed after SCN infection. Forty-four transcripts from SCN were predicted to be potential targets of ZP03-5373-specific differential miRNAs. These findings suggest that miRNAs play an important role in the soybean response to SCN.	[Xu, Miaoyun; Zhang, Qiuxue; Xu, Tao; Fan, Yunliu; Wang, Lei] Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Li, Yinghui; Qiu, Lijuan] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, L (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	wanglei01@caas.cn	xu, miaoyun/AAF-3676-2021		National Key Basic Research Program [2010CB125903]; National Natural Science Foundation of China [31271801, 31171575]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program (Grant Number 2010CB125903). And the National Natural Science Foundation of China (Grant Number 31271801, 31171575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fan Yuan, 2007, Zhonghua Nan Ke Xue, V13, P660; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guerra-Assuncao JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-133; Hofmann NR, 2010, PLANT CELL, V22, P994, DOI 10.1105/tpc.110.220411; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2008, CURR OPIN PLANT BIOL, V11, P560, DOI 10.1016/j.pbi.2008.06.008; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-3; Newmark PA, 1997, DEVELOPMENT, V124, P3197; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schwach Frank, 2009, Briefings in Functional Genomics & Proteomics, V8, P472, DOI 10.1093/bfgp/elp024; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; Sobczak M GW, 2009, STRUCTURE CYST NEMAT, P153; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Thadani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S20; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL HOST MICROBE, V6, P99, DOI 10.1016/j.chom.2009.08.002; Wang Chunmei, 2007, Journal of Genetics and Genomics, V34, P966, DOI 10.1016/S1673-8527(07)60109-X; Wrather JA, 2009, PLANT HLTH PROGR; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Xia HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044206; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Zeng QY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-182; Zhao XF, 2000, GENOMICS, V63, P145, DOI 10.1006/geno.1999.6064	55	24	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110051	10.1371/journal.pone.0110051	http://dx.doi.org/10.1371/journal.pone.0110051			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356812	gold, Green Submitted, Green Published			2022-12-27	WOS:000346765000011
J	Zhang, L; Han, JJ; Wu, HY; Liang, XH; Zhang, JX; Li, J; Xie, L; Xie, YF; Sheng, XG; Yu, JM				Zhang, Lu; Han, Jianjun; Wu, Huiyong; Liang, Xiaohong; Zhang, Jianxin; Li, Jian; Xie, Li; Xie, Yinfa; Sheng, Xiugui; Yu, Jinming			The Association of HMGB1 Expression with Clinicopathological Significance and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis and Literature Review	PLOS ONE			English	Review							GLYCATION END-PRODUCTS; GROUP BOX 1; MOBILITY GROUP BOX-1; SERUM ALPHA-FETOPROTEIN; CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; TISSUE-DAMAGE; PROTEIN HMGB1; LIVER-CANCER; TUMOR-GROWTH	Background: Hepatocellular carcinoma (HCC) is the fifth most common cancer, and it is the second most common cancer-related mortality globally. The prognostic value of high mobility group box 1 (HMGB1) remains controversial. The purpose of this study is to conduct a meta-analysis and literature review to evaluate the association of HMGB1 expression with the prognosis of patients with HCC. Methods: A detailed literature search was made in Medline, Google Scholar and others for related research publications. The data were extracted and assessed by two reviewers independently. Analysis of pooled data were performed, Hazard Ratio (HR) and mean difference with corresponding confidence intervals (CIs) were calculated and summarized respectively. Results: 10 relevant articles were included for this meta-analysis study. HMGB1 mRNA levels in HCC were significantly higher than those in normal (p < 0.00001) and para-tumor tissues (p = 0.002) respectively. The protein levels of HMGB1 in HCC were significantly higher than those in para-tumor tissues (p = 0.005). Two studies reported the serum HMGB1 levels in patients with HCC of TNM stages, and indicating significantly different between stage I and II, stage II and III, as well as stage III and IV (two studies showed p < 0.01 and p < 0.001 respectively). The overall survival (OS) was significantly shorter in HCC patients with high HMGB1 expression compared those with low HMGB1 expression and the pooled HR was 1.31 with 95% CI 1.20-1.44, Z = 5.82, p < 0.0001. Two additional studies showed that there were higher serum HMGB1 levels in patients with chronic hepatitis than those in healthy people (p < 0.05). Conclusions: The results of this meta-analysis suggest that HMGB1 mRNA and protein tissue levels in the patients with HCC are significantly higher than those in para-tumor and normal liver tissues respectively. Tissue HMGB1 overexpression is a potential biomarker for HCC diagnosis, and it is significantly associated with the prognosis of patients with HCC.	[Zhang, Lu] Univ Jinan, Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Sch Med & Life Sci,Dept Gynecol Oncol, Jinan, Shandong, Peoples R China; [Han, Jianjun; Wu, Huiyong; Zhang, Jianxin; Li, Jian; Xie, Yinfa] Shandong Canc Hosp & Inst, Dept Canc Intervent Radiol, Jinan, Shandong, Peoples R China; [Liang, Xiaohong] Shandong Univ, Sch Med, Dept Immunol, Jinan 250100, Shandong, Peoples R China; [Xie, Li] Shandong Canc Hosp & Inst, Prov Key Lab Radiat Oncol, Jinan, Shandong, Peoples R China; [Sheng, Xiugui] Shandong Canc Hosp & Inst, Dept Gynecol Oncol, Jinan, Shandong, Peoples R China; [Yu, Jinming] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Sheng, XG (corresponding author), Shandong Canc Hosp & Inst, Dept Gynecol Oncol, Jinan, Shandong, Peoples R China.	xiuguisheng@yahoo.com; jinmingyu70@yahoo.com			Jinan Municipal Science and Technology Development Plan [201401246]; Natural Science Foundation of Shandong Province [ZR2013H047]	Jinan Municipal Science and Technology Development Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	Funding from Jinan Municipal Science and Technology Development Plan (201401246) and Natural Science Foundation of Shandong Province (ZR2013H047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 2007, ANTICANCER RES, V27, P449; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Brezniceanu ML, 2003, FASEB J, V17, P1295, DOI 10.1096/fj.02-0621fje; Cheng BQ, 2008, DIGEST LIVER DIS, V40, P446, DOI 10.1016/j.dld.2007.11.024; Chiharu Tabata ES, 2013, BMC CANCER, V13, P1; Choi YR, 2003, CANCER RES, V63, P2188; Dong XD, 2007, J IMMUNOTHER, V30, P596, DOI 10.1097/CJI.0b013e31804efc76; Dong YD, 2013, ONCOL REP, V29, P87, DOI 10.3892/or.2012.2070; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Evans A, 2004, J SURG ONCOL, V88, P86, DOI 10.1002/jso.20136; Fahmueller YN, 2013, INT J CANCER, V132, P2349, DOI 10.1002/ijc.27894; Feng H, 2011, THESIS, V11-17; Forner A, 2008, HEPATOLOGY, V47, P5, DOI 10.1002/hep.22152; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; GOODWIN GH, 1973, EUR J BIOCHEM, V40, P215, DOI 10.1111/j.1432-1033.1973.tb03188.x; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; Gou H SL, 2013, J PREVENTIVE MED, V40; Han F WT, 2014, J MED POSTGRADUATES, V4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao Quan, 2008, Zhonghua Zhongliu Zazhi, V30, P292; He Y, 2013, CANCER RES, V73, P629, DOI 10.1158/0008-5472.CAN-12-2704; Huttunen HJ, 2002, CANCER RES, V62, P4805; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang W, 2012, PATHOL ONCOL RES, V18, P293, DOI 10.1007/s12253-011-9442-3; Jube S, 2012, CANCER RES, V72, P3290, DOI 10.1158/0008-5472.CAN-11-3481; Jung JH, 2011, J VIROL, V85, P9359, DOI 10.1128/JVI.00682-11; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Khien VV, 2001, INT J BIOL MARKER, V16, P105, DOI 10.1177/172460080101600204; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Kusume A, 2009, PATHOBIOLOGY, V76, P155, DOI 10.1159/000218331; Liu FR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-135; Liu Hong-Bo, 2007, Zhonghua Gan Zang Bing Za Zhi, V15, P812; Liu Y, 2010, EUR J CANCER, V46, P3007, DOI 10.1016/j.ejca.2010.07.016; Liu Y, 2010, BBA-GENE REGUL MECH, V1799, P119, DOI 10.1016/j.bbagrm.2009.11.008; Liu ZQ, 2011, J IMMUNOL, V187, P118, DOI 10.4049/jimmunol.1003378; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Naglova H, 2012, BRATISL MED J, V113, P163, DOI 10.4149/BLL_2012_039; Nakamura S, 2006, AM J GASTROENTEROL, V101, P2038, DOI 10.1111/j.1572-0241.2006.00681.x; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pinato DJ, 2014, ADV ANAT PATHOL, V21, P270, DOI 10.1097/PAP.0000000000000029; Poser I, 2003, MOL CELL BIOL, V23, P2991, DOI 10.1128/MCB.23.8.2991-2998.2003; Qi J, 2013, NEOPLASMA, V60, P135, DOI 10.4149/neo_2013_018; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Sasahira T, 2007, VIRCHOWS ARCH, V450, P287, DOI 10.1007/s00428-006-0359-2; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tafani M, 2011, CARCINOGENESIS, V32, P1167, DOI 10.1093/carcin/bgr101; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takada M, 2004, HEPATO-GASTROENTEROL, V51, P928; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tian LY, 2011, INT J CANCER, V129, P1923, DOI 10.1002/ijc.25838; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Ueno Shinichi, 2011, Medical Journal of Kagoshima University, V62, P27; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang T HF, 2013, CHINESE J LAB DIAGNO, V17, P1783; Wang Y, 2013, THESIS U SCI TECHNOL, V2013, P11; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Wu D, 2008, J PATHOL, V216, P167, DOI 10.1002/path.2391; Xiao JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095214, 10.1371/journal.pone.0090396]; Yamamoto K, 2010, J GASTROENTEROL, V45, P1272, DOI 10.1007/s00535-010-0278-5; Yan W, 2012, HEPATOLOGY, V55, P1863, DOI 10.1002/hep.25572; Yoshida S, 2002, INT J ONCOL, V20, P305; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhou RR, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-21	73	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110626	10.1371/journal.pone.0110626	http://dx.doi.org/10.1371/journal.pone.0110626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356587	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000018
J	Choi, BH; Chattopadhaya, S; Thanh, LN; Feng, L; Nguyen, QT; Lim, CB; Harikishore, A; Nanga, RPR; Bharatham, N; Zhao, Y; Liu, XW; Yoon, HS				Choi, Bo-Hwa; Chattopadhaya, Souvik; Le Nguyen Thanh; Feng, Lin; Quoc Toan Nguyen; Lim, Chuan Bian; Harikishore, Amaravadhi; Nanga, Ravi Prakash Reddy; Bharatham, Nagakumar; Zhao, Yan; Liu, Xuewei; Yoon, Ho Sup			Suprafenacine, an Indazole-Hydrazide Agent, Targets Cancer Cells Through Microtubule Destabilization	PLOS ONE			English	Article							BCL2 PHOSPHORYLATION; SIGNALING PATHWAY; BREAST-CANCER; BAD COUPLES; IN-VIVO; DEATH; ACTIVATION; SURVIVAL; BINDING; RESISTANT	Microtubules are a highly validated target in cancer therapy. However, the clinical development of tubulin binding agents (TBA) has been hampered by toxicity and chemoresistance issues and has necessitated the search for new TBAs. Here, we report the identification of a novel cell permeable, tubulin-destabilizing molecule - 4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid [1p-tolyl-meth-(E)-ylidene]-hydrazide (termed as Suprafenacine, SRF). SRF, identified by in silico screening of annotated chemical libraries, was shown to bind microtubules at the colchicine-binding site and inhibit polymerization. This led to G(2)/M cell cycle arrest and cell death via a mitochondria-mediated apoptotic pathway. Cell death was preceded by loss of mitochondrial membrane potential, JNK - mediated phosphorylation of Bcl-2 and Bad, and activation of caspase-3. Intriguingly, SRF was found to selectively inhibit cancer cell proliferation and was effective against drug-resistant cancer cells by virtue of its ability to bypass the multidrug resistance transporter P-glycoprotein. Taken together, our results suggest that SRF has potential as a chemotherapeutic agent for cancer treatment and provides an alternate scaffold for the development of improved anti-cancer agents.	[Choi, Bo-Hwa; Chattopadhaya, Souvik; Feng, Lin; Quoc Toan Nguyen; Lim, Chuan Bian; Harikishore, Amaravadhi; Nanga, Ravi Prakash Reddy; Bharatham, Nagakumar; Zhao, Yan; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore; [Le Nguyen Thanh; Liu, Xuewei] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 639798, Singapore; [Yoon, Ho Sup] Kyung Hee Univ, Coll Life Sci, Dept Genet Engn, Yongin, Gyeonggi Do, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Kyung Hee University	Yoon, HS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore.	hsyoon@ntu.edu.sg	Le, Thanh/AAW-5776-2021; Zhao, Yan/A-2197-2011; Le, Thanh/GRY-4094-2022; Amaravadhi, Harikishore/E-9294-2016; Yoon, Ho Sup/A-2193-2011	Le, Thanh/0000-0002-8375-4187; Amaravadhi, Harikishore/0000-0001-6552-1534; Yoon, Ho Sup/0000-0002-8243-3904; Nguyen, Toan/0000-0002-8015-6130	Ministry of Health Singapore [NMRC1177/2008]	Ministry of Health Singapore(Ministry of Health-Singapore)	This work was supported by Ministry of Health Singapore Grant NMRC1177/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Argyriou AA, 2008, CRIT REV ONCOL HEMAT, V66, P218, DOI 10.1016/j.critrevonc.2008.01.008; Bacher G, 2001, CANCER RES, V61, P392; Basu A, 1998, INT J ONCOL, V13, P659; BATES SE, 1989, MOL CELL BIOL, V9, P4337, DOI 10.1128/MCB.9.10.4337; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dimitroulis J, 2005, ONCOL REP, V13, P923; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Haldar S, 1998, CANCER RES, V58, P1609; Haldar S, 1997, CANCER RES, V57, P229; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Liou JP, 2007, J PHARMACOL EXP THER, V323, P398, DOI 10.1124/jpet.107.126680; Luduena RF, 1998, INT REV CYTOL, V178, P207; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Okano J, 2001, J BIOL CHEM, V276, P19555, DOI 10.1074/jbc.M011164200; Pajk B, 2008, BREAST, V17, P180, DOI 10.1016/j.breast.2007.09.002; Poommipanit PB, 1999, J BIOL CHEM, V274, P1033, DOI 10.1074/jbc.274.2.1033; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Watanabe T, 1997, J NATL CANCER I, V89, P512, DOI 10.1093/jnci/89.7.512; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; WU L, 1992, CANCER RES, V52, P3029; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	50	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110955	10.1371/journal.pone.0110955	http://dx.doi.org/10.1371/journal.pone.0110955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354194	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204200049
J	Ferrario, V; Siragusa, L; Ebert, C; Baroni, M; Foscato, M; Cruciani, G; Gardossi, L				Ferrario, Valerio; Siragusa, Lydia; Ebert, Cynthia; Baroni, Massimo; Foscato, Marco; Cruciani, Gabriele; Gardossi, Lucia			BioGPS Descriptors for Rational Engineering of Enzyme Promiscuity and Structure Based Bioinformatic Analysis	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; BINDING-SITES; PROTEINS; AMIDASE; GROMACS	A new bioinformatic methodology was developed founded on the Unsupervised Pattern Cognition Analysis of GRID-based BioGPS descriptors (Global Positioning System in Biological Space). The procedure relies entirely on three-dimensional structure analysis of enzymes and does not stem from sequence or structure alignment. The BioGPS descriptors account for chemical, geometrical and physical-chemical features of enzymes and are able to describe comprehensively the active site of enzymes in terms of "pre-organized environment'' able to stabilize the transition state of a given reaction. The efficiency of this new bioinformatic strategy was demonstrated by the consistent clustering of four different Ser hydrolases classes, which are characterized by the same active site organization but able to catalyze different reactions. The method was validated by considering, as a case study, the engineering of amidase activity into the scaffold of a lipase. The BioGPS tool predicted correctly the properties of lipase variants, as demonstrated by the projection of mutants inside the BioGPS "roadmap''.	[Ferrario, Valerio; Ebert, Cynthia; Foscato, Marco; Gardossi, Lucia] Univ Trieste, Dipartimento Sci Chim & Farmaceut, Lab Appl & Computat Biocatalysis, Trieste, TS, Italy; [Siragusa, Lydia; Cruciani, Gabriele] Univ Perugia, Dipartimento Chim Biol & Biotecnol, Lab Chemometr & Mol Modeling, I-06100 Perugia, PG, Italy; [Baroni, Massimo] Mol Discovery Ltd, London, Middx, England	University of Trieste; University of Perugia	Gardossi, L (corresponding author), Univ Trieste, Dipartimento Sci Chim & Farmaceut, Lab Appl & Computat Biocatalysis, Trieste, TS, Italy.	gardossi@units.it	Cruciani, Gabriele/E-5927-2014; Ferrario, Valerio VF/F-3846-2012; CRUCIANI, Gabriele/AAH-4627-2019; Ferrario, Valerio/AAN-8963-2020	Cruciani, Gabriele/0000-0002-4162-8692; Ferrario, Valerio VF/0000-0002-4233-4805; CRUCIANI, Gabriele/0000-0002-4162-8692; Ferrario, Valerio/0000-0002-4233-4805; Siragusa, Lydia/0000-0003-4596-7242; Foscato, Marco/0000-0001-7762-6931	European Community [227279]; Molecular Discovery Ltd	European Community(European Commission); Molecular Discovery Ltd	This work has received funding from the European Community's Seventh Framework Programme under the FP7-KBBE-2008-2B grant agreement nu 227279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Moreover: MB is an employee of Molecular Discovery Ltd. Molecular Discovery Ltd provided support in the form of salary for author MB but Molecular Discovery Ltd. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], PYMOL MOL GRAPH SYST; Baroni M, 2007, J CHEM INF MODEL, V47, P279, DOI 10.1021/ci600253e; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Besenmatter W, 2004, METHOD ENZYMOL, V388, P91; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Bommarius AS, 2011, CURR OPIN CHEM BIOL, V15, P194, DOI 10.1016/j.cbpa.2010.11.011; Boutros PC, 2005, BRIEF BIOINFORM, V6, P331, DOI 10.1093/bib/6.4.331; Braiuca P, 2006, ADV SYNTH CATAL, V348, P773, DOI 10.1002/adsc.200505346; Brincat JP, 2011, J MED CHEM, V54, P354, DOI 10.1021/jm1011963; Carboni C, 2006, TETRAHEDRON-ASYMMETR, V17, P245, DOI 10.1016/j.tetasy.2005.12.023; Cross S, 2012, J CHEM INF MODEL, V52, P2587, DOI 10.1021/ci300153d; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferrario V, 2014, J MOL CATAL B-ENZYM, V101, P7, DOI 10.1016/j.molcatb.2013.12.004; Ferrario V, 2011, ADV SYNTH CATAL, V353, P2466, DOI 10.1002/adsc.201100397; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; GHOSH D, 1995, STRUCTURE, V3, P279, DOI 10.1016/S0969-2126(01)00158-7; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Hediger MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049849; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Ho BK, 2005, PROTEIN SCI, V14, P1011, DOI 10.1110/ps.041156905; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khoury GA, 2009, PROTEIN SCI, V18, P2125, DOI 10.1002/pro.227; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ouzounis CA, 2003, BIOINFORMATICS, V19, P2176, DOI 10.1093/bioinformatics/btg309; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Sciabola S, 2010, J CHEM INF MODEL, V50, P155, DOI 10.1021/ci9003317; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Suplatov DA, 2012, PROTEIN ENG DES SEL, V25, P689, DOI 10.1093/protein/gzs068; Suplatov D, 2014, J BIOMOL STRUCT DYN, V32, P75, DOI 10.1080/07391102.2012.750249; Syren PO, 2012, CHEMBIOCHEM, V13, P645, DOI 10.1002/cbic.201100779; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004	43	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109354	10.1371/journal.pone.0109354	http://dx.doi.org/10.1371/journal.pone.0109354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353170	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204200007
J	Li, C; Zhang, YY; Frieler, RA; Zheng, XJ; Zhang, WC; Sun, XN; Yang, QZ; Ma, SM; Huang, BZ; Berger, S; Wang, W; Wu, Y; Yu, Y; Duan, SZ; Mortensen, RM				Li, Chao; Zhang, Yu Yao; Frieler, Ryan A.; Zheng, Xiao Jun; Zhang, Wu Chang; Sun, Xue Nan; Yang, Qing Zhen; Ma, Shu Min; Huang, Baozhuan; Berger, Stefan; Wang, Wang; Wu, Yong; Yu, Ying; Duan, Sheng Zhong; Mortensen, Richard M.			Myeloid Mineralocorticoid Receptor Deficiency Inhibits Aortic Constriction-Induced Cardiac Hypertrophy in Mice	PLOS ONE			English	Article							SELECTIVE ALDOSTERONE BLOCKER; HEART-FAILURE; OXIDATIVE STRESS; NADPH OXIDASE; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; BLOOD-PRESSURE; INFLAMMATION; ATHEROSCLEROSIS; DYSFUNCTION	Mineralocorticoid receptor (MR) blockade has been shown to suppress cardiac hypertrophy and remodeling in animal models of pressure overload (POL). This study aims to determine whether MR deficiency in myeloid cells modulates aortic constriction-induced cardiovascular injuries. Myeloid MR knockout (MMRKO) mice and littermate control mice were subjected to abdominal aortic constriction (AAC) or sham operation. We found that AAC-induced cardiac hypertrophy and fibrosis were significantly attenuated in MMRKO mice. Expression of genes important in generating reactive oxygen species was decreased in MMRKO mice, while that of manganese superoxide dismutase increased. Furthermore, expression of genes important in cardiac metabolism was increased in MMRKO hearts. Macrophage infiltration in the heart was inhibited and expression of inflammatory genes was decreased in MMRKO mice. In addition, aortic fibrosis and inflammation were attenuated in MMRKO mice. Taken together, our data indicated that MR deficiency in myeloid cells effectively attenuated aortic constriction-induced cardiac hypertrophy and fibrosis, as well as aortic fibrosis and inflammation.	[Li, Chao; Zhang, Yu Yao; Zheng, Xiao Jun; Zhang, Wu Chang; Sun, Xue Nan; Yang, Qing Zhen; Ma, Shu Min; Yu, Ying; Duan, Sheng Zhong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Zhang, Yu Yao; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Frieler, Ryan A.; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Huang, Baozhuan] Xuhui Cent Hosp, Dept Nephrol, Shanghai, Peoples R China; [Berger, Stefan] German Canc Res Ctr, Div Mol Biol Cell 1, Heidelberg, Germany; [Wang, Wang] Univ Washington, Mitochondria & Metab Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Wu, Yong] Charles R Drew Univ Med & Sci, Dept Internal Med, Div Canc Res & Training, Los Angeles, CA 90059 USA; [Wu, Yong] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ); University of Washington; University of Washington Seattle; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan	Duan, SZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	szduan@sibs.ac.cn; rmort@umich.edu	wang, wang/GWQ-7272-2022	Frieler, Ryan/0000-0003-2780-3244; Wang, Wang/0000-0001-9093-412X	One Hundred Talents Program of the Chinese Academy of Sciences [2012OHTP06]; Ministry of Science and Technology of China (973 Program) [2012CB524900]; National Natural Science Foundation of China [31371153, 91339110, 31171133]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-08]; Xuhui Central Hospital, Shanghai, China [CRC2011003]; NIH [R01HL083201]; American Diabetes Association [1-08-RA-137]; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083201, R01HL112610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077780] Funding Source: NIH RePORTER	One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Xuhui Central Hospital, Shanghai, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences (2012OHTP06), the Ministry of Science and Technology of China (973 Program 2012CB524900), the National Natural Science Foundation of China (31371153, 91339110, 31171133), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-08), and Xuhui Central Hospital, Shanghai, China (CRC2011003) (to S.Z. Duan), as well as grants from the National Heart, Lung, and Blood Institute, NIH (R01HL083201) and American Diabetes Association (1-08-RA-137) (to R. M. Mortensen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahokas RA, 2003, CIRC RES, V93, pE124, DOI 10.1161/01.RES.0000102404.81461.25; Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bienvenu LA, 2012, ENDOCRINOLOGY, V153, P3416, DOI 10.1210/en.2011-2098; Cat AND, 2012, CURR OPIN NEPHROL HY, V21, P147, DOI 10.1097/MNH.0b013e32834fb25b; Duan SZ, 2007, PHYSIOL MEAS, V28, P1329, DOI 10.1088/0967-3334/28/11/001; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Kalogeropoulos AP, 2012, HEART FAIL CLIN, V8, P113, DOI 10.1016/j.hfc.2011.08.002; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Keidar S, 2003, J CARDIOVASC PHARM, V41, P955, DOI 10.1097/00005344-200306000-00019; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Kuster GM, 2005, CIRCULATION, V111, P420, DOI 10.1161/01.CIR.0000153800.09920.40; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Lother A, 2011, HYPERTENSION, V57, P746, DOI 10.1161/HYPERTENSIONAHA.110.163287; Maejima Y, 2011, J MOL CELL CARDIOL, V50, P408, DOI 10.1016/j.yjmcc.2010.12.018; McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.0000203772.78696.67; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pruthi D, 2014, ARTERIOSCL THROM VAS, V34, P355, DOI 10.1161/ATVBAHA.113.302854; Rickard AJ, 2014, HYPERTENSION; Rickard AJ, 2009, HYPERTENSION, V54, P537, DOI 10.1161/HYPERTENSIONAHA.109.131110; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Schafer N, 2013, EUR HEART J, V34, P3515, DOI 10.1093/eurheartj/eht095; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Whaley-Connell A, 2010, PROG CARDIOVASC DIS, V52, P401, DOI 10.1016/j.pcad.2009.12.004; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	35	41	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110950	10.1371/journal.pone.0110950	http://dx.doi.org/10.1371/journal.pone.0110950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354087	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200048
J	Maliti, D; Ranson, H; Magesa, S; Kisinza, W; Mcha, J; Haji, K; Killeen, G; Weetman, D				Maliti, Deodatus; Ranson, Hilary; Magesa, Stephen; Kisinza, William; Mcha, Juma; Haji, Khamis; Killeen, Gerald; Weetman, David			Islands and Stepping-Stones: Comparative Population Structure of Anopheles gambiae sensu stricto and Anopheles arabiensis in Tanzania and Implications for the Spread of Insecticide Resistance	PLOS ONE			English	Article							TREATED BED NETS; MALARIA VECTOR; GENETIC DIFFERENTIATION; MOLECULAR-FORMS; LYMPHATIC FILARIASIS; DIPTERA-CULICIDAE; FIELD-EVALUATION; WESTERN KENYA; RIFT-VALLEY; TRANSMISSION	Population genetic structures of the two major malaria vectors Anopheles gambiae s.s. and An. arabiensis, differ markedly across Sub-Saharan Africa, which could reflect differences in historical demographies or in contemporary gene flow. Elucidation of the degree and cause of population structure is important for predicting the spread of genetic traits such as insecticide resistance genes or artificially engineered genes. Here the population genetics of An. gambiae s.s. and An. arabiensis in the central, eastern and island regions of Tanzania were compared. Microsatellite markers were screened in 33 collections of female An. gambiae s.l., originating from 22 geographical locations, four of which were sampled in two or three years between 2008 and 2010. An. gambiae were sampled from six sites, An. arabiensis from 14 sites, and both species from two sites, with an additional colonised insectary sample of each species. Frequencies of the knock-down resistance (kdr) alleles 1014S and 1014F were also determined. An. gambiae exhibited relatively high genetic differentiation (average pairwise F-ST = 0.131), significant even between nearby samples, but without clear geographical patterning. In contrast, An. arabiensis exhibited limited differentiation (average F-ST = 0.015), but strong isolation-by-distance (Mantel test r = 0.46, p = 0.0008). Most time-series samples of An. arabiensis were homogeneous, suggesting general temporal stability of the genetic structure. An. gambiae populations from Dar es Salaam and Bagamoyo were found to have high frequencies of kdr 1014S (around 70%), with almost 50% homozygote but was at much lower frequency on Unguja Island, with no. An. gambiae population genetic differentiation was consistent with an island model of genetic structuring with highly restricted gene flow, contrary to An. arabiensis which was consistent with a stepping-stone model of extensive, but geographically-restricted gene flow.	[Maliti, Deodatus; Killeen, Gerald] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania; [Maliti, Deodatus] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Ranson, Hilary; Killeen, Gerald; Weetman, David] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Mcha, Juma; Haji, Khamis] Zanzibar Malaria Eliminat Programme, Unguja, Zanzibar, Tanzania; [Magesa, Stephen] RTI Int, Global Hlth Div, Dar Es Salaam, Tanzania; [Kisinza, William] Natl Inst Med Res, Amani Res Ctr, Muheza, Tanga, Tanzania	Ifakara Health Institute; University of Glasgow; Liverpool School of Tropical Medicine; University of Liverpool; Research Triangle Institute; National Institute of Medical Research	Maliti, D (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania.	dmaliti@ihi.or.tz	Weetman, David/M-1261-2014	Weetman, David/0000-0002-5820-1388; Ranson, Hilary/0000-0003-2332-8247	Wellcome Trust through the Wellcome Trust Masters of Science Fellowship Programme [08703/Z/08/Z]; Bill and Melinda Gates Foundation through the Malaria Transmission Consortium [45114]	Wellcome Trust through the Wellcome Trust Masters of Science Fellowship Programme; Bill and Melinda Gates Foundation through the Malaria Transmission Consortium	The authors thank the Wellcome Trust for funding this work through the Wellcome Trust Masters of Science Fellowship Programme (award number 08703/Z/08/Z). The authors thank the Bill and Melinda Gates Foundation through the Malaria Transmission Consortium (award number 45114) for supporting the initial processes of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelmaali SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080549; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Balding D, 2001, HDB STAT GENETICS; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Cartaxo MFS, 2011, T ROY SOC TROP MED H, V105, P491, DOI 10.1016/j.trstmh.2011.05.004; Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Cornuet JM, 1996, GENETICS, V144, P2001; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Czeher C, 2010, J MED ENTOMOL, V47, P355, DOI 10.1603/ME09173; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Dia I, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-61; Donnelly MJ, 1999, HEREDITY, V83, P408, DOI 10.1038/sj.hdy.6885930; Donnelly MJ, 2000, INSECT MOL BIOL, V9, P357, DOI 10.1046/j.1365-2583.2000.00197.x; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Duchemin JB, 2001, MED VET ENTOMOL, V15, P50, DOI 10.1046/j.1365-2915.2001.00276.x; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Faye O, 1997, J MED ENTOMOL, V34, P285, DOI 10.1093/jmedent/34.3.285; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Gillies MT, 1987, ANOPHELINAE AFRICA S, V55; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hood GM, 2008, POPTOOLS VERS 2 5 9; Hutchison WD, 1999, EVOLUTION, V53; Jones CM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-343; Kabula B, 2013, MED VET ENTOMOL; Kabula B, 2014, TROP MED INT HEALTH, V19, P331, DOI 10.1111/tmi.12248; Kamau L, 1998, AM J TROP MED HYG, V58, P64, DOI 10.4269/ajtmh.1998.58.64; Kamau L, 1999, INSECT MOL BIOL, V8, P287, DOI 10.1046/j.1365-2583.1999.820287.x; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323; Kayondo JK, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-59; Kent RJ, 2007, AM J TROP MED HYG, V77, P316, DOI 10.4269/ajtmh.2007.77.316; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lunde TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-78; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; Mawejje HD, 2013, MED VET ENTOMOL, V27, P276, DOI 10.1111/j.1365-2915.2012.01055.x; Midega JT, 2010, ACTA TROP, V114, P103, DOI 10.1016/j.actatropica.2010.01.011; Moreno M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-137; Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Ng'habi KR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-289; Nyanjom SRG, 2003, J HERED, V94, P457, DOI 10.1093/jhered/esg100; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Onyabe DY, 2001, MOL ECOL, V10, P2577, DOI 10.1046/j.0962-1083.2001.01387.x; Pinto J, EVOLUTIONARY APPL, V6, P910; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rambaut A, 2008, FIGTREE 1 3 1; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; ROMANS P, 1991, J MED ENTOMOL, V28, P147, DOI 10.1093/jmedent/28.1.147; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-24; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Simard F, 2000, INSECT MOL BIOL, V9, P467, DOI 10.1046/j.1365-2583.2000.00210.x; Simard F, 1999, AM J TROP MED HYG, V60, P1000, DOI 10.4269/ajtmh.1999.60.1000; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Temu EA, 2005, AM J TROP MED HYG, V73, P726, DOI 10.4269/ajtmh.2005.73.726; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; van den Broek IVF, 1999, J INSECT PHYSIOL, V45, P1001, DOI 10.1016/S0022-1910(99)00081-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Witzig C, 2013, PARASITOLOGY, V140, P1468, DOI 10.1017/S0031182013000024; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; World Health Organization, 2012, WHO MAL REP; World Health Organization, 2012, WHO GLOB MAL PROGR G; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738; Zheng LB, 1996, GENETICS, V143, P941	91	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110910	10.1371/journal.pone.0110910	http://dx.doi.org/10.1371/journal.pone.0110910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353688	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000345204200046
J	Martin-Fernandez, B; de las Heras, N; Valero-Munoz, M; Ballesteros, S; Yao, YZ; Stanton, PG; Fuller, PJ; Lahera, V				Martin-Fernandez, Beatriz; de las Heras, Natalia; Valero-Munoz, Maria; Ballesteros, Sandra; Yao, Yi-Zhou; Stanton, Peter G.; Fuller, Peter J.; Lahera, Vicente			Beneficial Effects of Proanthocyanidins in the Cardiac Alterations Induced by Aldosterone in Rat Heart through Mineralocorticoid Receptor Blockade	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ANGIOTENSIN-II; POSSIBLE INVOLVEMENT; DIETARY-SODIUM; PROTEIN-KINASE; EXPRESSION; PROCYANIDINS; INFLAMMATION; FIBROSIS; FAILURE	Aldosterone administration in rats results in several cardiac alterations. Previous studies have demonstrated that proanthocyanidins, phenolic bioactive compounds, have cardioprotective effects. We studied the potential beneficial effects of the proanthocyanidin-rich almond skin extract (PASE) on the cardiac alterations induced by aldosterone-salt treatment, their effects in mineralocorticoid receptor activity and we sought to confirm proanthocyanidins as the specific component of the extract involved in the beneficial cardiac effects. Male Wistar rats received aldosterone (1 mg/Kg/day) + 1% NaCl for 3 weeks. Half of the animals in each group were simultaneously treated with either PASE (100 mg/Kg/day) or spironolactone (200 mg/Kg/day). The ability of PASE to act as an antagonist of the mineralocorticoid receptor was examined using a transactivation assay. High performance liquid chromatography was used to identify and to isolate proanthocyanidins. Hypertension and diastolic dysfunction induced by aldosterone were abolished by treatment with PASE. Expression of the aldosterone mediator SGK-1, together with fibrotic, inflammatory and oxidative mediators were increased by aldosteronesalt treatment; these were reduced by PASE. Aldosterone-salt induced transcriptional activity of the mineralocorticoid receptor was reduced by PASE. HPLC confirmed proanthocyanidins as the compound responsible for the beneficial effects of PASE. The effects of PASE were comparable to those seen with the mineralocorticoid antagonist, spironolactone. The observed responses in the aldosterone-salt treated rats together with the antagonism of transactivation at the mineralocorticoid receptor by PASE provides evidence that the beneficial effect of this proanthocyanidin-rich almond skin extract is via as a mineralocorticoid receptor antagonist with proanthocyanidins identified as the compounds responsible for the beneficial effects of PASE.	[Martin-Fernandez, Beatriz; de las Heras, Natalia; Valero-Munoz, Maria; Ballesteros, Sandra; Lahera, Vicente] Univ Complutense, Sch Med, Dept Physiol, E-28040 Madrid, Spain; [Martin-Fernandez, Beatriz; Yao, Yi-Zhou; Stanton, Peter G.; Fuller, Peter J.] Prince Henrys Inst Med Res, Clayton, Vic, Australia	Complutense University of Madrid; Prince Henry's Institute of Medical Research	Lahera, V (corresponding author), Univ Complutense, Sch Med, Dept Physiol, E-28040 Madrid, Spain.	vlahera@med.ucm.es	Martín Fernández, Beatriz/ABG-8713-2021	Martin-Fernandez, Beatriz/0000-0002-1904-6194; Lahera, Vicente/0000-0002-9688-4503; Fuller, Peter/0000-0002-0948-2072; DE LAS HERAS, NATALIA/0000-0002-2960-6175	VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana [SAF2011-30396]; National Health and Medical Research Council of Australia [1002559, 1002575]; Victorian Government's Operational Infrastructure Program	VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Program	This work was supported by grants from VI Programa Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica de Espana (SAF2011-30396) and the National Health and Medical Research Council of Australia through a Fellowship (#1002559) and Project Grant (#1002575) support to PJF. Prince Henry's Institute is supported by the Victorian Government's Operational Infrastructure Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman L, 2014, MOL NUTR FOOD RES, V58, P1708, DOI 10.1002/mnfr.201300559; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Barreiros ALBS, 2000, PHYTOCHEMISTRY, V55, P805, DOI 10.1016/S0031-9422(00)00297-1; Bauersachs J, 2008, PHARMACOL REP, V60, P119; Belleville J, 2002, NUTRITION, V18, P173, DOI 10.1016/S0899-9007(01)00721-3; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; BRILLA CG, 1992, J LAB CLIN MED, V120, P893; BRILLA CG, 1990, CIRC RES, V67, P1355, DOI 10.1161/01.RES.67.6.1355; Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727; Chanet A, 2013, BRIT J NUTR, V110, P587, DOI 10.1017/S0007114512005454; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Dietz JD, 2008, HYPERTENSION, V51, P742, DOI 10.1161/HYPERTENSIONAHA.107.103580; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Fraga CG, 2011, FREE RADICAL BIO MED, V51, P813, DOI 10.1016/j.freeradbiomed.2011.06.002; Funder JW, 2007, AM J CARDIOVASC DRUG, V7, P151, DOI 10.2165/00129784-200707030-00001; Garcia-Conesa MT, 2009, MOL NUTR FOOD RES, V53, P266, DOI 10.1002/mnfr.200800134; Goto T, 2012, BRIT J NUTR, V107, P769, DOI 10.1017/S0007114511003758; Guler A, 2011, MED SCI MONITOR, V17, pBR326, DOI 10.12659/MSM.882042; Hamalainen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Kwak CJ, 2009, J HYPERTENS, V27, P92, DOI 10.1097/HJH.0b013e3283186994; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Martin-Fernandez B, 2011, J CARDIOVASC PHARM, V57, P114, DOI 10.1097/FJC.0b013e31820088ca; Martin-Fernandez B, 2009, EXP PHYSIOL, V94, P675, DOI 10.1113/expphysiol.2009.047688; Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Milenkovic D, 2013, FREE RADICAL BIO MED, V64, P40, DOI 10.1016/j.freeradbiomed.2013.05.046; Mill JG, 2003, CLIN EXP PHARMACOL P, V30, P739, DOI 10.1046/j.1440-1681.2003.03906.x; Monagas M, 2007, J AGR FOOD CHEM, V55, P8498, DOI 10.1021/jf071780z; Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466, DOI 10.1093/ajcn/77.6.1466; Nishiyama A, 2004, HYPERTENSION, V43, P841, DOI 10.1161/01.HYP.0000118519.66430.22; Nocun M, 2008, BIOMED PHARMACOTHER, V62, P168, DOI 10.1016/j.biopha.2007.07.002; Palfi A, 2009, J NUTR BIOCHEM, V20, P418, DOI 10.1016/j.jnutbio.2008.04.009; Pitt B, 2005, J AM COLL CARDIOL, V46, P425, DOI 10.1016/j.jacc.2005.04.038; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; Ricchiuti V, 2011, J ENDOCRINOL, V211, P47, DOI 10.1530/JOE-10-0458; Rocha R, 2000, ENDOCRINOLOGY, V141, P3871, DOI 10.1210/en.141.10.3871; Rocha R, 2002, ENDOCRINOLOGY, V143, P4828, DOI 10.1210/en.2002-220120; Rogerson FM, 1999, J BIOL CHEM, V274, P36305, DOI 10.1074/jbc.274.51.36305; Rogerson FM, 2007, MOL ENDOCRINOL, V21, P817, DOI 10.1210/me.2006-0246; Rossi GP, 2005, TRENDS ENDOCRIN MET, V16, P104, DOI 10.1016/j.tem.2005.02.010; Sano T, 2005, THROMB RES, V115, P115, DOI 10.1016/j.thromres.2004.07.015; Satoh M, 2002, CLIN SCI, V102, P381, DOI 10.1042/CS20010219; Schafer A, 2006, BIOMED PHARMACOTHER, V60, P5, DOI 10.1016/j.biopha.2005.08.006; Schafer A, 2003, THROMB HAEMOSTASIS, V89, P1024, DOI 10.1055/s-0037-1613404; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; SCOTT BC, 1993, FREE RADICAL RES COM, V19, P241, DOI 10.3109/10715769309056512; Sheng R, 2007, ACTA PHARMACOL SIN, V28, P191, DOI 10.1111/j.1745-7254.2007.00495.x; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Spiller GA, 2003, J AM COLL NUTR, V22, P195, DOI 10.1080/07315724.2003.10719293; Spiller GA, 1998, J AM COLL NUTR, V17, P285, DOI 10.1080/07315724.1998.10718761; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Struthers AD, 2004, EUR J HEART FAIL, V6, P539, DOI 10.1016/j.ejheart.2004.04.013; Sun Y, 1997, CARDIOVASC RES, V35, P138, DOI 10.1016/S0008-6363(97)00097-7; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; Takeda Y, 2000, ENDOCRINOLOGY, V141, P1901, DOI 10.1210/en.141.5.1901; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Toufektsian MC, 2008, J NUTR, V138, P747, DOI 10.1093/jn/138.4.747; Wilke A, 1996, BASIC RES CARDIOL, V91, P79, DOI 10.1007/BF00795367; Young M, 2004, ENDOCRINOLOGY, V145, P3153, DOI 10.1210/en.2004-0005; Young MJ, 1996, STEROIDS, V61, P233, DOI 10.1016/0039-128X(96)00020-7; Zhao XH, 2006, PHYSIOL MEAS, V27, pN27, DOI 10.1088/0967-3334/27/6/N01	67	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111104	10.1371/journal.pone.0111104	http://dx.doi.org/10.1371/journal.pone.0111104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353961	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204200055
J	Mertens, BJA; Jacobs, WCH; Brand, R; Peul, WC				Mertens, Bart J. A.; Jacobs, Wilco C. H.; Brand, Ronald; Peul, Wilco C.			Assessment of Patient-Specific Surgery Effect Based on Weighted Estimation and Propensity Scoring in the Re-Analysis of the Sciatica Trial	PLOS ONE			English	Article							LUMBAR-DISK HERNIATION; NONOPERATIVE TREATMENT; CONSERVATIVE TREATMENT; SPORT	We consider a re-analysis of the wait-and-see (control) arm of a recent clinical trial on sciatica. While the original randomised trial was designed to evaluate the public policy effect of a conservative wait-and-see approach versus early surgery, we investigate the impact of surgery at the individual patient level in a re-analysis of the wait-and-see group data. Both marginal structural model re-weighted estimates as well as propensity score adjusted analyses are presented. Results indicate that patients with high propensity to receive surgery may have beneficial effects at 2 years from delayed disc surgery.	[Mertens, Bart J. A.; Brand, Ronald] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands; [Jacobs, Wilco C. H.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Peul, Wilco C.] Med Ctr Haaglanden, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center	Mertens, BJA (corresponding author), Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands.	b.mertens@lumc.nl						CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Kerr D, 2014, CLIN ORTHOPAEDICS RE; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Osterman H, 2006, SPINE, V31, P2409; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Senn S, 2007, STAT MED, V26, P5529, DOI 10.1002/sim.3133; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; WEBER H, 1993, SPINE, V18, P1433, DOI 10.1097/00007632-199309010-00006; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wheeler AH, 2011, LOW BACK PAIN SCIATI; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483	18	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111325	10.1371/journal.pone.0111325	http://dx.doi.org/10.1371/journal.pone.0111325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353633	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200072
J	van Bommel, L; Johnson, CN				van Bommel, Linda; Johnson, Chris N.			Where Do Livestock Guardian Dogs Go? Movement Patterns of Free-Ranging Maremma Sheepdogs	PLOS ONE			English	Article							HOME-RANGE; ESTIMATORS; AUSTRALIA; BEHAVIOR; LOSSES	In many parts of the world, livestock guardian dogs (LGDs) are a relatively new and increasingly popular method for controlling the impact of wild predators on livestock. On large grazing properties in Australia, LGDs are often allowed to range freely over large areas, with minimal supervision by their owners. How they behave in this situation is mostly unknown. We fitted free-ranging Maremma sheepdogs with GPS tracking collars on three properties in Victoria, Australia; on two properties, four sheep were also fitted with GPS collars. We investigated how much time the Maremmas spent with their livestock, how far they moved outside the ranges of their stock, and tested whether they use their ranges sequentially, which is an effective way of maintaining a presence over a large area. The 95% kernel isopleth of the Maremmas ranged between 31 and 1161 ha, the 50% kernel isopleth ranged between 4 and 252 ha. Maremmas spent on average 90% of their time in sheep paddocks. Movements away from sheep occurred mostly at night, and were characterised by high-speed travel on relatively straight paths, similar to the change in activity at the edge of their range. Maremmas used different parts of their range sequentially, similar to sheep, and had a distinct early morning and late afternoon peak in activity. Our results show that while free-ranging LGDs spend the majority of their time with livestock, movements away from stock do occur. These movements could be important in allowing the dogs to maintain large territories, and could increase the effectiveness of livestock protection. Allowing LGDs to range freely can therefore be a useful management decision, but property size has to be large enough to accommodate the large areas that the dogs use.	[van Bommel, Linda; Johnson, Chris N.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [van Bommel, Linda] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	University of Tasmania; Australian National University	van Bommel, L (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas, Australia.	linda.vanbommel@anu.edu.au	Johnson, Christopher/J-7894-2014	Johnson, Christopher/0000-0002-9719-3771	Hermon Slade Foundation; Australian Research Council; Australian Postgraduate Award	Hermon Slade Foundation; Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	The research was funded by the Hermon Slade Foundation and the Australian Research Council. Linda van Bommel was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLES ED, 1969, J WILDLIFE MANAGE, V33, P145, DOI 10.2307/3799662; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; BLACK HL, 1985, J RANGE MANAGE, V38, P11, DOI 10.2307/3899323; BOWNS JE, 1971, J RANGE MANAGE, V24, P105, DOI 10.2307/3896515; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Coppinger L, 2007, LIVESTOCK HANDLING AND TRANSPORT, 3RD EDITION, P199, DOI 10.1079/9781845932190.0199; Coppinger R., 1983, P 1 E WILDL DAM CONT, P129; Coppinger R., 2001, DOGS NEW UNDERSTANDI; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Demma DJ, 2009, J WILDLIFE MANAGE, V73, P380, DOI 10.2193/2008-114; ESRI, 2011, ARCGIS DESKT REL 10; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fleming P. J. S., 1989, Australian Rangeland Journal, V11, P61; Gehring Thomas M., 2011, Human-Wildlife Interactions, V5, P106; Gehring TM, 2010, WILDLIFE RES, V37, P715, DOI 10.1071/WR10023; Gingold G, 2009, ANIM CONSERV, V12, P155, DOI 10.1111/j.1469-1795.2009.00235.x; GREEN JS, 1983, APPL ANIM ETHOL, V11, P141, DOI 10.1016/0304-3762(83)90123-2; GREENSITE J, 1990, NATO ADV SCI I B-PHY, V224, P233; Hansen I, 1999, J RANGE MANAGE, V52, P312, DOI 10.2307/4003539; Hansen I, 2002, ACTA AGR SCAND A-AN, V52, P43, DOI 10.1080/09064700252806416; Jacques CN, 2009, J MAMMAL, V90, P433, DOI 10.1644/07-MAMM-A-395.1; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; LINHART SB, 1979, J RANGE MANAGE, V32, P238, DOI 10.2307/3897131; Marker LL, 2005, RANGELAND ECOL MANAG, V58, P329, DOI 10.2111/1551-5028(2005)058[0329:PEOLDP]2.0.CO;2; MCGREW JC, 1982, J RANGE MANAGE, V35, P693, DOI 10.2307/3898240; Otstavel Teet, 2009, Estonian Journal of Ecology, V58, P216, DOI 10.3176/eco.2009.3.06; PHILLIPS M, 1991, WILDLIFE RES, V18, P677, DOI 10.1071/WR9910677; R Core Team, 2018, R LANG ENV STAT COMP; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; REYNOLDS TD, 1990, J WILDLIFE MANAGE, V54, P316, DOI 10.2307/3809049; Rigg R., 2001, LIVESTOCK GUARDING D; Rigg R, 2011, ORYX, V45, P272, DOI 10.1017/S0030605310000074; Sims DE, 2004, LIVESTOCK PROTECTION; Squires V. R., 1974, Applied Animal Ethology, V1, P17, DOI 10.1016/0304-3762(74)90004-2; THOMSON PC, 1992, WILDLIFE RES, V19, P519, DOI 10.1071/WR9920519; Turchin Peter, 1998; van Bommel L, 2014, MOVEMENTS FREE RANGI, DOI [10.5441/001/1.pv048q7v, DOI 10.5441/001/1.PV048Q7V]; van Bommel L., 2010, GUARDIAN DOGS BEST P; van Bommel L, 2012, WILDLIFE RES, V39, P220, DOI 10.1071/WR11135; WARREN JT, 1991, J RANGE MANAGE, V44, P2, DOI 10.2307/4002628; White G.C., 1990, ANAL WILDLIFE RADIO; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	43	30	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111444	10.1371/journal.pone.0111444	http://dx.doi.org/10.1371/journal.pone.0111444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353319	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200080
J	Antonini, V; Perez-Barzaga, V; Bampi, S; Penton, D; Martinez, D; Serra, MD; Tejuca, M				Antonini, Valeria; Perez-Barzaga, Victor; Bampi, Silvia; Penton, David; Martinez, Diana; Serra, Mauro Dalla; Tejuca, Mayra			Functional Characterization of Sticholysin I and W111C Mutant Reveals the Sequence of the Actinoporin's Pore Assembly	PLOS ONE			English	Article							CYTOLYSIN EQUINATOXIN-II; SEA-ANEMONE; FORMING TOXIN; MODEL MEMBRANES; PROTEIN; MECHANISM; CONSTRUCTION; INSIGHTS; CRYSTAL; BINDING	The use of pore-forming toxins in the construction of immunotoxins against tumour cells is an alternative for cancer therapy. In this protein family one of the most potent toxins are the actinoporins, cytolysins from sea anemones. We work on the construction of tumour proteinase-activated immunotoxins using sticholysin I (StI), an actinoporin isolated from the sea anemone Stichodactyla helianthus. To accomplish this objective, recombinant StI (StIr) with a mutation in the membrane binding region has been employed. In this work, it was evaluated the impact of mutating tryptophan 111 to cysteine on the toxin pore forming capability. StI W111C is still able to permeabilize erythrocytes and liposomes, but at ten-fold higher concentration than StI. This is due to its lower affinity for the membrane, which corroborates the importance of residue 111 for the binding of actinoporins to the lipid bilayer. In agreement, other functional characteristics not directly associated to the binding, are essentially the same for both variants, that is, pores have oligomeric structures with similar radii, conductance, cation-selectivity, and instantaneous current-voltage behavior. In addition, this work provides experimental evidence sustaining the toroidal protein-lipid actinoporins lytic structures, since the toxins provoke the trans-bilayer movement (flip-flop) of a pyrene-labeled analogue of phosphatidylcholine in liposomes, indicating the existence of continuity between the outer and the inner membrane leaflet. Finally, our planar lipid membranes results have also contributed to a better understanding of the actinoporin's pore assembly mechanism. After the toxin binding and the N-terminal insertion in the lipid membrane, the pore assembly occurs by passing through different transient sub-conductance states. These states, usually 3 or 4, are due to the successive incorporation of N-terminal a-helices and lipid heads to the growing pores until a stable toroidal oligomeric structure is formed, which is mainly tetrameric.	[Antonini, Valeria; Bampi, Silvia; Serra, Mauro Dalla] Inst Biophys & Bruno Kessler Fdn, Natl Res Council Italy, Trento, Italy; [Perez-Barzaga, Victor; Penton, David; Martinez, Diana; Tejuca, Mayra] Univ Havana, Fac Biol, Ctr Prot Studies, Vedado, Ciudad de La Ha, Cuba	Consiglio Nazionale delle Ricerche (CNR); Fondazione Bruno Kessler; Universidad de la Habana	Serra, MD (corresponding author), Inst Biophys & Bruno Kessler Fdn, Natl Res Council Italy, Trento, Italy.	mauro.dallaserra@cnr.it; mayra@cepes.uh.cu	Serra, Mauro Dalla/A-6218-2010; Penton, David/L-2597-2016; Serra, Mauro Dalla/AAK-9299-2021	Serra, Mauro Dalla/0000-0003-1048-2739; Serra, Mauro Dalla/0000-0003-1048-2739				Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Anderluh G, 2005, J MOL BIOL, V347, P27, DOI 10.1016/j.jmb.2004.12.058; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Anderluh G, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P141; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Carneiro CMM, 1997, FEBS LETT, V416, P187, DOI 10.1016/S0014-5793(97)01198-8; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Dalla Serra M, 2000, METH MOL B, V145, P171; Dalla Serra M, 2011, ELS; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; Epand RM, 1998, BBA-REV BIOMEMBRANES, V1376, P353, DOI 10.1016/S0304-4157(98)00015-X; Fradin C, 2009, HANDB MOD BIOPHYS, V2, P223, DOI 10.1007/978-1-60761-314-5_9; Garcia-Linares S, 2013, ARCH BIOCHEM BIOPHYS, V532, P39, DOI 10.1016/j.abb.2013.01.005; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; GINSBURG H, 1987, J MEMBRANE BIOL, V96, P1, DOI 10.1007/BF01869329; Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; KUGA S, 1981, J CHROMATOGR, V206, P449, DOI 10.1016/S0021-9673(00)88914-1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Muller P, 2000, CHEM PHYS LIPIDS, V106, P89, DOI 10.1016/S0009-3084(00)00134-1; Pazos F, 2006, TOXICON, V48, P1083, DOI 10.1016/j.toxicon.2006.09.004; PEDERZOLLI C, 1995, BIOCONJUGATE CHEM, V6, P166, DOI 10.1021/bc00032a003; Penton D, 2011, PROTEIN ENG DES SEL, V24, P485, DOI 10.1093/protein/gzr002; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Sher D, 2005, TOXICON, V45, P865, DOI 10.1016/j.toxicon.2005.02.004; Stoddart D, 2014, P NATL ACAD SCI USA, V111, P2425, DOI 10.1073/pnas.1312976111; Tejuca M, 2004, INT IMMUNOPHARMACOL, V4, P731, DOI 10.1016/j.intimp.2004.02.010; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Tosatto L, 2012, BBA-BIOMEMBRANES, V1818, P2876, DOI 10.1016/j.bbamem.2012.07.007; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3	48	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110824	10.1371/journal.pone.0110824	http://dx.doi.org/10.1371/journal.pone.0110824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350457	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100043
J	Chen, Q; Zhang, WQ; Ran, H; Feng, LZ; Yan, H; Mu, XY; Han, YY; Liu, W; Xia, GL; Wang, C				Chen, Qian; Zhang, Wenqiang; Ran, Hao; Feng, Lizhao; Yan, Hao; Mu, Xinyi; Han, Yingying; Liu, Wei; Xia, Guoliang; Wang, Chao			PKC delta and theta Possibly Mediate FSH-Induced Mouse Oocyte Maturation via NOX-ROS-TACE Cascade Signaling Pathway	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; NADPH OXIDASE; MEIOTIC MATURATION; HUMAN NEUTROPHILS; FACTOR RECEPTOR; MESSENGER-RNA; CUMULUS CELLS; IN-VITRO	In mammals, gonadotropins stimulate oocyte maturation via the epidermal growth factor (EGF) network, and the protein kinase C (PKC) signaling pathway mediates this process. Tumor necrosis factor-alpha converting enzyme (TACE) is an important protein responding to PKC activation. However, the detailed signaling cascade between PKC and TACE in follicle-stimulating hormone (FSH)-induced oocyte maturation in vitro remains unclear. In this study, we found that rottlerin (mallotoxin, MTX), the inhibitor of PKC delta and h, blocked FSH-induced maturation of mouse cumulus-oocyte complexes (COCs) in vitro. We further clarified the relationship between two molecules downstream of PKC delta and theta and TACE in COCs: nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and its products, reactive oxygen species (ROS). We proved that the respective inhibitors of NOX, ROS and TACE could block FSH-stimulated oocyte maturation dose-dependently, but these inhibitory effects could be reversed partially by amphiregulin (Areg), an EGF family member. Notably, inhibition of PKC delta and theta prevented FSH-induced translocation of two cytosolic components of NOX, p47(phox) and p67(phox), to the plasma membrane in cumulus cells. Moreover, FSH-induced TACE activity in cumulus cells was decreased markedly by inhibition of NOX and ROS. In conclusion, PKC delta and theta possibly mediate FSH-induced meiotic resumption in mouse COCs via NOX-ROS-TACE signaling pathway.	[Chen, Qian; Zhang, Wenqiang; Ran, Hao; Feng, Lizhao; Yan, Hao; Liu, Wei; Xia, Guoliang; Wang, Chao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Mu, Xinyi] Chongqing Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China; [Han, Yingying] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	China Agricultural University; Chongqing Medical University; Beijing Forestry University	Wang, C (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	wangcam@126.com		Feng, Lizhao/0000-0002-9843-3941; Yan, Hao/0000-0003-1468-6165	National Basic Research Program of China [2013CB945500]; National Natural Science Foundation of China [C120102]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB945500) and National Natural Science Foundation of China (C120102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Aroca P, 2000, FEBS LETT, V483, P27, DOI 10.1016/S0014-5793(00)02075-5; Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blondin P, 1997, J ANDROL, V18, P454; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Chen XF, 2008, J ENDOCRINOL, V197, P409, DOI 10.1677/JOE-07-0592; DOWNS SM, 1988, J EXP ZOOL, V245, P86, DOI 10.1002/jez.1402450113; Downs SM, 2008, MOL REPROD DEV, V75, P105, DOI 10.1002/mrd.20781; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; HANSEL W, 1991, J REPROD FERTIL, P77; Jain S, 2000, LIFE SCI, V66, P1139, DOI 10.1016/S0024-3205(00)00417-3; JONES SA, 1995, J AM SOC NEPHROL, V5, P1483; Kawashima I, 2008, REPRODUCTION, V136, P9, DOI 10.1530/REP-08-0074; Liu L, 2013, REPROD FERT DEVELOP, V25, P463, DOI 10.1071/RD12310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Park JW, 1996, BIOCHEM BIOPH RES CO, V220, P31, DOI 10.1006/bbrc.1996.0351; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; SHIMAMOTO T, 1993, ENDOCRINOLOGY, V133, P2127, DOI 10.1210/en.133.5.2127; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Takami M, 2000, AM J PHYSIOL-CELL PH, V278, pC646, DOI 10.1152/ajpcell.2000.278.4.C646; Viveiros MM, 2003, BIOL REPROD, V69, P1494, DOI 10.1095/biolreprod.103.019018; Wang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045043; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Yamashita Y, 2007, ENDOCRINOLOGY, V148, P6164, DOI 10.1210/en.2007-0195; Yamashita Y, 2014, ENDOCRINOLOGY, V155, P1080, DOI 10.1210/en.2013-1655; Yamashita Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-20; Yamashita Y, 2010, J REPROD DEVELOP, V56, P315, DOI 10.1262/jrd.09-199H; Zhang ZL, 2001, FASEB J, V15, P303	36	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111423	10.1371/journal.pone.0111423	http://dx.doi.org/10.1371/journal.pone.0111423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350560	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100071
J	Hoang, DT; Matsunari, H; Nagaya, M; Nagashima, H; Millis, JM; Witkowski, P; Periwal, V; Hara, M; Jo, J				Hoang, Danh-Tai; Matsunari, Hitomi; Nagaya, Masaki; Nagashima, Hiroshi; Millis, J. Michael; Witkowski, Piotr; Periwal, Vipul; Hara, Manami; Jo, Junghyo			A Conserved Rule for Pancreatic Islet Organization	PLOS ONE			English	Article							CELL-ADHESION; CONFOCAL MICROSCOPY; INSULIN-SECRETION; BETA-CELLS; ARCHITECTURE; LANGERHANS; AGGREGATION; ORGANOGENESIS; MORPHOGENESIS; MICROANATOMY	Morphogenesis, spontaneous formation of organism structure, is essential for life. In the pancreas, endocrine alpha, beta, and delta cells are clustered to form islets of Langerhans, the critical micro-organ for glucose homeostasis. The spatial organization of endocrine cells in islets looks different between species. Based on the three-dimensional positions of individual cells in islets, we computationally inferred the relative attractions between cell types, and found that the attractions between homotypic cells were slightly, but significantly, stronger than the attractions between heterotypic cells commonly in mouse, pig, and human islets. The difference between alpha - beta cell attraction and beta - beta cell attraction was minimal in human islets, maximizing the plasticity of islet structures. Our result suggests that although the cellular composition and attractions of pancreatic endocrine cells are quantitatively different between species, the physical mechanism of islet morphogenesis may be evolutionarily conserved.	[Hoang, Danh-Tai; Jo, Junghyo] Asia Pacific Ctr Theoret Phys, Pohang, South Korea; [Matsunari, Hitomi; Nagaya, Masaki; Nagashima, Hiroshi] Meiji Univ, Int Inst Bioresource Res, Kanagawa, Japan; [Millis, J. Michael; Witkowski, Piotr] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Periwal, Vipul] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA; [Hara, Manami] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Jo, Junghyo] POSTECH, Dept Phys, Pohang, South Korea	Asia Pacific Center for Theoretical Physics; Meiji University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Chicago; Pohang University of Science & Technology (POSTECH)	Hara, M (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhara@uchicago.edu; jojunghyo@apctp.org	Hara, Masayuki/AAH-4361-2019; Jo, Junghyo/D-4889-2011; Millis, Michael/K-5346-2019	Nagashima, Hiroshi/0000-0001-9940-8783; Hoang, Danh-Tai/0000-0003-2640-4196	Basic Science Research Program through the National Foundation of Korea - Ministry of Science, ICT & Future Planning [2013R1A1A1006655]; Max Planck Society; Korea Ministry of Education, Science and Technology; Gyeongsangbuk-Do and Pohang City; Intramural Research Program of the NIH; National Institute of Diabetes and Digestive and Kidney Diseases;  [DK-020595];  [DK-072473];  [AG-042151]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075038, P60DK020595, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	Basic Science Research Program through the National Foundation of Korea - Ministry of Science, ICT & Future Planning; Max Planck Society(Max Planck SocietyFoundation CELLEX); Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeongsangbuk-Do and Pohang City; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by Basic Science Research Program through the National Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (No. 2013R1A1A1006655) and by the Max Planck Society, the Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), the Intramural Research Program of the NIH, the National Institute of Diabetes and Digestive and Kidney Diseases (V. P.), and DK-020595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, AG-042151, and a gift from the Kovler Family Foundation (M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2008, DIABETES, V57, P2899, DOI 10.2337/db07-1842; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; BRELJE TC, 1989, DIABETES, V38, P808, DOI 10.2337/diabetes.38.6.808; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; BRITT LD, 1981, DIABETES, V30, P580, DOI 10.2337/diabetes.30.7.580; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Charollais A, 2000, J CLIN INVEST, V106, P235, DOI 10.1172/JCI9398; CIRULLI V, 1994, J CELL SCI, V107, P1429; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; ERLANDSEN SL, 1976, J HISTOCHEM CYTOCHEM, V24, P883, DOI 10.1177/24.7.60437; GRUBE D, 1983, BIOMED RES-TOKYO, V4, P25; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; HALBAN PA, 1988, ENDOCRINOLOGY, V123, P113, DOI 10.1210/endo-123-1-113; Hoang DT, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062725; Hong H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032711; Hopcroft DW, 1985, IN VITRO CELL DEV, V2, P421; Jamal AM, 2005, CELL DEATH DIFFER, V12, P702, DOI 10.1038/sj.cdd.4401617; Jia D, 2007, DEV DYNAM, V236, P2039, DOI 10.1002/dvdy.21207; Jo J, 2009, J THEOR BIOL, V257, P312, DOI 10.1016/j.jtbi.2008.12.005; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; KUO CY, 1992, PANCREAS, V7, P320, DOI 10.1097/00006676-199205000-00008; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; ORCI L, 1976, METABOLISM, V25, P1303, DOI 10.1016/S0026-0495(76)80129-1; ROUILLER DG, 1990, EXP CELL RES, V191, P305, DOI 10.1016/0014-4827(90)90019-7; ROUILLER DG, 1991, DEV BIOL, V148, P233, DOI 10.1016/0012-1606(91)90332-W; Sivia DS, 2006, DATA ANLYSIS BAYESIA; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815	36	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110384	10.1371/journal.pone.0110384	http://dx.doi.org/10.1371/journal.pone.0110384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350558	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943100026
J	Li, ZL; Yu, JH; Liu, L; Wei, ZH; Ehrlich, ES; Liu, GC; Li, JL; Liu, X; Wang, H; Yu, XF; Zhang, WY				Li, Zhaolong; Yu, Jinghua; Liu, Li; Wei, Zhenhong; Ehrlich, Elana S.; Liu, Guanchen; Li, Jingliang; Liu, Xin; Wang, Hong; Yu, Xiao-fang; Zhang, Wenyan			Coxsackievirus A16 Infection Induces Neural Cell and Non-Neural Cell Apoptosis In Vitro	PLOS ONE			English	Article							MOUTH-DISEASE; ENTEROVIRUS 71; HAND; FOOT; TAIWAN; EPIDEMIOLOGY; CHILDREN; MALAYSIA; FAS; SINGAPORE	Coxsackievirus A16 (CA16) is one of the main causative pathogens of hand, foot and mouth disease (HFMD). Viral replication typically results in host cell apoptosis. Although CA16 infection has been reported to induce apoptosis in the human rhabdomyosarcoma (RD) cell line, it remains unclear whether CA16 induces apoptosis in diverse cell types, especially neural cells which have important clinical significance. In the current study, CA16 infection was found to induce similar apoptotic responses in both neural cells and non-neural cells in vitro, including nuclear fragmentation, DNA fragmentation and phosphatidylserine translocation. CA16 generally is not known to lead to serious neurological symptoms in vivo. In order to further clarify the correlation between clinical symptoms and cell apoptosis, two CA16 strains from patients with different clinical features were investigated. The results showed that both CA16 strains with or without neurological symptoms in infected patients led to neural and muscle cell apoptosis. Furthermore, mechanistic studies showed that CA16 infection induced apoptosis through the same mechanism in both neural and non-neural cells, namely via activation of both the mitochondrial (intrinsic) pathway-related caspase 9 protein and the Fas death receptor (extrinsic) pathway-related caspase 8 protein. Understanding the mechanisms by which CA16 infection induces apoptosis in both neural and non-neural cells will facilitate a better understanding of CA16 pathogenesis.	[Li, Zhaolong; Yu, Jinghua; Wei, Zhenhong; Liu, Guanchen; Li, Jingliang; Liu, Xin; Wang, Hong; Yu, Xiao-fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Peoples R China; [Liu, Li] Jilin Univ, Hosp 1, Dept Pediat Pulmonol, Changchun 130023, Peoples R China; [Li, Zhaolong] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Ehrlich, Elana S.] Towson Univ, Dept Biol Sci, Towson, MD USA; [Yu, Xiao-fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Jilin University; Jilin University; University System of Maryland; Towson University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, WY (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Peoples R China.	zhangwenyan@jlu.edu.cn			National Natural Science Foundation of China [31270202, 81301416]; Chinese Ministry of Science and Technology [2012CB911102, 2013ZX10001-005]; Health and Family Planning Commission of Jilin Province [2013Z066]; Key Laboratory of Molecular Virology of Jilin Province [20102209]; Chinese Ministry of Education [IRT1016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Health and Family Planning Commission of Jilin Province; Key Laboratory of Molecular Virology of Jilin Province; Chinese Ministry of Education(Ministry of Education, China)	This work was supported in part by funding from the National Natural Science Foundation of China (31270202), Chinese Ministry of Science and Technology (2012CB911102 and 2013ZX10001-005), the National Natural Science Foundation of China (81301416), Health and Family Planning Commission of Jilin Province (2013Z066), Key Laboratory of Molecular Virology of Jilin Province (20102209), and Chinese Ministry of Education (IRT1016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Belov GA, 2003, J VIROL, V77, P45, DOI 10.1128/JVI.77.1.45-56.2003; Brisac C, 2010, J VIROL, V84, P12226, DOI 10.1128/JVI.00994-10; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P629; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chang SC, 2004, J NEUROVIROL, V10, P338, DOI 10.1080/13550280490521032; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Fu QX, 2013, APOPTOSIS, V18, P998, DOI 10.1007/s10495-013-0849-z; Gay RT, 2006, P NATL ACAD SCI USA, V103, P13825, DOI 10.1073/pnas.0605507103; Huang PN, 2014, CURR OPIN VIROL, V5, P98, DOI 10.1016/j.coviro.2014.03.007; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Jia Lei, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P635; Li J, 2014, J GEN VIROL; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lopez-Guerrero JA, 2000, VIROLOGY, V272, P250, DOI 10.1006/viro.2000.0405; Lu JR, 2013, J GEN VIROL, V94, P1477, DOI 10.1099/vir.0.047753-0; Mao QY, 2012, J VIROL, V86, P11967, DOI 10.1128/JVI.00902-12; Martelli AM, 2001, J CELL BIOCHEM, V82, P634, DOI 10.1002/jcb.1186; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Saraste A, 2003, CARDIOVASC PATHOL, V12, P255, DOI 10.1016/S1054-8807(03)00077-2; Shi WF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-327; Shih SR, 2004, ANTIMICROB AGENTS CH, V48, P3523, DOI 10.1128/AAC.48.9.3523-3529.2004; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang SM, 2014, EXPERT REV ANTI-INFE, V12, P447, DOI 10.1586/14787210.2014.895666; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094746; WRIGHT HT, 1963, NEW ENGL J MED, V268, P1041, DOI 10.1056/NEJM196305092681904; Xu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065948; Yang EX, 2012, SCI CHINA LIFE SCI, V55, P336, DOI 10.1007/s11427-012-4313-z; Yang Zhi-hong, 2005, Zhonghua Er Ke Za Zhi, V43, P648; Yen FB, 2009, J MICROBIOL IMMUNOL, V42, P38; Yu JH, 2007, ACTA PHARMACOL SIN, V28, P1975, DOI 10.1111/j.1745-7254.2007.00706.x; Zeng M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002599; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhu GG, 2013, BIOCHEM BIOPH RES CO, V441, P856, DOI 10.1016/j.bbrc.2013.10.142	47	11	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111174	10.1371/journal.pone.0111174	http://dx.doi.org/10.1371/journal.pone.0111174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350381	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100060
J	Paulson, NB; Gilbertsen, AJ; Dalluge, JJ; Welchlin, CW; Hughes, J; Han, W; Blackwell, TS; Laguna, TA; Williams, BJ				Paulson, Nick B.; Gilbertsen, Adam J.; Dalluge, Joseph J.; Welchlin, Cole W.; Hughes, John; Han, Wei; Blackwell, Timothy S.; Laguna, Theresa A.; Williams, Bryan J.			The Arginine Decarboxylase Pathways of Host and Pathogen Interact to Impact Inflammatory Pathways in the Lung	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA MUTANTS; CYSTIC-FIBROSIS SPUTUM; NITRIC-OXIDE SYNTHASE; IN-VIVO; AGMATINE; BIOFILM; MACROPHAGES; INFECTION; PRODUCTS; ENHANCE	The arginine decarboxylase pathway, which converts arginine to agmatine, is present in both humans and most bacterial pathogens. In humans agmatine is a neurotransmitter with affinities towards alpha 2-adrenoreceptors, serotonin receptors, and may inhibit nitric oxide synthase. In bacteria agmatine serves as a precursor to polyamine synthesis and was recently shown to enhance biofilm development in some strains of the respiratory pathogen Pseudomonas aeruginosa. We determined agmatine is at the center of a competing metabolism in the human lung during airways infections and is influenced by the metabolic phenotypes of the infecting pathogens. Ultra performance liquid chromatography with mass spectrometry detection was used to measure agmatine in human sputum samples from patients with cystic fibrosis, spent supernatant from clinical sputum isolates, and from bronchoalvelolar lavage fluid from mice infected with P. aeruginosa agmatine mutants. Agmatine in human sputum peaks during illness, decreased with treatment and is positively correlated with inflammatory cytokines. Analysis of the agmatine metabolic phenotype in clinical sputum isolates revealed most deplete agmatine when grown in its presence; however a minority appeared to generate large amounts of agmatine presumably driving sputum agmatine to high levels. Agmatine exposure to inflammatory cells and in mice demonstrated its role as a direct immune activator with effects on TNF-alpha production, likely through NF-kappa B activation. P. aeruginosa mutants for agmatine detection and metabolism were constructed and show the real-time evolution of host-derived agmatine in the airways during acute lung infection. These experiments also demonstrated pathogen agmatine production can upregulate the inflammatory response. As some clinical isolates have adapted to hypersecrete agmatine, these combined data would suggest agmatine is a novel target for immune modulation in the host-pathogen dynamic.	[Paulson, Nick B.; Gilbertsen, Adam J.; Williams, Bryan J.] Univ Minnesota, Pulm Allergy Crit Care & Sleep Div, Minneapolis, MN 55455 USA; [Dalluge, Joseph J.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Welchlin, Cole W.; Laguna, Theresa A.] Univ Minnesota, Div Pediat Pulmonol, Minneapolis, MN USA; [Hughes, John] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm Crit Care & Med, Nashville, TN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University	Williams, BJ (corresponding author), Univ Minnesota, Pulm Allergy Crit Care & Sleep Div, Minneapolis, MN 55455 USA.	bjwillia@umn.edu		Laguna, Theresa/0000-0003-4255-0310	National Institutes of Health (NIH) [P30 HL101311-01]; NIH [K08 PA-10-059]; Gold Family Foundation; National Center for Advancing Translational Sciences of the NIH [UL1TR000114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101311, K08HL105466] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gold Family Foundation; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by National Institutes of Health (NIH) P30 HL101311-01, NIH K08 PA-10-059, Gold Family Foundation, and the National Center for Advancing Translational Sciences of the NIH Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAL AT, 1979, ANNU REV MICROBIOL, V33, P139, DOI 10.1146/annurev.mi.33.100179.001035; AUGUET M, 1995, JPN J PHARMACOL, V69, P285, DOI 10.1254/jjp.69.285; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gerova A, 2004, PHYSIOL RES, V53, P357; HAAS D, 1984, MOL GEN GENET, V193, P437, DOI 10.1007/BF00382081; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Jin Y, 2011, ANN OCCUP HYG, V55, P97, DOI 10.1093/annhyg/meq061; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Li YM, 1997, J IMMUNOL METHODS, V201, P183, DOI 10.1016/S0022-1759(96)00224-4; Lortie MJ, 2000, AM J PHYSIOL-CELL PH, V278, pC1191, DOI 10.1152/ajpcell.2000.278.6.C1191; Lu CD, 2002, J BACTERIOL, V184, P3765, DOI 10.1128/JB.184.14.3765-3773.2002; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Nakada Y, 2001, J BACTERIOL, V183, P6517, DOI 10.1128/JB.183.22.6517-6524.2001; Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325; OHMAN DE, 1982, INFECT IMMUN, V37, P662, DOI 10.1128/IAI.37.2.662-669.1982; Palm E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-155; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Piletz JE, 2013, DRUG DISCOV TODAY, V18, P880, DOI 10.1016/j.drudis.2013.05.017; RAASCH W, 1995, LIFE SCI, V56, P2319, DOI 10.1016/0024-3205(95)00226-V; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sud R, 2008, EUR J PHARMACOL, V588, P217, DOI 10.1016/j.ejphar.2008.04.043; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; Wade CL, 2009, J PHARMACOL EXP THER, V331, P539, DOI 10.1124/jpet.109.155424; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Williams BJ, 2010, MOL MICROBIOL, V76, P104, DOI 10.1111/j.1365-2958.2010.07083.x; Yull FE, 2003, J HISTOCHEM CYTOCHEM, V51, P741, DOI 10.1177/002215540305100605; Zhao SL, 2006, J CHROMATOGR A, V1123, P138, DOI 10.1016/j.chroma.2006.05.038	38	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111441	10.1371/journal.pone.0111441	http://dx.doi.org/10.1371/journal.pone.0111441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350753	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100073
J	Verly, E; Steluti, J; Fisberg, RM; Marchioni, DML				Verly-, Eliseu, Jr.; Steluti, Josiane; Fisberg, Regina Mara; Marchioni, Dirce Maria Lobo			A Quantile Regression Approach Can Reveal the Effect of Fruit and Vegetable Consumption on Plasma Homocysteine Levels	PLOS ONE			English	Article							FOLIC-ACID INTAKE; REPRESENTATIVE SAMPLE; SERUM HOMOCYSTEINE; FOOD-INTAKE; FOLATE; RECOMMENDATIONS; DETERMINANTS; ADOLESCENTS; DISEASE; HEALTH	Introduction: A reduction in homocysteine concentration due to the use of supplemental folic acid is well recognized, although evidence of the same effect for natural folate sources, such as fruits and vegetables (FV), is lacking. The traditional statistical analysis approaches do not provide further information. As an alternative, quantile regression allows for the exploration of the effects of covariates through percentiles of the conditional distribution of the dependent variable. Objective: To investigate how the associations of FV intake with plasma total homocysteine (tHcy) differ through percentiles in the distribution using quantile regression. Materials and Methods: A cross-sectional population-based survey was conducted among 499 residents of Sao Paulo City, Brazil. The participants provided food intake and fasting blood samples. Fruit and vegetable intake was predicted by adjusting for day-to-day variation using a proper measurement error model. We performed a quantile regression to verify the association between tHcy and the predicted FV intake. The predicted values of tHcy for each percentile model were calculated considering an increase of 200 g in the FV intake for each percentile. Results: The results showed that tHcy was inversely associated with FV intake when assessed by linear regression whereas, the association was different when using quantile regression. The relationship with FV consumption was inverse and significant for almost all percentiles of tHcy. The coefficients increased as the percentile of tHcy increased. A simulated increase of 200 g in the FV intake could decrease the tHcy levels in the overall percentiles, but the higher percentiles of tHcy benefited more. Conclusions: This study confirms that the effect of FV intake on lowering the tHcy levels is dependent on the level of tHcy using an innovative statistical approach. From a public health point of view, encouraging people to increase FV intake would benefit people with high levels of tHcy.	[Verly-, Eliseu, Jr.] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil; [Steluti, Josiane; Fisberg, Regina Mara; Marchioni, Dirce Maria Lobo] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo	Verly, E (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil.	verlyjr@ims.uerj.br	Fisberg, Regina Mara/Q-6494-2019; Verly, Eliseu/AFS-6374-2022; Marchioni, Dirce M/C-6053-2012; Fisberg, Regina M/C-4069-2012; Steluti, Josiane/A-5017-2015; Marchioni, Dirce/ABH-7023-2020	Fisberg, Regina Mara/0000-0002-4490-9035; Marchioni, Dirce M/0000-0002-6810-5779; Fisberg, Regina M/0000-0002-4490-9035; Steluti, Josiane/0000-0001-7629-4189; Marchioni, Dirce/0000-0002-6810-5779	Municipal Health Secretariat of Sao Paulo; National Counsel of Technological [481176/2008-0, 473100/20096]; Scientific Development and Sao Paulo Research Foundation - FAPESP [2009/15831-0, 2010/19899-5, 2011/19788-1]	Municipal Health Secretariat of Sao Paulo; National Counsel of Technological; Scientific Development and Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Municipal Health Secretariat of Sao Paulo; National Counsel of Technological (Process: #481176/2008-0 and 473100/20096); and Scientific Development and Sao Paulo Research Foundation - FAPESP (Process: #2009/15831-0, #2010/19899-5 and #2011/19788-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2000, CIRCULATION, V102, P852, DOI 10.1161/01.CIR.102.8.852; Bailey RL, 2010, AM J CLIN NUTR, V92, P383, DOI 10.3945/ajcn.2010.29499; Bates CJ, 1997, EUR J CLIN NUTR, V51, P691, DOI 10.1038/sj.ejcn.1600468; Bigio RS, 2013, ANN NUTR METAB, V62, P331, DOI 10.1159/000348883; Bogers RP, 2007, NUTRITION, V23, P97, DOI 10.1016/j.nut.2006.11.002; Broekmans WMR, 2000, J NUTR, V130, P1578, DOI 10.1093/jn/130.6.1578; Brouwer IA, 1999, J NUTR, V129, P1135, DOI 10.1093/jn/129.6.1135; BROWN RD, 1982, PATHOLOGY, V14, P449, DOI 10.3109/00313028209092126; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Caudill MA, 2010, AM J CLIN NUTR, V91, p1455S, DOI 10.3945/ajcn.2010.28674E; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171; de Bree A, 2001, AM J CLIN NUTR, V73, P1027; de Carvalho AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096667; de Carvalho AM, 2013, PUBLIC HEALTH NUTR, V16, P1893, DOI 10.1017/S1368980012003916; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Ganji V, 2003, AM J CLIN NUTR, V77, P826, DOI 10.1093/ajcn/77.4.826; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Kipnis V, 2009, BIOMETRICS, V65, P1003, DOI 10.1111/j.1541-0420.2009.01223.x; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Konstantinova SV, 2007, BRIT J NUTR, V98, P201, DOI 10.1017/S0007114507691788; KUBASIK NP, 1980, CLIN CHEM, V26, P598; Liang S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/560183; Marchioni DML, 2013, CAD SAUDE PUBLICA, V29, P2083, DOI 10.1590/0102-311X00084712; Lutsey PL, 2006, AM J CLIN NUTR, V83, P1380, DOI 10.1093/ajcn/83.6.1380; McNulty H, 2002, AM J CLIN NUTR, V76, P436, DOI 10.1093/ajcn/76.2.436; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Riddell LJ, 2000, AM J CLIN NUTR, V71, P1448; Rybak ME, 2005, CLIN CHEM, V51, P1223, DOI 10.1373/clinchem.2005.050278; Selhub J, 2000, Public Health Rev, V28, P117; Stead LM, 2004, ADV ENZYME REGUL, V44, P321, DOI 10.1016/j.advenzreg.2003.11.012; Ubbink JB, 1999, CLIN CHEM, V45, P670; Ueland PM, 2001, TRENDS PHARMACOL SCI, V22, P195, DOI 10.1016/S0165-6147(00)01675-8; Venn BJ, 2002, AM J CLIN NUTR, V76, P758, DOI 10.1093/ajcn/76.4.758; Ward M, 1997, QJM-MON J ASSOC PHYS, V90, P519, DOI 10.1093/qjmed/90.8.519; WHO/FAO, 2003, DIET NUTR; Williams KT, 2007, J NUTR, V137, P311, DOI 10.1093/jn/137.2.311	41	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111619	10.1371/journal.pone.0111619	http://dx.doi.org/10.1371/journal.pone.0111619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365261	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100090
J	Vieira, E; Ruano, EG; Figueroa, ALC; Aranda, G; Momblan, D; Carmona, F; Gomis, R; Vidal, J; Hanzu, FA				Vieira, Elaine; Ruano, Elena G.; Figueroa, Ana Lucia C.; Aranda, Gloria; Momblan, Dulce; Carmona, Francesc; Gomis, Ramon; Vidal, Josep; Hanzu, Felicia A.			Altered Clock Gene Expression in Obese Visceral Adipose Tissue Is Associated with Metabolic Syndrome	PLOS ONE			English	Article							REV-ERB-ALPHA; HIGH-FAT DIET; CONTROLS LIPID-METABOLISM; ORPHAN NUCLEAR RECEPTOR; CIRCADIAN-RHYTHMS; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; PPAR-GAMMA; ROR-ALPHA; MICE	Clock gene expression was associated with different components of metabolic syndrome (MS) in human adipose tissue. However, no study has been done to compare the expression of clock genes in visceral adipose tissue (VAT) from lean and obese subjects and its clinical implications. Therefore, we studied in lean and obese women the endogenous 24 h expression of clock genes in isolated adipocytes and its association with MS components. VAT was obtained from lean (BMI 21-25 kg/m(2); n = 21) and morbidly obese women (BMI >40 kg/m(2); n = 28). The 24 h pattern of clock genes was analyzed every 6 hours using RT-PCR. Correlation of clinical data was studied by Spearman analysis. The 24 h pattern of clock genes showed that obesity alters the expression of CLOCK, BMAL1, PER1, CRY2 and REV-ERB ALPHA in adipocytes with changes found in CRY2 and REV-ERB ALPHA throughout the 24 h period. The same results were confirmed in VAT and stromal cells (SC) showing an upregulation of CRY2 and REV-ERB ALPHA from obese women. A positive correlation was observed for REV-ERB ALPHA gene expression with BMI and waist circumference in the obese population. Expression of ROR ALPHA was correlated with HDL levels and CLOCK with LDL. Obese subjects with MS exhibited positive correlation in the PER2 gene with LDL cholesterol, whereas REV-ERB ALPHA was correlated with waist circumference. We identified CRY2 and REV-ERB ALPHA as the clock genes upregulated in obesity during the 24 h period and that REV-ERB ALPHA is an important gene associated with MS.	[Vieira, Elaine; Ruano, Elena G.; Aranda, Gloria; Gomis, Ramon; Vidal, Josep; Hanzu, Felicia A.] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain; [Vieira, Elaine; Ruano, Elena G.; Figueroa, Ana Lucia C.; Gomis, Ramon; Vidal, Josep; Hanzu, Felicia A.] IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain; [Aranda, Gloria; Gomis, Ramon; Vidal, Josep; Hanzu, Felicia A.] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Carmona, Francesc] Univ Barcelona, Hosp Clin, Inst Clin Gynecol Obstet & Neonatol, Barcelona, Spain; [Momblan, Dulce] Univ Barcelona, Hosp Clin, Dept Gastrointestinal Surg, Barcelona, Spain; [Carmona, Francesc; Gomis, Ramon; Vidal, Josep] Univ Barcelona, Fac Med, Barcelona 7, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Vieira, E (corresponding author), CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain.	evieira@ciberdem.org	Vieira, Elaine/F-7273-2019; Vieira, Elaine/AAG-1127-2020	Vieira, Elaine/0000-0002-0621-9367; Vieira, Elaine/0000-0002-0621-9367; Castillo-Figueroa, Ana/0000-0002-6036-2770; Hanzu, Felicia Alexandra/0000-0002-2399-4023; Vidal, Josep/0000-0002-4564-4518	Spanish Ministry of Economy and Competitiveness [PI13/01500]; Government of Catalonia [2014SGR659]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Government of Catalonia(Generalitat de Catalunya)	This work was sponsored by the Spanish Ministry of Economy and Competitiveness under grant agreement number PI13/01500 and by the Government of Catalonia under grant agreement number 2014SGR659. The work was conducted at the Centre Esther Koplowitz, Barcelona; CIBERDEM is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE S1, V35, pS11; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Barnea M, 2012, BBA-MOL BASIS DIS, V1822, P1796, DOI 10.1016/j.bbadis.2012.08.005; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2013, MOL NUTR FOOD RES; Garaulet M, 2011, J CELL PHYSIOL, V226, P2075, DOI 10.1002/jcp.22531; Garaulet M, 2009, CURR OPIN LIPIDOL, V20, P127, DOI 10.1097/MOL.0b013e3283292399; Garcia-Rios A, 2012, J NUTR, V142, P1213, DOI 10.3945/jn.111.156968; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Goumidi L, 2013, INT J OBESITY, V37, P666, DOI 10.1038/ijo.2012.117; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hernandez-Morante JJ, 2009, INT J OBESITY, V33, P473, DOI 10.1038/ijo.2009.4; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Otway DT, 2011, DIABETES, V60, P1577, DOI 10.2337/db10-1098; Ruano EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104065; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shostak A, 2013, DIABETES, V62, P2195, DOI 10.2337/db12-1449; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Tsuzaki K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-150; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Vieira E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1032, DOI 10.1152/ajpendo.90510.2008; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; Wu X, 2009, INT J OBESITY, V33, P971, DOI 10.1038/ijo.2009.137; Wu XY, 2007, OBESITY, V15, P2560, DOI 10.1038/oby.2007.308; Zvonic S, 2007, OBESITY, V15, P539, DOI 10.1038/oby.2007.544	39	43	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111678	10.1371/journal.pone.0111678	http://dx.doi.org/10.1371/journal.pone.0111678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365257	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100102
J	Yukawa, H; Nakagawa, S; Yoshizumi, Y; Watanabe, M; Saito, H; Miyamoto, Y; Noguchi, H; Oishi, K; Ono, K; Sawada, M; Kato, I; Onoshima, D; Obayashi, M; Hayashi, Y; Kaji, N; Ishikawa, T; Hayashi, S; Baba, Y				Yukawa, Hiroshi; Nakagawa, Shingo; Yoshizumi, Yasuma; Watanabe, Masaki; Saito, Hiroaki; Miyamoto, Yoshitaka; Noguchi, Hirofumi; Oishi, Koichi; Ono, Kenji; Sawada, Makoto; Kato, Ichiro; Onoshima, Daisuke; Obayashi, Momoko; Hayashi, Yumi; Kaji, Noritada; Ishikawa, Tetsuya; Hayashi, Shuji; Baba, Yoshinobu			Novel Positively Charged Nanoparticle Labeling for In Vivo Imaging of Adipose Tissue-Derived Stem Cells	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MEDIATED GENE-TRANSFER; MAGNETIC NANOPARTICLES; CONTRAST AGENTS; STROMAL CELLS; PROTEIN TRANSDUCTION; MRI; MOUSE; CYTOTOXICITY; EFFICIENCY	Stem cell transplantation has been expected to have various applications for regenerative medicine. However, in order to detect and trace the transplanted stem cells in the body, non-invasive and widely clinically available cell imaging technologies are required. In this paper, we focused on magnetic resonance (MR) imaging technology, and investigated whether the trimethylamino dextran-coated magnetic iron oxide nanoparticle -03 (TMADM-03), which was newly developed by our group, could be used for labeling adipose tissue-derived stem cells (ASCs) as a contrast agent. No cytotoxicity was observed in ASCs transduced with less than 100 mu g-Fe/mL of TMADM-03 after a one hour transduction time. The transduction efficiency of TMADM-03 into ASCs was about four-fold more efficient than that of the alkali-treated dextran-coated magnetic iron oxide nanoparticle (ATDM), which is a major component of commercially available contrast agents such as ferucarbotran (Resovist), and the level of labeling was maintained for at least two weeks. In addition, the differentiation ability of ASCs labeled with TMADM-03 and their ability to produce cytokines such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF) and prostaglandin E2 (PGE2), were confirmed to be maintained. The ASCs labeled with TMADM-03 were transplanted into the left kidney capsule of a mouse. The labeled ASCs could be imaged with good contrast using a 1T MR imaging system. These data suggest that TMADM-03 can therefore be utilized as a contrast agent for the MR imaging of stem cells.	[Yukawa, Hiroshi; Obayashi, Momoko; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Res Ctr Innovat Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nakagawa, Shingo; Yoshizumi, Yasuma; Hayashi, Yumi; Ishikawa, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Med Technol, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Watanabe, Masaki; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Saito, Hiroaki; Kato, Ichiro] MEITO Sangyo Co Ltd, Nagoya Res Lab, Kiyosu 4520067, Japan; [Miyamoto, Yoshitaka; Hayashi, Shuji] Nagoya Univ, Grad Sch Med, Dept Adv Med Biotechnol & Robot, Higashi Ku, Nagoya, Aichi 4610047, Japan; [Noguchi, Hirofumi] Univ Ryukyus, Grad Sch Med, Dept Regenerat Med, Nishihara, Okinawa 9030215, Japan; [Oishi, Koichi; Ono, Kenji; Sawada, Makoto] Nagoya Univ, Res Inst Environm Med Stress Adapt & Protect, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Onoshima, Daisuke] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; University of the Ryukyus; Nagoya University; Nagoya University; National Institute of Advanced Industrial Science & Technology (AIST)	Yukawa, H (corresponding author), Nagoya Univ, Res Ctr Innovat Nanobiodevices, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	hiroshiy@med.nagoya-u.ac.jp	Miyamoto, Yoshitaka/X-6637-2018; Kaji, Noritada/M-8432-2019; Ono, Kenji/I-6163-2014; Kaji, Noritada/K-5623-2016	Ono, Kenji/0000-0002-5402-6535; Kaji, Noritada/0000-0002-9828-873X; Miyamoto, Yoshitaka/0000-0001-6697-7453; Noguchi, Hirofumi/0000-0002-0880-6805	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [24681027, 26750146, 24390316] Funding Source: KAKEN	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) and partially supported by the Japan Science and Technology Agency (JST) through its "Research Center Network for Realization of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Bae JE, 2011, BIOMATERIALS, V32, P9401, DOI 10.1016/j.biomaterials.2011.08.075; Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462; Bhirde A, 2011, NANOSCALE, V3, P142, DOI 10.1039/c0nr00493f; BULL BS, 1975, J THORAC CARDIOV SUR, V69, P685; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chen R, 2011, INT J NANOMED, V6, P511, DOI 10.2147/IJN.S16934; Chien LY, 2011, BIOMATERIALS, V32, P3275, DOI 10.1016/j.biomaterials.2011.01.042; Crabbe A, 2010, CELL TRANSPLANT, V19, P919, DOI 10.3727/096368910X494623; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Hart C, 2011, METHODS MOL BIOL, V698, P459, DOI 10.1007/978-1-60761-999-4_33; Hu SL, 2009, J CELL BIOCHEM, V108, P529, DOI 10.1002/jcb.22283; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Kazemi T, 2008, INT J CANCER, V123, P2113, DOI 10.1002/ijc.23751; Kim HM, 2011, ACS NANO, V5, P8230, DOI 10.1021/nn202912b; Kim JI, 2012, BIOMATERIALS, V33, P218, DOI 10.1016/j.biomaterials.2011.09.033; Kim TH, 2010, MAGN RESON IMAGING, V28, P1004, DOI 10.1016/j.mri.2010.03.047; Kim T, 2011, J AM CHEM SOC, V133, P2955, DOI 10.1021/ja1084095; Lalande C, 2011, EUR CELLS MATER, V21, P341, DOI 10.22203/eCM.v021a25; Liu G, 2009, J MATER RES, V24, P1317, DOI 10.1557/JMR.2009.0179; Liu KY, 2011, STEM CELLS DEV, V20, P1679, DOI 10.1089/scd.2010.0447; Mailander V, 2008, MOL IMAGING BIOL, V10, P138, DOI 10.1007/s11307-007-0130-3; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Nohroudi K, 2010, CELL TRANSPLANT, V19, P431, DOI 10.3727/096368909X484699; Oishi K, 2008, CELL TRANSPLANT, V17, P35, DOI 10.3727/000000008783906937; Oishi K, 2012, CELL MED, V3, P43, DOI 10.3727/215517912X639397; Oishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057046; Oishi K, 2010, CELL TRANSPLANT, V19, P887, DOI 10.3727/096368910X509013; Patel D, 2011, BIOMATERIALS, V32, P1167, DOI 10.1016/j.biomaterials.2010.10.013; Phelan A, 1998, NAT BIOTECHNOL, V16, P440, DOI 10.1038/nbt0598-440; Pierzchalski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074745; Rosen JE, 2010, NANOMEDICINE, V8, P275; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Son KR, 2010, WORLD J GASTROENTERO, V16, P5611, DOI 10.3748/wjg.v16.i44.5611; Sponarova D, 2011, J BIOMED NANOTECHNOL, V7, P384, DOI 10.1166/jbn.2011.1289; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Thorek DLJ, 2008, BIOMATERIALS, V29, P3583, DOI 10.1016/j.biomaterials.2008.05.015; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tseng CL, 2010, BIOMATERIALS, V31, P5427, DOI 10.1016/j.biomaterials.2010.03.049; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; van Buul GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017001; Xiao L, 2011, ACS NANO, V5, P6315, DOI 10.1021/nn201348s; Yukawa H, 2008, CELL TRANSPLANT, V17, P43, DOI 10.3727/000000008783907071; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Yukawa H, 2009, CELL TRANSPLANT, V18, P601, DOI 10.1177/096368970901805-616; Zhang B, 2013, BIOMATERIALS, V34, P5843, DOI 10.1016/j.biomaterials.2013.04.021	46	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110142	10.1371/journal.pone.0110142	http://dx.doi.org/10.1371/journal.pone.0110142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365191	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100017
J	Dong, BQ; Liang, DB; Lin, M; Wang, ML; Zeng, J; Liao, HZ; Zhou, LY; Huang, J; Wei, XL; Zou, GY; Jing, HQ				Dong, Baiqing; Liang, Dabin; Lin, Mei; Wang, Mingliu; Zeng, Jun; Liao, Hezhuang; Zhou, Lingyun; Huang, Jun; Wei, Xiaolin; Zou, Guanyang; Jing, Huaiqi			Bacterial Etiologies of Five Core Syndromes: Laboratory-Based Syndromic Surveillance Conducted in Guangxi, China	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INFLUENZAE TYPE-B; STREPTOCOCCUS-SUIS; ENTEROPATHOGENIC BACTERIA; ACUTE DIARRHEA; RISK-FACTORS; INFECTION; CHILDREN; EPIDEMIOLOGY; PROVINCE	Background: Under the existing national surveillance system in China for selected infectious diseases, bacterial cultures are performed for only a small percentage of reported cases. We set up a laboratory-based syndromic surveillance system to elucidate bacterial etiologic spectrum and detect infection by rare etiologies (or serogroups) for five core syndromes in the given study area. Methods: Patients presenting with one of five core syndromes at nine sentinel hospitals in Guagnxi, China were evaluated using laboratory-based syndrome surveillance to elucidate bacterial etiologies. We collected respiratory and stool specimens, as well as CSF, blood and other related samples for bacterial cultures and pulse field gel electrophoresis (PFGE) assays. Results: From February 2009 to December 2011, 2,964 patients were enrolled in the study. Etiologies were identified in 320 (10.08%) patients. Streptococcus pneumonia (37 strains, 24.18%), Klebsiella pneumonia (34, 22.22%), Pseudomonas aeruginosa (19, 12.42%) and Haemophilus influenza (18, 11.76%) were the most frequent pathogens for fever and respiratory syndrome, while Salmonella (77, 81.05%) was most often seen in diarrhea syndrome cases. Salmonella paratyphi A (38, 86.36%) occurred in fever and rash syndrome, with Cryptococcus neoformans (20, 35.09%), Streptococcus pneumonia (5, 8.77%), Klebsiella pneumonia (5, 8.77%), streptococcus suis (3, 5.26%) and Neisseria meningitides group B (2, 3.51%) being the most frequently detected in encephalitis-meningitis syndrome. To date no pathogen was isolated from the specimens from fever and hemorrhage patients. Conclusions: In addition to common bacterial pathogens, opportunistic pathogens and fungal infections require more attention. Our study contributes to the strengthening of the existing national surveillance system and provides references for other regions that are similar to the study area.	[Dong, Baiqing] Guagnxi Zhuang Autonomous Reg Hlth Bur, Dept Emergency Response, Nanning, Guangxi, Peoples R China; [Liang, Dabin; Lin, Mei; Wang, Mingliu; Zeng, Jun; Liao, Hezhuang; Zhou, Lingyun; Huang, Jun] Guagnxi Zhuang Autonomous Reg Ctr Dis Prevent, Div Bacterial Infect Dis Control, Nanning, Guangxi, Peoples R China; [Wang, Mingliu; Wei, Xiaolin] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Zou, Guanyang] Univ Leeds, Nuffield Ctr Int Hlth & Dev, COMDIS Hlth Serv Delivery Res Consortium, China Program, Shenzhen, Peoples R China; [Jing, Huaiqi] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Jing, Huaiqi] Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Chinese University of Hong Kong; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Lin, M (corresponding author), Guagnxi Zhuang Autonomous Reg Ctr Dis Prevent, Div Bacterial Infect Dis Control, Nanning, Guangxi, Peoples R China.	gxlinmei@126.com			Chinese Center for Disease Control and Prevention [2009ZX10004203-003]; Department of Science and Technology of the Guangxi Zhuang Autonomous Region, China [2012GXNSFAA053159]	Chinese Center for Disease Control and Prevention; Department of Science and Technology of the Guangxi Zhuang Autonomous Region, China	BQD received funding by the Chinese Center for Disease Control and Prevention (2009ZX10004203-003) (http://www.chinacdc.cn/). The Chinese Center for Disease Control and Prevention played a role in study design. ML received the funding by the Department of Science and Technology of the Guangxi Zhuang Autonomous Region, China (2012GXNSFAA053159) (http://www.gxst.gov.cn/). The Department of Science and Technology of Guangxi has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abio A, 2013, PATHOG GLOB HEALTH, V107, P373, DOI 10.1179/2047773213Y.0000000119; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1148; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Barr W, 2014, AM FAM PHYSICIAN, V89, P180; Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Cai J, 2014, J MED VIROL, V86, P1602, DOI 10.1002/jmv.23884; Chaisuksant S, 2013, SE ASIAN J TROP MED, V44, P289; Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749; Favaro M, 2013, MOL BIOTECHNOL, V53, P74, DOI 10.1007/s12033-012-9534-7; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Jafari F, 2008, JPN J INFECT DIS, V61, P269; Jefferies JMC, 2012, J MED MICROBIOL, V61, P1052, DOI 10.1099/jmm.0.044818-0; Kim SA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-310; Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003; Levine OS, 2000, EMERG INFECT DIS, V6, P165, DOI 10.3201/eid0602.000209; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li YX, 2014, EMERG INFECT DIS, V20, P61, DOI 10.3201/eid2001.120375; Liu YF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-309; Liu YX, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-82; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Makoka MH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-67; Mengistu Mebratenesh, 2011, Ethiop Med J, V49, P349; Murphy CN, 2012, FUTURE MICROBIOL, V7, P991, DOI [10.2217/fmb.12.74, 10.2217/FMB.12.74]; Negroni R, 2012, CLIN DERMATOL, V30, P599, DOI 10.1016/j.clindermatol.2012.01.005; Owusu M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-28; Pachirat O, 2012, CLIN MED INSIGHTS-CA, V6, P119, DOI 10.4137/CMC.S9793; Panatto D, 2013, INDIAN J MED RES, V138, P835; Pavic I, 2013, COLLEGIUM ANTROPOL, V37, P619; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Qu M, 2012, J INFECTION, V65, P214, DOI 10.1016/j.jinf.2012.04.010; Ran L, 2011, FOODBORNE PATHOG DIS, V8, P921, DOI 10.1089/fpd.2010.0827; Sabiiti W, 2012, FUTURE MICROBIOL, V7, P1297, DOI [10.2217/FMB.12.102, 10.2217/fmb.12.102]; Shibli F, 2010, ISR MED ASSOC J, V12, P477; Tudose C, 2010, MAEDICA BUCUR, V5, P258; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Weil-Olivier C, 2014, VACCINE, V32, P2022, DOI 10.1016/j.vaccine.2014.02.008; Weinberger M, 2013, EMERG INFECT DIS, V19, P1828, DOI 10.3201/eid1911.120900; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024; World Health Organisation (WHO), 2008, COMM DIS AL RESP MAS; Yan Youwang, 2005, J Chin Med Assoc, V68, P571, DOI 10.1016/S1726-4901(09)70096-6; Zar HJ, 2013, THORAX, V68, P1052, DOI 10.1136/thoraxjnl-2013-204247; Zhang QL, 2011, PEDIATR INFECT DIS J, V30, P7, DOI 10.1097/INF.0b013e3181ec6245; Zhu M, 2013, EPIDEMIOL INFECT, V141, P540, DOI 10.1017/S0950268812000970	45	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110876	10.1371/journal.pone.0110876	http://dx.doi.org/10.1371/journal.pone.0110876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360596	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700050
J	Ferguson, LR; Grover, S; Dominguez, JM; Balaiya, S; Chalam, KV				Ferguson, Lee R.; Grover, Sandeep; Dominguez, James M., II; Balaiya, Sankarathi; Chalam, Kakarla V.			Retinal Thickness Measurement Obtained with Spectral Domain Optical Coherence Tomography Assisted Optical Biopsy Accurately Correlates with Ex Vivo Histology	PLOS ONE			English	Article							EYES; REPRODUCIBILITY; DEGENERATION; MODEL; MICE	Background: This study determines 'correlation constants' between the gold standard histological measurement of retinal thickness and the newer spectral-domain optical coherence tomography (SD-OCT) technology in adult C57BL/6 mice. Methods: Forty-eight eyes from adult mice underwent SD-OCT imaging and then were histologically prepared for frozen sectioning with H&E staining. Retinal thickness was measured via 10x light microscopy. SD-OCT images and histological sections were standardized to three anatomical sites relative to the optic nerve head (ONH) location. The ratios between SD-OCT to histological thickness for total retinal thickness (TRT) and six sublayers were defined as 'correlation constants'. Results: Mean (+/- SE) TRT for SD-OCT and histological sections was 210.95 mu m (+/- 1.09) and 219.58 mu m (+/- 2.67), respectively. The mean 'correlation constant' for TRT between the SD-OCT and histological sections was 0.96. The retinal thickness for all sublayers measured by SD-OCT vs. histology were also similar, the 'correlation constant' values ranged from 0.70 to 1.17. All SD-OCT and histological measurements demonstrated highly significant (p<0.01) strong positive correlations. Conclusion: This study establishes conversion factors for the translation of ex vivo data into in vivo information; thus enhancing the applicability of SD-OCT in translational research.	[Ferguson, Lee R.; Grover, Sandeep; Balaiya, Sankarathi; Chalam, Kakarla V.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL 32209 USA; [Dominguez, James M., II] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chalam, KV (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL 32209 USA.	Kakarla.Chalam@jax.ufl.edu	Chalam, kakarla/K-7507-2019	Chalam, K V/0000-0002-0004-9416	Department of Ophthalmology Jacksonville, Jacksonville, Florida	Department of Ophthalmology Jacksonville, Jacksonville, Florida	The Department of Ophthalmology Jacksonville, Jacksonville, Florida provided all financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown NH, 2009, GRAEF ARCH CLIN EXP, V247, P1069, DOI 10.1007/s00417-009-1044-3; Cebulla CM, 2010, EXP EYE RES, V90, P521, DOI 10.1016/j.exer.2010.01.008; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Chen TC, 2006, AM J OPHTHALMOL, V141, P1165, DOI 10.1016/j.ajo.2006.01.086; Curcio CA, 2011, INVEST OPHTH VIS SCI, V52, P3943, DOI 10.1167/iovs.10-6377; Ferguson LR, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-9; Ferguson LR, 2013, PLOS ONE, V27, P8; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Gabriele ML, 2010, INVEST OPHTH VIS SCI, V51, P6519, DOI 10.1167/iovs.10-5662; Giani A, 2010, AM J OPHTHALMOL, V150, P815, DOI 10.1016/j.ajo.2010.06.025; Gloesmann M, 2003, INVEST OPHTH VIS SCI, V44, P1696, DOI 10.1167/iovs.02-0654; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004; Yehoshua Z, 2012, OPHTHALMIC RES, V48, P6, DOI 10.1159/000339841; Zhou XT, 2008, VISION RES, V48, P1137, DOI 10.1016/j.visres.2008.01.030	21	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111203	10.1371/journal.pone.0111203	http://dx.doi.org/10.1371/journal.pone.0111203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360629	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700072
J	Lu, Y; Roy, R				Lu, Yu; Roy, Richard			Centrosome/Cell Cycle Uncoupling and Elimination in the Endoreduplicating Intestinal Cells of C. elegans	PLOS ONE			English	Article							CENTRIOLE DUPLICATION; PHOSPHORYLATION SITES; POLO KINASE; PROTEIN; MATURATION; SEPARATION; DIVISION; ENCODES; ORGANIZATION; CILIOGENESIS	The centrosome cycle is most often coordinated with mitotic cell division through the activity of various essential cell cycle regulators, consequently ensuring that the centriole is duplicated once, and only once, per cell cycle. However, this coupling can be altered in specific developmental contexts; for example, multi-ciliated cells generate hundreds of centrioles without any S-phase requirement for their biogenesis, while Drosophila follicle cells eliminate their centrosomes as they begin to endoreduplicate. In order to better understand how the centrosome cycle and the cell cycle are coordinated in a developmental context we use the endoreduplicating intestinal cell lineage of C. elegans to address how novel variations of the cell cycle impact this important process. In C. elegans, the larval intestinal cells undergo one nuclear division without subsequent cytokinesis, followed by four endocycles that are characterized by successive rounds of S-phase. We monitored the levels of centriolar/centrosomal markers and found that centrosomes lose their pericentriolar material following the nuclear division that occurs during the L1 stage and is thereafter never re-gained. The centrioles then become refractory to S phase regulators that would normally promote duplication during the first endocycle, after which they are eliminated during the L2 stage. Furthermore, we show that SPD-2 plays a central role in the numeral regulation of centrioles as a potential target of CDK activity. On the other hand, the phosphorylation on SPD-2 by Polo-like kinase, the transcriptional regulation of genes that affect centriole biogenesis, and the ubiquitin/proteasome degradation pathway, contribute collectively to the final elimination of the centrioles during the L2 stage.	[Lu, Yu; Roy, Richard] McGill Univ, Dept Biol, Dev Biol Res Initiat, Montreal, PQ H3A 1B1, Canada	McGill University	Roy, R (corresponding author), McGill Univ, Dept Biol, Dev Biol Res Initiat, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	richard.roy@mcgill.ca			Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 1999, DEVELOPMENT, V126, P1947; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bobinnec Y, 2000, J CELL SCI, V113, P3747; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Bolivar J, 2001, DEVELOPMENT, V128, P1889; Boxem M, 1999, DEVELOPMENT, V126, P2227; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; BRENNER S, 1974, GENETICS, V77, P71; Cabral G, 2013, CURR BIOL, V23, P1380, DOI 10.1016/j.cub.2013.06.043; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Crasta K, 2006, EMBO J, V25, P2551, DOI 10.1038/sj.emboj.7601136; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Enjolras C, 2012, J CELL BIOL, V197, P313, DOI 10.1083/jcb.201109148; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; Inglis P, 2006, SENSORY CILIA CAENOR; Kais Z, 2008, CANCER BIOL THER, V7, P1540, DOI 10.4161/cbt.7.10.7053; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kim DY, 2006, J CELL BIOL, V174, P751, DOI 10.1083/jcb.200512160; Kipreos ET, 2005, NAT REV MOL CELL BIO, V6, P766, DOI 10.1038/nrm1738; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kitagawa D, 2011, DEV CELL, V20, P550, DOI 10.1016/j.devcel.2011.02.005; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; MAHOWALD AP, 1979, EXP CELL RES, V118, P404, DOI 10.1016/0014-4827(79)90167-8; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; McMahon L, 2001, J CELL SCI, V114, P2265; Mikeladze-Dvali T, 2012, DEVELOPMENT, V139, P1670, DOI 10.1242/dev.075440; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell KF, 1998, GENETICS, V149, P1303; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; O'Toole E, 2012, PLOS ONE, V7, P140, DOI 10.1371/journal.pone.0029795; Ouellet J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-38; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Pepper ASR, 2004, DEVELOPMENT, V131, P2049, DOI 10.1242/dev.01098; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schvarzstein M, 2013, P NATL ACAD SCI USA, V110, pE898, DOI 10.1073/pnas.1213888110; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Song MH, 2011, DEV CELL, V20, P563, DOI 10.1016/j.devcel.2011.03.007; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zielinska DF, 2009, J PROTEOME RES, V8, P4039, DOI 10.1021/pr900384k	78	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110958	10.1371/journal.pone.0110958	http://dx.doi.org/10.1371/journal.pone.0110958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360893	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700055
J	Zheng, TC; Li, S; Zang, LN; Dai, LJ; Yang, CP; Qu, GZ				Zheng, Tangchun; Li, Shuang; Zang, Lina; Dai, Lijuan; Yang, Chuanping; Qu, Guan-Zheng			Overexpression of Two PsnAP1 Genes from Populus simonii x P. nigra Causes Early Flowering in Transgenic Tobacco and Arabidopsis	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL MERISTEM IDENTITY; CONSTITUTIVE EXPRESSION; ECTOPIC EXPRESSION; APETALA1; TIME; CHLOROPHYLLS; PRENYLATION; ACTIVATION; TRANSITION	In Arabidopsis, AP1 is a floral meristem identity gene and plays an important role in floral organ development. In this study, PsnAP1-1 and PsnAP1-2 were isolated from the male reproductive buds of poplar (Populus simonii x P. nigra), which are the orthologs of AP1 in Arabidopsis, by sequence analysis. Northern blot and qRT-PCR analysis showed that PsnAP1-1 and PsnAP1-2 exhibited high expression level in early inflorescence development of poplar. Subcellular localization showed the PsnAP1-1 and PsnAP1-2 proteins are localized in the nucleus. Overexpression of PsnAP1-1 and PsnAP1-2 in tobacco under the control of a CaMV 35S promoter significantly enhanced early flowering. These transgenic plants also showed much earlier stem initiation and higher rates of photosynthesis than did wild-type tobacco. qRT-PCR analysis further indicated that overexpression of PsnAP1-1 and PsnAP1-2 resulted in up-regulation of genes related to flowering, such as NtMADS4, NtMADS5 and NtMADS11. Overexpression of PsnAP1-1 and PsnAP1-2 in Arabidopsis also induced early flowering, but did not complement the ap1-10 floral morphology to any noticeable extent. This study indicates that PsnAP1-1 and PsnAP1-2 play a role in floral transition of poplar.	[Zheng, Tangchun; Li, Shuang; Zang, Lina; Dai, Lijuan; Yang, Chuanping; Qu, Guan-Zheng] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	Northeast Forestry University - China	Yang, CP (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China.	yangchuanpingnefu@yahoo.com; quguanzheng@yahoo.com			Program for New Century Excellent Talents in University [NCET-12-0808]; National Natural Science Foundation of China [31370661]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by Program for New Century Excellent Talents in University (No. NCET-12-0808) and National Natural Science Foundation of China (No. 31370661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Berbel A, 2001, PLANT J, V25, P441, DOI 10.1046/j.1365-313x.2001.00974.x; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Calonje M, 2004, PLANT PHYSIOL, V135, P1491, DOI 10.1104/pp.104.040832; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Davies B, 1994, Results Probl Cell Differ, V20, P235; Elo A, 2001, PHYSIOL PLANTARUM, V112, P95, DOI 10.1034/j.1399-3054.2001.1120113.x; Fernando DD, 2006, DEV GENES EVOL, V216, P19, DOI 10.1007/s00427-005-0026-7; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Hsu HF, 2003, PLANT CELL PHYSIOL, V44, P783, DOI 10.1093/pcp/pcg099; Huang HJ, 2014, PHYSIOL PLANTARUM, V151, P495, DOI 10.1111/ppl.12123; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Jang S, 1999, MOL CELLS, V9, P576; Jang SH, 2002, PLANT CELL PHYSIOL, V43, P230, DOI 10.1093/pcp/pcf015; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kotoda N, 2002, PLANT SCI, V162, P679, DOI 10.1016/S0168-9452(02)00024-9; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma GY, 2011, PLANT MOL BIOL REP, V29, P573, DOI 10.1007/s11105-010-0263-4; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Niwa Y., 2003, PLANT BIOTECHNOL-NAR, V20, P1, DOI [10.5511/plantbiotechnology.20.1, DOI 10.5511/PLANTBIOTECHNOLOGY.20.1]; Pelaz S, 2001, PLANT J, V26, P385, DOI 10.1046/j.1365-313X.2001.2641042.x; Pena L, 2001, NAT BIOTECHNOL, V19, P263, DOI 10.1038/85719; Pomar F, 2002, PROTOPLASMA, V220, P17, DOI 10.1007/s00709-002-0030-y; Qu GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063398; Rodriguez-Concepcion M, 1999, PLANT MOL BIOL, V39, P865, DOI 10.1023/A:1006170020836; Shinano T, 1996, PHOTOSYNTHETICA, V32, P409; Smykal P, 2007, PLANT MOL BIOL, V65, P233, DOI 10.1007/s11103-007-9211-6; Sung SK, 1999, PLANT PHYSIOL, V120, P969, DOI 10.1104/pp.120.4.969; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Yalovsky S, 2000, PLANT CELL, V12, P1257, DOI 10.1105/tpc.12.8.1257; Zhang BY, 2008, TREE PHYSIOL, V28, P929, DOI 10.1093/treephys/28.6.929	42	13	15	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111725	10.1371/journal.pone.0111725	http://dx.doi.org/10.1371/journal.pone.0111725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360739	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700144
J	Leite, C; Silva, NT; Mendes, S; Ribeiro, A; de Faria, JP; Lourenco, T; dos Santos, F; Andrade, PZ; Cardoso, CMP; Vieira, M; Paiva, A; da Silva, CL; Cabral, JMS; Relvas, JB; Graos, M				Leite, Cristiana; Silva, N. Tatiana; Mendes, Sandrine; Ribeiro, Andreia; de Faria, Joana Paes; Lourenco, Tania; dos Santos, Francisco; Andrade, Pedro Z.; Cardoso, Carla M. P.; Vieira, Margarida; Paiva, Artur; da Silva, Claudia L.; Cabral, Joaquim M. S.; Relvas, Joao B.; Graos, Mario			Differentiation of Human Umbilical Cord Matrix Mesenchymal Stem Cells into Neural-Like Progenitor Cells and Maturation into an Oligodendroglial-Like Lineage	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; SPINAL-CORD; ADIPOSE-TISSUE; NESTIN; EXPRESSION; NEURONS; MYELIN; PRECURSORS; GENERATION	Mesenchymal stem cells (MSCs) are viewed as safe, readily available and promising adult stem cells, which are currently used in several clinical trials. Additionally, their soluble-factor secretion and multi-lineage differentiation capacities place MSCs in the forefront of stem cell types with expected near-future clinical applications. In the present work MSCs were isolated from the umbilical cord matrix (Wharton's jelly) of human umbilical cord samples. The cells were thoroughly characterized and confirmed as bona-fide MSCs, presenting in vitro low generation time, high proliferative and colony-forming unit-fibroblast (CFU-F) capacity, typical MSC immunophenotype and osteogenic, chondrogenic and adipogenic differentiation capacity. The cells were additionally subjected to an oligodendroglial-oriented step-wise differentiation protocol in order to test their neural-and oligodendroglial-like differentiation capacity. The results confirmed the neural-like plasticity of MSCs, and suggested that the cells presented an oligodendroglial-like phenotype throughout the differentiation protocol, in several aspects sharing characteristics common to those of bona-fide oligodendrocyte precursor cells and differentiated oligodendrocytes.	[Leite, Cristiana; Silva, N. Tatiana; Lourenco, Tania; Graos, Mario] Biocant Pk, Biocant Technol Transfer Assoc, Cantanhede, Portugal; [Mendes, Sandrine; Ribeiro, Andreia; Paiva, Artur] Portuguese Inst Blood & Transplantat, Blood & Transplantat Ctr Coimbra, Coimbra, Portugal; [de Faria, Joana Paes; Relvas, Joao B.] Inst Biol Mol & Celular, Oporto, Portugal; [dos Santos, Francisco; Andrade, Pedro Z.; da Silva, Claudia L.; Cabral, Joaquim M. S.] Univ Lisbon, Inst Biotechnol & Bioengn, P-1699 Lisbon, Portugal; [dos Santos, Francisco; Andrade, Pedro Z.; da Silva, Claudia L.; Cabral, Joaquim M. S.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Cardoso, Carla M. P.; Vieira, Margarida] Biocant Pk, Crioestaminal Saude & Tecnol SA, Cantanhede, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Graos, M (corresponding author), Biocant Pk, Biocant Technol Transfer Assoc, Biocant Pk, Cantanhede, Portugal.	mgraos@biocant.pt	Ribeiro, Andreia/C-1557-2019; Paiva, Artur/AAH-2330-2022; Relvas, Joao B/A-1142-2008; Cabral, Joaquim M S/G-2052-2010; Andrade, Pedro/A-2471-2010; da Silva, Claudia L./K-6104-2012; de Faria, Joana Paes/M-8815-2014; Grãos, Mário/O-7273-2017; Paiva, Artur/AFM-0035-2022; Santos, Francisco F dos/N-9832-2016	Ribeiro, Andreia/0000-0001-6539-6649; Paiva, Artur/0000-0002-6562-5859; Relvas, Joao B/0000-0001-7636-0924; Cabral, Joaquim M S/0000-0002-2405-5845; da Silva, Claudia L./0000-0002-1091-7651; de Faria, Joana Paes/0000-0001-7046-6197; Grãos, Mário/0000-0002-2707-1488; Paiva, Artur/0000-0002-6562-5859; Santos, Francisco F dos/0000-0002-2046-2742; Pires Lourenco, Tania Milene/0000-0003-1198-8117; Almeida Silva, Neuza Tatiana/0000-0003-0542-9677; Cardoso, Carla/0000-0002-0985-7487	Portuguese program QREN/Mais Centro-Programa Operacional Regional do Centro [CENTRO -07-0202 -FEDER -005547]; European Regional Development Fund (ERDF); ERDF through Programa Operacional Factores de Competitividade - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) [FCOMP-01-0124-FEDER-021150 - PTDC/SAU-ENB/119292/2010]; COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine'') [Centro-07-ST24-FEDER-002008]; FCT [SFRH/BPD/81861/2011, SFRH/BPD/81909/2011, SFRH/BPD/34834/2007]	Portuguese program QREN/Mais Centro-Programa Operacional Regional do Centro; European Regional Development Fund (ERDF)(European Commission); ERDF through Programa Operacional Factores de Competitividade - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology); COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine''); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Authors acknowledge "ISOCORD'' project, led by Crioestaminal - Saude e Tecnologia S.A., supported by the Portuguese program QREN/Mais Centro-Programa Operacional Regional do Centro (project nr. CENTRO -07-0202 -FEDER -005547) and co-funded by the European Regional Development Fund (ERDF). This work was partially funded by the ERDF through Programa Operacional Factores de Competitividade - COMPETE and by national funds by FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) through grant FCOMP-01-0124-FEDER-021150 - PTDC/SAU-ENB/119292/2010, which included a research fellowship awarded to TL, and COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine'', Centro-07-ST24-FEDER-002008). FCT financially supported FS, PZA, and JPF through fellowships SFRH/BPD/81861/2011, SFRH/BPD/81909/2011 and SFRH/BPD/34834/2007, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan G, 2001, MICROSC RES TECHNIQ, V52, P753, DOI 10.1002/jemt.1060; Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Baas D, 1997, GLIA, V19, P324, DOI 10.1002/(SICI)1098-1136(199704)19:4<324::AID-GLIA5>3.0.CO;2-X; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Boggs JM, 2006, BIOCHEMISTRY-US, V45, P391, DOI 10.1021/bi0519194; Boggs JM, 2011, BBA-BIOMEMBRANES, V1808, P761, DOI 10.1016/j.bbamem.2010.12.016; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Ciavarella S, 2009, STEM CELLS DEV, V18, P1211, DOI 10.1089/scd.2008.0340; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Corotchi MC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt232; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Harris VK, 2012, STEM CELL TRANSL MED, V1, P536, DOI 10.5966/sctm.2012-0015; Hayashi T, 2013, J CLIN INVEST, V123, P272, DOI 10.1172/JCI62516; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Hoffmann SA, 2014, DEVELOPMENT, V141, P39, DOI 10.1242/dev.098418; Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kennea NL, 2009, CELL CYCLE, V8, P1069, DOI 10.4161/cc.8.7.8121; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; La Rocca G, 2012, OPEN TISSUE ENG REGE, V5, P50, DOI DOI 10.2174/1875043501205010050; Lee HJ, 2013, J NEUROSCI RES, V91, P196, DOI 10.1002/jnr.23151; Lee JC, 2000, GLIA, V30, P105, DOI 10.1002/(SICI)1098-1136(200004)30:2<105::AID-GLIA1>3.0.CO;2-H; Lu L, 2008, STEM CELLS, V26, P580, DOI 10.1634/stemcells.2007-0106; Margossian T, 2012, BIO-MED MATER ENG, V22, P243, DOI 10.3233/BME-2012-0714; Martins AA, 2009, TRANSPL P, V41, P943, DOI 10.1016/j.transproceed.2009.01.059; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reinisch Andreas, 2009, J Vis Exp, DOI 10.3791/1525; Ribeiro A, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt336; Santos SD, 2012, J BIOL CHEM, V287, P6868, DOI 10.1074/jbc.M111.322909; Scheers I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071374; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Turnovcova K, 2009, CYTOTHERAPY, V11, P874, DOI 10.3109/14653240903188947; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wang Z, 2007, GLIA, V55, P537, DOI 10.1002/glia.20480; Whittaker MT, 2012, GLIA, V60, P281, DOI 10.1002/glia.21262; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Zhang HT, 2010, DIFFERENTIATION, V79, P15, DOI 10.1016/j.diff.2009.09.002	65	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111059	10.1371/journal.pone.0111059	http://dx.doi.org/10.1371/journal.pone.0111059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357129	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000038
J	Tangiisuran, B; Scutt, G; Stevenson, J; Wright, J; Onder, G; Petrovic, M; van der Cammen, TJ; Rajkumar, C; Davies, G				Tangiisuran, Balamurugan; Scutt, Greg; Stevenson, Jennifer; Wright, Juliet; Onder, G.; Petrovic, M.; van der Cammen, T. J.; Rajkumar, Chakravarthi; Davies, Graham			Development and Validation of a Risk Model for Predicting Adverse Drug Reactions in Older People during Hospital Stay: Brighton Adverse Drug Reactions Risk (BADRI) Model	PLOS ONE			English	Article							EVENTS; SURVEILLANCE; DEFINITIONS; METHODOLOGY; ADMISSION; FAILURE	Background: Older patients are at an increased risk of developing adverse drug reactions (ADR). Of particular concern are the oldest old, which constitute an increasingly growing population. Having a validated clinical tool to identify those older patients at risk of developing an ADR during hospital stay would enable healthcare staff to put measures in place to reduce the risk of such an event developing. The current study aimed to (1) develop and (2) validate an ADR risk prediction model. Methods: We used a combination of univariate analysis and multivariate binary logistic regression to identify clinical risk factors for developing an ADR in a population of older people from a UK teaching hospital. The final ADR risk model was then validated in a European population (European dataset). Results: Six-hundred-ninety patients (median age 85 years) were enrolled in the development stage of the study. Ninety-five reports of ADR were confirmed by independent review in these patients. Five clinical variables were identified through multivariate analysis and included in our final model; each variable was attributed a score of 1. Internal validation produced an AUROC of 0.74, a sensitivity of 80%, and specificity of 55%. During the external validation stage the AUROC was 0.73, with sensitivity and specificity values of 84% and 43% respectively. Conclusions: We have developed and successfully validated a simple model to use ADR risk score in a population of patients with a median age of 85, i.e. the oldest old. The model is based on 5 clinical variables (>= 8 drugs, hyperlipidaemia, raised white cell count, use of anti-diabetic agents, length of stay >12 days), some of which have not been previously reported.	[Tangiisuran, Balamurugan] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Scutt, Greg; Stevenson, Jennifer; Davies, Graham] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Wright, Juliet; van der Cammen, T. J.; Rajkumar, Chakravarthi] Brighton & Sussex Med Sch, Dept Med, Brighton, E Sussex, England; [Onder, G.] Univ Cattolica Sacro Cuore, Dept Geriatr, I-00168 Rome, Italy; [Petrovic, M.] Ghent Univ Hosp, Dept Geriatr & Gerontol, Ghent, Belgium; [van der Cammen, T. J.] Erasmus Univ, Med Ctr, Dept Internal Med, Geriatr Med Sect, Rotterdam, Netherlands; [van der Cammen, T. J.] Delft Univ Technol, Fac Ind Design Engn, Delft, Netherlands	Universiti Sains Malaysia; University of London; King's College London; University of Brighton; University of Sussex; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Scutt, G (corresponding author), Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England.	g.scutt@brighton.ac.uk	Tangiisuran, Balamurugan/E-2708-2012	Tangiisuran, Balamurugan/0000-0002-4354-3342; Stevenson, Jennifer/0000-0001-5664-1737				Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Catananti C, 2009, CLIN PHARMACOL THER, V86, P307, DOI 10.1038/clpt.2009.89; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Corsonello A, 2005, J GERONTOL A-BIOL, V60, P1147, DOI 10.1093/gerona/60.9.1147; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Handler SM, 2008, J AM GERIATR SOC, V56, P808, DOI 10.1111/j.1532-5415.2008.01665.x; Hanlon JT, 2006, J GERONTOL A-BIOL, V61, P511, DOI 10.1093/gerona/61.5.511; HOSMER DW, 1989, APPL LOGISTIC REGRES; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; KANNEL WB, 1987, AM HEART J, V113, P799, DOI 10.1016/0002-8703(87)90722-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mannesse CK, 1997, BRIT MED J, V315, P1057, DOI 10.1136/bmj.315.7115.1057; McElnay JC, 1997, CLIN DRUG INVEST, V13, P47, DOI 10.2165/00044011-199713010-00006; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; O'Connor MN, 2012, AGE AGEING, V41, P771, DOI 10.1093/ageing/afs046; Office for National Statistics, 2007, NAT POP PROJ 2006 BA; Onder G, 2002, EUR J CLIN PHARMACOL, V58, P371, DOI 10.1007/s00228-002-0493-y; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Resar RK, 2003, QUAL SAF HEALTH CARE, V12, pII39, DOI 10.1136/qhc.12.suppl_2.ii39; Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194; SCHNEIDER JK, 1992, AM J HOSP PHARM, V49, P90, DOI 10.1093/ajhp/49.1.90; Tangiisuran B, 2012, DRUG AGING, V29, P669, DOI 10.2165/11632630-000000000-00000; Trivalle C, 2010, J NUTR HEALTH AGING, V14, P57, DOI 10.1007/s12603-010-0010-4; U. S. Census Bureau, 2012, PROJ POP SEL AG GROU; *US CENS BUR, 2000, PROJ TOT RES POP 5 Y; World Health Organization, 2004, INT STAT CLASS DIS R; Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829; Zhang M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2752; Zopf Y, 2008, DRUG SAFETY, V31, P789, DOI 10.2165/00002018-200831090-00007	33	58	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111254	10.1371/journal.pone.0111254	http://dx.doi.org/10.1371/journal.pone.0111254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356898	Green Published, gold, Green Accepted			2022-12-27	WOS:000346765000048
J	Malmstrom, H; Walldius, G; Grill, V; Jungner, I; Gudbjornsdottir, S; Hammar, N				Malmstrom, Hakan; Walldius, Goran; Grill, Valdemar; Jungner, Ingmar; Gudbjornsdottir, Soffia; Hammar, Niklas			Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies - Cross-Sectional and Longitudinal Experience from the AMORIS Cohort	PLOS ONE			English	Article							GLYCATED ALBUMIN; ION-EXCHANGE; HEMOGLOBIN; PREDICTION; GLYCEMIA; PLASMA; RISK	Context: Fructosamine is a glycemic biomarker which may be useful for indication and control of diabetes respectively. Objective: The objective of the study was to evaluate fructosamine as an indicator of hyperglycaemia and glucose control in subjects with diabetes. Design, Setting & Patients: From the AMORIS cohort, subjects with serum glucose, fructosamine and HbA(1c) from the same examination were studied cross-sectionally and longitudinally (n = 10,987; 5,590 overnight-fasting). The guidelines of the American Diabetes Association were followed for classification of prediabetes and diabetes. Separate analyses were performed in patients with a newly detected or a known diagnosis of type 1 or type 2 diabetes respectively. Results: All three biomarkers were strongly correlated. With regard to the association between fructosamine and HbA(1c) Pearson linear correlation coefficients in the range of 0.67-0.75 were observed in fasting and non-fasting subjects with type 1 or type 2 diabetes. Analyses of glucose control in fasting patients with type 2 diabetes having all three biomarkers measured at three separate occasions within on average 290 days of the index examination showed similar trends over time for glucose, fructosamine and HbA(1c). Discrimination of subjects with and without diabetes across the range of fructosamine levels was good (area under curve (AUC) 0.91-0.95) and a fructosamine level of 2.5 mmol/L classified subjects to diabetes with a sensitivity of 61% and a specificity of 97%. Conclusions: Fructosamine is closely associated with HbA(1c) and glucose respectively and may be a useful biomarker of hyperglycaemia and glucose control in clinical and epidemiological studies.	[Malmstrom, Hakan; Hammar, Niklas] Karolinska Inst, Inst Environm Med, Epidemiol Unit, S-10401 Stockholm, Sweden; [Walldius, Goran; Jungner, Ingmar] Karolinska Inst, Inst Environm Med, Unit Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Grill, Valdemar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Grill, Valdemar] Univ Trondheim Hosp, Dept Endocrinol, Trondheim, Norway; [Jungner, Ingmar] CALAB Res, Stockholm, Sweden; [Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden; [Hammar, Niklas] AstraZeneca R&D, Dept Epidemiol, Molndal, Sweden	Karolinska Institutet; Karolinska Institutet; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Sahlgrenska University Hospital; University of Gothenburg; AstraZeneca	Malmstrom, H (corresponding author), Karolinska Inst, Inst Environm Med, Epidemiol Unit, S-10401 Stockholm, Sweden.	Hakan.Malmstrom@ki.se			Gunnar and Ingmar Jungner Foundation for Laboratory Medicine, Stockholm, Sweden	Gunnar and Ingmar Jungner Foundation for Laboratory Medicine, Stockholm, Sweden	The study was funded by the Gunnar and Ingmar Jungner Foundation for Laboratory Medicine, Stockholm, Sweden. The funder had no role in study design and analysis, decision to publish, or preparation of the manuscript but was responsible for the laboratory data Collection in 1985-1996 via the CALAB laboratory.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; American Diabetes Association, 2013, DIABETES CARE, V36; BAKER JR, 1983, BRIT MED J, V287, P863, DOI 10.1136/bmj.287.6396.863; BAKER JR, 1985, CLIN CHEM, V31, P1550; Baker JR, 1983, BRIT MED J, V290, P352; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Cohen RM, 2012, CLIN CHEM, V58, P1615, DOI 10.1373/clinchem.2012.196139; FLUCKIGER R, 1988, J CHROMATOGR-BIOMED, V429, P279, DOI 10.1016/S0378-4347(00)83874-8; Frank EA, 2012, J CLIN LAB ANAL, V26, P317, DOI 10.1002/jcla.21524; Holzmann MJ, 2012, ANN MED, V44, P262, DOI 10.3109/07853890.2010.532153; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Juraschek SP, 2012, CLIN CHEM, V58, P1648, DOI 10.1373/clinchem.2012.188367; Kilpatrick ES, 1997, DIABETIC MED, V14, P819, DOI 10.1002/(SICI)1096-9136(199710)14:10<819::AID-DIA459>3.0.CO;2-A; KLENK DC, 1982, CLIN CHEM, V28, P2088; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; LAMB E, 1991, CLIN CHEM, V37, P2138; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MIDDLE FA, 1983, BIOCHEM J, V209, P771, DOI 10.1042/bj2090771; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Selvin E, 2014, LANCET DIABETES ENDO, V2, P279, DOI 10.1016/S2213-8587(13)70199-2; True Mark W, 2009, J Diabetes Sci Technol, V3, P743; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Walldius G, 1992, Blood Press Suppl, V4, P35; Walldius G, 2012, LIPOPROTEINS - ROLE IN HEALTH AND DISEASES, P95, DOI 10.5772/47869; World Health Organization, 2011, US GLYC HBA1C DIAGN, P1; World Health Organization, 2006, DEF DIAGN DIAB MELL; ZANDER R, 1984, CLIN CHIM ACTA, V136, P83, DOI 10.1016/0009-8981(84)90250-X	27	41	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111463	10.1371/journal.pone.0111463	http://dx.doi.org/10.1371/journal.pone.0111463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353659	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200082
J	Vanuytsel, T; Vanormelingen, C; Vanheel, H; Masaoka, T; Rasoel, SS; Toth, J; Houben, E; Verbeke, K; De Hertogh, G; Vanden Berghe, P; Tack, J; Farre, R				Vanuytsel, Tim; Vanormelingen, Christophe; Vanheel, Hanne; Masaoka, Tatsuhiro; Rasoel, Shadea Salim; Toth, Joran; Houben, Els; Verbeke, Kristin; De Hertogh, Gert; Vanden Berghe, Pieter; Tack, Jan; Farre, Ricard			From Intestinal Permeability to Dysmotility: The Biobreeding Rat as a Model for Functional Gastrointestinal Disorders	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TIGHT JUNCTION PROTEINS; BARRIER DYSFUNCTION; EPITHELIAL PERMEABILITY; IMMUNE ACTIVATION; INTERFERON-GAMMA; MYENTERIC PLEXUS; BB-RAT; INFLAMMATION; EXPRESSION	Background: Impaired intestinal barrier function, low-grade inflammation and altered neuronal control are reported in functional gastrointestinal disorders. However, the sequence of and causal relation between these events is unclear, necessitating a spontaneous animal model. The aim of this study was to describe the natural history of intestinal permeability, mucosal and neuromuscular inflammation and nitrergic motor neuron function during the lifetime of the BioBreeding (BB) rat. Methods: Normoglycemic BB-diabetes prone (DP) and control rats were sacrificed at different ages and jejunum was harvested to characterize intestinal permeability, inflammation and neuromuscular function. Results: Both structural and functional evidence of increased intestinal permeability was found in young BB-DP rats from the age of 50 days. In older animals, starting in the mucosa from 70 days and in half of the animals also in the muscularis propria from 110 days, an inflammatory reaction, characterized by an influx of polymorphonuclear cells and higher myeloperoxidase activity, was observed. Finally, in animals older than 110 days, coinciding with a myenteric ganglionitis, a loss of nitrergic neurons and motor function was demonstrated. Conclusion: In the BB-rat, mucosal inflammatory cell infiltration is preceded by intestinal barrier dysfunction and followed by myenteric ganglionitis and loss of nitrergic function. This sequence supports a primary role for impaired barrier function and provides an insightful model for the pathogenesis of functional gastrointestinal disorders.	[Vanuytsel, Tim; Vanormelingen, Christophe; Vanheel, Hanne; Masaoka, Tatsuhiro; Rasoel, Shadea Salim; Toth, Joran; Houben, Els; Verbeke, Kristin; Vanden Berghe, Pieter; Tack, Jan; Farre, Ricard] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium; [De Hertogh, Gert] Univ Leuven, Univ Hosp, Dept Pathol, Leuven, Belgium; [Farre, Ricard] Inst Salud Carlos II, CIBERehd, Barcelona, Spain	KU Leuven; KU Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Tack, J (corresponding author), Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium.	jan.tack@med.kuleuven.be	Farre, Ricard/O-4549-2016; Farre, Ricard/M-9275-2013; Vanuytsel, Tim/O-9972-2016	Farre, Ricard/0000-0001-7158-171X; Farre, Ricard/0000-0001-7158-171X; Verbeke, Kristin/0000-0002-5352-7565; Vanden Berghe, Pieter/0000-0002-0009-2094; Tack, Jan/0000-0002-3206-6704; Vanuytsel, Tim/0000-0001-8728-0903	Methusalem grant from Leuven University; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO)	Methusalem grant from Leuven University; Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO)(FWO)	Funding was provided by a Methusalem grant from Leuven University to JT and by the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen, FWO) through doctoral (TV and HV) and post-doctoral (RF) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Biesiekierski J.R., 2013, GASTROENTEROLOGY; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Buhner S, 2009, GASTROENTEROLOGY, V137, P1425, DOI 10.1053/j.gastro.2009.07.005; Camilleri M, 2007, NEUROGASTROENT MOTIL, V19, P545, DOI 10.1111/j.1365-2982.2007.00925.x; Camilleri M, 2012, NEW ENGL J MED, V367, P1626, DOI 10.1056/NEJMra1207068; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; Demedts I, 2006, NEUROGASTROENT MOTIL, V18, P1102, DOI 10.1111/j.1365-2982.2006.00857.x; Demedts I, 2013, J NEUROGASTROENTEROL, V19, P161, DOI 10.5056/jnm.2013.19.2.161; Depoortere I, 2002, BRIT J PHARMACOL, V135, P2011, DOI 10.1038/sj.bjp.0704648; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; Graham S, 2004, GUT, V53, P1437, DOI 10.1136/gut.2004.042481; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Kindt S, 2008, GASTROENTEROLOGY, V134, pA533; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kristjansson G, 2004, GUT, V53, P1806, DOI 10.1136/gut.2003.036418; Lindberg G, 2009, GUT, V58, P1084, DOI 10.1136/gut.2008.148296; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Martinez C, 2013, GUT, V62, P1160, DOI 10.1136/gutjnl-2012-302093; Matricon J, 2012, ALIMENT PHARM THER, V36, P1009, DOI 10.1111/apt.12080; Meddings JB, 1999, AM J PHYSIOL-GASTR L, V276, pG951, DOI 10.1152/ajpgi.1999.276.4.G951; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Odenwald MA, 2013, CLIN GASTROENTEROL H; Patrick C, 2013, DIABETES, V62, P2036, DOI 10.2337/db12-1243; Ramanathan S, 2001, IMMUNOL REV, V184, P161, DOI 10.1034/j.1600-065x.2001.1840115.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tack J, 2002, GASTROENTEROLOGY, V122, P1738, DOI 10.1053/gast.2002.33663; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Takahashi T, 1997, GASTROENTEROLOGY, V113, P1535, DOI 10.1053/gast.1997.v113.pm9352855; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Vanheel H, 2013, NAT REV GASTRO HEPAT, V10, P142, DOI 10.1038/nrgastro.2012.255; Vanormelingen C, 2013, GASTROENTEROLOGY, V144, pS542; Vazquez-Roque MI, 2013, GASTROENTEROLOGY, V144, P903, DOI 10.1053/j.gastro.2013.01.049; Visser J, 2003, METABOLISM, V52, P333, DOI 10.1053/meta.2003.50052; Visser JTJ, 2010, DIABETOLOGIA, V53, P2621, DOI 10.1007/s00125-010-1903-9; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Watts T, 2005, P NATL ACAD SCI USA, V102, P2916, DOI 10.1073/pnas.0500178102; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; YOUNG HM, 1992, HISTOCHEMISTRY, V97, P375, DOI 10.1007/BF00270041; Zandecki M, 2008, NEUROGASTROENT MOTIL, V20, P818, DOI 10.1111/j.1365-2982.2008.01091.x; Zandecki M, 2006, NEUROGASTROENT MOTIL, V18, P307, DOI 10.1111/j.1365-2982.2005.00755.x	57	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111132	10.1371/journal.pone.0111132	http://dx.doi.org/10.1371/journal.pone.0111132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354336	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204200059
J	Nagai, H; Kuwahira, I; Schwenke, DO; Tsuchimochi, H; Nara, A; Inagaki, T; Ogura, S; Fujii, Y; Umetani, K; Shimosawa, T; Yoshida, KI; Pearson, JT; Uemura, K; Shirai, M				Nagai, Hisashi; Kuwahira, Ichiro; Schwenke, Daryl O.; Tsuchimochi, Hirotsugu; Nara, Akina; Inagaki, Tadakatsu; Ogura, Sayoko; Fujii, Yutaka; Umetani, Keiji; Shimosawa, Tatsuo; Yoshida, Ken-ichi; Pearson, James T.; Uemura, Koichi; Shirai, Mikiyasu			beta(2)-Adrenergic Receptor-Dependent Attenuation of Hypoxic Pulmonary Vasoconstriction Prevents Progression of Pulmonary Arterial Hypertension in Intermittent Hypoxic Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SYNCHROTRON-RADIATION MICROANGIOGRAPHY; BETA-ADRENOCEPTOR AGONISTS; BLOOD-FLOW DISTRIBUTION; SYMPATHETIC ACTIVITY; NITRIC-OXIDE; PRESSURE; MICE; CIRCULATION; ENDOTHELIN-1	In sleep apnea syndrome (SAS), intermittent hypoxia (IH) induces repeated episodes of hypoxic pulmonary vasoconstriction (HPV) during sleep, which presumably contribute to pulmonary arterial hypertension (PAH). However, the prevalence of PAH was low and severity is mostly mild in SAS patients, and mild or no right ventricular hypertrophy (RVH) was reported in IH-exposed animals. The question then arises as to why PAH is not a universal finding in SAS if repeated hypoxia of sufficient duration causes cycling HPV. In the present study, rats underwent IH at a rate of 3 min cycles of 4-21% O-2 for 8 h/d for 6w. Assessment of diameter changes in small pulmonary arteries in response to acute hypoxia and drugs were performed using synchrotron radiation microangiography on anesthetized rats. In IH-rats, neither PAH nor RVH was observed and HPV was strongly reversed. Nadolol (a hydrophilic beta(1,2)-blocker) augmented the attenuated HPV to almost the same level as that in N-rats, but atenolol (a hydrophilic beta(1)-blocker) had no effect on the HPV in IH. These beta-blockers had almost no effect on the HPV in N-rats. Chronic administration of nadolol during 6 weeks of IH exposure induced PAH and RVH in IH-rats, but did not in N-rats. Meanwhile, atenolol had no effect on morphometric and hemodynamic changes in N and IH-rats. Protein expression of the beta(1)-adrenergic receptor (AR) was down-regulated while that of beta(2)AR was preserved in pulmonary arteries of IH-rats. Phosphorylation of p85 (chief component of phosphoinositide 3-kinase (PI3K)), protein kinase B (Akt), and endothelial nitric oxide synthase (eNOS) were abrogated by chronic administration of nadolol in the lung tissue of IH-rats. We conclude that IH-derived activation of beta(2)AR in the pulmonary arteries attenuates the HPV, thereby preventing progression of IH-induced PAH. This protective effect may depend on the beta(2)AR-Gi mediated PI3K/Akt/eNOS signaling pathway.	[Nagai, Hisashi; Uemura, Koichi] Tokyo Med & Dent Univ, Dept Forens Med, Tokyo, Japan; [Nagai, Hisashi; Nara, Akina; Ogura, Sayoko; Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Tokyo, Japan; [Kuwahira, Ichiro] Tokai Univ, Tokyo Hosp, Dept Pulm Med, Tokyo, Japan; [Schwenke, Daryl O.] Univ Otago, Dept Physiol Heart Otago, Dunedin, New Zealand; [Tsuchimochi, Hirotsugu; Inagaki, Tadakatsu; Fujii, Yutaka; Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cardiac Physiol, Osaka, Japan; [Ogura, Sayoko] Nihon Univ, Fac Med, Sch Med, Dept Pathol & Microbiol,Div Lab Med, Tokyo, Japan; [Umetani, Keiji] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan; [Shimosawa, Tatsuo] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Yoshida, Ken-ichi] Tokyo Med Univ, Dept Forens Med, Tokyo 1608402, Japan; [Pearson, James T.] Monash Univ, Monash Biomed Imaging Facil, Clayton, Vic, Australia; [Pearson, James T.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Pearson, James T.] Australian Synchrotron, Clayton, Vic, Australia	Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokai University; University of Otago; National Cerebral & Cardiovascular Center - Japan; Nihon University; Japan Synchrotron Radiation Research Institute; University of Tokyo; Tokyo Medical University; Monash University; Monash University	Nagai, H (corresponding author), Tokyo Med & Dent Univ, Dept Forens Med, Tokyo, Japan.	nagai@legalmed.jp	Pearson, James T/B-4631-2012; Tsuchimochi, Hirotsugu/D-8224-2011; Shimosawa, Tatsuo/A-2920-2015	Pearson, James T/0000-0002-3318-5406; Tsuchimochi, Hirotsugu/0000-0001-7591-2520; Shimosawa, Tatsuo/0000-0002-8742-5129	Japan Society for the Promotion of Science (JSPS) [23249038, 23590843]; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center [22-2-3, 25-3-1];  [23650213];  [24790863];  [24.2221]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center; ; ; 	This study was supported in part by a Grant-in-Aid for Scientific Research (A) and (C) from the Japan Society for the Promotion of Science (JSPS) (Grant No. 23249038 (A), and 23590843 (C)), and was also supported in part by Intramural Research Fund (22-2-3, 25-3-1) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center, and a Grant-in Aid for Scientific Research (No. 23650213, 24790863, and 24.2221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ACS, 3 IM PROPL; Bosc LVG, 2010, J CELL MOL MED, V14, P3, DOI 10.1111/j.1582-4934.2009.00929.x; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Campen MJ, 2005, J APPL PHYSIOL, V99, P2028, DOI 10.1152/japplphysiol.00411.2005; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dumas JP, 1999, BRIT J PHARMACOL, V127, P421, DOI 10.1038/sj.bjp.0702575; Dumas M, 1998, EUR J PHARMACOL, V348, P223, DOI 10.1016/S0014-2999(98)00146-0; DUPONT AG, 1985, BRIT J CLIN PHARMACO, V20, P93, DOI 10.1111/j.1365-2125.1985.tb05037.x; Fagan KA, 2001, J APPL PHYSIOL, V90, P2502, DOI 10.1152/jappl.2001.90.6.2502; FLETCHER EC, 1992, HYPERTENSION, V19, P555, DOI 10.1161/01.HYP.19.6.555; Fletcher EC, 1996, J APPL PHYSIOL, V81, P2088, DOI 10.1152/jappl.1996.81.5.2088; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; HIRAWA N, 1991, CLIN SCI, V81, P499, DOI 10.1042/cs0810499; HYMAN AL, 1981, CIRC RES, V48, P407, DOI 10.1161/01.RES.48.3.407; Iaccarino G, 2001, HYPERTENSION, V38, P255, DOI 10.1161/01.HYP.38.2.255; Kanagy NL, 2001, HYPERTENSION, V37, P511, DOI 10.1161/01.HYP.37.2.511; Kimura H, 1998, INTERNAL MED, V37, P127, DOI 10.2169/internalmedicine.37.127; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; Leuenberger UA, 2005, AUTON NEUROSCI-BASIC, V121, P87, DOI 10.1016/j.autneu.2005.06.003; Marrone O, 2002, SLEEP MED REV, V6, P175, DOI 10.1053/smrv.2001.0185; McGuire M, 1999, RESP PHYSIOL, V117, P53, DOI 10.1016/S0034-5687(99)00047-X; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; Norton CE, 2011, J APPL PHYSIOL, V111, P980, DOI 10.1152/japplphysiol.01286.2010; Peng H, 2008, FASEB J, V22, P11; Phillips BG, 1999, J HYPERTENS, V17, P61, DOI 10.1097/00004872-199917010-00010; Prabhakar NR, 2012, J APPL PHYSIOL, V113, P1304, DOI 10.1152/japplphysiol.00444.2012; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P230, DOI 10.1016/j.resp.2010.08.022; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Priest RM, 1997, BRIT J PHARMACOL, V122, P1375, DOI 10.1038/sj.bjp.0701528; RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818, DOI 10.1152/ajpheart.1979.236.6.H818; Reinke C, 2011, AM J PHYSIOL-LUNG C, V300, pL266, DOI 10.1152/ajplung.00239.2010; SAEED M, 1982, J CARDIOVASC PHARM, V4, P44, DOI 10.1097/00005344-198201000-00008; Sajkov D, 2009, PROG CARDIOVASC DIS, V51, P363, DOI 10.1016/j.pcad.2008.06.001; Schwenke DO, 2008, J APPL PHYSIOL, V104, P88, DOI 10.1152/japplphysiol.00610.2007; Schwenke DO, 2007, J APPL PHYSIOL, V102, P787, DOI 10.1152/japplphysiol.00596.2006; Schwenke DO, 2009, J HYPERTENS, V27, P1410, DOI 10.1097/HJH.0b013e32832af6a1; Seljeflot I, 1999, J CARDIOVASC PHARM, V34, P584, DOI 10.1097/00005344-199910000-00016; Sharma V, 2011, WORLD J CARDIOL, V3, P281, DOI 10.4330/wjc.v3.i9.281; SHIRAI M, 1994, AM J PHYSIOL, V266, pH1777, DOI 10.1152/ajpheart.1994.266.5.H1777; Shirai M, 2013, CIRC RES, V112, P209, DOI 10.1161/CIRCRESAHA.111.300096; Sica AL, 2000, RESP PHYSIOL, V121, P173, DOI 10.1016/S0034-5687(00)00126-2; Snow JB, 2008, J APPL PHYSIOL, V104, P110, DOI 10.1152/japplphysiol.00698.2005; SVENDSEN TL, 1981, CLIN PHARMACOL THER, V29, P711, DOI 10.1038/clpt.1981.100; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Tamisier R, 2011, EUR RESPIR J, V37, P119, DOI 10.1183/09031936.00204209; Xavier CH, 2010, FASEB J, V24, P20	47	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110693	10.1371/journal.pone.0110693	http://dx.doi.org/10.1371/journal.pone.0110693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350545	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100035
J	Garcia, RA; Yan, MJ; Search, D; Zhang, R; Carson, NL; Ryan, CS; Smith-Monroy, C; Zheng, J; Chen, J; Kong, Y; Tang, HP; Hellings, SE; Wardwell-Swanson, J; Dinchuk, JE; Psaltis, GC; Gordon, DA; Glunz, PW; Gargalovic, PS				Garcia, Ricardo A.; Yan, Mujing; Search, Debra; Zhang, Rongan; Carson, Nancy L.; Ryan, Carol S.; Smith-Monroy, Constance; Zheng, Joanna; Chen, Jian; Kong, Yan; Tang, Huaping; Hellings, Samuel E.; Wardwell-Swanson, Judith; Dinchuk, Joseph E.; Psaltis, George C.; Gordon, David A.; Glunz, Peter W.; Gargalovic, Peter S.			P2Y(6) Receptor Potentiates Pro-Inflammatory Responses in Macrophages and Exhibits Differential Roles in Atherosclerotic Lesion Development	PLOS ONE			English	Article							E-DEFICIENT MICE; BONE-MARROW-TRANSPLANTATION; SMOOTH-MUSCLE-CELLS; CHEMOKINES; UDP; APOPTOSIS; CYTOKINES; ADHESION	Background: P2Y(6), a purinergic receptor for UDP, is enriched in atherosclerotic lesions and is implicated in pro-inflammatory responses of key vascular cell types and macrophages. Evidence for its involvement in atherogenesis, however, has been lacking. Here we use cell-based studies and three murine models of atherogenesis to evaluate the impact of P2Y(6) deficiency on atherosclerosis. Methodology/Principal Findings: Cell-based studies in 1321N1 astrocytoma cells, which lack functional P2Y(6) receptors, showed that exogenous expression of P2Y(6) induces a robust, receptor-and agonist-dependent secretion of inflammatory mediators IL-8, IL-6, MCP-1 and GRO1. P2Y(6)-mediated inflammatory responses were also observed, albeit to a lesser extent, in macrophages endogenously expressing P2Y(6) and in acute peritonitis models of inflammation. To evaluate the role of P2Y(6) in atherosclerotic lesion development, we used P2Y(6)-deficient mice in three mouse models of atherosclerosis. A 43% reduction in aortic arch plaque was observed in high fat-fed LDLR knockout mice lacking P2Y(6) receptors in bone marrow-derived cells. In contrast, no effect on lesion development was observed in fat-fed whole body P2Y(6)xLDLR double knockout mice. Interestingly, in a model of enhanced vascular inflammation using angiotensin II, P2Y(6) deficiency enhanced formation of aneurysms and exhibited a trend towards increased atherosclerosis in the aorta of LDLR knockout mice. Conclusions: P2Y(6) receptor augments pro-inflammatory responses in macrophages and exhibits a pro-atherogenic role in hematopoietic cells. However, the overall impact of whole body P2Y(6) deficiency on atherosclerosis appears to be modest and could reflect additional roles of P2Y(6) in vascular disease pathophysiologies, such as aneurysm formation.	[Garcia, Ricardo A.; Yan, Mujing; Search, Debra; Zhang, Rongan; Carson, Nancy L.; Ryan, Carol S.; Hellings, Samuel E.; Gordon, David A.; Gargalovic, Peter S.] Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA; [Smith-Monroy, Constance; Chen, Jian; Dinchuk, Joseph E.] Bristol Myers Squibb Co, Appl Genom, Pennington, NJ USA; [Zheng, Joanna] Bristol Myers Squibb Co, Pharmaceut Compound Optimizat Discovery Toxicol, Pennington, NJ USA; [Kong, Yan; Tang, Huaping] Bristol Myers Squibb Co, Lead Evaluat, Pennington, NJ USA; [Psaltis, George C.] Bristol Myers Squibb Co, Vet Sci, Pennington, NJ USA; [Glunz, Peter W.] Bristol Myers Squibb Co, Discovery Chem, Pennington, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Gargalovic, PS (corresponding author), Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA.	peter.gargalovic@bms.com		Glunz, Peter/0000-0001-9921-2385	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	All studies were supported by Bristol-Myers Squibb Company. The authors agree with the following statement regarding organizational support: The funder provided support in the form of salaries for authors [RAG, MY, DS, RZ, NLC, CSR, CSM, JZ, JC, YK, HT, SEH, JWS, JED, GCP, DAG, PWG, PSG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Boisvert WA, 1999, J LIPID RES, V40, P806; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; El-Tayeb A, 2006, J MED CHEM, V49, P7076, DOI 10.1021/jm060848j; Garcia RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053192; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Hou MY, 2002, AM J PHYSIOL-HEART C, V282, pH784, DOI 10.1152/ajpheart.00997.2000; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Kukulski F, 2007, J LEUKOCYTE BIOL, V81, P1269, DOI 10.1189/jlb.1206758; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Riegel AK, 2011, BLOOD, V117, P2548, DOI 10.1182/blood-2010-10-313957; Rowe VL, 2000, J VASC SURG, V31, P567; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; SCHWARTZ D, 1994, J CLIN INVEST, V94, P1968, DOI 10.1172/JCI117548; Uratsuji H, 2012, J IMMUNOL, V188, P436, DOI 10.4049/jimmunol.1003746; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02	31	44	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111385	10.1371/journal.pone.0111385	http://dx.doi.org/10.1371/journal.pone.0111385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360548	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700098
J	Hamaneh, MB; Yu, YK				Hamaneh, Mehdi Bagheri; Yu, Yi-Kuo			Relating Diseases by Integrating Gene Associations and Information Flow through Protein Interaction Network	PLOS ONE			English	Article							MUTATIONS; IDENTIFICATION; ONTOLOGY; DATABASE; LRP5	Identifying similar diseases could potentially provide deeper understanding of their underlying causes, and may even hint at possible treatments. For this purpose, it is necessary to have a similarity measure that reflects the underpinning molecular interactions and biological pathways. We have thus devised a network-based measure that can partially fulfill this goal. Our method assigns weights to all proteins (and consequently their encoding genes) by using information flow from a disease to the protein interaction network and back. Similarity between two diseases is then defined as the cosine of the angle between their corresponding weight vectors. The proposed method also provides a way to suggest disease-pathway associations by using the weights assigned to the genes to perform enrichment analysis for each disease. By calculating pairwise similarities between 2534 diseases, we show that our disease similarity measure is strongly correlated with the probability of finding the diseases in the same disease family and, more importantly, sharing biological pathways. We have also compared our results to those of MimMiner, a text-mining method that assigns pairwise similarity scores to diseases. We find the results of the two methods to be complementary. It is also shown that clustering diseases based on their similarities and performing enrichment analysis for the cluster centers significantly increases the term association rate, suggesting that the cluster centers are better representatives for biological pathways than the diseases themselves. This lends support to the view that our similarity measure is a good indicator of relatedness of biological processes involved in causing the diseases. Although not needed for understanding this paper, the raw results are available for download for further study at ftp://ftp.ncbi.nlm.nih.gov/pub/qmbpmn/DiseaseRelations/.	[Hamaneh, Mehdi Bagheri; Yu, Yi-Kuo] NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yu, YK (corresponding author), NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20892 USA.	yyu@ncbi.nlm.nih.gov			National Library of Medicine at the National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	National Library of Medicine at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldahmesh MA, 2011, J MED GENET, V48, P597, DOI 10.1136/jmedgenet-2011-100306; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Coletti MH, 2001, J AM MED INFORM ASSN, V8, P317, DOI 10.1136/jamia.2001.0080317; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Davis AP, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar065; Farkas IJ, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/180; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Medina-Kauwe LK, 1999, J INHERIT METAB DIS, V22, P414, DOI 10.1023/A:1005500122231; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orange JS, 2004, J ALLERGY CLIN IMMUN, V114, P650, DOI 10.1016/j.jaci.2004.06.052; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Seven M, 2000, GENET COUNSEL, V11, P41; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; Stojmircivic A, 2007, J COMPUT BIOL, V14, P1115, DOI 10.1089/cmb.2007.0069; Stojmirovic A, 2012, J COMPUT BIOL, V19, P379, DOI 10.1089/cmb.2010.0228; Stojmirovic A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar036; Stojmirovic A, 2010, BIOINFORMATICS, V26, P2752, DOI 10.1093/bioinformatics/btq511; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Voermans NC, 2009, AM J MED GENET A, V149A, P2311, DOI 10.1002/ajmg.a.32997; Zhang XH, 2011, EUR J HUM GENET, V19, P783, DOI 10.1038/ejhg.2011.30; Zitnik M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03202	41	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110936	10.1371/journal.pone.0110936	http://dx.doi.org/10.1371/journal.pone.0110936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360770	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700053
J	Pang, MH; Wu, G; Hou, XL; Hou, NY; Liang, LQ; Jia, GQ; Shuai, P; Luo, B; Wang, K; Li, GX				Pang, Minghui; Wu, Gang; Hou, Xiaolin; Hou, Nengyi; Liang, Liqin; Jia, Guiqing; Shuai, Ping; Luo, Bin; Wang, Kang; Li, Guoxin			LIN28B Promotes Colon Cancer Migration and Recurrence	PLOS ONE			English	Article							MYC; IDENTIFICATION; TRANSFORMATION; GENES	LIN28B is involved in "stemness'' and tumourigenesis by negatively regulating the maturation of let-7 microRNA family members. In this study, we showed that LIN28B expression promotes migration and recurrence of colon cancer. Immunohistochemistry and reverse-transcription polymerase chain reactions were performed to detect LIN28B expression in colon cancer tissue microarrays, paraffin-embedded surgical resected tissues and cancer cells. Loss-of-function, migration and proliferation analyses were performed to delineate the potential roles of LIN28B in colon cancer. LIN28B was upregulated in colon cancer tissue compared to normal mucosa, and its overexpression correlated with reduced patient survival and increased tumour recurrence. LIN28B suppression inhibited the migration of SW480 colon cancer cells and facilitated the cytotoxicity induced by oxaliplatin in SW480 and HCT116 colon cancer cells. In conclusion, LIN28B overexpression contributes to colon tumourigenesis, and LIN28B may serve as a diagnostic tool and therapeutic target for colon cancer.	[Pang, Minghui; Wu, Gang; Hou, Xiaolin; Hou, Nengyi; Liang, Liqin; Jia, Guiqing; Luo, Bin; Wang, Kang] Sichuan Acad Med Sci, Dept Gen Surg, Chengdu, Peoples R China; [Pang, Minghui; Wu, Gang; Hou, Xiaolin; Hou, Nengyi; Liang, Liqin; Jia, Guiqing; Shuai, Ping; Luo, Bin; Wang, Kang] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Shuai, Ping] Sichuan Acad Med Sci, Dept Hlth, Ctr Management, Chengdu, Peoples R China; [Li, Guoxin] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Southern Medical University - China	Wang, K (corresponding author), Sichuan Acad Med Sci, Dept Gen Surg, Chengdu, Peoples R China.	wangk_kwang@163.com; wugang5544@hotmail.com			Department of Public Health of Sichuan Province [110167]	Department of Public Health of Sichuan Province	This work was supported by grants from the Department of Public Health of Sichuan Province (110167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; CERDA AP, 1993, REV INVEST CLIN, V45, P493; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Dansranjavin T, 2009, CELL CYCLE, V8, P916, DOI 10.4161/cc.8.6.7934; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Guo J, 2009, BIOCHEM BIOPH RES CO, V390, P1081, DOI 10.1016/j.bbrc.2009.11.017; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jeanteur P, 1998, B CANCER, V85, P925; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; ROTHBERG PG, 1987, SEMIN SURG ONCOL, V3, P152, DOI 10.1002/ssu.2980030305; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	27	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109169	10.1371/journal.pone.0109169	http://dx.doi.org/10.1371/journal.pone.0109169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360631	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700009
J	Ren, DR; Chin, KR; French, JA				Ren, Dongren; Chin, Kelvin R.; French, Jeffrey A.			Molecular Variation in AVP and AVPR1a in New World Monkeys (Primates, Platyrrhini): Evolution and Implications for Social Monogamy	PLOS ONE			English	Article							V-1A VASOPRESSIN RECEPTOR; NONNEUTRAL EVOLUTION; N-TERMINUS; OXYTOCIN; SUBSTITUTION; PRECURSORS; GENES; SITES; BRAIN; RATES	The neurohypophysial hormone arginine vasopressin (AVP) plays important roles in fluid regulation and vascular resistance. Differences in AVP receptor expression, particularly mediated through variation in the noncoding promoter region of the primary receptor for AVP (AVPR1a), may play a role in social phenotypes, particularly social monogamy, in rodents and humans. Among primates, social monogamy is rare, but is common among New World monkeys (NWM). AVP is a nonapeptide and generally conserved among eutherian mammals, although a recent paper demonstrated that some NWM species possess a novel form of the related neuropeptide hormone, oxytocin. We therefore characterized variation in the AVP and AVPR1a genes in 22 species representing every genus in the three major platyrrhine families (Cebidae, Atelidae and Pitheciidae). For AVP, a total of 16 synonymous substitutions were detected in 15 NWM species. No non-synonymous substitutions were noted, hence, AVP is conserved in NWM. By contrast, relative to the human AVPR1a, 66 predicted amino acids (AA) substitutions were identified in NWM. The AVPR1a N-terminus (ligand binding domain), third intracellular (G-protein binding domain), and C-terminus were variable among species. Complex evolution of AVPR1a is also apparent in NWM. A molecular phylogenetic tree inferred from AVPR1a coding sequences revealed some consensus taxonomic separation by families, but also a mixed group composed of genera from all three families. The overall dN/dS ratio of AVPR1a was 0.11, but signals of positive selection in distinct AVPR1a regions were observed, including the N-terminus, in which we identified six potential positive selection sites. AA substitutions at positions 241, 319, 399 and 409 occurred uniquely in marmosets and tamarins. Our results enhance the appreciation of genetic diversity in the mammalian AVP/AVPR1a system, and set the stage for molecular modeling of the neurohypophyseal hormones and social behavior in primates.	[Ren, Dongren; Chin, Kelvin R.; French, Jeffrey A.] Univ Nebraska, Callitrichid Res Ctr, Dept Psychol, Omaha, NE 68182 USA; [Ren, Dongren] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Ren, Dongren] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Ren, Dongren; Chin, Kelvin R.; French, Jeffrey A.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	University of Nebraska System; Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs; University of Nebraska System	Ren, DR (corresponding author), Univ Nebraska, Callitrichid Res Ctr, Dept Psychol, Omaha, NE 68182 USA.	dren@unomaha.edu		French, Jeffrey/0000-0001-5304-1592	NIH [HD042882]; Nebraska Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071998, R01HD053555, R01HD042882] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD042882] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, P51OD011133] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by funds from the NIH (HD042882) and the Nebraska Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHER R, 1995, FRONT NEUROENDOCRIN, V16, P237, DOI 10.1006/frne.1995.1009; Acher R, 1995, ADV EXP MED BIOL, V395, P615; Anacker AMJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00185; Babb PL, 2010, J MOL EVOL, V71, P279, DOI 10.1007/s00239-010-9383-6; Barberis C, 1998, J ENDOCRINOL, V156, P223, DOI 10.1677/joe.0.1560223; Berrada K, 2000, J BIOL CHEM, V275, P27229; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Donaldson ZR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-180; FERGUSON DR, 1969, GEN COMP ENDOCR, V12, P609, DOI 10.1016/0016-6480(69)90181-6; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Fink S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-176; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Fleagle JG, 1998, PRIMATE ADAPTATION E, P596; Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162; Goodson JL, 2013, PSYCHONEUROENDOCRINO, V38, P465, DOI 10.1016/j.psyneuen.2012.12.005; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Hawtin SR, 2002, MOL ENDOCRINOL, V16, P600, DOI 10.1210/me.16.3.600; Hawtin SR, 2000, BIOCHEMISTRY-US, V39, P13524, DOI 10.1021/bi0013400; Huck M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0195; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Koshimizu TA, 2012, PHYSIOL REV, V92, P1813, DOI 10.1152/physrev.00035.2011; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lee AG, 2011, BIOL LETTERS, V7, P584, DOI 10.1098/rsbl.2011.0107; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Liu J, 1996, J BIOL CHEM, V271, P8772, DOI 10.1074/jbc.271.15.8772; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Nair HP, 2006, PHYSIOLOGY, V21, P146, DOI 10.1152/physiol.00049.2005; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Rosso L, 2008, BIOL LETTERS, V4, P375, DOI 10.1098/rsbl.2008.0122; Saito S, 2003, J HUM GENET, V48, P461, DOI 10.1007/s10038-003-0062-y; Shoshani J, 1996, MOL PHYLOGENET EVOL, V5, P102, DOI 10.1006/mpev.1996.0009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thibonnier M, 2001, AM J PHYSIOL-ENDOC M, V281, pE81, DOI 10.1152/ajpendo.2001.281.1.E81; Thibonnier M, 2000, J MOL CELL CARDIOL, V32, P557, DOI 10.1006/jmcc.2000.1108; Turner LM, 2010, MOL BIOL EVOL, V27, P1269, DOI 10.1093/molbev/msq013; Wallis M, 2012, GEN COMP ENDOCR, V179, P313, DOI 10.1016/j.ygcen.2012.07.030; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	49	16	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111638	10.1371/journal.pone.0111638	http://dx.doi.org/10.1371/journal.pone.0111638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360668	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700135
J	Yang, XL; Jiang, C; Pan, W; Xu, WM; Liang, F; Li, N; Mu, HJ; Na, J; Lv, M; An, XX; Yu, CY; Fu, ZG; Li, LL; Yu, LZ; Tong, LJ; Pan, GW				Yang Xiaoli; Jiang Chao; Pan Wen; Xu Wenming; Liang Fang; Li Ning; Mu Huijuan; Na Jun; Lv Ming; An Xiaoxia; Yu Chuanyou; Fu Zenguo; Li Lili; Yu Lianzheng; Tong Lijuan; Pan Guowei			Prevalence of Psychiatric Disorders among Children and Adolescents in Northeast China	PLOS ONE			English	Article							DSM-IV DISORDERS; MENTAL-HEALTH; EMOTIONAL-PROBLEMS; DIFFICULTIES QUESTIONNAIRE; TEACHER REPORTS; RISK-FACTORS; SERVICE USE; HONG-KONG; PARENT; PSYCHOPATHOLOGY	Background: To describe the prevalence of DSM-IV disorders and comorbidity in a large school-based sample of 6-17 year old children and adolescents in northeast China. Methods: A two-phase cross-sectional study was conducted on 9,806 children. During the screening phase, 8848 children (90.23%) and their mothers and teachers were interviewed using the Strengths and Difficulties Questionnaire (SDQ). During the diagnostic phase, 1129 children with a positive SDQ and 804 randomly selected children with a negative SDQ (11%), and their mothers and teachers, were interviewed using the Development and Well-Being Assessment (DAWBA). Results: The overall prevalence of DSM-IV disorders was 9.49% (95% CI = 8.10-11.10%). Anxiety disorders were the most common (6.06%, 95% CI = 4.92-7.40), followed by depression (1.32%, 95% CI = 0.91-1.92%), oppositional defiant disorder (1.21%, 95% CI = 0.77-1.87) and attention-deficit hyperactivity disorder (0.84%, 95% CI = 0.52-1.36%). Of the 805 children with a psychiatric disorder, 15.2% had two or more comorbid disorders. Conclusions: Approximately one in ten Chinese school children has psychiatric disorders involving a level of distress or social impairment likely to warrant treatment. Prevention, early identification and treatment of these disorders are urgently needed and pose a serious challenge in China.	[Yang Xiaoli; Pan Wen; Li Ning; Mu Huijuan; Na Jun; Yu Lianzheng; Pan Guowei] Liaoning Prov Ctr Dis Control & Prevent, Inst Chron Dis, Shenyang, Peoples R China; [Jiang Chao] Dalian Med Univ, Dept Psychiat, Dalian, Peoples R China; [Xu Wenming] Panjin Oil Field Ctr Dis Control & Prevent, Dept Chron Dis, Panjin City, Peoples R China; [Liang Fang] Dalian Municipal Hosp Psychiat Dis, Dept Psychiat, Dalian, Peoples R China; [Lv Ming] Donggang Cty Municipal Ctr Dis Control & Prevent, Dept Chron Dis, Guangzhou, Liaoning Provin, Peoples R China; [An Xiaoxia] Benxi Municipal Ctr Dis Control & Prevent, Dept Chron Dis, Benxi, Peoples R China; [Yu Chuanyou] Qingyuan Cty Ctr Dis Control & Prevent, Dept Chron Dis, Qingyuan, Liaoning Provin, Peoples R China; [Fu Zenguo] Zhangwu Cty Ctr Dis Control & Prevent, Dept Chron Dis, Zhangwu, Liaoning Provin, Peoples R China; [Li Lili] China Med Univ, Attached Hosp 1, Dept Psychiat, Shenyang, Peoples R China; [Tong Lijuan] Panjin Municipal Ctr Dis Control & Prevent, Dept Chron Dis, Panjin City, Peoples R China	Dalian Medical University; China Medical University	Pan, GW (corresponding author), Liaoning Prov Ctr Dis Control & Prevent, Inst Chron Dis, Shenyang, Peoples R China.	panpgw@163.com			Science and Technology Department of Liaoning Province [2005225012]	Science and Technology Department of Liaoning Province	This study was supported by a grant from Science and Technology Department of Liaoning Province (No. 2005225012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyahri A, 2008, SOC PSYCH PSYCH EPID, V43, P224, DOI 10.1007/s00127-007-0293-x; Belfer ML, 2005, REV PANAM SALUD PUBL, V18, P359, DOI 10.1590/S1020-49892005000900016; Canino G, 2004, ARCH GEN PSYCHIAT, V61, P85, DOI 10.1001/archpsyc.61.1.85; CHAO RK, 1995, ETHOS, V23, P328, DOI 10.1525/eth.1995.23.3.02a00030; Chen XY, 1997, MERRILL PALMER QUART, V43, P663; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Du Yasong, 2008, Child Adolesc Psychiatry Ment Health, V2, P8, DOI 10.1186/1753-2000-2-8; Dunn G, 1999, BRIT J PSYCHIAT, V174, P95, DOI 10.1192/bjp.174.2.95; Fan F, 2010, SOC PSYCH PSYCH EPID, V45, P655, DOI 10.1007/s00127-009-0107-4; Farbstein I, 2010, J CHILD PSYCHOL PSYC, V51, P630, DOI 10.1111/j.1469-7610.2009.02188.x; Fleitlich-Bilyk B, 2004, J AM ACAD CHILD PSY, V43, P727, DOI 10.1097/01.chi.0000120021.14101.ca; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Frigerio A, 2009, EUR CHILD ADOLES PSY, V18, P217, DOI 10.1007/s00787-008-0720-x; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2005, EUR CHILD ADOLES PSY, V14, P28, DOI 10.1007/s00787-005-0420-8; Goodman R, 2005, SOC PSYCH PSYCH EPID, V40, P11, DOI 10.1007/s00127-005-0851-z; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Guan Bing-Qing, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P123; Heiervang E, 2007, J AM ACAD CHILD PSY, V46, P438, DOI 10.1097/chi.0b013e31803062bf; Hesketh T, 2010, ARCH DIS CHILD, V95, P136, DOI 10.1136/adc.2009.171660; HO DYF, 1984, DEV PSYCHOL, V20, P1004, DOI 10.1037/0012-1649.20.6.1004; KAGAN J, 1978, INFANCY ITS PLACE HU; Leung PWL, 2008, EUR CHILD ADOLES PSY, V17, P452, DOI 10.1007/s00787-008-0687-7; Liu H, 2004, CHINESE J EPIDEMIOLO, V15, P88; Liu JH, 2011, J ABNORM CHILD PSYCH, V39, P251, DOI 10.1007/s10802-010-9452-8; Liu XC, 2001, J AM ACAD CHILD PSY, V40, P828, DOI 10.1097/00004583-200107000-00018; MANN EM, 1992, AM J PSYCHIAT, V149, P1539; Mullick MSI, 2005, SOC PSYCH PSYCH EPID, V40, P663, DOI 10.1007/s00127-005-0939-5; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Pillai A, 2008, BRIT J PSYCHIAT, V192, P45, DOI 10.1192/bjp.bp.106.034223; Posserud M, 2010, SOC PSYCH PSYCH EPID, V45, P319, DOI 10.1007/s00127-009-0087-4; RAHIM SIA, 1986, SOC SCI MED, V22, P723, DOI 10.1016/0277-9536(86)90222-4; Roberts RE, 1998, AM J PSYCHIAT, V155, P715; Shaffer D, 1996, J AM ACAD CHILD PSY, V35, P865, DOI 10.1097/00004583-199607000-00012; Tang Guang-zheng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P878; Verhulst FC, 2003, AM J PSYCHIAT, V160, P1479, DOI 10.1176/appi.ajp.160.8.1479; Wang JN, 2013, CHILD CARE IN PRESS; WEINE AM, 1995, J ABNORM CHILD PSYCH, V23, P619, DOI 10.1007/BF01447666; WEISZ JR, 1993, CHILD DEV, V64, P98, DOI 10.1111/j.1467-8624.1993.tb02897.x; Wichstrom L, 2012, J CHILD PSYCHOL PSYC, V53, P695, DOI 10.1111/j.1469-7610.2011.02514.x; Yang HJ, 2000, J AM ACAD CHILD PSY, V39, P232, DOI 10.1097/00004583-200002000-00024; Yang Z., 1997, CHINESE MENTAL HLTH, V11, P260; Ye JZ, 2011, J PEASANT STUD, V38, P355, DOI 10.1080/03066150.2011.559012; Zahn-Waxler C, 2000, DEV PSYCHOPATHOL, V12, P443, DOI 10.1017/S0954579400003102; [张郭莺 ZHANG Guo-Ying], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P211; Zhang SP, 2006, CHILDRENS SURVIVAL D, P154; Zhang Y, 2007, MATERN CHILD HLTH J, V22, P1829	49	31	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111223	10.1371/journal.pone.0111223	http://dx.doi.org/10.1371/journal.pone.0111223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360718	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700074
J	Bassani, DG; Corsi, DJ; Gaffey, MF; Barros, AJD				Bassani, Diego G.; Corsi, Daniel J.; Gaffey, Michelle F.; Barros, Aluisio J. D.			Local Distributions of Wealth to Describe Health Inequalities in India: A New Approach for Analyzing Nationally Representative Household Survey Data, 1992-2008	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CHILD HEALTH; MORTALITY; EQUITY; COUNTDOWN; POSITION; NEWBORN; INDEXES; TRENDS	Background: Worse health outcomes including higher morbidity and mortality are most often observed among the poorest fractions of a population. In this paper we present and validate national, regional and state-level distributions of national wealth index scores, for urban and rural populations, derived from household asset data collected in six survey rounds in India between 1992-3 and 2007-8. These new indices and their sub-national distributions allow for comparative analyses of a standardized measure of wealth across time and at various levels of population aggregation in India. Methods: Indices were derived through principal components analysis (PCA) performed using standardized variables from a correlation matrix to minimize differences in variance. Valid and simple indices were constructed with the minimum number of assets needed to produce scores with enough variability to allow definition of unique decile cut-off points in each urban and rural area of all states. Results: For all indices, the first PCA components explained between 36% and 43% of the variance in household assets. Using sub-national distributions of national wealth index scores, mean height-for-age z-scores increased from the poorest to the richest wealth quintiles for all surveys, and stunting prevalence was higher among the poorest and lower among the wealthiest. Urban and rural decile cut-off values for India, for the six regions and for the 24 major states revealed large variability in wealth by geographical area and level, and rural wealth score gaps exceeded those observed in urban areas. Conclusions: The large variability in sub-national distributions of national wealth index scores indicates the importance of accounting for such variation when constructing wealth indices and deriving score distribution cut-off points. Such an approach allows for proper within-sample economic classification, resulting in scores that are valid indicators of wealth and correlate well with health outcomes, and enables wealth-related analyses at whichever geographical area and level may be most informative for policy-making processes.	[Bassani, Diego G.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Corsi, Daniel J.] Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Gaffey, Michelle F.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Barros, Aluisio J. D.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil	University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universidade Federal de Pelotas	Bassani, DG (corresponding author), Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada.	diego.bassani@sickkids.ca	Bassani, Diego/G-2827-2015; Barros, Aluisio JD/A-7417-2008; Corsi, Daniel J/S-4689-2018	Bassani, Diego/0000-0001-6704-3820; Barros, Aluisio JD/0000-0002-2022-8729; Corsi, Daniel J/0000-0001-7063-3354				Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Dunteman GH, 1985, PRINCIPAL COMPONENT; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garza C, 2006, ACTA PAEDIATR, V95, P56, DOI 10.1080/08035320500495514; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Houweling TAJ, 2010, BRIT MED BULL, V93, P7, DOI 10.1093/bmb/ldp048; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; IIPS Macro International., 2007, NAT FAM HLTH SURV NF, VII; IIPS & ORC Macro, 1995, NATL FAMILY HLTH SUR; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; India Planning Commission, 2002, NAT HUM DEV REP; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS SURV; International Institute for Population Sciences (IIPS), 2001, REPR CHILD HLTH PROJ; McNeil M, 2005, PUTTING KNOWLEDGE WO; Mohanty Sanjay K., 2009, Genus, V65, P113; Pande RP, 2003, SOC SCI MED, V57, P2075, DOI 10.1016/S0277-9536(03)00085-6; Pathak PK, 2011, SOC SCI MED, V73, P576, DOI 10.1016/j.socscimed.2011.06.024; Rutstein SO, 2004, DHS COMP REPORTS, V6; StataCorp, 2011, STAT STAT SOFTW REL, P173; Subramanyam MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011392; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; World Bank, 2013, WORLD DEV IND 2013	31	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110694	10.1371/journal.pone.0110694	http://dx.doi.org/10.1371/journal.pone.0110694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2HU	25356667	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000020
J	Andrei, C; Lestini, E; Crosbie, S; de Frein, C; O'Reilly, T; Zerulla, D				Andrei, Codrin; Lestini, Elena; Crosbie, Stephen; de Frein, Caoimhe; O'Reilly, Thomas; Zerulla, Dominic			Plasmonic Enhancement of Dye Sensitized Solar Cells via a Tailored Size-Distribution of Chemically Functionalized Gold Nanoparticles	PLOS ONE			English	Article							CONVERSION EFFICIENCY; LIGHT; DESIGN; PHOTOCATALYSTS; RECOMBINATION; ALKANETHIOLS	A substantial and stable increase of the current density Jsc of ruthenium (Ru) dye sensitized solar cells (DSC) of up to 16.18% and of the power efficiency of up to 25.5% is demonstrated in this article via plasmonic enhancement. The key aspect of this work is the use of a tailored bimodal size distribution of functionalized gold nanoparticles (AuNPs) that have been chemically immobilized onto the mesoporous titanium dioxide (TiO2) layer via short, stable dithiodibutyric acid linkers. The size distribution of the AuNPs is a result of theoretical calculations that aimed at the perfection of the absorption characteristics of the complete solar cell system over a wide range of wavelengths. The functionalization of the AuNPs serves to bind them at a close but defined distance to TiO2-particles and additionally to chemically protect them against potential corrosion by the electrolyte. Simulations of near field (enhanced absorption) and far field (scattering) contributions have been used to tailor a complex AuNPs bimodal size distribution that had subsequently demonstrated experimentally a close to optimum improvement of the absorbance over a wide wavelength range (500-675 nm) and therefore an impressive DSC efficiency enhancement. Finally, the modified DSCs are exhibiting pronounced longevity and stable performance as confirmed via long time measurements. In summary, the presented systems show increased performance compared to non plasmonic enhanced cells with otherwise identical composition, and are demonstrating a previously unpublished longevity for iodide electrolyte/AuNPs combinations.	[Andrei, Codrin; Lestini, Elena; Crosbie, Stephen; de Frein, Caoimhe; O'Reilly, Thomas; Zerulla, Dominic] Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Grp, Dublin 2, Ireland; [Andrei, Codrin] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland	University College Dublin; University College Dublin	Andrei, C (corresponding author), Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Grp, Dublin 2, Ireland.	codrin.andrei@ucd.ie	Zerulla, Dominic/L-6090-2018	Zerulla, Dominic/0000-0001-8479-9654	Irish Research Council (IRC) [RS/2010/2943]; Science Foundation Ireland (SFI) [11/RFP/MTR/3113]	Irish Research Council (IRC)(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland (SFI)(Science Foundation Ireland)	The authors acknowledge and thank Irish Research Council (IRC) scholarship funding (RS/2010/2943) and Science Foundation Ireland (SFI) research funding number 11/RFP/MTR/3113. They also acknowledge and thank Science Foundation Ireland for their funding of the Strategic Research Cluster in Advanced Biomimetic Materials for Solar Energy Conversion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 2010, PHYS CHEM CHEM PHYS, V12, P7241, DOI 10.1039/c000072h; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Beck FJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3140609; Becquerel E, 1839, CR HEBD ACAD SCI, P561; Bessho T, 2010, ANGEW CHEM INT EDIT, V49, P6646, DOI 10.1002/anie.201002118; Biesinger MC, 2010, APPL SURF SCI, V257, P887, DOI 10.1016/j.apsusc.2010.07.086; Deceglie MG, 2012, NANO LETT, V12, P2894, DOI 10.1021/nl300483y; Derkacs D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336629; Ding IK, 2011, ADV ENERGY MATER, V1, P52, DOI 10.1002/aenm.201000041; Doyle G, 2007, APPL PHYS A-MATER, V89, P351, DOI 10.1007/s00339-007-4126-2; Ferry VE, 2011, NANO LETT, V11, P4239, DOI 10.1021/nl202226r; Ferry VE, 2010, ADV MATER, V22, P4794, DOI 10.1002/adma.201000488; Ferry VE, 2008, NANO LETT, V8, P4391, DOI 10.1021/nl8022548; Gratzel M, 2004, J PHOTOCH PHOTOBIO A, V164, P3, DOI 10.1016/j.jphotochem.2004.02.023; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Gratzel M, 2012, MAGIC WORLD NANOCRYS; Gratzel M, 2007, PHILOS T R SOC A, V365, P993, DOI 10.1098/rsta.2006.1963; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P320, DOI 10.1002/pip.911; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Ho CI, 2012, J APPL PHYS, V112, DOI 10.1063/1.4739289; Ito S, 2006, CHEM COMMUN, P4004, DOI 10.1039/b608279c; Kume T, 1995, JPN J APPL PHYS 1, V34, P6448, DOI 10.1143/JJAP.34.6448; Lee JY, 2010, NANO LETT, V10, P1276, DOI 10.1021/nl903892x; Lim SH, 2007, J APPL PHYS, V101; Liu Y, 2010, J PHYS CHEM C, V114, P1641, DOI 10.1021/jp910500c; Mishra A, 2009, ANGEW CHEM INT EDIT, V48, P2474, DOI 10.1002/anie.200804709; Nakayama K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988288; Nogueira AF, 2004, COORDIN CHEM REV, V248, P1455, DOI 10.1016/j.ccr.2004.05.018; OHSAKA T, 1978, J RAMAN SPECTROSC, V7, P321, DOI 10.1002/jrs.1250070606; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Pillai S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734885; Pillai S, 2010, SOL ENERG MAT SOL C, V94, P1481, DOI 10.1016/j.solmat.2010.02.046; Polman A, 2012, NAT MATER, V11, P174, DOI 10.1038/nmat3263; Schaadt DM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1855423; Smestad GP, 1998, J CHEM EDUC, V75, P752, DOI 10.1021/ed075p752; Snaith HJ, 2007, NANO LETT, V7, P3372, DOI 10.1021/nl071656u; STENZEL O, 1995, SOL ENERG MAT SOL C, V37, P337, DOI 10.1016/0927-0248(95)00027-5; Temple TL, 2009, SOL ENERG MAT SOL C, V93, P1978, DOI 10.1016/j.solmat.2009.07.014; Wang P, 2003, NAT MATER, V2, P402, DOI 10.1038/nmat904; Wang P, 2012, PHYS CHEM CHEM PHYS, V14, P9813, DOI 10.1039/c2cp40823f; Wang XD, 2011, J MATER CHEM, V21, P20, DOI 10.1039/c0jm02620d; Williamson A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3633349; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Yum JH, 2011, ENERG ENVIRON SCI, V4, P842, DOI 10.1039/c0ee00536c; Zedler L, 2012, RSC ADV, V2, P4463, DOI 10.1039/c2ra01248k; Zerulla D, 1999, LANGMUIR, V15, P5285, DOI 10.1021/la980300i; Zerulla D, 2009, J ELECTRON SPECTROSC, V172, P78, DOI 10.1016/j.elspec.2009.03.017; Zhang Y, 2012, ADV MATER, V24, P2485, DOI 10.1002/adma.201103991; Zhang Y, 2011, LANGMUIR, V27, P15292, DOI 10.1021/la203863p; Zhu K, 2006, J PHYS CHEM B, V110, P25174, DOI 10.1021/jp065284+	50	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109836	10.1371/journal.pone.0109836	http://dx.doi.org/10.1371/journal.pone.0109836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354362	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200015
J	Darmon, E; Eykelenboom, JK; Lopez-Vernaza, MA; White, MA; Leach, DRF				Darmon, Elise; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; White, Martin A.; Leach, David R. F.			Repair on the Go: E. coli Maintains a High Proliferation Rate while Repairing a Chronic DNA Double-Strand Break	PLOS ONE			English	Article							IRRADIATED ESCHERICHIA-COLI; BACTERIAL-CELL DIVISION; Z-RING FORMATION; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; DAMAGE CHECKPOINT; SOS INDUCTION; FISSION YEAST; LEXA PROTEIN; REPLICATION	DNA damage checkpoints exist to promote cell survival and the faithful inheritance of genetic information. It is thought that one function of such checkpoints is to ensure that cell division does not occur before DNA damage is repaired. However, in unicellular organisms, rapid cell multiplication confers a powerful selective advantage, leading to a dilemma. Is the activation of a DNA damage checkpoint compatible with rapid cell multiplication? By uncoupling the initiation of DNA replication from cell division, the Escherichia coli cell cycle offers a solution to this dilemma. Here, we show that a DNA double-strand break, which occurs once per replication cycle, induces the SOS response. This SOS induction is needed for cell survival due to a requirement for an elevated level of expression of the RecA protein. Cell division is delayed, leading to an increase in average cell length but with no detectable consequence on mutagenesis and little effect on growth rate and viability. The increase in cell length caused by chronic DNA double-strand break repair comprises three components: two types of increase in the unit cell size, one independent of SfiA and SlmA, the other dependent of the presence of SfiA and the absence of SlmA, and a filamentation component that is dependent on the presence of either SfiA or SlmA. These results imply that chronic checkpoint induction in E. coli is compatible with rapid cell multiplication. Therefore, under conditions of chronic low-level DNA damage, the SOS checkpoint operates seamlessly in a cell cycle where the initiation of DNA replication is uncoupled from cell division.	[Darmon, Elise; Eykelenboom, John K.; Lopez-Vernaza, Manuel A.; White, Martin A.; Leach, David R. F.] Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Leach, DRF (corresponding author), Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland.	D.Leach@ed.ac.uk	Leach, David R/H-7159-2012	Leach, David R/0000-0003-4964-6913; White, Martin/0000-0001-6482-8462; Lopez Vernaza, Manuel Augusto/0000-0002-9542-7028; Eykelenboom, John/0000-0003-4115-9686	Medical Research Council (UK) [G0901622]; MRC [G0901622] Funding Source: UKRI; Medical Research Council [G0901622] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by grant G0901622 to DL from the Medical Research Council (UK) [http://www.mrc.ac.uk/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; Cambridge J, 2014, J BACTERIOL, V196, P36, DOI 10.1128/JB.01230-12; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Courcelle J, 2001, GENETICS, V158, P41; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Cromie GA, 2000, GENETICS, V154, P513; Delmas S, 2006, P NATL ACAD SCI USA, V103, P4564, DOI 10.1073/pnas.0509012103; di Domenico EG, 2009, DNA REPAIR, V8, P209, DOI 10.1016/j.dnarep.2008.10.005; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Keller KL, 2001, MUTAT RES-DNA REPAIR, V486, P21, DOI 10.1016/S0921-8777(01)00077-5; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; Lee M, 2008, CELL BIOCHEM FUNCT, V26, P125, DOI 10.1002/cbf.1428; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rudolph CJ, 2007, GENE DEV, V21, P668, DOI 10.1101/gad.417607; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Thoms B, 1998, J BACTERIOL, V180, P5639, DOI 10.1128/JB.180.21.5639-5645.1998; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; Vlasic I, 2008, BIOCHIMIE, V90, P1347, DOI 10.1016/j.biochi.2008.04.002; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Weinert T, 2007, SCIENCE, V315, P1374, DOI 10.1126/science.1140759; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Zaritsky A, 2011, MICROBIOL-SGM, V157, P1876, DOI 10.1099/mic.0.049403-0	53	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110784	10.1371/journal.pone.0110784	http://dx.doi.org/10.1371/journal.pone.0110784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353327	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200035
J	Proulx, MJ; Parker, MO; Tahir, Y; Brennan, CH				Proulx, Michael J.; Parker, Matthew O.; Tahir, Yasser; Brennan, Caroline H.			Parallel Mechanisms for Visual Search in Zebrafish	PLOS ONE			English	Article							DANIO-RERIO RESPONDS; TOP-DOWN; INTEGRATION; ATTENTION; SALIENCE; MODELS; SYSTEM; SERIAL; FISH; MAP	Parallel visual search mechanisms have been reported previously only in mammals and birds, and not animals lacking an expanded telencephalon such as bees. Here we report the first evidence for parallel visual search in fish using a choice task where the fish had to find a target amongst an increasing number of distractors. Following two-choice discrimination training, zebrafish were presented with the original stimulus within an increasing array of distractor stimuli. We found that zebrafish exhibit no significant change in accuracy and approach latency as the number of distractors increased, providing evidence of parallel processing. This evidence challenges theories of vertebrate neural architecture and the importance of an expanded telencephalon for the evolution of executive function.	[Proulx, Michael J.] Univ Bath, Dept Psychol, Crossmodal Cognit Lab, Bath BA2 7AY, Avon, England; [Parker, Matthew O.; Tahir, Yasser; Brennan, Caroline H.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of Bath; University of London; Queen Mary University London	Brennan, CH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	c.h.brennan@qmul.ac.uk	Proulx, Michael J/A-1045-2008; Parker, Matthew/J-6815-2019	Parker, Matthew/0000-0002-7172-5231; Proulx, Michael/0000-0003-4066-3645	National Centre for the Replacement, Reduction and Refinement of animals in research (NC3Rs; UK) [G1000053]; Medical Research Council (MRC; UK); National Centre for the Replacement [G1000053/1] Funding Source: researchfish	National Centre for the Replacement, Reduction and Refinement of animals in research (NC3Rs; UK); Medical Research Council (MRC; UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement	This research was funded by project grant G1000053 from the National Centre for the Replacement, Reduction and Refinement of animals in research (NC3Rs; UK) and by the Medical Research Council (MRC; UK). CHB is a Royal Society (UK) Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Abaid N, 2010, J R SOC INTERFACE, V7, P1441, DOI 10.1098/rsif.2010.0175; Aoki I, 1980, B OCEAN RES I U TOKY, V12; Beane M, 2004, PROG NEUROBIOL, V74, P167, DOI 10.1016/j.pneurobio.2004.09.001; BLOUGH PM, 1984, PERCEPT PSYCHOPHYS, V35, P344, DOI 10.3758/BF03206338; Botly LC, 2011, CEREB CORTEX; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; de Sousa A, 2012, PROG BRAIN RES, V195, P293, DOI 10.1016/B978-0-444-53860-4.00014-3; Donnelly N, 2007, Q J EXP PSYCHOL, V60, P120, DOI 10.1080/17470210600625362; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Lopez U, 2012, INTERFACE FOCUS, V2, P693, DOI 10.1098/rsfs.2012.0033; Mokeichev A, 2010, P NATL ACAD SCI USA, V107, P16726, DOI 10.1073/pnas.1005446107; Neri P, 2012, ANIM BEHAV, V84, P485, DOI 10.1016/j.anbehav.2012.06.005; Parker MO, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00063; Parker MO, 2012, BEHAV BRAIN RES, V232, P264, DOI 10.1016/j.bbr.2012.04.035; Proulx MJ, 2007, J EXP PSYCHOL HUMAN, V33, P48, DOI 10.1037/0096-1523.33.1.48; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Spaethe J, 2006, J EXP BIOL, V209, P987, DOI 10.1242/jeb.02124; Spence R, 2008, ETHOLOGY, V114, P582, DOI 10.1111/j.1439-0310.2008.01515.x; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; TOWNSEND JT, 1990, PSYCHOL SCI, V1, P46, DOI 10.1111/j.1467-9280.1990.tb00067.x; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsotsos JK, 1997, CONSCIOUS COGN, V6, P429, DOI 10.1006/ccog.1997.0302; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Zirger JM, 2003, GENE EXPR PATTERNS, V3, P747, DOI 10.1016/S1567-133X(03)00126-1	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111540	10.1371/journal.pone.0111540	http://dx.doi.org/10.1371/journal.pone.0111540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353168	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200088
J	Faruque, MRI; Islam, MT				Faruque, Mohammad Rashed Iqbal; Islam, Mohammad Tariqul			Design of Miniaturized Double-Negative Material for Specific Absorption Rate Reduction in Human Head	PLOS ONE			English	Article							ELECTROMAGNETIC ABSORPTION; HANDSET ANTENNA; SAR REDUCTION; MOBILE; RADIATION; METAMATERIALS; EFFICIENCY; PIFA	In this study, a double-negative triangular metamaterial (TMM) structure, which exhibits a resounding electric response at microwave frequency, was developed by etching two concentric triangular rings of conducting materials. A finite-difference time-domain method in conjunction with the lossy-Drude model was used in this study. Simulations were performed using the CST Microwave Studio. The specific absorption rate (SAR) reduction technique is discussed, and the effects of the position of attachment, the distance, and the size of the metamaterials on the SAR reduction are explored. The performance of the double-negative TMMs in cellular phones was also measured in the cheek and the tilted positions using the COMOSAR system. The TMMs achieved a 52.28% reduction for the 10 g SAR. These results provide a guideline to determine the triangular design of metamaterials with the maximum SAR reducing effect for a mobile phone.	[Faruque, Mohammad Rashed Iqbal; Islam, Mohammad Tariqul] Univ Kebangsaan Malaysia, Ctr Space Sci ANGKASA, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Faruque, MRI (corresponding author), Univ Kebangsaan Malaysia, Ctr Space Sci ANGKASA, Res Ctr Bldg, Bangi, Selangor, Malaysia.	rashedgen@yahoo.com	Faruque, Mohammad Rashed Iqbal/Q-5957-2019; Islam, Mohammad Tariqul/M-7377-2016; Islam, Mohammad Tariqul/E-6380-2012	Faruque, Mohammad Rashed Iqbal/0000-0003-4086-7672; Islam, Mohammad Tariqul/0000-0002-4929-3209; Islam, Mohammad Tariqul/0000-0002-4929-3209	Universiti Kebangsaan Malaysia [UKM- DLP-2014]	Universiti Kebangsaan Malaysia	This work was supported by the Universiti Kebangsaan Malaysia, under grants Dana Lonjakan Penerbitan (UKM- DLP-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera J, 2013, INT J ANTENN PROPAG, V2013, DOI 10.1155/2013/838364; Bayindir M, 2002, APPL PHYS LETT, V81, P120, DOI 10.1063/1.1492009; Cabedo A, 2009, IEEE T ANTENN PROPAG, V57, P2526, DOI 10.1109/TAP.2009.2027039; Caloz C, 2006, ELECTROMAGNETIC METAMATERIALS: TRANSMISSION LINE THEORY AND MICROWAVE APPLICATIONS: THE ENGINEERING APPROACH, P1; Chih-Ming Kuo, 2003, IEEE Antennas and Propagation Society International Symposium. Digest. Held in conjunction with: USNC/CNC/URSI North American Radio Sci. Meeting (Cat. No.03CH37450), P1025; Faruque MRI, 2012, PROG ELECTROMAGN RES, V124, P119, DOI 10.2528/PIER11112301; Faruque MRI, 2011, ELECTROMAGNETICS, V31, P215, DOI 10.1080/02726343.2011.558457; Fung LC, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY, VOLS 1 AND 2, SYMPOSIUM RECORD, P656, DOI 10.1109/ISEMC.2002.1032669; Gandhi OP, 1996, IEEE T MICROW THEORY, V44, P1884, DOI 10.1109/22.539947; Hwang JN, 2006, IEEE T ANTENN PROPAG, V54, P3763, DOI 10.1109/TAP.2006.886501; I.C.N.I.R.P, 1988, HEALTH PHYS, V74, P494; Islam MT, 2009, PROG ELECTROMAGN RES, V98, P191, DOI 10.2528/PIER09082902; JENSEN MA, 1995, P IEEE, V83, P7, DOI 10.1109/5.362755; Kivekas O, 2004, IEEE T ELECTROMAGN C, V46, P71, DOI 10.1109/TEMC.2004.823613; KUSTER N, 1992, IEEE T VEH TECHNOL, V41, P17, DOI 10.1109/25.120141; Li CH, 2009, IEEE T ANTENN PROPAG, V57, P2763, DOI 10.1109/TAP.2009.2027081; Lin JC, 2000, IEEE ANTENN PROPAG M, V42, P138, DOI 10.1109/74.883512; Manapati MB, 2009, J ELECTROMAGNET WAVE, V23, P1385, DOI 10.1163/156939309789108606; Mochizuki S, 2007, IEEE T ELECTROMAGN C, V49, P512, DOI 10.1109/TEMC.2007.902189; Okoniewski M, 1996, IEEE T MICROW THEORY, V44, P1855, DOI 10.1109/22.539944; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Risco S, 2012, MICROW OPT TECHN LET, V54, P454, DOI 10.1002/mop.26565; Rowell C, 2012, IEEE ANTENN PROPAG M, V54, P14, DOI 10.1109/MAP.2012.6309152; Sievenpiper D, 1999, IEEE T MICROW THEORY, V47, P2059, DOI 10.1109/22.798001; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Tay RYS, 1998, IEEE T ANTENN PROPAG, V46, P798, DOI 10.1109/8.686765; Wang J, 1997, IEEE T MICROW THEORY, V47, P1528; Watanabe S, 1996, IEEE T MICROW THEORY, V44, P1874, DOI 10.1109/22.539946; Xu HX, 2013, OPT EXPRESS, V21, P24912, DOI 10.1364/OE.21.024912; Zhang JJ, 2010, OPT EXPRESS, V18, P17187, DOI 10.1364/OE.18.017187; Ziolkowski RW, 2003, IEEE T ANTENN PROPAG, V51, P1516, DOI 10.1109/TAP.2003.813622	31	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109947	10.1371/journal.pone.0109947	http://dx.doi.org/10.1371/journal.pone.0109947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350398	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100016
J	Burke-Gaffney, A; Svermova, T; Mumby, S; Finney, SJ; Evans, TW				Burke-Gaffney, Anne; Svermova, Tatiana; Mumby, Sharon; Finney, Simon J.; Evans, Timothy W.			Raised Plasma Robo4 and Cardiac Surgery-Associated Acute Kidney Injury	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ROUNDABOUT RECEPTOR; INFLAMMATORY RESPONSE; BARRIER DYSFUNCTION; MAGIC ROUNDABOUT; BIOMARKERS; ANGIOPOIETIN-2; ACTIVATION; EXPRESSION; NETWORK	Objective: Endothelial dysfunction associated with systemic inflammation can contribute to organ injury/failure following cardiac surgery requiring cardiopulmonary bypass (CPB). Roundabout protein 4 (Robo4), an endothelial-expressed transmembrane receptor and regulator of cell activation, is an important inhibitor of endothelial hyper-permeability. We investigated the hypothesis that plasma levels of Robo4 are indicative of organ injury, in particular acute kidney injury (AKI), after cardiac surgery. Methods: Patients (n = 32) undergoing elective cardiac surgery with CPB were enrolled, prospectively. Plasma Robo4 concentrations were measured pre-, 2 and 24 h post-operatively, using a commercially available ELISA. Plasma and endothelial markers of inflammation [interleukin (IL) -6, -8, -10: von Willibrand factor (vWF) and angiopoeitin-2 (Ang-2)] and the AKI marker, neutrophil gelatinase-associated lipocalin (NGAL), were also measured by ELISA. Results: Plasma Robo4 increased significantly (p<0.001) from pre-operative levels of 2515 +/- 904 pg/ml to 4473 +/- 1915 pg/ml, 2 h after surgery; and returned to basal levels (2682 +/- 979 pg/ml) by 24 h. Plasma cytokines, vWF and NGAL also increased 2 h post-operatively and remained elevated at 24 h. Ang-2 increased 24 h post-operatively, only. There was a positive, significant correlation (r = 0.385, p = 0.0298) between Robo-4 and IL-10, but not other cytokines, 2 h post-operatively. Whilst raised Robo4 did not correlate with indices of lung dysfunction or other biomarkers of endothelial activation; there was a positive, significant correlation between raised (2 h) plasma NGAL and Robo4 (r = 0.4322, p = 0.0135). When patients were classed as AKI or non-AKI either using NGAL cut-off of 150 ng/ml, or the AKI Network (AKIN) clinical classification; plasma Robo4 was significantly higher (p = 0.0073 and 0.003, respectively) in AKI vs. non-AKI patients (NGAL cut-off: 535062191 ng/ml, n = 16 vs. 359561068 pg/ml, n = 16; AKIN: 6546 pg/ml, IQR 5025-8079, n = 6; vs. 3727 pg/ml, IQR 1962-3727, n = 26) subjects. Conclusion: Plasma Robo4 levels are increased, transiently, following cardiac surgery requiring CPB; and higher levels in patients with AKI suggest a link between endothelial dysregulation and onset of AKI.	[Burke-Gaffney, Anne; Svermova, Tatiana; Mumby, Sharon] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst Div, London, England; [Finney, Simon J.; Evans, Timothy W.] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res, Resp Biomed Res Unit, London, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust	Burke-Gaffney, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst Div, London, England.	a.burke-gaffney@imperial.ac.uk	Finney, Simon/A-2168-2012	Finney, Simon/0000-0001-8219-1952	British Heart Foundation PhD studentship [FS/14/6/30573]; Royal Brompton Hospital; Doverdale Trust; NIHR Respiratory Diseases Biomedical Research Unit; Rosetrees Trust; British Heart Foundation [FS/14/6/30573] Funding Source: researchfish	British Heart Foundation PhD studentship; Royal Brompton Hospital; Doverdale Trust; NIHR Respiratory Diseases Biomedical Research Unit; Rosetrees Trust(Rosetrees Trust); British Heart Foundation(British Heart Foundation)	Tatiana Svermova is the recipient of a British Heart Foundation PhD studentship (FS/14/6/30573). The authors also thank the Royal Brompton Hospital, Doverdale Trust and NIHR Respiratory Diseases Biomedical Research Unit; and the Rosetrees Trust for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak R, 2014, J STRUCT BIOL, V186, P283, DOI 10.1016/j.jsb.2014.02.019; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Blockus H, 2014, CURR OPIN NEUROBIOL, V27, P82, DOI 10.1016/j.conb.2014.03.003; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Cheng Y, 2013, CURR EYE RES, V38, P128, DOI 10.3109/02713683.2012.738844; Clajus C, 2012, CYTOKINE, V60, P352, DOI 10.1016/j.cyto.2012.04.002; Coleman HA, 2010, DEVELOPMENT, V137, P2417, DOI 10.1242/dev.047993; Costa ELV, 2013, CURR OPIN CRIT CARE, V19, P16, DOI 10.1097/MCC.0b013e32835c50b1; Creagh-Brown BC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/496031; Dickinson RE, 2010, REPRODUCTION, V139, P697, DOI 10.1530/REP-10-0017; Giuliano JS, 2008, INTENS CARE MED, V34, P1851, DOI 10.1007/s00134-008-1174-9; Gorbunova EE, 2013, ANTIVIR RES, V99, P108, DOI 10.1016/j.antiviral.2013.05.004; Goto-Koshino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050849; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hohenester E, 2008, BIOCHEM SOC T, V36, P251, DOI 10.1042/BST0360251; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Jouan J, 2012, J THORAC CARDIOV SUR, V144, P467, DOI 10.1016/j.jtcvs.2011.12.022; Klinger JR, 2006, EXP CELL RES, V312, P401, DOI 10.1016/j.yexcr.2005.11.001; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Liu D, 2006, CIRC RES, V98, P480, DOI 10.1161/01.RES.0000205764.85931.4b; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Maccallum NS, 2014, CHEST; Mao H, 2013, CARDIORENAL MED, V3, P178, DOI 10.1159/000353134; Moreira RS, 2014, AM J PHYSIOL-REG I, V307, pR514, DOI 10.1152/ajpregu.00445.2013; Mulik S, 2011, J IMMUNOL, V186, P7195, DOI 10.4049/jimmunol.1100014; Ning YY, 2011, TOXICOLOGY, V283, P32, DOI 10.1016/j.tox.2011.01.026; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Panagiotopoulos I, 2010, J CLIN LAB ANAL, V24, P389, DOI 10.1002/jcla.20416; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Pintar Tatjana, 2003, Anesthesiol Clin North Am, V21, P453, DOI 10.1016/S0889-8537(03)00039-7; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Tsang GMK, 1998, EUR J CARDIO-THORAC, V13, P385, DOI 10.1016/S1010-7940(98)00022-0; Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145; Zhang XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002461; Zhao HL, 2014, J IMMUNOL, V192, P385, DOI 10.4049/jimmunol.1302021	39	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111459	10.1371/journal.pone.0111459	http://dx.doi.org/10.1371/journal.pone.0111459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360813	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700104
J	Chen, QH; Chen, K; Guo, GJ; Li, F; Chen, C; Wang, S; Nalepa, G; Huang, SL; Chen, JL				Chen, Qinghuang; Chen, Ke; Guo, Guijie; Li, Fang; Chen, Chao; Wang, Song; Nalepa, Grzegorz; Huang, Shile; Chen, Ji-Long			A Critical Role of CDKN3 in Bcr-Abl-Mediated Tumorigenesis	PLOS ONE			English	Article							MYELOGENOUS LEUKEMIA-CELLS; KINASE-ASSOCIATED PHOSPHATASE; CHRONIC MYELOID-LEUKEMIA; PROTEIN PHOSPHATASE; MOLECULAR PATHWAYS; DOWN-REGULATION; CANCER CELLS; APOPTOSIS; CYCLE; KAP	CDKN3 (cyclin-dependent kinase inhibitor 3), a dual specificity protein phosphatase, dephosphorylates cyclin-dependent kinases (CDKs) and thus functions as a key negative regulator of cell cycle progression. Deregulation or mutations of CDNK3 have been implicated in various cancers. However, the role of CDKN3 in Bcr-Abl-mediated chronic myelogenous leukemia (CML) remains unknown. Here we found that CDKN3 acts as a tumor suppressor in Bcr-Abl-mediated leukemogenesis. Overexpression of CDKN3 sensitized the K562 leukemic cells to imanitib-induced apoptosis and dramatically inhibited K562 xenografted tumor growth in nude mouse model. Ectopic expression of CDKN3 significantly reduced the efficiency of Bcr-Abl-mediated transformation of FDCP1 cells to growth factor independence. In contrast, depletion of CDKN3 expression conferred resistance to imatinib-induced apoptosis in the leukemic cells and accelerated the growth of xenograph leukemia in mice. In addition, we found that CDKN3 mutant (CDKN3-C140S) devoid of the phosphatase activity failed to affect the K562 leukemic cell survival and xenografted tumor growth, suggesting that the phosphatase of CDKN3 was required for its tumor suppressor function. Furthermore, we observed that overexpression of CDKN3 reduced the leukemic cell survival by dephosphorylating CDK2, thereby inhibiting CDK2-dependent XIAP expression. Moreover, overexpression of CDKN3 delayed G1/S transition in K562 leukemic cells. Our results highlight the importance of CDKN3 in Bcr-Abl-mediated leukemogenesis, and provide new insights into diagnostics and therapeutics of the leukemia.	[Chen, Qinghuang; Chen, Chao; Wang, Song; Chen, Ji-Long] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Fujian, Peoples R China; [Chen, Ke; Guo, Guijie; Li, Fang; Chen, Ji-Long] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Div Pediat Hematol Oncol, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Chen, JL (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Fujian, Peoples R China.	chenjl@im.ac.cn	Huang, Shile/I-1632-2019; Chen, Ji-Long/AAJ-2134-2021	Huang, Shile/0000-0002-3239-1072; Chen, Ji-Long/0000-0002-4274-0563; Nalepa, Grzegorz/0000-0002-5779-9103; Lab, Nalepa/0000-0002-7560-1906; Chao, Chen/0000-0002-3191-0838; Guo, Guijie/0000-0002-9031-1915	National Basic Research Program (973) of China [2015CB910502]; National Key Technologies Research and Development Program of China [2013ZX10004-611]; Natural Science Foundation of China [U1305212, 81171943, 81472611]; Chinese Academy of Sciences [KJZD-EW-L01-3]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068371] Funding Source: NIH RePORTER	National Basic Research Program (973) of China(National Basic Research Program of China); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Basic Research Program (973) of China (2015CB910502), National Key Technologies Research and Development Program of China (2013ZX10004-611), Natural Science Foundation of China (U1305212, 81171943, 81472611), Intramural grant of the Chinese Academy of Sciences (KJZD-EW-L01-3) to JLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Borriello A, 2011, CARCINOGENESIS, V32, P10, DOI 10.1093/carcin/bgq211; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Chen Y, 2010, LEUKEMIA, V24, P1545, DOI 10.1038/leu.2010.143; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; DEMETRICK DJ, 1995, CYTOGENET CELL GENET, V69, P190, DOI 10.1159/000133960; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Dong FQ, 2006, CANCER BIOL THER, V5, P165, DOI 10.4161/cbt.5.2.2316; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Guo G, 2010, ONCOGENE, V29, P3845, DOI 10.1038/onc.2010.149; Guo G, 2014, ONCOGENE; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HANNON GJ, 1994, P NATL ACAD SCI USA, V91, P1731, DOI 10.1073/pnas.91.5.1731; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; Lee SW, 2000, MOL CELL BIOL, V20, P1723, DOI 10.1128/MCB.20.5.1723-1732.2000; Li H., 2014, ONCOGENE; Li JH, 2011, J BIOL CHEM, V286, P39776, DOI 10.1074/jbc.M111.226464; Li TR, 2014, ONCOL REP, V31, P1825, DOI 10.3892/or.2014.3045; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MANDANAS RA, 1992, LEUKEMIA, V6, P796; Nalepa G, 2013, J CELL BIOL, V201, P997, DOI 10.1083/jcb.201205125; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Nimmanapalli R, 2001, CLIN CANCER RES, V7, P350; Qiu XX, 2012, NEOPLASIA, V14, P547, DOI 10.1596/neo.12230; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Silva KL, 2013, LEUKEMIA RES, V37, P1350, DOI 10.1016/j.leukres.2013.06.014; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Unsain N, 2013, CELL REP, V4, P751, DOI 10.1016/j.celrep.2013.07.015; Wang S, 2012, J BIOL CHEM, V287, P9804, DOI 10.1074/jbc.M111.312959; Wei HT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003845; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wright RHG, 2012, GENE DEV, V26, P1972, DOI 10.1101/gad.193193.112; Yang JL, 2013, CANCER RES, V73, P4898, DOI 10.1158/0008-5472.CAN-12-4277; Yeh CT, 2000, CANCER RES, V60, P4697; Yeh CT, 2003, BIOCHEM BIOPH RES CO, V305, P311, DOI 10.1016/S0006-291X(03)00757-5; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478	44	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111611	10.1371/journal.pone.0111611	http://dx.doi.org/10.1371/journal.pone.0111611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360622	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700128
J	Frouin, E; Guillot, B; Larrieux, M; Tempier, A; Boulle, N; Foulongne, V; Girard, C; Costes, V; Solassol, J				Frouin, Eric; Guillot, Bernard; Larrieux, Marion; Tempier, Ariane; Boulle, Nathalie; Foulongne, Vincent; Girard, Celine; Costes, Valerie; Solassol, Jerome			Cutaneous Epithelial Tumors Induced by Vemurafenib Involve the MAPK and Pi3KCA Pathways but Not HPV nor HPyV Viral Infection	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; H-RAS; BRAF INHIBITORS; CANCER; SKIN; POLYMORPHISM; MUTATIONS; CARCINOMA; MELANOMA; PROGRESSION	The inhibitors of mutant BRAF that are used to treat metastatic melanoma induce squamoproliferative lesions. We conducted a prospective histopathological and molecular study on 27 skin lesions from 12 patients treated with vemurafenib. Mutation hot spots in HRAS, NRAS, KRAS, BRAF, and Pi3KCA were screened. HPV and HPyV infection status were also determined. The lesions consisted of 19 verrucal papillomas, 1 keratoacanthoma and 7 squamous cell carcinomas. No mutations were found within BRAF and NRAS. KRAS, HRAS, and Pi3KCA oncogenic mutations were found in 10 (83.3%), 7 (58.3%), and 4 (33.3%) patients respectively; however, these mutations were not consistent within all tumors of a given patient. Pi3KCA mutation was always associated with a mutation in HRAS. Finally, no correlation was found between the mutated gene or type of mutation and the type of cutaneous tumor or clinical response to vemurafenib. P16 protein level was not indicative of HPV infection. HPV was detected in only two lesions. Two cases had MCPyV, and one had HPyV7. In conclusion, neither HPV nor HPyV seem to be involved in the development of squamoproliferative lesions induced by verumafenib. By contrast, HRAS and KRAS play a predominant role in the physiopathology of these tumors.	[Frouin, Eric; Larrieux, Marion; Tempier, Ariane; Boulle, Nathalie; Costes, Valerie; Solassol, Jerome] CHU Montpellier, Dept Biopathol, Montpellier, France; [Frouin, Eric; Guillot, Bernard; Boulle, Nathalie; Foulongne, Vincent; Girard, Celine; Costes, Valerie; Solassol, Jerome] Univ Montpellier I, Montpellier, France; [Guillot, Bernard; Girard, Celine] CHU Montpellier, Dept Dermatol, Montpellier, France; [Guillot, Bernard; Foulongne, Vincent; Girard, Celine; Costes, Valerie] Univ Montpellier I, INSERM, U1058, Montpellier, France; [Foulongne, Vincent] CHU Montpellier, Dept Virol, Montpellier, France; [Solassol, Jerome] Montpellier Canc Inst ICM, Dept Clin Oncoprote, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Frouin, E (corresponding author), CHU Montpellier, Dept Biopathol, Montpellier, France.	efrouin@orange.fr	Solassol, Jerome/G-2320-2018	Solassol, Jerome/0000-0002-0293-6158; Frouin, Eric/0000-0002-8432-3194				Anforth RM, 2012, BRIT J DERMATOL, V167, P1153, DOI 10.1111/j.1365-2133.2012.11155.x; Anforth R, 2012, PIGM CELL MELANOMA R, V25, P569, DOI 10.1111/j.1755-148X.2012.01031.x; Berkhout RJM, 2000, J CLIN MICROBIOL, V38, P2087; Boussemart L, 2013, ANN ONCOL, V24, P1691, DOI 10.1093/annonc/mdt015; Castro P, 2006, ONCOGENE, V25, P4620, DOI 10.1038/sj.onc.1209491; Coussens LM, 1996, AM J PATHOL, V149, P1899; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Duncavage EJ, 2011, J CUTAN PATHOL, V38, P790, DOI 10.1111/j.1600-0560.2011.01765.x; Falchook GS, 2013, JAMA DERMATOL, V149, P322, DOI 10.1001/jamadermatol.2013.2023; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Foulongne V, 2010, BRIT J DERMATOL, V162, P59, DOI 10.1111/j.1365-2133.2009.09381.x; Ganzenmueller T, 2013, EXP DERMATOL, V22, P725, DOI 10.1111/exd.12249; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Harvey NT, 2012, AM J DERMATOPATH, V34, P822, DOI 10.1097/DAD.0b013e3182604873; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2014, CANCER RES, V74, P2238, DOI 10.1158/0008-5472.CAN-13-1065-T; Johne A, 2003, CANCER EPIDEM BIOMAR, V12, P68; Ko CJ, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2012.03.027; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Pandith AA, 2013, UROL ONCOL-SEMIN ORI, V31, P487, DOI 10.1016/j.urolonc.2011.03.004; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rinderknecht JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058721; Sathyan KM, 2006, ORAL ONCOL, V42, P607, DOI 10.1016/j.oraloncology.2005.10.019; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Weedon D, 2010, WEEDONS SKIN PATHOLO, V3; Zhang YJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-256	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110478	10.1371/journal.pone.0110478	http://dx.doi.org/10.1371/journal.pone.0110478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360634	Green Published, gold			2022-12-27	WOS:000343943700037
J	Hart, EM; Aviles, L				Hart, Edmund M.; Aviles, Leticia			Reconstructing Local Population Dynamics in Noisy Metapopulations-The Role of Random Catastrophes and Allee Effects	PLOS ONE			English	Article							DEMOGRAPHIC STOCHASTICITY; DEPENDENT DISPERSAL; DENSITY-DEPENDENCE; EXTINCTION; CONSEQUENCES; PERSISTENCE; STABILITY; VIABILITY; BEHAVIOR; BIFURCATIONS	Reconstructing the dynamics of populations is complicated by the different types of stochasticity experienced by populations, in particular if some forms of stochasticity introduce bias in parameter estimation in addition to error. Identification of systematic biases is critical when determining whether the intrinsic dynamics of populations are stable or unstable and whether or not populations exhibit an Allee effect, i.e., a minimum size below which deterministic extinction should follow. Using a simulation model that allows for Allee effects and a range of intrinsic dynamics, we investigated how three types of stochasticity-demographic, environmental, and random catastrophes-affect our ability to reconstruct the intrinsic dynamics of populations. Demographic stochasticity aside, which is only problematic in small populations, we find that environmental stochasticity-positive and negative environmental fluctuations-caused increased error in parameter estimation, but bias was rarely problematic, except at the highest levels of noise. Random catastrophes, events causing large-scale mortality and likely to be more common than usually recognized, caused immediate bias in parameter estimates, in particular when Allee effects were large. In the latter case, population stability was predicted when endogenous dynamics were actually unstable and the minimum viable population size was overestimated in populations with small or nonexistent Allee effects. Catastrophes also generally increased extinction risk, in particular when endogenous Allee effects were large. We propose a method for identifying data points likely resulting from catastrophic events when such events have not been recorded. Using social spider colonies (Anelosimus spp.) as models for populations, we show that after known or suspected catastrophes are accounted for, reconstructed growth parameters are consistent with intrinsic dynamical instability and substantial Allee effects. Our results are applicable to metapopulation or time series data and are relevant for predicting extinction in conservation applications or the management of invasive species.	[Hart, Edmund M.; Aviles, Leticia] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Hart, EM (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	edmund.m.hart@gmail.com	Aviles, Leticia/AAL-8190-2020	Hart, Edmund/0000-0001-7367-7969	James S. McDonnell Foundation [467]	James S. McDonnell Foundation	We thank the James S. McDonnell Foundation "Studying Complex Systems" program for 467 research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 1996, OECOLOGIA, V105, P475, DOI 10.1007/BF00330010; Angulo E, 2007, CONSERV BIOL, V21, P1082, DOI 10.1111/j.1523-1739.2007.00721.x; Aviles L, 1999, EVOL ECOL RES, V1, P459; Aviles L, 1998, AM NAT, V152, P403, DOI 10.1086/286178; Aviles Leticia, 1997, P476; BASCOMPTE J, 1995, TRENDS ECOL EVOL, V10, P361, DOI 10.1016/S0169-5347(00)89134-X; BASCOMPTE J, 1994, J ANIM ECOL, V63, P256, DOI 10.2307/5544; BERRYMAN AA, 1989, TRENDS ECOL EVOL, V4, P26, DOI 10.1016/0169-5347(89)90014-1; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Brook BW, 2000, CONSERV BIOL, V14, P564, DOI 10.1046/j.1523-1739.2000.99039.x; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Burkey TV, 1997, AM NAT, V150, P568, DOI 10.1086/286082; Casagrandi R, 2002, THEOR POPUL BIOL, V61, P127, DOI 10.1006/tpbi.2001.1559; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dennis B, 2002, OIKOS, V96, P389, DOI 10.1034/j.1600-0706.2002.960301.x; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Denno Robert F., 1995, P113, DOI 10.1016/B978-012159270-7/50007-5; DOEBELI M, 1995, THEOR POPUL BIOL, V47, P82, DOI 10.1006/tpbi.1995.1004; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Engen S, 2003, ECOLOGY, V84, P2378, DOI 10.1890/02-0123; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Fowler MS, 2002, J THEOR BIOL, V215, P39, DOI 10.1006/jtbi.2001.2486; Good TP, 2008, ECOL APPL, V18, P246, DOI 10.1890/06-1724.1; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; GYLLENBERG M, 1994, J MATH BIOL, V32, P93, DOI 10.1007/BF00163026; Hackney EE, 2001, CONSERV BIOL, V15, P129, DOI 10.1046/j.1523-1739.2001.98546.x; HANSON FB, 1981, THEOR POPUL BIOL, V19, P1, DOI 10.1016/0040-5809(81)90032-0; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; HASSELL MP, 1975, J ANIM ECOL, V44, P283, DOI 10.2307/3863; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; HOLT RD, 1993, J ANIM ECOL, V62, P89, DOI 10.2307/5485; Holt RD, 1997, EVOL ECOL, V11, P723, DOI 10.1023/A:1018438403047; Horvath TG, 1996, J N AM BENTHOL SOC, V15, P564, DOI 10.2307/1467807; Johnson DM, 2006, NATURE, V444, P361, DOI 10.1038/nature05242; Kokko H, 2001, EVOL ECOL RES, V3, P537; Koprowski JL, 2005, BIOL CONSERV, V126, P491, DOI 10.1016/j.biocon.2005.06.028; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; MAY RM, 1973, AM NAT, V107, P621, DOI 10.1086/282863; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; MORRIS WF, 1990, ECOLOGY, V71, P1849, DOI 10.2307/1937593; Pardini EA, 2009, ECOL APPL, V19, P387, DOI 10.1890/08-0845.1; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Purcell J, 2007, J ANIM ECOL, V76, P590, DOI 10.1111/j.1365-2656.2007.01228.x; Reluga TC, 2004, THEOR POPUL BIOL, V66, P151, DOI 10.1016/j.tpb.2004.05.003; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Salazar, 2001, THESIS PONTIFICIA U; Schoener TW, 2003, AM NAT, V162, P558, DOI 10.1086/378693; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Sibly RM, 2007, ECOL LETT, V10, P970, DOI 10.1111/j.1461-0248.2007.01092.x; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; THOMAS WR, 1980, ECOLOGY, V61, P1312, DOI 10.2307/1939039; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Whitmire SL, 2006, OECOLOGIA, V147, P230, DOI 10.1007/s00442-005-0271-5; Wilcox C, 2003, J APPL ECOL, V40, P859, DOI 10.1046/j.1365-2664.2003.00852.x; Yu SC, 2006, ATMOS SCI LETT, V7, P26, DOI 10.1002/asl.125	65	15	15	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110049	10.1371/journal.pone.0110049	http://dx.doi.org/10.1371/journal.pone.0110049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360620	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700023
J	Hou, XG; Wang, C; Wang, SY; Yang, WF; Ma, ZQ; Wang, YL; Li, CQ; Li, M; Zhang, XP; Zhao, XM; Sun, Y; Song, J; Lin, P; Liang, K; Gong, L; Wang, MJ; Liu, FQ; Li, WJ; Yan, F; Yang, JP; Wang, LS; Tian, M; Liu, JD; Zhao, RX; Chen, SH; Chen, L				Hou, Xinguo; Wang, Chuan; Wang, Shaoyuan; Yang, Weifang; Ma, Zeqiang; Wang, Yulian; Li, Chengqiao; Li, Mei; Zhang, Xiuping; Zhao, Xiangmin; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Shihong; Chen, Li			Fluctuation between Fasting and 2-H Postload Glucose State Is Associated with Glomerular Hyperfiltration in Newly Diagnosed Diabetes Patients with HbA1c < 7%	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MICROVASCULAR COMPLICATIONS; HBA(1C) VARIABILITY; RISK; NEPHROPATHY; GLYCEMIA	Objective: To investigate whether fluctuations between the fasting and 2-h postload glucose ([2-hPBG]-fasting blood glucose [FBG]) states are associated with glomerular hyperfiltration (GHF) in middle-aged and elderly Chinese patients with newly diagnosed diabetes. Design and Methods: In this study, we included 679 newly diagnosed diabetes patients who were >= 40 years old. All the subjects were divided into two groups; those with HbA1c<7% and >= 7%. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to estimate the glomerular filtration rate (GFR). GHF was defined as an eGFR >= the 90th percentile. First, a multiple linear regression analysis was used to estimate the association of 2-hPBG-FBG with eGFR. Then, a generalized additive model was used to explore the possible nonlinear relationship between 2-hPBG-FBG and eGFR. Next, the 2-hPBG-FBG values were divided into four groups as follows: 0-36, 36-72, 72-108 and >= 108 mg/dl. Finally, a multiple logistic regression analysis was used to investigate the association of 2-hPBG-FBG with the risk of GHF. Results: For the group with HbA1c<7%, the eGFR and the percentage of GHF were significantly higher compared with the group with HbA1c >= 7%. After adjusting for age, gender, body mass index (BMI), systolic blood pressure (BP), diastolic BP, fasting insulin, cholesterol, triglycerides, smoking, drinking and glycated hemoglobin (HbA1c), 2-hPBG-FBG was significantly associated with increased eGFR and an increased risk of GHF (the GHF risk increased by 64.9% for every 36.0 mg/dl [2.0 mmol/L] 2-hPBG-FBG increase) only in those patients with HbA1c<7%. Additionally, 2-hPBG-FBG and eGFR showed a nonlinear association (P<0.001). Conclusions: Increased fluctuations between the fasting and 2-h postload glucose states are closely associated with increased eGFR and an increased risk of GHF in newly diagnosed diabetes patients with HbA1c<7%.	[Hou, Xinguo; Wang, Chuan; Sun, Yu; Song, Jun; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Wang, Shaoyuan; Yang, Weifang] Shandong Univ, Lukang Hosp Jining, Jinan, Shandong, Peoples R China; [Ma, Zeqiang] China Natl Heavy Duty Truck Grp Corp Hosp, Jinan, Shandong, Peoples R China; [Wang, Yulian; Li, Chengqiao; Li, Mei] Second Peoples Hosp Jining, Dept Endocrinol, Jining, Shandong, Peoples R China; [Zhang, Xiuping; Zhao, Xiangmin] Shantui Community Hlth Ctr, Jining, Shandong, Peoples R China; [Chen, Shihong] Shandong Univ, Hosp 2, Dept Endocrinol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Chen, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China.	wangchuansdu.edu@163.com		hou, xinguo/0000-0003-2045-1290	Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases; National Natural Science Foundation of China [81100617]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; National Science and Technology Support Plan [2009BAI80B04]; Natural Science Foundation of Shandong Province [ZR2012HM014]; International Science and Technology Projects of Shandong Province [2012GGE27126]; Business Plan of Jinan Students Studying Abroad [20110407]; Special Scientific Research Fund of Clinical Medicine of the Chinese Medical Association [12030420342]	Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Science and Technology Development Projects of Shandong Province; National Science and Technology Support Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); International Science and Technology Projects of Shandong Province; Business Plan of Jinan Students Studying Abroad; Special Scientific Research Fund of Clinical Medicine of the Chinese Medical Association	This study was supported by grants from the Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases, the National Natural Science Foundation of China (No. 81100617), the Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), the National Science and Technology Support Plan (2009BAI80B04), the Natural Science Foundation of Shandong Province (ZR2012HM014), the International Science and Technology Projects of Shandong Province (2012GGE27126), the Business Plan of Jinan Students Studying Abroad (20110407), and the Special Scientific Research Fund of Clinical Medicine of the Chinese Medical Association (12030420342). The funders had no roles in the study design, data collection or analysis, in the decision to publish, or in the preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; BRENNER BM, 1981, ACTA ENDOCRINOL-COP, V97, P7; BRUCE R, 1994, DIABETES RES CLIN PR, V25, P155, DOI 10.1016/0168-8227(94)90003-5; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; Ge QM, 2010, ACTA DIABETOL, V47, pS97, DOI 10.1007/s00592-009-0140-5; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Heine RJ, 2004, DIABETIC MED, V21, P208, DOI 10.1111/j.1464-5491.2004.01149.x; Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x; Jessani S, 2014, AM J KIDNEY DIS, V63, P49, DOI 10.1053/j.ajkd.2013.07.023; Keller CK, 1996, J AM SOC NEPHROL, V7, P2627; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; LEBOVITZ HE, 1990, DIABETES CARE, V13, P1186, DOI 10.2337/diacare.13.11.1186; LEE KU, 1995, AM J KIDNEY DIS, V26, P722, DOI 10.1016/0272-6386(95)90434-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Wang Huanjun, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P818, DOI 10.3969/j.issn.1672-7347.2013.08.010; Wang JS, 2013, CHIN J INTEGR MED, V19, P217, DOI 10.1007/s11655-012-1093-z; Zelmanovitz T, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-10	30	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111173	10.1371/journal.pone.0111173	http://dx.doi.org/10.1371/journal.pone.0111173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360521	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700070
J	Liu, LL; Dong, XS				Liu, Liangliang; Dong, Xuesen			Complex Impacts of PI3K/AKT Inhibitors to Androgen Receptor Gene Expression in Prostate Cancer Cells	PLOS ONE			English	Article							SPLICE VARIANTS; AKT; AMPLIFICATION; PROGRESSION; PROTEIN; GROWTH; POTENT; MECHANISM; LY294002; 3-KINASE	Background: Androgen deprivation therapy (ADT) is the first-line treatment to metastatic prostate cancer (PCa). However, sustained expression and function of the androgen receptor (AR) gene contribute to the progression of castration resistant prostate cancers (CRPC). Additionally, tumors can adapt the PI3K/AKT survival pathway to escape ADT. Co-targeting AR and PI3K/AKT signaling has been proposed to be a more effective therapeutic means for CRPC patients. Many clinical trials are ongoing to test whether PI3K/AKT inhibitors are beneficial to PCa patients. However whether these inhibitors have any impacts on the expressions of full length AR (AR-FL) and its splice variant (AR-V7) remains unclear. Methods: Four human prostate cancer cell lines (LNCaP, LNCaP95, VCaP and 22Rv1) with different genetic backgrounds were treated with five PI3K/AKT inhibitors (LY294002, Wortmannin, BKM120, AKTi and AZD5363) and or AKT siRNA. AR and AR-V7 protein and mRNA levels were measured by immunoblotting and real-time PCR assays. AR gene transcription initiation, alternative RNA splicing and AR mRNA degradation rates were also determined. Results: PI3K/AKT inhibitors had various impacts on AR protein expressions primarily through alterations of AR gene transcription initiation and RNA splicing. However, these effects remained unchanged in the presence RNA silencing of the AKT genes. Conclusion: PI3K/AKT inhibitors have off-target effects on AR gene expression in prostate cancer cells, which shall be considered when applying these inhibitors to PCa patients, particularly patients under ADT treatment.	[Liu, Liangliang; Dong, Xuesen] Univ British Columbia, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Dong, Xuesen] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of British Columbia; University of Toronto	Dong, XS (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada.	xdong@prostatecentre.com	Dong, Xuesen/AGF-9228-2022		Canadian Institutes of Health Research [MOP-137007]; Rising Star Award from Prostate Cancer Canada [RS2013-58]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rising Star Award from Prostate Cancer Canada	This work received an operating grant from Canadian Institutes of Health Research (MOP-137007) and a Rising Star Award from Prostate Cancer Canada (RS2013-58) to Xuesen Dong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Burger MT, 2011, ACS MED CHEM LETT, V2, P774, DOI 10.1021/ml200156t; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Velasco MA, 2014, CARCINOGENESIS; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; HOBISCH A, 1995, CANCER RES, V55, P3068; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Linja MJ, 2001, CANCER RES, V61, P3550; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Liu LL, 2013, J CLIN ENDOCR METAB, V98, P218, DOI 10.1210/jc.2012-2451; Lorente D, 2014, EUR J CANCER, V50, P753, DOI 10.1016/j.ejca.2013.12.004; Marcelli M, 2000, CANCER RES, V60, P944; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Suzuki H, 1998, CANCER RES, V58, P204; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092714; Yu Y, 2013, J CLIN ENDOCR METAB, V98, P2887, DOI 10.1210/jc.2012-4000; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111	42	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e108780	10.1371/journal.pone.0108780	http://dx.doi.org/10.1371/journal.pone.0108780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360799	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700006
J	Pollmacher, J; Figge, MT				Pollmaecher, Johannes; Figge, Marc Thilo			Agent-Based Model of Human Alveoli Predicts Chemotactic Signaling by Epithelial Cells during Early Aspergillus fumigatus Infection	PLOS ONE			English	Article							FUNGAL-INFECTIONS; MACROPHAGES; TIME; EPIDEMIOLOGY; NEUTROPHILS; DEFENSE; NUMBERS; CONIDIA; SINGLE; SPORES	Aspergillus fumigatus is one of the most important human fungal pathogens, causing life-threatening diseases. Since humans inhale hundreds to thousands of fungal conidia every day, the lower respiratory tract is the primary site of infection. Current interaction networks of the innate immune response attribute fungal recognition and detection to alveolar macrophages, which are thought to be the first cells to get in contact with the fungus. At present, these networks are derived from in vitro or in situ assays, as the peculiar physiology of the human lung makes in vivo experiments, including imaging on the cell-level, hard to realize. We implemented a spatio-temporal agent-based model of a human alveolus in order to perform in silico experiments of a virtual infection scenario, for an alveolus infected with A. fumigatus under physiological conditions. The virtual analog captures the three-dimensional alveolar morphology consisting of the two major alveolar epithelial cell types and the pores of Kohn as well as the dynamic process of respiration. To the best of our knowledge this is the first agent-based model of a dynamic human alveolus in the presence of respiration. A key readout of our simulations is the first-passage-time of alveolar macrophages, which is the period of time that elapses until the first physical macrophage-conidium contact is established. We tested for random and chemotactic migration modes of alveolar macrophages and varied their corresponding parameter sets. The resulting first-passage-time distributions imply that randomly migrating macrophages fail to find the conidium before the start of germination, whereas guidance by chemotactic signals derived from the alveolar epithelial cell associated with the fungus enables a secure and successful discovery of the pathogen in time.	[Pollmaecher, Johannes; Figge, Marc Thilo] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany; [Pollmaecher, Johannes; Figge, Marc Thilo] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Figge, MT (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany.	thilo.figge@hki-jena.de	Figge, Marc Thilo/J-7547-2017	Figge, Marc Thilo/0000-0002-4044-9166	excellence graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG) [CRC/TR124 FungiNet]	excellence graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by the excellence graduate school Jena School for Microbial Communication (JSMC: https://www.jsmc.uni-jena.de/) and the CRC/TR124 FungiNet (http://www.funginet.de/), Project B4, which are both funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balashazy I, 2008, INHAL TOXICOL, V20, P611, DOI [10.1080/08958370801915291, 10.1080/08958370801915291 ]; Balloy V, 2008, J BIOL CHEM, V283, P30513, DOI 10.1074/jbc.M803149200; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; BASTACKY J, 1992, J APPL PHYSIOL, V73, P88, DOI 10.1152/jappl.1992.73.1.88; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; CHARNICK SB, 1991, B MATH BIOL, V53, P591; Codina R, 2008, J INVEST ALLERG CLIN, V18, P156; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Entschladen F, 2005, EXP CELL RES, V307, P418, DOI 10.1016/j.yexcr.2005.03.029; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; GLASGOW JE, 1989, AM REV RESPIR DIS, V139, P320, DOI 10.1164/ajrccm/139.2.320; HANSEN JE, 1975, J APPL PHYSIOL, V38, P990, DOI 10.1152/jappl.1975.38.6.990; Harvey I, 1997, FROM ANIM ANIMAT, P67; Hasenberg M, 2013, IMMUNOL REV, V251, P189, DOI 10.1111/imr.12020; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; Horn Fabian, 2012, Front Microbiol, V3, P108, DOI 10.3389/fmicb.2012.00108; Hunniger K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003479; KAWAKAMI M, 1987, J APPL PHYSIOL, V63, P1866, DOI 10.1152/jappl.1987.63.5.1866; KOZEL TR, 1989, INFECT IMMUN, V57, P3412, DOI 10.1128/IAI.57.11.3412-3417.1989; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Latge JP, 2009, ASPERGILLUS FUMIGATU; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Mokhtari Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080808; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Tokarski C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00129; WALLACE WAH, 1992, THORAX, V47, P437, DOI 10.1136/thx.47.6.437; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	40	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111630	10.1371/journal.pone.0111630	http://dx.doi.org/10.1371/journal.pone.0111630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360787	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700132
J	Saha, M; Rempt, M; Stratil, SB; Wahl, M; Pohnert, G; Weinberger, F				Saha, Mahasweta; Rempt, Martin; Stratil, Stephanie B.; Wahl, Martin; Pohnert, Georg; Weinberger, Florian			Defence Chemistry Modulation by Light and Temperature Shifts and the Resulting Effects on Associated Epibacteria of Fucus vesiculosus	PLOS ONE			English	Article							BACTERIAL COMMUNITY; CHEMICAL DEFENSE; DMSP; SURFACE; DIMETHYLSULFONIOPROPIONATE; SETTLEMENT; ECOLOGY	The goals of this study were (1) to investigate whether Fucus vesiculosus regulates the production of its antifouling defence chemicals against epibacteria in response to light limitation and temperature shifts and (2) to investigate if different surface concentrations of defence compounds shape epibacterial communities. F. vesiculosus was incubated in indoor mesocosms at five different temperature conditions (5 to 25 degrees C) and in outdoor mesocosms under six differently reduced sunlight conditions (0 to 100%), respectively. Algal surface concentrations of previously identified antifouling compounds - dimethylsulphopropionate (DMSP), fucoxanthin and proline - were determined and the bacterial community composition was characterized by in-depth sequencing of the 16S-rRNA gene. Altogether, the effect of different treatment levels upon defence compound concentrations was limited. Under all conditions DMSP alone appeared to be sufficiently concentrated to warrant for at least a partial inhibitory action against epibiotic bacteria of F. vesiculosus. In contrast, proline and fucoxanthin rarely reached the necessary concentration ranges for self-contained inhibition. Nonetheless, in both experiments along with the direct influence of temperature and light, all three compounds apparently affected the overall bacterial community composition associated with F. vesiculosus since tendencies for insensitivity towards all three compounds were observed among bacterial taxa that typically dominate those communities. Given that the concentrations of at least one of the compounds (in most cases DMSP) were always high enough to inhibit bacterial settlement, we conclude that the capacity of F. vesiculosus for such defence will hardly be compromised by shading or warming to temperatures up to 25 degrees C.	[Saha, Mahasweta; Stratil, Stephanie B.; Wahl, Martin; Weinberger, Florian] Helmholtz Zentrum Ozeanforsch GEOMAR, Dept Benth Ecol, Kiel, Germany; [Rempt, Martin; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem Bioorgan Analyt, Jena, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Friedrich Schiller University of Jena	Saha, M (corresponding author), Helmholtz Zentrum Ozeanforsch GEOMAR, Dept Benth Ecol, Kiel, Germany.	sahamahasweta@gmail.com	Weinberger, Florian/O-5554-2015; Wahl, Martin/D-2038-2016; Pohnert, Georg/D-3721-2013; Saha, Mahasweta/K-4867-2014	Weinberger, Florian/0000-0003-3366-6880; Wahl, Martin/0000-0001-8703-3857; Pohnert, Georg/0000-0003-2351-6336; Saha, Mahasweta/0000-0001-9308-1054	German academic exchange service (DAAD) [A077 1469]; Volkswagen Foundation; DFG; DFG cluster of excellence "The Future Ocean''	German academic exchange service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); DFG cluster of excellence "The Future Ocean''(German Research Foundation (DFG))	This study was supported by a PhD scholarship (A077 1469) to MS from the German academic exchange service (DAAD). MR acknowledges funding by the Volkswagen Foundation and the DFG. FW was supported financially by the DFG cluster of excellence "The Future Ocean''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TM, 2003, OIKOS, V100, P406, DOI 10.1034/j.1600-0706.2003.11680.x; Bornland T, 1989, CHLOROPHYTE ALGAE PR, P37; Brock E, 2007, MAR ECOL PROG SER, V337, P165, DOI 10.3354/meps337165; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Cronin G, 2001, CRC MAR SCI, P325; Dickschat JS, 2010, CHEMBIOCHEM, V11, P417, DOI 10.1002/cbic.200900668; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; Ferreira JG, 2014, NEW PHYTOL, DOI [10.1111/nph.12749, DOI 10.1111/NPH.12749)]; Fisher LD, 1993, SAMPLE SIZES OBSERVA, P844; Hollants J, 2013, FEMS MICROBIOL ECOL, V83, P1, DOI 10.1111/j.1574-6941.2012.01446.x; Jennings JG, 1997, OECOLOGIA, V109, P461, DOI 10.1007/s004420050106; Jormalainen V, 2009, OIKOS, V118, P713, DOI 10.1111/j.1600-0706.2008.17178.x; KARSTEN U, 1992, POLAR BIOL, V12, P603; Kasamatsu N, 2004, J PHYCOL, V40, P874, DOI 10.1111/j.1529-8817.2004.03122.x; Kim SJ, 2009, INT J SYST EVOL MICR, V59, P3030, DOI 10.1099/ijs.0.009134-0; Kirst GO, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P121; Lachnit T, 2010, BIOFOULING, V26, P247, DOI 10.1080/08927010903474189; Lyons DA, 2010, MAR ECOL PROG SER, V417, P51, DOI 10.3354/meps08818; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Nylund GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061291; Saha M, 2012, BIOFOULING, V28, P593, DOI 10.1080/08927014.2012.698615; Saha M, 2011, BIOFOULING, V27, P423, DOI 10.1080/08927014.2011.580841; Saha M, 2013, BIOFOULING, V29, P661, DOI 10.1080/08927014.2013.795953; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Spielmeyer A, 2010, J CHROMATOGR B, V878, P3238, DOI 10.1016/j.jchromb.2010.09.031; Stratil S, 2013, THESIS U KIEL KIEL; Stratil SB, 2013, MICROBIOLOGYOPEN, V2, P338, DOI 10.1002/mbo3.79; Sudatti DB, 2011, MAR BIOL, V158, P1439, DOI 10.1007/s00227-011-1660-4; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P306; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; VAS'KOVSKII V E, 1972, Khimiya Prirodnykh Soedinenii, V8, P596; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Wahl M, 2011, ADV MAR BIOL, V59, P37, DOI 10.1016/B978-0-12-385536-7.00002-9; Weinberger F, 2011, MAR ECOL PROG SER, V427, P83, DOI 10.3354/meps09044	36	33	33	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e105333	10.1371/journal.pone.0105333	http://dx.doi.org/10.1371/journal.pone.0105333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360717	Green Published, Green Accepted, gold			2022-12-27	WOS:000343943700003
J	Wang, DG; Chen, JY; Yang, LJ; Mou, YH; Yang, YJ				Wang, Dongguo; Chen, Jiayu; Yang, Linjun; Mou, Yonghua; Yang, Yijun			Phenotypic and Enzymatic Comparative Analysis of the KPC Variants, KPC-2 and Its Recently Discovered Variant KPC-15	PLOS ONE			English	Article							HYDROLYZING BETA-LACTAMASE; CARBAPENEM-RESISTANT STRAIN; KLEBSIELLA-PNEUMONIAE; IMIPENEM RESISTANCE; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; EMERGENCE; EPIDEMIOLOGY; GENES	Sixteen different variants (KPC-2 to KPC-17) in the KPC family have been reported, and most current studies are focusing on KPC-2 and KPC-3. The KPC-15 variant, which isolated from Klebsiella pneumoniae in a Chinese hospital, was a recently discovered KPC enzyme. To compare the characteristics of KPC-15 and KPC-2, the variants were determined by susceptibility testing, PCR amplification and sequencing, and study of kinetic parameters. The strain harboring the KPC-15 showed resistance to 18 conventional antimicrobial agents, especially to cabapenem antibiotics, and the strain involving the KPC-2 also indicated resistance to cabapenem antibiotics, but both strains were susceptible to polymyxin B and colistin. The conjugation experiments showed that the changes of MIC values to the antibiotics were due to the transferred plasmids. The differences of amino acids were characterised at sites of 119 leucine and 146 lysine with KPC-15 and KPC-2. The minimum evolution tree indicated the KPC alleles evolution, and showed that the KPC-15 appeared to be homogenous with KPC-4 closely. Steady-state kinetic parameters showed the catalytic efficiency of KPC-15 was higher than that of KPC-2 for all tested antibiotics in this study. The catalytic efficiency of KPC-15 caused resistance to beta-lactam antibiotics was higher than that of KPC-2. Meanwhile, an evolutionary transformation changed KPC from an efficient carbapenemase to its variants (KPC-15) with better ceftazidimase catalytic efficiency, and the old antibiotics polymyxin B and colistin might play a role in the therapy for multi-resistant strains.	[Wang, Dongguo] Taizhou Univ, Taizhou Municipal Hosp, Dept Clin Lab Med, Taizhou, Zhejiang, Peoples R China; [Wang, Dongguo; Chen, Jiayu] Taizhou Univ, Inst Mol Diagnost, Taizhou, Zhejiang, Peoples R China; [Chen, Jiayu] Taizhou Univ, Sch Med, Dept Lab Med, Taizhou, Zhejiang, Peoples R China; [Yang, Linjun] Taizhou Univ, Taizhou Municipal Hosp, Dept Thyroid Breast Surg, Taizhou, Zhejiang, Peoples R China; [Mou, Yonghua] Taizhou Univ, Taizhou Municipal Hosp, Dept Hepatobiliary Surg, Taizhou, Zhejiang, Peoples R China; [Yang, Yijun] Taizhou Univ, Taizhou Municipal Hosp, Dept Qual Control, Taizhou, Zhejiang, Peoples R China	Taizhou University; Taizhou University; Taizhou University; Taizhou University; Taizhou University; Taizhou University	Wang, DG (corresponding author), Taizhou Univ, Taizhou Municipal Hosp, Dept Clin Lab Med, Taizhou, Zhejiang, Peoples R China.	wdgtzs@163.com			Zhejiang Natural Science Foundation [Y2100248]; Foundation of the Department of Science and Technology of Zhejiang Province [2014C33153]; Foundation of the Zhejiang Health Department [2014KYB313]; Foundation of the Taizhou Science and Technology Bureau [1102KY15, 1201KY22, 1301KY36]; Foundation of the Jiaojiang Science and Technology Bureau of Taizhou, China [83041, 112071]	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Foundation of the Department of Science and Technology of Zhejiang Province; Foundation of the Zhejiang Health Department; Foundation of the Taizhou Science and Technology Bureau; Foundation of the Jiaojiang Science and Technology Bureau of Taizhou, China	This study was supported by grants from the Zhejiang Natural Science Foundation (Y2100248), the Foundation of the Department of Science and Technology of Zhejiang Province (2014C33153), the Foundation of the Zhejiang Health Department (2014KYB313), the Foundation of the Taizhou Science and Technology Bureau (1102KY15, 1201KY22 and 1301KY36), and the Foundation of the Jiaojiang Science and Technology Bureau of Taizhou (83041 and 112071), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao VTB, 2000, J ANTIMICROB CHEMOTH, V46, P895, DOI 10.1093/jac/46.6.895; CLSI, 2012, M100S22 CLSI, P31; Deshpande LM, 2006, DIAGN MICR INFEC DIS, V56, P367, DOI 10.1016/j.diagmicrobio.2006.07.004; FRERE JM, 1982, BIOCHEM J, V207, P437, DOI 10.1042/bj2070437; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Lin S, 1998, BIOCHEM J, V333, P395, DOI 10.1042/bj3330395; Lledo W., 2009, Morbidity and Mortality Weekly Report, V58, P256; Maltezou HC, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.09.003; MATAGNE A, 1995, ANTIMICROB AGENTS CH, V39, P227, DOI 10.1128/AAC.39.1.227; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P798, DOI 10.1128/AAC.01185-07; Miriagou V, 2003, ANTIMICROB AGENTS CH, V47, P1297, DOI 10.1128/AAC.47.4.1297-1300.2003; Moland ES, 2003, J ANTIMICROB CHEMOTH, V51, P711, DOI 10.1093/jac/dkg124; Naas T, 2005, ANTIMICROB AGENTS CH, V49, P4423, DOI 10.1128/AAC.49.10.4423-4424.2005; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128/AAC.00438-06; NEUWIRTH C, 1995, J ANTIMICROB CHEMOTH, V36, P335, DOI 10.1093/jac/36.2.335; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Palepou M. F., 2005, 15 EUR C CLIN MICR I; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Sacha P, 2008, FOLIA HISTOCHEM CYTO, V46, P137, DOI 10.2478/v10042-008-0020-9; Sacha P, 2007, FOLIA HISTOCHEM CYTO, V45, P405; Shen P, 2009, ANTIMICROB AGENTS CH, V53, P4333, DOI 10.1128/AAC.00260-09; Thomson JM, 2007, BIOCHEMISTRY-US, V46, P11361, DOI 10.1021/bi700792a; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Wang DG, 2014, J MED MICROBIOL, V63, P981, DOI 10.1099/jmm.0.073841-0; Wang MG, 2003, ANTIMICROB AGENTS CH, V47, P2242, DOI 10.1128/AAC.47.7.2242-2248.2003; Wieczorek P, 2008, FOLIA HISTOCHEM CYTO, V46, P257, DOI 10.2478/v10042-008-0056-x; Wolter DJ, 2009, ANTIMICROB AGENTS CH, V53, P557, DOI 10.1128/AAC.00734-08; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Wu QO, 2009, ANTIMICROB AGENTS CH, V53, P271, DOI 10.1128/AAC.00748-08; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Yigit H, 2003, ANTIMICROB AGENTS CH, V47, P3881, DOI 10.1128/AAC.47.12.3881-3889.2003; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111491	10.1371/journal.pone.0111491	http://dx.doi.org/10.1371/journal.pone.0111491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360633	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700107
J	Thomson, G; Morgan, H; Crossland, N; Bauld, L; Dykes, F; Hoddinott, P				Thomson, Gill; Morgan, Heather; Crossland, Nicola; Bauld, Linda; Dykes, Fiona; Hoddinott, Pat		BIBS Team	Unintended Consequences of Incentive Provision for Behaviour Change and Maintenance around Childbirth	PLOS ONE			English	Article							FINANCIAL INCENTIVES; SMOKING-CESSATION; QUALITY; REWARDS; CARE; PAY	Financial (positive or negative) and non-financial incentives or rewards are increasingly used in attempts to influence health behaviours. While unintended consequences of incentive provision are discussed in the literature, evidence syntheses did not identify any primary research with the aim of investigating unintended consequences of incentive interventions for lifestyle behaviour change. Our objective was to investigate perceived positive and negative unintended consequences of incentive provision for a shortlist of seven promising incentive strategies for smoking cessation in pregnancy and breastfeeding. A multi-disciplinary, mixed-methods approach included involving two service-user mother and baby groups from disadvantaged areas with experience of the target behaviours as study co-investigators. Systematic reviews informed the shortlist of incentive strategies. Qualitative semi-structured interviews and a web-based survey of health professionals asked open questions on positive and negative consequences of incentives. The participants from three UK regions were a diverse sample with and without direct experience of incentive interventions: 88 pregnant women/recent mothers/partners/family members; 53 service providers; 24 experts/decision makers and interactive discussions with 63 conference attendees. Maternity and early years health professionals (n = 497) including doctors, midwives, health visitors, public health and related staff participated in the survey. Qualitative analysis identified ethical, political, cultural, social and psychological implications of incentive delivery at population and individual levels. Four key themes emerged: how incentives can address or create inequalities; enhance or diminish intrinsic motivation and wellbeing; have a positive or negative effect on relationships with others within personal networks or health providers; and can impact on health systems and resources by raising awareness and directing service delivery, but may be detrimental to other health care areas. Financial incentives are controversial and generated emotive and oppositional responses. The planning, design and delivery of future incentive interventions should evaluate unexpected consequences to inform the evidence for effectiveness, cost-effectiveness and future implementation.	[Thomson, Gill; Crossland, Nicola; Dykes, Fiona] Univ Cent Lancashire, Sch Hlth, Maternal & Infant Nutr & Nurture Unit MAINN, Preston PR1 2HE, Lancs, England; [Morgan, Heather] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Bauld, Linda; Hoddinott, Pat] Univ Stirling, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling FK9 4LA, Scotland	University of Central Lancashire; University of Aberdeen; University of Stirling	Thomson, G (corresponding author), Univ Cent Lancashire, Sch Hlth, Maternal & Infant Nutr & Nurture Unit MAINN, Preston PR1 2HE, Lancs, England.	gthomson@uclan.ac.uk	Sniehotta, Falko F/C-5481-2008	Sniehotta, Falko F/0000-0003-1738-4269; Dykes, Fiona/0000-0002-2728-7967; Thomson, Gill/0000-0003-3392-8182; Moran, Victoria Hall/0000-0003-3165-4448; Morgan, Heather/0000-0002-6118-8911	NIHR HTA Programme [10/31/02]; Medical Research Council [MR/K023195/1B, MR/K023195/1] Funding Source: researchfish; Chief Scientist Office [HSRU2, NMAHP2] Funding Source: researchfish	NIHR HTA Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This report was commissioned by the NIHR HTA Programme as project number 10/31/02. http://www.nets.nihr.ac.uk/projects/hta/103102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BREASTF NHS BOARD RE; Ashcroft RE, 2011, HEALTH EXPECT, V14, P191, DOI 10.1111/j.1369-7625.2011.00664.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cahill K, 2008, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD004307.PUB3; Cahill K, 2008, COCHRANE DB SYST REV, V4; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub3; Cattaneo A, 2001, EUR J PUBLIC HEALTH, V11, P397, DOI 10.1093/eurpub/11.4.397; Chamberlain LB, 2006, J HUM LACT, V22, P94, DOI 10.1177/0890334405284226; Cinciripini PM, 2010, J CONSULT CLIN PSYCH, V78, P44, DOI 10.1037/a0018168; Coleman T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-167; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Edinburgh: Information Statistics Division, BREASTF STAT FIN YEA; Edinburgh: Information Statistics Division, DAT TABL BIRTHS SCOT; Fiszbein Ariel, 2009, 47603 WORLD BANK; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Frey B., 1997, NOT JUST MONEY EC TH; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Glasziou PP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5047; Graham H, 2012, USING QUALITATIVE RE; Gulliver Suzy Bird, 2004, Med Health R I, V87, P9; Heil SH, 2008, ADDICTION, V103, P1009, DOI 10.1111/j.1360-0443.2008.02237.x; Hoddinott P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000504corr1; Hoddinott P, 2013, LANCET S3, V380, pS48, DOI DOI 10.1016/S0140-6736(13)60404-3; Hoddinott P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005524; Jepson RG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-538; Johnston M, 2010, J HEALTH SERV RES PO, V15, P131, DOI 10.1258/jhsrp.2010.010048; Kane R L, 2004, Evid Rep Technol Assess (Summ), P1; Kavanagh J, 2006, SYSTEMATIC REV EVIDE; Kavanagh J, 2009, INCENTIVES IMPROVE S; Marmot M, 2004, STATUS SYNDROME; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; McAndrew F, 2012, INFANT FEEDING SURVE; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Morgan H, HLTH TECHNO IN PRESS; National Institute of Health and Clinical Excellence, 2010, US INC IMPR HLTH CIT; Park JD, 2012, PREV MED, V55, pS41, DOI 10.1016/j.ypmed.2012.06.013; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Pugh LC, 1998, APPL NURS RES, V11, P190, DOI 10.1016/S0897-1897(98)80318-2; Radley A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-343; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Schmied V, 2011, BIRTH-ISS PERINAT C, V38, P49, DOI 10.1111/j.1523-536X.2010.00446.x; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440; Tappin DM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-113; Thaler R.H., 2021, NUDGE FINAL EDITION; Thomson G, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-22; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Volpe E M, 2000, J Hum Lact, V16, P196, DOI 10.1177/089033440001600303; Walsh RA, 1997, AM J PUBLIC HEALTH, V87, P1201, DOI 10.2105/AJPH.87.7.1201	53	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111322	10.1371/journal.pone.0111322	http://dx.doi.org/10.1371/journal.pone.0111322			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2HU	25357121	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000050
J	Coluzzi, E; Colamartino, M; Cozzi, R; Leone, S; Meneghini, C; O'Callaghan, N; Sgura, A				Coluzzi, Elisa; Colamartino, Monica; Cozzi, Renata; Leone, Stefano; Meneghini, Carlo; O'Callaghan, Nathan; Sgura, Antonella			Oxidative Stress Induces Persistent Telomeric DNA Damage Responsible for Nuclear Morphology Change in Mammalian Cells	PLOS ONE			English	Article							HUMAN PRIMARY FIBROBLASTS; CHROMOSOME INSTABILITY; GENOMIC INSTABILITY; GGG SEQUENCE; COMET ASSAY; BASE DAMAGE; LENGTH; CANCER; REPAIR; MICRONUCLEUS	One main function of telomeres is to maintain chromosome and genome stability. The rate of telomere shortening can be accelerated significantly by chemical and physical environmental agents. Reactive oxygen species are a source of oxidative stress and can produce modified bases (mainly 8-oxoG) and single strand breaks anywhere in the genome. The high incidence of guanine residues in telomeric DNA sequences makes the telomere a preferred target for oxidative damage. Our aim in this work is to evaluate whether chromosome instability induced by oxidative stress is related specifically to telomeric damage. We treated human primary fibroblasts (MRC-5) in vitro with hydrogen peroxide (100 and 200 mu M) for 1 hr and collected data at several time points. To evaluate the persistence of oxidative stress-induced DNA damage up to 24 hrs after treatment, we analysed telomeric and genomic oxidative damage by qPCR and a modified comet assay, respectively. The results demonstrate that the genomic damage is completely repaired, while the telomeric oxidative damage persists. The analysis of telomere length reveals a significant telomere shortening 48 hrs after treatment, leading us to hypothesise that residual telomere damage could be responsible for the telomere shortening observed. Considering the influence of telomere length modulation on genomic stability, we quantified abnormal nuclear morphologies (Nucleoplasmic Bridges, Nuclear Buds and Micronuclei) and observed an increase of chromosome instability in the same time frame as telomere shortening. At subsequent times (72 and 96 hrs), we observed a restoration of telomere length and a reduction of chromosome instability, leaving us to conjecture a correlation between telomere shortening/dysfunction and chromosome instability. We can conclude that oxidative base damage leads to abnormal nuclear morphologies and that telomere dysfunction is an important contributor to this effect.	[Coluzzi, Elisa; Colamartino, Monica; Cozzi, Renata; Leone, Stefano; Meneghini, Carlo; Sgura, Antonella] Univ Roma Tre, Dept Sci, Rome, Italy; [O'Callaghan, Nathan] CSIRO Food & Nutr Sci, Nutr Genom Lab, Adelaide, SA, Australia	Italfarmaco; Roma Tre University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sgura, A (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	antonella.sgura@uniroma3.it	Sgura, Antonella/H-3274-2019; o'callaghan, nathan j/E-8363-2011; meneghini, carlo/F-7761-2013	meneghini, carlo/0000-0003-4846-8422; Leone, Stefano/0000-0001-6339-6397; O'Callaghan, Nathan/0000-0002-8879-1542				Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Berardinelli F, 2010, RADIAT RES, V174, P539, DOI 10.1667/RR2127.1; Berardinelli F, 2013, ENVIRON MOL MUTAGEN, V54, P172, DOI 10.1002/em.21761; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; Blackburn EH, 2000, COLD SPRING HARB SYM, V65, P253, DOI 10.1101/sqb.2000.65.253; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; COLLINS AR, 1993, CARCINOGENESIS, V14, P1733, DOI 10.1093/carcin/14.9.1733; Counter CM, 1996, MUTAT RES-REV GENET, V366, P45, DOI 10.1016/S0165-1110(96)90006-8; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Durante M, 1998, INT J RADIAT BIOL, V74, P457, DOI 10.1080/095530098141320; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2002, MUTAT RES-FUND MOL M, V504, P131, DOI 10.1016/S0027-5107(02)00086-6; Festa F, 2003, ENVIRON RES, V91, P54, DOI 10.1016/S0013-9351(02)00003-8; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffin CS, 2002, MUTAT RES-FUND MOL M, V504, P149, DOI 10.1016/S0027-5107(02)00088-X; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KirschVolders M, 1996, MUTAGENESIS, V11, P307, DOI 10.1093/mutage/11.4.307; KRUK PA, 1995, P NATL ACAD SCI USA, V92, P258, DOI 10.1073/pnas.92.1.258; Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200; Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; O'Callaghan N, 2011, BIOTECHNIQUES, V51, P403, DOI 10.2144/000113788; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Perner S, 2003, AM J PATHOL, V163, P1751, DOI 10.1016/S0002-9440(10)63534-1; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Rubio MA, 2004, EXP CELL RES, V298, P17, DOI 10.1016/j.yexcr.2004.04.004; SAITO M, 1995, EUR J PHARM-MOLEC PH, V291, P217, DOI 10.1016/0922-4106(95)90147-7; Serra V, 2000, ANN NY ACAD SCI, V908, P327; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shimizu N, 2000, MUTAT RES-FUND MOL M, V448, P81, DOI 10.1016/S0027-5107(00)00003-8; Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8; Slijepcevic Predrag, 2001, Methods in Cell Science, V23, P17, DOI 10.1023/A:1013177128297; Ting APL, 2010, J CELL MOL MED, V14, P403, DOI 10.1111/j.1582-4934.2009.00945.x; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wong HP, 2004, CYTOGENET GENOME RES, V105, P464, DOI 10.1159/000078220	56	108	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110963	10.1371/journal.pone.0110963	http://dx.doi.org/10.1371/journal.pone.0110963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354277	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200050
J	Neto, OA; Tassy, O; Biancalana, V; Zanoteli, E; Pourquie, O; Laporte, J				Neto, Osorio Abath; Tassy, Olivier; Biancalana, Valerie; Zanoteli, Edmar; Pourquie, Olivier; Laporte, Jocelyn			Integrative Data Mining Highlights Candidate Genes for Monogenic Myopathies	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DEPENDENT CALCIUM-CHANNEL; SKELETAL-MUSCLE; CONGENITAL MYOPATHIES; MUTATIONS CAUSE; DIAGNOSIS; PROTEINS; DISORDER; SPECTRUM; ACTIN	Inherited myopathies are a heterogeneous group of disabling disorders with still barely understood pathological mechanisms. Around 40% of afflicted patients remain without a molecular diagnosis after exclusion of known genes. The advent of high-throughput sequencing has opened avenues to the discovery of new implicated genes, but a working list of prioritized candidate genes is necessary to deal with the complexity of analyzing large-scale sequencing data. Here we used an integrative data mining strategy to analyze the genetic network linked to myopathies, derive specific signatures for inherited myopathy and related disorders, and identify and rank candidate genes for these groups. Training sets of genes were selected after literature review and used in Manteia, a public web-based data mining system, to extract disease group signatures in the form of enriched descriptor terms, which include functional annotation, human and mouse phenotypes, as well as biological pathways and protein interactions. These specific signatures were then used as an input to mine and rank candidate genes, followed by filtration against skeletal muscle expression and association with known diseases. Signatures and identified candidate genes highlight both potential common pathological mechanisms and allelic disease groups. Recent discoveries of gene associations to diseases, like B3GALNT2, GMPPB and B3GNT1 to congenital muscular dystrophies, were prioritized in the ranked lists, suggesting a posteriori validation of our approach and predictions. We show an example of how the ranked lists can be used to help analyze high-throughput sequencing data to identify candidate genes, and highlight the best candidate genes matching genomic regions linked to myopathies without known causative genes. This strategy can be automatized to generate fresh candidate gene lists, which help cope with database annotation updates as new knowledge is incorporated.	[Neto, Osorio Abath; Biancalana, Valerie; Laporte, Jocelyn] Univ Strasbourg, Dept Translat Med & Neurogenet, UMR7104, IGBMC,INSERM,CNRS,Coll France,U964, Strasbourg, France; [Neto, Osorio Abath; Zanoteli, Edmar] Fac Med Sao Paulo FMUSP, Dept Neurol, Sao Paulo, Brazil; [Tassy, Olivier; Pourquie, Olivier] Univ Strasbourg, Dept Dev & Stem Cells, UMR7104, IGBMC,INSERM,CNRS,Coll France,U964, Strasbourg, France; [Biancalana, Valerie] Nouvel Hop Civil, Fac Med, Lab Diagnost Genet, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Laporte, J (corresponding author), Univ Strasbourg, Dept Translat Med & Neurogenet, UMR7104, IGBMC,INSERM,CNRS,Coll France,U964, Strasbourg, France.	jocelyn@igbmc.fr	Pourquié, Olivier/CAJ-5443-2022; Abath Neto, Osorio/H-1420-2017; Biancalana, Valerie/O-2351-2016; laporte, jocelyn/J-7008-2012; Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019	Pourquié, Olivier/0000-0001-5189-1227; Abath Neto, Osorio/0000-0003-2787-5483; 	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Strasbourg University; Agence Nationale de la Recherche [ANR-11-BSV1-026]; Association Francaise contre les Myopathies [15352]; Muscular Dystrophy Association [186985]; Myotubular Trust; CAPES Foundation; Ministry of Education of Brazil [1286/51-2]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Strasbourg University; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association); Myotubular Trust; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Strasbourg University, Agence Nationale de la Recherche (ANR-11-BSV1-026), Association Francaise contre les Myopathies (15352), Muscular Dystrophy Association (186985), and Myotubular Trust (http://www.myotubulartrust.com/). OAN was supported by a fellowship from CAPES Foundation, Ministry of Education of Brazil, process number 1286/51-2 (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetturo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012742; Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510; Attali R, 2009, HUM MOL GENET, V18, P3462, DOI 10.1093/hmg/ddp290; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Blandin G, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-3; Bogershausen N, 2013, AM J HUM GENET, V93, P181, DOI 10.1016/j.ajhg.2013.05.028; Bohm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067527; Bohm J, 2013, AM J HUM GENET, V92, P271, DOI 10.1016/j.ajhg.2012.12.007; Bohm J, 2012, HUM MUTAT, V33, P949, DOI 10.1002/humu.22067; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Burguiere AC, 2011, DEV DYNAM, V240, P1856, DOI 10.1002/dvdy.22677; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; Chang SH, 2012, PROTEIN CELL, V3, P526, DOI 10.1007/s13238-012-2931-7; Cortese A, 2014, NEUROLOGY; Cuisset JM, 2013, REV NEUROL-FRANCE, V169, P632, DOI 10.1016/j.neurol.2012.11.011; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fernandez-Valle C, 2002, NAT GENET, V31, P354, DOI 10.1038/ng930; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Heatwole CR, 2013, MUSCLE NERVE, V47, P632, DOI 10.1002/mus.23683; ILES DE, 1993, HUM MOL GENET, V2, P863; Kaplan JC, GENETABLE NEUROMUSCU; Kaplan JC, 2013, NEUROMUSCULAR DISORD, V23, P1081, DOI 10.1016/j.nmd.2013.10.006; Kumamoto T, 2000, MUSCLE NERVE, V23, P1686, DOI 10.1002/1097-4598(200011)23:11<1686::AID-MUS3>3.0.CO;2-F; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058116; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Majczenko K, 2012, AM J HUM GENET, V91, P365, DOI 10.1016/j.ajhg.2012.06.012; Melia MJ, 2013, BRAIN, V136, P1508, DOI 10.1093/brain/awt074; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Mohaupt MG, 2009, CAN MED ASSOC J, V181, pE11, DOI 10.1503/cmaj.081785; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nigro Vincenzo, 2012, Acta Myol, V31, P196; Nilsson MI, 2013, AM J PATHOL, V183, P1703, DOI 10.1016/j.ajpath.2013.08.010; Ohkawara B, 2014, HUM MOL GENET, V23, P1856, DOI 10.1093/hmg/ddt578; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Randazzo D, 2013, J CELL BIOL, V200, P523, DOI 10.1083/jcb.201205118; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Robinson RL, 2000, ANN HUM GENET, V64, P307, DOI 10.1046/j.1469-1809.2000.6440307.x; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Tassy O, 2014, NUCLEIC ACIDS RES, V42, pD882, DOI 10.1093/nar/gkt807; Torella A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063536; Vasli N, 2013, ACTA NEUROPATHOL, V125, P173, DOI 10.1007/s00401-012-1072-7; VAUGHAN KT, 1993, GENOMICS, V16, P34, DOI 10.1006/geno.1993.1136; Wicik Z, 2011, POL J VET SCI, V14, P643, DOI 10.2478/v10181-011-0095-7; Zhang M, 2014, BIOCHEM BIOPH RES CO, V449, P62, DOI 10.1016/j.bbrc.2014.04.156; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	62	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110888	10.1371/journal.pone.0110888	http://dx.doi.org/10.1371/journal.pone.0110888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353622	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200045
J	Baldock, AL; Ahn, S; Rockne, R; Johnston, S; Neal, M; Corwin, D; Clark-Swanson, K; Sterin, G; Trister, AD; Malone, H; Ebiana, V; Sonabend, AM; Mrugala, M; Rockhill, JK; Silbergeld, DL; Lai, A; Cloughesy, T; McKhann, GM; Bruce, JN; Rostomily, RC; Canoll, P; Swanson, KR				Baldock, Anne L.; Ahn, Sunyoung; Rockne, Russell; Johnston, Sandra; Neal, Maxwell; Corwin, David; Clark-Swanson, Kamala; Sterin, Greg; Trister, Andrew D.; Malone, Hani; Ebiana, Victoria; Sonabend, Adam M.; Mrugala, Maciej; Rockhill, Jason K.; Silbergeld, Daniel L.; Lai, Albert; Cloughesy, Timothy; McKhann, Guy M., II; Bruce, Jeffrey N.; Rostomily, Robert C.; Canoll, Peter; Swanson, Kristin R.			Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; INDIVIDUAL PATIENTS; RADIOTHERAPY; GROWTH; PROLIFERATION; SURVIVAL; EXTENT; PROOF; MRI	Object: Malignant gliomas are incurable, primary brain neoplasms noted for their potential to extensively invade brain parenchyma. Current methods of clinical imaging do not elucidate the full extent of brain invasion, making it difficult to predict which, if any, patients are likely to benefit from gross total resection. Our goal was to apply a mathematical modeling approach to estimate the overall tumor invasiveness on a patient-by-patient basis and determine whether gross total resection would improve survival in patients with relatively less invasive gliomas. Methods: In 243 patients presenting with contrast-enhancing gliomas, estimates of the relative invasiveness of each patient's tumor, in terms of the ratio of net proliferation rate of the glioma cells to their net dispersal rate, were derived by applying a patient-specific mathematical model to routine pretreatment MR imaging. The effect of varying degrees of extent of resection on overall survival was assessed for cohorts of patients grouped by tumor invasiveness. Results: We demonstrate that patients with more diffuse tumors showed no survival benefit (P = 0.532) from gross total resection over subtotal/biopsy, while those with nodular (less diffuse) tumors showed a significant benefit (P = 0.00142) with a striking median survival benefit of over eight months compared to sub-totally resected tumors in the same cohort (an 80% improvement in survival time for GTR only seen for nodular tumors). Conclusions: These results suggest that our patient-specific, model-based estimates of tumor invasiveness have clinical utility in surgical decision making. Quantification of relative invasiveness assessed from routinely obtained pre-operative imaging provides a practical predictor of the benefit of gross total resection.	[Baldock, Anne L.; Rockne, Russell; Corwin, David; Clark-Swanson, Kamala; Swanson, Kristin R.] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Ahn, Sunyoung; Johnston, Sandra; Neal, Maxwell; Sterin, Greg] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Trister, Andrew D.; Rockhill, Jason K.] Univ Washington, Seattle, WA 98195 USA; [Malone, Hani; Ebiana, Victoria; Sonabend, Adam M.; McKhann, Guy M., II; Bruce, Jeffrey N.] Columbia Univ, Dept Neurosurg, New York, NY USA; [Mrugala, Maciej; Silbergeld, Daniel L.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Silbergeld, Daniel L.; Rostomily, Robert C.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Lai, Albert; Cloughesy, Timothy] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Swanson, Kristin R.] Univ Washington, Nancy & Buster Alvord Brain Tumor Ctr, Seattle, WA 98195 USA; [Swanson, Kristin R.] Northwestern Brain Tumor Inst, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Columbia University; University of Washington; University of Washington Seattle; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center	Swanson, KR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA.	kristin.swanson@northwestern.edu	Rockne, Russell/T-1549-2017; Bruce, Jeffrey N/AAC-5307-2022; Cloughesy, Timothy Francis/AGV-1013-2022	Rockne, Russell/0000-0002-1557-159X; Rostomily, Robert/0000-0003-1431-162X; Neal, Maxwell/0000-0002-2390-6572; Malone, Hani/0000-0002-4180-7017	James S. McDonnell Foundation; University of Washington Academic Pathology fund; National Institutes of Health [U54 CA143970, R01 NS060752, R01 CA16437]; James D. Murray Endowed Chair in the Nancy and Buster Alvord Brain Tumor Center at the University of Washington; Northwestern Brain Tumor Institute; Zell Scholars Fund; Wirtz Innovation Fund at Northwestern University; NATIONAL CANCER INSTITUTE [U54CA143970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060752] Funding Source: NIH RePORTER	James S. McDonnell Foundation; University of Washington Academic Pathology fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James D. Murray Endowed Chair in the Nancy and Buster Alvord Brain Tumor Center at the University of Washington; Northwestern Brain Tumor Institute; Zell Scholars Fund; Wirtz Innovation Fund at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research supported by James S. McDonnell Foundation, the University of Washington Academic Pathology fund, the National Institutes of Health (U54 CA143970, R01 NS060752, R01 CA16437), the James D. Murray Endowed Chair in the Nancy and Buster Alvord Brain Tumor Center at the University of Washington as well as the Northwestern Brain Tumor Institute, the Zell Scholars Fund and the Wirtz Innovation Fund at Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita H, 2011, CANCER; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Eyupoglu IY, 2013, NAT REV NEUROL; GARDNER WJ, 1955, BRAIN, V78, P487, DOI 10.1093/brain/78.4.487; Gu S, 2011, APPL PATIENT SPECIFI; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Kubben PL, 2011, LANCET ONCOL, V12, P1062, DOI 10.1016/S1470-2045(11)70130-9; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Neal ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051951; Ngwenya LB, 2011, J NEUROSURG, V115, P1, DOI 10.3171/2010.9.JNS101437; Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582; Ramakrishna R, 2010, SURG NEUROL INT, P1; Roberts DW, 2011, J NEUROSURG, V114, P595, DOI 10.3171/2010.2.JNS091322; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Senft C, 2011, LANCET ONCOL; Stummer W, 2011, ACTA NEUROCHIR, V153, P1211, DOI 10.1007/s00701-011-1001-x; Swanson K, 2002, NEUROONCOL; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Swanson K. R., 1999, MATH MODELING GROWTH; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2002, BIOMATHEMATICAL PATH; Swanson KR, 2008, MATH COMPUT MODEL, V47, P638, DOI 10.1016/j.mcm.2007.02.024; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; Wang CH, 2009, CANCER RES, V69, P9133, DOI 10.1158/0008-5472.CAN-08-3863; Zinn PO, 2013, INT J ONCOL, V42, P929, DOI 10.3892/ijo.2013.1770	28	57	57	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e99057	10.1371/journal.pone.0099057	http://dx.doi.org/10.1371/journal.pone.0099057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350742	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100001
J	Lu, S; Pardini, B; Cheng, B; Naccarati, A; Huhn, S; Vymetalkova, V; Vodickova, L; Buchler, T; Hemminki, K; Vodicka, P; Forsti, A				Lu, Shun; Pardini, Barbara; Cheng, Bowang; Naccarati, Alessio; Huhn, Stefanie; Vymetalkova, Veronika; Vodickova, Ludmila; Buchler, Thomas; Hemminki, Kari; Vodicka, Pavel; Forsti, Asta			Single Nucleotide Polymorphisms within Interferon Signaling Pathway Genes Are Associated with Colorectal Cancer Susceptibility and Survival	PLOS ONE			English	Article							IFN-GAMMA RECEPTOR; PROMOTER POLYMORPHISMS; ALPHA PROMOTES; RISK; COLON; IDENTIFICATION; EXPRESSION; LOCI; POLB	Interferon (IFN) signaling has been suggested to play an important role in colorectal carcinogenesis. Our study aimed to examine potentially functional genetic variants in interferon regulatory factor 3 (IRF3), IRF5, IRF7, type I and type II IFN and their receptor genes with respect to colorectal cancer (CRC) risk and clinical outcome. Altogether 74 single nucleotide polymorphisms (SNPs) were covered by the 34 SNPs genotyped in a hospital-based case-control study of 1327 CRC cases and 758 healthy controls from the Czech Republic. We also analyzed these SNPs in relation to overall survival and event-free survival in a subgroup of 483 patients. Seven SNPs in IFNA1, IFNA13, IFNA21, IFNK, IFNAR1 and IFNGR1 were associated with CRC risk. After multiple testing correction, the associations with the SNPs rs2856968 (IFNAR1) and rs2234711 (IFNGR1) remained formally significant (P = 0.0015 and P<0.0001, respectively). Multivariable survival analyses showed that the SNP rs6475526 (IFNA7/IFNA14) was associated with overall survival of the patients (P = 0.041 and event-free survival among patients without distant metastasis at the time of diagnosis, P = 0.034). The hazard ratios (HRs) for rs6475526 remained statistically significant even after adjustment for age, gender, grade and stage (P = 0.029 and P = 0.036, respectively), suggesting that rs6475526 is an independent prognostic marker for CRC. Our data suggest that genetic variation in the IFN signaling pathway genes may play a role in the etiology and survival of CRC and further studies are warranted.	[Lu, Shun; Cheng, Bowang; Huhn, Stefanie; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Pardini, Barbara; Naccarati, Alessio] Human Genet Fdn HuGeF, Turin, Italy; [Naccarati, Alessio; Vymetalkova, Veronika; Vodickova, Ludmila; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic; [Vymetalkova, Veronika; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Vodickova, Ludmila] Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic; [Buchler, Thomas] Thomayer Hosp, Dept Oncol, Prague, Czech Republic; [Hemminki, Kari; Forsti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Thomayer Hospital; Lund University	Forsti, A (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	a.foersti@dkfz.de	Vymetalkova, Veronika/H-3167-2014; Pardini, Barbara/ABI-2295-2020; Buchler, Tomas/I-6580-2017; Pardini, Barbara/K-9451-2016	Vymetalkova, Veronika/0000-0001-6870-6788; Pardini, Barbara/0000-0001-9571-4257; Buchler, Tomas/0000-0001-6667-994X; Pardini, Barbara/0000-0001-9571-4257	Grant agency of the Czech Republic (GACR) [CZ:GACR:GA P304/10/1286, P304/12/1585]; COST Action [BM1206]	Grant agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); COST Action(European Cooperation in Science and Technology (COST))	This study was supported by the Grant agency of the Czech Republic (GACR) [CZ:GACR:GA P304/10/1286 and P304/12/1585] and COST Action BM1206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2011, GENES IMMUN, V12, P653, DOI 10.1038/gene.2011.43; Burghel GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083859; Canedo P, 2008, GUT, V57, P1504, DOI 10.1136/gut.2007.143578; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Chen CG, 2012, AM J PATHOL, V180, P661, DOI 10.1016/j.ajpath.2011.10.040; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; Esteban-Jurado C, 2014, WORLD J GASTROENTERO, V20, P1961, DOI 10.3748/wjg.v20.i8.1961; Garrity-Park MM, 2008, AM J GASTROENTEROL, V103, P407, DOI 10.1111/j.1572-0241.2007.01572.x; Hemminki K, 2009, AM J GASTROENTEROL, V104, P789, DOI 10.1038/ajg.2008.100; Hiroishi K, 2000, J IMMUNOL, V164, P567, DOI 10.4049/jimmunol.164.2.567; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Iwatsuki M, 2009, J SURG ONCOL, V100, P261, DOI 10.1002/jso.21275; Juliger S, 2003, IMMUNOGENETICS, V54, P675, DOI 10.1007/s00251-002-0516-y; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Leyva L, 2005, J NEUROIMMUNOL, V163, P165, DOI 10.1016/j.jneuroim.2005.02.010; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lu S, 2013, INT J CANCER, V133, P2325, DOI 10.1002/ijc.28251; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Pardini B, 2011, MUTAT RES-GEN TOX EN, V721, P74, DOI 10.1016/j.mrgentox.2010.12.008; Pechlivanis S, 2009, EUR J ENDOCRINOL, V160, P933, DOI 10.1530/EJE-09-0039; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rosenzweig SD, 2004, CLIN IMMUNOL, V112, P113, DOI 10.1016/j.clim.2004.03.018; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Valle L, 2014, HUM MOL GENET; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang Y, 2008, CANCER RES, V68, P1136, DOI 10.1158/0008-5472.CAN-07-5021; Whiffin N, 2014, HUM MOL GENET, V23, P4729, DOI 10.1093/hmg/ddu177; Wilkening S, 2008, CARCINOGENESIS, V29, P1202, DOI 10.1093/carcin/bgn101; Wong KK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh072; Yang JL, 2005, ONCOLOGY-BASEL, V69, P224, DOI 10.1159/000088070; Yang JL, 2005, CANCER LETT, V225, P61, DOI 10.1016/j.canlet.2004.11.041; Zhou CX, 2012, GENE, V507, P95, DOI 10.1016/j.gene.2012.06.073; Zhou J, 2009, IMMUNOGENETICS, V61, P423, DOI 10.1007/s00251-009-0377-8; Zufferey C, 2009, IMMUNOLOGY, V128, P351, DOI 10.1111/j.1365-2567.2009.03110.x	45	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111061	10.1371/journal.pone.0111061	http://dx.doi.org/10.1371/journal.pone.0111061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350395	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100052
J	Sengupta, MB; Basu, M; Iswarari, S; Mukhopadhyay, KK; Sardar, KP; Acharyya, B; Mohanty, PK; Mukhopadhyay, D				Sengupta, Mohor Biplab; Basu, Mahashweta; Iswarari, Sourav; Mukhopadhyay, Kiran Kumar; Sardar, Krishna Pada; Acharyya, Biplab; Mohanty, Pradeep K.; Mukhopadhyay, Debashis			CSF Proteomics of Secondary Phase Spinal Cord Injury in Human Subjects: Perturbed Molecular Pathways Post Injury	PLOS ONE			English	Article							AXON REGENERATION; GENE-EXPRESSION; RECEPTORS; NETWORKS; PREVALENCE; ACTIVATION	Recovery of sensory and motor functions following traumatic spinal cord injury (SCI) is dependent on injury severity. Here we identified 49 proteins from cerebrospinal fluid (CSF) of SCI patients, eight of which were differentially abundant among two severity groups of SCI. It was observed that the abundance profiles of these proteins change over a time period of days to months post SCI. Statistical analysis revealed that these proteins take part in several molecular pathways including DNA repair, protein phosphorylation, tRNA transcription, iron transport, mRNA metabolism, immune response and lipid and ATP catabolism. These pathways reflect a set of mechanisms that the system may adopt to cope up with the assault depending on the injury severity, thus leading to observed physiological responses. Apart from putting forward a picture of the molecular scenario at the injury site in a human study, this finding further delineates consequent pathways and molecules that may be altered by external intervention to restrict neural degeneration.	[Sengupta, Mohor Biplab; Mukhopadhyay, Debashis] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, W Bengal, India; [Basu, Mahashweta; Mohanty, Pradeep K.] Saha Inst Nucl Phys, Condensed Matter Phys Div, Kolkata, W Bengal, India; [Iswarari, Sourav] Nil Ratan Sircar Med Coll & Hosp, Dept Phys Med & Rehabil, Kolkata, W Bengal, India; [Mukhopadhyay, Kiran Kumar; Sardar, Krishna Pada; Acharyya, Biplab] Nil Ratan Sircar Med Coll & Hosp, Dept Orthopaed Surg, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics	Mukhopadhyay, D (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata, W Bengal, India.	debashis.mukhopadhyay@saha.ac.in	Iswarari, Sourav/J-6322-2019	Mohanty, Pradeep Kumar/0000-0002-5240-8396	Project Title: Integrative Biology on Omics Platform (IBOP), Department of Atomic Energy (DAE), Government of India [12-RD-SIN-5.04-0101]; Council of Scientific and Industrial Research (CSIR), Government of India	Project Title: Integrative Biology on Omics Platform (IBOP), Department of Atomic Energy (DAE), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Grant Number: 12-R&D-SIN-5.04-0101, Project Title: Integrative Biology on Omics Platform (IBOP), Department of Atomic Energy (DAE), Government of India, author receiving funding: DM. MBS acknowledges Council of Scientific and Industrial Research (CSIR), Government of India, for her fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Beattie MS, 2000, TOP SPINAL CORD INJ, V6, P14; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Chakrabarti Arunabha, 2012, Genomics Proteomics & Bioinformatics, V10, P208, DOI 10.1016/j.gpb.2012.07.002; Chan Danny T M, 2004, Asian J Surg, V27, P39, DOI 10.1016/S1015-9584(09)60242-6; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Esposito E, 2012, J NEUROINFLAMM, V9, P1; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; Filbin MT, 2003, NAT REV NEUROSCI, V4, P1019, DOI 10.1038/nrn1288; Floriddia EM, 2012, J NEUROSCI, V32, P13956, DOI 10.1523/JNEUROSCI.1925-12.2012; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Koszyca B, 2002, J CLIN NEUROSCI, V9, P298, DOI 10.1054/jocn.2001.0969; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Light M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-122; Lin YH, 2012, FASEB J, V26, P81, DOI 10.1096/fj.11-192914; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Rabert D, 2004, J CLIN NEUROSCI, V11, P289, DOI 10.1016/j.jocn.2003.05.008; RAZDAN S, 1994, NEUROEPIDEMIOLOGY, V13, P113, DOI 10.1159/000110368; Roy S, 2013, CLIN BIOCHEM, V46, P160, DOI 10.1016/j.clinbiochem.2012.10.028; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi ZX, 2014, J BIOL CHEM, V289, P6415, DOI 10.1074/jbc.M113.515601; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tachibana T, 2002, NEUROSCI LETT, V327, P133, DOI 10.1016/S0304-3940(02)00375-0; Wang HD, 2013, BRIT J PHARMACOL, V170, P796, DOI 10.1111/bph.12301; Yang H, 2012, NEUROCHEM INT, V61, P175, DOI 10.1016/j.neuint.2012.04.020; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhao GJ, 2012, MOL MED, V18, P149, DOI 10.2119/molmed.2011.00183	36	21	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110885	10.1371/journal.pone.0110885	http://dx.doi.org/10.1371/journal.pone.0110885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350754	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100046
J	Wang, B; Yang, XL				Wang, Bo; Yang, Xiaolan			Teasing Apart the Effects of Seed Size and Energy Content on Rodent Scatter-Hoarding Behavior	PLOS ONE			English	Article							OAK-DISPERSAL SYNDROME; CACHING BEHAVIOR; ACORN DISPERSAL; PREDATION; TANNIN; DISTANCE; RAIN; REMOVAL; FOREST; PREFERENCES	Scatter-hoarding rodents are known to play a crucial role in the seed dispersal of many plant species. Numerous studies have indicated that both seed size and the energy content of seeds can affect rodent foraging behavior. However, seed size is usually associated with energy content per seed, making it difficult to isolate how seed size and energy affect rodent foraging preferences. This study used 99 treatments of artificial seeds (11 seed sizesx9 levels of energy content) to tease apart the effect of seed size and energy content on rodent seed-caching behavior. Both seed traits showed significant effects, but their details depended on the stage of the rodent foraging process. Seeds with higher energy content were harvested more rapidly while seed size only had a modest effect on harvest rate. However, after harvesting, seed size showed a much stronger effect on rodent foraging behavior. Rodents' choice of which seeds to remove and cache, as well as seed dispersal distance, seemed to reflect an optimal seed size. Our findings could be adapted in future studies to gain a better understanding of scatter-hoarding rodent foraging behavior, and the co-evolutionary dynamics between plant seed production and seed dispersers.	[Wang, Bo; Yang, Xiaolan] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan Province, Peoples R China; [Yang, Xiaolan] Southwest Forestry Univ, Ecotourism Fac, Kunming, Yunnan Province, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Southwest Forestry University - China	Wang, B (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Mengla, Yunnan Province, Peoples R China.	yangblue@xtbg.org.cn		Wang, Bo/0000-0003-1010-6573	National Natural Science Foundation of China [31470494, 31100315]; Chinese Academy of Sciences [KSCX2-EW-Q-17]; Youth Innovation Promotion Association of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of Chinese Academy of Sciences	This study was supported by the National Natural Science Foundation of China (31470494 & 31100315), Key Project of Chinese Academy of Sciences (KSCX2-EW-Q-17), and the Youth Innovation Promotion Association of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelmess EL, 2001, ETHOL ECOL EVOL, V13, P115; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Beck MJ, 2010, J ECOL, V98, P1300, DOI 10.1111/j.1365-2745.2010.01716.x; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Chang G, 2012, PLANT ECOL, V213, P1633, DOI 10.1007/s11258-012-0118-1; Forget P.-M., 1998, P25; FORGET PM, 1991, OECOLOGIA, V87, P596, DOI 10.1007/BF00320426; Guimaraes PR, 2003, J CHEM ECOL, V29, P1065, DOI 10.1023/A:1023817203748; Holl KD, 1997, BIOTROPICA, V29, P459, DOI 10.1111/j.1744-7429.1997.tb00040.x; JACOBS LF, 1992, ANIM BEHAV, V43, P522, DOI 10.1016/S0003-3472(05)80111-3; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; Jansen Patrick A., 2002, P209, DOI 10.1079/9780851995250.0209; Jenkins SH, 1998, J MAMMAL, V79, P1221, DOI 10.2307/1383013; KERLEY GIH, 1991, OECOLOGIA, V86, P261, DOI 10.1007/BF00317539; Kollmann J, 1998, FUNCT ECOL, V12, P683, DOI 10.1046/j.1365-2435.1998.00239.x; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Li HJ, 2007, FOREST ECOL MANAG, V242, P511, DOI 10.1016/j.foreco.2007.01.063; LIMA SL, 1985, ANIM BEHAV, V33, P155, DOI 10.1016/S0003-3472(85)80129-9; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Moles AT, 1999, NEW ZEAL J BOT, V37, P83, DOI 10.1080/0028825X.1999.9512615; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Munoz A, 2008, ANIM BEHAV, V76, P709, DOI 10.1016/j.anbehav.2008.03.017; Perea R, 2012, EUR J FOREST RES, V131, P623, DOI 10.1007/s10342-011-0536-y; Perea R, 2011, ANIM BEHAV, V82, P717, DOI 10.1016/j.anbehav.2011.07.001; Perea R, 2011, BASIC APPL ECOL, V12, P432, DOI 10.1016/j.baae.2011.05.002; R Development Core Team, 2014, R LANG ENV STAT COMP; Smallwood PD, 2001, AM ZOOL, V41, P840, DOI 10.1668/0003-1569(2001)041[0840:TUBOTC]2.0.CO;2; SMALLWOOD PD, 1986, ECOLOGY, V67, P168, DOI 10.2307/1938515; Steele MA, 2001, AM ZOOL, V41, P852, DOI 10.1668/0003-1569(2001)041[0852:TPBOTO]2.0.CO;2; STEELE MA, 1993, AM MIDL NAT, V130, P229, DOI 10.2307/2426123; Steele Michael A., 1998, Virginia Museum of Natural History Special Publication, V6, P223; Stephens D.W., 1986, pi; Takahashi K, 2007, FOREST ECOL MANAG, V250, P187, DOI 10.1016/j.foreco.2007.05.014; Theimer TC, 2003, J TROP ECOL, V19, P95, DOI 10.1017/S0266467403003110; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB, 1998, CAN J ZOOL, V76, P154, DOI 10.1139/cjz-76-1-154; Vander Wall SB, 2003, OIKOS, V100, P25, DOI 10.1034/j.1600-0706.2003.11973.x; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; WAITE TA, 1994, ANIM BEHAV, V48, P1466, DOI 10.1006/anbe.1994.1385; Wall SBV, 1995, OIKOS, V74, P533, DOI 10.2307/3545999; Wang B, 2008, ACTA OECOL, V34, P379, DOI 10.1016/j.actao.2008.07.001; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wang B, 2012, PLANT ECOL, V213, P1329, DOI 10.1007/s11258-012-0091-8; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040640; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026424; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Xiao ZS, 2008, ANIM BEHAV, V75, P1235, DOI 10.1016/j.anbehav.2007.08.017; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020; Xiao ZS, 2005, ACTA OECOL, V28, P221, DOI 10.1016/j.actao.2005.04.006; Xiao ZS, 2004, FOREST ECOL MANAG, V195, P141, DOI 10.1016/j.foreco.2004.02.041	52	22	22	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111389	10.1371/journal.pone.0111389	http://dx.doi.org/10.1371/journal.pone.0111389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350369	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100069
J	Awata, T; Yamashita, H; Kurihara, S; Morita-Ohkubo, T; Miyashita, Y; Katayama, S; Mori, K; Yoneya, S; Kohda, M; Okazaki, Y; Maruyama, T; Shimada, A; Yasuda, K; Nishida, N; Tokunaga, K; Koike, A				Awata, Takuya; Yamashita, Hisakuni; Kurihara, Susumu; Morita-Ohkubo, Tomoko; Miyashita, Yumi; Katayama, Shigehiro; Mori, Keisuke; Yoneya, Shin; Kohda, Masakazu; Okazaki, Yasushi; Maruyama, Taro; Shimada, Akira; Yasuda, Kazuki; Nishida, Nao; Tokunaga, Katsushi; Koike, Asako			A Genome-Wide Association Study for Diabetic Retinopathy in a Japanese Population: Potential Association with a Long Intergenic Non-Coding RNA	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; SUSCEPTIBILITY GENES; MEXICAN-AMERICANS; MACULAR EDEMA; STARR COUNTY; POLYMORPHISM; GENETICS; PROTEIN; VASOREGRESSION; CILIOPATHIES	Elucidation of the genetic susceptibility factors for diabetic retinopathy (DR) is important to gain insight into the pathogenesis of DR, and may help to define genetic risk factors for this condition. In the present study, we conducted a three-stage genome-wide association study (GWAS) to identify DR susceptibility loci in Japanese patients, which comprised a total of 837 type 2 diabetes patients with DR (cases) and 1,149 without DR (controls). From the stage 1 genome-wide scan of 446 subjects (205 cases and 241 controls) on 614,216 SNPs, 249 SNPs were selected for the stage 2 replication in 623 subjects (335 cases and 288 controls). Eight SNPs were further followed up in a stage 3 study of 297 cases and 620 controls. The top signal from the present association analysis was rs9362054 in an intron of RP1-90L14.1 showing borderline genomewide significance (P-met = 1.4x10(-7), meta-analysis of stage 1 and stage 2, allele model). RP1-90L14.1 is a long intergenic noncoding RNA (lincRNA) adjacent to KIAA1009/QN1/CEP162 gene; CEP162 plays a critical role in ciliary transition zone formation before ciliogenesis. The present study raises the possibility that the dysregulation of ciliary-associated genes plays a role in susceptibility to DR.	[Awata, Takuya; Yamashita, Hisakuni; Kurihara, Susumu; Morita-Ohkubo, Tomoko; Katayama, Shigehiro] Saitama Med Univ, Fac Med, Dept Endocrinol & Diabet, Saitama, Japan; [Miyashita, Yumi] Saitama Med Univ, Biomed Res Ctr, Div RI Lab, Saitama, Japan; [Mori, Keisuke; Yoneya, Shin] Saitama Med Univ, Fac Med, Dept Ophthalmol, Saitama, Japan; [Kohda, Masakazu; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Saitama, Japan; [Maruyama, Taro] Saitama Social Insurance Hosp, Dept Internal Med, Saitama, Japan; [Shimada, Akira] Saiseikai Cent Hosp, Dept Internal Med, Tokyo, Japan; [Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Metab Disorder, Tokyo, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Nishida, Nao; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Koike, Asako] Hitachi Ltd, Cent Res Lab, Tokyo, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Tokyo Saiseikai Central Hospital; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; University of Tokyo; Hitachi Limited	Awata, T (corresponding author), Saitama Med Univ, Fac Med, Dept Endocrinol & Diabet, Saitama, Japan.	awatatakuya@gmail.com		Awata, Takuya/0000-0003-2622-8129; Okazaki, Yasushi/0000-0003-3241-5502; KOHDA, Masakazu/0000-0001-5970-2224	MEXT of Japan; National Center for Global Health and Medicine; JST (Japan Science and Technology Agency)	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); JST (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST))	This study was supported in part by a Grant-in-Aid for the Support Project of Strategic Research Center in Private Universities to the Saitama Medical University Research Center for Genomic Medicine from MEXT of Japan, research grants from National Center for Global Health and Medicine, and "Database Integration Coordination Program'' from JST (Japan Science and Technology Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2011, CURR DIABETES REV, V7, P190, DOI 10.2174/157339911795843168; Abhary S, 2009, DIABETES, V58, P2137, DOI 10.2337/db09-0059; Arts HH, 2013, PEDIATR NEPHROL, V28, P863, DOI 10.1007/s00467-012-2259-9; Awata T, 2005, BIOCHEM BIOPH RES CO, V333, P679, DOI 10.1016/j.bbrc.2005.05.167; Awata T, 2004, DIABETES CARE, V27, P2184, DOI 10.2337/diacare.27.9.2184; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Awata T, 2013, BIOCHEM BIOPH RES CO, V437, P521, DOI 10.1016/j.bbrc.2013.06.102; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; Emanuele N, 2005, DIABETES CARE, V28, P1954, DOI 10.2337/diacare.28.8.1954; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Feng Y, 2014, ACTA DIABETOL, V51, P211, DOI 10.1007/s00592-013-0488-4; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Fu YP, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/861291; Grassi MA, 2011, HUM MOL GENET, V20, P2472, DOI 10.1093/hmg/ddr121; Hallman DM, 2007, DIABETES, V56, P1167, DOI 10.2337/db06-1373; Hallman DM, 2005, DIABETES CARE, V28, P1163, DOI 10.2337/diacare.28.5.1163; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hotta K, 2011, J HUM GENET, V56, P647, DOI 10.1038/jhg.2011.74; Huang YC, 2011, OPHTHALMOLOGY, V118, P642, DOI 10.1016/j.ophtha.2010.07.020; Iizuka H, 2007, BIOCHEM BIOPH RES CO, V361, P421, DOI 10.1016/j.bbrc.2007.07.025; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Kuo JZ, 2014, JAMA OPHTHALMOL, V132, P96, DOI 10.1001/jamaophthalmol.2013.5024; Leon A, 2006, ONCOGENE, V25, P1887, DOI 10.1038/sj.onc.1209215; LESLIE RDG, 1982, DIABETES, V31, P19, DOI 10.2337/diabetes.31.1.19; Looker HC, 2007, DIABETES, V56, P1160, DOI 10.2337/db06-1299; Monti MC, 2007, J CLIN ENDOCR METAB, V92, P4650, DOI 10.1210/jc.2007-1185; Neron B, 2001, MECH DEVELOP, V102, P107, DOI 10.1016/S0925-4773(01)00297-0; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu M, 2013, GENE, V518, P310, DOI 10.1016/j.gene.2013.01.018; Rema M, 2002, DIABETIC MED, V19, P910, DOI 10.1046/j.1464-5491.2002.00820.x; Schwartz SG, 2013, CURR DIABETES REV, V9, P86, DOI 10.2174/1573399811309010086; Sheu WHH, 2013, HUM MOL GENET, V22, P3165, DOI 10.1093/hmg/ddt161; Simo-Servat O, 2013, CURR GENOMICS, V14, P289, DOI 10.2174/13892029113149990008; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang WJ, 2013, NAT CELL BIOL, V15, P591, DOI 10.1038/ncb2739; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wheway G, 2014, ORGANOGENESIS, V10, P69, DOI 10.4161/org.26710; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zhang XD, 2010, EUR J OPHTHALMOL, V20, P911, DOI 10.1177/112067211002000516	48	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111715	10.1371/journal.pone.0111715	http://dx.doi.org/10.1371/journal.pone.0111715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364816	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100110
J	Reikeras, O; Borgen, P				Reikeras, Olav; Borgen, Pal			Activation of Markers of Inflammation, Coagulation and Fibrinolysis in Musculoskeletal Trauma	PLOS ONE			English	Article							MULTIPLE ORGAN DYSFUNCTION; HIP-REPLACEMENT SURGERY; FEMORAL FRACTURES; INTERLEUKIN-6; CYTOKINES; INSTRUMENTATION; THROMBOSIS; INJURY; IL-8	Background: Traumatic injury induces changes in mediators of inflammation and coagulation, but the pivotal roles of inflammation and coagulation has not been precisely clarified. Therefore we have studied markers of inflammation and coagulation after a standardized musculoskeletal trauma like total hip replacement surgery. Methods: We allocated 21 patients aged 50 to 84 years who underwent total hip replacement surgery. Releases of TNF-alpha, IL-1 beta, IL-6, IL-8 and IL-10 and protrombin fragment F1.2 and plasmin-antiplasmin complex (PAP) were examined during surgery and up 6 days postoperatively, and systemic releases were compared to pre-operative values. Surgery induced significant increments in serum levels of IL-6 at 6 hours and at 1 day after surgery and in levels of IL-8 at 6 hours after surgery. There were no significant changes in serum levels of TNF-alpha, IL-1 beta or IL-10. There were significant increments in blood levels of F1.2 and PAP up to 6 days postoperatively with highest levels at 6 hours after surgery. There were only week correlations between IL-6 and IL-8 and F1.2 and PAP. Conclusion: Major musculoskeletal surgery causes changes of the inflammatory, coagulatory and fibrinolytic cascades in stable patients, but with no correlations between inflammation and coagulation and fibrinolysis.	[Reikeras, Olav] Oslo Univ Hosp, Rikshosp, Inst Clin Med, Oslo, Norway; [Borgen, Pal] Martina Hansens Hosp, Oslo, Norway	University of Oslo; National Hospital Norway	Reikeras, O (corresponding author), Oslo Univ Hosp, Rikshosp, Inst Clin Med, Oslo, Norway.	olav.reikeras@ous-hf.no						Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Arnesen H, 2003, J THROMB HAEMOST, V1, P971, DOI 10.1046/j.1538-7836.2003.00111.x; BAIGRIE RJ, 1992, BRIT J SURG, V79, P757, DOI 10.1002/bjs.1800790813; Bastian D, 2008, EUR SURG RES, V41, P334, DOI 10.1159/000157176; CHEADLE WG, 1991, AM J SURG, V161, P639, DOI 10.1016/0002-9610(91)91247-G; Dahl OE, 1995, BLOOD COAGUL FIBRIN, V6, P709, DOI 10.1097/00001721-199512000-00003; Easton R, 2014, INJURY, V45, P934, DOI 10.1016/j.injury.2013.12.002; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Flohe S, 2004, INTENS CARE MED, V30, P96, DOI 10.1007/s00134-003-2041-3; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Giannoudis PV, 2010, INJURY, V41, pS57, DOI 10.1016/S0020-1383(10)70011-5; Giannoudis PV, 1999, J BONE JOINT SURG BR, V81B, P356, DOI 10.1302/0301-620X.81B2.8988; HEIM D, 1995, J TRAUMA, V38, P899, DOI 10.1097/00005373-199506000-00013; Horn F, 2000, IMMUNOBIOLOGY, V202, P151, DOI 10.1016/S0171-2985(00)80061-3; JORGENSEN LN, 1990, THROMB RES, V59, P69, DOI 10.1016/0049-3848(90)90272-E; KWAAN HC, 1984, SEMIN THROMB HEMOST, V10, P71, DOI 10.1055/s-2007-1004409; Lee CC, 2001, ANN EMERG MED, V38, P170, DOI 10.1067/mem.2001.114313; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Mimasaka S, 2007, INJURY, V38, P1047, DOI 10.1016/j.injury.2007.02.045; Neunaber C, 2013, IMMUNOL LETT, V152, P159, DOI 10.1016/j.imlet.2013.05.012; Ozturk H, 2008, PEDIATR SURG INT, V24, P235, DOI 10.1007/s00383-007-2083-7; Pape HC, 1998, J TRAUMA, V45, P720, DOI 10.1097/00005373-199810000-00017; Pape HC, 2000, CRIT CARE MED, V28, P3441, DOI 10.1097/00003246-200010000-00012; Pape HC, 2003, J TRAUMA, V55, P7, DOI 10.1097/01.TA.0000075787.69695.4E; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; RISEBOROUGH EJ, 1976, CLIN ORTHOP RELAT R, P248; SAKAMOTO K, 1994, CYTOKINE, V6, P181, DOI 10.1016/1043-4666(94)90040-X; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004	31	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e107881	10.1371/journal.pone.0107881	http://dx.doi.org/10.1371/journal.pone.0107881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364904	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100003
J	Cella, L; Palma, G; Deasy, JO; Oh, JH; Liuzzi, R; D'Avino, V; Conson, M; Pugliese, N; Picardi, M; Salvatore, M; Pacelli, R				Cella, Laura; Palma, Giuseppe; Deasy, Joseph O.; Oh, Jung Hun; Liuzzi, Raffaele; D'Avino, Vittoria; Conson, Manuel; Pugliese, Novella; Picardi, Marco; Salvatore, Marco; Pacelli, Roberto			Complication Probability Models for Radiation-Induced Heart Valvular Dysfunction: Do Heart-Lung Interactions Play a Role?	PLOS ONE			English	Article							RELATIVE SERIALITY MODEL; TERM CARDIAC MORTALITY; HODGKINS LYMPHOMA; CARDIOVASCULAR-DISEASE; DOSE-VOLUME; MEDIASTINAL IRRADIATION; INDUCED HYPOTHYROIDISM; BREAST-CANCER; NTCP MODELS; RADIOTHERAPY	Purpose: The purpose of this study is to compare different normal tissue complication probability (NTCP) models for predicting heart valve dysfunction (RVD) following thoracic irradiation. Methods: All patients from our institutional Hodgkin lymphoma survivors database with analyzable datasets were included (n = 90). All patients were treated with three-dimensional conformal radiotherapy with a median total dose of 32 Gy. The cardiac toxicity profile was available for each patient. Heart and lung dose-volume histograms (DVHs) were extracted and both organs were considered for Lyman-Kutcher-Burman (LKB) and Relative Seriality (RS) NTCP model fitting using maximum likelihood estimation. Bootstrap refitting was used to test the robustness of the model fit. Model performance was estimated using the area under the receiver operating characteristic curve (AUC). Results: Using only heart-DVHs, parameter estimates were, for the LKB model: D-50 = 32.8 Gy, n = 0.16 and m = 0.67; and for the RS model: D-50 = 32.4 Gy, s = 0.99 and gamma = 0.42. AUC values were 0.67 for LKB and 0.66 for RS, respectively. Similar performance was obtained for models using only lung-DVHs (LKB: D-50 = 33.2 Gy, n = 0.01, m = 0.19, AUC = 0.68; RS: D-50 = 24.4 Gy, s = 0.99, gamma = 2.12, AUC = 0.66). Bootstrap result showed that the parameter fits for lung-LKB were extremely robust. A combined heart-lung LKB model was also tested and showed a minor improvement (AUC = 0.70). However, the best performance was obtained using the previously determined multivariate regression model including maximum heart dose with increasing risk for larger heart and smaller lung volumes (AUC = 0.82). Conclusions: The risk of radiation induced valvular disease cannot be modeled using NTCP models only based on heart dose-volume distribution. A predictive model with an improved performance can be obtained but requires the inclusion of heart and lung volume terms, indicating that heart-lung interactions are apparently important for this endpoint.	[Cella, Laura; Palma, Giuseppe; Liuzzi, Raffaele; D'Avino, Vittoria; Conson, Manuel; Pacelli, Roberto] CNR, CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Cella, Laura; Liuzzi, Raffaele; Conson, Manuel; Salvatore, Marco; Pacelli, Roberto] Univ Naples Federico II, Sch Med, Dept Adv Biomed Sci, Naples, Italy; [Deasy, Joseph O.; Oh, Jung Hun] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Pugliese, Novella; Picardi, Marco] Univ Naples Federico II, Sch Med, Dept Clin Med & Surg, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; Memorial Sloan Kettering Cancer Center; University of Naples Federico II	Cella, L (corresponding author), CNR, CNR, Inst Biostruct & Bioimaging, Naples, Italy.	laura.cella@cnr.it	Palma, Giuseppe/AAX-1413-2020; Pacelli, Roberto/AFS-0333-2022; Liuzzi, Raffaele/AIC-0886-2022; D'Avino, Vittoria/ABG-1242-2020; Cella, Laura/L-5802-2019; Palma, Giuseppe/GXV-0228-2022; Salvatore, Marco/K-8083-2016	Liuzzi, Raffaele/0000-0002-2350-6691; D'Avino, Vittoria/0000-0001-8925-1022; Cella, Laura/0000-0003-0058-4029; Palma, Giuseppe/0000-0002-0210-268X; Oh, Jung Hun/0000-0001-8791-2755; CONSON, Manuel/0000-0002-0495-3656; Salvatore, Marco/0000-0001-9734-7702; Deasy, Joseph/0000-0002-9437-266X; PICARDI, Marco/0000-0001-8508-2524; Pacelli, Roberto/0000-0002-2048-7675	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [RBFR10Q0PT_001, RBNE08YFN3]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) in the framework of Fondo per gli Interventi alla Ricerca di Base (FIRB, RBFR10Q0PT_001 and RBNE08YFN3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Andratschke N, 2010, RADIOTHER ONCOL; BENTZEN SM, 1994, RADIOTHER ONCOL, V31, P85, DOI 10.1016/0167-8140(94)90416-2; Bentzen SM, 2000, INT J RADIAT BIOL, V76, P453, DOI 10.1080/095530000138448; Cella L, 2013, INT J RADIAT ONCOL, V87, P304, DOI 10.1016/j.ijrobp.2013.05.049; Cella L, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-22; Cella L, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-224; Cella L, 2012, INT J RADIAT ONCOL, V82, P1802, DOI 10.1016/j.ijrobp.2010.09.054; Cella L, 2011, RADIOTHER ONCOL, V101, P316, DOI 10.1016/j.radonc.2011.08.040; Cella L, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-33; Deasy JO, 2003, MED PHYS, V30, P979, DOI 10.1118/1.1568978; Deasy JO, 2001, INT J RADIAT ONCOL, V51, P1389, DOI 10.1016/S0360-3016(01)02659-1; Di Biase A, 2014, RADIOTHER ONCOL, V11, P423; El Naqa I, 2006, INT J RADIAT ONCOL, V64, P1275, DOI 10.1016/j.ijrobp.2005.11.022; Eriksson F, 2000, RADIOTHER ONCOL, V55, P153, DOI 10.1016/S0167-8140(00)00166-3; Feng M, 2011, INT J RADIAT ONCOL, V79, P10, DOI 10.1016/j.ijrobp.2009.10.058; Gagliardi G, 1996, BRIT J RADIOL, V69, P839, DOI 10.1259/0007-1285-69-825-839; Gagliardi G, 2001, SEMIN RADIAT ONCOL, V11, P224, DOI 10.1053/srao.2001.23483; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Ghobadi G, 2012, INT J RADIAT ONCOL, V84, pE639, DOI 10.1016/j.ijrobp.2012.07.2362; Heidenreich PA, 2003, J AM COLL CARDIOL, V42, P743, DOI 10.1016/S0735-1097(03)00759-9; Huang EX, 2011, ACTA ONCOL, V50, P51, DOI 10.3109/0284186X.2010.521192; JOINER MC, 2002, BASIC CLIN RADIOBIOL, P120; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; Kong FM, 2007, SEMIN RADIAT ONCOL, V17, P108, DOI 10.1016/j.semradonc.2006.11.007; Kong FM, 2011, INT J RADIAT ONCOL, V81, P1442, DOI 10.1016/j.ijrobp.2010.07.1977; KUTCHER GJ, 1989, INT J RADIAT ONCOL, V16, P1623, DOI 10.1016/0360-3016(89)90972-3; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P721, DOI 10.1093/ehjci/jet123; Lee TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089700; Louwe RJW, 2007, MED PHYS, V34, P1354, DOI 10.1118/1.2713216; Maraldo MV, 2013, ANN ONCOL, V24, P2113, DOI 10.1093/annonc/mdt156; Maraldo MV, 2012, INT J RADIAT ONCOL, V83, P1232, DOI 10.1016/j.ijrobp.2011.09.020; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; Schellong G, 2010, PEDIATR BLOOD CANCER, V55, P1145, DOI 10.1002/pbc.22664; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; SCHULTZHECTOR S, 1992, RADIOTHER ONCOL, V23, P33, DOI 10.1016/0167-8140(92)90303-C; Semenenko VA, 2008, PHYS MED BIOL, V53, P737, DOI 10.1088/0031-9155/53/3/014; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Trott KR, 2012, RADIOTHER ONCOL, V105, P79, DOI 10.1016/j.radonc.2012.05.008; van Luijk P, 2005, CANCER RES, V65, P6509, DOI 10.1158/0008-5472.CAN-05-0786; van Luijk P, 2007, INT J RADIAT ONCOL, V69, P552, DOI 10.1016/j.ijrobp.2007.05.065; [No title captured], DOI DOI 10.2307/2347496)	42	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111753	10.1371/journal.pone.0111753	http://dx.doi.org/10.1371/journal.pone.0111753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360627	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700149
J	Hill, NA; Barrett, N; Lawrence, E; Hulls, J; Dambacher, JM; Nichol, S; Williams, A; Hayes, KR				Hill, Nicole A.; Barrett, Neville; Lawrence, Emma; Hulls, Justin; Dambacher, Jeffrey M.; Nichol, Scott; Williams, Alan; Hayes, Keith R.			Quantifying Fish Assemblages in Large, Offshore Marine Protected Areas: An Australian Case Study	PLOS ONE			English	Article							UNDERWATER VIDEO STATIONS; CONTINENTAL-SHELF; SPECIES RICHNESS; NEW-ZEALAND; REEF FISH; PERFORMANCE; MANAGEMENT; RESOURCES; ABUNDANCE; HOTSPOTS	As the number of marine protected areas (MPAs) increases globally, so does the need to assess if MPAs are meeting their management goals. Integral to this assessment is usually a long-term biological monitoring program, which can be difficult to develop for large and remote areas that have little available fine-scale habitat and biological data. This is the situation for many MPAs within the newly declared Australian Commonwealth Marine Reserve (CMR) network which covers approximately 3.1 million km(2) of continental shelf, slope, and abyssal habitat, much of which is remote and difficult to access. A detailed inventory of the species, types of assemblages present and their spatial distribution within individual MPAs is required prior to developing monitoring programs to measure the impact of management strategies. Here we use a spatially-balanced survey design and non-extractive baited video observations to quantitatively document the fish assemblages within the continental shelf area (a multiple use zone, IUCN VI) of the Flinders Marine Reserve, within the Southeast marine region. We identified distinct demersal fish assemblages, quantified assemblage relationships with environmental gradients (primarily depth and habitat type), and described their spatial distribution across a variety of reef and sediment habitats. Baited videos recorded a range of species from multiple trophic levels, including species of commercial and recreational interest. The majority of species, whilst found commonly along the southern or south-eastern coasts of Australia, are endemic to Australia, highlighting the global significance of this region. Species richness was greater on habitats containing some reef and declined with increasing depth. The trophic breath of species in assemblages was also greater in shallow waters. We discuss the utility of our approach for establishing inventories when little prior knowledge is available and how such an approach may inform future monitoring efforts within the CMR network.	[Hill, Nicole A.; Barrett, Neville; Hulls, Justin] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Hill, Nicole A.; Barrett, Neville; Hulls, Justin; Dambacher, Jeffrey M.; Hayes, Keith R.] CSIRO, Digital Prod Flagship, Brisbane, Qld, Australia; [Nichol, Scott] Geosci Australia, Canberra, ACT, Australia; [Williams, Alan] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Geoscience Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hill, NA (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Nicole.Hill@utas.edu.au	Hill, Nicole/AAI-7323-2021; Barrett, Neville S/J-7593-2014; Hill, Nicole A/J-7856-2014; Hayes, Keith R/A-4550-2009; Williams, Alan/C-6999-2012; Lawrence, Emma/A-5584-2009	Hill, Nicole/0000-0001-9329-6717; Barrett, Neville S/0000-0002-6167-1356; Hill, Nicole A/0000-0001-9329-6717; Hayes, Keith R/0000-0003-4094-3575; Williams, Alan/0000-0002-2867-7713; 	Australian Government's National Environmental Research Program (NERP)	Australian Government's National Environmental Research Program (NERP)(Australian Government)	This work was undertaken for the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2012, GUIDELINES APPL IUCN; [Anonymous], 1995, MARINE PROTECTED ARE; ANZECC TFMPA, 1998, GUID EST NAT REPR SY; Bailey DM, 2007, MAR ECOL PROG SER, V350, P179, DOI 10.3354/meps07187; Barr LM, 2013, MAR POLICY, V42, P39, DOI 10.1016/j.marpol.2013.01.012; Bax NJ, 2001, MAR FRESHWATER RES, V52, P451, DOI 10.1071/MF00001; Bruce BD, 2001, ICES J MAR SCI, V58, P1072, DOI 10.1006/jmsc.2001.1099; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; CBD, 1995, 2 M C PART CONV BIOL; Chatfield BS, 2010, J BIOGEOGR, V37, P593, DOI 10.1111/j.1365-2699.2009.02246.x; Commonwealth of Australia, 2006, GUID INT MAR COAST R; Currie DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030138; Dambacher JM, 2009, N AM J FISH MANAGE, V29, P1091, DOI 10.1577/M08-077.1; Director of National Parks, 2013, S E COMM MAR RES NET; Edgar G.J., 2008, AUSTR MARINE LIFE PL, V2nd; Edgar G. J., 2014, NATURE; Fandry C, 1983, MARINE FRESHWATER RE, V34, P121, DOI DOI 10.1071/MF9830121; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Fulton CJ, 2004, MAR BIOL, V144, P429, DOI 10.1007/s00227-003-1216-3; Gomon MF, 2008, FISHES AUSTR SE COAS; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; HARRIS G, 1987, AUST J MAR FRESH RES, V38, P569; Harvey E. S., 2013, PLOS ONE, V8; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Kemp J, 2012, OCEANOGR MAR BIOL, V50, P287; Kloser RJ, 2006, MAPPING SEAFLOOR HAB, P93; Langlois TJ, 2012, ECOL INDIC, V23, P524, DOI 10.1016/j.ecolind.2012.04.030; Larsen DP, 2008, J AGR BIOL ENVIR ST, V13, P243, DOI 10.1198/108571108X336593; Last PR, 2011, J BIOGEOGR, V38, P1484, DOI 10.1111/j.1365-2699.2011.02484.x; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Lucieer V, 2011, CONT SHELF RES, V31, P1236, DOI 10.1016/j.csr.2011.04.016; Maechler M., 2013, CLUSTER CLUSTER ANAL; National Tidal Centre, 2014, TID PRED AUSTR S PAC; Olsen A.R., 2012, DESIGN ANAL LONG TER, P126, DOI [10.1017/CBO9781139022422.010, DOI 10.1017/CBO9781139022422.010]; Phillips JA, 2001, BIODIVERS CONSERV, V10, P1555, DOI 10.1023/A:1011813627613; R Core Team, 2018, R LANG ENV STAT COMP; Schultz AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049437; Seager J, 2014, TRANSECT MEASURE; Spalding MD, 2013, OCEAN YEARB, V27, P213, DOI 10.1163/22116001-90000160; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens DL, 2003, ENVIRONMETRICS, V14, P593, DOI 10.1002/env.606; Venables WN., 2002, MODERN APPL STAT S 4; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; Whiteway TG, 2009, AUSTR BATHMETRY TOPO; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Zintzen V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048522	51	21	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110831	10.1371/journal.pone.0110831	http://dx.doi.org/10.1371/journal.pone.0110831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360763	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700048
J	Lin, YL; Hu, YC; Liang, CC; Lin, SY; Liang, YC; Yuan, HP; Chiang, BL				Lin, Yu-Li; Hu, Yu-Chen; Liang, Cheng-Chao; Lin, Shih-Yeh; Liang, Yu-Chih; Yuan, Hui-Ping; Chiang, Bor-Luen			Enterovirus-71 Virus-Like Particles Induce the Activation and Maturation of Human Monocyte-Derived Dendritic Cells through TLR4 Signaling	PLOS ONE			English	Article							PAPILLOMAVIRUS-LIKE PARTICLES; NF-KAPPA-B; IMMUNE; EXPRESSION; RECEPTORS; LIPOPOLYSACCHARIDE; IMMUNIZATION; BLOOD; ENDOTOXINS; INFECTION	Enterovirus 71 (EV71) causes seasonal epidemics of hand-foot-and-mouth disease and has a high mortality rate among young children. We recently demonstrated potent induction of the humoral and cell-mediated immune response in monkeys immunized with EV71 virus-like particles (VLPs), with a morphology resembling that of infectious EV71 virions but not containing a viral genome, which could potentially be safe as a vaccine for EV71. To elucidate the mechanisms through which EV71 VLPs induce cell-mediated immunity, we studied the immunomodulatory effects of EV71 VLPs on human monocyte-derived dendritic cells (DCs), which bind to and incorporate EV71 VLPs. DC treatment with EV71 VLPs enhanced the expression of CD80, CD86, CD83, CD40, CD54, and HLA-DR on the cell surface; increased the production of interleukin (IL)-12 p40, IL-12 p70, and IL-10 by DCs; and suppressed the capacity of DCs for endocytosis. Treatment with EV71 VLPs also enhanced the ability of DCs to stimulate naive T cells and induced secretion of interferon (IFN)-gamma by T cells and Th1 cell responses. Neutralization with antibodies against Toll-like receptor (TLR) 4 suppressed the capacity of EV71 VLPs to induce the production of IL-12 p40, IL-12 p70, and IL-10 by DCs and inhibited EV71 VLPs binding to DCs. Our study findings clarified the important role for TLR4 signaling in DCs in response to EV71 VLPs and showed that EV71 VLPs induced inhibitor of kappaB alpha (I kappa B alpha) degradation and nuclear factor of kappaB (NF-kappa B) activation.	[Lin, Yu-Li; Yuan, Hui-Ping; Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Med Res, Hsinchu, Taiwan; [Hu, Yu-Chen; Lin, Shih-Yeh] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan; [Liang, Cheng-Chao] Far Eastern Mem Hosp, Dept Internal Med, Taipei, Taiwan; [Liang, Yu-Chih] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; Far Eastern Memorial Hospital; Taipei Medical University; National Taiwan University	Chiang, BL (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Hsinchu, Taiwan.	gicmbor@ntu.edu.tw		CHIANG, BOR-LUEN/0000-0002-6705-0286	National Science Council Taiwan [NSC 101-2321-B-002-093, NSC 101-2321-B-002-094]; National Taiwan University Hospital [102-S2200]	National Science Council Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by grants (NSC 101-2321-B-002-093 and NSC 101-2321-B-002-094) from the National Science Council Taiwan (http://web1.nsc.gov.tw/) and from the National Taiwan University Hospital (102-S2200) (http://www.ntuh.gov.tw/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Ausiello CM, 2002, J INFECT DIS, V186, P351, DOI 10.1086/341510; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Buonaguro FM, 2009, EXPERT REV VACCINES, V8, P1379, DOI 10.1586/ERV.09.81; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chen JG, 2012, J MED VIROL, V84, P763, DOI 10.1002/jmv.23254; Chou NT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/735396; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Da Silva DM, 2007, J IMMUNOL, V178, P7587, DOI 10.4049/jimmunol.178.12.7587; Duenas AI, 2004, INT IMMUNOL, V16, P1467, DOI 10.1093/intimm/dxh148; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Hu YC, 2003, BIOTECHNOL LETT, V25, P919, DOI 10.1023/A:1024071514438; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Korokhov N, 2005, MOL PHARMACEUT, V2, P218, DOI 10.1021/mp050002w; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Lin YL, 2009, J LEUKOCYTE BIOL, V86, P877, DOI 10.1189/jlb.0708441; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Petsch D, 1998, ANAL BIOCHEM, V259, P42, DOI 10.1006/abio.1998.2655; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Ramqvist T, 2007, EXPERT OPIN BIOL TH, V7, P997, DOI 10.1517/14712598.7.7.997; Ren XX, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-47; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Schulte BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062502; Shi L, 2007, CLIN PHARMACOL THER, V81, P259, DOI 10.1038/sj.clpt.6100055; Szarewski A, 2010, EXPERT OPIN BIOL TH, V10, P477, DOI 10.1517/14712591003601944; TAGAYA I, 1981, JPN J MED SCI BIOL, V34, P191, DOI 10.7883/yoken1952.34.191; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; Vacher G, 2013, MOL PHARMACEUT, V10, P1596, DOI 10.1021/mp300597g; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083711; Yamayoshi S, 2013, J VIROL, V87, P3335, DOI 10.1128/JVI.02070-12; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yan MY, 2005, IMMUNOL CELL BIOL, V83, P83, DOI 10.1111/j.1440-1711.2004.01291.x; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Yoshimoto T, 1996, J IMMUNOL, V156, P1082; Young KR, 2006, METHODS, V40, P98, DOI 10.1016/j.ymeth.2006.05.024; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4	49	15	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111496	10.1371/journal.pone.0111496	http://dx.doi.org/10.1371/journal.pone.0111496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360749	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700109
J	O'Hara, NN; Mugarura, R; Slobogean, GP; Bouchard, M				O'Hara, Nathan N.; Mugarura, Rodney; Slobogean, Gerard P.; Bouchard, Maryse			The Orthopaedic Trauma Patient Experience: A Qualitative Case Study of Orthopaedic Trauma Patients in Uganda	PLOS ONE			English	Article							GLOBAL BURDEN; INJURIES; KAMPALA	The disability adjusted life years (DALYs) associated with injuries have increased by 34% from 1990 to 2010, making it the 10 th leading cause of disability worldwide, with most of the burden affecting low-income countries. Although disability from injuries is often preventable, limited access to essential surgical services contributes to these increasing DALY rates. Similar to many other low-and middle-income countries (LMIC), Uganda is plagued by a growing volume of traumatic injuries. The aim of this study is to explore the orthopaedic trauma patient's experience in accessing medical care in Uganda and what affects the injury might have on the socioeconomic status for the patient and their dependents. We also evaluate the factors that impact an individual's ability to access an appropriate treatment facility for their traumatic injury. Semi-structured interviews were conducted with patients 18 year of age or older admitted with a fractured tibia or femur at Mulago National Referral Hospital in Kampala, Uganda. As limited literature exists on the socioeconomic impacts of disability from trauma, we designed a descriptive qualitative case study, using thematic analysis, to extract unique information for which little has been previously been documented. This methodology is subject to less bias than other qualitative methods as it imposes fewer preconceptions. Data analysis of the patient interviews (n = 35) produced over one hundred codes, nine sub-themes and three overarching themes. The three overarching categories revealed by the data were: 1) the importance of social supports; 2) the impact of and on economic resources; and 3) navigating the healthcare system. Limited resources to fund the treatment of orthopaedic trauma patients in Uganda leads to reliance of patients on their friends, family, and hospital connections, and a tremendous economic burden that falls on the patient and their dependents.	[O'Hara, Nathan N.; Slobogean, Gerard P.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Mugarura, Rodney] Makerere Univ, Dept Orthopaed, Kampala, Uganda; [Bouchard, Maryse] Seattle Childrens Hosp, Dept Orthopaed, Seattle, WA USA	University of British Columbia; Makerere University; Seattle Children's Hospital	O'Hara, NN (corresponding author), Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada.	nathan.ohara@vch.ca	O'Hara, Nathan/O-7168-2018; O'Hara, Nathan/AAD-2819-2019	O'Hara, Nathan/0000-0003-0537-3474; O'Hara, Nathan/0000-0003-0537-3474; Bouchard, Maryse/0000-0003-1321-2478	Uganda Sustainable Trauma Orthopaedic Program	Uganda Sustainable Trauma Orthopaedic Program	This study was funded by the Uganda Sustainable Trauma Orthopaedic Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begg S, 2003, GLOBAL BURDEN INJURY; Bloom DE, 2004, WORLD DEV, V32, P1, DOI 10.1016/j.worlddev.2003.07.002; Bouchard M, 2011, THESIS U TORONTO; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Galukande M., 2009, East and Central African Journal of Surgery, V14, P33; Grimes CE, 2011, WORLD J SURG, V35, P941, DOI 10.1007/s00268-011-1010-1; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; International Labour Organization, 2012, RES GUID INF EC; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Mock C, 2008, CLIN ORTHOP RELAT R, V466, P2306, DOI 10.1007/s11999-008-0416-z; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Sandelowski M, 1991, Image J Nurs Sch, V23, P161, DOI 10.1111/j.1547-5069.1991.tb00662.x; The World Bank, 2011, UG 2011 12 NAT PAN S; The World Bank, 2013, WORK INF EC; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	17	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110940	10.1371/journal.pone.0110940	http://dx.doi.org/10.1371/journal.pone.0110940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360815	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943700054
J	Sekulic, V; Lawrence, JJ; Skinner, FK				Sekulic, Vladislav; Lawrence, J. Josh; Skinner, Frances K.			Using Multi-Compartment Ensemble Modeling As an Investigative Tool of Spatially Distributed Biophysical Balances: Application to Hippocampal Oriens-Lacunosum/Moleculare (O-LM) Cells	PLOS ONE			English	Article							I-H; GLOBUS-PALLIDUS; INHIBITORY INTERNEURONS; CHANNEL EXPRESSION; NEURON MODELS; THETA-RHYTHM; VARIABILITY; MODULATION; DENDRITES; COMPENSATION	Multi-compartmental models of neurons provide insight into the complex, integrative properties of dendrites. Because it is not feasible to experimentally determine the exact density and kinetics of each channel type in every neuronal compartment, an essential goal in developing models is to help characterize these properties. To address biological variability inherent in a given neuronal type, there has been a shift away from using hand-tuned models towards using ensembles or populations of models. In collectively capturing a neuron's output, ensemble modeling approaches uncover important conductance balances that control neuronal dynamics. However, conductances are never entirely known for a given neuron class in terms of its types, densities, kinetics and distributions. Thus, any multi-compartment model will always be incomplete. In this work, our main goal is to use ensemble modeling as an investigative tool of a neuron's biophysical balances, where the cycling between experiment and model is a design criterion from the start. We consider orienslacunosum/moleculare (O-LM) interneurons, a prominent interneuron subtype that plays an essential gating role of information flow in hippocampus. O-LM cells express the hyperpolarization-activated current (I-h). Although dendritic I-h could have a major influence on the integrative properties of O-LM cells, the compartmental distribution of I-h on O-LM dendrites is not known. Using a high-performance computing cluster, we generated a database of models that included those with or without dendritic I-h. A range of conductance values for nine different conductance types were used, and different morphologies explored. Models were quantified and ranked based on minimal error compared to a dataset of OLM cell electrophysiological properties. Co-regulatory balances between conductances were revealed, two of which were dependent on the presence of dendritic I-h. These findings inform future experiments that differentiate between somatic and dendritic I-h, thereby continuing a cycle between model and experiment.	[Sekulic, Vladislav; Skinner, Frances K.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Sekulic, Vladislav; Skinner, Frances K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Skinner, Frances K.] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Lawrence, J. Josh] Univ Montana, NIH, COBRE Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Lawrence, J. Josh] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); University of Montana System; University of Montana; University of Montana System; University of Montana	Sekulic, V (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	vlad.sekulic@utoronto.ca		Skinner, Frances/0000-0001-7819-4202	National Institutes of Health; SciNet HPC Consortium; NIH [R01 NS069689]; NSERC [RGPIN203700-11]; University of Toronto Fellowship; Natural Sciences and Engineering Research Council; Dept. of Physiology; University of Toronto; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SciNet HPC Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto Fellowship(University of Toronto); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dept. of Physiology; University of Toronto(University of Toronto); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health, Natural Sciences and Engineering Research Council, a Dept. of Physiology, University of Toronto Fellowship, and the SciNet HPC Consortium. The relevant grant numbers and websites for the funding agencies are: NIH R01 NS069689 http://www.nih.gov; NSERC RGPIN203700-11 http://www.nserc-crsng.gc.ca/; University of Toronto Fellowship http://www.physiology.utoronto.ca; SciNet HPC Consortium http://www.scinethpc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-06.2007; Bartos M, 2011, NEUROPHARMACOLOGY, V60, P730, DOI 10.1016/j.neuropharm.2010.12.017; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Chittajallu R, 2013, NAT NEUROSCI, V16, P1598, DOI 10.1038/nn.3538; Cutsuridis V, 2012, HIPPOCAMPUS, V22, P1597, DOI 10.1002/hipo.21002; Cutsuridis V, 2010, HIPPOCAMPUS, V20, P423, DOI 10.1002/hipo.20661; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Druckmann S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002133; Edgerton JR, 2011, J NEUROSCI, V31, P10919, DOI 10.1523/JNEUROSCI.6062-10.2011; Edgerton JR, 2010, J NEUROSCI, V30, P15146, DOI 10.1523/JNEUROSCI.2662-10.2010; Fino E, 2013, NEUROSCIENTIST, V19, P228, DOI 10.1177/1073858412456743; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; Gunay C, 2009, NEUROINFORMATICS, V7, P93, DOI 10.1007/s12021-009-9048-z; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Kispersky TJ, 2012, J NEUROSCI, V32, P3637, DOI 10.1523/JNEUROSCI.1361-11.2012; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Lawrence JJ, 2006, J PHYSIOL-LONDON, V571, P555, DOI 10.1113/jphysiol.2005.103218; Leao RN, 2012, NAT NEUROSCI, V15, P1524, DOI 10.1038/nn.3235; Lien CC, 2002, J PHYSIOL-LONDON, V538, P405, DOI 10.1113/jphysiol.2001.013066; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Loken Chris, 2010, Journal of Physics: Conference Series, V256, DOI 10.1088/1742-6596/256/1/012026; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Matt L, 2011, CELL MOL LIFE SCI, V68, P125, DOI 10.1007/s00018-010-0446-z; model Rall, 2009, SCHOLARPEDIA, V4, P1369; Morse TM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00016; Nemri A, 2010, SCHOLARPEDIA, V5, P8577, DOI DOI 10.4249/SCHOLARPEDIA.8577; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; O'Leary T, 2013, P NATL ACAD SCI USA, V110, pE2645, DOI 10.1073/pnas.1309966110; Pangalos M, 2013, P NATL ACAD SCI USA, V110, P4398, DOI 10.1073/pnas.1215496110; Peng W, 2004, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2004, PROCEEDINGS, P89; Peng W, 2005, THESIS WORCESTER POL; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Ransdell JL, 2013, J NEUROSCI, V33, P9950, DOI 10.1523/JNEUROSCI.1095-13.2013; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Saraga F, 2003, J PHYSIOL-LONDON, V552, P673, DOI 10.1113/jphysiol.2003.046177; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; SIK A, 1995, J NEUROSCI, V15, P6651; Skinner F, 2010, SPR SER COMPUT NEURO, V5, P399, DOI 10.1007/978-1-4419-0996-1_14; Smolinski Tomasz G., 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P2964, DOI 10.1109/IJCNN.2009.5178722; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Temporal S, 2012, J NEUROPHYSIOL, V107, P718, DOI 10.1152/jn.00622.2011; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Van Geit W, 2008, BIOL CYBERN, V99, P241, DOI 10.1007/s00422-008-0257-6	75	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e106567	10.1371/journal.pone.0106567	http://dx.doi.org/10.1371/journal.pone.0106567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360752	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700004
J	Benck, JD; Pinaud, BA; Gorlin, Y; Jaramillo, TF				Benck, Jesse D.; Pinaud, Blaise A.; Gorlin, Yelena; Jaramillo, Thomas F.			Substrate Selection for Fundamental Studies of Electrocatalysts and Photoelectrodes: Inert Potential Windows in Acidic, Neutral, and Basic Electrolyte	PLOS ONE			English	Article							GLASSY-CARBON ELECTRODES; INDIUM-TIN OXIDE; TRANSPARENT CONDUCTING OXIDES; SCANNING-TUNNELING-MICROSCOPY; HYDROGEN EVOLUTION REACTION; ORDERED PYROLYTIC-GRAPHITE; ELECTROCHEMICAL OXIDATION; SURFACE-STRUCTURE; OXYGEN REDUCTION; GOLD	The selection of an appropriate substrate is an important initial step for many studies of electrochemically active materials. In order to help researchers with the substrate selection process, we employ a consistent experimental methodology to evaluate the electrochemical reactivity and stability of seven potential substrate materials for electrocatalyst and photoelectrode evaluation. Using cyclic voltammetry with a progressively increased scan range, we characterize three transparent conducting oxides (indium tin oxide, fluorine-doped tin oxide, and aluminum-doped zinc oxide) and four opaque conductors (gold, stainless steel 304, glassy carbon, and highly oriented pyrolytic graphite) in three different electrolytes (sulfuric acid, sodium acetate, and sodium hydroxide). We determine the inert potential window for each substrate/electrolyte combination and make recommendations about which materials may be most suitable for application under different experimental conditions. Furthermore, the testing methodology provides a framework for other researchers to evaluate and report the baseline activity of other substrates of interest to the broader community.	[Benck, Jesse D.; Pinaud, Blaise A.; Gorlin, Yelena; Jaramillo, Thomas F.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University	Jaramillo, TF (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jaramillo@stanford.edu	Jaramillo, Thomas F/C-4174-2014; Gorlin, Yelena/O-3423-2014	Jaramillo, Thomas F/0000-0001-9900-0622; 	Center of Nanostructuring for Efficient Energy Conversion, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0001060]; CCI Solar Fuels, a National Science Foundation Center for Chemical Innovation [CHE-1305124]; National Science Foundation Graduate Research Fellowship Program; Stanford Graduate Fellowship; United Technologies Research Center fellowship in Sustainable Energy; Natural Sciences and Engineering Research Council of Canada graduate award	Center of Nanostructuring for Efficient Energy Conversion, an Energy Frontier Research Center - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); CCI Solar Fuels, a National Science Foundation Center for Chemical Innovation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); United Technologies Research Center fellowship in Sustainable Energy; Natural Sciences and Engineering Research Council of Canada graduate award(Natural Sciences and Engineering Research Council of Canada (NSERC))	JDB and YG were supported as part of the Center of Nanostructuring for Efficient Energy Conversion, an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under Award No. DE-SC0001060. Funding source websites: (http://cneec.stanford.edu/) and (http://science.energy.gov/bes/). BAP was supported by CCI Solar Fuels, a National Science Foundation Center for Chemical Innovation under Grant No. CHE-1305124. Funding source websites: (http://www.ccisolar.caltech.edu/) and (http://www.nsf.gov/). JDB received support from the National Science Foundation Graduate Research Fellowship Program and a Stanford Graduate Fellowship. Funding source websites: (http://www.nsfgrfp.org/) and (http://sgf. stanford.edu/). BAP received funding from a United Technologies Research Center fellowship in Sustainable Energy and a Natural Sciences and Engineering Research Council of Canada graduate award. Funding source websites: (http://www.utrc.utc.com/about-fellows.html) and (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, CARBON ELECTROCHEMIC, DOI DOI 10.1016/j.jpowsour.2007.12.091; ARMSTRONG NR, 1976, ANAL CHEM, V48, P741, DOI 10.1021/ac60368a035; Azom: Stainless Steel-Grade 304, 2013, GRADE 304 STAINLESS; Bard A. J., 1980, ELECTROCHEMICAL METH; BARNARTT S, 1959, J ELECTROCHEM SOC, V106, P991, DOI 10.1149/1.2427196; BEILBY AL, 1995, ANAL CHEM, V67, P976, DOI 10.1021/ac00101a027; BELLINGHAM JR, 1992, J MATER SCI LETT, V11, P263, DOI 10.1007/BF00729407; Benck JD, 2014, ADV ENERGY IN PRESS; Bio-Logic Science Instruments, 2013, 28 BIOL SCI INSTR; BOND AM, 1990, Z CHEM, V30, P117; BOWERS ML, 1991, ANAL CHIM ACTA, V243, P43, DOI 10.1016/S0003-2670(00)82538-6; BOWERS ML, 1991, ANAL CHIM ACTA, V248, P127, DOI 10.1016/S0003-2670(00)80877-6; BOWLING RJ, 1989, J AM CHEM SOC, V111, P1217, DOI 10.1021/ja00186a008; BURKE LD, 1992, ELECTROCHIM ACTA, V37, P2087, DOI 10.1016/0013-4686(92)87126-K; BURKE LD, 1992, J ELECTROCHEM SOC, V139, P399, DOI 10.1149/1.2069230; BURKE LD, 1992, ELECTROCHIM ACTA, V37, P585, DOI 10.1016/0013-4686(92)80058-T; Cai M, 1996, J ELECTROCHEM SOC, V143, P2125, DOI 10.1149/1.1836970; Chen FY, 2012, INT J ELECTROCHEM SC, V7, P3750; Chen Z., 2013, PHOTOELECTROCHEMICAL; Chen ZB, 2011, NANO LETT, V11, P4168, DOI 10.1021/nl2020476; CHOPRA KL, 1983, THIN SOLID FILMS, V102, P1, DOI 10.1016/0040-6090(83)90256-0; Dekanski A, 2001, CARBON, V39, P1195, DOI 10.1016/S0008-6223(00)00228-1; ENGSTROM RC, 1984, ANAL CHEM, V56, P136, DOI 10.1021/ac00266a005; ENGSTROM RC, 1982, ANAL CHEM, V54, P2310, DOI 10.1021/ac00250a038; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Ginley DS, 2010, HANDBOOK OF TRANSPARENT CONDUCTORS, P1, DOI 10.1007/978-1-4419-1638-9; Gordon RG, 2000, MRS BULL, V25, P52, DOI 10.1557/mrs2000.151; GOSS CA, 1993, ANAL CHEM, V65, P1378, DOI 10.1021/ac00058a014; Goyal RN, 2010, TALANTA, V83, P149, DOI 10.1016/j.talanta.2010.08.054; Guenther G, 2008, J APPL PHYS, V104, DOI 10.1063/1.2958323; HAMMER B, 1995, NATURE, V376, P238, DOI 10.1038/376238a0; Han J, 2010, J HAZARD MATER, V178, P115, DOI 10.1016/j.jhazmat.2010.01.050; HAUPT S, 1995, CORROS SCI, V37, P43, DOI 10.1016/0010-938X(94)00104-E; HOARE JP, 1984, J ELECTROCHEM SOC, V131, P1808, DOI 10.1149/1.2115966; HU IF, 1985, J ELECTROANAL CHEM, V188, P59, DOI 10.1016/S0022-0728(85)80050-4; Huang CA, 2003, ELECTROCHIM ACTA, V48, P3599, DOI 10.1016/S0013-4686(03)00480-8; IZUMI T, 1991, J ELECTROANAL CHEM, V303, P151, DOI 10.1016/0022-0728(91)85122-6; JAKSIC MM, 1993, INT J HYDROGEN ENERG, V18, P91, DOI 10.1016/0360-3199(93)90196-H; Jaramillo TF, 2008, J PHYS CHEM C, V112, P17492, DOI 10.1021/jp802695e; Jegdic B, 2006, J SERB CHEM SOC, V71, P543, DOI 10.2298/JSC0605543J; Ji XB, 2006, J PHYS CHEM B, V110, P22306, DOI 10.1021/jp065776m; Juodkazis K, 2000, ELECTROCHEM COMMUN, V2, P503, DOI 10.1016/S1388-2481(00)00069-2; JURGEN D, 1992, J ELECTROANAL CHEM, V333, P177, DOI 10.1016/0022-0728(92)80390-P; KAMAU GN, 1988, ANAL CHIM ACTA, V207, P1, DOI 10.1016/S0003-2670(00)80777-1; KAMAU GN, 1985, ANAL CHEM, V57, P545, DOI 10.1021/ac50001a049; KEPLEY LJ, 1988, ANAL CHEM, V60, P1459, DOI 10.1021/ac00165a022; Kibsgaard J, 2006, J AM CHEM SOC, V128, P13950, DOI 10.1021/ja0651106; Kiema GK, 2003, J ELECTROANAL CHEM, V540, P7, DOI 10.1016/S0022-0728(02)01264-0; Klein A, 2013, J AM CERAM SOC, V96, P331, DOI 10.1111/jace.12143; KRAFT A, 1994, J ELECTROANAL CHEM, V365, P191, DOI 10.1016/0022-0728(93)03056-U; Kuhl K, 2013, ELECTROCHEMICAL REDU; Lee HBR, 2013, NANO LETT, V13, P457, DOI 10.1021/nl303803p; Li G., 2013, ELECTROCHEMICAL ANAL, P5, DOI DOI 10.1007/978-3-642-34252-3; Ling Y, 1997, J ELECTROCHEM SOC, V144, P2689, DOI 10.1149/1.1837883; Liu HY, 2010, SUPERLATTICE MICROST, V48, P458, DOI 10.1016/j.spmi.2010.08.011; MARTINEZ MA, 1992, ELECTROCHIM ACTA, V37, P2565, DOI 10.1016/0013-4686(92)87053-3; Matveeva E, 2005, J ELECTROCHEM SOC, V152, pH138, DOI 10.1149/1.1984348; McNaught A.D., 1997, COMPENDIUM CHEM TERM; Michalkiewicz S, 2004, CHEM ANAL-WARSAW, V49, P121; Minami T, 2005, SEMICOND SCI TECH, V20, pS35, DOI 10.1088/0268-1242/20/4/004; Moore RR, 2004, ANAL CHEM, V76, P2677, DOI 10.1021/ac040017q; OGURA K, 1971, J ELECTROCHEM SOC, V118, P531, DOI 10.1149/1.2408105; Olivares-Ramirez JM, 2007, INT J HYDROGEN ENERG, V32, P3170, DOI 10.1016/j.ijhydene.2006.03.017; Olsson COA, 2003, ELECTROCHIM ACTA, V48, P1093, DOI 10.1016/S0013-4686(02)00841-1; Olsson J, 2002, TRANSPASSIVE CORROSI; Orlik M., 2007, ELECTROCHEMISTRY GOL; Paulauskas IE, 2011, INT J ELECTROCHEM, V2011, DOI 10.4061/2011/563427; Pourbaix M., 1966, ATLAS ELECTROCHEMICA, Vfirst English; Qiao LJ, 1998, CORROSION, V54, P281, DOI 10.5006/1.3284854; Qiao Q, 2006, SOL ENERG MAT SOL C, V90, P1034, DOI 10.1016/j.solmat.2005.05.020; Revie RW, 2008, IRON STEEL CORROSION; Revie RW, 2008, PASSIVITY CORROSION; Senthilkumar M, 2008, MATER CHEM PHYS, V108, P403, DOI 10.1016/j.matchemphys.2007.10.030; SPI Supplies, 2013, HIGHL ORD PYR GRAPH; Stadler A, 2012, MATERIALS, V5, P661, DOI 10.3390/ma5040661; Steel AK., 2007, 304 304L STAINL STEE; The Economist, 2014, THE ECONOMIST; THORNTON DC, 1985, ANAL CHEM, V57, P150, DOI 10.1021/ac00279a037; Timperman L, 2010, ELECTROCHIM ACTA, V55, P7558, DOI 10.1016/j.electacta.2009.09.076; VANDERLINDEN WE, 1980, ANAL CHIM ACTA, V119, P1, DOI 10.1016/S0003-2670(00)00025-8; Vanysek P., 2012, CRC HDB CHEM PHYS, V93rd; Vesborg PCK, 2012, RSC ADV, V2, P7933, DOI 10.1039/c2ra20839c; Wang H, 2009, ACTA PHYS-CHIM SIN, V25, P835, DOI 10.3866/PKU.WHXB20090504; YAMADA S, 1962, NATURE, V193, P261, DOI 10.1038/193261b0; Yeo BS, 2010, CHEMPHYSCHEM, V11, P1854, DOI 10.1002/cphc.201000294; ZHANG BL, 1995, ELECTROCHIM ACTA, V40, P2627, DOI 10.1016/0013-4686(95)00111-Q; Zhang JD, 1996, BIOELECTROCH BIOENER, V39, P267, DOI 10.1016/0302-4598(95)01893-X; Zhang JL, 2005, ANGEW CHEM INT EDIT, V44, P2132, DOI 10.1002/anie.200462335; Zhao QL, 2008, ELECTROCHEM COMMUN, V10, P181, DOI 10.1016/j.elecom.2007.11.017; Zhao QL, 2009, BIOSENS BIOELECTRON, V24, P3003, DOI 10.1016/j.bios.2009.03.005; ZITTEL HE, 1965, ANAL CHEM, V37, P200, DOI 10.1021/ac60221a006; Zoski CG, 2007, HANDBOOK OF ELECTROCHEMISTRY, pV, DOI 10.1016/B978-044451958-0.50000-8	92	160	161	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e107942	10.1371/journal.pone.0107942	http://dx.doi.org/10.1371/journal.pone.0107942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357131	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000003
J	Gomez, M; Perez-Gallardo, RV; Sanchez, LA; Diaz-Perez, AL; Cortes-Rojo, C; Carmen, VM; Saavedra-Molina, A; Lara-Romero, J; Jimenez-Sandoval, S; Rodriguez, F; Rodriguez-Zavala, JS; Campos-Garcia, J				Gomez, Mauricio; Perez-Gallardo, Rocio V.; Sanchez, Luis A.; Diaz-Perez, Alma L.; Cortes-Rojo, Christian; Meza Carmen, Victor; Saavedra-Molina, Alfredo; Lara-Romero, Javier; Jimenez-Sandoval, Sergio; Rodriguez, Francisco; Rodriguez-Zavala, Jose S.; Campos-Garcia, Jesus			Malfunctioning of the Iron-Sulfur Cluster Assembly Machinery in Saccharomyces cerevisiae Produces Oxidative Stress via an Iron-Dependent Mechanism, Causing Dysfunction in Respiratory Complexes	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; ELECTRON-TRANSPORT; PROTEIN BIOGENESIS; YEAST; ETHANOL; MITOCHONDRIA; LIVER; DEHYDROGENASE; MATURATION; GENE	Biogenesis and recycling of iron-sulfur (Fe-S) clusters play important roles in the iron homeostasis mechanisms involved in mitochondrial function. In Saccharomyces cerevisiae, the Fe-S clusters are assembled into apoproteins by the iron-sulfur cluster machinery (ISC). The aim of the present study was to determine the effects of ISC gene deletion and consequent iron release under oxidative stress conditions on mitochondrial functionality in S. cerevisiae. Reactive oxygen species (ROS) generation, caused by H2O2, menadione, or ethanol, was associated with a loss of iron homeostasis and exacerbated by ISC system dysfunction. ISC mutants showed increased free Fe2+ content, exacerbated by ROS-inducers, causing an increase in ROS, which was decreased by the addition of an iron chelator. Our study suggests that the increment in free Fe2+ associated with ROS generation may have originated from mitochondria, probably Fe-S cluster proteins, under both normal and oxidative stress conditions, suggesting that Fe-S cluster anabolism is affected. Raman spectroscopy analysis and immunoblotting indicated that in mitochondria from SSQ1 and ISA1 mutants, the content of [Fe-S] centers was decreased, as was formation of Rieske protein-dependent supercomplex III2IV2, but this was not observed in the iron-deficient ATX1 and MRS4 mutants. In addition, the activity of complexes II and IV from the electron transport chain (ETC) was impaired or totally abolished in SSQ1 and ISA1 mutants. These results confirm that the ISC system plays important roles in iron homeostasis, ROS stress, and in assembly of supercomplexes III2IV2 and III2IV1, thus affecting the functionality of the respiratory chain.	[Gomez, Mauricio; Perez-Gallardo, Rocio V.; Sanchez, Luis A.; Diaz-Perez, Alma L.; Meza Carmen, Victor; Campos-Garcia, Jesus] Univ Michoacana, Inst Invest Quim Biol, Lab Biotecnol Microbiana, Morelia, Michoacan, Mexico; [Cortes-Rojo, Christian; Saavedra-Molina, Alfredo] Univ Michoacana, Inst Invest Quim Biol, Lab Bioquim, Morelia, Michoacan, Mexico; [Lara-Romero, Javier] Univ Michoacana, Fac Ingn Quim, Morelia, Michoacan, Mexico; [Jimenez-Sandoval, Sergio; Rodriguez, Francisco] IPN, Ctr Invest & Estudios Avanzados, Unidad Queretaro, Queretaro, Mexico; [Rodriguez-Zavala, Jose S.] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; National Institute of Cardiology - Mexico	Campos-Garcia, J (corresponding author), Univ Michoacana, Inst Invest Quim Biol, Lab Biotecnol Microbiana, Morelia, Michoacan, Mexico.	jcgarcia@umich.mx	Rodriguez-Zavala, Jose S/AAI-3604-2020; Cortes, Christian./ABF-4312-2021; Campos-Garcia, Jesus/A-9368-2013; Sandoval, Sergio Joaquín Jiménez/A-9627-2015; Saavedra-Molina, Alfredo/AAH-5607-2020	Rodriguez-Zavala, Jose S/0000-0002-7094-5523; Campos-Garcia, Jesus/0000-0002-8337-5830; Sandoval, Sergio Joaquín Jiménez/0000-0002-2143-3759; Cortes-Rojo, Christian/0000-0002-4850-772X; MEZA-CARMEN, VICTOR/0000-0003-2838-7211; Gomez Gallardo, Mauricio/0000-0001-8132-7854	CONACYT [106567]; Universidad Michoacana de San Nicolas de Hidalgo (UMSNH) [C.I.C. 2.14];  [FOMIX-C01-117130]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Michoacana de San Nicolas de Hidalgo (UMSNH); 	This research was funded by CONACYT (106567), FOMIX-C01-117130, and C.I.C. 2.14/Universidad Michoacana de San Nicolas de Hidalgo (UMSNH) grants. RVPG, MG, and LAS received a scholarship by CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS V, 1991, BIOCHEM MED METAB B, V45, P271, DOI 10.1016/0885-4505(91)90032-G; Bakker BM, 2000, J BACTERIOL, V182, P4730, DOI 10.1128/JB.182.17.4730-4737.2000; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Conte L, 2011, BIOINORG CHEM APPL, V2011, DOI 10.1155/2011/363941; Cortes-Rojo C, 2009, J BIOENERG BIOMEMBR, V41, P15, DOI 10.1007/s10863-009-9200-3; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; De Freitas J, 2003, BIOMETALS, V16, P185, DOI 10.1023/A:1020771000746; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Esfandiari N, 2003, J ANDROL, V24, P862; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; GUIARD B, 1985, EMBO J, V4, P3265, DOI 10.1002/j.1460-2075.1985.tb04076.x; HENSON CP, 1967, J BIOL CHEM, V242, P3833; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HIRANO T, 1992, HEPATOLOGY, V16, P1423; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Lange H, 2004, J BIOL CHEM, V279, P29101, DOI 10.1074/jbc.M403721200; Lemire BD, 2002, BBA-BIOENERGETICS, V1553, P102, DOI 10.1016/S0005-2728(01)00229-8; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; NELSON MJ, 1991, J AM CHEM SOC, V113, P7072, DOI 10.1021/ja00018a074; NORDMANN R, 1987, ENZYME, V37, P57, DOI 10.1159/000469241; Pahlman IL, 2002, J BIOL CHEM, V277, P27991, DOI 10.1074/jbc.M204079200; Perez-Gallardo RV, 2013, FEMS YEAST RES, V13, P804, DOI 10.1111/1567-1364.12090; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; STAL P, 1993, J HEPATOL, V17, P108, DOI 10.1016/S0168-8278(05)80530-6; Stames EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077234; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; THAYER WS, 1981, J BIOL CHEM, V256, P6090; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Xu N, 2012, FEMS YEAST RES, V12, P844, DOI 10.1111/j.1567-1364.2012.00835.x; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	62	35	36	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111585	10.1371/journal.pone.0111585	http://dx.doi.org/10.1371/journal.pone.0111585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356756	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000070
J	Vandrangi, P; Gott, SC; Kozaka, R; Rodgers, VGJ; Rao, MP				Vandrangi, Prashanthi; Gott, Shannon C.; Kozaka, Ryan; Rodgers, Victor G. J.; Rao, Masaru P.			Comparative Endothelial Cell Response on Topographically Patterned Titanium and Silicon Substrates with Micrometer to Sub-Micrometer Feature Sizes	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; E-SELECTIN; SHEAR-STRESS; EXPRESSION; SURFACES; ATHEROSCLEROSIS; NANOSCALE; DYNAMICS; GUIDANCE; VCAM-1	In this work, we evaluate the in vitro response of endothelial cells (EC) to variation in precisely-defined, micrometer to sub-micrometer scale topography on two different substrate materials, titanium (Ti) and silicon (Si). Both substrates possess identically-patterned surfaces composed of microfabricated, groove-based gratings with groove widths ranging from 0.5 to 50 mu m, grating pitch twice the groove width, and groove depth of 1.3 mu m. These specific materials are chosen due to their relevance for implantable microdevice applications, while grating-based patterns are chosen for the potential they afford for inducing elongated and aligned cellular morphologies reminiscent of the native endothelium. Using EA926 cells, a human EC variant, we show significant improvement in cellular adhesion, proliferation, morphology, and function with decreasing feature size on patterned Ti substrates. Moreover, we show similar trending on patterned Si substrates, albeit to a lesser extent than on comparably patterned Ti substrates. Collectively, these results suggest promise for sub-micrometer topographic patterning in general, and sub-micrometer patterning of Ti specifically, as a means for enhancing endothelialization and neovascularisation for novel implantable microdevice applications.	[Vandrangi, Prashanthi; Gott, Shannon C.; Rao, Masaru P.] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Vandrangi, Prashanthi; Kozaka, Ryan; Rodgers, Victor G. J.; Rao, Masaru P.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Rodgers, Victor G. J.; Rao, Masaru P.] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Rao, MP (corresponding author), Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA.	mprao@engr.ucr.edu	Rodgers, Victor G/G-3652-2016; Rodgers, Victor G. J./AAF-3838-2021; Rao, Masaru P/H-3864-2011	Rodgers, Victor G/0000-0002-1857-8025; Rodgers, Victor G. J./0000-0002-1857-8025; Rao, Masaru P/0000-0002-5939-6332	University of California, Riverside Collaborative Seed Grant Program; National Science Foundation Graduate Research Fellowship Program	University of California, Riverside Collaborative Seed Grant Program; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported in part by the University of California, Riverside Collaborative Seed Grant Program (MPR & VGJR), and the National Science Foundation Graduate Research Fellowship Program (SCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimi MF, 2004, NAT MATER, V3, P103, DOI 10.1038/nmat1058; Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001; Barbucci R, 2003, J MATER SCI-MATER M, V14, P721, DOI 10.1023/A:1024919917969; Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029; Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003; Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009; Brown A, 2011, BIOTECHNOL BIOENG, V108, P1148, DOI 10.1002/bit.23022; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Elter P, 2012, COLLOID SURFACE B, V89, P139, DOI 10.1016/j.colsurfb.2011.09.021; Farra R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003276; Franco D, 2013, BIOMATERIALS, V34, P1488, DOI 10.1016/j.biomaterials.2012.10.007; Franco D, 2011, SOFT MATTER, V7, P7313, DOI 10.1039/c1sm05191a; Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007; Gasiorowski JZ, 2010, BIOMATERIALS, V31, P8882, DOI 10.1016/j.biomaterials.2010.08.026; Gott SC, 2012, 34 ANN INT C IEEE EN; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Hopcroft MA, 2010, J MICROELECTROMECH S, V19, P229, DOI 10.1109/JMEMS.2009.2039697; Hwang SY, 2010, ANAL CHEM, V82, P3016, DOI 10.1021/ac100107z; Hwang SJ, 1997, CIRCULATION, V96, P4219; Jiang XY, 2002, LANGMUIR, V18, P3273, DOI 10.1021/la011668+; Le Saux G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021869; Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045; Luetjering G., 2007, TITANIUM; Luong-Van E, 2013, J MATER RES, V28, P165, DOI 10.1557/jmr.2012.398; MITSUMATA M, 1993, AM J PHYSIOL, V265, pH3, DOI 10.1152/ajpheart.1993.265.1.H3; Morgan JT, 2012, BIOMATERIALS, V33, P4126, DOI 10.1016/j.biomaterials.2012.02.047; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; NEREM RM, 1993, J CARDIOVASC PHARM, V21, pS6, DOI 10.1097/00005344-199321001-00002; OBrien KD, 1996, CIRCULATION, V93, P672, DOI 10.1161/01.CIR.93.4.672; Ohya S, 2005, BIOMATERIALS, V26, P3105, DOI 10.1016/j.biomaterials.2004.08.006; Parker ER, 2005, J ELECTROCHEM SOC, V152, pC675, DOI 10.1149/1.2006647; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Rienzo C Di, 2013, SCI REPORTS, V3, P8; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; Salakhutdinov I, 2008, J NANOMATER, V2008, DOI 10.1155/2008/543170; Song KH, 2012, BIOMATERIALS, V33, P2007, DOI 10.1016/j.biomaterials.2011.12.002; Sprague EA, 2012, CIRC-CARDIOVASC INTE, V5, P499, DOI 10.1161/CIRCINTERVENTIONS.111.967901; Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046; Uttayarat P, 2008, AM J PHYSIOL-HEART C, V294, pH1027, DOI 10.1152/ajpheart.00816.2007; Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478; Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e; Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308; Wallace CS, 2007, AM J PHYSIOL-HEART C, V293, pH1978, DOI 10.1152/ajpheart.00618.2007; Wheeldon I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/212001; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zorlutuna P, 2009, ACTA BIOMATER, V5, P2451, DOI 10.1016/j.actbio.2009.03.027; Zuruzi AS, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245304	50	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111465	10.1371/journal.pone.0111465	http://dx.doi.org/10.1371/journal.pone.0111465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357245	gold, Green Published			2022-12-27	WOS:000346765000064
J	Zhang, L; Ye, L; Ojcius, DM; Lou, XY; Wang, CW; Feng, C; Sun, Y; Wang, ZF; Li, SB; Zhang, YJ				Zhang, Lei; Ye, Ling; Ojcius, David M.; Lou, Xiuyu; Wang, Chengwei; Feng, Cen; Sun, Yi; Wang, Zhongfa; Li, Shibo; Zhang, Yanjun			Characterization of Severe Fever with Thrombocytopenia Syndrome in Rural Regions of Zhejiang, China	PLOS ONE			English	Article							SYNDROME VIRUS; SHANDONG PROVINCE; RISK-FACTORS; BUNYAVIRUS; SEROPREVALENCE; INFECTIONS; ANTIBODIES; JIANGSU	Severe fever with thrombocytopenia syndrome virus (SFTSV) infections have recently been found in rural regions of Zhejiang. A severe fever with thrombocytopenia syndrome (SFTS) surveillance and sero-epidemiological investigation was conducted in the districts with outbreaks. During the study period of 2011-2014, a total of 51 SFTSV infection cases were identified and the case fatality rate was 12% (6/51). Ninety two percent of the patients (47/51) were over 50 years of age, and 63% (32/51) of laboratory confirmed cases occurred from May to July. Nine percent (11/120) of the serum samples from local healthy people without symptoms were found to be positive for antibodies to the SFTS virus. SFTSV strains were isolated by culture using Vero, and the whole genomic sequences of two SFTSV strains (01 and Zhao) were sequenced and submitted to the GenBank. Homology analysis showed that the similarity of the target nucleocapsid gene from the SFTSV strains from different geographic areas was 94.2-100%. From the constructed phylogenetic tree, it was found that all the SFTSV strains diverged into two main clusters. Only the SFTSV strains from the Zhejiang (Daishan) region of China and the Yamaguchi, Miyazakj regions of Japan, were clustered into lineage II, consistent with both of these regions being isolated areas with similar geographic features. Two out of eight predicted linear B cell epitopes from the nucleocapsid protein showed mutations between the SFTSV strains of different clusters, but did not contribute to the binding ability of the specific SFTSV antibodies. This study confirmed that SFTSV has been circulating naturally and can cause a seasonal prevalence in Daishan, China. The results also suggest that the molecular characteristics of SFTSV are associated with the geographic region and all SFTSV strains can be divided into two genotypes.	[Zhang, Lei; Lou, Xiuyu; Feng, Cen; Sun, Yi; Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhang, Lei] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB, Canada; [Ye, Ling; Wang, Chengwei; Wang, Zhongfa] Ctr Dis Control & Prevent Daishan, Zhoushan, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Li, Shibo] Zhoushan Hosp, Zhoushan, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; University of Alberta; University of California System; University of California Merced; University of California System; University of California Merced	Zhang, YJ (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	yjzhang@cdc.zj.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [81401370]; Zhejiang Provincial Natural Science Foundation of China [LY14H260005]; Science and Technology department of Zhejiang, China [2012C33063, 2011R50021]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Provincial Medical Research Program [2014KYB058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science and Technology department of Zhejiang, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Provincial Medical Research Program	Support from National Natural Science Foundation of China (81401370) (http://www.nsfc.gov.cn/), ZL; Zhejiang Provincial Natural Science Foundation of China (LY14H260005) (http://www.zjnsf.gov.cn/), ZL. Grants from Science and Technology department of Zhejiang, China (2012C33063) (2011R50021) (http:// www.zjkjt.gov.cn/), YZ; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents (http://www.zjwst.gov.cn/), YZ; and Zhejiang Provincial Medical Research Program (2014KYB058) (http://www.zjwst.gov.cn/), XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Cui F, 2013, AM J TROP MED HYG, V88, P510, DOI 10.4269/ajtmh.11-0760; Cui N, 2014, J CLIN VIROL, V59, P12, DOI 10.1016/j.jcv.2013.10.024; Deng BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080802; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Guo XL, 2013, CLIN VACCINE IMMUNOL, V20, P1426, DOI 10.1128/CVI.00222-13; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020; Liang SY, 2014, AM J TROP MED HYG, V90, P256, DOI 10.4269/ajtmh.13-0423; Liu K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002820; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Liu SL, 2014, REV MED VIROL, V24, P90, DOI 10.1002/rmv.1776; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Yu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038291; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang L, 2013, INT J INFECT DIS, V17, pE137, DOI 10.1016/j.ijid.2012.07.007; Zhang YZ, 2012, J VIROL, V86, P2864, DOI 10.1128/JVI.06192-11; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	20	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111127	10.1371/journal.pone.0111127	http://dx.doi.org/10.1371/journal.pone.0111127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356556	Green Published, gold			2022-12-27	WOS:000346765000041
J	Abascal, JFPJ; Montesinos, P; Marinetto, E; Pascau, J; Desco, M				Abascal, Juan F. P. J.; Montesinos, Paula; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel			Comparison of Total Variation with a Motion Estimation Based Compressed Sensing Approach for Self-Gated Cardiac Cine MRI in Small Animal Studies	PLOS ONE			English	Article							ACCELERATED DYNAMIC MRI; SPLIT BREGMAN METHOD; IMAGE-RECONSTRUCTION; REGISTRATION; REGULARIZATION; INTERPOLATION; ALGORITHM; SPARSITY	Purpose: Compressed sensing (CS) has been widely applied to prospective cardiac cine MRI. The aim of this work is to study the benefits obtained by including motion estimation in the CS framework for small-animal retrospective cardiac cine. Methods: We propose a novel B-spline-based compressed sensing method (SPLICS) that includes motion estimation and generalizes previous spatiotemporal total variation (ST-TV) methods by taking into account motion between frames. In addition, we assess the effect of an optimum weighting between spatial and temporal sparsity to further improve results. Both methods were implemented using the efficient Split Bregman methodology and were evaluated on rat data comparing animals with myocardial infarction with controls for several acceleration factors. Results: ST-TV with optimum selection of the weighting sparsity parameter led to results similar to those of SPLICS; ST-TV with large relative temporal sparsity led to temporal blurring effects. However, SPLICS always properly corrected temporal blurring, independently of the weighting parameter. At acceleration factors of 15, SPLICS did not distort temporal intensity information but led to some artefacts and slight over-smoothing. At an acceleration factor of 7, images were reconstructed without significant loss of quality. Conclusion: We have validated SPLICS for retrospective cardiac cine in small animal, achieving high acceleration factors. In addition, we have shown that motion modelling may not be essential for retrospective cine and that similar results can be obtained by using ST-TV provided that an optimum selection of the spatiotemporal sparsity weighting parameter is performed.	[Abascal, Juan F. P. J.; Montesinos, Paula; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain; [Abascal, Juan F. P. J.; Montesinos, Paula; Marinetto, Eugenio; Pascau, Javier; Desco, Manuel] IiSGM, Madrid, Spain; [Desco, Manuel] Ctr Invest Red Salud Mental CIBERSAM, Madrid, Spain	Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Abascal, JFPJ (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain.	jabascal@hggm.es	Desco, Manuel/AAD-7137-2019; Pascau, Javier/B-5734-2013; ABASCAL, JUAN FPJ/L-7062-2014	Desco, Manuel/0000-0003-0989-3231; Pascau, Javier/0000-0003-1484-731X; ABASCAL, JUAN FPJ/0000-0002-2757-8676; Marinetto, Eugenio/0000-0001-5970-4780	Cardiovascular Research Network (RIC) from the Ministerio de Economia y Competitividad [RD12/0042/0057]	Cardiovascular Research Network (RIC) from the Ministerio de Economia y Competitividad	JFPJ Abascal and P Montesinos were funded by the Cardiovascular Research Network (RIC, RD12/0042/0057) from the Ministerio de Economia y Competitividad (www.mineco.gob.es/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JFPJ, 2011, MED PHYS, V38, P6275, DOI 10.1118/1.3656063; Abascal JFPJ, 2013, 13 MED C MED BIOL EN, P233; Asif MS, 2013, MAGN RESON MED, V70, P800, DOI 10.1002/mrm.24524; Bilen C, 2011, SIGN PROC MED BIOL S, P1; Blu T, 2003, IEEE T IMAGE PROCESS, V12, P1297, DOI 10.1109/TIP.2003.818018; Blu T, 2001, IEEE T IMAGE PROCESS, V10, P1069, DOI 10.1109/83.931101; Bovens SM, 2011, NMR BIOMED, V24, P307, DOI 10.1002/nbm.1593; Brinegar C, 2009, IEEE ENG MED BIO, P4383, DOI 10.1109/IEMBS.2009.5333482; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Christodoulou AG, 2011, I S BIOMED IMAGING, P57, DOI 10.1109/ISBI.2011.5872353; de Boor C., 1972, Journal of Approximation Theory, V6, P50, DOI 10.1016/0021-9045(72)90080-9; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Goud S, 2010, I S BIOMED IMAGING, P988, DOI 10.1109/ISBI.2010.5490154; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757; Lingala SG, 2011, IEEE T MED IMAGING, V30, P1042, DOI 10.1109/TMI.2010.2100850; Lustig M., 2006, P INT SOC MAG RESON, V14, P2420; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Madore B, 1999, MAGNET RESON MED, V42, P813, DOI 10.1002/(SICI)1522-2594(199911)42:5<813::AID-MRM1>3.0.CO;2-S; Moghari MH, 2011, MAGN RESON MED, V66, P1674, DOI 10.1002/mrm.22950; Montefusco LB, 2011, IEEE T MED IMAGING, V30, P1064, DOI 10.1109/TMI.2010.2068306; Montesinos P, 2014, MAGN RESON MED, V72, P369, DOI 10.1002/mrm.24936; Motaal AG, 2013, NMR BIOMED, V26, P451, DOI 10.1002/nbm.2883; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tsao J, 2003, MAGNET RESON MED, V50, P1031, DOI 10.1002/mrm.10611; Usman M, 2011, MAGN RESON MED, V66, P1163, DOI 10.1002/mrm.22883; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wech T, 2012, J CARDIOVASC MAGN S1, V14, pP65; Wech T, 2011, J MAGN RESON IMAGING, V34, P1072, DOI 10.1002/jmri.22718; Xie ZY, 2004, IEEE T VIS COMPUT GR, V10, P85, DOI 10.1109/TVCG.2004.1260760; Yang ZQ, 2004, CIRCULATION, V109, P1161, DOI 10.1161/01.CIR.0000118495.88442.32; Zhao B, 2010, IEEE ENG MED BIO, P3390, DOI 10.1109/IEMBS.2010.5627934	37	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110594	10.1371/journal.pone.0110594	http://dx.doi.org/10.1371/journal.pone.0110594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350290	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100032
J	Pan, WT; Cheng, GX; Xing, HX; Shi, J; Lu, C; Wei, JY; Li, LC; Zhou, CC; Yuan, QP; Zhou, LQ; Yang, M				Pan, Wenting; Cheng, Guangxia; Xing, Huaixin; Shi, Juan; Lu, Chao; Wei, Jinyu; Li, Lichao; Zhou, Changchun; Yuan, Qipeng; Zhou, Liqing; Yang, Ming			Leukocyte Telomere Length-Related rs621559 and rs398652 Genetic Variants Influence Risk of HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CIGARETTE-SMOKING; CANCER; SUSCEPTIBILITY; LOCUS; CONTRIBUTE; POLYMORPHISMS; DYSFUNCTION; 14Q21; TERC	Recent genome-wide association studies (GWAS) have identified eleven leukocyte telomere length (LTL)-related single nucleotide polymorphisms (SNPs). Since LTL has been associated with risk of many malignancies, LTL-related SNPs may contribute to cancer susceptibility. To test this hypothesis in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we genotyped these eleven LTL-related SNPs in a case-control set including 1186 HBV-related HCC cases, 508 chronic HBV carriers and 1308 healthy controls at the discovery stage. The associations of HCC risk with these SNPs were further confirmed in an independent case-control set. We found that 1p34.2 rs621559 and 14q21 rs398652 were significantly associated with HBV-related HCC risk (both P<0.005 after Bonferroni corrections). There was no significant difference of either rs621559 or rs398652 genotypes between chronic HBV carriers and healthy controls, demonstrating that the association was not due to predisposition to HBV infection. In the pooled analyses (1806 HBV-related HCC cases and 1954 controls), we observed a decreased HCC risk, 0.72-times, associated with the 1p34.2 rs621559 AA genotype compared to the GG genotype (P = 1.6 x 10(-6)). Additionally, there was an increased HCC risk, 1.27-fold, associated with the rs398652 GG genotype (P = 3.3 x 10(-6)). A statistical joint effect between the rs621559 GG and rs398652 GG genotypes may exist in elevating risk of HBV-related HCC. We show, for the first time, that rs398652 and rs621559 might be marker genetic variants for risk of HBV-related HCC in the Chinese population.	[Pan, Wenting; Shi, Juan; Lu, Chao; Wei, Jinyu; Li, Lichao; Yuan, Qipeng; Yang, Ming] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing Lab Biomed Mat, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Cheng, Guangxia] Shandong Univ, Jinan Infect Dis Hosp, Clin Lab, Jinan, Shandong, Peoples R China; [Xing, Huaixin] Shandong Acad Med Sci, Shandong Canc Hosp, Dept Anesthesiol, Jinan, Shandong, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan, Shandong, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China	Beijing University of Chemical Technology; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhou, LQ (corresponding author), Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China.	zlq-hill@163.com; yangm@mail.buct.edu.cn	Yang, Ming/G-4705-2012; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; 	National Natural Science Foundation of China [81201586, 31271382]; Beijing Natural Science Foundation [5122020]; open project of State Key Laboratory of Molecular Oncology [SKL-KF-2013-03]; Beijing Higher Education Young Elite Teacher Project [YETP0521]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13045]; Beijing City Talent Training Project [2012D009016000002]; Shandong Provincial Natural Science Foundation [Y2008C36]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); open project of State Key Laboratory of Molecular Oncology; Beijing Higher Education Young Elite Teacher Project; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing City Talent Training Project; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study was supported by the National Natural Science Foundation of China (81201586 & 31271382); Beijing Natural Science Foundation (5122020); the open project of State Key Laboratory of Molecular Oncology (SKL-KF-2013-03); Beijing Higher Education Young Elite Teacher Project (YETP0521); Program for Changjiang Scholars and Innovative Research Team in University (IRT13045); Beijing City Talent Training Project (2012D009016000002); Shandong Provincial Natural Science Foundation (Y2008C36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2006, J GERONTOL A-BIOL, V61, P871, DOI 10.1093/gerona/61.8.871; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; Chan KYK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028798; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Liu J, 2011, CANCER-AM CANCER SOC, V117, P4247, DOI 10.1002/cncr.26015; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Masi S, 2011, FREE RADICAL BIO MED, V50, P730, DOI 10.1016/j.freeradbiomed.2010.12.031; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Xing JL, 2009, CANCER PREV RES, V2, P459, DOI 10.1158/1940-6207.CAPR-08-0227; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zheng YL, 2011, HUM MOL GENET, V20, P378, DOI 10.1093/hmg/ddq461; Zhou LQ, 2012, INT J CLIN EXP MED, V5, P72	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110863	10.1371/journal.pone.0110863	http://dx.doi.org/10.1371/journal.pone.0110863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365256	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100030
J	Autelitano, F; Loyaux, D; Roudieres, S; Deon, C; Guette, F; Fabre, P; Ping, QG; Wang, S; Auvergne, R; Badarinarayana, V; Smith, M; Guillemot, JC; Goldman, SA; Natesan, S; Ferrara, P; August, P				Autelitano, Francois; Loyaux, Denis; Roudieres, Sebastien; Deon, Catherine; Guette, Frederique; Fabre, Philippe; Ping, Qinggong; Wang, Su; Auvergne, Romane; Badarinarayana, Vasudeo; Smith, Michael; Guillemot, Jean-Claude; Goldman, Steven A.; Natesan, Sridaran; Ferrara, Pascual; August, Paul			Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics	PLOS ONE			English	Article							TITANIUM-DIOXIDE CHROMATOGRAPHY; TYROSINE-PHOSPHATASE-ZETA; MONOCLONAL-ANTIBODY; IN-VITRO; THERAPEUTIC TARGET; ADHESION MOLECULE; MALIGNANT GLIOMAS; PHASE-II; IMMUNOTOXIN; EXPRESSION	Glioblastoma multiform (GBM) remains clinical indication with significant "unmet medical need''. Innovative new therapy to eliminate residual tumor cells and prevent tumor recurrences is critically needed for this deadly disease. A major challenge of GBM research has been the identification of novel molecular therapeutic targets and accurate diagnostic/prognostic biomarkers. Many of the current clinical therapeutic targets of immunotoxins and ligand-directed toxins for high-grade glioma (HGG) cells are surface sialylated glycoproteins. Therefore, methods that systematically and quantitatively analyze cell surface sialoglycoproteins in human clinical tumor samples would be useful for the identification of potential diagnostic markers and therapeutic targets for malignant gliomas. In this study, we used the bioorthogonal chemical reporter strategy (BOCR) in combination with label-free quantitative mass spectrometry (LFQ-MS) to characterize and accurately quantify the individual cell surface sialoproteome in human GBM tissues, in fetal, adult human astrocytes, and in human neural progenitor cells (NPCs). We identified and quantified a total of 843 proteins, including 801 glycoproteins. Among the 843 proteins, 606 (72%) are known cell surface or secreted glycoproteins, including 156 CD-antigens, all major classes of cell surface receptor proteins, transporters, and adhesion proteins. Our findings identified several known as well as new cell surface antigens whose expression is predominantly restricted to human GBM tumors as confirmed by microarray transcription profiling, quantitative RT-PCR and immunohistochemical staining. This report presents the comprehensive identification of new biomarkers and therapeutic targets for the treatment of malignant gliomas using quantitative sialoglycoproteomics with clinically relevant, patient derived primary glioma cells.	[Autelitano, Francois; Loyaux, Denis; Roudieres, Sebastien; Deon, Catherine; Guette, Frederique; Fabre, Philippe; Guillemot, Jean-Claude; Ferrara, Pascual] Ctr Toulouse, Sanofi Aventis Rech & Dev, Toulouse, France; [Ping, Qinggong] ALS Therapy Dev Inst, Cambridge, MA USA; [Wang, Su; Auvergne, Romane; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; [Natesan, Sridaran] Sanofi US, Cambridge, MA USA; [Badarinarayana, Vasudeo; Smith, Michael; August, Paul] Sanofi Tucson Res Ctr, Oro Valley, AZ USA	Sanofi-Aventis; Sanofi France; University of Rochester; Sanofi-Aventis	Autelitano, F (corresponding author), Ctr Toulouse, Sanofi Aventis Rech & Dev, Toulouse, France.	francois.autelitano@sanofi.com	Auvergne, Romane M/N-2624-2016	Auvergne, Romane M/0000-0002-9497-0184; Goldman, Steven/0000-0002-5498-4303; Cornwell, Adam/0000-0002-0572-3107; Autelitano, Francois/0000-0001-6269-2629	Adelson Medical Research Foundation; New York State Stem Cell Research Program (NYSTEM); Sanofi; Novo Nordisk Fonden [NNF13OC0004260] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099578, R01MH104701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345] Funding Source: NIH RePORTER	Adelson Medical Research Foundation; New York State Stem Cell Research Program (NYSTEM); Sanofi; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the Steven A Goldman lab was supported by the Adelson Medical Research Foundation and the New York State Stem Cell Research Program (NYSTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sanofi supported in part the work performed in the Steven A Goldman lab by providing technical assistance and research materials. Co-authors Francois Autelitano, Denis Loyaux, Sebastien Roudieres, Catherine Deon, Frederique Guette, Philippe Fabre, Jean-Claude Guillemot and Pascual Ferrara are employed by Sanofi-Aventis Recherche & Developpement. Co-author Sridaran Natesan is employed by Sanofi US. Co-authors Vasudeo Badarinarayana, Michael Smith and Paul August are employed by Sanofi Tucson Research Center. Sanofi provided support in the form of salaries for authors FA, DL, SR, CD, FG, PF, J-CG, PF, SN, VB, MS and PA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; Auvergne RM, 2013, CELL REP, V3, P2127, DOI 10.1016/j.celrep.2013.04.035; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Buzy A, 2011, ANN M 6 JOURN SPECTR; Calvano CD, 2008, J PROTEOMICS, V71, P304, DOI 10.1016/j.jprot.2008.06.013; Candolfi M, 2010, P NATL ACAD SCI USA, V107, P20021, DOI 10.1073/pnas.1008261107; Chandramohan V, 2013, CLIN CANCER RES, V19, P4717, DOI 10.1158/1078-0432.CCR-12-3891; Chandramohan V, 2013, INT J CANCER, V132, P2339, DOI 10.1002/ijc.27919; Chandramohan V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/480429; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Deighton RF, 2010, BRAIN PATHOL, V20, P691, DOI 10.1111/j.1750-3639.2010.00376.x; Deng JP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/517172; Foehr ED, 2006, CANCER RES, V66, P2271, DOI 10.1158/0008-5472.CAN-05-1221; Gahmberg C, 1996, TRENDS BIOCHEM SCI, V21, P491; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hagglund P, 2004, J PROTEOME RES, V3, P556, DOI 10.1021/pr034112b; He JT, 2011, J PROTEOME RES, V10, P330, DOI 10.1021/pr101158p; Hjortland GO, 2004, J NEUROSURG, V100, P320, DOI 10.3171/jns.2004.100.2.0320; HOPKINS K, 1995, RADIOTHER ONCOL, V34, P121, DOI 10.1016/0167-8140(95)01514-H; Howley R, 2012, EXP CELL RES, V318, P2245, DOI 10.1016/j.yexcr.2012.06.007; Kalinina J, 2011, NEURO-ONCOLOGY, V13, P926, DOI 10.1093/neuonc/nor078; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Konya C, 2011, NEUROCHEM INT, V59, P251, DOI 10.1016/j.neuint.2011.05.012; Kuan CT, 2010, INT J CANCER, V127, P598, DOI 10.1002/ijc.25062; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Kunwar S, 2010, NEURO-ONCOLOGY, V12, P871, DOI 10.1093/neuonc/nop054; Larsen MR, 2007, MOL CELL PROTEOMICS, V6, P1778, DOI 10.1074/mcp.M700086-MCP200; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Li CB, 2002, PROTEIN ENG, V15, P419, DOI 10.1093/protein/15.5.419; Li LN, 2010, J NEUROSURG, V113, P192, DOI 10.3171/2010.2.JNS091211; Liu TF, 2005, CLIN CANCER RES, V11, P329; Liu Yashu, 2013, Methods Mol Biol, V951, P69, DOI 10.1007/978-1-62703-146-2_6; Luther N, 2010, MOL CANCER THER, V9, P1039, DOI 10.1158/1535-7163.MCT-09-0996; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MARUNO M, 1994, J NEURO-ONCOL, V19, P155, DOI 10.1007/BF01306457; Mazzarelli P, 2009, ADV CANCER RES, V105, P45, DOI 10.1016/S0065-230X(09)05003-9; Muller S, 2004, EXPERT OPIN THER TAR, V8, P211, DOI 10.1517/14728222.8.3.211; Mut M, 2008, EXPERT OPIN BIOL TH, V8, P805, DOI 10.1517/14712598.8.6.805 ; Niclou SP, 2010, J PROTEOMICS, V73, P1823, DOI 10.1016/j.jprot.2010.03.007; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Oh S, 2011, J NEUROSURG, V114, P1662, DOI 10.3171/2010.11.JNS101214; Oh S, 2009, J NEURO-ONCOL, V95, P331, DOI 10.1007/s11060-009-9932-2; Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Panico F, 2009, ADV CANCER RES, V105, P63, DOI 10.1016/S0065-230X(09)05004-0; PAPANASTASSIOU V, 1993, BRIT J CANCER, V67, P144, DOI 10.1038/bjc.1993.25; Piao HL, 2013, MABS-AUSTIN, V5, P748, DOI 10.4161/mabs.25860; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Pooler AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.005; Potter NE, 2009, EXP CELL RES, V315, P2835, DOI 10.1016/j.yexcr.2009.06.003; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pucci S, 2009, AM J GASTROENTEROL, V104, P2807, DOI 10.1038/ajg.2009.412; Rainov NG, 2006, REV RECENT CLIN TRIA, V1, P119, DOI 10.2174/157488706776876454; Rajcevic U, 2009, MOL CELL PROTEOMICS, V8, P2595, DOI 10.1074/mcp.M900124-MCP200; Reardon DA, 2007, EXPERT REV ANTICANC, V7, P675, DOI 10.1586/14737140.7.5.675; Ren H, 2007, REV RECENT CLIN TRIA, V2, P87, DOI 10.2174/157488707780599384; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; RICHARDSON RB, 1986, EUR J NUCL MED, V12, P313, DOI 10.1007/BF00263810; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Rustamzadeh E, 2007, INT J CANCER, V120, P411, DOI 10.1002/ijc.22278; Sampson JH, 2008, NEURO-ONCOLOGY, V10, P320, DOI 10.1215/15228517-2008-012; Sampson JH, 2010, J NEUROSURG, V113, P301, DOI 10.3171/2009.11.JNS091052; Sasaki H, 1998, CANCER, V82, P1921, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1921::AID-CNCR16>3.0.CO;2-V; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapiro WR, 2006, EXPERT OPIN BIOL TH, V6, P539, DOI 10.1517/14712598.6.5.539; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Sim FJ, 2009, NEURON GLIA BIOL, V5, P45, DOI 10.1017/S1740925X09990317; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Solomon DA, 2009, CANCER RES, V69, P5630, DOI 10.1158/0008-5472.CAN-09-1055; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tabatabai G, 2010, TARGET ONCOL, V5, P175, DOI 10.1007/s11523-010-0156-3; Teicher BA, 2009, CURR CANCER DRUG TAR, V9, P982, DOI 10.2174/156800909790192365; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; Vitolo D, 1996, HISTOPATHOLOGY, V28, P521, DOI 10.1046/j.1365-2559.1996.d01-471.x; Wadhwa S, 2003, J BIOSCIENCES, V28, P181, DOI 10.1007/BF02706217; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Weaver M, 2003, J NEURO-ONCOL, V65, P3, DOI 10.1023/A:1026246500788; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331; Weber F, 2003, J NEURO-ONCOL, V64, P125, DOI 10.1023/A:1024901501173; Whittle IR, 2007, BRIT J NEUROSURG, V21, P576, DOI 10.1080/02688690701721691; Witusik-Perkowska M, 2011, J NEURO-ONCOL, V102, P395, DOI 10.1007/s11060-010-0352-0; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamamoto H, 2001, CANCER RES, V61, P6822; Yamanaka R, 2009, ANN NEUROL, V66, P717, DOI 10.1002/ana.21793; Yang ZP, 2005, J CHROMATOGR A, V1070, P57, DOI 10.1016/j.chroma.2005.02.034; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	97	30	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110316	10.1371/journal.pone.0110316	http://dx.doi.org/10.1371/journal.pone.0110316			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360666	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700030
J	Claes, N; Dhaeze, T; Fraussen, J; Broux, B; Van Wijmeersch, B; Stinissen, P; Hupperts, R; Hellings, N; Somers, V				Claes, Nele; Dhaeze, Tessa; Fraussen, Judith; Broux, Bieke; Van Wijmeersch, Bart; Stinissen, Piet; Hupperts, Raymond; Hellings, Niels; Somers, Veerle			Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; ORAL FINGOLIMOD; MARGINAL ZONE; SYSTEMIC AUTOIMMUNITY; IMMUNE CELLS; PHASE-II; FTY720; SUBSETS; MEMORY; FOXP3	Background and objective: The long term effects of fingolimod, an oral treatment for relapsing-remitting (RR) multiple sclerosis (MS), on blood circulating B and T cell subtypes in MS patients are not completely understood. This study describes for the first time the longitudinal effects of fingolimod treatment on B and T cell subtypes. Furthermore, expression of surface molecules involved in antigen presentation and costimulation during fingolimod treatment are assessed in MS patients in a 12 month follow-up study. Methods: Using flow cytometry, B and T cell subtypes, and their expression of antigen presentation, costimulation and migration markers were measured during a 12 month follow-up in the peripheral blood of MS patients. Data of fingolimod-treated MS patients (n = 49) were compared to those from treatment-naive (n = 47) and interferon-treated (n = 27) MS patients. Results: In the B cell population, we observed a decrease in the proportion of non class-switched and class-switched memory B cells (p<0.001), both implicated in MS pathogenesis, while the proportion of naive B cells was increased during fingolimod treatment in the peripheral blood (PB) of MS patients (p<0.05). The remaining T cell population, in contrast, showed elevated proportions of memory conventional and regulatory T cells (p<0.01) and declined proportions of naive conventional and regulatory cells (p<0.05). These naive T cell subtypes are main drivers of MS pathogenesis. B cell expression of CD80 and CD86 and programmed death (PD) -1 expression on circulating follicular helper T cells was increased during fingolimod follow-up (p<0.05) pointing to a potentially compensatory mechanism of the remaining circulating lymphocyte subtypes that could provide additional help during normal immune responses. Conclusions: MS patients treated with fingolimod showed a change in PB lymphocyte subtype proportions and expression of functional molecules on T and B cells, suggesting an association with the therapeutic efficacy of fingolimod.	[Claes, Nele; Dhaeze, Tessa; Fraussen, Judith; Broux, Bieke; Van Wijmeersch, Bart; Stinissen, Piet; Hellings, Niels; Somers, Veerle] Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium; [Claes, Nele; Dhaeze, Tessa; Fraussen, Judith; Broux, Bieke; Van Wijmeersch, Bart; Stinissen, Piet; Hellings, Niels; Somers, Veerle] Transnat Univ Limburg, Sch Life Sci, Diepenbeek, Belgium; [Van Wijmeersch, Bart] Rehabil & MS Ctr, Overpelt, Belgium; [Hupperts, Raymond] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Maastricht, Netherlands; [Hupperts, Raymond] Orbis Med Ctr, Dept Neurol, Sittard, Netherlands	Hasselt University; Hasselt University; Maastricht University; Orbis Medical Center	Somers, V (corresponding author), Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium.	veerle.somers@uhasselt.be	Somers, Veerle/H-6965-2017; Fraussen, Judith/AAJ-2488-2020; Broux, Bieke/AAK-3721-2021; HELLINGS, Niels/AAS-5033-2020	Somers, Veerle/0000-0002-4950-8724; Fraussen, Judith/0000-0003-0272-8209; Broux, Bieke/0000-0001-8509-2415; Hellings, Niels/0000-0003-2308-406X; Stinissen, Piet/0000-0002-4830-4084	Hasselt University, Belgium; Maastricht University, the Netherlands	Hasselt University, Belgium; Maastricht University, the Netherlands(Netherlands Government)	This work was funded by Hasselt University, Belgium and Maastricht University, the Netherlands. J. Fraussen and B. Broux are postdoctoral fellows of the Fund for Scientific Research (FWO), Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton C, 2012, J CLIN PHARMACOL, V52, P1879, DOI 10.1177/0091270011427908; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Broux B, 2013, CRIT REV IMMUNOL, V33, P283; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Comi G, 2010, MULT SCLER, V16, P197, DOI 10.1177/1352458509357065; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fraussen J, 2009, AUTOIMMUN REV, V8, P654, DOI 10.1016/j.autrev.2009.02.030; Han SH, 2004, BLOOD, V104, P4129, DOI 10.1182/blood-2004-06-2075; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kowarik MC, 2011, NEUROLOGY, V76, P1214, DOI 10.1212/WNL.0b013e3182143564; Linterman MA, 2012, IMMUNOL REV, V247, P143, DOI 10.1111/j.1600-065X.2012.01121.x; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2011, NEUROLOGY, V76, pS20, DOI 10.1212/WNL.0b013e31820db341; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Mehling M, 2011, ANN NEUROL, V69, P408, DOI 10.1002/ana.22352; Miyazaki Y, 2014, CLIN IMMUNOL, V151, P127, DOI 10.1016/j.clim.2014.02.001; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Nakamura M., 2014, MULT SCLER; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Qin YF, 1998, J CLIN INVEST, V102, P1045, DOI 10.1172/JCI3568; Sato DK, 2014, J NEUROIMMUNOL, V268, P95, DOI 10.1016/j.jneuroim.2014.01.008; Serpero LD, 2013, J NEUROIMMUNE PHARM; Tellier J, 2013, CELL MOL LIFE SCI, V70, P4771, DOI 10.1007/s00018-013-1420-3; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003; von Wenckstern H, 2006, ARCH IMMUNOL THER EX, V54, P239, DOI 10.1007/s00005-006-0028-9; Vora KA, 2005, J LEUKOCYTE BIOL, V78, P471, DOI 10.1189/jlb.0904487; Weinstein JS, 2012, IMMUNOL REV, V247, P160, DOI 10.1111/j.1600-065X.2012.01122.x; Zhou PJ, 2009, CLIN EXP IMMUNOL, V157, P40, DOI 10.1111/j.1365-2249.2009.03942.x	38	68	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111115	10.1371/journal.pone.0111115	http://dx.doi.org/10.1371/journal.pone.0111115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360562	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700063
J	Deepthi, A; Liew, CW; Liang, ZX; Swaminathan, K; Lescar, J				Deepthi, Angeline; Liew, Chong Wai; Liang, Zhao-Xun; Swaminathan, Kunchithapadam; Lescar, Julien			Structure of a Diguanylate Cyclase from Thermotoga maritima: Insights into Activation, Feedback Inhibition and Thermostability	PLOS ONE			English	Article							C-DI-GMP; ALLOSTERIC CONTROL; PROTEIN THERMOSTABILITY; PHOSPHODIESTERASE; DETERMINANTS; DISRUPTION; MECHANISM; MOLECULE; GENOMICS; DOMAINS	Large-scale production of bis-39-59-cyclic-di-GMP (c-di-GMP) would facilitate biological studies of numerous bacterial signaling pathways and phenotypes controlled by this second messenger molecule, such as virulence and biofilm formation. C-di-GMP constitutes also a potentially interesting molecule as a vaccine adjuvant. Even though chemical synthesis of c-di-GMP can be done, the yields are incompatible with mass-production. tDGC, a stand-alone diguanylate cyclase (DGC or GGDEF domain) from Thermotoga maritima, enables the robust enzymatic production of large quantities of c-di-GMP. To understand the structural correlates of tDGC thermostability, its catalytic mechanism and feedback inhibition, we determined structures of an active-like dimeric conformation with both active (A) sites facing each other and of an inactive dimeric conformation, locked by c-di-GMP bound at the inhibitory (I) site. We also report the structure of a single mutant of tDGC, with the R158A mutation at the I-site, abolishing product inhibition and unproductive dimerization. A comparison with structurally characterized DGC homologues from mesophiles reveals the presence of a higher number of salt bridges in the hyperthermophile enzyme tDGC. Denaturation experiments of mutants disrupting in turn each of the salt bridges unique to tDGC identified three salt-bridges critical to confer thermostability.	[Deepthi, Angeline; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Liew, Chong Wai; Liang, Zhao-Xun; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Lescar, Julien] CHU Pitie Salpetriere, Fac Med Pierre & Marie Curie, Ctr Immunol & Malad Infect, Paris, France	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsks@nus.edu.sg; julien@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011	Liang, Zhao-Xun/0000-0002-3128-1330	National Research Foundation [CRP2008]	National Research Foundation	Supported by Competitive Research Programme Grant CRP2008 from the National Research Foundation (to the J. L. laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Giardina G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081324; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kiburu I, 2008, MOL BIOSYST, V4, P518, DOI 10.1039/b719423d; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709; PACE CN, 1992, J MOL BIOL, V226, P29, DOI 10.1016/0022-2836(92)90121-Y; Pappenberger G, 1997, J MOL BIOL, V274, P676, DOI 10.1006/jmbi.1997.1421; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Robinson-Rechavi M, 2005, STRUCTURE, V13, P857, DOI 10.1016/j.str.2005.03.011; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1990, J BIOL CHEM, V265, P18933; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schrodinger L., 2020, PYMOL; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Vorobiev Sergey M., 2012, Journal of Structural and Functional Genomics, V13, P177, DOI 10.1007/s10969-012-9136-4; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X; Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026	34	19	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110912	10.1371/journal.pone.0110912	http://dx.doi.org/10.1371/journal.pone.0110912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360685	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700052
J	Whidden, CE; DeZeeuw, KG; Zorz, JK; Joy, AP; Barnett, DA; Johnson, MS; Zhaxybayeva, O; Cockshutt, AM				Whidden, Caroline E.; DeZeeuw, Katrina G.; Zorz, Jackie K.; Joy, Andrew P.; Barnett, David A.; Johnson, Milo S.; Zhaxybayeva, Olga; Cockshutt, Amanda M.			Quantitative and Functional Characterization of the Hyper-Conserved Protein of Prochlorococcus and Marine Synechococcus	PLOS ONE			English	Article							TRANSCRIPTIONAL START SITES; HYPERCONSERVED PROTEIN; SEQUENCE; ECOTYPES; PHOTOSYNTHESIS; PHYTOPLANKTON; ACQUISITION; SEARCH; LIGHT	A large fraction of any bacterial genome consists of hypothetical protein-coding open reading frames (ORFs). While most of these ORFs are present only in one or a few sequenced genomes, a few are conserved, often across large phylogenetic distances. Such conservation provides clues to likely uncharacterized cellular functions that need to be elucidated. Marine cyanobacteria from the Prochlorococcus/marine Synechococcus clade are dominant bacteria in oceanic waters and are significant contributors to global primary production. A Hyper Conserved Protein (PSHCP) of unknown function is 100% conserved at the amino acid level in genomes of Prochlorococcus/marine Synechococcus, but lacks homologs outside of this clade. In this study we investigated Prochlorococcus marinus strains MED4 and MIT 9313 and Synechococcus sp. strain WH 8102 for the transcription of the PSHCP gene using RT-Q-PCR, for the presence of the protein product through quantitative immunoblotting, and for the protein's binding partners in a pull down assay. Significant transcription of the gene was detected in all strains. The PSHCP protein content varied between 8 +/- 1 fmol and 26 +/- 9 fmol per ug total protein, depending on the strain. The 50 S ribosomal protein L2, the Photosystem I protein PsaD and the Ycf48-like protein were found associated with the PSHCP protein in all strains and not appreciably or at all in control experiments. We hypothesize that PSHCP is a protein associated with the ribosome, and is possibly involved in photosystem assembly.	[Whidden, Caroline E.; DeZeeuw, Katrina G.; Zorz, Jackie K.; Cockshutt, Amanda M.] Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada; [Joy, Andrew P.; Barnett, David A.] Atlantic Canc Res Inst, Moncton, NB, Canada; [Johnson, Milo S.; Zhaxybayeva, Olga] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Zhaxybayeva, Olga] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA	Mount Allison University; Dartmouth College; Dartmouth College	Zhaxybayeva, O (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	olga.zhaxybayeva@dartmouth.edu; acockshutt@mta.ca		Barnett, David/0000-0001-9205-058X; Joy, Andrew/0000-0002-5477-1615; Zhaxybayeva, Olga/0000-0002-1809-3909	Marjorie Young Bell Faculty Fellow Award; Mount Allison President's Research and Creative Activity Fund; Natural Science and Engineering Research Council (NSERC) Discovery Team grant; NSERC; Mount Allison University; start-up funds from Dartmouth College; Dartmouth College Dean of Faculty start-up funds; Walter and Constance Burke Research Initiation Award	Marjorie Young Bell Faculty Fellow Award; Mount Allison President's Research and Creative Activity Fund; Natural Science and Engineering Research Council (NSERC) Discovery Team grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mount Allison University; start-up funds from Dartmouth College; Dartmouth College Dean of Faculty start-up funds; Walter and Constance Burke Research Initiation Award	This work was supported by the Marjorie Young Bell Faculty Fellow Award, the Mount Allison President's Research and Creative Activity Fund (www.mta.ca) and the Natural Science and Engineering Research Council (NSERC) (http://www.nserc-crsng.gc.ca) Discovery Team grant to AMC. JKZ and CEW received Undergraduate Summer Research Awards from NSERC (http://www.nserc-crsng.gc.ca) and Mount Allison University (www.mta.ca). OZ was supported in part by a research stipend from Mount Allison University and by start-up funds from Dartmouth College. The study was in part supported by Dartmouth College Dean of Faculty start-up funds and Walter and Constance Burke Research Initiation Award to OZ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2001, BERGEYS MANUAL SYSTE; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Gierga G, 2012, ISME J, V6, P1544, DOI 10.1038/ismej.2011.215; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2012, PLANT PHYSIOL, V158, P476, DOI 10.1104/pp.111.184184; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kutovaya OA, 2010, J BASIC MICROB, V50, P227, DOI 10.1002/jobm.200900337; Luo HW, 2011, MOL BIOL EVOL, V28, P2751, DOI 10.1093/molbev/msr081; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; Petrov AS, 2013, NUCLEIC ACIDS RES, V41, P7522, DOI 10.1093/nar/gkt513; Pittera J, 2014, ISME J, V8, P1221, DOI 10.1038/ismej.2013.228; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts E, 2008, P NATL ACAD SCI USA, V105, P13953, DOI 10.1073/pnas.0804861105; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Six C, 2004, AQUAT MICROB ECOL, V35, P17, DOI 10.3354/ame035017; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P2890, DOI 10.1093/nar/gkg398; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; WILMOTTE A., 2001, BERGEYS MANUAL SYSTE; Zhaxybayeva O, 2007, FEMS MICROBIOL LETT, V274, P30, DOI 10.1111/j.1574-6968.2007.00806.x; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	47	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109327	10.1371/journal.pone.0109327	http://dx.doi.org/10.1371/journal.pone.0109327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360678	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700010
J	Winer, LSP; Wu, M				Winer, Lisa S. Pike; Wu, Min			Rapid Analysis of Glycolytic and Oxidative Substrate Flux of Cancer Cells in a Microplate	PLOS ONE			English	Article							C-MYC; METABOLISM; INHIBITION; EXPRESSION; WARBURG; GROWTH; TUMORS	Cancer cells exhibit remarkable alterations in cellular metabolism, particularly in their nutrient substrate preference. We have devised several experimental methods that rapidly analyze the metabolic substrate flux in cancer cells: glycolysis and the oxidation of major fuel substrates glucose, glutamine, and fatty acids. Using the XF Extracellular Flux analyzer, these methods measure, in real-time, the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of living cells in a microplate as they respond to substrates and metabolic perturbation agents. In proof-of-principle experiments, we analyzed substrate flux and mitochondrial bioenergetics of two human glioblastoma cell lines, SF188s and SF188f, which were derived from the same parental cell line but proliferate at slow and fast rates, respectively. These analyses led to three interesting observations: 1) both cell lines respired effectively with substantial endogenous substrate respiration; 2) SF188f cells underwent a significant shift from glycolytic to oxidative metabolism, along with a high rate of glutamine oxidation relative to SF188s cells; and 3) the mitochondrial proton leak-linked respiration of SF188f cells increased significantly compared to SF188s cells. It is plausible that the proton leak of SF188f cells may play a role in allowing continuous glutamine-fueled anaplerotic TCA cycle flux by partially uncoupling the TCA cycle from oxidative phosphorylation. Taken together, these rapid, sensitive and high-throughput substrate flux analysis methods introduce highly valuable approaches for developing a greater understanding of genetic and epigenetic pathways that regulate cellular metabolism, and the development of therapies that target cancer metabolism.	[Winer, Lisa S. Pike; Wu, Min] Seahorse Biosci Inc, North Billerica, MA USA		Wu, M (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	mwu13@mgh.harvard.edu			Seahorse Bioscience	Seahorse Bioscience	This work was conducted in and funded by Seahorse Bioscience. LSPW is an employee and MW was an employee at the time of the work in the company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artemov D, 1998, NMR BIOMED, V11, P395, DOI 10.1002/(SICI)1099-1492(199812)11:8<395::AID-NBM536>3.0.CO;2-R; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Brooks GA, 2010, J APPL PHYSIOL, V108, P1450, DOI 10.1152/japplphysiol.00308.2010; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Ibrahim-Hashim A., 2011, J CANC SCI THER, VSuppl 1, pJCST, DOI [DOI 10.4172/1948-5956.S1-004, 10.4172/1948-5956.S1-004]; Ipata PB, 2012, METABOLOMICS, V8; Kemp G, 2005, AM J PHYSIOL-REG I, V289, pR895, DOI 10.1152/ajpregu.00641.2004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lane AN, 2009, METABOLOMICS, V5, P163, DOI 10.1007/s11306-008-0142-2; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Medina MA, 2001, J NUTR, V131, p2539S, DOI 10.1093/jn/131.9.2539S; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pike LS, 2010, BIOCH BIOPHYS ACTA; Rivenzon-Segal D, 2003, INT J CANCER, V107, P177, DOI 10.1002/ijc.11387; Samudio I, 2008, MOL CANCER THER, V7, P1130, DOI 10.1158/1535-7163.MCT-07-0553; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Swift AL, 2011, F1000 POSTERS, V2, P52; TRENT J, 1986, P NATL ACAD SCI USA, V83, P470, DOI 10.1073/pnas.83.2.470; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P35; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048	45	80	80	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109916	10.1371/journal.pone.0109916	http://dx.doi.org/10.1371/journal.pone.0109916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360519	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700021
J	Pan, WG; Wang, T; Wang, XP; Hitchman, G; Wang, LJ; Chen, AT				Pan, Weigang; Wang, Ting; Wang, Xiangpeng; Hitchman, Glenn; Wang, Lijun; Chen, Antao			Identifying the Core Components of Emotional Intelligence: Evidence from Amplitude of Low-Frequency Fluctuations during Resting State	PLOS ONE			English	Article							PRESUPPLEMENTARY MOTOR AREA; COGNITIVE CONTROL NETWORK; INFERIOR FRONTAL-CORTEX; LARGE-SCALE BRAIN; FUNCTIONAL CONNECTIVITY; SOCIAL COGNITION; BASAL GANGLIA; NEURAL BASIS; CEREBELLUM; ARCHITECTURE	Emotional intelligence (EI) is a multi-faceted construct consisting of our ability to perceive, monitor, regulate and use emotions. Despite much attention being paid to the neural substrates of EI, little is known of the spontaneous brain activity associated with EI during resting state. We used resting-state fMRI to investigate the association between the amplitude of low-frequency fluctuations (ALFFs) and EI in a large sample of young, healthy adults. We found that EI was significantly associated with ALFFs in key nodes of two networks: the social emotional processing network (the fusiform gyrus, right superior orbital frontal gyrus, left inferior frontal gyrus and left inferior parietal lobule) and the cognitive control network (the bilateral pre-SMA, cerebellum and right precuneus). These findings suggest that the neural correlates of EI involve several brain regions in two crucial networks, which reflect the core components of EI: emotion perception and emotional control.	[Pan, Weigang; Wang, Ting; Wang, Xiangpeng; Hitchman, Glenn; Wang, Lijun; Chen, Antao] Southwest Univ, Fac Psychol, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China	Southwest University - China	Chen, AT (corresponding author), Southwest Univ, Fac Psychol, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China.	xscat@swu.edu.cn	Hitchman, Glenn/F-6974-2014	Hitchman, Glenn/0000-0003-3268-5246	National Natural Science Foundation of China [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-10698]; Fundamental Research Funds for the Central Universities [SWU1009001, SWU1309351]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by "the National Natural Science Foundation of China'' (31170980, 81271477) to W. Pan and A. Chen, the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107) to A. Chen, the New Century Excellent Talents in University (NCET-10698), and the Fundamental Research Funds for the Central Universities (SWU1009001, SWU1309351) to A. Chen and research fellow. Study design and data collection were supported by "the National Natural Science Foundation of China'' (31170980, 81271477). Data analysis, preparation of the manuscript and decision to publish was supported by the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET- 110698), and the Fundamental Research Funds for the Central Universities (SWU1009001, SWU1309351).	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Akkal D, 2007, J NEUROSCI, V27, P10659, DOI 10.1523/JNEUROSCI.3134-07.2007; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Bar-On R, 2000, PERS INDIV DIFFER, V28, P1107, DOI 10.1016/S0191-8869(99)00160-9; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Craig A, 2009, PERS INDIV DIFFER, V46, P111, DOI 10.1016/j.paid.2008.09.011; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Davis SK, 2012, PERS INDIV DIFFER, V52, P144, DOI 10.1016/j.paid.2011.09.016; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fernandez-Berrocal P., 2006, INDIVID DIFFER RES, V4, P16; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hertel J, 2009, J CLIN PSYCHOL, V65, P942, DOI 10.1002/jclp.20597; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jarcho JM, 2013, BIOL PSYCHOL, V92, P306, DOI 10.1016/j.biopsycho.2012.09.008; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Killgore WDS, 2012, NEUROREPORT, V23, P551, DOI 10.1097/WNR.0b013e32835446f7; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; KORNHUBER HH, 1971, KYBERNETIK, V8, P157, DOI 10.1007/BF00290561; Koven NS, 2011, SOC COGN AFFECT NEUR, V6, P582, DOI 10.1093/scan/nsq084; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Law KS, 2004, J APPL PSYCHOL, V89, P483, DOI 10.1037/0021-9010.89.3.483; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lizeretti NP, 2011, PSYCHIAT QUART, V82, P253, DOI 10.1007/s11126-011-9167-1; Lopes PN, 2005, EMOTION, V5, P113, DOI 10.1037/1528-3542.5.1.113; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610, DOI 10.1152/jn.1999.82.3.1610; Ng KM, 2007, INT J ADV COUNS, V29, P173, DOI 10.1007/s10447-007-9037-6; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; O'Boyle EH, 2011, J ORGAN BEHAV, V32, P788, DOI 10.1002/job.714; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Petrides KV, 2000, SEX ROLES, V42, P449, DOI 10.1023/A:1007006523133; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Satpute AB, 2013, BIOL PSYCHIAT, V73, P631, DOI 10.1016/j.biopsych.2012.10.001; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Schraa-Tam CKL, 2012, CEREBELLUM, V11, P233, DOI 10.1007/s12311-011-0301-2; Schutte NS, 2002, COGNITION EMOTION, V16, P769, DOI 10.1080/02699930143000482; Schutter DJLG, 2009, CEREBELLUM, V8, P28, DOI 10.1007/s12311-008-0056-6; Shi JQ, 2007, PERS INDIV DIFFER, V43, P377, DOI 10.1016/j.paid.2006.12.012; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sripada C, 2014, NEUROIMAGE, V89, P110, DOI 10.1016/j.neuroimage.2013.11.006; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Takeuchi H, 2013, NEUROIMAGE, V83, P318, DOI 10.1016/j.neuroimage.2013.06.044; Takeuchi H, 2013, HUM BRAIN MAPP, V34, P1025, DOI 10.1002/hbm.21492; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; van der Velde J, 2013, NEUROSCI BIOBEHAV R, V37, P1774, DOI 10.1016/j.neubiorev.2013.07.008; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; Wang XY, 2013, NEUROIMAGE, V76, P252, DOI 10.1016/j.neuroimage.2013.03.010; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; Wei T, 2012, J NEUROSCI, V32, P481, DOI 10.1523/JNEUROSCI.1953-11.2012; Wong CS, 2002, LEADERSHIP QUART, V13, P243, DOI 10.1016/S1048-9843(02)00099-1; Xie B, 2013, BRAIN RES, V1490, P225, DOI 10.1016/j.brainres.2012.10.048; Xu K, 2014, J AFFECT DISORDERS, V152, P237, DOI 10.1016/j.jad.2013.09.017; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang JQ, 2013, BEHAV BRAIN RES, V252, P18, DOI 10.1016/j.bbr.2013.05.039; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	83	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111435	10.1371/journal.pone.0111435	http://dx.doi.org/10.1371/journal.pone.0111435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2HU	25356830	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000059
J	Parker, CS; Deligianni, F; Cardoso, MJ; Daga, P; Modat, M; Dayan, M; Clark, CA; Ourselin, S; Clayden, JD				Parker, Christopher S.; Deligianni, Fani; Cardoso, M. Jorge; Daga, Pankaj; Modat, Marc; Dayan, Michael; Clark, Chris A.; Ourselin, Sebastien; Clayden, Jonathan D.			Consensus between Pipelines in Structural Brain Networks	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; HUMAN CEREBRAL-CORTEX; CONNECTIVITY PATTERNS; TRACTOGRAPHY; TENSOR; REGISTRATION; OPTIMIZATION; ARCHITECTURE; DENSITY; ATLAS	Structural brain networks may be reconstructed from diffusion MRI tractography data and have great potential to further our understanding of the topological organisation of brain structure in health and disease. Network reconstruction is complex and involves a series of processesing methods including anatomical parcellation, registration, fiber orientation estimation and whole-brain fiber tractography. Methodological choices at each stage can affect the anatomical accuracy and graph theoretical properties of the reconstructed networks, meaning applying different combinations in a network reconstruction pipeline may produce substantially different networks. Furthermore, the choice of which connections are considered important is unclear. In this study, we assessed the similarity between structural networks obtained using two independent state-of-the-art reconstruction pipelines. We aimed to quantify network similarity and identify the core connections emerging most robustly in both pipelines. Similarity of network connections was compared between pipelines employing different atlases by merging parcels to a common and equivalent node scale. We found a high agreement between the networks across a range of fiber density thresholds. In addition, we identified a robust core of highly connected regions coinciding with a peak in similarity across network density thresholds, and replicated these results with atlases at different node scales. The binary network properties of these core connections were similar between pipelines but showed some differences in atlases across node scales. This study demonstrates the utility of applying multiple structural network reconstrution pipelines to diffusion data in order to identify the most important connections for further study.	[Parker, Christopher S.; Cardoso, M. Jorge; Daga, Pankaj; Modat, Marc; Ourselin, Sebastien] UCL, Ctr Med Image Comp, London, England; [Parker, Christopher S.; Deligianni, Fani; Dayan, Michael; Clark, Chris A.; Clayden, Jonathan D.] UCL Inst Child Hlth, Imaging & Biophys Unit, London, England; [Ourselin, Sebastien] UCL, Dementia Res Ctr, London, England; [Dayan, Michael] Weill Cornell Med Coll, Dept Radiol, New York, NY USA	University of London; University College London; University of London; University College London; University of London; University College London; Cornell University	Parker, CS (corresponding author), UCL, Ctr Med Image Comp, London, England.	christopher.parker.10@ucl.ac.uk	Deligianni, Fani/M-9116-2018; Clayden, Jonathan D/C-1894-2008; Dayan, Michael/G-4760-2016; Cardoso, M. Jorge/N-5511-2018; Ourselin, Sebastien/K-6960-2015	Deligianni, Fani/0000-0003-1306-5017; Clayden, Jonathan D/0000-0002-6608-0619; Dayan, Michael/0000-0002-2666-0969; Cardoso, M. Jorge/0000-0003-1284-2558; Ourselin, Sebastien/0000-0002-5694-5340; Modat, Marc/0000-0002-5277-8530	EPSRC [EP/J016292/1, EP/H046410/1, EP/J020990/1, EP/K005278]; EPSRC-CRUK Comprehensive Cancer Imaging Centre of UCL; CBRC Strategic Investment Award [168]; MRC [MR/J01107X/1]; EU-FP7 project VPH-DARE@IT [FP7-ICT-2011-9-601055]; NIHR Biomedical Research Unit (Dementia) at UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative); UCL Leonard Wolfson Experimental Neurology Centre; KCL [C1519AO]; MRC [G0300117, G1002276] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H046410/1, EP/J016292/1, EP/J020990/1] Funding Source: researchfish; Medical Research Council [G0300117, MR/J01107X/1, G1002276] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC-CRUK Comprehensive Cancer Imaging Centre of UCL(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CBRC Strategic Investment Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU-FP7 project VPH-DARE@IT; NIHR Biomedical Research Unit (Dementia) at UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative)(General Electric); UCL Leonard Wolfson Experimental Neurology Centre; KCL; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FD and JDC were supported by the EPSRC (EP/J016292/1). PD was funded by EPSRC-CRUK Comprehensive Cancer Imaging Centre of UCL and KCL (grant number C1519AO). SO and MJC were supported by both the EPSRC (EP/H046410/1) and the CBRC Strategic Investment Award (Ref. 168). SO receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the MRC (MR/J01107X/1), the EU-FP7 project VPH-DARE@IT (FP7-ICT-2011-9-601055), the NIHR Biomedical Research Unit (Dementia) at UCL and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative). MM is supported by the UCL Leonard Wolfson Experimental Neurology Centre. The Dementia Research Centre is an Alzheimers Research Trust Co-ordinating centre and has also received equipment founded by the Alzheimers Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardoso MJ, 2013, MED IMAGE ANAL, V17, P671, DOI 10.1016/j.media.2013.02.006; Cardoso MJ, 2011, NEUROIMAGE, V56, P1386, DOI 10.1016/j.neuroimage.2011.02.013; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Cheng H, 2012, J NEUROSCI METH, V203, P264, DOI 10.1016/j.jneumeth.2011.09.021; Clayden JD, 2011, J STAT SOFTW, V44, P1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; Echtermeyer Christoph, 2011, Front Neuroinform, V5, P10, DOI 10.3389/fninf.2011.00010; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li LC, 2012, HUM BRAIN MAPP, V33, P1894, DOI 10.1002/hbm.21332; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shao JM, 2012, NEUROBIOL AGING, V33, P2756, DOI 10.1016/j.neurobiolaging.2012.01.017; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Team RC, 2012, R LANG ENV STAT COMP; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	58	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111262	10.1371/journal.pone.0111262	http://dx.doi.org/10.1371/journal.pone.0111262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356977	Green Published, gold, Green Accepted			2022-12-27	WOS:000346765000049
J	Rodrigues, TB; Khajuria, C; Wang, HC; Matz, N; Cardoso, DC; Valicente, FH; Zhou, XG; Siegfried, B				Rodrigues, Thais Barros; Khajuria, Chitvan; Wang, Haichuan; Matz, Natalie; Cardoso, Danielle Cunha; Valicente, Fernando Hercos; Zhou, Xuguo; Siegfried, Blair			Validation of Reference Housekeeping Genes for Gene Expression Studies in Western Corn Rootworm (Diabrotica virgifera virgifera)	PLOS ONE			English	Article							PCR REFERENCE GENES; QUANTITATIVE PCR; FIELD-RESISTANCE; APIS-MELLIFERA; SELECTION; IDENTIFICATION; PROTEINS; BORER	Quantitative Real-time PCR (qRT-PCR) is a powerful technique to investigate comparative gene expression. In general, normalization of results using a highly stable housekeeping gene (HKG) as an internal control is recommended and necessary. However, there are several reports suggesting that regulation of some HKGs is affected by different conditions. The western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte (Coleoptera: Chrysomelidae), is a serious pest of corn in the United States and Europe. The expression profile of target genes related to insecticide exposure, resistance, and RNA interference has become an important experimental technique for study of western corn rootworms; however, lack of information on reliable HKGs under different conditions makes the interpretation of qRT-PCR results difficult. In this study, four distinct algorithms (Genorm, NormFinder, BestKeeper and delta-CT) and five candidate HKGs to genes of reference (beta-actin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; beta-tubulin; RPS9, ribosomal protein S9; EF1a, elongation factor-1 alpha) were evaluated to determine the most reliable HKG under different experimental conditions including exposure to dsRNA and Bt toxins and among different tissues and developmental stages. Although all the HKGs tested exhibited relatively stable expression among the different treatments, some differences were noted. Among the five candidate reference genes evaluated, beta-actin exhibited highly stable expression among different life stages. RPS9 exhibited the most similar pattern of expression among dsRNA treatments, and both experiments indicated that EF1a was the second most stable gene. EF1a was also the most stable for Bt exposure and among different tissues. These results will enable researchers to use more accurate and reliable normalization of qRT-PCR data in WCR experiments.	[Rodrigues, Thais Barros] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Rodrigues, Thais Barros] Univ Fed Lavras, Lavras, MG, Brazil; [Khajuria, Chitvan; Wang, Haichuan; Matz, Natalie; Siegfried, Blair] Univ Nebraska, Dept Entomol, Lincoln, NE USA; [Cardoso, Danielle Cunha] Agron Inst Campinas, Campinas, SP, Brazil; [Valicente, Fernando Hercos] Embrapa Maize & Sorghum, Sete Lagoas, MG, Brazil; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade Federal de Lavras; University of Nebraska System; University of Nebraska Lincoln; Instituto Agronomico de Campinas (IAC); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Kentucky	Rodrigues, TB (corresponding author), Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil.	thaisbarros.bio@gmail.com	Rodrigues, Thais Barros/G-3367-2014; Barros Rodrigues, Thais/F-6380-2010	Rodrigues, Thais Barros/0000-0003-3857-3114; Barros Rodrigues, Thais/0000-0003-3857-3114	CAPES Foundation (Ministry of Education of Brazil, Brasilia, Brazil) [DF 70040-020]; USDA National Institute of Food and Agriculture [2011-33522-30749]	CAPES Foundation (Ministry of Education of Brazil, Brasilia, Brazil); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was partially supported by CAPES Foundation (Ministry of Education of Brazil, Brasilia - DF 70040-020, Brazil) for TBR's scholarship. This work was also partially supported by Biotechnology Risk Assessment Grant Program Competitive Grant No. 2011-33522-30749 from the USDA National Institute of Food and Agriculture. These funding programs did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bustin Stephen A, 2010, Expert Rev Mol Diagn, V10, P713, DOI 10.1586/erm.10.65; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Docimo Teresa, 2013, F1000Res, V2, P37, DOI 10.12688/f1000research.2-37.v1; Dun Z, 2010, J APPL ENTOMOL, V134, P409, DOI 10.1111/j.1439-0418.2009.01487.x; Ellis RT, 2002, APPL ENVIRON MICROB, V68, P1137, DOI 10.1128/AEM.68.3.1137-1145.2002; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; METCALF RL, 1986, METHODS STUDY PEST D; Moellenbeck DJ, 2001, NAT BIOTECHNOL, V19, P668, DOI 10.1038/90282; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pleau MJ, 2002, ENTOMOL EXP APPL, V105, P1, DOI 10.1023/A:1021703530932; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Rudeen ML, 2013, PEST MANAG SCI, V69, P709, DOI 10.1002/ps.3425; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xu YY, 2012, BIOCHEM BIOPH RES CO, V424, P398, DOI 10.1016/j.bbrc.2012.06.119	41	55	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e109825	10.1371/journal.pone.0109825	http://dx.doi.org/10.1371/journal.pone.0109825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356627	Green Published, gold			2022-12-27	WOS:000346765000007
J	Soundararajan, R; Won, J; Stearns, TM; Charette, JR; Hicks, WL; Collin, GB; Naggert, JK; Krebs, MP; Nishina, PM				Soundararajan, Ramani; Won, Jungyeon; Stearns, Timothy M.; Charette, Jeremy R.; Hicks, Wanda L.; Collin, Gayle B.; Naggert, Juergen K.; Krebs, Mark P.; Nishina, Patsy M.			Gene Profiling of Postnatal Mfrp(rd6) Mutant Eyes Reveals Differential Accumulation of Prss56, Visual Cycle and Phototransduction mRNAs	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; POSTERIOR MICROPHTHALMOS; SERINE-PROTEASE; MFRP; MUTATION; MOUSE; NANOPHTHALMOS; MICE	Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice. To better understand MFRP function, microarray analysis was performed on eyes of homozygous Mfrp(rd6) and C57BL/6J mice at postnatal days (P) 0 and P14, prior to photoreceptor loss. Data analysis revealed no changes at P0 but significant differences in RPE and retina-specific transcripts at P14, suggesting a postnatal influence of the Mfrp(rd6) allele. A subset of these transcripts was validated by quantitative real-time PCR (qRT-PCR). In Mfrp(rd6) eyes, a significant 1.5- to 2.0- fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2). Levels of RPE65 were significantly decreased by 2.0-fold. Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrp(rd6) eyes by 17-fold. Validation by qRT-PCR indicated a 3.5-, 14- and 70-fold accumulation of Prss56 transcripts relative to controls at P7, P14 and P21, respectively. This trend was not observed in other RPE or photoreceptor mutant mouse models with similar disease progression, suggesting that Prss56 upregulation is a specific attribute of the disruption of Mfrp. Prss56 and Glul in situ hybridization directly identified Muller glia in the inner nuclear layer as the cell type expressing Prss56. In summary, the Mfrp(rd6) allele causes significant postnatal changes in transcript and protein levels in the retina and RPE. The link between Mfrp deficiency and Prss56 up-regulation, together with the genetic association of human MFRP or PRSS56 variants and ocular size, raises the possibility that these genes are part of a regulatory network influencing postnatal posterior eye development.	[Soundararajan, Ramani; Stearns, Timothy M.; Charette, Jeremy R.; Hicks, Wanda L.; Collin, Gayle B.; Naggert, Juergen K.; Krebs, Mark P.; Nishina, Patsy M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Won, Jungyeon] Natl Disaster Management Inst, Seoul, South Korea	Jackson Laboratory	Nishina, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	patsy.nishina@jax.org		Stearns, Timothy/0000-0002-5533-6076; Krebs, Mark/0000-0001-9017-6066	National Institutes of Health (NIH) [EY011996]; National Institutes of Health Cancer Center Support (CORE) [5P30CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011996] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support (CORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the National Institutes of Health (NIH) grant EY011996 awarded to P.M.N. and National Institutes of Health Cancer Center Support (CORE) grant 5P30CA034196 to The Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ubaidi MR, 2013, INVEST OPHTH VIS SCI, V54, P8119, DOI 10.1167/iovs.13-13536; Ayala-Ramirez R, 2006, MOL VIS, V12, P1483; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Cai X, 2009, OPHTHALMIC GENET, V30, P57, DOI 10.1080/13816810802626399; Cheng Christiana L, 2013, Mol Vis, V19, P955; Crespi J, 2008, AM J OPHTHALMOL, V146, P323, DOI 10.1016/j.ajo.2008.04.029; Dinculescu A, 2012, HUM GENE THER, V23, P367, DOI 10.1089/hum.2011.169; Fogerty J, 2011, INVEST OPHTH VIS SCI, V52, P7256, DOI 10.1167/iovs.11-8112; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gal A, 2011, AM J HUM GENET, V88, P382, DOI 10.1016/j.ajhg.2011.02.006; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hawes NL, 2000, INVEST OPHTH VIS SCI, V41, P3149; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Ikeda S, 2000, HUM MOL GENET, V9, P155, DOI 10.1093/hmg/9.2.155; Kameya S, 2002, HUM MOL GENET, V11, P1879, DOI 10.1093/hmg/11.16.1879; Katoh M, 2001, BIOCHEM BIOPH RES CO, V282, P116, DOI 10.1006/bbrc.2001.4551; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Liu H, 2000, GENETICS, V154, P1735; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5514, DOI 10.1167/iovs.06-0449; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mukhopadhyay R, 2010, MOL VIS, V16, P540; Nair KS, 2011, NAT GENET, V43, P579, DOI 10.1038/ng.813; Neri A, 2012, MOL VIS, V18, P2623; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Said MB, 2013, GENE, V528, P288, DOI 10.1016/j.gene.2013.06.045; Sharma YV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031371; Sundin OH, 2005, P NATL ACAD SCI USA, V102, P9553, DOI 10.1073/pnas.0501451102; Sundin OH, 2008, OPHTHALMIC GENET, V29, P1, DOI 10.1080/13816810701651241; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Won J, 2008, VISUAL NEUROSCI, V25, P563, DOI 10.1017/S0952523808080723; Won JY, 2014, EXP EYE RES, V118, P30, DOI 10.1016/j.exer.2013.10.020; Won J, 2012, ADV EXP MED BIOL, V723, P391, DOI 10.1007/978-1-4614-0631-0_50; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Wride Michael A., 2006, Birth Defects Research, V78, P90, DOI 10.1002/bdrc.20063; Yokokura S, 2005, INVEST OPHTH VIS SCI, V46, P2905, DOI 10.1167/iovs.04-0856; Zenteno JC, 2009, MOL VIS, V15, P1794	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110299	10.1371/journal.pone.0110299	http://dx.doi.org/10.1371/journal.pone.0110299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357075	gold, Green Submitted, Green Published			2022-12-27	WOS:000346765000014
J	Hu, JD; Wang, TT; Wang, S; Chen, MW; Wang, MP; Mu, LY; Chen, HY; Hu, XR; Liang, H; Zhu, JH; Jiang, M				Hu, Jiandong; Wang, Tingting; Wang, Shun; Chen, Mingwen; Wang, Manping; Mu, Linying; Chen, Hongyin; Hu, Xinran; Liang, Hao; Zhu, Juanhua; Jiang, Min			Development of a Surface Plasmon Resonance Biosensing Approach for the Rapid Detection of Porcine Circovirus Type2 in Sample Solutions	PLOS ONE			English	Article							REAL-TIME PCR; PARVOVIRUS; DIAGNOSIS; DISEASES; VIRUS; PCV2	A sensitive and label-free analytical approach for the detection of porcine circovirus type 2 (PCV2) instead of PCV2 antibody in serum sample was systematically investigated in this research based on surface plasmon resonance (SPR) with an establishment of special molecular identification membrane. The experimental device for constructing the biosensing analyzer is composed of an integrated biosensor, a home-made microfluidic module, and an electrical control circuit incorporated with a photoelectric converter. In order to detect the PCV2 using the surface plasmon resonance immunoassay, the mercaptopropionic acid has been used to bind the Au film in advance through the known form of the strong S-Au covalent bonds formed by the chemical radical of the mercaptopropionic acid and the Au film. PCV2 antibodies were bonded with the mercaptopropionic acid by covalent -CO-NH- amide bonding. For the purpose of evaluating the performance of this approach, the known concentrations of PCV2 Cap protein of 10 mu g/mL, 7.5 mu g/mL, 5 mu g/mL, 2.5 mu g/mL, 1 mu g/mL, and 0.5 mu g/mL were prepared by diluting with PBS successively and then the delta response units (Delta RUs) were measured individually. Using the data collected from the linear CCD array, the Delta RUs gave a linear response over a wide concentration range of standard known concentrations of PCV2 Cap protein with the R-Squared value of 0.99625. The theoretical limit of detection was calculated to be 0.04 mu g/mL for the surface plasmon resonance biosensing approach. Correspondingly, the recovery rate ranged from 81.0% to 89.3% was obtained. In contrast to the PCV2 detection kits, this surface plasmon resonance biosensing system was validated through linearity, precision and recovery, which demonstrated that the surface plasmon resonance immunoassay is reliable and robust. It was concluded that the detection method which is associated with biomembrane properties is expected to contribute much to determine the PCV2 in sample solutions instead of PCV2 antibody in serum samples quantitatively.	[Hu, Jiandong; Wang, Tingting; Wang, Shun; Wang, Manping; Mu, Linying; Zhu, Juanhua] Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China; [Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Chen, Mingwen] Zhengzhou Oriole Elect Grp Joint Stock Co Ltd, Zhengzhou, Peoples R China; [Chen, Hongyin] Henan Agr Univ, Coll Anim Husb & Vet, Zhengzhou, Peoples R China; [Hu, Xinran] McGill Univ, Sch Human Nutr & Dietet, Ste Anne De Bellevue, PQ, Canada; [Liang, Hao] Univ Gavle, Dept Elect & Telecommun, Gavle, Sweden; [Jiang, Min] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University; McGill University; University of Gavle; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China.	jiandonghu@163.com	wang, tingting/AAK-2640-2020		National Natural Science Foundation of China [U1304305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was also performed in State Key Laboratory of Wheat and Maize Crop Science and funded by National Natural Science Foundation of China (No. U1304305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang GN, 2010, J MICROBIOL IMMUNOL, V43, P85, DOI 10.1016/S1684-1182(10)60014-X; [车勇良 Che Yongliang], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P290; Chen HT, 2008, J VIROL METHODS, V149, P264, DOI 10.1016/j.jviromet.2008.01.023; Chul Park, 2011, [Korean Journal of Veterinary Service, 한국가축위생학회지], V34, P1; Fossum C, 2014, J VIROL METHODS, V196, P185, DOI 10.1016/j.jviromet.2013.10.042; Ge XN, 2012, VIRUS RES, V164, P100, DOI 10.1016/j.virusres.2011.10.005; Grau-Roma L, 2011, VET J, V187, P23, DOI 10.1016/j.tvjl.2010.01.018; Hu JD, 2012, BIOSENS BIOELECTRON, V31, P475, DOI 10.1016/j.bios.2011.11.019; Hu JD, 2009, BIOSENS BIOELECTRON, V24, P1974, DOI 10.1016/j.bios.2008.10.033; Huang LP, 2011, VIRUS RES, V161, P115, DOI 10.1016/j.virusres.2011.05.015; Huang LP, 2011, J VIROL METHODS, V171, P26, DOI 10.1016/j.jviromet.2010.09.023; Huang YL, 2014, RES VET SCI, V96, P187, DOI 10.1016/j.rvsc.2013.11.020; McClenahan SD, 2011, VACCINE, V29, P4745, DOI 10.1016/j.vaccine.2011.04.087; Pejsak Z, 2010, COMP IMMUNOL MICROB, V33, pE1, DOI 10.1016/j.cimid.2009.09.006; Perez LJ, 2012, J VIROL METHODS, V179, P233, DOI 10.1016/j.jviromet.2011.11.009; Rodriguez-Carino C, 2010, J COMP PATHOL, V142, P291, DOI 10.1016/j.jcpa.2009.12.001; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Vidigal PMP, 2012, VIRUS RES, V163, P320, DOI 10.1016/j.virusres.2011.10.019; Vilcek S, 2010, J VIROL METHODS, V165, P216, DOI 10.1016/j.jviromet.2010.01.023; Vlasakova M, 2012, J VIROL METHODS, V179, P311, DOI 10.1016/j.jviromet.2011.11.014; [张文通 Zhang Wentong], 2012, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V34, P728; Zheng LL, 2013, J VIROL METHODS, V187, P15, DOI 10.1016/j.jviromet.2012.06.024	22	55	56	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111292	10.1371/journal.pone.0111292	http://dx.doi.org/10.1371/journal.pone.0111292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354302	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200068
J	Woloszyk, A; Dircksen, SH; Bostanci, N; Muller, R; Hofmann, S; Mitsiadis, TA				Woloszyk, Anna; Dircksen, Sabrina Holsten; Bostanci, Nagihan; Mueller, Ralph; Hofmann, Sandra; Mitsiadis, Thimios A.			Influence of the Mechanical Environment on the Engineering of Mineralised Tissues Using Human Dental Pulp Stem Cells and Silk Fibroin Scaffolds	PLOS ONE			English	Article							IN-VITRO; BONE-MARROW; TOOTH DEVELOPMENT; OXYGEN GRADIENTS; STROMAL CELLS; ILIAC CREST; DIFFERENTIATION; MECHANOTRANSDUCTION; RADIATION; REPAIR	Teeth constitute a promising source of stem cells that can be used for tissue engineering and regenerative medicine purposes. Bone loss in the craniofacial complex due to pathological conditions and severe injuries could be treated with new materials combined with human dental pulp stem cells (hDPSCs) that have the same embryonic origin as craniofacial bones. Optimising combinations of scaffolds, cells, growth factors and culture conditions still remains a great challenge. In the present study, we evaluate the mineralisation potential of hDPSCs seeded on porous silk fibroin scaffolds in a mechanically dynamic environment provided by spinner flask bioreactors. Cell-seeded scaffolds were cultured in either standard or osteogenic media in both static and dynamic conditions for 47 days. Histological analysis and micro-computed tomography of the samples showed low levels of mineralisation when samples were cultured in static conditions (0.16 +/- 0.1 BV/TV%), while their culture in a dynamic environment with osteogenic medium and weekly mu CT scans (4.9 +/- 1.6 BV/TV%) significantly increased the formation of homogeneously mineralised structures, which was also confirmed by the elevated calcium levels (4.5 +/- 1.0 vs. 8.8 +/- 1.7 mg/mL). Molecular analysis of the samples showed that the expression of tooth correlated genes such as Dentin Sialophosphoprotein and Nestin were downregulated by a factor of 6.7 and 7.4, respectively, in hDPSCs when cultured in presence of osteogenic medium. This finding indicates that hDPSCs are able to adopt a nondental identity by changing the culture conditions only. Also an increased expression of Osteocalcin (1.4x) and Collagen type I (1.7x) was found after culture under mechanically dynamic conditions in control medium. In conclusion, the combination of hDPSCs and silk scaffolds cultured under mechanical loading in spinner flask bioreactors could offer a novel and promising approach for bone tissue engineering where appropriate and rapid bone regeneration in mechanically loaded tissues is required.	[Woloszyk, Anna; Bostanci, Nagihan; Mitsiadis, Thimios A.] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Dircksen, Sabrina Holsten; Mueller, Ralph; Hofmann, Sandra] ETH, Inst Biomech, Zurich, Switzerland; [Hofmann, Sandra] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Hofmann, Sandra] Eindhoven Univ Technol, Inst Complex Mol Sci, NL-5600 MB Eindhoven, Netherlands	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology; Eindhoven University of Technology	Mitsiadis, TA (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	thimios.mitsiadis@zzm.uzh.ch	Müller, Ralph/A-1198-2008; Mitsiadis, Thimios/B-5564-2016; Hofmann, Sandra/F-2832-2010; Bostanci, Nagihan/ABD-5524-2020	Müller, Ralph/0000-0002-5811-7725; Mitsiadis, Thimios/0000-0002-9812-9982; Hofmann, Sandra/0000-0002-2568-8388; Bostanci, Nagihan/0000-0002-6742-3556; Woloszyk, Anna/0000-0002-8850-0397	University of Zurich; ETH Zurich	University of Zurich; ETH Zurich(ETH Zurich)	This work was supported by funds from University of Zurich, funds from ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate Michele, 2013, Muscles Ligaments Tendons J, V3, P63, DOI 10.11138/mltj/2013.3.2.063; Abe S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt43; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; Bluteau G, 2008, EUR CELLS MATER, V16, P1; Bonnamain V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00357; Camps J, 2002, CONNECT TISSUE RES, V43, P396, DOI 10.1080/03008200290001069; Caton J, 2011, J CELL MOL MED, V15, P1054, DOI 10.1111/j.1582-4934.2010.01251.x; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136; GRAPINBOTTON A, 1995, DEVELOPMENT, V121, P2707; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2; Han MJ, 2008, BIOTECHNOL BIOPROC E, V13, P410, DOI [10.1007/s12257-008-0146-9, 10.1007/S12257-008-0146-9]; Hata M, 2013, TISSUE ENG PT A, V19, P625, DOI 10.1089/ten.tea.2012.0099; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729; Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011; Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020; Hung BP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt158; Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352; Kraehenbuehl TP, 2010, BIOMED TECH, V55, P245, DOI 10.1515/BMT.2010.031; Krishnan L, 2014, ANN BIOMED ENG, V42, P432, DOI 10.1007/s10439-014-0969-9; Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Lizier NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039885; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252; MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368; Mitsiadis T A, 2011, Adv Dent Res, V23, P275, DOI 10.1177/0022034511405386; Mitsiadis TA, 2004, J DENT RES, V83, P896, DOI 10.1177/154405910408301202; Mitsiadis TA, 2012, NANOMEDICINE-UK, V7, P1743, DOI [10.2217/NNM.12.146, 10.2217/nnm.12.146]; Mitsiadis TA, 2011, REGEN MED, V6, P135, DOI 10.2217/RME.10.101; Mitsiadis TA, 2009, BIRTH DEFECTS RES C, V87, P199, DOI 10.1002/bdrc.20160; Muthna D, 2010, STEM CELLS DEV, V19, P1855, DOI 10.1089/scd.2009.0449; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Orsini G, 2012, REV NATURE ROLE FU 1, P1; Pagella P, 2014, CELL MOL LIFE SCI, V71, P2241, DOI 10.1007/s00018-013-1549-0; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Qin CL, 2003, CONNECT TISSUE RES, V44, P179, DOI 10.1080/03008200390152296; Rauh J, 2011, TISSUE ENG PART B-RE, V17, P263, DOI [10.1089/ten.teb.2010.0612, 10.1089/ten.TEB.2010.0612]; Remedios A, 1999, VET CLIN N AM-SMALL, V29, P1029, DOI 10.1016/S0195-5616(99)50101-0; Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020; Silver FH, 2011, CONNECT TISSUE RES, V52, P242, DOI 10.3109/03008207.2010.551567; Sittichokechaiwut A, 2010, EUR CELLS MATER, V20, P45; Steward AJ, 2014, J MECH BEHAV BIOMED, V38, P174, DOI 10.1016/j.jmbbm.2013.07.020; Tamaki Y, 2013, ODONTOLOGY, V101, P121, DOI 10.1007/s10266-012-0075-0; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; VEIS A, 1993, J BONE MINER RES, V8, pS493; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x; Wang X, 2013, ORGANOGENESIS, V9, P280, DOI 10.4161/org.26080; Yu JH, 2007, BIOL CELL, V99, P465, DOI 10.1042/BC20070013; Yu V, 2009, BIOCHEM BIOPH RES CO, V386, P661, DOI 10.1016/j.bbrc.2009.06.106	63	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111010	10.1371/journal.pone.0111010	http://dx.doi.org/10.1371/journal.pone.0111010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354351	Green Published, gold, Green Accepted			2022-12-27	WOS:000345204200051
J	Dehmer, M; Tsoy, YR				Dehmer, Matthias; Tsoy, Yury Robertovich			Numerical Evaluation and Comparison of Kalantari's Zero Bounds for Complex Polynomials	PLOS ONE			English	Article								In this paper, we investigate the performance of zero bounds due to Kalantari and Dehmer by using special classes of polynomials. Our findings are evidenced by numerical as well as analytical results.	[Dehmer, Matthias] Univ Bundeswehr Munchen, Dept Comp Sci, Neubiberg, Germany; [Dehmer, Matthias] UMIT Hlth & Life Sci Univ, Dept Biomed Informat & Mechatron, Hall In Tirol, Austria; [Tsoy, Yury Robertovich] Inst Pasteur Korea, Image Min Grp, Songnam, Gyeonggi Do, South Korea	Bundeswehr University Munich; Institut Pasteur Korea	Dehmer, M (corresponding author), Univ Bundeswehr Munchen, Dept Comp Sci, Neubiberg, Germany.	matthias.dehmer@umit.at						BONCHEV D, 1995, THEOCHEM-J MOL STRUC, V336, P137, DOI 10.1016/0166-1280(94)04081-3; Chou CP, 2014, MATCH-COMMUN MATH CO, V71, P741; Cvetkovic D., 1980, SPECTRA GRAPHS THEOR; Dehmer M., 2006, J INEQUALITIES PURE, V7; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102459; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039537; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028328; Dehmer M, 2011, APPL MATH COMPUT, V218, P4128, DOI 10.1016/j.amc.2011.09.043; Heitzinger W, 1985, PRAXIS NICHTLINEARER; Householder, 1970, NUMERICAL TREATMENT; JOYAL A, 1967, CAN MATH BULLETIN, V10, P53, DOI 10.4153/CMB-1967-006-3; Kalantari B, 2005, MATH COMPUT, V74, P841; Kojima J, 1914, TOHOKU MATH J, V5, P54; Kuniyeda M, 1916, B AM MATH SOC, V8, P167; Lou ZZ, 2014, MATCH-COMMUN MATH CO, V72, P153; Marden M, 1966, MATH SURVEYS AM MATH, V3; McNamee JM, 2005, P 17 IMACS WORLD C P; Mignotte M., 1999, POLYNOMIALS ALGORITH; MOHAMMAD QG, 1965, AM MATH MON, V72, P35, DOI 10.2307/2312995; Obreschkoff N, 1963, HOCHSCHULBUCHER MATH, V55; Prasolov V. V, 2004, ALGORITHM COMP MATH; Rahman Q.I., 2002, ANAL THEORY POLYNOMI; Sagan H, 1989, BOUNDARY EIGENVALUE; Schutte M, 2014, J MATH CHEM, V52, P805, DOI 10.1007/s10910-013-0294-9	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110540	10.1371/journal.pone.0110540	http://dx.doi.org/10.1371/journal.pone.0110540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350861	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100029
J	Villringer, K; Grittner, U; Schaafs, LA; Nolte, CH; Audebert, H; Fiebach, JB				Villringer, Kersten; Grittner, Ulrike; Schaafs, Lars-Arne; Nolte, Christian H.; Audebert, Heinrich; Fiebach, Jochen B.			IV t-PA Influences Infarct Volume in Minor Stroke: A Pilot Study	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; LESION VOLUMES; DIFFUSION; MILD; THROMBOLYSIS; MISMATCH; MRI; RECANALIZATION; DESMOTEPLASE; PREDICTION	Background: There is an ongoing debate whether stroke patients presenting with minor or moderate symptoms benefit from thrombolysis. Up until now, stroke severity on admission is typically measured with the NIHSS, and subsequently used for treatment decision. Hypothesis: Acute MRI lesion volume assessment can aid in therapy decision for iv-tPA in minor stroke. Methods: We analysed 164 patients with NIHSS 0-7 from a prospective stroke MRI registry, the 1000+ study (clinicaltrials.org NCT00715533). Patients were examined in a 3 T MRI scanner and either received (n = 62) or did not receive thrombolysis (n = 102). DWI (diffusion weighted imaging) and PI (perfusion imaging) at admission were evaluated for diffusion - perfusion mismatch. Our primary outcome parameter was final lesion volume, defined by lesion volume on day 6 FLAIR images. Results: The association between t-PA and FLAIR lesion volume on day 6 was significantly different for patients with smaller DWI volume compared to patients with larger DWI volume (interaction between DWI and t-PA: p = 0.021). Baseline DWI lesion volume was dichotomized at the median (0.7 ml): final lesion volume at day 6 was larger in patients with large baseline DWI volumes without t-PA treatment (median difference 3, IQR 20.4-9.3 ml). Conversely, in patients with larger baseline DWI volumes final lesion volumes were smaller after t-PA treatment (median difference 0, IQR 24.1-5 ml). However, this did not translate into a significant difference in the mRS at day 90 (p = 0.577). Conclusion: Though this study is only hypothesis generating considering the number of cases, we believe that the size of DWI lesion volume may support therapy decision in patients with minor stroke.	[Villringer, Kersten; Schaafs, Lars-Arne; Fiebach, Jochen B.] Acad Neuroradiol, Charite, Dept Neurol, Berlin, Germany; [Villringer, Kersten; Grittner, Ulrike; Schaafs, Lars-Arne; Nolte, Christian H.; Audebert, Heinrich; Fiebach, Jochen B.] Ctr Stroke Res, Charite, Berlin, Germany; [Grittner, Ulrike] Dept Biostat & Clin Epidemiol, Charite, Berlin, Germany; [Nolte, Christian H.; Audebert, Heinrich] Dept Neurol, Charite, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Villringer, K (corresponding author), Acad Neuroradiol, Charite, Dept Neurol, Berlin, Germany.	kersten.villringer@charite.de	Nolte, Christian/AAA-2651-2022; Grittner, Ulrike/I-2026-2019; Schaafs, Lars-Arne/ABC-5936-2021	Nolte, Christian/0000-0001-5577-1775; Grittner, Ulrike/0000-0003-2595-0224; Schaafs, Lars-Arne/0000-0002-2250-5419; Fiebach, Jochen B./0000-0002-7936-6958; Audebert, Heinrich J./0000-0002-4785-0366	Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin [01 EO 0801]	Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin	The study was supported by the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01 EO 0801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asdaghi N, 2013, STROKE, V44, P2486, DOI 10.1161/STROKEAHA.111.000208; Baird AE, 2000, CEREBROVASC DIS, V10, P441, DOI 10.1159/000016105; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Barrett KM, 2009, STROKE, V40, P2422, DOI 10.1161/STROKEAHA.109.548933; Coutts SB, 2012, STROKE, V43, P1013, DOI 10.1161/STROKEAHA.111.637421; Fiebach JB, 2012, STROKE, V43, P1561, DOI 10.1161/STROKEAHA.111.642322; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hermier M, 2003, J CEREBR BLOOD F MET, V23, P240, DOI 10.1097/01.WCB.0000043340.09081.7E; Jansen O, 1999, LANCET, V353, P2036, DOI 10.1016/S0140-6736(99)01146-0; Kakuda W, 2008, J CEREBR BLOOD F MET, V28, P887, DOI 10.1038/sj.jcbfm.9600604; Kim JT, 2011, J NEUROIMAGING, V21, P399, DOI 10.1111/j.1552-6569.2010.00564.x; Kimura K, 2011, J NEUROL SCI, V304, P35, DOI 10.1016/j.jns.2011.02.024; Leira EC, 2012, STROKE, V43, P782, DOI 10.1161/STROKEAHA.111.620674; Lovblad KO, 1997, ANN NEUROL, V42, P164; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; Phan TG, 2010, NEUROIMAGE, V49, P127, DOI 10.1016/j.neuroimage.2009.07.067; Rajajee V, 2006, NEUROLOGY, V67, P980, DOI 10.1212/01.wnl.0000237520.88777.71; Roquer J, 2010, J NEUROL, V257, P947, DOI 10.1007/s00415-009-5443-5; Schepers VPM, 2006, DISABIL REHABIL, V28, P1035, DOI 10.1080/09638280500494694; Schwab-Malek S, 2010, J NEUROL, V257, P1848, DOI 10.1007/s00415-010-5622-4; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Urra X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059420; Warach S, 2012, STROKE, V43, P2313, DOI 10.1161/STROKEAHA.111.642348; Wendt M, 2013, J STROKE CEREBROVASC, V22, P550, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.021	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110477	10.1371/journal.pone.0110477	http://dx.doi.org/10.1371/journal.pone.0110477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350762	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100028
J	Singh, SP; Jeet, R; Kumar, J; Shukla, V; Srivastava, R; Mantri, SS; Tuli, R				Singh, Sudhir P.; Jeet, Raja; Kumar, Jitendra; Shukla, Vishnu; Srivastava, Rakesh; Mantri, Shrikant S.; Tuli, Rakesh			Comparative Transcriptional Profiling of Two Wheat Genotypes, with Contrasting Levels of Minerals in Grains, Shows Expression Differences during Grain Filling	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; ARABIDOPSIS-THALIANA; GENE FAMILY; SEED DEVELOPMENT; MOLECULAR CHARACTERIZATION; METAL HYPERACCUMULATION; THLASPI-CAERULESCENS; DISEASE RESISTANCE; VACUOLAR PROTEINS; ABIOTIC STRESS	Wheat is one of the most important cereal crops in the world. To identify the candidate genes for mineral accumulation, it is important to examine differential transcriptome between wheat genotypes, with contrasting levels of minerals in grains. A transcriptional comparison of developing grains was carried out between two wheat genotypes-Triticum aestivum Cv. WL711 (low grain mineral), and T. aestivum L. IITR26 (high grain mineral), using Affymetrix GeneChip Wheat Genome Array. The study identified a total of 580 probe sets as differentially expressed (with log2 fold change of >= 2 at p <= 0.01) between the two genotypes, during grain filling. Transcripts with significant differences in induction or repression between the two genotypes included genes related to metal homeostasis, metal tolerance, lignin and flavonoid biosynthesis, amino acid and protein transport, vacuolar-sorting receptor, aquaporins, and stress responses. Meta-analysis revealed spatial and temporal signatures of a majority of the differentially regulated transcripts.	[Singh, Sudhir P.; Jeet, Raja; Kumar, Jitendra; Shukla, Vishnu; Mantri, Shrikant S.; Tuli, Rakesh] Natl Agrifood Biotechnol Inst, Dept Biotechnol DBT, C-127,Phase 8, Mohali 160071, India; [Srivastava, Rakesh] Banaras Hindu Univ, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Banaras Hindu University (BHU)	Singh, SP (corresponding author), Natl Agrifood Biotechnol Inst, Dept Biotechnol DBT, C-127,Phase 8, Mohali 160071, India.	pratapsudhir17@gmail.com; rakeshtuli@hotmail.com	Shukla, Vishnu/Y-5518-2019; Srivastava, Rakesh/ABC-6445-2021; shukla, vishnu/AAI-3807-2021; Kumar, Jitendra/AAP-5018-2020; Singh, Sudhir/AAE-5413-2019; TULI, RAKESH/AAD-3047-2021	Srivastava, Rakesh/0000-0002-6640-1216; shukla, vishnu/0000-0002-2778-0719; Jeet, Raja/0000-0002-8351-7704; Mantri, Shrikant/0000-0002-7493-459X; Singh, Sudhir/0000-0001-5437-4292	ICMR; CSIR	ICMR(Indian Council of Medical Research (ICMR)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Executive Director, National Agri-Food Biotechnology Institute (Department of Biotechnology) for facilitating the research work, and Prof. H. S. Dhaliwal of Eternal University for providing seeds. RJ and JK acknowledge ICMR and CSIR, respectively, for providing fellowship.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Behmer ST, 2005, FUNCT ECOL, V19, P55, DOI 10.1111/j.0269-8463.2005.00943.x; Bohn L, 2007, J AGR FOOD CHEM, V55, P7547, DOI 10.1021/jf071191t; Boutrot F, 2007, PLANTA, V225, P843, DOI 10.1007/s00425-006-0397-7; Boyd RS, 2007, PLANT SOIL, V293, P153, DOI 10.1007/s11104-007-9240-6; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; Cantu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-166; Chen RG, 2014, INT J MOL SCI, V15, P2413, DOI 10.3390/ijms15022413; Cheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072017; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Clarke B, 2005, THEOR APPL GENET, V110, P1259, DOI 10.1007/s00122-005-1962-3; Corpas FJ, 2013, ANN BOT, V113, P87, DOI DOI 10.1093/A0B/MCT260; Cuesta S, 2013, J EXP BOT, V64, P5133, DOI 10.1093/jxb/ert299; de Abreu-Neto JB, 2013, FEBS J, V280, P1604, DOI 10.1111/febs.12159; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Evers T, 2002, J CEREAL SCI, V36, P261, DOI 10.1006/jcrs.2002.0435; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Fones HN, 2013, PLANT PATHOL, V62, P63, DOI 10.1111/ppa.12171; FRIC F, 1993, BIOL PLANTARUM, V35, P95, DOI 10.1007/BF02921127; Fuji K, 2007, PLANT CELL, V19, P597, DOI 10.1105/tpc.106.045997; Gao CQ, 2012, INT J MOL SCI, V13, P5468, DOI 10.3390/ijms13055468; Gao W, 2010, PLANT SIGNAL BEHAV, V5, P1025, DOI 10.4161/psb.5.8.12294; GAWWAD MRA, 2013, NETW BIOL, V3, P87; Gregersen PL, 2005, TRANSGENIC RES, V14, P887, DOI 10.1007/s11248-005-1526-y; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073163; Hegelund JN, 2012, PLANT PHYSIOL, V159, P1125, DOI 10.1104/pp.112.197798; Himi Eiko, 2011, Int J Plant Genomics, V2011, P369460, DOI 10.1155/2011/369460; Hong MJ, 2010, GENES GENET SYST, V85, P97, DOI 10.1266/ggs.85.97; Houshmandfar A., 2011, Advances in Environmental Biology, V5, P1058; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jiang SY, 2013, GENOME BIOL EVOL, V5, P2032, DOI 10.1093/gbe/evt152; Kang H, 2012, PLANT CELL, V24, P5058, DOI 10.1105/tpc.112.103481; Keinanen SI, 2007, TREE PHYSIOL, V27, P1243, DOI 10.1093/treephys/27.9.1243; Kovalchuk N, 2010, PLANT BIOTECHNOL J, V8, P47, DOI 10.1111/j.1467-7652.2009.00465.x; Kruger C, 2002, J BIOL CHEM, V277, P25062, DOI 10.1074/jbc.M201896200; Kumar V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065535; Kutman UB, 2010, CEREAL CHEM, V87, P1, DOI 10.1094/CCHEM-87-1-0001; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; Lee Y, 2013, PLANT PHYSIOL, V161, P121, DOI 10.1104/pp.112.210914; Leopoldini M, 2006, J AGR FOOD CHEM, V54, P6343, DOI 10.1021/jf060986h; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Loebus J, 2011, J BIOL INORG CHEM, V16, P683, DOI 10.1007/s00775-011-0770-2; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; McIntosh S, 2007, PLANT BIOTECHNOL J, V5, P69, DOI 10.1111/j.1467-7652.2006.00218.x; Monroe-Augustus M, 2011, PLANT MOL BIOL, V77, P1, DOI 10.1007/s11103-011-9782-0; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Nijeholt JALA, 2013, FEBS LETT, V587, P3083, DOI 10.1016/j.febslet.2013.07.046; Noret N, 2005, NEW PHYTOL, V165, P763, DOI 10.1111/j.1469-8137.2004.01286.x; Ozturk L, 2006, PHYSIOL PLANTARUM, V128, P144, DOI 10.1111/j.1399-3054.2006.00737.x; Paris N, 1996, CELL, V85, P563, DOI 10.1016/S0092-8674(00)81256-8; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Przedpelska-Wasowicz EM, 2011, PROTOPLASMA, V248, P663, DOI 10.1007/s00709-010-0222-9; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Rajiv Sharma, 2012, Wheat Information Service, P1; Rawat N, 2011, GENOME, V54, P943, DOI [10.1139/G11-059, 10.1139/g11-059]; Rawat N, 2009, GENET RESOUR CROP EV, V56, P53, DOI 10.1007/s10722-008-9344-8; Reddy SK, 2013, PLANT SCI, V212, P26, DOI 10.1016/j.plantsci.2013.08.002; Regvar M, 2011, J EXP BOT, V62, P3929, DOI 10.1093/jxb/err090; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Robert P, 2011, PLANTA, V233, P393, DOI 10.1007/s00425-010-1306-7; Routray P, 2007, GENET RESOUR CROP EV, V54, P1315, DOI 10.1007/s10722-006-9112-6; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salunke R, 2014, LWT-FOOD SCI TECHNOL, P1; Sanders MR, 2013, J AGR FOOD CHEM, V61, P6890, DOI 10.1021/jf401336a; Sands DC, 2009, PLANT SCI, V177, P377, DOI 10.1016/j.plantsci.2009.07.011; Schuurmans JAMJ, 2003, PLANT MOL BIOL, V53, P655, DOI 10.1023/B:PLAN.0000019070.60954.77; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Scossa F, 2008, PROTEOMICS, V8, P2948, DOI 10.1002/pmic.200700861; Sharma M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-196; Shenkin A, 2006, POSTGRAD MED J, V82, P559, DOI 10.1136/pgmj.2006.047670; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Singh A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-29; Singh SP, 2014, PLANTA, V240, P277, DOI 10.1007/s00425-014-2084-4; Singh SP, 2013, J EXP BOT, V64, P3249, DOI 10.1093/jxb/ert160; Singh SP, 2010, PLANT BIOTECHNOL J, V8, P1005, DOI 10.1111/j.1467-7652.2010.00527.x; Takahashi H, 2004, BIOSCI BIOTECH BIOCH, V68, P1728, DOI 10.1271/bbb.68.1728; Tiwari VK, 2011, WHEAT SCI DYNAMICS C, P607; Tolra R, 2009, J INORG BIOCHEM, V103, P1486, DOI 10.1016/j.jinorgbio.2009.06.013; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Ueki S, 2002, NAT CELL BIOL, V4, P478, DOI 10.1038/ncb806; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Vollenweider P, 2005, ENVIRON POLLUT, V137, P455, DOI 10.1016/j.envpol.2005.01.032; Walker EL, 2011, CURR OPIN PLANT BIOL, V14, P318, DOI 10.1016/j.pbi.2011.03.025; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; Weber M, 2013, PLANT J, V76, P151, DOI 10.1111/tpj.12279; Wilson Ian D., 2005, Functional & Integrative Genomics, V5, P144, DOI 10.1007/s10142-005-0137-2; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xu HW, 2006, J EXP BOT, V57, P1899, DOI 10.1093/jxb/erj131; Yang XL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-513; Yao YA, 2012, J EXP BOT, V63, P5155, DOI 10.1093/jxb/ers175; Zeven AC, 1998, EUPHYTICA, V104, P127, DOI 10.1023/A:1018683119237; Zhou ML, 2013, FUNCT INTEGR GENOMIC, V13, P229, DOI 10.1007/s10142-013-0315-6; Zhou XJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-238; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x	105	15	16	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111718	10.1371/journal.pone.0111718	http://dx.doi.org/10.1371/journal.pone.0111718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364903	gold, Green Submitted, Green Published			2022-12-27	WOS:000345558100111
J	Arslan, M; Afzal, M; Amin, I; Iqbal, S; Khan, QM				Arslan, Muhammad; Afzal, Muhammad; Amin, Imran; Iqbal, Samina; Khan, Qaiser M.			Nutrients Can Enhance the Abundance and Expression of Alkane Hydroxylase CYP153 Gene in the Rhizosphere of Ryegrass Planted in Hydrocarbon-Polluted Soil	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; INOCULUM PRETREATMENT; PHYTOREMEDIATION; COLONIZATION; DEGRADATION; SURVIVAL; GROWTH	Plant-bacteria partnership is a promising strategy for the remediation of soil and water polluted with hydrocarbons. However, the limitation of major nutrients (N, P and K) in soil affects the survival and metabolic activity of plant associated bacteria. The objective of this study was to explore the effects of nutrients on survival and metabolic activity of an alkane degrading rhizo-bacterium. Annual ryegrass (Lolium multiflorum) was grown in diesel-contaminated soil and inoculated with an alkane degrading bacterium, Pantoea sp. strain BTRH79, in greenhouse experiments. Two levels of nutrients were applied and plant growth, hydrocarbon removal, and gene abundance and expression were determined after 100 days of sowing of ryegrass. Results obtained from these experiments showed that the bacterial inoculation improved plant growth and hydrocarbon degradation and these were further enhanced by nutrients application. Maximum plant biomass production and hydrocarbon mineralization was observed by the combined use of inoculum and higher level of nutrients. The presence of nutrients in soil enhanced the colonization and metabolic activity of the inoculated bacterium in the rhizosphere. The abundance and expression of CYP153 gene in the rhizosphere of ryegrass was found to be directly associated with the level of applied nutrients. Enhanced hydrocarbon degradation was associated with the population of the inoculum bacterium, the abundance and expression of CYP153 gene in the rhizosphere of ryegrass. It is thus concluded that the combination between vegetation, inoculation with pollutant-degrading bacteria and nutrients amendment was an efficient approach to reduce hydrocarbon contamination.	[Arslan, Muhammad; Afzal, Muhammad; Iqbal, Samina; Khan, Qaiser M.] Natl Inst Biotechnol & Genet Engn, Soil & Environm Biotechnol Div, Faisalabad, Pakistan; [Amin, Imran] Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan; [Arslan, Muhammad] King Fahd Univ Petr & Minerals, Dept Earth Sci, Dhahran 31261, Saudi Arabia	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; King Fahd University of Petroleum & Minerals	Arslan, M (corresponding author), Natl Inst Biotechnol & Genet Engn, Soil & Environm Biotechnol Div, Faisalabad, Pakistan.	arsilan324@gmail.com	Arslan, Muhammad/E-3931-2019; Khan, Qaiser Mahmood/I-6401-2015; Alotaibi, Majed/GZG-1828-2022; Afzal, Muhammad/G-2699-2011	Arslan, Muhammad/0000-0002-9620-6710; Afzal, Muhammad/0000-0003-1511-816X	Higher Education Commission of Pakistan (HEC) [20-1997/RD/11/9210]	Higher Education Commission of Pakistan (HEC)(Higher Education Commission of Pakistan)	The work was supported by the Higher Education Commission of Pakistan (HEC-No. 20-1997/R&D/11/9210). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adesemoye AO, 2008, CAN J MICROBIOL, V54, P876, DOI [10.1139/W08-081, 10.1139/w08-081]; Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; Afzal M., 2013, MOL MICROBIAL ECOLOG, V92, P975, DOI DOI 10.1002/9781118297674.CH92; Afzal M, 2014, CHEMOSPHERE, V117, P232, DOI 10.1016/j.chemosphere.2014.06.078; Afzal M, 2013, INT BIODETER BIODEGR, V85, P331, DOI 10.1016/j.ibiod.2013.08.022; Afzal M, 2012, INT J PHYTOREMEDIAT, V14, P35, DOI 10.1080/15226514.2011.552928; Afzal M, 2011, J HAZARD MATER, V186, P1568, DOI 10.1016/j.jhazmat.2010.12.040; Andria V, 2009, ENVIRON POLLUT, V157, P3347, DOI 10.1016/j.envpol.2009.08.023; Arshad M, 2007, TRENDS BIOTECHNOL, V25, P356, DOI 10.1016/j.tibtech.2007.05.005; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Batty LC, 2013, CRIT REV ENV SCI TEC, V43, P217, DOI 10.1080/10643389.2011.604254; Carvalhais LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068555; Cebron A, 2009, APPL ENVIRON MICROB, V75, P6322, DOI 10.1128/AEM.02862-08; Chen LS, 2013, PLANT SOIL, V368, P355, DOI 10.1007/s11104-012-1517-8; Cunliffe M, 2006, FEMS MICROBIOL ECOL, V58, P364, DOI 10.1111/j.1574-6941.2006.00167.x; Glick BR, 2011, INT J PHYTOREMEDIAT, V13, P4, DOI 10.1080/15226514.2011.568533; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Ho CH, 2007, INT J PHYTOREMEDIAT, V9, P107, DOI 10.1080/15226510701232765; Hutchinson SL, 2003, ENVIR SC T, P355; Juhanson J, 2009, FEMS MICROBIOL ECOL, V70, P446, DOI 10.1111/j.1574-6941.2009.00754.x; Khan S, 2013, CHEMOSPHERE, V91, P663, DOI 10.1016/j.chemosphere.2013.01.025; Khan S, 2013, CHEMOSPHERE, V90, P1317, DOI 10.1016/j.chemosphere.2012.09.045; Mehmood R, 2013, J APPL STAT, V40, P483, DOI 10.1080/02664763.2012.740624; Merkl N, 2005, WATER AIR SOIL POLL, V165, P195, DOI 10.1007/s11270-005-4979-y; Merkl Nicole, 2004, Bioremediation Journal, V8, P177, DOI 10.1080/10889860490887527; Nerandzic MM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-120; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; Ololade IA, 2010, B ENVIRON CONTAM TOX, V85, P238, DOI 10.1007/s00128-010-0090-1; Patil G.P., 1994, HANDB STAT, P167; Tara N, 2014, INT J PHYTOREMEDIAT, V16, P1268, DOI 10.1080/15226514.2013.828013; van Beilen JB, 2007, APPL MICROBIOL BIOT, V74, P13, DOI 10.1007/s00253-006-0748-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000; Yousaf S, 2010, J APPL MICROBIOL, V109, P1389, DOI 10.1111/j.1365-2672.2010.04768.x; Yousaf S, 2011, ENVIRON POLLUT, V159, P2675, DOI 10.1016/j.envpol.2011.05.031; Zhang N, 2014, PLANT SOIL, V374, P689, DOI 10.1007/s11104-013-1915-6	38	62	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111208	10.1371/journal.pone.0111208	http://dx.doi.org/10.1371/journal.pone.0111208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360680	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700073
J	Goncharova, EA; James, ML; Kudryashova, TV; Goncharov, DA; Krymskaya, VP				Goncharova, Elena A.; James, Melane L.; Kudryashova, Tatiana V.; Goncharov, Dmitry A.; Krymskaya, Vera P.			Tumor Suppressors TSC1 and TSC2 Differentially Modulate Actin Cytoskeleton and Motility of Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							PULMONARY LYMPHANGIOLEIOMYOMATOSIS LAM; REPRODUCTIVE-TRACT LEIOMYOMATA; TUBEROUS SCLEROSIS COMPLEX; MUSCLE-CELL-MIGRATION; CURRENT CHALLENGES; RODENT MODEL; PHOSPHORYLATION; ACTIVATION; MTOR; GTPASE	TSC1 and TSC2 mutations cause neoplasms in rare disease pulmonary LAM and neuronal pathfinding in hamartoma syndrome TSC. The specific roles of TSC1 and TSC2 in actin remodeling and the modulation of cell motility, however, are not well understood. Previously, we demonstrated that TSC1 and TSC2 regulate the activity of small GTPases RhoA and Rac1, stress fiber formation and cell adhesion in a reciprocal manner. Here, we show that Tsc1(-/-) MEFs have decreased migration compared to littermate-derived Tsc1(+/+) MEFs. Migration of Tsc1(-/-) MEFs with re-expressed TSC1 was comparable to Tsc1(+/+) MEF migration. In contrast, Tsc2(-/-) MEFs showed an increased migration compared to Tsc2(+/+) MEFs that were abrogated by TSC2 re-expression. Depletion of TSC1 and TSC2 using specific siRNAs in wild type MEFs and NIH 3T3 fibroblasts also showed that TSC1 loss attenuates cell migration while TSC2 loss promotes cell migration. Morphological and immunochemical analysis demonstrated that Tsc1(-/-) MEFs have a thin protracted shape with a few stress fibers; in contrast, Tsc2(-/-) MEFs showed a rounded morphology and abundant stress fibers. Expression of TSC1 in either Tsc1(-/-) or Tsc2(-/-) MEFs promoted stress fiber formation, while TSC2 re-expression induced stress fiber disassembly and the formation of cortical actin. To assess the mechanism(s) by which TSC2 loss promotes actin re-arrangement and cell migration, we explored the role of known downstream effectors of TSC2, mTORC1 and mTORC2. Increased migration of Tsc2(-/-) MEFs is inhibited by siRNA mTOR and siRNA Rictor, but not siRNA Raptor. siRNA mTOR or siRNA Rictor promoted stress fiber disassembly in TSC2-null cells, while siRNA Raptor had little effect. Overexpression of kinase-dead mTOR induced actin stress fiber disassembly and suppressed TSC2-deficient cell migration. Our data demonstrate that TSC1 and TSC2 differentially regulate actin stress fiber formation and cell migration, and that only TSC2 loss promotes mTOR-and mTORC2-dependent pro-migratory cell phenotype.	[Goncharova, Elena A.; James, Melane L.; Kudryashova, Tatiana V.; Goncharov, Dmitry A.; Krymskaya, Vera P.] Univ Penn, Perelman Sch Med, Dept Med, Airways Biol Initiat,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Krymskaya, VP (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Airways Biol Initiat,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	krymskay@mail.med.upenn.edu			NIH/NHLBI [RO1 HL090829, 2RO1 HL071106, RO1 HL114085]; DOD IDEA [TS030012]; LAM Foundation; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114085, R01HL110551, R01HL113178, R01HL071106] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DOD IDEA; LAM Foundation; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by grants from the NIH/NHLBI RO1 HL090829 (V.P.K.), 2RO1 HL071106 (V.P.K.), and RO1 HL114085 (V.P.K.), DOD IDEA TS030012 (V.P.K.), the LAM Foundation (V.P.K. and E.A.G.), and the American Thoracic Society (E.A.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian C. S., 2011, PHYS BIOL, V8; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chang KC, 2013, MOD PATHOL; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Crooks DM, 2004, P NATL ACAD SCI USA, V101, P17462, DOI 10.1073/pnas.0407971101; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; EKER R, 1981, DIAGN HISTOPATHOL, V4, P99; EVERITT JI, 1995, AM J PATHOL, V146, P1556; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Goncharova EA, 2003, AM J RESP CELL MOL, V29, P19, DOI 10.1165/rcmb.2002-0254OC; Goncharova EA, 2002, AM J PHYSIOL-LUNG C, V283, pL354, DOI 10.1152/ajplung.00010.2002; Goncharova EA, 2002, BIOL CHEM, V383, P115, DOI 10.1515/BC.2002.012; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2008, J CELL BIOCHEM, V103, P369, DOI 10.1002/jcb.21419; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Goncharova EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003840; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; HOWE SR, 1995, AM J PATHOL, V146, P1568; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Juvet SC, 2007, AM J RESP CELL MOL, V36, P398, DOI 10.1165/rcmb.2006-0372TR; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; Krymskaya VP, 2012, AM J RESP CELL MOL, V46, P563, DOI 10.1165/rcmb.2011-0381ED; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Kumasaka T, 2005, AM J SURG PATHOL, V29, P1356, DOI 10.1097/01.pas.0000172192.25295.45; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Nellist M, 2001, HUM MOL GENET, V10, P2889, DOI 10.1093/hmg/10.25.2889; Rivera LB, 2013, CANCER CELL, V24, P687, DOI 10.1016/j.ccr.2013.11.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2002, J HUM GENET, V47, P20, DOI 10.1007/s10038-002-8651-8; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Swartz MA, 2008, SEMIN IMMUNOL, V20, P147, DOI 10.1016/j.smim.2007.11.007; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Yu J, 2001, AM J RESP CRIT CARE, V164, P1537, DOI 10.1164/ajrccm.164.8.2104095; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	43	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111476	10.1371/journal.pone.0111476	http://dx.doi.org/10.1371/journal.pone.0111476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360538	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700105
J	Mbaka, JG; Somlai, C; Kopfer, D; Maeck, A; Lorke, A; Schafer, RB				Mbaka, John Gichimu; Somlai, Celia; Koepfer, Denis; Maeck, Andreas; Lorke, Andreas; Schaefer, Ralf B.			Methane-Derived Carbon in the Benthic Food Web in Stream Impoundments	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; CHIRONOMID LARVAE; WATER; PRESERVATION; EMISSIONS; OXIDATION; BACTERIA; DIPTERA; CYCLE; LAKES	Methane gas (CH4) has been identified as an important alternative source of carbon and energy in some freshwater food webs. CH4 is oxidized by methane oxidizing bacteria (MOB), and subsequently utilized by chironomid larvae, which may exhibit low delta C-13 values. This has been shown for chironomid larvae collected from lakes, streams and backwater pools. However, the relationship between CH4 concentrations and delta C-13 values of chironomid larvae for in-stream impoundments is unknown. CH4 concentrations were measured in eleven in-stream impoundments located in the Queich River catchment area, South-western Germany. Furthermore, the delta C-13 values of two subfamilies of chironomid larvae (i.e. Chironomini and Tanypodinae) were determined and correlated with CH4 concentrations. Chironomini larvae had lower mean delta C-13 values (-29.2 to 225.5 parts per thousand), than Tanypodinae larvae (226.9 to 225.3 parts per thousand). No significant relationships were established between CH4 concentrations and delta C-13 values of chironomids (p. 0.05). Mean delta C-13 values of chironomid larvae (mean: 226.8 parts per thousand, range: 2 29.2 parts per thousand to 225.3 parts per thousand) were similar to those of sedimentary organic matter (SOM) (mean: 228.4 parts per thousand, range: -29.3 parts per thousand to 227.1 parts per thousand) and tree leaf litter (mean: 229.8 parts per thousand, range: 230.5 parts per thousand to 229.1 parts per thousand). We suggest that CH4 concentration has limited influence on the benthic food web in stream impoundments.	[Mbaka, John Gichimu; Somlai, Celia; Koepfer, Denis; Maeck, Andreas; Lorke, Andreas; Schaefer, Ralf B.] Univ Koblenz Landau, Inst Environm Sci, Landau, Rhineland Palat, Germany	University of Koblenz & Landau	Mbaka, JG (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Rhineland Palat, Germany.	mbakagichimu@gmail.com	Schaefer, Ralf/E-1926-2011; Lorke, Andreas/B-9195-2008	Schaefer, Ralf/0000-0003-3510-1701; Lorke, Andreas/0000-0001-5533-1817; Somlai, Celia/0000-0003-0405-237X	German Academic Exchange service (DAAD) [A/12/91652]	German Academic Exchange service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	JGM was funded by the German Academic Exchange service (DAAD) (Grant number: A/12/91652). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1995, THE CHIRONOMIDAE, VXII, P572, DOI 10.1007/978-94-011-0715-0; Ashe P., 2009, WORLD CATALOGUE CH 1; Baird AJ, 2010, ECOHYDROLOGY, V3, P360, DOI 10.1002/eco.109; BAKER AS, 1979, HYDROBIOLOGIA, V62, P283, DOI 10.1007/BF00043546; Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Bastviken D, 2010, ENVIRON SCI TECHNOL, V44, P5450, DOI 10.1021/es1005048; Berg M.B., 1995, P136; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; CHRISTIAN JR, 1995, MAR ECOL PROG SER, V123, P217, DOI 10.3354/meps123217; Crawford JT, 2014, GLOBAL CHANGE BIOL, V20, P3408, DOI 10.1111/gcb.12614; Deborde J, 2010, ESTUAR COAST SHELF S, V89, P256, DOI 10.1016/j.ecss.2010.07.013; Deines P, 2007, AQUAT MICROB ECOL, V46, P273, DOI 10.3354/ame046273; Deines P, 2006, ARCH HYDROBIOL, V167, P317, DOI 10.1127/0003-9136/2006/0167-0317; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DILLON P M, 1985, Freshwater Invertebrate Biology, V4, P22, DOI 10.2307/1467195; Eller G, 2005, FEMS MICROBIOL ECOL, V54, P339, DOI 10.1016/j.femsec.2005.04.006; Feuchtmayr H, 2003, RAPID COMMUN MASS SP, V17, P2605, DOI 10.1002/rcm.1227; Frouz J, 2002, J AM MOSQUITO CONTR, V18, P222; Fuentes N, 2013, INT REV HYDROBIOL, V98, P1, DOI 10.1002/iroh.201201532; GORDON ND, 1994, STREAM HYDROLOGY INT; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Guerin F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027929; Hauke J, 2011, QUAEST GEOGR, V30, P87, DOI 10.2478/v10117-011-0021-1; Hershey AE, 2010, INT VER THEOR ANGEW, V30, P1321; Hofmann H, 2010, LIMNOL OCEANOGR, V55, P1990, DOI 10.4319/lo.2010.55.5.1990; Jones RI, 2004, BOREAL ENVIRON RES, V9, P17; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Jones RI, 2011, FRESHWATER BIOL, V56, P213, DOI 10.1111/j.1365-2427.2010.02494.x; Kajan R, 1999, FEMS MICROBIOL ECOL, V28, P121, DOI 10.1111/j.1574-6941.1999.tb00567.x; Kelly A, 2004, J N AM BENTHOL SOC, V23, P287, DOI 10.1899/0887-3593(2004)023&lt;0287:SIAPFI&gt;2.0.CO;2; Khalil MAK, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000461; Kiyashko SI, 2001, AQUAT MICROB ECOL, V24, P203, DOI 10.3354/ame024203; Kohzu A, 2004, AQUAT MICROB ECOL, V36, P189, DOI 10.3354/ame036189; Maeck A, 2013, ENVIRON SCI TECHNOL, V47, P8130, DOI 10.1021/es4003907; MEILI M, 1992, HYDROBIOLOGIA, V229, P23, DOI 10.1007/BF00006988; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; MINAMI K, 1994, CLIMATIC CHANGE, V27, P13, DOI 10.1007/BF01098470; Orendt C., 2012, CHIRONOMINI DIPTERA; Orendt C, 2012, CHIRONOMUS MEIGEN KE; Orendt C, 2012, CHIRONOMIDAE LARVAE; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; R Core Team, 2021, R LANGUAGE ENV STAT; Rueda F, 2006, ECOL MODEL, V191, P260, DOI 10.1016/j.ecolmodel.2005.04.030; Sanseverino AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042723; Shelley F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2854; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Teh YA, 2006, J GEOPHYS RES-BIOGEO, V111, pG2; Trimmer M, 2010, LIMNOL OCEANOGR, V55, P560, DOI 10.4319/lo.2009.55.2.0560; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P1541, DOI 10.4319/lo.2009.54.5.1541; van Hardenbroek M, 2013, QUATERNARY SCI REV, V66, P74, DOI 10.1016/j.quascirev.2012.04.009; van Hardenbroek M, 2012, FRESHWATER BIOL, V57, P166, DOI 10.1111/j.1365-2427.2011.02710.x; Van Looy K, 2014, ECOL INDIC, V37, P10, DOI 10.1016/j.ecolind.2013.10.006; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; Yasuno N, 2013, LIMNOLOGY, V14, P239, DOI 10.1007/s10201-013-0400-5; Zanden M. Jake Vander, 1999, Ecology (Washington D C), V80, P1395, DOI 10.1890/0012-9658(1999)080[1395:PCCANA]2.0.CO;2; Zemskaya TI, 2012, GEO-MAR LETT, V32, P437, DOI 10.1007/s00367-012-0297-8	56	3	3	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111392	10.1371/journal.pone.0111392	http://dx.doi.org/10.1371/journal.pone.0111392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360609	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700099
J	Zhou, XY; Yang, J; Lin, ZH; Zhang, JP				Zhou, Xueyan; Yang, Jing; Lin, Zehong; Zhang, Jianpei			ITEPE: A Source Tracing Algorithm for the Microblog	PLOS ONE			English	Article								Finding the true source of a social network is a crucial component of social network information tracing. Using the new media microblog as an example, this paper provides a source tracing algorithm ITEPE (Initiators and Early Participants Extraction) to solve this problem. First, the cascade (session tree) is built according to the retweeting of a microblog, after which the cascade set (session forest) is clustered by topical relevance. Second, real initiators are identified through the user relationship network and information cascade network. The influence index and conformity index of every node is then iteratively calculated according to text sentiment analysis and information cascades and the early important participants are extracted. Finally, the real initiators and early participants are evaluated through an experiment.	[Zhou, Xueyan; Yang, Jing; Zhang, Jianpei] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China; [Zhou, Xueyan; Lin, Zehong] Harbin Univ, Coll Engn, Harbin, Peoples R China	Harbin Engineering University; Harbin University	Yang, J (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China.	yangjing@hrbeu.edu.cn			National Natural Science Foundation of China [61370083, 61073043, 61073041, 61402126]; Specialized Research Fund for the Doctoral Program of Higher Education [20112304110011, 20122304110012]; Research Fund for the Harbin Science and Technology Innovative Talents [2014RFQXJ081]; Heilongjiang Education Scientific Research Youth Subject [GBD1213045]; Education Department humanities social sciences Fund [12542083]; Harbin University Subject Development Youth Fund [HUYF2013-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Fund for the Harbin Science and Technology Innovative Talents; Heilongjiang Education Scientific Research Youth Subject; Education Department humanities social sciences Fund; Harbin University Subject Development Youth Fund	The work was supported by The National Natural Science Foundation of China (No. 61370083, No. 61073043, No. 61073041 and and 61402126), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20112304110011, No. 20122304110012), Research Fund for the Harbin Science and Technology Innovative Talents (No. 2014RFQXJ081), Heilongjiang Education Scientific Research Youth Subject (GBD1213045), Education Department humanities social sciences Fund(12542083) and Harbin University Subject Development Youth Fund (No. HUYF2013-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Carrington P. J., 2005, MODELS METHODS SOCIA; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Dabeer O, 2011, TIMING TWEETS INCREA, P105; Degenne A., 1999, INTRO SOCIAL NETWORK, DOI 10.4135/9781849209373; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Leskovec J, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P551; Li H, 2014, DATA MIN KNOWL DISC, V28, P442, DOI 10.1007/s10618-013-0307-0; Macskassy S. A., 2011, P 5 INT AAAI C WEBL, P209; Pal A., 2011, P 4 ACM INT C WEB SE, P45, DOI DOI 10.1145/1935826.1935843; Sabidussi G, 1996, PSYCHOMETRIKA, V31, P581; Tsur O, 2012, P 5 ACM INT C WEB SE, P643, DOI [10.1145/2124295.2124320, DOI 10.1145/2124295.2124320]; Ver Steeg G., 2012, P 21 INT C WORLD WID, P509, DOI DOI 10.1145/2187836.2187906; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Welch M.J., P 4 ACM INT C WEB SE, P327, DOI DOI 10.1145/1935826.1935882; Yang J, 2010, ICIM 2010: PROCEEDINGS OF THE TENTH INTERNATIONAL CONFERENCE ON INDUSTRIAL MANAGEMENT, P356; Yang J, 2010, 2010 IEEE INTERNATIONAL CONFERENCE ON WIRELESS COMMUNICATIONS, NETWORKING AND INFORMATION SECURITY (WCNIS), VOL 2, P593, DOI 10.1109/ICCSIT.2010.5564008; Yang Zi, 2010, P 19 ACM INT C INFOR, P1633, DOI DOI 10.1145/1871437.1871691; Zhaoyun D, 2014, J COMPUTER RES DEV, V51, P691; Zhou X, 2014, J COMPUTATIONAL INFO, V10, P2571	21	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111380	10.1371/journal.pone.0111380	http://dx.doi.org/10.1371/journal.pone.0111380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360751	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700095
J	Gruber, S; Zeilinger, S				Gruber, Sabine; Zeilinger, Susanne			The Transcription Factor Ste12 Mediates the Regulatory Role of the Tmk1 MAP Kinase in Mycoparasitism and Vegetative Hyphal Fusion in the Filamentous Fungus Trichoderma atroviride	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FUSARIUM-OXYSPORUM; CELL-FUSION; APPRESSORIUM FORMATION; SIGNAL-TRANSDUCTION; BIOCONTROL ACTIVITY; SCLEROTIUM-ROLFSII; PLANT INFECTION; ENCODING GENE; EXPRESSION	Mycoparasitic species of the fungal genus Trichoderma are potent antagonists able to combat plant pathogenic fungi by direct parasitism. An essential step in this mycoparasitic fungus-fungus interaction is the detection of the fungal host followed by activation of molecular weapons in the mycoparasite by host-derived signals. The Trichoderma atroviride MAP kinase Tmk1, a homolog of yeast Fus3/Kss1, plays an essential role in regulating the mycoparasitic host attack, aerial hyphae formation and conidiation. However, the transcription factors acting downstream of Tmk1 are hitherto unknown. Here we analyzed the functions of the T. atroviride Ste12 transcription factor whose orthologue in yeast is targeted by the Fus3 and Kss1 MAP kinases. Deletion of the ste12 gene in T. atroviride not only resulted in reduced mycoparasitic overgrowth and lysis of host fungi but also led to loss of hyphal avoidance in the colony periphery and a severe reduction in conidial anastomosis tube formation and vegetative hyphal fusion events. The transcription of several orthologues of Neurospora crassa hyphal fusion genes was reduced upon ste12 deletion; however, the Delta ste12 mutant showed enhanced expression of mycoparasitism-relevant chitinolytic and proteolytic enzymes and of the cell wall integrity MAP kinase Tmk2. Based on the comparative analyses of Delta ste12 and Delta tmk1 mutants, an essential role of the Ste12 transcriptional regulator in mediating outcomes of the Tmk1 MAPK pathway such as regulation of the mycoparasitic activity, hyphal fusion and carbon source-dependent vegetative growth is suggested. Aerial hyphae formation and conidiation, in contrast, were found to be independent of Ste12.	[Gruber, Sabine; Zeilinger, Susanne] Vienna Univ Technol, Inst Chem Engn, Res Area Biotechnol & Microbiol, Vienna, Austria	Technische Universitat Wien	Zeilinger, S (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Area Biotechnol & Microbiol, Vienna, Austria.	szeiling@mail.tuwien.ac.at	Zeilinger, Susanne/AAX-6578-2020; Gruber, Sabine/AAD-5734-2021	Zeilinger, Susanne/0000-0003-3112-0948; Gruber, Sabine/0000-0001-6232-763X	Vienna Science and Technology Fund WWTF [LS09-036]; Austrian Science Fund FWF [V139]; Austrian Science Fund (FWF) [V 139] Funding Source: researchfish	Vienna Science and Technology Fund WWTF; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The Vienna Science and Technology Fund WWTF (www.wwtf.at, grant number LS09-036 to SZ) and the Austrian Science Fund FWF (www.fwf.ac.at, grant number V139 to SZ) are acknowledged for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Sanchez MA, 2010, FUNGAL GENET BIOL, V47, P216, DOI 10.1016/j.fgb.2009.11.006; Atanasova L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-121; Bauer R, 2004, MYCOLOGIA, V96, P960, DOI 10.2307/3762080; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Chang YC, 2004, MOL MICROBIOL, V53, P1385, DOI 10.1111/j.1365-2958.2004.04188.x; Cortes C, 1998, MOL GEN GENET, V260, P218, DOI 10.1007/s004380050889; DENNIS C, 1971, T BRIT MYCOL SOC, V57, P25, DOI 10.1016/S0007-1536(71)80077-3; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; ELAD Y, 1983, PHYTOPATHOLOGY, V73, P85, DOI 10.1094/Phyto-73-85; Fleissner Andre, 2008, V475, P21, DOI 10.1007/978-1-59745-250-2_2; Flores A, 1997, CURR GENET, V31, P30, DOI 10.1007/s002940050173; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; FURLANETO MC, 1992, FEMS MICROBIOL LETT, V90, P191, DOI 10.1111/j.1574-6968.1992.tb05150.x; Garcia-Pedrajas MD, 2008, FUNGAL GENET BIOL, V45, P379, DOI 10.1016/j.fgb.2007.11.001; Glass NL, 2004, TRENDS MICROBIOL, V12, P135, DOI 10.1016/j.tim.2004.01.007; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Gruber S, 2012, MICROBIOL-SGM, V158, P26, DOI 10.1099/mic.0.052613-0; Gruber S, 2011, GLYCOBIOLOGY, V21, P122, DOI 10.1093/glycob/cwq142; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; HARMAN GE, 1993, PHYTOPATHOLOGY, V83, P313, DOI 10.1094/Phyto-83-313; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hjeljord L, 1998, TRICHODERMA GLIOCLAD, V2, P131; Hoi JWS, 2007, MOL MICROBIOL, V64, P68, DOI 10.1111/j.1365-2958.2007.05639.x; Hoi JWS, 2010, EUKARYOT CELL, V9, P480, DOI 10.1128/EC.00333-09; INBAR J, 1994, MICROBIOL-SGM, V140, P651, DOI 10.1099/00221287-140-3-651; Jin QC, 2013, GENE EXPR PATTERNS, V13, P133, DOI 10.1016/j.gep.2013.02.003; KELLNER M, 1993, CURR GENET, V23, P334, DOI 10.1007/BF00310895; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kumar A, 2010, BIOCHEM BIOPH RES CO, V398, P765, DOI 10.1016/j.bbrc.2010.07.020; Leeder AC, 2013, GENETICS, V195, P883, DOI 10.1534/genetics.113.156984; Lev S, 2003, PLANT CELL, V15, P835, DOI 10.1105/tpc.010546; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Lorito M, 1996, P NATL ACAD SCI USA, V93, P14868, DOI 10.1073/pnas.93.25.14868; Lu ZX, 2004, APPL ENVIRON MICROB, V70, P3073, DOI 10.1128/AEM.70.5.3073-3081.2004; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MANCZINGER L, 1985, APPL MICROBIOL BIOT, V22, P72; Mead O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078368; Mendoza-Mendoza A, 2003, P NATL ACAD SCI USA, V100, P15965, DOI 10.1073/pnas.2136716100; Mukherjee PK, 2003, EUKARYOT CELL, V2, P446, DOI 10.1128/EC.2.3.446-455.2003; Mukherjee PK, 2013, ANNU REV PHYTOPATHOL, V51, P105, DOI 10.1146/annurev-phyto-082712-102353; Omero C, 1999, MYCOL RES, V103, P1637, DOI 10.1017/S0953756299008886; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2004, MOL MICROBIOL, V53, P1695, DOI 10.1111/j.1365-2958.2004.04220.x; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Park JY, 2009, PLANT PHYSIOL, V149, P474, DOI 10.1104/pp.108.129536; Peterbauer CK, 2002, MOL GENET GENOMICS, V267, P162, DOI 10.1007/s00438-001-0620-y; Peterbauer CK, 2002, MOL GENET GENOMICS, V268, P223, DOI 10.1007/s00438-002-0732-z; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reithrier B, 2007, FUNGAL GENET BIOL, V44, P1123, DOI 10.1016/j.fgb.2007.04.001; Rispail Nicolas, 2010, Commun Integr Biol, V3, P327; Rispail N, 2009, MOL PLANT MICROBE IN, V22, P830, DOI 10.1094/MPMI-22-7-0830; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; SAMBROOK E, 1989, MOL CLONING LAB MANU; Schamber A, 2010, MOL PLANT PATHOL, V11, P105, DOI [10.1111/j.1364-3703.2009.00579.x, 10.1111/j.1364-3703.2009.00579.X]; Seidl V, 2006, MICROBIOL-SGM, V152, P2003, DOI 10.1099/mic.0.28897-0; Seidl V, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-567; Seo J, 2002, COMPUTER, V35, P80; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Trushina N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-138; Vallim MA, 2000, MOL MICROBIOL, V36, P290, DOI 10.1046/j.1365-2958.2000.01874.x; Wang LI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019162; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; YUAN YLO, 1991, MOL CELL BIOL, V11, P5910, DOI 10.1128/MCB.11.12.5910; Zeilinger S, 2004, CURR GENET, V45, P54, DOI 10.1007/s00294-003-0454-8; Zeilinger S, 2005, APPL ENVIRON MICROB, V71, P1591, DOI 10.1128/AEM.71.3.1591-1597.2005; Zeilinger S, 1999, FUNGAL GENET BIOL, V26, P131, DOI 10.1006/fgbi.1998.1111; Zeilinger S, 2007, GENE REGUL SYST BIO, V1, P227; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x; Zhou XY, 2011, MOL MICROBIOL, V80, P33, DOI 10.1111/j.1365-2958.2011.07556.x	77	32	33	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111636	10.1371/journal.pone.0111636	http://dx.doi.org/10.1371/journal.pone.0111636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356841	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000072
J	Kwan, ML; Lo, JC; Tang, L; Laurent, CA; Roh, JM; Chandra, M; Hahn, TE; Hong, CC; Sucheston-Campbell, L; Hershman, DL; Quesenberry, CP; Ambrosone, CB; Kushi, LH; Yao, S				Kwan, Marilyn L.; Lo, Joan C.; Tang, Li; Laurent, Cecile A.; Roh, Janise M.; Chandra, Malini; Hahn, Theresa E.; Hong, Chi-Chen; Sucheston-Campbell, Lara; Hershman, Dawn L.; Quesenberry, Charles P., Jr.; Ambrosone, Christine B.; Kushi, Lawrence H.; Yao, Song			Bone Health History in Breast Cancer Patients on Aromatase Inhibitors	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; AMERICAN SOCIETY; MINERAL DENSITY; HIP FRACTURE; RISK-FACTORS; ANASTROZOLE; OUTCOMES; UPDATE	A cross-sectional study was performed to assess bone health history among aromatase inhibitor (AI) users before breast cancer (BC) diagnosis, which may impact fracture risk after AI therapy and choice of initial hormonal therapy. A total of 2,157 invasive BC patients initially treated with an AI were identified from a prospective cohort study at Kaiser Permanente Northern California (KPNC). Data on demographic and lifestyle factors were obtained from in-person interviews, and bone health history and clinical data from KPNC clinical databases. The prevalence of osteoporosis and fractures in postmenopausal AI users was assessed, compared with 325 postmenopausal TAM users. The associations of bone health history with demographic and lifestyle factors in AI users were also examined. Among all initial AI users, 11.2% had a prior history of osteoporosis, 16.3% had a prior history of any fracture, and 4.6% had a prior history of major fracture. Postmenopausal women who were taking TAM as their initial hormonal therapy had significantly higher prevalence of prior osteoporosis than postmenopausal AI users (21.5% vs. 11.8%, p<0.0001). Among initial AI users, the associations of history of osteoporosis and fracture in BC patients with demographic and lifestyle factors were, in general, consistent with those known in healthy older women. This study is one of the first to characterize AI users and risk factors for bone morbidity before BC diagnosis. In the future, this study will examine lifestyle, molecular, and genetic risk factors for AI-induced fractures.	[Kwan, Marilyn L.; Lo, Joan C.; Laurent, Cecile A.; Roh, Janise M.; Chandra, Malini; Quesenberry, Charles P., Jr.; Kushi, Lawrence H.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA; [Tang, Li; Hahn, Theresa E.; Hong, Chi-Chen; Sucheston-Campbell, Lara; Ambrosone, Christine B.; Yao, Song] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Hershman, Dawn L.] Columbia Univ, Dept Med, New York, NY USA; [Hershman, Dawn L.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Kaiser Permanente; Roswell Park Cancer Institute; Columbia University; Columbia University	Kwan, ML (corresponding author), Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA.	Marilyn.L.Kwan@kp.org	Kwan, Marilyn/AAH-4850-2021; Hershman, Dawn/AAG-2114-2020	Yao, Song/0000-0001-9442-1313; Kushi, Lawrence/0000-0001-9136-1175	U.S. National Institutes of Health, National Cancer Institute [R01 CA166701, R01 CA105274]; NATIONAL CANCER INSTITUTE [R01CA105274, K07CA148888, R01CA166701] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the U.S. National Institutes of Health, National Cancer Institute (R01 CA166701 to M. L. K. and S.Y. and R01 CA105274 to L. H. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, AM BON HLTH STAT OST; Boccardo F, 2008, NAT CLIN PRACT ONCOL, V5, P76, DOI 10.1038/ncponc1015; Body JJ, 2007, OSTEOPOROSIS INT, V18, P1439, DOI 10.1007/s00198-007-0439-4; Bouvard B, 2012, ANN ONCOL, V23, P1151, DOI 10.1093/annonc/mdr356; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Chau S, 2014, J BONE ONCOL, V3, P49, DOI 10.1016/j.jbo.2014.03.002; Chien AJ, 2006, J CLIN ONCOL, V24, P5305, DOI 10.1200/JCO.2006.07.5382; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Eastell R, 2007, J CLIN ENDOCR METAB, V92, P42, DOI 10.1210/jc.2006-2437; Geisler J, 2002, J CLIN ONCOL, V20, P751, DOI 10.1200/JCO.2002.20.3.751; Gralow JR, 2013, J NATL COMPR CANC NE, V11, pS1; Hadji P, 2009, CRIT REV ONCOL HEMAT, V69, P73, DOI 10.1016/j.critrevonc.2008.07.013; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Kwan M, 2008, CANCER CAUSE CONTROL, V19, P1065, DOI 10.1007/s10552-008-9170-5; Liu XS, 2011, J BONE MINER RES, V26, P1783, DOI 10.1002/jbmr.378; Lustberg MB, 2012, J CLIN ONCOL, V30, P3665, DOI 10.1200/JCO.2012.42.2097; Nguyen ND, 2007, J CLIN ENDOCR METAB, V92, P955, DOI 10.1210/jc.2006-1476; Oehrli MD., 2013, 2013 ANN REPORT TREN; Reid DS, 2008, J SCI FOOD AGR, V88, P1, DOI 10.1002/jsfa.3156; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; Selby JV, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P241; Servitja S, 2012, BREAST, V21, P95, DOI 10.1016/j.breast.2011.09.001; Siris ES, 2007, OSTEOPOROSIS INT, V18, P761, DOI 10.1007/s00198-006-0306-8; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Spangler L, 2013, J WOMENS HEALTH, V22, P132, DOI 10.1089/jwh.2012.3687; Staten LK, 2001, MED SCI SPORT EXER, V33, P1959, DOI 10.1097/00005768-200111000-00024; Walker MD, 2011, J BONE MINER RES, V26, P1392, DOI 10.1002/jbmr.352	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111477	10.1371/journal.pone.0111477	http://dx.doi.org/10.1371/journal.pone.0111477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354083	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200084
J	Mallett, S; Halligan, S; Collins, GS; Altman, DG				Mallett, Susan; Halligan, Steve; Collins, Gary S.; Altman, Doug G.			Exploration of Analysis Methods for Diagnostic Imaging Tests: Problems with ROC AUC and Confidence Scores in CT Colonography	PLOS ONE			English	Article							OPERATING CHARACTERISTIC ANALYSIS; COMPUTER-AIDED DETECTION; CHARACTERISTIC CURVES; PREDICTIVE ABILITY; PERFORMANCE; MAMMOGRAPHY; MODELS; CANCER; AREA; RECLASSIFICATION	Background: Different methods of evaluating diagnostic performance when comparing diagnostic tests may lead to different results. We compared two such approaches, sensitivity and specificity with area under the Receiver Operating Characteristic Curve (ROC AUC) for the evaluation of CT colonography for the detection of polyps, either with or without computer assisted detection. Methods: In a multireader multicase study of 10 readers and 107 cases we compared sensitivity and specificity, using radiological reporting of the presence or absence of polyps, to ROC AUC calculated from confidence scores concerning the presence of polyps. Both methods were assessed against a reference standard. Here we focus on five readers, selected to illustrate issues in design and analysis. We compared diagnostic measures within readers, showing that differences in results are due to statistical methods. Results: Reader performance varied widely depending on whether sensitivity and specificity or ROC AUC was used. There were problems using confidence scores; in assigning scores to all cases; in use of zero scores when no polyps were identified; the bimodal non-normal distribution of scores; fitting ROC curves due to extrapolation beyond the study data; and the undue influence of a few false positive results. Variation due to use of different ROC methods exceeded differences between test results for ROC AUC. Conclusions: The confidence scores recorded in our study violated many assumptions of ROC AUC methods, rendering these methods inappropriate. The problems we identified will apply to other detection studies using confidence scores. We found sensitivity and specificity were a more reliable and clinically appropriate method to compare diagnostic tests.	[Mallett, Susan] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Halligan, Steve] UCL, Ctr Med Imaging, London, England; [Collins, Gary S.; Altman, Doug G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford; University of London; University College London; University of Oxford	Mallett, S (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	susan.mallett@phc.ox.ac.uk	Collins, Gary Stephen/A-2258-2014; Halligan, Steve/C-5875-2009; Mallett, Sue/GPS-9933-2022	Collins, Gary Stephen/0000-0002-2772-2316; Halligan, Steve/0000-0003-0632-5108; Mallett, Sue/0000-0002-0596-8200	United Kingdom (UK) Department of Health via a National Institute for Health Research (NIHR) [RP-PG-0407-10338]; Cancer Research UK [C5529]; Medical Research Council [G1100513]; NIHR Comprehensive Biomedical Research Centre; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10338] Funding Source: researchfish; MRC [G1100513] Funding Source: UKRI	United Kingdom (UK) Department of Health via a National Institute for Health Research (NIHR); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by United Kingdom (UK) Department of Health via a National Institute for Health Research (NIHR) programme grant (RP-PG-0407-10338) and Cancer Research UK programme grant (C5529) and Medical Research Council (G1100513). A proportion of this work was undertaken at UCLH/UCL, which receives a proportion of funding from the NIHR Comprehensive Biomedical Research Centre funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NM, 2000, COMPUT BIOL MED, V30, P89, DOI 10.1016/S0010-4825(99)00025-6; Agresti A, 1999, STAT MED, V18, P2191, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2191::AID-SIM249>3.0.CO;2-M; Baker ME, 2007, RADIOLOGY, V245, P140, DOI 10.1148/radiol.2451061116; Bandos AI, 2006, ACAD RADIOL, V13, P414, DOI 10.1016/j.acra.2005.12.012; Beiden SV, 2000, ACAD RADIOL, V7, P341, DOI 10.1016/S1076-6332(00)80008-2; Boone D, 2013, PLOS ONE IN PRESS; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Dorfman DD, 2000, ACAD RADIOL, V7, P420, DOI 10.1016/S1076-6332(00)80382-7; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; Eng J, 2012, ACAD RADIOL, V19, P1452, DOI 10.1016/j.acra.2012.09.003; Gallas BD, 2006, ACAD RADIOL, V13, P353, DOI 10.1016/j.acra.2005.11.030; Gur D, 2008, RADIOLOGY, V247, P12, DOI 10.1148/radiol.2471071321; Gur D, 2007, ACAD RADIOL, V14, P871, DOI 10.1016/j.acra.2007.03.014; Halligan S, 2006, GASTROENTEROLOGY, V131, P1690, DOI 10.1053/j.gastro.2006.09.051; Halligan S, 2011, RADIOLOGY, V258, P469, DOI 10.1148/radiol.10100354; HANLEY JA, 1988, MED DECIS MAKING, V8, P197, DOI 10.1177/0272989X8800800308; Harrington M B, 1990, J Digit Imaging, V3, P211; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; Hussain HK, 2004, RADIOLOGY, V230, P637, DOI 10.1148/radiol.2303020921; Jiang YL, 2006, ACAD RADIOL, V13, P84, DOI 10.1016/j.acra.2005.09.086; Kim MJ, 2004, AM J ROENTGENOL, V182, P1469, DOI 10.2214/ajr.182.6.1821469; Krupinski EA, 2006, ACAD RADIOL, V13, P289, DOI 10.1016/j.acra.2005.11.006; Krupinski EA, 2008, MED PHYS, V35, P645, DOI 10.1118/1.2830376; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; Lewin JM, 2001, RADIOLOGY, V218, P873, DOI 10.1148/radiology.218.3.r01mr29873; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; METZ CE, 1989, INVEST RADIOL, V24, P234, DOI 10.1097/00004424-198903000-00012; METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009; Moons KGM, 1997, MED DECIS MAKING, V17, P447, DOI 10.1177/0272989X9701700410; Obuchowski NA, 1997, BIOMETRICS, V53, P567, DOI 10.2307/2533958; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Obuchowski NA, 2004, ACAD RADIOL, V11, P980, DOI 10.1016/j.arca.2004.04.014; Obuchowski NA, 2012, ACAD RADIOL, V19, P1508, DOI 10.1016/j.acra.2012.09.012; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2008, STAT MED, V27, P173, DOI 10.1002/sim.2991; Petrick N, 2008, RADIOLOGY, V246, P148, DOI 10.1148/radiol.2453062161; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Staff DGfIaF, 2012, CLIN PERF ASS CONS C; SWETS JA, 1986, PSYCHOL BULL, V99, P181, DOI 10.1037/0033-2909.99.2.181; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; WAYMIRE E, 1981, WATER RESOUR RES, V17, P1261, DOI 10.1029/WR017i005p01261; Westphalen AC, 2008, RADIOLOGY, V246, P177, DOI 10.1148/radiol.2453062042	42	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e107633	10.1371/journal.pone.0107633	http://dx.doi.org/10.1371/journal.pone.0107633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353643	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200002
J	Gjoni, E; Brioschi, L; Cinque, A; Coant, N; Islam, MN; Ng, CKY; Verderio, C; Magnan, C; Riboni, L; Viani, P; Le Stunff, H; Giussani, P				Gjoni, Enida; Brioschi, Loredana; Cinque, Alessandra; Coant, Nicolas; Islam, M. Nurul; Ng, Carl K. -Y.; Verderio, Claudia; Magnan, Christophe; Riboni, Laura; Viani, Paola; Le Stunff, Herve; Giussani, Paola			Glucolipotoxicity Impairs Ceramide Flow from the Endoplasmic Reticulum to the Golgi Apparatus in INS-1 beta-Cells	PLOS ONE			English	Article							INSULIN GENE-EXPRESSION; FATTY-ACID; INDUCED APOPTOSIS; STRESS; TRAFFICKING; INHIBITION; PALMITATE; CERT; GLUCOSE; PROTEIN	Accumulating evidence suggests that glucolipotoxicity, arising from the combined actions of elevated glucose and free fatty acid levels, acts as a key pathogenic component in type II diabetes, contributing to beta-cell dysfunction and death. Endoplasmic reticulum (ER) stress is among the molecular pathways and regulators involved in these negative effects, and ceramide accumulation due to glucolipotoxicity can be associated with the induction of ER stress. Increased levels of ceramide in ER may be due to enhanced ceramide biosynthesis and/or decreased ceramide utilization. Here, we studied the effect of glucolipotoxic conditions on ceramide traffic in INS-1 cells in order to gain insights into the molecular mechanism(s) of glucolipotoxicity. We showed that glucolipotoxicity inhibited ceramide utilization for complex sphingolipid biosynthesis, thereby reducing the flow of ceramide from the ER to Golgi. Glucolipotoxicity impaired both vesicular-and CERT-mediated ceramide transport through (1) the decreasing of phospho-Akt levels which in turn possibly inhibits vesicular traffic, and (2) the reducing of the amount of active CERT mainly due to a lower protein levels and increased protein phosphorylation to prevent its localization to the Golgi. In conclusion, our findings provide evidence that glucolipotoxicity-induced ceramide overload in the ER, arising from a defect in ceramide trafficking may be a mechanism that contributes to dysfunction and/or death of beta-cells exposed to glucolipotoxicity.	[Gjoni, Enida; Brioschi, Loredana; Cinque, Alessandra; Riboni, Laura; Viani, Paola; Giussani, Paola] Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy; [Coant, Nicolas; Magnan, Christophe; Le Stunff, Herve] Univ PARIS DIDEROT, Unite Biol Fonctionnelle & Adaptat, UMR CNRS 8251, Paris, France; [Islam, M. Nurul; Ng, Carl K. -Y.] Univ Coll Dublin, Sch Biol & Environm Sci, Belfield, Ireland; [Islam, M. Nurul; Ng, Carl K. -Y.] Univ Coll Dublin, Earth Inst, Belfield, Ireland; [Verderio, Claudia] Univ Milan, CNR, Inst Neurosci, Dept Med Biotechnol & Translat Med, Milan, Italy	University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University College Dublin; University College Dublin; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Giussani, P (corresponding author), Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy.	paola.giussani@unimi.it	Riboni, Laura/R-4281-2017; Verderio, Claudia/K-4415-2016; magnan, christophe/AAJ-7622-2021; Giussani, Paola/R-4268-2017; VIANI, PAOLA/Q-5955-2017; LE STUNFF, Hervé/AAA-6882-2019; Cinque, Alessandra/AAN-3846-2020	Riboni, Laura/0000-0002-4149-8226; Verderio, Claudia/0000-0001-7216-5873; magnan, christophe/0000-0002-7044-2571; Giussani, Paola/0000-0002-7793-1757; VIANI, PAOLA/0000-0002-5728-6631; Gjoni, Enida/0000-0003-4028-9294; Cinque, Alessandra/0000-0002-5739-742X; Ng, Carl/0000-0001-5832-3265; COANT, Nicolas/0000-0001-9237-2132	University of Milan PUR; Italian Ministry of University and Scientific and Technological Research PRIN; Science Foundation Ireland [SFI/06/RFP/GEN034, SFI/08/RFP/EOB1087]; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-06-JCJC-0040]; Universite Paris Diderot; French Society of Nutrition (SFN)	University of Milan PUR; Italian Ministry of University and Scientific and Technological Research PRIN(Ministry of Education, Universities and Research (MIUR)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite Paris Diderot; French Society of Nutrition (SFN)	This work was supported by grants from the University of Milan PUR to PG, grants from the Italian Ministry of University and Scientific and Technological Research PRIN to PV, and grants from Science Foundation Ireland (SFI/06/RFP/GEN034 and SFI/08/RFP/EOB1087) to CK-YN. This project was partly supported by grants from Centre National de la Recherche Scientifique (CNRS) and Agence Nationale de la Recherche (ANR-06-JCJC-0040) to HLS. NC received a postdoctoral fellowship from the Universite Paris Diderot and the French Society of Nutrition (SFN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Chandran S, 2012, BIOCHEM J, V442, P391, DOI 10.1042/BJ20111461; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Giussani P, 2009, J BIOL CHEM, V284, P5088, DOI 10.1074/jbc.M808934200; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Guo J, 2010, CELL PHYSIOL BIOCHEM, V26, P717, DOI 10.1159/000322339; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Lang F, 2011, EXPERT OPIN THER TAR, V15, P1061, DOI 10.1517/14728222.2011.588209; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lei X, 2010, DIABETES OBES METAB, V12, P93, DOI 10.1111/j.1463-1326.2010.01270.x; Lei X, 2012, AM J PHYSIOL-ENDOC M, pE1386; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Pinget M, 2002, DIABETES METAB, V28, pS21; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Riboni L, 2000, J NEUROCHEM, V75, P503, DOI 10.1046/j.1471-4159.2000.0750503.x; Riboni L, 2010, ADV EXP MED BIOL, V688, P24; RICHIERI GV, 1995, J LIPID RES, V36, P229; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Veret J, 2014, J CLIN MED, V3, P646, DOI 10.3390/jcm3020646; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Veret J, 2011, BIOCHEM J, V438, P177, DOI 10.1042/BJ20101386; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Voelker DR, 2009, ANNU REV BIOCHEM, V78, P827, DOI 10.1146/annurev.biochem.78.081307.112144; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83	45	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110875	10.1371/journal.pone.0110875	http://dx.doi.org/10.1371/journal.pone.0110875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350564	gold, Green Published			2022-12-27	WOS:000343943100044
J	Andersson, MG; Faverjon, C; Vial, F; Legrand, L; Leblond, A				Andersson, Mats Gunnar; Faverjon, Celine; Vial, Flavie; Legrand, Loic; Leblond, Agnes			Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance	PLOS ONE			English	Article							EQUINE INFLUENZA; OUTBREAK DETECTION; VACCINATED HORSES; VIRUS; CHALLENGES; EPIDEMIC; FRANCE; HEALTH; H3N8	In this work we propose the adoption of a statistical framework used in the evaluation of forensic evidence as a tool for evaluating and presenting circumstantial "evidence" of a disease outbreak from syndromic surveillance. The basic idea is to exploit the predicted distributions of reported cases to calculate the ratio of the likelihood of observing n cases given an ongoing outbreak over the likelihood of observing n cases given no outbreak. The likelihood ratio defines the Value of Evidence (V). Using Bayes' rule, the prior odds for an ongoing outbreak are multiplied by V to obtain the posterior odds. This approach was applied to time series on the number of horses showing clinical respiratory symptoms or neurological symptoms. The separation between prior beliefs about the probability of an outbreak and the strength of evidence from syndromic surveillance offers a transparent reasoning process suitable for supporting decision makers. The value of evidence can be translated into a verbal statement, as often done in forensics or used for the production of risk maps. Furthermore, a Bayesian approach offers seamless integration of data from syndromic surveillance with results from predictive modeling and with information from other sources such as disease introduction risk assessments.	[Andersson, Mats Gunnar] Natl Vet Inst, Dept Chem Environm & Feed Hyg, S-75007 Uppsala, Sweden; [Faverjon, Celine] VetagroSup, INRA Anim Epidemiol UR346, Marcy Letoile, France; [Vial, Flavie] Vetsuisse Fak, DCR VPH, Vet Publ Hlth Inst, Bern, Switzerland; [Legrand, Loic] Normandie Univ, Unite Risques Microbiens U2RM, EA 4655, LABEO Frank Duncombe, Caen, Normandy, France; [Legrand, Loic; Leblond, Agnes] RESPE, Caen, France; [Leblond, Agnes] VetAgroSup, INRA Anim Epidemiol UR346, Marcy Letoile, France; [Leblond, Agnes] VetAgroSup, Dept Hipp, Marcy Letoile, France	National Veterinary Institute SVA; INRAE; VetAgro Sup; Universite de Caen Normandie; INRAE; VetAgro Sup; VetAgro Sup	Andersson, MG (corresponding author), Natl Vet Inst, Dept Chem Environm & Feed Hyg, S-75007 Uppsala, Sweden.	gunnar.andersson@sva.se	Leblond, Agnes/G-8972-2012	Vial, Flavie/0000-0003-3603-4694; LEBLOND, AGNES/0000-0001-9136-4544; Faverjon, Celine/0000-0001-6737-1883	EMIDA ERA-NET through the Swedish research council Formas [221-2011-2214]; Dutch Ministry of Economic Affairs [BO 20-009-009]; IFCE (Institut Francais du Cheval et de l'Equitation); INRA (Animal epidemiology Unit - EPIA)	EMIDA ERA-NET through the Swedish research council Formas(Swedish Research Council Formas); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); IFCE (Institut Francais du Cheval et de l'Equitation); INRA (Animal epidemiology Unit - EPIA)	This work was funded by EMIDA ERA-NET through the Swedish research council Formas (http://www.formas.se/en/) (Contract no. 221-2011-2214) to MGA; EMIDA ERA-NET through Netherlands Food Consumer Product Safety Authority (www.nvwa.nl/english) and the Dutch Ministry of Economic Affairs (http://www.government.nl/ministries/ez) (project no. BO 20-009-009), and IFCE (Institut Francais du Cheval et de l'Equitation) (http://www.ifce.fr/) to CF; INRA (Animal epidemiology Unit - EPIA) (http://www.inra.fr/en/Scientists-Students) and IFCE (Institut Francais du Cheval et de l'Equitation) (http://www.ifce.fr/) to AL; 'Conseils Generaux du Calvados, de la Manche et de l'Orne' (County Councils) (http://www.calvados.fr/cms) to LL; Veterinary Public Health Institute, DCRVPH, Vetsuisse Fakultat, (http://www.vetsuisse.unibe.ch/vphi/content/index_ger.html) to FV. Labeo Frank Duncombe (http://www.labo-frank-duncombe.fr/) provided support in the form of a salary for author LL. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The specific roles of these authors are articulated in the 'author contributions' section.	Aitken C., 2010, FUNDAMENTALS PROBABI; Andersson G, 2013, S SALM SALM I3S SAIN; Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234; Brownson RC, 2009, ANNU REV PUBL HEALTH, V30, P175, DOI 10.1146/annurev.publhealth.031308.100134; Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231; Burkom Howard S, 2004, MMWR Suppl, V53, P67; Cameron AR, 2012, PREV VET MED, V105, P280, DOI 10.1016/j.prevetmed.2012.01.009; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Gesualdo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082489; Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143; Gittelson Simone, 2013, EVOLVING INFERENCES; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; Jarman KH, 2008, APPL ENVIRON MICROB, V74, P3573, DOI 10.1128/AEM.02526-07; Katz R, 2011, J EPIDEMIOL GLOB HEA, V1, P21, DOI 10.1016/j.jegh.2011.06.003; Keats A, 2006, P 14 ANN C COMP FLUI; Leblond A, 2007, VECTOR-BORNE ZOONOT, V7, P403, DOI 10.1089/vbz.2006.0593; Legrand LJ, 2013, EQUINE VET J, V45, P776, DOI 10.1111/evj.12100; Martella V, 2007, VET MICROBIOL, V121, P56, DOI 10.1016/j.vetmic.2006.11.017; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Newton JR, 2006, VET REC, V158, P185, DOI 10.1136/vr.158.6.185; Nordgaard A, 2012, LAW PROBAB RISK, V11, P1, DOI 10.1093/lpr/mgr020; OIE, 2011, OIE TERR AN HLTH COD; R Core Team, 2021, R LANGUAGE ENV STAT; Schmidt AM, 2011, INT STAT REV, V79, P48, DOI 10.1111/j.1751-5823.2010.00123.x; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; Sosin DM, 2003, J URBAN HEALTH, V80, pI8; Taroni F., 2014, BAYESIAN NETWORKS PR, VSecond, DOI 10.1002/0470091754; Venables WN., 2002, MODERN APPL STAT S 4; Yamanaka T, 2008, J VET MED SCI, V70, P623, DOI 10.1292/jvms.70.623	30	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111335	10.1371/journal.pone.0111335	http://dx.doi.org/10.1371/journal.pone.0111335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364823	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100062
J	Casabianca, A; Orlandi, C; Canovari, B; Scotti, M; Acetoso, M; Valentini, M; Petrelli, E; Magnani, M				Casabianca, Anna; Orlandi, Chiara; Canovari, Benedetta; Scotti, Maddalena; Acetoso, Marcello; Valentini, Massimo; Petrelli, Enzo; Magnani, Mauro			A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients	PLOS ONE			English	Article							VIRUS TYPE-1 DNA; CD4(+) T-CELLS; MONONUCLEAR-CELLS; ANTIRETROVIRAL THERAPY; QUANTITATIVE ASSAY; INFECTION; TRANSCRIPTION; REPLICATION; PERSISTENCE; EXPRESSION	Background: The quantitative measurement of various HIV-1 DNA forms including total, unintegrated and integrated provirus play an increasingly important role in HIV-1 infection monitoring and treatment-related research. We report the development and validation of a SYBR Green real time PCR (TotUFsys platform) for the simultaneous quantification of total and extrachromosomal HIV-1 DNA forms in patients. This innovative technique makes it possible to obtain both measurements in a single PCR run starting from frozen blood employing the same primers and standard curve. Moreover, due to identical amplification efficiency, it allows indirect estimation of integrated level. To specifically detect 2-LTR a qPCR method was also developed. Methodology/Findings: Primers used for total HIV-1 DNA quantification spanning a highly conserved region were selected and found to detect all HIV-1 clades of group M and the unintegrated forms of the same. A total of 195 samples from HIV-1 patients in a wide range of clinical conditions were analyzed with a 100% success rate, even in patients with suppressed plasma viremia, regardless of CD4+ or therapy. No significant correlation was observed between the two current prognostic markers, CD4+ and plasma viremia, while a moderate or high inverse correlation was found between CD4+ and total HIV DNA, with strong values for unintegrated HIV DNA. Conclusions/Significance: Taken together, the results support the use of HIV DNA as another tool, in addition to traditional assays, which can be used to estimate the state of viral infection, the risk of disease progression and to monitor the effects of ART. The TotUFsys platform allowed us to obtain a final result, expressed as the total and unintegrated HIV DNA copy number per microgram of DNA or 10 4 CD4+, for 12 patients within two working days.	[Casabianca, Anna; Orlandi, Chiara; Scotti, Maddalena; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Canovari, Benedetta; Acetoso, Marcello; Valentini, Massimo; Petrelli, Enzo] Presidio Osped San Salvatore, Azienda Osped Osped Riuniti Marche Nord, Pesaro, PU, Italy	University of Urbino	Casabianca, A (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	anna.casabianca@uniurb.it	Magnani, Mauro/A-1919-2008	orlandi, chiara/0000-0003-3288-7286; Magnani, Mauro/0000-0001-6456-6626	Gilead Science Srl	Gilead Science Srl	This work was supported by Gilead Science Srl. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto LM, 2011, VIROLOGY, V409, P46, DOI 10.1016/j.virol.2010.08.024; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bell P, 2001, J VIROL, V75, P7683, DOI 10.1128/JVI.75.16.7683-7691.2001; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Brussel A, 2003, AIDS, V17, P645, DOI 10.1097/00002030-200303280-00001; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Carr JM, 2007, J CLIN MICROBIOL, V45, P1288, DOI 10.1128/JCM.01926-06; Casabianca A, 2007, MOL CELL PROBE, V21, P368, DOI 10.1016/j.mcp.2007.05.005; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Foley BT, 2013, HIV SEQUENCE COMPEND, P13; Griffiths DJ, 2001, GENOME BIOL, V2; Grignani F, 1998, CANCER RES, V58, P14; Helsel DR, 2005, ENVIRON SCI TECHNOL, V39, p419A, DOI 10.1021/es053368a; JURRIAANS S, 1992, J GEN VIROL, V73, P1537, DOI 10.1099/0022-1317-73-6-1537; Katzenstein TL, 2002, SCAND J INFECT DIS, V34, P529, DOI 10.1080/00365540110080845; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Kostrikis LG, 2002, J VIROL, V76, P10099, DOI 10.1128/JVI.76.20.10099-10108.2002; Lewin SR, 2008, JAIDS-J ACQ IMM DEF, V47, P140, DOI 10.1097/QAI.0b013e31815dbf7f; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Morand-Doubert L, 2005, JAIDS-J ACQ IMM DEF, V38, P268; Munir S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-87; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Parisi SG, 2012, J CLIN MICROBIOL, V50, P258, DOI 10.1128/JCM.06022-11; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Sambrook J., 2001, MOL CLONING LAB MANU; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sloan RD, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-52; Teo I, 1997, J VIROL, V71, P2928, DOI 10.1128/JVI.71.4.2928-2933.1997; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Yu JJQ, 2008, VIROLOGY, V379, P78, DOI 10.1016/j.virol.2008.05.030	40	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111919	10.1371/journal.pone.0111919	http://dx.doi.org/10.1371/journal.pone.0111919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364909	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100135
J	Parsons, MB; Gillespie, TR; Lonsdorf, EV; Travis, D; Lipende, I; Gilagiza, B; Kamenya, S; Pintea, L; Vazquez-Prokopec, GM				Parsons, Michele B.; Gillespie, Thomas R.; Lonsdorf, Elizabeth V.; Travis, Dominic; Lipende, Iddi; Gilagiza, Baraka; Kamenya, Shadrack; Pintea, Lilian; Vazquez-Prokopec, Gonzalo M.			Global Positioning System Data-Loggers: A Tool to Quantify Fine-Scale Movement of Domestic Animals to Evaluate Potential for Zoonotic Transmission to an Endangered Wildlife Population	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; CRYPTOSPORIDIUM-PARVUM; GIARDIA; VIRUS; RISK; INFECTION; PARASITES; PATTERNS; DISEASES; HABITAT	Domesticated animals are an important source of pathogens to endangered wildlife populations, especially when anthropogenic activities increase their overlap with humans and wildlife. Recent work in Tanzania reports the introduction of Cryptosporidium into wild chimpanzee populations and the increased risk of ape mortality associated with SIVcpz-Cryptosporidium co-infection. Here we describe the application of novel GPS technology to track the mobility of domesticated animals (27 goats, 2 sheep and 8 dogs) with the goal of identifying potential routes for Cryptosporidium introduction into Gombe National Park. Only goats (5/27) and sheep (2/2) were positive for Cryptosporidium. Analysis of GPS tracks indicated that a crop field frequented by both chimpanzees and domesticated animals was a potential hotspot for Cryptosporidium transmission. This study demonstrates the applicability of GPS data-loggers in studies of fine-scale mobility of animals and suggests that domesticated animal-wildlife overlap should be considered beyond protected boundaries for long-term conservation strategies.	[Parsons, Michele B.; Gillespie, Thomas R.; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA; [Parsons, Michele B.; Gillespie, Thomas R.; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Parsons, Michele B.; Gillespie, Thomas R.; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Hlth, Atlanta, GA 30322 USA; [Parsons, Michele B.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA; [Travis, Dominic] Univ Minnesota, Coll Vet Med, Minneapolis, MN 55455 USA; [Lipende, Iddi; Gilagiza, Baraka; Kamenya, Shadrack; Pintea, Lilian] Jane Goodall Inst, Kigoma, Tanzania	Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Franklin & Marshall College; University of Minnesota System; University of Minnesota Twin Cities	Gillespie, TR (corresponding author), Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA.	thomas.gillespie@emory.edu; gmvazqu@emory.edu	Gillespie, Thomas R/A-5132-2010	Gillespie, Thomas R/0000-0002-7901-7248	Morris Animal Foundation [MAF D09ZO-041, MAF D09ZO-634]; Emory University Global Health Institute; Arcus Foundation; Leo S. Guthman Foundation; National Institutes of Health [R01 AI58715]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058715] Funding Source: NIH RePORTER	Morris Animal Foundation; Emory University Global Health Institute; Arcus Foundation; Leo S. Guthman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study comes from the Morris Animal Foundation (MAF D09ZO-041 and MAF D09ZO-634), the Emory University Global Health Institute, the Arcus Foundation, the Leo S. Guthman Foundation and the National Institutes of Health (R01 AI58715). QuickBird satellite imagery was kindly contributed to the Jane Goodall Institute at no cost by DigitalGlobe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of	Appelbee AJ, 2005, TRENDS PARASITOL, V21, P370, DOI 10.1016/j.pt.2005.06.004; Biggins DE MB, 2006, RECOVERY BLACK FOOTE, P175; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; CRAIGHEAD FC, 1982, TRACK GRIZZLY; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; da Silva AJ, 1999, MOL DIAGN, V4, P57, DOI 10.1016/S1084-8592(99)80050-2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Fayer R., 1997, CRYPTOSPORIDIUM CRYP; Gillespie TR, 2010, AM J PHYS ANTHROPOL, V143, P534, DOI 10.1002/ajpa.21348; Gillespie TR, 2001, BEHAV ECOL SOCIOBIOL, V50, P329, DOI 10.1007/s002650100371; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Great Outdoor Recreation Pages, 2010, GOMB STREAM NAT PARK; Gurtler RE, 2007, PARASITOLOGY, V134, P69, DOI 10.1017/S0031182006001259; Hagen IJ, 2011, J HERPETOL, V45, P36, DOI 10.1670/10-074.1; Hanski I, 2012, ANN NY ACAD SCI, V1249, P1, DOI 10.1111/j.1749-6632.2011.06419.x; Hunter PR, 2005, INT J PARASITOL, V35, P1181, DOI 10.1016/j.ijpara.2005.07.009; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; KETTLEWELL H. B. D., 1955, HEREDITY, V9, P323, DOI 10.1038/hdy.1955.36; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Newman SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005729; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Parashar UD, 2000, J INFECT DIS, V181, P1755, DOI 10.1086/315457; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pintea L., 2007, APPL SATELLITE IMAGE; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Rudnick DA, 2012, 16 EC SOC AM, P1; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; Schwartz Charles C., 1999, Ursus, V11, P261; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Smith HV, 2007, VET PARASITOL, V149, P29, DOI 10.1016/j.vetpar.2007.07.015; Sterck EHM, 2005, BEHAVIOUR, V142, P845, DOI 10.1163/1568539055010093; Tilman D, 1997, SPATIAL ECOLOGY ROLE; TZIPORI S, 1988, ADV PARASIT, V27, P63, DOI 10.1016/S0065-308X(08)60353-X; United States Department of Defense, 2000, GLOB POS SYST STAND; Vazquez-Prokopec GM, 2009, AM J TROP MED HYG, V81, P230; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; Weyher AH, 2006, INT J PRIMATOL, V27, P1519, DOI 10.1007/s10764-006-9089-1; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578	46	24	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110984	10.1371/journal.pone.0110984	http://dx.doi.org/10.1371/journal.pone.0110984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365070	Green Published, gold			2022-12-27	WOS:000345558100040
J	Chatterjee, D; Addya, S; Khan, RS; Kenyon, LC; Choe, A; Cohrs, RJ; Shindler, KS; Das Sarma, J				Chatterjee, Dhriti; Addya, Sankar; Khan, Reas S.; Kenyon, Lawrence C.; Choe, Alexander; Cohrs, Randall J.; Shindler, Kenneth S.; Das Sarma, Jayasri			Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INTERFERON-STIMULATED GENES; IFN-GAMMA; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; CORONAVIRUS; EXPRESSION; NEUROINFLAMMATION; CYTOKINE; ALPHA	Neurotropic recombinant strain of Mouse Hepatitis Virus, RSA59, induces meningo-encephalitis, myelitis and demyelination following intracranial inoculation. RSA59 induced neuropathology is partially caused by activation of CNS resident microglia, as demonstrated by changes in cellular morphology and increased expression of a microglia/macrophage specific calcium ion binding factor, Iba1. Affymetrix Microarray analysis for mRNA expression data reveals expression of inflammatory mediators that are known to be released by activated microglia. Microglia-specific cell surface molecules, including CD11b, CD74, CD52 and CD68, are significantly upregulated in contrast to CD4, CD8 and CD19. Protein analysis of spinal cord extracts taken from mice 6 days post-inoculation, the time of peak inflammation, reveals robust expression of IFN-gamma, IL-12 and mKC. Data suggest that activated microglia and inflammatory mediators contribute to a local CNS microenvironment that regulates viral replication and IFN-gamma production during the acute phase of infection, which in turn can cause phagolysosome maturation and phagocytosis of the myelin sheath, leading to demyelination.	[Chatterjee, Dhriti; Das Sarma, Jayasri] IISER K, Dept Biol Sci, Mohanpur, W Bengal, India; [Addya, Sankar] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Khan, Reas S.; Shindler, Kenneth S.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Khan, Reas S.; Shindler, Kenneth S.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Kenyon, Lawrence C.] Thomas Jefferson Univ, Dept Anat, Philadelphia, PA 19107 USA; [Kenyon, Lawrence C.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [Choe, Alexander; Cohrs, Randall J.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Choe, Alexander; Cohrs, Randall J.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA	Indian Institute of Science Education & Research (IISER) - Kolkata; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Jefferson University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Shindler, KS (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.	Kenneth.Shindler@uphs.upenn.edu; dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020	majumder, dhriti/0000-0001-9292-6430; Kenyon, Lawrence/0000-0002-3719-9565	Department of Biotechnology India, Indian Institute of Science Education and Research-Kolkata (IISER-K), India [BT/PR14260/MED/30/437/2010]; NIH [EY015014]; ASM-IUSSTF Indo-US Research Professorship Award; University Grant Commission (UGC), India; NATIONAL EYE INSTITUTE [R01EY019014, R43EY015014] Funding Source: NIH RePORTER	Department of Biotechnology India, Indian Institute of Science Education and Research-Kolkata (IISER-K), India; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASM-IUSSTF Indo-US Research Professorship Award; University Grant Commission (UGC), India(University Grants Commission, India); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by Research Grant (BT/PR14260/MED/30/437/2010) from Department of Biotechnology India, Indian Institute of Science Education and Research-Kolkata (IISER-K), India start up Fund to JDS and NIH grant (EY015014) to KSS. This work is also partially supported by 2013 ASM-IUSSTF Indo-US Research Professorship Award to JDS and RC to develop bi-lateral research relationship between India and US. We thank University Grant Commission (UGC), India, for providing the research support to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bell JE, 1998, REV NEUROL-FRANCE, V154, P816; Butchi NB, 2014, J VIROL, V88, P1051, DOI 10.1128/JVI.02272-13; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chatterjee D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/510396; Cheeran MCJ, 2003, J VIROL, V77, P4502, DOI 10.1128/JVI.77.8.4502-4515.2003; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; COCKFIELD SM, 1993, J IMMUNOL, V150, P342; Das Sarma J, 2000, J VIROL, V74, P9206, DOI 10.1128/JVI.74.19.9206-9213.2000; Das Sarma J, 2002, J NEUROVIROL, V8, P381, DOI [10.1080/13550280290100815, 10.1080/13550280260422686]; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma J, 2014, J NEUROVIROL, V20, P122, DOI 10.1007/s13365-013-0188-4; Das Sarma Jayasri, 2010, Interdiscip Perspect Infect Dis, V2010, P109239, DOI 10.1155/2010/109239; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Das Sarma S., 2013, ISRN IMMUNOLOGY, V2013, P10, DOI [10.1155/2013/205431, DOI 10.1155/2013/205431]; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Elliott R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075346; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Gessani S, 1998, CYTOKINE GROWTH F R, V9, P117, DOI 10.1016/S1359-6101(98)00007-0; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Lane TE, 1998, J IMMUNOL, V160, P970; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Matthews AE, 2002, J NEUROVIROL, V8, P257, DOI 10.1080/13550280290049697; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Mogensen S C, 1987, Interferon, V8, P55; Muse M, 2008, VIROLOGY, V382, P132, DOI 10.1016/j.virol.2008.09.032; Phillips JJ, 1999, J VIROL, V73, P7752, DOI 10.1128/JVI.73.9.7752-7760.1999; Phillips JJ, 2002, VIROLOGY, V301, P109, DOI 10.1006/viro.2002.1551; Phillips JJ, 2001, J NEUROVIROL, V7, P421; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarma J Das, 2013, ONLINE J BIOSCIENCES, V4, P64; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shindler KS, 2008, J VIROL, V82, P8882, DOI 10.1128/JVI.00920-08; Shindler KS, 2011, J NEUROPATH EXP NEUR, V70, P470, DOI 10.1097/NEN.0b013e31821da499; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Streit WJ, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00022; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Versijpt JJ, 2003, EUR NEUROL, V50, P39, DOI 10.1159/000070857; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Weitz Tara M, 2012, Int J Alzheimers Dis, V2012, P314185, DOI 10.1155/2012/314185; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Young HA, 1996, J INTERF CYTOK RES, V16, P563, DOI 10.1089/jir.1996.16.563; Zhao L, 2013, J VIROL, V87, P8408, DOI 10.1128/JVI.00769-13	54	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111351	10.1371/journal.pone.0111351	http://dx.doi.org/10.1371/journal.pone.0111351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360880	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700089
J	Sang, YF; Liu, CM; Wang, ZG; Wen, J; Shang, LY				Sang, Yan-Fang; Liu, Changming; Wang, Zhonggen; Wen, Jun; Shang, Lunyu			Energy-Based Wavelet De-Noising of Hydrologic Time Series	PLOS ONE			English	Article							RAINFALL-RUNOFF; PRACTICAL GUIDE; DECOMPOSITION; REDUCTION	De-noising is a substantial issue in hydrologic time series analysis, but it is a difficult task due to the defect of methods. In this paper an energy-based wavelet de-noising method was proposed. It is to remove noise by comparing energy distribution of series with the background energy distribution, which is established from Monte-Carlo test. Differing from wavelet threshold de-noising (WTD) method with the basis of wavelet coefficient thresholding, the proposed method is based on energy distribution of series. It can distinguish noise from deterministic components in series, and uncertainty of de-noising result can be quantitatively estimated using proper confidence interval, but WTD method cannot do this. Analysis of both synthetic and observed series verified the comparable power of the proposed method and WTD, but de-noising process by the former is more easily operable. The results also indicate the influences of three key factors (wavelet choice, decomposition level choice and noise content) on wavelet de-noising. Wavelet should be carefully chosen when using the proposed method. The suitable decomposition level for wavelet de-noising should correspond to series' deterministic sub-signal which has the smallest temporal scale. If too much noise is included in a series, accurate de-noising result cannot be obtained by the proposed method or WTD, but the series would show pure random but not autocorrelation characters, so de-noising is no longer needed.	[Sang, Yan-Fang; Liu, Changming; Wang, Zhonggen] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proc, Beijing, Peoples R China; [Sang, Yan-Fang; Wen, Jun; Shang, Lunyu] Chinese Acad Sci, Key Lab Land Surface Proc & Climate Change Cold &, Lanzhou, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences	Sang, YF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proc, Beijing, Peoples R China.	sangyf@igsnrr.ac.cn	sang, yan-fang/I-8277-2016	sang, yan-fang/0000-0001-6770-9311	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB03030202]; National Natural Science Foundation of China (NSFC) [41201036, 41330529]; Key Laboratory of Land Surface Process and Climate Change in Cold and Arid Regions [LPCC201203]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Laboratory of Land Surface Process and Climate Change in Cold and Arid Regions	The Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDB03030202), the National Natural Science Foundation of China (NSFC) (No. 41201036 and 41330529), and the Opening Fund of Key Laboratory of Land Surface Process and Climate Change in Cold and Arid Regions (No. LPCC201203) provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniadis A., 2001, J STAT SOFTW, V6, P1, DOI [10.18637/jss.v006.i06, DOI 10.18637/JSS.V006.I06]; Biemans H, 2009, J HYDROMETEOROL, V10, P1011, DOI 10.1175/2008JHM1067.1; Bormann H, 2008, J HYDROL, V351, P154, DOI 10.1016/j.jhydrol.2007.12.011; Bruni V, 2006, SIGNAL PROCESS, V86, P859, DOI 10.1016/j.sigpro.2005.06.017; Chanerley AA, 2007, COMPUT STRUCT, V85, P1679, DOI 10.1016/j.compstruc.2007.02.025; Danbechins I, 1992, 10 LECT WAVELETS; Ding J., 1988, STOCHASTIC HYDROLOGY; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Elshorbagy A, 2002, J HYDROL, V256, P147, DOI 10.1016/S0022-1694(01)00534-0; Garfias-Soliz J, 2010, HYDROL PROCESS, V24, P300, DOI 10.1002/hyp.7487; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jansen M, 2006, IEEE SIGNAL PROC LET, V13, P296, DOI 10.1109/LSP.2006.870355; Jayawardena AW, 2000, J HYDROL, V228, P242, DOI 10.1016/S0022-1694(00)00142-6; Koutsoyiannis D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005592; Labat D, 2000, J HYDROL, V238, P149, DOI 10.1016/S0022-1694(00)00322-X; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; MASRY E, 1993, IEEE T INFORM THEORY, V39, P260, DOI 10.1109/18.179371; Montanari A, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002540; Ravines RR, 2008, J HYDROL, V353, P189, DOI 10.1016/j.jhydrol.2008.02.008; Sang YF, 2013, WATER RESOUR MANAG, V27, P2807, DOI 10.1007/s11269-013-0316-1; Sang YF, 2011, IAHS-AISH P, V350, P622; Sang YF, 2012, WATER RESOUR MANAG, V26, P3345, DOI 10.1007/s11269-012-0075-4; Sang YF, 2010, ENTROPY-SWITZ, V12, P1499, DOI 10.3390/e12061499; Sang YF, 2009, ENTROPY-SWITZ, V11, P1123, DOI 10.3390/e11041123; SCHREIBER T, 1993, PHYS REV E, V47, P2401, DOI 10.1103/PhysRevE.47.2401; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Walker J.S., 1999, ST ADV MATH; WORNELL GW, 1993, P IEEE, V81, P1428, DOI 10.1109/5.241506; Yevjevich V., 1972, STOCHASTIC PROCESS H	30	6	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110733	10.1371/journal.pone.0110733	http://dx.doi.org/10.1371/journal.pone.0110733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360533	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700042
J	Zarei, S; Mirtar, A; Rohwer, F; Salamon, P				Zarei, Sara; Mirtar, Ali; Rohwer, Forest; Salamon, Peter			Stochastic Tracking of Infection in a CF Lung	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; CYSTIC-FIBROSIS; INFLAMMATION; MRI	Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scan are the two ubiquitous imaging sources that physicians use to diagnose patients with Cystic Fibrosis (CF) or any other Chronic Obstructive Pulmonary Disease (COPD). Unfortunately the cost constraints limit the frequent usage of these medical imaging procedures. In addition, even though both CT scan and MRI provide mesoscopic details of a lung, in order to obtain microscopic information a very high resolution is required. Neither MRI nor CT scans provide micro level information about the location of infection in a binary tree structure the binary tree structure of the human lung. In this paper we present an algorithm that enhances the current imaging results by providing estimated micro level information concerning the location of the infection. The estimate is based on a calculation of the distribution of possible mucus blockages consistent with available information using an offline Metropolis-Hastings algorithm in combination with a real-time interpolation scheme. When supplemented with growth rates for the pockets of mucus, the algorithm can also be used to estimate how lung functionality as manifested in spirometric tests will change in patients with CF or COPD.	[Zarei, Sara] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Mirtar, Ali] Univ Calif San Diego, Dept Elect & Comp Eng, San Diego, CA 92103 USA; [Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Salamon, Peter] San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA	California State University System; San Diego State University; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University	Zarei, S (corresponding author), San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA.	sara.zarei@alumni.ucsd.edu	Rohwer, Forest/AAC-5315-2019	Rohwer, Forest/0000-0003-1548-5429	National Institutes of Health [56586B]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This material is based upon work supported by the National Institutes of Health under Grant no. 56586B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2005, J APPL PHYSIOL, V98, P850, DOI 10.1152/japplphysiol.00801.2004; Eichinger M, 2006, RADIOLOGE, V46, P275, DOI 10.1007/s00117-005-1308-9; FIEL SB, 1987, CHEST, V91, P181, DOI 10.1378/chest.91.2.181; Glenny RW, 2000, J APPL PHYSIOL, V89, P742, DOI 10.1152/jappl.2000.89.2.742; Hopkins SR, 2007, J APPL PHYSIOL, V102, P1244, DOI 10.1152/japplphysiol.00738.2006; Kitaoka H, 1997, J APPL PHYSIOL, V82, P968, DOI 10.1152/jappl.1997.82.3.968; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Lim YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064285; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; Marieb EN, 2010, HUMAN ANATOMY PHYSL; McPhail GL, 2013, DRUG TODAY, V49, P253, DOI 10.1358/dot.2013.49.4.1940984; Richey M, 2010, AM MATH MON, V117, P383, DOI 10.4169/000298910X485923; Saeta PN, 2004, METROPOLIS ALGORITHM; Salamon P, 2002, FACTS CONJECTURE IMP; Theilmann RJ, 2009, J MAGN RESON IMAGING, V30, P527, DOI 10.1002/jmri.21866; Tirouvanziam R, 2006, DRUG NEWS PERSPECT, V19, P609, DOI 10.1358/dnp.2006.19.10.1068008; Voit EO, 2014, BBA-PROTEINS PROTEOM, V1844, P258, DOI 10.1016/j.bbapap.2013.03.023; Weibel ER, 1991, LUNG SCI FDN, V1, P1061; WEST BJ, 1990, ANN BIOMED ENG, V18, P135, DOI 10.1007/BF02368426; Whiteson KL, 2014, ISME J; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Zarei S, 2012, J COMP MATH METH MED; Zarei S, 2013, J NON-EQUIL THERMODY, V38, P119, DOI 10.1515/jnetdy-2012-0019	25	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111245	10.1371/journal.pone.0111245	http://dx.doi.org/10.1371/journal.pone.0111245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360611	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700078
J	Zicari, AM; Duse, M; Occasi, F; Luzzi, V; Ortolani, E; Bardanzellu, F; Bertin, S; Polimeni, A				Zicari, Anna Maria; Duse, Marzia; Occasi, Francesca; Luzzi, Valeria; Ortolani, Emanuela; Bardanzellu, Flaminia; Bertin, Serena; Polimeni, Antonella			Cephalometric Pattern and Nasal Patency in Children with Primary Snoring: The Evidence of a Direct Correlation	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; DENTOFACIAL MORPHOLOGY; DIMENSIONS; ADENOIDS; SENSITIVITY; INFANCY; HISTORY; TONSILS; GROWTH; AIRWAY	Introduction: Sleep disordered breathing (SDB) might affect craniofacial growth and children with obstructive sleep apnea syndrome present an increase in total and lower anterior heights of the face and a more anterior and inferior position of the hyoid bone when compared to nasal breathers. Objective: To investigate the correlation between rhinomanometric and cephalometric parameters in children with primary snoring (PS), without apnea or gas exchange abnormalities. Materials and Methods: Thirty children with habitual snoring (16 females and 14 males) aged 4-8 years (mean age 6.85 +/- 1.51 years) were selected by a SDB validate questionnaire. All subjects underwent lateral cephalometric, panoramic radiographies. Results: In our sample 10 children (33%) had snoring 3 nights/week, 11 (37%) 4-6 nights/week and 9 (30%) every night/week. Overall 7 patients (23.3%) were affected by adenoid hypertrophy (AH), 4 (13.3%) by tonsillar hypertrophy (TH) and 13 (43.3%) by AH and TH. We found a more vertical position of the hyoid bone to the mandibular plane (HHVT) in patients with a higher frequency (7.3 +/- 2.7 vs 7.6 +/- 3.7 vs 10.9 +/- 2.5 in children snoring 3 nights/week, 4-6 nights/week and every night/week respectively; p = 0.032). Concerning nasal patency significant correlations were found with ANB (maxillary and jaw position with respect to the cranial base), (NSAr)-Ar-boolean AND (growth predictor), sumangle, FMA (total divergence), SnaSnp(boolean AND)GoMe (inferior divergence), BaN(boolean AND)PtGn (facial growth pattern), Phw1_PsP (posterosuperior airway space), AHC3H (the horizontal distance between the most anterosuperior point of the hyoid bone and the third cervical vertebra). Conclusion: The present study supports the relationship between nasal obstruction and specific craniofacial characteristics in children with primary snoring and lead us to hypothesize that nasal obstruction might explain the indirect link between snoring and cephalometric alterations.	[Zicari, Anna Maria; Duse, Marzia; Occasi, Francesca; Bardanzellu, Flaminia] Univ Roma La Sapienza, Dept Pediat, I-00185 Rome, Italy; [Luzzi, Valeria; Polimeni, Antonella] Univ Roma La Sapienza, Dept Oral & Maxillofacial Sci, I-00185 Rome, Italy; [Ortolani, Emanuela] George Eastman Odontoiatr Hosp, Rome, Italy; [Bertin, Serena] Univ Roma La Sapienza, Dept Pediat Otorhinolaryngol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Occasi, F (corresponding author), Univ Roma La Sapienza, Dept Pediat, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	occasi.f@gmail.com	ZICARI, Anna Maria/K-7921-2018	ZICARI, Anna Maria/0000-0002-2476-1790				Akpinar ME, 2011, EUR ARCH OTO-RHINO-L, V268, P1053, DOI 10.1007/s00405-010-1448-z; Balasubramanian S, 2004, J IND ORTHOD SOC, V37, P89; BRODSKY L, 1987, INT J PEDIATR OTORHI, V13, P149, DOI 10.1016/0165-5876(87)90091-7; BROUILETTE R, 1984, J PEDIATR-US, V105, P10, DOI 10.1016/S0022-3476(84)80348-0; Brouillette RT, 2000, PEDIATRICS, V105, P405, DOI 10.1542/peds.105.2.405; CARROLL JL, 1995, CHEST, V108, P610, DOI 10.1378/chest.108.3.610; Cassano P, 2003, INT J PEDIATR OTORHI, V67, P1303, DOI 10.1016/j.ijporl.2003.07.018; CHENG MC, 1988, ANGLE ORTHOD, V58, P309; Clement P A, 1984, Rhinology, V22, P151; Franco LP, 2013, AM J ORTHOD DENTOFAC, V144, P341, DOI 10.1016/j.ajodo.2013.03.025; Frasson Jussara Marinho Dias, 2006, Braz J Otorhinolaryngol, V72, P72; Harari D, 2010, LARYNGOSCOPE, V120, P2089, DOI 10.1002/lary.20991; Kulnis R, 2000, CHEST, V118, P596, DOI 10.1378/chest.118.3.596; Linder-Aronson S, 1970, Acta Otolaryngol Suppl, V265, P1; Nixon GM, 2004, PEDIATRICS, V113, pE19, DOI 10.1542/peds.113.1.e19; ORYAN FS, 1982, AM J ORTHOD DENTOFAC, V82, P403, DOI 10.1016/0002-9416(82)90189-0; Piteo AM, 2011, SLEEP MED, V12, P787, DOI 10.1016/j.sleep.2011.01.019; PRACHARKTAM N, 1994, ANGLE ORTHOD, V64, P63; Rizzi M, 2002, INT J PEDIATR OTORHI, V65, P7, DOI 10.1016/S0165-5876(02)00119-2; Sin S, 2014, LARYNGOSCOP IN PRESS; SORENSEN H, 1980, ACTA OTO-LARYNGOL, V89, P227, DOI 10.3109/00016488009127132; SUBTELNY JD, 1975, ANN OTO RHINOL LARYN, V84, P50; Trotman CA, 1997, ANGLE ORTHOD, V67, P425; Urschitz MS, 2004, CHEST, V126, P790, DOI 10.1378/chest.126.3.790; VANASPEREN PP, 1984, J ALLERGY CLIN IMMUN, V73, P381, DOI 10.1016/0091-6749(84)90412-3; Vieira BB, 2012, INT J PEDIATR OTORHI, V76, P1140, DOI 10.1016/j.ijporl.2012.04.019; Vig KWL, 1998, AM J ORTHOD DENTOFAC, V113, P603, DOI 10.1016/S0889-5406(98)70219-7; VIG PS, 1991, AM J ORTHOD DENTOFAC, V99, P354, DOI 10.1016/0889-5406(91)70018-R; Zapletal A, 2002, PEDIATR PULM, V33, P174, DOI 10.1002/ppul.10066	29	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111675	10.1371/journal.pone.0111675	http://dx.doi.org/10.1371/journal.pone.0111675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360610	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700141
J	Colombo, M; Priori, D; Trevisi, P; Bosi, P				Colombo, Michela; Priori, Davide; Trevisi, Paolo; Bosi, Paolo			Differential Gene Expression in the Oxyntic and Pyloric Mucosa of the Young Pig	PLOS ONE			English	Article							H+-K+-ATPASE; AE2 CL-/HCO3-EXCHANGER; ACID-SECRETION; CELLS; PROTEIN; CHANNEL; TRANSLOCATION; MICE; RNA	The stomach is often considered a single compartment, although morphological differences among specific areas are well known. Oxyntic mucosa (OXY) and pyloric mucosa (PYL, in other species called antral mucosa) are primarily equipped for acid secretion and gastrin production, respectively, while it is not yet clear how the remainder of genes expressed differs in these areas. Here, the differential gene expression between OXY and PYL mucosa was assessed in seven starter pigs. Total RNA expression was analyzed by whole genome Affymetrix Porcine Gene 1.1_ST array strips. Exploratory functional analysis of gene expression values was done by Gene Set Enrichment Analysis, comparing OXY and PYL. Normalized enrichment scores (NESs) were calculated for each gene (statistical significance defined when False Discovery Rate % < 25 and P-values of NES<0.05). Expression values were selected for a set of 44 genes and the effect of point of gastric sample was tested by analysis of variance with the procedure for repeated measures. In OXY, HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY gene set was the most enriched set compared to PYL, including the two genes for H+/K+-ATPase. Pathways related to mitochondrial activity and feeding behavior were also enriched (primarily cholecystokinin receptors and ghrelin). Aquaporin 4 was the top-ranking gene. In PYL, two gene sets were enriched compared with OXY: LYMPHOCYTE ACTIVATION and LIPID RAFT, a gene set involved in cholesterol-rich microdomains of the plasma membrane. The single most differentially expressed genes were gastrin and secretoglobin 1A, member 1, presumably located in the epithelial line, to inactivate inflammatory mediators. Several genes related to mucosal integrity, immune response, detoxification and epithelium renewal were also enriched in PYL (P<0.05). The data indicate that there is significant differential gene expression between OXY of the young pig and PYL and further functional studies are needed to confirm their physiological importance.	[Colombo, Michela; Priori, Davide; Trevisi, Paolo; Bosi, Paolo] Univ Bologna, Dipartimento Sci & Tecnol Agroalimentari, Bologna, Italy	University of Bologna	Bosi, P (corresponding author), Univ Bologna, Dipartimento Sci & Tecnol Agroalimentari, Bologna, Italy.	paolo.bosi@unibo.it		TREVISI, PAOLO/0000-0001-7019-6828	European Union [227549]	European Union(European Commission)	Research funded by the European Union (Interplay project, Grant agreement no. 227549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bosi P, 2006, J NUTR, V136, P1229, DOI 10.1093/jn/136.5.1229; Broeckaert F, 2000, ANN NY ACAD SCI, V923, P68; Chu SJ, 2012, CURR OPIN GASTROEN, V28, P587, DOI 10.1097/MOG.0b013e328358e5cc; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Da Costa LA, 2012, ANN NUTR METAB, V60, P27, DOI 10.1159/000337311; Du GM, 2007, RES VET SCI, V82, P99, DOI 10.1016/j.rvsc.2006.06.004; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Gawenis LR, 2010, AM J PHYSIOL-GASTR L, V298, pG493, DOI 10.1152/ajpgi.00178.2009; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Goebel M, 2011, PHYSIOL GENOMICS, V43, P237, DOI 10.1152/physiolgenomics.00193.2010; He WJ, 2011, AM J PHYSIOL-GASTR L, V301, pG591, DOI 10.1152/ajpgi.00460.2010; Hoffmann W, 2012, CURR MED CHEM, V19, P5975; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; LAMBRECHT N, 1993, GASTROENTEROLOGY, V104, P1371, DOI 10.1016/0016-5085(93)90345-D; Lambrecht NWG, 2005, PHYSIOL GENOMICS, V21, P81, DOI 10.1152/physiolgenomics.00212.2004; Ma L, 2000, LIFE SCI, V66, pPL213; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; Mazzoni M, 2008, J NUTR, V138, P1426, DOI 10.1093/jn/138.8.1426; Mukherjee A B, 1988, Adv Exp Med Biol, V231, P135; Nguyen N, 2013, AM J PHYSIOL-GASTR L, V304, pG157, DOI 10.1152/ajpgi.00346.2012; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Ohno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050381; PATEL S, 1993, GUT, V34, P893, DOI 10.1136/gut.34.7.893; Puccinelli E, 2011, CURR DRUG METAB, V12, P507; Rao R, 2004, CYTOKINE GROWTH F R, V15, P103, DOI 10.1016/j.cytogfr.2004.01.003; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; San Roman AK, 2011, EXP CELL RES, V317, P2711, DOI 10.1016/j.yexcr.2011.07.011; Shi ZM, 2005, WORLD J GASTROENTERO, V11, P6707, DOI 10.3748/wjg.v11.i42.6707; Surls J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038733; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Wang J, 2011, MOL CELL PROTEOMICS, V10; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yuan Y, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099952	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111447	10.1371/journal.pone.0111447	http://dx.doi.org/10.1371/journal.pone.0111447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357124	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000062
J	Kudo, H; Wada, H; Sasaki, H; Tsuji, H; Otsuka, R; Baghdadi, M; Kojo, S; Chikaraishi, T; Seino, K				Kudo, Hiroya; Wada, Haruka; Sasaki, Hajime; Tsuji, Hyuma; Otsuka, Ryo; Baghdadi, Muhammad; Kojo, Satoshi; Chikaraishi, Tatsuya; Seino, Ken-ichiro			Induction of Macrophage-Like Immunosuppressive Cells from Mouse ES Cells That Contribute to Prolong Allogeneic Graft Survival	PLOS ONE			English	Article							MISMATCHED RENAL-TRANSPLANTATION; PLURIPOTENT STEM-CELLS; DENDRITIC CELLS; T-CELLS; MAINTENANCE IMMUNOSUPPRESSION; ACTIVATION; TOLERANCE; DIFFERENTIATION; GENERATION; COSTIMULATION	Recent progress in regenerative medicine has enabled the utilization of pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) as a donor resource for transplantation. However, immune suppression is still needed when the donor-recipient combination is allogeneic. Protection of ESCs-derived grafts from host immune response might be achieved thought the utilization of immunosuppressive cells generated from ESCs. In the present study, we show that a certain fraction of immunosuppressive cells can be generated from ESCs and help to suppress immune response against allogeneic grafts. ESCs-derived suppressor cells (ES-SCs) resembled macrophages in terms of cell surface molecule and gene expressions. Furthermore, gene expression analysis including microarray showed that ES-SCs have M1/M2 hybrid phenotype with high expression of genes correlated to immunosuppression of T cell response. Indeed, ES-SCs were effective to block allogeneic T cell proliferation in a nitric oxide-dependent manner, and prolonged the survival of ESCs-derived embryoid bodies or cardiomyocytes grafts transplanted into mouse kidney capsule. Thus, we consider the potential use of these ESCs-derived macrophage-like immunosuppressive cells as cellular therapies to promote long-term graft survival in future therapies.	[Kudo, Hiroya; Wada, Haruka; Sasaki, Hajime; Tsuji, Hyuma; Otsuka, Ryo; Baghdadi, Muhammad; Kojo, Satoshi; Seino, Ken-ichiro] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan; [Kudo, Hiroya; Chikaraishi, Tatsuya] St Marianna Univ, Sch Med, Dept Urol, Miyamae Ku, Kawasaki, Kanagawa, Japan	Hokkaido University; Saint Marianna University	Seino, K (corresponding author), Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan.	seino@igm.hokudai.ac.jp	Kojo, Satoshi/N-7135-2018	Kojo, Satoshi/0000-0002-9263-8831; Otsuka, Ryo/0000-0002-3730-9867; Baghdadi, Muhammad/0000-0002-2347-8889	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [26640066] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HW and KS. This work was also supported in part by the Uehara Memorial Foundation to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SI, 2008, NEW ENGL J MED, V358, P369, DOI 10.1056/NEJMoa0707255; Bashuda H, 2005, J CLIN INVEST, V115, P1896, DOI 10.1172/JCI23743; Brem-Exner BG, 2008, J IMMUNOL, V180, P335, DOI 10.4049/jimmunol.180.1.335; Cyranoski D, 2012, NATURE, V488, P139, DOI 10.1038/488139a; DENIS M, 1994, J LEUKOCYTE BIOL, V55, P682, DOI 10.1002/jlb.55.5.682; Dreymueller D, 2013, WOUND REPAIR REGEN, V21, P44, DOI 10.1111/j.1524-475X.2012.00858.x; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Kawai T, 2013, NEW ENGL J MED, V368, P1850, DOI 10.1056/NEJMc1213779; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pilat N, 2012, CURR OPIN ORGAN TRAN, V17, P368, DOI 10.1097/MOT.0b013e328355fc94; Riquelme P, 2013, MOL THER, V21, P409, DOI 10.1038/mt.2012.168; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scandling JD, 2008, NEW ENGL J MED, V358, P362, DOI 10.1056/NEJMoa074191; Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2254; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wada H, 2011, INT IMMUNOL, V23, P65, DOI 10.1093/intimm/dxq458; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111826	10.1371/journal.pone.0111826	http://dx.doi.org/10.1371/journal.pone.0111826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356669	Green Published, gold			2022-12-27	WOS:000346765000080
J	Gorriz, JM; Ramirez, J; Olivares, A; Padilla, P; Puntonet, CG; Canton, M; Laguna, P				Manuel Gorriz, Juan; Ramirez, Javier; Olivares, Alberto; Padilla, Pablo; Puntonet, Carlos G.; Canton, Manuel; Laguna, Pablo			Real Time QRS Detection Based on M-ary Likelihood Ratio Test on the DFT Coefficients	PLOS ONE			English	Article							VOICE ACTIVITY DETECTION; SPEECH RECOGNITION; TRANSFORM; FILTER; MODEL	This paper shows an adaptive statistical test for QRS detection of electrocardiography (ECG) signals. The method is based on a M-ary generalized likelihood ratio test (LRT) defined over a multiple observation window in the Fourier domain. The motivations for proposing another detection algorithm based on maximum a posteriori (MAP) estimation are found in the high complexity of the signal model proposed in previous approaches which i) makes them computationally unfeasible or not intended for real time applications such as intensive care monitoring and (ii) in which the parameter selection conditions the overall performance. In this sense, we propose an alternative model based on the independent Gaussian properties of the Discrete Fourier Transform (DFT) coefficients, which allows to define a simplified MAP probability function. In addition, the proposed approach defines an adaptive MAP statistical test in which a global hypothesis is defined on particular hypotheses of the multiple observation window. In this sense, the observation interval is modeled as a discontinuous transmission discrete-time stochastic process avoiding the inclusion of parameters that constraint the morphology of the QRS complexes.	[Manuel Gorriz, Juan; Ramirez, Javier; Olivares, Alberto; Padilla, Pablo] Univ Granada, CITIC, Dept Signal Theory Telemat & Commun, Granada, Spain; [Puntonet, Carlos G.] Univ Granada, CITIC, Dept Comp Architecture & Comp Technol, Granada, Spain; [Canton, Manuel] Univ Almeria, Dept Informat, Almeria, Spain; [Laguna, Pablo] Univ Zaragoza, Dept Elect Engn & Commun, Zaragoza, Spain	University of Granada; University of Granada; Universidad de Almeria; University of Zaragoza	Gorriz, JM (corresponding author), Univ Granada, CITIC, Dept Signal Theory Telemat & Commun, Granada, Spain.	gorriz@ugr.es	CANTÓN-GARBÍN, MANUEL/Q-1819-2015; Ramírez, Javier/B-1836-2012; laguna, Pablo/I-6669-2013; Padilla, Pablo/E-1010-2012; Gorriz, Juan Manuel/C-2385-2012	CANTÓN-GARBÍN, MANUEL/0000-0002-7034-2503; Ramírez, Javier/0000-0002-6229-2921; laguna, Pablo/0000-0003-3434-9254; Padilla, Pablo/0000-0002-4874-6106; Gorriz, Juan Manuel/0000-0001-7069-1714	Spanish government [TEC2012 34306]; Andalusian government [P09-TIC-4530, P11-TIC-7103]	Spanish government(Spanish GovernmentEuropean Commission); Andalusian government	This work has received research funding from the Spanish government (www.micinn.es) under project TEC2012 34306 (DiagnoSIS, Diagnosis by means of Statistical Intelligent Systems, 70K(sic)) and projects P09-TIC-4530 (300K(sic)) and P11-TIC-7103 (156K(sic)) from the Andalusian government (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMI, 1998, EC57293 AM NAT STAND; Afonso VX, 1999, IEEE T BIO-MED ENG, V46, P192, DOI 10.1109/10.740882; Agarwal Anshu, 1999, P IEEE WORKSH AUT SP, P12; Association for the Advancement of Medical Instrumentation, 2002, CARD MON HEART RAT M, P1; Bayes De Luna A, 2012, CLIN ELECT TXB; BORJESSON PO, 1982, IEEE T BIO-MED ENG, V29, P341, DOI 10.1109/TBME.1982.324901; COAST DA, 1990, IEEE T BIO-MED ENG, V37, P826, DOI 10.1109/10.58593; EPHRAIM Y, 1984, IEEE T ACOUST SPEECH, V32, P1109, DOI 10.1109/TASSP.1984.1164453; Goldberger AL, 1984, CIRCULATION, V23, P215; Gorriz JM, 2006, J ACOUST SOC AM, V120, P470, DOI 10.1121/1.2208450; HAMILTON PS, 1986, IEEE T BIO-MED ENG, V33, P1157, DOI 10.1109/TBME.1986.325695; Kadambe S, 1999, IEEE T BIO-MED ENG, V46, P838, DOI 10.1109/10.771194; Kohler BU, 2002, IEEE ENG MED BIOL, V21, P42, DOI 10.1109/51.993193; Gorriz JM, 2008, IEEE T AUDIO SPEECH, V16, P1565, DOI 10.1109/TASL.2008.2004293; MCAULAY RJ, 1980, IEEE T ACOUST SPEECH, V28, P137, DOI 10.1109/TASSP.1980.1163394; McSharry PE, 2003, IEEE T BIO-MED ENG, V50, P289, DOI 10.1109/TBME.2003.808805; MEYER CR, 1977, COMPUT BIOMED RES, V10, P459, DOI 10.1016/0010-4809(77)90021-0; Nallathambi G, 2014, IEEE T BIO-MED ENG, V61, P317, DOI 10.1109/TBME.2013.2282954; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; PEARLMAN WA, 1978, IEEE T INFORM THEORY, V24, P683, DOI 10.1109/TIT.1978.1055950; POLI R, 1995, IEEE T BIO-MED ENG, V42, P1137, DOI 10.1109/10.469381; Ramirez J, 2004, SPEECH COMMUN, V42, P271, DOI 10.1016/j.specom.2003.10.002; Ramirez J, 2007, IEEE T AUDIO SPEECH, V15, P2177, DOI 10.1109/TASL.2007.903937; SORNMO L, 1985, IEEE T BIO-MED ENG, V32, P392, DOI 10.1109/TBME.1985.325465; THAKOR NV, 1991, IEEE T BIO-MED ENG, V38, P785, DOI 10.1109/10.83591; Vecht R, 2009, ECG DIAGNOSIS CLIN P, P177; Vijaya G, 1998, J MED ENG TECHNOLOGY	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110629	10.1371/journal.pone.0110629	http://dx.doi.org/10.1371/journal.pone.0110629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356628	Green Published, gold			2022-12-27	WOS:000346765000019
J	Yermalovich, MA; Semeiko, GV; Samoilovich, EO; Svirchevskaya, EY; Muller, CP; Hubschen, JM				Yermalovich, Marina A.; Semeiko, Galina V.; Samoilovich, Elena O.; Svirchevskaya, Ekaterina Y.; Muller, Claude P.; Huebschen, Judith M.			Etiology of Maculopapular Rash in Measles and Rubella Suspected Patients from Belarus	PLOS ONE			English	Article							HUMAN PARVOVIRUS B19; SURVEILLANCE; INFECTION; FEVER; ILLNESSES; CHILDREN	As a result of successful implementation of the measles/rubella elimination program, the etiology of more and more double negative cases remains elusive. The present study determined the role of different viruses as causative agents in measles or rubella suspected cases in Belarus. A total of 856 sera sent to the WHO National Laboratory between 2009 and 2011 were tested for specific IgM antibodies to measles virus (MV), rubella virus (RV) and human parvovirus B19 (B19V). The negatives were further investigated for antibodies to enterovirus (EV) and adenovirus (AdV). Children of up to 3 years were tested for IgM antibodies to human herpesvirus 6 (HHV6). A viral etiology was identified in 451 (52.7%) cases, with 6.1% of the samples being positive for MV; 2.6% for RV; 26.2% for B19V; 9.7% for EV; 4.6% for AdV; and 3.6% for HHV6. Almost all measles and rubella cases occurred during limited outbreaks in 2011 and nearly all patients were at least 15 years old. B19V, EV and AdV infections were prevalent both in children and adults and were found throughout the 3 years. B19V occurred mainly in 3-10 years old children and 20-29 years old adults. EV infection was most common in children up to 6 years of age and AdV was confirmed mainly in 3-6 years old children. HHV6 infection was mostly detected in 6-11 months old infants. Laboratory investigation of measles/rubella suspected cases also for B19V, EV, AdV and HHV6 allows diagnosing more than half of all cases, thus strengthening rash/fever disease surveillance in Belarus.	[Yermalovich, Marina A.; Semeiko, Galina V.; Samoilovich, Elena O.; Svirchevskaya, Ekaterina Y.] Republican Res & Pract Ctr Epidemiol & Microbiol, Minsk, BELARUS; [Muller, Claude P.; Huebschen, Judith M.] Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, Luxembourg, Luxembourg	Luxembourg Institute of Health	Yermalovich, MA (corresponding author), Republican Res & Pract Ctr Epidemiol & Microbiol, Minsk, BELARUS.	yermalovich@mail.ru	Hübschen, Judith/AAF-5113-2020; Hübschen, Judith/ABA-7931-2021	Hübschen, Judith/0000-0002-5001-2128	Ministry of Cooperation; Centre de Recherche Public de la Sante in Luxembourg	Ministry of Cooperation; Centre de Recherche Public de la Sante in Luxembourg	The authors wish to thank the Ministry of Cooperation and the Centre de Recherche Public de la Sante in Luxembourg for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidkin I, 1998, J INFECT DIS, V178, P1567, DOI 10.1086/314513; de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490; Vianna RAD, 2008, PEDIATR INFECT DIS J, V27, P533, DOI 10.1097/INF.0b013e3181673c50; El-Mahallawy Hadir A, 2005, J Egypt Natl Canc Inst, V17, P121; Irons B, 2011, J INFECT DIS, V204, pS622, DOI 10.1093/infdis/jir437; Kramkimel N, 2010, J EUR ACAD DERMATOL, V24, P1468, DOI 10.1111/j.1468-3083.2010.03672.x; Mankertz A, 2011, EMERG INFECT DIS, V17, P1396, DOI 10.3201/eid1708.101994; Pedranti MS, 2012, EPIDEMIOL INFECT, V140, P454, DOI 10.1017/S0950268811000823; Ramsay M, 2002, ARCH DIS CHILD, V87, P202, DOI 10.1136/adc.87.3.202; Samoilovich EO, 2011, ZDRAVOOKHRANENIE, V12, P32; Samoilovich EO, 2012, ZH MIKROBIOL EPIDEMI, V1, P21; Siennicka Joanna, 2011, Przegl Epidemiol, V65, P39; Velicko I, 2008, VACCINE, V26, P6980, DOI 10.1016/j.vaccine.2008.09.012; Wananukul S, 2003, ASIAN PAC J ALLERGY, V21, P217; Wang YHJ, 2007, EPIDEMIOL INFECT, V135, P1363, DOI 10.1017/S095026880700828X; WHO, 2012, SURV GUID MEASL RUB; World Health Organization (WHO), 2014, RUB REP CAS; Yermalovich MA, 2012, J MED VIROL, V84, P973, DOI 10.1002/jmv.23294; Zaki MES, 2008, CURR MICROBIOL, V56, P105, DOI 10.1007/s00284-007-9054-z; Zhang Hui, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P686	20	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111541	10.1371/journal.pone.0111541	http://dx.doi.org/10.1371/journal.pone.0111541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356680	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000068
J	Bouet-Cararo, C; Contreras, V; Caruso, A; Top, S; Szelechowski, M; Bergeron, C; Viarouge, C; Desprat, A; Relmy, A; Guibert, JM; Dubois, E; Thiery, R; Breard, E; Bertagnoli, S; Richardson, J; Foucras, G; Meyer, G; Schwartz-Cornil, I; Zientara, S; Klonjkowski, B				Bouet-Cararo, Coraline; Contreras, Vanessa; Caruso, Agathe; Top, Sokunthea; Szelechowski, Marion; Bergeron, Corinne; Viarouge, Cyril; Desprat, Alexandra; Relmy, Anthony; Guibert, Jean-Michel; Dubois, Eric; Thiery, Richard; Breard, Emmanuel; Bertagnoli, Stephane; Richardson, Jennifer; Foucras, Gilles; Meyer, Gilles; Schwartz-Cornil, Isabelle; Zientara, Stephan; Klonjkowski, Bernard			Expression of VP7, a Bluetongue Virus Group Specific Antigen by Viral Vectors: Analysis of the Induced Immune Responses and Evaluation of Protective Potential in Sheep	PLOS ONE			English	Article							SMALL RUMINANTS; CORE PROTEIN; VACCINE; CHALLENGE; INFECTION; CELLS; EFFICACY; GENOME; STRAIN	Bluetongue virus (BTV) is an economically important Orbivirus transmitted by biting midges to domestic and wild ruminants. The need for new vaccines has been highlighted by the occurrence of repeated outbreaks caused by different BTV serotypes since 1998. The major group-reactive antigen of BTV, VP7, is conserved in the 26 serotypes described so far, and its role in the induction of protective immunity has been proposed. Viral-based vectors as antigen delivery systems display considerable promise as veterinary vaccine candidates. In this paper we have evaluated the capacity of the BTV-2 serotype VP7 core protein expressed by either a non-replicative canine adenovirus type 2 (Cav-VP7 R-0) or a leporipoxvirus (SG33-VP7), to induce immune responses in sheep. Humoral responses were elicited against VP7 in almost all animals that received the recombinant vectors. Both Cav-VP7 R-0 and SG33-VP7 stimulated an antigen-specific CD4(+) response and Cav-VP7 R-0 stimulated substantial proliferation of antigen-specific CD8(+) lymphocytes. Encouraged by the results obtained with the Cav-VP7 R-0 vaccine vector, immunized animals were challenged with either the homologous BTV-2 or the heterologous BTV-8 serotype and viral burden in plasma was followed by real-time RT-PCR. The immune responses triggered by Cav-VP7 R-0 were insufficient to afford protective immunity against BTV infection, despite partial protection obtained against homologous challenge. This work underscores the need to further characterize the role of BTV proteins in cross-protective immunity.	[Bouet-Cararo, Coraline; Bergeron, Corinne; Viarouge, Cyril; Desprat, Alexandra; Relmy, Anthony; Breard, Emmanuel; Richardson, Jennifer; Zientara, Stephan; Klonjkowski, Bernard] UPE, ANSES, INRA, UMR ANSES INRA ENVA 1161, Maisons Alfort, France; [Contreras, Vanessa; Schwartz-Cornil, Isabelle] UR 892 INRA, Jouy En Josas, France; [Caruso, Agathe; Top, Sokunthea; Bertagnoli, Stephane; Foucras, Gilles; Meyer, Gilles] Univ Toulouse, INRA, IHAP, UMR1225,INP,ENVT, Toulouse, France; [Szelechowski, Marion] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, CNRS, INSERM, F-31062 Toulouse, France; [Guibert, Jean-Michel; Dubois, Eric] ANSES, Unite Pathol Petits Ruminants, Sophia Antipolis, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Klonjkowski, B (corresponding author), UPE, ANSES, INRA, UMR ANSES INRA ENVA 1161, Maisons Alfort, France.	bklonjkowski@vet-alfort.fr	Zientara, Stephan/AAA-7661-2021; FOUCRAS, Gilles/A-3061-2014; Klonjkowski, Bernard/N-7785-2019; breard, emmanuel/E-2123-2011; Zientara, Stephan/A-5336-2016; schwartz-cornil, isabelle/D-8547-2011; Szelechowski, Marion/X-7343-2019; Thiery, Richard/GRR-1496-2022	Zientara, Stephan/0000-0002-6733-8503; FOUCRAS, Gilles/0000-0002-0363-0337; Zientara, Stephan/0000-0003-0089-8175; Klonjkowski, Bernard/0000-0003-3372-0656; Thiery, Richard/0000-0003-2049-918X; Dubois, Eric/0000-0003-1035-2782; Richardson, Jennifer/0000-0002-4137-3984; Contreras, Vanessa/0000-0003-4072-9819; , Szelechowski/0000-0002-2929-7413	FP7 project ORBIVAC [245266]; UE Network of Excellence, EPIZONE [FOOD-CT-2006-016236]	FP7 project ORBIVAC; UE Network of Excellence, EPIZONE	This work was supported by the FP7 project ORBIVAC (contract N o. 245266) and the UE Network of Excellence, EPIZONE (Contract N o. FOOD-CT-2006-016236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Blanie S, 2009, VET RES, V40, DOI 10.1051/vetres:2008049; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Bouet-Cararo C, 2011, VACCINE, V29, P1304, DOI 10.1016/j.vaccine.2010.11.068; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Brun A, 2008, VACCINE, V26, P6508, DOI 10.1016/j.vaccine.2008.09.044; Calvo-Pinilla E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034735; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hamers C, 2009, VACCINE, V27, P2789, DOI 10.1016/j.vaccine.2009.02.099; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; Jabbar TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060574; Janardhana V, 1999, RES VET SCI, V67, P213, DOI 10.1053/rvsc.1999.0306; JEGGO MH, 1984, RES VET SCI, V36, P81, DOI 10.1016/S0034-5288(18)32007-1; JEGGO MH, 1984, IMMUNOLOGY, V52, P403; Kar AK, 2005, J VIROL, V79, P11487, DOI 10.1128/JVI.79.17.11487-11495.2005; Klonjkowski B, 2009, VACCINE, V27, P928, DOI 10.1016/j.vaccine.2008.11.086; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; MACLACHLAN N J, 1985, P79; Millar J, 2007, CELL IMMUNOL, V250, P55, DOI 10.1016/j.cellimm.2008.01.005; Murray PK, 1996, AUST VET J, V73, P207, DOI 10.1111/j.1751-0813.1996.tb10036.x; Perez de Diego AC, 2012, SCI WORLD J, V2012; Perrin A, 2007, VACCINE, V25, P6774, DOI 10.1016/j.vaccine.2007.06.052; Pignolet B, 2008, J GEN VIROL, V89, P1371, DOI 10.1099/vir.0.83595-0; Rojas JM, 2011, VACCINE, V29, P6848, DOI 10.1016/j.vaccine.2011.07.061; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Spiller OB, 2002, J GEN VIROL, V83, P45, DOI 10.1099/0022-1317-83-1-45; Stewart M, 2012, VACCINE, V30, P2131, DOI 10.1016/j.vaccine.2012.01.042; Szelechowski M, 2009, J GEN VIROL, V90, P1215, DOI 10.1099/vir.0.007773-0; TAKAMATSU H, 1989, IMMUNOLOGY, V66, P258; Top S, 2012, VACCINE, V30, P1609, DOI 10.1016/j.vaccine.2011.12.108; Tordo N, 2008, DEV BIOLOGICALS, V131, P467; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Umeshappa CS, 2010, VACCINE, V28, P2522, DOI 10.1016/j.vaccine.2010.01.039; Veronesi E, 2010, VACCINE, V28, P1397, DOI 10.1016/j.vaccine.2009.10.107; WadeEvans AM, 1996, VIROLOGY, V220, P227, DOI 10.1006/viro.1996.0306; Wilson WC, 2000, VIRUS RES, V67, P141, DOI 10.1016/S0168-1702(00)00138-6; Zientara S, 2002, VET REC, V150, P598, DOI 10.1136/vr.150.19.598	42	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111605	10.1371/journal.pone.0111605	http://dx.doi.org/10.1371/journal.pone.0111605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364822	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100086
J	Cabral, LG; Holland, B				Cabral, Larry G.; Holland, Brett			Courtship Song Does Not Increase the Rate of Adaptation to a Thermally Stressful Environment in a Drosophila melanogaster Laboratory Population	PLOS ONE			English	Article							REDUCING MUTATION LOAD; SEMINAL FLUID PROTEIN; SEXUAL SELECTION; EXPERIMENTAL REMOVAL; GENETIC QUALITY; CONFLICT; EVOLUTION; COSTS; INDICATOR; STRENGTH	Courtship song in D. melanogaster contributes substantially to male mating success through female selection. We used experimental evolution to test whether this display trait is maintained through adaptive female selection because it indicates heritable male quality for thermal stress tolerance. We used non-displaying, outbred populations of D. melanogaster (nub 1) mutants and measured their rate of adaptation to a new, thermally stressful environment, relative to wild-type control populations that retained courtship song. This design retains sexually selected conflict in both treatments. Thermal stress should select across genomes for newly beneficial alleles, increasing the available genetic and phenotypic variation and, therefore, the magnitude of female benefit derived from courtship song. Following introduction to the thermally stressful environment, net reproductive rate decreased 50% over four generations, and then increased 19% over the following 16 generations. There were no differences between the treatments. Possible explanations for these results are discussed.	[Cabral, Larry G.; Holland, Brett] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA	California State University System; California State University Sacramento	Cabral, LG (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	lgcabral@uci.edu			CSUS grants: Goethe Foundation Grants [100237, 100247]; Research and Creative Activities Grant [06-07-070]	CSUS grants: Goethe Foundation Grants; Research and Creative Activities Grant	This work was supported by CSUS grants: Goethe Foundation Grants (100237 and 100247), and Research and Creative Activities Grant (06-07-070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Almbro M, 2014, EVOLUTION, V68, P295, DOI 10.1111/evo.12238; Arbuthnott D, 2012, EVOLUTION, V66, P2127, DOI 10.1111/j.1558-5646.2012.01584.x; Arnqvist Goran, 2005, pUnpaginated; Ashburner M., 1989, DROSOPHILA LAB HDB; BASOLO AL, 1990, SCIENCE, V250, P808, DOI 10.1126/science.250.4982.808; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Cameron E, 2003, J EVOLUTION BIOL, V16, P1055, DOI 10.1046/j.1420-9101.2003.00584.x; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clark SCA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037351; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; David J. R., 1983, GENET BIOL DROSOPHIL, P107; EWING AW, 1964, ANIM BEHAV, V12, P316, DOI 10.1016/0003-3472(64)90018-1; Feder ME, 1997, FUNCT ECOL, V11, P90, DOI 10.1046/j.1365-2435.1997.00060.x; Firman RC, 2012, ECOL LETT, V15, P42, DOI 10.1111/j.1461-0248.2011.01706.x; Forsman A, 2006, EVOLUTION, V60, P2148, DOI 10.1111/j.0014-3820.2006.tb01852.x; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Friberg U, 2005, EVOLUTION, V59, P1540; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Holland B, 2002, EVOLUTION, V56, P721, DOI 10.1554/0014-3820(2002)056[0721:SSFTPA]2.0.CO;2; Hollis B, 2011, J EVOLUTION BIOL, V24, P1918, DOI 10.1111/j.1420-9101.2011.02323.x; Hollis B, 2009, EVOLUTION, V63, P324, DOI 10.1111/j.1558-5646.2008.00551.x; JAMES AC, 1995, J EVOLUTION BIOL, V8, P315, DOI 10.1046/j.1420-9101.1995.8030315.x; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Lew TA, 2005, EVOL ECOL RES, V7, P633; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Lung O, 2002, GENETICS, V160, P211; Martin OY, 2003, EVOLUTION, V57, P2765, DOI 10.1111/j.0014-3820.2003.tb01518.x; McGuigan K, 2011, EVOLUTION, V65, P2816, DOI 10.1111/j.1558-5646.2011.01346.x; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; NG M, 1995, DEVELOPMENT, V121, P589; Parker G.A., 1979, P123; PARTRIDGE L, 1980, NATURE, V283, P290, DOI 10.1038/283290a0; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; Perea D, 2013, MECH DEVELOP, V130, P467, DOI 10.1016/j.mod.2013.06.002; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Pischedda A, 2005, J EVOLUTION BIOL, V18, P1115, DOI 10.1111/j.1420-9101.2005.00915.x; Plesnar A, 2011, EVOL ECOL RES, V13, P209; Proulx SR, 1999, AM NAT, V154, P89, DOI 10.1086/303218; Radwan J, 2004, ECOL LETT, V7, P1149, DOI 10.1111/j.1461-0248.2004.00681.x; Radwan J, 2004, J EVOLUTION BIOL, V17, P94, DOI 10.1046/j.1420-9101.2003.00646.x; Rice WR, 2006, PHILOS T R SOC B, V361, P287, DOI 10.1098/rstb.2005.1787; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rundle HD, 2006, EVOLUTION, V60, P2218, DOI 10.1111/j.0014-3820.2006.tb01859.x; RYAN M.J., 1990, OXFORD SURV EVOL BIO, V7, P156; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; Sakaluk SK, 2006, AM NAT, V167, P94, DOI 10.1086/498279; Sharp NP, 2008, EVOLUTION, V62, P857, DOI 10.1111/j.1558-5646.2008.00333.x; Shorey HH, 1962, SCIENCE; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; SPIETH HERMAN T., 1952, BULL AMER MUS NAT HIST, V99, P395; Stewart AD, 2008, J EVOLUTION BIOL, V21, P1808, DOI 10.1111/j.1420-9101.2008.01593.x; Stewart AD, 2005, P ROY SOC B-BIOL SCI, V272, P2029, DOI 10.1098/rspb.2005.3182; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Talyn Becky, 2003, Drosophila Information Service, V86, P148; von Schilcher F., 1977, Behavior Genet, V7, P251; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; WHITE FN, 1982, PHYSIOL REV, V62, P40, DOI 10.1152/physrev.1982.62.1.40; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wigby S, 2004, EVOLUTION, V58, P1028; Williams G. C., 1966, P307; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; [No title captured]	76	1	1	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111148	10.1371/journal.pone.0111148	http://dx.doi.org/10.1371/journal.pone.0111148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365209	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100053
J	Coulibaly, M; Meda, N; Yonaba, C; Ouedraogo, S; Congo, M; Barry, M; Thio, E; Siribie, I; Koueta, F; Ye, D; Kam, L; Blanche, S; Van De Perre, P; Leroy, V				Coulibaly, Malik; Meda, Nicolas; Yonaba, Caroline; Ouedraogo, Sylvie; Congo, Malika; Barry, Mamoudou; Thio, Elisabeth; Siribie, Issa; Koueta, Fla; Ye, Diarra; Kam, Ludovic; Blanche, Stephane; Van De Perre, Phillipe; Leroy, Valeriane		MONOD Study Grp ANRS 12206	Missed Opportunities for Early Access to Care of HIV-Infected Infants in Burkina Faso	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; SERVICE UTILIZATION; COTE-DIVOIRE; AFRICA; MORTALITY; PREVENTION; DIAGNOSIS; PROGRAM; OUTCOMES	Objective: The World Health Organization (WHO) has recommended a universal antiretroviral therapy (ART) for all HIV-infected children before the age of two since 2010, but this implies an early identification of these infants. We described the Prevention of Mother-to-Child HIV Transmission (PMTCT) cascade, the staffing and the quality of infrastructures in pediatric HIV care facilities, in Ouagadougou, Burkina Faso. Methods: We conducted a cross-sectional survey in 2011 in all health care facilities involved in PMTCT and pediatric HIV care in Ouagadougou. We assessed them according to their coverage in pediatric HIV care and WHO standards, through a desk review of medical registers and a semi-structured questionnaire administered to health-care workers (HCW). Results: In 2011, there was no offer of care in primary health care facilities for HIV-infected children in Ouagadougou. Six district hospitals and two university hospitals provided pediatric HIV care. Among the 67 592 pregnant women attending antenatal clinics in 2011, 85.9% were tested for HIV. The prevalence of HIV was 1.8% (95% Confidence Interval: 1.7%-1.9%). Among the 1 064 HIV-infected pregnant women attending antenatal clinics, 41.4% received a mother-to-child HIV transmission prevention intervention. Among the HIV-exposed infants, 313 (29.4%) had an early infant HIV test, and 306 (97.8%) of these infants tested received their result within a four-month period. Among the 40 children initially tested HIV-infected, 33 (82.5%) were referred to a health care facility, 3 (9.0%) were false positive, and 27 (90.0%) were initiated on ART. Although health care facilities were adequately supplied with HIV drugs, they were hindered by operational challenges such as shortage of infrastructures, laboratory reagents, and trained HCW. Conclusions: The PMTCT cascade revealed bottle necks in PMTCT intervention and HIV early infant diagnosis. The staffing in HIV care and quality of health care infrastructures were also insufficient in 2011 in Ouagadougou.	[Coulibaly, Malik; Meda, Nicolas; Thio, Elisabeth; Siribie, Issa] Univ Ouagadougou, Site ANRS Burkina, Ctr Rech Int Sante, Projet MONOD ANRS 12206, Ouagadougou, Burkina Faso; [Meda, Nicolas] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Yonaba, Caroline; Kam, Ludovic] CHU Yalgado Ouedraogo, Serv Pediat, Ouagadougou, Burkina Faso; [Ouedraogo, Sylvie; Koueta, Fla; Ye, Diarra] CHU Charles Gaulle, Serv Pediat Med, Ouagadougou, Burkina Faso; [Congo, Malika] CHU Yalgado Ouedraogo, Lab Bacteriol Virol, Ouagadougou, Burkina Faso; [Barry, Mamoudou] CHU Charles Gaulle, Lab Serv, Ouagadougou, Burkina Faso; [Blanche, Stephane] Grp Hosp Necker Enfants Malades, Paris, France; [Van De Perre, Phillipe] Univ Montpellier I, INSERM, U1058, Montpellier, France; [Leroy, Valeriane] Univ Bordeaux, Inst Sante Publ Epidemiol & Dev ISPED, INSERM, U897, Bordeaux, France	Centre Muraz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Coulibaly, M (corresponding author), Univ Ouagadougou, Site ANRS Burkina, Ctr Rech Int Sante, Projet MONOD ANRS 12206, Ouagadougou, Burkina Faso.	coulmalik@yahoo.fr	Leroy, Valeriane/GQB-1102-2022; Van de Perre, Philippe/B-9692-2008; Leroy, Valeriane/F-8129-2013; Leroy, Valeriane/AAO-5175-2020; treluyer, Jean-Marc/F-8036-2010; Anglaret, Xavier/F-7333-2013; Urien, Saïk/G-3240-2013	Leroy, Valeriane/0000-0003-3542-8616; Van de Perre, Philippe/0000-0002-3912-0427; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Urien, Saïk/0000-0002-1065-0600; Odette, Ky-Zerbo/0000-0002-0018-1580; Moussa, OUEDRAOGO/0000-0002-3534-8301; Anglaret, Xavier/0000-0003-3319-8423; Seguin-Devaux, Carole/0000-0003-0636-5222	MONOD ANRS - European and Developing Countries Clinical Trial Partnership (EDCTP) [12206]; CRP-sante in Luxembourg; French ANRS-Inserm; MONOD consortium	MONOD ANRS - European and Developing Countries Clinical Trial Partnership (EDCTP); CRP-sante in Luxembourg; French ANRS-Inserm; MONOD consortium	The study was supported in part by the MONOD ANRS 12206 project granted by the European and Developing Countries Clinical Trial Partnership (EDCTP), the CRP-sante in Luxembourg and the French ANRS-Inserm. Dr. Malik Coulibaly is a fellow PhD candidate of the Doctoral School of Society, Politics and Public Health, Bordeaux, France funded by the MONOD consortium. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjorlolo-Johnson G, 2013, JAIDS-J ACQ IMM DEF, V62, pE7, DOI 10.1097/QAI.0b013e3182706401; Bland RM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f550; Brou H, 2008, AIDS CARE, V20, P413, DOI 10.1080/09540120701867065; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Desgrees-Du-Lou A, 2009, AIDS BEHAV, V13, P348, DOI 10.1007/s10461-007-9316-6; Desmonde S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-182; Folquet-Amonissani M, 2012, IVORY COAST 2011; Forthofer R. N., 2006, BIOSTATISTICS GUIDE; Goetghebuer T, 2012, CLIN INFECT DIS, V54, P878, DOI 10.1093/cid/cir950; Institut National de la Statistique et de la Demographie Burkina Faso, 2011, REG CTR CHIFFR; Institut National de la Statistique et de la Demographie Burkina Faso, 2013, TABLEAU 05 34 EVOLUT; Leroy V, 2013, JAIDS-J ACQ IMM DEF, V62, P208, DOI 10.1097/QAI.0b013e31827b70bf; Ministere de l'Economie et des Finances Burkina Faso, 2011, ENQ DEM SANT IND MUL; Ministere de la Sante Comite Ministeriel de Lutte contre le SIDA Burkina Faso, 2008, NORM PROT PRIS CHARG; Ministere de la Sante du Burkina Faso, 2011, ANN STAT 2010; Ministere Sante-Burkina Faso, 2012, ANN STAT 2011; Ndondoki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067996; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Nielsen K, 2000, PEDIATR CLIN N AM, V47, P39, DOI 10.1016/S0031-3955(05)70194-2; Nigatu T, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-6; Oga MA, 2011, JAIDS-J ACQ IMM DEF, V57, pS16, DOI 10.1097/QAI.0b013e31821fd487; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Prendergast AJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001273; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Tchidjou HK, 2012, J TROP PEDIATRICS, V58, P451, DOI 10.1093/tropej/fms015; Thairu L, 2011, AIDS CARE, V23, P814, DOI 10.1080/09540121.2010.541416; Van Rompaey S, 2011, AIDS CARE, V23, P686, DOI 10.1080/09540121.2010.532538; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2014, MARCH 2014 S 2013 CO; World Health Organization, 2008, OP MAN DEL HIV PREV; World Health Organization, 2010, WHO REC DIAGN HIV IN; World Health Organization, 2010, ANT THER HIV INF INF; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	35	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111240	10.1371/journal.pone.0111240	http://dx.doi.org/10.1371/journal.pone.0111240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360551	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700077
J	Ernstbrunner, M; Kostner, L; Kimberger, O; Wabel, P; Saemann, M; Markstaller, K; Fleischmann, E; Kabon, B; Hecking, M				Ernstbrunner, Matthaeus; Kostner, Lisa; Kimberger, Oliver; Wabel, Peter; Saeemann, Marcus; Markstaller, Klaus; Fleischmann, Edith; Kabon, Barbara; Hecking, Manfred			Bioimpedance Spectroscopy for Assessment of Volume Status in Patients before and after General Anaesthesia	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; RANDOMIZED CONTROLLED-TRIAL; MAJOR ABDOMINAL-SURGERY; HEMODIALYSIS-PATIENTS; DILUTION METHODS; FLUID BALANCE; EXCESS FLUID; BODY; TISSUE; OPTIMIZATION	Background: Technically assisted assessment of volume status before surgery may be useful to direct intraoperative fluid administration. We therefore tested a recently developed whole-body bioimpedance spectroscopy device to determine pre-to postoperative fluid distribution. Methods: Using a three-compartment physiologic tissue model, the body composition monitor (BCM, Fresenius Medical Care, Germany) measures total body fluid volume, extracellular volume, intracellular volume and fluid overload as surplus or deficit of 'normal' extracellular volume. BCM-measurements were performed before and after standardized general anaesthesia for gynaecological procedures (laparotomies, laparoscopies and vaginal surgeries). BCM results were blinded to the attending anaesthesiologist and data analysed using the 2-sided, paired Student's t-test and multiple linear regression. Results: In 71 females aged 45 +/- 15 years with body weight 67 +/- 13 kg and duration of anaesthesia 154 +/- 68 min, pre-to postoperative fluid overload increased from -0.7 +/- 1.1 L to 0.1 +/- 1.0 L, corresponding to 25.1 +/- 7.5% and 0.8 +/- 6.7% of normal extracellular volume, respectively (both p<0.001), after patients had received 1.9 +/- 0.9 L intravenous crystalloid fluid. Perioperative urinary excretion was 0.4 +/- 0.3 L. The increase in extracellular volume was paralleled by an increase in total body fluid volume, while intracellular volume increased only slightly and without reaching statistical significance (p = 0.15). Net perioperative fluid balance (administered fluid volume minus urinary excretion) was significantly associated with change in extracellular volume (r(2) = 0.65), but was not associated with change in intracellular volume (r(2) = 0.01). Conclusions: Routine intraoperative fluid administration results in a significant, and clinically meaningful increase in the extracellular compartment. BCM-measurements yielded plausible results and may become useful to guide intraoperative fluid therapy in future studies.	[Ernstbrunner, Matthaeus; Kostner, Lisa; Kimberger, Oliver; Markstaller, Klaus; Fleischmann, Edith; Kabon, Barbara; Hecking, Manfred] Med Univ Vienna, Dept Anaesthesiol & Crit Care Med, Vienna, Austria; [Wabel, Peter] Fresenius Med Care, Bad Homburg, Germany; [Saeemann, Marcus; Hecking, Manfred] Med Univ Vienna, Dept Internal Med 3, Clin Div Nephrol & Dialysis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Hecking, M (corresponding author), Med Univ Vienna, Dept Anaesthesiol & Crit Care Med, Vienna, Austria.	manfred.hecking@meduniwien.ac.at	Hecking/AAK-7399-2021	Kimberger, Oliver/0000-0002-9766-1360; Kabon, Barbara/0000-0002-9269-4657; Hecking, Manfred/0000-0002-8047-2395				[Anonymous], 2010, MILLERS ANESTHESIA; [Anonymous], 2012, US MAN FRESN MED CAR; Bracco D, 1998, CRIT CARE MED, V26, P1065, DOI 10.1097/00003246-199806000-00029; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Cagini L, 2011, EUR J CARDIO-THORAC, V40, pE71, DOI 10.1016/j.ejcts.2011.03.030; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chazot C, 2012, NEPHROL DIAL TRANSPL, V27, P2404, DOI 10.1093/ndt/gfr678; COLE KS, 1969, EXP NEUROL, V24, P459, DOI 10.1016/0014-4886(69)90149-6; Cordemans C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S1; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Doherty M, 2012, BRIT J ANAESTH, V109, P69, DOI 10.1093/bja/aes171; Elliott S, 1998, EUR J ANAESTH, V15, P50, DOI 10.1097/00003643-199801000-00010; FLECK A, 1985, LANCET, V1, P781; Forbes GB, 1987, TECHNIQUES ESTIMATIN; Frumento RJ B-GE, 2003, PERIOPERATIVE ORGAN, P1; Gulec B, 2006, ANZ J SURG, V76, P904, DOI 10.1111/j.1445-2197.2006.03906.x; Hecking M, 2013, AM J NEPHROL, V38, P78, DOI 10.1159/000353104; Holte K, 2003, ANESTH ANALG, V96, P1504, DOI 10.1213/01.ANE.0000055820.56129.EE; Holte K, 2006, J AM COLL SURGEONS, V202, P971, DOI 10.1016/j.jamcollsurg.2006.01.003; Itobi E, 2006, BRIT J SURG, V93, P354, DOI 10.1002/bjs.5259; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lang K, 2001, ANESTH ANALG, V93, P405, DOI 10.1097/00000539-200108000-00034; LJUNGGREN H, 1957, Acta Endocrinol Suppl (Copenh), V25, P1; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; LOWELL JA, 1990, CRIT CARE MED, V18, P728, DOI 10.1097/00003246-199007000-00010; Lyons FM, 1997, INT ANESTHESIOL CLIN, V35, P1, DOI 10.1097/00004311-199703540-00002; Machek P, 2010, NEPHROL DIAL TRANSPL, V25, P538, DOI 10.1093/ndt/gfp487; Moissl U, 2008, NDT PLUS S2, V1, P215; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Moller AM, 2002, EUR J ANAESTH, V19, P57, DOI 10.1017/S0265021502000091; Morgan GEM, 2005, FLUID MANAGEMENT TRA; MORSE WI, 1963, METABOLISM, V12, P99; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Passauer J, 2010, NEPHROL DIAL TRANSPL, V25, P545, DOI 10.1093/ndt/gfp517; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Piccoli A, 2014, KIDNEY INT, V85, P738, DOI 10.1038/ki.2013.434; Raimann JG, 2014, KIDNEY INT, V85, P898, DOI 10.1038/ki.2013.358; Rasmussen L A, 1996, Ugeskr Laeger, V158, P5286; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Sheeran P, 1997, BRIT J ANAESTH, V78, P201, DOI 10.1093/bja/78.2.201; Sinclair S, 1997, BMJ-BRIT MED J, V315, P909; Smith TPC, 2009, BODY FLUIDS FUNDAMEN; Tatara T, 1998, CRIT CARE MED, V26, P470, DOI 10.1097/00003246-199803000-00017; Tsai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082566; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2007, NEPHROL DIAL TRAN S6, V22, pVI129; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; WANG J, 1976, J NUTR, V106, P1687, DOI 10.1093/jn/106.12.1687; Wizemann V, 2008, CONTRIB NEPHROL, V161, P115, DOI 10.1159/000130423; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707	51	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111139	10.1371/journal.pone.0111139	http://dx.doi.org/10.1371/journal.pone.0111139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360698	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700065
J	Jacobs, S; Cui, ZZ; Feng, RB; Wang, HM; Wang, DH; Tsien, JZ				Jacobs, Stephanie; Cui, Zhenzhong; Feng, Ruiben; Wang, Huimin; Wang, Deheng; Tsien, Joe Z.			Molecular and Genetic Determinants of the NMDA Receptor for Superior Learning and Memory Functions	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; NR2B TRANSGENIC MICE; MOTOR PROTEIN KIF17; SYNAPTIC PLASTICITY; BRAIN MAGNESIUM; ION CHANNELS; HIPPOCAMPAL; DEPRESSION; RAT	The opening-duration of the NMDA receptors implements Hebb's synaptic coincidence-detection and is long thought to be the rate-limiting factor underlying superior memory. Here, we investigate the molecular and genetic determinants of the NMDA receptors by testing the "synaptic coincidence-detection time-duration" hypothesis vs. "GluN2B intracellular signaling domain" hypothesis. Accordingly, we generated a series of GluN2A, GluN2B, and GluN2D chimeric subunit transgenic mice in which C-terminal intracellular domains were systematically swapped and overexpressed in the forebrain excitatory neurons. The data presented in the present study supports the second hypothesis, the "GluN2B intracellular signaling domain" hypothesis. Surprisingly, we found that the voltage-gated channel opening-durations through either GluN2A or GluN2B are sufficient and their temporal differences are marginal. In contrast, the C-terminal intracellular domain of the GluN2B subunit is necessary and sufficient for superior performances in long-term novel object recognition and cued fear memories and superior flexibility in fear extinction. Intriguingly, memory enhancement correlates with enhanced long-term potentiation in the 10-100 Hz range while requiring intact long-term depression capacity at the 1-5 Hz range.	[Jacobs, Stephanie; Cui, Zhenzhong; Feng, Ruiben; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30901 USA; [Jacobs, Stephanie; Cui, Zhenzhong; Feng, Ruiben; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Wang, Huimin] E China Normal Univ, Shanghai Inst Funct Gen, Shanghai 200062, Peoples R China; [Wang, Deheng] Banna Biomed Res Inst, Xi Shuang Ban Na Prefect, Yunnan, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; East China Normal University	Tsien, JZ (corresponding author), Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30901 USA.	jtsien@gru.edu	wang, huimin/HDM-8421-2022	Wang, Deheng/0000-0001-7979-9756	National Institute of Mental Health [MH060236]; National Institute on Aging [AG024022, AG034663, AG025918]; Georgia Research Alliance;  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025918, R01AG024022, R01AG034663] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institute of Mental Health (MH060236), National Institute on Aging (AG024022, AG034663 & AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaria N, 2013, BEHAV PHARMACOL, V24, P255, DOI 10.1097/FBP.0b013e32836357c7; Abumaria N, 2011, J NEUROSCI, V31, P14871, DOI 10.1523/JNEUROSCI.3782-11.2011; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Clayton DA, 2002, J NEUROSCI, V22, P3628; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; Cui ZZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01036; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Cyranoski D, 2012, NATURE NEWS; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; FALLS WA, 1992, J NEUROSCI, V12, P854; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Gerkin RC, 2007, J NEUROPHYSIOL, V97, P2851, DOI 10.1152/jn.00860.2006; GHO M, 1992, SCIENCE, V258, P313, DOI 10.1126/science.1384131; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Jacobs SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036387; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kennedy PR, 1997, BRAIN RES, V760, P251, DOI 10.1016/S0006-8993(97)00051-6; Kohr G, 2003, J NEUROSCI, V23, P10791; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Li YH, 2008, BRAIN RES, V1190, P49, DOI 10.1016/j.brainres.2007.11.006; Liu HN, 2004, J NEUROPHYSIOL, V92, P1077, DOI 10.1152/jn.00602.2003; LYNCH MA, 1983, NATURE, V303, P175, DOI 10.1038/303175a0; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Punnakkal P, 2012, NEUROPHARMACOLOGY, V62, P1985, DOI 10.1016/j.neuropharm.2011.12.018; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Shipton OA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0163; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stevens CF, 1998, CURR BIOL, V8, pR151, DOI 10.1016/S0960-9822(98)70097-1; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Zhang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079454; Zhang XL, 2008, NEUROPHARMACOLOGY, V55, P1238, DOI 10.1016/j.neuropharm.2008.08.018	73	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111865	10.1371/journal.pone.0111865	http://dx.doi.org/10.1371/journal.pone.0111865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360708	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700157
J	Jia, ZY; Yi, Y; Liu, JH; Cao, JY; Zhang, Y; Tian, RG; Yu, T; Wang, H; Wang, XY; Su, QD; Zhou, WT; Cui, FQ; Liang, XF; Bi, SL				Jia, Zhiyuan; Yi, Yao; Liu, Jianhua; Cao, Jingyuan; Zhang, Yong; Tian, Ruiguang; Yu, Tao; Wang, Hao; Wang, Xinying; Su, Qiudong; Zhou, Wenting; Cui, Fuqiang; Liang, Xiaofeng; Bi, Shengli			Epidemiology of Hepatitis E Virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006	PLOS ONE			English	Article							GENERAL-POPULATION; E VACCINE; SEROPREVALENCE; ANTIBODIES; INFECTION; JAPAN; SEROEPIDEMIOLOGY; ANIMALS; HUMANS; INDIA	In China, hepatitis E virus (HEV) is prevalent and causes disease, but its epidemiological profile is not well understood. We used a commercial enzyme-linked immunosorbent assay to detect total antibodies to hepatitis E virus in 15,862 serum samples collected during the Third National Viral Hepatitis Prevalence Survey. The results were analyzed to calculate estimates of HEV seroprevalence and to examine the effects of some putative risk factors. The seroprevalence of HEV in the general Chinese population during the period from 2005 through 2006 was 23.46% (95% confidence interval [CI], 18.41%-28.50%). The farming population, the age group of 15-60 year olds, and those living in the Midwest or Mideast region and in Xinjiang province had the highest seroprevalence estimates. The prevalence of HEV is high in China. The seroprevalence rate of HEV shows an unbalanced distribution among areas with different geographic location and economic development levels. The characteristics of the distribution associated may be due to the route of HEV transmission (via contaminated water or animal reservoirs). Within the same region, the seroprevalence of HEV is generally increased with age.	[Jia, Zhiyuan; Yi, Yao; Cao, Jingyuan; Zhang, Yong; Tian, Ruiguang; Yu, Tao; Wang, Hao; Wang, Xinying; Su, Qiudong; Zhou, Wenting; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Virol Dis Control & Prevent, Beijing, Peoples R China; [Liu, Jianhua] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Cui, Fuqiang; Liang, Xiaofeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Bi, SL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Virol Dis Control & Prevent, Beijing, Peoples R China.	jiazy@chinacdc.cn		Wang, Hao/0000-0001-9425-4666; Bi, Shengli/0000-0002-0380-5790; Wang, Hao/0000-0001-7988-6120	China Centers for Disease Control and Prevention; China Ministry of Health; Ministry of Science and Technology [2004BA718B01]	China Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); China Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the China Centers for Disease Control and Prevention, China Ministry of Health and Ministry of Science and Technology (NO: 2004BA718B01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2008, HEPATOL INT, V2, P308, DOI 10.1007/s12072-008-9071-4; Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; Bawazir AA, 2010, T ROY SOC TROP MED H, V104, P801, DOI 10.1016/j.trstmh.2010.08.007; Cai JL, 2010, J TROPICAL MED, V10, P90; Chiu DMY, 2013, J MED VIROL, V85, P459, DOI 10.1002/jmv.23429; El-Tras WF, 2013, ZOONOSES PUBLIC HLTH, V60, P244, DOI 10.1111/j.1863-2378.2012.01516.x; Emerson SU, 2006, HEPATITIS E VIRUS FI, P3047; Faramawi MF, 2011, EPIDEMIOL INFECT, V139, P1145, DOI 10.1017/S0950268810002177; Fogeda M, 2012, J MED VIROL, V84, P71, DOI 10.1002/jmv.22270; Geng JB, 2012, WORLD J GASTROENTERO, V18, P965, DOI 10.3748/wjg.v18.i9.965; GQea Zhicheng Dai, 1997, VIRAL HEPATITIS CHIN; Holla RP, 2013, SEMIN LIVER DIS, V33, P3, DOI 10.1055/s-0033-1338110; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111; Krumbholz A, 2012, MED MICROBIOL IMMUN, V201, P239, DOI 10.1007/s00430-011-0210-5; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Labrique AB, 2009, AM J TROP MED HYG, V81, P875, DOI 10.4269/ajtmh.2009.09-0352; Li K, 2002, CHINESE MED J-PEKING, V115, P1058; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Li WG, 2011, ARCH VIROL, V156, P1989, DOI 10.1007/s00705-011-1089-6; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu P, 2012, INFECT GENET EVOL, V12, P428, DOI 10.1016/j.meegid.2012.01.017; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Majumdar M, 2013, J MED VIROL, V85, P823, DOI 10.1002/jmv.23529; Meader E, 2010, ZOONOSES PUBLIC HLTH, V57, P504, DOI 10.1111/j.1863-2378.2009.01254.x; Mohebbi SR, 2012, T ROY SOC TROP MED H, V106, P528, DOI 10.1016/j.trstmh.2012.05.013; Villalba MCM, 2010, T ROY SOC TROP MED H, V104, P772, DOI 10.1016/j.trstmh.2010.08.006; Romano L, 2011, J HEPATOL, V54, P34, DOI 10.1016/j.jhep.2010.06.017; Scotto G, 2013, J MED VIROL, V85, P261, DOI 10.1002/jmv.23400; Takahashi M, 2010, J MED VIROL, V82, P271, DOI 10.1002/jmv.21678; Taniguchi M, 2009, J INFECTION, V58, P232, DOI 10.1016/j.jinf.2009.01.011; Verhoef L, 2012, EPIDEMIOL INFECT, V140, P1838, DOI 10.1017/S0950268811002913; Vivek R, 2010, T ROY SOC TROP MED H, V104, P307, DOI 10.1016/j.trstmh.2009.07.017; Wu T, 2012, HUM VACC IMMUNOTHER, V8, P823, DOI 10.4161/hv.20042; XU ZY, 1992, VACCINE, V10, pS67, DOI 10.1016/0264-410X(92)90547-W; Xue-feng ZJ, 2008, ACTA U MED NANJING N, V3, P360; Yan J, 2012, HEPATOL RES, V42, P974, DOI 10.1111/j.1872-034X.2012.01009.x; Yao G B, 1989, Zhonghua Yi Xue Za Zhi, V69, P113; Yu YH, 2009, INFECT GENET EVOL, V9, P554, DOI 10.1016/j.meegid.2009.02.008; Zhang J, 2013, CLIN MICROBIOL INFEC; Zhang SJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-152; ZHUANG H, 1991, GASTROENTEROL JPN, V26, P135	43	32	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110837	10.1371/journal.pone.0110837	http://dx.doi.org/10.1371/journal.pone.0110837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360522	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700049
J	Kubota, H; Sakai, T; Gawad, A; Makino, H; Akiyama, T; Ishikawa, E; Oishi, K				Kubota, Hiroyuki; Sakai, Takafumi; Gawad, Agata; Makino, Hiroshi; Akiyama, Takuya; Ishikawa, Eiji; Oishi, Kenji			Development of TaqMan-Based Quantitative PCR for Sensitive and Selective Detection of Toxigenic Clostridium difficile in Human Stools	PLOS ONE			English	Article							TERM-CARE FACILITIES; REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; RIBOSOMAL-RNA MOLECULES; TOXIN-B GENE; RAPID DETECTION; DIARRHEA; CULTURE; INFECTION; STRAINS	Background: Clostridium difficile is the main cause of nosocomial diarrhea, but is also found in asymptomatic subjects that are potentially involved in transmission of C. difficile infection. A sensitive and accurate detection method of C. difficile, especially toxigenic strains is indispensable for the epidemiological investigation. Methods: TaqMan-based quantitative-PCR (qPCR) method for targeting 16S rRNA, tcdB, and tcdA genes of C. difficile was developed. The detection limit and accuracy of qPCR were evaluated by analyzing stool samples spiked with known amounts of C. difficile. A total of 235 stool specimens collected from 82 elderly nursing home residents were examined by qPCR, and the validity was evaluated by comparing the detection result with that by C. difficile selective culture (CDSC). Results: The analysis of C. difficile-spiked stools confirmed that qPCR quantified whole C. difficile (TcdA(+)TcdB(+), TcdA(-)TcdB(+), and TcdA(-)TcdB(-) types), TcdB-producing strains (TcdA(+)TcdB(+) and TcdA(-)TcdB(+) types), and TcdA-producing strains (TcdA(+)TcdB(+) type), respectively, with a lower detection limit of 10(3) cells/g of stool. Of the 235 specimens examined, 12 specimens (5.1%) were C. difficile-positive by qPCR: TcdA(+)TcdB(+) strain in six specimens and TcdA(-)TcdB(-) strain in the other six. CDSC detected C. difficile in 9 of the 12 specimens, and toxigenic types of the isolates from the 9 specimens were consistent with those identified by qPCR, supporting the validity of our qPCR method. Moreover, the qPCR examination revealed that the carriage rate of whole C. difficile and that of toxigenic strains in the 82 subjects over a 6-month period ranged from 2.4 to 6.8% and 1.2 to 3.8%, respectively. An average qPCR count of C. difficile detected was 10(4.5) cells/g of stool, suggesting that C. difficile constituted a very small fraction of intestinal microbiota. Conclusion: Our qPCR method should be an effective tool for both clinical diagnosis and epidemiological investigation of C. difficile.	[Kubota, Hiroyuki; Gawad, Agata; Akiyama, Takuya; Oishi, Kenji] Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium; [Kubota, Hiroyuki; Sakai, Takafumi; Makino, Hiroshi; Akiyama, Takuya; Ishikawa, Eiji; Oishi, Kenji] Yakult Cent Inst, Tokyo, Japan	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited	Kubota, H (corresponding author), Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium.	hiroyuki.kubota@yher.be		Ishikawa, Eiji/0000-0002-4179-9010	Yakult Honsha European Research Center for Microbiology ESV	Yakult Honsha European Research Center for Microbiology ESV	This work was funded by Yakult Honsha European Research Center for Microbiology ESV (http://institute.yakult.co.jp/english/about/labo/). The funder provided support in the form of salaries for authors [HK, TS, AG, HM, TA, EI, KO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso R, 1999, J HOSP INFECT, V41, P145, DOI 10.1016/S0195-6701(99)90052-X; Arvand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030183; Belanger SD, 2003, J CLIN MICROBIOL, V41, P730, DOI 10.1128/JCM.41.2.730-734.2003; Dionne LL, 2013, J CLIN MICROBIOL, V51, P3624, DOI 10.1128/JCM.01444-13; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Guilbault C, 2002, J CLIN MICROBIOL, V40, P2288, DOI 10.1128/JCM.40.6.2288-2290.2002; Houser BA, 2010, FOODBORNE PATHOG DIS, V7, P719, DOI 10.1089/fpd.2009.0483; Huang HH, 2009, J CLIN MICROBIOL, V47, P3729, DOI 10.1128/JCM.01280-09; Jansen GJ, 1999, J MICROBIOL METH, V37, P215, DOI 10.1016/S0167-7012(99)00049-4; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Makris AT, 2007, J AM MED DIR ASSOC, V8, P290, DOI 10.1016/j.jamda.2007.01.098; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2012, APPL ENVIRON MICROB, V78, P5111, DOI 10.1128/AEM.07990-11; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Naaber P, 2011, J CLIN MICROBIOL, V49, P3656, DOI 10.1128/JCM.05115-11; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Pancholi P, 2012, J CLIN MICROBIOL, V50, P1331, DOI 10.1128/JCM.06597-11; Peterson LR, 2007, CLIN INFECT DIS, V45, P1152, DOI 10.1086/522185; Pituch H, 2005, J MED MICROBIOL, V54, P143, DOI 10.1099/jmm.0.45799-0; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Sambol SP, 2000, INFECT IMMUN, V68, P5480, DOI 10.1128/IAI.68.10.5480-5487.2000; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; Simor AE, 2010, J AM GERIATR SOC, V58, P1556, DOI 10.1111/j.1532-5415.2010.02958.x; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; WALKER KJ, 1993, J AM GERIATR SOC, V41, P940, DOI 10.1111/j.1532-5415.1993.tb06759.x; Wren M, 2010, METHODS MOL BIOL, V646, P39, DOI 10.1007/978-1-60327-365-7_3	35	16	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111684	10.1371/journal.pone.0111684	http://dx.doi.org/10.1371/journal.pone.0111684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360662	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943700142
J	Li, X; Yang, Q; Dierckens, K; Milton, DL; Defoirdt, T				Li, Xuan; Yang, Qian; Dierckens, Kristof; Milton, Debra L.; Defoirdt, Tom			RpoS and Indole Signaling Control the Virulence of Vibrio anguillarum towards Gnotobiotic Sea Bass (Dicentrarchus labrax) Larvae	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; CHALLENGE TEST; FISH; IDENTIFICATION; TRYPTOPHANASE; REQUIRES; HOST; BIOSYNTHESIS; PREVENTION	Quorum sensing, bacterial cell-to-cell communication with small signal molecules, controls the virulence of many pathogens. In contrast to other vibrios, neither the VanI/VanR acylhomoserine lactone quorum sensing system, nor the three-channel quorum sensing system affects virulence of the economically important aquatic pathogen Vibrio anguillarum. Indole is another molecule that recently gained attention as a putative signal molecule. The data presented in this study indicate that indole signaling and the alternative sigma factor RpoS have a significant impact on the virulence of V. anguillarum. Deletion of rpoS resulted in increased expression of the indole biosynthesis gene tnaA and in increased production of indole. Both rpoS deletion and the addition of exogenous indole (50-100 mu M) resulted in decreased biofilm formation, exopolysaccharide production (a phenotype that is required for pathogenicity) and expression of the exopolysaccharide synthesis gene wbfD. Further, indole inhibitors increased the virulence of the rpoS deletion mutant, suggesting that indole acts downstream of RpoS. Finally, in addition to the phenotypes found to be affected by indole, the rpoS deletion mutant also showed increased motility and decreased sensitivity to oxidative stress.	[Li, Xuan; Yang, Qian; Dierckens, Kristof; Defoirdt, Tom] Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium; [Li, Xuan; Yang, Qian; Dierckens, Kristof; Defoirdt, Tom] Univ Ghent, Artemia Reference Ctr, B-9000 Ghent, Belgium; [Milton, Debra L.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Defoirdt, Tom] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Umea University; Ghent University	Defoirdt, T (corresponding author), Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium.	Tom.Defoirdt@UGent.be	Defoirdt, Tom/A-5120-2009; dierckens, kristof/GWM-4184-2022	Defoirdt, Tom/0000-0002-7446-2246; Yang, Qian/0000-0001-9538-936X	Scientific Research Fund of Flanders (FWO-Vlaanderen) [1.5.013.12N]; Ghent University (GOA) [BOF12/GOA/022]; China Scholarship Council; Ghent University	Scientific Research Fund of Flanders (FWO-Vlaanderen)(FWO); Ghent University (GOA)(Ghent University); China Scholarship Council(China Scholarship Council); Ghent University(Ghent University)	This work was financially supported by the Scientific Research Fund of Flanders (FWO-Vlaanderen project n o 1.5.013.12N) and the Special Research Fund of Ghent University (GOA project n o BOF12/GOA/022). XL and QY are doctoral researchers funded by a China Scholarship Council grant and a Special Research Grant (BOF-UGent) of Ghent University. TD is a postdoctoral fellow of FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Austin B., 2012, BACTERIAL FISH PATHO; Bansal T, 2009, P NATL ACAD SCI; Brackman G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-149; CROSA JH, 1980, NATURE, V284, P566, DOI 10.1038/284566a0; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; Defoirdt T, 2013, ANTIMICROB AGENTS CH, V57, P2870, DOI 10.1128/AAC.00401-13; Dierckens K, 2009, ENVIRON MICROBIOL, V11, P526, DOI 10.1111/j.1462-2920.2008.01794.x; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Lelong C, 2007, MOL CELL PROTEOMICS, V6, P648, DOI 10.1074/mcp.M600191-MCP200; Li X, 2014, DIS AQUAT ORGAN, V108, P211, DOI 10.3354/dao02722; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2009, FEMS MICROBIOL ECOL, V70, P286, DOI 10.1111/j.1574-6941.2009.00713.x; McGee K, 1996, J BACTERIOL, V178, P5188, DOI 10.1128/jb.178.17.5188-5198.1996; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Natrah FMI, 2011, VET MICROBIOL, V154, P124, DOI 10.1016/j.vetmic.2011.06.024; NEWTON WA, 1965, J BACTERIOL, V89, P355, DOI 10.1128/JB.89.2.355-364.1965; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; Ruwandeepika HAD, 2011, ENVIRON MICROBIOL, V13, P506, DOI 10.1111/j.1462-2920.2010.02354.x; Scherzer R, 2009, J ENZYM INHIB MED CH, V24, P350, DOI [10.1080/14756360802187612, 10.1080/14756360802187612 ]; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080604; Stork M, 2007, J BACTERIOL, V189, P3479, DOI 10.1128/JB.00619-06; Wang X, 2011, FISH SHELLFISH IMMUN, V30, P944, DOI 10.1016/j.fsi.2011.01.019; Weber B, 2008, MICROBIOL-SGM, V154, P767, DOI 10.1099/mic.0.2007/014167-0; Yang H, 2007, FEMS MICROBIOL LETT, V267, P56, DOI 10.1111/j.1574-6968.2006.00533.x	33	29	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111801	10.1371/journal.pone.0111801	http://dx.doi.org/10.1371/journal.pone.0111801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360804	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700152
J	Lieberman, LA; Tsokos, GC				Lieberman, Linda A.; Tsokos, George C.			Lupus-Prone Mice Fail to Raise Antigen-Specific T Cell Responses to Intracellular Infection	PLOS ONE			English	Article							TOXOPLASMA-GONDII; IFN-GAMMA; ERYTHEMATOSUS; INTERFERON; AUTOIMMUNITY; INTERLEUKIN-12; POLYMORPHISMS; MORTALITY; BLOCKADE; VAL14MET	Systemic lupus erythematosus (SLE) is characterized by multiple cellular abnormalities culminating in the production of autoantibodies and immune complexes, resulting in tissue inflammation and organ damage. Besides active disease, the main cause of morbidity and mortality in SLE patients is infections, including those from opportunistic pathogens. To understand the failure of the immune system to fend off infections in systemic autoimmunity, we infected the lupus-prone murine strains B6.lpr and BXSB with the intracellular parasite Toxoplasma gondii and survival was monitored. Furthermore, mice were sacrificed days post infection and parasite burden and cellular immune responses such as cytokine production and cell activation were assessed. Mice from both strains succumbed to infection acutely and we observed greater susceptibility to infection in older mice. Increased parasite burden and a defective antigen-specific IFN-gamma response were observed in the lupus-prone mice. Furthermore, T cell: dendritic cell co-cultures established the presence of an intrinsic T cell defect responsible for the decreased antigen-specific response. An antigen-specific defect in IFN-gamma production prevents lupus-prone mice from clearing infection effectively. This study reveals the first cellular insight into the origin of increased susceptibility to infections in SLE disease and may guide therapeutic approaches.	[Lieberman, Linda A.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02138 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	National Institutes of Health - NIH [AI049954]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049954, R01AI049954] Funding Source: NIH RePORTER	National Institutes of Health - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health - NIH AI049954. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chen M, 2004, INT IMMUNOL, V16, P937, DOI 10.1093/intimm/dxh095; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; Dupont CD, 2012, SEMIN IMMUNOPATHOL, V34, P793, DOI 10.1007/s00281-012-0339-3; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Goldblatt F, 2009, LUPUS, V18, P682, DOI 10.1177/0961203308101019; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Iliopoulos AG, 1996, SEMIN ARTHRITIS RHEU, V25, P318, DOI 10.1016/S0049-0172(96)80018-7; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; Maddur MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001077; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Nakashima H, 1999, FEBS LETT, V453, P187, DOI 10.1016/S0014-5793(99)00701-2; NICKELL SP, 1985, PARASITE IMMUNOL, V7, P377, DOI 10.1111/j.1365-3024.1985.tb00084.x; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; SHARMA SD, 1983, J IMMUNOL, V131, P977; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tanaka Y, 1999, IMMUNOGENETICS, V49, P266, DOI 10.1007/s002510050492; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Tucci M, 2008, CLIN EXP IMMUNOL, V154, P247, DOI 10.1111/j.1365-2249.2008.03758.x; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WILCOX MH, 1990, ANN RHEUM DIS, V49, P254, DOI 10.1136/ard.49.4.254; Yao X, 2007, ARCH DERMATOL RES, V299, P367, DOI 10.1007/s00403-007-0741-1; Zamir D, 1999, MAYO CLIN PROC, V74, P575, DOI 10.4065/74.6.575	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111382	10.1371/journal.pone.0111382	http://dx.doi.org/10.1371/journal.pone.0111382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360768	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700096
J	Madkhali, AM; Alkurbi, MO; Szestak, T; Bengtsson, A; Patil, PR; Wu, Y; Alharthi, S; Jensen, ATR; Pleass, R; Craig, AG				Madkhali, Aymen M.; Alkurbi, Mohammed O.; Szestak, Tadge; Bengtsson, Anja; Patil, Pradeep R.; Wu, Yang; Alharthi, Saeed; Jensen, Anja T. R.; Pleass, Richard; Craig, Alister G.			An Analysis of the Binding Characteristics of a Panel of Recently Selected ICAM-1 Binding Plasmodium falciparum Patient Isolates	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; N-TERMINAL DOMAIN; INFECTED ERYTHROCYTES; SEVERE MALARIA; ENDOTHELIAL ACTIVATION; CEREBRAL MALARIA; IN-VITRO; RECEPTOR; CD36; CYTOADHERENCE	The basis of severe malaria pathogenesis in part includes sequestration of Plasmodium falciparum-infected erythrocytes (IE) from the peripheral circulation. This phenomenon is mediated by the interaction between several endothelial receptors and one of the main parasite-derived variant antigens (PfEMP1) expressed on the surface of the infected erythrocyte membrane. One of the commonly used host receptors is ICAM-1, and it has been suggested that ICAM-1 has a role in cerebral malaria pathology, although the evidence to support this is not conclusive. The current study examined the cytoadherence patterns of lab-adapted patient isolates after selecting on ICAM-1. We investigated the binding phenotypes using variant ICAM-1 proteins including ICAM-1(Ref), ICAM-1(Kilifi), ICAM-1(S22/A), ICAM-1(L42/A) and ICAM-1(L44/A) using static assays. The study also examined ICAM-1 blocking by four anti-ICAM-1 monoclonal antibodies (mAb) under static conditions. We also characterised the binding phenotypes using Human Dermal Microvascular Endothelial Cells (HDMEC) under flow conditions. The results show that different isolates have variant-specific binding phenotypes under both static and flow conditions, extending our previous observations that this variation might be due to variable contact residues on ICAM-1 being used by different parasite PfEMP1 variants.	[Madkhali, Aymen M.; Alkurbi, Mohammed O.; Szestak, Tadge; Patil, Pradeep R.; Wu, Yang; Pleass, Richard; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Madkhali, Aymen M.] Jazan Univ, Coll Appl Med Sci, Dept Med Labs Technol, Jazan, Saudi Arabia; [Alkurbi, Mohammed O.; Alharthi, Saeed] Umm Al Qura Univ, Coll Appl Med Sci, Dept Lab Med, Makkah Al Mukarramah, Saudi Arabia; [Bengtsson, Anja; Jensen, Anja T. R.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	Liverpool School of Tropical Medicine; University of Liverpool; Jazan University; Umm Al Qura University; University of Copenhagen	Craig, AG (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.	alister.craig@lstmed.ac.uk	Pleass, Richard J/L-4148-2015; Madkhali, Aymen/AAC-5660-2021; Jensen, Anja Tatiana TR Ramstedt/T-3583-2017; Jensen, Anja Ramstedt/AAL-3119-2021; Pleass, Richard/N-7831-2019	Pleass, Richard J/0000-0001-7438-8296; Jensen, Anja Tatiana TR Ramstedt/0000-0002-4004-7554; Jensen, Anja Ramstedt/0000-0002-4004-7554; Pleass, Richard/0000-0001-7438-8296; Craig, Alister/0000-0003-0914-6164; Bengtsson, Anja/0000-0001-9523-8369	Wellcome Trust [095507]; Jazan University, Saudi Arabia; Medical Research Council [G0400417, MC_PC_12017] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0006249] Funding Source: researchfish; MRC [G0400417, MC_PC_12017] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Jazan University, Saudi Arabia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Wellcome Trust (Ref 095507) and Jazan University, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Bengtsson A, 2013, J IMMUNOL, V190, P240, DOI 10.4049/jimmunol.1202578; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Brown A, 2013, J BIOL CHEM, V288, P5992, DOI 10.1074/jbc.M112.416347; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chilongola J, 2009, TROP MED INT HEALTH, V14, P810, DOI 10.1111/j.1365-3156.2009.02298.x; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Cortes A, 2005, MOL BIOCHEM PARASIT, V142, P252, DOI 10.1016/j.molbiopara.2005.03.016; Davis SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003590; Dormeyer M, 2006, ANTIMICROB AGENTS CH, V50, P724, DOI 10.1128/AAC.50.2.724-730.2006; Esser C, 2014, CELL MICROBIOL, V16, P701, DOI 10.1111/cmi.12270; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Gray C, 2002, INFECT IMMUN, V70, P3962, DOI 10.1128/IAI.70.7.3962-3964.2002; GREENWALT DE, 1992, BLOOD, V80, P1105; Gullingsrud J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061323; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; Ohashi J, 2001, JPN J INFECT DIS, V54, P114; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Patil PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-348; Poyomtip T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-7; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Traub S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003520; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; Turner GDH, 1998, AM J PATHOL, V152, P1477; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004	57	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111518	10.1371/journal.pone.0111518	http://dx.doi.org/10.1371/journal.pone.0111518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360558	Green Published, gold, Green Accepted			2022-12-27	WOS:000343943700112
J	Martinez-Nunez, RT; Bondanese, VP; Louafi, F; Francisco-Garcia, AS; Rupani, H; Bedke, N; Holgate, S; Howarth, PH; Davies, DE; Sanchez-Elsner, T				Martinez-Nunez, Rocio T.; Bondanese, Victor P.; Louafi, Fethi; Francisco-Garcia, Ana S.; Rupani, Hitasha; Bedke, Nicole; Holgate, Stephen; Howarth, Peter H.; Davies, Donna E.; Sanchez-Elsner, Tilman			A MicroRNA Network Dysregulated in Asthma Controls IL-6 Production in Bronchial Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENOME-WIDE SEARCH; AIRWAY INFLAMMATION; TGF-BETA; EXPRESSION; TARGETS; ANTAGONISM; INTERLEUKIN-8; SUPPRESSOR; MANAGEMENT	MicroRNAs are short non-coding single stranded RNAs that regulate gene expression. While much is known about the effects of individual microRNAs, there is now growing evidence that they can work in co-operative networks. MicroRNAs are known to be dysregulated in many diseases and affect pathways involved in the pathology. We investigated dysregulation of microRNA networks using asthma as the disease model. Asthma is a chronic inflammatory disease of the airways characterized by bronchial hyperresponsiveness and airway remodelling. The airway epithelium is a major contributor to asthma pathology and has been shown to produce an excess of inflammatory and pro-remodelling cytokines such as TGF-beta, IL-6 and IL-8 as well as deficient amounts of anti-viral interferons. After performing microRNA arrays, we found that microRNAs -18a, -27a, -128 and -155 are down-regulated in asthmatic bronchial epithelial cells, compared to cells from healthy donors. Interestingly, these microRNAs are predicted in silico to target several components of the TGF-beta, IL-6, IL-8 and interferons pathways. Manipulation of the levels of individual microRNAs in bronchial epithelial cells did not have an effect on any of these pathways. Importantly, knock-down of the network of microRNAs miR-18a, -27a, -128 and -155 led to a significant increase of IL-8 and IL-6 expression. Interestingly, despite strong in silico predictions, down-regulation of the pool of microRNAs did not have an effect on the TGF-beta and Interferon pathways. In conclusion, using both bioinformatics and experimental tools we found a highly relevant potential role for microRNA dysregulation in the control of IL-6 and IL-8 expression in asthma. Our results suggest that microRNAs may have different roles depending on the presence of other microRNAs. Thus, interpretation of in silico analysis of microRNA function should be confirmed experimentally in the relevant cellular context taking into account interactions with other microRNAs when studying disease.	[Martinez-Nunez, Rocio T.; Bondanese, Victor P.; Louafi, Fethi; Francisco-Garcia, Ana S.; Rupani, Hitasha; Bedke, Nicole; Holgate, Stephen; Howarth, Peter H.; Davies, Donna E.; Sanchez-Elsner, Tilman] Univ Southampton, Sch Med, Southampton Gen Hosp, Sir Henry Wellcome Labs, Southampton, Hants, England; [Howarth, Peter H.] Southampton Gen Hosp, Southampton Ctr Biomed Res MP218, Southampton Resp Biomed Res Unit, NIHR, Southampton SO9 4XY, Hants, England	University of Southampton; University of Southampton	Sanchez-Elsner, T (corresponding author), Univ Southampton, Sch Med, Southampton Gen Hosp, Sir Henry Wellcome Labs, Southampton, Hants, England.	T.Sanchez-Elsner@soton.ac.uk	Davies, Donna E/H-2993-2012	Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Davies, Donna/0000-0002-5117-2991; Howarth, Peter/0000-0003-0619-7927; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Medical Research Council (MRC) [G0801984, MR/K001035/1]; MRC [G0801984, MR/K001035/1, G1000351]; MRC [G0900453, G0501506, G0800649] Funding Source: UKRI; Medical Research Council [G0900453, G1000351, MR/K001035/1, G0501506, G0800649, G0801984] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by grants from the Medical Research Council (MRC) grants to TSE (G0801984 and MR/K001035/1). VPB and FL were supported by MRC grant G0801984. RTMN was supported by MRC grant MR/K001035/1. HR is supported by an MRC Clinical Research Fellowship (G1000351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi S, 2001, JPN J CANCER RES, V92, P257, DOI 10.1111/j.1349-7006.2001.tb01090.x; Baines KJ, 2014, J ALLERGY CLIN IMMUN, V133, P997, DOI 10.1016/j.jaci.2013.12.1091; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blumenthal MN, 2006, J ALLERGY CLIN IMMUN, V117, P79, DOI 10.1016/j.jaci.2005.09.038; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chang CC, 2012, J IMMUNOL, V188, P3042, DOI 10.4049/jimmunol.1102899; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Devalia JL, 1999, INT ARCH ALLERGY IMM, V118, P437, DOI 10.1159/000024157; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Fukuyama S, 2009, AM J RESP CRIT CARE, V179, P992, DOI 10.1164/rccm.200806-992OC; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ge Q, 2010, J CELL PHYSIOL, V225, P846, DOI 10.1002/jcp.22295; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Grainge CL, 2013, CHEST, V144, P1906, DOI 10.1378/chest.12-1944; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kumar RK, 2004, CLIN EXP ALLERGY, V34, P567, DOI 10.1111/j.1365-2222.2004.1917.x; Lanone S, 2002, J CLIN INVEST, V110, P463, DOI 10.1172/JCI200214136; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Manuyakorn W, 2013, ASIAN PAC J ALLERGY, V31, P3; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Neveu WA, 2011, AM J RESP CELL MOL, V45, P1133, DOI 10.1165/rcmb.2011-0054OC; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Poos K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003210; Provost V, 2013, J LEUKOCYTE BIOL, V94, P213, DOI 10.1189/jlb.0212074; Reddel R.R., 1989, U.S. Patent, Patent No. [4,885,238, 4885238]; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rothenberg ME, 2011, J IMMUNOL, V187, P4873, DOI 10.4049/jimmunol.1004159; Rupani H, 2013, EUR RESPIR J, V41, P695, DOI 10.1183/09031936.00212011; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharma A, 2012, J APPL PHYSIOL, V113, P459, DOI 10.1152/japplphysiol.00001.2012; Shu JM, 2012, RNA BIOL, V9, P1275, DOI 10.4161/rna.21998; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082	62	57	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111659	10.1371/journal.pone.0111659	http://dx.doi.org/10.1371/journal.pone.0111659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360780	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000343943700139
J	Pan, XF; Zhao, ZM; Sun, J; Chen, F; Wen, QL; Liu, K; Song, GQ; Zhang, JJ; Wen, Y; Fu, CJ; Yang, CX				Pan, Xiong-Fei; Zhao, Zhi-Mei; Sun, Jing; Chen, Feng; Wen, Qing-Lian; Liu, Kang; Song, Gui-Qin; Zhang, Jing-Jing; Wen, Ying; Fu, Chun-Jing; Yang, Chun-Xia			Acceptability and Correlates of Primary and Secondary Prevention of Cervical Cancer among Medical Students in Southwest China: Implications for Cancer Education	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS HPV; VISUAL INSPECTION; VACCINE INTRODUCTION; SCREENING BEHAVIOR; MULTICENTER SURVEY; ACETIC-ACID; KNOWLEDGE; WOMEN; ATTITUDES; PERCEPTIONS	Objectives: To understand knowledge about, and acceptability of, cervical cancer screening and HPV vaccines among medical students; and to explore potential factors that influence their acceptability in China. Methods: We conducted a survey among medical students at six universities across southwest China using a 58-item questionnaire regarding knowledge and perceptions of HPV, cervical cancer, and HPV vaccines. Results: We surveyed 1878 medical students with a mean age of 20.8 years (standard deviation: 1.3 years). Of these, 48.8% and 80.1% believed cervical cancer can be prevented by HPV vaccines and screening respectively, while 60.2% and 71.2% would like to receive or recommend HPV vaccines and screening. 35.4% thought HPV vaccines ought to be given to adolescents aged 13-18 years. 32% stated that women should start to undergo screening from the age of 25. 49.2% felt that women should receive screening every year. Concern about side effects (38.3% and 39.8%), and inadequate information (42.4% and 35.0%) were the most cited barriers to receiving or recommending HPV vaccination and cervical cancer screening. Females were more likely to accept HPV vaccines (OR, 1.86; 95% CI: 1.47-2.35) or cervical cancer screening (OR, 3.69; 95% CI: 2.88-4.74). Students with a higher level of related knowledge were much more willing to receive or recommend vaccines (P<0.001) or screening (P<0.001). Students who showed negative or uncertain attitudes towards premarital sex were less likely to accept either HPV vaccines (OR, 0.67; 95% CI: 0.47-0.96), or screening (OR, 0.68; 0.47-0.10). Non-clinical students showed lower acceptability of cervical screening compared to students in clinical medicine (OR, 0.74; 95% CI: 0.56-0.96). Conclusions: The acceptability of HPV vaccines and cervical cancer screening is relatively low among medical students in southwest China. Measures should be taken to improve knowledge about cervical cancer and awareness of HPV vaccines and screening among medical students at university.	[Pan, Xiong-Fei; Zhao, Zhi-Mei; Wen, Ying; Yang, Chun-Xia] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol, Chengdu 610064, Peoples R China; [Sun, Jing] Chengdu Med Coll, Dept Pathol, Dev & Regenerat Key Lab Sichuan Prov, Chengdu, Peoples R China; [Chen, Feng] Deyang Peoples Hosp, Dept Prevent Healthcare & Hosp Infect Control, Deyang, Peoples R China; [Wen, Qing-Lian] Luzhou Med Coll, Affiliated Hosp, Dept Oncol, Luzhou, Peoples R China; [Liu, Kang] North Sichuan Med Coll, Clin Hosp 2, Inst Tissue Engn & Stem Cells, Nanchong, Peoples R China; North Sichuan Med Coll, Dept Biol, Nanchong, Peoples R China; [Zhang, Jing-Jing] Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China; [Fu, Chun-Jing] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China	Sichuan University; Chengdu Medical College; Southwest Medical University; North Sichuan Medical University; North Sichuan Medical University; Kunming Medical University; Chongqing Medical University	Yang, CX (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol, Chengdu 610064, Peoples R China.	chunxia815@aliyun.com	Pan, Xiongfei/G-7882-2011; Liu, Kang/AAE-9964-2020	Pan, Xiongfei/0000-0002-9350-9230; Liu, Kang/0000-0002-4640-0849				Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; Agorastos T, 2009, VACCINE, V27, P7270, DOI 10.1016/j.vaccine.2009.09.097; [Anonymous], 2009, Lancet, V374, P358, DOI 10.1016/S0140-6736(09)61394-5; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Chang IJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-916; Chelimo C, 2009, NEW ZEAL MED J, V122, P33; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; Dempsey AF, 2006, AM J MANAG CARE, V12, pS484; Deng L, 2014, LANCET ONCOL, V15, pE300, DOI 10.1016/S1470-2045(14)70278-5; Deng L, 2011, ASIAN PAC J CANCER P, V12, P2801; Dijkstra MG, 2014, ANN ONCOL; Dong Z, 2005, RECOMMENDAT IN PRESS; Ferlay J, 2013, IARC CANCERBASE; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Gu C, 2013, EUR J ONCOL NURS, V17, P154, DOI 10.1016/j.ejon.2012.04.005; Gu C, 2012, PSYCHO-ONCOLOGY, V21, P1299, DOI 10.1002/pon.2037; Gu C, 2010, CANCER NURS, V33, P445, DOI 10.1097/NCC.0b013e3181e456dc; Hong Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-696; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067005; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Kuznetsov L, 2012, INT J PUBLIC HEALTH, V57, P651, DOI 10.1007/s00038-012-0351-3; Kwan TTC, 2011, PATIENT EDUC COUNS, V84, P118, DOI 10.1016/j.pec.2010.06.018; Li J, 2009, VACCINE, V27, P1210, DOI 10.1016/j.vaccine.2008.12.020; Li R, 2013, TROP DOCT, V43, P96, DOI 10.1177/0049475513495615; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Madhivanan P, 2009, VACCINE, V27, P5203, DOI 10.1016/j.vaccine.2009.06.073; Marek E, 2011, VACCINE, V29, P5122, DOI 10.1016/j.vaccine.2011.05.048; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; McCusker SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-264; Mehta Sumita, 2013, Indian J Community Med, V38, P92, DOI 10.4103/0970-0218.112438; Mesher D, 2013, VACCINE, V32, P26, DOI 10.1016/j.vaccine.2013.10.085; Pandey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040619; Paul P, 2013, ONCOLOGIST, V18, P1278, DOI 10.1634/theoncologist.2013-0253; Rashwan HH, 2012, ASIAN PAC J CANCER P, V13, P2279, DOI 10.7314/APJCP.2012.13.5.2279; Sauvageau C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-304; Shetty P, 2014, NATURE, V507, pS12, DOI 10.1038/507S12a; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Vesco KK, 2011, ANN INTERN MED, V155, P698, DOI 10.7326/0003-4819-155-10-201111150-00377; Wei Min-xi, 2009, Chinese Journal of Virology, V25, P245; Wen Y, 2014, ASIAN PAC J CANCER P, V15, P5773, DOI 10.7314/APJCP.2014.15.14.5773; Who, 2009, Biologicals, V37, P338, DOI 10.1016/j.biologicals.2009.04.005; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang SK, 2013, VACCINE, V31, P3244, DOI 10.1016/j.vaccine.2013.05.046; Zhao FH, 2012, ASIAN PAC J CANCER P, V13, P2369, DOI 10.7314/APJCP.2012.13.5.2369; Zhao FH, 2012, CANCER EPIDEMIOL, V36, P384, DOI 10.1016/j.canep.2012.01.009; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	53	10	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110353	10.1371/journal.pone.0110353	http://dx.doi.org/10.1371/journal.pone.0110353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360743	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700032
J	Royer, C; Koch, S; Qin, X; Zak, J; Buti, L; Dudziec, E; Zhong, S; Ratnayaka, I; Srinivas, S; Lu, X				Royer, Christophe; Koch, Sofia; Qin, Xiao; Zak, Jaroslav; Buti, Ludovico; Dudziec, Ewa; Zhong, Shan; Ratnayaka, Indrika; Srinivas, Shankar; Lu, Xin			ASPP2 Links the Apical Lateral Polarity Complex to the Regulation of YAP Activity in Epithelial Cells	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; PHOSPHORYLATION; APOPTOSIS; ANGIOMOTIN; YORKIE; P53	The Hippo pathway, by tightly controlling the phosphorylation state and activity of the transcription cofactors YAP and TAZ is essential during development and tissue homeostasis whereas its deregulation may lead to cancer. Recent studies have linked the apicobasal polarity machinery in epithelial cells to components of the Hippo pathway and YAP and TAZ themselves. However the molecular mechanism by which the junctional pool of YAP proteins is released and activated in epithelial cells remains unknown. Here we report that the tumour suppressor ASPP2 forms an apical-lateral polarity complex at the level of tight junctions in polarised epithelial cells, acting as a scaffold for protein phosphatase 1 (PP1) and junctional YAP via dedicated binding domains. ASPP2 thereby directly induces the dephosphorylation and activation of junctional YAP. Collectively, this study unearths a novel mechanistic paradigm revealing the critical role of the apical-lateral polarity complex in activating this localised pool of YAP in vitro, in epithelial cells, and in vivo, in the murine colonic epithelium. We propose that this mechanism may commonly control YAP functions in epithelial tissues.	[Royer, Christophe; Koch, Sofia; Qin, Xiao; Zak, Jaroslav; Buti, Ludovico; Dudziec, Ewa; Zhong, Shan; Ratnayaka, Indrika; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England; [Royer, Christophe; Srinivas, Shankar] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Ludwig Institute for Cancer Research; University of Oxford; University of Oxford	Royer, C (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England.	royer@dpag.ox.ac.uk; xin.lu@ludwig.ox.ac.uk		Lu, Xin/0000-0002-6587-1152; Srinivas, Shankar/0000-0001-5726-7791; Royer, Christophe/0000-0002-9882-7676	Oxford Stem Cell Institute Fellowship from the Oxford Martin School; Medical Research Council [MR/J000930/1]; BBSRC [BB/F011512/1, BB/J00989X/1] Funding Source: UKRI; MRC [MR/J000930/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J00989X/1, BB/F011512/1] Funding Source: researchfish	Oxford Stem Cell Institute Fellowship from the Oxford Martin School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CR was supported by an Oxford Stem Cell Institute Fellowship from the Oxford Martin School (http://www.oxfordmartin.ox.ac.uk/institutes/stem_cells/). XL was supported by the Medical Research Council (MR/J000930/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Hauri S, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304750; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Llanos S, 2011, J BIOL CHEM, V286, P43039, DOI 10.1074/jbc.M111.270751; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Skene-Arnold TD, 2013, BIOCHEM J, V449, P649, DOI 10.1042/BJ20120506; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Tordella L, 2013, P NATL ACAD SCI USA, V110, P17969, DOI 10.1073/pnas.1309362110; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024288; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	32	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111384	10.1371/journal.pone.0111384	http://dx.doi.org/10.1371/journal.pone.0111384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360797	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700097
J	Guo, SE; Bruce, A				Guo, Su-Er; Bruce, Anne			Improving Understanding of and Adherence to Pulmonary Rehabilitation in Patients with COPD: A Qualitative Inquiry of Patient and Health Professional Perspectives	PLOS ONE			English	Article							SOCIAL SUPPORT; SELF-EFFICACY; DROP-OUT; DISEASE; BARRIERS; PREDICTORS; ATTENDANCE; PEOPLE; MODEL	Objectives: Although patients with Chronic Obstructive Pulmonary Disease (COPD) who adhere to a pulmonary rehabilitation program are better able to manage their illness and experience a better health-related quality of life, pulmonary rehabilitation remains underused. This study aims to describe the experiences of patients who are in a pulmonary rehabilitation program, and explore the perceptions of both patients and health professionals about what improves effective pulmonary rehabilitation. Methods: A qualitative research design, including focus groups and individual interviews with 25 patients and 7 program health professionals, was used to obtain combined perspectives about the factors underpinning the COPD patient's reasons for participation in a rehabilitation program. Results: Three themes were derived from the descriptive content analysis: (1) building confidence, (2) a perception of immediate tangible results, and (3) being ready and having access to the program. Conclusions and Practical Implications: Qualitative findings from this study suggest that a patient's adherence to a COPD rehabilitation program can be improved by quickly building up the participant's confidence, promoting tangible results, and by timely recognizing and responding to the issues of readiness and access. Based on these findings, health care providers could develop strategies to better serve COPD patients who face multiple barriers to access and successfully complete a pulmonary rehabilitation program.	[Guo, Su-Er] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan; [Guo, Su-Er] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Chiayi, Taiwan; [Bruce, Anne] Univ Victoria, Sch Nursing, Victoria, BC, Canada	Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; University of Victoria	Guo, SE (corresponding author), Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan.	seguo@gw.cgust.edu.tw		Guo, Su-Er/0000-0001-8521-5331	Interdisciplinary Capacity Enhancement: Bridging Excellence in Respiratory Disease and Gender Studies (ICEBERGS) of BC - Canadian Institutes of Health Research	Interdisciplinary Capacity Enhancement: Bridging Excellence in Respiratory Disease and Gender Studies (ICEBERGS) of BC - Canadian Institutes of Health Research	The grant was supported by the Interdisciplinary Capacity Enhancement: Bridging Excellence in Respiratory Disease and Gender Studies (ICEBERGS) (http://www.zoominfo.com/CachedPage/?archive_id=0&page_id=1507660449&page_url=//www.icebergs.ubc.ca/about_icebergs/achievements.htm&page_ last_updated=2010-11-07T02:12:32&firstName=Pat&lastName=Camp) of BC funded by a grant from the Canadian Institutes of Health Research: SEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadana V, 2014, CHEST, V145, DOI 10.1378/chest.1788096; Arnold E, 2006, RESP MED, V100, P1716, DOI 10.1016/j.rmed.2006.02.007; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bentsen SB, 2013, SCAND J CARING SCI, V27, P905, DOI 10.1111/scs.12002; Brooks D, 1999, Can Respir J, V6, P55; Brooks D, 2007, CAN RESPIR J, V14, P87, DOI 10.1155/2007/951498; Corhay JL, 2014, INT J CHRONIC OBSTR, V9, P27, DOI 10.2147/COPD.S52012; Eitel P, 1998, PSYCHOL HEALTH, V13, P953, DOI 10.1080/08870449808407442; Fischer MJ, 2007, CLIN REHABIL, V21, P212, DOI 10.1177/0269215506070783; Fischer MJ, 2009, RESP MED, V103, P1564, DOI 10.1016/j.rmed.2008.11.020; Fraser DD, 2006, J ADV NURS, V55, P550, DOI 10.1111/j.1365-2648.2006.03946.x; Guba E., 2005, SAGE HDB QUALITATIVE, V3rd, P191; Harris D, 2008, BRIT J GEN PRACT, V58, P703, DOI 10.3399/bjgp08X342363; Hayton C, 2013, RESP MED, V107, P401, DOI 10.1016/j.rmed.2012.11.016; Holloway I., 2010, QUALITATIVE RES NURS; Johnson NA, 1998, PREV MED, V27, P56, DOI 10.1006/pmed.1997.0235; Johnston K, 2010, PHYSIOTHER CAN, V62, P368, DOI 10.3138/physio.62.4.368; Johnston KN, 2013, PRIM CARE RESP J, V22, P319, DOI 10.4104/pcrj.2013.00062; Jones SE, 2013, THORAX, V68, P1015, DOI 10.1136/thoraxjnl-2013-203576; Keating A, 2011, J PHYSIOTHER, V57, P183, DOI 10.1016/S1836-9553(11)70040-6; Keating A, 2011, CHRON RESP DIS, V8, P89, DOI 10.1177/1479972310393756; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Lomborg B, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P1; McAuley E, 2000, Exerc Sport Sci Rev, V28, P85; Ngamvitroj A, 2007, INT J NURS STUD, V44, P882, DOI 10.1016/j.ijnurstu.2006.03.001; Nigg CR, 2011, PSYCHOL SPORT EXERC, V12, P7, DOI 10.1016/j.psychsport.2010.04.004; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Prochaska J. O., 2002, TRANSTHEORETICAL MOD, P99; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; Prochaska JO, 2013, SYSTEMS PSYCHOTHERAP, P456; Puhan MA, 2014, CLIN CHEST MED, V35, P295, DOI 10.1016/j.ccm.2014.02.001; Rhodes RE, 2001, PERCEPT MOTOR SKILL, V93, P693, DOI 10.2466/PMS.93.7.693-703; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Rubi M, 2010, ARCH PHYS MED REHAB, V91, P364, DOI 10.1016/j.apmr.2009.09.025; Sabit R, 2008, RESP MED, V102, P819, DOI 10.1016/j.rmed.2008.01.019; Statistic Canada, 2014, TABL 1 RANK NUMB PER; World Health Organization, 2014, TOP 10 CAUS DEATH; World Health Organization, 2014, 10 LEAD CAUS DEATH W; Yang Pei-Shuan, 2005, J Nurs Res, V13, P97	41	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110835	10.1371/journal.pone.0110835	http://dx.doi.org/10.1371/journal.pone.0110835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2HU	25357128	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000027
J	Nussbaum, I; Weindling, E; Jubran, R; Cohen, A; Bar-Nun, S				Nussbaum, Inbal; Weindling, Esther; Jubran, Ritta; Cohen, Aviv; Bar-Nun, Shoshana			Deteriorated Stress Response in Stationary-Phase Yeast: Sir2 and Yap1 Are Essential for Hsf1 Activation by Heat Shock and Oxidative Stress, Respectively	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; NICOTINAMIDE RIBOSIDE; CALORIE RESTRICTION; GLUCOSE STARVATION; BINDING-PROTEIN; GENE-EXPRESSION; KEY FEATURES; LONGEVITY	Stationary-phase cultures have been used as an important model of aging, a complex process involving multiple pathways and signaling networks. However, the molecular processes underlying stress response of non-dividing cells are poorly understood, although deteriorated stress response is one of the hallmarks of aging. The budding yeast Saccharomyces cerevisiae is a valuable model organism to study the genetics of aging, because yeast ages within days and are amenable to genetic manipulations. As a unicellular organism, yeast has evolved robust systems to respond to environmental challenges. This response is orchestrated largely by the conserved transcription factor Hsf1, which in S. cerevisiae regulates expression of multiple genes in response to diverse stresses. Here we demonstrate that Hsf1 response to heat shock and oxidative stress deteriorates during yeast transition from exponential growth to stationary-phase, whereas Hsf1 activation by glucose starvation is maintained. Overexpressing Hsf1 does not significantly improve heat shock response, indicating that Hsf1 dwindling is not the major cause for Hsf1 attenuated response in stationary-phase yeast. Rather, factors that participate in Hsf1 activation appear to be compromised. We uncover two factors, Yap1 and Sir2, which discretely function in Hsf1 activation by oxidative stress and heat shock. In Delta yap1 mutant, Hsf1 does not respond to oxidative stress, while in Delta sir2 mutant, Hsf1 does not respond to heat shock. Moreover, excess Sir2 mimics the heat shock response. This role of the NAD(+)-dependent Sir2 is supported by our finding that supplementing NAD(+) precursors improves Hsf1 heat shock response in stationary-phase yeast, especially when combined with expression of excess Sir2. Finally, the combination of excess Hsf1, excess Sir2 and NAD(+) precursors rejuvenates the heat shock response.	[Nussbaum, Inbal; Weindling, Esther; Jubran, Ritta; Cohen, Aviv; Bar-Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Bar-Nun, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	shoshbn@tauex.tau.ac.il			Israel Science Foundation [384/11]	Israel Science Foundation(Israel Science Foundation)	Israel Science Foundation (www.isf.org.il) grant no. 384/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Cohen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044785; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Ferguson SB, 2005, GENETICS, V169, P1203, DOI 10.1534/genetics.104.034256; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; Gibney PA, 2013, P NATL ACAD SCI USA, V110, pE4393, DOI 10.1073/pnas.1318100110; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hashikawa N, 2004, MOL CELL BIOL, V24, P3648, DOI 10.1128/MCB.24.9.3648-3659.2004; Hashikawa N, 2007, J BIOL CHEM, V282, P10333, DOI 10.1074/jbc.M609708200; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; HOJ A, 1994, EMBO J, V13, P2617; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JAKOBSEN BK, 1988, MOL CELL BIOL, V8, P5040, DOI 10.1128/MCB.8.11.5040; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kennedy BK, 2005, CELL, V123, P548, DOI 10.1016/j.cell.2005.11.002; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu Xiao-Dong, 1996, Genes and Development, V10, P592, DOI 10.1101/gad.10.5.592; Longo V.D., 2004, SCI AGING KNOWLEDGE, V2004, ppe6; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; MCDANIEL D, 1989, MOL CELL BIOL, V9, P4789, DOI 10.1128/MCB.9.11.4789; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rahman MM, 2013, AGING CELL, V12, P554, DOI 10.1111/acel.12078; Raynes R, 2012, J BIOL CHEM, V287, P29045, DOI 10.1074/jbc.M112.353714; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; SEWELL AK, 1995, J BIOL CHEM, V270, P25079, DOI 10.1074/jbc.270.42.25079; Shore DE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002792; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; TORRES FAG, 1995, MOL CELL BIOL, V15, P5063; TUITE MF, 1988, NUCLEIC ACIDS RES, V16, P11845, DOI 10.1093/nar/16.24.11845; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Wang CL, 2008, GENETICS, V180, P1955, DOI 10.1534/genetics.108.094516; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200	74	11	11	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111505	10.1371/journal.pone.0111505	http://dx.doi.org/10.1371/journal.pone.0111505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356557	gold, Green Submitted, Green Published			2022-12-27	WOS:000346765000065
J	Yan, L; DeMars, LC				Yan, Lin; DeMars, Lana C.			Effects of a High-Fat Diet on Spontaneous Metastasis of Lewis Lung Carcinoma in Plasminogen Activator Inhibitor-1 Deficient and Wild-Type Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NEGATIVE BREAST-CANCER; FACTOR-ALPHA; PROSTATE-CANCER; ADIPOSE-TISSUE; IN-VIVO; RADICAL PROSTATECTOMY; METHYLSELENINIC ACID; CELL-ADHESION; OBESITY	This study investigated the effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma (LLC) in plasminogen activator inhibitor-1 deficient (PAI-1(-/-)) and wild-type mice. The high-fat diet increased the number of pulmonary metastases by 60% (p<0.01), tumor cross-sectional area by 82% (p<0.05) and tumor volume by 130% (p<0.05) compared to the AIN93G diet. Deficiency in PAI-1 reduced the number of metastases by 35% (p<0.01) compared to wildtype mice. In mice fed the high-fat diet, PAI-1 deficiency reduced tumor cross-sectional area by 52% (p<0.05) and tumor volume by 61% (p<0.05) compared to their wild-type counterparts; however, PAI-1 deficiency affected neither area nor volume in mice fed the AIN93G diet. Adipose and plasma concentrations of PAI-1 were significantly higher in high-fat fed wild-type mice than in their AIN93G-fed counterparts. Adipose and plasma PAI-1 were not detectable in PAI-1(-/-) mice regardless of the diet. Mice deficient in PAI-1 showed significantly greater plasma concentrations of monocyte chemotactic protein-1, tumor necrosis factor-alpha, leptin, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-1 and insulin compared to wild-type mice, indicating a compensatory overproduction of inflammatory cytokines, angiogenic factors and insulin in the absence of PAI-1. We conclude that PAI-1 produced by the host, including that by adipose tissue, promotes high-fat enhanced metastasis of LLC.	[Yan, Lin; DeMars, Lana C.] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA	United States Department of Agriculture (USDA)	Yan, L (corresponding author), USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA.	lin.yan@ars.usda.gov		yan, lin/0000-0003-3646-6374	U.S. Department of Agriculture, ARS, Research project [5450-51000-045-00D]	U.S. Department of Agriculture, ARS, Research project	Funding for this work was provided by the U.S. Department of Agriculture, ARS, Research project 5450-51000-045-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHBAROU A, 1994, CANCER RES, V54, P2372; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Algamas-Dimantov A, 2012, J LIPID RES, V53, P1056, DOI 10.1194/jlr.M021949; Almholt K, 2003, ONCOGENE, V22, P4389, DOI 10.1038/sj.onc.1206601; Amling CL, 2004, J CLIN ONCOL, V22, P439, DOI 10.1200/JCO.2004.03.132; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Barcelo-Coblijn G, 2009, PROG LIPID RES, V48, P355, DOI 10.1016/j.plipres.2009.07.002; Bassett WW, 2005, UROLOGY, V66, P1060, DOI 10.1016/j.urology.2005.05.040; Blake CM, 2009, OLIGONUCLEOTIDES, V19, P117, DOI 10.1089/oli.2008.0177; BRODT P, 1986, CANCER RES, V46, P2442; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Corn Refiners Association, 2006, CORN OIL; Czekay RP, 2004, EXP BIOL MED, V229, P1090, DOI 10.1177/153537020422901102; DANIELL HW, 1988, CANCER, V62, P429, DOI 10.1002/1097-0142(19880715)62:2<429::AID-CNCR2820620230>3.0.CO;2-4; Dool CJ, 2011, ENDOCR-RELAT CANCER, V18, P699, DOI 10.1530/ERC-11-0136; Eitzman DT, 1996, BLOOD, V87, P4718; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Fidler IJ, 1978, METHOD CANCER RES, P399; Fierz Y, 2010, DIABETES, V59, P686, DOI 10.2337/db09-1291; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Guo RP, 2006, J CANCER RES CLIN, V132, P547, DOI 10.1007/s00432-006-0097-5; Gutierrez LS, 2000, CANCER RES, V60, P5839; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hennan JK, 2005, J PHARMACOL EXP THER, V314, P710, DOI 10.1124/jpet.105.084129; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; JANICKE F, 1993, BREAST CANCER RES TR, V24, P195, DOI 10.1007/BF01833260; Kido A, 1999, CANCER LETT, V137, P209, DOI 10.1016/S0304-3835(98)00368-1; Kimura Y, 2007, NUTR CANCER, V59, P207, DOI 10.1080/01635580701499537; Kockx M, 1999, THROMB HAEMOSTASIS, V82, P1490; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; KRUITHOF EKO, 1988, THROMB HAEMOSTASIS, V59, P7; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Leik CE, 2006, J THROMB HAEMOST, V4, P2710, DOI 10.1111/j.1538-7836.2006.02244.x; LIU GH, 1995, INT J CANCER, V60, P501, DOI 10.1002/ijc.2910600413; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Maillard CM, 2008, CARCINOGENESIS, V29, P2236, DOI 10.1093/carcin/bgn204; Mavri A, 1999, ARTERIOSCL THROM VAS, V19, P1582, DOI 10.1161/01.ATV.19.6.1582; MCGILL JB, 1994, DIABETES, V43, P104, DOI 10.2337/diabetes.43.1.104; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Morange PE, 2000, ARTERIOSCL THROM VAS, V20, P1150, DOI 10.1161/01.ATV.20.4.1150; OKAHARA H, 1994, CANCER RES, V54, P3233; Ortega FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033233; Phoenix KN, 2010, BREAST CANCER RES TR, V123, P333, DOI 10.1007/s10549-009-0647-z; QUAX PHA, 1990, J BIOL CHEM, V265, P15560; Ree AH, 1997, CLIN CANCER RES, V3, P1623; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seetoo DQ, 2003, J SURG ONCOL, V82, P184, DOI 10.1002/jso.10210; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Tsuchiya H, 1997, ANTICANCER RES, V17, P313; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; WELCH DR, 1983, INVAS METAST, V3, P65; Yan L, 2014, CARCINOGENESIS, V35, P2308, DOI 10.1093/carcin/bgu153; Yan L, 2013, J AGR FOOD CHEM, V61, P9373, DOI 10.1021/jf401588h; Yan L, 2012, INT J CANCER, V131, P1260, DOI 10.1002/ijc.27355; Yan L, 2012, NUTR RES, V32, P458, DOI 10.1016/j.nutres.2012.05.006; Yan L, 2010, CLIN EXP METASTAS, V27, P581, DOI 10.1007/s10585-010-9347-7	62	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110869	10.1371/journal.pone.0110869	http://dx.doi.org/10.1371/journal.pone.0110869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356654	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000031
J	Huchzermeyer, C; Schlomberg, J; Welge-Lussen, U; Berendschot, TTJM; Pokorny, J; Kremers, J				Huchzermeyer, Cord; Schlomberg, Juliane; Welge-Luessen, Ulrich; Berendschot, Tos T. J. M.; Pokorny, Joel; Kremers, Jan			Macular Pigment Optical Density Measured by Heterochromatic Modulation Photometry	PLOS ONE			English	Article							FLICKER PHOTOMETRY; GANGLION-CELLS; LUTEIN SUPPLEMENTATION; HUMAN OBSERVERS; IN-VIVO; SENSITIVITY; LUMINANCE; PHOTORECEPTORS; REFLECTOMETRY; DEGENERATION	Purpose: To psychophysically determine macular pigment optical density (MPOD) employing the heterochromatic modulation photometry (HMP) paradigm by estimating 460 nm absorption at central and peripheral retinal locations. Methods: For the HMP measurements, two lights (B: 460 nm and R: 660 nm) were presented in a test field and were modulated in counterphase at medium or high frequencies. The contrasts of the two lights were varied in tandem to determine flicker detection thresholds. Detection thresholds were measured for different R: B modulation ratios. The modulation ratio with minimal sensitivity (maximal threshold) is the point of equiluminance. Measurements were performed in 25 normal subjects (11 male, 14 female; age: 30 +/- 11 years, mean +/- sd) using an eight channel LED stimulator with Maxwellian view optics. The results were compared with those from two published techniques - one based on heterochromatic flicker photometry (Macular Densitometer) and the other on fundus reflectometry (MPR). Results: We were able to estimate MPOD with HMP using a modified theoretical model that was fitted to the HMP data. The resultant MPODHMP values correlated significantly with the MPODMPR values and with the MPODHFP values obtained at 0.25 degrees and 0.5 degrees retinal eccentricity. Conclusions: HMP is a flicker-based method with measurements taken at a constant mean chromaticity and luminance. The data can be well fit by a model that allows all data points to contribute to the photometric equality estimate. Therefore, we think that HMP may be a useful method for MPOD measurements, in basic and clinical vision experiments.	[Huchzermeyer, Cord; Schlomberg, Juliane; Welge-Luessen, Ulrich; Kremers, Jan] Univ Erlangen Nurnberg, Univ Eye Hosp Erlangen, D-91054 Erlangen, Germany; [Schlomberg, Juliane] Univ Med Berlin, Charite, Dept Ophthalmol, Berlin, Germany; [Berendschot, Tos T. J. M.] Univ Eye Clin Maastricht, Maastricht, Netherlands; [Pokorny, Joel] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA	University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Maastricht University; Maastricht University Medical Centre (MUMC); University of Chicago	Huchzermeyer, C (corresponding author), Univ Erlangen Nurnberg, Univ Eye Hosp Erlangen, D-91054 Erlangen, Germany.	Cord.Huchzermeyer@uk-erlangen.de; Jan.Kremers@uk-erlangen.de	Kremers, Jan/X-3125-2019; Berendschot, Tos TJM/M-8509-2016	Kremers, Jan/0000-0002-9293-7380; Berendschot, Tos TJM/0000-0002-8101-939X; Huchzermeyer, Cord/0000-0002-0408-8981	Erlanger Leistungsbezogene Anschub- und Nachwuchsfinanzierung (ELAN) der Universitat Erlangen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Erlangen Rotationsstelle	Erlanger Leistungsbezogene Anschub- und Nachwuchsfinanzierung (ELAN) der Universitat Erlangen; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Erlangen Rotationsstelle	Support was provided by Erlanger Leistungsbezogene Anschub- und Nachwuchsfinanzierung (ELAN) der Universitat Erlangen to CH (http://www.elan.med.uni-erlangen.de/); Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Erlangen Rotationsstelle to CH (http://www.izkf.med.uni-erlangen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 1969, P TEL HASHOMER HOSPI, V8, P2; Berendschot TT, 2005, EXP EYE RES, V81, P602, DOI 10.1016/j.exer.2005.03.019; Berendschot TTJM, 2000, INVEST OPHTH VIS SCI, V41, P3322; BONE RA, 1992, VISION RES, V32, P105, DOI 10.1016/0042-6989(92)90118-3; BONE RA, 1985, VISION RES, V25, P1531, DOI 10.1016/0042-6989(85)90123-3; Bone RA, 2004, VISION RES, V44, P3045, DOI 10.1016/j.visres.2004.07.008; Chucair AJ, 2007, INVEST OPHTH VIS SCI, V48, P5168, DOI 10.1167/iovs.07-0037; Delori FC, 2001, J OPT SOC AM A, V18, P1212, DOI 10.1364/JOSAA.18.001212; Engles M, 2007, INVEST OPHTH VIS SCI, V48, P2922, DOI 10.1167/iovs.06-0883; Howells O, 2011, GRAEF ARCH CLIN EXP, V249, P315, DOI 10.1007/s00417-010-1577-5; KAISER PK, 1988, VISION RES, V28, P455, DOI 10.1016/0042-6989(88)90186-1; KREMERS J, 1992, J OPT SOC AM A, V9, P1477, DOI 10.1364/JOSAA.9.001477; KREMERS J, 1993, VISION RES, V33, P1997, DOI 10.1016/0042-6989(93)90023-P; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; LENNIE P, 1993, J OPT SOC AM A, V10, P1283, DOI 10.1364/JOSAA.10.001283; Loughman J, 2012, INVEST OPHTH VIS SCI, V53, P7871, DOI 10.1167/iovs.12-10690; LUTZE M, 1990, VISION RES, V30, P149, DOI 10.1016/0042-6989(90)90134-7; Nolan JM, 2008, INVEST OPHTH VIS SCI, V49, P2134, DOI 10.1167/iovs.07-0933; NYGAARD RW, 1982, VISION RES, V22, P433, DOI 10.1016/0042-6989(82)90189-4; POKORNY J, 1989, J OPT SOC AM A, V6, P1618, DOI 10.1364/JOSAA.6.001618; POKORNY J, 1991, NATO ADV SCI I A-LIF, V203, P23; Pokorny J, 2004, VISUAL NEUROSCI, V21, P263, DOI 10.1017/S0952523804213207; POKORNY J, 1993, J OPT SOC AM A, V10, P1304, DOI 10.1364/JOSAA.10.001304; Puts MJH, 2005, J NEUROSCI METH, V142, P77, DOI 10.1016/j.jneumeth.2004.07.013; RUSHTON WAH, 1964, VISION RES, V4, P75, DOI 10.1016/0042-6989(64)90034-3; Shapiro AG, 1996, J OPT SOC AM A, V13, P2319, DOI 10.1364/JOSAA.13.002319; Sharpe LT, 2005, J VISION, V5, P948, DOI 10.1167/5.11.3; Snodderly DM, 2004, INVEST OPHTH VIS SCI, V45, P531, DOI 10.1167/iovs.03-0762; Stockman A, 2008, J VISION, V8, DOI 10.1167/8.16.1; Stringham JM, 2008, EXP EYE RES, V87, P445, DOI 10.1016/j.exer.2008.08.005; Sun H, 2001, COLOR RES APPL, V26, pS69, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL16>3.0.CO;2-A; van de Kraats J, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398925; van der Veen RLP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275481; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; vandeKraats J, 1996, VISION RES, V36, P2229, DOI 10.1016/0042-6989(96)00001-6; WALD G, 1945, SCIENCE, V101, P653, DOI 10.1126/science.101.2635.653; WALD G., 1949, DOCUMENTA OPHTHALMOL, V3, P94, DOI 10.1007/BF00162600; Wallstein R, 1981, THESIS U CHICAGO; Weigert G, 2011, INVEST OPHTH VIS SCI, V52, P8174, DOI 10.1167/iovs.11-7522; WERNER JS, 1987, VISION RES, V27, P257, DOI 10.1016/0042-6989(87)90188-X; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P33, DOI 10.1016/S0304-4165(97)00006-8; Wooten BR, 1999, INVEST OPHTH VIS SCI, V40, P2481	43	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110521	10.1371/journal.pone.0110521	http://dx.doi.org/10.1371/journal.pone.0110521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354049	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200029
J	Meek, PD; Ballard, GA; Fleming, PJS; Schaefer, M; Williams, W; Falzon, G				Meek, Paul D.; Ballard, Guy-Anthony; Fleming, Peter J. S.; Schaefer, Michael; Williams, Warwick; Falzon, Greg			Camera Traps Can Be Heard and Seen by Animals	PLOS ONE			English	Article							COLOR-VISION; WILDLIFE; COYOTES; RAT; EAR; LOCALIZATION; SENSITIVITY; THRESHOLDS; AUDIOGRAM; ABUNDANCE	Camera traps are electrical instruments that emit sounds and light. In recent decades they have become a tool of choice in wildlife research and monitoring. The variability between camera trap models and the methods used are considerable, and little is known about how animals respond to camera trap emissions. It has been reported that some animals show a response to camera traps, and in research this is often undesirable so it is important to understand why the animals are disturbed. We conducted laboratory based investigations to test the audio and infrared optical outputs of 12 camera trap models. Camera traps were measured for audio outputs in an anechoic chamber; we also measured ultrasonic (n = 5) and infrared illumination outputs (n = 7) of a subset of the camera trap models. We then compared the perceptive hearing range (n = 21) and assessed the vision ranges (n = 3) of mammals species (where data existed) to determine if animals can see and hear camera traps. We report that camera traps produce sounds that are well within the perceptive range of most mammals' hearing and produce illumination that can be seen by many species.	[Meek, Paul D.; Ballard, Guy-Anthony; Fleming, Peter J. S.; Falzon, Greg] Invas Anim CRC, Coffs Harbour, NSW, Australia; [Meek, Paul D.; Ballard, Guy-Anthony] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Armidale, NSW, Australia; [Meek, Paul D.; Ballard, Guy-Anthony; Fleming, Peter J. S.; Schaefer, Michael] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Fleming, Peter J. S.] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Orange, NSW, Australia; [Falzon, Greg] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Schaefer, Michael] CSIRO, Canberra, ACT, Australia; [Williams, Warwick] Natl Acoust Lab, Sydney, NSW, Australia	NSW Department of Primary Industries; University of New England; NSW Department of Primary Industries; University of New England; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Acoustic Laboratories	Meek, PD (corresponding author), Invas Anim CRC, Coffs Harbour, NSW, Australia.	paul.meek@invasiveanimals.com	Meek, Paul D/R-5019-2016; Falzon, Greg A/A-2657-2012	Falzon, Greg A/0000-0002-1989-9357; Ballard, Guy/0000-0002-0287-9720; Meek, Paul/0000-0002-3792-5723; Fleming, Peter/0000-0002-3490-6148				AITKIN LM, 1994, J COMP NEUROL, V349, P377, DOI 10.1002/cne.903490305; Arrese C, 2002, J ZOOL, V256, P151, DOI 10.1017/S0952836902000183; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bies DA, 2009, ENG NOISE CONTROL TH; Caughley G., 1977, ANAL VERTEBRATE POPU; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Cuevas A, 2006, COMPUT STAT DATA AN, V51, P1063, DOI 10.1016/j.csda.2005.10.012; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Ewer R.F., 1998, CARNIVORES; Gekeler F, 2006, VISION RES, V46, P357, DOI 10.1016/j.visres.2005.06.023; Gibeau M.L., 2009, WILDLIFE PROFESSIONA, V2009, P35; Gogoleva SS, 2008, BIOACOUSTICS, V18, P99, DOI 10.1080/09524622.2008.9753595; GRIFFIN DR, 1947, J OPT SOC AM, V37, P546, DOI 10.1364/JOSA.37.000546; GUNTER R, 1951, J PHYSIOL-LONDON, V114, P8, DOI 10.1113/jphysiol.1951.sp004599; HEFFNER H, 1980, J ACOUST SOC AM, V68, P1584, DOI 10.1121/1.385213; HEFFNER HE, 1983, BEHAV NEUROSCI, V97, P310, DOI 10.1037/0735-7044.97.2.310; HEFFNER HE, 1969, J AUD RES, V9, P12; HEFFNER HE, 1985, J COMP PSYCHOL, V99, P275, DOI 10.1037/0735-7036.99.3.275; Heffner H, 2010, J ACOUST SOC AM, V127, pEL111, DOI 10.1121/1.3284546; HEFFNER RS, 1992, J COMP NEUROL, V317, P219, DOI 10.1002/cne.903170302; HEFFNER RS, 1985, HEARING RES, V19, P85, DOI 10.1016/0378-5955(85)90100-5; HEFFNER RS, 1983, BEHAV NEUROSCI, V97, P299, DOI 10.1037/0735-7044.97.2.299; Hemmi JM, 2000, VISION RES, V40, P591, DOI 10.1016/S0042-6989(99)00210-2; Huang GT, 2000, J COMP PHYSIOL A, V186, P447, DOI 10.1007/s003590050444; Huang GT, 2002, J COMP PHYSIOL A, V188, P663, DOI 10.1007/s00359-002-0332-8; ISLEY TE, 1975, J MAMMAL, V56, P397, DOI 10.2307/1379369; Jackson LL, 1997, J COMP PSYCHOL, V111, P100, DOI 10.1037/0735-7036.111.1.100; Jacobs GH, 2010, OPHTHAL PHYSL OPT, V30, P422, DOI 10.1111/j.1475-1313.2010.00719.x; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; LEHNER PN, 1976, J WILDLIFE MANAGE, V40, P145, DOI 10.2307/3800169; Long RA, 2008, NONINVASIVE SURVEY M; Mahon PS, 1998, WILDLIFE RES, V25, P217, DOI 10.1071/WR97007_CO; Meek PD, 2012, WILDLIFE RES, V39, P649, DOI 10.1071/WR12138; Meek PD, 2013, AUST MAMMAL, V35, P123, DOI 10.1071/AM12014; Newbold HG, 2009, WILDLIFE RES, V36, P309, DOI 10.1071/WR08083; Newton-Fisher Nick, 1993, Bioacoustics, V5, P1; Pater L, 2000, TERRA BOREALIS, P22; PRICE MA, 1988, J ACOUST SOC AM, V84, P1836, DOI 10.1121/1.397150; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Sathyakumar S, 2011, MAMMALIA, V75, P257, DOI 10.1515/MAMM.2011.023; Schipper J., 2007, SMALL CARNIVORE CONS, V36, P38; Sequin ES, 2003, CAN J ZOOL, V81, P2015, DOI 10.1139/Z03-204; Signal T, 2001, PHYSIOL BEHAV, V73, P195, DOI 10.1016/S0031-9384(01)00446-2; SLINEY DH, 1976, J OPT SOC AM, V66, P339, DOI 10.1364/JOSA.66.000339; Sumner P, 2005, J EXP BIOL, V208, P1803, DOI 10.1242/jeb.01610; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; WEBSTER DB, 1971, BRAIN BEHAV EVOLUT, V4, P310, DOI 10.1159/000125441; Wegge P, 2004, ANIM CONSERV, V7, P251, DOI 10.1017/S1367943004001441; Windberg LA, 1996, CAN J ZOOL, V74, P2248, DOI 10.1139/z96-255	55	77	83	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110832	10.1371/journal.pone.0110832	http://dx.doi.org/10.1371/journal.pone.0110832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354356	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200042
J	Xu, J; Xu, T; Bu, XQ; Peng, H; Li, HM; Zhang, MZ; Zhang, YH				Xu, Juan; Xu, Tian; Bu, Xiaoqing; Peng, Hao; Li, Hongmei; Zhang, Mingzhi; Zhang, Yonghong			The Predictive Value of Waist-To-Height Ratio for Ischemic Stroke in a Population-Based Prospective Cohort Study among Mongolian Men in China	PLOS ONE			English	Article							INNER MONGOLIANS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; OBESITY; CIRCUMFERENCE; HYPERTENSION; ADULTS; TRENDS	Objective: To explore the associations between waist-to-height ratio (WHtR), body mass index (BMI) and waist circumference (WC) and risk of ischemic stroke among Mongolian men in China. Methods: A population-based prospective cohort study was conducted from June 2003 to July 2012 in Inner Mongolia, an autonomous region in north China. A total of 1034 men aged 20 years and older free of cardiovascular disease were included in the cohort and followed up for an average of 9.2 years. The subjects were divided into four groups by WHtR levels (WHtR<0.40, 0.40 <= WHtR <= 0.50, 0.50, WHtR <= 0.60, WHtR>0.60). The cumulative survival rates of ischemic stroke among the four groups were estimated with the Kaplan-Meier curves and compared by log-rank test. Cox proportional hazards models and Receiver Operating Characteristic (ROC) curves were employed to evaluate the associations between obesity indices and ischemic stroke. Results: A total of 47 ischemic stroke patients were observed during the follow-up period. The cumulative incidence and incidence density of ischemic stroke were 4.55% and 507.61/100 000 person-years, respectively. After the major risk factors were adjusted, individuals with WHtR>0.60 had a 3.56-fold increased risk of ischemic stroke compared with those with 0.40 <= WHtR <= 0.50. Hazard ratio (HR) and 95% confidence intervals (CI) of ischemic stroke for a 1-SD increase in WHtR was 1.34(95% CI: 1.00-1.81). After adding BMI or WC to models, higher WHtR remained significantly associated with increased risk of ischemic stroke. The Kaplan-Meier survival curves showed that the cumulative survival rate in the group with WHtR. 0.60 was significantly lower than in the group with 0.40 <= WHtR <= 0.50 (log-rank test, P = 0.025). The areas under the curve for each index were as follows: 0.586 for WHtR, 0.543 for WC; 0.566 for BMI. Conclusions: Higher WHtR is associated with risk of ischemic stroke in Mongolian males. WHtR may be useful in predicting ischemic stroke incidence in males.	[Xu, Juan; Xu, Tian; Bu, Xiaoqing; Peng, Hao; Li, Hongmei; Zhang, Mingzhi; Zhang, Yonghong] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China	Soochow University - China	Zhang, YH (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China.	yhzhang@suda.edu.cn	Peng, Hao/AAB-4759-2022; Peng, Hao/I-1134-2014	Peng, Hao/0000-0001-6277-662X	National Natural Science Foundation of China [81172761, 30972531]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by National Natural Science Foundation of China (Grant Nos. 81172761 and 30972531) and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI [10.2174/1876823701103010078, DOI 10.2174/1876823701103010078]; Ashwell M, 2011, NUTR TODAY, V46, P85, DOI DOI 10.1097/NT.0B013E3182118779; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Chiquete E, 2013, EUR NEUROL, V70, P117, DOI 10.1159/000350762; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; He J, 2014, JAMA-J AM MED ASSOC, V311, P479, DOI 10.1001/jama.2013.282543; He Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092763; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hu J, 2013, CHIN J DIS CONTROL P, V17, P302; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Shang WY, 2012, J NEUROL SCI, V314, P66, DOI 10.1016/j.jns.2011.10.029; Stepien M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-29; Tang LY, 2014, J HYPERTENS, V32, P1091, DOI 10.1097/HJH.0000000000000142; Tatsumi Y, 2013, J EPIDEMIOL, V23, P351, DOI 10.2188/jea.JE20130004; Terao S, 2008, STROKE, V39, P943, DOI 10.1161/STROKEAHA.107.494542; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wu Gui-xian, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P551; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xu T, 2013, STROKE, V44, P2457, DOI 10.1161/STROKEAHA.111.000648; [张春雨 Zhang Chunyu], 2014, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V30, P464; Zhang YH, 2010, J HYPERTENS, V28, P35, DOI 10.1097/HJH.0b013e3283324650; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	30	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110245	10.1371/journal.pone.0110245	http://dx.doi.org/10.1371/journal.pone.0110245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353632	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200018
J	Martinez-Silva, L; Manjarrez, E; Gutierrez-Ospina, G; Quevedo, JN				Martinez-Silva, Lourdes; Manjarrez, Elias; Gutierrez-Ospina, Gabriel; Quevedo, Jorge N.			Electrophysiological Representation of Scratching CPG Activity in the Cerebellum	PLOS ONE			English	Article							LATERAL RETICULAR NUCLEUS; PURKINJE-CELLS; ANTERIOR LOBE; SPINAL-CORD; CAT CEREBELLUM; SPINOCEREBELLAR PATHWAYS; FUNCTIONAL-ORGANIZATION; CORTICAL ACTIVITY; PARAVERMAL PART; LOCOMOTION	We analyzed the electrical activity of neuronal populations in the cerebellum and the lumbar spinal cord during fictive scratching in adult decerebrate cats before and after selective sections of the Spino-Reticulo Cerebellar Pathway (SRCP) and the Ventral-Spino Cerebellar Tract (VSCT). During fictive scratching, we found a conspicuous sinusoidal electrical activity, called Sinusoidal Cerebellar Potentials (SCPs), in the cerebellar vermis, which exhibited smaller amplitude in the paravermal and hemisphere cortices. There was also a significant spino-cerebellar coherence between these SCPs and the lumbar sinusoidal cord dorsum potentials (SCDPs). However, during spontaneous activity such spino-cerebellar coherence between spontaneous potentials recorded in the same regions decreased. We found that the section of the SRCP and the VSCT did not abolish the amplitude of the SCPs, suggesting that there are additional pathways conveying information from the spinal CPG to the cerebellum. This is the first evidence that the sinusoidal activity associated to the spinal CPG circuitry for scratching has a broad representation in the cerebellum beyond the sensory representation from hindlimbs previously described. Furthermore, the SCPs represent the global electrical activity of the spinal CPG for scratching in the cerebellar cortex.	[Martinez-Silva, Lourdes; Quevedo, Jorge N.] Biofis Neurociencias CINVESTAV, Dept Fisiol, Mexico City, DF, Mexico; [Manjarrez, Elias] BUAP, Inst Fisiol, Puebla, Mexico; [Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico	Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico	Manjarrez, E (corresponding author), BUAP, Inst Fisiol, Puebla, Mexico.	eliasmanjarrez@gmail.com; jquevedo@fisio.cinvestav.mx	Manjarrez, Elias/B-8492-2012	Manjarrez, Elias/0000-0002-3277-0101; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	CONACYT [36219-N, F1-62610]; VIEP-PIFI-Catedra Moshinsky, Mexico	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); VIEP-PIFI-Catedra Moshinsky, Mexico	This work was supported by CONACYT 36219-N (JQ), CONACyT F1-62610 (EM), and VIEP-PIFI-Catedra Moshinsky (EM), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1943, BRAIN, V66, P289, DOI 10.1093/brain/66.4.289; Alstermark B, 2013, J PHYSIOL-LONDON, V591, P5453, DOI 10.1113/jphysiol.2013.256669; ANTZIFEROVA LI, 1980, BRAIN RES, V200, P239, DOI 10.1016/0006-8993(80)90916-6; APPS R, 1989, NEUROSCI LETT, V102, P205, DOI 10.1016/0304-3940(89)90079-7; ARMSTRONG DM, 1984, J PHYSIOL-LONDON, V352, P403, DOI 10.1113/jphysiol.1984.sp015300; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V400, P425, DOI 10.1113/jphysiol.1988.sp017130; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V400, P405, DOI 10.1113/jphysiol.1988.sp017128; Arshavskii Yu. I., 1972, Biophysics, V17, P1169; ARSHAVSKY YI, 1984, BRAIN RES, V290, P33, DOI 10.1016/0006-8993(84)90733-9; ARSHAVSKY YI, 1980, BRAIN RES, V200, P249, DOI 10.1016/0006-8993(80)90917-8; ARSHAVSKY YI, 1984, EXP BRAIN RES, V54, P426; ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; ARSHAVSKY YI, 1978, BRAIN RES, V151, P479, DOI 10.1016/0006-8993(78)91081-8; CHAMBERS WW, 1955, ARCH NEURO PSYCHIATR, V74, P653, DOI 10.1001/archneurpsyc.1955.02330180071008; CLENDENIN M, 1974, BRAIN RES, V69, P136, DOI 10.1016/0006-8993(74)90378-3; CLENDENIN M, 1974, EXP BRAIN RES, V21, P473; COSTON JA, 1970, J PHYSIOL-PARIS, V62, P264; Cuellar CA, 2009, J NEUROSCI, V29, P798, DOI 10.1523/JNEUROSCI.3408-08.2009; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; DEGTYARENKO A M, 1990, Neirofiziologiya, V22, P123; DEGTYARENKO A M, 1991, Neirofiziologiya, V23, P142; Deliagina T G, 1977, Neirofiziologiia, V9, P619; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Gallarda BW, 2010, ANN NY ACAD SCI, V1198, P133, DOI 10.1111/j.1749-6632.2010.05437.x; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Grinsted A. M. J., 2004, CROSSWAVELET WAVELET; Hamm TM, 2001, METH NE FRO NEUROSCI, P135; JASMIN L, 1994, NEUROSCIENCE, V58, P275, DOI 10.1016/0306-4522(94)90034-5; KUHTA PC, 1990, J NEUROPHYSIOL, V64, P1653, DOI 10.1152/jn.1990.64.6.1653; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; LUNDBERG A, 1962, ACTA PHYSIOL SCAND, V54, P252, DOI 10.1111/j.1748-1716.1962.tb02350.x; Malakhovskaya D B, 1965, Fed Proc Transl Suppl, V24, P665; Martinez-Silva L, 2011, FOS LIKE IMMUNOREACT; Mor Y, 2007, J NEUROPHYSIOL, V98, P2807, DOI 10.1152/jn.00740.2007; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; ORLOVSKII G N, 1972, Biophysics (English Translation of Biofizika), V17, P935; Orlovskii G. N., 1972, Biophysics, V17, P1177; Orlovsky GN, 1999, NEURONAL CONTROL LOC, P215; ORSAL D, 1988, BEHAV BRAIN RES, V28, P159, DOI 10.1016/0166-4328(88)90092-7; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Ozden I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042650; Perez T, 2009, J NEUROSCI, V29, P10254, DOI 10.1523/JNEUROSCI.1737-09.2009; Person AL, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00097; SCHWARTZ AB, 1987, EXP BRAIN RES, V67, P323; Smith SS, 1998, NEUROSCIENCE, V82, P69; Stecina K, 2013, J PHYSIOL-LONDON, V591, P5433, DOI 10.1113/jphysiol.2012.249110; Tapia JA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.129; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; UDO M, 1980, J NEUROPHYSIOL, V44, P119, DOI 10.1152/jn.1980.44.1.119; UDO M, 1981, EXP BRAIN RES, V41, P292; Valle MS, 2008, EXP BRAIN RES, V187, P359, DOI 10.1007/s00221-008-1311-2; Valle MS, 2012, EXP BRAIN RES, V216, P349, DOI 10.1007/s00221-011-2938-y; VIALA G, 1970, CR ACAD SCI D NAT, V271, P688; VINAY L, 1993, EXP BRAIN RES, V97, P61; XU Q, 1994, J COMP NEUROL, V345, P288, DOI 10.1002/cne.903450210; Xu QY, 2005, EXP BRAIN RES, V162, P250, DOI 10.1007/s00221-004-2132-6	56	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109936	10.1371/journal.pone.0109936	http://dx.doi.org/10.1371/journal.pone.0109936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350378	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100015
J	Savanur, MA; Eligar, SM; Pujari, R; Chen, C; Mahajan, P; Borges, A; Shastry, P; Ingle, A; Kalraiya, RD; Swamy, BM; Rhodes, JM; Yu, LG; Inamdar, SR				Savanur, Mohammed Azharuddin; Eligar, Sachin M.; Pujari, Radha; Chen, Chen; Mahajan, Pravin; Borges, Anita; Shastry, Padma; Ingle, Arvind.; Kalraiya, Rajiv D.; Swamy, Bale M.; Rhodes, Jonathan M.; Yu, Lu-Gang; Inamdar, Shashikala R.			Sclerotium rolfsii Lectin Induces Stronger Inhibition of Proliferation in Human Breast Cancer Cells than Normal Human Mammary Epithelial Cells by Induction of Cell Apoptosis	PLOS ONE			English	Article							FRIEDENREICH CARBOHYDRATE ANTIGEN; PLANT-LECTINS; TF-ANTIGEN; ACTIVATION; GLYCOPROTEIN; MECHANISMS	Scleratium rolfsii lectin (SRL) isolated from the phytopathogenic fungus Scierotiurn rolfsii has exquisite binding towards O-linked, Thomsen-Freidenreich (Gal beta 1-3GaINAc alpha l-Ser/Thr, TF) associated glycans. This study invest nfluence of SRL on proliferation of human breast cancer cells (MCF-7 and ZR-75), non-turriorigenic breast epithelial cells MCF-10A) and normal mammary epithelial cells (HMECs). SRL caused marked, dose-dependent, inhibition of proliferation of CF-7 and ZR-75 cells but only weak inhibition of proliferation of non-tumorigenic MCF-10A and HMEC cells. The inhibitory effect of SRL on cancer cell proliferation was shown to be a consequence of SRL. cell surface binding and subsequent induction of cellular apoptosis, an effect that was largely prevented by the presence of inhibitors against caspases -8, or histochemistry using biotin-labelled SRL showed little binding of SRL to normal human breast tissue but intense Lies. In conclusion, SRL inhibits he growth of human breast cancer cells via induction of cell apoptosis but has subs ally less effect on normal epithelial cells. As a lectin that binds specifically to a cancer-associated glycan, has potential to be developed as an anti-cancer agent	[Savanur, Mohammed Azharuddin; Eligar, Sachin M.; Swamy, Bale M.; Inamdar, Shashikala R.] Karnatak Univ, Dept Studies Biochem, Dharwad, Karnataka, India; [Savanur, Mohammed Azharuddin; Eligar, Sachin M.; Chen, Chen; Swamy, Bale M.; Rhodes, Jonathan M.; Yu, Lu-Gang; Inamdar, Shashikala R.] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Ingle, Arvind.; Kalraiya, Rajiv D.] Adv Ctr Treatment Res & Educ Canc, Kharghar, Navi Mumabi, India; [Mahajan, Pravin; Borges, Anita] SL Raheja Hosp, Bombay, Maharashtra, India; [Pujari, Radha; Shastry, Padma] Natl Ctr Cell Sci, Pune, Maharashtra, India	Karnatak University; University of Liverpool; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Inamdar, SR (corresponding author), Karnatak Univ, Dept Studies Biochem, Dharwad, Karnataka, India.	pinkisri2001@yahoo.co.in			UKIERI from British Council [5A006/2008]; Department of Bio-Technology (DBT), New-Delhi, India [BT/PR11017/MED/ 30/122/2008]; UGC; UPE; CPEPA programme	UKIERI from British Council; Department of Bio-Technology (DBT), New-Delhi, India(Department of Biotechnology (DBT) India); UGC(University Grants Commission, India); UPE; CPEPA programme	This work was supported by UKIERI (5A006/2008) from British Council, Department of Bio-Technology (DBT), New-Delhi, India (No. BT/PR11017/MED/ 30/122/2008) and received partial support from UGC sponsored UPE and CPEPA programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe PC, 2003, PROG NEURO-PSYCHOPH, V27, P199, DOI 10.1016/S0278-5846(03)00016-2; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BOLAND CR, 1991, CANCER RES, V51, P657; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Chachadi VB, 2011, GLYCOCONJ J, V28, P2849; Cruijsen HV, 2009, BMC CANCER, V9, P180; DUK M, 1994, ANAL BIOCHEM, V221, P266, DOI 10.1006/abio.1994.1410; Eligar SM, 2012, CELL PROLIFERAT, V45, P397, DOI 10.1111/j.1365-2184.2012.00831.x; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Gambi N, 2008, BIOCHEM PHARMACOL, V75, P2356, DOI 10.1016/j.bcp.2008.03.015; Goldman M., 1968, FLUORESCENT ANTIBODY, P101; GREEN DR, 1995, CURR OPIN IMMUNOL, V7, P694, DOI 10.1016/0952-7915(95)80079-4; Hanisch FG, 1997, HISTOL HISTOPATHOL, V12, P263; Heimburg-Molinaro J, 2009, NEOPLASIA, V11, P780, DOI 10.1593/neo.09504; Inamdar SR, 2012, GLYCOBIOLOGY, V22, P1227, DOI 10.1093/glycob/cws090; Leonidas DD, 2007, J MOL BIOL, V368, P1145, DOI 10.1016/j.jmb.2007.02.092; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; MODY R, 1995, J PHARMACOL TOX MET, V33, P1, DOI 10.1016/1056-8719(94)00052-6; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Samraj AN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00033; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Swamy BM, 2004, GLYCOBIOLOGY, V14, P951, DOI 10.1093/glycob/cwh130; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Wyllie AH, 1997, BRIT MED BULL, V53, P451; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3	27	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110107	10.1371/journal.pone.0110107	http://dx.doi.org/10.1371/journal.pone.0110107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364905	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100015
J	Zhang, XL; Wang, N; Chen, P; Gao, MM; Liu, J; Wang, YF; Zhao, TJ; Li, Y; Gai, JY				Zhang, Xiaolian; Wang, Ning; Chen, Pei; Gao, Mengmeng; Liu, Juge; Wang, Yufeng; Zhao, Tuanjie; Li, Yan; Gai, Junyi			Overexpression of a Soybean Ariadne-Like Ubiquitin Ligase Gene GmARl1 Enhances Aluminum Tolerance in Arabidopsis	PLOS ONE			English	Article							DNA-DAMAGE; OXIDATIVE STRESS; RBR FAMILY; E3 LIGASE; RING; ACID; PARKIN; GROWTH; TOXICITY; DETOXIFICATION	Ariadne (ARI) subfamily of RBR (Ring Between Ring fingers) proteins have been found as a group of putative E3 ubiquitin ligases containing RING (Really Interesting New Gene) finger domains in fruitfly, mouse, human and Arabidopsis. Recent studies showed several RING-type E3 ubiquitin ligases play important roles in plant response to abiotic stresses, but the function of ARI in plants is largely unknown. In this study, an ariadne-like E3 ubiquitin ligase gene was isolated from soybean, Glycine max (L.) Merr., and designated as GmARI1. It encodes a predicted protein of 586 amino acids with a RBR supra-domain. Subcellular localization studies using Arabidopsis protoplast cells indicated GmARI protein was located in nucleus. The expression of GmARI1 in soybean roots was induced as early as 2-4 h after simulated stress treatments such as aluminum, which coincided with the fact of aluminum toxicity firstly and mainly acting on plant roots. In vitro ubiquitination assay showed GmARI1 protein has E3 ligase activity. Overexpression of GmARI1 significantly enhanced the aluminum tolerance of transgenic Arabidopsis. These findings suggest that GmARI1 encodes a RBR type E3 ligase, which may play important roles in plant tolerance to aluminum stress.	[Zhang, Xiaolian; Wang, Ning; Chen, Pei; Gao, Mengmeng; Liu, Juge; Wang, Yufeng; Zhao, Tuanjie; Li, Yan; Gai, Junyi] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Key Lab Biol & Genet Improvement Soybean, Natl Ctr Soybean Improvement,Minist Agr, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Li, Y (corresponding author), Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Key Lab Biol & Genet Improvement Soybean, Natl Ctr Soybean Improvement,Minist Agr, Nanjing, Jiangsu, Peoples R China.	yanli1@njau.edu.cn; sri@njau.edu.cn	Li, Yan/AAF-5886-2019	Li, Yan/0000-0002-1627-7763	National Hightech R & D Program of China [2013AA102602]; National Key Basic Research Program of China [2011CB1093]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT13073]; Program for New Century Excellent Talents in University [NCET-12-0891]; MOE 111 Project [B08025]; Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province; Jiangsu Higher Education PAPD Program	National Hightech R & D Program of China(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); MOE 111 Project(Ministry of Education, China - 111 Project); Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province; Jiangsu Higher Education PAPD Program	This work was supported by the National Hightech R & D Program of China (2013AA102602), the National Key Basic Research Program of China (2011CB1093), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT13073), the Program for New Century Excellent Talents in University (NCET-12-0891), the MOE 111 Project (B08025), the Program for High-level Innovative and Entrepreneurial Talents in Jiangsu Province, and the Jiangsu Higher Education PAPD Program. The funders had no role in study design, data collection and analysis, decision or preparation of the manuscript.	Achary VMM, 2008, ECOTOX ENVIRON SAFE, V70, P300, DOI 10.1016/j.ecoenv.2007.10.022; Achary VMM, 2010, MUTAGENESIS, V25, P201, DOI 10.1093/mutage/gep063; Aguilera M, 2000, GENETICS, V155, P1231; Ardie SW, 2009, J EXP BOT, V60, P3491, DOI 10.1093/jxb/erp184; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Bartocci Cristina, 2013, Frontiers in Genetics, V4, P128, DOI 10.3389/fgene.2013.00128; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bromann PA, 2004, GENE EXPR PATTERNS, V4, P77, DOI 10.1016/S1567-133X(03)00146-7; Cheng MC, 2012, PLANT PHYSIOL, V158, P363, DOI 10.1104/pp.111.189738; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Du QL, 2010, MOL BIOL REP, V37, P685, DOI 10.1007/s11033-009-9535-1; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Foy CD, 1996, J PLANT NUTR, V19, P1361, DOI 10.1080/01904169609365205; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang BQ, 2001, CHINESE B BOT, V18, P385; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kunihiro S, 2011, PLANT SIGNAL BEHAV, V6, P611, DOI 10.4161/psb.6.5.14895; Lang-Mladek C, 2012, PHYSIOL PLANTARUM, V145, P527, DOI 10.1111/j.1399-3054.2011.01561.x; Lee DH, 2011, PLANT PHYSIOL, V156, P2011, DOI 10.1104/pp.111.177568; Liang CY, 2013, PLANT PHYSIOL, V161, P1347, DOI 10.1104/pp.112.208934; Liu Qiang, 2004, Yingyong Shengtai Xuebao, V15, P1641; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 2003, J INORG BIOCHEM, V97, P46, DOI 10.1016/S0162-0134(03)00245-9; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011579; Markkanen E, 2012, CELL CYCLE, V11, P1070, DOI 10.4161/cc.11.6.19448; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Nezames CD, 2012, PLANT CELL, V24, P608, DOI 10.1105/tpc.112.095596; Nian H, 1998, SOYBEAN SCI, V16, P191; NORUSIS MJ, 1990, SPSS ADV STAT USERS; Panda SK, 2013, MOL BIOTECHNOL, V54, P551, DOI 10.1007/s12033-012-9595-7; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; SAPRA VT, 1982, AGRON J, V74, P687, DOI 10.2134/agronj1982.00021962007400040022x; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; TAYLOR GJ, 1988, COMMUN SOIL SCI PLAN, V19, P1179, DOI 10.1080/00103628809368004; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xue YJ, 2008, J AGR FOOD CHEM, V56, P9676, DOI 10.1021/jf802001v; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.010417; Yin LN, 2010, PLANT PHYSIOL, V152, P1406, DOI 10.1104/pp.109.151449; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488	52	15	16	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111120	10.1371/journal.pone.0111120	http://dx.doi.org/10.1371/journal.pone.0111120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364908	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100051
J	Kayode, GA; Amoakoh-Coleman, M; Agyepong, IA; Ansah, E; Grobbee, DE; Klipstein-Grobusch, K				Kayode, Gbenga A.; Amoakoh-Coleman, Mary; Agyepong, Irene Akua; Ansah, Evelyn; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin			Contextual Risk Factors for Low Birth Weight: A Multilevel Analysis	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; PRETERM BIRTH; FETAL-GROWTH; COGNITIVE FUNCTION; HEART-DISEASE; COHORT; DETERMINANTS; PREDICTORS; MORTALITY; DRINKING	Background: Low birth weight (LBW) remains to be a leading cause of neonatal death and a major contributor to infant and under-five mortality. Its prevalence has not declined in the last decade in sub-Saharan Africa (SSA) and Asia. Some individual level factors have been identified as risk factors for LBW but knowledge is limited on contextual risk factors for LBW especially in SSA. Methods: Contextual risk factors for LBW in Ghana were identified by performing multivariable multilevel logistic regression analysis of 6,900 mothers dwelling in 412 communities that participated in the 2003 and 2008 Demographic and Health Surveys in Ghana. Results: Contextual-level factors were significantly associated with LBW: Being a rural dweller increased the likelihood of having a LBW infant by 43% (OR 1.43; 95% CI 1.01-2.01; P-value <0.05) while living in poverty-concentrated communities increased the risk of having a LBW infant twofold (OR 2.16; 95% CI 1.29-3.61; P-value <0.01). In neighbourhoods with a high coverage of safe water supply the odds of having a LBW infant reduced by 28% (OR 0.74; 95% CI 0.57-0.96; P-value <0.05). Conclusion: This study showed contextual risk factors to have independent effects on the prevalence of LBW infants. Being a rural dweller, living in a community with a high concentration of poverty and a low coverage of safe water supply were found to increase the prevalence of LBW infants. Implementing appropriate community-based intervention programmes will likely reduce the occurrence of LBW infants.	[Kayode, Gbenga A.; Amoakoh-Coleman, Mary; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Amoakoh-Coleman, Mary; Agyepong, Irene Akua; Ansah, Evelyn] Ghana Hlth Serv, Accra, Ghana; [Agyepong, Irene Akua] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa	Utrecht University; Utrecht University Medical Center; Ghana Health Service; University of Ghana; University of Witwatersrand	Kayode, GA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	g.a.kayode@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Kayode, Gabenga A./C-8992-2015	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Kayode, Gabenga A./0000-0001-6313-010X; Ansah, Evelyn/0000-0003-0401-8606; Agyepong, Irene Akua/0000-0002-0193-5882	Netherlands Organisation for Scientific Research/WOTRO Science for Development [07.45.102.00]	Netherlands Organisation for Scientific Research/WOTRO Science for Development	The authors appreciate Measures DHS for permission to analyse the Ghana DHS. GAK and MAC have been financially supported by the Netherlands Organisation for Scientific Research/WOTRO Science for Development (Grant Number: 07.45.102.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Heija A, 1998, J Obstet Gynaecol Res, V24, P141; Adekanmbi VT, 2013, MATERN CHILD NUTR, V9, P244, DOI 10.1111/j.1740-8709.2011.00361.x; [Anonymous], 2008, GHAN DEM HLTH SURV 2; [Anonymous], REP AD HOC COMM WHOL; [Anonymous], CAUS DEATHS CHILDR 5; [Anonymous], GIV BIRTH CAN COST; [Anonymous], INF HLTH LOW BIRTH W; [Anonymous], 2002, DHS DIMENSIONS, V4, P1; [Anonymous], 2003, GHAN DEM HLTH SURV 2; Antai D, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-6; Aragão Vânia Maria de Farias, 2004, Cad. Saúde Pública, V20, P57, DOI 10.1590/S0102-311X2004000100019; Channon AAR, 2011, J BIOSOC SCI, V43, P555, DOI 10.1017/S0021932011000198; Channon AR, MULTILEVEL MULTIPLE; Chhabra P, 2004, Asia Pac J Public Health, V16, P95, DOI 10.1177/101053950401600203; de Moraes AB, 2012, CAD SAUDE PUBLICA, V28, P2293, DOI 10.1590/S0102-311X2012001400008; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Forrester TE, 1996, BRIT MED J, V312, P156; Gao WZ, 2006, J PAEDIATR CHILD H, V42, P785, DOI 10.1111/j.1440-1754.2006.00978.x; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Grady SC, 2006, SOC SCI MED, V63, P3013, DOI 10.1016/j.socscimed.2006.08.017; Heaman M, 2013, PAEDIATR PERINAT EP, V27, P54, DOI 10.1111/ppe.12016; Hillemeier MM, 2007, J RURAL HEALTH, V23, P42, DOI 10.1111/j.1748-0361.2006.00066.x; Johnson K, 2004, DHS COMP REPORTS; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LAZZARONI F, 1993, EUR J EPIDEMIOL, V9, P599, DOI 10.1007/BF00211433; Leger J, 1997, BRIT MED J, V315, P341; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; MOELLER GL, 1989, SOCIOL INQ, V59, P208, DOI 10.1111/j.1475-682X.1989.tb00101.x; Nguyen N, 2004, INT J GYNECOL OBSTET, V86, P70, DOI 10.1016/j.ijgo.2004.04.003; Nkansah-Amankra S, 2010, MATERN CHILD HLTH J, V14, P215, DOI 10.1007/s10995-009-0447-4; Nobile CGA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-192; OCampo P, 1997, AM J PUBLIC HEALTH, V87, P1113, DOI 10.2105/AJPH.87.7.1113; Olsen P, 1998, PEDIATRICS, V102, P329, DOI 10.1542/peds.102.2.329; Osypuk TL, 2010, SOC SCI MED, V70, P550, DOI 10.1016/j.socscimed.2009.10.034; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Schothorst PF, 1996, J AM ACAD CHILD PSY, V35, P175, DOI 10.1097/00004583-199602000-00011; Sebayang SK, 2012, TROP MED INT HEALTH, V17, P938, DOI 10.1111/j.1365-3156.2012.03039.x; Shi L, 2004, J EPIDEMIOL COMMUN H, V58, P374, DOI 10.1136/jech.2003.013078; Silva AAM, 2005, PAEDIATR PERINAT EP, V19, P43, DOI 10.1111/j.1365-3016.2004.00624.x; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Sprauve ME, 1997, OBSTET GYNECOL, V89, P674, DOI 10.1016/S0029-7844(97)00078-1; UNICEF, MON SIT CHILDR WOM; Uthman OA, 2009, J TROP PEDIATRICS, V55, P109, DOI 10.1093/tropej/fmn093; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Whitaker H, 2005, J EXPO ANAL ENV EPID, V15, P138, DOI 10.1038/sj.jea.7500380; WHO, 1995, EXP COMM REP PHYS ST; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624	49	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109333	10.1371/journal.pone.0109333	http://dx.doi.org/10.1371/journal.pone.0109333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360709	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700011
J	Ouedraogo, S; Traore, B; Bi, ZABN; Yonli, FT; Kima, D; Bonane, P; Congo, L; Traore, RO; Ye, D; Marguet, C; Plantier, JC; Vabret, A; Gueudin, M				Ouedraogo, Solange; Traore, Blaise; Bi, Zah Ange Brice Nene; Yonli, Firmin Tiandama; Kima, Donatien; Bonane, Pierre; Congo, Lassane; Traore, Rasmata Ouedraogo; Ye, Diarra; Marguet, Christophe; Plantier, Jean-Christophe; Vabret, Astrid; Gueudin, Marie			Viral Etiology of Respiratory Tract Infections in Children at the Pediatric Hospital in Ouagadougou (Burkina Faso)	PLOS ONE			English	Article							SYNCYTIAL VIRUS; SOUTH-AFRICA; EPIDEMIOLOGY; INFANTS; MALARIA; COINFECTIONS; SEASONALITY; SEVERITY; ILLNESS; KENYA	Background: Acute respiratory infections (ARIs) are a major cause of morbidity and mortality in children in Africa. The circulation of viruses classically implicated in ARIs is poorly known in Burkina Faso. The aim of this study was to identify the respiratory viruses present in children admitted to or consulting at the pediatric hospital in Ouagadougou. Methods: From July 2010 to July 2011, we tested nasal aspirates of 209 children with upper or lower respiratory infection for main respiratory viruses (respiratory syncytial virus (RSV), metapneumovirus, adenovirus, parainfluenza viruses 1, 2 and 3, influenza A, B and C, rhinovirus/enterovirus), by immunofluorescence locally in Ouagadougou, and by PCR in France. Bacteria have also been investigated in 97 samples. Results: 153 children (73.2%) carried at least one virus and 175 viruses were detected. Rhinoviruses/enteroviruses were most frequently detected (rhinovirus n = 88; enterovirus n = 38) and were found to circulate throughout the year. An epidemic of RSV infections (n = 25) was identified in September/October, followed by an epidemic of influenza virus (n = 13), mostly H1N1pdm09. This epidemic occurred during the period of the year in which nighttime temperatures and humidity were at their lowest. Other viruses tested were detected only sporadically. Twenty-two viral co-infections were observed. Bacteria were detected in 29/97 samples with 22 viral/bacterial co-infections. Conclusions: This study, the first of its type in Burkina Faso, warrants further investigation to confirm the seasonality of RSV infection and to improve local diagnosis of influenza. The long-term objective is to optimize therapeutic management of infected children.	[Ouedraogo, Solange; Traore, Blaise; Bi, Zah Ange Brice Nene; Yonli, Firmin Tiandama; Kima, Donatien; Bonane, Pierre; Congo, Lassane; Traore, Rasmata Ouedraogo; Ye, Diarra] Charles Gaulle Pediat Univ Hosp, Ouagadougou, Burkina Faso; [Marguet, Christophe] Rouen Univ Hosp Charles Nicolle, INSERM, CIC204, EA3830,Allergy & CF Unit Resp Dis, Rouen, France; [Plantier, Jean-Christophe] Rouen Univ Hosp Charles Nicolle, GRAM EA 2656, Virol Lab, Rouen, France; [Vabret, Astrid] Caen Univ Hosp Clemenceau, Lab Human & Mol Virol, F-14032 Caen, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU de Caen NORMANDIE; Universite de Caen Normandie	Gueudin, M (corresponding author), Rouen Univ Hosp Charles Nicolle, GRAM EA 2656, Virol Lab, Rouen, France.	Marie.Gueudin@chu-rouen.fr		VABRET, Astrid/0000-0002-8940-7645; PLANTIER, Jean-Christophe/0000-0001-6417-4083	Sanofi Pasteur	Sanofi Pasteur	Sanofi Pasteur funded this study in its entirety. The funder approved the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; Ho A, 2010, J INFECTION, V60, P83, DOI 10.1016/j.jinf.2009.11.001; Karakitsos P, 2012, CLIN MICROBIOL INFEC; Kwofie TB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-78; Laurent C, 2012, PEDIATR INFECT DIS J, V31, P827, DOI 10.1097/INF.0b013e3182566005; Laxminarayan R., 2006, ACUTE RESP INFECT CH; Lillie PJ, 2012, TRAVEL MED INFECT DI, V10, P192, DOI 10.1016/j.tmaid.2012.03.008; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Marcone DN, 2013, PEDIATR INFECT DIS J, V32, pE105, DOI 10.1097/INF.0b013e31827cd06f; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Okiro EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052520; Onyango CO, 2012, J MED VIROL, V84, P823, DOI 10.1002/jmv.23251; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; TALL FR, 1994, ARCH PEDIATRIE, V1, P249; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	29	33	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110435	10.1371/journal.pone.0110435	http://dx.doi.org/10.1371/journal.pone.0110435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360527	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700035
J	Al Olaby, RR; Cocquerel, L; Zemla, A; Saas, L; Dubuisson, J; Vielmetter, J; Marcotrigiano, J; Khan, AG; Catalan, FV; Perryman, AL; Freundlich, JS; Forli, S; Levy, S; Balhorn, R; Azzazy, HM				Al Olaby, Reem R.; Cocquerel, Laurence; Zemla, Adam; Saas, Laure; Dubuisson, Jean; Vielmetter, Jost; Marcotrigiano, Joseph; Khan, Abdul Ghafoor; Catalan, Felipe Vences; Perryman, Alexander L.; Freundlich, Joel S.; Forli, Stefano; Levy, Shoshana; Balhorn, Rod; Azzazy, Hassan M.			Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; N-LINKED GLYCANS; ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; RECOMBINANT VACCINIA; AUTODOCK VINA; PROTEIN E2; CD81; BINDING; EXPRESSION	Hepatitis C Virus (HCV) infects 200 million individuals worldwide. Although several FDA approved drugs targeting the HCV serine protease and polymerase have shown promising results, there is a need for better drugs that are effective in treating a broader range of HCV genotypes and subtypes without being used in combination with interferon and/or ribavirin. Recently, two crystal structures of the core of the HCV E2 protein (E2c) have been determined, providing structural information that can now be used to target the E2 protein and develop drugs that disrupt the early stages of HCV infection by blocking E2' s interaction with different host factors. Using the E2c structure as a template, we have created a structural model of the E2 protein core (residues 421-645) that contains the three amino acid segments that are not present in either structure. Computational docking of a diverse library of 1,715 small molecules to this model led to the identification of a set of 34 ligands predicted to bind near conserved amino acid residues involved in the HCV E2: CD81 interaction. Surface plasmon resonance detection was used to screen the ligand set for binding to recombinant E2 protein, and the best binders were subsequently tested to identify compounds that inhibit the infection of Huh-7 cells by HCV. One compound, 281816, blocked E2 binding to CD81 and inhibited HCV infection in a genotype-independent manner with IC50' s ranging from 2.2 mu M to 4.6 mu M. 281816 blocked the early and late steps of cell-free HCV entry and also abrogated the cell-to-cell transmission of HCV. Collectively the results obtained with this new structural model of E2c suggest the development of small molecule inhibitors such as 281816 that target E2 and disrupt its interaction with CD81 may provide a new paradigm for HCV treatment.	[Al Olaby, Reem R.; Azzazy, Hassan M.] Amer Univ Cairo, Dept Chem, New Cairo, Egypt; [Cocquerel, Laurence; Saas, Laure; Dubuisson, Jean] Univ Lille North France, Pasteur Inst Lille, CNRS, Ctr Infect & Immun Lille,CNRS UMR8204,Inserm U019, Lille, France; [Zemla, Adam] Lawrence Livermore Natl Lab, Livermore, CA USA; [Vielmetter, Jost] CALTECH, Prot Express Ctr, Beckman Inst, Pasadena, CA 91125 USA; [Marcotrigiano, Joseph; Khan, Abdul Ghafoor] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Catalan, Felipe Vences; Levy, Shoshana] Stanford Univ, Ctr Med, Dept Med, Stanford, CA 94305 USA; [Perryman, Alexander L.; Freundlich, Joel S.] Rutgers State Univ, New Jersey Med Sch, Ctr Emerging & Reemerging Pathogens, Dept Med,Div Infect Dis, Newark, NJ USA; [Freundlich, Joel S.] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ USA; [Forli, Stefano] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Balhorn, Rod] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA	Egyptian Knowledge Bank (EKB); American University Cairo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; California Institute of Technology; Rutgers State University New Brunswick; Stanford University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Scripps Research Institute; University of California System; University of California Davis	Balhorn, R (corresponding author), SHAL Technol Inc, Livermore, CA 94550 USA.	rod@shaltech.com	Forli, Stefano/AFR-7638-2022; Marcotrigiano, Joseph/K-6697-2016; Cocquerel, Laurence/P-1951-2016; Azzazy, Hassan M. E./G-6831-2013; Khan, Abdul/P-1569-2016; Dubuisson, Jean/E-6813-2016	Forli, Stefano/0000-0002-5964-7111; Marcotrigiano, Joseph/0000-0003-0346-3353; Cocquerel, Laurence/0000-0002-2136-5178; Khan, Abdul/0000-0001-8600-8254; Azzazy, Hassan/0000-0003-2047-4222; Dubuisson, Jean/0000-0003-1626-7693	Yousif Jameel PhD Fellowship from The American University in Cairo; Alberta Innovates [201201140] Funding Source: researchfish	Yousif Jameel PhD Fellowship from The American University in Cairo(American University Cairo); Alberta Innovates	This work was conducted as part of the first authors PhD thesis work. This work was supported by a Yousif Jameel PhD Fellowship from The American University in Cairo awarded to Reem Al Olaby. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel Golo, 2013, Immune Netw, V13, P168, DOI 10.4110/in.2013.13.5.168; Allen MH, 2011, J CLIN PSYCHIAT, V72, P1313, DOI 10.4088/JCP.10m06011yel; Anwar MI, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-351; Asselah T, 2014, EXPERT OPIN PHARMACO, V15, P121, DOI 10.1517/14656566.2014.857656; BAN TA, 1982, INT PHARMACOPSYCHIAT, V17, P18, DOI 10.1159/000468553; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Brazzoli M, 2005, VIROLOGY, V332, P438, DOI 10.1016/j.virol.2004.11.034; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Carlsen THR, 2013, J VIROL, V87, P1385, DOI 10.1128/JVI.00684-12; Catanese MT, 2013, J VIROL, V87, P8282, DOI 10.1128/JVI.01102-13; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Colombo M, 2014, GUT, V63, P1150, DOI 10.1136/gutjnl-2013-305667; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Drummer HE, 2004, J BIOL CHEM, V279, P30066, DOI 10.1074/jbc.M405098200; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; El-Awady MK, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-66; Feneant L, 2014, VIRUSES-BASEL, V6, P535, DOI 10.3390/v6020535; Ferrer M, 1998, CLIN EXP IMMUNOL, V113, P346; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fofana I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064221; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; HORMAZABAL L, 1985, PSYCHOPHARMACOLOGY, V86, P205, DOI 10.1007/BF00431710; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kwentus J, 2012, BIPOLAR DISORD, V14, P31, DOI 10.1111/j.1399-5618.2011.00975.x; LANFORD RE, 1993, VIROLOGY, V197, P225, DOI 10.1006/viro.1993.1583; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Li YP, 2006, WORLD J GASTROENTERO, V12, P7126, DOI 10.3748/wjg.v12.i44.7126; Liu J, 2001, BIOTECHNOL APPL BIOC, V34, P109, DOI 10.1042/BA20010036; Luo RF, 2010, HUM PATHOL, V41, P271, DOI 10.1016/j.humpath.2009.07.022; Maher Alicia R, 2012, J Manag Care Pharm, V18, pS1; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Marks KM, 2012, ANTIVIR THER, V17, P1119, DOI 10.3851/IMP2424; Martinez-Donato G, 2007, MOL BIOTECHNOL, V35, P225, DOI 10.1007/BF02686008; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; *NIH MOL LIBR PROB, QHTS FOR INHIBITORS; *NIH MOL LIBR PROB, HTS ASSAY FOR ALLOST; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perryman AL, 2014, J COMPUT AID MOL DES, V28, P429, DOI 10.1007/s10822-014-9709-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Potel J, 2013, CELL MICROBIOL, V15, P1234, DOI 10.1111/cmi.12112; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Ray R, 2010, J INFECT DIS, V202, P862, DOI 10.1086/655902; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rodriguez-Rodriguez M, 2009, VIRUS RES, V139, P91, DOI 10.1016/j.virusres.2008.10.013; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; *SO RES I, HIGH THROUGHPUT SCRE; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Thase M. E., 2008, NEUROPSYCH DIS TREAT, V4, P21; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UHLIR F, 1975, ACTIV NERV SUPER, V17, P215; VanCompernolle SE, 2003, VIROLOGY, V314, P371, DOI 10.1016/S0042-6822(03)00406-9; Vausselin T, 2013, HEPATOLOGY, V58, P86, DOI 10.1002/hep.26273; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P899, DOI 10.1001/archneurol.2011.139; Whidby J, 2009, J VIROL, V83, P11078, DOI 10.1128/JVI.00800-09; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Yi MK, 1997, VIROLOGY, V231, P119, DOI 10.1006/viro.1997.8516; Yurkova MS, 2004, PROTEIN EXPRES PURIF, V37, P119, DOI 10.1016/j.pep.2004.05.016; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zemla AT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-226; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x; Zhang YY, 2010, J VIROL, V84, P3396, DOI 10.1128/JVI.02391-09	99	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111333	10.1371/journal.pone.0111333	http://dx.doi.org/10.1371/journal.pone.0111333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357246	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000346765000052
J	Doron, L; Coppenhagen-Glazer, S; Ibrahim, Y; Eini, A; Naor, R; Rosen, G; Bachrach, G				Doron, Lior; Coppenhagen-Glazer, Shunit; Ibrahim, Yara; Eini, Amir; Naor, Ronit; Rosen, Graciela; Bachrach, Gilad			Identification and Characterization of Fusolisin, the Fusobacterium nucleatum Autotransporter Serine Protease	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; PORPHYROMONAS-GINGIVALIS; ESCHERICHIA-COLI; PERIODONTAL BACTERIA; TREPONEMA-DENTICOLA; OUTER-MEMBRANE; PRETERM BIRTH; SECRETION; COAGGREGATION; PLAQUE	Fusobacterium nucleatum is an oral anaerobe associated with periodontal disease, adverse pregnancy outcomes and colorectal carcinoma. A serine endopeptidase of 61-65 kDa capable of damaging host tissue and of inactivating immune effectors was detected previously in F. nucleatum. Here we describe the identification of this serine protease, named fusolisin, in three oral F. nucleatum sub-species. Gel zymogram revealed fusobacterial proteolytic activity with molecular masses ranging from 55-101 kDa. All of the detected proteases were inhibited by the serine protease inhibitor PMSF. analysis revealed that all of the detected proteases are encoded by genes encoding an open reading frame (ORF) with a calculated mass of approximately 115 kDa. Bioinformatics analysis of the identified ORFs demonstrated that they consist of three domains characteristic of autotransporters of the type Va secretion system. Our results suggest that the F. nucleatum fusolisins are derived from a precursor of approximately 115 kDa. After crossing the cytoplasmic membrane and cleavage of the leader sequence, the C-terminal autotransporter domain of the remaining 96-113 kDa protein is embedded in the outer membrane and delivers the N-terminal S8 serine protease passenger domain to the outer cell surface. In most strains the N-terminal catalytic 55-65 kDa domain self cleaves and liberates itself from the autotransporter domain after its transfer across the outer cell membrane. In F. nucleatum ATCC 25586 this autocatalytic activity is less efficient resulting in a full length membrane-anchored serine protease. The mature serine protease was found to cleave after Thr, Gly, Ala and Leu residues at the P1 position. Growth of F. nucleatum in complex medium was inhibited when serine protease inhibitors were used. Additional experiments are needed to determine whether fusolisin might be used as a target for controlling fusobacterial infections.	[Doron, Lior; Coppenhagen-Glazer, Shunit; Ibrahim, Yara; Eini, Amir; Naor, Ronit; Rosen, Graciela; Bachrach, Gilad] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Dent Med, Inst Dent Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Bachrach, G (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Dent Med, Inst Dent Sci, Jerusalem, Israel.	giladba@ekmd.huji.ac.il		Bachrach, Gilad/0000-0003-1350-2280	Israel Science Foundation [208/10]; United States-Israel Binational Science Foundation [2005084]	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the Israel Science Foundation (grant 208/10) and in part by the United States-Israel Binational Science Foundation (grant number 2005084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach G, 2004, APPL ENVIRON MICROB, V70, P6957, DOI 10.1128/AEM.70.12.6957-6962.2004; Bachrach G, 2004, ORAL MICROBIOL IMMUN, V19, P155, DOI 10.1111/j.0902-0055.2004.00132.x; BAKKEN V, 1989, SCAND J DENT RES, V97, P42; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; BROKSTAD KA, 1990, FEMS MICROBIOL LETT, V66, P235; BROKSTAD KA, 1991, SCAND J DENT RES, V99, P20; Canizalez-Roman A, 2003, MOL MICROBIOL, V48, P947, DOI 10.1046/j.1365-2958.2003.03492.x; Coutte L, 2003, MOL MICROBIOL, V49, P529, DOI 10.1046/j.1365-2958.2003.03573.x; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Desvaux M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/j.bbamem.2005.05.002; Eini A, 2013, ANAEROBE, V22, P20, DOI 10.1016/j.anaerobe.2013.04.014; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; GHARBIA SE, 1991, ORAL MICROBIOL IMMUN, V6, P264, DOI 10.1111/j.1399-302X.1991.tb00489.x; GHARBIA SE, 1992, INT J SYST BACTERIOL, V42, P296, DOI 10.1099/00207713-42-2-296; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Haake SK, 2006, PLASMID, V55, P27, DOI 10.1016/j.plasmid.2005.06.002; Haake SK, 2000, J BACTERIOL, V182, P1176, DOI 10.1128/JB.182.4.1176-1180.2000; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Henderson IR, 2000, TRENDS MICROBIOL, V8, P534, DOI 10.1016/S0966-842X(00)01884-9; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Higgins D G, 1994, Methods Mol Biol, V25, P307; HILL GB, 1993, CLIN INFECT DIS, V16, pS423, DOI 10.1093/clinids/16.Supplement_4.S423; HOLT S C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P177; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kaplan A, 2014, MICROB ECOL; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4584, DOI 10.1128/IAI.63.12.4584-4588.1995; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lievin-Le Moal V, 2011, CELL MICROBIOL, V13, P992, DOI 10.1111/j.1462-5822.2011.01595.x; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Ogawa AT, 2006, J ENDODONT, V32, P521, DOI 10.1016/j.joen.2005.10.045; Orth D, 2010, INFECT IMMUN, V78, P4294, DOI 10.1128/IAI.00488-10; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; ROGERS AH, 1991, ORAL MICROBIOL IMMUN, V6, P250, DOI 10.1111/j.1399-302X.1991.tb00486.x; Rogers AH, 1998, ANAEROBE, V4, P111, DOI 10.1006/anae.1997.0140; Rosen G, 2006, FEMS MICROBIOL LETT, V256, P304, DOI 10.1111/j.1574-6968.2006.00131.x; Rosen G, 2003, INFECT IMMUN, V71, P3652, DOI 10.1128/IAI.71.6.3652-3656.2003; Rosen G, 2012, INFECT IMMUN, V80, P1107, DOI 10.1128/IAI.05903-11; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Shah H N, 1987, Chemioterapia, V6, P16; SHAH HN, 1989, INFECTION, V17, P264, DOI 10.1007/BF01639537; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Siezen RJ, 2007, PROTEINS, V67, P681, DOI 10.1002/prot.21290; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sol A, 2014, J BIOL CHEM; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Villaseca JM, 2000, INFECT IMMUN, V68, P5920, DOI 10.1128/IAI.68.10.5920-5927.2000; Wilkins MR, 1999, METH MOL B, V112, P531; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Wing HJ, 2005, INFECT IMMUN, V73, P1217, DOI 10.1128/IAI.73.2.1217-1220.2005; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yoneda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099263	68	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111329	10.1371/journal.pone.0111329	http://dx.doi.org/10.1371/journal.pone.0111329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357190	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000051
J	Liao, KL; Bai, XF; Friedman, A				Liao, Kang-Ling; Bai, Xue-Feng; Friedman, Avner			Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis	PLOS ONE			English	Article							REGULATORY T-CELLS; EPSTEIN-BARR-VIRUS; TGF-BETA; PERIPHERAL-BLOOD; HIV-1 INFECTION; BREAST-CANCER; GM-CSF; IL-35; EXPRESSION; MACROPHAGES	Interleukin-35 (IL-35), a cytokine from the Interleukin-12 cytokine family, has been considered as an anti-inflammatory cytokine which promotes tumor progression and tumor immune evasion. It has also been demonstrated that IL-35 is secreted by regulatory T cells. Recent mouse experiments have shown that IL-35 produced by cancer cells promotes tumor growth via enhancing myeloid cell accumulation and angiogenesis, and reducing the infiltration of activated CD8(+) T cells into tumor microenvironment. In the present paper we develop a mathematical model based on these experimental results. We include in the model an anti-IL-35 drug as treatment. The extended model (with drug) is used to design protocols of anti-IL-35 injections for treatment of cancer. We find that with a fixed total amount of drug, continuous injection has better efficacy than intermittent injections in reducing the tumor load while the treatment is ongoing. We also find that the percentage of tumor reduction under anti-IL-35 treatment improves when the production of IL-35 by cancer is increased.	[Liao, Kang-Ling; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Bai, Xue-Feng] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liao, KL (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	liao.92@mbi.osu.edu	Bai, Xue-feng/E-2681-2011; Bai, Xue-Feng/H-5164-2013	Bai, Xue-Feng/0000-0001-9476-8376	National Science Council of Taiwan, R. O. C. [NSC 101-2917-I-564-062]; National Science Foundation, Division of Mathematical Sciences [DMS. 0931642]; National Cancer Institute [R01CA138427]; American Cancer Society [RSG-09-188-01-LIB]; NATIONAL CANCER INSTITUTE [R01CA138427] Funding Source: NIH RePORTER	National Science Council of Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan); National Science Foundation, Division of Mathematical Sciences(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in part, by the National Science Council of Taiwan, R. O. C. (http://web1.nsc.gov.tw/) under No. NSC 101-2917-I-564-062, the National Science Foundation, Division of Mathematical Sciences (http://www.nsf.gov/) under Agreement DMS. 0931642, the National Cancer Institute (http:// www.cancer.gov/) under R01CA138427, and American Cancer Society (http://www.cancer. org/) under RSG-09-188-01-LIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Baek HJ, 2006, BIOCHEM BIOPH RES CO, V346, P1150, DOI 10.1016/j.bbrc.2006.05.195; Boelte KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018534; Breward CJW, 2001, EUR J APPL MATH, V12, P529, DOI 10.1017/S095679250100448X; BUTTERWORTH AE, 1967, BRIT J CANCER, V21, P373, DOI 10.1038/bjc.1967.43; CASCIARI JJ, 1988, CANCER RES, V48, P3905; Chaplain MAJ, 1995, ACTA BIOTHEOR, V43, P387, DOI 10.1007/BF00713561; CHAPLAIN MAJ, 1995, J MATH BIOL, V33, P744; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; DiLeo MV, 2009, ANN BIOMED ENG, V37, P222, DOI 10.1007/s10439-008-9587-8; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Eubank TD, 2004, IMMUNITY, V21, P831, DOI 10.1016/j.immuni.2004.10.011; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Freeman BJ, 1999, BLOOD, V94, P2142, DOI 10.1182/blood.V94.6.2142.418k16_2142_2150; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Hengel RL, 1999, J IMMUNOL, V163, P3539; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Jeng C-J, 2011, ISRN IMMUNOL, V2011, DOI DOI 10.5402/2011/497397; Kendall M, 1998, DYING LIVE OUR BODIE; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Kretzschmar M, 2000, BREAST CANCER RES, V2, P107, DOI 10.1186/bcr42; Kross KW, 2007, ACTA OTO-LARYNGOL, V127, P532, DOI 10.1080/00016480600951384; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; Lee SM, 1996, BLOOD, V88, P945; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Liao KL, 2013, J THEOR BIOL, V328, P65, DOI 10.1016/j.jtbi.2013.03.017; Lin YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052490; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lo WC, 2013, B MATH BIOL, V75, P1417, DOI 10.1007/s11538-013-9853-2; Long J, 2013, BIOCHEM BIOPH RES CO, V430, P364, DOI 10.1016/j.bbrc.2012.11.004; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Morishima N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/605483; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Nicholl MB, 2014, CYTOKINE IN PRESS; Niedobitek G, 2002, J PATHOL, V198, P310, DOI 10.1002/path.1217; Nishino R, 2011, CLIN CANCER RES, V17, P6272, DOI 10.1158/1078-0432.CCR-11-0060; Oren H, 2001, PEDIATRICS, V108, P329, DOI 10.1542/peds.108.2.329; Owen MR, 1997, J THEOR BIOL, V189, P63, DOI 10.1006/jtbi.1997.0494; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Plank MJ, 2004, J THEOR BIOL, V229, P435, DOI 10.1016/j.jtbi.2004.04.012; Putheti P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008706; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Quatromoni JG, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-30; Robertson, 1996, Oncologist, V1, P88; Robertson MJ, 1999, CLIN CANCER RES, V5, P9; Robertson-Tessi M, 2011, J THEOR BIOL, V10, P294; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Sanchez-Hernandez Carla, 2010, BMC Res Notes, V3, P151, DOI 10.1186/1756-0500-3-151; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; SPRENT J, 1973, CELL IMMUNOL, V7, P40, DOI 10.1016/0008-8749(73)90181-0; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Tang SS, 2000, CHINESE SCI BULL, V45, P1697, DOI 10.1007/BF02898990; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Tiemessen MM, 2003, INT IMMUNOL, V15, P1495, DOI 10.1093/intimm/dxg147; Todorovic-Rakovic N., 2003, ARCH ONCOL, V11, P131; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Utting JC, 2010, CELL BIOCHEM FUNCT, V28, P374, DOI 10.1002/cbf.1660; Vaupel P, 2003, CANCER RES, V63, P7634; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; WAGNER H, 1982, CLIN HAEMATOL, V11, P607; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Xu M, 2010, CLIN DEV IMMUNOL, V14; Yang WC, 2013, J MOL CELL BIOL, V5, P207, DOI 10.1093/jmcb/mjt009; Yates A, 2001, DISCRETE CONT DYN-B, V1, P43; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z; Zeng JC, 2013, INT J CLIN EXP PATHO, V6, P1806	90	30	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110126	10.1371/journal.pone.0110126	http://dx.doi.org/10.1371/journal.pone.0110126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356878	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000012
J	Welk, A; Welk, E; Bruelheide, H				Welk, Astrid; Welk, Erik; Bruelheide, Helge			Biotic Interactions Overrule Plant Responses to Climate, Depending on the Species' Biogeography	PLOS ONE			English	Article							GEOGRAPHIC DISTRIBUTIONS; POSITIVE INTERACTIONS; RANGE LIMITS; HERBIVORY; GRADIENT; COMMUNITIES; TEMPERATURE; DEMOGRAPHY; GRASSLAND; EVOLUTION	This study presents an experimental approach to assess the relative importance of climatic and biotic factors as determinants of species' geographical distributions. We asked to what extent responses of grassland plant species to biotic interactions vary with climate, and to what degree this variation depends on the species' biogeography. Using a gradient from oceanic to continental climate represented by nine common garden transplant sites in Germany, we experimentally tested whether congeneric grassland species of different geographic distribution (oceanic vs. continental plant range type) responded differently to combinations of climate, competition and mollusc herbivory. We found the relative importance of biotic interactions and climate to vary between the different components of plant performance. While survival and plant height increased with precipitation, temperature had no effect on plant performance. Additionally, species with continental plant range type increased their growth in more benign climatic conditions, while those with oceanic range type were largely unable to take a similar advantage of better climatic conditions. Competition generally caused strong reductions of aboveground biomass and growth. In contrast, herbivory had minor effects on survival and growth. Against expectation, these negative effects of competition and herbivory were not mitigated under more stressful continental climate conditions. In conclusion we suggest variation in relative importance of climate and biotic interactions on broader scales, mediated via species-specific sensitivities and factor-specific response patterns. Our results have important implications for species distribution models, as they emphasize the large-scale impact of biotic interactions on plant distribution patterns and the necessity to take plant range types into account.	[Welk, Astrid; Welk, Erik; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Germany; [Welk, Erik; Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg	Welk, A (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Germany.	astrid.welk@botanik.uni-halle.de	WELK, Erik/AGL-4971-2022; Bruelheide, Helge/G-3907-2013	Bruelheide, Helge/0000-0003-3135-0356	Graduate School of Saxony-Anhalt; DFG [BR 1698/14-1]	Graduate School of Saxony-Anhalt; DFG(German Research Foundation (DFG))	Graduate School of Saxony-Anhalt and the DFG Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories'' (BR 1698/14-1) supported the study financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Bennington CC, 2012, J ECOL, V100, P841, DOI 10.1111/j.1365-2745.2012.01984.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Bruelheide H, 2002, FLORA, V197, P475, DOI 10.1078/0367-2530-00064; Bruelheide H, 1999, J ECOL, V87, P839, DOI 10.1046/j.1365-2745.1999.00403.x; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Butof A, 2012, GLOBAL CHANGE BIOL, V18, P127, DOI 10.1111/j.1365-2486.2011.02539.x; Butof A, 2011, PRESLIA, V83, P205; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; COLWELL RK, 1975, ANNU REV ECOL SYST, V6, P281, DOI 10.1146/annurev.es.06.110175.001433; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ellenberg H., 1953, BER DT BOT GES, V65, P351, DOI 10.1111/j.1438-8677.1953.tb00671.x; Engels JG, 2010, OIKOS, V119, P679, DOI 10.1111/j.1600-0706.2009.17940.x; Finnie TJR, 2007, J BIOGEOGR, V34, P1848, DOI 10.1111/j.1365-2699.2007.01750.x; Gaston JK, 2003, STRUCTURE DYNAMICS G; Godsoe W, 2010, OIKOS, V119, P53, DOI 10.1111/j.1600-0706.2009.17630.x; Hector A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043358; Hennenberg KJ, 2003, PLANT ECOL, V166, P167, DOI 10.1023/A:1023280109225; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofmann M, 2013, PRESLIA, V85, P1; Hunt R., 1990, BASIC GROWTH ANAL; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jager EJ, 1968, FEDDES REPERT, V79, P157, DOI 10.1002/fedr.19680790302; Jager EJ, 2005, WERNER ROTHMALER EXK; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; le Roux PC, 2013, ECOLOGY, V94, P671, DOI 10.1890/12-1482.1; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; Louda S. M., 1990, Perspectives on plant competition., P413; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maurer K, 2003, BASIC APPL ECOL, V4, P307, DOI 10.1078/1439-1791-00162; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Rodriguez-Castaneda G, 2013, GLOBAL ECOL BIOGEOGR, V22, P118, DOI 10.1111/j.1466-8238.2012.00795.x; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Salisbury EJ, 1926, GEOGR J, V67, P312, DOI 10.2307/1782828; Scheidel U, 2001, OECOLOGIA, V129, P75, DOI 10.1007/s004420100695; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	42	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111023	10.1371/journal.pone.0111023	http://dx.doi.org/10.1371/journal.pone.0111023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356912	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000036
J	Altermatt, F; Alther, R; Fiser, C; Jokela, J; Konec, M; Kury, D; Machler, E; Stucki, P; Westram, AM				Altermatt, Florian; Alther, Roman; Fiser, Cene; Jokela, Jukka; Konec, Marjeta; Kuery, Daniel; Maechler, Elvira; Stucki, Pascal; Westram, Anja Marie			Diversity and Distribution of Freshwater Amphipod Species in Switzerland (Crustacea: Amphipoda)	PLOS ONE			English	Article							GAMMARUS-FOSSARUM COMPLEX; LIFE-HISTORY TRAITS; CRYPTIC DIVERSITY; ADJACENT REGIONS; ASIA CRUSTACEA; NORTH-AFRICA; DIKEROGAMMARUS-VILLOSUS; EUROPE; PERSPECTIVE; METACOMMUNITIES	Amphipods are key organisms in many freshwater systems and contribute substantially to the diversity and functioning of macroinvertebrate communities. Furthermore, they are commonly used as bioindicators and for ecotoxicological tests. For many areas, however, diversity and distribution of amphipods is inadequately known, which limits their use in ecological and ecotoxicological studies and handicaps conservation initiatives. We studied the diversity and distribution of amphipods in Switzerland (Central Europe), covering four major drainage basins, an altitudinal gradient of>2,500 m, and various habitats (rivers, streams, lakes and groundwater). We provide the first provisional checklist and detailed information on the distribution and diversity of all amphipod species from Switzerland. In total, we found 29 amphipod species. This includes 16 native and 13 non-native species, one of the latter (Orchestia cavimana) reported here for the first time for Switzerland. The diversity is compared to neighboring countries. We specifically discuss species of the genus Niphargus, which are often receiving less attention. We also found evidence of an even higher level of hidden diversity, and the potential occurrence of further cryptic species. This diversity reflects the biogeographic past of Switzerland, and suggests that amphipods are ideally suited to address questions on endemism and adaptive radiations, post-glaciation re-colonization and invasion dynamics as well as biodiversity-ecosystem functioning relationships in aquatic systems.	[Altermatt, Florian; Alther, Roman; Jokela, Jukka; Maechler, Elvira; Westram, Anja Marie] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Altermatt, Florian; Jokela, Jukka] ETH Zentrum, Dept Environm Syst Sci, Zurich, Switzerland; [Altermatt, Florian] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Fiser, Cene; Konec, Marjeta] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Kuery, Daniel] Life Sci AG, Basel, Switzerland; [Stucki, Pascal] Aquabug, Neuchatel, Switzerland; [Westram, Anja Marie] Univ Sheffield, Sheffield, S Yorkshire, England	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Ljubljana; University of Sheffield	Altermatt, F (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.	florian.altermatt@eawag.ch	Alther, Roman/H-8545-2019	Alther, Roman/0000-0001-7582-3966; Altermatt, Florian/0000-0002-4831-6958; Westram, Anja Marie/0000-0003-1050-4969; Jokela, Jukka/0000-0002-1731-727X	Swiss National Science Foundation [31003A_135622, PP00P3_150698]; Swiss Federal Office for the Environment (BAFU); Eawag Matching funds; ETH-CCES project BioChange; EAWAG project AquaDivers; Life Science AG; Aquabug	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office for the Environment (BAFU); Eawag Matching funds; ETH-CCES project BioChange; EAWAG project AquaDivers; Life Science AG; Aquabug	The study was funded by the Swiss National Science Foundation Grants 31003A_135622 and PP00P3_150698 (to FA), the Swiss Federal Office for the Environment (BAFU, to FA), Eawag Matching funds (to FA and RA), ETH-CCES project BioChange (to JJ) and EAWAG project AquaDivers (to JJ). Life Science AG and Aquabug provided support in the form of salaries for authors DK & PS respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alp M, 2012, FRESHWATER BIOL, V57, P969, DOI 10.1111/j.1365-2427.2012.02758.x; Altermatt F, 2013, J BIOGEOGR, V40, P2249, DOI 10.1111/jbi.12178; Altermatt F, 2013, AQUAT ECOL, V47, P365, DOI 10.1007/s10452-013-9450-3; AquaPlus, 2008, BIOL UNT SEIT AAR ZW; Bacela-Spychalska K, 2013, AQUAT CONSERV, V23, P606, DOI 10.1002/aqc.2329; Baden-Wurrtemberg LfU, 2005, WIRBELLOSE NEOZOEN B; BAFU, 2002, SCHRIFT UNW, V345, P101; Balian EV, 2008, HYDROBIOLOGIA, V595, P627, DOI 10.1007/s10750-007-9246-3; Bernasconi R, 1969, STALACTITE S, V3, P76; Bundschuh M, 2011, ECOTOXICOLOGY, V20, P466, DOI 10.1007/s10646-011-0599-z; Bundschuh M, 2011, CHEMOSPHERE, V82, P355, DOI 10.1016/j.chemosphere.2010.10.006; Carrara F, 2012, P NATL ACAD SCI USA, V109, P5761, DOI 10.1073/pnas.1119651109; Colgan DJ, 2000, ZOOL SCR, V29, P29, DOI 10.1046/j.1463-6409.2000.00021.x; de Jong YSDM, 2014, FAUNA EUROPAEA 2 6; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Eberstraller J, 2007, MONITORING ALPENRHEI; Eggers Thomas Ols, 2001, Lauterbornia, V42, P1; Eme D, 2013, MOL ECOL, V22, P5685, DOI 10.1111/mec.12520; Feckler A, 2012, SCI TOTAL ENVIRON, V439, P158, DOI 10.1016/j.scitotenv.2012.09.003; Fiser C, 2008, ZOOL SCR, V37, P665, DOI 10.1111/j.1463-6409.2008.00347.x; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2010, ORG DIVERS EVOL, V10, P5, DOI 10.1007/s13127-010-0006-2; Fiser C, 2009, CRUSTACEANA, V82, P593, DOI 10.1163/156854009X407704; Fuchs A, 2007, ERHEBUNG BESCHREIBUN; Gerhardt A, 2011, INT J ZOOLOGY, V2011; Grabowski M, 2007, HYDROBIOLOGIA, V590, P75, DOI 10.1007/s10750-007-0759-6; Hanselmann Almut J., 2008, Lauterbornia, V62, P21; Hartke TR, 2011, J CRUSTACEAN BIOL, V31, P701, DOI 10.1651/10-3434.1; HOLSINGER JR, 1987, CAN J ZOOL, V65, P2202, DOI 10.1139/z87-334; KARAMAN GS, 1987, BIJDR DIERKD, V57, P207, DOI 10.1163/26660644-05702005; KARAMAN GS, 1977, BIJDR DIERKD, V47, P1; KARAMAN GS, 1977, BIJDR DIERKD, V47, P165, DOI 10.1163/26660644-04702003; Karaman GS, 1993, CRUSTACEA AMPHIPODA; Karaman GS, 1980, BIOSISTEMATIKA, V6, P175; Karaman S., 1952, ACAD SCI ARTIUM SLAV, V1, P5; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Ketmaier V, 2010, J CRUSTACEAN BIOL, V30, P307, DOI 10.1651/09-3162.1; Kury D, 2010, ERFOLGSKONTROLLE BIR; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Lods-Crozet Brigitte, 2006, Journal of Limnology, V65, P141; Lubini V, 2011, BIOLOGISCHE GEWASSER; Lubini V, 2010, UNTERSUCHUNG BENTHOS; Lubini V., 2012, ROTE LISTEN EINTAGSF; MAC ARTHUR ROBERT H., 1967; Macdonald KS, 2005, MOL PHYLOGENET EVOL, V35, P323, DOI 10.1016/j.ympev.2005.01.013; Machler E, 2014, FRESHWATER IN PRESS, DOI [10.1086/678128, DOI 10.1086/678128]; Malard F, 2009, FRESHWATER BIOL, V54, P756, DOI 10.1111/j.1365-2427.2009.02180.x; Moeschler P, 1983, STALACTITE, V39, P75; Moritz C, 2001, FACHBERICHT MAKROZOO; Muller J, 1998, J EVOLUTION BIOL, V11, P79, DOI 10.1046/j.1420-9101.1998.11010079.x; Muller J, 2000, MOL PHYLOGENET EVOL, V15, P260, DOI 10.1006/mpev.1999.0740; Murle U, 2003, NEUER FLOHKREBS BODE, P3; Murle U, 2003, LAUTERBORNIA, V48, P61; NOCENTINI A M, 1967, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V21, P213; Nychka D, 2014, FIELDS TOOLS SPATIAL; Ortlepp J, 2003, BIOLOGISCHE UNTERSUC; PINKSTER S, 1970, Beaufortia, V17, P85; R Development Core Team, 2013, LANG ENV STAT COMP V; Rey P, 2000, MITTEILUNGEN BADISCH, V18, P19; Rey P, 2004, WIRBELLOSE NEOZOEN H; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruffo S, 2014, ITAL J ZOOL, V81, P92, DOI 10.1080/11250003.2014.891662; Ruffo S, 2001, J CRUSTACEAN BIOL, V21, P484, DOI 10.1651/0278-0372(2001)021[0484:IBNSAI]2.0.CO;2; Ruffo S, 1993, B MUSEO CIVICO STORI, V17, P57; RUFFO S, 2006, SEZIONE SCI VITA, V17, P1; Schellenberg A, 1942, KREBSTIERE CRUSTACEA, P81; SKET B, 1974, Bioloski Vestnik, V22, P91; Sket B, 1996, NARAVA SLOVENIJE STA, P222; Steinmann P, 2006, ABKLARUNG DIKEROGAMM; Steinmann P, 2008, MAKROZOOBENTHOS AQUA; Steinmann P, 2006, DIKEROGAMMARUS VILLO; STOCK J H, 1974, Bijdragen tot de Dierkunde, V44, P73; Strinati P, 1966, FAUNE CAVERNICOLE SU; Stucki P, 2010, METHODEN UNTERSUCHUN; Stucki P, 2011, SUIVI QUALITE BIOL C; TARAMELLI ESTER, 1956, MEM IST ITAL IDROBIOL DOTT MARCO DE MARCHI, V9, P61; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vainola R, 2008, HYDROBIOLOGIA, V595, P241, DOI 10.1007/s10750-007-9020-6; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Vornatscher J, 1969, MITTEILUNGEN NATURWI, V99, P123; Ward JV, 2003, ECOLOGY GLACIAL FLOO; Weiss M, 2014, HYDROBIOLOGIA, V721, P165, DOI 10.1007/s10750-013-1658-7; Westram AM, 2010, CONSERV GENET RESOUR, V2, P401, DOI 10.1007/s12686-010-9287-1; Westram AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069576; Westram AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023879; Zagmajster M, 2014, GLOBAL ECOLOGY BIOGE; Zaksek V, 2007, MOL PHYLOGENET EVOL, V42, P223, DOI 10.1016/j.ympev.2006.07.009	92	40	44	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110328	10.1371/journal.pone.0110328	http://dx.doi.org/10.1371/journal.pone.0110328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354099	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200021
J	Capitanio, JP; Hawkley, LC; Cole, SW; Cacioppo, JT				Capitanio, John P.; Hawkley, Louise C.; Cole, Steven W.; Cacioppo, John T.			A Behavioral Taxonomy of Loneliness in Humans and Rhesus Monkeys (Macaca mulatta)	PLOS ONE			English	Article							SOCIAL-ISOLATION; ENVIRONMENTAL CONTRIBUTIONS; GLUCOCORTICOID REGULATION; PERSONALITY DIMENSIONS; CHICAGO HEALTH; OLD-AGE; RISK; STABILITY; MORTALITY; RESPONSES	Social relationships endow health and fitness benefits, but considerable variation exists in the extent to which individuals form and maintain salutary social relationships. The mental and physical health effects of social bonds are more strongly related to perceived isolation (loneliness) than to objective social network characteristics. We sought to develop an animal model to facilitate the experimental analysis of the development of, and the behavioral and biological consequences of, loneliness. In Study 1, using a population-based sample of older adults, we examined how loneliness was influenced both by social network size and by the extent to which individuals believed that their daily social interactions reflected their own choice. Results revealed three distinct clusters of individuals: (i) individuals with large networks who believed they had high choice were lowest in loneliness, (ii) individuals with small social networks who believed they had low choice were highest in loneliness, and (iii) the remaining two groups were intermediate and equivalent in loneliness. In Study 2, a similar three-group structure was identified in two separate samples of adult male rhesus monkeys (Macaca mulatta) living in large social groups: (i) those high in sociability who had complex social interaction with a broad range of social partners (putatively low in loneliness), (ii) those low in sociability who showed tentative interactions with certain classes of social partners (putatively high in loneliness), and (iii) those low in sociability who interacted overall at low levels with a broad range of social partners (putatively low or intermediate in loneliness). This taxonomy in monkeys was validated in subsequent experimental social probe studies. These results suggest that, in highly social nonhuman primate species, some animals may show a mismatch between social interest and social attainment that could serve as a useful animal model for experimental and mechanistic studies of loneliness.	[Capitanio, John P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Capitanio, John P.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Hawkley, Louise C.] Univ Chicago, Natl Opin Res Ctr, Chicago, IL 60637 USA; [Cole, Steven W.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Cole, Steven W.] Univ Calif Los Angeles, Norman Cousins Ctr, Los Angeles, CA USA; [Cacioppo, John T.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Cacioppo, John T.] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Chicago; University of Chicago	Capitanio, JP (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	jpcapitanio@ucdavis.edu			US National Institutes of Health: National Institute on Aging [R01-AG033590, R01-AG034052, R01-AG036433]; National Cancer Institute [R01-CA116778]; National Institute of Mental Health [R01-MH49033]; National Center for Research Resources [P51-RR000169]; NATIONAL CANCER INSTITUTE [R01CA116778] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036433, R01AG034052, R01AG033590] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	US National Institutes of Health: National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the following components of the US National Institutes of Health: National Institute on Aging (R01-AG033590 and R01-AG034052 to JTC and R01-AG036433 to LCH); the National Cancer Institute (R01-CA116778 to SWC); the National Institute of Mental Health (R01-MH49033 to JPC); and the National Center for Research Resources (P51-RR000169 to the California National Primate Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersson L, 1998, AGING MENT HEALTH, V2, P264, DOI 10.1080/13607869856506; Bartels M, 2008, AM J MED GENET B, V147B, P385, DOI 10.1002/ajmg.b.30608; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; Bondevik M, 1998, WESTERN J NURS RES, V20, P325, DOI 10.1177/019394599802000305; Boomsma DI, 2005, BEHAV GENET, V35, P745, DOI 10.1007/s10519-005-6040-8; Boomsma DI, 2007, TWIN RES HUM GENET, V10, P267, DOI 10.1375/twin.10.2.267; Cacioppo JT, 2006, J RES PERS, V40, P1054, DOI 10.1016/j.jrp.2005.11.007; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, ANN REV PSYCHOL, P66; Capitanio JP, 2008, BRAIN BEHAV IMMUN, V22, P676, DOI 10.1016/j.bbi.2007.05.006; Capitanio JP, 2006, ILAR J, V47, P294, DOI 10.1093/ilar.47.4.294; Capitanio JP, 2011, AM J PRIMATOL, V73, P507, DOI 10.1002/ajp.20870; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; Capitanio JP, 2005, AM J PRIMATOL, V65, P289, DOI 10.1002/ajp.20116; Capitanio JP, 1998, P NATL ACAD SCI USA, V95, P4714, DOI 10.1073/pnas.95.8.4714; Capitanio JP, 2002, PRIMATES, V43, P169, DOI 10.1007/BF02629645; Capitanio JP, 2011, OXFORD HDB HLTH PSYC, P860; Centers for Disease Control (CDC), 2008, PROM IND FAM COMM CO; Cutrona CE, 1982, LONELINESS SOURCEBOO, P291; Distel MA, 2010, BEHAV GENET, V40, P480, DOI 10.1007/s10519-010-9341-5; Dixson AF, 2012, PRIMATE SEXUALITY: COMPARATIVE STUDIES OF THE PROSIMIANS, MONKEYS, APES, AND HUMANS, 2ND EDITION, P1, DOI 10.1093/acprof:osobl/9780199544646.001.0001; DUGAN E, 1994, GERONTOLOGIST, V34, P340, DOI 10.1093/geront/34.3.340; Dykstra P A, 1999, Tijdschr Gerontol Geriatr, V30, P212; Eysenck HJ, 1947, DIMENSIONS PERSONALI; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Gawronski B, 2013, PERS SOC PSYCHOL REV, V17, P187, DOI 10.1177/1088868313480096; Gold LH, 1998, J MED PRIMATOL, V27, P104, DOI 10.1111/j.1600-0684.1998.tb00234.x; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Hawkley LC, 2005, PSYCHOL SCI, V16, P798, DOI 10.1111/j.1467-9280.2005.01617.x; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; Hawkley LC, 2008, J GERONTOL B-PSYCHOL, V63, pS375, DOI 10.1093/geronb/63.6.S375; HectorTaylor L, 1996, PSYCHOL REP, V78, P1329, DOI 10.2466/pr0.1996.78.3c.1329; Holmen K, 1992, Vard Nord Utveckl Forsk, V12, P9; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holwerda TJ, 2012, PSYCHOL MED, V42, P843, DOI 10.1017/S0033291711001772; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; JONES DC, 1992, J SOC PERS RELAT, V9, P219, DOI 10.1177/0265407592092004; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Kinnally EL, 2010, DEV PSYCHOPATHOL, V22, P35, DOI 10.1017/S0954579409990241; LEARY MR, 1983, J PERS ASSESS, V47, P66, DOI 10.1207/s15327752jpa4701_8; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Maninger N, 2003, AM J PRIMATOL, V61, P73, DOI 10.1002/ajp.10111; McGuire S, 2000, PSYCHOL SCI, V11, P487, DOI 10.1111/1467-9280.00293; Melnick D.J., 1987, P121; MULLINS LC, 1990, GERONTOLOGIST, V30, P377, DOI 10.1093/geront/30.3.377; Nei M, 2002, J HERED, V93, P157, DOI 10.1093/jhered/93.3.157; NOLDUS LPJJ, 1991, BEHAV RES METH INSTR, V23, P415, DOI 10.3758/BF03203406; Nunn CL, 2006, INFECT DIS PRIMATES; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Pinquart M, 2003, ADV PSY RES, V19, P111; Routasalo PE, 2006, GERONTOLOGY, V52, P181, DOI 10.1159/000091828; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Samuelsson G, 1998, J MENTAL HLTH AGING, V4, P361; Savikko N, 2005, ARCH GERONTOL GERIAT, V41, P223, DOI 10.1016/j.archger.2005.03.002; Segrin C, 1999, J SOC CLIN PSYCHOL, V18, P14, DOI 10.1521/jscp.1999.18.1.14; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Weinstein TAR, 2012, J COMP PSYCHOL, V126, P97, DOI 10.1037/a0025607; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wolff JO, 2007, RODENT SOC ECOLOGICA, P610	67	26	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110307	10.1371/journal.pone.0110307	http://dx.doi.org/10.1371/journal.pone.0110307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354040	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200020
J	Chang, TI; Kim, YL; Kim, H; Ryu, GW; Kang, EW; Park, JT; Yoo, TH; Shin, SK; Kang, SW; Choi, KH; Han, DS; Han, SH				Chang, Tae Ik; Kim, Yung Ly; Kim, Hyungwoo; Ryu, Geun Woo; Kang, Ea Wha; Park, Jung Tak; Yoo, Tae-Hyun; Shin, Sug Kyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Dae Suk; Han, Seung Hyeok			Hyponatremia as a Predictor of Mortality in Peritoneal Dialysis Patients	PLOS ONE			English	Article							MAINTENANCE HEMODIALYSIS-PATIENTS; SERUM SODIUM CONCENTRATION; OUTCOMES; LEVEL; RISK	Background and Aim: Hyponatremia is common in patients with chronic kidney disease and is associated with increased mortality in hemodialysis patients. However, few studies have addressed this issue in peritoneal dialysis (PD) patients. Methods: This prospective observational study included a total of 441 incident patients who started PD between January 2000 and December 2005. Using time-averaged serum sodium (TA-Na) levels, we aimed to investigate whether hyponatremia can predict mortality in these patients. Results: Among the baseline parameters, serum sodium level was positively associated with serum albumin (beta = 0.145; p = 0.003) and residual renal function (RRF) (beta = 0.130; p = 0.018) and inversely associated with PD ultrafiltration (beta = 20.114; p = 0.024) in a multivariable linear regression analysis. During a median follow-up of 34.8 months, 149 deaths were recorded. All-cause death occurred in 81 (55.9%) patients in the lowest tertile compared to 37 (25.0%) and 31 (20.9%) patients in the middle and highest tertiles, respectively. After adjusting for multiple potentially confounding covariates, increased TA-Na level was associated with a significantly decreased risk of all-cause (HR per 1 mEq/L increase, 0.79; 95% CI, 0.73-0.86; p<0.001) and infection-related (HR per 1 mEq/L increase, 0.77; 95% CI, 0.70-0.85; p<0.001) deaths. Conclusions: This study showed that hyponatremia is an independent predictor of mortality in PD patients. Nevertheless, whether correcting hyponatremia improves patient survival is unknown. Future interventional studies should address this question more appropriately.	[Chang, Tae Ik; Kang, Ea Wha; Shin, Sug Kyun] Ilsan Hosp, NHIS Med Ctr, Dept Internal Med, Goyangshi, Gyeonggi Do, South Korea; [Kim, Yung Ly; Kim, Hyungwoo; Ryu, Geun Woo; Park, Jung Tak; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Dae Suk; Han, Seung Hyeok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Brain Korea Med Sci 21, Seoul 120749, South Korea	NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System; Yonsei University	Han, SH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	hansh@yuhs.ac	Barretti, Pasqual/K-4156-2012; Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Barretti, Pasqual/0000-0003-4979-4836; Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Choi, Kyu Hun/0000-0003-0095-9011; Park, Jung Tak/0000-0002-2325-8982; Yoo, Tae-Hyun/0000-0002-9183-4507; Kim, Hyung Woo/0000-0002-6305-452X; Kang, Shin-Wook/0000-0002-5677-4756	Brain Korea 21 Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2011-0030711]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea (NRF) grant - Korean government (MEST); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; ARROYO V, 1976, AM J DIG DIS, V21, P249, DOI 10.1007/BF01095898; Bettari L, 2012, J CARD FAIL, V18, P74, DOI 10.1016/j.cardfail.2011.09.005; Beukhof CM, 2007, CLIN ENDOCRINOL, V66, P367, DOI 10.1111/j.1365-2265.2007.02741.x; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cherney DZ, 2001, PERITON DIALYSIS INT, V21, P7; Combs S, 2014, AM J KIDNEY DIS, V63, P294, DOI 10.1053/j.ajkd.2013.09.017; Dimitriadis C, 2014, PERITON DIALYSIS INT, V34, P260, DOI 10.3747/pdi.2012.00095; EDELMAN IS, 1958, J CLIN INVEST, V37, P1236, DOI 10.1172/JCI103712; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gokal R, 2002, KIDNEY INT, V62, pS62, DOI 10.1046/j.1523-1755.62.s81.9.x; Han SH, 2012, NAT REV NEPHROL, V8, P163, DOI 10.1038/nrneph.2012.12; Hecking M, 2012, AM J KIDNEY DIS, V59, P238, DOI 10.1053/j.ajkd.2011.07.013; Hoorn EJ, 2008, NEPHRON PHYSIOL, V108, P46, DOI 10.1159/000119709; Hoorn EJ, 2013, AM J KIDNEY DIS, V62, P139, DOI 10.1053/j.ajkd.2012.09.019; Kang SH, 2013, NEPHROLOGY, V18, P132, DOI 10.1111/nep.12013; KATZ MA, 1973, NEW ENGL J MED, V289, P843, DOI 10.1056/NEJM197310182891607; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; Kovesdy CP, 2012, CIRCULATION, V125, P677, DOI 10.1161/CIRCULATIONAHA.111.065391; Mandai S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-276; Mc Causland FR, 2012, NEPHROL DIAL TRANSPL, V27, P1613, DOI 10.1093/ndt/gfr497; Nguyen MK, 2005, AM J PHYSIOL-RENAL, V288, pF1113, DOI 10.1152/ajprenal.00387.2004; Nigwekar SU, 2013, AM J KIDNEY DIS, V62, P755, DOI 10.1053/j.ajkd.2013.02.367; NOLPH KD, 1993, PERITON DIALYSIS INT, V13, P178; Posthuma N, 1997, PERITON DIALYSIS INT, V17, P602; Randerson DH, 1981, PERITONEAL DIALYSIS, P180; Swart RM, 2011, NEPHRON PHYSIOL, V118, P45, DOI 10.1159/000322238; Tseng MH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-113; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661; Vilar E, 2011, SEMIN DIALYSIS, V24, P487, DOI 10.1111/j.1525-139X.2011.00968.x; Waikar SS, 2011, AM J MED, V124, P77, DOI 10.1016/j.amjmed.2010.07.029; Wang AYM, 2011, SEMIN NEPHROL, V31, P159, DOI 10.1016/j.semnephrol.2011.01.005; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27; Zevallos G, 2001, PERITON DIALYSIS INT, V21, P72; 이현희, 2010, Kidney Research and Clinical Practice, V29, P31	38	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111373	10.1371/journal.pone.0111373	http://dx.doi.org/10.1371/journal.pone.0111373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354265	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200076
J	Lusk, RW				Lusk, Richard W.			Diverse and Widespread Contamination Evident in the Unmapped Depths of High Throughput Sequencing Data	PLOS ONE			English	Article							DNA-SEQUENCES; PCR; CELLS	Trace quantities of contaminating DNA are widespread in the laboratory environment, but their presence has received little attention in the context of high throughput sequencing. This issue is highlighted by recent works that have rested controversial claims upon sequencing data that appear to support the presence of unexpected exogenous species. I used reads that preferentially aligned to alternate genomes to infer the distribution of potential contaminant species in a set of independent sequencing experiments. I confirmed that dilute samples are more exposed to contaminating DNA, and, focusing on four single-cell sequencing experiments, found that these contaminants appear to originate from a wide diversity of clades. Although negative control libraries prepared from 'blank' samples recovered the highest-frequency contaminants, low-frequency contaminants, which appeared to make heterogeneous contributions to samples prepared in parallel within a single experiment, were not well controlled for. I used these results to show that, despite heavy replication and plausible controls, contamination can explain all of the observations used to support a recent claim that complete genes pass from food to human blood. Contamination must be considered a potential source of signals of exogenous species in sequencing data, even if these signals are replicated in independent experiments, vary across conditions, or indicate a species which seems a priori unlikely to contaminate. Negative control libraries processed in parallel are essential to control for contaminant DNAs, but their limited ability to recover low-frequency contaminants must be recognized.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lusk, RW (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	rlusk@umich.edu			NIH [F32-GM100685]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100685] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RWL was supported by NIH postdoctoral fellowship F32-GM100685 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, R LANG ENV STAT COMP; Astua-Monge G, 2002, THEOR APPL GENET, V104, P48, DOI 10.1007/s001220200005; BINNS M, 1993, NUCLEIC ACIDS RES, V21, P779, DOI 10.1093/nar/21.3.779; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Cherepanova AV, 2008, ANN NY ACAD SCI, V1137, P218, DOI 10.1196/annals.1448.016; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Ehricht R, 2007, BIOLOGICALS, V35, P145, DOI 10.1016/j.biologicals.2006.04.001; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Evans GE, 2003, J CLIN MICROBIOL, V41, P3452, DOI 10.1128/JCM.41.7.3452-3453.2003; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Gill P, 2000, FORENSIC SCI INT, V112, P17, DOI 10.1016/S0379-0738(00)00158-4; GOSSLING J, 1974, INFECT IMMUN, V9, P719, DOI 10.1128/IAI.9.4.719-729.1974; Gouba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059474; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Marschner IC, 2011, R J, V3, P12; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Parkinson NJ, 2012, GENOME RES, V20, P754; Percudani R, 2013, BIOINFORM BIOL INSIG, V7, P55, DOI 10.4137/BBI.S11064; PERSING DH, 1991, J CLIN MICROBIOL, V29, P1281, DOI 10.1128/JCM.29.7.1281-1285.1991; Peters RPH, 2004, FEMS IMMUNOL MED MIC, V42, P249, DOI 10.1016/j.femsim.2004.05.009; Salazar LA, 1998, CLIN CHEM, V44, P1748; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; SCHMIDT T, 1995, NATURWISSENSCHAFTEN, V82, P423, DOI 10.1007/BF01133677; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Shtarkman YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067221; Spisak S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069805; Tosar JP, 2014, RNA, V20, P754, DOI 10.1261/rna.044263.114; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yim SM, 2010, ANN DERMATOL, V22, P41, DOI 10.5021/ad.2010.22.1.41; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158	41	118	121	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110808	10.1371/journal.pone.0110808	http://dx.doi.org/10.1371/journal.pone.0110808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354084	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204200039
J	Scheidt, SN; Hurlbert, AH				Scheidt, Spencer N.; Hurlbert, Allen H.			Range Expansion and Population Dynamics of an Invasive Species: The Eurasian Collared-Dove (Streptopelia decaocto)	PLOS ONE			English	Article							MODEL; DISPERSAL; SPREAD	Invasive species offer ecologists the opportunity to study the factors governing species distributions and population growth. The Eurasian Collared-Dove (Streptopelia decaocto) serves as a model organism for invasive spread because of the wealth of abundance records and the recent development of the invasion. We tested whether a set of environmental variables were related to the carrying capacities and growth rates of individual populations by modeling the growth trajectories of individual populations of the Collared-Dove using Breeding Bird Survey (BBS) and Christmas Bird Count (CBC) data. Depending on the fit of our growth models, carrying capacity and growth rate parameters were extracted and modeled using historical, geographical, land cover and climatic predictors. Model averaging and individual variable importance weights were used to assess the strength of these predictors. The specific variables with the greatest support in our models differed between data sets, which may be the result of temporal and spatial differences between the BBS and CBC. However, our results indicate that both carrying capacity and population growth rates are related to developed land cover and temperature, while growth rates may also be influenced by dispersal patterns along the invasion front. Model averaged multivariate models explained 35-48% and 41-46% of the variation in carrying capacities and population growth rates, respectively. Our results suggest that widespread species invasions can be evaluated within a predictable population ecology framework. Land cover and climate both have important effects on population growth rates and carrying capacities of Collared-Dove populations. Efforts to model aspects of population growth of this invasive species were more successful than attempts to model static abundance patterns, pointing to a potentially fruitful avenue for the development of improved invasive distribution models.	[Scheidt, Spencer N.; Hurlbert, Allen H.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Scheidt, SN (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA.	spencer.scheidt@gmail.com		Hurlbert, Allen/0000-0002-5678-9907				Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Best L.B., 1981, Studies in Avian Biology, P252; Bled F, 2011, ECOL APPL, V21, P290, DOI 10.1890/09-1877.1; Bonter DN, 2010, ECOGRAPHY, V33, P494, DOI 10.1111/j.1600-0587.2009.06017.x; Breiman L., 1984, CLASSIFICATION REGRE; Bruno JF, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P13; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bystrak D., 1981, Studies in Avian Biology, P34; COOMBS CFB, 1981, J APPL ECOL, V18, P41, DOI 10.2307/2402478; Cushman SA, 2002, LANDSCAPE ECOL, V17, P637, DOI 10.1023/A:1021571603605; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; ELTON CS, 1958, ECOLOGY INVASIONS PL; Eraud C, 2007, J BIOGEOGR, V34, P1077, DOI 10.1111/j.1365-2699.2006.01673.x; Fisher J., 1953, British Birds, V46, P153; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Fujisaki I, 2010, IBIS, V152, P622, DOI 10.1111/j.1474-919X.2010.01038.x; HENGEVELD R, 1988, J BIOGEOGR, V15, P819, DOI 10.2307/2845342; HENGEVELD R, 1993, J FIELD ORNITHOL, V64, P477; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hooten MB, 2008, ENVIRON ECOL STAT, V15, P59, DOI 10.1007/s10651-007-0040-1; Hudson R., 1972, British Birds, V65, P139; Kinlan BP, 2005, RATES POPULATION SPR, P381; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; McKinney ML, 2007, GLOBAL ECOL BIOGEOGR, V16, P394, DOI 10.1111/j.1466-8238.2007.00296.x; National Audubon Society, 2010, CHRISTM BIRD COUNT H; Poling TD, 2006, J WILDLIFE MANAGE, V70, P998, DOI 10.2193/0022-541X(2006)70[998:DOAFCB]2.0.CO;2; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, V5; Ricklefs RE, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P165; Romagosa CM, 2000, J FIELD ORNITHOL, V71, P159, DOI 10.1648/0273-8570-71.1.159; Romagosa CM, 2012, BIRDS N AM ONLINE; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Telford RJ, 2005, QUATERNARY SCI REV, V24, P2173, DOI 10.1016/j.quascirev.2005.05.001; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	40	24	26	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111510	10.1371/journal.pone.0111510	http://dx.doi.org/10.1371/journal.pone.0111510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354270	Green Submitted, gold, Green Published			2022-12-27	WOS:000345204200086
J	Shi, GL; Dutta, S; Paul, S; Wang, B; Jacques, FMB				Shi, Gongle; Dutta, Suryendu; Paul, Swagata; Wang, Bo; Jacques, Frederic M. B.			Terpenoid Compositions and Botanical Origins of Late Cretaceous and Miocene Amber from China	PLOS ONE			English	Article							EOCENE FUSHUN AMBER; PALEOBOTANICAL ORIGIN; DIVERSE PALEOBIOTA; FOSSIL; RESIN; DIPTEROCARPACEAE; SESQUITERPENOIDS; IDENTIFICATION; DITERPENOIDS; INCLUSIONS	The terpenoid compositions of the Late Cretaceous Xixia amber from Central China and the middle Miocene Zhangpu amber from Southeast China were analyzed by gas chromatography-mass spectrometry (GC-MS) to elucidate their botanical origins. The Xixia amber is characterized by sesquiterpenoids, abietane and phyllocladane type diterpenoids, but lacks phenolic abietanes and labdane derivatives. The molecular compositions indicate that the Xixia amber is most likely contributed by the conifer family Araucariaceae, which is today distributed primarily in the Southern Hemisphere, but widely occurred in the Northern Hemisphere during the Mesozoic according to paleobotanical evidence. The middle Miocene Zhangpu amber is characterized by amyrin and amyrone-based triterpenoids and cadalene-based sesquiterpenoids. It is considered derived from the tropical angiosperm family Dipterocarpaceae based on these compounds and the co-occurring fossil winged fruits of the family in Zhangpu. This provides new evidence for the occurrence of a dipterocarp forest in the middle Miocene of Southeast China. It is the first detailed biomarker study for amber from East Asia.	[Shi, Gongle; Wang, Bo] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Dutta, Suryendu; Paul, Swagata] Indian Inst Technol, Dept Earth Sci, Bombay, Maharashtra, India; [Wang, Bo] Univ Bonn, Steinmann Inst, Bonn, Germany; [Jacques, Frederic M. B.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China	Chinese Academy of Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Bonn; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Shi, GL (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China.	glshi@nigpas.ac.cn	Shi, Gongle/E-3840-2012; Wang, Bo/AAU-1329-2021	Shi, Gongle/0000-0003-3374-6637; Wang, Bo/0000-0001-8947-8526; Dutta, Suryendu/0000-0003-2969-116X	973 Project of China [2012CB821900]; National Natural Science Foundation of China [41206173]; Humboldt Research Fellowship for Postdoctoral Researchers	973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humboldt Research Fellowship for Postdoctoral Researchers	This work was supported by the 973 Project of China (2012CB821900, http://program.most.gov.cn/), National Natural Science Foundation of China (41206173, http://www.nsfc.gov.cn/), and the Humboldt Research Fellowship for Postdoctoral Researchers to BW (http://www.humboldt-foundation.de/web/humboldt-fellowship-postdoc.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Anderson JM, 2007, STRELITZIA, V20, P1; ANDERSON KB, 1992, ORG GEOCHEM, V18, P829, DOI 10.1016/0146-6380(92)90051-X; Ashton P. S., 1982, Flora Malesiana, I, Spermatophyta, V9, P237; Bohme M., 2013, ZITTELIANA A, V53, P120; Bray PS, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-3; Cao Meizhen, 2011, Acta Micropalaeontologica Sinica, V28, P98; Chen Jin-hua, 2007, Acta Palaeontologica Sinica, V46, P299; Cox RE, 2007, BIOCHEM SYST ECOL, V35, P342, DOI 10.1016/j.bse.2006.09.013; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Dayanandan S, 1999, AM J BOT, V86, P1182, DOI 10.2307/2656982; Delclos X, 2007, CR PALEVOL, V6, P135, DOI 10.1016/j.crpv.2006.09.003; Ducousso M, 2004, MOL ECOL, V13, P231, DOI 10.1046/j.1365-294X.2003.02032.x; Dutta S, 2011, REV PALAEOBOT PALYNO, V166, P63, DOI 10.1016/j.revpalbo.2011.05.002; Dutta S, 2011, INT J COAL GEOL, V85, P49, DOI 10.1016/j.coal.2010.09.006; Dutta S, 2010, J EARTH SYST SCI, V119, P711, DOI 10.1007/s12040-010-0041-6; Dutta S, 2009, INT J COAL GEOL, V80, P44, DOI 10.1016/j.coal.2009.07.006; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; GRANTHAM PJ, 1980, GEOCHIM COSMOCHIM AC, V44, P1801, DOI 10.1016/0016-7037(80)90229-X; Ho KS, 2003, CHEM GEOL, V197, P287, DOI 10.1016/S0009-2541(02)00399-6; Kunzmann L, 2007, ZOOL ANZ, V246, P257, DOI 10.1016/j.jcz.2007.08.001; Li G, 2009, CRETACEOUS RES, V30, P477, DOI 10.1016/j.cretres.2008.09.002; Mallick M, 2014, INT J COAL GEOL, V121, P129, DOI 10.1016/j.coal.2013.11.013; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; McKellar RC, 2011, P ROY SOC B-BIOL SCI, V278, P3219, DOI 10.1098/rspb.2011.0276; Menor-Salvan C, 2010, ORG GEOCHEM, V41, P1089, DOI 10.1016/j.orggeochem.2010.06.013; Morley Robert J., 2011, Smithsonian Contributions to Botany, P21; NOBLE RA, 1986, ORG GEOCHEM, V10, P825, DOI 10.1016/S0146-6380(86)80019-5; Otto A, 2002, SCIENCE, V297, P1543, DOI 10.1126/science.1074225; Otto A, 2001, BOT REV, V67, P141, DOI 10.1007/BF02858076; Penalver E, 2007, CRETACEOUS RES, V28, P791, DOI 10.1016/j.cretres.2006.12.004; Pereira R, 2009, ORG GEOCHEM, V40, P863, DOI 10.1016/j.orggeochem.2009.05.002; PHILIPPE M., 2005, HIST BIOL, V17, P1; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Rudra A, 2014, J EARTH SYST SCI, V123, P935, DOI 10.1007/s12040-014-0443-y; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Schmidt AR, 2006, NATURE, V444, P835, DOI 10.1038/444835a; Schmidt AR, 2012, P NATL ACAD SCI USA, V109, P14796, DOI 10.1073/pnas.1208464109; Shi GL, 2014, REV PALAEOBOT PALYNO, V200, P97, DOI 10.1016/j.revpalbo.2013.09.003; Shi GL, 2010, REV PALAEOBOT PALYNO, V162, P599, DOI 10.1016/j.revpalbo.2010.08.001; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; van der Ham RWJM, 2010, PALAEOGEOGR PALAEOCL, V291, P469, DOI 10.1016/j.palaeo.2010.03.017; VANAARSSEN BGK, 1994, GEOCHIM COSMOCHIM AC, V58, P223, DOI 10.1016/0016-7037(94)90459-6; Wang B, 2014, CURR BIOL, V24, P1606, DOI 10.1016/j.cub.2014.05.048; Wang B, 2011, J PALEONTOL, V85, P1154; Wang De-You, 2006, Acta Palaeontologica Sinica, V45, P494; Wolfe AP, 2009, P R SOC B, V276, P3403, DOI 10.1098/rspb.2009.0806; Wu, 1980, VEGETATION CHINA; Zheng Y.H., 1994, ACTA PALAEONTOL SIN, V33, P200; Zhong H, 1995, CHINA GEMS JADES, V4, P58; Zhou S, 2005, MINERAL RESOURCES GE, V19, P57	51	22	23	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111303	10.1371/journal.pone.0111303	http://dx.doi.org/10.1371/journal.pone.0111303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354364	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200069
J	Hong, YS; Kim, J; Pectasides, E; Fox, C; Hong, SW; Ma, QP; Wong, GS; Peng, S; Stachler, MD; Thorner, AR; Van Hummelen, P; Bass, AJ				Hong, Yong Sang; Kim, Jihun; Pectasides, Eirini; Fox, Cameron; Hong, Seung-Woo; Ma, Qiuping; Wong, Gabrielle S.; Peng, Shouyong; Stachler, Matthew D.; Thorner, Aaron R.; Van Hummelen, Paul; Bass, Adam J.			Src Mutation Induces Acquired Lapatinib Resistance in ERBB2-Amplified Human Gastroesophageal Adenocarcinoma Models	PLOS ONE			English	Article							ADVANCED GASTRIC-CANCER; INHIBITOR SARACATINIB AZD0530; RANDOMIZED PHASE-III; TRASTUZUMAB RESISTANCE; BREAST-CANCER; KINASE INHIBITOR; IN-VIVO; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; 1ST-LINE THERAPY	ERBB2-directed therapy is now a routine component of therapy for ERBB2-amplified metastatic gastroesophageal adenocarcinomas. However, there is little knowledge of the mechanisms by which these tumors develop acquired resistance to ERBB2 inhibition. To investigate this question we sought to characterize cell line models of ERBB2-amplified gastroesophageal adenocarcinoma with acquired resistance to ERBB2 inhibition. We generated lapatinib-resistant (LR) subclones from an initially lapatinib-sensitive ERBB2-amplified esophageal adenocarcinoma cell line, OE19. We subsequently performed genomic characterization and functional analyses of resistant subclones with acquired lapatinib resistance. We identified a novel, acquired Src(E527K) mutation in a subset of LR OE19 subclones. Cells with this mutant allele harbour increased Src phosphorylation. Genetic and pharmacologic inhibition of Src resensitized these subclones to lapatinib. Biochemically, Src mutations could activate both the phosphatidylinositol 3-kinase and mitogen activated protein kinase pathways in the lapatinib-treated LR OE19 cells. Ectopic expression of Src (E527K) mutation also was sufficient to induce lapatinib resistance in drug-naive cells. These results indicate that pathologic activation of Src is a potential mechanism of acquired resistance to ERBB2 inhibition in ERBB2-amplified gastroesophageal cancer. Although Src mutation has not been described in primary tumor samples, we propose that the Src hyperactivation should be investigated in the settings of acquired resistance to ERBB2 inhibition in esophageal and gastric adenocarcinoma.	[Hong, Yong Sang; Kim, Jihun; Pectasides, Eirini; Fox, Cameron; Ma, Qiuping; Wong, Gabrielle S.; Peng, Shouyong; Stachler, Matthew D.; Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hong, Yong Sang] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Kim, Jihun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Pectasides, Eirini] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; [Hong, Seung-Woo] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Peng, Shouyong; Bass, Adam J.] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Stachler, Matthew D.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Thorner, Aaron R.; Van Hummelen, Paul] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Bass, Adam J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bass, Adam J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Bass, AJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	adam_bass@dfci.harvard.edu		van hummelen, paul/0000-0002-4801-8600; Fox, Cameron/0000-0002-8922-876X	American Gastroenterological Association; Anna Fuller Fund; Phi Beta Psi; American Cancer Society; National Institute of Health [P01 CA098101]; NATIONAL CANCER INSTITUTE [P01CA098101] Funding Source: NIH RePORTER	American Gastroenterological Association; Anna Fuller Fund; Phi Beta Psi; American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Funderburg Research Award in Gastric Biology Related to Cancer from the American Gastroenterological Association, The Anna Fuller Fund, Phi Beta Psi, a Research Scholar Grant from the American Cancer Society and P01 CA098101 from the National Institute of Health, all to A.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Arcaroli JJ, 2012, CLIN CANCER RES, V18, P2704, DOI 10.1158/1078-0432.CCR-11-3167; Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bang YJ, 2011, INVEST NEW DRUG, V29, P1449, DOI 10.1007/s10637-010-9438-y; Baselga J, 2010, CLIN CANCER RES, V16, P4876, DOI 10.1158/1078-0432.CCR-10-0748; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bertotti A, 2010, CLIN CANCER RES, V16, P3933, DOI 10.1158/1078-0432.CCR-10-0106; Cavalloni G, 2012, MOL CANCER THER, V11, P1528, DOI 10.1158/1535-7163.MCT-11-1020; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Dank M, 2008, ANN ONCOL, V19, P1450, DOI 10.1093/annonc/mdn166; De Luca A, 2013, CELL CYCLE, V13; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Ferguson J, 2013, ONCOGENE, V32, P86, DOI 10.1038/onc.2012.25; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Fujisaka Y, 2013, INVEST NEW DRUG, V31, P108, DOI 10.1007/s10637-012-9809-7; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Han SQ, 2014, MABS-AUSTIN, V6, P403, DOI 10.4161/mabs.27443; Hettmer S, 2013, J PATHOL, V231, P44, DOI 10.1002/path.4229; Hong J, 2012, CANCER RES, V72, P4504, DOI 10.1158/0008-5472.CAN-12-1119; Janjigian YY, 2013, J NUCL MED, V54, P936, DOI 10.2967/jnumed.112.110239; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kang YK, 2013, INVEST NEW DRUGS; Kim HS, 2013, ANN ONCOL, V24, P2850, DOI 10.1093/annonc/mdt351; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mackay HJ, 2012, INVEST NEW DRUG, V30, P1158, DOI 10.1007/s10637-011-9650-4; Morrow CJ, 2010, CANCER RES, V70, P5931, DOI 10.1158/0008-5472.CAN-10-0694; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nam HJ, 2013, MOL CANCER THER, V12, P16, DOI 10.1158/1535-7163.MCT-12-0109; Olayioye MA, 2001, EXP CELL RES, V267, P81, DOI 10.1006/excr.2001.5242; Pastuskovas CV, 2012, MOL CANCER THER, V11, P752, DOI 10.1158/1535-7163.MCT-11-0742-T; Rajeshkumar NV, 2009, CLIN CANCER RES, V15, P4138, DOI 10.1158/1078-0432.CCR-08-3021; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Schwartzberg PL, 1998, ONCOGENE, V17, P1463, DOI 10.1038/sj.onc.1202176; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wainberg ZA, 2010, CLIN CANCER RES, V16, P1509, DOI 10.1158/1078-0432.CCR-09-1112; Wang XL, 2012, ACTA PHARMACOL SIN, V33, P513, DOI 10.1038/aps.2011.205; Wetterskog D, 2013, ONCOGENE; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	49	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e109440	10.1371/journal.pone.0109440	http://dx.doi.org/10.1371/journal.pone.0109440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350844	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943100011
J	OuYang, PY; Su, Z; Tang, J; Lan, XW; Mao, YP; Deng, WG; Xie, FY				OuYang, Pu-Yun; Su, Zhen; Tang, Jie; Lan, Xiao-Wen; Mao, Yan-Ping; Deng, Wuguo; Xie, Fang-Yun			Diabetes, Prediabetes and the Survival of Nasopharyngeal Carcinoma: A Study of 5,860 Patients	PLOS ONE			English	Article							FASTING BLOOD-GLUCOSE; INTENSITY-MODULATED RADIOTHERAPY; PROGNOSTIC IMPACT; ALL-CAUSE; CANCER; OUTCOMES; RISK; MELLITUS; EPIDEMIOLOGY; MORTALITY	Background: The incidence of diabetes is increasing. But the impact of diabetes and prediabetes on survival of patients with nasopharyngeal carcinoma (NPC) has received little evaluation. Methods: In a cohort of 5,860 patients, we compared the disease specific survival (DSS), locoregional relapse-free survival (LRFS) and distant metastasis-free survival (DMFS) of patients with diabetes, prediabetes and normoglycemia defined by pretreatment fasting plasma glucose (FPG) using Kaplan-Meier method, log-rank test and Cox proportional hazards model. Results: Comparing to normoglycemic patients, the diabetic and the prediabetic were generally older, fatter, had hypertension, heart diseases and hyperlipaemia and usually received radiotherapy alone. But both the diabetic and the prediabetic had similar DSS, LRFS and DMFS to normoglycemic patients, even adjusting for such important factors as age, gender, smoking, drinking, hypertension, heart diseases, body mass index, hyperlipaemia, titer of VCA-IgA and EA-IgA, pathology, T-stage, N-stage, chemotherapy and radiotherapy (P>0.05 for all). Additionally, the findings remained unchanged in sensitivity analysis by excluding patients with known diabetes history and in subgroups of the various factors. Conclusions: The diabetic and prediabetic NPC patients had similar survival to normoglycemic NPC patients. These data, in the largest reported cohort, are the first to evaluate the association between diabetes, prediabetes and the survival in NPC. The findings are relevant to patient management and provided evidence of the effect on this disease exerted by comorbidities.	[OuYang, Pu-Yun; Su, Zhen; Tang, Jie; Lan, Xiao-Wen; Mao, Yan-Ping; Xie, Fang-Yun] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Expt Res,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xie, FY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	xiefy@sysucc.org.cn						Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Bosetti C, 2012, NUTR CANCER, V64, P643, DOI 10.1080/01635581.2012.676141; Cai Q, 2013, BRIT J CANCER, V108, P380, DOI 10.1038/bjc.2012.566; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chu CK, 2010, ANN SURG ONCOL, V17, P502, DOI 10.1245/s10434-009-0789-6; COX DR, 1972, J R STAT SOC B, V34, P187; Edge SB, 2010, AJCC CANC STAGING MA; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hofner T, 2013, WORLD J UROL; Huang PY, 2013, EUR J CANCER, V49, P1923, DOI 10.1016/j.ejca.2013.01.027; Ioacara S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093132; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kiderlen M, 2013, ANN ONCOL, V24, P3011, DOI 10.1093/annonc/mdt367; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Liu H, 2006, MED ONCOL, V23, P341, DOI 10.1385/MO:23:3:341; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Luo J, 2014, BRIT J CANCER, V110, P1847, DOI 10.1038/bjc.2014.68; Luo JH, 2012, LUNG CANCER, V76, P242, DOI 10.1016/j.lungcan.2011.10.019; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Minicozzi P, 2013, EUR J CANCER, V49, P3881, DOI 10.1016/j.ejca.2013.08.004; OuYang PY, 2013, BRIT J CANCER, V109, P788, DOI 10.1038/bjc.2013.343; OuYang PY, 2013, CANCER EPIDEM BIOMAR, V22, P2285, DOI 10.1158/1055-9965.EPI-13-0546; Richardson LC, 2005, NAT CLIN PRACT ONCOL, V2, P48, DOI 10.1038/ncponc0062; Schmid D, 2013, EUR J EPIDEMIOL, V28, P945, DOI 10.1007/s10654-013-9865-0; Sonabend RY, 2009, J PEDIATR-US, V155, P73, DOI 10.1016/j.jpeds.2009.01.072; Stott-Miller M, 2012, CANCER EPIDEM BIOMAR, V21, P294, DOI 10.1158/1055-9965.EPI-11-0590; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	33	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111073	10.1371/journal.pone.0111073	http://dx.doi.org/10.1371/journal.pone.0111073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350747	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100055
J	Feng, J; Wang, T; Zhang, S; Shi, WL; Zhang, Y				Feng, Jie; Wang, Ting; Zhang, Shuo; Shi, Wanliang; Zhang, Ying			An Optimized SYBR Green I/PI Assay for Rapid Viability Assessment and Antibiotic Susceptibility Testing for Borrelia burgdorferi	PLOS ONE			English	Article							3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYL TETRAZOLIUM BROMIDE; MYCOBACTERIUM-TUBERCULOSIS; QUANTIFICATION; BACTERIA; GROWTH	Lyme disease caused by Borrelia burgdorferi is the most common tick-borne disease in the US and Europe. Unlike most bacteria, measurements of growth and viability of B. burgdorferi are challenging. The current B. burgdorferi viability assays based on microscopic counting and PCR are cumbersome and tedious and cannot be used in a high throughput format. Here, we evaluated several commonly used viability assays including MTT and XTT assays, fluorescein diacetate assay, Sytox Green/Hoechst 33342 assay, the commercially available LIVE/DEAD BacLight assay, and SYBR Green I/PI assay by microscopic counting and by automated 96-well plate reader for rapid viability assessment of B. burgdorferi. We found that the optimized SYBR Green I/PI assay based on green to red fluorescence ratio is superior to all the other assays for measuring the viability of B. burgdorferi in terms of sensitivity, accuracy, reliability, and speed in automated 96-well plate format and in comparison with microscopic counting. The BSK-H medium which produced a high background for the LIVE/DEAD BacLight assay did not affect the SYBR Green I/PI assay, and the viability of B. burgdorferi culture could be directly measured using a microtiter plate reader. The SYBR Green I/PI assay was found to reliably assess the viability of planktonic as well as biofilm B. burgdorferi and could be used as a rapid antibiotic susceptibility test. Thus, the SYBR Green I/PI assay provides a more sensitive, rapid and convenient method for evaluating viability and antibiotic susceptibility of B. burgdorferi and can be used for high-throughput drug screens.	[Feng, Jie; Wang, Ting; Zhang, Shuo; Shi, Wanliang; Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, Y (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	yzhang@jhsph.edu	Feng, Jie/AAZ-1723-2021	Feng, Jie/0000-0001-8358-5654	Lyme Research Alliance (lymedisease.org)	Lyme Research Alliance (lymedisease.org)	Support was provided by the Lyme Research Alliance (lymedisease.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Barbesti S, 2000, CYTOMETRY, V40, P214, DOI 10.1002/1097-0320(20000701)40:3<214::AID-CYTO6>3.0.CO;2-M; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Brorson O, 2009, P NATL ACAD SCI USA, V106, P18656, DOI 10.1073/pnas.0908236106; Centers for Disease Control, 2014, LYM DIS; Cerca F, 2011, CAN J MICROBIOL, V57, P850, DOI [10.1139/W11-078, 10.1139/w11-078]; Cornell KA, 2009, J ANTIMICROB CHEMOTH, V63, P1163, DOI 10.1093/jac/dkp129; Diterich I, 2003, INFECT IMMUN, V71, P3979, DOI 10.1128/IAI.71.7.3979-3987.2003; Feng J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.53; Gabrielson J, 2002, J MICROBIOL METH, V50, P63, DOI 10.1016/S0167-7012(02)00011-8; Hunfeld KP, 2006, WIEN KLIN WOCHENSCHR, V118, P659, DOI 10.1007/s00508-006-0693-z; Mshana RN, 1998, J CLIN MICROBIOL, V36, P1214, DOI 10.1128/JCM.36.5.1214-1219.1998; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Sapi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048277; Sapi Eva, 2011, Infect Drug Resist, V4, P97, DOI 10.2147/IDR.S19201; Sun ZH, 1999, J BACTERIOL, V181, P7626, DOI 10.1128/JB.181.24.7626-7628.1999; Taylor JP, 2002, SOIL BIOL BIOCHEM, V34, P387, DOI 10.1016/S0038-0717(01)00199-7; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Zambrano MC, 2004, INFECT IMMUN, V72, P3138, DOI 10.1128/IAI.72.6.3138-3146.2004	19	63	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111809	10.1371/journal.pone.0111809	http://dx.doi.org/10.1371/journal.pone.0111809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365247	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100126
J	Zadra, JR; Proffitt, DR				Zadra, Jonathan R.; Proffitt, Dennis R.			Implicit Associations Have a Circadian Rhythm	PLOS ONE			English	Article							BLOOD-GLUCOSE; SELF-CONTROL; AUTOMATIC ATTITUDES; EXECUTIVE FUNCTION; INSULIN-SECRETION; DIURNAL-VARIATION; COGNITIVE DEMAND; STRENGTH MODEL; EGO DEPLETION; ENERGY	The current study shows that people's ability to inhibit implicit associations that run counter to their explicit views varies in a circadian pattern. The presence of this rhythmic variation suggests the involvement of a biological process in regulating automatic associations-specifically, with the current data, associations that form undesirable social biases. In 1998, Greenwald, McGhee, and Schwartz introduced the Implicit Association Test as a means of measuring individual differences in implicit cognition. The IAT is a powerful tool that has become widely used. Perhaps most visibly, studies employing the IAT demonstrate that people generally hold implicit biases against social groups, which often conflict with their explicitly held views. The IAT engages inhibitory processes similar to those inherent in self-control tasks. Because the latter processes are known to be resource-limited, we considered whether IAT scores might likewise be resource dependent. Analyzing IAT performance from over a million participants across all times of day, we found a clear circadian pattern in scores. This finding suggests that the IAT measures not only the strength of implicit associations, but also the effect of variations in the physiological resources available to inhibit their undesirable influences on explicit behavior.	[Zadra, Jonathan R.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Zadra, Jonathan R.; Proffitt, Dennis R.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	Utah System of Higher Education; University of Utah; University of Virginia	Zadra, JR (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	j.zadra@utah.edu						Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Benton D, 1996, J BIOSOC SCI, V28, P463, DOI 10.1017/S0021932000022537; Benton D, 2001, PHYSIOL BEHAV, V74, P559, DOI 10.1016/S0031-9384(01)00601-1; BENTON D, 1992, BIOL PSYCHOL, V33, P207, DOI 10.1016/0301-0511(92)90032-P; BODENHAUSEN GV, 1990, PSYCHOL SCI, V1, P319, DOI 10.1111/j.1467-9280.1990.tb00226.x; BOLLI GB, 1984, DIABETES, V33, P1150, DOI 10.2337/diabetes.33.12.1150; CARROLL KF, 1973, DIABETES, V22, P333, DOI 10.2337/diab.22.5.333; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Dasgupta N, 2001, J PERS SOC PSYCHOL, V81, P800, DOI 10.1037/0022-3514.81.5.800; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Donohoe RT, 1999, PSYCHOPHARMACOLOGY, V145, P378, DOI 10.1007/s002130051071; Donohoe RT, 2000, PHYSIOL BEHAV, V71, P395, DOI 10.1016/S0031-9384(00)00359-0; Fairclough SH, 2004, BIOL PSYCHOL, V66, P177, DOI 10.1016/j.biopsycho.2003.10.001; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Gailliot MT, 2009, J EXP SOC PSYCHOL, V45, P288, DOI 10.1016/j.jesp.2008.09.003; Gailliot MT, 2008, PERSPECT PSYCHOL SCI, V3, P245, DOI 10.1111/j.1745-6924.2008.00077.x; Gordijn EH, 2004, PERS SOC PSYCHOL B, V30, P212, DOI 10.1177/0146167203259935; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hofmann W, 2007, J EXP SOC PSYCHOL, V43, P497, DOI 10.1016/j.jesp.2006.05.004; Hucklebridge FH, 1999, LIFE SCI, V64, P931, DOI 10.1016/S0024-3205(99)00019-3; Ingwersen J, 2007, APPETITE, V49, P240, DOI 10.1016/j.appet.2006.06.009; JARRETT RJ, 1972, BRIT MED J, V1, P199, DOI 10.1136/bmj.1.5794.199; Kurzban R, 2010, EVOL PSYCHOL-US, V8, P244, DOI 10.1177/147470491000800208; Lai CK, J EXP PSYCHOL GEN; McGrath JE., 1986, TIME HUMAN INTERACTI; MESSIER C, 1987, BEHAV NEURAL BIOL, V48, P104, DOI 10.1016/S0163-1047(87)90634-0; Miller HC, 2013, J PSYCHOPHARMACOL, V27, P645, DOI 10.1177/0269881112473790; Miller HC, 2012, BEHAV PROCESS, V91, P313, DOI 10.1016/j.beproc.2012.09.012; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Ostafin BD, 2008, BEHAV RES THER, V46, P1210, DOI 10.1016/j.brat.2008.08.003; Owens DS, 1997, PHYSIOL BEHAV, V62, P471, DOI 10.1016/S0031-9384(97)00156-X; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Richeson JA, 2005, J PERS SOC PSYCHOL, V88, P934, DOI 10.1037/0022-3514.88.6.934; Richeson JA, 2003, PSYCHOL SCI, V14, P287, DOI 10.1111/1467-9280.03437; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Scholey AB, 2001, PHYSIOL BEHAV, V73, P585, DOI 10.1016/S0031-9384(01)00476-0; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Townsend J. T., 1992, COGNITION INFORMATIO, P105; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; VANCAUTER E, 1992, AM J PHYSIOL, V262, pE467, DOI 10.1152/ajpendo.1992.262.4.E467; Wallace HM, 2002, SELF IDENTITY, V1, P35, DOI 10.1080/152988602317232786; WENK GL, 1989, PSYCHOPHARMACOLOGY, V99, P431, DOI 10.1007/BF00589888	52	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110149	10.1371/journal.pone.0110149	http://dx.doi.org/10.1371/journal.pone.0110149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU4DB	25365254	Green Published, gold, Green Submitted			2022-12-27	WOS:000345558100018
J	Devauges, V; Matthews, DR; Aluko, J; Nedbal, J; Levitt, JA; Poland, SP; Coban, O; Weitsman, G; Monypenny, J; Ng, T; Ameer-Beg, SM				Devauges, Viviane; Matthews, Daniel R.; Aluko, Justin; Nedbal, Jakub; Levitt, James A.; Poland, Simon P.; Coban, Oana; Weitsman, Gregory; Monypenny, James; Ng, Tony; Ameer-Beg, Simon M.			Steady-State Acceptor Fluorescence Anisotropy Imaging under Evanescent Excitation for Visualisation of FRET at the Plasma Membrane	PLOS ONE			English	Article							INTERNAL-REFLECTION FLUORESCENCE; RESONANCE ENERGY-TRANSFER; NUMERICAL-APERTURE OBJECTIVES; LIVING CELLS; IMMUNOLOGICAL SYNAPSE; BREAST-CANCER; RHO-GTPASE; LIVE CELLS; STRUCTURED ILLUMINATION; POLARIZATION MICROSCOPY	We present a novel imaging system combining total internal reflection fluorescence (TIRF) microscopy with measurement of steady-state acceptor fluorescence anisotropy in order to perform live cell Forster Resonance Energy Transfer (FRET) imaging at the plasma membrane. We compare directly the imaging performance of fluorescence anisotropy resolved TIRF with epifluorescence illumination. The use of high numerical aperture objective for TIRF required correction for induced depolarization factors. This arrangement enabled visualisation of conformational changes of a Raichu-Cdc42 FRET biosensor by measurement of intramolecular FRET between eGFP and mRFP1. Higher activity of the probe was found at the cell plasma membrane compared to intracellularly. Imaging fluorescence anisotropy in TIRF allowed clear differentiation of the Raichu-Cdc42 biosensor from negative control mutants. Finally, inhibition of Cdc42 was imaged dynamically in live cells, where we show temporal changes of the activity of the Raichu-Cdc42 biosensor.	[Devauges, Viviane; Matthews, Daniel R.; Nedbal, Jakub; Levitt, James A.; Poland, Simon P.; Coban, Oana; Weitsman, Gregory; Monypenny, James; Ng, Tony; Ameer-Beg, Simon M.] Kings Coll London, Div Canc Studies, Richard Dimbleby Canc Res Lab, London WC2R 2LS, England; [Devauges, Viviane; Matthews, Daniel R.; Nedbal, Jakub; Levitt, James A.; Poland, Simon P.; Coban, Oana; Weitsman, Gregory; Monypenny, James; Ng, Tony; Ameer-Beg, Simon M.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Aluko, Justin] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Ng, Tony] UCL, UCL Canc Inst, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London	Ameer-Beg, SM (corresponding author), Kings Coll London, Div Canc Studies, Richard Dimbleby Canc Res Lab, London WC2R 2LS, England.	simon.ameer-beg@kcl.ac.uk		Ng, Tony/0000-0003-3894-5619; Ameer-Beg, Simon/0000-0001-5227-575X	Biotechnology and Biological Sciences Research Council UK [BB/G007160/1, BB/I022074/1]; Cancer Research UK; Engineering and Physical Sciences Research Council (UK); Medical Research Council (UK); Department of Health (UK); KCL/UCL Comprehensive Cancer Imaging Centre; Dimbleby Cancer Care endowment fund; Biotechnology and Biological Sciences Research Council [BB/G007160/1, BB/I022074/1] Funding Source: researchfish; Cancer Research UK [16463] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1413605] Funding Source: researchfish; BBSRC [BB/G007160/1, BB/I022074/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (UK); KCL/UCL Comprehensive Cancer Imaging Centre; Dimbleby Cancer Care endowment fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Biotechnology and Biological Sciences Research Council UK, http://www.bbsrc.ac.uk, BB/G007160/1 (TN, SMA) and BB/I022074/1 (SMA, DRM, TN), Cancer Research UK, Engineering and Physical Sciences Research Council (UK), Medical Research Council (UK) and Department of Health (UK), KCL/UCL Comprehensive Cancer Imaging Centre, and by The Dimbleby Cancer Care endowment fund to King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2012, CANCER SCI, V103, P614, DOI 10.1111/j.1349-7006.2011.02196.x; AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Axelrod D, 2013, BIOPHYS J, V104, P1401, DOI 10.1016/j.bpj.2013.02.044; Axelrod D, 2012, J MICROSC-OXFORD, V247, P147, DOI 10.1111/j.1365-2818.2012.03625.x; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Bahlmann K, 2000, APPL PHYS LETT, V77, P612, DOI 10.1063/1.127061; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; BALLEW RM, 1989, ANAL CHEM, V61, P30, DOI 10.1021/ac00176a007; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Barroca T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218101; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BERBERANSANTOS MN, 1991, J CHEM PHYS, V95, P8048, DOI 10.1063/1.461285; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Beutler M, 2008, EUR BIOPHYS J BIOPHY, V38, P69, DOI 10.1007/s00249-008-0361-5; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BREMARD C, 1985, APPL SPECTROSC, V39, P1036, DOI 10.1366/0003702854249754; Brunstein M, 2014, BIOPHYS J, V106, P1044, DOI 10.1016/j.bpj.2013.12.051; Brunstein M, 2013, OPT EXPRESS, V21, P26162, DOI 10.1364/OE.21.026162; BURGHARDT TP, 1984, BIOPHYS J, V46, P729, DOI 10.1016/S0006-3495(84)84071-0; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carlin LM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001729; Chen QY, 2012, INT J ONCOL, V40, P1561, DOI 10.3892/ijo.2012.1336; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Del Pulgar TG, 2008, INT J ONCOL, V33, P185; Devauges V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044434; Elson DS, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/180; Ems-McClung SC, 2013, CURR BIOL, V23, P2491, DOI 10.1016/j.cub.2013.10.054; Enderlein J, 2011, OPT EXPRESS, V19, P8011, DOI 10.1364/OE.19.008011; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fiolka R, 2008, OPT LETT, V33, P1629, DOI 10.1364/OL.33.001629; Fisz JJ, 2007, J PHYS CHEM A, V111, P8606, DOI 10.1021/jp072113b; Fisz JJ, 2005, CHEM PHYS LETT, V412, P263, DOI 10.1016/j.cplett.2005.06.108; Forkey JN, 2005, BIOPHYS J, V89, P1261, DOI 10.1529/biophysj.104.053470; FORSTER T, 1946, NATURWISSENSCHAFTEN, V33, P166, DOI 10.1007/BF00585226; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fruhwirth GO, 2011, CHEMPHYSCHEM, V12, P442, DOI 10.1002/cphc.201000866; Fruhwirth GO, 2010, OPT EXPRESS, V18, P11148, DOI 10.1364/OE.18.011148; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gee ML, 2004, EUR BIOPHYS J BIOPHY, V33, P130, DOI 10.1007/s00249-003-0360-5; Gliko O, 2008, BIOMEDICAL OPTICS BI; Godfrey TM, 1953, GLYCEROL; Grant DM, 2007, OPT EXPRESS, V15, P15656, DOI 10.1364/OE.15.015656; Guo F, 2011, PLOS ONE, V6; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; HELLEN EH, 1987, J OPT SOC AM B, V4, P337, DOI 10.1364/JOSAB.4.000337; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kikuchi K, 2011, FEBS LETT, V585, P286, DOI 10.1016/j.febslet.2010.12.010; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Levitt JA, 2009, CURR OPIN BIOTECH, V20, P28, DOI 10.1016/j.copbio.2009.01.004; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Makrogianneli K, 2009, MOL CELL BIOL, V29, P2997, DOI 10.1128/MCB.01008-08; Marquer C, 2011, FASEB J, P1; Matthews DR, 2010, J MICROSC-OXFORD, V237, P51, DOI 10.1111/j.1365-2818.2009.03301.x; Matthews DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033231; Mattheyses AL, 2004, BIOPHYS J, V87, P2787, DOI 10.1529/biophysj.103.036194; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; MIKI T, 1995, METHOD ENZYMOL, V256, P90; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morishita H, 2000, J RAMAN SPECTROSC, V31, P455, DOI 10.1002/1097-4555(200006)31:6<455::AID-JRS551>3.0.CO;2-Q; Nakamura T, 2005, METHODS, V37, P146, DOI 10.1016/j.ymeth.2005.05.021; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Perrin F, 1926, J PHYS-PARIS, V7, P390, DOI 10.1051/jphysrad:01926007012039000; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Scholes CA, 2011, J PHYS CHEM B, V115, P6329, DOI 10.1021/jp201332w; Shribak M, 2002, OPT ENG, V41, P943, DOI 10.1117/1.1467669; Siegel J, 2003, REV SCI INSTRUM, V74, P182, DOI 10.1063/1.1519934; Smith TA, 2005, REV FLUORESCENCE, V2, P245; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Suhling K, 2002, J FLUORESC, V12, P91, DOI 10.1023/A:1015323606154; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; Suzuki Y, 2013, DIRECT MOL INTERACTI; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Torok P, 1998, OPT COMMUN, V148, P300, DOI 10.1016/S0030-4018(97)00576-2; Tramier M, 2008, METHOD CELL BIOL, V85, P395, DOI 10.1016/S0091-679X(08)85017-0; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Zhu XW, 2000, INT J DEV NEUROSCI, V18, P433, DOI 10.1016/S0736-5748(00)00010-1; Zuo YF, 2012, J CELL PHYSIOL, V227, P1399, DOI 10.1002/jcp.22853	102	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110695	10.1371/journal.pone.0110695	http://dx.doi.org/10.1371/journal.pone.0110695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360776	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700041
J	Huang, KH; Lan, YT; Fang, WL; Chen, JH; Lo, SS; Li, AFY; Chiou, SH; Wu, CW; Shyr, YM				Huang, Kuo-Hung; Lan, Yuan-Tzu; Fang, Wen-Liang; Chen, Jen-Hao; Lo, Su-Shun; Li, Anna Fen-Yau; Chiou, Shih-Hwa; Wu, Chew-Wun; Shyr, Yi-Ming			Comparison of the Operative Outcomes and Learning Curves between Laparoscopic and Robotic Gastrectomy for Gastric Cancer	PLOS ONE			English	Article							METAANALYSIS; DISSECTION	Background: Minimally invasive surgery, including laparoscopic and robotic gastrectomy, has become more popular in the treatment of gastric cancer. However, few studies have compared the learning curves between laparoscopic and robotic gastrectomy for gastric cancer. Methods: Data were prospectively collected between July 2008 and Aug 2014. A total of 145 patients underwent minimally invasive gastrectomy for gastric cancer by a single surgeon, including 73 laparoscopic and 72 robotic gastrectomies. The clinicopathologic characteristics, operative outcomes and learning curves were compared between the two groups. Results: Compared with the laparoscopic group, the robotic group was associated with less blood loss and longer operative time. After the surgeon learning curves were overcome for each technique, the operative outcomes became similar between the two groups except longer operative time in the robotic group. After accumulating more cases of robotic gastrectomy, the operative time in the laparoscopic group decreased dramatically. Conclusions: After overcoming the learning curves, the operative outcomes became similar between laparoscopic and robotic gastrectomy. The experience of robotic gastrectomy could affect the learning process of laparoscopic gastrectomy.	[Huang, Kuo-Hung; Fang, Wen-Liang; Wu, Chew-Wun; Shyr, Yi-Ming] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Li, Anna Fen-Yau] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan; [Lan, Yuan-Tzu] Taipei Vet Gen Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan; [Huang, Kuo-Hung; Lan, Yuan-Tzu; Fang, Wen-Liang; Chen, Jen-Hao; Lo, Su-Shun; Li, Anna Fen-Yau; Wu, Chew-Wun; Shyr, Yi-Ming] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Kuo-Hung; Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chen, Jen-Hao] En Chu Kong Hosp, New Taipei City, Taiwan; [Lo, Su-Shun] Natl Yang Ming Univ Hosp, Yilan City, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; En Chu Kong Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Fang, WL (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.	s821094@hotmail.com			Division of Experimental Surgery of the Department of Surgery, Taipei Veterans General Hospital [V103C-135]; Ministry of Science and Technology [103-2314-B-075-042]	Division of Experimental Surgery of the Department of Surgery, Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Division of Experimental Surgery of the Department of Surgery, Taipei Veterans General Hospital (V103C-135) and Ministry of Science and Technology (103-2314-B-075-042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huang KH, 2012, J GASTROINTEST SURG, V16, P1303, DOI 10.1007/s11605-012-1874-x; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Hyun MH, 2013, BRIT J SURG, V100, P1566, DOI 10.1002/bjs.9242; Kim HI, 2013, EUR J SURG ONCOL; Kim HH, 2014, J CLIN ONCOL, V32, P627, DOI 10.1200/JCO.2013.48.8551; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Lee JH, 2014, SURGERY, V155, P154, DOI 10.1016/j.surg.2013.06.015; Liao GX, 2013, ASIAN PAC J CANCER P, V14, P4871, DOI 10.7314/APJCP.2013.14.8.4871; Liao GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081946; Marano A, 2013, J GASTRIC CANCER, V13, P136, DOI 10.5230/jgc.2013.13.3.136; Park SS, 2012, SURG ENDOSC, V26, P60, DOI 10.1007/s00464-011-1828-5; Sobin L, 2009, TNM CLASSIFICATION M; Song J, 2009, ANN SURG, V249, P927, DOI 10.1097/01.sla.0000351688.64999.73; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Xiong BH, 2012, SURG ONCOL, V21, P274, DOI 10.1016/j.suronc.2012.05.004; Xiong JJ, 2013, J LAPAROENDOSC ADV S, V23, P965, DOI 10.1089/lap.2013.0279	16	61	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111499	10.1371/journal.pone.0111499	http://dx.doi.org/10.1371/journal.pone.0111499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360767	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700110
J	Ipinza, F; Collao, B; Monsalva, D; Bustamante, VH; Luraschi, R; Alegria-Arcos, M; Almonacid, DE; Aguayo, D; Calderon, IL; Gil, F; Santiviago, CA; Morales, EH; Calva, E; Saavedra, CP				Ipinza, Francisco; Collao, Bernardo; Monsalva, Debbie; Bustamante, Victor H.; Luraschi, Roberto; Alegria-Arcos, Melissa; Almonacid, Daniel E.; Aguayo, Daniel; Calderon, Ivan L.; Gil, Fernando; Santiviago, Carlos A.; Morales, Eduardo H.; Calva, Edmundo; Saavedra, Claudia P.			Participation of the Salmonella OmpD Porin in the Infection of RAW264.7 Macrophages and BALB/c Mice	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NADPH PHAGOCYTE OXIDASE; IN-VIVO; ANTIMICROBIAL ACTIONS; ESCHERICHIA-COLI; METHYL VIOLOGEN; PROTEIN; GENE; EXPRESSION; VIRULENCE	Salmonella Typhimurium is the etiological agent of gastroenteritis in humans and enteric fever in mice. Inside these hosts, Salmonella must overcome hostile conditions to develop a successful infection, a process in which the levels of porins may be critical. Herein, the role of the Salmonella Typhimurium porin OmpD in the infection process was assessed for adherence, invasion and proliferation in RAW264.7 mouse macrophages and in BALB/c mice. In cultured macrophages, a Delta ompD strain exhibited increased invasion and proliferation phenotypes as compared to its parental strain. In contrast, overexpression of ompD caused a reduction in bacterial proliferation but did not affect adherence or invasion. In the murine model, the Delta ompD strain showed increased ability to survive and replicate in target organs of infection. The ompD transcript levels showed a down-regulation when Salmonella resided within cultured macrophages and when it colonized target organs in infected mice. Additionally, cultured macrophages infected with the Delta ompD strain produced lower levels of reactive oxygen species, suggesting that down-regulation of ompD could favor replication of Salmonella inside macrophages and the subsequent systemic dissemination, by limiting the reactive oxygen species response of the host.	[Ipinza, Francisco; Collao, Bernardo; Monsalva, Debbie; Luraschi, Roberto; Calderon, Ivan L.; Gil, Fernando; Saavedra, Claudia P.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Lab Microbiol Mol, Santiago, Chile; [Bustamante, Victor H.; Calva, Edmundo] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [Alegria-Arcos, Melissa; Almonacid, Daniel E.; Aguayo, Daniel] Univ Andres Bello, Fac Ciencias Biol, Ctr Bioinformat & Integrat Biol, Santiago, Chile; [Santiviago, Carlos A.] Univ Chile, Fac Ciencias Quim & Farm, Dept Bioquim & Biol Mol, Lab Microbiol, Santiago, Chile; [Morales, Eduardo H.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Morales, Eduardo H.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA	Universidad Andres Bello; Universidad Nacional Autonoma de Mexico; Universidad Andres Bello; Universidad de Chile; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Saavedra, CP (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Lab Microbiol Mol, Santiago, Chile.	csaavedra@unab.cl	Bustamante, Victor/GXF-0780-2022; Santiviago, Carlos/N-9991-2018; Luraschi, Roberto/AAI-7965-2021	Santiviago, Carlos/0000-0002-7043-7908; Luraschi, Roberto/0000-0001-5611-4320; Almonacid, Daniel E/0000-0002-1788-2084; Alegria-Arcos, Melissa/0000-0002-9372-9153	FONDECYT [1085131, 1120384, 1110172, 1140754, 11130576]; Nucleo UNAB DI [222-12/N]; CONACYT Mexico [179946]; MECESUP [UAB0802]; Universidad Andres Bello [DI -UNAB DI-187-12/I]; CONICYT	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Nucleo UNAB DI; CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MECESUP; Universidad Andres Bello; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was financed by grants from FONDECYT #1085131 and #1120384 and Nucleo UNAB DI 222-12/N (to C. P. S.), CONACYT Mexico #179946 and MECESUP UAB0802 (to E. B. C.). F. I. was supported by grants DI -UNAB DI-187-12/I from Universidad Andres Bello. B. C. received doctoral fellowships by CONICYT. C. A. S. was supported by FONDECYT grants 1110172 and 1140754. D. A. was supported by grant FONDECYT #11130576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Alberti S, 1996, INFECT IMMUN, V64, P4719; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Calderon IL, 2011, RES MICROBIOL, V162, P214, DOI 10.1016/j.resmic.2010.11.001; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Echave P, 2003, J BIOL CHEM, V278, P30193, DOI 10.1074/jbc.M304351200; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Gil F, 2007, RES MICROBIOL, V158, P529, DOI 10.1016/j.resmic.2007.05.004; Gil-Cruz C, 2004, P NATL ACAD SCI USA, V106, P9803; Hara-Kaonga B, 2004, CAN J MICROBIOL, V50, P719, DOI 10.1139/W04-056; He X, 2011, INT J FOOD SCI TECH, V46, P2164, DOI 10.1111/j.1365-2621.2011.02732.x; Holm MM, 2004, INFECT IMMUN, V72, P1906, DOI 10.1128/IAI.72.4.1906-1913.2004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LISSNER CR, 1983, J IMMUNOL, V131, P3006; Liu YF, 2012, INFECT IMMUN, V80, P1815, DOI 10.1128/IAI.06395-11; Loessner H, 2007, CELL MICROBIOL, V9, P1529, DOI 10.1111/j.1462-5822.2007.00890.x; Lukk T, 2012, P NATL ACAD SCI USA, V109, P4122, DOI 10.1073/pnas.1112081109; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Meyer PN, 1998, INFECT IMMUN, V66, P387, DOI 10.1128/IAI.66.1.387-390.1998; Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63; Negm RS, 1998, FEMS IMMUNOL MED MIC, V20, P191, DOI 10.1016/S0928-8244(98)00011-X; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodriguez-Morales O, 2006, INFECT IMMUN, V74, P1398, DOI 10.1128/IAI.74.2.1398-1402.2006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Santiviago CA, 2003, J BACTERIOL, V185, P5901, DOI 10.1128/JB.185.19.5901-5905.2003; Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x; Santiviago CA, 2001, MICROBIOL-SGM, V147, P1897, DOI 10.1099/00221287-147-7-1897; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Torii I, 2008, J IMMUNOL, V181, P4229, DOI 10.4049/jimmunol.181.6.4229; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Yoon H, 2011, INFECT IMMUN, V79, P2182, DOI 10.1128/IAI.01277-10; Zou Y, 2012, LETT APPL MICROBIOL, V55, P274, DOI 10.1111/j.1472-765X.2012.03288.x	47	15	16	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111062	10.1371/journal.pone.0111062	http://dx.doi.org/10.1371/journal.pone.0111062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360745	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700060
J	Quan, LQ; Chen, YQ; Song, J; Yan, QM; Zhang, QJ; Lai, SS; Fan, NN; Xin, JG; Zou, QJ; Lai, LX				Quan, Longquan; Chen, Yongqiang; Song, Jun; Yan, Quanmei; Zhang, Quanjun; Lai, Sisi; Fan, Nana; Xin, Jige; Zou, Qingjian; Lai, Liangxue			Establishment of a Rabbit Oct4 Promoter-Based EGFP Reporter System	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER EMBRYOS; FLUORESCENT PROTEIN; POU5F1 GENE; EXPRESSION; GENERATION	Rabbits are commonly used as laboratory animal models to investigate human diseases and phylogenetic development. However, pluripotent stem cells that contribute to germline transmission have yet to be established in rabbits. The transcription factor Oct4, also known as Pou5f1, is considered essential for the maintenance of the pluripotency of stem cells. Hence, pluripotent cells can be identified by monitoring Oct4 expression using a well-established Oct4 promoter-based reporter system. This study developed a rabbit Oct4 promoter-based enhanced green fluorescent protein (EGFP) reporter system by transfecting pROP2-EGFP into rabbit fetal fibroblasts (RFFs). The transgenic RFFs were used as donor cells for somatic cell nuclear transfer (SCNT). The EGFP expression was detected in the blastocysts and genital ridges of SCNT fetuses. Fibroblasts and neural stem cells (NSCs) were derived from the SCNT fetuses. EGFP was also reactivated in blastocysts after the second SCNT, and induced pluripotent stem cells (iPSCs) were obtained after reprogramming using Yamanaka's factors. The results above indicated that a rabbit reporter system used to monitor the differentiating status of cells was successfully developed.	[Quan, Longquan; Xin, Jige; Lai, Liangxue] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China; [Chen, Yongqiang; Song, Jun; Yan, Quanmei; Zhang, Quanjun; Lai, Sisi; Fan, Nana; Zou, Qingjian; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zou, QJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.	zou_qingjian@gibh.ac.cn; lai_liangxue@gibh.ac.cn	Song, Jun/A-3487-2013	Song, Jun/0000-0002-6128-6378	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA010201070]; Ministry of Science and Technology, National Basic Research Program of China (973 Program) [2010CB945402]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology, National Basic Research Program of China (973 Program)	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences (http://www.cas.cn/) Grant XDA010201070 and by Ministry of Science and Technology (http://www.most.gov.cn/index.htm) National Basic Research Program of China (973 Program) Grants 2010CB945402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Hao R, 2007, REPROD FERT DEVELOP, V19, P137, DOI 10.1071/RDv19n1Ab38; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Huang LZ, 2011, CELL REPROGRAM, V13, P93, DOI 10.1089/cell.2010.0069; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim JB, 2008, NATURE; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kobolak J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-88; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Miyoshi K, 2009, J REPROD DEVELOP, V55, P661, DOI 10.1262/jrd.09-089A; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Osteil P, 2013, BIOL OPEN, V2, P613, DOI 10.1242/bio.20134242; Ritter DI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035202; Shi JJ, 2008, DNA SEQUENCE, V19, P56, DOI 10.1080/10425170701388834; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; Tsung HC, 2003, CELL RES, V13, P195, DOI 10.1038/sj.cr.7290164; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yin MR, 2013, INT J DEV BIOL, V57, P845, DOI 10.1387/ijdb.130128sl; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	30	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109728	10.1371/journal.pone.0109728	http://dx.doi.org/10.1371/journal.pone.0109728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360692	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700017
J	Zhang, TH; Jiang, YZ; Qu, X; Shen, HC; Liu, Q; Du, JJ				Zhang, Tiehong; Jiang, Yuanzhu; Qu, Xiao; Shen, Hongchang; Liu, Qi; Du, Jiajun			Evaluation of Preoperative Hematologic Markers as Prognostic Factors and Establishment of Novel Risk Stratification in Resected pN0 Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; POOR SURVIVAL; NEUTROPHIL; THROMBOCYTOSIS; LEUKOCYTOSIS; INFLAMMATION; ASSOCIATION; PROTEIN	Background: The aims of this study were to investigate whether the preoperative hematologic markers, the neutrophillymphocyte ratio (NLR) or the platelet-lymphocyte ratio (PLR) were prognostic indicators and to develop a novel risk stratification model in pN0 non-small-cell lung cancer (NSCLC). Methods: We performed a retrospective analysis of 400 consecutive pN0 NSCLC patients. Prognostic values were evaluated by Cox proportional hazard model analyses and patients were stratified according to relative risks for patients' survival. Results: During the follow-up, 117 patients had cancer recurrence, and 86 patients died. In univariate analysis, age, gender, smoke status and tumor size as well as WBC, NEU, LYM, PLR and NLR were significantly associated with patients' prognosis. In multivariate analysis, age, tumor size and NLR were independent predictors for patients' overall survival (P = 0.024, 0.001, and 0.002 respectively). PLR didn't associated with patients' survival in multivariate analysis. Patients were stratified into 3 risk groups and the differences among the groups were significant according to disease free survival and overall survival (P = 0.000 and 0.000 respectively). Conclusions: We confirmed that NLR other than PLR was an independent prognostic factor. Combination of NLR, age and tumor size could stratify pN0 NSCLC patients into 3 risk groups and enabled us to develop a novel risk stratification model.	[Zhang, Tiehong; Qu, Xiao; Shen, Hongchang; Liu, Qi; Du, Jiajun] Shandong Univ, Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China; [Jiang, Yuanzhu; Du, Jiajun] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	Shandong University; Shandong University	Liu, Q (corresponding author), Shandong Univ, Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China.	liuqi66@sdu.edu.cn; dujiajun@sdu.edu.cn			Provincial Science and Technology Development Planning of Shandong [2011GGH21819, 2012G0021836]; Provincial Natural Science Foundation of Shandong [ZR2011HM077]	Provincial Science and Technology Development Planning of Shandong; Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	The work was supported by Provincial Science and Technology Development Planning of Shandong (2011GGH21819), Provincial Science and Technology Development Planning of Shandong (2012G0021836) and Provincial Natural Science Foundation of Shandong (ZR2011HM077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrakis MG, 2002, RESP MED, V96, P553, DOI 10.1053/rmed.2002.1328; Arrieta O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-50; Asahi Y, 1996, JPN J CANCER RES, V87, P451, DOI 10.1111/j.1349-7006.1996.tb00245.x; Azab B, 2013, MED ONCOL, V30, P1; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Gondo T, 2012, UROLOGY, V79, P1085, DOI 10.1016/j.urology.2011.11.070; Gorczyca W, 2011, POL J PATHOL, V62, P189; He W, 2013, MED ONCOL, V30, P1; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Kim D, 2012, EUROPEAN J SURG ONCO, V38, P861; Kobayashi N, 2012, LUNG CANCER, V75, P223, DOI 10.1016/j.lungcan.2011.06.009; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Metz CE, 1978, BASIC PRINCIPLES ROC, P283; Peterson JE, 2012, ANGIOGENESIS, V15, P265, DOI 10.1007/s10456-012-9259-z; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tomita M, 2012, ANTICANCER RES, V32, P3535; Tomita M, 2011, ANTICANCER RES, V31, P2995; Tomita M, 2009, ANTICANCER RES, V29, P2687; VANDERSCHOUW YT, 1992, FAM PRACT, V9, P506, DOI 10.1093/fampra/9.4.506; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Yao Y., 2013, P 2013 C LAS EL OPT, P1	26	21	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111494	10.1371/journal.pone.0111494	http://dx.doi.org/10.1371/journal.pone.0111494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360716	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700108
J	Matsui, Y; Matsubara, H; Ueno, S; Ito, Y; Terasaki, H; Kondo, M				Matsui, Yoshitsugu; Matsubara, Hisashi; Ueno, Shinji; Ito, Yasuki; Terasaki, Hiroko; Kondo, Mineo			Changes in Outer Retinal Microstructures during Six Month Period in Eyes with Acute Zonal Occult Outer Retinopathy-Complex	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; WHITE DOT SYNDROME; SEGMENT TIPS LINE; EPIRETINAL MEMBRANE SURGERY; MACULAR DYSTROPHY; SPOT SYNDROMES; AZOOR; PHOTORECEPTORS; ABNORMALITIES; CHOROIDOPATHY	Purpose: To study the changes in the outer retinal microstructures during a six month period after the onset of acute zonal occult outer retinopathy (AZOOR)-complex by spectral-domain optical coherence tomography (SD-OCT). Methods: Seventeen eyes of 17 patients with the AZOOR-complex were studied. The integrity of the external limiting membrane (ELM), ellipsoid zone (EZ; also called the inner/outer segment junction), and interdigitation zone (IDZ; also called the cone outer segment tips) were evaluated in the SD-OCT images obtained at the initial visit and at six months. The three highly reflective bands were divided into three types; continuous, discontinuous, and absent. The integrity of the outer nuclear layer (ONL) was also assessed. Results: Among the three highly reflective bands, the IDZ was most altered at the initial visit and least recovered at six months. Fifteen of 17 eyes (88%) had a recovery of at least one of the three bands at six months in the retinal area where the ONL was intact, and these areas showed an improvement of visual field. Three eyes (18%) had retinal areas where the ONL was absent at the initial visit, and there was no recovery in both the retinal structures and visual fields in these areas. Conclusions: Our results indicate that more than 85% eyes with AZOOR-complex show some recovery in the microstructures of the outer retina during a six month period if the ONL is intact. We conclude that SD-OCT is a useful method to monitor the changes of the outer retinal microstructure in eyes with the AZOOR-complex.	[Matsui, Yoshitsugu; Matsubara, Hisashi; Kondo, Mineo] Mie Univ, Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan; [Ueno, Shinji; Ito, Yasuki; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan	Mie University; Nagoya University	Kondo, M (corresponding author), Mie Univ, Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan.	mineo@clin.medic.mie-u.ac.jp	Ito, Yasuki/M-4876-2014; Terasaki, Hiroko/M-5054-2014; Ueno, Shinji/M-5063-2014	Ito, Yasuki/0000-0001-9219-9261; 	Ministry of Education, Culture, Sports, Science and Technology [20592603]; Grants-in-Aid for Scientific Research [25462710] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research C (#20592603) from Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, JPN J OPHTHALMOL, V48, P486, DOI 10.1007/s10384-004-0107-6; Bryan RG, 2002, RETINA-J RET VIT DIS, V22, P317, DOI 10.1097/00006982-200206000-00010; Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153; Fine HF, 2009, ARCH OPHTHALMOL-CHIC, V127, P66, DOI 10.1001/archophthalmol.2008.530; Francis PJ, 2005, BRIT J OPHTHALMOL, V89, P70, DOI 10.1136/bjo.2004.042416; Fujita K, 2012, AM J OPHTHALMOL, V154, P579, DOI 10.1016/j.ajo.2012.03.043; Fujiwara T, 2010, RETINA-J RET VIT DIS, V30, P1206, DOI 10.1097/IAE.0b013e3181e097f0; Gass JD, 2003, AM J OPHTHALMOL, V135, P380, DOI 10.1016/S0002-9394(03)00030-8; Gass JD, 2002, AM J OPHTHALMOL, V134, P329, DOI 10.1016/S0002-9394(02)01640-9; GASS JDM, 1993, J CLIN NEURO-OPHTHAL, V13, P79; GASS JDM, 1989, ARCH OPHTHALMOL-CHIC, V107, P189, DOI 10.1001/archopht.1989.01070010195021; Hangai M, 2009, ARCH OPHTHALMOL-CHIC, V127, P1307, DOI 10.1001/archophthalmol.2009.250; HOLZ FG, 1994, EYE, V8, P77, DOI 10.1038/eye.1994.15; Itoh Y, 2013, INVEST OPHTH VIS SCI, V54, P7302, DOI 10.1167/iovs.13-12702; JACOBSON SG, 1995, OPHTHALMOLOGY, V102, P1187, DOI 10.1016/S0161-6420(95)30891-3; JAMPOL LM, 1995, RETINA-J RET VIT DIS, V15, P373; Jampol LM, 2003, AM J OPHTHALMOL, V135, P376, DOI 10.1016/S0002-9394(02)02088-3; Li D, 2007, ARCH OPHTHALMOL-CHIC, V125, P1194, DOI 10.1001/archopht.125.9.1194; Li DJ, 2009, OPHTHALMOLOGY, V116, P762, DOI 10.1016/j.ophtha.2008.12.060; Mkrtchyan M, 2012, AM J OPHTHALMOL, V153, P757, DOI 10.1016/j.ajo.2011.09.007; Monson DM, 2011, SURV OPHTHALMOL, V56, P23, DOI 10.1016/j.survophthal.2010.07.004; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Nguyen MHT, 2007, RETINA-J RET VIT DIS, V27, P414, DOI 10.1097/01.iae.0000246676.88033.25; Park SJ, 2010, INVEST OPHTH VIS SCI, V51, P3673, DOI 10.1167/iovs.09-4169; Rii T, 2012, AM J OPHTHALMOL, V153, P524, DOI 10.1016/j.ajo.2011.08.021; Shimozono M, 2012, AM J OPHTHALMOL, V153, P698, DOI 10.1016/j.ajo.2011.09.011; So K, 2011, CASE REP OPHTHALM, V2, P307, DOI 10.1159/000332734; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Taira K, 2006, GRAEF ARCH CLIN EXP, V244, P880, DOI 10.1007/s00417-005-0172-7; Terasaki H, 2012, OPHTHALMOLOGY, V119, P2319, DOI 10.1016/j.ophtha.2012.07.012; Tsunoda K, 2012, RETINA-J RET VIT DIS, V32, P1135, DOI 10.1097/IAE.0b013e318232c32e; Tsunoda K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1099, DOI 10.1001/archophthalmol.2011.217; Watanabe K, 2013, JAMA OPHTHALMOL, V131, P172, DOI 10.1001/jamaophthalmol.2013.686; Zibrandtsen N, 2008, ACTA OPHTHALMOL, V86, P913, DOI 10.1111/j.1600-0420.2007.01140.x	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110592	10.1371/journal.pone.0110592	http://dx.doi.org/10.1371/journal.pone.0110592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356549	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000017
J	Salvo, SAGD; Hirsch, CN; Buell, CR; Kaeppler, SM; Kaeppler, HF				Salvo, Stella A. G. D.; Hirsch, Candice N.; Buell, C. Robin; Kaeppler, Shawn M.; Kaeppler, Heidi F.			Whole Transcriptome Profiling of Maize during Early Somatic Embryogenesis Reveals Altered Expression of Stress Factors and Embryogenesis-Related Genes	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; STEM-CELL MAINTENANCE; POLAR AUXIN TRANSPORT; PLANT-REGENERATION; EMBRYO DEVELOPMENT; MOLECULAR CHARACTERIZATION; REGULATORY NETWORK; ARABIDOPSIS; WUSCHEL; IDENTIFICATION	Embryogenic tissue culture systems are utilized in propagation and genetic engineering of crop plants, but applications are limited by genotype-dependent culture response. To date, few genes necessary for embryogenic callus formation have been identified or characterized. The goal of this research was to enhance our understanding of gene expression during maize embryogenic tissue culture initiation. In this study, we highlight the expression of candidate genes that have been previously regarded in the literature as having important roles in somatic embryogenesis. We utilized RNA based sequencing (RNA-seq) to characterize the transcriptome of immature embryo explants of the highly embryogenic and regenerable maize genotype A188 at 0, 24, 36, 48, and 72 hours after placement of explants on tissue culture initiation medium. Genes annotated as functioning in stress response, such as glutathione-S-transferases and germin-like proteins, and genes involved with hormone transport, such as PINFORMED, increased in expression over 8-fold in the study. Maize genes with high sequence similarity to genes previously described in the initiation of embryogenic cultures, such as transcription factors BABY BOOM, LEAFY COTYLEDON, and AGAMOUS, and important receptor-like kinases such as SOMATIC EMBRYOGENESIS RECEPTOR LIKE KINASES and CLAVATA, were also expressed in this time course study. By combining results from whole genome transcriptome analysis with an in depth review of key genes that play a role in the onset of embryogenesis, we propose a model of coordinated expression of somatic embryogenesis-related genes, providing an improved understanding of genomic factors involved in the early steps of embryogenic culture initiation in maize and other plant species.	[Salvo, Stella A. G. D.; Kaeppler, Shawn M.; Kaeppler, Heidi F.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Hirsch, Candice N.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Buell, C. Robin] Michigan State Univ, DOE Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA	University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; Michigan State University; United States Department of Energy (DOE)	Kaeppler, HF (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	hfkaeppl@wisc.edu		Kaeppler, Shawn/0000-0002-5964-1668; Buell, C Robin/0000-0002-6727-4677	National Institute of Food and Agriculture, United States Department of Agriculture [WIS01226]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding for this research was provided by National Institute of Food and Agriculture, United States Department of Agriculture Hatch funding (WIS01226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiev EV, 2009, CHROMOSOMA, V118, P157, DOI 10.1007/s00412-008-0191-3; ARMSTRONG CL, 1992, THEOR APPL GENET, V84, P755, DOI 10.1007/BF00224181; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; Baudino S, 2001, PLANTA, V213, P1, DOI 10.1007/s004250000471; Borlaug NE, 2000, PLANT PHYSIOL, V124, P487, DOI 10.1104/pp.124.2.487; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Breen J, 2010, FUNCT INTEGR GENOMIC, V10, P463, DOI 10.1007/s10142-010-0184-1; Caliskan M, 2004, PLANTA, V219, P132, DOI 10.1007/s00425-003-1199-9; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Chintamanani S, 2010, GENETICS, V184, P813, DOI 10.1534/genetics.109.111880; CHU CC, 1975, SCI SINICA, V18, P659; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DEJONG AJ, 1992, PLANT CELL, V4, P425, DOI 10.2307/3869444; Delporte F, 2012, PLANT SIGNAL BEHAV, V7, P1608, DOI 10.4161/psb.22424; Deng W, 2009, PLANT SCI, V177, P43, DOI 10.1016/j.plantsci.2009.03.009; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Feher Attila, 2008, Acta Biologica Szegediensis, V52, P53; Forestan C, 2012, MOL PLANT, V5, P787, DOI 10.1093/mp/ssr103; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Frame B, 2011, METHODS MOL BIOL, V710, P327, DOI 10.1007/978-1-61737-988-8_22; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Galland R, 2007, PLANT SIGNAL BEHAV, V2, P343, DOI 10.4161/psb.2.5.4652; Gambino G, 2011, J EXP BOT, V62, P1089, DOI 10.1093/jxb/erq349; GRAY DJ, 1991, CRIT REV PLANT SCI, V10, P33, DOI 10.1080/07352689109382306; GREEN CE, 1975, CROP SCI, V15, P417, DOI 10.2135/cropsci1975.0011183X001500030040x; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; Heidmann I, 2011, PLANT CELL REP, V30, P1107, DOI 10.1007/s00299-011-1018-x; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; HODGES TK, 1986, BIO-TECHNOL, V4, P219, DOI 10.1038/nbt0386-219; Hoenemann C, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue1-fulltext-9; HUYNH QK, 1992, J BIOL CHEM, V267, P6635; Jia HY, 2014, WIRES DEV BIOL, V3, P135, DOI 10.1002/wdev.126; Karami O, 2010, MOL BIOL REP, V37, P2493, DOI 10.1007/s11033-009-9764-3; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Landi P, 2002, MAYDICA, V47, P21; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledwon A, 2011, PLANT GROWTH REGUL, V65, P157, DOI 10.1007/s10725-011-9585-y; Ledwon A, 2009, PLANT CELL REP, V28, P1677, DOI 10.1007/s00299-009-0767-2; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McGonigle B, 2000, PLANT PHYSIOL, V124, P1105, DOI 10.1104/pp.124.3.1105; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mena M, 1996, SCIENCE, V274, P1537, DOI 10.1126/science.274.5292.1537; Murray SC, 2013, NAT BIOTECHNOL, V31, P877, DOI 10.1038/nbt.2707; Nardmann J, 2006, MOL BIOL EVOL, V23, P2492, DOI 10.1093/molbev/msl125; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; Passarinho P, 2008, PLANT MOL BIOL, V68, P225, DOI 10.1007/s11103-008-9364-y; Perry SE, 1999, PLANT PHYSIOL, V120, P121, DOI 10.1104/pp.120.1.121; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Sang Y, 2009, SEMIN CELL DEV BIOL, V20, P1143, DOI 10.1016/j.semcdb.2009.09.006; SCHMIDT RJ, 1993, PLANT CELL, V5, P729, DOI 10.1105/tpc.5.7.729; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shen B, 2010, PLANT PHYSIOL, V153, P980, DOI 10.1104/pp.110.157537; Shen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032237; SLATER A, 2007, PLANT BIOTECHNOLOGY, P37; SONGSTAD DD, 1991, PLANT CELL REP, V9, P699, DOI 10.1007/BF00235361; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Targonska M, 2013, PLANT CELL REP, V32, P1, DOI 10.1007/s00299-012-1342-9; Thakare D, 2008, PLANT PHYSIOL, V146, P1663, DOI 10.1104/pp.108.115832; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Weijers D, 2005, PLANT CELL, V17, P2517, DOI 10.1105/tpc.105.034637; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Zavattieri MA, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue1-fulltext-4; Zeng FC, 2007, GENOMICS, V90, P620, DOI 10.1016/j.ygeno.2007.07.007; Zhang SB, 2002, PLANTA, V215, P191, DOI 10.1007/s00425-002-0735-3; Zhang SZ, 2011, PLANT CELL TISS ORG, V105, P29, DOI 10.1007/s11240-010-9834-1; Zheng YM, 2009, PLANT CELL, V21, P2563, DOI 10.1105/tpc.109.068890	81	49	50	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111407	10.1371/journal.pone.0111407	http://dx.doi.org/10.1371/journal.pone.0111407			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356773	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000058
J	Bi, ZD; Zhou, HJ				Bi, Zedong; Zhou, Hai-Jun			Optimal Cooperation-Trap Strategies for the Iterated Rock-Paper-Scissors Game	PLOS ONE			English	Article							PRISONERS-DILEMMA; BIODIVERSITY; PROMOTES	In an iterated non-cooperative game, if all the players act to maximize their individual accumulated payoff, the system as a whole usually converges to a Nash equilibrium that poorly benefits any player. Here we show that such an undesirable destiny is avoidable in an iterated Rock-Paper-Scissors (RPS) game involving two rational players, X and Y. Player X has the option of proactively adopting a cooperation-trap strategy, which enforces complete cooperation from the rational player Y and leads to a highly beneficial and maximally fair situation to both players. That maximal degree of cooperation is achievable in such a competitive system with cyclic dominance of actions may stimulate further theoretical and empirical studies on how to resolve conflicts and enhance cooperation in human societies.	[Bi, Zedong; Zhou, Hai-Jun] Chinese Acad Sci, Inst Theoret Phys, State Key Lab Theoret Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Theoretical Physics, CAS	Zhou, HJ (corresponding author), Chinese Acad Sci, Inst Theoret Phys, State Key Lab Theoret Phys, Beijing 100080, Peoples R China.	zhouhj@itp.ac.cn	Zhou, Hai-Jun/A-9804-2009	Zhou, Hai-Jun/0000-0003-4228-4438; Bi, Zedong/0000-0002-2267-7368	National Basic Research Program of China [2013CB932804]; National Science Foundation of China [11121403, 11225526]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by The National Basic Research Program of China (grant number 2013CB932804) to HJZ and The National Science Foundation of China (grant number 11121403 and 11225526) to HJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Fisher Len, 2008, ROCK PAPER SCISSORS; GROFMAN B, 1977, J MATH SOCIOL, V5, P173, DOI 10.1080/0022250X.1977.9989871; Hilbe C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4976; Jiang LL, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021912; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; KRAINES D, 1993, THEOR DECIS, V35, P107, DOI 10.1007/BF01074955; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak NA, 2011, SUPERCOOPERATORS ALT; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rapoport A., 1965, PRISONERS DILEMMA ST; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Sandholm WH., 2010, POPULATION GAMES EVO; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Wang ZJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05830	21	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111278	10.1371/journal.pone.0111278	http://dx.doi.org/10.1371/journal.pone.0111278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354212	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204200067
J	Cigoli, MS; Avemaria, F; De Benedetti, S; Gesu, GP; Accorsi, LG; Parmigiani, S; Corona, MF; Capra, V; Mosca, A; Giovannini, S; Notturno, F; Ciccocioppo, F; Volpi, L; Estienne, M; De Michele, G; Antenora, A; Bilo, L; Tavoni, A; Zamponi, N; Alfei, E; Baranello, G; Riva, D; Penco, S				Cigoli, Maria Sole; Avemaria, Francesca; De Benedetti, Stefano; Gesu, Giovanni P.; Accorsi, Lucio Giordano; Parmigiani, Stefano; Corona, Maria Franca; Capra, Valeria; Mosca, Andrea; Giovannini, Simona; Notturno, Francesca; Ciccocioppo, Fausta; Volpi, Lilia; Estienne, Margherita; De Michele, Giuseppe; Antenora, Antonella; Bilo, Leda; Tavoni, Antonietta; Zamponi, Nelia; Alfei, Enrico; Baranello, Giovanni; Riva, Daria; Penco, Silvana			PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations	PLOS ONE			English	Article							VASCULAR MALFORMATIONS; NATURAL-HISTORY; GCKIII PROTEINS; RECENT INSIGHTS; ITALIAN FAMILY; ENCODING KRIT1; CCM3; IDENTIFICATION; ANGIOMAS; DISEASE	Cerebral cavernous malformations (CCMs) are vascular abnormalities that may cause seizures, intracerebral haemorrhages, and focal neurological deficits. Familial form shows an autosomal dominant pattern of inheritance with incomplete penetrance and variable clinical expression. Three genes have been identified causing familial CCM: KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3. Aim of this study is to report additional PDCD10/CCM3 families poorly described so far which account for 10-15% of hereditary cerebral cavernous malformations. Our group investigated 87 consecutive Italian affected individuals (i.e. positive Magnetic Resonance Imaging) with multiple/familial CCM through direct sequencing and Multiplex Ligation-Dependent Probe Amplification (MLPA) analysis. We identified mutations in over 97.7% of cases, and PDCD10/CCM3 accounts for 13.1%. PDCD10/CCM3 molecular screening revealed four already known mutations and four novel ones. The mutated patients show an earlier onset of clinical manifestations as compared to CCM1/CCM2 mutated patients. The study of further families carrying mutations in PDCD10/CCM3 may help define a possible correlation between genotype and phenotype; an accurate clinical follow up of the subjects would help define more precisely whether mutations in PDCD10/CCM3 lead to a characteristic phenotype.	[Cigoli, Maria Sole; Avemaria, Francesca; De Benedetti, Stefano; Gesu, Giovanni P.; Penco, Silvana] Osped Niguarda Ca Granda, Med Genet Unit, Dept Lab Med, Milan, Italy; [Accorsi, Lucio Giordano] Childrens Hosp Brescia, Reg Ctr Epilepsy Childhood & Adolescence, Brescia, Italy; [Parmigiani, Stefano; Corona, Maria Franca] Eastern Liguria Hosp, Paediat & Neonatol Unit, La Spezia, Italy; [Capra, Valeria] G Gaslini Inst Children, Neurosurg Unit, Genoa, Italy; [Mosca, Andrea] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Giovannini, Simona] AUSL Bologna, Child Neurol & Psychiat Unit, Bologna, Italy; [Notturno, Francesca; Ciccocioppo, Fausta] Univ G DAnnunzio, Inst Aging, Dept Human Motor Sci, Chieti, Italy; [Notturno, Francesca; Ciccocioppo, Fausta] Univ G DAnnunzio, Inst Aging, Neuromuscular Dis Unit, Chieti, Italy; [Volpi, Lilia] Bellaria Pizzardi Hosp, AUSL Bologna, Neurol Unit, Bologna, Italy; [Estienne, Margherita; Alfei, Enrico; Baranello, Giovanni; Riva, Daria] Fdn IRCCS Neurol Inst Carlo Besta, Milan, Italy; [De Michele, Giuseppe; Antenora, Antonella; Bilo, Leda] Univ Naples Federico II, Naples, Italy; [Tavoni, Antonietta; Zamponi, Nelia] AOU United Hosp Ancona, Ancona, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Milan; AUSL di Bologna; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; AUSL di Bologna; IRCCS Istituto Neurologico Besta; University of Naples Federico II	Penco, S (corresponding author), Osped Niguarda Ca Granda, Med Genet Unit, Dept Lab Med, Milan, Italy.	silvana.penco@ospedaleniguarda.it	Bilo, Leonilda/AHH-0365-2022; Estienne, Margherita/AAI-9393-2021; Valeria, Capra/AAB-1501-2019; Parmigiani, Stefano/AAC-2624-2021; De Benedetti, Stefano/N-3662-2015; capra, valeria/N-4367-2013	Bilo, Leonilda/0000-0002-9817-4193; Estienne, Margherita/0000-0002-6769-5631; Parmigiani, Stefano/0000-0002-4127-5911; De Benedetti, Stefano/0000-0002-7787-9645; capra, valeria/0000-0002-3097-0388; Penco, Silvana/0000-0003-1050-095X; Notturno, Francesca/0000-0002-4191-6619	Massimo Collice Foundation	Massimo Collice Foundation	MSC was partially financed by Massimo Collice Foundation. No other funds financed the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battistini S, 2007, ARCH NEUROL-CHICAGO, V64, P843, DOI 10.1001/archneur.64.6.843; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; BICKNELL JM, 1978, ARCH NEUROL-CHICAGO, V35, P746, DOI 10.1001/archneur.1978.00500350050010; Cave-Riant F, 2002, EUR J HUM GENET, V10, P733, DOI 10.1038/sj.ejhg.5200870; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Chen L, 2009, STROKE, V40, P1474, DOI 10.1161/STROKEAHA.108.527135; Choe CU, 2010, J NEUROL, V257, P2097, DOI 10.1007/s00415-010-5648-7; Choquet H, 2014, CEREBROVASC DIS, V37, P57, DOI 10.1159/000356839; Coban A, 2008, NEUROLOGIST, V14, P46, DOI 10.1097/NRL.0b013e31813e343f; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Denier C, 2006, ANN NEUROL, V60, P550, DOI 10.1002/ana.20947; Ding JJ, 2010, BIOCHEM BIOPH RES CO, V399, P587, DOI 10.1016/j.bbrc.2010.07.119; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gaetzner S, 2007, NEUROSURG REV, V30, P155, DOI 10.1007/s10143-006-0057-1; Gault J, 2006, NEUROSURGERY, V59, P1278, DOI 10.1227/01.NEU.0000249188.38409.03; Gianfrancesco F, 2007, AM J MED GENET B, V144B, P691, DOI 10.1002/ajmg.b.30381; GOMORI JM, 1986, RADIOLOGY, V158, P707, DOI 10.1148/radiology.158.3.3945744; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guarnieri V, 2007, NEUROGENETICS, V8, P29, DOI 10.1007/s10048-006-0056-y; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lee ST, 2008, J NEUROL SCI, V267, P177, DOI 10.1016/j.jns.2007.10.018; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liquori CL, 2008, NEUROGENETICS, V9, P25, DOI 10.1007/s10048-007-0109-x; Liquori Christina L, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9389; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Marini V, 2003, J NEUROL SCI, V212, P75, DOI 10.1016/S0022-510X(03)00108-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mosca L, 2012, J MOL NEUROSCI, V47, P475, DOI 10.1007/s12031-012-9741-5; Muscarella LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/854737; Nannucci S, 2009, NEUROL SCI, V30, P143, DOI 10.1007/s10072-009-0020-3; Penco S, 2009, J NEUROSURG, V110, P929, DOI 10.3171/2008.8.17640; Pileggi S, 2010, J MOL NEUROSCI, V42, P235, DOI 10.1007/s12031-010-9360-y; Porter PJ, 1997, J NEUROSURG, V87, P190, DOI 10.3171/jns.1997.87.2.0190; Riant F, 2013, MOL SYNDROMOL, V4, P165, DOI 10.1159/000350042; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Verlaan DJ, 2005, NEUROLOGY, V65, P1982, DOI 10.1212/01.wnl.0000188903.75144.49; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; WILKINS RH, 1985, NEUROSURGERY, V16, P421, DOI 10.1227/00006123-198503000-00026; Yoruk B, 2012, DEV BIOL, V362, P121, DOI 10.1016/j.ydbio.2011.12.006; You C, 2013, J CELL MOL MED, V17, P407, DOI 10.1111/jcmm.12022; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhu YA, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS1090	51	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110438	10.1371/journal.pone.0110438	http://dx.doi.org/10.1371/journal.pone.0110438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354366	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200024
J	Genovese, F; Karsdal, MA; Leeming, DJ; Scholze, A; Tepel, M				Genovese, Federica; Karsdal, Morten A.; Leeming, Diana J.; Scholze, Alexandra; Tepel, Martin			Association of Versican Turnover with All-Cause Mortality in Patients on Haemodialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HEART-DISEASE; CALCIFICATION; PROTEOGLYCANS; HYPERTROPHY; DIALYSIS	Objective: Cardiovascular diseases are among the most common causes of mortality in renal failure patients undergoing haemodialysis. A high turnover rate of the proteoglycan versican, represented by the increased presence of its fragmentation products in plasma, has previously been associated with cardiovascular diseases. The objective of the study was to investigate the association of versican turnover assessed in plasma with survival in haemodialysis patients. Methods: A specific matrix metalloproteinase-generated neo-epitope fragment of versican (VCANM) was measured in plasma of 364 haemodialysis patients with a 5-years follow-up, using a robust competitive enzyme-linked immunosorbent assays. Association between VCANM plasma concentration and survival was assessed by Kaplan-Meier analysis and adjusted Cox model. Results: Haemodialysis patients with plasma VCANM concentrations in the lowest quartile had increased risk of death (odds ratio, as compared to the highest quartile: 7.1, p < 0.001), with a reduced survival of 152 days compared to 1295 days for patients with plasma VCANM in the highest quartile. Multivariate analysis showed that low VCANM (p < 0.001) and older age (p < 0.001) predicted death in haemodialysis patients. Conclusions: Low concentrations of the versican fragment VCANM in plasma were associated with higher risk of death among haemodialysis patients. A possible protective role for the examined versican fragment is suggested.	[Genovese, Federica; Karsdal, Morten A.; Leeming, Diana J.] Nord Biosci, Fibrosis Biol & Biomarkers, Herlev, Denmark; [Scholze, Alexandra; Tepel, Martin] Univ Southern Denmark, Odense Univ Hosp, Dept Nephrol, Inst Mol Med Cardiovasc & Renal Res,Inst Clin Res, Odense, Denmark	Nordic Bioscience; University of Southern Denmark; Odense University Hospital	Genovese, F (corresponding author), Nord Biosci, Fibrosis Biol & Biomarkers, Herlev, Denmark.	fge@nordicbioscience.com	Scholze, Alexandra/ABD-2442-2020; Tepel, Martin/GRS-9581-2022	Scholze, Alexandra/0000-0002-3100-8692; Genovese, Federica/0000-0003-1984-1881; Tepel, Martin/0000-0002-0086-0997; Karsdal, Morten/0000-0001-5026-8740	Danish Research Fund (Den Danske Forskningfond); Nordic Bioscience	Danish Research Fund (Den Danske Forskningfond); Nordic Bioscience	The authors acknowledge the Danish Research Fund (Den Danske Forskningfond) for providing the funding for this research. FG, DJL, and MAK are full-time employees at Nordic Bioscience. Nordic Bioscience provided support in the form of salaries for authors FG, DJL, and MAK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Dadah Ashraf, 2012, Adv Perit Dial, V28, P56; Barascuk N, 2013, INT J CLIN EXP MED, V6, P174; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Merrilees MJ, 2012, ELSEVIER CURRENT OPI, DOI [10.1016/j.ceb.2013.01.001, DOI 10.1016/J.CEB.2013.01.001]; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Rudnicki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044891; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Stokes MB, 2001, KIDNEY INT, V59, P532, DOI 10.1046/j.1523-1755.2001.059002532.x; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111134	10.1371/journal.pone.0111134	http://dx.doi.org/10.1371/journal.pone.0111134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354390	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200060
J	Miramontes, O; DeSouza, O; Paiva, LR; Marins, A; Orozco, S				Miramontes, Octavio; DeSouza, Og; Paiva, Leticia Ribeiro; Marins, Alessandra; Orozco, Sirio			Levy Flights and Self-Similar Exploratory Behaviour of Termite Workers: Beyond Model Fitting	PLOS ONE			English	Article							ANOMALOUS DIFFUSION; PATTERNS; DISTRIBUTIONS; TURBULENCE; LAWS; WALK	Animal movements have been related to optimal foraging strategies where self-similar trajectories are central. Most of the experimental studies done so far have focused mainly on fitting statistical models to data in order to test for movement patterns described by power-laws. Here we show by analyzing over half a million movement displacements that isolated termite workers actually exhibit a range of very interesting dynamical properties -including Levy flights- in their exploratory behaviour. Going beyond the current trend of statistical model fitting alone, our study analyses anomalous diffusion and structure functions to estimate values of the scaling exponents describing displacement statistics. We evince the fractal nature of the movement patterns and show how the scaling exponents describing termite space exploration intriguingly comply with mathematical relations found in the physics of transport phenomena. By doing this, we rescue a rich variety of physical and biological phenomenology that can be potentially important and meaningful for the study of complex animal behavior and, in particular, for the study of how patterns of exploratory behaviour of individual social insects may impact not only their feeding demands but also nestmate encounter patterns and, hence, their dynamics at the social scale.	[Miramontes, Octavio; Orozco, Sirio] Univ Nacl Autonoma Mexico, Inst Fis, Dept Sistemas Complejos, Mexico City, DF, Mexico; [Miramontes, Octavio] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [DeSouza, Og; Paiva, Leticia Ribeiro; Marins, Alessandra] Univ Fed Vicosa, Lab Termitol, Vicosa, MG, Brazil; [Paiva, Leticia Ribeiro] Univ Fed Ouro Preto, Dept Fis, Ouro Preto, MG, Brazil	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Federal de Vicosa; Universidade Federal de Ouro Preto	Miramontes, O (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Dept Sistemas Complejos, Mexico City, DF, Mexico.	octavio@fisica.unam.mx	DeSouza, Og/A-7140-2008; Miramontes, Octavio/A-1870-2012; Orozco-Fuentes, Sirio/AAG-7746-2021; miramontes, octavio/ABG-8963-2020; de Paiva, Leticia Ribeiro/X-6730-2019	DeSouza, Og/0000-0002-7108-0242; Orozco-Fuentes, Sirio/0000-0002-6192-7710; miramontes, octavio/0000-0001-8306-0014; Paiva, Leticia/0000-0002-3469-5889	DGAPA-PAPIIT [IN101712]; Brazilian Ciencia Sem Fronteiras program (CSF-CAPES) [0148/2012]; CNPq-Brasil [305736/2013-2]	DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Brazilian Ciencia Sem Fronteiras program (CSF-CAPES); CNPq-Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	OM thanks DGAPA-PAPIIT Grant IN101712 and the Brazilian Ciencia Sem Fronteiras program (CSF-CAPES) 0148/2012. ODS is supported by CNPq-Brasil, fellowship 305736/2013-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2006, P NATL ACAD SCI USA, V103, P4352, DOI 10.1073/pnas.0600482103; Bardunias P, 2009, ANIM BEHAV, V78, P755, DOI 10.1016/j.anbehav.2009.06.024; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; BENZI R, 1993, PHYS REV E, V48, pR29, DOI 10.1103/PhysRevE.48.R29; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brunow GS, 2005, BRAZ ARCH BIOL TECHN, V48, P575, DOI 10.1590/S1516-89132005000500010; Chapman SC, 2005, NONLINEAR PROC GEOPH, V12, P767, DOI 10.5194/npg-12-767-2005; Chechkin AV, 2000, PHYSICA A, V277, P312, DOI 10.1016/S0378-4371(99)00392-1; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DeSouza O, 2004, SOCIOBIOLOGY, V44, P527; FRISCH U, 1991, P R SOC-MATH PHYS SC, V434, P89, DOI 10.1098/rspa.1991.0082; JANDER R, 1974, INSECT SOC, V21, P45, DOI 10.1007/BF02222979; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Klafter J, 2005, PHYS WORLD, V18, P29; KLAFTER J, 1987, PHYS REV A, V35, P3081, DOI 10.1103/PhysRevA.35.3081; Miramontes O, 2001, INT J BIFURCAT CHAOS, V11, P1655, DOI 10.1142/S0218127401002912; Miramontes O, 1998, P ROY SOC B-BIOL SCI, V265, P785, DOI 10.1098/rspb.1998.0361; Miramontes O, 2014, 14046267 ARXIV, P232; Miramontes Octavio, 2008, Journal of Insect Science (Tucson), V8, P1, DOI 10.1673/031.008.2201; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Padoan P, 2003, ASTROPHYS J, V583, P308, DOI 10.1086/345351; Padoan P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.191102; Padoan P, 2002, ASTROPHYS J, V580, pL57, DOI 10.1086/345403; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Schmitt FG, 2001, PHYSICA A, V301, P375, DOI 10.1016/S0378-4371(01)00429-0; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; SOLOMON TH, 1993, PHYS REV LETT, V71, P3975, DOI 10.1103/PhysRevLett.71.3975; SU NY, 1990, SOCIOBIOLOGY, V17, P77; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan G. M., 2011, PHYS FORAGING; Wearmouth VJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2997; Yu CX, 2003, PHYS PLASMAS, V10, P2772, DOI 10.1063/1.1583711; ZUMOFEN G, 1995, PHYS REV E, V51, P1818, DOI 10.1103/PhysRevE.51.1818	36	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111183	10.1371/journal.pone.0111183	http://dx.doi.org/10.1371/journal.pone.0111183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353958	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000345204200064
J	Dey, S; Roy, D; Majumder, GC; Bhattacharyya, D				Dey, Souvik; Roy, Debarun; Majumder, Gopal C.; Bhattacharyya, Debdas			Extracellular Regulation of Sperm Transmembrane Adenylyl Cyclase by a Forward Motility Stimulating Protein	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; EPIDIDYMAL SPERMATOZOA; SEMINAL PLASMA; IDENTIFICATION; CAPACITATION; MEMBRANE; GLYCOPROTEIN; PURIFICATION; FERTILITY; INHIBITOR	Forward motility stimulating factor (FMSF), a glycoprotein isolated from buffalo serum, binds to the surface of the mature sperm cells to promote their progressive motility. This article reports the mode of signal transduction of this extracellular factor in goat sperm. The mechanism was investigated by assaying intracellular second messenger level and forward motility in presence of different pharmacological modulators. Mg++-dependent Forskolin responsive form of transmembrane adenylyl cyclase (tmAC) of goat spermatozoa was probed for its involvement in FMSF action. Dideoxyadenosine, a selective inhibitor of tmACs, was used to identify the role of this enzyme in the scheme of FMSF-signaling. Involvement of the a-subunit of G-protein in this regard has been inspected using GTPcS. Participation of protein kinase A (PKA) and tyrosine kinase was checked using IP20 and genistein, respectively. FMSF promotes tmAC activity in a dose-dependent manner through receptor/G-protein activation to enhance intracellular cAMP and forward motility. Motility boosting effects of this glycoprotein are almost lost in presence of dideoxyadenosine. But, FMSF displayed substantial motility promoting activity when movement of spermatozoa was inhibited with KH7, the specific inhibitor of soluble adenylyl cyclase indicating tmAC to be the primary target of FMSF action. Involvement of cAMP in mediating FMSF action was confirmed by the application of dibutyryl cAMP. Observed motility regulatory effects with IP20 and genistein indicate contribution of PKA and tyrosine kinase in FMSF activity; enhanced phosphorylation of a tyrosine containing approximate to 50 kDa protein was detected in this regard. FMSF initiates a novel signaling cascade to stimulate tmAC activity that augments intracellular cAMP, which through downstream crosstalk of phosphokinases leads to enhanced forward motility in mature spermatozoa. Thus, this article for the first time describes conventional tmAC-dependent profound activation of progressive motility by a physiologic extracellular factor in a mammalian species.	[Dey, Souvik; Roy, Debarun; Majumder, Gopal C.; Bhattacharyya, Debdas] Jadavpur Univ, Ctr Rural & Cryogen Technol, Div Cryobiol, Kolkata, W Bengal, India	Jadavpur University	Bhattacharyya, D (corresponding author), Jadavpur Univ, Ctr Rural & Cryogen Technol, Div Cryobiol, Kolkata, W Bengal, India.	ddbhattacharyya@gmail.com	Dey, Souvik/AAB-2252-2021	Dey, Souvik/0000-0003-1799-5270; Roy, Debarun/0000-0003-3579-7497	Department of Biotechnology (DBT), Government of India [BT/PR13167/AAQ/01/416/2009]; Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India [37 [1406]/10/EMR-II]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India	This work was supported by Department of Biotechnology (DBT), Government of India (grant number: BT/PR13167/AAQ/01/416/2009) URL:http://dbtindia.nic.in/index.asp and Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India (grant number: 37 [1406]/10/EMR-II). URL: http://csirhrdg.res.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Barbonetti A, 2010, ASIAN J ANDROL, V12, P853, DOI 10.1038/aja.2010.52; BAVISTER BD, 1975, J REPROD FERTIL, V43, P363; Bharshankar Rajay N., 2000, Indian Journal of Physiology and Pharmacology, V44, P456; BISWAS R, 1984, J BIOSCIENCE, V6, P69, DOI 10.1007/BF02702858; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; Chatterjee M, 2010, MOL CELL BIOCHEM, V336, P39, DOI 10.1007/s11010-009-0261-8; CHENG HC, 1986, J BIOL CHEM, V261, P989; Das K, 2012, ANDROLOGIA, V44, P807, DOI 10.1111/j.1439-0272.2011.01161.x; Dey S, 2014, P 2 PHARM TECH IAPST, P113; Dey S, 2014, BIOCHEM CELL BIOL, V92, P43, DOI 10.1139/bcb-2013-0080; Ding ZD, 2007, MOL REPROD DEV, V74, P1124, DOI 10.1002/mrd.20624; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Flesch FM, 2001, MOL REPROD DEV, V60, P107, DOI 10.1002/mrd.1067; GAUR RD, 1975, INT J FERTIL, V20, P133; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2010, J CELL PHYSIOL, V222, P254, DOI 10.1002/jcp.21947; JALAL F, 1992, BIOCHEM J, V288, P945, DOI 10.1042/bj2880945; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; Liu JH, 2003, ASIAN J ANDROL, V5, P113; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJUMDER GC, 1984, J REPROD FERTIL, V70, P235, DOI 10.1530/jrf.0.0700235; Majumder GC, 2001, India, Patent No. 185383; MAJUMDER GC, 1999, COMP ENDOCRINOLOGY R, P242; Majumder GC, 2003, Patent No. [6613737 (USA), 6613737]; MANDAL M, 1989, BIOL REPROD, V41, P983, DOI 10.1095/biolreprod41.6.983; Mandal M, 2006, J CELL PHYSIOL, V209, P353, DOI 10.1002/jcp.20734; MORITA Z, 1971, J REPROD FERTIL, V24, P247, DOI 10.1530/jrf.0.0240247; Mortimer D, 1995, REPROD FERT DEVELOP, V7, P951, DOI 10.1071/RD9950951; MORTON B, 1973, J REPROD FERTIL, V35, P255, DOI 10.1530/jrf.0.0350255; MORTON BE, 1979, FERTIL STERIL, V32, P107; O'Brien ED, 2011, DEV BIOL, V350, P80, DOI 10.1016/j.ydbio.2010.11.019; Posternak T, 1974, Methods Enzymol, V38, P399; RANA APS, 1987, PREP BIOCHEM, V17, P261, DOI 10.1080/00327488708062493; RANA APS, 1989, PREP BIOCHEM, V19, P167, DOI 10.1080/10826068908544906; ROY N, 1989, BIOCHIM BIOPHYS ACTA, V991, P114, DOI 10.1016/0304-4165(89)90036-6; Saha S, 2013, FERTIL STERIL, V100, P269, DOI 10.1016/j.fertnstert.2013.03.012; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHETH AR, 1981, ANDROLOGIA, V13, P142; Shiu PJ, 2013, PROTEIN EXPRES PURIF, V89, P219, DOI 10.1016/j.pep.2013.03.011; Sivars U, 2000, BBA-GEN SUBJECTS, V1474, P133, DOI 10.1016/S0304-4165(99)00208-1; SOKOLOSKI JE, 1977, FERTIL STERIL, V28, P1337; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Thomsen W, 2005, CURR OPIN BIOTECH, V16, P655, DOI 10.1016/j.copbio.2005.10.008; Tomar AK, 2011, DIS MARKERS, V31, P379, DOI [10.1155/2011/798072, 10.3233/DMA-2011-0853]; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; VIJAYARAGHAVAN S, 1985, BIOL REPROD, V32, P489, DOI 10.1095/biolreprod32.3.489; Williams R J, 1995, Methods Mol Biol, V41, P63; Wojtczak M, 2007, COMP BIOCHEM PHYS B, V148, P426, DOI 10.1016/j.cbpb.2007.07.011; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110669	10.1371/journal.pone.0110669	http://dx.doi.org/10.1371/journal.pone.0110669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350397	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943100034
J	Nakakura, S; Yamamoto, M; Terao, E; Nagasawa, T; Tabuchi, H; Kiuchi, Y				Nakakura, Shunsuke; Yamamoto, Minami; Terao, Etsuko; Nagasawa, Toshihiko; Tabuchi, Hitoshi; Kiuchi, Yoshiaki			The Whole Macular Choroidal Thickness in Subjects with Primary Open Angle Glaucoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NORMAL-TENSION GLAUCOMA; SWEPT-SOURCE; HEALTHY-SUBJECTS; EYES; PROGRESSION; NERVE; DISC; APPEARANCES; VOLUME	Purpose: We investigated the whole macular choroidal thickness in subjects with glaucoma in order to evaluate the effects of glaucoma and glaucoma visual field damage on the choroidal thickness. Subjects and Methods: We examined 40 primary open angle glaucoma patients with only superior visual field defects and 48 normal controls. The macular choroidal thickness was measured using swept-source optical coherence tomography according to the three-dimensional raster scan protocol (6x6 mm). We used the choroidal thickness within a 1.0-mm circle measured on ETDRS grids as the central sector and then used a 6x6 rectangular grid to divide the area into six sectors. Results: No significant differences were found in the choroidal thickness values between the glaucoma and normal subjects in any of the sectors after adjusting for the age and axial length (all P>0.4, ANCOVA). According to a stepwise analysis of the glaucoma subjects performed using the parameters of age, axial length, central corneal thickness and mean deviation (MD value) obtained by static perimetry, age was the most predictive and significant factor in all sectors (coefficient = -3.091 to -4.091 and F value = 15.629 to 22.245), followed by axial length (coefficient = -10.428 to -23.458 and F value = 2.454 to 6.369). The central corneal thickness and MD values were not significant predictive factors in any of the sectors. No significant predictive factors were found for the differences in the choroidal thickness values observed between the superior and inferior field sectors. Conclusions: Neither the glaucoma-related visual field damage nor glaucoma itself have any apparent associations with the whole macular choroidal thickness.	[Nakakura, Shunsuke; Yamamoto, Minami; Terao, Etsuko; Nagasawa, Toshihiko; Tabuchi, Hitoshi] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	Hiroshima University	Nakakura, S (corresponding author), Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	shunsukenakakura@yahoo.co.jp						Aksoy Y, 2014, INVEST OPHTH VIS SCI, V55, P1311, DOI 10.1167/iovs.13-13820; Alm A., 1992, ADLERS PHYSL EYE, P198; Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P7813, DOI 10.1167/iovs.12-10483; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hirooka K, 2012, CLIN EXP OPHTHALMOL, V40, P576, DOI 10.1111/j.1442-9071.2012.02762.x; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kanamori A, 2013, INVEST OPHTH VIS SCI, V54, P6401, DOI 10.1167/iovs.13-12805; Kim DY, 2013, ACTA OPHTHALMOL, V91, P183, DOI 10.1111/j.1755-3768.2011.02305.x; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; Mansouri K, 2014, AM J OPHTHALMOL, V157, P1022, DOI 10.1016/j.ajo.2014.02.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Mwanza JC, 2012, INVEST OPHTH VIS SCI, V53, P6695, DOI 10.1167/iovs.12-10388; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Nagasawa T, 2013, INVEST OPHTH VIS SCI, V54, P7068, DOI 10.1167/iovs.13-12350; Nakazawa T, 2012, J GLAUCOMA, V21, P426, DOI 10.1097/IJG.0b013e3182182897; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Rhew JY, 2014, J GLAUCOMA, V23, P46, DOI 10.1097/IJG.0b013e31825af772; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Suh W, 2014, JPN J OPHTHALMOL, V58, P62, DOI 10.1007/s10384-013-0290-4; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Usui S, 2012, INVEST OPHTH VIS SCI, V53, P2300, DOI 10.1167/iovs.11-8383; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Wong IY, 2013, RETINA-J RET VIT DIS, V33, P423, DOI 10.1097/IAE.0b013e3182753b5a	30	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110265	10.1371/journal.pone.0110265	http://dx.doi.org/10.1371/journal.pone.0110265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350379	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100024
J	Du, J; Pang, Y; Liu, YH; Mi, FL; Xu, SF; Li, L				Du, Jian; Pang, Yu; Liu, Yuhong; Mi, Fengling; Xu, Shaofa; Li, Liang			Survey of Tuberculosis Hospitals in China: Current Status and Challenges	PLOS ONE			English	Article							PUBLIC-HEALTH SYSTEM	Background: Hospitals will play an increasingly important role in delivering TB services in China, however little is known in terms of the current landscape of the hospital system that delivers TB care. Methodology/Principal Findings: In order to examine the status of TB hospitals we performed a study in which a total of 203 TB hospitals, with 30 beds or more, were enrolled from 31 provinces and Xinjiang Production and Construction Corps. Of the 203 hospitals, 93 (45.8%) were located in the eastern region of China, 84 (41.4%) in the central region, and 26 (12.8%) in the western region, while there were 34.6 million TB patients in western China, accounting for 34.6% of the TB burden nationwide. The total number of staff in these 203 hospitals was 83,011, of which 18,899 (22.8%) provided health services for TB patients, (physicians, nurses, lab technicians, etc). Although both the overall number of the health care workers and TB staff in the 203 hospitals increased from the year 1999 to 2009, the former increased by 52%, while the latter increased only by 34%, showing that the percentage of TB staff declined significantly (chi(2) = 181.7, P<0.01). The total annual income of the 203 hospitals increased 5.5 fold from 1999 to 2009, while that from TB care increased 3.8 fold during the same period. TB care and control experienced a relatively slower development during this period as shown by the lower percentage of TB staff and the lesser increase in income from TB care in the hospitals. Conclusions/Significance: In conclusion, our findings demonstrated that hospital resources are scarcer in western China as compared with eastern China. In view of the current findings, policymakers are urged to address the uneven distribution of medical resources between the underdeveloped west and the more affluent eastern provinces.	[Du, Jian; Liu, Yuhong; Mi, Fengling; Xu, Shaofa; Li, Liang] Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China; [Du, Jian; Liu, Yuhong; Mi, Fengling; Xu, Shaofa; Li, Liang] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Du, Jian; Liu, Yuhong; Mi, Fengling; Xu, Shaofa; Li, Liang] China CDC, Clin Ctr TB, Adm Off, Beijing, Peoples R China; [Pang, Yu] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China	Capital Medical University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Xu, SF (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China.	xushaofa@tb123.org; liliang69@tb123.org			Ministry of Health of China	Ministry of Health of China	This study was supported by Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Chai SJ, 2013, HEALTH POLICY PLANN, V28, P100, DOI 10.1093/heapol/czs029; Kane Robert L, 2007, Evid Rep Technol Assess (Full Rep), P1; Kaufmann SHE, 2005, NEW ENGL J MED, V353, P2423, DOI 10.1056/NEJMp058131; Minstry of Health, 2011, NAT PROGR NURS 2011; Minstry of Health, 2011, NAT TUB CONTR PROGR; Pang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032976; Sherenian M, 2013, NEONATOLOGY, V104, P179, DOI 10.1159/000353458; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wang L, 2014, LANCET; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	15	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e111945	10.1371/journal.pone.0111945	http://dx.doi.org/10.1371/journal.pone.0111945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25365259	Green Published, Green Submitted, gold			2022-12-27	WOS:000345558100138
J	Almeida, OP; Hankey, GJ; Yeap, BB; Golledge, J; Norman, PE; Flicker, L				Almeida, Osvaldo P.; Hankey, Graeme J.; Yeap, Bu B.; Golledge, Jonathan; Norman, Paul E.; Flicker, Leon			Mortality among People with Severe Mental Disorders Who Reach Old Age: A Longitudinal Study of a Community-Representative Sample of 37892 Men	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; NATIONAL EPIDEMIOLOGIC SURVEY; LIFETIME PREVALENCE; COGNITIVE FUNCTION; WESTERN-AUSTRALIA; BIPOLAR DISORDER; EXCESS MORTALITY; HEART-DISEASE; GLOBAL BURDEN; RISK	Background: Severe mental illnesses are leading causes of disability worldwide. Their prevalence declines with age, possibly due to premature death. It is unclear, however, if people with severe mental disorders who reach older age still have lower life expectancy compared with their peers and if their causes of death differ. Methods and Findings: Cohort study of a community-representative sample of 37892 Australian men aged 65-85 years in 1996-1998. Follow up was censored on the 31st December 2010. Lifetime prevalence of schizophrenia spectrum, bipolar, depressive and alcohol-induced disorder was established through record linkage. A subsample of 12136 consented to a face-to-face assessment of sociodemographic, lifestyle and clinical variables. Information about causes of death was retrieved from the Australian Death Registry. The prevalence of schizophrenia spectrum, bipolar, depressive and alcohol-induced disorders was 1.2%, 0.3%, 2.5% and 1.8%. The mortality hazard for men with a severe mental disorder was 2.3 and their life expectancy was reduced by 3 years. Mortality rates increased with age, but the gap between men with and without severe mental disorders was not attenuated by age. Cardiovascular diseases and cancer were the most frequent causes of death. The excess mortality associated with severe mental disorders could not be explained by measured sociodemographic, lifestyle or clinical variables. Conclusions: The excess mortality associated with severe mental disorders persists in later life, and the causes of death of younger and older people with severe mental disorders are similar. Hazardous lifestyle choices, suboptimal access to health care, poor compliance with treatments, and greater severity of medical comorbidities may all contribute to this increased mortality. Unlike young adults, most older people will visit their primary care physician at least once a year, offering health professionals an opportunity to intervene in order to minimise the harms associated with severe mental disorders.	[Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Hankey, Graeme J.; Yeap, Bu B.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol, Fremantle, WA, Australia; [Golledge, Jonathan] James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Sch Med & Dent, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; James Cook University; University of Western Australia; Royal Perth Hospital; University of Western Australia	Almeida, OP (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia.	osvaldo.almeida@uwa.edu.au	Hankey, Graeme J/H-4968-2014; Flicker, Leon/AAE-1530-2022; golledge, jonathan/I-2371-2013; Almeida, Osvaldo P./A-4925-2008	Hankey, Graeme J/0000-0002-6044-7328; Flicker, Leon/0000-0002-3650-0475; Almeida, Osvaldo P./0000-0002-8689-6199; golledge, jonathan/0000-0002-5779-8848	National Health and Medical Research Council of Australia (NHMRC) [279408, 379600, 403963, 513823, 634492]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) project grant numbers 279408, 379600, 403963, 513823 and 634492 (URL: www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2011, 34010 ABS; Almeida OP, 2002, INT PSYCHOGERIATR, V14, P311, DOI 10.1017/S1041610202008517; Almeida OP, 2013, PREV MED, V57, P878, DOI 10.1016/j.ypmed.2013.09.021; Almeida OP, 2012, ANN FAM MED, V10, P347, DOI 10.1370/afm.1368; Almeida OP, 2011, NEUROIMAGE, V55, P1480, DOI 10.1016/j.neuroimage.2011.01.063; Almeida OP, 2011, INT PSYCHOGERIATR, V23, P280, DOI 10.1017/S1041610210001870; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; Barak Y, 2005, CANCER-AM CANCER SOC, V104, P2817, DOI 10.1002/cncr.21574; Britt H, 2009, GEN PRACTICE ACTIIVI; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Correll CU, 2006, J CLIN PSYCHIAT, V67, P575, DOI 10.4088/JCP.v67n0408; Dalton EJ, 2003, BIPOLAR DISORD, V5, P58, DOI 10.1034/j.1399-5618.2003.00017.x; Diaz FJ, 2009, BIPOLAR DISORD, V11, P154, DOI 10.1111/j.1399-5618.2009.00664.x; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Eliasen M, 2014, EUR J EPIDEMIOL, V29, P15, DOI 10.1007/s10654-013-9855-2; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Hall W, 1999, ADDICTION, V94, P1541, DOI 10.1046/j.1360-0443.1999.9410154110.x; Hirata ES, 2001, AM J GERIAT PSYCHIAT, V9, P30, DOI 10.1176/appi.ajgp.9.1.30; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jablensky AV, 2005, AM J PSYCHIAT, V162, P79, DOI 10.1176/appi.ajp.162.1.79; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lawrence D, 2000, SOC PSYCH PSYCH EPID, V35, P341, DOI 10.1007/s001270050248; Lawrence D, 2000, PSYCHOL MED, V30, P813, DOI 10.1017/S0033291799002391; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; Lawrence DM, 2003, BRIT J PSYCHIAT, V182, P31, DOI 10.1192/bjp.182.1.31; Lee M, 2009, J AM MED DIR ASSOC, V10, P466, DOI 10.1016/j.jamda.2009.03.014; Lemogne C, 2013, J PSYCHIATR RES, V47, P851, DOI 10.1016/j.jpsychires.2013.03.015; Lin JC, 2011, AM J GERIAT PSYCHIAT, V19, P292, DOI 10.1097/JGP.0b013e3181e898b4; Meesters PD, 2012, AM J GERIAT PSYCHIAT, V20, P18, DOI 10.1097/JGP.0b013e3182011b7f; Morgan VA, 2014, PSYCHOL MED, V44, P2163, DOI 10.1017/S0033291713002973; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Osby U, 2000, SCHIZOPHR RES, V45, P21, DOI 10.1016/S0920-9964(99)00191-7; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Pirkis J, 2009, J AFFECT DISORDERS, V115, P54, DOI 10.1016/j.jad.2008.08.014; REGIER DA, 1993, ACTA PSYCHIAT SCAND, V88, P35, DOI 10.1111/j.1600-0447.1993.tb03411.x; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Weeke P, 2012, CLIN PHARMACOL THER, V92, P72, DOI 10.1038/clpt.2011.368; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	46	51	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111882	10.1371/journal.pone.0111882	http://dx.doi.org/10.1371/journal.pone.0111882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360781	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000343943700158
J	Ilie, M; Hofman, V; Long-Mira, E; Selva, E; Vignaud, JM; Padovani, B; Mouroux, J; Marquette, CH; Hofman, P				Ilie, Marius; Hofman, Veronique; Long-Mira, Elodie; Selva, Eric; Vignaud, Jean-Michel; Padovani, Bernard; Mouroux, Jerome; Marquette, Charles-Hugo; Hofman, Paul			"Sentinel" Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SENESCENCE; RISK; METASTASIS; STATISTICS; MORTALITY; INVASION; INSIGHTS; COPD; SIZE	Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer. Migration of circulating tumor cells (CTCs) into the blood stream is an early event that occurs during carcinogenesis. We aimed to examine the presence of CTCs in complement to CT-scan in COPD patients without clinically detectable lung cancer as a first step to identify a new marker for early lung cancer diagnosis. The presence of CTCs was examined by an ISET filtration-enrichment technique, for 245 subjects without cancer, including 168 (68.6%) COPD patients, and 77 subjects without COPD (31.4%), including 42 control smokers and 35 non-smoking healthy individuals. CTCs were identified by cytomorphological analysis and characterized by studying their expression of epithelial and mesenchymal markers. COPD patients were monitored annually by low-dose spiral CT. CTCs were detected in 3% of COPD patients (5 out of 168 patients). The annual surveillance of the CTC-positive COPD patients by CT-scan screening detected lung nodules 1 to 4 years after CTC detection, leading to prompt surgical resection and histopathological diagnosis of early-stage lung cancer. Follow-up of the 5 patients by CT-scan and ISET 12 month after surgery showed no tumor recurrence. CTCs detected in COPD patients had a heterogeneous expression of epithelial and mesenchymal markers, which was similar to the corresponding lung tumor phenotype. No CTCs were detected in control smoking and non-smoking healthy individuals. CTCs can be detected in patients with COPD without clinically detectable lung cancer. Monitoring "sentinel" CTC-positive COPD patients may allow early diagnosis of lung cancer.	[Ilie, Marius; Hofman, Veronique; Long-Mira, Elodie; Hofman, Paul] Pasteur Hosp, Lab Clin & Expt Pathol, Nice, France; [Ilie, Marius; Hofman, Veronique; Selva, Eric; Hofman, Paul] Pasteur Hosp, Human Biobank BB 0033 00025, Nice, France; [Ilie, Marius; Hofman, Veronique; Long-Mira, Elodie; Marquette, Charles-Hugo; Hofman, Paul] Univ Nice Sophia Antipolis, Fac Med Nice, UMR CNRS 7284, INSERM U1081,IRCAN Team 3, F-06189 Nice, France; [Vignaud, Jean-Michel] Univ Nancy, Cent Hosp, Dept Pathol, Nancy, France; [Padovani, Bernard] Pasteur Hosp, Dept Radiol, Nice, France; [Mouroux, Jerome] Pasteur Hosp, Dept Thorac Surg, Nice, France; [Marquette, Charles-Hugo] Pasteur Hosp, Dept Pulm Med, Nice, France	CHU Nice; CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU de Nancy; Universite de Lorraine; CHU Nice; CHU Nice; CHU Nice	Hofman, P (corresponding author), Pasteur Hosp, Lab Clin & Expt Pathol, Nice, France.	hofman.p@chu-nice.fr	Ilié, Marius/M-7964-2019; Marquette, Charles Hugo/O-4084-2016; Hofman, Paul/P-7654-2018	Ilié, Marius/0000-0002-2014-1236; Marquette, Charles Hugo/0000-0002-0846-9941; Hofman, Paul/0000-0003-0431-9353; long, elodie/0000-0002-1923-6713; Mouroux, Jerome/0000-0003-0877-4679; veronique, HOFMAN/0000-0003-0943-1627	Canceropole PACA; "Association Regionale Assistance Respiratoire a Domicile" (ARARD), Aubagne, France; Fondation Lefort-Beaumont de l'Institut de France; INSERM Unit, Paris	Canceropole PACA(Region Grand-Est); "Association Regionale Assistance Respiratoire a Domicile" (ARARD), Aubagne, France; Fondation Lefort-Beaumont de l'Institut de France; INSERM Unit, Paris	The authors wish to thank the "Canceropole PACA" (Procan 2012-2015, Axe C) and the "Association Regionale Assistance Respiratoire a Domicile" (ARARD), Aubagne, France for their financial support. MI was supported by the "Fondation Lefort-Beaumont de l'Institut de France" through collaboration with INSERM Unit 807, Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Blanchon F, 2006, LANCET ONCOL, V7, P829, DOI 10.1016/S1470-2045(06)70868-3; Boelens MC, 2011, LUNG CANCER, V72, P177, DOI 10.1016/j.lungcan.2010.08.014; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; Deisboeck TS, 2006, MED HYPOTHESES, V67, P1338, DOI 10.1016/j.mehy.2006.05.029; Farlow EC, 2010, BRIT J CANCER, V103, P1221, DOI 10.1038/sj.bjc.6605865; Farlow EC, 2010, CLIN CANCER RES, V16, P3452, DOI 10.1158/1078-0432.CCR-09-3192; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hofman V, 2012, CYTOPATHOLOGY, V23, P30, DOI 10.1111/j.1365-2303.2010.00835.x; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; KOHN EC, 1995, CANCER RES, V55, P1856; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; Mazzone P, 2012, RESP MED, V106, P473, DOI 10.1016/j.rmed.2011.10.016; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Michaelson JS, 2005, BRIT J CANCER, V93, P1244, DOI 10.1038/sj.bjc.6602848; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Parimon T, 2007, AM J RESP CRIT CARE, V175, P712, DOI 10.1164/rccm.200608-1125OC; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rodriguez-Roisin Roberto, 2008, Proc Am Thorac Soc, V5, P842, DOI 10.1513/pats.200807-075TH; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schwartz AG, 2009, J THORAC ONCOL, V4, P291, DOI 10.1097/JTO.0b013e3181951cd1; Sekine Y, 2007, ANN THORAC SURG, V84, P946, DOI 10.1016/j.athoracsur.2007.04.038; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Witney TH, 2014, CANCER RES, V74, P1319, DOI 10.1158/0008-5472.CAN-13-2768; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Yu JQ, 2011, J NUCL MED, V52, P1501, DOI 10.2967/jnumed.111.097683	47	229	246	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111597	10.1371/journal.pone.0111597	http://dx.doi.org/10.1371/journal.pone.0111597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360587	Green Published, gold			2022-12-27	WOS:000343943700127
J	Ishikawa, G; Nakamura, K; Ito, H; Saito, M; Sato, M; Jinno, H; Yoshimura, Y; Nishimura, T; Maejima, H; Uehara, Y; Kobayashi, F; Nakamura, T				Ishikawa, Goro; Nakamura, Kazuhiro; Ito, Hiroyuki; Saito, Mika; Sato, Mikako; Jinno, Hironobu; Yoshimura, Yasuhiro; Nishimura, Tsutomu; Maejima, Hidekazu; Uehara, Yasushi; Kobayashi, Fuminori; Nakamura, Toshiki			Association Mapping and Validation of QTLs for Flour Yield in the Soft Winter Wheat Variety Kitahonami	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE DISEQUILIBRIUM; QUALITY TRAITS; MOLECULAR-GENETICS; BAKING QUALITY; MILLING YIELD; DIVERSITY; PUROINDOLINES; POPULATION; IMPROVEMENT	The winter wheat variety Kitahonami shows a superior flour yield in comparison to other Japanese soft wheat varieties. To map the quantitative trait loci (QTL) associated with this trait, association mapping was performed using a panel of lines from Kitahonami's pedigree, along with leading Japanese varieties and advanced breeding lines. Using a mixed linear model corrected for kernel types and familial relatedness, 62 marker-trait associations for flour yield were identified and classified into 21 QTLs. In eighteen of these, Kitahonami alleles showed positive effects. Pedigree analysis demonstrated that a continuous pyramiding of QTLs had occurred throughout the breeding history of Kitahonami. Linkage analyses using three sets of doubled haploid populations from crosses in which Kitahonami was used as a parent were performed, leading to the validation of five of the eight QTLs tested. Among these, QTLs on chromosomes 3B and 7A showed highly significant and consistent effects across the three populations. This study shows that pedigree-based association mapping using breeding materials can be a useful method for QTL identification at the early stages of breeding programs.	[Ishikawa, Goro; Nakamura, Kazuhiro; Ito, Hiroyuki; Saito, Mika; Nakamura, Toshiki] NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan; [Nakamura, Kazuhiro] NARO Kyusyu Okinawa Agr Res Ctr, Chikugo, Fukuoka, Japan; [Saito, Mika; Sato, Mikako; Jinno, Hironobu; Yoshimura, Yasuhiro] Hokkaido Res Org, Kitami Agr Expt Stn, Memuro, Hokkaido, Japan; [Sato, Mikako] Hokkaido Res Org, Cent Agr Expt Stn, Memuro, Hokkaido, Japan; [Nishimura, Tsutomu] Hokkaido Res Org, Kamikawa Agr Expt Stn, Memuro, Hokkaido, Japan; [Maejima, Hidekazu; Uehara, Yasushi] Nagano Agr Expt Stn, Suzaka, Nagano, Japan; [Kobayashi, Fuminori] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan	Ishikawa, G (corresponding author), NARO Tohoku Agr Res Ctr, Morioka, Iwate, Japan.	goro@affrc.go.jp; tnaka@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [TRG-1009, NGB-1002, NGB-2004]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was partially supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (TRG-1009, NGB-1002 and NGB-2004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Bhave M, 2008, PLANT MOL BIOL, V66, P205, DOI 10.1007/s11103-007-9263-7; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; BURTON GW, 1953, AGRON J, V45, P478, DOI 10.2134/agronj1953.00021962004500100005x; Campbell KG, 2001, CROP SCI, V41, P1275, DOI 10.2135/cropsci2001.4141275x; Carter AH, 2012, THEOR APPL GENET, V124, P1079, DOI 10.1007/s00122-011-1770-x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fox GP, 2013, EUPHYTICA, V192, P453, DOI 10.1007/s10681-013-0885-3; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Huang BE, 2012, PLANT BIOTECHNOL J, V10, P826, DOI 10.1111/j.1467-7652.2012.00702.x; Jannink JL, 2001, TRENDS PLANT SCI, V6, P337, DOI 10.1016/S1360-1385(01)02017-9; Lehmensiek A, 2006, AUST J AGR RES, V57, P1115, DOI 10.1071/AR05375; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Parker GD, 1999, MOL BREEDING, V5, P561, DOI 10.1023/A:1009678023431; Rosyara UR, 2009, THEOR APPL GENET, V118, P1617, DOI 10.1007/s00122-009-1010-9; Smith AB, 2001, AUST J AGR RES, V52, P1207, DOI 10.1071/AR01058; Smith N, 2011, CROP SCI, V51, P1424, DOI 10.2135/cropsci2010.04.0193; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stodart BJ, 2007, AUST J AGR RES, V58, P1174, DOI 10.1071/AR07010; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; White J, 2008, THEOR APPL GENET, V116, P439, DOI 10.1007/s00122-007-0681-3; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Yanagisawa A., 2007, Bulletin of Hokkaido Prefectural Agricultural Experiment Stations, P1; Zhang KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057853	39	17	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111337	10.1371/journal.pone.0111337	http://dx.doi.org/10.1371/journal.pone.0111337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360619	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700085
J	Martinez-Ramirez, D; Morishita, T; Zeilman, PR; Peng-Chen, ZX; Foote, KD; Okun, MS				Martinez-Ramirez, Daniel; Morishita, Takashi; Zeilman, Pamela R.; Peng-Chen, Zhongxing; Foote, Kelly D.; Okun, Michael S.			Atrophy and Other Potential Factors Affecting Long Term Deep Brain Stimulation Response: A Case Series	PLOS ONE			English	Article							AGE-RELATED-CHANGES; PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; SUBCORTICAL STRUCTURES; ESSENTIAL TREMOR; ELECTRODE; COMPLICATIONS; IMPLANTATION; DISORDERS; IMPEDANCE	Objective: To describe three DBS cases which presented with new side effects or loss of benefit from stimulation after long-term follow-up and to discuss the potential contributing factors. Methods: A University of Florida (UF) database (INFORM) search was performed, identifying three patients, two Parkinson's disease (PD) and one Essential Tremor (ET), with an unexpected change in long-term programming thresholds as compared to initial evaluation. Clinical follow-up, programming, imaging studies, and lead measurements were reviewed. The UF Institutional Review Board (IRB) approved this study. Results: A substantial increase in the 3rd ventricular width (120%), Evans index (6%), ventricular index (5%), and cella media index (17%) was uncovered. A change in thresholds across lead contacts with a decrease in current densities as well as a relative lateral change of lead location was also observed. Hardware-related complications, lead migration, and impedance variability were not identified. Conclusions: Potential factors contributing to long-term side effects should be examined during a DBS troubleshooting assessment. Clinicians should be aware that in DBS therapy there is delivery of electricity to a changing brain, and atrophy may possibly affect DBS programming settings as part of long-term follow-up.	[Martinez-Ramirez, Daniel; Zeilman, Pamela R.; Peng-Chen, Zhongxing; Okun, Michael S.] Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Morishita, Takashi; Foote, Kelly D.; Okun, Michael S.] Univ Florida, Coll Med, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	okun@neurology.ufl.edu	Martinez-Ramirez, Daniel/H-2546-2016; Ramirez, Daniel Martinez/O-6719-2018	Martinez-Ramirez, Daniel/0000-0001-8003-0610; Ramirez, Daniel Martinez/0000-0001-8003-0610; Okun, Michael/0000-0002-6247-9358; Foote, Kelly/0000-0002-2436-4138	University of Florida Foundation; UF INFORM database; Japan Society for Promotion of Science; St. Luke life Institute in Japan	University of Florida Foundation(University of Florida); UF INFORM database; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); St. Luke life Institute in Japan	This work was supported by the University of Florida Foundation, the UF INFORM database, and partly by the Japan Society for Promotion of Science, and St. Luke life Institute in Japan. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomstedt P, 2005, ACTA NEUROCHIR, V147, P1061, DOI 10.1007/s00701-005-0576-5; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; Cheung T, 2013, BRAIN STIMUL, V6, P746, DOI 10.1016/j.brs.2013.03.010; Fakhar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058665; Farris S, 2008, MOVEMENT DISORD, V23, P755, DOI 10.1002/mds.21936; Farris Sierra, 2013, Surg Neurol Int, V4, P69, DOI 10.4103/2152-7806.112612; Favilla CG, 2012, BRAIN, V135, P1455, DOI 10.1093/brain/aws026; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Goodro M, 2012, PSYCHIAT RES-NEUROIM, V203, P38, DOI 10.1016/j.pscychresns.2011.09.014; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; Hariz M, 2012, MOVEMENT DISORD, V27, P930, DOI 10.1002/mds.25007; Henderson JM, 2000, BRAIN, V123, P1410, DOI 10.1093/brain/123.7.1410; Hu MTM, 2001, J NEURAL TRANSM, V108, P571, DOI 10.1007/s007020170057; Hunsche S, 2009, STEREOT FUNCT NEUROS, V87, P322, DOI 10.1159/000235804; Jankovic J, 1993, PARKINSONS DISEASE M, P1; Keller SS, 2012, NEUROINFORMATICS, V10, P341, DOI 10.1007/s12021-012-9147-0; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Marks W.J., 2011, DEEP BRAIN STIMULATI; Morishita T, 2010, NAT REV NEUROL, V6, P52, DOI 10.1038/nrneurol.2009.195; Munivenkatappa A, 2013, AGING DIS, V4, P65; Obuchi T, 2008, NEUROMODULATION, V11, P302, DOI 10.1111/j.1525-1403.2008.00180.x; Okun MS, 2008, PARKINSONISM RELAT D, V14, P532, DOI 10.1016/j.parkreldis.2008.01.001; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Rodriguez-Oroz MC, 2012, MOVEMENT DISORD, V27, P1718, DOI 10.1002/mds.25214; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Shih LC, 2013, PARKINSONISM RELAT D, V19, P676, DOI 10.1016/j.parkreldis.2013.03.006; Sullivan EV, 2004, NEUROBIOL AGING, V25, P185, DOI 10.1016/S0197-4580(03)00044-7; Uitti RJ, 2002, NEUROSURGERY, V51, P1423, DOI 10.1097/00006123-200212000-00012; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Zibetti M, 2011, MOVEMENT DISORD, V26, P2327, DOI 10.1002/mds.23903	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111561	10.1371/journal.pone.0111561	http://dx.doi.org/10.1371/journal.pone.0111561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360599	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700120
J	Waschbusch, D; Michels, H; Strassheim, S; Ossendorf, E; Kessler, D; Gloeckner, CJ; Barnekow, A				Waschbuesch, Dieter; Michels, Helen; Strassheim, Swantje; Ossendorf, Edith; Kessler, Daniel; Gloeckner, Christian Johannes; Barnekow, Angelika			LRRK2 Transport Is Regulated by Its Novel Interacting Partner Rab32	PLOS ONE			English	Article							REPEAT KINASE 2; PARKINSON-DISEASE; PROTEIN; EXPRESSION; TRAFFICKING; PREDICTION; ENDOSOMES; MUTATION; GTPASES; IDENTIFICATION	Leucine-rich repeat kinase 2 (LRRK2) is a multi-domain 280 kDa protein that is linked to Parkinson's disease (PD). Mutations especially in the GTPase and kinase domains of LRRK2 are the most common causes of heritable PD and are also found in sporadic forms of PD. Although the cellular function of LRRK2 is largely unknown there is increasing evidence that these mutations cause cell death due to autophagic dysfunction and mitochondrial damage. Here, we demonstrate a novel mechanism of LRRK2 binding and transport, which involves the small GTPases Rab32 and Rab38. Rab32 and its closest homologue Rab38 are known to organize the trans-Golgi network and transport of key enzymes in melanogenesis, whereas their function in non-melanogenic cells is still not well understood. Cellular processes such as autophagy, mitochondrial dynamics, phagocytosis or inflammatory processes in the brain have previously been linked to Rab32. Here, we demonstrate that Rab32 and Rab38, but no other GTPase tested, directly interact with LRRK2. GFP-Trap analyses confirmed the interaction of Rab32 with the endogenous LRRK2. In yeast two-hybrid experiments we identified a predicted coiled-coil motif containing region within the aminoterminus of LRRK2 as the possible interacting domain. Fluorescence microscopy demonstrated a co-localization of Rab32 and LRRK2 at recycling endosomes and transport vesicles, while overexpression of a constitutively active mutant of Rab32 led to an increased co-localization with Rab7/9 positive perinuclear late endosomes/MVBs. Subcellular fractionation experiments supported the novel role of Rab32 in LRRK2 late endosomal transport and sorting in the cell. Thus, Rab32 may regulate the physiological functions of LRRK2.	[Waschbuesch, Dieter; Michels, Helen; Strassheim, Swantje; Ossendorf, Edith; Kessler, Daniel; Barnekow, Angelika] Univ Munster, Dept Expt Tumorbiol, Munster, Germany; [Gloeckner, Christian Johannes] Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany; [Gloeckner, Christian Johannes] Eberhard Karls Univ Tubingen, Med Proteome Ctr, Inst Ophthalm Res, Tubingen, Germany	University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Waschbusch, D (corresponding author), Univ Munster, Dept Expt Tumorbiol, Munster, Germany.	d.waschbuesch@uni-muenster.de	Gloeckner, Christian Johannes/R-5374-2019	Gloeckner, Christian Johannes/0000-0001-6494-6944; Waschbusch, Dieter/0000-0002-8953-2585	LRRK2 Biology LEAPS award of the Michael J. Fox Foundation; Verband der chemischen Industrie; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of the University of Muenster	LRRK2 Biology LEAPS award of the Michael J. Fox Foundation; Verband der chemischen Industrie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Muenster	This work was supported by the LRRK2 Biology LEAPS 2012 award of the Michael J. Fox Foundation to CJG and from the Verband der chemischen Industrie to AB. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Ambrosio AL, 2012, BLOOD, V120, P4072, DOI 10.1182/blood-2012-04-420745; Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Bultema Jarred J, 2013, Small GTPases, V4, P16, DOI 10.4161/sgtp.22349; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Chan D, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.234005; Cohen-Solal KA, 2003, BBA-PROTEINS PROTEOM, V1651, P68, DOI 10.1016/S1570-9639(03)00236-X; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Gillardon F, 2013, J NEUROSCI METH, V214, P62, DOI 10.1016/j.jneumeth.2012.12.015; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gomez-Suaga P, 2014, HUM MOL GENET; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Hatano T, 2007, HUM MOL GENET, V16, P678, DOI 10.1093/hmg/ddm013; HAUGEN A, 1989, BIOL TRACE ELEM RES, V21, P451, DOI 10.1007/BF02917288; Higashi S, 2009, J NEUROPATH EXP NEUR, V68, P994, DOI 10.1097/NEN.0b013e3181b44ed8; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Kail Mark, 2008, V440, P111, DOI 10.1007/978-1-59745-178-9_9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang YJ, 2012, NEUROSCI LETT, V527, P110, DOI 10.1016/j.neulet.2012.08.039; Lozach PY, 2011, CURR OPIN VIROL, V1, P35, DOI 10.1016/j.coviro.2011.05.004; Lupas A, 1996, METHOD ENZYMOL, V266, P513; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Mills RD, 2014, HUM MUTAT, V35, P395, DOI 10.1002/humu.22515; Mills RD, 2012, BIOCHEM SOC T, V40, P1086, DOI 10.1042/BST20120088; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Muda K, 2014, P NATL ACAD SCI USA, V111, pE34, DOI 10.1073/pnas.1312701111; Parisiadou L, 2014, NAT NEUROSCI, V17, P367, DOI 10.1038/nn.3636; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Santpere G, 2009, ACTA NEUROPATHOL, V117, P227, DOI 10.1007/s00401-008-0478-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Thyrock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064149; Vivier PH, 2010, PEDIATR RADIOL, V40, P739, DOI 10.1007/s00247-009-1536-7; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Yamamoto Shuji, 2009, Nihon Hoshasen Gijutsu Gakkai Zasshi, V65, P1680	66	65	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111632	10.1371/journal.pone.0111632	http://dx.doi.org/10.1371/journal.pone.0111632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360523	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700133
J	Yang, CC; Huang, EY; Li, HC; Su, PY; Shih, C				Yang, Ching-Chun; Huang, Er-Yi; Li, Hung-Cheng; Su, Pei-Yi; Shih, Chiaho			Nuclear Export of Human Hepatitis B Virus Core Protein and Pregenomic RNA Depends on the Cellular NXF1-p15 Machinery	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATORY ELEMENT; REVERSE TRANSCRIPTION; IMMATURE SECRETION; HIGHLY FREQUENT; ANTIGEN; TREX; CONTAINS; BINDING; DOMAIN; REV	Hepatitis B virus (HBV) core protein (HBc) can shuttle between nucleus and cytoplasm. Cytoplasm-predominant HBc is clinically associated with severe liver inflammation. Previously, we found that HBc arginine-rich domain (ARD) can associate with a host factor NXF1 (TAP) by coimmunoprecipitation. It is well known that NXF1-p15 heterodimer can serve as a major export receptor of nuclear mRNA as a ribonucleoprotein complex (RNP). In the NXF1-p15 pathway, TREX (transcription/export) complex plays an important role in coupling nuclear pre-mRNA processing with mRNA export in mammalian cells. Here, we tested the hypothesis whether HBc and HBV specific RNA can be exported via the TREX and NXF1-p15 mediated pathway. We demonstrated here that HBc can physically and specifically associate with TREX components, and the NXF1-p15 export receptor by coimmunoprecipitation. Accumulation of HBc protein in the nucleus can be induced by the interference with TREX and NXF1-p15 mediated RNA export machinery. HBV transcripts encodes a non-spliced 3.5 kb pregenomic RNA (pgRNA) which can serve as a template for reverse transcription. Cytoplasmic HBV pgRNA appeared to be reduced by siRNA treatment specific for the NXF1-p15 complex by quantitative RT-qPCR and Northern blot analyses. This result suggests that the pgRNA was also exported via the NXF1-p15 machinery. We entertain the hypothesis that HBc protein can be exported as an RNP cargo via the mRNA export pathway by hijacking the TREX and NXF1-p15 complex. In our current and previous studies, HBc is not required for pgRNA accumulation in the cytoplasm. Furthermore, HBc ARD can mediate nuclear export of a chimeric protein containing HBc ARD in a pgRNA-independent manner. Taken together, it suggests that while both pgRNA and HBc protein exports are dependent on NXF1-p15, they are using the same export machinery in a manner independent of each other.	[Yang, Ching-Chun; Su, Pei-Yi] Natl Yang Ming Univ, TIGP Mol Med, Taipei 112, Taiwan; [Yang, Ching-Chun; Su, Pei-Yi] Acad Sinica, Taipei 115, Taiwan; [Yang, Ching-Chun; Huang, Er-Yi; Li, Hung-Cheng; Su, Pei-Yi; Shih, Chiaho] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Shih, C (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	cshih@ibms.sinica.edu	Shih, Chiaho/S-7017-2018; Su, Pei-Yi/AAS-9792-2021	Su, Pei-Yi/0000-0002-6354-2152	Academia Sinica, Taiwan; National Health Research Institute (NHRI Taiwan) Grant [NHRI-EX102-10203BI]; Ministry of Science and Technology (MOST Taiwan) grant	Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Health Research Institute (NHRI Taiwan) Grant; Ministry of Science and Technology (MOST Taiwan) grant	Funding sources include a grant to CS from Academia Sinica, Taiwan (http://www.sinica.edu.tw/main_e.shtml); National Health Research Institute (NHRI Taiwan) Grant Number: NHRI-EX102-10203BI to CS (http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do); and Ministry of Science and Technology (MOST Taiwan) grant to CS. (http://www.most.gov.tw/mp.aspx?mp=7) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Bodem J, 2011, J VIROL, V85, P2333, DOI 10.1128/JVI.01518-10; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Chen HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034116; Chi BK, 2014, NUCLEIC ACIDS RES, V42, P7305, DOI 10.1093/nar/gku350; Chi BK, 2013, NUCLEIC ACIDS RES, V41, P1294, DOI 10.1093/nar/gks1188; Chu CM, 1987, GASTROENTEROLOGY, V92, P220, DOI 10.1016/0016-5085(87)90863-8; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Heise T, 2006, NUCLEIC ACIDS RES, V34, P353, DOI 10.1093/nar/gkj440; Herold A, 2001, RNA, V7, P1768; HSU HC, 1987, J HEPATOL, V5, P45, DOI 10.1016/S0168-8278(87)80060-0; Huang C, 2011, FEBS J, V278, P1533, DOI 10.1111/j.1742-4658.2011.08077.x; HUANG JK, 1993, MOL CELL BIOL, V13, P7476, DOI 10.1128/MCB.13.12.7476; HUANG ZM, 1994, J VIROL, V68, P3193, DOI 10.1128/JVI.68.5.3193-3199.1994; HUANG ZM, 1995, MOL CELL BIOL, V15, P3864; Jackson BR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002138; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; Juillard F, 2009, J VIROL, V83, P12759, DOI 10.1128/JVI.01276-09; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Le Pogam S, 2002, J VIROL, V76, P6510, DOI 10.1128/JVI.76.13.6510-6517.2002; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Natalizio BJ, 2013, TRENDS CELL BIOL, V23, P365, DOI 10.1016/j.tcb.2013.03.006; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; Ning B, 2004, J VIROL, V78, P13653, DOI 10.1128/JVI.78.24.13653-13668.2004; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Ou JH, 1997, J GASTROEN HEPATOL, V12, pS178, DOI 10.1111/j.1440-1746.1997.tb00499.x; Popa I, 2002, MOL CELL BIOL, V22, P2057, DOI 10.1128/MCB.22.7.2057-2067.2002; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P2401, DOI 10.1073/pnas.91.7.2401; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Roth J, 1997, J VIROL, V71, P8933, DOI 10.1128/JVI.71.11.8933-8939.1997; Sakuma T, 2014, J VIROL, V88, P4069, DOI 10.1128/JVI.03584-13; Schmid M, 2012, J VIROL, V86, P2282, DOI 10.1128/JVI.06275-11; Selth Luke A, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5234; Sherer NM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002395; Shih C, 2013, CHRONIC HEPATITIS B AND C: BASIC SCIENCE TO CLINICAL APPLICATIONS, P1; Smith GJ, 1998, NUCLEIC ACIDS RES, V26, P4818, DOI 10.1093/nar/26.21.4818; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Stieler JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091279; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; TAKAHASHI K, 1983, J IMMUNOL, V130, P2903; Tunnicliffe RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003907; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Verheggen C, 2012, NUCLEUS-AUSTIN, V3, P132, DOI 10.4161/nucl.19266; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Williams BJL, 2005, BIOCHEM J, V387, P295, DOI 10.1042/BJ20041223; Yuan TTT, 1999, J VIROL, V73, P5731, DOI 10.1128/JVI.73.7.5731-5740.1999; Yuan TTT, 1999, J VIROL, V73, P10122, DOI 10.1128/JVI.73.12.10122-10128.1999; YUAN TTT, 1995, VIROLOGY, V211, P144, DOI 10.1006/viro.1995.1387; Zang WQ, 1999, VIROLOGY, V259, P299, DOI 10.1006/viro.1999.9777; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	65	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e106683	10.1371/journal.pone.0106683	http://dx.doi.org/10.1371/journal.pone.0106683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360769	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700005
J	van den Berg, TNA; Deinum, J; Bilos, A; Donders, ART; Rongen, GA; Riksen, NP				van den Berg, T. N. A.; Deinum, Jaap; Bilos, Albert; Donders, A. Rogier T.; Rongen, Gerard A.; Riksen, Niels P.			The Effect of Eplerenone on Adenosine Formation in Humans In Vivo: A Double-Blinded Randomised Controlled Study	PLOS ONE			English	Article							ROSUVASTATIN INCREASES; RAT-HEART; METHOTREXATE; MECHANISMS	Background: It has been suggested that mineralocorticoid receptor antagonists have direct cardioprotective properties, because these drugs reduce mortality in patients with heart failure. In murine models of myocardial infarction, mineralocorticoid receptor antagonists reduce infarct size. Using gene deletion and pharmacological approaches, it has been shown that extracellular formation of the endogenous nucleoside adenosine is crucial for this protective effect. We now aim to translate this finding to humans, by investigating the effects of the selective mineralocorticoid receptor antagonist eplerenone on the vasodilator effect of the adenosine uptake inhibitor dipyridamole, which is a well-validated surrogate marker for extracellular adenosine formation. Methods and Results: In a randomised, double-blinded, placebo-controlled, cross-over study we measured the forearm blood flow response to the intrabrachial administration of dipyridamole in 14 healthy male subjects before and after treatment with placebo or eplerenone (50 mg bid for 8 days). The forearm blood flow during administration of dipyridamole (10, 30 and 100 mu g.min(-1).dl(-1)) was 1.63 (0.60), 2.13 (1.51) and 2.71 (1.32) ml.dl(-1).min(-1) during placebo use, versus 2.00 (1.45), 2.68 (1.87) and 3.22 (1.94) ml.dl(-1).min(-1) during eplerenone treatment (median (interquartile range); P = 0.51). Concomitant administration of the adenosine receptor antagonist caffeine attenuated dipyridamole-induced vasodilation to a similar extent in both groups. The forearm blood flow response to forearm ischemia, as a stimulus for increased formation of adenosine, was similar during both conditions. Conclusion: In a dosage of 50 mg bid, eplerenone does not augment extracellular adenosine formation in healthy human subjects. Therefore, it is unlikely that an increased extracellular adenosine formation contributes to the cardioprotective effect of mineralocorticoid receptor antagonists.	[van den Berg, T. N. A.; Bilos, Albert; Rongen, Gerard A.; Riksen, Niels P.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol, NL-6525 ED Nijmegen, Netherlands; [van den Berg, T. N. A.; Deinum, Jaap; Rongen, Gerard A.; Riksen, Niels P.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Donders, A. Rogier T.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Riksen, NP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol, NL-6525 ED Nijmegen, Netherlands.	niels.riksen@radboudumc.nl	Rongen, Gerard/AAJ-9694-2021; Donders, A.R.T./L-4277-2015; Rongen, Gerard A/C-1578-2018; Riksen, Niels P/G-8260-2015; Deinum, J./L-4261-2015	Donders, A.R.T./0000-0002-0484-1419; Riksen, Niels P/0000-0001-9197-8124; Deinum, J./0000-0003-2465-1986	Netherlands Foundation for Cardiovascular Excellence; Netherlands Organisation for Health Research and Development (ZonMW) [40-00703-97-354]; Netherlands Heart Foundation [2012T051]	Netherlands Foundation for Cardiovascular Excellence; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by a grant from the Netherlands Foundation for Cardiovascular Excellence [grant 2012 to NPR]. In addition, NPR is recipient of a Clinical Fellowship from the Netherlands Organisation for Health Research and Development (ZonMW) [grant number 40-00703-97-354] and the Netherlands Heart Foundation [dr. Dekker grant number 2012T051]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma H, 2004, J CARDIOVASC PHARM, V43, P574, DOI 10.1097/00005344-200404000-00013; Chai WX, 2006, HYPERTENSION, V47, P665, DOI 10.1161/01.HYP.0000205831.39339.a5; Deussen A, 2000, N-S ARCH PHARMACOL, V362, P351, DOI 10.1007/s002100000318; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Meijer P, 2008, BRIT J PHARMACOL, V153, P1169, DOI 10.1038/bjp.2008.10; Meijer P, 2010, HYPERTENSION, V56, P722, DOI 10.1161/HYPERTENSIONAHA.110.155689; Meijer P, 2009, ARTERIOSCL THROM VAS, V29, P963, DOI 10.1161/ATVBAHA.108.179622; Mihailidou AS, 2009, HYPERTENSION, V54, P1306, DOI 10.1161/HYPERTENSIONAHA.109.136242; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Paiva M, 2009, J CARDIOVASC PHARM, V53, P373, DOI 10.1097/FJC.0b013e31819fd4e7; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ramakers BP, 2008, CURR DRUG METAB, V9, P679, DOI 10.2174/138920008786049249; Riksen NP, 2008, EUR J PHARMACOL, V585, P220, DOI 10.1016/j.ejphar.2008.01.053; Riksen NP, 2012, EXPERT REV CLIN PHAR, V5, P199, DOI [10.1586/ECP.12.8, 10.1586/ecp.12.8]; Riksen NP, 2006, ANN RHEUM DIS, V65, P465, DOI 10.1136/ard.2005.048637; Riksen NP, 2005, J APPL PHYSIOL, V99, P522, DOI 10.1152/japplphysiol.00108.2005; Sanada S, 2004, CIRCULATION, V110, P2143, DOI 10.1161/01.CIR.0000143830.59419.73; Schmidt K, 2010, EUR HEART J, V31, P1655, DOI 10.1093/eurheartj/ehp555; SchreiberDeturmeny E, 1996, J CHROMATOGR B, V677, P305, DOI 10.1016/0378-4347(95)00383-5; Le TYL, 2012, HYPERTENSION, V59, P1164, DOI 10.1161/HYPERTENSIONAHA.111.190488; van den Berg TNA, 2014, PHARMACOL THERAPEUT, V142, P72, DOI 10.1016/j.pharmthera.2013.11.006; van den Borne SWM, 2009, JACC-CARDIOVASC IMAG, V2, P187, DOI 10.1016/j.jcmg.2008.11.011; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111248	10.1371/journal.pone.0111248	http://dx.doi.org/10.1371/journal.pone.0111248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356826	Green Published, Green Submitted, gold			2022-12-27	WOS:000346765000047
J	Ho, AL; Mouminah, A; Du, R				Ho, Allen L.; Mouminah, Amr; Du, Rose			Posterior Cerebral Artery Angle and the Rupture of Basilar Tip Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; WALL SHEAR-STRESS; ASPECT RATIO; SURGICAL-TREATMENT; BOTTLENECK FACTOR; NATURAL-HISTORY; RISK-FACTORS; BLOOD-FLOW; SHAPE; GEOMETRY	Since the initial publication of the International Study of Unruptured Intracranial Aneurysms (ISUIA), management of unruptured intracranial aneurysms has been mainly based on the size of the aneurysm. The contribution of morphological characteristics to treatment decisions of unruptured aneurysms has not been well studied in a systematic and location specific manner. We present a large sample of basilar artery tip aneurysms (BTA) that were assessed using a diverse array of morphological variables to determine the parameters associated with ruptured aneurysms. Demographic and clinical risk factors of aneurysm rupture were obtained from chart review. CT angiograms (CTA) were evaluated with Slicer, an open source visualization and image analysis software, to generate 3-D models of the aneurysms and surrounding vascular architecture. Morphological parameters examined in each model included aneurysm volume, aspect ratio, size ratio, aneurysm angle, basilar vessel angle, basilar flow angle, and vessel to vessel angles. Univariate and multivariate analyses were performed to determine statistical significance. From 2008-2013, 54 patients with BTA aneurysms were evaluated in a single institution, and CTAs from 33 patients (15 ruptured, 18 unruptured) were available and analyzed. Aneurysms that underwent reoperation, that were associated with arteriovenous malformations, or that lacked preoperative CTA were excluded. Multivariate logistic regression revealed that a larger angle between the posterior cerebral arteries (P1-P1 angle, p = 0.037) was most strongly associated with aneurysm rupture after adjusting for other morphological variables. In this location specific study of BTA aneurysms, the larger the angle formed between posterior cerebral arteries was found to be a new morphological parameter significantly associated with ruptured BTA aneurysms. This is a physically intuitive parameter that can be measured easily and readily applied in the clinical setting.	[Ho, Allen L.; Mouminah, Amr; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Ho, Allen L.; Du, Rose] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Du, Rose/0000-0003-2641-6496	American Heart Association Scholarship in Cerebrovascular Disease and Stroke	American Heart Association Scholarship in Cerebrovascular Disease and Stroke(American Heart Association)	This work was supported by the American Heart Association Scholarship in Cerebrovascular Disease and Stroke (http://my.americanheart.org) (ALH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjmandi-Tash O, 2012, BIOIMPACTS, V2, P195, DOI 10.5681/bi.2012.023; Backes D, 2014, DIFFERENCE ANEURYSM; Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Barakat AI, 1998, CHEST, V114, p58S, DOI 10.1378/chest.114.1_Supplement.58S; Beck J, 2003, ACTA NEUROCHIR, V145, P861, DOI 10.1007/s00701-003-0124-0; de Rooij NK, 2009, J NEUROL, V256, P45, DOI 10.1007/s00415-009-0028-x; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Drake CG, 1996, SURG VERTEBROBASILAR; Ecker Robert D, 2004, Neurosurg Focus, V17, pE4; Ford MD, 2008, J BIOMECH, V41, P241, DOI 10.1016/j.jbiomech.2007.09.032; Gabriel RA, 2010, STROKE, V41, P21, DOI 10.1161/STROKEAHA.109.566018; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Ho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094837; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Huang MC, 2011, STROKE, V42, P1730, DOI 10.1161/STROKEAHA.110.603803; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838; Kaiser D, 1997, BIOCHEM BIOPH RES CO, V231, P586, DOI 10.1006/bbrc.1997.6146; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E; Laaksamo E, 2012, NEUROSURGERY, V70, P1565, DOI 10.1227/NEU.0b013e31824c057e; Lauric A, 2012, NEUROSURGERY, V71, P38, DOI 10.1227/NEU.0b013e3182503bf9; Lin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079635; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Ma BS, 2004, ANN BIOMED ENG, V32, P264, DOI 10.1023/B:ABME.0000012746.31343.92; Ma D, 2010, NEUROL RES, V32, P482, DOI 10.1179/016164109X12581096796558; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Matsukawa H, 2012, J NEUROSURG; Matsukawa H, 2014, J NEUROSURG, V120, P104, DOI 10.3171/2013.9.JNS13921; Meng H, 2007, STROKE, V38, P1924, DOI 10.1161/STROKEAHA.106.481234; Mocco J, 2004, Neurosurg Focus, V17, pE3; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Nader-Sepahi A, 2004, NEUROSURGERY, V54, P1343, DOI 10.1227/01.NEU.0000124482.03676.8B; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Nguyen KT, 2008, J BIOMECH, V41, P11, DOI 10.1016/j.jbiomech.2007.08.012; Parlea L, 1999, AM J NEURORADIOL, V20, P1079; PERKTOLD K, 1991, J BIOMED ENG, V13, P507, DOI 10.1016/0141-5425(91)90100-L; Piccinelli M, 2012, ANN BIOMED ENG, V40, P2188, DOI 10.1007/s10439-012-0577-5; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Pieper S, 2006, I S BIOMED IMAGING, P698; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Ryu CW, 2011, NEURORADIOLOGY, V53, P883, DOI 10.1007/s00234-010-0804-4; Sadatomo T, 2008, NEUROSURGERY, V62, P602, DOI 10.1227/01.NEU.0000311347.35583.0C; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wells DR, 1996, J VASC SURG, V23, P667, DOI 10.1016/S0741-5214(96)80048-6; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401	51	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110946	10.1371/journal.pone.0110946	http://dx.doi.org/10.1371/journal.pone.0110946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353989	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200047
J	Le, PT; Pearce, MM; Zhang, SB; Campbell, EM; Fok, CS; Mueller, ER; Brincat, CA; Wolfe, AJ; Brubaker, L				Le, Phong T.; Pearce, Meghan M.; Zhang, Shubin; Campbell, Edward M.; Fok, Cynthia S.; Mueller, Elizabeth R.; Brincat, Cynthia A.; Wolfe, Alan J.; Brubaker, Linda			IL22 Regulates Human Urothelial Cell Sensory and Innate Functions through Modulation of the Acetylcholine Response, Immunoregulatory Cytokines and Antimicrobial Peptides: Assessment of an In Vitro Model	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; RECURRENT BACTERIAL CYSTITIS; INTESTINAL EPITHELIAL-CELLS; ADULT FEMALE BLADDER; URINARY-TRACT; GENE-EXPRESSION; FIMH-ADHESIN; UROPLAKIN-IA; INFECTION; RECEPTOR	Human urinary disorders are generally studied in rodent models due to limitations of functional in vitro culture models of primary human urothelial cells (HUCs). Current HUC culture models are often derived from immortalized cancer cell lines, which likely have functional characteristics differ from healthy human urothelium. Here, we described a simple explant culture technique to generate HUCs and assessed their in vitro functions. Using transmission electron microscopy, we assessed morphology and heterogeneity of the generated HUCs and characterized their intercellular membrane structural proteins relative to ex vivo urothelium tissue. We demonstrated that our cultured HUCs are free of fibroblasts. They are also heterogeneous, containing cells characteristic of both immature basal cells and mature superficial urothelial cells. The cultured HUCs expressed muscarinic receptors (MR1 and MR2), carnitine acetyltransferase (CarAT), immunoregulatory cytokines IL7, IL15, and IL23, as well as the chemokine CCL20. HUCs also expressed epithelial cell-specific molecules essential for forming intercellular structures that maintain the functional capacity to form the physiological barrier of the human bladder urothelium. A subset of HUCs, identified by the high expression of CD44, expressed the Toll-like receptor 4 (TLR4) along with its co-receptor CD14. We demonstrated that HUCs express, at the mRNA level, both forms of the IL22 receptor, the membrane-associated (IL22RA1) and the secreted soluble (IL22RA2) forms; in turn, IL22 inhibited expression of MR1 and induced expression of CarAT and two antimicrobial peptides (S100A9 and lipocalin-2). While the cellular sources of IL22 have yet to be identified, the HUC cytokine and chemokine profiles support the concept that IL22-producing cells are present in the human bladder mucosa tissue and that IL22 plays a regulatory role in HUC functions. Thus, the described explant technique is clearly capable of generating functional HUCs suitable for the study of human urinary tract disorders, including interactions between urothelium and IL22-producing cells.	[Le, Phong T.; Pearce, Meghan M.; Zhang, Shubin; Campbell, Edward M.; Wolfe, Alan J.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Mueller, Elizabeth R.; Brincat, Cynthia A.; Brubaker, Linda] Loyola Univ Chicago, Stritch Sch Med, Dept Obstet & Gynecol, Maywood, IL USA; [Fok, Cynthia S.] Univ Minnesota, Dept Urol, Minneapolis, MN USA	Loyola University Chicago; Loyola University Chicago; University of Minnesota System; University of Minnesota Twin Cities	Le, PT (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA.	ple@luc.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589	Ralph and Marian Falk Medical Research Trust, Immunology and Infectious Disease Research Institute, Loyola University [LU205650, LU203919, LU202567]	Ralph and Marian Falk Medical Research Trust, Immunology and Infectious Disease Research Institute, Loyola University	Funding provided by the Ralph and Marian Falk Medical Research Trust, Immunology and Infectious Disease Research Institute, Loyola University LU205650 and LU203919 (PTL), LU202567 (AJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudette-Zlatanova BC, 2011, EXP HEMATOL, V39, P570, DOI 10.1016/j.exphem.2011.01.014; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Bschleipfer T, 2007, LIFE SCI, V80, P2303, DOI 10.1016/j.lfs.2007.01.053; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; De Vita D, 2013, INT UROGYNECOL J, V24, P545, DOI 10.1007/s00192-012-1957-y; De Vita D, 2012, INT UROGYNECOL J, V23, P1707, DOI 10.1007/s00192-012-1794-z; Dokun OY, 2008, INT J CANCER, V123, P2798, DOI 10.1002/ijc.23893; Edwards LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015398; ESHDAT Y, 1981, INFECT IMMUN, V34, P980, DOI 10.1128/IAI.34.3.980-986.1981; Fahlgren A, 2004, CLIN EXP IMMUNOL, V137, P379, DOI 10.1111/j.1365-2249.2004.02543.x; Fisher JF, 2011, CLIN INFECT DIS, V52, pS437, DOI 10.1093/cid/cir110; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Green M, 2004, UROLOGY, V63, P688, DOI 10.1016/j.urology.2003.11.022; Guimond M, 2005, J IMMUNOTHER, V28, P289, DOI 10.1097/01.cji.0000165356.03924.e7; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0; Ishii M, 2006, CURR PHARM DESIGN, V12, P3573, DOI 10.2174/138161206778522056; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lips KS, 2007, EUR UROL, V51, P1042, DOI 10.1016/j.eururo.2006.10.028; Liu AY, 2012, CELL TISSUE RES, V348, P589, DOI 10.1007/s00441-012-1383-y; Liu JZ, 2009, CYTOKINE, V48, P156, DOI 10.1016/j.cyto.2009.07.005; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; SOUTHGATE J, 1994, LAB INVEST, V71, P583; SOUTHGATE J, 1995, INT J CANCER, V62, P449, DOI 10.1002/ijc.2910620415; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Trzpis M, 2008, TRANSGENIC RES, V17, P229, DOI 10.1007/s11248-007-9141-8; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Tu L, 2000, MOL BIOL CELL, V13, P4221; Veranic P, 2004, EUR J CELL BIOL, V83, P27, DOI 10.1078/0171-9335-00351; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Yoshida M, 2006, UROLOGY, V67, P425, DOI 10.1016/j.urology.2005.08.014; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang JP, 1996, SCIENCE, V273, P1234, DOI 10.1126/science.273.5279.1234; Zhou G, 2001, J CELL SCI, V114, P4095; Zook EC, 2013, J IMMUNOL, V191, P5583, DOI 10.4049/jimmunol.1202278	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111375	10.1371/journal.pone.0111375	http://dx.doi.org/10.1371/journal.pone.0111375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354343	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200077
J	Schrimpf, R; Dierks, C; Martinsson, G; Sieme, H; Distl, O				Schrimpf, Rahel; Dierks, Claudia; Martinsson, Gunilla; Sieme, Harald; Distl, Ottmar			Genome-Wide Association Study Identifies Phospholipase C zeta 1 (PLCz1) as a Stallion Fertility Locus in Hanoverian Warmblood Horses	PLOS ONE			English	Article							TRIGGERS CA2+ OSCILLATIONS; CHILDHOOD ABSENCE EPILEPSY; EXONIC SPLICING ENHANCER; MESSENGER-RNA DECAY; C-ZETA; CANDIDATE GENES; EGG ACTIVATION; NUCLEAR TRANSLOCATION; OOCYTE ACTIVATION; MOLECULAR-CLONING	A consistently high level of stallion fertility plays an economically important role in modern horse breeding. We performed a genome-wide association study for estimated breeding values of the paternal component of the pregnancy rate per estrus cycle (EBV-PAT) in Hanoverian stallions. A total of 228 Hanoverian stallions were genotyped using the Equine SNP50 Beadchip. The most significant association was found on horse chromosome 6 for a single nucleotide polymorphism (SNP) within phospholipase C zeta 1 (PLCz1). In the close neighbourhood to PLCz1 is located CAPZA3 (capping protein (actin filament) muscle Z-line, alpha 3). The gene PLCz1 encodes a protein essential for spermatogenesis and oocyte activation through sperm induced Ca2+-oscillation during fertilization. We derived equine gene models for PLCz1 and CAPZA3 based on cDNA and genomic DNA sequences. The equine PLCz1 had four different transcripts of which two contained a premature termination codon. Sequencing all exons and their flanking sequences using genomic DNA samples from 19 Hanoverian stallions revealed 47 polymorphisms within PLCz1 and one SNP within CAPZA3. Validation of these 48 polymorphisms in 237 Hanoverian stallions identified three intronic SNPs within PLCz1 as significantly associated with EBV-PAT. Bioinformatic analysis suggested regulatory effects for these SNPs via transcription factor binding sites or microRNAs. In conclusion, non-coding polymorphisms within PLCz1 were identified as conferring stallion fertility and PLCz1 as candidate locus for male fertility in Hanoverian warmblood. CAPZA3 could be eliminated as candidate gene for fertility in Hanoverian stallions.	[Schrimpf, Rahel; Dierks, Claudia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Martinsson, Gunilla] State Stud Celle Lower Saxony, Celle, Germany; [Sieme, Harald] Univ Vet Med Hannover, Reprod Med Unit, Clin Horses, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Dierks, Claudia/0000-0003-1299-6063	Mehl-Mulhens Stiftung, Koln [DI-MM/1-1]	Mehl-Mulhens Stiftung, Koln	This study was supported by the Mehl-Mulhens Stiftung, Koln (DI-MM/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Halima M, 2014, FERTIL STERIL, V101, P78, DOI 10.1016/j.fertnstert.2013.09.009; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arraiano Cecilia Maria, 2003, Molecular Microbiology, V49, P267, DOI 10.1046/j.1365-2958.2003.03545.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bedford-Guaus SJ, 2011, BIOL REPROD, V85, P78, DOI 10.1095/biolreprod.110.089466; Bedford-Guaus SJ, 2012, J EQUINE VET SCI, V32, P445, DOI 10.1016/j.jevs.2012.06.002; Blazquez L, 2013, HUM MUTAT, V34, P1387, DOI 10.1002/humu.22379; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen X, 2014, CURR DRUG TARGETS, V15, P361, DOI 10.2174/1389450115666140120102935; Coward K, 2005, REPRODUCTION, V130, P157, DOI 10.1530/rep.1.00707; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ferlin A, 2004, FERTIL STERIL, V81, P1013, DOI 10.1016/j.fertnstert.2003.08.053; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Geyer CB, 2009, DEV BIOL, V330, P142, DOI 10.1016/j.ydbio.2009.03.020; Giesecke K, 2011, ANIM REPROD SCI, V126, P200, DOI 10.1016/j.anireprosci.2011.05.007; Giesecke K, 2010, REPROD DOMEST ANIM, V45, pE124, DOI 10.1111/j.1439-0531.2009.01533.x; Giesecke K, 2010, REPROD DOMEST ANIM, V45, P342, DOI 10.1111/j.1439-0531.2008.01325.x; Giesecke K, 2009, ANIM GENET, V40, P359, DOI 10.1111/j.1365-2052.2008.01844.x; Gould PS, 2014, RNA, V20, P373, DOI 10.1261/rna.041574.113; Gradil C, 2006, ANIM REPROD SCI, V94, P23, DOI 10.1016/j.anireprosci.2006.03.095; Guido C, 2011, J CELL PHYSIOL, V226, P3403, DOI 10.1002/jcp.22703; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamann H, 2007, ANIM GENET, V38, P259, DOI 10.1111/j.1365-2052.2007.01594.x; Hamann H, 2005, ANIM REPROD SCI, V89, P201; Harti M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00051; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Heytens E, 2009, HUM REPROD, V24, P2417, DOI 10.1093/humrep/dep207; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Homolova K, 2010, HUM MUTAT, V31, P437, DOI 10.1002/humu.21206; Hossain MM, 2012, CELL TISSUE RES, V349, P679, DOI 10.1007/s00441-012-1469-6; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ito M, 2008, BIOL REPROD, V78, P1081, DOI 10.1095/biolreprod.108.067801; Johnson AD, 2005, PHARMACOL THERAPEUT, V106, P19, DOI 10.1016/j.pharmthera.2004.11.001; Kaewmala K, 2012, REPROD DOMEST ANIM, V47, P213, DOI 10.1111/j.1439-0531.2011.01831.x; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kashir J, 2012, FERTIL STERIL, V98, P423, DOI 10.1016/j.fertnstert.2012.05.002; Kashir J, 2012, HUM REPROD, V27, P222, DOI 10.1093/humrep/der384; Kashir J, 2011, HUM REPROD, V26, P3372, DOI 10.1093/humrep/der336; Kasimanickam V, 2012, THERIOGENOLOGY, V78, P2007, DOI 10.1016/j.theriogenology.2012.07.016; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kosova G, 2012, AM J HUM GENET, V90, P950, DOI 10.1016/j.ajhg.2012.04.016; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuroda K, 2006, J BIOL CHEM, V281, P27794, DOI 10.1074/jbc.M603473200; Kurokawa M, 2004, BIOL CELL, V96, P37, DOI 10.1016/j.biolcel.2003.11.003; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Layman LC, 2003, ENDOCRIN METAB CLIN, V32, P549, DOI 10.1016/S0889-8529(03)00040-9; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Miyagawa Y, 2002, MOL HUM REPROD, V8, P531, DOI 10.1093/molehr/8.6.531; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Nomikos M, 2013, FERTIL STERIL, V99, P76, DOI 10.1016/j.fertnstert.2012.08.035; Nomikos M, 2012, BIOESSAYS, V34, P126, DOI 10.1002/bies.201100127; Nomikos M, 2011, BIOCHEM J, V434, P211, DOI 10.1042/BJ20101772; Pan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058795; Penagaricano F, 2012, ANIM GENET, V43, P65, DOI 10.1111/j.1365-2052.2012.02350.x; Pentikainen V, 2000, J CLIN ENDOCR METAB, V85, P2057, DOI 10.1210/jc.85.5.2057; Peterlin B, 2006, MOL HUM REPROD, V12, P777, DOI 10.1093/molehr/gal088; Quadros L, 2008, HAEMOPHILIA, V14, P628, DOI 10.1111/j.1365-2516.2008.01704.x; Raudsepp T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003139; Russo A, 2010, BBA-GENE REGUL MECH, V1799, P419, DOI 10.1016/j.bbagrm.2010.01.008; Sato K, 2013, ANIM SCI J, V84, P359, DOI 10.1111/asj.12044; Saunders CM, 2007, BIOCHEM SOC SYMP, V74, P23, DOI 10.1042/BSS2007c03; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Sieme H, 2012, J EQUINE VET SCI, V32, P467, DOI 10.1016/j.jevs.2012.06.016; Skok DJ, 2013, ANIM GENET, V44, P669, DOI 10.1111/age.12072; Swann K, 2006, SEMIN CELL DEV BIOL, V17, P264, DOI 10.1016/j.semcdb.2006.03.009; Swann K, 2013, CELL CALCIUM, V53, P55, DOI 10.1016/j.ceca.2012.11.001; Tian MN, 2012, J NEUROSCI, V32, P5937, DOI 10.1523/JNEUROSCI.5332-11.2012; Truong BN, 2003, ASIAN J ANDROL, V5, P137; Vickers KC, 2014, CLIN SCI, V126, P183, DOI 10.1042/CS20130203; Walenkamp MJE, 2013, HORM RES PAEDIAT, V80, P406, DOI 10.1159/000355928; Wang JCW, 2000, J BIOL CHEM, V275, P18418, DOI 10.1074/jbc.M910211199; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Yoneda A, 2006, REPRODUCTION, V132, P393, DOI 10.1530/rep.1.01018; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	88	18	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109675	10.1371/journal.pone.0109675	http://dx.doi.org/10.1371/journal.pone.0109675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354211	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204200013
J	Yan, S; Zhu, JL; Zhu, WL; Zhang, XF; Li, Z; Liu, XX; Zhang, QW				Yan, Shuo; Zhu, Jialin; Zhu, Weilong; Zhang, Xinfang; Li, Zhen; Liu, Xiaoxia; Zhang, Qingwen			The Expression of Three Opsin Genes from the Compound Eye of Helicoverpa armigera (Lepidoptera: Noctuidae) Is Regulated by a Circadian Clock, Light Conditions and Nutritional Status	PLOS ONE			English	Article							MESSENGER-RNA; COLOR-VISION; MOLECULAR-CLONING; VISUAL PIGMENTS; SENSITIVE PHOTORECEPTORS; CYSTEINE RESIDUE-110; MANDUCA-SEXTA; PROTEIN; RETINA; PHEROMONE	Visual genes may become inactive in species that inhabit poor light environments, and the function and regulation of opsin components in nocturnal moths are interesting topics. In this study, we cloned the ultraviolet (UV), blue (BL) and long-wavelength-sensitive (LW) opsin genes from the compound eye of the cotton bollworm and then measured their mRNA levels using quantitative real-time PCR. The mRNA levels fluctuated over a daily cycle, which might be an adaptation of a nocturnal lifestyle, and were dependent on a circadian clock. Cycling of opsin mRNA levels was disturbed by constant light or constant darkness, and the UV opsin gene was up-regulated after light exposure. Furthermore, the opsin genes tended to be down-regulated upon starvation. Thus, this study illustrates that opsin gene expression is determined by multiple endogenous and exogenous factors and is adapted to the need for nocturnal vision, suggesting that color vision may play an important role in the sensory ecology of nocturnal moths.	[Yan, Shuo; Zhu, Weilong; Zhang, Xinfang; Li, Zhen; Liu, Xiaoxia; Zhang, Qingwen] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhu, Jialin] Beijing Entry Exit Inspect & Quarantine Bur, Beijing, Peoples R China	China Agricultural University	Liu, XX (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	liuxiaoxia611@cau.edu.cn; zhangqingwen@263.net			Natural Science Foundation of China [31371943]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Natural Science Foundation of China (31371943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Battelle BA, 2013, INTEGR COMP BIOL, V53, P144, DOI 10.1093/icb/ict020; Battelle BA, 2000, VISUAL NEUROSCI, V17, P217, DOI 10.1017/S0952523800172049; Battelle BA, 2013, J EXP BIOL, V216, P1837, DOI 10.1242/jeb.083519; Bentrop J, 1997, EMBO J, V16, P1600, DOI 10.1093/emboj/16.7.1600; Bobu C, 2013, MOL VIS, V19, P1060; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chase MR, 1997, J EXP BIOL, V200, P2469; Choi MY, 1998, J INSECT PHYSIOL, V44, P653, DOI 10.1016/S0022-1910(98)00029-8; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CRAFT CM, 1990, J NEUROCHEM, V55, P1461, DOI 10.1111/j.1471-4159.1990.tb04927.x; CUTLER DE, 1995, J EXP BIOL, V198, P1909; Egan ES, 1999, J NEUROSCI, V19, P3665; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Eriksson BJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-186; Everett A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-232; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; GORDON WC, 1977, Z NATURFORSCH C, V32, P662; Hill GE, 2004, ANIM BEHAV, V67, P27, DOI 10.1016/j.anbehav.2003.02.002; Hillier NK, 2011, J CHEM ECOL, V37, P1127, DOI 10.1007/s10886-011-0017-2; Hillier NK, 2004, CHEM SENSES, V29, P499, DOI 10.1093/chemse/bjh052; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ikeno T, 2008, GENE, V419, P56, DOI 10.1016/j.gene.2008.05.002; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kihara J, 2009, FEMS MICROBIOL LETT, V295, P289, DOI 10.1111/j.1574-6968.2009.01609.x; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kitamoto J, 1998, J EXP BIOL, V201, P1255; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; Langham GM, 2004, EVOLUTION, V58, P2783; Laver CRJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-81; Leboulle G, 2013, INSECT BIOCHEM MOLEC, V43, P959, DOI 10.1016/j.ibmb.2013.07.006; Lecomte C, 1998, J CHEM ECOL, V24, P655, DOI 10.1023/A:1022390102631; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda T, 2003, ZOOL SCI, V20, P989, DOI 10.2108/zsj.20.989; Merlin C, 2007, J BIOL RHYTHM, V22, P502, DOI 10.1177/0748730407307737; Nagy AD, 2007, GEN COMP ENDOCR, V152, P144, DOI 10.1016/j.ygcen.2007.01.019; Nowinszky L, 2011, INDIAN J AGR SCI, V81, P154; Ogawa Y, 2013, J EXP BIOL, V216, P1916, DOI 10.1242/jeb.083485; Ogawa Y, 2012, J COMP PHYSIOL A, V198, P857, DOI 10.1007/s00359-012-0756-8; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Sasagawa H, 2003, EUR J NEUROSCI, V17, P963, DOI 10.1046/j.1460-9568.2003.02528.x; Seki T, 1998, COMP BIOCHEM PHYS B, V119, P53, DOI 10.1016/S0305-0491(97)00322-2; SILVER R, 1988, CELL TISSUE RES, V253, P189; Takeuchi Y, 2011, COMP BIOCHEM PHYS A, V160, P486, DOI 10.1016/j.cbpa.2011.08.007; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053907; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; Wei Guoshu, 1999, Acta Biophysica Sinica, V15, P682; White RH, 2003, J EXP BIOL, V206, P3337, DOI 10.1242/jeb.00571; Wu Kunjun, 1997, Entomologia Sinica, V4, P277; Xu PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078140; Yan Shuo, 2012, Acta Entomologica Sinica, V55, P1337; [闫硕 Yan Shuo], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1808; Yan S, 2013, J ECON ENTOMOL, V106, P708, DOI 10.1603/EC12402; Yan S, 2013, J ECON ENTOMOL, V106, P450, DOI 10.1603/EC12290; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	68	32	44	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111683	10.1371/journal.pone.0111683	http://dx.doi.org/10.1371/journal.pone.0111683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353953	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200091
J	Arendt, LM; Laurent, JS; Wronski, A; Caballero, S; Lyle, SR; Naber, SP; Kuperwasser, C				Arendt, Lisa M.; Laurent, Jessica St.; Wronski, Ania; Caballero, Silvia; Lyle, Stephen R.; Naber, Stephen P.; Kuperwasser, Charlotte			Human Breast Progenitor Cell Numbers Are Regulated by WNT and TBX3	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; ESTROGEN-RECEPTOR-ALPHA; STEM-CELLS; CANCER-CELLS; PROGESTERONE-RECEPTOR; MENSTRUAL-CYCLE; MOUSE MODEL; PROLIFERATION; GENE; EXPRESSION	Background: Although human breast development is mediated by hormonal and non-hormonal means, the mechanisms that regulate breast progenitor cell activity remain to be clarified. This limited understanding of breast progenitor cells has been due in part to the lack of appropriate model systems to detect and characterize their properties. Methods: To examine the effects of WNT signaling and TBX3 expression on progenitor activity in the breast, primary human mammary epithelial cells (MEC) were isolated from reduction mammoplasty tissues and transduced with lentivirus to overexpress WNT1 or TBX3 or reduce expression of their cognate receptors using shRNA. Changes in progenitor activity were quantified using characterized assays. We identified WNT family members expressed by cell populations within the epithelium and assessed alterations in expression of WNT family ligands by MECs in response to TBX3 overexpression and treatment with estrogen and progesterone. Results: Growth of MECs on collagen gels resulted in the formation of distinct luminal acinar and basal ductal colonies. Overexpression of TBX3 in MECs resulted in increased ductal colonies, while shTBX3 expression diminished both colony types. Increased WNT1 expression led to enhanced acinar colony formation, shLRP6 decreased both types of colonies. Estrogen stimulated the formation of acinar colonies in control MEC, but not shLRP6 MEC. Formation of ductal colonies was enhanced in response to progesterone. However, while shLRP6 decreased MEC responsiveness to progesterone, shTBX3 expression did not alter this response. Conclusions: We identified two phenotypically distinguishable lineage-committed progenitor cells that contribute to different structural elements and are regulated via hormonal and non-hormonal mechanisms. WNT signaling regulates both types of progenitor activity. Progesterone favors the expansion of ductal progenitor cells, while estrogen stimulates the expansion of acinar progenitor cells. Paracrine WNT signaling is stimulated by estrogen and progesterone, while autocrine WNT signaling is induced by the embryonic T-box transcription factor TBX3.	[Arendt, Lisa M.; Laurent, Jessica St.; Wronski, Ania; Caballero, Silvia; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dev Mol & Chem Biol Dept, Boston, MA 02111 USA; [Arendt, Lisa M.; Laurent, Jessica St.; Wronski, Ania; Caballero, Silvia; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Lyle, Stephen R.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Naber, Stephen P.] Tufts Med Ctr, Dept Pathol, Boston, MA USA	Tufts University; Tufts Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Tufts Medical Center	Kuperwasser, C (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dev Mol & Chem Biol Dept, Boston, MA 02111 USA.	Charlotte.Kuperwasser@tufts.edu		Arendt, Lisa/0000-0002-7954-3635	Breast Cancer Research Foundation; NIH/NICHD [HD073035]; NIH/NCI [CA125554, CA170851]; NCRR [K01-RR021858]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA125554, R01CA170851] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR021858] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the Breast Cancer Research Foundation (C. K.), the NIH/NICHD HD073035 (C. K.), the NIH/NCI CA125554 and CA170851 (C. K.), and the NCRR K01-RR021858 (L. M. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Clarke RB, 1997, CANCER RES, V57, P4987; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Diaz J, 2012, J ENDOCRINOL, V214, P165, DOI 10.1530/JOE-11-0310; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Eblaghie MC, 2004, J ANAT, V205, P1, DOI 10.1111/j.0021-8782.2004.00309.x; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Hilton HN, 2012, MOL CELL ENDOCRINOL, V361, P191, DOI 10.1016/j.mce.2012.04.010; Hilton HN, 2014, BREAST CANCER RES TR, V143, P423, DOI 10.1007/s10549-013-2817-2; Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258; HUSEBY RA, 1984, CANCER RES, V44, P2654; Iyer V, 2012, CANCER RES, V72, P2705, DOI 10.1158/0008-5472.CAN-11-3287; Jarde T, 2011, ACTA PHYSL OXF, V204, P118; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kenney NJ, 2003, BREAST CANCER RES TR, V79, P161, DOI 10.1023/A:1023938510508; King M, 2006, AM J MED GENET A, V140A, P1407, DOI 10.1002/ajmg.a.31250; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu J, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-65; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; MISHELL DR, 1971, AM J OBSTET GYNECOL, V111, P60, DOI 10.1016/0002-9378(71)90927-6; NARDULLI AM, 1988, ENDOCRINOLOGY, V122, P1532, DOI 10.1210/endo-122-4-1532; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Raafat AM, 2001, J CELL PHYSIOL, V187, P81, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1056>3.0.CO;2-0; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; SCHATZ RW, 1985, J CELL PHYSIOL, V124, P386, DOI 10.1002/jcp.1041240305; SOULE HD, 1990, CANCER RES, V50, P6075; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Tanos T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005654; Uehara J, 1998, INT J GYNECOL OBSTET, V62, P77, DOI 10.1016/S0020-7292(98)00050-2; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	61	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111442	10.1371/journal.pone.0111442	http://dx.doi.org/10.1371/journal.pone.0111442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350852	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100074
J	Bernardo, SM; Allen, CP; Waller, A; Young, SM; Oprea, T; Sklar, LA; Lee, SA				Bernardo, Stella M.; Allen, Christopher P.; Waller, Anna; Young, Susan M.; Oprea, Tudor; Sklar, Larry A.; Lee, Samuel A.			An Automated High-Throughput Cell-Based Multiplexed Flow Cytometry Assay to Identify Novel Compounds to Target Candida albicans Virulence-Related Proteins	PLOS ONE			English	Article							REDUCED SUSCEPTIBILITY; OPPORTUNISTIC YEAST; ANTIFUNGAL AGENTS; ABC TRANSPORTER; RESISTANCE; ECHINOCANDIN; MECHANISMS; INFECTIONS; TRENDS; CONTRIBUTES	Although three major classes of systemic antifungal agents are clinically available, each is characterized by important limitations. Thus, there has been considerable ongoing effort to develop novel and repurposed agents for the therapy of invasive fungal infections. In an effort to address these needs, we developed a novel high-throughput, multiplexed screening method that utilizes small molecules to probe candidate drug targets in the opportunistic fungal pathogen Candida albicans. This method is amenable to high-throughput automated screening and is based upon detection of changes in GFP levels of individually tagged target proteins. We first selected four GFP-tagged membrane-bound proteins associated with virulence or antifungal drug resistance in C. albicans. We demonstrated proof-of-principle that modulation of fluorescence intensity can be used to assay the expression of specific GFP-tagged target proteins to inhibitors (and inducers), and this change is measurable within the HyperCyt automated flow cytometry sampling system. Next, we generated a multiplex of differentially color-coded C. albicans strains bearing C-terminal GFP-tags of each gene encoding candidate drug targets incubated in the presence of small molecules from the Prestwick Chemical Library in 384-well microtiter plate format. Following incubation, cells were sampled through the HyperCyt system and modulation of protein levels, as indicated by changes in GFP-levels of each strain, was used to identify compounds of interest. The hit rate for both inducers and inhibitors identified in the primary screen did not exceed 1% of the total number of compounds in the small-molecule library that was probed, as would be expected from a robust target-specific, high-throughput screening campaign. Secondary assays for virulence characteristics based on null mutant strains were then used to further validate specificity. In all, this study presents a method for the identification and verification of new antifungal drugs targeted to fungal virulence proteins using C. albicans as a model fungal pathogen.	[Bernardo, Stella M.; Lee, Samuel A.] New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA; [Bernardo, Stella M.; Lee, Samuel A.] Univ New Mexico Hlth Sci Ctr, Div Infect Dis, Albuquerque, NM USA; [Allen, Christopher P.; Waller, Anna; Young, Susan M.; Oprea, Tudor; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico	Lee, SA (corresponding author), New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA.	SamALee@salud.unm.edu	cao, miao/ABT-0929-2022; Oprea, Tudor/A-5746-2011	Allen, Christopher/0000-0003-3808-5209; Waller, Anna/0000-0003-3676-2501; Oprea, Tudor/0000-0002-6195-6976	Department of Veterans' Affairs [5I01BX001130]; Biomedical Research Institute of New Mexico; National Institutes of Health [1U54MH084690-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	Department of Veterans' Affairs(US Department of Veterans Affairs); Biomedical Research Institute of New Mexico; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by funding from the Department of Veterans' Affairs (Merit Award 5I01BX001130), Biomedical Research Institute of New Mexico (SAL), and the National Institutes of Health (1U54MH084690-01) (LAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Alvarez FJ, 2008, MOL BIOL CELL, V19, P5214, DOI 10.1091/mbc.E08-05-0479; BANERJEE SN, 1991, AM J MED, V91, pS86, DOI 10.1016/0002-9343(91)90349-3; Bernardo SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-133; Beyda ND, 2012, ANN PHARMACOTHER, V46, P1086, DOI 10.1345/aph.1R020; Black CB, 2011, ASSAY DRUG DEV TECHN, V9, P13, DOI 10.1089/adt.2010.0308; Chavez-Dozal AA, 2014, INT J ANTIMICROB AG, V43, P86, DOI 10.1016/j.ijantimicag.2013.08.018; Chen J, 2012, ACS CHEM BIOL, V7, P715, DOI 10.1021/cb200452r; Cheng G, 2006, EUKARYOT CELL, V5, P180, DOI 10.1128/EC.5.1.180-191.2006; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Douglas LM, 2012, MBIO, V3, DOI 10.1128/mBio.00254-11; Eder J, 2007, CURR PHARM DESIGN, V13, P271, DOI 10.2174/138161207779313560; Edwards BS, 2007, EXPERT OPIN DRUG DIS, V2, P685, DOI 10.1517/17460441.2.5.685; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993; Fanos V, 2000, J CHEMOTHERAPY, V12, P463, DOI 10.1179/joc.2000.12.6.463; Fothergill AW, 2014, J CLIN MICROBIOL, V52, P994, DOI 10.1128/JCM.03044-13; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Holmes AR, 2008, ANTIMICROB AGENTS CH, V52, P3851, DOI 10.1128/AAC.00463-08; JARVIS WR, 1995, CLIN INFECT DIS, V20, P1526, DOI 10.1093/clinids/20.6.1526; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Karnani N, 2004, YEAST, V21, P219, DOI 10.1002/yea.1067; Knight SAB, 2005, INFECT IMMUN, V73, P5482, DOI 10.1128/IAI.73.9.5482-5492.2005; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Kuckuck FW, 2001, CYTOMETRY, V44, P83, DOI 10.1002/1097-0320(20010501)44:1<83::AID-CYTO1085>3.3.CO;2-F; Lee SA, 2005, MED MYCOL, V43, P423, DOI 10.1080/13693780400013340; Liang Y, 2009, FEMS YEAST RES, V9, P270, DOI 10.1111/j.1567-1364.2008.00468.x; Mateus C, 2004, ANTIMICROB AGENTS CH, V48, P3358, DOI 10.1128/AAC.48.9.3358-3366.2004; Miceli MH, 2011, MYCOSES, V54, pE666, DOI 10.1111/j.1439-0507.2011.02032.x; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Orasch C, 2013, CLIN MICROBIOL INFEC; Park S, 2005, ANTIMICROB AGENTS CH, V49, P3264, DOI 10.1128/AAC.49.8.3264-3273.2005; Pfaller MA, 2013, J CLIN MICROBIOL, V51, P2571, DOI 10.1128/JCM.00308-13; Pierce CG, 2013, EXPERT OPIN DRUG DIS, V8, P1117, DOI 10.1517/17460441.2013.807245; Ramage G, 2005, METH MOLEC MED, V118, P71; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Robinson JP, 2012, EXPERT OPIN DRUG DIS, V7, P679, DOI 10.1517/17460441.2012.693475; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Srinivasan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019036; Theiss S, 2002, MOL MICROBIOL, V43, P571, DOI 10.1046/j.1365-2958.2002.02769.x; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	49	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110354	10.1371/journal.pone.0110354	http://dx.doi.org/10.1371/journal.pone.0110354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350399	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100025
J	Domingues, MR; Matijasevich, A; Barros, AJD; Santos, IS; Horta, BL; Hallal, PC				Domingues, Marlos R.; Matijasevich, Alicia; Barros, Aluisio J. D.; Santos, Ina S.; Horta, Bernardo L.; Hallal, Pedro C.			Physical Activity during Pregnancy and Offspring Neurodevelopment and IQ in the First 4 Years of Life	PLOS ONE			English	Article							PRETERM BIRTH; EXERCISE; WOMEN; COHORT; CHILDREN; OBESITY; IMPACT	Background: Maternal physical activity during pregnancy could alter offspring's IQ and neurodevelopment in childhood. Methods: Children belonging to a birth cohort were followed at 3, 12, 24 and 48 months of age. Physical activity during pregnancy was assessed retrospectively at birth. Neurodevelopment was evaluated by Battelle's Development Inventory (12, 24 and 48 months) and IQ by the Weschler's Intelligence Scale (48 months). Neurodevelopment was based on Battelles' (90th percentile) and also analyzed as a continuous outcome. IQ was analyzed as a continuous outcome. Potential confounders were: family income, mother's age, schooling, skin color, number of previous births and smoking; and newborns': preterm birth, sex and low birth weight. Results: was slightly higher (5 points) among children from active women. The Battelle's score at 12 and 24 months was higher among offspring from active mothers. After controlling for confounders, physical activity during pregnancy was positively associated to the Battelle's Inventory at 12 months IQ, however, at 48 months no association was observed. Conclusion: Physical activity during pregnancy does not seem to impair children's neurodevelopment and children from active mothers presented better performance at 12 months.	[Domingues, Marlos R.; Hallal, Pedro C.] Univ Fed Pelotas, Sports Dept, Pelotas, RS, Brazil; [Matijasevich, Alicia; Barros, Aluisio J. D.; Santos, Ina S.; Horta, Bernardo L.; Hallal, Pedro C.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, RS, Brazil; [Matijasevich, Alicia] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade de Sao Paulo	Domingues, MR (corresponding author), Univ Fed Pelotas, Sports Dept, Pelotas, RS, Brazil.	marlosufpel@gmail.com	Domingues, Marlos R/A-4758-2009; Matijasevich, Alicia/C-5576-2009; Barros, Aluisio JD/A-7417-2008; Horta, Bernardo/A-7604-2008; Hallal, Pedro C/A-3249-2011; Santos, Ina S/C-2001-2009	Domingues, Marlos R/0000-0002-2503-2944; Matijasevich, Alicia/0000-0003-0060-1589; Barros, Aluisio JD/0000-0002-2022-8729; Horta, Bernardo/0000-0001-9843-412X; Hallal, Pedro C/0000-0003-1470-6461; 	Wellcome Trust Initiative [086974/Z/08/Z]; World Health Organization; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Ministry of Health; Children's Mission	Wellcome Trust Initiative(Wellcome Trust); World Health Organization(World Health Organization); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health; Children's Mission	The 2004 birth cohort study is currently supported by the Wellcome Trust Initiative entitled Major Awards for Latin America on Health Consequences of Population Change, grant entitled: "Implications of early life and contemporary exposures on body composition, human capital, mental health and precursors of complex chronic diseases in three Brazilian cohorts (1982, 1993 and 2004)", grant No 086974/Z/08/Z. Previous phases of the study were supported by the World Health Organization, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq), the Brazilian Ministry of Health, and the Children's Mission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Barros AJD, 2006, REV SAUDE PUBL, V40, P402, DOI 10.1590/S0034-89102006000300007; Barros AJD, 2010, INT J EPIDEMIOL, V39, P285, DOI 10.1093/ije/dyp272; Clapp JF, 2006, PLACENTA, V27, P527, DOI 10.1016/j.placenta.2005.07.010; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Clapp JF, 1999, AM J OBSTET GYNECOL, V180, P91, DOI 10.1016/S0002-9378(99)70155-9; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; Clapp JF, 1998, AM J OBSTET GYNECOL, V178, P594, DOI 10.1016/S0002-9378(98)70444-2; Comm Obstetric Practice, 2002, INT J GYNECOL OBSTET, V77, P79; Devlieger R, 2008, OBES REV, V9, P181, DOI 10.1111/j.1467-789X.2007.00460.x; Domingues MR, 2008, INT J GYNECOL OBSTET, V103, P9, DOI 10.1016/j.ijgo.2008.05.029; Domingues MR, 2007, REV SAUDE PUBL, V41, P173, DOI 10.1590/s0034-89102007000200002; Domingues MR, 2009, SPORTS MED, V39, P961, DOI 10.2165/11317900-000000000-00000; Duncombe D, 2009, MIDWIFERY, V25, P430, DOI 10.1016/j.midw.2007.03.002; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Gerardin P, 2011, J CLIN PSYCHIAT, V72, P378, DOI 10.4088/JCP.09m05724blu; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Haakstad LAH, 2009, ACTA OBSTET GYN SCAN, V88, P1267, DOI 10.3109/00016340903284901; Hernandez-Martinez C, 2008, EARLY HUM DEV, V84, P745, DOI 10.1016/j.earlhumdev.2008.05.002; Huisman M, 2010, EUR J EPIDEMIOL, V25, P569, DOI 10.1007/s10654-010-9473-1; Newborg J., 1988, BATTELLE DEV INVENTO; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; Pivarnik JM, 2006, MED SCI SPORT EXER, V38, P989, DOI 10.1249/01.mss.0000218147.51025.8a; Poudevigne MS, 2006, SPORTS MED, V36, P19, DOI 10.2165/00007256-200636010-00003; Santos DN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-202; Santos IS, 2010, INT J EPIDEMIOL; Silverman BL, 1998, DIABETES CARE, V21, pB142; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; To T, 2004, ARCH PEDIAT ADOL MED, V158, P643, DOI 10.1001/archpedi.158.7.643; Wechsler, 2012, WPPSI 4 WECHSLER PRE	30	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110050	10.1371/journal.pone.0110050	http://dx.doi.org/10.1371/journal.pone.0110050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350666	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943100018
J	Ji, RJ; Liu, YH; Diao, RQ; Xu, CC; Li, XP; Cai, BP; Zhang, YZ				Ji, Renjie; Liu, Yonghong; Diao, Ruiqiang; Xu, Chenchen; Li, Xiaopeng; Cai, Baoping; Zhang, Yanzhen			Influence of Electrical Resistivity and Machining Parameters on Electrical Discharge Machining Performance of Engineering Ceramics	PLOS ONE			English	Article								Engineering ceramics have been widely used in modern industry for their excellent physical and mechanical properties, and they are difficult to machine owing to their high hardness and brittleness. Electrical discharge machining (EDM) is the appropriate process for machining engineering ceramics provided they are electrically conducting. However, the electrical resistivity of the popular engineering ceramics is higher, and there has been no research on the relationship between the EDM parameters and the electrical resistivity of the engineering ceramics. This paper investigates the effects of the electrical resistivity and EDM parameters such as tool polarity, pulse interval, and electrode material, on the ZnO/Al2O3 ceramic's EDM performance, in terms of the material removal rate (MRR), electrode wear ratio (EWR), and surface roughness (SR). The results show that the electrical resistivity and the EDM parameters have the great influence on the EDM performance. The ZnO/Al2O3 ceramic with the electrical resistivity up to 3410 Omega.cm can be effectively machined by EDM with the copper electrode, the negative tool polarity, and the shorter pulse interval. Under most machining conditions, the MRR increases, and the SR decreases with the decrease of electrical resistivity. Moreover, the tool polarity, and pulse interval affect the EWR, respectively, and the electrical resistivity and electrode material have a combined effect on the EWR. Furthermore, the EDM performance of ZnO/Al2O3 ceramic with the electrical resistivity higher than 687 Omega.cm is obviously different from that with the electrical resistivity lower than 687 Omega.cm, when the electrode material changes. The microstructure character analysis of the machined ZnO/Al2O3 ceramic surface shows that the ZnO/Al2O3 ceramic is removed by melting, evaporation and thermal spalling, and the material from the working fluid and the graphite electrode can transfer to the workpiece surface during electrical discharge machining ZnO/Al2O3 ceramic.	[Ji, Renjie; Liu, Yonghong; Diao, Ruiqiang; Xu, Chenchen; Li, Xiaopeng; Cai, Baoping; Zhang, Yanzhen] China Univ Petr, Coll Electromech Engn, Qingdao, Shandong, Peoples R China	China University of Petroleum	Ji, RJ (corresponding author), China Univ Petr, Coll Electromech Engn, Qingdao, Shandong, Peoples R China.	jirenjie@upc.edu.cn	Zhang, Yanzhen/L-6446-2018	Zhang, Yanzhen/0000-0002-9802-2843; Liu, Yonghong/0000-0002-4339-6389	National Natural Science Foundation of China [51205411]; Shandong Provincial Natural Science Foundation of China [ZR2012EEL15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	The study was financially supported by the National Natural Science Foundation of China under grant number 51205411, and Shandong Provincial Natural Science Foundation of China under grant number ZR2012EEL15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SG, 2013, INT J ADV MANUF TECH, V66, P431, DOI 10.1007/s00170-012-4338-2; Feng J, 2013, INT J ADV MANUF TECH, V68, P1039, DOI 10.1007/s00170-013-4895-z; Hanaoka D, 2013, PROC CIRP, V6, P95, DOI 10.1016/j.procir.2013.03.033; Ji RJ, 2011, MATER MANUF PROCESS, V26, P1050, DOI 10.1080/10426914.2010.529590; Ku┬nig W., 1988, ANN CIRP, V37, P623, DOI [DOI 10.1016/S0007-8506(07)60759-8, 10.1016/S0007-8506(07)60759-8]; Lalchhuanvela H, 2013, INT J ADV MANUF TECH, V67, P1683, DOI 10.1007/s00170-012-4601-6; Liang XH, 2012, APPL SURF SCI, V258, P6406, DOI 10.1016/j.apsusc.2012.03.050; Liu CC, 2003, MAT SCI ENG A-STRUCT, V363, P221, DOI 10.1016/S0921-5093(03)00630-0; Liu YH, 2008, INT J MACH TOOL MANU, V48, P1504, DOI 10.1016/j.ijmachtools.2008.03.012; Liu YHH, 2009, J ALLOY COMPD, V472, P406, DOI 10.1016/j.jallcom.2008.04.072; Okada A, 2008, J EUR CERAM SOC, V28, P1097, DOI 10.1016/j.jeurceramsoc.2007.09.016; Patel KM, 2010, INT J ADV MANUF TECH, V47, P1137, DOI 10.1007/s00170-009-2249-7; Puertas I, 2012, INT J ADV MANUF TECH, V59, P575, DOI 10.1007/s00170-011-3509-x; Qiu MB, 2013, PRECIS ENG, V37, P902, DOI 10.1016/j.precisioneng.2013.05.009; Tak HS, 2011, T NONFERR METAL SOC, V21, pS28, DOI 10.1016/S1003-6326(11)61055-8; Wei C, 2013, INT J ADV MANUF TECH, V64, P187, DOI 10.1007/s00170-012-3995-5	16	19	19	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110775	10.1371/journal.pone.0110775	http://dx.doi.org/10.1371/journal.pone.0110775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364912	gold, Green Published, Green Submitted			2022-12-27	WOS:000345558100027
J	Faisy, C; Grassin-Delyle, S; Blouquit-Laye, S; Brollo, M; Naline, E; Chapelier, A; Devillier, P				Faisy, Christophe; Grassin-Delyle, Stanislas; Blouquit-Laye, Sabine; Brollo, Marion; Naline, Emmanuel; Chapelier, Alain; Devillier, Philippe			Wnt/beta-Catenin Signaling Modulates Human Airway Sensitization Induced by beta(2)-Adrenoceptor Stimulation	PLOS ONE			English	Article							BETA-CATENIN; WNT; PATHWAY; EXPRESSION; RECEPTORS; CELLS; INHIBITION; MECHANISMS; EPITHELIUM; AGONIST	Background: Regular use of beta(2)-agonists may enhance non-specific airway responsiveness. The wingless/integrated (Wnt) signaling pathways are responsible for several cellular processes, including airway inflammation and remodeling while cAMP-PKA cascade can activate the Wnt signaling. We aimed to investigate whether the Wnt signaling pathways are involved in the bronchial hyperresponsiveness induced by prolonged exposure to beta(2)-adrenoceptor agonists in human isolated airways. Methods: Bronchi were surgically removed from 44 thoracic surgery patients. After preparation, bronchial rings and primary cultures of bronchial epithelial cells were incubated with fenoterol (0.1 mu M, 15 hours, 37 degrees C), a beta(2)-agonist with high intrinsic efficacy. The effects of inhibitors/blockers of Wnt signaling on the fenoterol-induced airway sensitization were examined and the impact of fenoterol exposure on the mRNA expression of genes interacting with Wnt signaling or cAMP-PKA cascade was assessed in complete bronchi and in cultured epithelial cells. Results: Compared to paired controls, fenoterol-sensitization was abolished by inhibition/blockage of the Wnt/beta-catenin signaling, especially the cell-surface LRP5/6 co-receptors or Fzd receptors (1 mu M SFRP1 or 1 mu M DKK1) and the nuclear recruitment of TCF/LEF transcriptions factors (0.3 mu M FH535). Wnt proteins secretion did not seem to be involved in the fenoterol-induced sensitization since the mRNA expression of Wnt remained low after fenoterol exposure and the inactivator of Wnt secretion (1 mu M IWP2) had no effect on the fenoterol-sensitization. Fenoterol exposure did not change the mRNA expression of genes regulating Wnt signaling or cAMP-PKA cascade. Conclusions: Collectively, our pharmacological investigations indicate that fenoterol-sensitization is modulated by the inhibition/blockage of canonical Wnt/beta-catenin pathway, suggesting a phenomenon of biased agonism in connection with the beta(2)-adrenoceptor stimulation. Future experiments based on the results of the present study will be needed to determine the impact of prolonged fenoterol exposure on the extra-and intracellular Wnt signaling pathways at the protein expression level.	[Faisy, Christophe; Grassin-Delyle, Stanislas; Blouquit-Laye, Sabine; Brollo, Marion; Naline, Emmanuel; Devillier, Philippe] Univ Versailles St Quentin, Unite Propre Rech Enseignement Super, Equipe Accueil 220, Hop Foch, Suresnes, France; [Faisy, Christophe] Hop Europeen Georges Pompidou, AP HP, Med Intens Care Unit, Paris, France; [Chapelier, Alain] Hop Foch, Dept Thorac Surg, Suresnes, France	Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch	Faisy, C (corresponding author), Univ Versailles St Quentin, Unite Propre Rech Enseignement Super, Equipe Accueil 220, Hop Foch, Suresnes, France.	christophe.faisy@egp.aphp.fr	Grassin-Delyle, Stanislas/AAC-5921-2021	Grassin-Delyle, Stanislas/0000-0001-5747-4432	French Ministry of Higher Education (Chancellerie des Universites de Paris, Legs Gaston Poix)	French Ministry of Higher Education (Chancellerie des Universites de Paris, Legs Gaston Poix)	This research was funded by the French Ministry of Higher Education (Chancellerie des Universites de Paris, Legs Gaston Poix). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2004, J ALLERGY CLIN IMMUN, V113, P503, DOI 10.1016/j.jaci.2003.12.039; Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Blouquit S, 2002, AM J RESP CELL MOL, V27, P503, DOI 10.1165/rcmb.4869; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dun YY, 2013, NEUROPHARMACOLOGY, V67, P168, DOI 10.1016/j.neuropharm.2012.10.031; Faisy C, 2006, AM J RESP CELL MOL, V34, P410, DOI 10.1165/rcmb.2005-0091OC; Faisy C, 2004, N-S ARCH PHARMACOL, V370, P167, DOI 10.1007/s00210-004-0974-x; Faisy C, 2002, AM J PHYSIOL-LUNG C, V283, pL1033, DOI 10.1152/ajplung.00063.2002; Faisy C, 2011, CRIT CARE, V15, DOI 10.1186/cc10443; Faisy C, 2010, PHARMACOL RES, V61, P121, DOI 10.1016/j.phrs.2009.08.003; Gallegos TF, 2012, DEV BIOL, V364, P11, DOI 10.1016/j.ydbio.2012.01.014; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; Hahne G, 2013, BIOORGAN MED CHEM, V21, P4020, DOI 10.1016/j.bmc.2013.02.050; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Holden NS, 2010, BRIT J PHARMACOL, V160, P410, DOI 10.1111/j.1476-5381.2010.00708.x; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kim GH, 2013, BIOCHEM BIOPH RES CO, V435, P182, DOI 10.1016/j.bbrc.2013.04.088; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Levanen B, 2011, RESP MED, V105, P282, DOI 10.1016/j.rmed.2010.11.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Niwa H, 2011, NAT CELL BIOL, V13, P1024, DOI 10.1038/ncb2333; Panza A, 2013, BBA-MOL CELL RES, V1833, P1853, DOI 10.1016/j.bbamcr.2013.04.004; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reis M, 2013, EXP CELL RES, V319, P1317, DOI 10.1016/j.yexcr.2012.12.023; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roth HM, 2012, PULM PHARMACOL THER, V25, P420, DOI 10.1016/j.pupt.2012.09.004; Saini S, 2011, NAT REV UROL, V8, P690, DOI 10.1038/nrurol.2011.146; Sears MR, 2002, J ALLERGY CLIN IMMUN, V110, P322; Shi QP, 2013, BIOMED PHARMACOTHER, V67, P745, DOI 10.1016/j.biopha.2013.04.002; Spina D, 1998, AM J RESP CRIT CARE, V158, pS141, DOI 10.1164/ajrccm.158.supplement_2.13tac100a; Takahashi-Yanaga F, 2013, BIOCHEM PHARMACOL, V86, P191, DOI 10.1016/j.bcp.2013.04.022; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Verkaar F, 2009, CELL SIGNAL, V21, P22, DOI 10.1016/j.cellsig.2008.09.008; Villar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023914; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111350	10.1371/journal.pone.0111350	http://dx.doi.org/10.1371/journal.pone.0111350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360795	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700088
J	Iturrieta-Gonzalez, IA; Padovan, ACB; Bizerra, FC; Hahn, RC; Colombo, AL				Iturrieta-Gonzalez, Isabel Antonieta; Barbosa Padovan, Ana Carolina; Bizerra, Fernando Cesar; Hahn, Rosane Christine; Colombo, Arnaldo Lopes			Multiple Species of Trichosporon Produce Biofilms Highly Resistant to Triazoles and Amphotericin B	PLOS ONE			English	Article							GLOBAL ANTIFUNGAL SURVEILLANCE; MOLECULAR-IDENTIFICATION; CANDIDA-PARAPSILOSIS; VIRULENCE FACTORS; WHITE PIEDRA; ASAHII; SUSCEPTIBILITY; VORICONAZOLE; FLUCONAZOLE; INFECTIONS	Invasive infections caused by Trichosporon spp. have increased considerably in recent years, especially in neutropenic and critically ill patients using catheters and antibiotics. The genus presents limited sensitivity to different antifungal agents, but triazoles are the first choice for treatment. Here, we investigated the biofilm production and antifungal susceptibility to triazoles and amphotericin B of 54 Trichosporon spp. isolates obtained from blood samples (19), urine (20) and superficial mycosis (15). All isolates and 7 reference strains were identified by sequence analysis and phylogenetic inferences of the IGS1 region of the rDNA. Biofilms were grown on 96-well plates and quantitation was performed using crystal violet staining, complemented with Scanning Electron Microscopy (SEM). Susceptibility tests for fluconazole, itraconazole, voriconazole and amphotericin B were processed using the microdilution broth method (CLSI) for planktonic cells and XTT reduction assay for biofilm-forming cells. Our results showed that T. asahii was the most frequent species identified (66.7%), followed by T. faecale (11.1%), T. asteroides (9.3%), T. inkin (7.4%), T. dermatis (3.7%) and one T. coremiiforme (1.8%). We identified 4 genotypes within T. asahii isolates (G1, G3, G4 and G5) and 2 genotypes within T. faecale (G1 and G3). All species exhibited high adhesion and biofilm formation capabilities, mainly T. inkin, T. asteroides and T. faecale. Microscopy images of high biofilm-producing isolates showed that T. asahii presented mainly hyphae and arthroconidia, whereas T. asteroides exhibited mainly short arthroconidia and few filaments. Voriconazole exhibited the best in vitro activity against all species tested. Biofilm-forming cells of isolates and reference strains were highly resistant to all antifungals tested. We concluded that levels of biofilm formation by Trichosporon spp. were similar or even greater than those described for the Candida genus. Biofilm-forming cells were at least 1,000 times more resistant to antifungals than planktonic cells, especially to voriconazole.	[Iturrieta-Gonzalez, Isabel Antonieta; Barbosa Padovan, Ana Carolina; Bizerra, Fernando Cesar; Colombo, Arnaldo Lopes] Univ Fed Sao Paulo, Lab Especial Micol, Disciplina Infectol, Sao Paulo, Brazil; [Barbosa Padovan, Ana Carolina] Univ Fed Alfenas, Inst Ciencias Biomed, Dept Microbiol & Immunol, Alfenas, MG, Brazil; [Hahn, Rosane Christine] Univ Fed Mato Grosso, Fac Med, Microbiol Lab, Cuiaba, MT, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alfenas; Universidade Federal de Mato Grosso	Colombo, AL (corresponding author), Univ Fed Sao Paulo, Lab Especial Micol, Disciplina Infectol, Sao Paulo, Brazil.	arnaldolcolombo@gmail.com	Colombo, Arnaldo Lopes/H-4397-2012; Padovan, Ana Carolina B/D-3619-2013; González, Isabel Iturrieta/AAE-9251-2021; Colombo, Arnaldo Lopes/V-4417-2019	González, Isabel Iturrieta/0000-0001-8426-9530; Colombo, Arnaldo Lopes/0000-0003-0793-8491; Bizerra, Fernando Cesar/0000-0002-5070-1089	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2007/08575-1, 2010/17179-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [PNPD 02640-09-0]; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	This study received funds through A.L.C. from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (grant 2007/08575-1) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. I.A.I.G. received a master training fellowship from CNPq; A.C.B.P. received a postdoctoral fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (PNPD 02640-09-0). F.C.B. received a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (2010/17179-5). R.C.H. received funds from the the Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, J MED MICROBIOL, V54, P639, DOI 10.1099/jmm.0.45972-0; ANAISSIE E, 1992, CLIN INFECT DIS, V15, P781, DOI 10.1093/clind/15.5.781; ANDO M, 1995, INTERNAL MED, V34, P707, DOI 10.2169/internalmedicine.34.707; Arikan S, 2002, DIAGN MICR INFEC DIS, V43, P107, DOI 10.1016/S0732-8893(02)00376-0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; da Silva Rodrigues Gustavo, 2006, Revista Iberoamericana de Micologia, V23, P85; Dag Aylin, 2006, Mikrobiyoloji Bulteni, V40, P225; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Fonseca FL, 2009, FUNGAL GENET BIOL, V46, P496, DOI 10.1016/j.fgb.2009.03.003; Freydiere AM, 2001, MED MYCOL, V39, P9, DOI 10.1080/714030980; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hazirolan G, 2013, ANTIMICROB AGENTS CH, V57, P4841, DOI 10.1128/AAC.00850-13; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Karashima R, 2002, J MED MICROBIOL, V51, P423, DOI 10.1099/0022-1317-51-5-423; Kiken DA, 2006, J AM ACAD DERMATOL, V55, P956, DOI 10.1016/j.jaad.2005.11.1033; Kontoyiannis DP, 2004, SCAND J INFECT DIS, V36, P564, DOI 10.1080/00365540410017563; Larone DH., 1995, MED IMPORTANT FUNGI; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magalhaes AR, 2008, MEM I OSWALDO CRUZ, V103, P786, DOI 10.1590/S0074-02762008000800008; Martinez LR, 2007, APPL ENVIRON MICROB, V73, P4592, DOI 10.1128/AEM.02506-06; Mekha N, 2010, MYCOPATHOLOGIA, V169, P67, DOI 10.1007/s11046-009-9225-5; Melo ASA, 2006, GENET MOL RES, V5, P664; Melo AS, 2011, MED MYCOL, V49, P253, DOI 10.3109/13693786.2010.530032; Nunes JM, 2013, ANTIMICROB AGENTS CH, V57, P382, DOI 10.1128/AAC.01647-12; Paphitou NI, 2002, ANTIMICROB AGENTS CH, V46, P1144, DOI 10.1128/AAC.46.4.1144-1146.2002; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pfaller MA, 2005, J CLIN MICROBIOL, V43, P5848, DOI 10.1128/JCM.43.12.5848-5859.2005; Ribeiro MA, 2008, REV IBEROAM MICOL, V25, P221, DOI 10.1016/S1130-1406(08)70053-6; Rodriguez-Tudela JL, 2005, ANTIMICROB AGENTS CH, V49, P4026, DOI 10.1128/AAC.49.10.4026-4034.2005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruan SY, 2009, CLIN INFECT DIS, V49, pE11, DOI 10.1086/599614; Santos DWCL, 2013, MYCOPATHOLOGIA, V175, P445, DOI 10.1007/s11046-012-9608-x; Silva Victor, 2003, Revista Iberoamericana de Micologia, V20, P21; Sugita T, 2004, J CLIN MICROBIOL, V42, P5467, DOI 10.1128/JCM.42.12.5467-5471.2004; Sugita T, 2002, J CLIN MICROBIOL, V40, P1826, DOI 10.1128/JCM.40.5.1826-1830.2002; Sun W, 2012, J MED MICROBIOL, V61, P1750, DOI 10.1099/jmm.0.049817-0; Suzuki K, 2010, EUR J HAEMATOL, V84, P441, DOI 10.1111/j.1600-0609.2010.01410.x; Taj-Aldeen SJ, 2004, MED MYCOL, V42, P87, DOI 10.1080/1369378032000141453; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Walsh TJ, 2004, CLIN MICROBIOL INFEC, V10, P48, DOI 10.1111/j.1470-9465.2004.00839.x; WATSON KC, 1970, J MED MICROBIOL, V3, P191, DOI 10.1099/00222615-3-1-191; Xia ZK, 2012, MYCOPATHOLOGIA, V173, P127, DOI 10.1007/s11046-011-9478-7	46	61	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109553	10.1371/journal.pone.0109553	http://dx.doi.org/10.1371/journal.pone.0109553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360765	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700013
J	Nieblas, AE; Drushka, K; Reygondeau, G; Rossi, V; Demarcq, H; Dubroca, L; Bonhommeau, S				Nieblas, Anne-Elise; Drushka, Kyla; Reygondeau, Gabriel; Rossi, Vincent; Demarcq, Herve; Dubroca, Laurent; Bonhommeau, Sylvain			Defining Mediterranean and Black Sea Biogeochemical Subprovinces and Synthetic Ocean Indicators Using Mesoscale Oceanographic Features	PLOS ONE			English	Article							SIZE LYAPUNOV EXPONENTS; GENERAL-CIRCULATION; CONSERVATION; VARIABILITY; ECOSYSTEMS; PROVINCES	The Mediterranean and Black Seas are semi-enclosed basins characterized by high environmental variability and growing anthropogenic pressure. This has led to an increasing need for a bioregionalization of the oceanic environment at local and regional scales that can be used for managerial applications as a geographical reference. We aim to identify biogeochemical subprovinces within this domain, and develop synthetic indices of the key oceanographic dynamics of each subprovince to quantify baselines from which to assess variability and change. To do this, we compile a data set of 101 months (2002-2010) of a variety of both "classical'' (i.e., sea surface temperature, surface chlorophyll-a, and bathymetry) and "mesoscale'' (i.e., eddy kinetic energy, finite-size Lyapunov exponents, and surface frontal gradients) ocean features that we use to characterize the surface ocean variability. We employ a k-means clustering algorithm to objectively define biogeochemical subprovinces based on classical features, and, for the first time, on mesoscale features, and on a combination of both classical and mesoscale features. Principal components analysis is then performed on the oceanographic variables to define integrative indices to monitor the environmental changes within each resultant subprovince at monthly resolutions. Using both the classical and mesoscale features, we find five biogeochemical subprovinces for the Mediterranean and Black Seas. Interestingly, the use of mesoscale variables contributes highly in the delineation of the open ocean. The first axis of the principal component analysis is explained primarily by classical ocean features and the second axis is explained by mesoscale features. Biogeochemical subprovinces identified by the present study can be useful within the European management framework as an objective geographical framework of the Mediterranean and Black Seas, and the synthetic ocean indicators developed here can be used to monitor variability and long-term change.	[Nieblas, Anne-Elise; Bonhommeau, Sylvain] IFREMER, Unite Mixte Rech Ecosyst Marins Explo 212, Sete, France; [Drushka, Kyla] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Reygondeau, Gabriel] Tech Univ Denmark DTU Aqua, Ctr Macroecol Evolut & Climate, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Rossi, Vincent] CSIC UIB, Inst Cross Disciplinary Phys & Complex Syst, Inst Fis Interdisciplinary Sistemas Complejos, Palma de Mallorca, Spain; [Demarcq, Herve] IRD, Unite Mixte Rech Ecosyst Marins Explo 212, Sete, France; [Dubroca, Laurent] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy	Ifremer; University of Washington; University of Washington Seattle; Technical University of Denmark; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Institut de Recherche pour le Developpement (IRD); European Commission Joint Research Centre; EC JRC ISPRA Site	Nieblas, AE (corresponding author), IFREMER, Unite Mixte Rech Ecosyst Marins Explo 212, Sete, France.	anne.elise.nieblas@gmail.com	Rossi, Vincent/AAL-9090-2021; Dubroca, Laurent/AAS-5187-2021; Reygondeau, Gabriel/G-1903-2017; Demarcq, Herve/AAU-6514-2020; Rossi, Vincent/A-2897-2015; Bonhommeau, Sylvain/P-8654-2014	Rossi, Vincent/0000-0001-7291-0415; Dubroca, Laurent/0000-0002-1861-0507; Reygondeau, Gabriel/0000-0001-9074-625X; Demarcq, Herve/0000-0003-1995-1183; Rossi, Vincent/0000-0001-7291-0415; Bonhommeau, Sylvain/0000-0002-0882-5918; Drushka, Kyla/0000-0001-6810-6758	France Filiere Peche; Institut Francais de Recherche pour l'Exploitation de la Mer; Ministerio de Ciencia e Innovacion; FEDER through the ESCOLA project [CTM2012-39025-C02-01]; Agence nationale de la recherche SEAS-ERA MERMAID project [ANR-12-SEAS-0003]; French National Research project INSU-MERMEX	France Filiere Peche; Institut Francais de Recherche pour l'Exploitation de la Mer; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER through the ESCOLA project; Agence nationale de la recherche SEAS-ERA MERMAID project(French National Research Agency (ANR)); French National Research project INSU-MERMEX(French National Research Agency (ANR))	A. -E. N. was supported by a joint grant from France Filiere Peche (http://www.francefilierepeche.fr/) and Institut Francais de Recherche pour l'Exploitation de la Mer (http://wwz.ifremer.fr/). V. R. acknowledges support from Ministerio de Ciencia e Innovacion (http://www.idi.mineco.gob.es/portal/site/MICINN/) and FEDER (http://www.europe-en-france.gouv.fr/Configuration-Generale-Pages-secondaires/FEDER) through the ESCOLA project (CTM2012-39025-C02-01). S. B. was supported by the Agence nationale de la recherche SEAS-ERA MERMAID project (ANR-12-SEAS-0003) and the French National Research project INSU-MERMEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Beaugrand G, 2004, MAR ECOL PROG SER, V284, P35, DOI 10.3354/meps284035; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CAYULA JF, 1992, J ATMOS OCEAN TECH, V9, P67, DOI 10.1175/1520-0426(1992)009<0067:EDAFSI>2.0.CO;2; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Coll M, 2013, REV FISH BIOL FISHER, V23, P415, DOI 10.1007/s11160-013-9305-y; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; d'Ovidio F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020328; d'Ovidio F, 2009, DEEP-SEA RES PT I, V56, P15, DOI 10.1016/j.dsr.2008.07.014; de Madron XD, 2011, PROG OCEANOGR, V91, P97, DOI 10.1016/j.pocean.2011.02.003; Edgar GJ, 1997, BIOL CONSERV, V79, P227, DOI 10.1016/S0006-3207(96)00095-X; Fernandez V, 2005, PROG OCEANOGR, V66, P321, DOI 10.1016/j.pocean.2004.07.010; FRASCHETTI S, 2012, BIOL MAR MEDITERR, V19, P79; Gabrie C, 2012, STATUS MARINE PROTEC; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Grant S, 2006, BIOREGIONALISTION SO; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Henson SA, 2008, DEEP-SEA RES PT I, V55, P163, DOI 10.1016/j.dsr.2007.11.005; Hernandez-Carrasco I, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008222; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Josey SA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006685; Kai ET, 2009, P NATL ACAD SCI USA, V106, P8245, DOI 10.1073/pnas.0811034106; Kavanaugh MT, 2014, PROG OCEANOGR, V120, P291, DOI 10.1016/j.pocean.2013.10.013; Larnicol G, 2002, J MARINE SYST, V33, P63, DOI 10.1016/S0924-7963(02)00053-2; Lehahn Y, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003927; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; Malanotte-Rizzoli P, 1997, PROG OCEANOGR, V39, P153, DOI 10.1016/S0079-6611(97)00013-X; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059038; Millot C, 2005, HANDB ENVIRON CHEM, V5, P29, DOI 10.1007/b107143; MILLOT C, 1991, DYNAM ATMOS OCEANS, V15, P179, DOI 10.1016/0377-0265(91)90020-G; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Nieto K, 2012, REMOTE SENS ENVIRON, V123, P339, DOI 10.1016/j.rse.2012.03.028; OKUBO A, 1970, DEEP-SEA RES, V17, P445, DOI 10.1016/0011-7471(70)90059-8; Oliver MJ, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002072; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Papadopoulos VP, 2012, J CLIMATE, V25, P6079, DOI 10.1175/JCLI-D-11-00657.1; Parry ML, 2007, CLIMATE CHANGE 2007; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Portman ME, 2013, MAR POLICY, V42, P270, DOI 10.1016/j.marpol.2013.03.004; Reygondeau G, 2013, EGU GEN ASS C, V15, P10011; Reygondeau G, 2013, GLOBAL BIOGEOCHEM CY, V27, P1046, DOI 10.1002/gbc.20089; Rice J, 2011, OCEAN COAST MANAGE, V54, P110, DOI 10.1016/j.ocecoaman.2010.10.010; ROBINSON AR, 1992, EARTH-SCI REV, V32, P285, DOI 10.1016/0012-8252(92)90002-B; Rossi V, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033610; Rossi V, 2014, GEOPHYS RES LETT, V41, P2883, DOI 10.1002/2014GL059540; Sherman K, 2005, MAR ECOL PROG SER, V300, P275; Sherman K., 1989, BIOMASS YIELDS GEOGR; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sydeman WJ, 2014, PROG OCEANOGR, V120, P352, DOI 10.1016/j.pocean.2013.10.017; Vierros M, 2008, ECOSYSTEM APPROACH TO FISHERIES, P39, DOI 10.1079/9781845934149.0039; WEISS J, 1991, PHYSICA D, V48, P273, DOI 10.1016/0167-2789(91)90088-Q; ZAVATARELLI M, 1995, J PHYS OCEANOGR, V25, P1384, DOI 10.1175/1520-0485(1995)025<1384:ANSOTM>2.0.CO;2	57	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111251	10.1371/journal.pone.0111251	http://dx.doi.org/10.1371/journal.pone.0111251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360783	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700081
J	Patel, M; Palani, S; Chakravarty, A; Yang, J; Shyu, WC; Mettetal, JT				Patel, Mayankbhai; Palani, Santhosh; Chakravarty, Arijit; Yang, Johnny; Shyu, Wen Chyi; Mettetal, Jerome T.			Dose Schedule Optimization and the Pharmacokinetic Driver of Neutropenia	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED MYELOSUPPRESSION; BREAST-CANCER PATIENTS; CELL LUNG-CANCER; HEMATOLOGICAL TOXICITY; 3-WEEKLY DOCETAXEL; PEMETREXED THERAPY; ORAL ETOPOSIDE; OVARIAN-CANCER; SOLID TUMORS; PK/PD MODEL	Toxicity often limits the utility of oncology drugs, and optimization of dose schedule represents one option for mitigation of this toxicity. Here we explore the schedule-dependency of neutropenia, a common dose-limiting toxicity. To this end, we analyze previously published mathematical models of neutropenia to identify a pharmacokinetic (PK) predictor of the neutrophil nadir, and confirm this PK predictor in an in vivo experimental system. Specifically, we find total AUC and C-max are poor predictors of the neutrophil nadir, while a PK measure based on the moving average of the drug concentration correlates highly with neutropenia. Further, we confirm this PK parameter for its ability to predict neutropenia in vivo following treatment with different doses and schedules. This work represents an attempt at mechanistically deriving a fundamental understanding of the underlying pharmacokinetic drivers of neutropenia, and provides insights that can be leveraged in a translational setting during schedule selection.	[Patel, Mayankbhai; Palani, Santhosh; Chakravarty, Arijit; Yang, Johnny; Shyu, Wen Chyi; Mettetal, Jerome T.] Takeda Pharmaceut Int Co, Drug Metab & Pharmacokinet, Cambridge, MA USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Mettetal, JT (corresponding author), Takeda Pharmaceut Int Co, Drug Metab & Pharmacokinet, Cambridge, MA USA.	mettetal@alum.mit.edu						Amadori S, 2012, BRIT J HAEMATOL, V156, P205, DOI 10.1111/j.1365-2141.2011.08940.x; Ando M, 1999, CLIN CANCER RES, V5, P1690; Arakawa Atsushi, 2001, International Journal of Clinical Oncology, V6, P248, DOI 10.1007/PL00012113; Brain EGC, 2008, BRIT J CLIN PHARMACO, V65, P607, DOI 10.1111/j.1365-2125.2007.03095.x; Bria E, 2006, CANCER TREAT REV, V32, P583, DOI 10.1016/j.ctrv.2006.07.003; DuBois SG, 2012, CANCER CHEMOTH PHARM, V69, P1021, DOI 10.1007/s00280-011-1798-2; Duffull SB, 1997, CLIN PHARMACOKINET, V33, P161, DOI 10.2165/00003088-199733030-00002; EGORIN MJ, 1984, CANCER RES, V44, P5432; Fetterly GJ, 2001, BIOPHARM DRUG DISPOS, V22, P251, DOI 10.1002/bdd.283; Friberg LE, 2000, J PHARMACOL EXP THER, V295, P734; Friberg LE, 2010, INVEST NEW DRUG, V28, P744, DOI 10.1007/s10637-009-9308-7; GIANNI L, 1995, J CLIN ONCOL, V13, P180, DOI 10.1200/JCO.1995.13.1.180; HANDE KR, 1993, J CLIN ONCOL, V11, P374, DOI 10.1200/JCO.1993.11.2.374; Hansson EK, 2012, CANCER CHEMOTH PHARM, V69, P881, DOI 10.1007/s00280-011-1769-7; Hansson EK, 2010, CANCER CHEMOTH PHARM, V65, P839, DOI 10.1007/s00280-009-1089-3; Henningsson A, 2003, EUR J CANCER, V39, P1105, DOI 10.1016/S0959-8049(03)00126-6; Hikichi Y, 2012, MOL CANCER THER, V11, P700, DOI 10.1158/1535-7163.MCT-11-0762; Huang TC, 2012, CANCER TREAT REV, V38, P613, DOI 10.1016/j.ctrv.2011.10.008; HUIZING MT, 1993, J CLIN ONCOL, V11, P2127, DOI 10.1200/JCO.1993.11.11.2127; JAKOBSEN P, 1991, CANCER CHEMOTH PHARM, V28, P465, DOI 10.1007/BF00685824; JODRELL DI, 1992, J CLIN ONCOL, V10, P520, DOI 10.1200/JCO.1992.10.4.520; Karlsson MO, 1998, CLIN PHARMACOL THER, V63, P11, DOI 10.1016/S0009-9236(98)90117-5; Kloft C, 2006, CLIN CANCER RES, V12, P5481, DOI 10.1158/1078-0432.CCR-06-0815; Latz J, 2006, CANCER CHEMOTH PHARM, V57, P412, DOI 10.1007/s00280-005-0077-5; Latz JE, 2006, CANCER CHEMOTH PHARM, V57, P427, DOI 10.1007/s00280-005-0035-2; Leger F, 2004, CLIN PHARMACOL THER, V76, P567, DOI 10.1016/j.clpt.2004.08.008; Link BK, 2001, CANCER-AM CANCER SOC, V92, P1354, DOI 10.1002/1097-0142(20010915)92:6<1354::AID-CNCR1458>3.0.CO;2-P; MILLER AA, 1995, J CLIN ONCOL, V13, P1871, DOI 10.1200/JCO.1995.13.8.1871; OOSTERHUIS B, 1984, J PHARMACOL EXP THER, V229, P539; Qi M, 2010, BREAST CANCER RES TR, V123, P197, DOI 10.1007/s10549-010-1000-2; Sandstrom M, 1999, CANCER CHEMOTH PHARM, V44, P469, DOI 10.1007/s002800051120; Sandstrom M, 2005, J CLIN ONCOL, V23, P413, DOI 10.1200/JCO.2005.09.161; Sandstrom M, 2006, CANCER CHEMOTH PHARM, V58, P143, DOI 10.1007/s00280-005-0140-2; Silber JH, 1998, J CLIN ONCOL, V16, P2392, DOI 10.1200/JCO.1998.16.7.2392; Socinski M A, 1999, Oncologist, V4, P408; Tabernero J, 2004, ANN ONCOL, V15, P1358, DOI 10.1093/annonc/mdh349; Testart-Paillet D, 2007, CRIT REV ONCOL HEMAT, V63, P1, DOI 10.1016/j.critrevonc.2007.01.005; Toffoli G, 2004, CLIN PHARMACOKINET, V43, P441, DOI 10.2165/00003088-200443070-00002; Troconiz IF, 2006, CANCER CHEMOTH PHARM, V57, P727, DOI 10.1007/s00280-005-0112-6; van Kesteren C, 2005, INVEST NEW DRUG, V23, P225, DOI 10.1007/s10637-005-6730-3; VANGROENINGEN CJ, 1988, CANCER RES, V48, P6956; Walker LG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-179; Wallin JE, 2010, BASIC CLIN PHARMACOL, V106, P234, DOI 10.1111/j.1742-7843.2009.00520.x; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Zandvliet AS, 2008, CLIN PHARMACOL THER, V83, P829, DOI 10.1038/sj.clpt.6100344	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109892	10.1371/journal.pone.0109892	http://dx.doi.org/10.1371/journal.pone.0109892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360756	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700019
J	Salloum, RH; Yurosko, C; Santiago, L; Sandridge, SA; Kaltenbach, JA				Salloum, Rony H.; Yurosko, Christopher; Santiago, Lia; Sandridge, Sharon A.; Kaltenbach, James A.			Induction of Enhanced Acoustic Startle Response by Noise Exposure: Dependence on Exposure Conditions and Testing Parameters and Possible Relevance to Hyperacusis	PLOS ONE			English	Article							COCHLEAR ROOT NEURONS; INDUCED HEARING-LOSS; INTENSE SOUND EXPOSURE; AUDITORY BRAIN-STEM; GUINEA-PIG; RETICULAR-FORMATION; BACKGROUND-NOISE; GENE-EXPRESSION; GIANT-NEURONS; TINNITUS	There has been a recent surge of interest in the development of animal models of hyperacusis, a condition in which tolerance to sounds of moderate and high intensities is diminished. The reasons for this decreased tolerance are likely multifactorial, but some major factors that contribute to hyperacusis are increased loudness perception and heightened sensitivity and/or responsiveness to sound. Increased sound sensitivity is a symptom that sometimes develops in human subjects after acoustic insult and has recently been demonstrated in animals as evidenced by enhancement of the acoustic startle reflex following acoustic over-exposure. However, different laboratories have obtained conflicting results in this regard, with some studies reporting enhanced startle, others reporting weakened startle, and still others reporting little, if any, change in the amplitude of the acoustic startle reflex following noise exposure. In an effort to gain insight into these discrepancies, we conducted measures of acoustic startle responses (ASR) in animals exposed to different levels of sound, and repeated such measures on consecutive days using a range of different startle stimuli. Since many studies combine measures of acoustic startle with measures of gap detection, we also tested ASR in two different acoustic contexts, one in which the startle amplitudes were tested in isolation, the other in which startle amplitudes were measured in the context of the gap detection test. The results reveal that the emergence of chronic hyperacusis-like enhancements of startle following noise exposure is highly reproducible but is dependent on the post-exposure thresholds, the time when the measures are performed and the context in which the ASR measures are obtained. These findings could explain many of the discrepancies that exist across studies and suggest guidelines for inducing in animals enhancements of the startle reflex that may be related to hyperacusis.	[Salloum, Rony H.; Yurosko, Christopher; Kaltenbach, James A.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Santiago, Lia; Sandridge, Sharon A.; Kaltenbach, James A.] Cleveland Clin, Head & Neck Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kaltenbach, JA (corresponding author), Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA.	kaltenj@ccf.org			National Institutes of Health [DC R01-009097]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health Grant # DC R01-009097 to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2002, INT J AUDIOL, V41, P545, DOI 10.3109/14992020209056075; Asako M, 2005, J NEUROSCI RES, V81, P102, DOI 10.1002/jnr.20542; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Baguley DM, 2014, SEM HEARING, V35, P4; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Carlson S, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P83; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; DAVIS M, 1982, J NEUROSCI, V2, P791; Davis M., 1984, P287; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Emmerich E, 2005, HEARING RES, V201, P90, DOI 10.1016/j.heares.2004.09.009; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; FREDELIUS L, 1987, HEARING RES, V30, P157, DOI 10.1016/0378-5955(87)90133-X; GERRARD RL, 1990, J EXP PSYCHOL-ANIM B, V16, P106, DOI 10.1037/0097-7403.16.1.106; Gomez-Nieto R, 2008, J COMP NEUROL, V506, P452, DOI 10.1002/cne.21554; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; HARRISON JM, 1962, SCIENCE, V138, P893, DOI 10.1126/science.138.3543.893; Hebert S, 2013, J NEUROSCI, V33, P2356, DOI 10.1523/JNEUROSCI.3461-12.2013; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Ison JR, 1997, BEHAV NEUROSCI, V111, P1335, DOI 10.1037/0735-7044.111.6.1335; ISON JR, 1973, J COMP PHYSIOL PSYCH, V83, P324, DOI 10.1037/h0034423; Jastreboff P. J., 2004, TINNITUS RETRAINING, P1; KALTENBACH JA, 1992, HEARING RES, V60, P205, DOI 10.1016/0378-5955(92)90022-F; KANDLER K, 1991, BRAIN RES, V562, P230, DOI 10.1016/0006-8993(91)90626-7; Kim J, 1997, HEAR RES, V103, P169; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lee YL, 1996, J NEUROSCI, V16, P3775; Li S, 2013, P NATL ACAD SCI USA, V110, P9980, DOI 10.1073/pnas.1302770110; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIBERMAN MC, 1984, HEARING RES, V16, P43, DOI 10.1016/0378-5955(84)90024-8; LINGENHOHL K, 1992, J COMP NEUROL, V325, P473, DOI 10.1002/cne.903250403; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2012, BRAIN RES, V1485, P54, DOI 10.1016/j.brainres.2012.02.067; Lopez DE, 1999, J COMP NEUROL, V415, P160; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Meloni EG, 1998, HEARING RES, V119, P69, DOI 10.1016/S0378-5955(98)00040-9; MERCHAN MA, 1988, J NEUROCYTOL, V17, P711, DOI 10.1007/BF01260998; Morest DK, 1997, HEARING RES, V103, P151, DOI 10.1016/S0378-5955(96)00172-4; MOREST DK, 1983, HEARING RES, V9, P145, DOI 10.1016/0378-5955(83)90024-2; Nodal FR, 2003, J COMP NEUROL, V460, P80, DOI 10.1002/cne.10656; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; PELLET J, 1990, PHYSIOL BEHAV, V48, P727, DOI 10.1016/0031-9384(90)90218-S; Puel JL, 1998, NEUROREPORT, V9, P2109, DOI 10.1097/00001756-199806220-00037; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rubinstein B, 1993, Swed Dent J Suppl, V95, P1; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; Sinex DG, 2001, HEARING RES, V158, P28, DOI 10.1016/S0378-5955(01)00293-3; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Stebbins W C, 1979, Am J Otolaryngol, V1, P15, DOI 10.1016/S0196-0709(79)80004-6; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Tyler R. S., 2009, HDB CLIN AUDIOLOGY, P726; Tyler RS, 2014, AM J AUDIOL; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Weber H, 2002, MULT SCLER, V8, P505, DOI 10.1191/1352458502ms814oa; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	65	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111747	10.1371/journal.pone.0111747	http://dx.doi.org/10.1371/journal.pone.0111747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360877	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700146
J	Zenk, J; Schulman, R				Zenk, John; Schulman, Rebecca			An Assembly Funnel Makes Biomolecular Complex Assembly Efficient	PLOS ONE			English	Article							MOLECULAR ARCHITECTURE; NANOSCALE SHAPES; DNA; BINDING; DESIGN; PRINCIPLES; JUNCTIONS; KINETICS	Like protein folding and crystallization, the self-assembly of complexes is a fundamental form of biomolecular organization. While the number of methods for creating synthetic complexes is growing rapidly, most require empirical tuning of assembly conditions and/or produce low yields. We use coarse-grained simulations of the assembly kinetics of complexes to identify generic limitations on yields that arise because of the many simultaneous interactions allowed between the components and intermediates of a complex. Efficient assembly occurs when nucleation is fast and growth pathways are few, i.e. when there is an assembly "funnel''. For typical complexes, an assembly funnel occurs in a narrow window of conditions whose location is highly complex specific. However, by redesigning the components this window can be drastically broadened, so that complexes can form quickly across many conditions. The generality of this approach suggests assembly funnel design as a foundational strategy for robust biomolecular complex synthesis.	[Zenk, John; Schulman, Rebecca] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Schulman, R (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	rschulm3@jhu.edu		Zenk, Johannes/0000-0003-3281-6189	National Science Foundation [1161941, 1445749]; Turing Centenary Fellowship	National Science Foundation(National Science Foundation (NSF)); Turing Centenary Fellowship	This study was supported by National Science Foundation award #1161941, National Science Foundation award #1445749, Turing Centenary Fellowship (http://www.mathcomp.leeds.ac.uk/turing2012/give-page.php?704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9; Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deeds EJ, 2012, P NATL ACAD SCI USA, V109, P2348, DOI 10.1073/pnas.1113095109; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; Evans CG, 2012, J AM CHEM SOC, V134, P10485, DOI 10.1021/ja301026z; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grant J, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3662140; Groschel AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1707; Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Hormoz S, 2011, P NATL ACAD SCI USA, V108, P5193, DOI 10.1073/pnas.1014094108; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jankowski E, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3223834; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kim AJ, 2009, NAT MATER, V8, P52, DOI 10.1038/NMAT2338; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Neumann MA, 2008, ANGEW CHEM INT EDIT, V47, P2427, DOI 10.1002/anie.200704247; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Petsko GA, 1999, NATURE, V401, P115, DOI 10.1038/43565; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Recht MI, 2001, J MOL BIOL, V313, P35, DOI 10.1006/jmbi.2001.5018; Reinhardt A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.238103; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Saiz L, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100061; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Sweeney B, 2008, BIOPHYS J, V94, P772, DOI 10.1529/biophysj.107.107284; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Villar G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118106; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; WETMUR JG, 1991, CRIT REV BIOCHEM MOL, V26, P227, DOI 10.3109/10409239109114069; Whitelam S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.265506; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Wilber AW, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2759922; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	51	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111233	10.1371/journal.pone.0111233	http://dx.doi.org/10.1371/journal.pone.0111233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360818	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700076
J	Bhutta, MS; Roy, B; Gould, GW; McInerny, CJ				Bhutta, Musab S.; Roy, Brinta; Gould, Gwyn W.; McInerny, Christopher J.			A Complex Network of Interactions between Mitotic Kinases, Phosphatases and ESCRT Proteins Regulates Septation and Membrane Trafficking in S-pombe	PLOS ONE			English	Article							FISSION YEAST; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; MULTIVESICULAR BODIES; GENE-EXPRESSION; CYTOKINESIS; ABSCISSION; TRANSCRIPTION; MACHINERY; CLP1P	Cytokinesis and cell separation are critical events in the cell cycle. We show that Endosomal Sorting Complex Required for Transport (ESCRT) genes are required for cell separation in Schizosaccharomyces pombe. We identify genetic interactions between ESCRT proteins and polo and aurora kinases and Cdc14 phosphatase that manifest as impaired growth and exacerbated defects in septation, suggesting that the encoded proteins function together to control these processes. Furthermore, we observed defective endosomal sorting in mutants of plo1, ark1 and clp1, as has been reported for ESCRT mutants, consistent with a role for these kinases in the control of ESCRT function in membrane traffic. Multiple observations indicate functional interplay between polo and ESCRT components: firstly, two-hybrid in vivo interactions are reported between Plo1p and Sst4p, Vps28p, Vps25p, Vps20p and Vps32p; secondly, co-immunoprecipitation of human homologues of Vps20p, Vps32p, Vps24p and Vps2p by human Plk1; and thirdly, in vitro phosphorylation of budding yeast Vps32p and Vps20p by polo kinase. Two-hybrid analyses also identified interactions between Ark1p and Vps20p and Vps32p, and Clp1p and Vps28p. These experiments indicate a network of interactions between ESCRT proteins, plo1, ark1 and clp1 that coordinate membrane trafficking and cell separation in fission yeast.	[Bhutta, Musab S.; Roy, Brinta; Gould, Gwyn W.; McInerny, Christopher J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Glasgow, Lanark, Scotland	University of Glasgow	Gould, GW (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Davidson Bldg, Glasgow, Lanark, Scotland.	Gwyn.Gould@Glasgow.ac.uk; Chris.McInerny@Glasgow.ac.uk	Gould, Gwyn/AAF-6721-2019	Gould, Gwyn/0000-0001-6571-2875; /0000-0002-9201-3479	Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Programme in Biochemistry and Molecular Biology at the University of Glasgow [BB/F016735/1]; Cancer Research UK [13082] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Programme in Biochemistry and Molecular Biology at the University of Glasgow; Cancer Research UK(Cancer Research UK)	The work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Programme in Biochemistry and Molecular Biology at the University of Glasgow (BB/F016735/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Clifford DM, 2008, J CELL BIOL, V181, P79, DOI 10.1083/jcb.200709060; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Halova L, 2011, J CELL SCI, V124, P3441, DOI 10.1242/jcs.083683; Hu CK, 2012, MOL BIOL CELL, V23, P2702, DOI 10.1091/mbc.E12-01-0058; Iwaki T, 2007, MICROBIOL-SGM, V153, P2753, DOI 10.1099/mic.0.2007/006072-0; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Leverson JD, 2002, MOL BIOL CELL, V13, P1132, DOI 10.1091/mbc.01-07-0330; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; McMurray MA, 2011, BIOL CHEM, V392, P699, DOI 10.1515/BC.2011.091; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Papadopoulou K, 2008, J CELL SCI, V121, P38, DOI 10.1242/jcs.019489; Papadopoulou K, 2010, J CELL SCI, V123, P4374, DOI 10.1242/jcs.073056; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; Sambrook J., 2001, MOL CLONING LAB MANU; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Wolfe BA, 2006, DEV CELL, V11, P423, DOI 10.1016/j.devcel.2006.07.016; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111789	10.1371/journal.pone.0111789	http://dx.doi.org/10.1371/journal.pone.0111789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356547	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000346765000077
J	Kaiser, JC; Meckbach, R; Jacob, P				Kaiser, Jan Christian; Meckbach, Reinhard; Jacob, Peter			Genomic Instability and Radiation Risk in Molecular Pathways to Colon Cancer	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; HEREDITARY COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CHROMOSOMAL INSTABILITY; IONIZING-RADIATION; MULTISTAGE CARCINOGENESIS; ADENOMATOUS-POLYPOSIS; UNITED-STATES; IN-VIVO; MODEL	Colon cancer is caused by multiple genomic alterations which lead to genomic instability (GI). GI appears in molecular pathways of microsatellite instability (MSI) and chromosomal instability (CIN) with clinically observed case shares of about 15-20% and 80-85%. Radiation enhances the colon cancer risk by inducing GI, but little is known about different outcomes for MSI and CIN. Computer-based modelling can facilitate the understanding of the phenomena named above. Comprehensive biological models, which combine the two main molecular pathways to colon cancer, are fitted to incidence data of Japanese a-bomb survivors. The preferred model is selected according to statistical criteria and biological plausibility. Imprints of cell-based processes in the succession from adenoma to carcinoma are identified by the model from age dependences and secular trends of the incidence data. Model parameters show remarkable compliance with mutation rates and growth rates for adenoma, which has been reported over the last fifteen years. Model results suggest that CIN begins during fission of intestinal crypts. Chromosomal aberrations are generated at a markedly elevated rate which favors the accelerated growth of premalignant adenoma. Possibly driven by a trend of Westernization in the Japanese diet, incidence rates for the CIN pathway increased notably in subsequent birth cohorts, whereas rates pertaining to MSI remained constant. An imbalance between number of CIN and MSI cases began to emerge in the 1980s, whereas in previous decades the number of cases was almost equal. The CIN pathway exhibits a strong radio-sensitivity, probably more intensive in men. Among young birth cohorts of both sexes the excess absolute radiation risk related to CIN is larger by an order of magnitude compared to the MSI-related risk. Observance of pathway-specific risks improves the determination of the probability of causation for radiation-induced colon cancer in individual patients, if their exposure histories are known.	[Kaiser, Jan Christian; Meckbach, Reinhard; Jacob, Peter] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Radiat Protect, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kaiser, JC (corresponding author), Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Radiat Protect, Neuherberg, Germany.	christian.kaiser@helmholtz-muenchen.de		Kaiser, Jan Christian/0000-0003-0359-2251	European Commission [269553, Fission-2010-3.1.1]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under FP7 project EpiRadBio (Fission-2010-3.1.1, project no. 269553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boman BM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00244; Council NR, 2006, HLTH RISKS EXP LOW L, DOI DOI 10.17226/11340; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; de Gonzalez AB, 2011, AM J ROENTGENOL, V196, P816, DOI 10.2214/AJR.10.4907; Diergaarde B, 2003, CANCER EPIDEM BIOMAR, V12, P1130; FELLER W, 1971, INTRO PROBABILITY TH, V1; Foster PA, 2013, INT J COLORECTAL DIS, V28, P737, DOI 10.1007/s00384-012-1628-y; Goel A, 2003, CANCER RES, V63, P1608; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Heidenreich WE, 2008, RADIAT RES, V170, P613, DOI 10.1667/RR0957.1; Heidenreich WF, 2007, RADIAT RES, V168, P750, DOI 10.1667/RR0919.1; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; Herrero-Jimenez P, 2000, MUTAT RES-FUND MOL M, V447, P73, DOI 10.1016/S0027-5107(99)00201-8; Hornsby C, 2008, AM J PATHOL, V172, P1062, DOI 10.2353/ajpath.2008.070724; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Iwama T, 2001, JPN J CLIN ONCOL, V31, P185, DOI 10.1093/jjco/hye042; Jacob P, 2010, MUTAT RES-FUND MOL M, V687, P34, DOI 10.1016/j.mrfmmm.2010.01.005; James F., 1994, MINUIT FUNCTION MINI; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Kaiser JC, 2012, RADIAT ENVIRON BIOPH, V51, P1, DOI 10.1007/s00411-011-0387-4; Kaiser J.C., 2010, MECAN SOFTWARE PACKA; Kaiser JC, 2013, RADIAT ENVIRON BIOPH, V52, P17, DOI 10.1007/s00411-012-0437-6; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kocher DC, 2008, HEALTH PHYS, V95, P119, DOI 10.1097/01.HP.0000291191.49583.f7; Koike M, 1996, J SURG ONCOL, V62, P97, DOI 10.1002/(SICI)1096-9098(199606)62:2<97::AID-JSO5>3.0.CO;2-L; Koornstra JJ, 2003, CRIT REV ONCOL HEMAT, V45, P37, DOI 10.1016/S1040-8428(01)00228-1; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Little MP, 2008, RADIAT PROT DOSIM, V132, P156, DOI 10.1093/rpd/ncn264; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008915; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Lynch HT, 2008, FAM CANCER, V7, P27, DOI 10.1007/s10689-007-9165-5; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Meza R, 2010, CANCER RES, V70, P5419, DOI 10.1158/0008-5472.CAN-09-4417; MOOLGAVKAR SH, 1992, J NATL CANCER I, V84, P610, DOI 10.1093/jnci/84.8.610; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; Muleris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001632; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakaji S, 2003, INT J COLORECTAL DIS, V18, P481, DOI 10.1007/s00384-003-0485-0; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Potten CS, 2003, CELL PROLIFERAT, V36, P115, DOI 10.1046/j.1365-2184.2003.00264.x; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; PRESTON D. L., 1993, EPICURE USERS GUIDE; Sampson JR, 2005, BIOCHEM SOC T, V33, P679, DOI 10.1042/BST0330679; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Takachi R, 2011, ASIA PAC J CLIN NUTR, V20, P603; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; UNSCEAR, 2008, 1 UNSCEAR; Valentin J, 2007, 2007 RECOMMENDATIONS; Yang K, 1998, CANCER RES, V58, P5713; Yiu HY, 2004, INT J CANCER, V109, P777, DOI 10.1002/ijc.20030	66	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111024	10.1371/journal.pone.0111024	http://dx.doi.org/10.1371/journal.pone.0111024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356998	Green Submitted, Green Published, gold			2022-12-27	WOS:000346765000037
J	Oh, M; Ahn, J; Yoon, Y				Oh, Min; Ahn, Jaegyoon; Yoon, Youngmi			A Network-Based Classification Model for Deriving Novel Drug-Disease Associations and Assessing Their Molecular Actions	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BREAST-CANCER; BETA-BLOCKERS; BRAIN; PROTEIN; SURVIVAL	The growing number and variety of genetic network datasets increases the feasibility of understanding how drugs and diseases are associated at the molecular level. Properly selected features of the network representations of existing drug-disease associations can be used to infer novel indications of existing drugs. To find new drug-disease associations, we generated an integrative genetic network using combinations of interactions, including protein-protein interactions and gene regulatory network datasets. Within this network, network adjacencies of drug-drug and disease-disease were quantified using a scored path between target sets of them. Furthermore, the common topological module of drugs or diseases was extracted, and thereby the distance between topological drug-module and disease (or disease-module and drug) was quantified. These quantified scores were used as features for the prediction of novel drug-disease associations. Our classifiers using Random Forest, Multilayer Perceptron and C4.5 showed a high specificity and sensitivity (AUC score of 0.855, 0.828 and 0.797 respectively) in predicting novel drug indications, and displayed a better performance than other methods with limited drug and disease properties. Our predictions and current clinical trials overlap significantly across the different phases of drug development. We also identified and visualized the topological modules of predicted drug indications for certain types of cancers, and for Alzheimer's disease. Within the network, those modules show potential pathways that illustrate the mechanisms of new drug indications, including propranolol as a potential anticancer agent and telmisartan as treatment for Alzheimer's disease.	[Oh, Min; Yoon, Youngmi] Gachon Univ, Dept Comp Engn, Songnam, South Korea; [Ahn, Jaegyoon] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	Gachon University; University of California System; University of California Los Angeles	Yoon, Y (corresponding author), Gachon Univ, Dept Comp Engn, Songnam, South Korea.	ymyoon@gachon.ac.kr	Oh, Min/AAJ-5094-2020	Oh, Min/0000-0002-0938-9046	Basic Science Research Program, through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2010-0008639]	Basic Science Research Program, through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program, through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2010-0008639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOINFORMATICS, V27, P1846, DOI 10.1093/bioinformatics/btr283; Al-Wadei HAN, 2012, PHARMACOL RES, V66, P33, DOI 10.1016/j.phrs.2012.03.014; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Craft S, 2003, PSYCHONEUROENDOCRINO, V28, P809, DOI 10.1016/S0306-4530(02)00087-2; Davis AP, 2009, NUCLEIC ACIDS RES, V37, pD786, DOI 10.1093/nar/gkn580; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Hajjar I, 2012, ARCH NEUROL-CHICAGO, V69, P1632, DOI 10.1001/archneurol.2012.1010; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kume K, 2012, GERIATR GERONTOL INT, V12, P207, DOI 10.1111/j.1447-0594.2011.00746.x; Kummer MP, 2008, PPAR RES, V2008, P8; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Shindo T, 2012, BIOL PHARM BULL, V35, P2141, DOI 10.1248/bpb.b12-00387; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang HM, 2013, ANN ONCOL, V24, P1312, DOI 10.1093/annonc/mds616; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Zhao SW, 2012, BIOINFORMATICS, V28, P955, DOI 10.1093/bioinformatics/bts057	44	36	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111668	10.1371/journal.pone.0111668	http://dx.doi.org/10.1371/journal.pone.0111668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356910	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000073
J	Clement, G; Wood, SJ				Clement, Gilles; Wood, Scott J.			Rocking or Rolling - Perception of Ambiguous Motion after Returning from Space	PLOS ONE			English	Article							VERTICAL AXIS ROTATION; LINEAR ACCELERATION; SPATIAL ORIENTATION; SELF-MOTION; PROLONGED WEIGHTLESSNESS; TILT PERCEPTION; EYE-MOVEMENTS; TRANSLATION; MICROGRAVITY; SPACEFLIGHT	The central nervous system must resolve the ambiguity of inertial motion sensory cues in order to derive an accurate representation of spatial orientation. Adaptive changes during spaceflight in how the brain integrates vestibular cues with other sensory information can lead to impaired movement coordination, vertigo, spatial disorientation, and perceptual illusions after return to Earth. The purpose of this study was to compare tilt and translation motion perception in astronauts before and after returning from spaceflight. We hypothesized that these stimuli would be the most ambiguous in the low-frequency range (i.e., at about 0.3 Hz) where the linear acceleration can be interpreted either as a translation or as a tilt relative to gravity. Verbal reports were obtained in eleven astronauts tested using a motion-based tilt-translation device and a variable radius centrifuge before and after flying for two weeks on board the Space Shuttle. Consistent with previous studies, roll tilt perception was overestimated shortly after spaceflight and then recovered with 1-2 days. During dynamic linear acceleration (0.15-0.6 Hz, +/- 1.7 m/s(2)) perception of translation was also overestimated immediately after flight. Recovery to baseline was observed after 2 days for lateral translation and 8 days for fore-aft translation. These results suggest that there was a shift in the frequency dynamic of tilt-translation motion perception after adaptation to weightlessness. These results have implications for manual control during landing of a space vehicle after exposure to microgravity, as it will be the case for human asteroid and Mars missions.	[Clement, Gilles] Int Space Univ, Illkirch Graffenstaden, France; [Clement, Gilles] Lyon Neurosci Res Ctr, Bron, France; [Wood, Scott J.] Azusa Pacific Univ, Azusa, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm)	Clement, G (corresponding author), Int Space Univ, Illkirch Graffenstaden, France.	gilles.clement@isunet.edu	Clement, Gilles/I-1973-2017		National Aeronautics and Space Administration Human Research Program Human Health Countermeasures Element; European Space Agency; Centre National d'Etudes Spatiales	National Aeronautics and Space Administration Human Research Program Human Health Countermeasures Element; European Space Agency(European Space AgencyEuropean Commission); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This research was supported by the National Aeronautics and Space Administration Human Research Program Human Health Countermeasures Element (SW), the European Space Agency (GC), and the Centre National d'Etudes Spatiales (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2003, J VESTIBUL RES-EQUIL, V13, P245; Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; ARROTT AP, 1990, AVIAT SPACE ENVIR MD, V61, P319; Benson AJ, 1997, J VESTIBUL RES-EQUIL, V7, P453, DOI 10.1016/S0957-4271(96)00167-X; Benson AJ, 2003, AVIATION MED, P419; CLARK B, 1966, AM J PSYCHOL, V79, P377, DOI 10.2307/1420878; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Clement G, 2001, EXP BRAIN RES, V138, P410, DOI 10.1007/s002210100706; Clement G., 2008, NEUROSCIENCE SPACE; Clement G, 2007, J VESTIBUL RES-EQUIL, V17, P209; Clement G, 2013, J VESTIBUL RES-EQUIL, V23, P13, DOI 10.3233/VES-130471; Dai MJ, 2010, EXP BRAIN RES, V204, P207, DOI 10.1007/s00221-010-2305-4; Denise P, 1996, NEUROSCI LETT, V203, P183, DOI 10.1016/0304-3940(96)12303-X; Glasauer S, 1998, BRAIN RES REV, V28, P185, DOI 10.1016/S0165-0173(98)00038-1; GLASAUER S, 1995, ACTA OTO-LARYNGOL, P37; GRAYBIEL A, 1952, AMA ARCH OPHTHALMOL, V48, P605; GRESTY MA, 1992, NEUROSCI LETT, V140, P63, DOI 10.1016/0304-3940(92)90682-W; GUEDRY FE, 1992, ANN NY ACAD SCI, V656, P315, DOI 10.1111/j.1749-6632.1992.tb25218.x; Guedry FE, 1998, BRAIN RES BULL, V47, P475, DOI 10.1016/S0361-9230(98)00087-2; GUEDRY FE, 1974, HDB SENSORY PHYSL, V2, P3; Harm D L, 1993, J Vestib Res, V3, P297; Mayne R, 1974, HDB SENSORY PHYSL, VVI/2, P493; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2003, J VESTIBUL RES-EQUIL, V13, P309; Merfeld DM, 1996, J APPL PHYSIOL, V81, P50, DOI 10.1152/jappl.1996.81.1.50; Paloski W.H., 2018, J GRAVIT PHYSL, V15, P1; PALOSKI WH, 1993, AM J OTOL, V14, P9; PARKER DE, 1985, AVIAT SPACE ENVIR MD, V56, P601; RESCHKE MF, 1987, AVIAT SPACE ENVIR MD, V58, pA153; Reschke MF, 2013, BIOMEDICAL RESULTS S, P171; SCHONE H, 1964, AEROSPACE MED, V35, P764; Seidman SH, 1998, EXP BRAIN RES, V119, P307, DOI 10.1007/s002210050346; Wertheim AH, 2001, PERCEPTION, V30, P733, DOI 10.1068/p3092; Wood SJ, 2007, EXP BRAIN RES, V182, P365, DOI 10.1007/s00221-007-0994-0; Wood SJ, 2002, NEUROSCI LETT, V323, P41, DOI 10.1016/S0304-3940(02)00118-0; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215; Zupan LH, 2005, J VESTIBUL RES-EQUIL, V15, P173	38	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111107	10.1371/journal.pone.0111107	http://dx.doi.org/10.1371/journal.pone.0111107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354042	Green Submitted, Green Published, gold			2022-12-27	WOS:000345204200056
J	Dehon, M; Michez, D; Nel, A; Engel, MS; De Meulemeester, T				Dehon, Manuel; Michez, Denis; Nel, Andre; Engel, Michael S.; De Meulemeester, Thibaut			Wing Shape of Four New Bee Fossils (Hymenoptera: Anthophila) Provides Insights to Bee Evolution	PLOS ONE			English	Article							BALTIC AMBER HYMENOPTERA; GEOMETRIC MORPHOMETRICS; MIDDLE EOCENE; DIVERSIFICATION; PHYLOGENY; CTENOPLECTRELLA; BIOGEOGRAPHY; OLIGOCENE; HISTORY; MIOCENE	Bees (Anthophila) are one of the major groups of angiosperm-pollinating insects and accordingly are widely studied in both basic and applied research, for which it is essential to have a clear understanding of their phylogeny, and evolutionary history. Direct evidence of bee evolutionary history has been hindered by a dearth of available fossils needed to determine the timing and tempo of their diversification, as well as episodes of extinction. Here we describe four new compression fossils of bees from three different deposits (Miocene of la Cerdanya, Spain; Oligocene of Cereste, France; and Eocene of the Green River Formation, U.S.A.). We assess the similarity of the forewing shape of the new fossils with extant and fossil taxa using geometric morphometrics analyses. Predictive discriminant analyses show that three fossils share similar forewing shapes with the Apidae [one of uncertain tribal placement and perhaps near Euglossini, one definitive bumble bee (Bombini), and one digger bee (Anthophorini)], while one fossil is more similar to the Andrenidae. The corbiculate fossils are described as Euglossopteryx biesmeijeri De Meulemeester, Michez, & Engel, gen. nov. sp. nov. (type species of Euglossopteryx Dehon & Engel, n. gen.) and Bombus cerdanyensis Dehon, De Meulemeester, & Engel, sp. nov. They provide new information on the distribution and timing of particular corbiculate groups, most notably the extension into North America of possible Eocene-Oligocene cooling-induced extinctions. Protohabropoda pauli De Meulemeester & Michez, gen. nov. sp. nov. (type species of Protohabropoda Dehon & Engel, n. gen.) reinforces previous hypotheses of anthophorine evolution in terms of ecological shifts by the Oligocene from tropical to mesic or xeric habitats. Lastly, a new fossil of the Andreninae, Andrena antoinei Michez & De Meulemeester, sp. nov., further documents the presence of the today widespread genus Andrena Fabricius in the Late Oligocene of France.	[Dehon, Manuel; Michez, Denis; De Meulemeester, Thibaut] Univ Mons, Res Inst Biosci, Zool Lab, B-7000 Mons, Belgium; [Nel, Andre] Museum Natl Hist Nat, CNRS, Unite Mixte Rech, Dept Entomol, Paris, France; [Engel, Michael S.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Engel, Michael S.] Univ Kansas, Museum Nat Hist, Div Entomol Paleoentomol, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [De Meulemeester, Thibaut] Nat Biodivers Ctr, Leiden, Netherlands	University of Mons; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); American Museum of Natural History (AMNH); University of Kansas; University of Kansas; Naturalis Biodiversity Center	Dehon, M (corresponding author), Univ Mons, Res Inst Biosci, Zool Lab, B-7000 Mons, Belgium.	manuel.dehon@umons.ac.be	Michez, Denis/L-1370-2019; Engel, Michael S/C-5461-2012	Michez, Denis/0000-0001-8880-1838; Engel, Michael S/0000-0003-3067-077X	Naturalis Biodiversity Museum, Leiden, The Netherlands; Division of Entomology, University of Kansas, Kansas, United States of America	Naturalis Biodiversity Museum, Leiden, The Netherlands; Division of Entomology, University of Kansas, Kansas, United States of America	Funding provided by Naturalis Biodiversity Museum, Leiden, The Netherlands. Represented by Dr. Thibaut and De Meulemeester. The NBC allowed the authors to do a sampling of diverse bee tribes with three submarginal cells. Funding also provided by the Division of Entomology, University of Kansas, Kansas, United States of America. Represented by Prof. Engel. This co-funder provided us one of the four fossils described and analysed: Euglossopteryx biesmeijeri sp. nov.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alexander B.A., 1992, Journal of Hymenoptera Research, V1, P25; Arillo Antonio, 2001, Coloquios de Paleontologia, V52, P79; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Cardinal S, 2007, CLADISTICS, V23, P99, DOI 10.1111/j.1096-0031.2006.00137.x; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Collomb FM, 2008, ANN SOC ENTOMOL FR, V44, P161, DOI 10.1080/00379271.2008.10697553; Danforth BN, 2013, ANNU REV ENTOMOL, V58, P57, DOI 10.1146/annurev-ento-120811-153633; De Meulemeester T, 2012, J SYST PALAEONTOL, V10, P755, DOI 10.1080/14772019.2011.628701; Dewulf A, 2014, ZOOKEYS, P35, DOI 10.3897/zookeys.389.7076; Dieguez C, 1996, REV PALAEOBOT PALYNO, V94, P329, DOI 10.1016/S0034-6667(96)00004-8; Dubitzky A, 2007, SYST ENTOMOL, V32, P585, DOI 10.1111/j.1365-3113.2007.00397.x; Engel MS, 2008, ACTA ZOOL ACAD SCI H, V54, P319; Engel Michael S., 2004, Transactions of the Kansas Academy of Science, V107, P97, DOI 10.1660/0022-8443(2004)107[0097:NOAMBH]2.0.CO;2; Engel Michael S., 2013, Journal of Melittology, V16, P1; Engel Michael S., 2014, Journal of Melittology, V30, P1; Engel Michael S., 2014, Novitates Paleoentomologicae, V7, P1; Engel Michael S., 2013, Journal of Melittology, V25, P1; Engel MS, 2012, AM MUS NOVIT, P1; Engel MS, 2011, SYST ENTOMOL, V36, P2, DOI 10.1111/j.1365-3113.2010.00544.x; Engel Michael S., 2009, Proceedings of the California Academy of Sciences, V60, P23; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Engel MS, 1996, J KANSAS ENTOMOL SOC, V69, P334; Engel MS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)504[0001:AGHBFT]2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Engel MS, 2002, NEUES JAHRB GEOL P-A, V225, P251; Engel MS, 2001, T AM ENTOMOL SOC, V127, P245; Engel MS, 2001, P NATL ACAD SCI USA, V98, P1661, DOI 10.1073/pnas.98.4.1661; Engel MS, 1999, AM MUSEUM NOVIT, V3272; Engel MS, 2004, REV TECNOLOGIA AMBIE, V10, P9; Forest CE, 1999, GEOL SOC AM BULL, V111, P497, DOI 10.1130/0016-7606(1999)111<0497:PIAPAB>2.3.CO;2; Franczyk KJ, 1992, US GEOL SURV B Q, V1787-Q; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Gonzalez VH, 2013, SYST ENTOMOL, V38, P645, DOI 10.1111/syen.12029; Gonzalez VH, 2011, ZOOKEYS, P41, DOI 10.3897/zookeys.111.1593; Hail Jr WJ, 1997, 2529 IMAP US GEOL SU; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hinojosa-Diaz IA, 2011, ZOOKEYS, P11, DOI 10.3897/zookeys.97.1106; Huberty C., 2006, APPL MANOVA DISCRIMI; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kandemir I, 2011, APIDOLOGIE, V42, P618, DOI 10.1007/s13592-011-0063-3; Kotthoff U, 2011, ZOOKEYS, P11, DOI 10.3897/zookeys.96.752; MacGinitie H.D., 1969, U CALIF PUBLS GEOL S, V83, P1; Mayr G, 2000, GEOBIOS-LYON, V33, P625, DOI 10.1016/S0016-6995(00)80034-0; Melo Gabriel A.R., 1999, Scientific Papers Natural History Museum the University of Kansas, V14, P1; MICHENER C D, 1988, American Museum Novitates, P1; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; Michener CD, 1944, B AM MUS NAT HIST, V82, P152; Michez D, 2007, ZOOL J LINN SOC-LOND, V150, P701, DOI 10.1111/j.1096-3642.2007.00307.x; Michez Denis, 2012, Systematics Association Special Volume Series, V81, P103; Michez D, 2009, ZOOL SCR, V38, P171, DOI 10.1111/j.1463-6409.2008.00362.x; Nel A, 1999, PALAEONTOLOGY, V42, P243, DOI 10.1111/1475-4983.00073; Ohl M., 2007, Denisia, P687; Pavlinov IY, 2001, INFORM TECHNOLOGY BI, P41; Penalver Enrique, 1999, Revista Espanola de Paleontologia, V14, P231; R Development Core Team, 2013, LANG ENV STAT COMP V; Rasmont P, 1988, MONOGRAPHIE ECOLOGIQ; Roberts DW, 2008, ECOLOGY, V89, P1246, DOI 10.1890/07-0136.1; Rohlf, 2013, TPSDIG VERSION 2 17; Rohlf F.J., 2013, TPSSMALL VERSION 1 2; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2013, TPSUTIL VERSION 1 56; Roig-Alsina Arturo, 1993, University of Kansas Science Bulletin, V55, P123; Roil H. H., 1936, Annals of the Entomological Society of America, V29, P99; SCHMIDT-KILLER N, 1985, Senckenbergiana Lethaea, V66, P89; Yazdi F, 2013, J ZOOL SYST EVOL RES, V51, P239, DOI 10.1111/jzs.12020; von Grego H-J, 2002, FLORA TERTIARIA MEDI, V4, P1; Wappler T, 2012, SYST ENTOMOL, V37, P784, DOI 10.1111/j.1365-3113.2012.00642.x; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Zeuner F. E., 1976, Bulletin of the British Museum (Natural History), Geology, V27, P149	75	20	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e108865	10.1371/journal.pone.0108865	http://dx.doi.org/10.1371/journal.pone.0108865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354170	Green Published, Green Submitted, gold			2022-12-27	WOS:000345204200005
J	Zohdy, S; Gerber, BD; Tecot, S; Blanco, MB; Winchester, JM; Wright, PC; Jernvall, J				Zohdy, Sarah; Gerber, Brian D.; Tecot, Stacey; Blanco, Marina B.; Winchester, Julia M.; Wright, Patricia C.; Jernvall, Jukka			Teeth, Sex, and Testosterone: Aging in the World's Smallest Primate	PLOS ONE			English	Article							RANOMAFANA NATIONAL-PARK; NATURAL-POPULATIONS; MOUSE LEMUR; NEUROFIBRILLARY CHANGES; BALANCE PERFORMANCE; MICROCEBUS-RUFUS; TOOTH WEAR; SURVIVAL; AGE; SENESCENCE	Mouse lemurs (Microcebus spp.) are an exciting new primate model for understanding human aging and disease. In captivity, Microcebus murinus develops human-like ailments of old age after five years (e.g., neurodegeneration analogous to Alzheimer's disease) but can live beyond 12 years. It is believed that wild Microcebus follow a similar pattern of senescence observed in captive animals, but that predation limits their lifespan to four years, thus preventing observance of these diseases in the wild. Testing whether this assumption is true is informative about both Microcebus natural history and environmental influences on senescence, leading to interpretation of findings for models of human aging. Additionally, the study of Microcebus longevity provides an opportunity to better understand mechanisms of sex-biased longevity. Longevity is often shorter in males of species with high male-male competition, such as Microcebus, but mouse lemurs are sexually monomorphic, suggesting similar lifespans. We collected individual-based observations of wild brown mouse lemurs (Microcebus rufus) from 2003-2010 to investigate sex-differences in survival and longevity. Fecal testosterone was measured as a potential mechanism of sex-based differences in survival. We used a combination of high-resolution tooth wear techniques, mark-recapture, and hormone enzyme immunoassays. We found no dental or physical signs of senescence in M. rufus as old as eight years (N = 189, ages 1-8, mean = 2.59 +/- 1.63 SE), three years older than captive, senescent congeners (M. murinus). Unlike other polygynandrous vertebrates, we found no sex difference in age-dependent survival, nor sex or age differences in testosterone levels. While elevated male testosterone levels have been implicated in shorter lifespans in several species, this is one of the first studies to show equivalent testosterone levels accompanying equivalent lifespans. Future research on captive aged individuals can determine if senescence is partially a condition of their captive environment, and studies controlling for various environmental factors will further our understanding of senescence.	[Zohdy, Sarah; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Zohdy, Sarah; Tecot, Stacey; Blanco, Marina B.; Wright, Patricia C.] Ctr ValBio Res Stn, Ranomafana, Ifanadiana, Madagascar; [Zohdy, Sarah] Emory Univ, Sch Publ Hlth, Dept Environm Studies, Atlanta, GA USA; [Gerber, Brian D.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Colorado Cooperat Fish & Wildlife Res Unit, Ft Collins, CO 80523 USA; [Tecot, Stacey] Univ Arizona, Sch Anthropol, Tucson, AZ USA; [Blanco, Marina B.] Duke Lemur Ctr, Durham, NC USA; [Winchester, Julia M.; Wright, Patricia C.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA	University of Helsinki; Emory University; Colorado State University; University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zohdy, S (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	sarahzohdy@gmail.com	Tecot, Stacey/AAN-6933-2020	TECOT, STACEY/0000-0002-6640-5049; Zohdy, Sarah/0000-0001-5316-0567	Academy of Finland; Juselius Foundation; Viikki Graduate School of Biosciences; EU [MEST-CT-2005-020546]	Academy of Finland(Academy of Finland); Juselius Foundation; Viikki Graduate School of Biosciences; EU(European Commission)	This project was funded by The Academy of Finland, Juselius Foundation, Viikki Graduate School of Biosciences, and EU Marie Curie Early Stage Training, grant number: MEST-CT-2005-020546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM GE, 1972, ANAL LETT, V5, P509, DOI 10.1080/00032717208062116; [Anonymous], 1956, BIOL SENESCENCE; Atsalis S, 1999, INT J PRIMATOL, V20, P193, DOI 10.1023/A:1020518419038; Atsalis S, 1999, INT J PRIMATOL, V20, P883, DOI 10.1023/A:1020826502103; Aujard F, 2004, PHYSIOL BEHAV, V81, P639, DOI 10.1016/j.physbeh.2004.03.003; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; Beltran WA, 2007, VET OPHTHALMOL, V10, P43, DOI 10.1111/j.1463-5224.2007.00491.x; Blanco MB, 2008, INT J PRIMATOL, V29, P323, DOI 10.1007/s10764-008-9238-9; Bonduriansky R, 2002, NATURE, V420, P377, DOI 10.1038/420377a; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; BONS N, 1991, CR ACAD SCI III-VIE, V313, P213; BONS N, 1994, NEUROBIOL AGING, V15, P215, DOI 10.1016/0197-4580(94)90115-5; Bons N, 1999, NEUROBIOL AGING, V20, P455, DOI 10.1016/S0197-4580(99)00075-5; BONS N, 1992, NEUROBIOL AGING, V13, P99, DOI 10.1016/0197-4580(92)90016-Q; Braude S, 1998, J MAMMAL, V79, P360, DOI 10.2307/1382873; Bronikowski AM, 2011, SCIENCE, V331, P1325, DOI 10.1126/science.1201571; Bryant MJ, 2004, AM NAT, V163, P55, DOI 10.1086/380650; Burnham K.P., 1987, American Fisheries Society Monograph, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Cuozzo FP, 2006, J HUM EVOL, V51, P490, DOI 10.1016/j.jhevol.2006.07.001; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Galbany J, 2011, AM J PHYS ANTHROPOL, V144, P51, DOI 10.1002/ajpa.21368; Goodman SM., 2003, NATURAL HIST MADAGAS, P1221; Hayflick L, 2000, NATURE, V403, P365, DOI 10.1038/35000303; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Kendall WL, 1997, ECOLOGY, V78, P563; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kraus C, 2008, P ROY SOC B-BIOL SCI, V275, P1635, DOI 10.1098/rspb.2008.0200; LYMAN CP, 1981, SCIENCE, V212, P668, DOI 10.1126/science.7221552; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Nemoz-Bertholet F, 2004, EXP GERONTOL, V39, P841, DOI 10.1016/j.exger.2004.01.010; Nemoz-Bertolet F, 2003, EXP GERONTOL, V38, P407, DOI 10.1016/S0531-5565(02)00244-9; Nussey DH, 2007, CURR BIOL, V17, pR1000, DOI 10.1016/j.cub.2007.10.005; OTIS DL, 1978, WILDLIFE MONOGR, P1; Owens IP, 2002, SCI SAGE KE, P12; Perret M, 2005, EXP GERONTOL, V40, P582, DOI 10.1016/j.exger.2005.05.002; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Radespiel L, 2003, ANIM BEHAV, V65, P709, DOI 10.1006/anbe.2003.2121; Radespiel U, 2001, AM J PRIMATOL, V54, P181, DOI 10.1002/ajp.1029; Rapaport LG, 2002, INT J PRIMATOL, V23, P1063, DOI 10.1023/A:1019650032735; Ricklefs RE, 2001, EXP GERONTOL, V36, P845, DOI 10.1016/S0531-5565(00)00245-X; ROBERTS SB, 2001, FUNCTIONAL NEUROBIOL, P829; Rose MR, 1994, EVOLUTIONARY BIOL AG; Schmid J, 1998, BEHAV ECOL SOCIOBIOL, V43, P125, DOI 10.1007/s002650050474; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; Tecot SR, 2013, BEHAV ECOL, V24, P987, DOI 10.1093/beheco/art008; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Trivers R. L., 1985, SOCIAL EVOLUTION; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitten PL, 1998, YEARB PHYS ANTHROPOL, V41, P1, DOI 10.1002/(SICI)1096-8644(1998)107:27+<1::AID-AJPA2>3.0.CO;2-H; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Wright P. C., 2003, NATURAL HIST MADAGAS; Wright Patricia C., 1992, Evolutionary Anthropology, V1, P25, DOI 10.1002/evan.1360010108; YOUNG AL, 1990, AM NAT, V135, P473, DOI 10.1086/285057; Ziegler TE, 1996, BIOL REPROD, V54, P91, DOI 10.1095/biolreprod54.1.91	64	24	24	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109528	10.1371/journal.pone.0109528	http://dx.doi.org/10.1371/journal.pone.0109528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354041	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200011
J	Jung, JI; Premraj, S; Cruz, PE; Ladd, TB; Kwak, Y; Koo, EH; Felsenstein, KM; Golde, TE; Ran, Y				Jung, Joo In; Premraj, Sasha; Cruz, Pedro E.; Ladd, Thomas B.; Kwak, Yewon; Koo, Edward H.; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong			Independent Relationship between Amyloid Precursor Protein (APP) Dimerization and gamma-Secretase Processivity	PLOS ONE			English	Article							A-BETA PEPTIDES; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; SUBSTRATE SEQUENCE; SENILE PLAQUES; PRESENILIN-1; DEPOSITION; MODULATORS; MUTATIONS; A-BETA-42	Altered production of beta-amyloid (A beta) from the amyloid precursor protein (APP) is closely associated with Alzheimer's disease (AD). APP has a number of homo- and hetero-dimerizing domains, and studies have suggested that dimerization of beta-secretase derived APP carboxyl terminal fragment (CTF beta, C99) impairs processive cleavage by gamma-secretase increasing production of long A beta s (e. g., A beta 1-42, 43). Other studies report that APP CTF beta dimers are not gamma-secretase substrates. We revisited this issue due to observations made with an artificial APP mutant referred to as 3xK-APP, which contains three lysine residues at the border of the APP ectodomain and transmembrane domain (TMD). This mutant, which dramatically increases production of long A beta, was found to form SDS-stable APP dimers, once again suggesting a mechanistic link between dimerization and increased production of long A beta. To further evaluate how multimerization of substrate affects both initial gamma-secretase cleavage and subsequent processivity, we generated recombinant wild type- (WT) and 3xK-C100 substrates, isolated monomeric, dimeric and trimeric forms of these proteins, and evaluated both epsilon-cleavage site utilization and A beta production. These show that multimerization significantly impedes gamma-secretase cleavage, irrespective of substrate sequence. Further, the monomeric form of the 3xK-C100 mutant increased long A beta production without altering the initial epsilon-cleavage utilization. These data confirm and extend previous studies showing that dimeric substrates are not efficient gamma-secretase substrates, and demonstrate that primary sequence determinants within APP substrate alter gamma-secretase processivity.	[Jung, Joo In; Premraj, Sasha; Cruz, Pedro E.; Ladd, Thomas B.; Kwak, Yewon; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Jung, Joo In; Cruz, Pedro E.; Ladd, Thomas B.; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Jung, Joo In; Cruz, Pedro E.; Ladd, Thomas B.; Felsenstein, Kevin M.; Golde, Todd E.; Ran, Yong] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA; [Premraj, Sasha] Univ Florida, Coll Pharm, Gainesville, FL USA; [Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California San Diego	Golde, TE (corresponding author), Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.	tgolde@mbi.ufl.edu; yran@ufl.edu			National Institutes of Health (NIH) [AG202063]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) Grant AG202063 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Conicella AE, 2014, BIOCHEMISTRY; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jumpertz T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030484; Jung JI, 2014, BIOCHEMISTRY-US, V53, P1947, DOI 10.1021/bi401521t; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murayama O, 1999, NEUROSCI LETT, V265, P61, DOI 10.1016/S0304-3940(99)00187-1; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Pozdnyakov N, 2013, J BIOL CHEM, V288, P9710, DOI 10.1074/jbc.M112.398602; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	53	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111553	10.1371/journal.pone.0111553	http://dx.doi.org/10.1371/journal.pone.0111553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350374	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943100078
J	Vercelloni, J; Caley, MJ; Kayal, M; Low-Choy, S; Mengersen, K				Vercelloni, Julie; Caley, M. Julian; Kayal, Mohsen; Low-Choy, Samantha; Mengersen, Kerrie			Understanding Uncertainties in Non-Linear Population Trajectories: A Bayesian Semi-Parametric Hierarchical Approach to Large-Scale Surveys of Coral Cover	PLOS ONE			English	Article							SPECIES RICHNESS; REEF; RESILIENCE; MODELS; DECLINE; ECOLOGY; FUTURE	Recently, attempts to improve decision making in species management have focussed on uncertainties associated with modelling temporal fluctuations in populations. Reducing model uncertainty is challenging; while larger samples improve estimation of species trajectories and reduce statistical errors, they typically amplify variability in observed trajectories. In particular, traditional modelling approaches aimed at estimating population trajectories usually do not account well for nonlinearities and uncertainties associated with multi-scale observations characteristic of large spatio-temporal surveys. We present a Bayesian semi-parametric hierarchical model for simultaneously quantifying uncertainties associated with model structure and parameters, and scale-specific variability over time. We estimate uncertainty across a four-tiered spatial hierarchy of coral cover from the Great Barrier Reef. Coral variability is well described; however, our results show that, in the absence of additional model specifications, conclusions regarding coral trajectories become highly uncertain when considering multiple reefs, suggesting that management should focus more at the scale of individual reefs. The approach presented facilitates the description and estimation of population trajectories and associated uncertainties when variability cannot be attributed to specific causes and origins. We argue that our model can unlock value contained in large-scale datasets, provide guidance for understanding sources of uncertainty, and support better informed decision making.	[Vercelloni, Julie; Low-Choy, Samantha; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Vercelloni, Julie; Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Kayal, Mohsen] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	Queensland University of Technology (QUT); Australian Institute of Marine Science; University of California System; University of California Santa Barbara	Vercelloni, J (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	julie.vercelloni@gmail.com	Mengersen, Kerrie/AHC-4096-2022; Caley, Julian/A-4042-2008	Kayal, Mohsen/0000-0003-3675-9855; Mengersen, Kerrie/0000-0001-8625-9168; Caley, Julian/0000-0001-5739-749X; Vercelloni, Julie/0000-0001-5227-014X; Low Choy, Samantha/0000-0002-1722-4428				Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caley MJ, 2014, TRENDS ECOL EVOL, V29, P187, DOI 10.1016/j.tree.2014.02.002; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Choy SL, 2009, ECOLOGY, V90, P265, DOI 10.1890/07-1886.1; Clark JS, 2006, TRENDS ECOL EVOL, V21, P375, DOI 10.1016/j.tree.2006.03.016; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connolly S, 2014, ANZIAM J IN PRESS; Crainiceanu C. M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I14; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Fisher R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026556; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gelman A, 2006, TECHNOMETRICS, V48, P432, DOI 10.1198/004017005000000661; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Hadfield JD, 2010, AM NAT, V175, P116, DOI 10.1086/648604; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Hughes TP, 2011, CORAL REEFS, V30, P653, DOI 10.1007/s00338-011-0787-6; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jonker M., 2008, LONG TERM MONITORING; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; MacNeil MA, 2009, ECOLOGY, V90, P252, DOI 10.1890/07-0487.1; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Miao ShiLi, 2009, P1, DOI 10.1007/978-0-387-77942-3_1; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rao P.V., 1998, STAT RES METHODS LIF; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Sweatman H, 2011, CORAL REEFS, V30, P661, DOI 10.1007/s00338-011-0794-7; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wikle CK, 2003, ECOLOGY, V84, P1382, DOI 10.1890/0012-9658(2003)084[1382:HBMFPT]2.0.CO;2; Wood SN, 2001, ECOL MONOGR, V71, P1, DOI 10.1890/0012-9615(2001)071[0001:PSEM]2.0.CO;2; Wu JG, 2002, ECOL MODEL, V153, P7, DOI 10.1016/S0304-3800(01)00499-9	55	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2014	9	11							e110968	10.1371/journal.pone.0110968	http://dx.doi.org/10.1371/journal.pone.0110968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DB	25364915	Green Submitted, Green Published, gold			2022-12-27	WOS:000345558100039
J	Capala, ME; Vellenga, E; Schuringa, JJ				Capala, Marta E.; Vellenga, Edo; Schuringa, Jan Jacob			ELMO1 Is Upregulated in AML CD34+Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GUANOSINE TRIPHOSPHATASES REPRESENT; GENE-EXPRESSION PROFILES; STEM-CELLS; STEM/PROGENITOR CELLS; SELF-RENEWAL; BCR-ABL; CANCER; TRANSFORMATION; ACTIVATION	Both normal as well leukemic hematopoietic stem cells critically depend on their microenvironment in the bone marrow for processes such as self-renewal, survival and differentiation, although the exact pathways that are involved remain poorly understood. We performed transcriptome analysis on primitive CD34(+) acute myeloid leukemia (AML) cells (n = 46), their more differentiated CD34(-) leukemic progeny, and normal CD34(+) bone marrow cells (n = 31) and focused on differentially expressed genes involved in adhesion and migration. Thus, Engulfment and Motility protein 1 (ELMO1) was identified amongst the top 50 most differentially expressed genes. ELMO1 is a crucial link in the signaling cascade that leads to activation of RAC GTPases and cytoskeleton rearrangements. We confirmed increased ELMO1 expression at the mRNA and protein level in a panel of AML samples and showed that high ELMO1 expression is an independent negative prognostic factor in normal karyotype (NK) AML in three large independent patient cohorts. Downmodulation of ELMO1 in human CB CD34(+) cells did not significantly alter expansion, progenitor frequency or differentiation in stromal co-cultures, but did result in a decreased frequency of stem cells in LTC-IC assays. In BCR-ABL-transduced human CB CD34(+) cells depletion of ELMO1 resulted in a mild decrease in proliferation, but replating capacity of progenitors was severely impaired. Downregulation of ELMO1 in a panel of primary CD34(+) AML cells also resulted in reduced long-term growth in stromal co-cultures in two out of three cases. Pharmacological inhibition of the ELMO1 downstream target RAC resulted in a severely impaired proliferation and survival of leukemic cells. Finally, ELMO1 depletion caused a marked decrease in SDF1-induced chemotaxis of leukemic cells. Taken together, these data show that inhibiting the ELMO1-RAC axis might be an alternative way to target leukemic cells.	[Capala, Marta E.; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, CRCG, Dept Expt Hematol, Groningen, Netherlands	University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, CRCG, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl			Netherlands Organization for Scientific Research [NWO-VIDI 91796312]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from The Netherlands Organization for Scientific Research (NWO-VIDI 91796312) to JJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Bonardi F, 2013, MOL CELL PROTEOMICS, V12, P626, DOI 10.1074/mcp.M112.021931; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; de Jonge HJM, 2011, LEUKEMIA, V25, P1825, DOI 10.1038/leu.2011.172; de Jonge HJM, 2010, BLOOD, V116, P1747, DOI 10.1182/blood-2010-03-270991; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Muller LUW, 2008, LEUKEMIA, V22, P1803, DOI 10.1038/leu.2008.196; Nieborowska-Skorska M, 2012, BLOOD, V119, P4253, DOI 10.1182/blood-2011-10-385658; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Radmacher MD, 2006, BLOOD, V108, P1677, DOI 10.1182/blood-2006-02-005538; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Rozenveld-Geugien M, 2007, EXP HEMATOL, V35, P782, DOI 10.1016/j.exphem.2007.02.006; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Schepers H, 2007, BLOOD, V110, P1317, DOI 10.1182/blood-2006-10-052175; Schuringa Jan Jacob, 2009, V538, P287, DOI 10.1007/978-1-59745-418-6_14; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Shimazaki A, 2006, KIDNEY INT, V70, P1769, DOI 10.1038/sj.ki.5001939; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Thomas EK, 2008, LEUKEMIA, V22, P898, DOI 10.1038/leu.2008.71; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang H, 2010, TUMOR BIOL, V31, P59, DOI 10.1007/s13277-009-0009-9; Wang J, 2014, INT J GYNECOLOGICAL, V24; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Williams DA, 2008, METHOD ENZYMOL, V439, P365, DOI 10.1016/S0076-6879(07)00427-2; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239	41	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111568	10.1371/journal.pone.0111568	http://dx.doi.org/10.1371/journal.pone.0111568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360637	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700121
J	Chirikure, S; Manyanga, M; Pollard, AM; Bandama, F; Mahachi, G; Pikirayi, I				Chirikure, Shadreck; Manyanga, Munyaradzi; Pollard, A. Mark; Bandama, Foreman; Mahachi, Godfrey; Pikirayi, Innocent			Zimbabwe Culture before Mapungubwe: New Evidence from Mapela Hill, South-Western Zimbabwe	PLOS ONE			English	Article							HEMISPHERE CALIBRATION; CHRONOLOGY; COMPLEXITY; PATHWAYS; BOTSWANA	Across the globe, the emergence of complex societies excites intense academic debate in archaeology and allied disciplines. Not surprisingly, in southern Africa the traditional assumption that the evolution of socio-political complexity began with ideological transformations from K2 to Mapungubwe between CE1200 and 1220 is clouded in controversy. It is believed that the K2-Mapungubwe transitions crystallised class distinction and sacred leadership, thought to be the key elements of the Zimbabwe culture on Mapungubwe Hill long before they emerged anywhere else. From Mapungubwe (CE1220-1290), the Zimbabwe culture was expressed at Great Zimbabwe (CE1300-1450) and eventually Khami (CE1450-1820). However, new fieldwork at Mapela Hill, when coupled with a Bayesian chronology, offers tremendous fresh insights which refute this orthodoxy. Firstly, Mapela possesses enormous prestige stone-walled terraces whose initial construction date from the 11th century CE, almost two hundred years earlier than Mapungubwe. Secondly, the basal levels of the Mapela terraces and hilltop contain elite solid dhaka (adobe) floors associated with K2 pottery and glass beads. Thirdly, with a hilltop and flat area occupation since the 11th century CE, Mapela exhibits evidence of class distinction and sacred leadership earlier than K2 and Mapungubwe, the supposed propagators of the Zimbabwe culture. Fourthly, Mapungubwe material culture only appeared later in the Mapela sequence and therefore post-dates the earliest appearance of stone walling and dhaka floors at the site. Since stone walls, dhaka floors and class distinction are the essence of the Zimbabwe culture, their earlier appearance at Mapela suggests that Mapungubwe can no longer be regarded as the sole cradle of the Zimbabwe culture. This demands not just fresh ways of accounting for the rise of socio-political complexity in southern Africa, but also significant adjustments to existing models.	[Chirikure, Shadreck; Bandama, Foreman] Univ Cape Town, Dept Archaeol, ZA-7925 Cape Town, South Africa; [Manyanga, Munyaradzi] Univ Zimbabwe, Dept Hist, Harare, Zimbabwe; [Pollard, A. Mark] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Mahachi, Godfrey] Natl Museums & Monuments Zimbabwe, Harare, Zimbabwe; [Pikirayi, Innocent] Univ Pretoria, Dept Archaeol & Anthropol, ZA-0002 Pretoria, South Africa	University of Cape Town; University of Zimbabwe; University of Oxford; University of Pretoria	Chirikure, S (corresponding author), Univ Cape Town, Dept Archaeol, ZA-7925 Cape Town, South Africa.	shadreck.chirikure@uct.ac.za	Pikirayi, Innocent/F-7559-2010	Pikirayi, Innocent/0000-0002-9598-7631; Bandama, Foreman/0000-0002-4664-3410; , Shadreck/0000-0002-2183-4253	National Research Foundation [85892]; UCT Research Office's Mellon; Research Office's Ad Hoc research funds	National Research Foundation; UCT Research Office's Mellon; Research Office's Ad Hoc research funds	Funding for this research was provided by the National Research Foundation through a Blue sky research grant (Grant: 85892). Additional funding was obtained from the UCT Research Office's Mellon funded Africa knowledge project and the Research Office's Ad Hoc research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandama, 2013, THESIS U CAPE TOWN; Beach D. N, 1994, ZIMBABWEAN SHONA DYN; Beach DN, 1984, ZIMBABWE 1900; Bent J.T., 1896, RUINED CITIES MASHON; Blanton RE, 1996, CURR ANTHROPOL, V37, P1, DOI 10.1086/204471; Bronk Ramsey C., 1994, ARCHAEOLOGICAL COMPU, V41, P11; BUCK CE, 1991, ANTIQUITY, V65, P808, DOI 10.1017/S0003598X00080534; Caton-Thompson G., 1931, ZIMBABWE CULTURE RUI; Chirikure S, 2013, AFR ARCHAEOL REV, V30, P339, DOI 10.1007/s10437-013-9142-3; Chirikure S, 2013, ANTIQUITY, V87, P854, DOI 10.1017/S0003598X00049516; Chirikure S, 2012, J SOC ARCHAEOL, V12, P356, DOI 10.1177/1469605312457291; Chirikure S, 2008, ANTIQUITY, V82, P976, DOI 10.1017/S0003598X00097726; Denbow J, 2008, J ARCHAEOL SCI, V35, P459, DOI 10.1016/j.jas.2007.04.011; Fouche L., 1937, MAPUNGUBWE; Gardner G.A., 1963, MAPUNGUBWE, VII; Garlake P. S., 1966, SHASHE EXPEDITION, P19; Garlake P. S., 1973, GREAT ZIMBABWE; Garlake P.S., 1968, ARNOLDIA RHODESIA, V3, P1; Hall R.N., 1902, ANCIENT RUINS RHODES; Hall RN, 1910, GREAT ZIMBABWE MASHO; Hanseth O, 1998, P 6 EUR C INF SYST, P1123, DOI [10.1093/gmo/9781561592630.article.00371, DOI 10.1093/GMO/9781561592630.ARTICLE.00371]; Herbert EW., 1984, RED GOLD AFRICA COPP; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Holleman J. F., 1952, SHONA CUSTOMARY LAW; Huffman T.N., 2007, HDB IRON AGE; Huffman T.N., 2000, S AFRICAN ARCHAEOLOG, V8, P14, DOI DOI 10.2307/3858043; Huffman T.N, 1974, MUSEUM MEMOIR, V6; HUFFMAN TN, 1982, ANNU REV ANTHROPOL, V11, P133, DOI 10.1146/annurev.an.11.100182.001025; Kim NC, 2008, AFR ARCHAEOL REV, V25, P131, DOI 10.1007/s10437-008-9031-3; Latour B, 1999, ACTOR NETWORK THEORY AND AFTER, P15; Manyanga M., 2006, RESILIENT LANDSCAPES; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Meyer A., 1998, ARCHAEOLOGICAL SITES; Mitchell P, 2002, ARCHAEOLOGY SO AFRIC; Monroe JC, 2013, ANNU REV ANTHROPOL, V42, P17, DOI 10.1146/annurev-anthro-092412-155539; Mudenge SIG, 1988, POLITICAL HIST MUNHU; Murimbika M., 2006, THESIS U WITWATERSRA; Nestl, 2020, MEET COFF FARM HALL; Pikirayi I., 2001, ZIMBABWE CULTURE ORI; Pwiti G, 1996, ZAMBEZIA, V23, P31; Pwiti G., 2005, AFRICAN ARCHAEOLOGY, P378; Randall-MacIver D, 1906, MEDIAEVAL RHODESIA; Renfrew C, 1986, CONTEMPORARY ARCHAEO, P114; Robertshaw P, 2010, J ARCHAEOL SCI, V37, P1898, DOI 10.1016/j.jas.2010.02.016; Robinson K.R., 1966, S AFR ARCHAEOL BULL, V21, P5, DOI DOI 10.2307/3887697; Robinson K.R., 1965, ARNOLDIA, V1, P1; ROBINSON KR, 1961, OCCASIONAL PAPERS NA, V3, P159; Robinson KR, 1959, KHAMI RUINS; Sadr K, 2012, J ARCHAEOL SCI, V39, P1034, DOI 10.1016/j.jas.2011.11.024; Schoeman M. H., 2006, THESIS U WITWATERSRA; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Sinclair P.J., 1987, SPACE TIME SOCIAL FO; Suchman L., 1987, PLANS SITUATED ACTIO; Whitty A., 1961, OCCASIONAL PAPERS NA, V23A, P15; Wilmsen EN, 2009, J AFR ARCHAEOL, V7, P3, DOI 10.3213/1612-1651-10125; Wood M., 2012, THESIS UPPSALA U UPP; Yoffee N., 2005, MYTH ARCHAIC STATE E	57	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111224	10.1371/journal.pone.0111224	http://dx.doi.org/10.1371/journal.pone.0111224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AS0BN	25360782	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700075
J	Debelec-Butuner, B; Alapinar, C; Ertunc, N; Gonen-Korkmaz, C; Yorukoglu, K; Korkmaz, KS				Debelec-Butuner, Bilge; Alapinar, Cansu; Ertunc, Nursah; Gonen-Korkmaz, Ceren; Yorukoglu, Kutsal; Korkmaz, Kemal Sami			TNF alpha-Mediated Loss of beta-Catenin/E-Cadherin Association and Subsequent Increase in Cell Migration Is Partially Restored by NKX3.1 Expression in Prostate Cells	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER; WNT; PHOSPHORYLATION; ADHESION; INHIBITION; ADENOCARCINOMA; ACTIVATION; RECEPTOR; PATHWAY	Inflammation-induced carcinogenesis is associated with increased proliferation and migration/invasion of various types of tumor cells. In this study, altered beta-catenin signaling upon TNF alpha exposure, and relation to loss of function of the tumor suppressor NKX3.1 was examined in prostate cancer cells. We used an in vitro prostate inflammation model to demonstrate altered sub-cellular localization of beta-catenin following increased phosphorylation of Akt((S473)) and GSK3 beta((S9)). Consistently, we observed that subsequent increase in beta-catenin transactivation enhanced c-myc, cyclin D1 and MMP2 expressions. Consequently, it was also observed that the beta-catenin-E-cadherin association at the plasma membrane was disrupted during acute cytokine exposure. Additionally, it was demonstrated that disrupting cell-cell interactions led to increased migration of LNCaP cells in real-time migration assay. Nevertheless, ectopic expression of NKX3.1, which is degraded upon proinflammatory cytokine exposure in inflammation, was found to induce the degradation of beta-catenin by inhibiting Akt((S473)) phosphorylation, therefore, partially rescued the disrupted beta-catenin-E-cadherin interaction as well as the cell migration in LNCaP cells upon cytokine exposure. As, the disrupted localization of beta-catenin at the cell membrane as well as increased Akt((S308)) priming phosphorylation was observed in human prostate tissues with prostatic inflammatory atrophy (PIA), high-grade prostatic intraepithelial neoplasia (H-PIN) and carcinoma lesions correlated with loss of NKX3.1 expression. Thus, the data indicate that the beta-catenin signaling; consequently sub-cellular localization is deregulated in inflammation, associates with prostatic atrophy and PIN pathology.	[Debelec-Butuner, Bilge; Alapinar, Cansu; Ertunc, Nursah; Korkmaz, Kemal Sami] Ege Univ, Fac Engn, Canc Biol Lab, Dept Bioengn, Izmir, Turkey; [Debelec-Butuner, Bilge] Ege Univ, Fac Pharm, Dept Pharmaceut Biotechnol, Izmir, Turkey; [Gonen-Korkmaz, Ceren] Ege Univ, Dept Pharmacol, Izmir, Turkey; [Yorukoglu, Kutsal] Dokuz Eylul Univ, Fac Med, Dept Pathol, Izmir, Turkey	Ege University; Ege University; Ege University; Dokuz Eylul University	Korkmaz, KS (corresponding author), Ege Univ, Fac Engn, Canc Biol Lab, Dept Bioengn, Izmir, Turkey.	ks_korkmaz@yahoo.com	Korkmaz, Kemal Sami/ABI-5112-2020; Butuner, Bilge Debelec/ABB-5370-2020	Korkmaz, Kemal Sami/0000-0003-4040-2568; Butuner, Bilge Debelec/0000-0001-8112-9241	Turkish Scientific and Technological Research Council (TUBITAK) [108S288, 210T066, 110S134, 113Z083]	Turkish Scientific and Technological Research Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This research was granted by projects from Turkish Scientific and Technological Research Council (TUBITAK) 108S288 (COST_CANGENIN), 210T066 and 110S134 and 113Z083 to KSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Andl CD, 2004, AM J PHYSIOL-GASTR L, V287, pG1227, DOI 10.1152/ajpgi.00253.2004; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Debelec-Butuner B., 2012, MOL CARCINOG; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Erbaykent-Tepedelen B, 2011, BIOCHEM BIOPH RES CO, V414, P123, DOI 10.1016/j.bbrc.2011.09.035; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Hamid SM, 2014, MOL CELL ENDOCRINOL, V383, P38, DOI 10.1016/j.mce.2013.12.003; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Ho E, 2004, ARCH BIOCHEM BIOPHYS, V428, P109, DOI 10.1016/j.abb.2004.01.009; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Korkmaz KS, 2000, GENE, V260, P25, DOI 10.1016/S0378-1119(00)00453-4; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Lazari P, 2013, UROL INT, V90, P109, DOI 10.1159/000345057; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu ZM, 2004, CELL CYCLE, V3, P571; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oh M, 2009, J BIOL CHEM, V284, P28579, DOI 10.1074/jbc.M109.002659; Park CS, 2004, J BIOL CHEM, V279, P19592, DOI 10.1074/jbc.M314208200; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Tindall DJ, 1999, PROSTATE, V38, P166, DOI 10.1002/(SICI)1097-0045(19990201)38:2<166::AID-PROS11>3.0.CO;2-A; Varisli L, 2011, DNA CELL BIOL, V30, P419, DOI 10.1089/dna.2010.1128; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhurinsky J, 2000, J CELL SCI, V113, P3127	44	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109868	10.1371/journal.pone.0109868	http://dx.doi.org/10.1371/journal.pone.0109868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360740	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700018
J	Koszarska, M; Kucsma, N; Kiss, K; Varady, G; Gera, M; Antalffy, G; Andrikovics, H; Tordai, A; Studzian, M; Strapagiel, D; Pulaski, L; Tani, Y; Sarkadi, B; Szakacs, G				Koszarska, Magdalena; Kucsma, Nora; Kiss, Katalin; Varady, Gyorgy; Gera, Melinda; Antalffy, Geza; Andrikovics, Hajnalka; Tordai, Attila; Studzian, Maciej; Strapagiel, Dominik; Pulaski, Lukasz; Tani, Yoshihiko; Sarkadi, Balazs; Szakacs, Gergely			Screening the Expression of ABCB6 in Erythrocytes Reveals an Unexpectedly High Frequency of Lan Mutations in Healthy Individuals	PLOS ONE			English	Article							MEMBRANE-PROTEINS; MISSENSE MUTATIONS; STROMAL CELLS; TRANSPORTER; LOCALIZES	Lan is a high-incidence blood group antigen expressed in more than 99.9% of the population. Identification of the human ABC transporter ABCB6 as the molecular basis of Lan has opened the way for studies assessing the relation of ABCB6 function and expression to health and disease. To date, 34 ABCB6 sequence variants have been described in association with reduced ABCB6 expression based on the genotyping of stored blood showing weak or no reactivity with anti-Lan antibodies. In the present study we examined the red blood cell (RBC) surface expression of ABCB6 by quantitative flow cytometry in a cohort of 47 healthy individuals. Sequencing of the entire coding region of the ABCB6 gene in low RBC ABCB6 expressors identified a new allele (IVS9+1G>A, affecting a putative splice site at the boundary of exon 9) and two nonsynonymous SNPs listed in the SNP database (R192Q (rs150221689) and G588 S (rs145526996)). The R192Q mutation showed co-segregation with reduced RBC ABCB6 expression in a family, and we found the G588 S mutation in a compound heterozygous individual with undetectable ABCB6 expression, suggesting that both mutations result in weak or no expression of ABCB6 on RBCs. Analysis of the intracellular expression pattern in HeLa cells by confocal microscopy indicated that these mutations do not compromise overall expression or the endolysosomal localization of ABCB6. Genotyping of two large cohorts, containing 235 and 1039 unrelated volunteers, confirmed the high allele frequency of Lan-mutations. Our results suggest that genetic variants linked to lower or absent cell surface expression of ABCB6/Langereis may be more common than previously thought.	[Koszarska, Magdalena; Andrikovics, Hajnalka; Tordai, Attila; Sarkadi, Balazs] Hungarian Natl Blood Transfus Serv, Budapest, Hungary; [Kucsma, Nora; Kiss, Katalin; Varady, Gyorgy; Gera, Melinda; Antalffy, Geza; Sarkadi, Balazs; Szakacs, Gergely] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Sarkadi, Balazs] Semmelweis Univ, Hungarian Acad Sci, Mol Biophys Res Grp, H-1085 Budapest, Hungary; [Studzian, Maciej; Pulaski, Lukasz] Univ Lodz, Dept Mol Biophys, PL-90131 Lodz, Poland; [Strapagiel, Dominik] Univ Lodz, Dept Mol Biophys, Biobank Lab, PL-90131 Lodz, Poland; [Tani, Yoshihiko] Japanese Red Cross Kinki Block Blood Ctr, Osaka, Japan	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; Semmelweis University; University of Lodz; University of Lodz	Szakacs, G (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	szakacs.gergely@ttk.mta.hu	Szakacs, Gergely/A-2580-2009; Sarkadi, Balazs/I-5024-2013; Strapagiel, Dominik/L-3247-2013; György, Várady/J-8118-2017; Strapagiel, Dominik/AAD-4351-2020	Szakacs, Gergely/0000-0002-9311-7827; Strapagiel, Dominik/0000-0001-9752-4270; Pulaski, Lukasz/0000-0001-8063-801X; Studzian, Maciej/0000-0002-1881-3072	Lendulet Program of the Hungarian Academy of Sciences; OTKA [83533]; Polish POIG grant - EU through the European Regional Development Fund [01.01.02-10-005/08 TESTOPLEK]; Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences	Lendulet Program of the Hungarian Academy of Sciences; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Polish POIG grant - EU through the European Regional Development Fund; Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences	This work was supported by the Lendulet Program of the Hungarian Academy of Sciences (GS), OTKA 83533 and by the Polish POIG grant 01.01.02-10-005/08 TESTOPLEK, supported by the EU through the European Regional Development Fund. Hajnalka Andrikovics is a recipient of the Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cui YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079808; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daniels G., 2013, HUMAN BLOOD GROUPS; Daniels G, 2009, HUM GENET, V126, P729, DOI 10.1007/s00439-009-0738-2; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Della Valle MC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006403; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Haer-Wigman L, 2014, TRANSFUSION, V54, P1836, DOI 10.1111/trf.12544; Helias V, 2012, NAT GENET; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Kasza I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048423; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kusnierz-Alejska Grazyna, 1993, Acta Haematologica Polonica, V24, P169; Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087250; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; MANDERS EMM, 1992, J CELL SCI, V103, P857; Nedelkov D, 2008, PROTEOMICS, V8, P779, DOI 10.1002/pmic.200700501; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Pomozi V, 2014, J INVEST DERMATOL, V134, P946, DOI 10.1038/jid.2013.482; Reid ME, 2014, TRANSFUSION, V54, P398, DOI 10.1111/trf.12285; Saison C, 2013, VOX SANG, V104, P159, DOI 10.1111/j.1423-0410.2012.01650.x; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Tanaka M, 2014, TRANSFUSION, V54, P1438, DOI 10.1111/trf.12540; Tatrai P, 2012, BIOCHEM BIOPH RES CO, V422, P28, DOI 10.1016/j.bbrc.2012.04.088; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Turk D, 2009, CURR OPIN DRUG DISC, V12, P246; Tusnady GE, 2006, FEBS LETT, V580, P1017, DOI 10.1016/j.febslet.2005.11.040; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Varady G, 2013, BIOMARK MED, V7, P803, DOI 10.2217/bmm.13.90; Wang L, 2012, AM J HUM GENET; Wu L, 2013, NATURE; Zhang CE, 2013, J INVEST DERMATOL, V133, P2221, DOI 10.1038/jid.2013.145	44	15	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111590	10.1371/journal.pone.0111590	http://dx.doi.org/10.1371/journal.pone.0111590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360778	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000343943700125
J	Mei, J; Guo, QZ; Wu, Y; Li, YF				Mei, Jun; Guo, Qizhen; Wu, Yan; Li, Yunfei			Microbial Diversity of a Camembert-Type Cheese Using Freeze-Dried Tibetan Kefir Coculture as Starter Culture by Culture-Dependent and Culture-Independent Methods	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; PCR-DGGE ANALYSIS; LACTOBACILLUS-KEFIRANOFACIENS; SACCHAROMYCES-CEREVISIAE; LACTOCOCCUS-LACTIS; CHEDDAR CHEESE; VOLATILE COMPOUNDS; BRAZILIAN KEFIR; MIXED CULTURE; MILK CHEESE	The biochemical changes occurring during cheese ripening are directly and indirectly dependent on the microbial associations of starter cultures. Freeze-dried Tibetan kefir coculture was used as a starter culture in the Camembert-type cheese production for the first time. Therefore, it's necessary to elucidate the stability, organization and identification of the dominant microbiota presented in the cheese. Bacteria and yeasts were subjected to culture-dependent on selective media and culture-independent polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis (DGGE) analysis and sequencing of dominant bands to assess the microbial structure and dynamics through ripening. In further studies, kefir grains were observed using scanning electron microscopy (SEM) methods. A total of 147 bacteria and 129 yeasts were obtained from the cheese during ripening. Lactobacillus paracasei represents the most commonly identified lactic acid bacteria isolates, with 59 of a total of 147 isolates, followed by Lactococcus lactis (29 isolates). Meanwhile, Kazachstania servazzii (51 isolates) represented the mainly identified yeast isolate, followed by Saccharomyces cerevisiae (40 isolates). However, some lactic acid bacteria detected by sequence analysis of DGGE bands were not recovered by plating. The yeast S. cerevisiae and K. servazzii are described for the first time with kefir starter culture. SEM showed that the microbiota were dominated by a variety of lactobacilli (long and curved) cells growing in close association with a few yeasts in the inner portion of the grain and the short lactobacilli were observed along with yeast cells on the exterior portion. Results indicated that conventional culture method and PCR-DGGE should be combined to describe in maximal detail the microbiological composition in the cheese during ripening. The data could help in the selection of appropriate commercial starters for Camembert-type cheese.	[Mei, Jun; Guo, Qizhen; Wu, Yan; Li, Yunfei] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Technol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Technol, Shanghai 200030, Peoples R China.	yfli@sjtu.edu.cn	Jun, MEI/AAJ-7340-2020	Mei, Jun/0000-0002-1566-0365	Ministry of Science and Technology of the People's Republic of China [2013BAD18B02]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was funded by the Ministry of Science and Technology of the People's Republic of China with project reference no. 2013BAD18B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arfi K, 2002, APPL MICROBIOL BIOT, V58, P503, DOI 10.1007/s00253-001-0925-0; Beshkova DM, 2003, INT DAIRY J, V13, P529, DOI 10.1016/S0958-6946(03)00058-X; Bove CG, 2011, INT J FOOD MICROBIOL, V144, P569, DOI 10.1016/j.ijfoodmicro.2010.11.017; Boylston TD, 2004, INT DAIRY J, V14, P375, DOI 10.1016/j.idairyj.2003.08.008; Broadbent JR, 2013, J DAIRY SCI, V96, P4212, DOI 10.3168/jds.2012-6443; Buzzini P, 2005, ARCH MICROBIOL, V184, P187, DOI 10.1007/s00203-005-0043-y; Callon C, 2004, J DAIRY RES, V71, P231, DOI 10.1017/S0022029904000159; Cheirsilp B, 2003, J BIOSCI BIOENG, V96, P279, DOI 10.1016/S1389-1723(03)80194-9; Cheirsilp B, 2003, J BIOTECHNOL, V100, P43, DOI 10.1016/S0168-1656(02)00228-6; Chen L, 2012, APPL SOIL ECOL, V62, P24, DOI 10.1016/j.apsoil.2012.07.005; Chen YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078789; Cocolin L, 2002, INT DAIRY J, V12, P407, DOI 10.1016/S0958-6946(02)00023-7; Coppola R, 2003, LAIT, V83, P211, DOI 10.1051/lait:2003011; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; Depouilly A, 2004, LAIT, V84, P155, DOI 10.1051/lait:2003036; deRuyter PGGA, 1997, NAT BIOTECHNOL, V15, P976, DOI 10.1038/nbt1097-976; Dimitrellou D, 2007, J APPL MICROBIOL, V103, P1170, DOI 10.1111/j.1365-2672.2007.03337.x; Dimitrellou D, 2009, FOOD MICROBIOL, V26, P809, DOI 10.1016/j.fm.2009.05.006; Hamet MF, 2013, FOOD MICROBIOL, V36, P327, DOI 10.1016/j.fm.2013.06.022; Ferreira AD, 2003, INT J FOOD MICROBIOL, V86, P131, DOI 10.1016/S0168-1605(03)00252-6; Fontana C, 2005, J MICROBIOL METH, V63, P254, DOI 10.1016/j.mimet.2005.03.010; Goncu A, 2005, INT DAIRY J, V15, P771, DOI 10.1016/j.idairyj.2004.10.008; Guzel-Seydim Z, 2005, INT J DAIRY TECHNOL, V58, P25, DOI 10.1111/j.1471-0307.2005.00177.x; Jamet E, 2012, FOOD MICROBIOL, V31, P191, DOI 10.1016/j.fm.2012.03.009; Jany JL, 2008, FOOD MICROBIOL, V25, P839, DOI 10.1016/j.fm.2008.06.003; JOLLIVET N, 1994, J DAIRY RES, V61, P241, DOI 10.1017/S0022029900028259; KAMINARIDES SE, 1992, AUST J DAIRY TECHNOL, V47, P68; Katechaki E, 2008, J AGR FOOD CHEM, V56, P5316, DOI 10.1021/jf703585y; Kesmen Z, 2011, J FOOD SCI, V76, pM276, DOI 10.1111/j.1750-3841.2011.02191.x; Kleppen HP, 2012, APPL ENVIRON MICROB, V78, P6769, DOI 10.1128/AEM.00562-12; Kourkoutas Y, 2006, APPL ENVIRON MICROB, V72, P6124, DOI 10.1128/AEM.03078-05; Leclercq-Perlat MN, 2004, J DAIRY RES, V71, P346, DOI 10.1017/S0022029904000196; LEGRAET Y, 1988, LAIT, V68, P219, DOI 10.1051/lait:1988215; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Li MY, 2006, FOOD MICROBIOL, V23, P607, DOI 10.1016/j.fm.2006.01.004; Lisdiyanti P, 2000, J GEN APPL MICROBIOL, V46, P147, DOI 10.2323/jgam.46.147; Lortal S, 2005, INT DAIRY J, V15, P857, DOI 10.1016/j.idairyj.2004.08.024; Magalhaes KT, 2010, WORLD J MICROB BIOT, V26, P1241, DOI 10.1007/s11274-009-0294-x; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Mas M, 2002, LAIT, V82, P579, DOI 10.1051/lait:2002034; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Murtaza MA, 2014, CRIT REV FOOD SCI, V54, P1309, DOI 10.1080/10408398.2011.634531; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Petersen KM, 2002, J DAIRY SCI, V85, P478, DOI 10.3168/jds.S0022-0302(02)74098-8; Phillips M, 2006, INT J FOOD MICROBIOL, V108, P276, DOI 10.1016/j.ijfoodmicro.2005.12.009; Piermaria J, 2011, FOOD HYDROCOLLOID, V25, P1261, DOI 10.1016/j.foodhyd.2010.11.024; Renouf V, 2006, FOOD MICROBIOL, V23, P136, DOI 10.1016/j.fm.2005.01.019; Roostita R, 1996, INT J FOOD MICROBIOL, V28, P393, DOI 10.1016/0168-1605(95)00018-6; Settanni L, 2013, INT DAIRY J, V32, P126, DOI 10.1016/j.idairyj.2013.04.010; TOBA T, 1990, INT J FOOD MICROBIOL, V10, P219, DOI 10.1016/0168-1605(90)90069-H; van Iersel MFM, 1999, ENZYME MICROB TECH, V24, P407, DOI 10.1016/S0141-0229(98)00146-X; Wang YP, 2008, INT J BIOL MACROMOL, V43, P283, DOI 10.1016/j.ijbiomac.2008.06.011; Weinrichter B, 2001, LEBENSM-WISS TECHNOL, V34, P556, DOI 10.1006/fstl.2001.0799; Zheng YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069868, 10.1371/journal.pone.0080122]; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	58	18	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111648	10.1371/journal.pone.0111648	http://dx.doi.org/10.1371/journal.pone.0111648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360757	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700138
J	Nguyen, TT; Yoon, S; Yang, Y; Lee, HB; Oh, S; Jeong, MH; Kim, JJ; Yee, ST; Crisan, F; Moon, C; Lee, KY; Kim, KK; Hur, JS; Kim, H				Nguyen, Thanh Thi; Yoon, Somy; Yang, Yi; Lee, Ho-Bin; Oh, Soonok; Jeong, Min-Hye; Kim, Jong-Jin; Yee, Sung-Tae; Crisan, Florin; Moon, Cheol; Lee, Kwang Youl; Kim, Kyung Keun; Hur, Jae-Seoun; Kim, Hangun			Lichen Secondary Metabolites in Flavocetraria cucullata Exhibit Anti-Cancer Effects on Human Cancer Cells through the Induction of Apoptosis and Suppression of Tumorigenic Potentials	PLOS ONE			English	Article							USNIC ACID; IN-VITRO; METASTASIS; INHIBITORS; HT-29; LINES	Lichens are symbiotic organisms which produce distinct secondary metabolic products. In the present study, we tested the cytotoxic activity of 17 lichen species against several human cancer cells and further investigated the molecular mechanisms underlying their anti-cancer activity. We found that among 17 lichens species, F. cucullata exhibited the most potent cytotoxicity in several human cancer cells. High performance liquid chromatography analysis revealed that the acetone extract of F. cucullata contains usnic acid, salazinic acid, Squamatic acid, Baeomycesic acid, d-protolichesterinic acid, and lichesterinic acid as subcomponents. MTT assay showed that cancer cell lines were more vulnerable to the cytotoxic effects of the extract than non-cancer cell lines. Furthermore, among the identified subcomponents, usnic acid treatment had a similar cytotoxic effect on cancer cell lines but with lower potency than the extract. At a lethal dose, treatment with the extract or with usnic acid greatly increased the apoptotic cell population and specifically activated the apoptotic signaling pathway; however, using sub-lethal doses, extract and usnic acid treatment decreased cancer cell motility and inhibited in vitro and in vivo tumorigenic potentials. In these cells, we observed significantly reduced levels of epithelial-mesenchymal transition (EMT) markers and phosphor-Akt, while phosphor-c-Jun and phosphor-ERK1/2 levels were only marginally affected. Overall, the anti-cancer activity of the extract is more potent than that of usnic acid alone. Taken together, F. cucullata and its subcomponent, usnic acid together with additional component, exert anti-cancer effects on human cancer cells through the induction of apoptosis and the inhibition of EMT.	[Nguyen, Thanh Thi; Yang, Yi; Oh, Soonok; Jeong, Min-Hye; Hur, Jae-Seoun] Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea; [Nguyen, Thanh Thi] Tay Nguyen Univ, Fac Nat Sci & Technol, Buon Ma Thuot, Vietnam; [Yoon, Somy; Kim, Kyung Keun] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju, South Korea; [Lee, Ho-Bin; Kim, Jong-Jin; Yee, Sung-Tae; Moon, Cheol; Kim, Hangun] Sunchon Natl Univ, Coll Pharm, Sunchon, South Korea; [Lee, Ho-Bin; Kim, Jong-Jin; Yee, Sung-Tae; Moon, Cheol; Kim, Hangun] Sunchon Natl Univ, Res Inst Life & Pharmaceut Sci, Sunchon, South Korea; [Crisan, Florin] Univ Babes Bolyai, Fac Biol & Geol, Dept Taxon & Ecol, R-3400 Cluj Napoca, Romania; [Lee, Kwang Youl] Chonnam Natl Univ, Coll Pharm, Kwangju, South Korea	Sunchon National University; Tay Nguyen University; Chonnam National University; Sunchon National University; Sunchon National University; Babes Bolyai University from Cluj; Chonnam National University	Hur, JS (corresponding author), Sunchon Natl Univ, Korean Lichen Res Inst, Sunchon, South Korea.	jshur1@sunchon.ac.kr; hangunkim@sunchon.ac.kr	Crisan, Florin/V-1240-2017	Moon, Cheol/0000-0003-2342-0860	Basic Science Research Program through the National Research Foundation of Korea [NRF-2013R1A1A2004677, NRF-2013R1A2A2A07067609]; Korea National Research Resource Center Program [NRF-2012M3A9B8021726]; Sunchon Research Center for Natural Medicine	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korea National Research Resource Center Program; Sunchon Research Center for Natural Medicine	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF-2013R1A1A2004677, NRF-2013R1A2A2A07067609) and by the Korea National Research Resource Center Program (NRF-2012M3A9B8021726). This study also received support from a research grant funded by the Sunchon Research Center for Natural Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backor M, 2006, MYCOL RES, V110, P994, DOI 10.1016/j.mycres.2006.05.007; Backorova M, 2012, TOXICOL IN VITRO, V26, P462, DOI 10.1016/j.tiv.2012.01.017; Burlando B, 2009, PLANTA MED, V75, P607, DOI 10.1055/s-0029-1185329; Cardarelli M, 1997, CELL MOL LIFE SCI, V53, P667, DOI 10.1007/s000180050086; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; FAHSELT D, 1994, SYMBIOSIS, V16, P117; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gingrich JC, 2000, BIOTECHNIQUES, V29, P636, DOI 10.2144/00293pf02; Haraldsdottir S, 2004, PLANTA MED, V70, P1098, DOI 10.1055/s-2004-832657; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kumar S, 1999, J NAT PROD, V62, P817, DOI 10.1021/np9803777; KUPCHAN SM, 1975, EXPERIENTIA, V31, P625; Lecomte N, 2011, P NATL ACAD SCI USA, V108, P15074, DOI 10.1073/pnas.1015247108; Manojlovic N, 2012, PHYTOMEDICINE, V19, P1166, DOI 10.1016/j.phymed.2012.07.012; Mayer M, 2005, ANTI-CANCER DRUG, V16, P805, DOI 10.1097/01.cad.0000175588.09070.77; Molnar K, 2010, Z NATURFORSCH C, V65, P157; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Ren MR, 2009, FOOD CHEM TOXICOL, V47, P2157, DOI 10.1016/j.fct.2009.05.042; Russo A, 2012, CHEM-BIOL INTERACT, V195, P1, DOI 10.1016/j.cbi.2011.10.005; Shrestha G, 2013, PHYTOCHEM REV, V12, P229, DOI 10.1007/s11101-013-9283-7; Shukla V, 2010, PHYTOCHEM REV, V9, P303, DOI 10.1007/s11101-010-9189-6; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh N, 2013, NUTR CANCER, V65, P36, DOI 10.1080/01635581.2013.785007; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; TAKAI M, 1979, J MED CHEM, V22, P1380, DOI 10.1021/jm00197a019; Wang JG, 2014, MOL CELL PROTEOMICS, V13, P876, DOI 10.1074/mcp.M113.029793; WHO, 2013, WORLD HLTH STAT; Zambare VP, 2012, PHARM BIOL, V50, P778, DOI 10.3109/13880209.2011.633089	30	46	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111575	10.1371/journal.pone.0111575	http://dx.doi.org/10.1371/journal.pone.0111575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360754	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700124
J	Omosa-Manyonyi, G; Park, H; Mutua, G; Farah, B; Bergin, PJ; Laufer, D; Lehrman, J; Chinyenze, K; Barin, B; Fast, P; Gilmour, J; Anzala, O				Omosa-Manyonyi, Gloria; Park, Harriet; Mutua, Gaudensia; Farah, Bashir; Bergin, Philip J.; Laufer, Dagna; Lehrman, Jennifer; Chinyenze, Kundai; Barin, Burc; Fast, Pat; Gilmour, Jill; Anzala, Omu			Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya	PLOS ONE			English	Article							ACQUISITION; SEX	Background: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low risk of HIV and other sexually transmitted infections. Methods and Findings: The Kenya AIDS Vaccine Initiative (KAVI) enrolled participants into three Phase 1 trials of preventive HIV candidate vaccines in 2011-2012 at two clinical research centers in Nairobi. After informed consent to a mucosal sub-study, participants were asked to undergo collection of mucosal secretions (saliva, oral fluids, semen, cervico-vaginal and rectal), but could opt out of any collection at any visit. Specimens were collected at baseline and two additional time points. A tolerability questionnaire was administered at the final sub-study visit. Of 105 trial participants, 27 of 34 women (79%) and 62 of 71 men (87%) enrolled in the mucosal sub-study. Nearly all sub-study participants gave saliva and oral fluids at all visits. Semen was collected from about half the participating men (47-48%) at all visits. Cervico-vaginal secretions were collected by Softcup from about two thirds of women (63%) at baseline, increasing to 78% at the following visits, with similar numbers for cervical secretion collection by Merocel sponge; about half of women (52%) gave cervico-vaginal samples at all visits. Rectal secretions were collected with Merocel sponge from about a quarter of both men and women (24%) at all 3 visits, with 16% of men and 19% of women giving rectal samples at all visits. Conclusions: Repeated mucosal sampling in clinical trial participants in Kenya is feasible, with a good proportion of participants consenting to most sampling methods with the exception of rectal samples. Experienced staff members of both sexes and trained counselors with standardized messaging may improve acceptance of rectal sampling.	[Omosa-Manyonyi, Gloria; Mutua, Gaudensia; Farah, Bashir; Anzala, Omu] Univ Nairobi, Inst Clin Res, Kenya AIDS Vaccine Initiat, Nairobi, Kenya; [Park, Harriet; Laufer, Dagna; Lehrman, Jennifer; Chinyenze, Kundai; Fast, Pat] Int AIDS Vaccine Initiat, New York, NY USA; [Bergin, Philip J.; Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, IAVI Human Immunol Lab, London, England; [Barin, Burc] EMMES Corp, Rockville, MD USA	University of Nairobi; International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; Emmes Corporation	Park, H (corresponding author), Univ Nairobi, Inst Clin Res, Kenya AIDS Vaccine Initiat, Nairobi, Kenya.	hpark@iavi.org		Bergin, Philip/0000-0001-5522-8350	Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); OPEC Fund for International Development (OFID); OPEC Member States; EMMES	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); OPEC Fund for International Development (OFID); OPEC Member States; EMMES	IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. This study was made possible by the generous support of the American people through USAID. The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government. Funding was also provided by the OPEC Fund for International Development (OFID), a development finance institution of the OPEC Member States, established to provide financial support for socio-economic development, particularly for low-income countries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Burc Barin is employed by The EMMES Corporation. EMMES provided support in the form of salary for author BB and other EMMES employees involved in the study design, data collection and analysis, and preparation of the manuscript. The specific role of the author BB is articulated in the 'author contributions' section. The EMMES Corporation otherwise did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castle PE, 2004, CLIN DIAGN LAB IMMUN, V11, P399, DOI 10.1128/CDLI.11.2.399-405.2004; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hasselrot K, 2009, AIDS, V23, P329, DOI 10.1097/QAD.0b013e32831f924c; Hirbod T, 2007, J INTERN MED, V262, P44, DOI 10.1111/j.1365-2796.2007.01822.x; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Kaul R, 2011, SEX TRANSM INFECT, V87, P125, DOI 10.1136/sti.2009.040931; Leroux-Roels G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055438; Musey L, 2003, J IMMUNOL, V171, P1094, DOI 10.4049/jimmunol.171.2.1094; North BB, 2011, J WOMENS HEALTH, V20, P303, DOI 10.1089/jwh.2009.1929; Pialoux G, 2008, VACCINE, V26, P2657, DOI 10.1016/j.vaccine.2007.11.002; Price CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024095; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Schneider JA, 2007, J INFECT DIS, V196, P1637, DOI 10.1086/522232; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560	16	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110228	10.1371/journal.pone.0110228	http://dx.doi.org/10.1371/journal.pone.0110228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360819	gold, Green Published, Green Submitted			2022-12-27	WOS:000343943700027
J	Pitts, RJ; Derryberry, SL; Pulous, FE; Zwiebel, LJ				Pitts, R. Jason; Derryberry, Stephen L., Jr.; Pulous, Fadi E.; Zwiebel, Laurence J.			Antennal-Expressed Ammonium Transporters in the Malaria Vector Mosquito Anopheles gambiae	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; OLFACTORY RECEPTORS; AMT/MEP/RH FAMILY; NH4+; PROTEIN; AMTB; IDENTIFICATION; EVOLUTION; NEURONS; CARRIER	The principal Afrotropical malaria vector mosquito, Anopheles gambiae remains a significant threat to human health. In this anthropophagic species, females detect and respond to a range of human-derived volatile kairomones such as ammonia, lactic acid, and other carboxylic acids in their quest for blood meals. While the molecular underpinnings of mosquito olfaction and host seeking are becoming better understood, many questions remain unanswered. In this study, we have identified and characterized two candidate ammonium transporter genes, AgAmt and AgRh50 that are expressed in the mosquito antenna and may contribute to physiological and behavioral responses to ammonia, which is an important host kairomone for vector mosquitoes. AgAmt transcripts are highly enhanced in female antennae while a splice variant of AgRh50 appears to be antennal-specific. Functional expression of AgAmt in Xenopus laevis oocytes facilitates inward currents in response to both ammonium and methylammonium, while AgRh50 is able to partially complement a yeast ammonium transporter mutant strain, validating their conserved roles as ammonium transporters. We present evidence to suggest that both AgAmt and AgRh50 are in vivo ammonium transporters that are important for ammonia sensitivity in An. gambiae antennae, either by clearing ammonia from the sensillar lymph or by facilitating sensory neuron responses to environmental exposure. Accordingly, AgAmt and AgRh50 represent new and potentially important targets for the development of novel vector control strategies.	[Pitts, R. Jason; Derryberry, Stephen L., Jr.; Pulous, Fadi E.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Pitts, R. Jason; Zwiebel, Laurence J.] Vanderbilt Inst Global Hlth, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Dept Pharmacol,Program Dev Biol, Nashville, TN 37235 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Chem Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zwiebel, LJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	l.zwiebel@vanderbilt.edu		Pulous, Fadi/0000-0002-0794-8078; Pitts, Jason/0000-0002-4863-9634; Zwiebel, Laurence/0000-0001-6686-7289	Vanderbilt University Innovation and Discovery in Engineering and Science; National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI056402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER	Vanderbilt University Innovation and Discovery in Engineering and Science; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Vanderbilt University Innovation and Discovery in Engineering and Science (www.vanderbilt.edu), and National Institutes of Health, National Institute of Allergy and Infectious Diseases AI056402, (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; Campbell R, 2002, BIOLOGY, P925; Carey AF, 2010, NATURE, P1; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Cougnon M, 1996, PFLUG ARCH EUR J PHY, V431, P658, DOI 10.1007/BF02191917; Coutts G, 2002, EMBO J; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Day DA, 2001, CELL MOL LIFE SCI, V58, P61, DOI 10.1007/PL00000778; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Guo M, 2014, INT J BIOL SCI, V10, P1, DOI 10.7150/ijbs.7624; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang CH, 2010, CELL MOL LIFE SCI, V67, P1203, DOI 10.1007/s00018-009-0217-x; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067; Khademi S, 2006, PHYSIOLOGY, V21, P419, DOI 10.1152/physiol.00051.2005; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ludewlg U, 2007, FEBS LETT, V581, P2301, DOI 10.1016/j.febslet.2007.03.034; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakhoul NL, 2013, MOL ASPECTS MED, V34, P629, DOI 10.1016/j.mam.2012.05.013; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; Neuhauser B, 2014, J BIOL CHEM, V289, P11650, DOI 10.1074/jbc.C114.552802; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Omasits U, 2013, BIOINFORMATICS; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santi C, 2013, ANN BOT-LONDON, V111, P743, DOI 10.1093/aob/mct048; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schymura D, 2010, INT J BIOL SCI, V6, P614; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Sparks JT, 2013, INSECT BIOCHEM MOLEC, V43, P1161, DOI 10.1016/j.ibmb.2013.10.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tremblay PL, 2008, J BACTERIOL, V190, P1588, DOI 10.1128/JB.01643-07; Tremblay PL, 2009, MOL MICROBIOL, V71, P12, DOI 10.1111/j.1365-2958.2008.06514.x; von Wiren N, 2004, TOP CURR GENET, V9, P95; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Weiner ID, 2013, COMPR PHYSIOL, V3, P201, DOI 10.1002/cphy.c120010; WHO, 2011, WHO TECH REP SER, V959, P1; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Yakunin AF, 2002, J BACTERIOL, V184, P4081, DOI 10.1128/JB.184.15.4081-4088.2002	65	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111858	10.1371/journal.pone.0111858	http://dx.doi.org/10.1371/journal.pone.0111858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360676	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700156
J	Verburg, IWM; de Keizer, NF; de Jonge, E; Peek, N				Verburg, Ilona W. M.; de Keizer, Nicolette F.; de Jonge, Evert; Peek, Niels			Comparison of Regression Methods for Modeling Intensive Care Length of Stay	PLOS ONE			English	Article							EVALUATION APACHE IV; ACUTE PHYSIOLOGY; MORTALITY; PERFORMANCE; PREDICTION; OUTCOMES; SURGERY; SYSTEM	Intensive care units (ICUs) are increasingly interested in assessing and improving their performance. ICU Length of Stay (LoS) could be seen as an indicator for efficiency of care. However, little consensus exists on which prognostic method should be used to adjust ICU LoS for case-mix factors. This study compared the performance of different regression models when predicting ICU LoS. We included data from 32,667 unplanned ICU admissions to ICUs participating in the Dutch National Intensive Care Evaluation (NICE) in the year 2011. We predicted ICU LoS using eight regression models: ordinary least squares regression on untransformed ICU LoS, LoS truncated at 30 days and log-transformed LoS; a generalized linear model with a Gaussian distribution and a logarithmic link function; Poisson regression; negative binomial regression; Gamma regression with a logarithmic link function; and the original and recalibrated APACHE IV model, for all patients together and for survivors and non-survivors separately. We assessed the predictive performance of the models using bootstrapping and the squared Pearson correlation coefficient (R-2), root mean squared prediction error (RMSPE), mean absolute prediction error (MAPE) and bias. The distribution of ICU LoS was skewed to the right with a median of 1.7 days (interquartile range 0.8 to 4.0) and a mean of 4.2 days (standard deviation 7.9). The predictive performance of the models was between 0.09 and 0.20 for R-2, between 7.28 and 8.74 days for RMSPE, between 3.00 and 4.42 days for MAPE and between 22.99 and 1.64 days for bias. The predictive performance was slightly better for survivors than for non-survivors. We were disappointed in the predictive performance of the regression models and conclude that it is difficult to predict LoS of unplanned ICU admissions using patient characteristics at admission time only.	[Verburg, Ilona W. M.; de Keizer, Nicolette F.; Peek, Niels] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [de Jonge, Evert] Leiden Univ, Med Ctr, Dept Intens Care, Leiden, Netherlands; [Peek, Niels] Univ Manchester, Ctr Hlth Informat, Hlth eRes Ctr, Manchester, Lancs, England	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Manchester	Verburg, IWM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.w.verburg@amc.uva.nl	Peek, Niels/AAD-9334-2019	Peek, Niels/0000-0002-6393-9969	NICE foundation; MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1] Funding Source: researchfish	NICE foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The NICE foundation (http://www.stichting-nice.nl) pays the department of Medical Informatics, Academic Medical Center for the processing and analyses of the data in the NICE registry. The NICE board assesses each study application on the registry, including this study, on scientific quality, feasibility, and privacy aspects.	Al Tehewy M, 2010, INT J HEALTH CARE Q, V23, P277, DOI 10.1108/09526861011029343; Austin PC, 2002, HLTH SERV OUTCOME RE, V3, P107, DOI DOI 10.1023/A:1024260023851; BECKER RB, 1995, J CARDIOVASC SURG, V36, P1; Becker RB, 1996, CRIT CARE CLIN, V12, P503, DOI 10.1016/S0749-0704(05)70258-X; Brinkman S, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.07.007; Hastie T, 2001, ELEMENTS STAT LEARNI, P115; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kramer AA, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-27; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Nathanson BH, 2007, CRIT CARE MED, V35, P1853, DOI 10.1097/01.CCM.0000275272.57237.53; Niskanen M, 2009, INTENS CARE MED, V35, P1060, DOI 10.1007/s00134-008-1377-0; R Foundation for Statistical Computing, 2005, LANG ENV STAT COMP; Rapoport J, 2003, MED CARE, V41, P386, DOI 10.1097/00005650-200303000-00007; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Steyerberg EW, 2009, CLIN PREDICTION MODE, P83, DOI DOI 10.1007/978-0-387-77244-8_5; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Vasilevskis EE, 2009, CHEST, V136, P89, DOI 10.1378/chest.08-2591; Widyastuti Y, 2012, INTERACT CARDIOV TH, V15, P825, DOI 10.1093/icvts/ivs302; Woods AW, 2000, ANAESTHESIA, V55, P1058, DOI 10.1046/j.1365-2044.2000.01552.x; Zhou Z.-H, 2012, ENSEMBLE METHODS FDN, DOI DOI 10.1201/B12207; Zimmerman JE, 2008, CURR OPIN CRIT CARE, V14, P491, DOI 10.1097/MCC.0b013e32830864c0; Zimmerman JE, 2006, CRIT CARE MED, V34, P2517, DOI 10.1097/01.CCM.0000240233.01711.D9; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	25	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e109684	10.1371/journal.pone.0109684	http://dx.doi.org/10.1371/journal.pone.0109684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360612	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700015
J	Waltman, L; van Raan, AFJ; Smart, S				Waltman, Ludo; van Raan, Anthony F. J.; Smart, Sue			Exploring the Relationship between the Engineering and Physical Sciences and the Health and Life Sciences by Advanced Bibliometric Methods	PLOS ONE			English	Article							INTERDISCIPLINARITY; MAP	We investigate the extent to which advances in the health and life sciences (HLS) are dependent on research in the engineering and physical sciences (EPS), particularly physics, chemistry, mathematics, and engineering. The analysis combines two different bibliometric approaches. The first approach to analyze the 'EPS-HLS interface' is based on term map visualizations of HLS research fields. We consider 16 clinical fields and five life science fields. On the basis of expert judgment, EPS research in these fields is studied by identifying EPS-related terms in the term maps. In the second approach, a large-scale citation-based network analysis is applied to publications from all fields of science. We work with about 22,000 clusters of publications, each representing a topic in the scientific literature. Citation relations are used to identify topics at the EPS-HLS interface. The two approaches complement each other. The advantages of working with textual data compensate for the limitations of working with citation relations and the other way around. An important advantage of working with textual data is in the in-depth qualitative insights it provides. Working with citation relations, on the other hand, yields many relevant quantitative statistics. We find that EPS research contributes to HLS developments mainly in the following five ways: new materials and their properties; chemical methods for analysis and molecular synthesis; imaging of parts of the body as well as of biomaterial surfaces; medical engineering mainly related to imaging, radiation therapy, signal processing technology, and other medical instrumentation; mathematical and statistical methods for data analysis. In our analysis, about 10% of all EPS and HLS publications are classified as being at the EPS-HLS interface. This percentage has remained more or less constant during the past decade.	[Waltman, Ludo; van Raan, Anthony F. J.] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; EPSRC, Swindon, Wilts, England	Leiden University; Leiden University - Excl LUMC; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC)	Waltman, L (corresponding author), Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands.	waltmanlr@cwts.leidenuniv.nl	Waltman, Ludo/B-5561-2008	Waltman, Ludo/0000-0001-8249-1752; van Raan, Anthony/0000-0001-8980-5937				Boyack KW, 2014, J ASSOC INF SCI TECH, V65, P670, DOI 10.1002/asi.22990; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Klavans R, 2009, J AM SOC INF SCI TEC, V60, P455, DOI 10.1002/asi.20991; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226; Merrill SA, 2013, ISSUES SCI TECHNOLOG; Morillo F, 2003, J AM SOC INF SCI TEC, V54, P1237, DOI 10.1002/asi.10326; PETERS HPF, 1993, RES POLICY, V22, P23, DOI 10.1016/0048-7333(93)90031-C; PORTER AL, 1985, SCIENTOMETRICS, V8, P161, DOI 10.1007/BF02016934; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; Raan Van, 2000, PRACTISING INTERDISC, P66; Rafols I, 2012, RES POLICY, V41, P1262, DOI 10.1016/j.respol.2012.03.015; Small H, 2014, RES POLICY, V43, P1450, DOI 10.1016/j.respol.2014.02.005; van Eck N.J., 2011, ARXIV11092058, DOI DOI 10.48550/ARXIV.1109.2058; van Eck NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062395; van Eck NJ, 2010, J AM SOC INF SCI TEC, V61, P2405, DOI 10.1002/asi.21421; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Van Eck NJ, MEASURING S IN PRESS; VANRAAN AFJ, 1993, SCIENTOMETRICS, V26, P169, DOI 10.1007/BF02016799; Varmus H, 2000, APS NEWS, V9, P4; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2378, DOI 10.1002/asi.22748	20	13	15	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111530	10.1371/journal.pone.0111530	http://dx.doi.org/10.1371/journal.pone.0111530			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360616	gold, Green Submitted, Green Published			2022-12-27	WOS:000343943700113
J	Wang, XB; Zhang, HW; Gao, YL; Sun, GL; Zhang, WM; Qiu, LJ				Wang, Xiaobo; Zhang, Haowei; Gao, Yali; Sun, Genlou; Zhang, Wenming; Qiu, Lijuan			A Comprehensive Analysis of the Cupin Gene Family in Soybean (Glycine max)	PLOS ONE			English	Article							GERMIN-LIKE PROTEINS; SUPEROXIDE-DISMUTASE ACTIVITY; OXALATE OXIDASE; MESSENGER-RNA; WHOLE-GENOME; SEQUENCE; EVOLUTIONARY; DIVERSIFICATION; DUPLICATION; DIVERSITY	Cupin superfamily of proteins, including germin and germin-like proteins (GLPs) from higher plants, is known to play crucial roles in plant development and defense. To date, no systematic analysis has been conducted in soybean (Glycine max) incorporating genome organization, gene structure, expression compendium. In this study, 69 putative Cupin genes were identified from the whole-genome of soybean, which were non-randomly distributed on 17 of the 20 chromosomes. These Gmcupin proteins were phylogenetically clustered into ten distinct subgroups among which the gene structures were highly conserved. Eighteen pairs (52.2%) of duplicate paralogous genes were preferentially retained in duplicated regions of the soybean genome. The distributions of GmCupin genes implied that long segmental duplications contributed significantly to the expansion of the GmCupin gene family. According to the RNA-seq data analysis, most of the Gmcupins were differentially expressed in tissue-specific expression pattern and the expression of some duplicate genes were partially redundant while others showed functional diversity, suggesting the Gmcupins have been retained by substantial subfunctionalization during soybean evolutionary processes. Selective analysis based on single nucleotide polymorphisms (SNPs) in cultivated and wild soybeans revealed sixteen Gmcupins had selected site(s), with all SNPs in Gmcupin10.3 and Gmcupin07.2 genes were selected sites, which implied these genes may have undergone strong selection effects during soybean domestication. Taken together, our results contribute to the functional characterization of Gmcupin genes in soybean.	[Wang, Xiaobo; Zhang, Haowei; Gao, Yali; Sun, Genlou; Zhang, Wenming] Anhui Agr Univ, Sch Agron, Hefei, Peoples R China; [Qiu, Lijuan] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat,Minist Agr, Beijing 100193, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Anhui Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Saint Marys University - Canada	Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Gene Resources & Genet Improvement, Key Lab Crop Germplasm Utilizat,Minist Agr, Beijing 100193, Peoples R China.	qiulijuan@caas.cn	wang, xiaobo/T-7023-2019		National Natural Science Foundation of China [31201226]; National Natural Science Foundation of Anhui Province [1308085QC49]; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Anhui Province; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	This study was supported by the National Natural Science Foundation of China (31201226), the National Natural Science Foundation of Anhui Province (1308085QC49) and the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Cannon SB, 2011, BREEDING SCI, V61, P437, DOI 10.1270/jsbbs.61.437; Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Carter C, 1998, PLANT MOL BIOL, V38, P929, DOI 10.1023/A:1006038117130; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Druka A, 2002, P NATL ACAD SCI USA, V99, P850, DOI 10.1073/pnas.022627999; Dunwell J M, 1998, Microb Comp Genomics, V3, P141, DOI 10.1089/omi.1.1998.3.141; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Ham BK, 2012, PLANT CELL, V24, P3630, DOI 10.1105/tpc.112.101063; JAIKARAN ASI, 1990, J BIOL CHEM, V265, P12503; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Leon-Galvan F, 2011, INT J MOL SCI, V12, P7301, DOI 10.3390/ijms12117301; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Y, 2011, PLANT GROWTH REGUL, V63, P225, DOI 10.1007/s10725-010-9519-0; Lu M, 2010, BMC GENOMICS, P11; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Nakata M, 2002, PLANT CELL PHYSIOL, V43, pS55; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; PELAH D, 1995, TREE PHYSIOL, V15, P673, DOI 10.1093/treephys/15.10.673; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON EW, 1980, J BIOL CHEM, V255, P5965; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Woo EJ, 2000, ACTA CRYSTALLOGR D, V56, P1476, DOI 10.1107/S0907444900010714; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Yamahara T, 1999, J BIOL CHEM, V274, P33274, DOI 10.1074/jbc.274.47.33274	46	16	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e110092	10.1371/journal.pone.0110092	http://dx.doi.org/10.1371/journal.pone.0110092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BN	25360675	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943700024
J	Yasaitis, LC; Bubolz, T; Skinner, JS; Chandra, A				Yasaitis, Laura C.; Bubolz, Thomas; Skinner, Jonathan S.; Chandra, Amitabh			Local Population Characteristics and Hemoglobin A1c Testing Rates among Diabetic Medicare Beneficiaries	PLOS ONE			English	Article							HEALTH-CARE; RACIAL DISPARITIES; QUALITY; NEIGHBORHOOD; HOSPITALS	Background: Proposed payment reforms in the US healthcare system would hold providers accountable for the care delivered to an assigned patient population. Annual hemoglobin A1c (HbA1c) tests are recommended for all diabetics, but some patient populations may face barriers to high quality healthcare that are beyond providers' control. The magnitude of fine-grained variations in care for diabetic Medicare beneficiaries, and their associations with local population characteristics, are unknown. Methods: HbA1c tests were recorded for 480,745 diabetic Medicare beneficiaries. Spatial analysis was used to create ZIP code-level estimated testing rates. Associations of testing rates with local population characteristics that are outside the control of providers - population density, the percent African American, with less than a high school education, or living in poverty - were assessed. Results: In 2009, 83.3% of diabetic Medicare beneficiaries received HbA1c tests. Estimated ZIP code-level rates ranged from 71.0% in the lowest decile to 93.1% in the highest. With each 10% increase in the percent of the population that was African American, associated HbA1c testing rates were 0.24% lower (95% CI -0.32--0.17); for identical increases in the percent with less than a high school education or the percent living in poverty, testing rates were 0.70% lower (-0.95--0.46) and 1.6% lower (-1.8--1.4), respectively. Testing rates were lowest in the least and most densely populated ZIP codes. Population characteristics explained 5% of testing rate variations. Conclusions: HbA1c testing rates are associated with population characteristics, but these characteristics fail to explain the vast majority of variations. Consequently, even complete risk-adjustment may have little impact on some process of care quality measures; much of the ZIP code-related variations in testing rates likely result from provider-based differences and idiosyncratic local factors not related to poverty, education, or race.	[Yasaitis, Laura C.] Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Bubolz, Thomas; Skinner, Jonathan S.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Dartmouth College; Dartmouth College; Harvard University	Yasaitis, LC (corresponding author), Harvard Univ, Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	yasaitis@hsph.harvard.edu			National Institute of Aging [PO1 AG19783-11]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work of all authors (LCY TB JSS AC) on this study was funded by a grant from the National Institute of Aging (http://www.nia.nih.gov), PO1 AG19783-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Baicker K, 2004, HEALTH AFFAIR, V23, pVAR33, DOI 10.1377/hlthaff.var.33; Baker LC, 2010, HEALTH AFFAIR, V29, P2068, DOI 10.1377/hlthaff.2009.0810; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bell S, 2013, ANN ASSOC AM GEOGR, V103, P85, DOI 10.1080/00045608.2012.685050; Blustein J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000297; Bynum JPW, 2010, MED CARE, V48, P1057, DOI 10.1097/MLR.0b013e3181f37fcf; Casper ML, 2008, ATLAS STROKE HOSPITA; CMS, 2012, HOSP COMP DAT WHAT A; CRESSIE N, 1989, BIOMETRICAL J, V31, P699, DOI 10.1002/bimj.4710310607; Harrington DW, 2012, HEALTH PLACE, V18, P814, DOI 10.1016/j.healthplace.2012.03.011; HRSA, 2013, WHAT IS HLTH CTR; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lewis VA, 2012, HEALTH AFFAIR, V31, P1777, DOI 10.1377/hlthaff.2012.0490; National Quality Forum, 2014, RISK ADJ SOC FACT; NCQA, 2012, NCQA HEDIS QUAL MEAS; Openshaw S., 1984, MODIFIABLE AREAL UNI; Ryan AM, 2012, HEALTH SERV RES, V47, P1418, DOI 10.1111/j.1475-6773.2012.01393.x; Talbot TO, 2000, STAT MED, V19, P2399, DOI 10.1002/1097-0258(20000915/30)19:17/18<2399::AID-SIM577>3.3.CO;2-I; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Waller L.A., 2004, APPL SPATIAL STAT PU; Wennberg J. E., 1996, DARTMOUTH ATLAS HLTH; Zhang YT, 2012, NEW ENGL J MED, V367, P1724, DOI 10.1056/NEJMsa1203980	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2014	9	10							e111119	10.1371/journal.pone.0111119	http://dx.doi.org/10.1371/journal.pone.0111119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AS0BN	25360615	Green Published, gold, Green Submitted			2022-12-27	WOS:000343943700064
J	Boscari, E; Pujolar, JM; Dupanloup, I; Corradin, R; Congiu, L				Boscari, Elisa; Pujolar, Jose Martin; Dupanloup, Isabelle; Corradin, Riccardo; Congiu, Leonardo			Captive Breeding Programs Based on Family Groups in Polyploid Sturgeons	PLOS ONE			English	Article							CONSERVATION GENETICS; MICROSATELLITE LOCI; ACIPENSER; MANAGEMENT; MARKERS	In species with long life cycles and discontinuous availability of individuals to reproduction, implementing a long-term captive breeding program can be difficult or impossible. In such cases, managing diversity among familiar groups instead of individuals could become a suitable approach to avoid inbreeding and increase the possibility to accomplish a breeding scheme. This is the case of several sturgeon species including the Adriatic sturgeon, whose recovery depends on the management of a few captive stocks directly descended from the same group of wild parents. In the present study, relatedness among 445 potential breeders was inferred with a novel software for pedigree reconstruction in tetraploids ("BreedingSturgeons''). This information was used to plan a breeding scheme considering familiar groups as breeding units and identifying mating priorities. A two-step strategy is proposed: a short-term breeding program, relying on the 13 remaining F0 individuals of certain wild origin; and a long-term plan based on F1 families. Simulations to evaluate the loss of alleles in the F2 generation under different pairing strategies and assess the number of individuals to breed, costs and logistical aquaculture constraints were performed. The strategy proposed is transferable to the several other tetraploid sturgeon species on the brink of extinction.	[Boscari, Elisa; Congiu, Leonardo] Univ Padua, Dept Biol, Padua, Italy; [Pujolar, Jose Martin] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Dupanloup, Isabelle] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Dupanloup, Isabelle] Swiss Inst Bioinformat, Lausanne, Switzerland; [Corradin, Riccardo] Univ Padua, Dept Stat, Padua, Italy	University of Padua; Aarhus University; University of Bern; Swiss Institute of Bioinformatics; University of Padua	Boscari, E (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	elisa.boscari@gmail.com	Congiu, Leonardo/G-7967-2011; Dupanloup, Isabelle/O-8609-2017; Dupanloup, Isabelle/AAD-5372-2020	Dupanloup, Isabelle/0000-0002-9258-6963; CONGIU, LEONARDO/0000-0002-9293-9837; pujolar, marti/0000-0002-5037-8840; CORRADIN, RICCARDO/0000-0001-5389-6873; Boscari, Elisa/0000-0001-8881-9907	"Parco Regionale Veneto del Delta del Po'' Progetto [2022EPPR12]	"Parco Regionale Veneto del Delta del Po'' Progetto	Research was funded by the "Parco Regionale Veneto del Delta del Po'' Progetto 2022EPPR12. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders PJ, 2011, J APPL ICHTHYOL, V27, P3, DOI 10.1111/j.1439-0426.2011.01830.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Boscari E, 2014, J APPL ICHTHYOL, V30, P1416, DOI 10.1111/jai.12545; Boscari E, 2014, MOL ECOL RESOUR, V14, P489, DOI 10.1111/1755-0998.12203; Boscari E, 2011, AQUACULTURE, V321, P223, DOI 10.1016/j.aquaculture.2011.09.015; Bronzi P, 1999, J APPL ICHTHYOL, V15, P224, DOI 10.1111/j.1439-0426.1999.tb00239.x; Chebanov M., 2011, 570 FAO; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Congiu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018249; Fontana F, 1999, GENOME, V42, P1008, DOI 10.1139/gen-42-5-1008; Forlani A, 2008, CONSERV GENET, V9, P461, DOI 10.1007/s10592-007-9335-x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Goldstein PZ, 2000, CONSERV BIOL, V14, P120, DOI 10.1046/j.1523-1739.2000.98122.x; Hayes B, 2006, AQUACULTURE, V255, P573, DOI 10.1016/j.aquaculture.2005.11.038; Henderson-Arzapalo A, 2002, MOL ECOL NOTES, V2, P437, DOI 10.1046/j.1471-8286.2002.00262.x; Hood G.M., 2010, POPTOOLS VERSION 3 2; Ivy JA, 2012, J HERED, V103, P186, DOI 10.1093/jhered/esr129; Kozfkay CC, 2008, CONSERV GENET, V9, P1421, DOI 10.1007/s10592-007-9466-0; Leus K, 2011, ZOOL MIDDLE EAST, P151; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludwig A, 2006, EUR J WILDLIFE RES, V52, P3, DOI 10.1007/s10344-005-0006-2; May B, 1997, CAN J FISH AQUAT SCI, V54, P1542, DOI 10.1139/cjfas-54-7-1542; PHILIPPART JC, 1995, BIOL CONSERV, V72, P281, DOI 10.1016/0006-3207(94)00090-D; Russello MA, 2004, MOL ECOL, V13, P2829, DOI 10.1111/j.1365-294X.2004.02266.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Dyke F., 2008, CONSERVATION BIOL FD; Witzenberger KA, 2011, BIODIVERS CONSERV, V20, P1843, DOI 10.1007/s10531-011-0074-4; Wuertz S, 2006, AQUACULTURE, V258, P685, DOI 10.1016/j.aquaculture.2006.03.042; Zane L, 2002, MOL ECOL NOTES, V2, P586, DOI 10.1046/j.1471-8286.2002.00328.x	31	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110951	10.1371/journal.pone.0110951	http://dx.doi.org/10.1371/journal.pone.0110951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356794	Green Submitted, gold, Green Published			2022-12-27	WOS:000346765000034
J	Li, XG; Zang, XH; Ning, CY; Feng, Y; Xie, CX; He, X; Takebe, Y; Sun, LY; Guo, Q; Xing, H; Kalish, ML; Shao, YM				Li, Xingguang; Zang, Xihui; Ning, Chuanyi; Feng, Yi; Xie, Cunxin; He, Xiang; Takebe, Yutaka; Sun, Liuyan; Guo, Qi; Xing, Hui; Kalish, Marcia L.; Shao, Yiming			Molecular Epidemiology of HIV-1 in Jilin Province, Northeastern China: Emergence of a New CRF07_BC Transmission Cluster and Intersubtype Recombinants	PLOS ONE			English	Article							INJECTION-DRUG-USERS; INFECTIOUS-DISEASE; SEXUAL-BEHAVIOR; SOCIAL NETWORK; MEN; PREVALENCE; SYPHILIS; SPREAD; MUNICIPALITY; DYNAMICS	Objective: To investigate the HIV-1 molecular epidemiology among newly diagnosed HIV-1 infected persons living in the Jilin province of northeastern China. Methods: Plasma samples from 189 newly diagnosed HIV-1 infected patients were collected between June 2010 and August 2011 from all nine cities of Jilin province. HIV-1 nucleotide sequences of gag P17-P24 and env C2-C4 gene regions were amplified using a multiplex RT-PCR method and sequenced. Phylogenetic and recombination analyses were used to determine the HIV-1 genotypes. Results: Based on all sequences generated, the subtype/CFR distribution was as follows: CRF01_AE (58.1%), CRF07_BC (13.2%), subtype B' (13.2%), recombinant viruses (8.1%), subtype B (3.7%), CRF02_AG (2.9%), subtype C (0.7%). In addition to finding CRF01_AE strains from previously reported transmission clusters 1, 4 and 5, a new transmission cluster was described within the CRF07_BC radiation. Among 11 different recombinants identified, 10 contained portions of gene regions from the CRF01_AE lineage. CRF02_AG was found to form a transmission cluster of 4 in local Jilin residents. Conclusions: Our study presents a molecular epidemiologic investigation describing the complex structure of HIV-1 strains co-circulating in Jilin province. The results highlight the critical importance of continuous monitoring of HIV-infections, along with detailed socio-demographic data, in order to design appropriate prevention measures to limit the spread of new HIV infections.	[Li, Xingguang; Ning, Chuanyi; Feng, Yi; Xie, Cunxin; He, Xiang; Takebe, Yutaka; Xing, Hui; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Xingguang; Ning, Chuanyi; Feng, Yi; Xie, Cunxin; He, Xiang; Takebe, Yutaka; Xing, Hui; Shao, Yiming] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Li, Xingguang] Univ Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, HIV Mol Epidemiol & Virol Res Grp, Wuhan, Hubei, Peoples R China; [Zang, Xihui; Sun, Liuyan; Guo, Qi] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Kalish, Marcia L.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Ning, Chuanyi] Guangxi Med Univ, Guangxi Key Lab AIDS Prevent & Treatment, Nanning, Guangxi, Peoples R China; [Ning, Chuanyi] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan Institute of Virology, CAS; National Institute of Infectious Diseases (NIID); Vanderbilt University; Guangxi Medical University; Guangxi Medical University	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com	Ning, Chuanyi/AAF-5601-2020; Ning, Chuanyi/B-4120-2016; He, Xiang/E-7082-2013	Ning, Chuanyi/0000-0002-8748-2780; Ning, Chuanyi/0000-0002-8748-2780; He, Xiang/0000-0003-2428-5349	National Science and Technology Major Project for Infectious Diseases Control and Prevention [2008ZX10001-004, 2012ZX10001-002, 2012ZX10001-008]; National Natural Science Foundation of China [81261120379]; NIH Foundation [1R01AI094562-01]; SKLID Development Grant [2012SKLID103]; U.S. National Institute of Health [R01AI094562];  [2009DFB30420]	National Science and Technology Major Project for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SKLID Development Grant; U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This study was supported by the National Science and Technology Major Project for Infectious Diseases Control and Prevention (2008ZX10001-004, 2012ZX10001-002, and 2012ZX10001-008), National Natural Science Foundation of China (81261120379), NIH Foundation (1R01AI094562-01), International Cooperative Grant (2009DFB30420) and SKLID Development Grant (2012SKLID103). This work was also supported by U.S. National Institute of Health grants R01AI094562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Cham F, 2000, AIDS RES HUM RETROV, V16, P1915, DOI 10.1089/08892220050195874; Chen LL, 2011, AIDS RES HUM RETROV, V27, P693, DOI [10.1089/aid.2010.0264, 10.1089/AID.2010.0264]; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Choi KH, 2003, LANCET, V361, P2125, DOI 10.1016/S0140-6736(03)13690-2; Chow EPF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048025; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Council PCOutS Statistics DoPaE Statistics NBo, 2010, TAB 2010 POP CENS PE; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Guo HX, 2009, AIDS RES HUM RETROV, V25, P463, DOI 10.1089/aid.2008.0250; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Health CMo (WHO) WHO, 2011, 2011 EST HIV AIDS EP; Helleringer S, 2009, DEMOGR RES, V21, P428, DOI 10.4054/DemRes.2009.21.15; Howard DL, 2006, JAIDS-J ACQ IMM DEF, V42, P325, DOI 10.1097/01.qai.0000214819.88163.22; Huang L, 2011, CHINESE J PUBLIC HLT, V10, P515; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Kretzschmar M, 2008, AIDS, V22, P1527, DOI 10.1097/QAD.0b013e3282ff6265; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li XH, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1472-1; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Lindenburg CEA, 2006, AIDS, V20, P1771, DOI 10.1097/01.aids.0000242824.59377.53; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; LIU H, 2007, CHIN J AIDS STD, V13, P230; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mastro TD, 2006, AIDS, V20, P1451, DOI 10.1097/01.aids.0000233580.56844.c1; Pisani E, 2003, JAIDS-J ACQ IMM DEF, V34, P403, DOI 10.1097/00126334-200312010-00007; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Qu S, 2002, CHIN J STD AIDS PREV, V8, P145; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Z, 2009, CHINESE FRONTIER HLT, p[32, 339]; Wang L, 2010, INT J EPIDEMIOL INFE, V37, P361; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Yang Y, 2008, PRACTICE, V7, P511; Young AM, 2013, AIDS BEHAV, V17, P2341, DOI 10.1007/s10461-012-0371-2; Zhang B, 2000, CHINESE JSTD AIDS PR, V6; ZHANG B, 2008, CHINESE J AIDS STD, V14, P541; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang M, 2006, NUCLEIC ACIDS RES, V34, pW463, DOI 10.1093/nar/gkl255; Zhu J, 2008, CHIN J AIDS STD, V14, P111	58	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e110738	10.1371/journal.pone.0110738	http://dx.doi.org/10.1371/journal.pone.0110738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25356726	Green Published, gold, Green Submitted			2022-12-27	WOS:000346765000021
J	Liu, Y; Liu, YH; Tan, N; Chen, JY; Zhou, YL; Li, LW; Duan, CY; Chen, PY; Luo, JF; Li, HL; Wei-Guo				Liu, Yong; Liu, Yuan-hui; Tan, Ning; Chen, Ji-yan; Zhou, Ying-ling; Li, Li-wen; Duan, Chong-yang; Chen, Ping-Yan; Luo, Jian-fang; Li, Hua-long; Wei-Guo			Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; REACTIVE PROTEIN; RENAL-FUNCTION; INJURY; TRIAL; PRETREATMENT; THERAPY; STATINS; BENEFITS; OUTCOMES	Objectives: We prospectively compared the preventive effects of rosuvastatin and atorvastatin on contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI). Methods: We enrolled 1078 consecutive patients with CKD undergoing elective PCI. Patients in Group 1 (n = 273) received rosuvastatin (10 mg), and those in group 2 (n = 805) received atorvastatin (20 mg). The primary end-point was the development of CIN, defined as an absolute increase in serum creatinine >= 0.5 mg/dL, or an increase >= 25% from baseline within 48-72 h after contrast medium exposure. Results: CIN was observed in 58 (5.4%) patients. The incidence of CIN was similar in patients pretreated with either rosuvastatin or atorvastatin (5.9% vs. 5.2%, p = 0.684). The same results were also observed when using other definitions of CIN. Clinical and procedural characteristics did not show significant differences between the two groups (p > 0.05). Additionally, there were no significant inter-group differences with respect to in-hospital mortality rates (0.4% vs. 1.5%, p = 0.141), or other in-hospital complications. Multivariate logistic regression analysis revealed that rosuvastatin and atorvastatin demonstrated similar efficacies for preventing CIN, after adjusting for potential confounding risk factors (odds ratio = 1.17, 95% confidence interval, 0.62-2.20, p = 0.623). A Kaplan-Meier survival analysis showed that patients taking either rosuvastatin or atorvastatin had similar incidences of all-cause mortality (9.4% vs. 7.1%, respectively; p = 0.290) and major adverse cardiovascular events (29.32% vs. 23.14%, respectively; p = 0.135) during follow-up. Conclusions: Rosuvastatin and atorvastatin have similar efficacies for preventing CIN in patients with CKD undergoing PCI.	[Liu, Yong; Liu, Yuan-hui; Tan, Ning; Chen, Ji-yan; Zhou, Ying-ling; Li, Li-wen; Luo, Jian-fang; Li, Hua-long; Wei-Guo] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Liu, Yuan-hui] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Duan, Chong-yang; Chen, Ping-Yan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Biostat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; Southern Medical University - China	Tan, N (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	tanning100@126.com; cgy01973@126.com	Duan, Chongyang/AAD-5378-2021; Liu, Yuanhui/L-4980-2018	Liu, Yuanhui/0000-0001-8568-623X	National Natural Science Foundation of China [81270286]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from the National Natural Science Foundation of China (grant no. 81270286). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript; the work was not funded by any industry sponsors.	Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; Ando G, 2013, CATHETER CARDIO INTE, V82, P878, DOI 10.1002/ccd.25023; Betteridge DJ, 2007, AM J CARDIOL, V100, P1245, DOI 10.1016/j.amjcard.2007.05.044; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; DiNicolantonio JJ, 2013, POSTGRAD MED, V125, P7, DOI 10.3810/pgm.2013.01.2620; Ferreira TS, 2014, INFLAMMATION; Fox ER, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-1; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Han YL, 2014, J AM COLL CARDIOL, V63, P62, DOI 10.1016/j.jacc.2013.09.017; Herregods MC, 2008, ACTA CARDIOL, V63, P493, DOI 10.2143/AC.63.4.2033049; Hoshi T, 2014, INT J CARDIOL, V171, P243, DOI 10.1016/j.ijcard.2013.12.017; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kandula P, 2010, NEPHROLOGY, V15, P165, DOI 10.1111/j.1440-1797.2009.01204.x; Kaya A, 2013, ACTA CARDIOL, V68, P489, DOI 10.1080/AC.68.5.2994472; Khanal S, 2005, AM J MED, V118, P843, DOI 10.1016/j.amjmed.2005.03.031; Leoncini M, 2014, J AM COLL CARDIOL, V63, P71, DOI 10.1016/j.jacc.2013.04.105; Li W, 2012, CARDIOLOGY, V122, P195, DOI 10.1159/000339472; Li YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034450; Liu YH, 2014, J CARDIOVASCULAR PHA; Liu Y, 2012, J NEPHROL, V25, P332, DOI 10.5301/jn.5000007; Liu YH, 2014, INT UROL NEPHROL, V46, P417, DOI 10.1007/s11255-013-0598-5; Luvai A, 2012, CLIN MED INSIGHTS-CA, V6, P17, DOI 10.4137/CMC.S4324; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Ongini E, 2004, P NATL ACAD SCI USA, V101, P8497, DOI 10.1073/pnas.0401996101; Patti G, 2011, AM J CARDIOL, V108, P1, DOI 10.1016/j.amjcard.2011.03.001; Qu HY, 2009, PHARM RES-DORDR, V26, P958, DOI 10.1007/s11095-008-9798-6; Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Takagi H, 2014, AM J CARDIOL, V113, P292, DOI 10.1016/j.amjcard.2013.08.043; Tawfik MK, 2010, EUR REV MED PHARMACO, V14, P499; Toso A, 2010, AM J CARDIOL, V105, P288, DOI 10.1016/j.amjcard.2009.09.026; Toth PP, 2014, POSTGRAD MED, V126, P7, DOI 10.3810/pgm.2014.03.2736; Tsai TT, 2014, JACC-CARDIOVASC INTE, V7, P1, DOI 10.1016/j.jcin.2013.06.016; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Wassmann S, 2003, CIRC RES, V93, pE98, DOI 10.1161/01.RES.0000099503.13312.7B; Wi J, 2011, HEART, V97, P1753, DOI 10.1136/hrt.2010.218677; Wong PCY, 2012, INT J CARDIOL, V158, P186, DOI 10.1016/j.ijcard.2011.06.115	39	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2014	9	10							e111124	10.1371/journal.pone.0111124	http://dx.doi.org/10.1371/journal.pone.0111124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2HU	25357250	gold, Green Published, Green Submitted			2022-12-27	WOS:000346765000040
J	Bai, B; Wang, YQ; Meng, J; Li, Q; Jin, X				Bai, Bin; Wang, Yuanqing; Meng, Jin; Li, Qian; Jin, Xun			New Early Eocene Basal tapiromorph from Southern China and Its Phylogenetic Implications	PLOS ONE			English	Article							EARLY TERTIARY; MIDDLE EOCENE; PERISSODACTYLA; MAMMALIA; PAKISTAN; SYSTEMATICS; RADIATION; ORIGIN	A new Early Eocene tapiromorph, Meridiolophus expansus gen. et sp. nov., from the Sanshui Basin, Guangdong Province, China, is described and discussed. It is the first reported Eocene mammal from the basin. The new taxon, represented by a left fragmentary mandible, is characterized by an expanded anterior symphyseal region, a long diastema between c1 and p1, a rather short diastema between p1 and p2, smaller premolars relative to molars, an incipient metaconid appressed to the protoconid on p3, a prominent entoconid on p4, molar metaconid not twinned, cristid obliqua extending mesially and slightly lingually from the hypoconid, inclined metalophid and hypolophid, and small hypoconulid on the lower preultimate molars. Meridiolophus is morphologically intermediate between basal Homogalax-like taxa and derived tapiromorphs (such as Heptodon). Phylogenetic analysis indicates Equidae is more closely related to Tapiromorpha than to Palaeotheriidae, although the latter is only represented by a single species Pachynolophus eulaliensis. 'Isectolophidae', with exception of Meridiolophus and Karagalax, has the closest affinity with Chalicotherioidea. Furthermore, the majority rule consensus tree shows that Meridiolophus is closer to Karagalax than to any other 'isectolophid', and both genera represent stem taxa to crown group Ceratomorpha.	[Bai, Bin; Wang, Yuanqing; Meng, Jin; Li, Qian; Jin, Xun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Bai, Bin; Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Bai, B (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	baibin@ivpp.ac.cn; wangyuanqing@ivpp.ac.cn	Bai, Bin/D-6898-2013	Bai, Bin/0000-0003-4394-8689	China Scholarship Council; Chinese Academy of Sciences [KZCX2-EW-106]; National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [41002009]; Special Fund for Fossil Excavation and Preparation, CAS; China Geological Survey [1212011120115, 1212011120142]; Frick Funds from the Division of Paleontology, American Museum of Natural History	China Scholarship Council(China Scholarship Council); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Fossil Excavation and Preparation, CAS; China Geological Survey(China Geological Survey); Frick Funds from the Division of Paleontology, American Museum of Natural History	This research was supported by China Scholarship Council, Chinese Academy of Sciences (KZCX2-EW-106), National Basic Research Program of China (973 Program) (2012CB821900), the National Natural Science Foundation of China (41002009), the Special Fund for Fossil Excavation and Preparation, CAS, the China Geological Survey (Nos. 1212011120115 and 1212011120142) and the Frick Funds from the Division of Paleontology, American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiola A, 2005, GEOBIOS-LYON, V38, P1, DOI 10.1016/j.geobios.2003.07.005; Bai B, 2010, AM MUS NOVIT, P1, DOI 10.1206/678.1; Colbert MW, 1998, EVOLUTION TERTIARY M, P569; Danilo L, 2013, J VERTEBR PALEONTOL, V33, P195, DOI 10.1080/02724634.2012.711404; Froehlich DJ, 1999, J VERTEBR PALEONTOL, V19, P140, DOI 10.1080/02724634.1999.10011129; Froehlich DJ, 2002, ZOOL J LINN SOC-LOND, V134, P141, DOI 10.1046/j.1096-3642.2002.00005.x; GINGERICH P D, 1991, Contributions from the Museum of Paleontology University of Michigan, V28, P181; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; Gingerich PD, 2003, J VERTEBR PALEONTOL, V23, P643, DOI 10.1671/2409; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Holbrook LT, 2004, J VERTEBR PALEONTOL, V24, P951, DOI 10.1671/0272-4634(2004)024[0951:SOTEPM]2.0.CO;2; Holbrook LT, 2001, ZOOL J LINN SOC-LOND, V132, P1, DOI 10.1006/zjls.2000.0262; Holbrook LT, 2011, J VERTEBR PALEONTOL, V31, P895, DOI 10.1080/02724634.2011.579669; Hooker J.J., 2010, MONOGRAPH PALAEONTOG, V165, P1; Hooker Jeremy J., 2005, P199; Hooker J, 2007, J VERTEBR PALEONTOL, V27, p91A; Hooker JJ, 2004, PALAEONTOLOGY, V47, P1363, DOI 10.1111/j.0031-0239.2004.00421.x; HOOKER JJ, 1984, ZOOL J LINN SOC-LOND, V82, P229, DOI 10.1111/j.1096-3642.1984.tb00545.x; HOOKER JJ, 1989, EVOLUTION PERISSODAC, P00079; LI CK, 1979, VERTEBRAT PALASIATIC, V17, P71; Maas MC, 2001, J PALEONTOL, V75, P407, DOI 10.1666/0022-3360(2001)075<0407:ANITPM>2.0.CO;2; Maddison WP, 2011, MESQUITE MODULAR SYS; Missiaen P, 2013, GEOL BELG, V16, P262; Missiaen P, 2012, ACTA PALAEONTOL POL, V57, P21, DOI 10.4202/app.2010.0093; RADINSKY LEONARD, 1963, PEABODY MUS NAT HIST BULL, V17, P1; ROSE KD, 2006, BEGINNING AGE MAMMAL; SIMPSON GEORGE GAYLORD, 1941, AMER MUS NOVITATES, V1136, P1; Steiner CC, 2011, ZOOL J LINN SOC-LOND, V163, P1289, DOI 10.1111/j.1096-3642.2011.00752.x; [孙勃 SUN Bo], 2009, [地层学杂志, Journal of Stratigraphy], V33, P62; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; Ting Su-Yin, 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V3, P201; Ting Suyin, 1998, Bulletin of Carnegie Museum of Natural History, V34, P124; Tong Y.S., 2006, PALEONT SIN NEW SER, V28, P1; Wang Banyue, 1997, Vertebrata Palasiatica, V35, P44; Wang JK, 1981, GUANGDONG PALAEONT C, V22, P1; Wang M, 2012, ACTA PALAEONTOL POL, V57, P519, DOI 10.4202/app.2011.0061; Wang Yuan, 1995, Vertebrata Palasiatica, V33, P138; Wang Yuan-Qing, 2011, Vertebrata Palasiatica, V49, P123; Wang YQ, 2010, SCI CHINA EARTH SCI, V53, P1918, DOI 10.1007/s11430-010-4095-8; Young CC, 1944, AM MUS NOVIT, P1; Zdansky O., 1930, PALAEONTOL SINICA, V6, P5; Zhang X., 1993, DIVISION CORRELATION, P179; Zhang Xian-qiu, 2010, Acta Palaeontologica Sinica, V49, P487; Zhang Xianqiu, 1999, Guangdong Geology, V14, P53	44	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110806	10.1371/journal.pone.0110806	http://dx.doi.org/10.1371/journal.pone.0110806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353987	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200038
J	Chen, JR; Liu, F; Tang, YH; Yuan, YM; Guo, QQ				Chen, Jianrong; Liu, Fang; Tang, Yinghong; Yuan, Youmei; Guo, Qingquan			Transcriptome Sequencing and Profiling of Expressed Genes in Phloem and Xylem of Ramie (Boehmeria nivea L. Gaud)	PLOS ONE			English	Article							FIBER QUALITY; YIELD; RNA; GROWTH; IDENTIFICATION; BIOSYNTHESIS; REGULATORS; LIBRARY	Ramie (Boehmeria nivea L. Gaud) is a highly versatile herbaceous plant which is widely cropped in southern China. The success of this herbaceous plant relies on wide use in modern industry. Understanding the profiling of expressed genes in phloem and xylem of ramie is crucial for improving its industrial performance. Herein, we uncover the transcriptome profile in phloem and xylem in present study. Using Illumina paired-end sequencing technology, 57 million high quality reads were generated. De novo assembly yielded 87,144 unigenes with an average length of 635 bp. By sequence similarity searching for public databases, a total of 32,541 (41.77%) unigenes were annotated for their function. Among these genes, 57,873 (66.4%) and 28,678 (32.9%) unigenes were assigned to categories of Gene Ontology and Orthologous Groups database, respectively. By searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG), 18,331 (21.0%) unigenes were mapped to 125 pathways. The metabolic pathways were assigned the most unigene (4,793, 26.2%). Furthermore, Pol II and Pol III subunits as well as the genes of Galactose metabolism pathway had higher expression in phloem compared to xylem. In addition, fatty acid metabolism pathway genes showed more abundant in xylem than phloem. These results suggest that high activities of RNA synthesis and Galactose metabolism pathway promises fiber synthesis in phloem. The present study is the initial exploration to uncover the fiber biosynthesis difference between phloem and xylem in ramie through the analysis of deep sequencing data.	[Chen, Jianrong; Liu, Fang; Tang, Yinghong; Yuan, Youmei; Guo, Qingquan] Changsha Univ, Dept Biotechnol & Environm Sci, Changsha, Hunan, Peoples R China	Changsha University	Guo, QQ (corresponding author), Changsha Univ, Dept Biotechnol & Environm Sci, Changsha, Hunan, Peoples R China.	jrchenramie@163.com			National Natural Science Foundation of China [31071457, 31301374]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 31071457 and 31301374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini LG, 2000, IND CROP PROD, V11, P145, DOI 10.1016/S0926-6690(99)00059-X; Angelini LG, 2013, IND CROP PROD, V51, P138, DOI 10.1016/j.indcrop.2013.09.009; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Carlsbecker A, 2005, CURR OPIN PLANT BIOL, V8, P512, DOI 10.1016/j.pbi.2005.07.001; Dahlke B, 1998, J CELL PLAST, V34, P361, DOI 10.1177/0021955X9803400406; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784, DOI 10.1038/77355; Foucart C, 2006, NEW PHYTOL, V170, P739, DOI 10.1111/j.1469-8137.2006.01705.x; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; KALCKAR HM, 1965, SCIENCE, V150, P305, DOI 10.1126/science.150.3694.305; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; Liu F, 2008, SCI AGR SINICA, V11; Liu FH, 2001, FIELD CROP RES, V69, P41, DOI 10.1016/S0378-4290(00)00132-5; Liu JX, 2009, AGR SCI CHINA, V8, P664, DOI 10.1016/S1671-2927(08)60262-X; Liu LJ, 2013, IND CROP PROD, V44, P677, DOI 10.1016/j.indcrop.2012.09.003; Liu LJ, 2012, J INTEGR AGR, V11, P1199, DOI 10.1016/S2095-3119(12)60115-4; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Liu XY, 2010, REACT FUNCT POLYM, V70, P972, DOI 10.1016/j.reactfunctpolym.2010.10.007; Mukhopadhyay A, 2013, BIORESOURCE TECHNOL, V137, P202, DOI 10.1016/j.biortech.2013.03.139; OHLROGGE JB, 1994, PLANT PHYSIOL, V104, P821, DOI 10.1104/pp.104.3.821; Roy S, 2012, WOODHEAD PUBL SER TE, P47; Schuster S. C., 2007, NATURE, V200; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang XX, 2010, MOL BIOL REP, V37, P2099, DOI 10.1007/s11033-009-9671-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Zhao CS, 2005, PLANT PHYSIOL, V138, P803, DOI 10.1104/pp.105.060202; Zhong RQ, 2001, PLANT PHYSIOL, V126, P477, DOI 10.1104/pp.126.2.477	31	16	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e110623	10.1371/journal.pone.0110623	http://dx.doi.org/10.1371/journal.pone.0110623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25354139	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204200030
J	Noordmans, GA; Huang, Y; Savage, H; van Dijk, MCRF; Schaart, G; Weerman, MAV; Heeringa, P; Hillebrands, JL; Korstanje, R; van Goor, H				Noordmans, Gerda A.; Huang, Yuan; Savage, Holly; van Dijk, Marcory C. R. F.; Schaart, Gert; Weerman, Marius A. van den Bergh; Heeringa, Peter; Hillebrands, Jan-Luuk; Korstanje, Ron; van Goor, Harry			Genetic Analysis of Intracapillary Glomerular Lipoprotein Deposits in Aging Mice	PLOS ONE			English	Article							GAMMA ERR-GAMMA; RECEPTOR-GAMMA; DEFICIENT MICE; NEPHROPATHY; CHANNEL; MOUSE; MODEL; POLYMORPHISM; METABOLISM; REGULATOR	Background: Renal aging is characterized by functional and structural changes like decreased glomerular filtration rate, and glomerular, tubular and interstitial damage. To gain insight in pathways involved in renal aging, we studied aged mouse strains and used genetic analysis to identify genes associated with aging phenotypes. Methods: Upon morphological screening in kidneys from 20-month-old mice from 26 inbred strains we noted intracapillary PAS-positive deposits. The severity of these deposits was quantified by scoring of a total of 50 glomeruli per section (grade 0-4). Electron microscopy and immunohistochemical staining for apoE, apoB, apoA-IV and perilipin-2 was performed to further characterize the lesions. To identify loci associated with these PAS-positive intracapillary glomerular deposits, we performed haplotype association mapping. Results: Six out of 26 mouse strains showed glomerular PAS-positive deposits. The severity of these deposits varied: NOD(0.97), NZW(0.41), NON(0.30), B10(0.21), C3 H(0.9) and C57BR(0.7). The intracapillary deposits were strongly positive for apoE and weakly positive for apoB and apoA-IV. Haplotype association mapping showed a strong association with a 30-Kb haplotype block on Chr 1 within the Esrrg gene. We investigated 1 Mb on each site of this region, which includes the genes Spata17, Gpatch2, Esrrg, Ush2a and Kctd3. Conclusions: By analyzing 26 aged mouse strains we found that some strains developed an intracapillary PAS and apoE-positive lesion and identified a small haplotype block on Chr 1 within the Esrrg gene to be associated with these lipoprotein deposits. The region spanning this haplotype block contains the genes Spata17, Gpatch2, Esrrg, Ush2a and Kctd3, which are all highly expressed in the kidney. Esrrg might be involved in the evolvement of these glomerular deposits by influencing lipid metabolism and possibly immune reponses.	[Noordmans, Gerda A.; Huang, Yuan; van Dijk, Marcory C. R. F.; Heeringa, Peter; Hillebrands, Jan-Luuk; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Savage, Holly; Korstanje, Ron] Jackson Lab, Bar Harbor, ME 04609 USA; [Weerman, Marius A. van den Bergh] Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Schaart, Gert] Maastricht Univ, Med Ctr, Dept Human Movement Sci, NUTRIM, Maastricht, Netherlands	University of Groningen; Jackson Laboratory; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Noordmans, GA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	g.a.noordmans@umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; van Goor, Harry/0000-0002-6670-1577; Hillebrands, Jan-Luuk/0000-0003-3135-3274	University of Groningen Graduate School of Medical Sciences; NIGMS [GM076468]; NIA [AG038070]; National Cancer Institute Cancer Core grant [CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038070] Funding Source: NIH RePORTER	University of Groningen Graduate School of Medical Sciences; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute Cancer Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the University of Groningen Graduate School of Medical Sciences (GAN), GM076468 from the NIGMS (RK), AG038070 from NIA (RK), and the National Cancer Institute Cancer Core grant (CA034196) to The Jackson Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Boguski MS, 2002, NATURE, V420, P515, DOI 10.1038/420515a; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cao-Ehlker X, 2013, J BIOL CHEM, V288, P7580, DOI 10.1074/jbc.M112.434803; ELLIS D, 1995, J AM SOC NEPHROL, V6, P1170; Eto M, 2002, AM J KIDNEY DIS, V40, P243, DOI 10.1053/ajkd.2002.34502; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Glassock RJ, 2012, KIDNEY INT; Hu ZX, 2014, KIDNEY INT, V85, P416, DOI 10.1038/ki.2013.335; Hurtado R, 2010, KIDNEY INT, V77, P500, DOI 10.1038/ki.2009.483; Ishigaki Y, 2000, J BIOL CHEM, V275, P31269, DOI 10.1074/jbc.M005906200; Ishimura A, 2009, CLIN EXP NEPHROL, V13, P430, DOI 10.1007/s10157-009-0195-1; Kanamuru Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015615.14428.67; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; KEANE WF, 1988, AM J NEPHROL, V8, P261, DOI 10.1159/000167599; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Lin ML, 2009, CANCER SCI, V100, P1443, DOI 10.1111/j.1349-7006.2009.01185.x; Misra J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086342; Misra J, 2013, NUCLEIC ACIDS RES, V41, P6960, DOI 10.1093/nar/gkt429; Mochizuki S, 2001, CLIN EXP NEPHROL, V5, P240; MOORHEAD JF, 1991, KIDNEY INT S, V31, pS35; Mooyaart AL, 2011, DIABETOLOGIA, V54, P544, DOI 10.1007/s00125-010-1996-1; Noordmans GA, 2013, J AM SOC NEPHROL; Percy CJ, 2008, NEPHROLOGY, V13, P147, DOI 10.1111/j.1440-1797.2008.00924.x; Perry DJ, 2012, J IMMUNOL, V189, P793, DOI 10.4049/jimmunol.1200411; SAITO T, 1989, AM J KIDNEY DIS, V13, P148, DOI 10.1016/S0272-6386(89)80134-9; Saito T, 2006, AM J KIDNEY DIS, V47, P199, DOI 10.1053/j.ajkd.2005.10.017; Sanoudou D, 2010, PHARMACOGENOMICS J, V10, P165, DOI 10.1038/tpj.2009.51; Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Tsaih SW, 2010, KIDNEY INT, V77, P201, DOI 10.1038/ki.2009.434; Tsaih SW, 2009, METHODS MOL BIOL, V573, P213, DOI 10.1007/978-1-60761-247-6_12; Tsimihodimos V, 2011, CURR OPIN LIPIDOL, V22, P262, DOI 10.1097/MOL.0b013e328345ebb0; VANGOOR H, 1993, AM J PATHOL, V142, P1804; WATANABE Y, 1991, NEPHRON, V58, P210, DOI 10.1159/000186417; WATANABE Y, 1989, NEPHRON, V51, P265, DOI 10.1159/000185297; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Wilson Karen H S, 2005, BMC Nephrol, V6, P17, DOI 10.1186/1471-2369-6-17; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yorioka N, 1999, NEPHRON, V83, P246, DOI 10.1159/000045517; Yuan R, 2011, ILAR J, V52, P4, DOI 10.1093/ilar.52.1.4; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x	44	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e111308	10.1371/journal.pone.0111308	http://dx.doi.org/10.1371/journal.pone.0111308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353171	Green Published, gold, Green Submitted			2022-12-27	WOS:000345204200070
J	Sharma, V; Sivapackiam, J; Harpstrite, SE; Prior, JL; Gu, H; Rath, NP; Piwnica-Worms, D				Sharma, Vijay; Sivapackiam, Jothilingam; Harpstrite, Scott E.; Prior, Julie L.; Gu, Hannah; Rath, Nigam P.; Piwnica-Worms, David			A Generator-Produced Gallium-68 Radiopharmaceutical for PET Imaging of Myocardial Perfusion	PLOS ONE			English	Article							MDR1 P-GLYCOPROTEIN; BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; GALLIUM(III) COMPLEXES; BIOLOGICAL EVALUATION; TRANSPORT; AGENTS; METAL; TECHNETIUM-99M-SESTAMIBI; MITOCHONDRIAL	Lipophilic cationic technetium-99m-complexes are widely used for myocardial perfusion imaging (MPI). However, inherent uncertainties in the supply chain of molybdenum-99, the parent isotope required for manufacturing Mo-99/Tc-99m generators, intensifies the need for discovery of novel MPI agents incorporating alternative radionuclides. Recently, germanium/gallium (Ge/Ga) generators capable of producing high quality Ga-68, an isotope with excellent emission characteristics for clinical PET imaging, have emerged. Herein, we report a novel Ga-68-complex identified through mechanism-based cell screening that holds promise as a generator-produced radiopharmaceutical for PET MPI.	[Sharma, Vijay; Sivapackiam, Jothilingam; Harpstrite, Scott E.; Prior, Julie L.; Gu, Hannah; Piwnica-Worms, David] Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63110 USA; [Sharma, Vijay] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Rath, Nigam P.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Missouri System; University of Missouri Saint Louis	Sharma, V (corresponding author), Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63110 USA.	sharmav@mir.wustl.edu; dpiwnica-worms@mdanderson.org	Sivapackiam, Jothilingam/O-9387-2014	Sivapackiam, Jothilingam/0000-0001-7979-1893	National Institutes of Health (NIH) [RO1 HL111163, R33 AG033328, P50 CA94056]; American Health Assistance Foundation [A2007-383]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R33AG033328] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health (NIH) grants RO1 HL111163 (VS), R33 AG033328 (VS), P50 CA94056 (DPW), and the American Health Assistance Foundation A2007-383 (VS). The Small Animal Imaging Core of Washington University Medical School is gratefully acknowledged (P30 CA91842). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atcher R, 2011, RSNA NEWS, V21, P9; Beller GA, 2010, HEART LUNG CIRC, V19, P193, DOI 10.1016/j.hlc.2009.11.003; Benard F, 2014, J NUCL MED, V55, P1017, DOI 10.2967/jnumed.113.133413; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Bonow RO, 2009, NEW ENGL J MED, V361, P990, DOI 10.1056/NEJMcp0902177; Chen WS, 2000, BIOCHEM PHARMACOL, V60, P413, DOI 10.1016/S0006-2952(00)00341-5; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Cutler CS, 1999, NUCL MED BIOL, V26, P305, DOI 10.1016/S0969-8051(98)00108-5; Damiani D, 1998, HAEMATOLOGICA, V83, P290; DelVecchio S, 1997, J NUCL MED, V38, P1348; Fellner M, 2011, MOL IMAGING BIOL, V13, P985, DOI 10.1007/s11307-010-0410-1; Gould P, 2009, NATURE, V460, P312, DOI 10.1038/460312a; Harpstrite SE, 2007, J INORG BIOCHEM, V101, P1347, DOI 10.1016/j.jinorgbio.2007.04.013; Hendrikse NH, 1998, BRIT J CANCER, V77, P353, DOI 10.1038/bjc.1998.57; HERMAN LW, 1995, J MED CHEM, V38, P2955, DOI 10.1021/jm00015a018; Hsiao YM, 2009, NUCL MED BIOL, V36, P39, DOI 10.1016/j.nucmedbio.2008.10.010; Jin Z, 2010, ORGANOMETALLICS, V29, P6578, DOI 10.1021/om100906n; Luker GD, 1997, BIOCHEMISTRY-US, V36, P14218, DOI 10.1021/bi971931z; Luker GD, 2001, J BIOL CHEM, V276, P49053, DOI 10.1074/jbc.M105192200; Luker GD, 1997, J NUCL MED, V38, P369; Madar I, 2007, EUR J NUCL MED MOL I, V34, P2057, DOI 10.1007/s00259-007-0500-8; Pagou M, 2009, HELL J NUCL MED, V12, P102; PIWNICAWORMS D, 1993, CANCER RES, V53, P977; PIWNICAWORMS D, 1988, J NUCL MED, V29, P55; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; Plossl K, 2008, NUCL MED BIOL, V35, P83, DOI 10.1016/j.nucmedbio.2007.08.002; Purohit A, 2008, J MED CHEM, V51, P2954, DOI 10.1021/jm701443n; Radeke H, 2007, J MED CHEM, V50, P4304, DOI 10.1021/jm0701831; Rowland DJ, 2008, SEMIN NUCL MED, V38, P209, DOI 10.1053/j.semnuclmed.2008.01.004; SCHINKEL AH, 1995, EUR J CANCER, V31A, P1295, DOI 10.1016/0959-8049(95)00130-B; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Sharma V, 2005, J NUCL MED, V46, P354; Sharma V, 1996, J MED CHEM, V39, P3483, DOI 10.1021/jm950823c; Sharma V, 2000, CHEM BIOL, V7, P335, DOI 10.1016/S1074-5521(00)00111-3; Sharma V., 1996, Journal of Nuclear Medicine, V37, p51P; Sharma V, 2004, BIOCONJUGATE CHEM, V15, P1464, DOI 10.1021/bc0498469; Sharma V, 1999, CHEM REV, V99, P2545, DOI 10.1021/cr980429x; Sivapackiam J, 2010, DALTON T, V39, P5842, DOI 10.1039/c002361b; Sivapackiam J, 2010, METHODS MOL BIOL, V596, P141, DOI 10.1007/978-1-60761-416-6_8; Slart RHJA, 2006, INT J CARDIOVAS IMAG, V22, P63, DOI 10.1007/s10554-005-7514-8; Tarkia M, 2012, NUCL MED BIOL, V39, P715, DOI 10.1016/j.nucmedbio.2011.11.007; TSANG BW, 1993, J NUCL MED, V34, P1127; TSANG BW, 1994, J MED CHEM, V37, P4400, DOI 10.1021/jm00051a018; Wong E, 1996, INORG CHEM, V35, P715, DOI 10.1021/ic951019j	44	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2014	9	10							e109361	10.1371/journal.pone.0109361	http://dx.doi.org/10.1371/journal.pone.0109361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TG	25353349	gold, Green Published, Green Submitted			2022-12-27	WOS:000345204200008
J	Alluin, O; Delivet-Mongrain, H; Gauthier, MK; Fehlings, MG; Rossignol, S; Karimi-Abdolrezaee, S				Alluin, Olivier; Delivet-Mongrain, Hugo; Gauthier, Marie-Krystel; Fehlings, Michael G.; Rossignol, Serge; Karimi-Abdolrezaee, Soheila			Examination of the Combined Effects of Chondroitinase ABC, Growth Factors and Locomotor Training following Compressive Spinal Cord Injury on Neuroanatomical Plasticity and Kinematics	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; NEUROLOGICAL RECOVERY; AXONAL REGENERATION; CORTICOSPINAL TRACT; FORELIMB FUNCTION; CONTUSION INJURY; BLADDER FUNCTION; GENE-EXPRESSION; RATS; CELLS	While several cellular and pharmacological treatments have been evaluated following spinal cord injury (SCI) in animal models, it is increasingly recognized that approaches to address the glial scar, including the use of chondroitinase ABC (ChABC), can facilitate neuroanatomical plasticity. Moreover, increasing evidence suggests that combinatorial strategies are key to unlocking the plasticity that is enabled by ChABC. Given this, we evaluated the anatomical and functional consequences of ChABC in a combinatorial approach that also included growth factor (EGF, FGF2 and PDGF-AA) treatments and daily treadmill training on the recovery of hindlimb locomotion in rats with mid thoracic clip compression SCI. Using quantitative neuroanatomical and kinematic assessments, we demonstrate that the combined therapy significantly enhanced the neuroanatomical plasticity of major descending spinal tracts such as corticospinal and serotonergic-spinal pathways. Additionally, the pharmacological treatment attenuated chronic astrogliosis and inflammation at and adjacent to the lesion with the modest synergistic effects of treadmill training. We also observed a trend for earlier recovery of locomotion accompanied by an improvement of the overall angular excursions in rats treated with ChABC and growth factors in the first 4 weeks after SCI. At the end of the 7-week recovery period, rats from all groups exhibited an impressive spontaneous recovery of the kinematic parameters during locomotion on treadmill. However, although the combinatorial treatment led to clear chronic neuroanatomical plasticity, these structural changes did not translate to an additional longterm improvement of locomotor parameters studied including hindlimb-forelimb coupling. These findings demonstrate the beneficial effects of combined ChABC, growth factors and locomotor training on the plasticity of the injured spinal cord and the potential to induce earlier neurobehavioral recovery. However, additional approaches such as stem cell therapies or a more adapted treadmill training protocol may be required to optimize this repair strategy in order to induce sustained functional locomotor improvement.	[Alluin, Olivier; Delivet-Mongrain, Hugo; Rossignol, Serge] Univ Montreal, CIHR, Multidisciplinary Team Locomotor Rehabil, Montreal, PQ, Canada; [Alluin, Olivier; Delivet-Mongrain, Hugo; Rossignol, Serge] Univ Montreal, FRQS, GRSNC, Montreal, PQ, Canada; [Gauthier, Marie-Krystel; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Gauthier, Marie-Krystel; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Spinal Cord Res Ctr, Winnipeg, MB, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg & Spinal Program, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Karimi-Abdolrezaee, Soheila] Regenerat Med Program, Winnipeg, MB, Canada; [Karimi-Abdolrezaee, Soheila] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	Universite de Montreal; Universite de Montreal; University of Manitoba; University of Manitoba; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Karimi-Abdolrezaee, S (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.	soheila.karimi@med.umanitoba.ca		Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663; Fehlings, Michael/0000-0002-5722-6364	Craig H. Neilsen Foundation; Christopher and Dana Reeve Foundation; Manitoba Health Research Council (MHRC); Canadian Institutes of Health Research (Sensorimotor Rehabilitation Research Team - SMRRT - grant); Canadian Institutes of Health Research (Canada Research Chair); Fonds de Recherche du Quebec-Sante; Sensorimotor Rehabilitation Research Team - SMRRT; Halbert Chair in Neural Repair and Regeneration; Krembil Foundation; Dezwirek Foundation	Craig H. Neilsen Foundation; Christopher and Dana Reeve Foundation; Manitoba Health Research Council (MHRC); Canadian Institutes of Health Research (Sensorimotor Rehabilitation Research Team - SMRRT - grant); Canadian Institutes of Health Research (Canada Research Chair)(Canada Research ChairsCanadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Sensorimotor Rehabilitation Research Team - SMRRT; Halbert Chair in Neural Repair and Regeneration; Krembil Foundation; Dezwirek Foundation	This work was supported by the operating grants from the following: 1) the Craig H. Neilsen Foundation to SKA, MGF and SR; 2) the Christopher and Dana Reeve Foundation to SKA, MGF and SR; 3) the Manitoba Health Research Council (MHRC) to SKA; 4) the Canadian Institutes of Health Research (Sensorimotor Rehabilitation Research Team - SMRRT - grant and Canada Research Chair) to SR; 5) OA was supported by a postdoctoral fellowship from the Fonds de Recherche du Quebec-Sante and Sensorimotor Rehabilitation Research Team - SMRRT; and 6) MGF is supported by the Halbert Chair in Neural Repair and Regeneration and by grants from the Krembil and Dezwirek Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Alluin O, 2011, J NEUROTRAUM, V28, P1963, DOI 10.1089/neu.2011.1840; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Barriere G, 2010, J NEUROPHYSIOL, V104, P1119, DOI 10.1152/jn.00255.2010; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Carter LM, 2011, EXP NEUROL, V228, P149, DOI 10.1016/j.expneurol.2010.12.023; Caudle KL, 2011, NEUROREHAB NEURAL RE, V25, P729, DOI 10.1177/1545968311407519; Cha J, 2007, J NEUROTRAUM, V24, P1000, DOI 10.1089/neu.2006.0233; Ciranna L, 2006, CURR NEUROPHARMACOL, V4, P101, DOI 10.2174/157015906776359540; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fouad K, 2009, SPINAL CORD, V47, P727, DOI 10.1038/sc.2009.10; Fouad K, 2000, BEHAV BRAIN RES, V115, P107, DOI 10.1016/S0166-4328(00)00244-8; Garcia-Alias G, 2011, J NEUROSCI, V31, P17788, DOI 10.1523/JNEUROSCI.4308-11.2011; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gauthier MK, 2013, EUR J NEUROSCI; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Heng C, 2009, EXP NEUROL, V216, P139, DOI 10.1016/j.expneurol.2008.11.023; Husch A, 2012, J NEUROSCI, V32, P13145, DOI 10.1523/JNEUROSCI.2995-12.2012; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Ichiyama R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006862; Jakeman LB, 2011, BRAIN RES BULL, V84, P317, DOI 10.1016/j.brainresbull.2010.06.002; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Karimi-Abdolrezaee S, 2002, J NEUROSCI, V22, P1816, DOI 10.1523/JNEUROSCI.22-05-01816.2002; Karimi-Abdolrezaee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037589; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kuerzi J, 2010, EXP NEUROL, V224, P178, DOI 10.1016/j.expneurol.2010.03.008; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Martinez M, 2013, J NEUROPHYSIOL, V109, P2909, DOI 10.1152/jn.01044.2012; Martinez M, 2012, J NEUROSCI, V32, P10961, DOI 10.1523/JNEUROSCI.1578-12.2012; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Mountney A, 2013, J NEUROTRAUM, V30, P181, DOI 10.1089/neu.2012.2353; Novotna I, 2011, CELL MOL NEUROBIOL, V31, P1129, DOI 10.1007/s10571-011-9714-1; Rolls A, 2008, PLOS MED, V5, P1262, DOI 10.1371/journal.pmed.0050171; Rossignol SS B.J., 2014, TXB NEURAL REPAIR RE; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Seif GI, 2007, J NEUROTRAUM, V24, P1513, DOI 10.1089/neu.2007.0323; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Smith RR, 2009, J NEUROTRAUM, V26, P1017, DOI [10.1089/neu.2008.0829, 10.1089/neu.2008-0829]; Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Tom VJ, 2009, J NEUROTRAUM, V26, P2323, DOI 10.1089/neu.2009.1047; van Hedel HJA, 2010, RESTOR NEUROL NEUROS, V28, P123, DOI 10.3233/RNN-2010-0508; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Wilson JR, 2012, J NEUROTRAUM, V29, P2263, DOI 10.1089/neu.2012.2417; Yang YG, 2009, J INT MED RES, V37, P1097, DOI 10.1177/147323000903700414	60	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111072	10.1371/journal.pone.0111072	http://dx.doi.org/10.1371/journal.pone.0111072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350665	Green Submitted, gold, Green Published			2022-12-27	WOS:000343943100054
J	Ek-Ramos, MJ; Avila, J; Dittrich, ACN; Su, D; Gray, JW; Devarenne, TP				Ek-Ramos, Maria J.; Avila, Julian; Dittrich, Anna C. Nelson; Su, Dongyin; Gray, Joel W.; Devarenne, Timothy P.			The Tomato Cell Death Suppressor Adi3 Is Restricted to the Endosomal System in Response to the Pseudomonas syringae Effector Protein AvrPto	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RECOGNITION RECEPTOR FLS2; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; DEPENDENT ENDOCYTOSIS; NUCLEAR TRAFFICKING; BAX INHIBITOR-1; HEAT-SHOCK; IN-VIVO; ARABIDOPSIS; KINASE	The tomato (Solanum lycopersicum) AGC protein kinase Adi3 functions as a suppressor of cell death and was first identified as an interactor with the tomato resistance protein Pto and the Pseudomonas syringae effector protein AvrPto. Models predict that loss of Adi3 cell death suppression (CDS) activity during Pto/AvrPto interaction leads to the cell death associated with the resistance response initiated from this interaction. Nuclear localization is required for Adi3 CDS. Prevention of nuclear accumulation eliminates Adi3 CDS and induces cell death by localizing Adi3 to intracellular punctate membrane structures. Here we use several markers of the endomembrane system to show that the punctate membrane structures to which non-nuclear Adi3 is localized are endosomal in nature. Wild-type Adi3 also localizes in these punctate endosomal structures. This was confirmed by the use of endosomal trafficking inhibitors, which were capable of trapping wild-type Adi3 in endosomal-like structures similar to the non-nuclear Adi3. This suggests Adi3 may traffic through the cell using the endomembrane system. Additionally, Adi3 was no longer found in the nucleus but was visualized in these punctate endosomal-like membranes during the cell death induced by the Pto/AvrPto interaction. Therefore we propose that inhibiting nuclear import and constraining Adi3 to the endosomal system in response to AvrPto is a mechanism to initiate the cell death associated with resistance.	[Ek-Ramos, Maria J.; Avila, Julian; Dittrich, Anna C. Nelson; Su, Dongyin; Gray, Joel W.; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Devarenne, TP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tpd8@tamu.edu	Ramos, Maria Julissa Ek/W-1017-2018	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Devarenne, Timothy/0000-0001-6032-8049; Avila, Julian/0000-0001-9388-3946	U.S. Department of Agriculture, Agriculture and Food Research Initiative [2010-65108-20526, 2014-67013-21560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	U.S. Department of Agriculture, Agriculture and Food Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. Department of Agriculture, Agriculture and Food Research Initiative, grant no. 2010-65108-20526 and 2014-67013-21560 to TPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Avila J, 2013, BIOCHEM BIOPH RES CO, V430, P119, DOI 10.1016/j.bbrc.2012.11.043; BAKER CJ, 1994, PLANT CELL TISS ORG, V39, P7, DOI 10.1007/BF00037585; Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Bogdanove AJ, 2000, P NATL ACAD SCI USA, V97, P8836, DOI 10.1073/pnas.97.16.8836; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Borlido J, 2009, TRAFFIC, V10, P1209, DOI 10.1111/j.1600-0854.2009.00922.x; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Choi SW, 2013, PLANT CELL, V25, P1174, DOI 10.1105/tpc.112.108803; Devarenne TP, 2007, PLANT SIGNAL BEHAV, V2, P188, DOI 10.4161/psb.2.3.4150; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Di Sansebastiano GP, 2014, INT J MOL SCI, V15, P4565, DOI 10.3390/ijms15034565; Ek-Ramos MJ, 2010, J BIOL CHEM, V285, P17584, DOI 10.1074/jbc.M110.117416; Frey NFD, 2009, CURR OPIN PLANT BIOL, V12, P437, DOI 10.1016/j.pbi.2009.06.002; Geldner N, 2004, PLANTA, V219, P547, DOI 10.1007/s00425-004-1302-x; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Gu YN, 2011, PLANT PHYSIOL, V155, P1827, DOI 10.1104/pp.110.171785; Henriksson ML, 2000, BIOCHEM J, V347, P217, DOI 10.1042/0264-6021:3470217; Irani NG, 2009, CURR OPIN PLANT BIOL, V12, P653, DOI 10.1016/j.pbi.2009.09.011; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kang HG, 2010, PLANT CELL, V22, P918, DOI 10.1105/tpc.109.071662; Kasai K, 2011, J BIOL CHEM, V286, P6175, DOI 10.1074/jbc.M110.184929; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Koukalova B, 1997, FEBS LETT, V414, P289, DOI 10.1016/S0014-5793(97)01008-9; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lam SK, 2007, TRENDS PLANT SCI, V12, P497, DOI 10.1016/j.tplants.2007.09.001; Leborgne-Castel N, 2010, PROTOPLASMA, V247, P177, DOI 10.1007/s00709-010-0195-8; Lee G.J., 2004, PLANT CELL PHYSIOL, V45, P1211, DOI 10.1093/pcp/pch142; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murphy JE, 2009, P NATL ACAD SCI US; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oh CS, 2011, TRENDS PLANT SCI, V16, P132, DOI 10.1016/j.tplants.2010.11.001; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Robatzek S, 2007, CELL MICROBIOL, V9, P1, DOI 10.1111/j.1462-5822.2006.00829.x; Robert HS, 2008, CURR OPIN PLANT BIOL, V11, P495, DOI 10.1016/j.pbi.2008.06.004; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Sharfman M, 2011, PLANT J, V68, P413, DOI 10.1111/j.1365-313X.2011.04696.x; Speth EB, 2009, PLANT PHYSIOL, V149, P1824, DOI 10.1104/pp.108.132092; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; van der Goot FG, 1997, ELECTROPHORESIS, V18, P2689, DOI 10.1002/elps.1150181426; van Gisbergen PAC, 2008, J MICROSC-OXFORD, V231, P284, DOI 10.1111/j.1365-2818.2008.02041.x; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Voigt B, 2005, EUR J CELL BIOL, V84, P609, DOI 10.1016/j.ejcb.2004.12.029; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Zhang Y, 2009, TRENDS PLANT SCI, V14, P689, DOI 10.1016/j.tplants.2009.09.006; Zuppini A, 2006, FUNCT PLANT BIOL, V33, P617, DOI 10.1071/FP06015	72	7	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110807	10.1371/journal.pone.0110807	http://dx.doi.org/10.1371/journal.pone.0110807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350368	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100042
J	Schilling, S; Fusco, FM; De Iaco, G; Bannister, B; Maltezou, HC; Carson, G; Gottschalk, R; Brodt, HR; Brouqui, P; Puro, V; Ippolito, G				Schilling, Stefan; Fusco, Francesco Maria; De Iaco, Giuseppina; Bannister, Barbara; Maltezou, Helena C.; Carson, Gail; Gottschalk, Rene; Brodt, Hans-Reinhard; Brouqui, Philippe; Puro, Vincenzo; Ippolito, Giuseppe		European Network Highly Infectious	Isolation Facilities for Highly Infectious Diseases in Europe - A Cross-Sectional Analysis in 16 Countries	PLOS ONE			English	Article							LEVEL ISOLATION UNITS; MANAGEMENT; NETWORK; CONSENSUS; CORONAVIRUS	Background: Highly Infectious Diseases (HIDs) are (i) easily transmissible form person to person; (ii) cause a life-threatening illness with no or few treatment options; and (iii) pose a threat for both personnel and the public. Hence, even suspected HID cases should be managed in specialised facilities minimizing infection risks but allowing state-of-the-art critical care. Consensus statements on the operational management of isolation facilities have been published recently. The study presented was set up to compare the operational management, resources, and technical equipment among European isolation facilities. Due to differences in geography, population density, and national response plans it was hypothesized that adherence to recommendations will vary. Methods and Findings: Until mid of 2010 the European Network for Highly Infectious Diseases conducted a cross-sectional analysis of isolation facilities in Europe, recruiting 48 isolation facilities in 16 countries. Three checklists were disseminated, assessing 44 items and 148 specific questions. The median feedback rate for specific questions was 97.9% (n = 47/48) (range: n = 7/48 (14.6%) to n = 48/48 (100%). Although all facilities enrolled were nominated specialised facilities' serving countries or regions, their design, equipment and personnel management varied. Eighteen facilities fulfilled the definition of a High Level Isolation Unit'. In contrast, 24 facilities could not operate independently from their co-located hospital, and five could not ensure access to equipment essential for infection control. Data presented are not representative for the EU in general, as only 16/27 (59.3%) of all Member States agreed to participate. Another limitation of this study is the time elapsed between data collection and publication; e. g. in Germany one additional facility opened in the meantime. Conclusion: There are disparities both within and between European countries regarding the design and equipment of isolation facilities. With regard to the International Health Regulations, terminology, capacities and equipment should be standardised.	[Schilling, Stefan] Staedt Kliniken Moenchengladbach, Dept Internal Med, Monchengladbach, Germany; [Fusco, Francesco Maria; Puro, Vincenzo; Ippolito, Giuseppe] Natl Inst Infect Dis Lazarro Spallanzani, Dept Infect Dis, Rome, Italy; [De Iaco, Giuseppina] Univ Osped Riuniti Marche, Azienda Osped, Dept Internal Med, Torrette, Italy; [Bannister, Barbara] Royal Free Hosp, Dept Infect Dis, London NW3 2QG, England; [Maltezou, Helena C.] Hellen Ctr Dis Control & Prevent, Dept Intervent Healthcare Facil, Athens, Greece; [Carson, Gail] Hlth Protect Agcy, Dept Rare & Imported Pathogens, Porton Down, England; [Gottschalk, Rene] Port Hlth Author, Dept Infect Dis, Frankfurt, Germany; [Brodt, Hans-Reinhard] Goethe Univ Frankfurt, Dept Infect Dis, D-60054 Frankfurt, Germany; [Brouqui, Philippe] Marseilles Univ, Dept Infect Dis & Trop Med, Marseille, France	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency; Goethe University Frankfurt; UDICE-French Research Universities; Aix-Marseille Universite	Schilling, S (corresponding author), Staedt Kliniken Moenchengladbach, Dept Internal Med, Monchengladbach, Germany.	stefan.schilling@kgu.de	Ippolito, Giuseppe/J-7207-2017; Brouqui, Philippe/P-5771-2016; Fusco, Francesco Maria/AFO-1279-2022; Lanini, Simone/C-7523-2012	Fusco, Francesco Maria/0000-0002-1293-5976; Lanini, Simone/0000-0002-6743-4001; Ippolito, Giuseppe/0000-0002-1076-2979; puro, vincenzo/0000-0003-0291-4490; Gottschalk, Professor M. D., Ph. D, Rene/0000-0003-0422-6456	European Commission/DG SANCO under the EU [2006205]	European Commission/DG SANCO under the EU	The "European Network for Highly Infectious Diseases - EuroNHID" is co-funded by the European Commission/DG SANCO under the EU contract number 2006205. Neither the Commission nor DG SANCO had an influence on the study design, data collection, or interpretation of results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin S, 2009, EUROSURVEILLANCE, V14; Baka A, 2007, Euro Surveill, V12, pE5; Bannister B, 2009, LANCET INFECT DIS, V9, P45, DOI 10.1016/S1473-3099(08)70304-9; Barr DA, 2013, LANCET, V382, P1458, DOI 10.1016/S0140-6736(13)61718-3; Bork KH, 2006, EURO SURVEILL, V11; Brouqui P, 2009, LANCET INFECT DIS, V9, P301, DOI 10.1016/S1473-3099(09)70070-2; Danielsson N, 2012, EUROSURVEILLANCE, V17, P9; De Iaco G, 2012, INFECT CONT HOSP EP, V33, P1008, DOI 10.1086/667729; Drosten C, 2003, TRENDS MOL MED, V9, P325, DOI 10.1016/S1471-4914(03)00133-3; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; European Commission, 1989, OFFICIAL J, V183; Fusco FM, 2009, J HOSP INFECT, V73, P15, DOI 10.1016/j.jhin.2009.06.009; Fusco FM, 2009, CLIN MICROBIOL INFEC, V15, P711, DOI 10.1111/j.1469-0691.2009.02874.x; Fusco FM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-27; Gunther S, 2011, J INFECT DIS, V204, pS785, DOI 10.1093/infdis/jir298; Kaji AH, 2007, JAMA-J AM MED ASSOC, V298, P2188, DOI 10.1001/jama.298.18.2188; Kitching A, 2009, EUROSURVEILLANCE, V14; Maltezou HC, 2012, J HOSP INFECT, V81, P184, DOI 10.1016/j.jhin.2012.04.019; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Nisii C, 2009, CLIN MICROBIOL INFEC, V15, P720, DOI 10.1111/j.1469-0691.2009.02946.x; Rodier G, 2006, EURO SURVEILL, V11; Schilling S, 2019, CLIN MICROBIOL INFEC, V21, pE1, DOI 10.1111/1469-0691.12290; Smith PW, 2006, BIOSECUR BIOTERROR, V4, P351, DOI 10.1089/bsp.2006.4.351; Thiberville Simon-Djamel, 2012, BMC Res Notes, V5, P527, DOI 10.1186/1756-0500-5-527; U.S. Department of Health and Human Services, 2005, NAT BIOT HOSP PERP P; van Paassen J, 2012, LANCET INFECT DIS, V12, P635, DOI 10.1016/S1473-3099(12)70018-X; World Health Organization Regional Office for Europe, 2012, ASS HEATH SYST CRIS; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	28	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e100401	10.1371/journal.pone.0100401	http://dx.doi.org/10.1371/journal.pone.0100401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350843	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100002
J	Zhang, YH; Wang, YF; Yu, SX				Zhang, Yuhua; Wang, Yongfan; Yu, Shixiao			Interspecific Neighbor Interactions Promote the Positive Diversity-Productivity Relationship in Experimental Grassland Communities	PLOS ONE			English	Article							FITNESS DIFFERENCES RELATE; PLANT DIVERSITY; SPECIES RICHNESS; ECOSYSTEM FUNCTION; BIODIVERSITY; COMPETITION; COMPLEMENTARITY; MAINTENANCE; SELECTION; PATTERNS	Because the frequency of heterospecific interactions inevitably increases with species richness in a community, biodiversity effects must be expressed by such interactions. However, little is understood how heterospecific interactions affect ecosystem productivity because rarely are biodiversity ecosystem functioning experiments spatially explicitly manipulated. To test the effect of heterospecific interactions on productivity, direct evidence of heterospecific neighborhood interaction is needed. In this study we conducted experiments with a detailed spatial design to investigate whether and how heterospecific neighborhood interactions promote primary productivity in a grassland community. The results showed that increasing the heterospecific: conspecific contact ratio significantly increased productivity. We found there was a significant difference in the variation in plant height between monoculture and mixture communities, suggesting that height-asymmetric competition for light plays a central role in promoting productivity. Heterospecific interactions make tall plants grow taller and short plants become smaller in mixtures compared to monocultures, thereby increasing the efficiency of light interception and utilization. Overyielding in the mixture communities arises from the fact that the loss in the growth of short plants is compensated by the increased growth of tall plants. The positive correlation between species richness and primary production was strengthened by increasing the frequency of heterospecific interactions. We conclude that species richness significantly promotes primary ecosystem production through heterospecific neighborhood interactions.	[Zhang, Yuhua; Wang, Yongfan; Yu, Shixiao] Sun Yat Sen Univ, Dept Ecol, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, YF (corresponding author), Sun Yat Sen Univ, Dept Ecol, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsswyf@mail.sysu.edu.cn		Yu, Shixiao/0000-0003-1943-0185	National Natural Science Foundation of China [30970472, 31230013]; Zhang-Hongda Science Foundation in Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhang-Hongda Science Foundation in Sun Yat-sen University	The research was funded by the National Natural Science Foundation of China (Project 30970472, 31230013) and by the Zhang-Hongda Science Foundation in Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Carroll IT, 2011, ECOLOGY, V92, P1157; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M, 2012, ECOLOGY, V93, P1482; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Potvin C, 2009, ECOLOGY, V90, P321, DOI 10.1890/08-0353.1; Sapijanskas J, 2013, ECOLOGY, V94, P941, DOI 10.1890/12-0337.1; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stoll P, 2001, ECOLOGY, V82, P319, DOI 10.1890/0012-9658(2001)082[0319:IAACII]2.0.CO;2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Wang YF, 2007, ECOL LETT, V10, P401, DOI 10.1111/j.1461-0248.2007.01031.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Yachi S, 2007, ECOL LETT, V10, P54, DOI 10.1111/j.1461-0248.2006.00994.x	34	6	6	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e111434	10.1371/journal.pone.0111434	http://dx.doi.org/10.1371/journal.pone.0111434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	25350670	Green Submitted, Green Published, gold			2022-12-27	WOS:000343943100072
J	Zhang, XX; Wang, GJ; Gurley, EC; Zhou, HP				Zhang, Xiaoxuan; Wang, Guangji; Gurley, Emily C.; Zhou, Huiping			Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response through Multiple Mechanisms in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASES; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; IL-6 PRODUCTION; POSTTRANSCRIPTIONAL REGULATION; CANCER CHEMOPREVENTION; SIGNALING PATHWAYS; NATURAL-PRODUCTS; RAW264.7 CELLS	Background: Apigenin is a non-toxic natural flavonoid that is abundantly present in common fruits and vegetables. It has been reported that apigenin has various beneficial health effects such as anti-inflammation and chemoprevention. Multiple studies have shown that inflammation is an important risk factor for atherosclerosis, diabetes, sepsis, various liver diseases, and other metabolic diseases. Although it has been long realized that apigenin has anti-inflammatory activities, the underlying functional mechanisms are still not fully understood. Methodology and Principal Findings: In the present study, we examined the effect of apigenin on LPS-induced inflammatory response and further elucidated the potential underlying mechanisms in human THP-1-induced macrophages and mouse J774A.1 macrophages. By using the PrimePCR array, we were able to identify the major target genes regulated by apigenin in LPS-mediated immune response. The results indicated that apigenin significantly inhibited LPS-induced production of pro-inflammatory cytokines, such as IL-6, IL-1 beta, and TNF-alpha through modulating multiple intracellular signaling pathways in macrophages. Apigenin inhibited LPS-induced IL-1 beta production by inhibiting caspase-1 activation through the disruption of the NLRP3 inflammasome assembly. Apigenin also prevented LPS-induced IL-6 and IL-1 beta production by reducing the mRNA stability via inhibiting ERK1/2 activation. In addition, apigenin significantly inhibited TNF-alpha and IL-1 beta-induced activation of NF-kappa B. Conclusion and Significance: Apigenin Inhibits LPS-induced Inflammatory Response through multiple mechanisms in macrophages. These results provided important scientific evidences for the potential application of apigenin as a therapeutic agent for inflammatory diseases.	[Zhang, Xiaoxuan; Wang, Guangji] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaoxuan; Gurley, Emily C.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Zhou, Huiping] Dept Internal Med Gastroenterol, Richmond, VA USA; [Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Zhou, Huiping] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China	China Pharmaceutical University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Wenzhou Medical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhou, Huiping/H-6875-2019; Zhou, Huiping/J-3639-2015; Suinesiaputra, Avan/W-6730-2019; Bluemke, David/GYU-8169-2022	Zhou, Huiping/0000-0002-0050-372X; Lee, Daniel/0000-0001-9447-4175; Suinesiaputra, Avan/0000-0003-1165-458X; Medrano-Gracia, Pau/0000-0002-6255-4864; Young, Alistair/0000-0001-5702-4220; Zhang, Xingyu/0000-0001-8108-1997; Bluemke, David/0000-0002-8323-8086	NIH [R01 DK-057543, R01AT004148]; VA Merit Award [1I01BX001390]; National Science Foundation of China [81070245, 81270489, 81273589, 81202591]; Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics [NM2012012]; Project for international S&T cooperation program of China [2011DFG333380]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics; Project for international S&T cooperation program of China; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants R01 DK-057543 and R01AT004148, VA Merit Award 1I01BX001390, National Science Foundation of China Grants (81070245, 81270489, 81273589, and 81202591), Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics (NM2012012), and Project for international S&T cooperation program of China (2011DFG333380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen R, 2014, MOL VIS, V20, P242; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Costa SS, 2012, EXPERT OPIN THER PAT, V22, P1111, DOI 10.1517/13543776.2012.724062; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Desai P, 2011, EUR J IMMUNOL, V41, P1764, DOI 10.1002/eji.201040932; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duarte S, 2013, INT J MOL SCI, V14, P17664, DOI 10.3390/ijms140917664; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Galleano M, 2012, ANN NY ACAD SCI, V1259, P87, DOI 10.1111/j.1749-6632.2012.06511.x; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Han JM, 2010, BIOL PHARM BULL, V33, P1019, DOI 10.1248/bpb.33.1019; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041383; Izzi V, 2012, FRONT BIOSCI-LANDMRK, V17, P2396, DOI 10.2741/4061; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Johnson JL, 2013, MOL NUTR FOOD RES, V57, P2112, DOI 10.1002/mnfr.201300307; Kim AR, 2005, ARCH PHARM RES, V28, P297, DOI 10.1007/BF02977796; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Kim Seewan, 2011, Chonnam Med J, V47, P104, DOI 10.4068/cmj.2011.47.2.104; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Koga T, 2011, CLIN EXP RHEUMATOL, V29, P906; Kowalski J, 2005, PHARMACOL REP, V57, P390; Li RR, 2010, IMMUNOPHARM IMMUNOT, V32, P364, DOI 10.3109/08923970903420566; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Mulvihill Erin E., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P84; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Nurmi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078537; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Park EJ, 2012, ANTI-CANCER AGENT ME, V12, P836, DOI 10.2174/187152012802650075; Patel D, 2007, INT J ONCOL, V30, P233; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; RAMBALDI A, 1993, BRIT J HAEMATOL, V83, P204, DOI 10.1111/j.1365-2141.1993.tb08273.x; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Romano B, 2013, PHYTOTHER RES, V27, P1588, DOI 10.1002/ptr.5023; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X; Sharma H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091588; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Sucher NJ, 2013, EXPERT OPIN DRUG DIS, V8, P21, DOI 10.1517/17460441.2013.739602; Takano-Ishikawa Y, 2006, PHYTOMEDICINE, V13, P310, DOI 10.1016/j.phymed.2005.01.016; Tanaka T, 2013, NUTRIENTS, V5, P2128, DOI 10.3390/nu5062128; Wang J, 2012, INFLAMMATION, V35, P1466, DOI 10.1007/s10753-012-9460-7; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Weiss U, 2008, NATURE, V454, P427, DOI 10.1038/454427a; Xagorari A, 2002, BRIT J PHARMACOL, V136, P1058, DOI 10.1038/sj.bjp.0704803; Xie CH, 2012, J NUTR BIOCHEM, V23, P1184, DOI 10.1016/j.jnutbio.2011.06.013; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang AH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257909; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008	64	123	132	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107072	10.1371/journal.pone.0107072	http://dx.doi.org/10.1371/journal.pone.0107072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25360520	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600095
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
